Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
LCRB, 30-KB DEL	HBB-LCR		Thalassemia, gamma-delta-beta	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000014445					14445	29484		
NM_024650.3(C11orf80):c.783dup (p.Glu262Ter)	C11orf80		HYDATIDIFORM MOLE, RECURRENT, 4	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000627625	11	66568510 - 66568511	11	66801039 - 66801040	627625	615980	rs779402951	NC_000011.10:66801039:T:TT
NM_152222.2(RELT):c.121-2A>G	RELT		AMELOGENESIS IMPERFECTA, TYPE IIIC	Pathogenic(Last reviewed: Apr 11, 2019)	no assertion criteria provided	VCV000625370	11	73101798	11	73390753	625370	613732	rs1565222166	NC_000011.10:73390752:A:G
NM_152222.2(RELT):c.1265G>C (p.Arg422Pro)	RELT	R422P	AMELOGENESIS IMPERFECTA, TYPE IIIC	Pathogenic(Last reviewed: Apr 11, 2019)	no assertion criteria provided	VCV000625369	11	73106508	11	73395463	625369	613731	rs762816338	NC_000011.10:73395462:G:C
NM_152222.2(RELT):c.1169_1170del (p.Pro390fs)	RELT	P390fs	AMELOGENESIS IMPERFECTA, TYPE IIIC	Pathogenic(Last reviewed: Apr 11, 2019)	no assertion criteria provided	VCV000625368	11	73106254 - 73106255	11	73395209 - 73395210	625368	613730	rs772929908	NC_000011.10:73395208:CT:
NM_013265.4(VPS51):c.1421_1423del (p.Phe474del)	VPS51	F474del	PONTOCEREBELLAR HYPOPLASIA, TYPE 13	Pathogenic(Last reviewed: Oct 2, 2019)	no assertion criteria provided	VCV000691590	11	64876362 - 64876364	11	65108890 - 65108892	691590	679290		NC_000011.10:65108889:CTTCT:CT
NM_013265.4(VPS51):c.1468C>T (p.Arg490Cys)	VPS51	R490C	PONTOCEREBELLAR HYPOPLASIA, TYPE 13	Pathogenic(Last reviewed: Oct 2, 2019)	no assertion criteria provided	VCV000691589	11	64876776	11	65109304	691589	679289		NC_000011.10:65109303:C:T
NM_013265.4(VPS51):c.2232del (p.Asp745fs)	VPS51	D745fs	PONTOCEREBELLAR HYPOPLASIA, TYPE 13	Pathogenic(Last reviewed: Oct 2, 2019)	no assertion criteria provided	VCV000691588	11	64878941	11	65111469	691588	679288		NC_000011.10:65111468:CC:C
NM_207341.3(ZP1):c.1775-8T>C	ZP1		Oocyte maturation defect 1	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689406	11	60642979	11	60875506	689406	676998		NC_000011.10:60875505:T:C
NM_207341.3(ZP1):c.1430+1G>T	ZP1		Oocyte maturation defect 1	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689405	11	60641038	11	60873565	689405	676997		NC_000011.10:60873564:G:T
NM_207341.3(ZP1):c.1708G>A (p.Val570Met)	ZP1	V570M	Oocyte maturation defect 1	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689404	11	60642655	11	60875182	689404	676996		NC_000011.10:60875181:G:A
NM_006268.5(DPF2):c.1099+1G>A	DPF2		COFFIN-SIRIS SYNDROME 7	Pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	VCV000545686	11	65116403	11	65348932	545686	536178	rs1555032074	NC_000011.10:65348931:G:A
NM_006268.5(DPF2):c.1037A>G (p.Asp346Gly)	DPF2	D346G, D360G	COFFIN-SIRIS SYNDROME 7	Pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	VCV000545685	11	65116340	11	65348869	545685	536177	rs1555032044	NC_000011.10:65348868:A:G
NM_006268.5(DPF2):c.1049G>A (p.Arg350His)	DPF2	R350H, R364H	COFFIN-SIRIS SYNDROME 7	Pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	VCV000545684	11	65116352	11	65348881	545684	536176	rs1555032051	NC_000011.10:65348880:G:A
NM_006268.5(DPF2):c.990C>G (p.Cys330Trp)	DPF2	C330W, C344W	COFFIN-SIRIS SYNDROME 7	Pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	VCV000545683	11	65113803	11	65346332	545683	536175	rs1555031500	NC_000011.10:65346331:C:G
NM_207341.3(ZP1):c.1169_1176del (p.Ile390fs)	ZP1	I390fs	Oocyte maturation defect 1	Pathogenic(Last reviewed: Mar 27, 2014)	no assertion criteria provided	VCV000127200	11	60640688 - 60640695	11	60873215 - 60873222	127200	132683	rs587777362	NC_000011.10:60873214:CCATTTTCCCA:CCA
NM_006268.5(DPF2):c.827G>T (p.Cys276Phe)	DPF2	C276F, C290F	Coffin-Siris syndrome 1|COFFIN-SIRIS SYNDROME 7	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000438643	11	65113452	11	65345981	438643	432263	rs1555031372	NC_000011.10:65345980:G:T
NM_181336.4(LEMD2):c.38T>G (p.Leu13Arg)	LEMD2	L13R	Cataract Hutterite type	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	VCV000235192	6	33756856	6	33789079	235192	236890	rs878852983	NC_000006.12:33789078:A:C
NM_001017361.3(KHDC3L):c.299_302del (p.Ile100fs)	KHDC3L	I100fs	Hydatidiform mole, recurrent, 2	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000157611	6	74072944 - 74072947	6	73363221 - 73363224	157611	167471	rs606231286	NC_000006.12:73363220:CAATCAA:CAA
NM_001017361.3(KHDC3L):c.1A>G (p.Met1Val)	KHDC3L	M1V	Hydatidiform mole, recurrent, 2	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000030928	6	74072453	6	73362730	30928	39885	rs606231235	NC_000006.12:73362729:A:G
MS4A1, IVS5DS, 11-BP INS AND 2-BP DEL	MS4A1		Common variable immunodeficiency 5	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000017705					17705	32744		
NM_001017361.3(KHDC3L):c.3G>T (p.Met1Ile)	KHDC3L	M1I	Hydatidiform mole, recurrent, 2	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000030926	6	74072455	6	73362732	30926	39883	rs606231233	NC_000006.12:73362731:G:T
NM_001144869.3(LIPT2):c.377T>G (p.Leu126Arg)	LIPT2	L126R	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000438639	11	74204372	11	74493327	438639	432260	rs753904927	NC_000011.10:74493326:A:C
NM_001017361.3(KHDC3L):c.322_325del (p.Asp108fs)	KHDC3L	D108fs	Hydatidiform mole, recurrent, 2	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000030927	6	74072968 - 74072971	6	73363245 - 73363248	30927	39884	rs606231234	NC_000006.12:73363244:CTGACT:CT
NM_002716.5(PPP2R1B):c.269G>A (p.Gly90Asp)	PPP2R1B	G90D	Lung cancer	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000006621	11	111635566	11	111764842	6621	21660	rs1805076	NC_000011.10:111764841:C:T
NM_017868.4(TTC12):c.1700T>G (p.Met567Arg)	TTC12	M567R, M542R, M568R, M573R	CILIARY DYSKINESIA, PRIMARY, 45	Pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000816693	11	113233208	11	113362486	816693	804899		NC_000011.10:113362485:T:G
NM_017868.4(TTC12):c.607del (p.Glu202_Ile203insTer)	TTC12		CILIARY DYSKINESIA, PRIMARY, 45	Pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000816692	11	113209524	11	113338802	816692	804898		NC_000011.10:113338801:AAA:AA
NM_017868.4(TTC12):c.1678C>T (p.Arg560Ter)	TTC12	R560*, R535*, R561*, R566*	CILIARY DYSKINESIA, PRIMARY, 45	Pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000816691	11	113233186	11	113362464	816691	804897		NC_000011.10:113362463:C:T
NM_017868.4(TTC12):c.1614+3A>T	TTC12		CILIARY DYSKINESIA, PRIMARY, 45	Pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000816690	11	113230733	11	113360011	816690	804896		NC_000011.10:113360010:A:T
NM_173348.2(FAM149B1):c.439C>T (p.Gln147Ter)	FAM149B1	Q1147*, Q147*	JOUBERT SYNDROME 36	Pathogenic(Last reviewed: Feb 4, 2020)	no assertion criteria provided	VCV000810830	10	74953248	10	73193490	810830	799079		NC_000010.11:73193489:C:T
NM_173348.2(FAM149B1):c.356_357del (p.Lys119fs)	FAM149B1	K119fs	JOUBERT SYNDROME 36	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000810829	10	74952387 - 74952388	10	73192629 - 73192630	810829	799078		NC_000010.11:73192628:AG:
NM_198947.4(FAM111B):c.1874C>A (p.Thr625Asn)	FAM111B	T625N, T595N	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000265955	11	58893444	11	59125971	265955	260669	rs886039852	NC_000011.10:59125970:C:A
NM_198947.4(FAM111B):c.1289A>C (p.Gln430Pro)	FAM111B	Q430P, Q400P	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000265954	11	58892859	11	59125386	265954	260668	rs551644836	NC_000011.10:59125385:A:C
NM_198947.4(FAM111B):c.1262_1264del (p.Lys421del)	FAM111B	K421del, K391del	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000265953	11	58892831 - 58892833	11	59125358 - 59125360	265953	260667	rs886039851	NC_000011.10:59125357:AAGA:A
NM_021814.5(ELOVL5):c.214C>G (p.Leu72Val)	ELOVL5	L72V	Spinocerebellar ataxia 38	Pathogenic(Last reviewed: Jul 8, 2019)	no assertion criteria provided	VCV000144076	6	53156606	6	53291808	144076	153827	rs587777671	NC_000006.12:53291807:G:C
NM_021814.5(ELOVL5):c.689G>T (p.Gly230Val)	ELOVL5	G230V, G257V, W188C	Spinocerebellar ataxia 38	Pathogenic(Last reviewed: Jul 8, 2019)	no assertion criteria provided	VCV000144075	6	53135458	6	53270660	144075	153826	rs587777670	NC_000006.12:53270659:C:A
NM_198947.4(FAM111B):c.1883G>A (p.Ser628Asn)	FAM111B	S628N, S598N	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000120219	11	58893453	11	59125980	120219	125816	rs587777238	NC_000011.10:59125979:G:A
NM_198947.4(FAM111B):c.1879A>G (p.Arg627Gly)	FAM111B	R627G, R597G	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000120218	11	58893449	11	59125976	120218	125815	rs587777237	NC_000011.10:59125975:A:G
NM_198947.4(FAM111B):c.1861T>G (p.Tyr621Asp)	FAM111B	Y621D, Y591D	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000120217	11	58893431	11	59125958	120217	125814	rs587777236	NC_000011.10:59125957:T:G
NM_002079.3(GOT1):c.1165_1167del (p.Asn389del)	GOT1	N389del	Aspartate aminotransferase, serum level of, quantitative trait locus 1	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000029724	10	101157379 - 101157381	10	99397622 - 99397624	29724	38679		NC_000010.11:99397621:GTTG:G
NM_005169.4(PHOX2A):c.215C>T (p.Ala72Val)	PHOX2A	A72V	Fibrosis of extraocular muscles, congenital, 2	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006840	11	71954834	11	72243790	6840	21879	rs104894269	NC_000011.10:72243789:G:A
NM_005169.4(PHOX2A):c.406-1G>A	PHOX2A		Fibrosis of extraocular muscles, congenital, 2	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006839	11	71951243	11	72240199	6839	21878		NC_000011.10:72240198:C:T
NM_005169.4(PHOX2A):c.217+1G>A	PHOX2A		Fibrosis of extraocular muscles, congenital, 2	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006838	11	71954831	11	72243787	6838	21877		NC_000011.10:72243786:C:T
NM_138775.3(ALKBH8):c.1785del (p.Trp596fs)	ALKBH8	W596fs, W599fs	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000636272	11	107375594	11	107504868	636272	624084		NC_000011.10:107504867:GGG:GG
NM_138775.3(ALKBH8):c.1651C>T (p.Arg551Ter)	ALKBH8	R554*, R551*	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000636271	11	107375728	11	107505002	636271	624083		NC_000011.10:107505001:G:A
NM_015221.4(DNMBP):c.2852_2855del (p.Thr951fs)	DNMBP	T951fs, T239fs, T583fs	CATARACT 48	Pathogenic(Last reviewed: May 6, 2019)	no assertion criteria provided	VCV000626919	10	101657908 - 101657911	10	99898151 - 99898154	626919	615272	rs1564723150	NC_000010.11:99898150:TTGGTT:TT
NM_015221.4(DNMBP):c.2947_2948del (p.Glu982_Asp983insTer)	DNMBP		CATARACT 48	Pathogenic(Last reviewed: May 6, 2019)	no assertion criteria provided	VCV000626918	10	101656127 - 101656128	10	99896370 - 99896371	626918	615271	rs1564722302	NC_000010.11:99896369:TCT:T
NM_005004.4(NDUFB8):c.184T>C (p.Tyr62His)	NDUFB8	Y62H, Y31H	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000548134	10	102289165	10	100529408	548134	538620	rs1554843434	NC_000010.11:100529407:A:G
NM_005004.4(NDUFB8):c.189del (p.Glu63fs)	NDUFB8	E32fs, E63fs	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000548133	10	102289160	10	100529403	548133	538619	rs1264186261	NC_000010.11:100529402:TT:T
NM_005004.4(NDUFB8):c.432C>G (p.Cys144Trp)	NDUFB8	C144W, C113W	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000548132	10	102286192	10	100526435	548132	538618	rs1554843251	NC_000010.11:100526434:G:C
NM_005004.4(NDUFB8):c.227C>A (p.Pro76Gln)	NDUFB8	P76Q, P45Q	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000548131	10	102286817	10	100527060	548131	538617	rs1239013578	NC_000010.11:100527059:G:T
CPN1, 1-BP INS, 385G	CPN1		Anaphylotoxin inactivator deficiency	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000006622					6622	21661		
NM_019096.5(GTPBP2):c.1408C>T (p.Arg470Ter)	GTPBP2	R470*, R382*	JABERI-ELAHI SYNDROME	Pathogenic(Last reviewed: May 22, 2018)	no assertion criteria provided	VCV000544689	6	43590429	6	43622692	544689	535234	rs1007812513	NC_000006.12:43622691:G:A
NM_019096.5(GTPBP2):c.1219C>T (p.Gln407Ter)	GTPBP2	Q407*, Q319*	JABERI-ELAHI SYNDROME	Pathogenic(Last reviewed: May 22, 2018)	no assertion criteria provided	VCV000544688	6	43591687	6	43623950	544688	535233	rs1554143448	NC_000006.12:43623949:G:A
NM_019096.5(GTPBP2):c.430C>T (p.Arg144Ter)	GTPBP2	R144*, R56*	JABERI-ELAHI SYNDROME	Pathogenic(Last reviewed: May 22, 2018)	no assertion criteria provided	VCV000544687	6	43593570	6	43625833	544687	535232	rs1554143844	NC_000006.12:43625832:G:A
NM_019096.5(GTPBP2):c.1237-1G>T	GTPBP2		JABERI-ELAHI SYNDROME	Pathogenic(Last reviewed: May 23, 2018)	no assertion criteria provided	VCV000544686	6	43591533	6	43623796	544686	535231	rs1554143424	NC_000006.12:43623795:C:A
NM_032930.3(CFAP300):c.200del (p.Phe67fs)	CFAP300	F67fs	Ciliary dyskinesia, primary, 38	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000807552	11	101929613	11	102058882	807552	798630		NC_000011.10:102058881:TTTTTT:TTTTT
NM_032930.3(CFAP300):c.198_200delinsCC (p.Phe67fs)	CFAP300		Ciliary dyskinesia, primary, 38	Pathogenic(Last reviewed: Jul 31, 2018)	no assertion criteria provided	VCV000549862	11	101929616 - 101929618	11	102058885 - 102058887	549862	540587	rs1555069023	NC_000011.10:102058884:TTT:CC
NM_032930.3(CFAP300):c.433A>T (p.Arg145Ter)	CFAP300	R145*	Ciliary dyskinesia, primary, 38	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000549861	11	101937380	11	102066649	549861	540586	rs754773453	NC_000011.10:102066648:A:T
NM_032930.3(CFAP300):c.154C>T (p.Gln52Ter)	CFAP300	Q52*	Ciliary dyskinesia, primary, 38	Pathogenic(Last reviewed: Jul 31, 2018)	no assertion criteria provided	VCV000549860	11	101918589	11	102047858	549860	540585	rs767760877	NC_000011.10:102047857:C:T
NM_032930.3(CFAP300):c.776A>G (p.His259Arg)	CFAP300	H259R, H235R	Ciliary dyskinesia, primary, 38	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000549858	11	101953902	11	102083171	549858	540583	rs1555071691	NC_000011.10:102083170:A:G
NM_020999.4(NEUROG3):c.162C>A (p.Cys54Ter)	NEUROG3	C54*	Diarrhea 4, malabsorptive, congenital	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000435975	10	71332638	10	69572882	435975	429123	rs1461650439	NC_000010.11:69572881:G:T
NM_052961.4(SLC26A8):c.2860C>T (p.Arg954Cys)	SLC26A8	R954C, R849C	Spermatogenic failure 3	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050911	6	35911730	6	35943953	50911	65573	rs398123027	NC_000006.12:35943952:G:A
NM_052961.4(SLC26A8):c.2434G>A (p.Glu812Lys)	SLC26A8	E812K, E707K	Spermatogenic failure 3	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050910	6	35918978	6	35951201	50910	65572	rs142724470	NC_000006.12:35951200:C:T
NM_052961.4(SLC26A8):c.260G>A (p.Arg87Gln)	SLC26A8	R87Q	Spermatogenic failure 3	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050909	6	35980078	6	36012301	50909	65571	rs140210148	NC_000006.12:36012300:C:T
NM_020999.4(NEUROG3):c.278G>T (p.Arg93Leu)	NEUROG3	R93L	Diarrhea 4, malabsorptive, congenital	Pathogenic(Last reviewed: Jul 20, 2006)	no assertion criteria provided	VCV000005323	10	71332522	10	69572766	5323	20362	rs121917838	NC_000010.11:69572765:C:A
NM_020999.4(NEUROG3):c.319C>A (p.Arg107Ser)	NEUROG3	R107S	Diarrhea 4, malabsorptive, congenital	Pathogenic(Last reviewed: Jul 20, 2006)	no assertion criteria provided	VCV000005322	10	71332481	10	69572725	5322	20361	rs121917837	NC_000010.11:69572724:G:T
NM_032930.3(CFAP300):c.361C>T (p.Arg121Ter)	CFAP300	R121*	Ciliary dyskinesia, primary, 38	Pathogenic(Last reviewed: Jul 31, 2018)	no assertion criteria provided	VCV000549859	11	101937308	11	102066577	549859	540584	rs561237622	NC_000011.10:102066576:C:T
NM_004311.4(ARL3):c.296G>T (p.Arg99Ile)	ARL3	R99I	Progressive cone degeneration	Pathogenic	no assertion criteria provided	VCV000617788	10	104449669	10	102689912	617788	609185		NC_000010.11:102689911:C:A
NM_018161.5(NADSYN1):c.1839C>G (p.Tyr613Ter)	NADSYN1	Y613*	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3	Pathogenic(Last reviewed: Apr 10, 2020)	no assertion criteria provided	VCV000834715	11	71208603	11	71497557	834715	853056		NC_000011.10:71497556:C:G
NM_018161.5(NADSYN1):c.735T>A (p.Cys245Ter)	NADSYN1	C245*	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3	Pathogenic(Last reviewed: Apr 10, 2020)	no assertion criteria provided	VCV000834713	11	71185509	11	71474463	834713	853055		NC_000011.10:71474462:T:A
NM_018161.5(NADSYN1):c.1819del (p.Val607fs)	NADSYN1	V607fs	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3	Pathogenic(Last reviewed: Apr 10, 2020)	no assertion criteria provided	VCV000834711	11	71208582	11	71497536	834711	853054		NC_000011.10:71497535:GG:G
NM_018161.5(NADSYN1):c.1717G>A (p.Ala573Thr)	NADSYN1	A573T	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3	Pathogenic(Last reviewed: Apr 10, 2020)	no assertion criteria provided	VCV000834710	11	71202902	11	71491856	834710	853053		NC_000011.10:71491855:G:A
NM_004311.4(ARL3):c.445C>T (p.Arg149Cys)	ARL3	R149C	JOUBERT SYNDROME 35	Pathogenic(Last reviewed: Oct 30, 2018)	no assertion criteria provided	VCV000587372	10	104445629	10	102685872	587372	578329	rs776901858	NC_000010.11:102685871:G:A
NM_012250.6(RRAS2):c.68G>T (p.Gly23Val)	RRAS2	G23V	Noonan syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000626911	11	14380349	11	14358803	626911	615266		NC_000011.10:14358802:C:A
NM_012250.6(RRAS2):c.65_73dup (p.Gly22_Gly24dup)	RRAS2		Noonan syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000626910	11	14380343 - 14380344	11	14358797 - 14358798	626910	615265		NC_000011.10:14358797:CGCCGCCCCCGCCG:CGCCGCCCCCGCCGCCCCCGCCG
NM_032131.6(ARMC2):c.421C>T (p.Gln141Ter)	ARMC2	Q141*	Male infertility with teratozoospermia due to single gene mutation|SPERMATOGENIC FAILURE 38	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000627631	6	109190156	6	108868953	627631	615986	rs1562332833	NC_000006.12:108868952:C:T
NM_032131.6(ARMC2):c.2353_2354del (p.Leu785fs)	ARMC2	L620fs, L785fs	Male infertility with teratozoospermia due to single gene mutation|SPERMATOGENIC FAILURE 38	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000627629	6	109286249 - 109286250	6	108965046 - 108965047	627629	615984	rs1562436860	NC_000006.12:108965045:TTT:T
NM_032131.6(ARMC2):c.2279T>A (p.Ile760Asn)	ARMC2	I760N, I595N	Male infertility with teratozoospermia due to single gene mutation|SPERMATOGENIC FAILURE 38	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000627628	6	109285509	6	108964306	627628	615983	rs1562435988	NC_000006.12:108964305:T:A
NM_012250.6(RRAS2):c.208G>A (p.Ala70Thr)	RRAS2	A35T, A70T	NOONAN SYNDROME 12|Noonan syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000626912	11	14316397	11	14294851	626912	615263		NC_000011.10:14294850:C:T
NM_213606.4(SLC16A12):c.733C>T (p.Gln245Ter)	SLC16A12	Q215*, Q245*	Cataract, juvenile, with microcornea and glucosuria	Pathogenic(Last reviewed: Aug 29, 2011)	no assertion criteria provided	VCV000000784	10	91198656	10	89438899	784	15823	rs121909386	NC_000010.11:89438898:G:A
NM_032131.6(ARMC2):c.1023+1G>A	ARMC2		Male infertility with teratozoospermia due to single gene mutation|SPERMATOGENIC FAILURE 38|Sperm tail anomaly	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000617790	6	109225609	6	108904406	617790	609187	rs1562372417	NC_000006.12:108904405:G:A
NM_012250.6(RRAS2):c.70_78dup (p.Gly24_Gly26dup)	RRAS2		NOONAN SYNDROME 12|Noonan syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000626913	11	14380338 - 14380339	11	14358792 - 14358793	626913	615264		NC_000011.10:14358792:GCCCACGCCGCCC:GCCCACGCCGCCCACGCCGCCC
NM_001206427.2(ATP5MD):c.87+1G>C	ATP5MD		MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6	Pathogenic(Last reviewed: Dec 2, 2019)	no assertion criteria provided	VCV000694833	10	105152127	10	103392370	694833	682950		NC_000010.11:103392369:C:G
NM_002645.3(PIK3C2A):c.(?_1-1)_4007+1_4008-1)del	PIK3C2A		OCULOSKELETODENTAL SYNDROME	Pathogenic(Last reviewed: May 21, 2019)	no assertion criteria provided	VCV000631522					631522	619909		
NM_032810.3(ATAD1):c.1070_1071del (p.His357fs)	ATAD1	H238fs, H357fs, H327fs	HYPEREKPLEXIA 4	Pathogenic(Last reviewed: Jun 8, 2018)	no assertion criteria provided	VCV000545496	10	89514459 - 89514460	10	87754702 - 87754703	545496	535757	rs751499706	NC_000010.11:87754701:AT:
NM_017633.3(TENT5A):c.692A>G (p.Asp231Gly)	TENT5A	D231G	Osteogenesis imperfecta, type 18	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000523123	6	82460049	6	81750332	523123	513748	rs1554200371	NC_000006.12:81750331:T:C
NM_017633.3(TENT5A):c.380A>G (p.His127Arg)	TENT5A	H127R	Osteogenesis imperfecta, type 18	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000523122	6	82461479	6	81751762	523122	513747	rs1187611948	NC_000006.12:81751761:T:C
NM_017633.3(TENT5A):c.610_611AT[3] (p.Ser205fs)	TENT5A		Osteogenesis imperfecta, type 18	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000523121	6	82460127 - 82460128	6	81750410 - 81750411	523121	513746	rs1554200383	NC_000006.12:81750410:ATATA:ATATATA
NM_001253823.1(BLVRA):c.131C>A (p.Ser44Ter)	BLVRA	S44*	Hyperbiliverdinemia	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000029613	7	43827621	7	43788022	29613	38567	rs387906596	NC_000007.14:43788021:C:A
NM_000712.4(BLVRA):c.52C>T (p.Arg18Ter)	BLVRA	R18*	Hyperbiliverdinemia	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000029612	7	43827542	7	43787943	29612	38566	rs387906595	NC_000007.14:43787942:C:T
NM_001134775.1(KLC2):c.-451_-235del	KLC2		Spastic paraplegia, optic atrophy, and neuropathy	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000222029	11	66024557 - 66024773	11	66257086 - 66257302	222029	223737	rs1554996989	
CLCF1, 676T-C	CLCF1		Cold-induced sweating syndrome 2	Pathogenic(Last reviewed: Jun 15, 2010)	no assertion criteria provided	VCV000039568					39568	48167		
NM_002645.4(PIK3C2A):c.1640+1G>T	PIK3C2A		OCULOSKELETODENTAL SYNDROME|Short stature	Pathogenic(Last reviewed: May 21, 2019)	no assertion criteria provided	VCV000599543	11	17167409	11	17145862	599543	590869	rs1565272952	NC_000011.10:17145861:C:A
NM_032810.3(ATAD1):c.826G>T (p.Glu276Ter)	ATAD1	E276*, E246*, E157*	HYPEREKPLEXIA 4	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000545495	10	89527435	10	87767678	545495	535756	rs1554874859	NC_000010.11:87767677:C:A
NM_145178.4(ATOH7):c.176C>T (p.Ala59Val)	ATOH7	A59V	Foveal hypoplasia|Optic nerve hypoplasia	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000812673	10	69991259	10	68231502	812673	800923		NC_000010.11:68231501:G:A
NM_145178.4(ATOH7):c.175G>A (p.Ala59Thr)	ATOH7	A59T	Foveal hypoplasia|Optic nerve hypoplasia	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000812672	10	69991260	10	68231503	812672	800924		NC_000010.11:68231502:C:T
NM_015368.4(PANX1):c.62_70del (p.Thr21_Pro23del)	PANX1		OOCYTE MATURATION DEFECT 7	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000689424	11	93862532 - 93862540	11	94129366 - 94129374	689424	677016		NC_000011.10:94129365:GGAGCCCACGGAGCCCA:GGAGCCCA
NM_015368.4(PANX1):c.1036A>G (p.Lys346Glu)	PANX1	K346E	OOCYTE MATURATION DEFECT 7	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000689423	11	93913258	11	94180092	689423	677015		NC_000011.10:94180091:A:G
NM_015368.4(PANX1):c.1040G>C (p.Cys347Ser)	PANX1	C347S	OOCYTE MATURATION DEFECT 7	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000689422	11	93913262	11	94180096	689422	677014		NC_000011.10:94180095:G:C
NM_015368.4(PANX1):c.1174C>T (p.Gln392Ter)	PANX1	Q392*	OOCYTE MATURATION DEFECT 7	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000689421	11	93913396	11	94180230	689421	677013		NC_000011.10:94180229:C:T
NM_006459.4(ERLIN1):c.149G>T (p.Gly50Val)	ERLIN1	G50V	Spastic paraplegia 62, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000226427	10	101943559	10	100183802	226427	228228	rs876661322	NC_000010.11:100183801:C:A
NM_006459.4(ERLIN1):c.763C>T (p.Arg255Ter)	ERLIN1	R255*, R171*, R95*	Spastic paraplegia 62, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000226426	10	101914679	10	100154922	226426	228227	rs876657413	NC_000010.11:100154921:G:A
NM_145178.4(ATOH7):c.53del (p.Pro18fs)	ATOH7	P18fs	Persistent hyperplastic primary vitreous, autosomal recessive	Pathogenic(Last reviewed: Feb 15, 2012)	no assertion criteria provided	VCV000144066	10	69991382	10	68231625	144066	153816	rs587777665	NC_000010.11:68231624:GGGGG:GGGG
NM_145178.4(ATOH7):c.136A>C (p.Asn46His)	ATOH7	N46H	Persistent hyperplastic primary vitreous, autosomal recessive	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000144067	10	69991299	10	68231542	144067	153817	rs587777666	NC_000010.11:68231541:T:G
NM_145178.4(ATOH7):c.146A>T (p.Glu49Val)	ATOH7	E49V	Persistent hyperplastic primary vitreous, autosomal recessive	Pathogenic(Last reviewed: Feb 15, 2012)	no assertion criteria provided	VCV000144065	10	69991289	10	68231532	144065	153815	rs587777664	NC_000010.11:68231531:T:A
NM_001102469.1(LIPN):c.397_398GA[1] (p.Glu133fs)	LIPN		Autosomal recessive congenital ichthyosis 8	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000031088	10	90524336 - 90524337	10	88764579 - 88764580	31088	40045	rs759880018	NC_000010.11:88764578:AGAGA:AGA
NM_021961.6(TEAD1):c.1261T>C (p.Tyr421His)	TEAD1	Y421H	Sveinsson chorioretinal atrophy	Pathogenic(Last reviewed: Oct 5, 2007)	no assertion criteria provided	VCV000012630	11	12958749	11	12937202	12630	27669	rs11567847	NC_000011.10:12937201:T:C
NC_000010.11:g.68247363_68253885del	ATOH7		Persistent hyperplastic primary vitreous, autosomal recessive	Pathogenic(Last reviewed: Oct 10, 2018)	no assertion criteria provided	VCV000030807	10	70007125 - 70013647	10	68247363 - 68253885	30807	39764		
NM_001127392.3(MYRF):c.789dup (p.Ser264fs)	MYRF		not provided	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000817718	11	61539012 - 61539013	11	61771540 - 61771541	817718	805700		NC_000011.10:61771540:CCCCCCCC:CCCCCCCCC
NM_001127392.3(MYRF):c.350_366delinsT (p.Gly117fs)	MYRF		CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Apr 6, 2019)	no assertion criteria provided	VCV000635276	11	61533645 - 61533661	11	61766173 - 61766189	635276	623108	rs1565286228	NC_000011.10:61766172:GCACCGGGCCCCCCATC:T
NM_001127392.3(MYRF):c.3239dup (p.Glu1081fs)	MYRF		CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Apr 6, 2019)	no assertion criteria provided	VCV000635275	11	61551793 - 61551794	11	61784321 - 61784322	635275	623110	rs1565308384	NC_000011.10:61784321:AAA:AAAA
NM_001127392.3(MYRF):c.3118A>G (p.Arg1040Gly)	MYRF	R1040G, R1000G	CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Apr 6, 2019)	no assertion criteria provided	VCV000635274	11	61551071	11	61783599	635274	623109	rs1565307564	NC_000011.10:61783598:A:G
NM_013279.4(MYRF):c.3241del (p.Arg1081fs)	MYRF	R1081fs, R1121fs	Nanophthalmos 1	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000635185	11	61553331	11	61785859	635185	623019		NC_000011.10:61785858:CC:C
NM_001127392.3(MYRF):c.2817G>A (p.Trp939Ter)	MYRF	W939*, W904*	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000620313	11	61549097	11	61781625	620313	611749	rs1367545625	NC_000011.10:61781624:G:A
NM_001127392.3(MYRF):c.2084G>A (p.Arg695His)	MYRF	R695H, R686H	CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619229	11	61546805	11	61779333	619229	610627	rs1382225004	NC_000011.10:61779332:G:A
NM_001127392.3(MYRF):c.1303G>A (p.Gly435Arg)	MYRF	G435R, G426R	CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619228	11	61541626	11	61774154	619228	610626	rs1565295550	NC_000011.10:61774153:G:A
NM_001127392.3(MYRF):c.1254_1255dup (p.Thr419fs)	MYRF		CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Jan 11, 2019)	no assertion criteria provided	VCV000599373	11	61541575 - 61541576	11	61774103 - 61774104	599373	590708	rs1565295395	NC_000011.10:61774103:AGA:AGAGA
NM_001127392.3(MYRF):c.2518C>T (p.Arg840Ter)	MYRF	R840*, R805*	CARDIAC-UROGENITAL SYNDROME	Pathogenic(Last reviewed: Jan 11, 2019)	no assertion criteria provided	VCV000599372	11	61548463	11	61780991	599372	590707	rs1565304230	NC_000011.10:61780990:C:T
NM_004279.3(PMPCB):c.1265T>C (p.Ile422Thr)	PMPCB	I422T	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523142	7	102952279	7	103311832	523142	513768	rs1461200360	NC_000007.14:103311831:T:C
NM_004279.3(PMPCB):c.530T>G (p.Val177Gly)	PMPCB	V177G	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523141	7	102944361	7	103303914	523141	513767	rs1436866272	NC_000007.14:103303913:T:G
NM_004279.3(PMPCB):c.524G>A (p.Arg175His)	PMPCB	R175H	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	Pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000523140	7	102944355	7	103303908	523140	513766	rs200188353	NC_000007.14:103303907:G:A
NM_004279.3(PMPCB):c.601G>C (p.Ala201Pro)	PMPCB	A210P, A201P	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000523139	7	102944432	7	103303985	523139	513765	rs146343535	NC_000007.14:103303984:G:C
NM_004279.3(PMPCB):c.523C>T (p.Arg175Cys)	PMPCB	R175C	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523138	7	102944354	7	103303907	523138	513764	rs145596167	NC_000007.14:103303906:C:T
NM_177987.2(TUBB8):c.426dup (p.Thr143fs)	TUBB8		Oocyte maturation defect 2	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378061	10	93905 - 93906	10	47965 - 47966	378061	380150	rs782246853	NC_000010.11:47965:CCCCCC:CCCCCCC
NM_177987.2(TUBB8):c.80_100del (p.Glu27_Ala33del)	TUBB8		Oocyte maturation defect 2	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378060	10	94810 - 94830	10	48870 - 48890	378060	380149	rs1057520307	NC_000010.11:48869:CAGCGGAGTCGATGGCATGTTCA:CA
NM_177987.2(TUBB8):c.713C>T (p.Thr238Met)	TUBB8	T238M	Oocyte maturation defect 2	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378059	10	93619	10	47679	378059	380148	rs1057520306	NC_000010.11:47678:G:A
NM_003014.3(SFRP4):c.481_487delGTACAGG	SFRP4	V161fs	Pyle metaphyseal dysplasia	Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000242997	7	37954014 - 37954020	7	37914412 - 37914418	242997	244077	rs879253778	NC_000007.14:37914411:CCTGTACC:C
NM_003014.3(SFRP4):c.694C>T	SFRP4	R232*	Pyle metaphyseal dysplasia	Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000242996	7	37951818	7	37912216	242996	244076	rs755007671	NC_000007.14:37912215:G:A
NM_003014.3(SFRP4):c.499dupG	SFRP4		Pyle metaphyseal dysplasia	Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000242995	7	37954001 - 37954002	7	37914399 - 37914400	242995	244075	rs879255603	NC_000007.14:37914399:C:CC
NM_177987.2(TUBB8):c.900G>A (p.Met300Ile)	TUBB8	M300I	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000223146	10	93432	10	47492	223146	224870	rs869025612	NC_000010.11:47491:C:T
NM_177987.2(TUBB8):c.1088T>C (p.Met363Thr)	TUBB8	M363T	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000223145	10	93244	10	47304	223145	224869	rs869025611	NC_000010.11:47303:A:G
NM_177987.2(TUBB8):c.785G>A (p.Arg262Gln)	TUBB8	R262Q	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000223144	10	93547	10	47607	223144	224871	rs869025610	NC_000010.11:47606:C:T
NM_001305581.2(LRMDA):c.664C>T (p.Arg222Ter)	LRMDA	R194*, R222*	Albinism, oculocutaneous, type VII	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000041916	10	78317029	10	76557271	41916	51085	rs587776952	NC_000010.11:76557270:C:T
NM_001127392.3(MYRF):c.1208A>G (p.Gln403Arg)	MYRF	Q403R, Q394R	ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION	Pathogenic(Last reviewed: Sep 11, 2018)	no assertion criteria provided	VCV000560883	11	61541531	11	61774059	560883	551990	rs1565295286	NC_000011.10:61774058:A:G
NM_177987.2(TUBB8):c.5G>A (p.Arg2Lys)	TUBB8	R2K	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000221270	10	95174	10	49234	221270	222975	rs869025273	NC_000010.11:49233:C:T
NM_177987.2(TUBB8):c.1249G>A (p.Asp417Asn)	TUBB8	D417N	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000221269	10	93083	10	47143	221269	222974	rs869025272	NC_000010.11:47142:C:T
NM_177987.2(TUBB8):c.686T>C (p.Val229Ala)	TUBB8	V229A	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000221268	10	93646	10	47706	221268	222973	rs869025271	NC_000010.11:47705:A:G
NM_177987.2(TUBB8):c.527C>T (p.Ser176Leu)	TUBB8	S176L	Oocyte maturation defect 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000223143	10	93805	10	47865	223143	224872	rs869025609	NC_000010.11:47864:G:A
NM_020338.4(ZMIZ1):c.1386dup (p.Thr463fs)	ZMIZ1		NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000694593	10	81056377 - 81056378	10	79296620 - 79296621	694593	682666		NC_000010.11:79296620:CCCCCC:CCCCCCC
NM_020338.4(ZMIZ1):c.3097-2A>G	ZMIZ1		NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000694592	10	81072397	10	79312640	694592	682665		NC_000010.11:79312639:A:G
NM_020338.4(ZMIZ1):c.887C>A (p.Thr296Lys)	ZMIZ1	T296K	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000694591	10	81052043	10	79292286	694591	682664		NC_000010.11:79292285:C:A
NM_020338.4(ZMIZ1):c.3112dup (p.Thr1038fs)	ZMIZ1		NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000694589	10	81072413 - 81072414	10	79312656 - 79312657	694589	682662		NC_000010.11:79312656:A:AA
NM_020338.4(ZMIZ1):c.899C>T (p.Thr300Met)	ZMIZ1	T300M	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000694588	10	81052055	10	79292298	694588	682661		NC_000010.11:79292297:C:T
NM_198514.4(NHLRC2):c.601_602del (p.Arg201fs)	NHLRC2	R201fs	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS	Pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	VCV000599378	10	115636549 - 115636550	10	113876790 - 113876791	599378	590715	rs757267294	NC_000010.11:113876789:AG:
NM_020338.4(ZMIZ1):c.2758dup (p.Gln920fs)	ZMIZ1		not provided	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000548962	10	81067244 - 81067245	10	79307487 - 79307488	548962	539444	rs777843533	NC_000010.11:79307487:CCCCCCC:CCCCCCCC
NM_003901.4(SGPL1):c.934del (p.Leu312fs)	SGPL1	L312fs	Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430868	10	72631615	10	70871858	430868	424413	rs1131692235	NC_000010.11:70871857:CCCC:CCC
NM_003901.4(SGPL1):c.1037G>T (p.Ser346Ile)	SGPL1	S346I	Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430866	10	72631721	10	70871964	430866	424411	rs1131692256	NC_000010.11:70871963:G:T
NM_003901.4(SGPL1):c.664C>T (p.Arg222Trp)	SGPL1	R222W	Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430865	10	72628150	10	70868393	430865	424410	rs1131692255	NC_000010.11:70868392:C:T
NM_003901.4(SGPL1):c.261+1G>A	SGPL1		Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430863	10	72610968	10	70851211	430863	424408	rs1131692253	NC_000010.11:70851210:G:A
NM_003901.4(SGPL1):c.1632_1634CTT[1] (p.Phe545del)	SGPL1	F545del	Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430862	10	72637016 - 72637018	10	70877259 - 70877261	430862	424407	rs1131692252	NC_000010.11:70877258:TCTTCTT:TCTT
NM_024928.5(STN1):c.469G>T (p.Asp157Tyr)	STN1	D157Y	Cerebroretinal microangiopathy with calcifications and cysts 2	Pathogenic(Last reviewed: Feb 10, 2017)	no assertion criteria provided	VCV000375592	10	105658747	10	103898989	375592	362403	rs765462548	NC_000010.11:103898988:C:A
NM_024928.5(STN1):c.404G>C (p.Arg135Thr)	STN1	R135T	Cerebroretinal microangiopathy with calcifications and cysts 2	Pathogenic(Last reviewed: Feb 10, 2017)	no assertion criteria provided	VCV000375591	10	105659873	10	103900115	375591	362402	rs1057519583	NC_000010.11:103900114:C:G
NM_000040.3(APOC3):c.232A>G (p.Lys78Glu)	APOC3	K58E, K78E	Hyperalphalipoproteinemia 2	Pathogenic(Last reviewed: May 1, 1991)	no assertion criteria provided	VCV000017903	11	116703532	11	116832816	17903	32942	rs121918382	NC_000011.10:116832815:A:G
NM_002233.4(KCNA4):c.266G>A (p.Arg89Gln)	KCNA4	R89Q	MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM	Pathogenic(Last reviewed: Jan 23, 2019)	no assertion criteria provided	VCV000599408	11	30033960	11	30012413	599408	590745	rs779101828	NC_000011.10:30012412:C:T
NM_003901.4(SGPL1):c.1513C>T (p.Arg505Ter)	SGPL1	R505*	Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430867	10	72636365	10	70876608	430867	424412	rs746887949	NC_000010.11:70876607:C:T
NM_003901.4(SGPL1):c.7dup (p.Ser3fs)	SGPL1		Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430864	10	72576615 - 72576616	10	70816859 - 70816860	430864	424409	rs1131692254	NC_000010.11:70816859:A:AA
NM_000040.3(APOC3):c.280A>G (p.Thr94Ala)	APOC3	T74A, T94A	Apolipoprotein c-iii, nonglycosylated	Pathogenic(Last reviewed: Dec 1, 1987)	no assertion criteria provided	VCV000017902	11	116703580	11	116832864	17902	32941	rs121918381	NC_000011.10:116832863:A:G
NM_198514.4(NHLRC2):c.442G>T (p.Asp148Tyr)	NHLRC2	D148Y	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS	Pathogenic(Last reviewed: Jan 17, 2019)	no assertion criteria provided	VCV000599377	10	115636390	10	113876631	599377	590714	rs201701259	NC_000010.11:113876630:G:T
NM_003901.4(SGPL1):c.665G>A (p.Arg222Gln)	SGPL1	R222Q	Nephrotic syndrome type 14	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000430861	10	72628151	10	70868394	430861	424406	rs769259446	NC_000010.11:70868393:G:A
NM_003931.3(WASF1):c.1482delinsGCCAGG (p.Ile494fs)	WASF1		NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES|Intellectual disability	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000561982	6	110422831	6	110101628	561982	553121	rs1562159599	NC_000006.12:110101627:G:CCTGGC
NM_003931.3(WASF1):c.1516C>T (p.Arg506Ter)	WASF1	R506*	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES|Intellectual disability	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000561980	6	110422797	6	110101594	561980	553120	rs1562159562	NC_000006.12:110101593:G:A
NG_016165.1:g.(170_?)_(?_2014)del	H19-ICR		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000162492					162492	172166		
NM_000040.3(APOC3):c.127G>A (p.Ala43Thr)	APOC3	A43T	Hyperalphalipoproteinemia 2|Coronary heart disease	Pathogenic, protective(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000139561	11	116701560	11	116830844	139561	143194	rs147210663	NC_000011.10:116830843:G:A
NM_000040.3(APOC3):c.55+1G>A	APOC3		Coronary heart disease|Hyperalphalipoproteinemia 2	Pathogenic, protective(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000139560	11	116701354	11	116830638	139560	143193	rs138326449	NC_000011.10:116830637:G:A
NM_003931.3(WASF1):c.1558C>T (p.Gln520Ter)	WASF1	Q520*	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES|Epileptic encephalopathy|Intellectual disability	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000561981	6	110421847	6	110100644	561981	553119	rs1562159088	NC_000006.12:110100643:G:A
NM_019842.4(KCNQ5):c.1106C>A (p.Pro369Gln)	KCNQ5	P369Q	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802242	6	73821107	6	73111384	802242	790657		NC_000006.12:73111383:C:A
NM_019842.3(KCNQ5):c.1106C>G (p.Pro369Arg)	KCNQ5	P369R	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431388	6	73821107	6	73111384	431388	424911	rs1135401958	NC_000006.12:73111383:C:G
NM_001160134.1(KCNQ5):c.1247+8947G>T	KCNQ5	S448I, S429I, S420I, S439I	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431387	6	73843182	6	73133459	431387	424910	rs1135401957	NC_000006.12:73133458:G:T
NM_019842.3(KCNQ5):c.1021C>A (p.Leu341Ile)	KCNQ5	L341I	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431386	6	73815082	6	73105359	431386	424909	rs1135401956	NC_000006.12:73105358:C:A
NM_019842.3(KCNQ5):c.434T>G (p.Val145Gly)	KCNQ5	V145G	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431385	6	73713666	6	73003943	431385	424908	rs1135401955	NC_000006.12:73003942:T:G
NM_004214.5(FIBP):c.175_176insTAA (p.His59delinsLeuAsn)	FIBP		Thauvin-Robinet-Faivre syndrome	Pathogenic(Last reviewed: Sep 15, 2016)	no assertion criteria provided	VCV000254242	11	65655513 - 65655514	11	65888042 - 65888043	254242	248750	rs886037928	NC_000011.10:65888042::TTA
NM_032340.4(UQCC2):c.214-3C>G	UQCC2		Mitochondrial complex III deficiency, nuclear type 7	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000133295	6	33668293	6	33700516	133295	137034	rs587777410	NC_000006.12:33700515:G:C
NM_003824.3(FADD):c.315T>G (p.Cys105Trp)	FADD	C105W	Infections, recurrent, associated with encephalopathy, hepatic dysfunction, and cardiovascular malformations	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030267	11	70052267	11	70206161	30267	39223	rs387906839	NC_000011.10:70206160:T:G
NM_005029.4(PITX3):c.38G>A (p.Ser13Asn)	PITX3	S13N	Cataract 11	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000006938	10	103991800	10	102232043	6938	21977	rs104894175	NC_000010.11:102232042:C:T
NM_004214.5(FIBP):c.652C>T (p.Gln218Ter)	FIBP	Q218*, Q225*	Macrocephalus|Large hands|Congenital ocular coloboma|facial dysmorphism|learning disabilities|Overgrowth|Thauvin-Robinet-Faivre syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2016)	no assertion criteria provided	VCV000189359	11	65652652	11	65885181	189359	187243	rs786204849	NC_000011.10:65885180:G:A
NM_005029.4(PITX3):c.650del (p.Gly217fs)	PITX3	G217fs	Cataract 11, posterior polar|Cataract 11, posterior polar, with microphthalmia and neurodevelopmental abnormalities	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000006939	10	103990530	10	102230773	6939	21978	rs1564991256	NC_000010.11:102230772:CCC:CC
NM_005029.4(PITX3):c.640_656dup (p.Gly220fs)	PITX3		not provided|Cataract 11|Anterior segment mesenchymal dysgenesis	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468353	10	103990523 - 103990524	10	102230766 - 102230767	468353	459553	rs1411557416	NC_000010.11:102230766:CCCAGGCCCTGCAGGGCCCCAGGCCCTG:CCCAGGCCCTGCAGGGCCCCAGGCCCTGCAGGGCCCCAGGCCCTG
NM_000324.2(RHAG):c.447T>G (p.Ile149Met)	RHAG	I149M	Overhydrated hereditary stomatocytosis	Pathogenic(Last reviewed: Jun 27, 2017)	no assertion criteria provided	VCV000438646	6	49585826	6	49618113	438646	432276	rs1554174425	NC_000006.12:49618112:A:C
NM_178014.4(TUBB):c.662C>T (p.Thr221Ile)	TUBB	T221I, T149I, T177I, T241I	Cortical dysplasia, complex, with other brain malformations 6	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000235892	6	30691501	6	30723724	235892	237527	rs878853162	NC_000006.12:30723723:C:T
NM_018292.5(QRSL1):c.850-3A>G	QRSL1		COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40	Pathogenic(Last reviewed: Apr 11, 2020)	no assertion criteria provided	VCV000834719	6	107102602	6	106654727	834719	853058		NC_000006.12:106654726:A:G
NM_018292.5(QRSL1):c.350G>A (p.Gly117Glu)	QRSL1	G117E	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40	Pathogenic(Last reviewed: Apr 10, 2020)	no assertion criteria provided	VCV000834718	6	107090935	6	106643060	834718	853057		NC_000006.12:106643059:G:A
NM_001199563.2(BVES):c.1A>G (p.Met1Val)	BVES	M1V	Muscular dystrophy, limb-girdle, type 2X	Pathogenic(Last reviewed: Apr 29, 2019)	no assertion criteria provided	VCV000626315	6	105581452	6	105133577	626315	614647	rs1332603843	NC_000006.12:105133576:T:C
NM_001199563.2(BVES):c.262C>T (p.Arg88Ter)	BVES	R88*	Muscular dystrophy, limb-girdle, type 2X	Pathogenic(Last reviewed: Apr 29, 2019)	no assertion criteria provided	VCV000626314	6	105577343	6	105129468	626314	614646	rs796206315	NC_000006.12:105129467:G:A
NM_001199563.2(BVES):c.816+2T>C	BVES		Muscular dystrophy, limb-girdle, type 2X	Pathogenic(Last reviewed: Apr 29, 2019)	no assertion criteria provided	VCV000626313	6	105564574	6	105116699	626313	614645	rs1562133291	NC_000006.12:105116698:A:G
NM_018292.5(QRSL1):c.587_596delinsACAAAAATCA (p.Thr196_Pro199delinsAsnLysAsnHis)	QRSL1		Cardiomyopathy, mitochondrial	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000559415	6	107100113 - 107100122	6	106652238 - 106652247	559415	550145	rs1562169661	NC_000006.12:106652237:CCAGAAATCC:ACAAAAATCA
NM_153614.3(DNAJB13):c.68+1G>C	DNAJB13		Ciliary dyskinesia, primary, 34	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000253329	11	73662183	11	73951138	253329	247777	rs775700619	NC_000011.10:73951137:G:C
NM_153614.3(DNAJB13):c.833T>G (p.Met278Arg)	DNAJB13	M278R	Ciliary dyskinesia, primary, 34	Pathogenic(Last reviewed: Aug 31, 2016)	no assertion criteria provided	VCV000253328	11	73681041	11	73969996	253328	247776	rs754776389	NC_000011.10:73969995:T:G
NM_001199563.2(BVES):c.602C>T (p.Ser201Phe)	BVES	S201F	Muscular dystrophy, limb-girdle, type 2X	Pathogenic(Last reviewed: Apr 22, 2019)	no assertion criteria provided	VCV000222033	6	105572468	6	105124593	222033	223742	rs869025337	NC_000006.12:105124592:G:A
NM_178014.4(TUBB):c.665A>T (p.Tyr222Phe)	TUBB	Y222F, Y178F, Y150F, Y242F	Symmetric circumferential skin creases, congenital, 1	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218926	6	30691504	6	30723727	218926	215752	rs864321677	NC_000006.12:30723726:A:T
NM_178014.4(TUBB):c.1057G>A (p.Val353Ile)	TUBB	V353I, V281I, V309I, V151I, V373I	Cortical dysplasia, complex, with other brain malformations 6	Pathogenic(Last reviewed: Dec 27, 2012)	no assertion criteria provided	VCV000127190	6	30691896	6	30724119	127190	132674	rs587777356	NC_000006.12:30724118:G:A
NM_178014.4(TUBB):c.895A>G (p.Met299Val)	TUBB	M299V, M227V, M255V, M319V	Cortical dysplasia, complex, with other brain malformations 6	Pathogenic(Last reviewed: Dec 27, 2012)	no assertion criteria provided	VCV000127189	6	30691734	6	30723957	127189	132673	rs587777355	NC_000006.12:30723956:A:G
NM_000324.2(RHAG):c.1139G>T (p.Gly380Val)	RHAG	G380V	Rh-null, regulator type	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000013066	6	49574634	6	49606921	13066	28105	rs121918589	NC_000006.12:49606920:C:A
NM_000324.2(RHAG):c.1067+1G>A	RHAG		Rh-null, regulator type	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000013064	6	49578736	6	49611023	13064	28103	rs1562012617	NC_000006.12:49611022:C:T
NM_000324.2(RHAG):c.3G>T (p.Met1Ile)	RHAG	M1I	Rh-mod syndrome	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000013063	6	49604523	6	49636810	13063	28102	rs121918588	NC_000006.12:49636809:C:A
NM_000324.2(RHAG):c.946-1G>A	RHAG		Rh-null, regulator type	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000013062	6	49578859	6	49611146	13062	28101	rs1562012697	NC_000006.12:49611145:C:T
NM_000324.2(RHAG):c.236G>A (p.Ser79Asn)	RHAG	S79N	Rh-mod syndrome	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000013059	6	49586997	6	49619284	13059	28098	rs121918586	NC_000006.12:49619283:C:T
NM_000324.2(RHAG):c.1086del (p.Ala363fs)	RHAG	A363fs	Rh-null, regulator type	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000013058	6	49574915	6	49607202	13058	28097	rs1562011389	NC_000006.12:49607201:T:
NM_000324.2(RHAG):c.154_157delinsGA (p.Pro52fs)	RHAG		Rh-null, regulator type	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000013057	6	49604369 - 49604372	6	49636656 - 49636659	13057	28096	rs387906519	NC_000006.12:49636655:GAGG:TC
NM_130439.3(MXI1):c.362C>T (p.Ala121Val)	MXI1	A54V, A121V, A18V	Neurofibrosarcoma	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000009537	10	111988034	10	110228276	9537	24576	rs137852604	NC_000010.11:110228275:C:T
NM_001278.5(CHUK):c.1264C>T (p.Gln422Ter)	CHUK	Q422*	Cocoon syndrome	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	VCV000008946	10	101964924	10	100205167	8946	23985	rs267606736	NC_000010.11:100205166:G:A
CITED2, 6-BP DEL, NT592	CITED2		Atrial septal defect 8	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000006723					6723	21762		
CITED2, 27-BP INS, NT534	CITED2		Atrial septal defect 8	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000006722					6722	21761		
CITED2, 27-BP DEL, NT508	CITED2		Ventricular septal defect 2	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000006721					6721	21760		
NM_207118.2(GTF2H5):c.62T>C (p.Leu21Pro)	GTF2H5	L21P	Trichothiodystrophy 3, photosensitive	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002104	6	158613035	6	158192003	2104	17143	rs121434365	NC_000006.12:158192002:T:C
NM_000324.2(RHAG):c.182T>G (p.Ile61Arg)	RHAG	I61R	Overhydrated hereditary stomatocytosis	Pathogenic(Last reviewed: Feb 5, 2009)	no assertion criteria provided	VCV000218296	6	49587051	6	49619338	218296	214933	rs863225469	NC_000006.12:49619337:A:C
NM_000324.2(RHAG):c.157+1G>A	RHAG		Rh-null, regulator type	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000013061	6	49604368	6	49636655	13061	28100	rs375508949	NC_000006.12:49636654:C:T
NM_000324.2(RHAG):c.836G>A (p.Gly279Glu)	RHAG	G279E	Rh-null, regulator type	Pathogenic(Last reviewed: Feb 15, 1998)	no assertion criteria provided	VCV000013060	6	49580219	6	49612506	13060	28099	rs121918587	NC_000006.12:49612505:C:T
NR_029512.1(MIR96):n.14C>A	MIR96		Deafness, autosomal dominant 50	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000000866	7	129414596	7	129774756	866	15905	rs587776523	NC_000007.14:129774755:G:T
NM_018292.5(QRSL1):c.1279_1280delinsTT (p.Ala427Leu)	QRSL1	A427L	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40|Cardiomyopathy, mitochondrial	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000559416	6	107110973 - 107110974	6	106663098 - 106663099	559416	550146	rs1562173313	NC_000006.12:106663097:GC:TT
NM_018292.5(QRSL1):c.555C>A (p.Tyr185Ter)	QRSL1	Y185*	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40|Cardiomyopathy, mitochondrial	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000559413	6	107097074	6	106649199	559413	550144	rs763443331	NC_000006.12:106649198:C:A
NM_178014.4(TUBB):c.43C>A (p.Gln15Lys)	TUBB	Q15K	Symmetric circumferential skin creases, congenital, 1	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218925	6	30688326	6	30720549	218925	215751	rs864321676	NC_000006.12:30720548:C:A
NM_207118.2(GTF2H5):c.166C>T (p.Arg56Ter)	GTF2H5	R56*	Trichothiodystrophy 3, photosensitive|not provided	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000002103	6	158613139	6	158192107	2103	17142	rs121434364	NC_000006.12:158192106:C:T
NR_029512.1(MIR96):n.13G>A	MIR96		Deafness, autosomal dominant 50	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000000865	7	129414597	7	129774757	865	15904	rs587776522	NC_000007.14:129774756:C:T
NM_018292.5(QRSL1):c.398G>T (p.Gly133Val)	QRSL1	G133V	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40|Cardiomyopathy, mitochondrial	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000559414	6	107096917	6	106649042	559414	550143	rs1562168768	NC_000006.12:106649041:G:T
NM_000829.4(GRIA4):c.2090G>C (p.Arg697Pro)	GRIA4	R697P	Intellectual functioning disability|NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446210	11	105804491	11	105933765	446210	439572	rs765556214	NC_000011.10:105933764:G:C
NM_000829.4(GRIA4):c.1931C>T (p.Ala644Val)	GRIA4	A644V	Intellectual functioning disability|NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446209	11	105797550	11	105926824	446209	439571	rs1555050174	NC_000011.10:105926823:C:T
NM_000829.4(GRIA4):c.1928C>G (p.Ala643Gly)	GRIA4	A643G	Intellectual functioning disability|NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446208	11	105797547	11	105926821	446208	439570	rs1555050171	NC_000011.10:105926820:C:G
NM_000829.4(GRIA4):c.1915A>T (p.Thr639Ser)	GRIA4	T639S	Intellectual functioning disability|NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446206	11	105797534	11	105926808	446206	439568	rs1555050158	NC_000011.10:105926807:A:T
PITX3, 17-BP DUP, NT657	PITX3		ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES|Cataract 11, posterior polar	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006937					6937	21976		
NM_130439.3(MXI1):c.656A>C (p.Glu219Ala)	MXI1	E152A, E106A, E219A	Malignant tumor of prostate	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000009536	10	112039775	10	110280017	9536	24575	rs137852603	NC_000010.11:110280016:A:C
NM_130439.3(MXI1):c.552+2T>C	MXI1		Malignant tumor of prostate	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000009535	10	112039054	10	110279296	9535	24574	rs387906417	NC_000010.11:110279295:T:C
MXI1, 1-BP DEL, A, CODON 140 OR 141	MXI1		Malignant tumor of prostate	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000009534					9534	24573		
NM_005797.4(MPZL2):c.463del (p.Ala155fs)	MPZL2	A155fs	DEAFNESS, AUTOSOMAL RECESSIVE 111	Pathogenic(Last reviewed: Aug 28, 2019)	no assertion criteria provided	VCV000689320	11	118130890	11	118260175	689320	676912		NC_000011.10:118260174:CC:C
NM_001320.6(CSNK2B):c.105dup (p.Leu36fs)	CSNK2B		not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000504210	6	31635676 - 31635677	6	31667899 - 31667900	504210	495277	rs1554169990	NC_000006.12:31667899:T:TT
NM_001320.6(CSNK2B):c.36G>A (p.Trp12Ter)	CSNK2B	W12*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000489241	6	31634644	6	31666867	489241	481759	rs1554169462	NC_000006.12:31666866:G:A
NM_001320.6(CSNK2B):c.27del (p.Ser8_Trp9insTer)	CSNK2B		not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000452393	6	31634634	6	31666857	452393	443944	rs1554169460	NC_000006.12:31666856:GG:G
NM_001320.7(CSNK2B):c.368-2A>G	CSNK2B		POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Pathogenic(Last reviewed: Mar 18, 2020)	no assertion criteria provided	VCV000805773	6	31637094	6	31669317	805773	794108		NC_000006.12:31669316:A:G
NM_001320.7(CSNK2B):c.265del (p.Thr90fs)	CSNK2B	T90fs	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Pathogenic(Last reviewed: Mar 18, 2020)	no assertion criteria provided	VCV000805772	6	31636404	6	31668627	805772	794107		NC_000006.12:31668626:CC:C
NM_001320.7(CSNK2B):c.621dup (p.Lys208fs)	CSNK2B		POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Pathogenic(Last reviewed: Mar 18, 2020)	no assertion criteria provided	VCV000805771	6	31637675 - 31637676	6	31669898 - 31669899	805771	794106		NC_000006.12:31669898:C:CC
NM_001320.7(CSNK2B):c.533_534insGT (p.Pro179fs)	CSNK2B		POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Pathogenic(Last reviewed: Mar 18, 2020)	no assertion criteria provided	VCV000805770	6	31637261 - 31637262	6	31669484 - 31669485	805770	794105		NC_000006.12:31669484::GT
NM_001320.7(CSNK2B):c.175+2T>G	CSNK2B		POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Pathogenic(Last reviewed: Jan 15, 2020)	no assertion criteria provided	VCV000805768	6	31635749	6	31667972	805768	794103		NC_000006.12:31667971:T:G
NM_003860.4(BANF1):c.34G>A (p.Ala12Thr)	BANF1	A12T	Nestor-Guillermo progeria syndrome	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000030390	11	65770755	11	66003284	30390	39347	rs387906871	NC_000011.10:66003283:G:A
TSPYL1, 1-BP INS, 457G	TSPYL1		Sudden infant death with dysgenesis of the testes syndrome	Pathogenic(Last reviewed: Aug 10, 2004)	no assertion criteria provided	VCV000005385					5385	20424		
NM_001320.7(CSNK2B):c.367+2T>C	CSNK2B		POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Pathogenic(Last reviewed: Mar 18, 2020)	no assertion criteria provided	VCV000812520	6	31636951	6	31669174	812520	800763		NC_000006.12:31669173:T:C
NM_005797.4(MPZL2):c.220C>T (p.Gln74Ter)	MPZL2	Q74*	DEAFNESS, AUTOSOMAL RECESSIVE 111	Pathogenic(Last reviewed: Aug 28, 2019)	no assertion criteria provided	VCV000585269	11	118133651	11	118262936	585269	576319	rs1565501066	NC_000011.10:118262935:G:A
NM_001320.6(CSNK2B):c.108dup (p.Thr37fs)	CSNK2B		POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME|Intellectual disability and seizures	Pathogenic(Last reviewed: Jan 15, 2020)	no assertion criteria provided	VCV000430724	6	31635678 - 31635679	6	31667901 - 31667902	430724	424262	rs1131692161	NC_000006.12:31667901:TT:TTT
NM_000040.3(APOC3):c.55C>T (p.Arg19Ter)	APOC3	R19*	Coronary heart disease|not provided|Hyperalphalipoproteinemia 2	Pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	VCV000017904	11	116701353	11	116830637	17904	32943	rs76353203	NC_000011.10:116830636:C:T
NM_005797.4(MPZL2):c.72del (p.Ile24fs)	MPZL2	I24fs	not provided|DEAFNESS, AUTOSOMAL RECESSIVE 111	Pathogenic(Last reviewed: Sep 3, 2018)	criteria provided, single submitter	VCV000585268	11	118133799	11	118263084	585268	576318	rs752672077	NC_000011.10:118263083:T:
NM_016621.5(PHF21A):c.666_667del (p.Pro222_Pro223insTer)	PHF21A		not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000817590	11	45991401 - 45991402	11	45969850 - 45969851	817590	805693		NC_000011.10:45969849:GAG:G
NM_016146.6(TRAPPC4):c.454+3A>G	TRAPPC4		NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000812649	11	118890966	11	119020256	812649	373902	rs375776811	NC_000011.10:119020255:A:G
NM_005720.4(ARPC1B):c.763_764del (p.Asp255fs)	ARPC1B	D255fs	PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802341	7	98988855 - 98988856	7	99391232 - 99391233	802341	790768		NC_000007.14:99391231:AGA:A
NM_001283.5(AP1S1):c.186T>G (p.Tyr62Ter)	AP1S1	Y62*	not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000620377	7	100800661	7	101157380	620377	611668	rs981747624	NC_000007.14:101157379:T:G
NM_005720.4(ARPC1B):c.739_743del (p.Leu247fs)	ARPC1B	L247fs	Congenital combined immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827687	7	98988832 - 98988836	7	99391209 - 99391213	827687	815920		NC_000007.14:99391208:CTGCT:
NC_000007.14:g.99369754_99378887del	ARPC1B		Congenital combined immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827686	7	98967377 - 98976510			827686	815918		
NM_005720.4(ARPC1B):c.490_491insCC (p.Phe164fs)	ARPC1B		Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827685	7	98987625 - 98987626	7	99390002 - 99390003	827685	815919		NC_000007.14:99390002::CC
NM_016621.4(PHF21A):c.1288G>A (p.Ala430Thr)	PHF21A	G429S, A429T, A430T, G430S	INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Feb 11, 2020)	no assertion criteria provided	VCV000800735	11	45970437	11	45948886	800735	789355		NC_000011.10:45948885:C:T
NM_016621.4(PHF21A):c.660_661insAA (p.Pro221fs)	PHF21A		INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Feb 11, 2020)	no assertion criteria provided	VCV000800733	11	45991407 - 45991408	11	45969856 - 45969857	800733	789353		NC_000011.10:45969856::TT
NM_016621.4(PHF21A):c.1223dup (p.Glu409fs)	PHF21A		INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Feb 11, 2020)	no assertion criteria provided	VCV000800732	11	45970956 - 45970957	11	45949405 - 45949406	800732	789352		NC_000011.10:45949405:GG:GGG
NM_018131.5(CEP55):c.514dup (p.Ile172fs)	CEP55		Hydranencephaly with renal aplasia-dysplasia	Pathogenic(Last reviewed: Sep 24, 2018)	no assertion criteria provided	VCV000562113	10	95266796 - 95266797	10	93507039 - 93507040	562113	553288	rs1169095680	NC_000010.11:93507039:AAA:AAAA
NM_005720.4(ARPC1B):c.314C>T (p.Ala105Val)	ARPC1B	A105V	PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444878	7	98985806	7	99388183	444878	438519	rs1186149065	NC_000007.14:99388182:C:T
ARPC1B, 2-BP DUP, 269CT	ARPC1B		PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444877					444877	438518		
NM_018131.5(CEP55):c.256C>T (p.Arg86Ter)	CEP55	R86*	Hydranencephaly with renal aplasia-dysplasia	Pathogenic(Last reviewed: Aug 28, 2017)	no assertion criteria provided	VCV000437875	10	95262942	10	93503185	437875	431496	rs141458677	NC_000010.11:93503184:C:T
NM_001283.5(AP1S1):c.183-2A>G	AP1S1		Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000039854	7	100800656	7	101157375	39854	48453	rs751430853	NC_000007.14:101157374:A:G
NM_030940.4(ISCA1):c.29T>G (p.Val10Gly)	ISCA1	V10G	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5	Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000695121	9	88897345	9	86282430	695121	683224		NC_000009.12:86282429:A:C
NM_016139.4(CHCHD2):c.300+5G>A	CHCHD2		Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218884	7	56171914	7	56104221	218884	215641	rs750014782	NC_000007.14:56104220:C:T
NM_016139.4(CHCHD2):c.434G>A (p.Arg145Gln)	CHCHD2	R145Q	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218883	7	56170571	7	56102878	218883	215640	rs752169833	NC_000007.14:56102877:C:T
NM_016139.4(CHCHD2):c.182C>T (p.Thr61Ile)	CHCHD2	T61I	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218882	7	56172037	7	56104344	218882	215639	rs864309650	NC_000007.14:56104343:G:A
NM_006006.6(ZBTB16):c.1849A>G (p.Met617Val)	ZBTB16	M617V, M588V	Skeletal defects, genital hypoplasia, and mental retardation	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000013376	11	114121104	11	114250382	13376	28415	rs121434606	NC_000011.10:114250381:A:G
NM_001098668.4(SFTPA2):c.593T>C (p.Phe198Ser)	SFTPA2	F198S, F208S	Idiopathic fibrosing alveolitis, chronic form	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000013200	10	81317119	10	79557363	13200	28239	rs121917738	NC_000010.11:79557362:A:G
NM_001098668.4(SFTPA2):c.692G>T (p.Gly231Val)	SFTPA2	G231V, G241V	Idiopathic fibrosing alveolitis, chronic form	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000013199	10	81317020	10	79557264	13199	28238	rs121917737	NC_000010.11:79557263:C:A
NM_018131.5(CEP55):c.1274C>A (p.Ser425Ter)	CEP55	S425*	Hydranencephaly with renal aplasia-dysplasia	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000437874	10	95287789	10	93528032	437874	431495	rs201430235	NC_000010.11:93528031:C:A
NM_002835.4(PTPN12):c.182A>G (p.Lys61Arg)	PTPN12	K61R	Carcinoma of colon	Pathogenic(Last reviewed: Feb 21, 1994)	no assertion criteria provided	VCV000009448	7	77200477	7	77571160	9448	24487	rs121434623	NC_000007.14:77571159:A:G
NM_030940.4(ISCA1):c.259G>A (p.Glu87Lys)	ISCA1	E87K	Multiple mitochondrial dysfunctions syndrome|MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5	Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000375415	9	88881089	9	86266174	375415	362182	rs776679653	NC_000009.12:86266173:C:T
NM_016401.4(HIKESHI):c.160G>C (p.Val54Leu)	HIKESHI	V54L, V15L	Leukodystrophy, hypomyelinating, 13	Pathogenic(Last reviewed: Aug 9, 2017)	no assertion criteria provided	VCV000224891	11	86017416	11	86306374	224891	226737	rs202003795	NC_000011.10:86306373:G:C
NM_000315.4(PTH):c.67T>C (p.Ser23Pro)	PTH	S23P, S55P	Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000013758	11	13514336	11	13492789	13758	28797	rs104894272	NC_000011.10:13492788:A:G
PTH, IVS2DS, G-C, +1, EX2DEL	PTH		Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000013757					13757	28796		
CYP26C1, 7-BP DUP, NT844	CYP26C1		Focal facial dermal dysplasia 4	Pathogenic(Last reviewed: Feb 15, 2013)	no assertion criteria provided	VCV000039843					39843	48442		
NM_000315.4(PTH):c.247C>T (p.Arg83Ter)	PTH	R83*, R115*	Primary hyperparathyroidism	Pathogenic(Last reviewed: Sep 11, 2008)	no assertion criteria provided	VCV000013759	11	13514053	11	13492506	13759	28798	rs6256	NC_000011.10:13492505:G:A
NM_000315.4(PTH):c.52T>C (p.Cys18Arg)	PTH	C18R, C50R	Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: Dec 11, 2007)	no assertion criteria provided	VCV000013756	11	13514351	11	13492804	13756	28795	rs104894271	NC_000011.10:13492803:A:G
NM_006831.3(CLP1):c.419G>A (p.Arg140His)	CLP1	R140H	not provided|Pontocerebellar hypoplasia, type 10	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143934	11	57427367	11	57659895	143934	153655	rs587777616	NC_000011.10:57659894:G:A
NM_017635.5(KMT5B):c.668_672del (p.Lys223fs)	KMT5B	K152fs, K200fs, K51fs, K223fs	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802695	11	67939158 - 67939162	11	68171691 - 68171695	802695	791164		NC_000011.10:68171690:TATTTT:T
GRCh37/hg19 7q33(chr7:134341813-134366849)x1	BPGM		not provided	Pathogenic(Last reviewed: Sep 20, 2017)	no assertion criteria provided	VCV000685463	7	134341813 - 134366849			685463	673055		
NM_004397.6(DDX6):c.1115A>G (p.His372Arg)	DDX6	H372R	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694353	11	118627028	11	118756319	694353	682247		NC_000011.10:118756318:T:C
NM_004397.6(DDX6):c.1171A>C (p.Thr391Pro)	DDX6	T391P	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694352	11	118626972	11	118756263	694352	682246		NC_000011.10:118756262:T:G
NM_004397.6(DDX6):c.1172C>T (p.Thr391Ile)	DDX6	T391I	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694351	11	118626971	11	118756262	694351	682245		NC_000011.10:118756261:G:A
NM_004397.6(DDX6):c.1168T>C (p.Cys390Arg)	DDX6	C390R	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694350	11	118626975	11	118756266	694350	682244		NC_000011.10:118756265:A:G
NM_004397.6(DDX6):c.1118G>A (p.Arg373Gln)	DDX6	R373Q	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694349	11	118627025	11	118756316	694349	682243		NC_000011.10:118756315:C:T
NM_017635.5(KMT5B):c.856C>T (p.Arg286Ter)	KMT5B	R114*, R263*, R215*, R286*, R46*	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000666575	11	67938603	11	68171136	666575	654136		NC_000011.10:68171135:G:A
NM_017635.5(KMT5B):c.219del (p.Ala74fs)	KMT5B	A3fs, A74fs	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560605	11	67953337	11	68185870	560605	551680	rs1565240833	NC_000011.10:68185869:GG:G
NM_017635.5(KMT5B):c.255del (p.Ser86fs)	KMT5B	S15fs, S86fs	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: Mar 28, 2018)	no assertion criteria provided	VCV000559640	11	67953301	11	68185834	559640	550364	rs1555034768	NC_000011.10:68185833:GG:G
NM_017635.5(KMT5B):c.1557_1558del (p.Asn520fs)	KMT5B	N280fs, N348fs, N520fs	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446522	11	67926255 - 67926256	11	68158788 - 68158789	446522	440040	rs1555023232	NC_000011.10:68158787:TCT:T
NM_017635.5(KMT5B):c.725del (p.Leu242fs)	KMT5B	L70fs, L2fs, L171fs, L219fs, L242fs	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446521	11	67939105	11	68171638	446521	440039	rs1555028154	NC_000011.10:68171637:A:
NM_001282716.1(STAG3):c.1573+5G>A	STAG3		Premature ovarian failure 8	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000430588	7	99796995	7	100199372	430588	423236	rs376787666	NC_000007.14:100199371:G:A
NM_005247.4(FGF3):c.270dup (p.Leu91fs)	FGF3		Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 7, 2016)	no assertion criteria provided	VCV000417891	11	69631141 - 69631142	11	69816373 - 69816374	417891	404807	rs1554981083	NC_000011.10:69816373:A:AA
NM_001282716.1(STAG3):c.1945_1946CT[3] (p.Tyr650fs)	STAG3		Premature ovarian failure 8	Pathogenic(Last reviewed: Apr 4, 2016)	no assertion criteria provided	VCV000224903	7	99798475 - 99798476	7	100200852 - 100200853	224903	226766	rs869320765	NC_000007.14:100200852:CTCT:CTCTCT
NM_001282716.1(STAG3):c.562del (p.Gln188fs)	STAG3	Q130fs, Q188fs	Premature ovarian failure 8	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000126427	7	99786485	7	100188862	126427	131960	rs587777267	NC_000007.14:100188861:CC:C
NM_001130145.3(YAP1):c.370C>T (p.Arg124Ter)	YAP1	R124*	Congenital ocular coloboma	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000120326	11	101984923	11	102114192	120326	125921	rs587777249	NC_000011.10:102114191:C:T
NM_199461.4(NANOS1):c.502_504GCC[5] (p.Ala173del)	NANOS1	A173del	Spermatogenic failure 12	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000065391	10	120789813 - 120789815	10	119030301 - 119030303	65391	76325	rs538539239	NC_000010.11:119030300:CCGCCGCCGCCGCCGCCGCC:CCGCCGCCGCCGCCGCC
NM_005247.4(FGF3):c.394del (p.Arg132fs)	FGF3	R132fs	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000038386	11	69625399	11	69810631	38386	46947	rs281860304	NC_000011.10:69810630:GGG:GG
NM_001724.5(BPGM):c.61del (p.Arg21fs)	BPGM	R21fs	Deficiency of bisphosphoglycerate mutase	Pathogenic(Last reviewed: Nov 15, 1992)	no assertion criteria provided	VCV000012092	7	134346319	7	134661567	12092	27131	rs786205092	NC_000007.14:134661566:CC:C
NM_002555.6(SLC22A18):c.257G>A (p.Arg86His)	SLC22A18	R86H, R171H	Rhabdomyosarcoma, somatic	Pathogenic(Last reviewed: Mar 31, 1998)	no assertion criteria provided	VCV000006977	11	2930440	11	2909210	6977	22016	rs78838117	NC_000011.10:2909209:G:A
NM_002555.5(SLC22A18):c.864_865insNC_000011.10:g.2919738_2919848	SLC22A18		Breast adenocarcinoma	Pathogenic(Last reviewed: Mar 31, 1998)	no assertion criteria provided	VCV000006976					6976	22015		
NM_002655.3(PLAG1):c.439del (p.Ser147fs)	PLAG1	S147fs, S65fs	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	VCV000253204	8	57079866	8	56167307	253204	247619	rs1114167317	NC_000008.11:56167306:TT:T
NM_002655.3(PLAG1):c.1363del (p.Gln455fs)	PLAG1	Q373fs, Q455fs	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	VCV000253033	8	57078942	8	56166383	253033	247440	rs1114167318	NC_000008.11:56166382:GGG:GG
NM_001130145.3(YAP1):c.1066G>T (p.Glu356Ter)	YAP1	E356*, E302*, E306*, E322*, E344*, E340*, E360*, E178*, E318*	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000120327	11	102094386	11	102223655	120327	125922	rs587777250	NC_000011.10:102223654:G:T
NM_005247.4(FGF3):c.455_456TG[1] (p.Trp153fs)	FGF3		Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000029818	11	69625335 - 69625336	11	69810567 - 69810568	29818	38773	rs281860307	NC_000011.10:69810566:CACA:CA
NM_005247.4(FGF3):c.317A>G (p.Tyr106Cys)	FGF3	Y106C	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000029817	11	69631095	11	69816327	29817	38772	rs281860306	NC_000011.10:69816326:T:C
NM_005247.4(FGF3):c.255del (p.Ile85fs)	FGF3	I85fs	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013842	11	69631157	11	69816389	13842	28881	rs281860302	NC_000011.10:69816388:AA:A
NM_005247.4(FGF3):c.616del (p.Val206fs)	FGF3	V206fs	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013839	11	69625177	11	69810409	13839	28878	rs281860305	NC_000011.10:69810408:CCCCC:CCCC
NM_005247.4(FGF3):c.466T>C (p.Ser156Pro)	FGF3	S156P	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013837	11	69625327	11	69810559	13837	28876	rs121917703	NC_000011.10:69810558:A:G
NM_001724.5(BPGM):c.268C>T (p.Arg90Cys)	BPGM	R89C, R90C	Deficiency of bisphosphoglycerate mutase	Pathogenic(Last reviewed: Nov 15, 1992)	no assertion criteria provided	VCV000012091	7	134346527	7	134661775	12091	27130	rs121964925	NC_000007.14:134661774:C:T
NM_000324.2(RHAG):c.194T>C (p.Phe65Ser)	RHAG	F65S	Overhydrated hereditary stomatocytosis	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000218295	6	49587039	6	49619326	218295	214932	rs863225468	NC_000006.12:49619325:A:G
NM_005247.4(FGF3):c.310C>T (p.Arg104Ter)	FGF3	R104*	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic	criteria provided, single submitter	VCV000013838	11	69631102	11	69816334	13838	28877	rs121917704	NC_000011.10:69816333:G:A
NM_002555.6(SLC22A18):c.698C>T (p.Ser233Phe)	SLC22A18	S233F, S135F, S318F	Lung cancer	Pathogenic(Last reviewed: Sep 15, 1998)	no assertion criteria provided	VCV000006978	11	2939260	11	2918030	6978	22017	rs121909071	NC_000011.10:2918029:C:T
NM_021800.3(DNAJC12):c.79-2A>G	DNAJC12		Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000694075	10	69583152	10	67823394	694075	681922		NC_000010.11:67823393:T:C
NM_021800.3(DNAJC12):c.596G>T (p.Ter199Leu)	DNAJC12	*199L	Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000694072	10	69556875	10	67797117	694072	681919		NC_000010.11:67797116:C:A
NM_021800.3(DNAJC12):c.85del (p.Gln29fs)	DNAJC12	Q29fs	Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000694071	10	69583144	10	67823386	694071	681918		NC_000010.11:67823385:G:
NM_021800.3(DNAJC12):c.58_59del (p.Gly20fs)	DNAJC12	G20fs	Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Jul 18, 2019)	no assertion criteria provided	VCV000636261	10	69597711 - 69597712	10	67837953 - 67837954	636261	624072		NC_000010.11:67837952:CCC:C
NM_052854.4(CREB3L1):c.1284C>A (p.Tyr428Ter)	CREB3L1	Y428*	Osteogenesis imperfecta, type xvi	Pathogenic(Last reviewed: Aug 7, 2018)	no assertion criteria provided	VCV000559484	11	46341840	11	46320289	559484	550208	rs779809838	NC_000011.10:46320288:C:A
NM_006744.4(RBP4):c.394T>A (p.Tyr132Asn)	RBP4	Y132N, Y130N	Microphthalmia|Congenital ocular coloboma	Pathogenic(Last reviewed: Apr 1, 2017)	no assertion criteria provided	VCV000430902	10	95353754	10	93593997	430902	424443	rs1329285216	NC_000010.11:93593996:A:T
NM_021800.3(DNAJC12):c.158-2A>T	DNAJC12		Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Mar 7, 2017)	no assertion criteria provided	VCV000393303	10	69571423	10	67811665	393303	380159	rs775029664	NC_000010.11:67811664:T:A
NM_021800.3(DNAJC12):c.215G>C (p.Arg72Pro)	DNAJC12	R72P	Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Mar 7, 2017)	no assertion criteria provided	VCV000393302	10	69571364	10	67811606	393302	380158	rs1035794099	NC_000010.11:67811605:C:G
NM_021800.2(DNAJC12):c.298-968_503-2603del	DNAJC12		Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Mar 7, 2017)	no assertion criteria provided	VCV000393301					393301	380157		
NM_018480.5(TMEM126B):c.208C>T (p.Gln70Ter)	TMEM126B	Q70*, T29I, Q24*, Q50*, Q40*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000253167	11	85345134	11	85634090	253167	247579	rs886037857	NC_000011.10:85634089:C:T
NM_001350393.1(TMEM126B):c.172+103G>A	TMEM126B	D133N, D103N, G103S, D87N, D113N, G133S, G113S	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000253166	11	85345323	11	85634279	253166	247578	rs573006534	NC_000011.10:85634278:G:A
NM_006744.4(RBP4):c.217G>A (p.Ala73Thr)	RBP4	A73T, A71T	Microphthalmia, isolated, with coloboma 10	Pathogenic(Last reviewed: Apr 23, 2015)	no assertion criteria provided	VCV000192377	10	95360455	10	93600698	192377	190164	rs794726862	NC_000010.11:93600697:C:T
NM_006744.4(RBP4):c.111+1G>A	RBP4		Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000041423	10	95360674	10	93600917	41423	49861	rs112811136	NC_000010.11:93600916:C:T
NM_138455.4(CTHRC1):c.131A>C (p.Gln44Pro)	CTHRC1	Q44P	Barrett esophagus/esophageal adenocarcinoma	Pathogenic(Last reviewed: Jul 27, 2011)	no assertion criteria provided	VCV000030848	8	104384015	8	103371787	30848	39805	rs387907029	NC_000008.11:103371786:A:C
NM_002526.4(NT5E):c.1608dup (p.Val537fs)	NT5E		Calcification of joints and arteries	Pathogenic(Last reviewed: Feb 3, 2011)	no assertion criteria provided	VCV000029689	6	86203602 - 86203603	6	85493884 - 85493885	29689	38644	rs774200574	NC_000006.12:85493884:AAA:AAAA
NM_002526.4(NT5E):c.1073G>A (p.Cys358Tyr)	NT5E	C358Y	Calcification of joints and arteries	Pathogenic(Last reviewed: Feb 3, 2011)	no assertion criteria provided	VCV000029688	6	86197176	6	85487458	29688	38643	rs387906620	NC_000006.12:85487457:G:A
NM_002526.4(NT5E):c.662C>A (p.Ser221Ter)	NT5E	S221*	Calcification of joints and arteries	Pathogenic(Last reviewed: Feb 3, 2011)	no assertion criteria provided	VCV000029687	6	86181054	6	85471336	29687	38642	rs373328681	NC_000006.12:85471335:C:A
NM_006744.4(RBP4):c.278G>A (p.Gly93Asp)	RBP4	G75D, G93D, G91D	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000013068	10	95360227	10	93600470	13068	28107	rs121918585	NC_000010.11:93600469:C:T
NM_021800.3(DNAJC12):c.187A>T (p.Lys63Ter)	DNAJC12	K63*	Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000694074	10	69571392	10	67811634	694074	681921		NC_000010.11:67811633:T:A
NM_021800.3(DNAJC12):c.214C>T (p.Arg72Ter)	DNAJC12	R72*	Hyperphenylalaninemia, mild, non-bh4-deficient	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000694073	10	69571365	10	67811607	694073	681920		NC_000010.11:67811606:G:A
NM_006744.4(RBP4):c.176T>A (p.Ile59Asn)	RBP4	I41N, I59N, I57N	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	Pathogenic(Last reviewed: Nov 4, 2005)	no assertion criteria provided	VCV000013067	10	95360496	10	93600739	13067	28106	rs121918584	NC_000010.11:93600738:A:T
NM_012250.6(RRAS2):c.215A>T (p.Gln72Leu)	RRAS2	L72Q, Q37L, Q72L	Neoplasm of ovary|NOONAN SYNDROME 12|Noonan syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000009447	11	14316390	11	14294844	9447	24486	rs113954997	NC_000011.10:14294843:T:A
NM_016366.3(CABP2):c.637+1G>T	CABP2		Deafness, autosomal recessive 93|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000597198	11	67287263	11	67519792	597198	588259	rs149712664	NC_000011.10:67519791:C:A
NM_052854.4(CREB3L1):c.928_930AAG[2] (p.Lys312del)	CREB3L1	K312del	Osteogenesis imperfecta|Osteogenesis imperfecta, type xvi	Pathogenic	criteria provided, single submitter	VCV000559483	11	46334187 - 46334189	11	46312636 - 46312638	559483	550207	rs1555222973	NC_000011.10:46312635:AAGAAGAAG:AAGAAG
NM_018480.5(TMEM126B):c.401del (p.Asn134fs)	TMEM126B	N114fs, N104fs, N134fs, N59fs, N88fs	Mitochondrial diseases|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000236208	11	85346713	11	85635669	236208	237763	rs886037835	NC_000011.10:85635668:AA:A
GRCh37/hg19 8q21.13(chr8:82571433-82604029)x1	IMPA1		not provided	Pathogenic(Last reviewed: Jan 25, 2018)	no assertion criteria provided	VCV000688202	8	82571433 - 82604029			688202	675794		
LRP12, (CGG)n REPEAT EXPANSION	LRP12		Oculopharyngodistal myopathy	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692233					692233	680037		
NM_005536.4(IMPA1):c.489_493dup (p.Ser165fs)	IMPA1		Mental retardation, autosomal recessive 59	Pathogenic(Last reviewed: May 16, 2017)	no assertion criteria provided	VCV000375412	8	82583246 - 82583247	8	81671011 - 81671012	375412	362179	rs1057519491	NC_000008.11:81671011:AGCCCA:AGCCCAGCCCA
NM_203330.2(CD59):c.146del (p.Asp49fs)	CD59	D49fs	CD59-mediated hemolytic anemia with or without immune-mediated polyneuropathy	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000100766	11	33738939	11	33717393	100766	106632	rs587777149	NC_000011.10:33717392:T:
NM_203330.2(CD59):c.266G>A (p.Cys89Tyr)	CD59	C89Y	CD59-mediated hemolytic anemia with or without immune-mediated polyneuropathy	Pathogenic(Last reviewed: Jan 3, 2013)	no assertion criteria provided	VCV000064690	11	33731793	11	33710247	64690	75619	rs397514767	NC_000011.10:33710246:C:T
CD59, 1-BP DEL, CODON 16	CD59		CD59-mediated hemolytic anemia with or without immune-mediated polyneuropathy	Pathogenic(Last reviewed: Jan 3, 2013)	no assertion criteria provided	VCV000018052					18052	33091		
NM_022454.4(SOX17):c.499_520del (p.Leu167fs)	SOX17	L167fs	not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000817453	8	55371799 - 55371820	8	54459239 - 54459260	817453	805579		NC_000008.11:54459238:GGCGGCCGCGCTGGGCCCCGAGGGCGGCCGCG:GGCGGCCGCG
NM_001198800.3(ASCC1):c.943C>T (p.Arg315Ter)	ASCC1	R343*, R275*, R276*, R297*, R315*, R337*	Spinal muscular atrophy with congenital bone fractures 2	Pathogenic(Last reviewed: Feb 20, 2020)	no assertion criteria provided	VCV000801337	10	73887854	10	72128096	801337	789719		NC_000010.11:72128095:G:A
NG_031890.1:g.(?_60461)_(94053_?)del	ASCC1		Spinal muscular atrophy with congenital bone fractures 2	Pathogenic(Last reviewed: Feb 20, 2020)	no assertion criteria provided	VCV000801336	10	73887840 - 73921432			801336	789718		
NM_001198800.3(ASCC1):c.328C>T (p.Arg110Ter)	ASCC1	R138*, R110*, R132*, R71*	Spinal muscular atrophy with congenital bone fractures 2	Pathogenic(Last reviewed: Jan 3, 2020)	no assertion criteria provided	VCV000801335	10	73956730	10	72196972	801335	789717		NC_000010.11:72196971:G:A
NM_001198800.3(ASCC1):c.382C>T (p.Arg128Ter)	ASCC1	R156*, R128*, R150*, R89*	Spinal muscular atrophy with congenital bone fractures 2	Pathogenic(Last reviewed: Jan 3, 2020)	no assertion criteria provided	VCV000801334	10	73956676	10	72196918	801334	789716		NC_000010.11:72196917:G:A
NM_022772.4(EPS8L2):c.738del (p.Val247fs)	EPS8L2	V247fs	DEAFNESS, AUTOSOMAL RECESSIVE 106	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000433530	11	721321	11	721321	433530	427104	rs1554952193	NC_000011.10:721320:CC:C
NM_022772.4(EPS8L2):c.1014del (p.Ser339fs)	EPS8L2	S339fs	DEAFNESS, AUTOSOMAL RECESSIVE 106	Pathogenic(Last reviewed: Aug 22, 2017)	no assertion criteria provided	VCV000433529	11	722117	11	722117	433529	427103	rs1554952443	NC_000011.10:722116:CCCC:CCC
NM_012200.4(B3GAT3):c.667G>A (p.Gly223Ser)	B3GAT3	G223S, G216S	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH CONGENITAL HEART DEFECTS	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000225924	11	62384220	11	62616748	225924	227735	rs372487178	NC_000011.10:62616747:C:T
NM_012200.4(B3GAT3):c.419C>T (p.Pro140Leu)	B3GAT3	P133L	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITHOUT CONGENITAL HEART DEFECTS	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000225764	11	62384658	11	62617186	225764	227579	rs879255269	NC_000011.10:62617185:G:A
NM_001142519.3(FAM111A):c.1020_1022TTC[2] (p.Ser343del)	FAM111A	S343del	Osteocraniostenosis	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000056811	11	58920161 - 58920163	11	59152688 - 59152690	56811	71438	rs1565206032	NC_000011.10:59152687:TTCTTCTTC:TTCTTC
SOX17, 6-BP INS, NT51	SOX17		Vesicoureteral reflux 3	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000018415					18415	33454		
NM_198965.2(PTHLH):c.358A>T (p.Lys120Ter)	PTHLH	K120*	Brachydactyly type E2	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000013741	12	28116447	12	27963514	13741	28780	rs267606988	NC_000012.12:27963513:T:A
NM_198965.2(PTHLH):c.534A>G (p.Ter178Trp)	PTHLH	*178W	Brachydactyly type E2	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000013740	12	28111492	12	27958559	13740	28779	rs267606987	NC_000012.12:27958558:T:C
NM_198965.2(PTHLH):c.131T>C (p.Leu44Pro)	PTHLH	L44P	Brachydactyly type E2	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000013739	12	28116674	12	27963741	13739	28778	rs267606986	NC_000012.12:27963740:A:G
NM_198965.2(PTHLH):c.179T>C (p.Leu60Pro)	PTHLH	L60P	Brachydactyly type E2	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000013738	12	28116626	12	27963693	13738	28777	rs267606985	NC_000012.12:27963692:A:G
NM_001142519.3(FAM111A):c.1579C>A (p.Pro527Thr)	FAM111A	P527T	Osteocraniostenosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056815	11	58920720	11	59153247	56815	71442	rs587777015	NC_000011.10:59153246:C:A
NM_001142519.3(FAM111A):c.1012A>G (p.Thr338Ala)	FAM111A	T338A	Osteocraniostenosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056814	11	58920153	11	59152680	56814	71441	rs587777014	NC_000011.10:59152679:A:G
NM_001142519.3(FAM111A):c.1583A>G (p.Asp528Gly)	FAM111A	D528G	Osteocraniostenosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056813	11	58920724	11	59153251	56813	71440	rs587777013	NC_000011.10:59153250:A:G
NM_012200.4(B3GAT3):c.175C>T (p.Arg59Ter)	B3GAT3	R59*, R52*	Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000577885	11	62388051	11	62620579	577885	565897	rs535206047	NC_000011.10:62620578:G:A
NM_024514.4(CYP2R1):c.296T>C (p.Leu99Pro)	CYP2R1	L99P	Vitamin d hydroxylation-deficient rickets, type 1b	Pathogenic(Last reviewed: May 18, 2004)	no assertion criteria provided	VCV000002134	11	14907393	11	14885847	2134	17173	rs61495246	NC_000011.10:14885846:A:G
NM_001198800.3(ASCC1):c.157dup (p.Glu53fs)	ASCC1		Spinal muscular atrophy with congenital bone fractures 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000224639	10	73970544 - 73970545	10	72210786 - 72210787	224639	226420	rs753324947	NC_000010.11:72210786:CC:CCC
NM_032228.6(FAR1):c.163C>T (p.Arg55Ter)	FAR1	R55*	not provided	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000860111	11	13716475	11	13694928	860111	838128		NC_000011.10:13694927:C:T
NM_001129.5(AEBP1):c.917dup (p.Tyr306Ter)	AEBP1		EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000545699	7	44147659 - 44147660	7	44108060 - 44108061	545699	536191	rs1443187318	NC_000007.14:44108060:A:AA
NM_001129.5(AEBP1):c.1320_1326del (p.Arg440fs)	AEBP1	R440fs	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000545024	7	44149861 - 44149867	7	44110262 - 44110268	545024	535288	rs1554327284	NC_000007.14:44110261:CCAGGACCCAG:CCAG
NM_001129.5(AEBP1):c.1470del (p.Asn490fs)	AEBP1	N490fs	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000545023	7	44150393	7	44110794	545023	535287	rs1554327449	NC_000007.14:44110793:C:
NM_032228.6(FAR1):c.1094A>G (p.Asp365Gly)	FAR1	D365G	Peroxisomal fatty acyl-coa reductase 1 disorder	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162214	11	13736194	11	13714647	162214	171922	rs724159963	NC_000011.10:13714646:A:G
NM_032228.6(FAR1):c.787C>T (p.Arg263Ter)	FAR1	R263*	Peroxisomal fatty acyl-coa reductase 1 disorder	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162213	11	13733493	11	13711946	162213	171921	rs724159962	NC_000011.10:13711945:C:T
NM_032228.6(FAR1):c.495_507delinsT (p.Glu165_Pro169delinsAsp)	FAR1		Peroxisomal fatty acyl-coa reductase 1 disorder	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162212	11	13729576 - 13729588	11	13708029 - 13708041	162212	171920	rs727502796	NC_000011.10:13708028:AGTAGTCTATCCA:T
NM_001129.5(AEBP1):c.1630+1G>A	AEBP1		EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000545021	7	44150657	7	44111058	545021	535285	rs369016031	NC_000007.14:44111057:G:A
NM_001198800.3(ASCC1):c.626+1G>A	ASCC1		Pena-Shokeir syndrome type I|Fetal akinesia sequence|Arthrogryposis multiplex congenita|Spinal muscular atrophy with congenital bone fractures 2	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619021	10	73921295	10	72161537	619021	610419		NC_000010.11:72161536:C:T
NM_005186.4(CAPN1):c.188dup (p.Val64fs)	CAPN1		not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000817644	11	64950354 - 64950355	11	65182883 - 65182884	817644	805706		NC_000011.10:65182883:CCCCCC:CCCCCCC
NM_005186.4(CAPN1):c.1176G>A (p.Trp392Ter)	CAPN1	W392*	Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802687	11	64972164	11	65204693	802687	791154		NC_000011.10:65204692:G:A
GRCh37/hg19 7p14.3(chr7:33074784-33084764)x1	NT5C3A		not provided	Pathogenic(Last reviewed: Jun 12, 2017)	no assertion criteria provided	VCV000687354	7	33074784 - 33084764			687354	674946		
NM_001198868.2(CAPN1):c.853C>T (p.Arg285Ter)	CAPN1	R285*	not provided	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000489121	11	64955435	11	65187964	489121	481998	rs1033093801	NC_000011.10:65187963:C:T
NM_021813.4(BACH2):c.2362G>A (p.Glu788Lys)	BACH2	E788K	IMMUNODEFICIENCY 60	Pathogenic(Last reviewed: Apr 17, 2019)	no assertion criteria provided	VCV000625844	6	90642291	6	89932572	625844	614148	rs757652995	NC_000006.12:89932571:C:T
NM_021813.4(BACH2):c.71T>C (p.Leu24Pro)	BACH2	L24P	IMMUNODEFICIENCY 60	Pathogenic(Last reviewed: Apr 17, 2019)	no assertion criteria provided	VCV000625843	6	90718493	6	90008774	625843	614147	rs1562364898	NC_000006.12:90008773:A:G
NM_019042.5(PUS7):c.329_332del (p.Thr110fs)	PUS7	T110fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619234	7	105148628 - 105148631	7	105508181 - 105508184	619234	610632	rs1562818383	NC_000007.14:105508180:TCAGT:T
NM_019042.5(PUS7):c.1507G>T (p.Asp503Tyr)	PUS7	D503Y, D509Y	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619233	7	105108802	7	105468355	619233	610631	rs1444559235	NC_000007.14:105468354:C:A
NM_019042.4(PUS7):c.(1757+1_1758-1)_(1848+1_1849-1)del	PUS7		INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619232					619232	610630		
NM_019042.5(PUS7):c.1348C>T (p.Arg450Ter)	PUS7	R450*, R456*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619231	7	105111185	7	105470738	619231	610629	rs772282094	NC_000007.14:105470737:G:A
NM_019042.5(PUS7):c.89_90del (p.Thr30fs)	PUS7	T30fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619230	7	105148870 - 105148871	7	105508423 - 105508424	619230	610628	rs752839979	NC_000007.14:105508422:TGT:T
NM_005186.4(CAPN1):c.338-1G>A	CAPN1		Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000617483	11	64950944	11	65183473	617483	608845		NC_000011.10:65183472:G:A
NM_002677.5(PMP2):c.151A>C (p.Thr51Pro)	PMP2	T51P	Pmp2-related charcot-marie-tooth disease type 1	Pathogenic(Last reviewed: Jan 16, 2019)	no assertion criteria provided	VCV000599407	8	82357147	8	81444912	599407	590744	rs1563518390	NC_000008.11:81444911:T:G
NM_005186.4(CAPN1):c.407del (p.Pro136fs)	CAPN1	P136fs	Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000225767	11	64951013	11	65183542	225767	227582	rs875989845	NC_000011.10:65183541:CC:C
NM_005186.4(CAPN1):c.1579C>T (p.Gln527Ter)	CAPN1	Q527*	Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000225766	11	64974264	11	65206793	225766	227581	rs875989787	NC_000011.10:65206792:C:T
NM_005186.4(CAPN1):c.884G>C (p.Arg295Pro)	CAPN1	R295P	Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000225765	11	64955466	11	65187995	225765	227580	rs756205995	NC_000011.10:65187994:G:C
NM_001080508.3(TBX18):c.487A>G (p.Lys163Glu)	TBX18	K163E		Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208529	6	85472272	6	84762554	208529	205047	rs797045022	NC_000006.12:84762553:T:C
NM_001080508.3(TBX18):c.1570C>T (p.His524Tyr)	TBX18	H524Y		Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208528	6	85446657	6	84736939	208528	205046	rs760905589	NC_000006.12:84736938:G:A
NM_001080508.3(TBX18):c.1010del (p.Gly337fs)	TBX18	G337fs		Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208527	6	85448304	6	84738586	208527	205045	rs869320679	NC_000006.12:84738585:CCC:CC
NM_005523.5(HOXA11):c.872del (p.Asn291fs)	HOXA11	N291fs	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000014897	7	27222485	7	27182866	14897	29936	rs864321666	NC_000007.14:27182865:TT:T
NM_016489.13(NT5C3A):c.721G>C (p.Gly241Arg)	NT5C3A	G241R, G280R, G229R, G275R	Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000004488	7	33055353	7	33015741	4488	19527	rs104894029	NC_000007.14:33015740:C:G
NM_016489.13(NT5C3A):c.577del (p.Asp193fs)	NT5C3A	D193fs, D227fs, D181fs	Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004487	7	33057065	7	33017453	4487	19526	rs397518438	NC_000007.14:33017452:CC:C
NM_016489.13(NT5C3A):c.569A>G (p.Asn190Ser)	NT5C3A	N190S, N229S, N178S, N224S	Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004486	7	33057073	7	33017461	4486	19525	rs104894028	NC_000007.14:33017460:T:C
NM_016489.13(NT5C3A):c.592-1G>C	NT5C3A		Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004485	7	33055483	7	33015871	4485	19524	rs397518435	NC_000007.14:33015870:C:G
NM_016489.12(NT5C3A):c.384dupA (p.Ala129Serfs)	NT5C3A		Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004484	7	33059290 - 33059291	7	33019678 - 33019679	4484	19523	rs397518437	NC_000007.14:33019678:TTTT:TTTTT
NM_016489.13(NT5C3A):c.592-1G>T	NT5C3A		Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000004481	7	33055483	7	33015871	4481	19520	rs397518435	NC_000007.14:33015870:C:A
NM_016489.13(NT5C3A):c.529C>T (p.Gln177Ter)	NT5C3A	Q177*, Q216*, Q165*, Q211*	Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000004480	7	33057113	7	33017501	4480	19519	rs104894026	NC_000007.14:33017500:G:A
NM_005186.4(CAPN1):c.618_619del (p.Gly208fs)	CAPN1	G208fs	not provided|Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802686	11	64953668 - 64953669	11	65186197 - 65186198	802686	791153		NC_000011.10:65186196:AG:
NM_016489.13(NT5C3A):c.543T>G (p.Tyr181Ter)	NT5C3A	Y181*, Y220*, Y169*, Y215*	Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004483	7	33057099	7	33017487	4483	19522	rs104894027	NC_000007.14:33017486:A:C
NM_016489.13(NT5C3A):c.742_743dup (p.Val249fs)	NT5C3A		Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004482	7	33055330 - 33055331	7	33015718 - 33015719	4482	19521	rs397518436	NC_000007.14:33015718:CC:CCCC
NM_016489.13(NT5C3A):c.293A>T (p.Asp98Val)	NT5C3A	D98V, D137V, D132V, D86V	Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000004479	7	33060929	7	33021317	4479	19518	rs104894025	NC_000007.14:33021316:T:A
NM_030751.6(ZEB1):c.1693G>T (p.Glu565Ter)	ZEB1	E498*, E545*, E565*, E566*, E477*, E491*, E347*, E474*, E548*, E549*, E551*, E552*	not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000817540	10	31809956	10	31521028	817540	805641		NC_000010.11:31521027:G:T
NM_030751.6(ZEB1):c.1328_1331CAAT[1] (p.Ile444fs)	ZEB1		not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000503716	10	31809591 - 31809594	10	31520663 - 31520666	503716	495671	rs1554930679	NC_000010.11:31520662:CAATCAAT:CAAT
NM_006060.6(IKZF1):c.584A>G (p.His195Arg)	IKZF1	H108R, H195R	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000428611	7	50450400	7	50382702	428611	420430	rs1131690788	NC_000007.14:50382701:A:G
NM_006060.6(IKZF1):c.484C>T (p.Arg162Trp)	IKZF1	R75W, R162W	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827710	7	50450300	7	50382602	827710	815914		NC_000007.14:50382601:C:T
NM_006060.6(IKZF1):c.476A>G (p.Asn159Ser)	IKZF1	N159S, N72S	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827709	7	50450292	7	50382594	827709	815913		NC_000007.14:50382593:A:G
NM_006060.6(IKZF1):c.546C>A (p.Cys182Ter)	IKZF1	C182*, C95*	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000692112	7	50450362	7	50382664	692112	679855		NC_000007.14:50382663:C:A
NM_030751.6(ZEB1):c.1576dup (p.Val526fs)	ZEB1		Corneal dystrophy	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000437319	10	31809832 - 31809833	10	31520904 - 31520905	437319	429065	rs766305306	NC_000010.11:31520904:GGGGGGG:GGGGGGGG
NM_015213.4(DENND5A):c.3811del (p.Gln1271fs)	DENND5A	Q1247fs, Q1271fs, Q1175fs	Epileptic encephalopathy, early infantile, 49	Pathogenic(Last reviewed: Apr 3, 2017)	no assertion criteria provided	VCV000374928	11	9161271	11	9139724	374928	361833	rs1057519310	NC_000011.10:9139723:G:
NM_015213.4(DENND5A):c.2547del (p.Lys850fs)	DENND5A	K826fs, K850fs, K754fs	Epileptic encephalopathy, early infantile, 49	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374926	11	9172286	11	9150739	374926	361831	rs1057519308	NC_000011.10:9150738:CC:C
NM_015213.4(DENND5A):c.515_516GA[1] (p.Asp173fs)	DENND5A		Epileptic encephalopathy, early infantile, 49	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374925	11	9225638 - 9225639	11	9204091 - 9204092	374925	361830	rs1057519307	NC_000011.10:9204090:TCTCT:TCT
NM_006060.5(IKZF1):c.161-8388_589+2308del	IKZF1		Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000224782	7	50435843 - 50452713	7	50368145 - 50385015	224782	226601		
NM_006060.6(IKZF1):c.551G>A (p.Arg184Gln)	IKZF1	R184Q, R97Q	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000224781	7	50450367	7	50382669	224781	226600	rs869312885	NC_000007.14:50382668:G:A
NM_006060.6(IKZF1):c.485G>A (p.Arg162Gln)	IKZF1	R162Q, R75Q	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000224779	7	50450301	7	50382603	224779	226598	rs770551610	NC_000007.14:50382602:G:A
NM_006060.6(IKZF1):c.485G>T (p.Arg162Leu)	IKZF1	R162L, R75L	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000224778	7	50450301	7	50382603	224778	226597	rs770551610	NC_000007.14:50382602:G:T
NM_001024613.4(FEZF1):c.832C>T (p.His278Tyr)	FEZF1	H278Y, H228Y	Hypogonadotropic hypogonadism 22 with anosmia	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156219	7	121943335	7	122303281	156219	166016	rs587777739	NC_000007.14:122303280:G:A
ZEB1, 1350C-T	ZEB1		Posterior polymorphous corneal dystrophy 3	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000012632					12632	27671		
EMX2, G-T, EXON 2, NT1	EMX2		SCHIZENCEPHALY	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000009522					9522	24561		
NM_004098.4(EMX2):c.407-4G>T	EMX2		SCHIZENCEPHALY	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000009521	10	119305139	10	117545628	9521	24560	rs1411887961	NC_000010.11:117545627:G:T
NM_004098.4(EMX2):c.407-1G>A	EMX2		SCHIZENCEPHALY	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000009520	10	119305142	10	117545631	9520	24559	rs1564751655	NC_000010.11:117545630:G:A
EMX2, 1-BP INS	EMX2		SCHIZENCEPHALY	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000009519					9519	24558		
NM_006060.6(IKZF1):c.629A>G (p.Tyr210Cys)	IKZF1	Y210C, Y67C, Y123C	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000224777	7	50455082	7	50387384	224777	226596	rs869312883	NC_000007.14:50387383:A:G
NM_030751.6(ZEB1):c.2916_2917del (p.Gly973fs)	ZEB1	G906fs, G882fs, G885fs, G960fs, G974fs, G755fs, G953fs, G959fs, G973fs, G899fs, G956fs, G957fs	Posterior polymorphous corneal dystrophy 3	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000012631	10	31815733 - 31815734	10	31526805 - 31526806	12631	27670		NC_000010.11:31526804:TG:
NM_030751.6(ZEB1):c.973C>T (p.Arg325Ter)	ZEB1	R325*, R237*, R305*, R311*, R251*, R309*, R234*, R107*, R258*, R308*, R312*, R326*	Polymorphous corneal dystrophy|Visual loss|Glaucoma|not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374184	10	31809236	10	31520308	374184	360918	rs1057518956	NC_000010.11:31520307:C:T
NM_006060.6(IKZF1):c.500A>G (p.His167Arg)	IKZF1	H167R, H80R	Inherited Immunodeficiency Diseases|Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000224780	7	50450316	7	50382618	224780	226599	rs869312884	NC_000007.14:50382617:A:G
NM_000771.4(CYP2C9):c.622T>G (p.Leu208Val)	CYP2C9	L208V	Warfarin response	Pathogenic(Last reviewed: Oct 15, 2001)	no assertion criteria provided	VCV000008410	10	96707676	10	94947919	8410	23449	rs72558191	NC_000010.11:94947918:T:G
NM_004056.6(CA8):c.710G>A (p.Arg237Gln)	CA8	R237Q, R205Q	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000029620	8	61135236	8	60222677	29620	38574	rs387906598	NC_000008.11:60222676:C:T
NM_004056.6(CA8):c.298T>C (p.Ser100Pro)	CA8	S100P	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000017604	8	61178603	8	60266044	17604	32643	rs267606695	NC_000008.11:60266043:A:G
NM_000281.4(PCBD1):c.272del (p.Asn91fs)	PCBD1	N91fs, N42fs	Hyperphenylalaninemia, BH4-deficient, D	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802585	10	72643750	10	70883993	802585	790977		NC_000010.11:70883992:TTT:TT
NM_015065.3(EXPH5):c.5786del (p.Pro1929fs)	EXPH5	P1922fs, P1929fs, P1741fs, P1773fs, P1853fs	not provided	Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000265125	11	108380448	11	108509721	265125	259976	rs749309384	NC_000011.10:108509720:GGG:GG
NM_016188.5(ACTL6B):c.999T>A (p.Cys333Ter)	ACTL6B	C333*	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 76	Pathogenic(Last reviewed: Jun 19, 2019)	no assertion criteria provided	VCV000635099	7	100244392	7	100646769	635099	622936	rs1562848142	NC_000007.14:100646768:A:T
NM_000281.4(PCBD1):c.313T>C (p.Ter105Gln)	PCBD1	*105Q, *56Q	Hyperphenylalaninemia, BH4-deficient, D	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000428616	10	72643709	10	70883952	428616	420435	rs770334825	NC_000010.11:70883951:A:G
NM_018685.5(ANLN):c.1291C>T (p.Arg431Cys)	ANLN	R431C	Focal segmental glomerulosclerosis 8	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000156221	7	36450671	7	36411062	156221	166018	rs587777741	NC_000007.14:36411061:C:T
NM_000281.4(PCBD1):c.236C>T (p.Thr79Ile)	PCBD1	T79I, T30I	Hyperphenylalaninemia, BH4-deficient, D	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000016797	10	72643786	10	70884029	16797	31836	rs121913014	NC_000010.11:70884028:G:A
NM_000281.4(PCBD1):c.244T>C (p.Cys82Arg)	PCBD1	C82R, C33R	Hyperphenylalaninemia, BH4-deficient, D	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000016796	10	72643778	10	70884021	16796	31835	rs104894177	NC_000010.11:70884020:A:G
NM_018685.5(ANLN):c.1852G>T (p.Gly618Cys)	ANLN	G618C, G580C, G581C	Focal segmental glomerulosclerosis 8	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000156222	7	36459071	7	36419462	156222	166019	rs1184529372	NC_000007.14:36419461:G:T
EXPH5, 1-BP DEL, 5786C	EXPH5		Epidermolysis bullosa, nonspecific, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039467					39467	48066		
NM_000281.4(PCBD1):c.292C>T (p.Gln98Ter)	PCBD1	Q98*, Q49*	Hyperphenylalaninemia, BH4-deficient, D	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000016799	10	72643730	10	70883973	16799	31838	rs121913015	NC_000010.11:70883972:G:A
NM_016188.5(ACTL6B):c.1279del (p.Ter427AspextTer?)	ACTL6B	*427fs	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 76|ACTL6B-related recessive epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2019)	no assertion criteria provided	VCV000635102	7	100240871	7	100643248	635102	622939	rs998928845	NC_000007.14:100643247:A:
NM_016023.5(OTUD6B):c.797+1G>A	OTUD6B		not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000488709	8	92096343	8	91084115	488709	481828	rs747009288	NC_000008.11:91084114:G:A
NM_004171.4(SLC1A2):c.244G>A (p.Gly82Arg)	SLC1A2	G82R, G73R	Epileptic encephalopathy, early infantile, 41	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000438736	11	35336636	11	35315089	438736	432363	rs886037942	NC_000011.10:35315088:C:T
NM_004171.4(SLC1A2):c.254T>C (p.Leu85Pro)	SLC1A2	L85P, L76P	Epileptic encephalopathy, early infantile, 41	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000254266	11	35336626	11	35315079	254266	248799	rs886037943	NC_000011.10:35315078:A:G
NM_004171.4(SLC1A2):c.244G>C (p.Gly82Arg)	SLC1A2	G82R, G73R	Epileptic encephalopathy, early infantile, 41	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000254265	11	35336636	11	35315089	254265	248798	rs886037942	NC_000011.10:35315088:C:G
NM_016188.5(ACTL6B):c.1027G>A (p.Gly343Arg)	ACTL6B	G343R	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS|Autism|ACTL6B-related dominant intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430804	7	100244260	7	100646637	430804	424349	rs1131692228	NC_000007.14:100646636:C:T
NM_012200.4(B3GAT3):c.830G>A (p.Arg277Gln)	B3GAT3	R277Q, R270Q	Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH CONGENITAL HEART DEFECTS|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000030573	11	62384057	11	62616585	30573	39530	rs387906937	NC_000011.10:62616584:C:T
NM_016023.5(OTUD6B):c.83-2A>G	OTUD6B		Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Dysmorphic features|Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000375703	8	92083364	8	91071136	375703	362593	rs1064797102	NC_000008.11:91071135:A:G
NM_003506.4(FZD6):c.1312G>A (p.Glu438Lys)	FZD6	E438K, E133K, E406K	Nail disorder, nonsyndromic congenital, 1	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827759	8	104337646	8	103325418	827759	815957		NC_000008.11:103325417:G:A
NM_003506.4(FZD6):c.1525C>T (p.Arg509Ter)	FZD6	R509*, R204*, R477*	Nail disorder, nonsyndromic congenital, 1	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827757	8	104340628	8	103328400	827757	815955		NC_000008.11:103328399:C:T
NM_018002.3(OXR1):c.2082+1G>T	OXR1		Congenital cerebellar hypoplasia	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000694397	8	107751812	8	106739584	694397	682315		NC_000008.11:106739583:G:T
NM_018002.3(OXR1):c.1100C>G (p.Ser367Ter)	OXR1	S360*, S367*, S368*	Congenital cerebellar hypoplasia	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000694396	8	107718849	8	106706621	694396	682313		NC_000008.11:106706620:C:G
NM_001110354.2(ZP3):c.763C>G (p.Arg255Gly)	ZP3	R255G, R204G	OOCYTE MATURATION DEFECT 3	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689403	7	76063404	7	76434087	689403	676995		NC_000007.14:76434086:C:G
NM_001220.5(CAMK2B):c.852A>T (p.Arg284Ser)	CAMK2B	R284S	Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560180	7	44281350	7	44241751	560180	550896	rs1554385203	NC_000007.14:44241750:T:A
NM_001220.5(CAMK2B):c.638C>T (p.Pro213Leu)	CAMK2B	P213L	Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560179	7	44282217	7	44242618	560179	550895	rs1554387293	NC_000007.14:44242617:G:A
NM_017696.2(MCM9):c.1483G>T (p.Glu495Ter)	MCM9	E495*	Ovarian dysgenesis 4	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000417973	6	119150256	6	118829093	417973	404862	rs1060505058	NC_000006.12:118829092:C:A
NM_000876.3(IGF2R):c.4391G>A (p.Gly1464Glu)	IGF2R	G1464E	Hepatocellular carcinoma	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	VCV000014796	6	160491038	6	160070006	14796	29835	rs121434588	NC_000006.12:160070005:G:A
NM_000876.3(IGF2R):c.4346G>T (p.Gly1449Val)	IGF2R	G1449V	Hepatocellular carcinoma	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	VCV000014795	6	160490993	6	160069961	14795	29834	rs121434587	NC_000006.12:160069960:G:T
NM_001220.5(CAMK2B):c.820-1G>A	CAMK2B		Intellectual disability	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000430924	7	44281383	7	44241784	430924	424465	rs1554385305	NC_000007.14:44241783:C:T
NM_003506.4(FZD6):c.346C>T (p.Arg116Ter)	FZD6	R116*, R84*	Wilms Tumor|not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000438765	8	104330986	8	103318758	438765	432403	rs769116796	NC_000008.11:103318757:C:T
NM_001110354.2(ZP3):c.400G>A (p.Ala134Thr)	ZP3	A134T, A83T	Empty follicle syndrome|OOCYTE MATURATION DEFECT 3	Pathogenic(Last reviewed: Oct 9, 2017)	no assertion criteria provided	VCV000437933	7	76058919	7	76429602	437933	431554	rs1554625334	NC_000007.14:76429601:G:A
NM_003506.4(FZD6):c.1531C>T (p.Arg511Cys)	FZD6	R511C, R479C, R206C	Nail disorder, nonsyndromic congenital, 1|Nail disease|not provided	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030356	8	104340634	8	103328406	30356	39312	rs151339003	NC_000008.11:103328405:C:T
NM_001220.5(CAMK2B):c.709G>A (p.Glu237Lys)	CAMK2B	E237K	Intellectual disability|Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000430923	7	44281927	7	44242328	430923	424466	rs1554386687	NC_000007.14:44242327:C:T
NM_001220.5(CAMK2B):c.328G>A (p.Glu110Lys)	CAMK2B	E110K	Intellectual disability|Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000430921	7	44294154	7	44254555	430921	424468	rs1554402092	NC_000007.14:44254554:C:T
NM_003506.4(FZD6):c.1750G>T (p.Glu584Ter)	FZD6	E584*, E279*, E552*	Nail disease|not provided|Nail disorder, nonsyndromic congenital, 1	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030355	8	104342091	8	103329863	30355	39311	rs151339002	NC_000008.11:103329862:G:T
NM_017696.2(MCM9):c.1732+2T>C	MCM9		Ovarian dysgenesis 4|Premature ovarian failure 1	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000156587	6	119149088	6	118827925	156587	166440	rs587777871	NC_000006.12:118827924:A:G
NM_016023.5(OTUD6B):c.379_383del (p.Leu127fs)	OTUD6B	L127fs, L26fs	not provided|Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Dysmorphic features|Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000375702	8	92090644 - 92090648	8	91078416 - 91078420	375702	362592	rs759317757	NC_000008.11:91078415:AACTTAAC:AAC
NM_016023.5(OTUD6B):c.343C>T (p.Arg115Ter)	OTUD6B	R14*, R145*, R115*	not provided|Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Dysmorphic features|Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375701	8	92090611	8	91078383	375701	362591	rs368313959	NC_000008.11:91078382:C:T
GRCh37/hg19 10q24.2(chr10:100690060-100911811)x1	HPSE2		not provided	Pathogenic(Last reviewed: Aug 9, 2018)	no assertion criteria provided	VCV000687772	10	100690060 - 100911811			687772	675364		
NM_001199835.1(SNX10):c.162T>A (p.Tyr54Ter)	SNX10	Y54*, Y51*, Y80*	not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000453176	7	26404205	7	26364585	453176	444118	rs377321694	NC_000007.14:26364584:T:A
NM_001039706.3(CFAP69):c.647G>A (p.Trp216Ter)	CFAP69	W216*, W198*	SPERMATOGENIC FAILURE 24	Pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000626909	7	89900954	7	90271640	626909	615241	rs1355278372	NC_000007.14:90271639:G:A
NM_001039706.3(CFAP69):c.1069_1070insAC (p.Leu357fs)	CFAP69		SPERMATOGENIC FAILURE 24	Pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000626908	7	89906561 - 89906562	7	90277247 - 90277248	626908	615240	rs764048407	NC_000007.14:90277247:C:CAC
NM_006295.3(VARS1):c.3192G>A (p.Met1064Ile)	VARS1	M1064I	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000590285	6	31747481	6	31779704	590285	581226	rs1562293093	NC_000006.12:31779703:C:T
NM_006295.3(VARS1):c.1577-2A>G	VARS1		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000590284	6	31752087	6	31784310	590284	581225	rs1562301511	NC_000006.12:31784309:T:C
NM_006295.3(VARS1):c.1325G>A (p.Arg442Gln)	VARS1	R442Q	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Sep 3, 2018)	no assertion criteria provided	VCV000561997	6	31753045	6	31785268	561997	553138	rs762729609	NC_000006.12:31785267:C:T
NM_006295.3(VARS1):c.1199A>C (p.Gln400Pro)	VARS1	Q400P	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Sep 3, 2018)	no assertion criteria provided	VCV000561996	6	31753412	6	31785635	561996	553141	rs1562303844	NC_000006.12:31785634:T:G
NM_001039706.3(CFAP69):c.763C>T (p.Gln255Ter)	CFAP69	Q255*, Q237*	SPERMATOGENIC FAILURE 24	Pathogenic(Last reviewed: May 7, 2018)	no assertion criteria provided	VCV000523227	7	89901175	7	90271861	523227	513865	rs1554359569	NC_000007.14:90271860:C:T
NM_001039706.3(CFAP69):c.860+1G>A	CFAP69		SPERMATOGENIC FAILURE 24	Pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000523226	7	89901273	7	90271959	523226	513864	rs1554359685	NC_000007.14:90271958:G:A
NM_006295.3(VARS1):c.1324C>T (p.Arg442Ter)	VARS1	R442*	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic	no assertion criteria provided	VCV000520393	6	31753046	6	31785269	520393	510990	rs763777257	NC_000006.12:31785268:G:A
NM_006295.3(VARS1):c.2074G>C (p.Ala692Pro)	VARS1	A692P	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic	no assertion criteria provided	VCV000520392	6	31750138	6	31782361	520392	510989	rs747824231	NC_000006.12:31782360:C:G
NM_001199835.1(SNX10):c.46C>T (p.Arg16Ter)	SNX10	R16*, R13*, R42*	Osteopetrosis, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000139565	7	26400616	7	26360996	139565	143196	rs587777490	NC_000007.14:26360995:C:T
NM_001199835.1(SNX10):c.152G>A (p.Arg51Gln)	SNX10	R51Q, R48Q, R77Q	Osteopetrosis, autosomal recessive 8	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000040050	7	26404195	7	26364575	40050	48564	rs398123011	NC_000007.14:26364574:G:A
NM_006295.3(VARS1):c.2825G>A (p.Arg942Gln)	VARS1	R942Q	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000561999	6	31748318	6	31780541	561999	553136	rs1336685414	NC_000006.12:31780540:C:T
NM_006295.3(VARS1):c.219_232dup (p.Leu78fs)	VARS1		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000561998	6	31762762 - 31762763	6	31794985 - 31794986	561998	553142	rs757026184	NC_000006.12:31794985:GCTGGGCCACAGCCG:GCTGGGCCACAGCCGCTGGGCCACAGCCG
NM_006295.3(VARS1):c.2464G>A (p.Gly822Ser)	VARS1	G822S	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000561995	6	31749338	6	31781561	561995	553137	rs376864621	NC_000006.12:31781560:C:T
NM_006295.3(VARS1):c.1300C>G (p.Leu434Val)	VARS1	L434V	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000561994	6	31753070	6	31785293	561994	553139	rs1562303235	NC_000006.12:31785292:G:C
NM_003797.5(EED):c.707G>C (p.Arg236Thr)	EED	R236T	Cohen-Gibson syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	no assertion criteria provided	VCV000430646	11	85975286	11	86264244	430646	424179	rs1131692176	NC_000011.10:86264243:G:C
NM_003797.5(EED):c.904A>G (p.Arg302Gly)	EED	R302G	Cohen-Gibson syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	no assertion criteria provided	VCV000430645	11	85979541	11	86268499	430645	424178	rs1131692175	NC_000011.10:86268498:A:G
NM_003797.5(EED):c.772C>T (p.His258Tyr)	EED	H258Y	Cohen-Gibson syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	no assertion criteria provided	VCV000430644	11	85977170	11	86266128	430644	424177	rs1131692174	NC_000011.10:86266127:C:T
NM_001166246.1(HPSE2):c.*51A>T	HPSE2	N543I, N485I, N431I	Urofacial syndrome 1	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000060719	10	100219482	10	98459725	60719	75281	rs397515452	NC_000010.11:98459724:T:A
HPSE2, EX8-9DEL	HPSE2		Urofacial syndrome 1	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000000086					86	15125		
NM_001166244.1(HPSE2):c.235_236CT[3] (p.Leu81fs)	HPSE2		Urofacial syndrome 1	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000000085	10	100995318 - 100995319	10	99235561 - 99235562	85	15124	rs1469962264	NC_000010.11:99235560:AGAGAGAG:AGAGAG
NM_032536.4(NTNG2):c.446T>C (p.Met149Thr)	NTNG2	M149T	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000691560	9	135073585	9	132198198	691560	679243		NC_000009.12:132198197:T:C
NM_032536.4(NTNG2):c.242G>A (p.Cys81Tyr)	NTNG2	C81Y	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000691559	9	135073381	9	132197994	691559	679241		NC_000009.12:132197993:G:A
NM_032536.4(NTNG2):c.1065C>G (p.Cys355Trp)	NTNG2	C355W	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000691558	9	135114501	9	132239114	691558	679245		NC_000009.12:132239113:C:G
NM_032536.4(NTNG2):c.319T>G (p.Trp107Gly)	NTNG2	W107G	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000691556	9	135073458	9	132198071	691556	679242		NC_000009.12:132198070:T:G
NM_032536.4(NTNG2):c.1367G>A (p.Cys456Tyr)	NTNG2	C456Y	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000691555	9	135117272	9	132241885	691555	679247		NC_000009.12:132241884:G:A
NM_003797.5(EED):c.906A>C (p.Arg302Ser)	EED	R302S	Cohen-Gibson syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	no assertion criteria provided	VCV000430643	11	85979543	11	86268501	430643	424176	rs1131692173	NC_000011.10:86268500:A:C
NM_016824.5(ADD3):c.1100G>A (p.Gly367Asp)	ADD3	G367D, G289D	Cerebral palsy, spastic quadriplegic, 3|Cerebral palsy	Pathogenic(Last reviewed: Jul 23, 2019)	no assertion criteria provided	VCV000242273	10	111882007	10	110122249	242273	243827	rs564185858	NC_000010.11:110122248:G:A
NM_021828.4(HPSE2):c.57dup (p.Ala20fs)	HPSE2		Urofacial syndrome 1	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000000090	10	100995502 - 100995503	10	99235745 - 99235746	90	15129	rs778121647	NC_000010.11:99235745:GGGGGGG:GGGGGGGG
NM_001166245.1(HPSE2):c.448+87957C>T	HPSE2	R153*	Urofacial syndrome 1	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000000089	10	100904148	10	99144391	89	15128	rs267606865	NC_000010.11:99144390:G:A
NM_021828.4(HPSE2):c.1414C>T (p.Arg472Ter)	HPSE2	R472*, R360*, R414*	Urofacial syndrome 1	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000000088	10	100249860	10	98490103	88	15127	rs267606864	NC_000010.11:98490102:G:A
HPSE2, EX3DEL	HPSE2		Urofacial syndrome 1	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000000087					87	15126		
NM_001220.5(CAMK2B):c.85C>T (p.Arg29Ter)	CAMK2B	R29*	not provided|Intellectual disability|Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000430920	7	44323805	7	44284206	430920	424469	rs1554434435	NC_000007.14:44284205:G:A
NM_032536.4(NTNG2):c.376dup (p.Ser126fs)	NTNG2		Generalized hypotonia|Stereotypical hand wringing|Global developmental delay|Areflexia|NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA	Pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000690370	9	135073512 - 135073513	9	132198125 - 132198126	690370	678055		NC_000009.12:132198125:TTT:TTTT
GRCh37/hg19 8q23.1(chr8:110059050-110132754)x1	TRHR		not provided	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000686772	8	110059050 - 110132754			686772	674364		
NM_198334.3(GANAB):c.181C>T (p.Arg61Ter)	GANAB	R61*	not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000620175	11	62406902	11	62639430	620175	611751	rs760625230	NC_000011.10:62639429:G:A
NM_198334.3(GANAB):c.2590C>T (p.Arg864Ter)	GANAB	R886*, R750*, R767*, R772*, R623*, R864*	Polycystic liver disease	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000590352	11	62393841	11	62626369	590352	581284	rs1210158408	NC_000011.10:62626368:G:A
NM_198334.3(GANAB):c.2443C>T (p.Arg815Ter)	GANAB	R837*, R574*, R723*, R701*, R815*, R718*	Polycystic liver disease	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000590351	11	62394111	11	62626639	590351	581285	rs1565088616	NC_000011.10:62626638:G:A
NM_198334.3(GANAB):c.1936+1G>C	GANAB		Polycystic liver disease	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000590350	11	62396665	11	62629193	590350	581287	rs1565092899	NC_000011.10:62629192:C:G
NM_198334.3(GANAB):c.1769G>C (p.Arg590Pro)	GANAB	R612P, R349P, R590P, R476P, R498P, R493P	Polycystic liver disease	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000590349	11	62397125	11	62629653	590349	581290	rs1465649718	NC_000011.10:62629652:C:G
NM_198334.3(GANAB):c.621del (p.Asp207fs)	GANAB	D229fs, D93fs, D110fs, D115fs, D207fs	Polycystic liver disease	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000590348	11	62400926	11	62633454	590348	581292	rs1565099895	NC_000011.10:62633453:A:
NM_003301.6(TRHR):c.392T>C (p.Ile131Thr)	TRHR	I131T	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7	Pathogenic(Last reviewed: Sep 6, 2019)	no assertion criteria provided	VCV000689396	8	110100133	8	109087904	689396	676988		NC_000008.11:109087903:T:C
NM_003301.6(TRHR):c.242C>G (p.Pro81Arg)	TRHR	P81R	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7	Pathogenic(Last reviewed: Sep 5, 2019)	no assertion criteria provided	VCV000689395	8	110099983	8	109087754	689395	676987		NC_000008.11:109087753:C:G
NM_198334.3(GANAB):c.2725+4_2725+12del	GANAB		POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Feb 21, 2018)	no assertion criteria provided	VCV000492969	11	62393525 - 62393533	11	62626053 - 62626061	492969	485919		NC_000011.10:62626052:TTGGTCACT:
NM_198334.3(GANAB):c.150_151GA[1] (p.Arg51fs)	GANAB		POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000253133	11	62406930 - 62406931	11	62639458 - 62639459	253133	247545	rs752158933	NC_000011.10:62639457:TCTCT:TCT
NM_198334.3(GANAB):c.2449C>T (p.Arg817Trp)	GANAB	R839W, R703W, R725W, R817W, R576W, R720W	POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000253132	11	62394105	11	62626633	253132	247544	rs879255643	NC_000011.10:62626632:G:A
NM_198334.3(GANAB):c.2624+2_2624+7del	GANAB		POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000253131	11	62393800 - 62393805	11	62626328 - 62626333	253131	247543	rs886037848	NC_000011.10:62626327:CCATTACC:CC
NM_198334.3(GANAB):c.1148C>G (p.Thr383Arg)	GANAB	T405R, T269R, T142R, T286R, T383R, T291R	POLYCYSTIC KIDNEY DISEASE 3 WITHOUT POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000253130	11	62398504	11	62631032	253130	247542	rs879255642	NC_000011.10:62631031:G:C
NM_198334.3(GANAB):c.1199G>T (p.Arg400Leu)	GANAB	R422L, R159L, R286L, R303L, R308L, R400L	POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000253128	11	62398260	11	62630788	253128	247540	rs770519542	NC_000011.10:62630787:C:A
NM_004356.3(CD81):c.561+1G>A	CD81		Common variable immunodeficiency 6	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000012743	11	2417201	11	2395971	12743	27782	rs587776775	NC_000011.10:2395970:G:A
NM_003301.6(TRHR):c.343_352delinsA (p.Ser115_Ala118delinsThr)	TRHR	A118T	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000012681	8	110100084 - 110100093	8	109087855 - 109087864	12681	27720		NC_000008.11:109087854:TCAATAACAG:A
NM_001708.2(OPN1SW):c.640T>C (p.Ser214Pro)	OPN1SW	S214P	Tritanopia	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000000063	7	128414599	7	128774545	63	15102	rs104894032	NC_000007.14:128774544:A:G
NM_017696.2(MCM9):c.394C>T (p.Arg132Ter)	MCM9	R132*	Ovarian dysgenesis 4|Premature ovarian failure 1	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000156588	6	119245203	6	118924038	156588	166441	rs587777872	NC_000006.12:118924037:G:A
NM_198334.3(GANAB):c.1848_1849del (p.Asp618fs)	GANAB	D377fs, D618fs, D504fs, D521fs, D526fs, D640fs	Polycystic kidney disease 3	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000253129	11	62396753 - 62396754	11	62629281 - 62629282	253129	247541	rs879255641	NC_000011.10:62629280:CT:
H19, 1.43-KB TRIPLICATION	H19		Wilms tumor 2	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000018244					18244	33283		
NM_003301.6(TRHR):c.49C>T (p.Arg17Ter)	TRHR	R17*	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7	Pathogenic(Last reviewed: Feb 12, 2009)	no assertion criteria provided	VCV000012682	8	110099790	8	109087561	12682	27721	rs121917847	NC_000008.11:109087560:C:T
NM_001708.2(OPN1SW):c.790C>T (p.Pro264Ser)	OPN1SW	P264S	Tritanopia	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000000064	7	128413840	7	128773786	64	15103	rs104894033	NC_000007.14:128773785:G:A
NM_198334.3(GANAB):c.11_16del (p.Val4_Ala5del)	GANAB		Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000590347	11	62414056 - 62414061	11	62646584 - 62646589	590347	581294	rs750723025	NC_000011.10:62646583:CCGCTACCGC:CCGC
NM_021828.4(HPSE2):c.1516C>T (p.Arg506Ter)	HPSE2	R506*, R394*, R448*	Urofacial syndrome 1|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000000083	10	100242490	10	98482733	83	15122	rs267606866	NC_000010.11:98482732:G:A
NM_001142519.3(FAM111A):c.1706G>A (p.Arg569His)	FAM111A	R569H	Kenny-Caffey syndrome type 2|not provided|Osteocraniostenosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056810	11	58920847	11	59153374	56810	71437	rs587777011	NC_000011.10:59153373:G:A
H19, 1.8-KB DEL	H19		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000018242					18242	33281		
NC_000008.10:g.119379055_119379157TGAAA[100_?]TAAAA[40_?]	SAMD12		Epilepsy, familial adult myoclonic, 1	Pathogenic	no assertion criteria provided	VCV000800660	8	119379055 - 119379157			800660	789260		
GRCh37/hg19 8q12.3(chr8:62449005-62474645)x1	ASPH		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000689195	8	62449005 - 62474645			689195	676787		
NM_018294.6(CWF19L1):c.779del (p.Asp260fs)	CWF19L1	D123fs, D15fs, D260fs	not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000504028	10	102006622	10	100246865	504028	495446	rs1554904186	NC_000010.11:100246864:T:
NM_018294.6(CWF19L1):c.622C>T (p.Arg208Ter)	CWF19L1	R208*, R71*	not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000419610	10	102013179	10	100253422	419610	407798	rs150239404	NC_000010.11:100253421:G:A
NM_018294.6(CWF19L1):c.850-2A>G	CWF19L1		not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000379851	10	102005672	10	100245915	379851	370574	rs1057520757	NC_000010.11:100245914:T:C
NM_004318.4(ASPH):c.171G>A (p.Trp57Ter)	ASPH	W57*, W28*	Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs	Pathogenic(Last reviewed: Mar 22, 2019)	no assertion criteria provided	VCV000623642	8	62596680	8	61684121	623642	612467	rs1563580963	NC_000008.11:61684120:C:T
NM_015239.2(AGTPBP1):c.1960T>G (p.Tyr654Asp)	AGTPBP1	Y694D, Y654D, Y746D, Y706D	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	VCV000599370	9	88236136	9	85621221	599370	590705	rs1564071824	NC_000009.12:85621220:A:C
NM_015239.2(AGTPBP1):c.2632C>T (p.Arg878Trp)	AGTPBP1	R918W, R930W, R970W, R878W	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	VCV000599369	9	88203364	9	85588449	599369	590704	rs1564035967	NC_000009.12:85588448:G:A
NM_015239.2(AGTPBP1):c.2242C>T (p.Gln748Ter)	AGTPBP1	Q788*, Q748*, Q840*, Q800*	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	VCV000599368	9	88211338	9	85596423	599368	590703	rs1564046794	NC_000009.12:85596422:G:A
NM_015239.2(AGTPBP1):c.2849A>T (p.His950Leu)	AGTPBP1	H990L, H950L, H1002L, H1042L	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Pathogenic(Last reviewed: Jan 11, 2019)	no assertion criteria provided	VCV000599367	9	88201810	9	85586895	599367	590702	rs1564034077	NC_000009.12:85586894:T:A
NM_015239.2(AGTPBP1):c.2432C>T (p.Thr811Met)	AGTPBP1	T851M, T903M, T811M, T863M	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Pathogenic(Last reviewed: Jan 11, 2019)	no assertion criteria provided	VCV000599366	9	88207491	9	85592576	599366	590701	rs760300826	NC_000009.12:85592575:G:A
NM_015239.2(AGTPBP1):c.2446C>T (p.Gln816Ter)	AGTPBP1	Q856*, Q868*, Q908*, Q816*	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Pathogenic(Last reviewed: Jan 11, 2019)	no assertion criteria provided	VCV000599365	9	88207477	9	85592562	599365	590700	rs1564041582	NC_000009.12:85592561:G:A
NM_145868.2(ANXA11):c.523G>A (p.Gly175Arg)	ANXA11	G175R, G142R		Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000488355	10	81928763	10	80169007	488355	481195	rs754594235	NC_000010.11:80169006:C:T
NM_145868.2(ANXA11):c.112G>A (p.Gly38Arg)	ANXA11	G38R, G5R		Pathogenic(Last reviewed: Jan 30, 2018)	no assertion criteria provided	VCV000488354	10	81930615	10	80170859	488354	481194	rs142083484	NC_000010.11:80170858:C:T
NM_145868.2(ANXA11):c.119A>G (p.Asp40Gly)	ANXA11	D40G, D7G		Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000488353	10	81930608	10	80170852	488353	481193	rs1247392012	NC_000010.11:80170851:T:C
NM_001655.5(ARCN1):c.633del (p.Val212fs)	ARCN1	V124fs, V212fs	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	Pathogenic(Last reviewed: Oct 19, 2016)	no assertion criteria provided	VCV000267210	11	118454706	11	118583991	267210	262089	rs886040860	NC_000011.10:118583990:AAAA:AAA
NM_001655.5(ARCN1):c.260C>A (p.Ser87Ter)	ARCN1	S87*	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	Pathogenic(Last reviewed: Oct 19, 2016)	no assertion criteria provided	VCV000267209	11	118452217	11	118581502	267209	262088	rs886040859	NC_000011.10:118581501:C:A
NM_018294.6(CWF19L1):c.467del (p.Pro156fs)	CWF19L1	P156fs, P19fs	Spinocerebellar ataxia, autosomal recessive 17	Pathogenic(Last reviewed: Aug 24, 2016)	no assertion criteria provided	VCV000253212	10	102016056	10	100256299	253212	247631	rs879255654	NC_000010.11:100256298:GGGG:GGG
NM_018294.6(CWF19L1):c.946A>T (p.Lys316Ter)	CWF19L1	D13H, K316*, K71*, K179*	Spinocerebellar ataxia, autosomal recessive 17	Pathogenic(Last reviewed: Aug 24, 2016)	no assertion criteria provided	VCV000253210	10	102005574	10	100245817	253210	247629	rs879255653	NC_000010.11:100245816:T:A
NM_004318.4(ASPH):c.1852_1856delinsGGG (p.Asn618fs)	ASPH		Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000137614	8	62438580 - 62438584	8	61526021 - 61526025	137614	141317	rs879255574	NC_000008.11:61526020:AGGTT:CCC
NM_001286715.1(AGTPBP1):c.2998C>T (p.Arg1000Ter)	AGTPBP1	R1000*, R948*, R908*, R960*	Global developmental delay|Aplasia/Hypoplasia of the cerebellum	Pathogenic	no assertion criteria provided	VCV000599381	9	88203274	9	85588359	599381	590718		NC_000009.12:85588358:G:A
SAMD12, 5-BP INS, TTTCA(n), IVS4	SAMD12		Epilepsy, familial adult myoclonic, 1	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000560216					560216	551266		
NM_001655.5(ARCN1):c.153_154AG[2] (p.Ser53fs)	ARCN1		Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	Pathogenic(Last reviewed: Oct 19, 2016)	no assertion criteria provided	VCV000267208	11	118452110 - 118452111	11	118581395 - 118581396	267208	262087	rs886040858	NC_000011.10:118581394:AGAGAG:AGAG
NM_001166244.1(HPSE2):c.1291_1292del (p.Asn431fs)	HPSE2	N377fs, N431fs, N489fs	Urofacial syndrome 1	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000000084	10	100249808 - 100249809	10	98490051 - 98490052	84	15123	rs397515338	NC_000010.11:98490050:TT:
NM_004318.4(ASPH):c.2203C>T (p.Arg735Trp)	ASPH	R735W, R706W	Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000137615	8	62415992	8	61503433	137615	141318	rs374385878	NC_000008.11:61503432:G:A
PPP1R3A, 2-BP DEL, 1985AG	PPP1R3A		Diabetes mellitus, type II, digenic|Insulin resistance, severe, digenic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000008707					8707	23746		
H19, 5.3-KB DEL	H19		Beckwith-Wiedemann syndrome|Wilms tumor 2	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000018243					18243	33282		
NM_001286715.1(AGTPBP1):c.2892del (p.Tyr964Terfs)	AGTPBP1		NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY|AGTPBP1-related condition	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000522817	9	88203380	9	85588465	522817	513435	rs780631499	NC_000009.12:85588464:G:
NM_001286715.1(AGTPBP1):c.2492-1G>T	AGTPBP1		NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY|AGTPBP1-related condition	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000522816	9	88211365	9	85596450	522816	513436	rs1554699491	NC_000009.12:85596449:C:A
NM_018294.6(CWF19L1):c.964+1G>A	CWF19L1		Spinocerebellar ataxia, autosomal recessive 17|not provided	Pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	VCV000128882	10	102005555	10	100245798	128882	134329	rs587780326	NC_000010.11:100245797:C:T
NM_198569.3(ADGRG6):c.738dup (p.Ala247fs)	ADGRG6		not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000504275	6	142691594 - 142691595	6	142370457 - 142370458	504275	495300	rs1349317802	NC_000006.12:142370457:TTTTT:TTTTTT
NM_138701.4(MPLKIP):c.173dup (p.Ser58_Arg59insTer)	MPLKIP		not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000280512	7	40173993 - 40173994	7	40134394 - 40134395	280512	264335	rs886041703	NC_000007.14:40134394:G:GG
NM_138701.4(MPLKIP):c.505dup (p.Thr169fs)	MPLKIP		Trichothiodystrophy 1, photosensitive	Pathogenic	no assertion criteria provided	VCV000218158	7	40172692 - 40172693	7	40133093 - 40133094	218158	214806	rs768342562	NC_000007.14:40133093:TTT:TTTT
NM_001354.5(AKR1C2):c.666T>C (p.His222=)	AKR1C2		CIC-DUX Sarcoma	Pathogenic	no assertion criteria provided	VCV000805966	10	5037962	10	4995770	805966	794307	rs13222	NC_000010.11:4995769:A:G
NM_024077.5(SECISBP2):c.800dup (p.Gly268_Glu269insTer)	SECISBP2		Thyroid hormone metabolism, abnormal	Pathogenic(Last reviewed: Jul 31, 2019)	no assertion criteria provided	VCV000638567	9	91943797 - 91943798	9	89328882 - 89328883	638567	626354		NC_000009.12:89328882:AAA:AAAA
NM_018063.5(HELLS):c.2394_2396GTT[2] (p.Leu801del)	HELLS	L801del, L847del	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000225528	10	96356840 - 96356842	10	94597083 - 94597085	225528	227435	rs879253737	NC_000010.11:94597082:GTTGTTGTT:GTTGTT
NM_018063.5(HELLS):c.374_381dup (p.Lys128Ter)	HELLS		Immunodeficiency-centromeric instability-facial anomalies syndrome 4	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000225527	10	96322570 - 96322571	10	94562813 - 94562814	225527	227434	rs879253736	NC_000010.11:94562813:ATGAGGAAA:ATGAGGAAATGAGGAAA
NM_018063.5(HELLS):c.610A>T (p.Lys204Ter)	HELLS	K204*, K188*, K80*, K66*	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000225526	10	96333849	10	94574092	225526	227433	rs879253735	NC_000010.11:94574091:A:T
NM_018063.5(HELLS):c.2283_2286del (p.Ser762fs)	HELLS	S356fs, S746fs, S762fs, S624fs, S730fs, S808fs, S632fs, S638fs, S401fs, S664fs	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000225525	10	96356648 - 96356651	10	94596891 - 94596894	225525	227432	rs879253734	NC_000010.11:94596890:TCTGTCT:TCT
NM_018063.5(HELLS):c.370+2T>A	HELLS		Immunodeficiency-centromeric instability-facial anomalies syndrome 4	Pathogenic(Last reviewed: Apr 21, 2016)	no assertion criteria provided	VCV000225524	10	96322486	10	94562729	225524	227431	rs140316223	NC_000010.11:94562728:T:A
NM_001354.5(AKR1C2):c.666T>G (p.His222Gln)	AKR1C2	H222Q, H196Q	46,XY sex reversal 8	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030067	10	5037962	10	4995770	30067	39022	rs13222	NC_000010.11:4995769:A:C
NM_001354.5(AKR1C2):c.899A>C (p.Asn300Thr)	AKR1C2	N300T, N274T	46,XY sex reversal 8	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030066	10	5034053	10	4991861	30066	39021	rs387906751	NC_000010.11:4991860:T:G
NM_001354.5(AKR1C2):c.270T>G (p.His90Gln)	AKR1C2	H90Q	46,XY sex reversal 8	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030065	10	5042841	10	5000649	30065	39020	rs797044460	NC_000010.11:5000648:A:C
NM_024077.5(SECISBP2):c.1212+29G>A	SECISBP2		Thyroid hormone metabolism, abnormal	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000002921	9	91953524	9	89338609	2921	17960	rs730880269	NC_000009.12:89338608:G:A
NM_024077.5(SECISBP2):c.1312A>T (p.Lys438Ter)	SECISBP2	K438*, K370*, K400*, K437*, K143*, K365*, K369*, K399*	Thyroid hormone metabolism, abnormal	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000002920	9	91956271	9	89341356	2920	17959	rs119461977	NC_000009.12:89341355:A:T
NM_024077.5(SECISBP2):c.1619G>A (p.Arg540Gln)	SECISBP2	R540Q, R245Q, R472Q, R501Q, R502Q, R539Q, R467Q, R471Q	Thyroid hormone metabolism, abnormal	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000002919	9	91963010	9	89348095	2919	17958	rs119461976	NC_000009.12:89348094:G:A
NM_138701.4(MPLKIP):c.148_152del (p.His50fs)	MPLKIP	H50fs	Trichothiodystrophy, nonphotosensitive 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001848	7	40174015 - 40174019	7	40134416 - 40134420	1848	16887	rs878854339	NC_000007.14:40134415:GTGTGGTG:GTG
NM_018063.5(HELLS):c.2096A>G (p.Gln699Arg)	HELLS	Q699R, Q745R, Q293R, Q561R, Q569R, Q338R, Q667R, Q683R, Q575R, Q601R	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000225523	10	96354459	10	94594702	225523	227430	rs879253733	NC_000010.11:94594701:A:G
NM_138701.4(MPLKIP):c.339+1G>A	MPLKIP		Trichothiodystrophy, nonphotosensitive 1	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000224867	7	40173827	7	40134228	224867	226712	rs869312900	NC_000007.14:40134227:C:T
NM_001354.5(AKR1C2):c.235A>G (p.Ile79Val)	AKR1C2	I79V	46,XY sex reversal 8	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030064	10	5043723	10	5001531	30064	39019	rs387906750	NC_000010.11:5001530:T:C
MPLKIP, EX1-2DEL	MPLKIP		Trichothiodystrophy, nonphotosensitive 1	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000001846					1846	16885		
NM_138701.4(MPLKIP):c.137_138del (p.Gly46fs)	MPLKIP	G46fs	Trichothiodystrophy, nonphotosensitive 1	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000001845	7	40174029 - 40174030	7	40134430 - 40134431	1845	16884	rs587776531	NC_000007.14:40134429:CCC:C
NM_138701.4(MPLKIP):c.430A>G (p.Met144Val)	MPLKIP	M144V	Trichothiodystrophy, nonphotosensitive 1	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000001844	7	40172768	7	40133169	1844	16883	rs137853117	NC_000007.14:40133168:T:C
NM_198569.3(ADGRG6):c.2306T>A (p.Val769Glu)	ADGRG6	V769E	Arthrogryposis multiplex congenita|Lethal congenital contracture syndrome 9	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000192349	6	142729324	6	142408187	192349	190137	rs793888525	NC_000006.12:142408186:T:A
NM_198569.3(ADGRG6):c.2144dup (p.Gln716fs)	ADGRG6		Arthrogryposis multiplex congenita|Lethal congenital contracture syndrome 9	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000192348	6	142726839 - 142726840	6	142405702 - 142405703	192348	190136	rs793888524	NC_000006.12:142405702:GG:GGG
NM_138701.4(MPLKIP):c.277del (p.Ser93fs)	MPLKIP	S93fs	Trichothiodystrophy, nonphotosensitive 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000001847	7	40173890	7	40134291	1847	16886	rs587776532	NC_000007.14:40134290:A:
NM_198569.3(ADGRG6):c.19C>T (p.Arg7Ter)	ADGRG6	R7*	Arthrogryposis multiplex congenita|Lethal congenital contracture syndrome 9	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000192347	6	142630697	6	142309560	192347	190135	rs749355583	NC_000006.12:142309559:C:T
NM_012479.4(YWHAG):c.395G>A (p.Arg132His)	YWHAG	R132H	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000807723	7	75959243	7	76329926	807723	798591		NC_000007.14:76329925:C:T
NM_012479.4(YWHAG):c.451G>T (p.Glu151Ter)	YWHAG	E151*	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802325	7	75959187	7	76329870	802325	790752		NC_000007.14:76329869:C:A
NM_001292034.3(TAB2):c.1321C>T (p.Arg441Ter)	TAB2	R441*, R409*	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488615	6	149700372	6	149379236	488615	481483	rs1554263321	NC_000006.12:149379235:C:T
NM_001292034.3(TAB2):c.911_912CA[1] (p.Gln305fs)	TAB2		not provided	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000422085	6	149699962 - 149699963	6	149378826 - 149378827	422085	406826	rs1064795547	NC_000006.12:149378825:CACA:CA
NM_001292034.3(TAB2):c.251C>A (p.Ser84Ter)	TAB2	S84*, S52*	not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000373469	6	149699302	6	149378166	373469	359722	rs1057518437	NC_000006.12:149378165:C:A
NM_001292034.3(TAB2):c.1386del (p.Lys461_Tyr462insTer)	TAB2		not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000280439	6	149700437	6	149379301	280439	264201	rs886041646	NC_000006.12:149379300:C:
NM_014489.4(PGAP2):c.391G>T (p.Glu131Ter)	PGAP2	E110*, E121*, E127*, E131*, E188*, E70*, E88*, G111V, G73V	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Aug 23, 2019)	no assertion criteria provided	VCV000827783	11	3845155	11	3823925	827783	815994		NC_000011.10:3823924:G:T
NM_014489.4(PGAP2):c.2T>G (p.Met1Arg)	PGAP2	C13G, M1R, M52R, M58R	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic	criteria provided, single submitter	VCV000694699	11	3832491	11	3811261	694699	682817		NC_000011.10:3811260:T:G
NM_001145860.2(POP1):c.1531G>T (p.Asp511Tyr)	POP1	D511Y	Anauxetic dysplasia 2	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000417738	8	99153053	8	98140825	417738	404639	rs1060505025	NC_000008.11:98140824:G:T
NM_001145860.2(POP1):c.2607del (p.Glu870fs)	POP1	E870fs	Anauxetic dysplasia 2	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000417737	8	99170028	8	98157800	417737	404638	rs1060505024	NC_000008.11:98157799:CCCC:CCC
NM_001145860.2(POP1):c.1748G>A (p.Gly583Glu)	POP1	G583E	Anauxetic dysplasia 2	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000393589	8	99161080	8	98148852	393589	380480	rs374828868	NC_000008.11:98148851:G:A
NM_001145860.2(POP1):c.1573C>T (p.Pro525Ser)	POP1	P525S, R513*	Anauxetic dysplasia 2	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000393588	8	99153095	8	98140867	393588	380479	rs769183311	NC_000008.11:98140866:C:T
NM_014489.4(PGAP2):c.491C>T (p.Thr164Ile)	PGAP2	T160I, T121I, T221I, T103I, T154I, T164I, T143I	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050506	11	3845255	11	3824025	50506	59545	rs587776970	NC_000011.10:3824024:C:T
NM_014489.4(PGAP2):c.46C>T (p.Arg16Trp)	PGAP2	R16W, R73W, R67W	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050505	11	3832535	11	3811305	50505	59544	rs773359554	NC_000011.10:3811304:C:T
NM_014489.4(PGAP2):c.563T>C (p.Leu188Ser)	PGAP2	L127S, L145S, L167S, L178S, L184S, L188S, L245S	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050504	11	3845327	11	3824097	50504	59543	rs879255233	NC_000011.10:3824096:T:C
NM_001292034.3(TAB2):c.688C>A (p.Gln230Lys)	TAB2	Q230K, Q198K	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000005212	6	149699739	6	149378603	5212	20251	rs267607100	NC_000006.12:149378602:C:A
NM_001292034.3(TAB2):c.622C>T (p.Pro208Ser)	TAB2	P208S, P176S	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000005211	6	149699673	6	149378537	5211	20250	rs267607101	NC_000006.12:149378536:C:T
NM_001292034.3(TAB2):c.1491T>A (p.Tyr497Ter)	TAB2	Y497*, Y465*	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561123	6	149700542	6	149379406	561123	552095	rs1562443558	NC_000006.12:149379405:T:A
NM_001145860.2(POP1):c.1744C>T (p.Pro582Ser)	POP1	P582S	Anauxetic dysplasia 2	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000417736	8	99161076	8	98148848	417736	404637	rs1060505023	NC_000008.11:98148847:C:T
NM_014489.4(PGAP2):c.479A>G (p.Tyr160Cys)	PGAP2	Y99C, Y117C, Y156C, Y217C, Y139C, Y150C, Y160C	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050502	11	3845243	11	3824013	50502	59541	rs879255232	NC_000011.10:3824012:A:G
NM_001292034.3(TAB2):c.679C>T (p.Arg227Ter)	TAB2	R227*, R195*	Congenital heart defects, multiple types, 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561124	6	149699730	6	149378594	561124	552094	rs1479104927	NC_000006.12:149378593:C:T
NM_014489.4(PGAP2):c.713G>C (p.Arg238Pro)	PGAP2	R177P, R195P, R230P, R173P, R217P, R234P, R295P, R228P, R238P	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic	criteria provided, single submitter	VCV000050503	11	3846254	11	3825024	50503	59542	rs774843232	NC_000011.10:3825023:G:C
NM_001254752.1(UQCRB):c.*20_*23del	UQCRB	R105fs, R73fs	not provided	Pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000286054	8	97243310 - 97243313	8	96231082 - 96231085	286054	270291	rs886043294	NC_000008.11:96231081:TTTT:
NM_006294.4(UQCRB):c.274del (p.Glu92fs)	UQCRB	E60fs, E92fs, N138fs	not provided	Pathogenic(Last reviewed: Jul 29, 2013)	criteria provided, single submitter	VCV000215348	8	97243345	8	96231117	215348	211352	rs863224259	NC_000008.11:96231116:C:
NM_018965.3(TREM2):c.197C>T (p.Thr66Met)	TREM2	T66M	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000192242	6	41129195	6	41161457	192242	190040	rs201258663	NC_000006.12:41161456:G:A
NM_018965.3(TREM2):c.113A>G (p.Tyr38Cys)	TREM2	Y38C	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000192241	6	41129279	6	41161541	192241	190041	rs797044603	NC_000006.12:41161540:T:C
UQCRB, 4-BP DEL, NT338	UQCRB		Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000012299					12299	27338		
NM_001300.6(KLF6):c.506T>C (p.Leu169Pro)	KLF6	L169P	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	VCV000007573	10	3824003	10	3781811	7573	22612	rs121909143	NC_000010.11:3781810:A:G
NM_001300.6(KLF6):c.190T>C (p.Trp64Arg)	KLF6	W64R	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	VCV000007572	10	3824319	10	3782127	7572	22611	rs121909142	NC_000010.11:3782126:A:G
NM_001300.6(KLF6):c.368C>A (p.Ala123Asp)	KLF6	A123D	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	VCV000007571	10	3824141	10	3781949	7571	22610	rs121909141	NC_000010.11:3781948:G:T
NM_001300.6(KLF6):c.410C>A (p.Ser137Ter)	KLF6	S137*	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	VCV000007570	10	3824099	10	3781907	7570	22609	rs121909140	NC_000010.11:3781906:G:T
NM_001300.6(KLF6):c.346T>C (p.Ser116Pro)	KLF6	S116P	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	VCV000007569	10	3824163	10	3781971	7569	22608	rs121909139	NC_000010.11:3781970:A:G
TREM2, IVS3DS, T-C, +2	TREM2		POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000005216					5216	20255		
NM_001300.6(KLF6):c.465C>A (p.Ser155Arg)	KLF6	S155R	Neoplasm of stomach	Pathogenic(Last reviewed: Jun 30, 2005)	no assertion criteria provided	VCV000007574	10	3824044	10	3781852	7574	22613	rs121909144	NC_000010.11:3781851:G:T
NM_001271821.2(TREM2):c.40+4_40+6del	TREM2		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000056723	6	41130775 - 41130777	6	41163037 - 41163039	56723	71362	rs386834142	NC_000006.12:41163036:TCCT:T
NM_030954.4(RNF170):c.595C>T (p.Arg199Cys)	RNF170	R199C, R115C	Ataxia, sensory, autosomal dominant	Pathogenic(Last reviewed: May 29, 2015)	no assertion criteria provided	VCV000031590	8	42711484	8	42856341	31590	40274	rs397514478	NC_000008.11:42856340:G:A
NM_018965.3(TREM2):c.40G>T (p.Glu14Ter)	TREM2	E14*	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000056724	6	41130781	6	41163043	56724	71363	rs386834143	NC_000006.12:41163042:C:A
NM_178161.3(PTF1A):c.571C>A (p.Pro191Thr)	PTF1A	P191T	Pancreatic agenesis 2	Pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800794	10	23482030	10	23193101	800794	788841		NC_000010.11:23193100:C:A
NM_152732.5(RSPH9):c.466C>T (p.Arg156Ter)	RSPH9	R156*, R141*	not provided	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000502312	6	43623371	6	43655634	502312	493736	rs376496894	NC_000006.12:43655633:C:T
NM_152732.5(RSPH9):c.333T>G (p.Tyr111Ter)	RSPH9	Y111*	not provided	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000379253	6	43618217	6	43650480	379253	370449	rs1057520543	NC_000006.12:43650479:T:G
NM_178161.3(PTF1A):c.705del (p.Pro236fs)	PTF1A	P236fs	not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000265703	10	23482159	10	23193230	265703	259936	rs886039746	NC_000010.11:23193229:GGGGGG:GGGGG
NM_004551.3(NDUFS3):c.568_569del (p.Asp190fs)	NDUFS3	D190fs	not provided	Pathogenic(Last reviewed: May 2, 2012)	criteria provided, single submitter	VCV000214807	11	47603960 - 47603961	11	47582408 - 47582409	214807	211539	rs863224107	NC_000011.10:47582407:AGA:A
NM_004551.3(NDUFS3):c.2T>G (p.Met1Arg)	NDUFS3	M1R	not provided	Pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	VCV000214805	11	47600645	11	47579093	214805	211535	rs863224106	NC_000011.10:47579092:T:G
NM_014285.7(EXOSC2):c.593G>A (p.Gly198Asp)	EXOSC2	G198D, G168D, G172D	Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome	Pathogenic(Last reviewed: Nov 10, 2017)	no assertion criteria provided	VCV000446203	9	133577618	9	130702231	446203	439563	rs756204866	NC_000009.12:130702230:G:A
NM_014285.7(EXOSC2):c.89G>T (p.Gly30Val)	EXOSC2	G30V	Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome	Pathogenic(Last reviewed: Nov 10, 2017)	no assertion criteria provided	VCV000446202	9	133569267	9	130693880	446202	439562	rs537467155	NC_000009.12:130693879:G:T
NM_006438.5(COLEC10):c.528C>G (p.Cys176Trp)	COLEC10	C176W, C107W		Pathogenic(Last reviewed: Apr 13, 2017)	no assertion criteria provided	VCV000417735	8	120118124	8	119105885	417735	404636	rs773764995	NC_000008.11:119105884:C:G
NM_006438.5(COLEC10):c.228del (p.Gly77fs)	COLEC10	G77fs, G8fs		Pathogenic(Last reviewed: Apr 13, 2017)	no assertion criteria provided	VCV000417734	8	120103393	8	119091154	417734	404635	rs1060505022	NC_000008.11:119091153:AAA:AA
NM_004055.5(CAPN5):c.731T>C (p.Leu244Pro)	CAPN5	L244P	Vitreoretinopathy, neovascular inflammatory	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000039807	11	76826472	11	77115426	39807	48406	rs397514602	NC_000011.10:77115425:T:C
PTF1A, 24-BP DEL, NT437	PTF1A		Diabetes mellitus, permanent neonatal, with cerebellar agenesis	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030651					30651	39608		
NM_178161.3(PTF1A):c.705dup (p.Pro236fs)	PTF1A		Diabetes mellitus, permanent neonatal, with cerebellar agenesis	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000003426	10	23482158 - 23482159	10	23193229 - 23193230	3426	18465		NC_000010.11:23193229:GGGGGG:GGGGGGG
NM_152732.5(RSPH9):c.200del (p.Gln67fs)	RSPH9	Q67fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000639923	6	43613035	6	43645298	639923	634935		NC_000006.12:43645297:A:
NM_152732.5(RSPH9):c.283C>T (p.Gln95Ter)	RSPH9	Q95*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000581601	6	43618167	6	43650430	581601	560861	rs1436804091	NC_000006.12:43650429:C:T
NM_152732.5(RSPH9):c.52C>T (p.Gln18Ter)	RSPH9	Q18*	Ciliary dyskinesia, primary, 12	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066995	6	43612887	6	43645150	66995	77880	rs397515488	NC_000006.12:43645149:C:T
NM_004055.5(CAPN5):c.728G>T (p.Arg243Leu)	CAPN5	R243L	Vitreoretinopathy, neovascular inflammatory	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000039806	11	76826469	11	77115423	39806	48405	rs397514601	NC_000011.10:77115422:G:T
NM_033164.4(FGF8):c.346C>G (p.Arg116Gly)	FGF8	R127G, R98G, R116G, R23G, R87G		Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000009125	10	103531285	10	101771528	9125	24164	rs137852663	NC_000010.11:101771527:G:C
NM_033164.4(FGF8):c.265A>G (p.Lys89Glu)	FGF8	K100E, K60E, K89E, K71E		Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000009124	10	103534528	10	101774771	9124	24163	rs137852662	NC_000010.11:101774770:T:C
NM_033164.4(FGF8):c.118T>C (p.Phe40Leu)	FGF8	F40L		Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000009123	10	103534925	10	101775168	9123	24162	rs137852661	NC_000010.11:101775167:A:G
NM_033164.4(FGF8):c.40C>A (p.His14Asn)	FGF8	H14N		Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000009121	10	103535526	10	101775769	9121	24160	rs137852659	NC_000010.11:101775768:G:T
NM_178161.3(PTF1A):c.886C>T (p.Arg296Ter)	PTF1A	R296*	Diabetes mellitus, permanent neonatal, with cerebellar agenesis	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000003425	10	23482734	10	23193805	3425	18464	rs104894186	NC_000010.11:23193804:C:T
NM_033164.4(FGF8):c.526_540del (p.Arg176_Gly180del)	FGF8		Holoprosencephaly sequence	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000545457	10	103530248 - 103530262	10	101770491 - 101770505	545457	535717	rs1554834321	NC_000010.11:101770490:GCCCTTGCGGGGCCGGCCCTTGCGGG:GCCCTTGCGGG
NM_152732.5(RSPH9):c.117C>A (p.Tyr39Ter)	RSPH9	Y39*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000525272	6	43612952	6	43645215	525272	522382	rs1233811324	NC_000006.12:43645214:C:A
NM_004055.5(CAPN5):c.865C>T (p.Arg289Trp)	CAPN5	R289W	not provided|Vitreoretinopathy, neovascular inflammatory	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000279987	11	76826606	11	77115560	279987	264453	rs886041303	NC_000011.10:77115559:C:T
NM_012415.3(RAD54B):c.1252G>T (p.Asp418Tyr)	RAD54B	D418Y, D234Y	Carcinoma of colon	Pathogenic(Last reviewed: Jun 3, 1999)	no assertion criteria provided	VCV000005639	8	95411768	8	94399540	5639	20678	rs119490107	NC_000008.11:94399539:C:A
NM_033164.4(FGF8):c.346C>T (p.Arg116Ter)	FGF8	R127*, R116*, R23*, R87*, R98*	|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000599013	10	103531285	10	101771528	599013	590112	rs137852663	NC_000010.11:101771527:G:A
NM_021729.5(VPS11):c.2536T>G (p.Cys846Gly)	VPS11	C846G, C836G	Leukodystrophy, hypomyelinating, 12|Leukoencephalopathy	Pathogenic(Last reviewed: Dec 17, 2015)	no assertion criteria provided	VCV000218366	11	118951899	11	119081189	218366	215093	rs34757931	NC_000011.10:119081188:T:G
NM_139315.3(TAF6):c.136C>T (p.Arg46Cys)	TAF6	R46C, R83C, R92C	Alazami-Yuan syndrome|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000180203	7	99711697	7	100114074	180203	178381	rs727503778	NC_000007.14:100114073:G:A
NM_033164.4(FGF8):c.352C>T (p.Arg118Ter)	FGF8	R129*, R100*, R118*, R25*, R89*	|Holoprosencephaly sequence	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	no assertion criteria provided	VCV000235082	10	103531279	10	101771522	235082	236854	rs876661330	NC_000010.11:101771521:G:A
GRCh37/hg19 6q23.3(chr6:138065475-138252638)x1	TNFAIP3		Autoinflammatory syndrome, familial, Behcet-like	Pathogenic	no assertion criteria provided	VCV000694368	6	138065475 - 138252638			694368	682261		
GRCh37/hg19 11p14.1(chr11:30217030-30276703)x1	FSHB		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	no assertion criteria provided	VCV000685976	11	30217030 - 30276703			685976	673568		
NM_001270508.2(TNFAIP3):c.1876_1877del (p.Leu626fs)	TNFAIP3	L626fs	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000423517	6	138200458 - 138200459	6	137879321 - 137879322	423517	406821	rs1064796470	NC_000006.12:137879320:CT:
NM_001270508.2(TNFAIP3):c.912del (p.Glu305fs)	TNFAIP3	E305fs	not provided	Pathogenic(Last reviewed: Feb 16, 2019)	criteria provided, single submitter	VCV000836614	6	138198316	6	137877179	836614	831618		NC_000006.12:137877178:AAAA:AAA
NM_001270508.2(TNFAIP3):c.1091_1094delinsAGGAA (p.Arg364fs)	TNFAIP3		not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000648194	6	138199673 - 138199676	6	137878536 - 137878539	648194	634656		NC_000006.12:137878535:GGAG:AGGAA
NM_002510.3(GPNMB):c.873_876GTTT[1] (p.Val293fs)	GPNMB		AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503502	7	23300246 - 23300249	7	23260627 - 23260630	503502	494925	rs773435101	NC_000007.14:23260626:TGTTTGTTT:TGTTT
NM_002510.3(GPNMB):c.717_718TG[1] (p.Val240fs)	GPNMB		AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503501	7	23300091 - 23300092	7	23260472 - 23260473	503501	494924	rs747723062	NC_000007.14:23260471:TGTG:TG
NM_002510.3(GPNMB):c.296del (p.Asn99fs)	GPNMB	N99fs	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503500	7	23293859	7	23254240	503500	494923	rs1554300664	NC_000007.14:23254239:AA:A
NM_002510.3(GPNMB):c.660T>G (p.Tyr220Ter)	GPNMB	Y220*	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503498	7	23299717	7	23260098	503498	494921	rs770211260	NC_000007.14:23260097:T:G
NM_001270508.2(TNFAIP3):c.727T>C (p.Cys243Arg)	TNFAIP3	C243R	not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000445906	6	138197225	6	137876088	445906	439178	rs1554225021	NC_000006.12:137876087:T:C
NM_001270508.2(TNFAIP3):c.801del (p.Pro268fs)	TNFAIP3	P268fs	Autoinflammatory syndrome, familial, Behcet-like	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000219113	6	138197297	6	137876160	219113	216915	rs864321685	NC_000006.12:137876159:GGG:GG
NM_001270508.2(TNFAIP3):c.918C>G (p.Tyr306Ter)	TNFAIP3	Y306*	Autoinflammatory syndrome, familial, Behcet-like	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000219112	6	138198325	6	137877188	219112	216914	rs864321684	NC_000006.12:137877187:C:G
NM_001270508.2(TNFAIP3):c.1809del (p.Thr604fs)	TNFAIP3	T604fs	Autoinflammatory syndrome, familial, Behcet-like	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000219111	6	138200388	6	137879251	219111	216913	rs864321683	NC_000006.12:137879250:GGGG:GGG
NM_001270508.2(TNFAIP3):c.671del (p.Phe224fs)	TNFAIP3	F224fs	Autoinflammatory syndrome, familial, Behcet-like	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000219109	6	138197167	6	137876030	219109	216911	rs864321682	NC_000006.12:137876029:TTT:TT
NM_001270508.2(TNFAIP3):c.680T>A (p.Leu227Ter)	TNFAIP3	L227*	Autoinflammatory syndrome, familial, Behcet-like	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000219108	6	138197178	6	137876041	219108	216910	rs864321625	NC_000006.12:137876040:T:A
NM_006721.4(ADK):c.89G>A (p.Gly30Glu)	ADK	G13E, G30E	Hypermethioninemia due to adenosine kinase deficiency	Pathogenic(Last reviewed: Oct 7, 2011)	no assertion criteria provided	VCV000029605	10	75960545	10	74200787	29605	38559	rs397514454	NC_000010.11:74200786:G:A
NM_002510.3(GPNMB):c.1056del (p.Pro353fs)	GPNMB	P353fs, P365fs	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503499	7	23306172	7	23266553	503499	494922	rs763065333	NC_000007.14:23266552:TT:T
NM_002510.3(GPNMB):c.565C>T (p.Arg189Ter)	GPNMB	R189*	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503497	7	23299622	7	23260003	503497	494920	rs140352180	NC_000007.14:23260002:C:T
NM_000510.3(FSHB):c.298T>C (p.Cys100Arg)	FSHB	C82R, C100R	Follicle-stimulating hormone deficiency, isolated	Pathogenic(Last reviewed: Nov 25, 2010)	no assertion criteria provided	VCV000189329	11	30255255	11	30233708	189329	187217	rs5030777	NC_000011.10:30233707:T:C
NM_000510.3(FSHB):c.282C>A (p.Tyr94Ter)	FSHB	Y76*, Y94*	Follicle-stimulating hormone deficiency, isolated	Pathogenic(Last reviewed: Nov 25, 2010)	no assertion criteria provided	VCV000016242	11	30255239	11	30233692	16242	31281	rs121909666	NC_000011.10:30233691:C:A
NM_000510.3(FSHB):c.205T>G (p.Cys69Gly)	FSHB	C51G, C69G	Follicle-stimulating hormone deficiency, isolated	Pathogenic(Last reviewed: Nov 25, 2010)	no assertion criteria provided	VCV000016241	11	30255162	11	30233615	16241	31280	rs5030776	NC_000011.10:30233614:T:G
NM_001270508.2(TNFAIP3):c.811C>T (p.Arg271Ter)	TNFAIP3	R271*	Autoinflammatory syndrome, familial, Behcet-like|not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000219110	6	138198218	6	137877081	219110	216912	rs864321626	NC_000006.12:137877080:C:T
NM_006721.4(ADK):c.953C>A (p.Ala318Glu)	ADK	A301E, A318E, A261E, A244E, H280N, A283E	Hypermethioninemia due to adenosine kinase deficiency	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000029603	10	76430016	10	74670258	29603	38557	rs397514452	NC_000010.11:74670257:C:A
NG_012130.1:g.(?_5165)_(7623_?)del	SNAI2		Partial albinism	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000007504	8	49831366 - 49833824	8	48918807 - 48921265	7504	22543		
NG_012130.1:g.(?_5165)_(7623_?)del	SNAI2		Waardenburg syndrome type 2D	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000007503	8	49831366 - 49833824	8	48918807 - 48921265	7503	22542		
NM_005142.3(CBLIF):c.1175dup (p.Thr393fs)	CBLIF		Intrinsic factor deficiency	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000001748	11	59599167 - 59599168	11	59831694 - 59831695	1748	16787		NC_000011.10:59831694:A:AA
NM_005142.3(CBLIF):c.161del (p.Asn54fs)	CBLIF	N54fs	Intrinsic factor deficiency	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000001747	11	59611447	11	59843974	1747	16786		NC_000011.10:59843973:TTT:TT
NM_005142.3(CBLIF):c.80-1G>A	CBLIF		Intrinsic factor deficiency	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000001745	11	59611529	11	59844056	1745	16784		NC_000011.10:59844055:C:T
GIF, IVS1DS, G-A, +1	CBLIF		Intrinsic factor deficiency	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000001744					1744	16783		
NM_001300734.1(DDB2):c.457-2529G>T	DDB2	D307Y	Xeroderma pigmentosum, group E	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000008790	11	47256859	11	47235308	8790	23829	rs121434642	NC_000011.10:47235307:G:T
NM_001300734.1(DDB2):c.457-2511C>T	DDB2	R313*	Xeroderma pigmentosum, group E	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000008789	11	47256877	11	47235326	8789	23828	rs121434641	NC_000011.10:47235325:C:T
NM_001300734.1(DDB2):c.457-2965G>A	DDB2	R273H	Xeroderma pigmentosum, group E	Pathogenic(Last reviewed: Dec 10, 1999)	no assertion criteria provided	VCV000008788	11	47256423	11	47234872	8788	23827	rs121434640	NC_000011.10:47234871:G:A
NM_001300734.1(DDB2):c.457-3053A>G	DDB2	K244E	Xeroderma pigmentosum, group E	Pathogenic(Last reviewed: Dec 10, 1999)	no assertion criteria provided	VCV000008787	11	47256335	11	47234784	8787	23826	rs121434639	NC_000011.10:47234783:A:G
PDE6H, -29G-C, 5-PRIME UTR	PDE6H		Retinal cone dystrophy 3A	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000008362					8362	23401		
GIF, 4-BP DEL, 183GAAT	CBLIF		Intrinsic factor deficiency	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000001743					1743	16782		
NM_139315.3(TAF6):c.212T>C (p.Ile71Thr)	TAF6	I108T, I71T, I117T, I61T	Alazami-Yuan syndrome|Syndromic intellectual disability|Global developmental delay|Abnormal facial shape	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000180204	7	99711522	7	100113899	180204	178380	rs374993554	NC_000007.14:100113898:A:G
NM_005142.3(CBLIF):c.183_186del (p.Met61fs)	CBLIF	M61fs	not provided|Intrinsic factor deficiency	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566919	11	59611422 - 59611425	11	59843949 - 59843952	566919	567344	rs765896727	NC_000011.10:59843948:ATTCAT:AT
NM_014754.3(PTDSS1):c.794T>C (p.Leu265Pro)	PTDSS1	L265P, L119P	Lenz-Majewski hyperostosis syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097036	8	97316309	8	96304081	97036	102941	rs587777090	NC_000008.11:96304080:T:C
NM_014754.3(PTDSS1):c.805C>T (p.Pro269Ser)	PTDSS1	P269S, P123S	Lenz-Majewski hyperostosis syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097035	8	97316320	8	96304092	97035	102940	rs587777089	NC_000008.11:96304091:C:T
NM_001142283.1(RPS24):c.13_14del (p.Val5fs)	RPS24	V5fs	Diamond-Blackfan anemia	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000662877	10	79795119 - 79795120	10	78035361 - 78035362	662877	639180		NC_000010.11:78035360:GT:
NM_001142283.1(RPS24):c.148A>C (p.Thr50Pro)	RPS24	T50P	Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000549764	10	79795347	10	78035589	549764	540530	rs1554841994	NC_000010.11:78035588:A:C
NM_007055.3(POLR3A):c.-6128_-995del	RPS24		Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088977	10	79790160 - 79795293	10	78030402 - 78035535	88977	94533		
NC_000010.11:g.(?_78033902)_(78033914_?)del	RPS24		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000831866	10	79793660 - 79793672			831866	820242		
NM_001142283.1(RPS24):c.4_6delinsTACGGATAG (p.Asn2delinsTyrGlyTer)	RPS24		Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Jun 25, 2009)	no assertion criteria provided	VCV000007247	10	79795110 - 79795112	10	78035352 - 78035354	7247	22286	rs116840806	NC_000010.11:78035351:AAC:TACGGATAG
NM_001142283.1(RPS24):c.316C>T (p.Gln106Ter)	RPS24	Q106*	Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Jun 25, 2009)	no assertion criteria provided	VCV000007245	10	79796988	10	78037230	7245	22284	rs104894188	NC_000010.11:78037229:C:T
NM_014754.3(PTDSS1):c.1058A>G (p.Gln353Arg)	PTDSS1	Q353R, Q207R	Lenz-Majewski hyperostosis syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097034	8	97321835	8	96309607	97034	102939	rs587777088	NC_000008.11:96309606:A:G
NM_001142283.1(RPS24):c.1A>G (p.Met1Val)	RPS24	M1V	not provided|Diamond-Blackfan anemia	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265439	10	79793660	10	78033902	265439	259941	rs886039545	NC_000010.11:78033901:A:G
GRCh37/hg19 8q24.13(chr8:126179381-126241524)x1	NSMCE2		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000686069	8	126179381 - 126241524			686069	673661		
NM_003638.3(ITGA8):c.2174dup (p.Cys726fs)	ITGA8		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000450375	10	15639242 - 15639243	10	15597243 - 15597244	450375	444575	rs1554775668	NC_000010.11:15597243:A:AA
NM_032730.5(RTN4IP1):c.587del (p.Gly196fs)	RTN4IP1	G96fs, G196fs	not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000844298	6	107067110	6	106619235	844298	831352		NC_000006.12:106619234:CC:C
CFAP43, TRP1502TER	CFAP43	W1502*	Normal pressure hydrocephalus	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805993					805993	794329		
NM_020680.4(SCYL1):c.526A>T (p.Lys176Ter)	SCYL1	K176*	Spinocerebellar ataxia, autosomal recessive 21	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000692036	11	65293745	11	65526274	692036	679782		NC_000011.10:65526273:A:T
NM_173685.4(NSMCE2):c.394C>T (p.Gln132Ter)	NSMCE2	Q132*	not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000657402	8	126194474	8	125182232	657402	636583		NC_000008.11:125182231:C:T
NM_025145.6(CFAP43):c.1040T>C (p.Val347Ala)	CFAP43	V347A	SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523149	10	105963485	10	104203727	523149	513775	rs147356105	NC_000010.11:104203726:A:G
NM_025145.6(CFAP43):c.1302dup (p.Leu435fs)	CFAP43		SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523148	10	105953763 - 105953764	10	104194005 - 104194006	523148	513774	rs1554882484	NC_000010.11:104194005:AA:AAA
NM_025145.6(CFAP43):c.3352C>T (p.Arg1118Ter)	CFAP43	R1118*	SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523147	10	105921781	10	104162023	523147	513773	rs760609580	NC_000010.11:104162022:G:A
NM_025145.6(CFAP43):c.1238_1239GT[1] (p.Val414fs)	CFAP43		SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523146	10	105956663 - 105956664	10	104196905 - 104196906	523146	513772	rs753300178	NC_000010.11:104196904:ACACA:ACA
NM_025145.6(CFAP43):c.3541-2A>C	CFAP43		SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000523145	10	105912486	10	104152728	523145	513771	rs1554862953	NC_000010.11:104152727:T:G
NM_025145.6(CFAP43):c.3661-2del	CFAP43		SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000523144	10	105907758	10	104148000	523144	513770	rs1554861288	NC_000010.11:104147999:T:
NM_003638.3(ITGA8):c.537C>A (p.Ser179Arg)	ITGA8	S179R	Renal hypodysplasia/aplasia 1	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522875	10	15726034	10	15684035	522875	513591	rs748467820	NC_000010.11:15684034:G:T
NM_020680.4(SCYL1):c.256G>T (p.Glu86Ter)	SCYL1	E86*	CALFAN syndrome	Pathogenic(Last reviewed: Nov 9, 2017)	no assertion criteria provided	VCV000446292	11	65293395	11	65525924	446292	439696	rs1554967761	NC_000011.10:65525923:G:T
NM_025145.6(CFAP43):c.3945-263_4431+252del	CFAP43		SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000430937	10	105900348 - 105903660	10	104140590 - 104143902	430937	424480		
NM_025145.6(CFAP43):c.253C>T (p.Arg85Trp)	CFAP43	R85W	SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000430936	10	105990414	10	104230656	430936	424479	rs376788209	NC_000010.11:104230655:G:A
NM_025145.6(CFAP43):c.386C>A (p.Ser129Tyr)	CFAP43	S129Y	SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000430935	10	105985249	10	104225491	430935	424478	rs1131692266	NC_000010.11:104225490:G:T
NM_025145.6(CFAP43):c.4132C>T (p.Arg1378Ter)	CFAP43	R1378*	SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000430934	10	105903210	10	104143452	430934	424477	rs768831533	NC_000010.11:104143451:G:A
NM_025145.6(CFAP43):c.2802T>A (p.Cys934Ter)	CFAP43	C934*	SPERMATOGENIC FAILURE 19	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000430933	10	105927385	10	104167627	430933	424476	rs373911488	NC_000010.11:104167626:A:T
NM_001080483.3(MYMK):c.461T>C (p.Ile154Thr)	MYMK	I154T	Congenital nonprogressive myopathy with Moebius and Robin sequences	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000430843	9	136380668	9	133515546	430843	424388	rs1131692249	NC_000009.12:133515545:A:G
NM_001080483.3(MYMK):c.2T>A (p.Met1Lys)	MYMK	M1K	Congenital nonprogressive myopathy with Moebius and Robin sequences	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000430842	9	136389965	9	133524843	430842	424387	rs1131692248	NC_000009.12:133524842:A:T
NM_001080483.3(MYMK):c.298G>A (p.Gly100Ser)	MYMK	G100S	Congenital nonprogressive myopathy with Moebius and Robin sequences	Pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	VCV000430841	9	136384097	9	133518975	430841	424386	rs964335184	NC_000009.12:133518974:C:T
NM_173685.4(NSMCE2):c.697_700dup (p.Ala234fs)	NSMCE2		Seckel syndrome 10	Pathogenic(Last reviewed: Dec 15, 2016)	no assertion criteria provided	VCV000372286	8	126379079 - 126379080	8	125366837 - 125366838	372286	359194	rs773917653	NC_000008.11:125366837:AGGG:AGGGAGGG
NM_173685.4(NSMCE2):c.346del (p.Ser116fs)	NSMCE2	S116fs	Seckel syndrome 10	Pathogenic(Last reviewed: Dec 15, 2016)	no assertion criteria provided	VCV000372285	8	126194425	8	125182183	372285	359193	rs757613817	NC_000008.11:125182182:TT:T
NM_032730.5(RTN4IP1):c.601A>T (p.Lys201Ter)	RTN4IP1	K201*, K101*	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000218933	6	107067096	6	106619221	218933	215759	rs200457692	NC_000006.12:106619220:T:A
NM_032730.5(RTN4IP1):c.308G>A (p.Arg103His)	RTN4IP1	R103H, R3H	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000218932	6	107070811	6	106622936	218932	215758	rs372054380	NC_000006.12:106622935:C:T
NM_003638.3(ITGA8):c.1219G>A (p.Gly407Arg)	ITGA8	G407R, G392R	Renal hypodysplasia/aplasia 1	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000126500	10	15686209	10	15644210	126500	132024	rs374664941	NC_000010.11:15644209:C:T
NM_003638.3(ITGA8):c.1622_1626del (p.Glu541fs)	ITGA8	E526fs, E541fs	Renal hypodysplasia/aplasia 1	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000126499	10	15649814 - 15649818	10	15607815 - 15607819	126499	132023	rs587777280	NC_000010.11:15607814:CACCTC:C
NM_003638.3(ITGA8):c.2982+2T>C	ITGA8		Renal hypodysplasia/aplasia 1	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000126498	10	15573047	10	15531048	126498	132022	rs587777279	NC_000010.11:15531047:A:G
NM_030667.3(PTPRO):c.2829+1G>A	PTPRO		Nephrotic syndrome, type 6	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030111	12	15722433	12	15569499	30111	39066		NC_000012.12:15569498:G:A
NM_030667.3(PTPRO):c.2627+1G>T	PTPRO		Nephrotic syndrome, type 6	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030110	12	15710458	12	15557524	30110	39065		NC_000012.12:15557523:G:T
CAT, 2-BP INS, 138GA	CAT		Acatalasia	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000029622					29622	38576		
NM_001752.4(CAT):c.358del (p.Ser120fs)	CAT	S120fs	Acatalasemia, japanese type	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000029621	11	34473632	11	34452085	29621	38575		NC_000011.10:34452084:T:
NM_001080483.3(MYMK):c.553T>C (p.Cys185Arg)	MYMK	C185R	Congenital nonprogressive myopathy with Moebius and Robin sequences	Pathogenic(Last reviewed: Jan 7, 2019)	no assertion criteria provided	VCV000430840	9	136379871	9	133514749	430840	424385	rs1131692247	NC_000009.12:133514748:A:G
NM_001752.4(CAT):c.480+5G>A	CAT		Acatalasemia, japanese type	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000017599	11	34473759	11	34452212	17599	32638		NC_000011.10:34452211:G:A
NM_020680.4(SCYL1):c.1534dup (p.Cys512fs)	SCYL1			Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000691875	11	65303570 - 65303571	11	65536099 - 65536100	691875	679589		NC_000011.10:65536099:T:TT
NM_020680.4(SCYL1):c.314C>T (p.Ala105Val)	SCYL1	A105V	CALFAN syndrome|Spinocerebellar ataxia, autosomal recessive 21	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000446294	11	65293453	11	65525982	446294	439697	rs942522644	NC_000011.10:65525981:C:T
NM_020680.4(SCYL1):c.169C>T (p.Gln57Ter)	SCYL1	Q57*	Spinocerebellar ataxia, autosomal recessive 21|CALFAN syndrome	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000446293	11	65293102	11	65525631	446293	439695	rs1554967681	NC_000011.10:65525630:C:T
NM_020680.4(SCYL1):c.1433A>G (p.Asp478Gly)	SCYL1	D478G	CALFAN syndrome|Spinocerebellar ataxia, autosomal recessive 21	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000446291	11	65303470	11	65535999	446291	439698	rs1554969925	NC_000011.10:65535998:A:G
NM_020680.4(SCYL1):c.1882C>T (p.Gln628Ter)	SCYL1	Q628*, Q611*	CALFAN syndrome|Spinocerebellar ataxia, autosomal recessive 21	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000446290	11	65304522	11	65537051	446290	439699	rs1554970375	NC_000011.10:65537050:C:T
NM_020680.4(SCYL1):c.1636C>T (p.Gln546Ter)	SCYL1	Q546*		Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218910	11	65303790	11	65536319	218910	215678	rs864309667	NC_000011.10:65536318:C:T
NM_020680.4(SCYL1):c.1230+1G>A	SCYL1			Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218909	11	65300277	11	65532806	218909	215677	rs864309666	NC_000011.10:65532805:G:A
NM_020680.4(SCYL1):c.1507_1508TG[1] (p.Ala504fs)	SCYL1			Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218908	11	65303544 - 65303545	11	65536073 - 65536074	218908	215676	rs864309665	NC_000011.10:65536072:TGTG:TG
NM_020680.4(SCYL1):c.937del (p.Val313fs)	SCYL1	V313fs		Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218907	11	65298186	11	65530715	218907	215675	rs864309664	NC_000011.10:65530714:GG:G
NM_001142283.1(RPS24):c.46C>T (p.Arg16Ter)	RPS24	R16*	Diamond-Blackfan anemia|Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000007246	10	79795152	10	78035394	7246	22285	rs104894189	NC_000010.11:78035393:C:T
NM_004771.4(MMP20):c.611A>G (p.His204Arg)	MMP20	H204R	Amelogenesis imperfecta, hypomaturation type, IIA2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000189295	11	102480674	11	102609943	189295	187181	rs786204826	NC_000011.10:102609942:T:C
NM_004697.4(PRPF4):c.-114_-97del	PRPF4		Retinitis pigmentosa 70	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000143058	9	116037910 - 116037927	9	113275630 - 113275647	143058	152777	rs541873609	NC_000009.12:113275629:TGTCAGTGACGCACTTCCTGTCAGTGACGCACTTCC:TGTCAGTGACGCACTTCC
NM_004697.4(PRPF4):c.944C>T (p.Pro315Leu)	PRPF4	P315L, P72L, P314L	Retinitis pigmentosa 70	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000143057	9	116050463	9	113288183	143057	152776	rs587777599	NC_000009.12:113288182:C:T
NM_004771.4(MMP20):c.102G>A (p.Trp34Ter)	MMP20	W34*	Amelogenesis imperfecta, hypomaturation type, IIA2	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000139625	11	102495949	11	102625218	139625	143248	rs587777516	NC_000011.10:102625217:C:T
NM_004771.4(MMP20):c.678T>A (p.His226Gln)	MMP20	H226Q	Amelogenesis imperfecta, hypomaturation type, IIA2	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000139624	11	102479801	11	102609070	139624	143247	rs587777515	NC_000011.10:102609069:A:T
NM_016464.5(TMEM138):c.376G>A (p.Ala126Thr)	TMEM138	A126T, A68T	Joubert syndrome 16	Pathogenic(Last reviewed: Feb 24, 2012)	no assertion criteria provided	VCV000031190	11	61135470	11	61367998	31190	40147	rs387907134	NC_000011.10:61367997:G:A
NM_016464.5(TMEM138):c.128+5G>A	TMEM138		Joubert syndrome 16	Pathogenic(Last reviewed: Feb 24, 2012)	no assertion criteria provided	VCV000031187	11	61131995	11	61364523	31187	40144		NC_000011.10:61364522:G:A
NM_016464.5(TMEM138):c.380C>T (p.Ala127Val)	TMEM138	A127V, A69V	Joubert syndrome 16	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000031189	11	61136072	11	61368600	31189	40146	rs387907133	NC_000011.10:61368599:C:T
NM_000476.2(AK1):c.139del (p.Val47fs)	AK1	V47fs, V63fs	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000018269	9	130635037	9	127872758	18269	33308	rs387906583	NC_000009.12:127872757:CC:C
NM_001318121.1(AK1):c.418_420GAC[1] (p.Asp141del)	AK1	D141del	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000018268	9	130630693 - 130630695	9	127868414 - 127868416	18268	33307	rs387906582	NC_000009.12:127868413:GTCGTC:GTC
NM_000476.2(AK1):c.190G>A (p.Gly64Arg)	AK1	G64R, G80R	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000018267	9	130634986	9	127872707	18267	33306	rs137853205	NC_000009.12:127872706:C:T
NM_000476.2(AK1):c.118G>A (p.Gly40Arg)	AK1	G40R, G56R	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000018266	9	130635058	9	127872779	18266	33305	rs137853204	NC_000009.12:127872778:C:T
NM_000476.2(AK1):c.491A>G (p.Tyr164Cys)	AK1	Y164C, Y180C	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000018265	9	130630625	9	127868346	18265	33304	rs137853203	NC_000009.12:127868345:T:C
NM_000476.2(AK1):c.319C>T (p.Arg107Ter)	AK1	R107*, R123*	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000018264	9	130634107	9	127871828	18264	33303	rs104894102	NC_000009.12:127871827:G:A
NM_000476.2(AK1):c.382C>T (p.Arg128Trp)	AK1	R128W, R144W	Adenylate kinase deficiency, hemolytic anemia due to	Pathogenic(Last reviewed: Jun 15, 1989)	no assertion criteria provided	VCV000018263	9	130630734	9	127868455	18263	33302	rs104894101	NC_000009.12:127868454:G:A
HBG1, C-T, -158	HBG1		Fetal hemoglobin quantitative trait locus 1	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000015040					15040	30079		
HBG1, 4-BP DEL, -222 TO -225, PROMOTER	HBG1		Fetal hemoglobin, a-gamma type, reduction in	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000015038					15038	30077		
NM_000510.3(FSHB):c.236_237del (p.Val79fs)	FSHB	V79fs	not provided|Follicle-stimulating hormone deficiency, isolated	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016240	11	30255192 - 30255193	11	30233645 - 30233646	16240	31279	rs5030646	NC_000011.10:30233644:GTG:G
NM_153816.6(SNX14):c.1725dup (p.Glu576Ter)	SNX14		not provided	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000817573	6	86243401 - 86243402	6	85533683 - 85533684	817573	805518		NC_000006.12:85533683:AAAAAA:AAAAAAA
NM_153816.6(SNX14):c.1608+1G>T	SNX14		Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802248	6	86246509	6	85536791	802248	790664		NC_000006.12:85536790:C:A
NM_153816.6(SNX14):c.2764_2770del (p.Leu921_Asp922insTer)	SNX14		not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000419155	6	86216983 - 86216989	6	85507265 - 85507271	419155	406939	rs1064793681	NC_000006.12:85507264:CAATGTCCAAT:CAAT
NM_153816.6(SNX14):c.1707_1708insTTTTTTTTTTT (p.Pro570fs)	SNX14		Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000375550	6	86243419 - 86243420	6	85533701 - 85533702	375550	362361	rs1057519561	NC_000006.12:85533701:AA:AAAAAAAAAAAAA
NM_153816.6(SNX14):c.1108G>T (p.Glu370Ter)	SNX14	E370*, E270*, E369*, E274*, E322*, E325*, E222*, E391*, E20*, E273*, E317*, E318*, E326*	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000373031	6	86256830	6	85547112	373031	359787	rs201128942	NC_000006.12:85547111:C:A
NM_153816.6(SNX14):c.1108G>A (p.Glu370Lys)	SNX14	E370K, E274K, E317K, E325K, E222K, E391K, E270K, E326K, E369K, E20K, E273K, E318K, E322K	Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268133	6	86256830	6	85547112	268133	263760	rs201128942	NC_000006.12:85547111:C:T
NM_153816.6(SNX14):c.331C>T (p.Arg111Ter)	SNX14	R111*, R132*, R59*, R110*, R58*	Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522726	6	86282023	6	85572305	522726	513288	rs760752847	NC_000006.12:85572304:G:A
NM_153816.6(SNX14):c.428T>A (p.Leu143Ter)	SNX14	L143*, L142*, L164*, L90*, L91*	Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190319	6	86277285	6	85567567	190319	188148	rs876657387	NC_000006.12:85567566:A:T
NM_153816.6(SNX14):c.1132C>T (p.Arg378Ter)	SNX14	R378*, R326*, R334*, R281*, R399*, R278*, R28*, R333*, R325*, R230*, R282*, R330*, R377*	Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190318	6	86253455	6	85543737	190318	188147	rs786205229	NC_000006.12:85543736:G:A
NM_153816.6(SNX14):c.1894+1G>T	SNX14		Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000190317	6	86239909	6	85530191	190317	188146	rs876657386	NC_000006.12:85530190:C:A
NM_153816.6(SNX14):c.645dup (p.Glu216fs)	SNX14		Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190316	6	86259586 - 86259587	6	85549868 - 85549869	190316	188145	rs869320748	NC_000006.12:85549868:T:TT
NM_153816.2(SNX14):c.1108+1181_2108-2342del	SNX14		Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000190315					190315	188144		
NM_006331.8(EMG1):c.257A>G (p.Asp86Gly)	EMG1	D86G	Bowen-Conradi syndrome	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000890	12	7083589	12	6974427	890	15929	rs74435397	NC_000012.12:6974426:A:G
NM_153816.6(SNX14):c.2670del (p.Lys889_Cys890insTer)	SNX14		Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000190320	6	86217761	6	85508043	190320	188149	rs774694340	NC_000006.12:85508042:A:
NM_153816.6(SNX14):c.2596C>T (p.Gln866Ter)	SNX14	Q866*, Q769*, Q857*, Q718*, Q802*, Q814*, Q818*, Q856*, Q865*, Q481*, Q766*, Q770*, Q813*, Q822*, Q887*, Q472*, Q516*, Q811*, Q821*	Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000190314	6	86223575	6	85513857	190314	188143	rs876657385	NC_000006.12:85513856:G:A
NM_053054.4(CATSPER1):c.944_948dup (p.Asp317fs)	CATSPER1			Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000004401	11	65792902 - 65792903	11	66025431 - 66025432	4401	19440	rs193929391	NC_000011.10:66025431:GCCATG:GCCATGCCATG
NM_053054.4(CATSPER1):c.539dup (p.His182fs)	CATSPER1			Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000004400	11	65793311 - 65793312	11	66025840 - 66025841	4400	19439	rs193929390	NC_000011.10:66025840:A:AA
NM_002072.5(GNAQ):c.548G>A (p.Arg183Gln)	GNAQ	R183Q	Capillary malformation|Capillary malformation|Sturge-Weber syndrome|Sturge-Weber syndrome	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000050853	9	80412493	9	77797577	50853	59839	rs397514698	NC_000009.12:77797576:C:T
GRCh37/hg19 9q31.2(chr9:108444651-108476067)x1	TMEM38B		not provided	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000688413	9	108444651 - 108476067			688413	676005		
GRCh37/hg19 9q31.2(chr9:108444651-108476067)x1	TMEM38B		not provided	Pathogenic(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000688394	9	108444651 - 108476067			688394	675986		
NM_001195518.2(MICU1):c.355C>T (p.Arg119Ter)	MICU1	R119*	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000431921	10	74311075	10	72551317	431921	425885	rs538329212	NC_000010.11:72551316:G:A
NM_001195518.2(MICU1):c.1072-1G>A	MICU1		not provided	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000373030	10	74167796	10	72408038	373030	359833	rs754639936	NC_000010.11:72408037:C:T
NM_001195518.2(MICU1):c.636_637CA[1] (p.Thr213fs)	MICU1		not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000280156	10	74267926 - 74267927	10	72508168 - 72508169	280156	264469	rs868338421	NC_000010.11:72508167:TGTG:TG
NM_001913.5(CUX1):c.61C>T (p.Gln21Ter)	CUX1	Q21*	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000618995	7	101459371	7	101816091	618995	610393	rs1562875556	NC_000007.14:101816090:C:T
CUX1, EX9-24DEL	CUX1		GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000618994					618994	610392		
NM_181552.4(CUX1):c.3750_3751dup (p.Leu1251fs)	CUX1		GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000618993	7	101882726 - 101882727	7	102239446 - 102239447	618993	610391	rs1563470335	NC_000007.14:102239446:GC:GCGC
NM_181552.4(CUX1):c.2584C>T (p.Gln862Ter)	CUX1	Q873*, Q862*	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000618991	7	101845161	7	102201881	618991	610389	rs1563398977	NC_000007.14:102201880:C:T
NM_181552.4(CUX1):c.2365del (p.Gln789fs)	CUX1	Q800fs, Q789fs	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000618990	7	101844940	7	102201660	618990	610388	rs1554519798	NC_000007.14:102201659:CCC:CC
NM_001135031.2(GFI1B):c.586del (p.His196fs)	GFI1B	H196fs, H242fs	Storage pool disease of platelets	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000585291	9	135865203	9	132989816	585291	576332	rs1564180346	NC_000009.12:132989815:CC:C
NM_001135031.2(GFI1B):c.785T>C (p.Leu262Pro)	GFI1B	L308P, L262P	Platelet-type bleeding disorder 17	Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000438347	9	135866367	9	132990980	438347	431978	rs775963992	NC_000009.12:132990979:T:C
NM_001135031.2(GFI1B):c.655A>T (p.Lys219Ter)	GFI1B	K265*, K219*	Platelet-type bleeding disorder 17	Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000438346	9	135865273	9	132989886	438346	431977	rs1554724694	NC_000009.12:132989885:A:T
GRCh38/hg38 9q31.2(chr9:105721899-105741297)x0	TMEM38B		See cases	Pathogenic(Last reviewed: Dec 3, 2013)	no assertion criteria provided	VCV000155632	9	108484180 - 108503578	9	105721899 - 105741297	155632	165386		
NM_001135031.2(GFI1B):c.721C>T (p.Gln241Ter)	GFI1B	Q287*, Q241*	Platelet-type bleeding disorder 17	Pathogenic(Last reviewed: Sep 1, 1968)	no assertion criteria provided	VCV000102428	9	135866303	9	132990916	102428	108170	rs587777211	NC_000009.12:132990915:C:T
NM_001195518.2(MICU1):c.735+1G>A	MICU1		Myopathy with extrapyramidal signs	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000101046	10	74236931	10	72477173	101046	106811	rs369915689	NC_000010.11:72477172:C:T
NM_001195518.2(MICU1):c.1072-1G>C	MICU1		Myopathy with extrapyramidal signs	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000101045	10	74167796	10	72408038	101045	106810	rs754639936	NC_000010.11:72408037:C:G
NM_002467.6(MYC):c.220C>G (p.Pro74Ala)	MYC	P59A, P74A, P73A	Burkitt lymphoma	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000012577	8	128750683	8	127738437	12577	27616	rs121918685	NC_000008.11:127738436:C:G
NM_002467.6(MYC):c.162G>C (p.Glu54Asp)	MYC	E39D, E54D, E53D	Burkitt lymphoma	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000012576	8	128750625	8	127738379	12576	27615	rs121918684	NC_000008.11:127738378:G:C
NM_002467.6(MYC):c.214C>T (p.Pro72Ser)	MYC	P57S, P72S, P71S	Burkitt lymphoma	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000012574	8	128750677	8	127738431	12574	27613	rs28933407	NC_000008.11:127738430:C:T
NM_001195518.2(MICU1):c.40del (p.Ala14fs)	MICU1	A14fs	Myopathy with extrapyramidal signs	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431146	10	74326512	10	72566754	431146	424658	rs749124658	NC_000010.11:72566753:CC:C
NM_001195518.2(MICU1):c.1042C>T (p.Gln348Ter)	MICU1	Q350*, Q150*, Q354*, Q348*	Myopathy with extrapyramidal signs	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431145	10	74183021	10	72423263	431145	424657	rs1135401814	NC_000010.11:72423262:G:A
NM_001195518.2(MICU1):c.547C>T (p.Gln183Ter)	MICU1	Q185*, Q183*, Q189*	not provided|Myopathy with extrapyramidal signs	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000265243	10	74268018	10	72508260	265243	259938	rs777327250	NC_000010.11:72508259:G:A
nsv1067890	TMEM38B		Osteogenesis imperfecta, type xiv	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000039494	9	108484281 - 108505262	9	105722000 - 105742981	39494	48093		
NM_181552.4(CUX1):c.3164dup (p.Ala1056fs)	CUX1		GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT|not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000618992	7	101870677 - 101870678	7	102227397 - 102227398	618992	610390	rs1563446668	NC_000007.14:102227397:CCC:CCCC
NM_001135031.2(GFI1B):c.742dup (p.His248fs)	GFI1B		Platelet-type bleeding disorder 17|not provided	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088891	9	135866321 - 135866322	9	132990934 - 132990935	88891	94450	rs397989794	NC_000009.12:132990934:CCC:CCCC
NM_198239.2(CCN6):c.707del (p.Ser236fs)	CCN6	S236fs	not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000817946	6	112389525	6	112068322	817946	805460		NC_000006.12:112068321:G:
NM_020771.4(HACE1):c.1712C>A (p.Ser571Ter)	HACE1	S377*, S409*, S493*, S527*, S537*, S403*, S571*, S310*, S474*	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802254	6	105224952	6	104777077	802254	790572		NC_000006.12:104777076:G:T
NM_020771.4(HACE1):c.1990C>T (p.Arg664Ter)	HACE1	R664*, R403*, R496*, R586*, R630*, R470*, R502*, R567*, R620*	not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000523851	6	105219824	6	104771949	523851	514517	rs761703540	NC_000006.12:104771948:G:A
NM_015354.3(NUP188):c.287dup (p.Tyr96Ter)	NUP188		SANDESTIG-STEFANOVA SYNDROME	Pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000816694	9	131719270 - 131719271	9	128956991 - 128956992	816694	804900		NC_000009.12:128956991:A:AA
NM_020771.4(HACE1):c.1396C>T (p.Gln466Ter)	HACE1	Q466*, Q205*, Q298*, Q304*, Q369*, Q272*, Q388*, Q422*, Q432*	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548455	6	105232873	6	104784998	548455	538991	rs1337798545	NC_000006.12:104784997:G:A
NM_173560.4(RFX6):c.2596C>T (p.Arg866Ter)	RFX6	R866*	Mitchell-Riley syndrome	Pathogenic(Last reviewed: Mar 7, 2016)	no assertion criteria provided	VCV000223241	6	117250119	6	116928956	223241	224973	rs749827445	NC_000006.12:116928955:C:T
NM_173560.4(RFX6):c.2176C>T (p.Arg726Ter)	RFX6	R726*	Mitchell-Riley syndrome	Pathogenic(Last reviewed: Mar 7, 2016)	no assertion criteria provided	VCV000223240	6	117248480	6	116927317	223240	224972	rs144648002	NC_000006.12:116927316:C:T
NM_020771.4(HACE1):c.240C>A (p.Cys80Ter)	HACE1	C80*, C46*	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221296	6	105297103	6	104849228	221296	223025	rs761086584	NC_000006.12:104849227:G:T
NM_020771.4(HACE1):c.454C>T (p.Gln152Ter)	HACE1	Q152*, Q118*	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221294	6	105280997	6	104833122	221294	223023	rs869025284	NC_000006.12:104833121:G:A
NM_020771.4(HACE1):c.1852_1853del (p.Gln618fs)	HACE1	Q450fs, Q574fs, Q424fs, Q456fs, Q521fs, Q540fs, Q584fs, Q618fs, Q357fs	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221293	6	105224627 - 105224628	6	104776752 - 104776753	221293	223022	rs751809418	NC_000006.12:104776751:TG:
NM_020771.4(HACE1):c.2487_2489TCT[1] (p.Leu832del)	HACE1	L832del	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221292	6	105192056 - 105192058	6	104744181 - 104744183	221292	223021	rs869025283	NC_000006.12:104744180:AGAAGAA:AGAA
NM_020771.3(HACE1):c.2019_2020insTTTAGGTATTTTTAGGTATT (p.Pro674Phefs)	HACE1		Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221291	6	105219259 - 105219260	6	104771384 - 104771385	221291	223020	rs869025282	NC_000006.12:104771384:AATACCTAAAAA:AATACCTAAAAATACCTAAAAATACCTAAAAA
NM_020771.4(HACE1):c.655C>T (p.Arg219Ter)	HACE1	R219*, R122*, R175*, R57*, R141*, R25*, R185*, R51*	Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221289	6	105244863	6	104796988	221289	223018	rs869025280	NC_000006.12:104796987:G:A
NM_005631.5(SMO):c.1685G>A (p.Arg562Gln)	SMO	R562Q	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000008118	7	128850838	7	129210997	8118	23157	rs121918348	NC_000007.14:129210996:G:A
NM_005631.5(SMO):c.1604G>T (p.Trp535Leu)	SMO	W535L	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000008117	7	128850341	7	129210500	8117	23156	rs121918347	NC_000007.14:129210499:G:T
NM_173560.4(RFX6):c.779_780+12del	RFX6		Mitchell-Riley syndrome	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000501	6	117232201 - 117232214	6	116911038 - 116911051	501	15540	rs587776517	NC_000006.12:116911037:ACAAGGTATCAATTACA:ACA
NM_173560.4(RFX6):c.672+2T>G	RFX6		Mitchell-Riley syndrome	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000498	6	117216372	6	116895209	498	15537	rs587776516	NC_000006.12:116895208:T:G
NM_198239.2(CCN6):c.692del (p.Val231fs)	CCN6	V249fs, V231fs	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000627567	6	112389510	6	112068307	627567	615922	rs1562599153	NC_000006.12:112068306:T:
NM_173560.4(RFX6):c.1316_1319del (p.Ile439fs)	RFX6	I439fs	Mitchell-Riley syndrome	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000587396	6	117241604 - 117241607	6	116920441 - 116920444	587396	578354	rs1562146029	NC_000006.12:116920440:TATCTA:TA
NM_152703.5(SAMD9L):c.2956C>T (p.Arg986Cys)	SAMD9L	R986C	Ataxia-pancytopenia syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	VCV000446530	7	92762329	7	93133016	446530	440047	rs1554341158	NC_000007.14:93133015:G:A
NM_152703.5(SAMD9L):c.2672T>C (p.Ile891Thr)	SAMD9L	I891T	Ataxia-pancytopenia syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	VCV000446529	7	92762613	7	93133300	446529	440048	rs1554341277	NC_000007.14:93133299:A:G
NM_198239.1(CCN6):c.643+1G>A	CCN6		Progressive pseudorheumatoid dysplasia	Pathogenic	criteria provided, single submitter	VCV000252451	6	112386201	6	112064998	252451	246855	rs879255273	NC_000006.12:112064997:G:A
NM_003880.3(CCN6):c.840del (p.Phe280fs)	CCN6	F280fs, F298fs	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000006389	6	112390596	6	112069393	6389	21428	rs797044440	NC_000006.12:112069392:TTT:TT
NM_003880.3(CCN6):c.1000T>C (p.Ser334Pro)	CCN6	S334P, S352P	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000006388	6	112390758	6	112069555	6388	21427	rs121908903	NC_000006.12:112069554:T:C
NM_003880.3(CCN6):c.43_44del (p.Ala15fs)	CCN6	A33fs, A15fs	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006386	6	112375603 - 112375604	6	112054400 - 112054401	6386	21425		NC_000006.12:112054399:GC:
NM_003880.3(CCN6):c.862_863dup (p.Gln289fs)	CCN6		Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006385	6	112390619 - 112390620	6	112069416 - 112069417	6385	21424	rs863223286	NC_000006.12:112069416:AC:ACAC
NM_003880.3(CCN6):c.48+2dup	CCN6		Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006384	6	112375609 - 112375610	6	112054406 - 112054407	6384	21423	rs797044439	NC_000006.12:112054406:T:TT
NM_003880.3(CCN6):c.232T>C (p.Cys78Arg)	CCN6	C78R, C96R	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006382	6	112382377	6	112061174	6382	21421	rs121908902	NC_000006.12:112061173:T:C
NM_003880.3(CCN6):c.993G>A (p.Trp331Ter)	CCN6	W331*, W349*	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006380	6	112390751	6	112069548	6380	21419	rs121908900	NC_000006.12:112069547:G:A
NM_003880.3(CCN6):c.434G>A (p.Cys145Tyr)	CCN6	C145Y, C163Y	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006379	6	112386045	6	112064842	6379	21418	rs121908899	NC_000006.12:112064841:G:A
NM_173560.4(RFX6):c.542G>A (p.Arg181Gln)	RFX6	R181Q	Mitchell-Riley syndrome	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000500	6	117203567	6	116882404	500	15539	rs267607013	NC_000006.12:116882403:G:A
NM_173560.4(RFX6):c.649T>C (p.Ser217Pro)	RFX6	S217P	Mitchell-Riley syndrome	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000499	6	117216347	6	116895184	499	15538	rs267607012	NC_000006.12:116895183:T:C
NM_173560.4(RFX6):c.224-12A>G	RFX6		Mitchell-Riley syndrome	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000497	6	117198947	6	116877784	497	15536	rs587776515	NC_000006.12:116877783:A:G
NM_173560.4(RFX6):c.380+2T>C	RFX6		Mitchell-Riley syndrome	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000496	6	117199117	6	116877954	496	15535	rs587776514	NC_000006.12:116877953:T:C
NM_020771.4(HACE1):c.2242C>T (p.Arg748Ter)	HACE1	R748*, R586*, R651*, R714*, R487*, R554*, R580*, R670*, R704*	not provided|Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000221290	6	105198317	6	104750442	221290	223019	rs869025281	NC_000006.12:104750441:G:A
NM_003880.3(CCN6):c.233G>A (p.Cys78Tyr)	CCN6	C78Y, C96Y	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000631969	6	112382378	6	112061175	631969	620208	rs1562595388	NC_000006.12:112061174:G:A
NM_152703.5(SAMD9L):c.2640C>A (p.His880Gln)	SAMD9L	H880Q	Ataxia-pancytopenia syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	VCV000242372	7	92762645	7	93133332	242372	243919	rs878855336	NC_000007.14:93133331:G:T
NM_020771.4(HACE1):c.805C>T (p.Arg269Ter)	HACE1	R269*, R235*, R225*, R101*, R172*, R75*, R8*, R107*, R191*	Spastic paraplegia and psychomotor retardation with or without seizures|Global developmental delay|Seizures|Generalized hypotonia	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221295	6	105244541	6	104796666	221295	223024	rs750371878	NC_000006.12:104796665:G:A
NM_001025295.3(IFITM5):c.119C>T (p.Ser40Leu)	IFITM5	S40L	Osteogenesis imperfecta type 5|not provided	Pathogenic(Last reviewed: Dec 28, 2015)	criteria provided, single submitter	VCV000183677	11	299372	11	299372	183677	181576	rs786201032	NC_000011.10:299371:G:A
NM_002467.6(MYC):c.302A>C (p.Asn101Thr)	MYC	N86T, N101T, N100T	Burkitt lymphoma|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000012575	8	128750765	8	127738519	12575	27614	rs121918683	NC_000008.11:127738518:A:C
NM_198239.1(CCN6):c.920_921AG[1] (p.Ser308fs)	CCN6		Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000453263	6	112390624 - 112390625	6	112069421 - 112069422	453263	446858	rs781838640	NC_000006.12:112069420:AGAG:AG
NM_005631.5(SMO):c.1417G>C (p.Asp473His)	SMO	D473H	Medulloblastoma|Basal cell carcinoma	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000375938	7	128849189	7	129209348	375938	362817	rs17710891	NC_000007.14:129209347:G:C
NM_152703.5(SAMD9L):c.3587G>C (p.Cys1196Ser)	SAMD9L	C1196S	Ataxia-pancytopenia syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	VCV000242373	7	92761698	7	93132385	242373	243920	rs878855337	NC_000007.14:93132384:C:G
NM_198239.1(CCN6):c.300del (p.Glu102fs)	CCN6	E102fs, E84fs	Progressive pseudorheumatoid dysplasia|not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000006383	6	112382391	6	112061188	6383	21422	rs797044438	NC_000006.12:112061187:A:
NM_017934.7(PHIP):c.2755_2758GAAA[1] (p.Arg920fs)	PHIP		not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000817994	6	79692610 - 79692613	6	78982893 - 78982896	817994	805516		NC_000006.12:78982892:TTTCTTTCTTT:TTTCTTT
NM_017934.7(PHIP):c.577C>T (p.Arg193Ter)	PHIP	R193*	not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000817522	6	79752583	6	79042866	817522	805517		NC_000006.12:79042865:G:A
NM_017934.7(PHIP):c.1340_1341CT[1] (p.Leu448fs)	PHIP		not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000424321	6	79725393 - 79725394	6	79015676 - 79015677	424321	406933	rs1064796911	NC_000006.12:79015675:AGAG:AG
NM_017934.7(PHIP):c.705T>G (p.Tyr235Ter)	PHIP	Y235*		Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634616	6	79735777	6	79026060	634616	622372	rs1562189451	NC_000006.12:79026059:A:C
NM_017934.7(PHIP):c.328C>A (p.Arg110Ser)	PHIP	R110S		Pathogenic(Last reviewed: Dec 2, 2019)	no assertion criteria provided	VCV000545397	6	79770397	6	79060680	545397	535661	rs768324201	NC_000006.12:79060679:G:T
NM_017934.7(PHIP):c.298_299del (p.Leu100fs)	PHIP	L100fs		Pathogenic(Last reviewed: Dec 2, 2019)	no assertion criteria provided	VCV000545395	6	79770426 - 79770427	6	79060709 - 79060710	545395	535659	rs1554212744	NC_000006.12:79060708:AAA:A
NM_145331.3(MAP3K7):c.721T>G (p.Trp241Gly)	MAP3K7	W241G	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000423266	6	91263192	6	90553473	423266	406944	rs886039237	NC_000006.12:90553472:A:C
NM_145331.3(MAP3K7):c.721T>A (p.Trp241Arg)	MAP3K7	W241R	Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264705	6	91263192	6	90553473	264705	259297	rs886039237	NC_000006.12:90553472:A:T
NM_145331.3(MAP3K7):c.145_147GTT[1] (p.Val50del)	MAP3K7	V50del	Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264704	6	91281497 - 91281499	6	90571778 - 90571780	264704	259296	rs886039236	NC_000006.12:90571777:AACAAC:AAC
NM_145331.3(MAP3K7):c.502G>C (p.Gly168Arg)	MAP3K7	G168R	Frontometaphyseal dysplasia 2	Pathogenic(Last reviewed: Oct 3, 2016)	no assertion criteria provided	VCV000264701	6	91266324	6	90556605	264701	259293	rs886039233	NC_000006.12:90556604:C:G
NM_145331.3(MAP3K7):c.208G>C (p.Glu70Gln)	MAP3K7	E70Q	Frontometaphyseal dysplasia 2	Pathogenic(Last reviewed: Oct 3, 2016)	no assertion criteria provided	VCV000264699	6	91281439	6	90571720	264699	259291	rs886039231	NC_000006.12:90571719:C:G
NM_002496.4(NDUFS8):c.187G>C (p.Glu63Gln)	NDUFS8	E63Q	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000039835	11	67800467	11	68033000	39835	48434	rs397514618	NC_000011.10:68032999:G:C
NM_002496.4(NDUFS8):c.476C>A (p.Ala159Asp)	NDUFS8	A159D	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000039834	11	67803823	11	68036356	39834	48433	rs397514617	NC_000011.10:68036355:C:A
NM_002496.4(NDUFS8):c.413G>A (p.Arg138His)	NDUFS8	R138H	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2	Pathogenic(Last reviewed: May 25, 2004)	no assertion criteria provided	VCV000007514	11	67803760	11	68036293	7514	22553	rs111033588	NC_000011.10:68036292:G:A
NM_002496.4(NDUFS8):c.254C>T (p.Pro85Leu)	NDUFS8	P85L	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2	Pathogenic(Last reviewed: May 25, 2004)	no assertion criteria provided	VCV000007513	11	67800632	11	68033165	7513	22552	rs121912639	NC_000011.10:68033164:C:T
NM_017934.7(PHIP):c.2744_2747del (p.Lys915fs)	PHIP	K915fs		Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000627525	6	79692625 - 79692628	6	78982908 - 78982911	627525	615881	rs1562150844	NC_000006.12:78982907:TTCTTT:TT
NM_017934.7(PHIP):c.540_541insA (p.Gly181fs)	PHIP			Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000627523	6	79752619 - 79752620	6	79042902 - 79042903	627523	615884	rs1562203136	NC_000006.12:79042902::T
NM_017934.7(PHIP):c.600+1del	PHIP		PHIP-Related disorders|not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504194	6	79752559	6	79042842	504194	495535	rs1554210066	NC_000006.12:79042841:C:
NM_001282534.2(KCNK9):c.706G>C (p.Gly236Arg)	KCNK9	G236R	Birk-Barel syndrome	Pathogenic(Last reviewed: Dec 12, 2016)	no assertion criteria provided	VCV000397636	8	140630920	8	139618677	397636	384602	rs121908332	NC_000008.11:139618676:C:G
NM_145331.3(MAP3K7):c.328G>T (p.Gly110Cys)	MAP3K7	G110C	Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264703	6	91271356	6	90561637	264703	259295	rs886039235	NC_000006.12:90561636:C:A
NM_145331.3(MAP3K7):c.130_135del (p.Arg44_Gly45del)	MAP3K7		Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264702	6	91281512 - 91281517	6	90571793 - 90571798	264702	259294	rs886039234	NC_000006.12:90571792:TCCTCTTCC:TCC
NM_145331.3(MAP3K7):c.299T>A (p.Val100Glu)	MAP3K7	V100E	Frontometaphyseal dysplasia 2	Pathogenic(Last reviewed: Oct 3, 2016)	no assertion criteria provided	VCV000264700	6	91271385	6	90561666	264700	259292	rs886039232	NC_000006.12:90561665:A:T
NM_145331.3(MAP3K7):c.1535C>T (p.Pro512Leu)	MAP3K7	P485L, P512L	Frontometaphyseal dysplasia 2	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264698	6	91228271	6	90518552	264698	259290	rs886039230	NC_000006.12:90518551:G:A
NM_017934.7(PHIP):c.598_599delinsT (p.Thr200fs)	PHIP		|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000524089	6	79752561 - 79752562	6	79042844 - 79042845	524089	514546	rs1554210073	NC_000006.12:79042843:GT:A
NC_000006.12:g.(?_57186982)_(57222324_?)del	RAB23		Carpenter syndrome	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000832125	6	57051780 - 57087122			832125	819703		
NM_016277.5(RAB23):c.5del (p.Leu2fs)	RAB23	L2fs	Carpenter syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000664887	6	57075174	6	57210376	664887	635117		NC_000006.12:57210375:AA:A
NM_016277.5(RAB23):c.481G>C (p.Val161Leu)	RAB23	V161L	Carpenter syndrome	Pathogenic(Last reviewed: Apr 15, 2017)	no assertion criteria provided	VCV000417740	6	57059568	6	57194770	417740	404641	rs1060505026	NC_000006.12:57194769:C:G
NM_016098.4(MPC1):c.236T>A (p.Leu79His)	MPC1	L79H, L36H	Mitochondrial pyruvate carrier deficiency	Pathogenic(Last reviewed: Jul 6, 2012)	no assertion criteria provided	VCV000035562	6	166779531	6	166366043	35562	44235	rs387907238	NC_000006.12:166366042:A:T
NM_016277.5(RAB23):c.86dup (p.Tyr29Ter)	RAB23		Carpenter syndrome 1	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000018426	6	57075092 - 57075093	6	57210294 - 57210295	18426	33465		NC_000006.12:57210294:T:TT
NM_016277.5(RAB23):c.408dup (p.Glu137Ter)	RAB23		Carpenter syndrome 1	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000004592	6	57059640 - 57059641	6	57194842 - 57194843	4592	19631		NC_000006.12:57194842:A:AA
NM_016098.4(MPC1):c.289C>T (p.Arg97Trp)	MPC1	R97W, R54W	Mitochondrial pyruvate carrier deficiency	Pathogenic(Last reviewed: Jul 6, 2012)	no assertion criteria provided	VCV000035561	6	166779478	6	166365990	35561	44234	rs387907237	NC_000006.12:166365989:G:A
NM_005631.5(SMO):c.1234C>T (p.Leu412Phe)	SMO	L412F		Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000245609	7	128846398	7	129206557	245609	245206	rs879255280	NC_000007.14:129206556:C:T
NM_002843.4(PTPRJ):c.827A>C (p.Gln276Pro)	PTPRJ	Q276P	Carcinoma of colon	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000008690	11	48145375	11	48123823	8690	23729	rs1566734	NC_000011.10:48123822:A:C
NM_002843.4(PTPRJ):c.640C>T (p.Arg214Cys)	PTPRJ	R214C	Carcinoma of colon	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000008689	11	48145188	11	48123636	8689	23728	rs121434507	NC_000011.10:48123635:C:T
GRCh37/hg19 7q31.32(chr7:121734934-121803684)x1	AASS		not provided	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000688682	7	121734934 - 121803684			688682	676274		
GRCh37/hg19 7q31.32(chr7:121734181-121803684)x1	AASS		not provided	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000687530	7	121734181 - 121803684			687530	675122		
NM_001130103.2(COL13A1):c.1470dup (p.Gly491fs)	COL13A1		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000423752	10	71689815 - 71689816	10	69930059 - 69930060	423752	407890	rs1554967575	NC_000010.11:69930059:A:AA
NM_001130103.2(COL13A1):c.621del (p.Gly208fs)	COL13A1	G17fs, G187fs, G208fs, G217fs, G205fs, G170fs, G179fs	not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000280690	10	71654444	10	69894688	280690	264432	rs763281993	NC_000010.11:69894687:AAAAA:AAAA
NM_001130103.2(COL13A1):c.271C>T (p.Arg91Ter)	COL13A1	R91*	not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000280688	10	71562450	10	69802694	280688	264464	rs769426298	NC_000010.11:69802693:C:T
NM_005918.4(MDH2):c.109G>A (p.Gly37Arg)	MDH2	G37R	Epileptic encephalopathy, early infantile, 51	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000267277	7	75684190	7	76054872	267277	262040	rs782308462	NC_000007.14:76054871:G:A
NM_005763.4(AASS):c.1256T>G (p.Leu419Arg)	AASS	L419R	Hyperlysinemia	Pathogenic(Last reviewed: Apr 9, 2013)	no assertion criteria provided	VCV000100647	7	121753194	7	122113140	100647	106519	rs587777126	NC_000007.14:122113139:A:C
NM_005763.4(AASS):c.194G>A (p.Arg65Gln)	AASS	R65Q	Hyperlysinemia	Pathogenic(Last reviewed: Apr 9, 2013)	no assertion criteria provided	VCV000100646	7	121773587	7	122133533	100646	106518	rs587777125	NC_000007.14:122133532:C:T
NM_005763.4(AASS):c.1925C>G (p.Ser642Ter)	AASS	S642*	Hyperlysinemia	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000100645	7	121731848	7	122091794	100645	106517	rs587777124	NC_000007.14:122091793:G:C
NM_005763.4(AASS):c.976_977del (p.Gln326fs)	AASS	Q326fs	Hyperlysinemia	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000100644	7	121755194 - 121755195	7	122115140 - 122115141	100644	106516	rs587777123	NC_000007.14:122115139:TG:
NM_005763.4(AASS):c.874A>G (p.Ile292Val)	AASS	I292V	Hyperlysinemia	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000100643	7	121756707	7	122116653	100643	106515	rs587777122	NC_000007.14:122116652:T:C
NM_005763.4(AASS):c.2662+1_2662+5delinsTT	AASS		Hyperlysinemia	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000100642	7	121717887 - 121717891	7	122077833 - 122077837	100642	106514	rs587777121	NC_000007.14:122077832:CTTAC:AA
NM_020634.3(GDF3):c.820C>T (p.Arg274Trp)	GDF3	R274W	Microphthalmia, isolated, with coloboma 6	Pathogenic(Last reviewed: Jan 15, 2010)	no assertion criteria provided	VCV000030594	12	7842749	12	7690153	30594	39551	rs387906946	NC_000012.12:7690152:G:A
NM_020634.3(GDF3):c.584G>A (p.Arg195Gln)	GDF3	R195Q	Microphthalmia, isolated 7	Pathogenic(Last reviewed: Jan 15, 2010)	no assertion criteria provided	VCV000030593	12	7842985	12	7690389	30593	39550	rs146973734	NC_000012.12:7690388:C:T
NM_020634.3(GDF3):c.914T>C (p.Leu305Pro)	GDF3	L305P	Microphthalmia, isolated 7	Pathogenic(Last reviewed: Jan 15, 2010)	no assertion criteria provided	VCV000030592	12	7842655	12	7690059	30592	39549	rs387906945	NC_000012.12:7690058:A:G
NM_001130103.1(COL13A1):c.523-1delG	COL13A1		Myasthenic syndrome, congenital, 19	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218906	10	71648059	10	69888303	218906	215674	rs864309663	NC_000010.11:69888302:GGG:GG
NM_001130103.2(COL13A1):c.1173del (p.Leu392fs)	COL13A1	L341fs, L373fs, L382fs, L391fs, L182fs, L370fs, L335fs, L403fs, L344fs, L392fs	Myasthenic syndrome, congenital, 19	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218905	10	71682524	10	69922768	218905	215673	rs864309662	NC_000010.11:69922767:GGG:GG
NM_005763.4(AASS):c.1601_1609del (p.Cys534_Glu537delinsTer)	AASS	C534*	Hyperlysinemia	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005209	7	121738550 - 121738558	7	122098496 - 122098504	5209	20248	rs387906333	NC_000007.14:122098495:CTTGTTTAC:
NM_005918.4(MDH2):c.596del (p.Gly199fs)	MDH2	G92fs, G199fs, G157fs	Epileptic encephalopathy, early infantile, 51|Infantile encephalopathy	Pathogenic	criteria provided, single submitter	VCV000266121	7	75692872	7	76063554	266121	260945	rs1057519567	NC_000007.14:76063553:GG:G
NM_005918.4(MDH2):c.620C>T (p.Pro207Leu)	MDH2	P207L, P165L, P100L	Epileptic encephalopathy, early infantile, 51|Infantile encephalopathy	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000265770	7	75692897	7	76063579	265770	260445	rs1057519566	NC_000007.14:76063578:C:T
NM_152732.5(RSPH9):c.801_803GAA[1] (p.Lys268del)	RSPH9	K268del	not provided|Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 12|Kartagener syndrome	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066994	6	43638655 - 43638657	6	43670918 - 43670920	66994	77879	rs397515340	NC_000006.12:43670917:AGAAGAA:AGAA
NM_005918.4(MDH2):c.398C>T (p.Pro133Leu)	MDH2	P133L, P26L	Epileptic encephalopathy, early infantile, 51|Infantile encephalopathy	Pathogenic	criteria provided, single submitter	VCV000265769	7	75687365	7	76058047	265769	260444	rs375002796	NC_000007.14:76058046:C:T
NM_001012415.3(SOHLH1):c.27C>G (p.Tyr9Ter)	SOHLH1	Y9*	Nonsyndromic hypergonadotropic hypogonadism|OVARIAN DYSGENESIS 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218902	9	138591287	9	135699441	218902	215662	rs864309646	NC_000009.12:135699440:G:C
NM_001282534.2(KCNK9):c.706G>A (p.Gly236Arg)	KCNK9	G236R	Birk-Barel syndrome|not provided	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004741	8	140630920	8	139618677	4741	19780	rs121908332	NC_000008.11:139618676:C:T
NM_007198.4(PLPBP):c.370_373del (p.Asp124fs)	PLPBP	D72fs, D124fs, D122fs	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000503895	8	37630321 - 37630324	8	37772803 - 37772806	503895	495361	rs755595256	NC_000008.11:37772802:CAGACA:CA
NM_001567.4(INPPL1):c.1845dup (p.Ile616fs)	INPPL1		Opsismodysplasia	Pathogenic	no assertion criteria provided	VCV000431058	11	71943801 - 71943802	11	72232757 - 72232758	431058	424585	rs1135401750	NC_000011.10:72232757:T:TT
NM_020374.4(C12orf4):c.1360C>T (p.Arg454Ter)	C12orf4	R454*, R170*, R238*, R281*, R411*	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66	Pathogenic(Last reviewed: Dec 6, 2018)	no assertion criteria provided	VCV000592164	12	4609384	12	4500218	592164	583170	rs749969789	NC_000012.12:4500217:G:A
NM_020374.4(C12orf4):c.983T>C (p.Leu328Pro)	C12orf4	L328P, L155P, L44P	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66	Pathogenic(Last reviewed: Dec 6, 2018)	no assertion criteria provided	VCV000592163	12	4627274	12	4518108	592163	583169	rs1468772495	NC_000012.12:4518107:A:G
NM_006908.5(RAC1):c.151G>C (p.Val51Leu)	RAC1	V51L	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445285	7	6431598	7	6391967	445285	438557	rs1554263625	NC_000007.14:6391966:G:C
NM_006908.5(RAC1):c.151G>A (p.Val51Met)	RAC1	V51M	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445284	7	6431598	7	6391967	445284	438556	rs1554263625	NC_000007.14:6391966:G:A
NM_006908.5(RAC1):c.190T>G (p.Tyr64Asp)	RAC1	Y64D	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445283	7	6431637	7	6392006	445283	438555	rs1554263626	NC_000007.14:6392005:T:G
NM_006908.5(RAC1):c.116A>G (p.Asn39Ser)	RAC1	N39S	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445281	7	6431563	7	6391932	445281	438553	rs1554263624	NC_000007.14:6391931:A:G
NM_006908.5(RAC1):c.53G>A (p.Cys18Tyr)	RAC1	C18Y	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445280	7	6426860	7	6387229	445280	438552	rs1554263326	NC_000007.14:6387228:G:A
NM_007198.4(PLPBP):c.722G>A (p.Arg241Gln)	PLPBP	R241Q, R239Q, R251Q, R189Q	Epilepsy, early-onset, vitamin b6-dependent	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000374857	8	37635516	8	37777998	374857	361762	rs760609867	NC_000008.11:37777997:G:A
NM_007198.4(PLPBP):c.260C>T (p.Pro87Leu)	PLPBP	P87L, P85L, P122L, P35L	Epilepsy, early-onset, vitamin b6-dependent	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000374856	8	37623814	8	37766296	374856	361761	rs755946598	NC_000008.11:37766295:C:T
NM_007198.4(PLPBP):c.320-2A>G	PLPBP		Epilepsy, early-onset, vitamin b6-dependent	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000374855	8	37630271	8	37772753	374855	361760	rs1057519424	NC_000008.11:37772752:A:G
NM_007198.4(PLPBP):c.207+1G>A	PLPBP		Epilepsy, early-onset, vitamin b6-dependent	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000374854	8	37623152	8	37765634	374854	361759	rs767795673	NC_000008.11:37765633:G:A
NM_007198.4(PLPBP):c.524T>C (p.Leu175Pro)	PLPBP	L175P, L173P, L185P, L123P	Epilepsy, early-onset, vitamin b6-dependent	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000374853	8	37632926	8	37775408	374853	361758	rs752753379	NC_000008.11:37775407:T:C
NM_001567.4(INPPL1):c.2071C>T (p.Arg691Trp)	INPPL1	R691W	Opsismodysplasia	Pathogenic(Last reviewed: Jan 8, 2013)	no assertion criteria provided	VCV000235826	11	71944515	11	72233471	235826	237482	rs878853123	NC_000011.10:72233470:C:T
NM_001567.4(INPPL1):c.2164T>A (p.Phe722Ile)	INPPL1	F722I	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039480	11	71944740	11	72233696	39480	48079	rs397514512	NC_000011.10:72233695:T:A
NM_001567.4(INPPL1):c.1201C>T (p.Arg401Trp)	INPPL1	R401W	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039479	11	71941843	11	72230799	39479	48078	rs397514511	NC_000011.10:72230798:C:T
NM_001567.4(INPPL1):c.278_282del (p.Gln93fs)	INPPL1	Q93fs	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039478	11	71939421 - 71939425	11	72228377 - 72228381	39478	48077	rs797044469	NC_000011.10:72228376:CCAGACC:CC
NM_001567.4(INPPL1):c.1975C>T (p.Pro659Ser)	INPPL1	P659S	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039477	11	71944142	11	72233098	39477	48076	rs397514510	NC_000011.10:72233097:C:T
NM_001567.4(INPPL1):c.768del (p.Glu258fs)	INPPL1	E258fs	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039475	11	71940721	11	72229677	39475	48074	rs797044468	NC_000011.10:72229676:A:
NM_001567.4(INPPL1):c.768_769del (p.Glu258fs)	INPPL1	E258fs	Opsismodysplasia	Pathogenic(Last reviewed: Jan 8, 2013)	no assertion criteria provided	VCV000235824	11	71940721 - 71940722	11	72229677 - 72229678	235824	237480	rs746647683	NC_000011.10:72229676:AG:
NM_001567.4(INPPL1):c.94_121del (p.Glu32fs)	INPPL1	E32fs	Opsismodysplasia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000039481	11	71936115 - 71936142	11	72225071 - 72225098	39481	48080	rs797044470	NC_000011.10:72225070:GGCCGCGGAGGAGCTGCTGGCCCGGGCGGGCCGCG:GGCCGCG
NM_001567.4(INPPL1):c.545C>A (p.Ser182Ter)	INPPL1	S182*	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039474	11	71940160	11	72229116	39474	48073	rs397514509	NC_000011.10:72229115:C:A
NM_001567.4(INPPL1):c.1976C>T (p.Pro659Leu)	INPPL1	P659L	Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039473	11	71944143	11	72233099	39473	48072	rs397514508	NC_000011.10:72233098:C:T
NM_007198.4(PLPBP):c.233C>G (p.Ser78Ter)	PLPBP	S78*, S113*, S26*, S76*	Epilepsy, early-onset, vitamin b6-dependent|not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000374852	8	37623254	8	37765736	374852	361757	rs1057519273	NC_000008.11:37765735:C:G
NM_001567.4(INPPL1):c.2415+1G>A	INPPL1		Opsismodysplasia	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039476	11	71945660	11	72234616	39476	48075	rs655423	NC_000011.10:72234615:G:A
NM_003880.3(CCN6):c.738_739GT[1] (p.Cys247fs)	CCN6		Progressive pseudorheumatoid dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000166615	6	112389555 - 112389556	6	112068352 - 112068353	166615	176922	rs727503755	NC_000006.12:112068351:TGTGT:TGT
NM_020374.4(C12orf4):c.639_640insACAA (p.Gln214fs)	C12orf4		Attention deficit hyperactivity disorder|Intellectual disability|Muscular hypotonia|MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183276	12	4634508 - 4634509	12	4525342 - 4525343	183276	181434	rs730882197	NC_000012.12:4525342:TT:TTGTTT
NM_182931.3(KMT2E):c.450dup (p.Arg151Ter)	KMT2E		O''''DONNELL-LURIA-RODAN SYNDROME	Pathogenic(Last reviewed: Jul 25, 2019)	no assertion criteria provided	VCV000638174	7	104707206 - 104707207	7	105066759 - 105066760	638174	625996		NC_000007.14:105066759:T:TT
NM_148919.4(PSMB8):c.313A>C (p.Lys105Gln)	PSMB8	K105Q, K101Q	Proteasome-associated autoinflammatory syndrome 1	Pathogenic(Last reviewed: Jul 24, 2019)	no assertion criteria provided	VCV000548954	6	32810543	6	32842766	548954	539436	rs1554239543	NC_000006.12:32842765:T:G
NM_001563.4(IMPG1):c.1519C>T (p.Arg507Ter)	IMPG1	R507*, R429*	Macular dystrophy, vitelliform, 4	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000162135	6	76660584	6	75950867	162135	171850	rs367576664	NC_000006.12:75950866:G:A
NM_001563.4(IMPG1):c.807+1G>T	IMPG1		Macular dystrophy, vitelliform, 4	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000162134	6	76728434	6	76018717	162134	171849	rs713993046	NC_000006.12:76018716:C:A
NM_001563.4(IMPG1):c.713T>G (p.Leu238Arg)	IMPG1	L238R, L160R	Macular dystrophy, vitelliform, 4	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000162133	6	76728529	6	76018812	162133	171848	rs713993045	NC_000006.12:76018811:A:C
NM_020207.5(ERCC6L2):c.1236_1239del (p.Thr413fs)	ERCC6L2	T402fs, T413fs	Bone marrow failure syndrome 2	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000125450	9	98683499 - 98683502	9	95921217 - 95921220	125450	130988	rs886037662	NC_000009.12:95921216:CAAACA:CA
NM_024769.4(CLMP):c.371T>A (p.Val124Asp)	CLMP	V124D	Intestinal pseudo-obstruction	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000050386	11	122955237	11	123084529	50386	59508	rs587776967	NC_000011.10:123084528:A:T
NM_024769.4(CLMP):c.821G>A (p.Arg274Gln)	CLMP	R274Q	Intestinal pseudo-obstruction	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000050384	11	122945410	11	123074702	50384	59506	rs587776965	NC_000011.10:123074701:C:T
PSMB8, GLY201VAL	PSMB8	G201V	Proteasome-associated autoinflammatory syndrome 1	Pathogenic(Last reviewed: Sep 6, 2011)	no assertion criteria provided	VCV000029861					29861	38816		
NM_002855.5(NECTIN1):c.969dup (p.Thr324fs)	NECTIN1		Cleft lip/palate-ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000008971	11	119545902 - 119545903	11	119675192 - 119675193	8971	24010	rs878853255	NC_000011.10:119675192:A:AA
CA2, 1-BP DEL, 207C	CA2		Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000920					920	15959		
CA2, IVS5AS, G-C, -1	CA2		Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000000917					917	15956		
NM_000067.3(CA2):c.707C>A (p.Pro236His)	CA2	P237H, P236H, P135H	CARBONIC ANHYDRASE II VARIANT	Pathogenic(Last reviewed: Jan 1, 1983)	no assertion criteria provided	VCV000000915	8	86392942	8	85480713	915	15954	rs118203932	NC_000008.11:85480712:C:A
NM_000067.3(CA2):c.52A>G (p.Lys18Glu)	CA2	K17E, K18E	CARBONIC ANHYDRASE II VARIANT	Pathogenic(Last reviewed: Oct 1, 1982)	no assertion criteria provided	VCV000000914	8	86377518	8	85465289	914	15953	rs118203931	NC_000008.11:85465288:A:G
NM_020207.5(ERCC6L2):c.1963C>T (p.Arg655Ter)	ERCC6L2	R655*, R644*	Bone marrow failure syndrome 2	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000125449	9	98718278	9	95955996	125449	130987	rs147948835	NC_000009.12:95955995:C:T
NM_024769.4(CLMP):c.230del (p.Glu77fs)	CLMP	E77fs	Intestinal pseudo-obstruction	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000050383	11	122955378	11	123084670	50383	59505	rs587776964	NC_000011.10:123084669:T:
NM_148919.4(PSMB8):c.405C>A (p.Cys135Ter)	PSMB8	C135*, C131*	Proteasome-associated autoinflammatory syndrome 1	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000029862	6	32810451	6	32842674	29862	38817		NC_000006.12:32842673:G:T
NM_148919.4(PSMB8):c.602G>T (p.Gly201Val)	PSMB8	G197V, G201V	Proteasome-associated autoinflammatory syndrome 1	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029860	6	32809448	6	32841671	29860	38815	rs387906680	NC_000006.12:32841670:C:A
NM_002855.5(NECTIN1):c.556del (p.Glu186fs)	NECTIN1	E186fs	Cleft lip/palate-ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000008970	11	119548442	11	119677732	8970	24009	rs876657374	NC_000011.10:119677731:CCC:CC
NM_000067.3(CA2):c.120T>G (p.Tyr40Ter)	CA2	Y40*	Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000000919	8	86377586	8	85465357	919	15958	rs118203934	NC_000008.11:85465356:T:G
NM_032273.4(TMEM126A):c.163C>T (p.Arg55Ter)	TMEM126A	R55*	Optic atrophy 7	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000000410	11	85365183	11	85654139	410	15449	rs121434508	NC_000011.10:85654138:C:T
NM_002855.5(NECTIN1):c.554G>A (p.Trp185Ter)	NECTIN1	W185*	Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000008969	11	119548444	11	119677734	8969	24008	rs104894281	NC_000011.10:119677733:C:T
NM_000067.3(CA2):c.319C>T (p.His107Tyr)	CA2	H107Y	Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000000916	8	86386008	8	85473779	916	15955	rs118203933	NC_000008.11:85473778:C:T
NM_003011.4(SET):c.78_81del (p.Lys26fs)	SET	K17fs, K26fs, K15fs, K39fs	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000817338	9	131453451 - 131453454	9	128691172 - 128691175	817338	805604		NC_000009.12:128691171:AAAGAA:AA
NM_003011.4(SET):c.185_186del (p.Lys62fs)	SET	K53fs, K75fs, K51fs, K62fs	not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000817064	9	131454189 - 131454190	9	128691910 - 128691911	817064	805605		NC_000009.12:128691909:AAA:A
NM_003011.4(SET):c.414_415TC[2] (p.Ser140fs)	SET		MENTAL RETARDATION, AUTOSOMAL DOMINANT 58	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000807681	9	131455182 - 131455183	9	128692903 - 128692904	807681	798613		NC_000009.12:128692902:TCTCTC:TCTC
NM_018646.6(TRPV6):c.607+5G>A	TRPV6		HYPERPARATHYROIDISM, TRANSIENT NEONATAL	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590770	7	142574890	7	142877137	590770	581707	rs1200458339	NC_000007.14:142877136:C:T
NM_018646.6(TRPV6):c.978_979del (p.Gly327_Asp328insTer)	TRPV6		HYPERPARATHYROIDISM, TRANSIENT NEONATAL	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590769	7	142573561 - 142573562	7	142875808 - 142875809	590769	581706	rs1342435095	NC_000007.14:142875807:CT:
NM_000039.2(APOA1):c.524_525GC[6] (p.His179fs)	APOA1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000565272	11	116706794 - 116706795	11	116836078 - 116836079	565272	556456	rs781350389	NC_000011.10:116836078:GCGCGCGCGCG:GCGCGCGCGCGCG
NM_003011.4(SET):c.660_662del (p.Tyr220_Leu221delinsTer)	SET		MENTAL RETARDATION, AUTOSOMAL DOMINANT 58	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000560209	9	131456084 - 131456086	9	128693805 - 128693807	560209	551261	rs1554776938	NC_000009.12:128693804:CTT:
NM_003011.4(SET):c.650_651dup (p.Gln218fs)	SET		MENTAL RETARDATION, AUTOSOMAL DOMINANT 58	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000560208	9	131456073 - 131456074	9	128693794 - 128693795	560208	551260	rs1554776933	NC_000009.12:128693794:TA:TATA
NM_003011.4(SET):c.313C>T (p.His105Tyr)	SET	H118Y, H105Y, H96Y, H94Y	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000560207	9	131454979	9	128692700	560207	551259	rs1564360978	NC_000009.12:128692699:C:T
NM_003011.4(SET):c.244T>G (p.Trp82Gly)	SET	W95G, W73G, W71G, W82G	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000560206	9	131454249	9	128691970	560206	551258	rs1554776500	NC_000009.12:128691969:T:G
NM_001098816.3(TENM4):c.3412G>A (p.Val1138Met)	TENM4	V1138M	Tremor, hereditary essential, 5	Pathogenic(Last reviewed: Oct 15, 2015)	no assertion criteria provided	VCV000219135	11	78437262	11	78726217	219135	216941	rs538881762	NC_000011.10:78726216:C:T
NM_001098816.3(TENM4):c.4324G>A (p.Ala1442Thr)	TENM4	A1442T	Tremor, hereditary essential, 5	Pathogenic(Last reviewed: Oct 15, 2015)	no assertion criteria provided	VCV000219134	11	78413334	11	78702289	219134	216940	rs375681722	NC_000011.10:78702288:C:T
NM_001098816.3(TENM4):c.4100C>A (p.Thr1367Asn)	TENM4	T1367N	Tremor, hereditary essential, 5	Pathogenic(Last reviewed: Oct 15, 2015)	no assertion criteria provided	VCV000219133	11	78419515	11	78708470	219133	216939	rs763485258	NC_000011.10:78708469:G:T
NM_003184.4(TAF2):c.1945T>C (p.Trp649Arg)	TAF2	W649R	Mental retardation, autosomal recessive 40	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000092249	8	120795788	8	119783548	92249	98160	rs398124645	NC_000008.11:119783547:A:G
NM_000039.2(APOA1):c.593T>C (p.Leu198Ser)	APOA1	L174S, L198S, L89S	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000017933	11	116706735	11	116836019	17933	32972	rs121912729	NC_000011.10:116836018:A:G
NM_000039.2(APOA1):c.518G>C (p.Arg173Pro)	APOA1	R173P, R64P	Amyloidosis, cardiac and cutaneous	Pathogenic(Last reviewed: Apr 13, 1999)	no assertion criteria provided	VCV000017932	11	116706810	11	116836094	17932	32971	rs387906571	NC_000011.10:116836093:C:G
APOA1, IVS2, G-C, +1	APOA1		HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000017930					17930	32969		
NM_000039.2(APOA1):c.539T>A (p.Val180Glu)	APOA1	V156E, V180E, V71E	Apolipoprotein A-I deficiency	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000017929	11	116706789	11	116836073	17929	32968	rs121912727	NC_000011.10:116836072:A:T
APOA1, 12-BP DEL AND 2-BP INS	APOA1		Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Jun 15, 1996)	no assertion criteria provided	VCV000017927					17927	32966		
APOA1, 1-BP DEL, CODON 202	APOA1		Apolipoprotein A-I deficiency	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000017921					17921	32960		
NM_000039.2(APOA1):c.566C>G (p.Pro189Arg)	APOA1	P165R, P189R, P80R	Apolipoprotein A-I deficiency	Pathogenic(Last reviewed: Dec 1, 1989)	no assertion criteria provided	VCV000017916	11	116706762	11	116836046	17916	32955	rs121912722	NC_000011.10:116836045:G:C
NM_000039.2(APOA1):c.664G>A (p.Glu222Lys)	APOA1	E198K, E222K, E113K	APOLIPOPROTEIN A-I (MUNSTER4)	Pathogenic(Last reviewed: Aug 1, 1988)	no assertion criteria provided	VCV000017912	11	116706664	11	116835948	17912	32951	rs121912717	NC_000011.10:116835947:C:T
NM_000039.2(APOA1):c.595G>C (p.Ala199Pro)	APOA1	A175P, A199P, A90P	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Jun 6, 2002)	no assertion criteria provided	VCV000017934	11	116706733	11	116836017	17934	32973	rs121912730	NC_000011.10:116836016:C:G
APOA1, DEL	APOA1		Apolipoprotein A-I deficiency	Pathogenic(Last reviewed: Oct 5, 1989)	no assertion criteria provided	VCV000017919					17919	32958		
NM_000039.2(APOA1):c.500C>G (p.Pro167Arg)	APOA1	P143R, P167R, P58R	APOLIPOPROTEIN A-I (GIESSEN)	Pathogenic(Last reviewed: Oct 15, 1984)	no assertion criteria provided	VCV000017910	11	116706828	11	116836112	17910	32949	rs121912719	NC_000011.10:116836111:G:C
NM_018646.6(TRPV6):c.530_533dup (p.Arg179fs)	TRPV6		HYPERPARATHYROIDISM, TRANSIENT NEONATAL|not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000590765	7	142574968 - 142574969	7	142877215 - 142877216	590765	581702	rs766719790	NC_000007.14:142877215:GCAAGCA:GCAAGCAAGCA
NM_000067.3(CA2):c.232+1G>A	CA2		Osteopetrosis with renal tubular acidosis|not provided	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000288909	8	86377699	8	85465470	288909	273146	rs573750741	NC_000008.11:85465469:G:A
NM_024769.4(CLMP):c.664C>T (p.Arg222Ter)	CLMP	R222*	Intestinal pseudo-obstruction	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000050385	11	122953808	11	123083100	50385	59507	rs587776966	NC_000011.10:123083099:G:A
NM_018965.3(TREM2):c.97C>T (p.Gln33Ter)	TREM2	Q33*	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000005219	6	41129295	6	41161557	5219	20258	rs104894002	NC_000006.12:41161556:G:A
NM_003880.3(CCN6):c.156C>A (p.Cys52Ter)	CCN6	C52*, C70*	Progressive pseudorheumatoid dysplasia	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000006381	6	112382301	6	112061098	6381	21420	rs121908901	NC_000006.12:112061097:C:A
NM_001015880.2(PAPSS2):c.639+1G>T	PAPSS2		not provided	Pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	VCV000197704	10	89474621	10	87714864	197704	194865	rs794727710	NC_000010.11:87714863:G:T
NM_001015880.2(PAPSS2):c.683_684del (p.Phe228fs)	PAPSS2	F228fs	Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000572534	10	89474784 - 89474785	10	87715027 - 87715028	572534	564850	rs1471554906	NC_000010.11:87715026:TTT:T
NM_006180.4(NTRK2):c.2159C>T (p.Thr720Ile)	NTRK2	T720I, T548I, T692I, T564I, T704I	Obesity, hyperphagia, and developmental delay	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000487685	9	87570419	9	84955504	487685	480767	rs1554774973	NC_000009.12:84955503:C:T
NM_015634.4(KIFBP):c.976C>T (p.Gln326Ter)	KIFBP	Q326*	Goldberg-Shprintzen megacolon syndrome	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437448	10	70770757	10	69011001	437448	430995	rs1293340864	NC_000010.11:69011000:C:T
NM_006180.4(NTRK2):c.1330G>T (p.Gly444Ter)	NTRK2	G444*, G288*, G431*, G432*	Obesity, hyperphagia, and developmental delay	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000427213	9	87366934	9	84752019	427213	415882	rs1085308029	NC_000009.12:84752018:G:T
NM_002095.6(GTF2E2):c.559G>T (p.Asp187Tyr)	GTF2E2	D187Y	Trichothiodystrophy 6, nonphotosensitive	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000225841	8	30464658	8	30607141	225841	227655	rs875989847	NC_000008.11:30607140:C:A
NM_002095.6(GTF2E2):c.448G>C (p.Ala150Pro)	GTF2E2	A150P	Trichothiodystrophy 6, nonphotosensitive	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000225840	8	30469917	8	30612400	225840	227654	rs875989846	NC_000008.11:30612399:C:G
GPIHBP1, DEL	GPIHBP1		Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000144022					144022	153753		
NM_178172.6(GPIHBP1):c.320C>G (p.Ser107Cys)	GPIHBP1	S107C	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Jul 11, 2014)	no assertion criteria provided	VCV000144021	8	144297158	8	143215283	144021	153752	rs587777643	NC_000008.11:143215282:C:G
NM_178172.6(GPIHBP1):c.266G>T (p.Cys89Phe)	GPIHBP1	C89F	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000144017	8	144296972	8	143215097	144017	153748	rs587777640	NC_000008.11:143215096:G:T
NM_178172.6(GPIHBP1):c.202T>G (p.Cys68Gly)	GPIHBP1	C68G	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000144015	8	144296908	8	143215033	144015	153746	rs587777639	NC_000008.11:143215032:T:G
NM_178172.6(GPIHBP1):c.194G>C (p.Cys65Ser)	GPIHBP1	C65S	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000144014	8	144296900	8	143215025	144014	153745	rs587777638	NC_000008.11:143215024:G:C
NM_001015880.2(PAPSS2):c.661del (p.Ile221fs)	PAPSS2	I221fs	Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000039646	10	89474762	10	87715005	39646	48245	rs786200934	NC_000010.11:87715004:AA:A
NM_001015880.2(PAPSS2):c.477_480dup (p.Lys161fs)	PAPSS2		Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000039645	10	89473894 - 89473895	10	87714137 - 87714138	39645	48244	rs606231243	NC_000010.11:87714137:ACGTA:ACGTACGTA
NM_001015880.2(PAPSS2):c.1305_1306AG[2] (p.Arg437fs)	PAPSS2		Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000039644	10	89503212 - 89503213	10	87743455 - 87743456	39644	48243	rs786200933	NC_000010.11:87743454:AGAGAG:AGAG
NM_001015880.2(PAPSS2):c.616_634del (p.Val206fs)	PAPSS2	V206fs	Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000039643	10	89474595 - 89474613	10	87714838 - 87714856	39643	48242	rs606231242	NC_000010.11:87714837:AGGTAGTGGAACTTCTGCAAG:AG
NM_001015880.2(PAPSS2):c.337dup (p.Ala113fs)	PAPSS2		Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000039642	10	89473022 - 89473023	10	87713265 - 87713266	39642	48241	rs606231241	NC_000010.11:87713265:G:GG
NM_006180.4(NTRK2):c.2165A>G (p.Tyr722Cys)	NTRK2	Y722C, Y706C, Y694C, Y550C, Y566C	Obesity, hyperphagia, and developmental delay	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000009127	9	87570425	9	84955510	9127	24166	rs121434633	NC_000009.12:84955509:A:G
NM_001015880.2(PAPSS2):c.143C>G (p.Thr48Arg)	PAPSS2	T48R	Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: May 28, 2009)	no assertion criteria provided	VCV000006687	10	89469068	10	87709311	6687	21726	rs121908951	NC_000010.11:87709310:C:G
NM_001077653.2(TBX20):c.363C>G (p.Ile121Met)	TBX20	I121M	Atrial septal defect 4	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000004634	7	35289580	7	35249968	4634	19673	rs267607106	NC_000007.14:35249967:G:C
NM_001077653.2(TBX20):c.583C>T (p.Gln195Ter)	TBX20	Q195*	Atrial septal defect 4	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000004633	7	35284632	7	35245020	4633	19672	rs137852955	NC_000007.14:35245019:G:A
NM_001077653.2(TBX20):c.456C>G (p.Ile152Met)	TBX20	I152M	Atrial septal defect 4	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000004632	7	35288378	7	35248766	4632	19671	rs137852954	NC_000007.14:35248765:G:C
NC_000010.11:g.(68989259_69000424)_(69005125_69005731)del	KIFBP		Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000183147			10	68989259 - 69005731	183147	181283		
NM_015634.4(KIFBP):c.605_606del (p.Arg202fs)	KIFBP	R202fs	Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Jun 15, 2013)	no assertion criteria provided	VCV000183146	10	70764880 - 70764881	10	69005124 - 69005125	183146	181282	rs730882151	NC_000010.11:69005123:AG:
NM_178172.6(GPIHBP1):c.194G>A (p.Cys65Tyr)	GPIHBP1	C65Y	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000144020	8	144296900	8	143215025	144020	153751	rs587777638	NC_000008.11:143215024:G:A
NM_178172.6(GPIHBP1):c.344A>C (p.Gln115Pro)	GPIHBP1	Q115P	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000144013	8	144297182	8	143215307	144013	153744	rs587777637	NC_000008.11:143215306:A:C
NM_001015880.2(PAPSS2):c.1439C>A (p.Ser480Ter)	PAPSS2	S438*, S475*, S480*	Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000006686	10	89503346	10	87743589	6686	21725	rs121908950	NC_000010.11:87743588:C:A
NM_015634.4(KIFBP):c.250G>T (p.Glu84Ter)	KIFBP	E84*	Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000001734	10	70748838	10	68989082	1734	16773	rs121434515	NC_000010.11:68989081:G:T
NM_015634.4(KIFBP):c.268C>T (p.Arg90Ter)	KIFBP	R90*	Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Jun 15, 2013)	no assertion criteria provided	VCV000001733	10	70748856	10	68989100	1733	16772	rs121434514	NC_000010.11:68989099:C:T
NM_001077653.2(TBX20):c.995del (p.Pro332fs)	TBX20	P332fs	Hypoplastic left heart syndrome|Hypoplastic right heart syndrome|Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000438266	7	35244090	7	35204478	438266	431889	rs1554284604	NC_000007.14:35204477:GGGG:GGG
NM_015634.4(KIFBP):c.599C>A (p.Ser200Ter)	KIFBP	S200*	Shprintzen-Goldberg syndrome|not provided	Pathogenic(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	VCV000183145	10	70764875	10	69005119	183145	181281	rs730882150	NC_000010.11:69005118:C:A
NM_000039.2(APOA1):c.589C>T (p.Arg197Cys)	APOA1	R173C, R197C, R88C	APOLIPOPROTEIN A-I (MILANO)	Pathogenic(Last reviewed: Nov 5, 2003)	no assertion criteria provided	VCV000017909	11	116706739	11	116836023	17909	32948	rs28931573	NC_000011.10:116836022:G:A
NM_178014.4(TUBB):c.1201G>A (p.Glu401Lys)	TUBB	E401K, E357K, E329K, E421K, E199K	Inborn genetic diseases|Cortical dysplasia, complex, with other brain malformations 6	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000127191	6	30692040	6	30724263	127191	132675	rs587777357	NC_000006.12:30724262:G:A
NM_031263.4(HNRNPK):c.229del (p.Ser77fs)	HNRNPK	S77fs	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000426851	9	86590405	9	83975490	426851	415203	rs1085307831	NC_000009.12:83975489:AAA:AA
NM_020427.3(SLURP1):c.240_246delinsAG (p.Asp81fs)	SLURP1		not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000372509	8	143822627 - 143822633	8	142741209 - 142741215	372509	359834	rs1057517823	NC_000008.11:142741208:GGGGTCG:CT
NM_031263.4(HNRNPK):c.1250C>A (p.Ser417Ter)	HNRNPK	S417*, S393*	not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000280716	9	86585188	9	83970273	280716	264549	rs767454980	NC_000009.12:83970272:G:T
NM_013291.3(CPSF1):c.1603_1604del (p.Met535fs)	CPSF1	M535fs	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000837526	8	145624203 - 145624204	8	144398813 - 144398814	837526	834316		NC_000008.11:144398812:AT:
NM_013291.3(CPSF1):c.2823_2824del (p.Val943fs)	CPSF1	V943fs	MYOPIA 27	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829516	8	145621815 - 145621816	8	144396600 - 144396601	829516	818126		NC_000008.11:144396599:CT:
NM_013291.3(CPSF1):c.1858C>T (p.Gln620Ter)	CPSF1	Q620*	MYOPIA 27	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829514	8	145623728	8	144398338	829514	818125		NC_000008.11:144398337:G:A
NM_013291.3(CPSF1):c.4146-2A>G	CPSF1		MYOPIA 27	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829510	8	145618807	8	144393592	829510	818123		NC_000008.11:144393591:T:C
NM_020427.3(SLURP1):c.1A>C (p.Met1Leu)	SLURP1	M1L	Acroerythrokeratoderma	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004604	8	143823803	8	142742385	4604	19643	rs28937889	NC_000008.11:142742384:T:G
NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg)	SLURP1	G86R	Acroerythrokeratoderma	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004602	8	143822617	8	142741199	4602	19641	rs28937888	NC_000008.11:142741198:C:T
NM_020427.3(SLURP1):c.286C>T (p.Arg96Ter)	SLURP1	R96*	Acroerythrokeratoderma	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004601	8	143822587	8	142741169	4601	19640	rs121908317	NC_000008.11:142741168:G:A
NM_020427.3(SLURP1):c.178+1G>A	SLURP1		Acroerythrokeratoderma	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004600	8	143823220	8	142741802	4600	19639	rs587776602	NC_000008.11:142741801:C:T
NM_031263.4(HNRNPK):c.673T>C (p.Tyr225His)	HNRNPK	Y201H, Y225H	AU-KLINE SYNDROME	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000818201	9	86587077	9	83972162	818201	806407		NC_000009.12:83972161:A:G
NM_002140.4(HNRNPK):c.1009delG	HNRNPK		AU-KLINE SYNDROME	Pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, single submitter	VCV000503602	9	86586271	9	83971356	503602	495042	rs1554698470	NC_000009.12:83971355:CC:C
NM_020427.3(SLURP1):c.296G>A (p.Cys99Tyr)	SLURP1	C99Y	Acroerythrokeratoderma	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000004607	8	143822577	8	142741159	4607	19646	rs121908320	NC_000008.11:142741158:C:T
NM_020427.3(SLURP1):c.229T>C (p.Cys77Arg)	SLURP1	C77R	Acroerythrokeratoderma	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000004606	8	143822644	8	142741226	4606	19645	rs121908319	NC_000008.11:142741225:A:G
NM_031263.4(HNRNPK):c.464T>C (p.Leu155Pro)	HNRNPK	L155P, L131P	AU-KLINE SYNDROME	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000625163	9	86588253	9	83973338	625163	613506	rs1564063967	NC_000009.12:83973337:A:G
NM_002140.4(HNRNPK):c.1094delG	HNRNPK		AU-KLINE SYNDROME	Pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, single submitter	VCV000503604	9	86585826	9	83970911	503604	495041	rs1554698213	NC_000009.12:83970910:CCC:CC
NM_001733.7(C1R):c.1303T>C (p.Trp435Arg)	C1R	W435R, W449R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000375582	12	7189381	12	7082077	375582	362392	rs1060499554	NC_000012.12:7082076:A:G
NM_001733.7(C1R):c.1200_1215delinsTCATGTAATA (p.Arg401_Tyr405delinsHisValIle)	C1R		Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000375581			12	7085919 - 7085934	375581	362387	rs1057519580	NC_000012.12:7085918:GTAGTACTGGATACGG:TATTACATGA
NM_001733.7(C1R):c.1113C>G (p.Cys371Trp)	C1R	C371W, C385W	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000375580			12	7086383	375580	362388	rs1057519579	NC_000012.12:7086382:G:C
NM_001733.7(C1R):c.1092G>C (p.Trp364Cys)	C1R	W364C, W378C	Ehlers-Danlos syndrome, periodontal type, 2|Ehlers-Danlos syndrome, type 8	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000375579			12	7086404	375579	362389	rs1057519578	NC_000012.12:7086403:C:G
NM_001733.7(C1R):c.1012T>C (p.Cys338Arg)	C1R	C338R, C352R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000375578	12	7241232	12	7088636	375578	362390	rs1057519577	NC_000012.12:7088635:A:G
NM_001733.7(C1R):c.905A>G (p.Tyr302Cys)	C1R	Y302C, Y316C	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000375577	12	7241446	12	7088850	375577	362391	rs1057519576	NC_000012.12:7088849:T:C
NM_001733.7(C1R):c.890G>A (p.Gly297Asp)	C1R	G297D, G311D	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000372129	12	7241461	12	7088865	372129	359036	rs1057519026	NC_000012.12:7088864:C:T
NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg)	SLURP1	G86R	Acroerythrokeratoderma	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004603	8	143822617	8	142741199	4603	19642	rs28937888	NC_000008.11:142741198:C:G
NM_031263.4(HNRNPK):c.1008+1G>A	HNRNPK		AU-KLINE SYNDROME|not provided	Pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449308	9	86586586	9	83971671	449308	444519	rs1554698658	NC_000009.12:83971670:C:T
NM_001733.7(C1R):c.149_150delinsAT (p.Val50Asp)	C1R	V32D	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000372130	12	7244129 - 7244130	12	7091533 - 7091534	372130	359037	rs1057519025	NC_000012.12:7091532:GA:AT
NM_006180.4(NTRK2):c.1301A>G (p.Tyr434Cys)	NTRK2	Y434C, Y422C, Y278C, Y421C	not provided|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000268204	9	87366905	9	84751990	268204	263820	rs886041091	NC_000009.12:84751989:A:G
NM_031263.4(HNRNPK):c.998dup (p.Tyr333Ter)	HNRNPK		AU-KLINE SYNDROME	Pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, single submitter	VCV000503601	9	86586596 - 86586597	9	83971681 - 83971682	503601	495043	rs1554698681	NC_000009.12:83971681:T:TT
NM_001733.7(C1R):c.869A>G (p.Asp290Gly)	C1R	D272G, D290G, D304G	Ehlers-Danlos syndrome, periodontal type, 2|Ehlers-Danlos syndrome, type 8	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267356	12	7241482	12	7088886	267356	262524	rs1057518643	NC_000012.12:7088885:T:C
NM_001733.7(C1R):c.917_927delinsGGACA (p.Ile306_Cys309delinsArgThr)	C1R		Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267355	12	7241317 - 7241327	12	7088721 - 7088731	267355	262523	rs1057518646	NC_000012.12:7088720:GCACTTGATGA:TGTCC
NM_001733.7(C1R):c.899T>C (p.Leu300Pro)	C1R	L282P, L300P, L314P	Ehlers-Danlos syndrome, periodontal type, 2|Ehlers-Danlos syndrome, type 8	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267354	12	7241452	12	7088856	267354	262522	rs1057515579	NC_000012.12:7088855:A:G
NM_001733.7(C1R):c.927C>G (p.Cys309Trp)	C1R	C291W, C309W, C323W	Ehlers-Danlos syndrome, periodontal type, 2|Ehlers-Danlos syndrome, type 8	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267353	12	7241317	12	7088721	267353	262521	rs769707492	NC_000012.12:7088720:G:C
NM_001733.7(C1R):c.902G>C (p.Arg301Pro)	C1R	R283P, R301P, R315P	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267352	12	7241449	12	7088853	267352	262520	rs760277934	NC_000012.12:7088852:C:G
NM_001733.7(C1R):c.1073G>T (p.Cys358Phe)	C1R	C340F, C358F, C372F	Ehlers-Danlos syndrome, periodontal type, 2|Ehlers-Danlos syndrome, type 8	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267351			12	7086423	267351	262519	rs1057518645	NC_000012.12:7086422:C:A
NM_031263.4(HNRNPK):c.931_932insTT (p.Pro311fs)	HNRNPK		AU-KLINE SYNDROME	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000221225	9	86586818 - 86586819	9	83971903 - 83971904	221225	222923	rs879255263	NC_000009.12:83971903::AA
NM_021224.6(ZNF462):c.1768_1771CCAC[1] (p.Pro591fs)	ZNF462		not provided	Pathogenic(Last reviewed: Dec 1, 2018)	criteria provided, single submitter	VCV000817907	9	109687961 - 109687964	9	106925680 - 106925683	817907	805593		NC_000009.12:106925679:CCACCCAC:CCAC
NM_021224.6(ZNF462):c.831_834del (p.Arg277fs)	ZNF462	R277fs	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000545075	9	109687021 - 109687024	9	106924740 - 106924743	545075	535315	rs1554703226	NC_000009.12:106924739:CAGACAG:CAG
NM_021224.6(ZNF462):c.3202C>T (p.Arg1068Ter)	ZNF462	R1068*	not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000489120	9	109689395	9	106927114	489120	481834	rs562767308	NC_000009.12:106927113:C:T
NM_021224.6(ZNF462):c.1234_1235insAA (p.Ser412Ter)	ZNF462		not provided	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000452539	9	109687427 - 109687428	9	106925146 - 106925147	452539	444331	rs1554703536	NC_000009.12:106925146::AA
NM_021224.6(ZNF462):c.4263del (p.Glu1422fs)	ZNF462	E1422fs	Mental retardation, autosomal dominant|Craniosynostosis	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	VCV000402117	9	109690455	9	106928174	402117	389090	rs1060499551	NC_000009.12:106928173:AA:A
NM_021224.6(ZNF462):c.1552del (p.Val518fs)	ZNF462	V518fs	WEISS-KRUSZKA SYNDROME	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801363	9	109687744	9	106925463	801363	789743		NC_000009.12:106925462:GG:G
NM_021224.6(ZNF462):c.4165C>T (p.Gln1389Ter)	ZNF462	Q1389*	WEISS-KRUSZKA SYNDROME	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000691882	9	109690358	9	106928077	691882	679596		NC_000009.12:106928076:C:T
NM_021224.6(ZNF462):c.763C>T (p.Arg255Ter)	ZNF462	R255*	WEISS-KRUSZKA SYNDROME	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000691880	9	109686956	9	106924675	691880	679594		NC_000009.12:106924674:C:T
NM_021224.6(ZNF462):c.2542del (p.Cys848fs)	ZNF462	C848fs	WEISS-KRUSZKA SYNDROME	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000691879	9	109688735	9	106926454	691879	679593		NC_000009.12:106926453:T:
NM_021224.6(ZNF462):c.5145del (p.Tyr1716fs)	ZNF462	Y1716fs	WEISS-KRUSZKA SYNDROME	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000691878	9	109691338	9	106929057	691878	679592		NC_000009.12:106929056:C:
NM_144585.4(SLC22A12):c.1082G>T (p.Gly361Val)	SLC22A12	G361V, G253V, G140V, G327V	Familial renal hypouricemia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000003517	11	64367159	11	64599687	3517	18556	rs121907897	NC_000011.10:64599686:G:T
NM_144585.4(SLC22A12):c.1253T>G (p.Leu418Arg)	SLC22A12	L418R, L310R, L197R, L384R	Familial renal hypouricemia	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000003515	11	64367330	11	64599858	3515	18554	rs121907895	NC_000011.10:64599857:T:G
NM_144585.4(SLC22A12):c.894G>T (p.Glu298Asp)	SLC22A12	E298D, E190D, E77D, E264D	Familial renal hypouricemia	Pathogenic(Last reviewed: May 23, 2002)	no assertion criteria provided	VCV000003514	11	64366051	11	64598579	3514	18553	rs121907894	NC_000011.10:64598578:G:T
NM_144585.4(SLC22A12):c.650C>T (p.Thr217Met)	SLC22A12	T217M	Familial renal hypouricemia	Pathogenic(Last reviewed: May 23, 2002)	no assertion criteria provided	VCV000003513	11	64361020	11	64593548	3513	18552	rs121907893	NC_000011.10:64593547:C:T
NM_021224.6(ZNF462):c.882dup (p.Ser295fs)	ZNF462		WEISS-KRUSZKA SYNDROME|not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000691881	9	109687070 - 109687071	9	106924789 - 106924790	691881	679595		NC_000009.12:106924789:CCCCC:CCCCCC
NM_021224.6(ZNF462):c.3787C>T (p.Arg1263Ter)	ZNF462	R1263*	WEISS-KRUSZKA SYNDROME|Mental retardation, autosomal dominant|Craniosynostosis	Pathogenic(Last reviewed: Oct 14, 2019)	no assertion criteria provided	VCV000402116	9	109689980	9	106927699	402116	389089	rs1060499549	NC_000009.12:106927698:C:T
NM_031263.4(HNRNPK):c.779dup (p.Phe261_Asp262insTer)	HNRNPK	D262*	AU-KLINE SYNDROME|not provided	Pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280639	9	86586970 - 86586971	9	83972055 - 83972056	280639	264416	rs886041807	NC_000009.12:83972055:CC:CCC
NM_002140.4(HNRNPK):c.953+1dupG	HNRNPK		AU-KLINE SYNDROME	Pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, single submitter	VCV000212775	9	86586795 - 86586796	9	83971880 - 83971881	212775	209407	rs863223402	NC_000009.12:83971880:CCCCCC:CCCCCCC
NM_178172.6(GPIHBP1):c.417_433del (p.Pro140fs)	GPIHBP1	P140fs	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000144019	8	144297251 - 144297267	8	143215376 - 143215392	144019	153750	rs587777642	NC_000008.11:143215375:TCCCACCCTGGCAAAGCTCCC:TCCC
NM_178172.6(GPIHBP1):c.331A>C (p.Thr111Pro)	GPIHBP1	T111P	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000144018	8	144297169	8	143215294	144018	153749	rs587777641	NC_000008.11:143215293:A:C
NM_001015880.2(PAPSS2):c.1000C>T (p.Arg334Ter)	PAPSS2	R329*, R334*	not provided|Spondyloepimetaphyseal dysplasia, pakistani type	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006688	10	89487160	10	87727403	6688	21727	rs121908952	NC_000010.11:87727402:C:T
NM_000073.2(CD3G):c.213dup (p.Trp72fs)	CD3G		Immunodeficiency 17	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000580586	11	118220582 - 118220583	11	118349867 - 118349868	580586	564450	rs570768621	NC_000011.10:118349867:AAAAAAAAA:AAAAAAAAAA
NM_001940.4(ATN1):c.3188T>G (p.Leu1063Arg)	ATN1	L1063R	Congenital ATN1 related disorder	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000487498	12	7048314	12	6939151	487498	480550	rs1555144360	NC_000012.12:6939150:T:G
NM_000073.2(CD3G):c.205A>T (p.Lys69Ter)	CD3G	K69*	Immunodeficiency 17	Pathogenic(Last reviewed: Feb 15, 2007)	no assertion criteria provided	VCV000100626	11	118220583	11	118349868	100626	106498	rs199676861	NC_000011.10:118349867:A:T
NM_000073.2(CD3G):c.80_96del	CD3G		Immunodeficiency 17	Pathogenic(Last reviewed: Aug 20, 1992)	no assertion criteria provided	VCV000012754	11	118220456 - 118220472	11	118349741 - 118349757	12754	27793	rs483352927	NC_000011.10:118349740:AGGAAACCACTTGGTTAAGG:AGG
NM_000073.2(CD3G):c.1A>G (p.Met1Val)	CD3G	M1V	Immunodeficiency 17	Pathogenic(Last reviewed: Aug 20, 1992)	no assertion criteria provided	VCV000012753	11	118215139	11	118344424	12753	27792	rs104894199	NC_000011.10:118344423:A:G
NM_001940.4(ATN1):c.3172C>T (p.His1058Tyr)	ATN1	H1058Y	Congenital ATN1 related disorder|CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES	Pathogenic(Last reviewed: Jul 12, 2019)	no assertion criteria provided	VCV000487497	12	7048298	12	6939135	487497	480549	rs1555144358	NC_000012.12:6939134:C:T
NM_001940.4(ATN1):c.3160C>A (p.His1054Asn)	ATN1	H1054N	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES|Congenital ATN1 related disorder	Pathogenic(Last reviewed: Jul 12, 2019)	no assertion criteria provided	VCV000487496	12	7048286	12	6939123	487496	480548	rs1555144357	NC_000012.12:6939122:C:A
NM_001940.4(ATN1):c.3185A>G (p.His1062Arg)	ATN1	H1062R	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES|Congenital ATN1 related disorder	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	no assertion criteria provided	VCV000590921	12	7048311	12	6939148	590921	581865	rs1565569158	NC_000012.12:6939147:A:G
NM_021224.6(ZNF462):c.2979_2980delinsA (p.Val994fs)	ZNF462		Mental retardation, autosomal dominant|Craniosynostosis|WEISS-KRUSZKA SYNDROME|not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000402118	9	109689172 - 109689173	9	106926891 - 106926892	402118	389091	rs1060499550	NC_000009.12:106926890:TG:A
NM_020427.3(SLURP1):c.43T>C (p.Trp15Arg)	SLURP1	W15R	Acroerythrokeratoderma	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000004605	8	143823761	8	142742343	4605	19644	rs121908318	NC_000008.11:142742342:A:G
NM_004268.5(MED17):c.1299_1302del (p.Ala435fs)	MED17	A435fs	not provided	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000862218	11	93530854 - 93530857	11	93797688 - 93797691	862218	839163		NC_000011.10:93797687:AAACAA:AA
NM_004268.5(MED17):c.1444C>T (p.Gln482Ter)	MED17	Q482*	not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000849753	11	93535116	11	93801950	849753	839165		NC_000011.10:93801949:C:T
NM_004268.5(MED17):c.1439dup (p.Ser481fs)	MED17		not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000849406	11	93535110 - 93535111	11	93801944 - 93801945	849406	839164		NC_000011.10:93801944:C:CC
NM_004268.5(MED17):c.407del (p.Pro136fs)	MED17	P136fs	not provided	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000844828	11	93521322	11	93788156	844828	839162		NC_000011.10:93788155:CC:C
NC_000011.10:g.(?_93796400)_(93807645_?)del	MED17		not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000831069	11	93529566 - 93540811			831069	820422		
NC_000011.10:g.(?_93784504)_(93812074_?)del	MED17		not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000830643	11	93517670 - 93545240			830643	820421		
NM_004268.5(MED17):c.1597C>T (p.Gln533Ter)	MED17	Q533*	not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000663716	11	93542895	11	93809729	663716	640504		NC_000011.10:93809728:C:T
NC_000011.9:g.(?_93517670)_(93521343_?)del	MED17		not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645868	11	93517670 - 93521343	11	93784504 - 93788177	645868	652202		
NM_001987.4(ETV6):c.614del (p.Leu205fs)	ETV6	L205fs	Thrombocytopenia 5	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000435100	12	12022508	12	11869574	435100	429367	rs1555144911	NC_000012.12:11869573:T:
NM_000921.4(PDE3A):c.1346G>T (p.Gly449Val)	PDE3A	G449V, G127V	Brachydactyly-arterial hypertension syndrome	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000193025	12	20769240	12	20616306	193025	190186	rs794726868	NC_000012.12:20616305:G:T
NM_000921.4(PDE3A):c.1340C>T (p.Ala447Val)	PDE3A	A447V, A125V	Brachydactyly-arterial hypertension syndrome	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000193024	12	20769234	12	20616300	193024	190185	rs794726867	NC_000012.12:20616299:C:T
NM_000921.4(PDE3A):c.1339G>A (p.Ala447Thr)	PDE3A	A447T, A125T	Brachydactyly-arterial hypertension syndrome	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000193023	12	20769233	12	20616299	193023	190184	rs794726866	NC_000012.12:20616298:G:A
NM_000921.4(PDE3A):c.1334C>G (p.Thr445Ser)	PDE3A	T445S, T123S	Brachydactyly-arterial hypertension syndrome	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000193022	12	20769228	12	20616294	193022	190183	rs794726864	NC_000012.12:20616293:C:G
NM_000921.4(PDE3A):c.1333A>G (p.Thr445Ala)	PDE3A	T445A, T123A	Brachydactyly-arterial hypertension syndrome	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000193021	12	20769227	12	20616293	193021	190182	rs794726865	NC_000012.12:20616292:A:G
NM_001987.4(ETV6):c.1252A>G (p.Arg418Gly)	ETV6	R418G	Thrombocytopenia 5	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190309	12	12038959	12	11886025	190309	188138	rs786205226	NC_000012.12:11886024:A:G
HBG2, T-G, -567	HBG2		Fetal hemoglobin quantitative trait locus 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000029754					29754	38709		
HBG2, HIS63LEU	HBG2	H63L	Cyanosis, transient neonatal	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000029752					29752	38707		
NM_004268.5(MED17):c.1112T>C (p.Leu371Pro)	MED17	L371P	Microcephaly, postnatal progressive, with seizures and brain atrophy	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000018441	11	93529675	11	93796509	18441	33480	rs267607232	NC_000011.10:93796508:T:C
NM_000921.4(PDE3A):c.1334C>A (p.Thr445Asn)	PDE3A	T445N, T123N	Brachydactyly-arterial hypertension syndrome	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000193020	12	20769228	12	20616294	193020	190181	rs794726864	NC_000012.12:20616293:C:A
NM_001987.4(ETV6):c.1046T>C (p.Leu349Pro)	ETV6	L349P	Acute lymphoid leukemia|Thrombocytopenia|Thrombocytopenia	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000190241	12	12037415	12	11884481	190241	188070	rs786205155	NC_000012.12:11884480:T:C
NM_001987.4(ETV6):c.1106G>A (p.Arg369Gln)	ETV6	R369Q	Hematologic neoplasm|Thrombocytopenia|Thrombocytopenia 5	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000162221	12	12037475	12	11884541	162221	171929	rs724159946	NC_000012.12:11884540:G:A
NM_001987.4(ETV6):c.1195C>T (p.Arg399Cys)	ETV6	R399C	Hematologic neoplasm|Thrombocytopenia|Thrombocytopenia 5	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000162220	12	12038902	12	11885968	162220	171930	rs724159945	NC_000012.12:11885967:C:T
NM_001987.4(ETV6):c.641C>T (p.Pro214Leu)	ETV6	P214L	Hematologic neoplasm|Thrombocytopenia|Thrombocytopenia 5	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000162222	12	12022535	12	11869601	162222	171928	rs724159947	NC_000012.12:11869600:C:T
NM_001987.4(ETV6):c.1307_1308insGGG (p.His436delinsGlnGly)	ETV6		Acute myeloid leukemia	Pathogenic(Last reviewed: Jun 9, 2005)	no assertion criteria provided	VCV000008985	12	12043928 - 12043929	12	11890994 - 11890995	8985	24024	rs587776710	NC_000012.12:11890994::GGG
NM_001987.4(ETV6):c.226G>T (p.Glu76Ter)	ETV6	E76*	Acute myeloid leukemia	Pathogenic(Last reviewed: Jun 9, 2005)	no assertion criteria provided	VCV000008984	12	11992136	12	11839202	8984	24023	rs121434637	NC_000012.12:11839201:G:T
NM_003793.4(CTSF):c.1247T>C (p.Ile416Thr)	CTSF	I416T	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000807589	11	66332103	11	66564632	807589	798644		NC_000011.10:66564631:A:G
NM_003793.4(CTSF):c.649C>T (p.Arg217Ter)	CTSF	R217*	Seizures	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000588283	11	66333834	11	66566363	588283	580009	rs375562245	NC_000011.10:66566362:G:A
NM_003793.4(CTSF):c.843_844del (p.Ala282fs)	CTSF	A282fs	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000434869	11	66333516 - 66333517	11	66566045 - 66566046	434869	429281	rs1555058286	NC_000011.10:66566044:CCCCC:CCC
NM_022138.3(SMOC2):c.681T>A (p.Cys227Ter)	SMOC2	C227*, C216*	Dentin dysplasia, type I, with extreme microdontia and misshapen teeth	Pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000225685	6	168999508	6	168598828	225685	227500	rs875989843	NC_000006.12:168598827:T:A
NM_000434.4(NEU1):c.1170C>G (p.Tyr390Ter)	NEU1	Y390*	|Non-immune hydrops fetalis	Pathogenic(Last reviewed: Jun 22, 2014)	no assertion criteria provided	VCV000218332	6	31827574	6	31859797	218332	215038	rs746607723	NC_000006.12:31859796:G:C
NM_000434.4(NEU1):c.353-2A>G	NEU1		|Non-immune hydrops fetalis	Pathogenic(Last reviewed: Jun 22, 2014)	no assertion criteria provided	VCV000218331	6	31829229	6	31861452	218331	215039	rs864309513	NC_000006.12:31861451:T:C
NM_003793.4(CTSF):c.213+1G>C	CTSF		Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: Nov 4, 2014)	no assertion criteria provided	VCV000208844	11	66335744	11	66568273	208844	205406	rs797045136	NC_000011.10:66568272:C:G
NM_003793.4(CTSF):c.954del (p.Ser319fs)	CTSF	S319fs	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060679	11	66333312	11	66565841	60679	75254	rs753084727	NC_000011.10:66565840:G:
NM_003793.4(CTSF):c.692A>G (p.Tyr231Cys)	CTSF	Y231C	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060678	11	66333791	11	66566320	60678	75253	rs143889283	NC_000011.10:66566319:T:C
NM_003793.4(CTSF):c.1439C>T (p.Ser480Leu)	CTSF	S480L	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060677	11	66331420	11	66563949	60677	75252	rs397514733	NC_000011.10:66563948:G:A
NM_003793.4(CTSF):c.1373G>C (p.Gly458Ala)	CTSF	G458A	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060676	11	66331566	11	66564095	60676	75251	rs397514732	NC_000011.10:66564094:C:G
NM_022138.3(SMOC2):c.84+1G>T	SMOC2		Dentin dysplasia, type I, with extreme microdontia and misshapen teeth	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030657	6	168842135	6	168441455	30657	39614	rs786200927	NC_000006.12:168441454:G:T
NM_021020.5(LZTS1):c.355A>G (p.Lys119Glu)	LZTS1	K119E	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Mar 30, 1999)	no assertion criteria provided	VCV000004246	8	20111087	8	20253576	4246	19285	rs119473032	NC_000008.11:20253575:T:C
NM_021020.5(LZTS1):c.85T>C (p.Ser29Pro)	LZTS1	S29P	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Mar 30, 1999)	no assertion criteria provided	VCV000004245	8	20112608	8	20255097	4245	19284	rs28937897	NC_000008.11:20255096:A:G
NM_000434.4(NEU1):c.69G>A (p.Trp23Ter)	NEU1	W23*		Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000002458	6	31830485	6	31862708	2458	17497	rs104893986	NC_000006.12:31862707:C:T
NM_000434.4(NEU1):c.674G>C (p.Arg225Pro)	NEU1	R225P		Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000002456	6	31828340	6	31860563	2456	17495	rs104893980	NC_000006.12:31860562:C:G
NM_000434.4(NEU1):c.1021+1G>C	NEU1			Pathogenic(Last reviewed: Jul 20, 2001)	no assertion criteria provided	VCV000002455	6	31827818	6	31860041	2455	17494		NC_000006.12:31860040:C:G
NM_000434.4(NEU1):c.946C>T (p.Pro316Ser)	NEU1	P316S	Sialidosis type I	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000002454	6	31827894	6	31860117	2454	17493	rs104893979	NC_000006.12:31860116:G:A
NM_000434.4(NEU1):c.718T>C (p.Trp240Arg)	NEU1	W240R		Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000002453	6	31828296	6	31860519	2453	17492	rs104893978	NC_000006.12:31860518:A:G
NM_000434.4(NEU1):c.239C>T (p.Pro80Leu)	NEU1	P80L		Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000002452	6	31829889	6	31862112	2452	17491	rs104893985	NC_000006.12:31862111:G:A
NM_000434.4(NEU1):c.87G>A (p.Trp29Ter)	NEU1	W29*		Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000002451	6	31830467	6	31862690	2451	17490	rs104893984	NC_000006.12:31862689:C:T
NM_000434.4(NEU1):c.625del (p.Glu209fs)	NEU1	E209fs		Pathogenic(Last reviewed: Apr 12, 2000)	no assertion criteria provided	VCV000002448	6	31828389	6	31860612	2448	17487		NC_000006.12:31860611:CCC:CC
NM_000434.4(NEU1):c.1088T>C (p.Leu363Pro)	NEU1	L303P, L363P		Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000002447	6	31827656	6	31859879	2447	17486	rs193922915	NC_000006.12:31859878:A:G
NEU1, 1-BP DEL, 1337C	NEU1			Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000002445					2445	17484		
NM_000434.4(NEU1):c.272T>G (p.Leu91Arg)	NEU1	L91R		Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000002444	6	31829856	6	31862079	2444	17483	rs104893972	NC_000006.12:31862078:A:C
NM_000434.4(NEU1):c.1129G>T (p.Glu377Ter)	NEU1	E377*	Sialidosis type I	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000002443	6	31827615	6	31859838	2443	17482	rs104893971	NC_000006.12:31859837:C:A
NM_014165.4(NDUFAF4):c.194T>C (p.Leu65Pro)	NDUFAF4	L65P	Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000000790	6	97344666	6	96896790	790	15829	rs63751061	NC_000006.12:96896789:A:G
NM_003793.4(CTSF):c.962A>G (p.Gln321Arg)	CTSF	Q321R	Ceroid lipofuscinosis, neuronal, 13	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000060675	11	66333304	11	66565833	60675	75250	rs397514731	NC_000011.10:66565832:T:C
NM_148919.4(PSMB8):c.224C>T (p.Thr75Met)	PSMB8	T75M, T71M	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC|Proteasome-associated autoinflammatory syndrome 1	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000659832	6	32810790	6	32843013	659832	634822		NC_000006.12:32843012:G:A
NM_000434.4(NEU1):c.114_115del (p.Leu40fs)	NEU1	L40fs	Sialidosis|not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000435974	6	31830439 - 31830440	6	31862662 - 31862663	435974	428609	rs754405067	NC_000006.12:31862661:ACA:A
NM_000434.4(NEU1):c.679G>A (p.Gly227Arg)	NEU1	G227R	Sialidosis|not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430342	6	31828335	6	31860558	430342	421583	rs769765227	NC_000006.12:31860557:C:T
NM_000434.4(NEU1):c.544A>G (p.Ser182Gly)	NEU1	S182G	Sialidosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000430337	6	31829036	6	31861259	430337	421584	rs398123392	NC_000006.12:31861258:T:C
KCNQ1OT1, DEL	KCNQ1OT1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000005825					5825	20864		
NM_000434.4(NEU1):c.727G>A (p.Gly243Arg)	NEU1	G243R	Sialidosis type I|not provided	Pathogenic(Last reviewed: Jun 28, 2013)	criteria provided, single submitter	VCV000002450	6	31828287	6	31860510	2450	17489	rs104893983	NC_000006.12:31860509:C:T
NM_000434.4(NEU1):c.649G>A (p.Val217Met)	NEU1	V217M	Sialidosis type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002449	6	31828365	6	31860588	2449	17488	rs28940583	NC_000006.12:31860587:C:T
NM_147191.1(MMP21):c.643G>A (p.Glu215Lys)	MMP21	E215K	Heterotaxy, visceral, 7, autosomal	Pathogenic(Last reviewed: May 28, 2018)	no assertion criteria provided	VCV000545547	10	127462454	10	125773885	545547	536049	rs145789868	NC_000010.11:125773884:C:T
NM_147191.1(MMP21):c.240dup (p.Lys81fs)	MMP21		not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000279945	10	127462856 - 127462857	10	125774287 - 125774288	279945	264451	rs886041273	NC_000010.11:125774287:GGGGG:GGGGGG
NM_000732.4(CD3D):c.128G>A (p.Trp43Ter)	CD3D	W43*	Immunodeficiency 19	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000643120	11	118211236	11	118340521	643120	639747		NC_000011.10:118340520:C:T
NM_001916.5(CYC1):c.288G>T (p.Trp96Cys)	CYC1	W96C	Mitochondrial complex III deficiency, nuclear type 6	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000066019	8	145150894	8	144095991	66019	76929	rs587777041	NC_000008.11:144095990:G:T
NM_001040651.2(CD3D):c.275-408C>A	CD3D	C93*	Immunodeficiency 19	Pathogenic(Last reviewed: Sep 12, 2017)	no assertion criteria provided	VCV000012748	11	118210617	11	118339902	12748	27787	rs111033581	NC_000011.10:118339901:G:T
NM_006416.5(SLC35A1):c.586G>A (p.Glu196Lys)	SLC35A1	E196K	Congenital disorder of glycosylation type 2F	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000488414	6	88218149	6	87508431	488414	481268	rs1554166844	NC_000006.12:87508430:G:A
NM_006416.5(SLC35A1):c.467C>G (p.Thr156Arg)	SLC35A1	T156R	Congenital disorder of glycosylation type 2F	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000488413	6	88210988	6	87501270	488413	481267	rs578205635	NC_000006.12:87501269:C:G
NM_006416.5(SLC35A1):c.303G>C (p.Gln101His)	SLC35A1	Q101H	Congenital disorder of glycosylation type 2F	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000488412	6	88210334	6	87500616	488412	481266	rs1554166294	NC_000006.12:87500615:G:C
NM_001916.5(CYC1):c.643C>T (p.Leu215Phe)	CYC1	L215F	Mitochondrial complex III deficiency, nuclear type 6|not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000066020	8	145151518	8	144096615	66020	76930	rs587777042	NC_000008.11:144096614:C:T
NM_147191.1(MMP21):c.1372C>T (p.Arg458Ter)	MMP21	R458*	Heterotaxia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265317	10	127456139	10	125767570	265317	259934	rs145119918	NC_000010.11:125767569:G:A
NM_000732.4(CD3D):c.274+5G>A	CD3D		Immunodeficiency 19	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000180674	11	118211085	11	118340370	180674	178842	rs730880296	NC_000011.10:118340369:C:T
NM_016628.5(WAC):c.310del (p.His104fs)	WAC	H104fs, H59fs	not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000817992	10	28872362	10	28583433	817992	805638		NC_000010.11:28583432:CC:C
NM_016628.5(WAC):c.670_673del (p.Thr224fs)	WAC	T179fs, T224fs	not provided	Pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000817803	10	28884718 - 28884721	10	28595789 - 28595792	817803	805640		NC_000010.11:28595788:CAAACAA:CAA
NM_016628.5(WAC):c.313dup (p.Ser105fs)	WAC		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000817437	10	28872365 - 28872366	10	28583436 - 28583437	817437	805639		NC_000010.11:28583436:A:AA
NM_016628.5(WAC):c.203_204del (p.Lys68fs)	WAC	K23fs, K68fs	not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000817273	10	28824614 - 28824615	10	28535685 - 28535686	817273	805637		NC_000010.11:28535684:AAA:A
NM_003801.4(GPAA1):c.1477_1478del (p.Arg493fs)	GPAA1	R493fs	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802447	8	145140501 - 145140502	8	144085598 - 144085599	802447	790787		NC_000008.11:144085597:AG:
GRCh37/hg19 10p12.1(chr10:28862876-28916803)x1	WAC		not provided	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000687244	10	28862876 - 28916803			687244	674836		
NM_016628.5(WAC):c.1633C>T (p.Gln545Ter)	WAC	Q500*, Q545*, Q442*	not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000620552	10	28905178	10	28616249	620552	611732	rs1564422380	NC_000010.11:28616248:C:T
NM_003801.4(GPAA1):c.619del (p.Met207fs)	GPAA1	M207fs	not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000523980	8	145139039	8	144084136	523980	514565	rs782615259	NC_000008.11:144084135:A:
NM_016628.5(WAC):c.577C>T (p.Gln193Ter)	WAC	Q148*, Q193*	not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000523849	10	28879728	10	28590799	523849	514609	rs963822803	NC_000010.11:28590798:C:T
NM_016628.5(WAC):c.257_258del (p.Val86fs)	WAC	V41fs, V86fs	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000503976	10	28824669 - 28824670	10	28535740 - 28535741	503976	495251	rs1554776457	NC_000010.11:28535739:TT:
NM_016628.5(WAC):c.382-2A>G	WAC		not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000489085	10	28878663	10	28589734	489085	481869	rs1554787096	NC_000010.11:28589733:A:G
NM_016628.5(WAC):c.251_252insAA (p.His84fs)	WAC		not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000452335	10	28824662 - 28824663	10	28535733 - 28535734	452335	444601	rs1554776447	NC_000010.11:28535733:A:AAA
NM_016628.5(WAC):c.250_251CA[1] (p.His84fs)	WAC		not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000432966	10	28824662 - 28824663	10	28535733 - 28535734	432966	425872	rs1554776446	NC_000010.11:28535732:CACA:CA
NM_016628.5(WAC):c.1837C>T (p.Arg613Ter)	WAC	R568*, R613*, R510*	not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000426162	10	28906676	10	28617747	426162	415221	rs1085307480	NC_000010.11:28617746:C:T
NM_016628.5(WAC):c.1198C>T (p.Gln400Ter)	WAC	Q355*, Q400*, Q297*	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000424030	10	28899660	10	28610731	424030	407852	rs1064796758	NC_000010.11:28610730:C:T
NM_016628.5(WAC):c.1707dup (p.His570fs)	WAC		not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000422741	10	28905248 - 28905249	10	28616319 - 28616320	422741	407853	rs1554791965	NC_000010.11:28616319:AAAA:AAAAA
NM_016628.5(WAC):c.1346C>G (p.Ser449Ter)	WAC	S404*, S449*, S346*	not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000392418	10	28900760	10	28611831	392418	371650	rs1057524482	NC_000010.11:28611830:C:G
NM_016628.5(WAC):c.1072C>T (p.Gln358Ter)	WAC	Q313*, Q358*, Q255*	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000373124	10	28897267	10	28608338	373124	359812	rs1057518233	NC_000010.11:28608337:C:T
NM_016628.5(WAC):c.1556+1G>A	WAC		not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000373100	10	28903615	10	28614686	373100	359831	rs1057518215	NC_000010.11:28614685:G:A
NM_016628.5(WAC):c.851dup (p.Ala285fs)	WAC		not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000280741	10	28884900 - 28884901	10	28595971 - 28595972	280741	264561	rs886041891	NC_000010.11:28595971:GG:GGG
NM_016628.5(WAC):c.1171dup (p.Thr391fs)	WAC		not provided	Pathogenic(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	VCV000280431	10	28899632 - 28899633	10	28610703 - 28610704	280431	264341	rs886041640	NC_000010.11:28610703:A:AA
NM_016628.5(WAC):c.451C>T (p.Arg151Ter)	WAC	R151*, R106*	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000280400	10	28878734	10	28589805	280400	264340	rs886041614	NC_000010.11:28589804:C:T
NM_016628.5(WAC):c.1820dup (p.Asn607fs)	WAC		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000280338	10	28906653 - 28906654	10	28617724 - 28617725	280338	264454	rs886041564	NC_000010.11:28617724:AAAAAA:AAAAAAA
NM_016628.5(WAC):c.1470_1477del (p.Gln492fs)	WAC	Q389fs, Q447fs, Q492fs	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000811315	10	28903524 - 28903531	10	28614595 - 28614602	811315	799603		NC_000010.11:28614594:CAGTGTCACAGT:CAGT
NM_016628.5(WAC):c.25C>T (p.Gln9Ter)	WAC	Q9*	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000662757	10	28822533	10	28533604	662757	638858		NC_000010.11:28533603:C:T
NM_003801.4(GPAA1):c.920del (p.Gly307fs)	GPAA1	G307fs	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453249	8	145139421	8	144084518	453249	446831	rs1554764067	NC_000008.11:144084517:GG:G
NM_003801.4(GPAA1):c.981_993del (p.Gln327fs)	GPAA1	Q327fs	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453248	8	145139483 - 145139495	8	144084580 - 144084592	453248	446830	rs1554764080	NC_000008.11:144084579:GTACAAGTATGAC:
NM_024854.5(PYROXD1):c.1160_1163dup (p.Lys388fs)	PYROXD1		Myopathy, myofibrillar, 8	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372282	12	21620457 - 21620458	12	21467523 - 21467524	372282	359190	rs1057518755	NC_000012.12:21467523:CAAA:CAAACAAA
NM_024854.5(PYROXD1):c.414+1G>A	PYROXD1		Myopathy, myofibrillar, 8	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372281	12	21602626	12	21449692	372281	359189	rs1057518754	NC_000012.12:21449691:G:A
NM_024854.5(PYROXD1):c.1116G>C (p.Gln372His)	PYROXD1	Q372H, Q301H, Q113H	Myopathy, myofibrillar, 8	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372279	12	21615796	12	21462862	372279	359187	rs755208949	NC_000012.12:21462861:G:C
NM_024854.5(PYROXD1):c.285+1G>A	PYROXD1		Myopathy, myofibrillar, 8	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372278	12	21598401	12	21445467	372278	359186	rs369083786	NC_000012.12:21445466:G:A
NM_000327.3(ROM1):c.239dup (p.Val81fs)	ROM1		Retinitis pigmentosa 7, digenic	Pathogenic(Last reviewed: Jun 10, 1994)	no assertion criteria provided	VCV000012997	11	62380989 - 62380990	11	62613517 - 62613518	12997	28036	rs1387102485	NC_000011.10:62613517:GGG:GGGG
TAPBP, 7.4-KB DEL	TAPBP		Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Aug 15, 2002)	no assertion criteria provided	VCV000007606					7606	22645		
NM_016628.5(WAC):c.1161_1164del (p.Asn387fs)	WAC	N342fs, N387fs, N284fs	not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000642241	10	28897354 - 28897357	10	28608425 - 28608428	642241	638859		NC_000010.11:28608424:AATGAA:AA
NM_016628.5(WAC):c.1537C>T (p.Arg513Ter)	WAC	R513*, R468*, R410*	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000584445	10	28903595	10	28614666	584445	575493	rs1564421528	NC_000010.11:28614665:C:T
NM_016628.5(WAC):c.1885_1886del (p.Leu629fs)	WAC	L629fs, L526fs, L584fs	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Aug 28, 2017)	no assertion criteria provided	VCV000496764	10	28908473 - 28908474	10	28619544 - 28619545	496764	488206	rs1554792658	NC_000010.11:28619543:TTTTT:TTT
NM_016628.5(WAC):c.498-2A>G	WAC		Desanto-shinawi syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431093	10	28879647	10	28590718	431093	424616	rs1135401769	NC_000010.11:28590717:A:G
NM_016628.5(WAC):c.1852C>T (p.Gln618Ter)	WAC	Q618*, Q573*, Q515*	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219143	10	28906691	10	28617762	219143	216949	rs864321634	NC_000010.11:28617761:C:T
NM_016628.5(WAC):c.267_268dup (p.Asp90fs)	WAC		Desanto-shinawi syndrome	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219141	10	28824677 - 28824678	10	28535748 - 28535749	219141	216947	rs864321691	NC_000010.11:28535748:GGG:GGGGG
NM_016628.5(WAC):c.1721G>A (p.Trp574Ter)	WAC	W574*, W529*, W471*	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219140	10	28905266	10	28616337	219140	216946	rs864321690	NC_000010.11:28616336:G:A
NM_024854.5(PYROXD1):c.464A>G (p.Asn155Ser)	PYROXD1	N155S, N84S	Myopathy, myofibrillar, 8	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000372280	12	21605064	12	21452130	372280	359188	rs781565158	NC_000012.12:21452129:A:G
NM_016628.5(WAC):c.1648C>T (p.Arg550Ter)	WAC	R505*, R550*, R447*	Desanto-shinawi syndrome|not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000496763	10	28905193	10	28616264	496763	488205	rs1554791943	NC_000010.11:28616263:C:T
NM_016628.5(WAC):c.112del (p.Ser38fs)	WAC	S38fs	Desanto-shinawi syndrome|not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000219144	10	28824524	10	28535595	219144	216950	rs864321693	NC_000010.11:28535594:A:
NM_016628.5(WAC):c.259_260AG[2] (p.Glu88fs)	WAC		Desanto-shinawi syndrome|not provided	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000219139	10	28824671 - 28824674	10	28535742 - 28535745	219139	216945	rs864321689	NC_000010.11:28535741:AGAGAGAG:AGAG
ATN1, (CAG)n REPEAT EXPANSION	ATN1			Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000590267					590267	581209		
NM_006755.2(TALDO1):c.931G>T (p.Gly311Trp)	TALDO1	G311W	Deficiency of transaldolase	Pathogenic(Last reviewed: Apr 18, 2019)	no assertion criteria provided	VCV000625864	11	764383	11	764383	625864	614168	rs753787975	NC_000011.10:764382:G:T
NM_006661.4(PDE10A):c.868T>C (p.Phe290Leu)	PDE10A	F300L, F290L	Striatal degeneration, autosomal dominant 2	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225636	6	165832223	6	165418735	225636	227470	rs875989841	NC_000006.12:165418734:A:G
NM_006661.4(PDE10A):c.970T>C (p.Phe324Leu)	PDE10A	F334L, F324L	Striatal degeneration, autosomal dominant 2	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225635	6	165829768	6	165416280	225635	227469	rs875989840	NC_000006.12:165416279:A:G
NM_006661.4(PDE10A):c.316G>C (p.Ala106Pro)	PDE10A	A116P, A106P	Dyskinesia, limb and orofacial, infantile-onset	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225634	6	165863730	6	165450242	225634	227468	rs875989839	NC_000006.12:165450241:C:G
NM_006755.1(TALDO1):c.516dupC	TALDO1		Deficiency of transaldolase	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	VCV000208617	11	763397 - 763398	11	763397 - 763398	208617	205196	rs797045110	NC_000011.10:763397:C:CC
NM_000900.5(MGP):c.87T>A (p.Tyr29Ter)	MGP	Y29*, Y54*	Keutel syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000014343	12	15037154	12	14884220	14343	29382	rs730880322	NC_000012.12:14884219:A:T
NM_000900.5(MGP):c.62-2A>G	MGP		Keutel syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000014342	12	15037181	12	14884247	14342	29381	rs112518413	NC_000012.12:14884246:T:C
NM_000900.5(MGP):c.43del (p.Ala14_Val15insTer)	MGP		Keutel syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000014341	12	15038683	12	14885749	14341	29380	rs730880321	NC_000012.12:14885748:CC:C
NM_006755.2(TALDO1):c.793del (p.Gln265fs)	TALDO1	Q265fs	Deficiency of transaldolase	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000162622	11	763902	11	763902	162622	172300	rs727502867	NC_000011.10:763901:C:
NM_018013.4(SOBP):c.1981C>T (p.Arg661Ter)	SOBP	R661*	Mental retardation, anterior maxillary protrusion, and strabismus	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000018392	6	107956029	6	107634825	18392	33431	rs267607078	NC_000006.12:107634824:C:T
NM_006755.2(TALDO1):c.512_514del (p.Ser171del)	TALDO1	S171del	Deficiency of transaldolase	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000007562	11	763392 - 763394	11	763392 - 763394	7562	22601	rs137853085	NC_000011.10:763391:CTCCT:CT
NM_001130690.2(PDE10A):c.1001T>G (p.Phe334Cys)	PDE10A	F334C, F324C	Dyskinesia, limb and orofacial, infantile-onset|Striatal degeneration, autosomal dominant 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522607	6	165829767	6	165416279	522607	513219	rs1554258695	NC_000006.12:165416278:A:C
NM_006661.4(PDE10A):c.290A>G (p.Tyr97Cys)	PDE10A	Y107C, Y97C	Dyskinesia, limb and orofacial, infantile-onset|Generalized hypotonia|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225633	6	165863756	6	165450268	225633	227467	rs778899140	NC_000006.12:165450267:T:C
NM_000900.5(MGP):c.94+1G>A	MGP		not provided|Keutel syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014344	12	15037146	12	14884212	14344	29383	rs111320759	NC_000012.12:14884211:C:T
NM_031263.4(HNRNPK):c.257G>A (p.Arg86His)	HNRNPK	R86H	AU-KLINE SYNDROME	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212776	9	86590377	9	83975462	212776	209408	rs863223403	NC_000009.12:83975461:C:T
NM_002427.4(MMP13):c.212T>C (p.Met71Thr)	MMP13	M71T	Spondyloepimetaphyseal dysplasia, Missouri type	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000560880	11	102826131	11	102955402	560880	551955	rs1565256477	NC_000011.10:102955401:A:G
NM_016525.5(UBAP1):c.316A>T (p.Lys106Ter)	UBAP1	K106*, K142*, K170*	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000827821	9	34241339	9	34241341	827821	815990		NC_000009.12:34241340:A:T
NM_016525.5(UBAP1):c.526G>T (p.Glu176Ter)	UBAP1	E176*, E212*, E240*	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Sep 10, 2019)	no assertion criteria provided	VCV000689456	9	34241549	9	34241551	689456	677049		NC_000009.12:34241550:G:T
NM_016525.5(UBAP1):c.247_248insGTGAATTC (p.Ile83fs)	UBAP1		SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Sep 10, 2019)	no assertion criteria provided	VCV000689455	9	34241270 - 34241271	9	34241272 - 34241273	689455	677048		NC_000009.12:34241272::GTGAATTC
NM_016525.5(UBAP1):c.361dup (p.Leu121fs)	UBAP1		SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627556	9	34241382 - 34241383	9	34241384 - 34241385	627556	615911	rs1563920132	NC_000009.12:34241384:CC:CCC
NM_016525.5(UBAP1):c.295dup (p.Asp99fs)	UBAP1		SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627555	9	34241317 - 34241318	9	34241319 - 34241320	627555	615910	rs1563920000	NC_000009.12:34241319:G:GG
NM_016525.5(UBAP1):c.286_290dup (p.Glu97fs)	UBAP1		SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627554	9	34241308 - 34241309	9	34241310 - 34241311	627554	615909	rs1563919973	NC_000009.12:34241310:CCAGA:CCAGACCAGA
NM_016525.5(UBAP1):c.373C>T (p.Gln125Ter)	UBAP1	Q125*, Q189*, Q161*	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627553	9	34241396	9	34241398	627553	615908	rs1563920172	NC_000009.12:34241397:C:T
NM_016525.5(UBAP1):c.436_437insTGAG (p.Ser146fs)	UBAP1		SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627551	9	34241459 - 34241460	9	34241461 - 34241462	627551	615906	rs1563920268	NC_000009.12:34241461::TGAG
NM_002427.4(MMP13):c.772dup (p.Asp258fs)	MMP13		not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000197743	11	102822767 - 102822768	11	102952038 - 102952039	197743	194904	rs797044754	NC_000011.10:102952038:C:CC
NM_002427.4(MMP13):c.325C>T (p.Arg109Ter)	MMP13	R109*	Metaphyseal chondrodysplasia, Spahr type	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183688	11	102826018	11	102955289	183688	181587	rs369083541	NC_000011.10:102955288:G:A
NM_000230.3(LEP):c.298G>T (p.Asp100Tyr)	LEP	D100Y	Leptin dysfunction	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162430	7	127894610	7	128254557	162430	172121	rs724159998	NC_000007.14:128254556:G:T
NM_002427.4(MMP13):c.272T>C (p.Met91Thr)	MMP13	M72T, M91T	Metaphyseal anadysplasia 1, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000009445	11	102826071	11	102955342	9445	24484	rs121909499	NC_000011.10:102955341:A:G
NM_002427.4(MMP13):c.221T>C (p.Phe74Ser)	MMP13	F55S, F74S	Metaphyseal anadysplasia 1, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000009444	11	102826122	11	102955393	9444	24483	rs121909498	NC_000011.10:102955392:A:G
TNFRSF10B, 2-BP INS	TNFRSF10B		Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Aug 15, 1998)	no assertion criteria provided	VCV000006194					6194	21233		
NM_000230.3(LEP):c.313C>T (p.Arg105Trp)	LEP	R105W	Leptin deficiency or dysfunction	Pathogenic(Last reviewed: Mar 30, 2004)	no assertion criteria provided	VCV000013987	7	127894625	7	128254572	13987	29026	rs104894023	NC_000007.14:128254571:C:T
NM_002427.4(MMP13):c.694C>A (p.His232Asn)	MMP13	H213N, H232N	Metaphyseal chondrodysplasia, Spahr type	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000009446	11	102822846	11	102952117	9446	24485	rs121909500	NC_000011.10:102952116:G:T
NM_002427.4(MMP13):c.224T>C (p.Phe75Ser)	MMP13	F56S, F75S	Spondyloepimetaphyseal dysplasia, Missouri type	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000009443	11	102826119	11	102955390	9443	24482	rs121909497	NC_000011.10:102955389:A:G
LEP, 1-BP DEL, FS147TER	LEP		Leptin deficiency or dysfunction	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000013986					13986	29025		
NM_001031689.3(PLAA):c.240_241insTAG (p.Pro81Ter)	PLAA		NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000807466	9	26935113 - 26935114	9	26935115 - 26935116	807466	798619		NC_000009.12:26935115::CTA
NC_000007.14:g.(?_120856698)_(120856763_?)del	TSPAN12		not provided	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000832120	7	120496752 - 120496817			832120	819808		
NM_001031689.3(PLAA):c.120C>G (p.Asp40Glu)	PLAA	D40E	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	Pathogenic	criteria provided, single submitter	VCV000828067	9	26946924	9	26946926	828067	816403		NC_000009.12:26946925:G:C
NM_012338.4(TSPAN12):c.100del (p.Trp34fs)	TSPAN12	W34fs	Vitreoretinopathy	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523501	7	120480130	7	120840076	523501	513968	rs1554403767	NC_000007.14:120840075:AA:A
NM_001031689.3(PLAA):c.68dup (p.Leu24fs)	PLAA		NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	Pathogenic(Last reviewed: Jun 21, 2017)	no assertion criteria provided	VCV000427942	9	26946975 - 26946976	9	26946977 - 26946978	427942	419137	rs1554662408	NC_000009.12:26946977:CCCC:CCCCC
NM_001031689.3(PLAA):c.68G>T (p.Gly23Val)	PLAA	G23V	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	Pathogenic(Last reviewed: Jun 21, 2017)	no assertion criteria provided	VCV000427941	9	26946976	9	26946978	427941	419136	rs747956857	NC_000009.12:26946977:C:A
NM_001031689.3(PLAA):c.2254C>T (p.Leu752Phe)	PLAA	L752F, L729F	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	Pathogenic(Last reviewed: Jun 21, 2017)	no assertion criteria provided	VCV000427940	9	26905643	9	26905645	427940	419135	rs1114167457	NC_000009.12:26905644:G:A
GRCh38/hg38 7q31.31(chr7:120795527-120842557)x1	TSPAN12		See cases	Pathogenic(Last reviewed: Apr 2, 2013)	no assertion criteria provided	VCV000155097	7	120435581 - 120482611	7	120795527 - 120842557	155097	164851		
NM_017946.3(FKBP14):c.34_35delCT	FKBP14		Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000657045	7	30066090 - 30066091	7	30026474 - 30026475	657045	636127		NC_000007.14:30026473:AGAG:AG
NM_017946.3(FKBP14):c.143T>A (p.Met48Lys)	FKBP14	M48K	Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	Pathogenic(Last reviewed: May 23, 2019)	no assertion criteria provided	VCV000638153	7	30065982	7	30026366	638153	625974		NC_000007.14:30026365:A:T
NM_017946.3(FKBP14):c.156T>A (p.Tyr52Ter)	FKBP14	Y52*	Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000567476	7	30065969	7	30026353	567476	561571	rs1562840744	NC_000007.14:30026352:A:T
NM_017946.3(FKBP14):c.197+5_197+8del	FKBP14		Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161456	7	30065920 - 30065923	7	30026304 - 30026307	161456	171290	rs747353360	NC_000007.14:30026303:TTACTTAC:TTAC
NM_012338.4(TSPAN12):c.285+1G>A	TSPAN12		Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: May 14, 2012)	no assertion criteria provided	VCV000126506	7	120478830	7	120838776	126506	132030	rs587777285	NC_000007.14:120838775:C:T
NM_012338.4(TSPAN12):c.146C>T (p.Thr49Met)	TSPAN12	T49M	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: May 14, 2012)	no assertion criteria provided	VCV000126505	7	120480084	7	120840030	126505	132029	rs538591733	NC_000007.14:120840029:G:A
NM_012338.4(TSPAN12):c.67-1G>C	TSPAN12		Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: May 14, 2012)	no assertion criteria provided	VCV000126504	7	120480164	7	120840110	126504	132028	rs587777284	NC_000007.14:120840109:C:G
NM_017946.3(FKBP14):c.42_60del (p.Val14_Thr15insTer)	FKBP14		Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031198	7	30066065 - 30066083	7	30026449 - 30026467	31198	40155	rs770271683	NC_000007.14:30026448:AGCCCCAATCAAAGAAGTGA:A
NM_012338.4(TSPAN12):c.734T>C (p.Leu245Pro)	TSPAN12	L245P	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000031006	7	120428830	7	120788776	31006	39963	rs200519776	NC_000007.14:120788775:A:G
NM_012338.4(TSPAN12):c.302T>A (p.Leu101His)	TSPAN12	L101H	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000324	7	120455841	7	120815787	324	15363	rs267607152	NC_000007.14:120815786:A:T
NM_012338.4(TSPAN12):c.361-5_361-1del	TSPAN12		Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000323	7	120450625 - 120450629	7	120810571 - 120810575	323	15362	rs794726655	NC_000007.14:120810570:CTGGT:
NM_012338.4(TSPAN12):c.205_211GCTGTTT[3] (p.Phe73fs)	TSPAN12		Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000321	7	120478897 - 120478898	7	120838843 - 120838844	321	15360	rs1554403626	NC_000007.14:120838843:AAACAGCAAACAGCAA:AAACAGCAAACAGCAAACAGCAA
NM_012338.4(TSPAN12):c.562G>C (p.Gly188Arg)	TSPAN12	G188R	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000320	7	120446653	7	120806599	320	15359	rs267607151	NC_000007.14:120806598:C:G
NM_012338.4(TSPAN12):c.709G>C (p.Ala237Pro)	TSPAN12	A237P	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000319	7	120428855	7	120788801	319	15358	rs267607154	NC_000007.14:120788800:C:G
NM_012338.4(TSPAN12):c.413A>G (p.Tyr138Cys)	TSPAN12	Y138C	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: May 14, 2012)	no assertion criteria provided	VCV000126503	7	120450572	7	120810518	126503	132027	rs587777283	NC_000007.14:120810517:T:C
CEL, 1-BP DEL, 1686T	CEL			Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000017600					17600	32639		
NM_012338.4(TSPAN12):c.419T>A (p.Leu140Ter)	TSPAN12	L140*	Exudative vitreoretinopathy 5	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000000322	7	120450566	7	120810512	322	15361	rs267607153	NC_000007.14:120810511:A:T
NM_000733.4(CD3E):c.490C>T (p.Arg164Ter)	CD3E	R164*	Immunodeficiency 18	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000847888	11	118184559	11	118313844	847888	838028		NC_000011.10:118313843:C:T
NM_000733.4(CD3E):c.261_262del (p.Ser88fs)	CD3E	S88fs	Immunodeficiency 18	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000847887	11	118183488 - 118183489	11	118312773 - 118312774	847887	838025		NC_000011.10:118312772:TTTT:TT
NM_000733.3(CD3E):c.128_129del (p.Thr43fs)	CD3E	T43fs	Immunodeficiency 18, severe combined immunodeficiency variant	Pathogenic(Last reviewed: Jan 10, 2020)	no assertion criteria provided	VCV000012746	11	118183357 - 118183358	11	118312642 - 118312643	12746	27785	rs483352929	NC_000011.10:118312641:CC:
NM_000733.3(CD3E):c.176G>A (p.Trp59Ter)	CD3E	W59*	Immunodeficiency 18	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000012745	11	118183405	11	118312690	12745	27784	rs121918659	NC_000011.10:118312689:G:A
NM_000733.3(CD3E):c.520+2T>C	CD3E		Immunodeficiency 18	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000012744	11	118184591	11	118313876	12744	27783	rs483352928	NC_000011.10:118313875:T:C
NM_000732.4(CD3D):c.202C>T (p.Arg68Ter)	CD3D	R68*	Immunodeficiency 19	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000012747	11	118211162	11	118340447	12747	27786	rs111033580	NC_000011.10:118340446:G:A
NC_000007.14:g.31008681G>T	GHRHR		Isolated growth hormone deficiency type 1B	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000626257	7	31048296	7	31008681	626257	614551	rs1562606449	NC_000007.14:31008680:G:T
NM_000823.4(GHRHR):c.194G>A (p.Trp65Ter)	GHRHR	W65*	not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000597306	7	31008711	7	30969096	597306	588367	rs1562592874	NC_000007.14:30969095:G:A
Single allele	GHRHR		Isolated growth hormone deficiency type 1B	Pathogenic(Last reviewed: Apr 22, 2013)	no assertion criteria provided	VCV000056966	7	30999250 - 31006943	7	30959635 - 30967328	56966	71561		
NM_014806.5(RUSC2):c.3952C>T (p.Arg1318Ter)	RUSC2	R1318*, R440*	Intellectual disability, autosomal recessive 61	Pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000446386	9	35560589	9	35560592	446386	439841	rs1554645052	NC_000009.12:35560591:C:T
NM_014806.5(RUSC2):c.2596C>T (p.Arg866Ter)	RUSC2	R866*	Intellectual disability, autosomal recessive 61	Pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000446385	9	35555638	9	35555641	446385	439840	rs1402086660	NC_000009.12:35555640:C:T
NM_203290.4(POLR1C):c.614del (p.Gly205fs)	POLR1C	G205fs	Leukodystrophy, hypomyelinating, 11	Pathogenic	no assertion criteria provided	VCV000375403	6	43488123	6	43520385	375403	362146	rs1057519456	NC_000006.12:43520384:GG:G
NM_000823.4(GHRHR):c.1089_1093del (p.Leu364fs)	GHRHR	L364fs	not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265396	7	31016156 - 31016160	7	30976541 - 30976545	265396	259859	rs748432685	NC_000007.14:30976540:GGACTGG:GG
NM_004588.5(SCN2B):c.83G>A (p.Arg28Gln)	SCN2B	R28Q	Atrial fibrillation, familial, 14	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000060770	11	118039454	11	118168739	60770	75312	rs72544145	NC_000011.10:118168738:C:T
GHRHR, -124A-C, PROMOTER	GHRHR		ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000015995					15995	31034		
NM_000823.4(GHRHR):c.985A>G (p.Lys329Glu)	GHRHR	K329E	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000015994	7	31016054	7	30976439	15994	31033	rs121918121	NC_000007.14:30976438:A:G
NM_000823.4(GHRHR):c.665C>A (p.Ala222Glu)	GHRHR	A222E	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000015993	7	31013667	7	30974052	15993	31032	rs121918120	NC_000007.14:30974051:C:A
NM_000823.4(GHRHR):c.725T>G (p.Phe242Cys)	GHRHR	F242C	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000015992	7	31013727	7	30974112	15992	31031	rs121918119	NC_000007.14:30974111:T:G
NM_000823.4(GHRHR):c.431T>A (p.Leu144His)	GHRHR	L144H	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000015991	7	31010798	7	30971183	15991	31030	rs121918118	NC_000007.14:30971182:T:A
NM_033500.2(HK1):c.1550T>C (p.Leu517Ser)	HK1	L529S, L517S, L528S, L533S, L501S, L564S, L497S	Hemolytic anemia due to hexokinase deficiency	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000014916	10	71144104	10	69384348	14916	29955	rs137853249	NC_000010.11:69384347:T:C
HK1, 96-BP DEL	HK1		Hemolytic anemia due to hexokinase deficiency	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000014915					14915	29954		
PDGRL, 2-BP DEL	PDGFRL		Hepatocellular carcinoma	Pathogenic(Last reviewed: Mar 2, 1995)	no assertion criteria provided	VCV000005469					5469	20508		
NM_003480.4(MFAP5):c.62G>T (p.Trp21Leu)	MFAP5	W21L	Aortic aneurysm, familial thoracic 9	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162200	12	8813491	12	8660895	162200	171908	rs724159961	NC_000012.12:8660894:C:A
NM_003480.4(MFAP5):c.472C>T (p.Arg158Ter)	MFAP5	R158*, R133*, R136*, R148*, R94*	Aortic aneurysm, familial thoracic 9	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162199	12	8800737	12	8648141	162199	171907	rs727502791	NC_000012.12:8648140:G:A
NM_033500.2(HK1):c.2003C>G (p.Thr668Ser)	HK1	T680S, T668S, T648S, T652S, T684S, T715S, T679S	Hemolytic anemia due to hexokinase deficiency	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000055851	10	71151884	10	69392128	55851	70505	rs398122379	NC_000010.11:69392127:C:G
NM_003863.3(DPM2):c.4-1G>C	DPM2		Congenital disorder of glycosylation type 1u	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039447	9	130699803	9	127937524	39447	48046	rs797044467	NC_000009.12:127937523:C:G
POLR1C, 1-BP DEL, 87T	POLR1C			Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030814					30814	39771		
NM_203290.4(POLR1C):c.979A>T (p.Lys327Ter)	POLR1C	K327*		Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030813	6	43488976	6	43521238	30813	39770	rs387907020	NC_000006.12:43521237:A:T
POLR1C, IVS8, 4-BP DEL, +3	POLR1C			Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030812					30812	39769		
NM_020427.3(SLURP1):c.82del (p.Cys28fs)	SLURP1	C28fs	Acroerythrokeratoderma|not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004599	8	143823317	8	142741899	4599	19638	rs587776601	NC_000008.11:142741898:A:
NM_203290.4(POLR1C):c.970G>A (p.Glu324Lys)	POLR1C	E324K	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635153	6	43488967	6	43521229	635153	622987		NC_000006.12:43521228:G:A
NM_203290.4(POLR1C):c.938C>T (p.Thr313Met)	POLR1C	T313M	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635152	6	43488935	6	43521197	635152	622986		NC_000006.12:43521196:C:T
NM_203290.4(POLR1C):c.916_920del (p.Tyr306fs)	POLR1C	Y306fs	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635151	6	43488778 - 43488782	6	43521040 - 43521044	635151	622985		NC_000006.12:43521039:ATTATAT:AT
NM_203290.4(POLR1C):c.785T>C (p.Ile262Thr)	POLR1C	I262T	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635150	6	43488492	6	43520754	635150	622984		NC_000006.12:43520753:T:C
NM_203290.4(POLR1C):c.733G>A (p.Val245Met)	POLR1C	V245M	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635149	6	43488440	6	43520702	635149	622983		NC_000006.12:43520701:G:A
NM_203290.4(POLR1C):c.502G>A (p.Val168Met)	POLR1C	V168M	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635147	6	43487923	6	43520185	635147	622981		NC_000006.12:43520184:G:A
NM_203290.4(POLR1C):c.461_462del (p.Lys154fs)	POLR1C	K154fs	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635146	6	43487881 - 43487882	6	43520143 - 43520144	635146	622980		NC_000006.12:43520142:AAA:A
NM_203290.4(POLR1C):c.395G>A (p.Gly132Asp)	POLR1C	G132D	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635145	6	43487816	6	43520078	635145	622979		NC_000006.12:43520077:G:A
NM_203290.4(POLR1C):c.349G>C (p.Ala117Pro)	POLR1C	A117P	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635144	6	43487543	6	43519805	635144	622978		NC_000006.12:43519804:G:C
NM_203290.4(POLR1C):c.325C>T (p.Arg109Cys)	POLR1C	R109C	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635143	6	43487519	6	43519781	635143	622977		NC_000006.12:43519780:C:T
NM_203290.4(POLR1C):c.322C>T (p.His108Tyr)	POLR1C	H108Y	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635142	6	43487516	6	43519778	635142	622976		NC_000006.12:43519777:C:T
NM_203290.4(POLR1C):c.313A>T (p.Ile105Phe)	POLR1C	I105F	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635141	6	43487507	6	43519769	635141	622975		NC_000006.12:43519768:A:T
NM_203290.4(POLR1C):c.281T>C (p.Val94Ala)	POLR1C	V94A	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635140	6	43487475	6	43519737	635140	622974		NC_000006.12:43519736:T:C
NM_203290.4(POLR1C):c.69+1G>A	POLR1C		Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000635139	6	43484917	6	43517179	635139	622988		NC_000006.12:43517178:G:A
NM_033500.2(HK1):c.1298C>T (p.Ser433Leu)	HK1	S433L, S445L, S413L, S417L, S480L, S444L, S449L	not provided|NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000421007	10	71142311	10	69382555	421007	407888	rs1064794848	NC_000010.11:69382554:C:T
NM_033500.2(HK1):c.-390-3818G>C	HK1		Neuropathy, hereditary motor and sensory, Russe type	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000040213	10	71038467	10	69278711	40213	48698	rs397514654	NC_000010.11:69278710:G:C
NM_003863.3(DPM2):c.68A>G (p.Tyr23Cys)	DPM2	Y23C	Congenital disorder of glycosylation type 1u	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039446	9	130699738	9	127937459	39446	48045	rs397514503	NC_000009.12:127937458:T:C
NM_001025295.3(IFITM5):c.-14C>T	IFITM5		Osteogenesis imperfecta type 5	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037143	11	299504	11	299504	37143	45805	rs587776916	NC_000011.10:299503:G:A
NM_203290.4(POLR1C):c.699C>G (p.Tyr233Ter)	POLR1C	Y233*	Leukodystrophy, hypomyelinating, 11|not provided	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280857	6	43488406	6	43520668	280857	264293	rs763593155	NC_000006.12:43520667:C:G
NM_203290.4(POLR1C):c.70-1G>A	POLR1C		not provided|Leukodystrophy, hypomyelinating, 11	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280457	6	43485043	6	43517305	280457	264263	rs886041661	NC_000006.12:43517304:G:A
NM_033500.2(HK1):c.-390-3838G>C	HK1		Neuropathy, hereditary motor and sensory, Russe type	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208363	10	71038447	10	69278691	208363	204592	rs797044964	NC_000010.11:69278690:G:C
NM_203290.4(POLR1C):c.77C>T (p.Thr26Ile)	POLR1C	T26I	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000204591	6	43485051	6	43517313	204591	200981	rs796052126	NC_000006.12:43517312:C:T
NM_203290.4(POLR1C):c.436T>C (p.Cys146Arg)	POLR1C	C146R	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000204589	6	43487857	6	43520119	204589	200979	rs796052125	NC_000006.12:43520118:T:C
NM_203290.4(POLR1C):c.95A>T (p.Asn32Ile)	POLR1C	N32I	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000204588	6	43485069	6	43517331	204588	200978	rs796052124	NC_000006.12:43517330:A:T
NM_203290.4(POLR1C):c.221A>G (p.Asn74Ser)	POLR1C	N74S	Leukodystrophy, hypomyelinating, 11	Pathogenic	criteria provided, single submitter	VCV000204587	6	43487150	6	43519412	204587	200977	rs371802902	NC_000006.12:43519411:A:G
GRCh37/hg19 11p15.4(chr11:5254694-5262112)x1	HBD		not provided	Pathogenic(Last reviewed: Jul 24, 2018)	no assertion criteria provided	VCV000686921	11	5254694 - 5262112			686921	674513		
NM_024747.5(HPS6):c.1864_1871del (p.Leu622fs)	HPS6	L622fs	not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000594577	10	103827092 - 103827099	10	102067335 - 102067342	594577	585640	rs1564899951	NC_000010.11:102067334:GCTCTGGAGCT:GCT
NM_003282.4(TNNI2):c.493A>T (p.Ile165Phe)	TNNI2	I165F	Distal arthrogryposis type 2B	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000694070	11	1862725	11	1841495	694070	681917		NC_000011.10:1841494:A:T
NM_177965.4(C8orf37):c.304A>T (p.Lys102Ter)	C8orf37	K102*	Bardet-Biedl syndrome 21	Pathogenic(Last reviewed: Mar 28, 2017)	no assertion criteria provided	VCV000417789	8	96272700	8	95260472	417789	404690	rs766087213	NC_000008.11:95260471:T:A
NM_177965.4(C8orf37):c.555G>A (p.Trp185Ter)	C8orf37	W185*, W153*	Retinitis pigmentosa 64	Pathogenic(Last reviewed: Mar 28, 2017)	no assertion criteria provided	VCV000417788	8	96259914	8	95247686	417788	404689	rs748014296	NC_000008.11:95247685:C:T
NM_177965.4(C8orf37):c.244-2A>C	C8orf37		Retinitis pigmentosa 64	Pathogenic(Last reviewed: Sep 25, 2019)	no assertion criteria provided	VCV000417787	8	96272762	8	95260534	417787	404688	rs1060505042	NC_000008.11:95260533:T:G
NM_021956.4(GRIK2):c.592C>T (p.Arg198Ter)	GRIK2	R198*	Mental retardation, autosomal recessive 6	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000189252	6	102124548	6	101676673	189252	187134	rs749995448	NC_000006.12:101676672:C:T
NM_003867.4(FGF17):c.530G>A (p.Arg177His)	FGF17	R177H, R166H	Hypogonadotropic hypogonadism 20 without anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050859	8	21905639	8	22048128	50859	59845	rs398123025	NC_000008.11:22048127:G:A
NM_177965.4(C8orf37):c.497T>A (p.Leu166Ter)	C8orf37	L166*, L134*	Retinitis pigmentosa 64	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000031192	8	96259972	8	95247744	31192	40149	rs1064792852	NC_000008.11:95247743:A:T
NM_024747.5(HPS6):c.1065dup (p.Leu356fs)	HPS6		Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000030671	10	103826295 - 103826296	10	102066538 - 102066539	30671	39628	rs1564899492	NC_000010.11:102066538:G:GG
C1S, 4-BP DEL, NT1087	C1S		Complement component c1s deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000017067					17067	32106		
GRIK2, DEL/INV, EX7-11	GRIK2		Mental retardation, autosomal recessive 6	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000016087					16087	31126		
HBD, IVS2AS, A-G, -2	HBD		delta Thalassemia	Pathogenic(Last reviewed: Dec 15, 1991)	no assertion criteria provided	VCV000015073					15073	30112		
NM_024747.5(HPS6):c.1711_1712insAG (p.Cys571Ter)	HPS6		Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000435465	10	103826942 - 103826943	10	102067185 - 102067186	435465	429038	rs1220869113	NC_000010.11:102067185::AG
NM_024747.5(HPS6):c.2038C>T (p.Gln680Ter)	HPS6	Q680*	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000431051	10	103827269	10	102067512	431051	424580	rs1131692333	NC_000010.11:102067511:C:T
NM_024747.5(HPS6):c.1898del (p.Pro633fs)	HPS6	P633fs	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000431050	10	103827128	10	102067371	431050	424579	rs1131692332	NC_000010.11:102067370:CC:C
NM_003867.4(FGF17):c.560A>G (p.Asn187Ser)	FGF17	N187S, N176S	Hypogonadotropic hypogonadism 20 with or without anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050860	8	21905669	8	22048158	50860	59846	rs398123026	NC_000008.11:22048157:A:G
NM_177965.4(C8orf37):c.156-2A>G	C8orf37		Cone-rod dystrophy 16	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000031193	8	96276004	8	95263776	31193	40150	rs1064792853	NC_000008.11:95263775:T:C
NM_024747.5(HPS6):c.1234C>T (p.Gln412Ter)	HPS6	Q412*	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030677	10	103826465	10	102066708	30677	39634	rs281865112	NC_000010.11:102066707:C:T
NM_024747.5(HPS6):c.223C>T (p.Gln75Ter)	HPS6	Q75*	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030676	10	103825454	10	102065697	30676	39633	rs281865107	NC_000010.11:102065696:C:T
NM_024747.5(HPS6):c.815C>T (p.Thr272Ile)	HPS6	T272I	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030675	10	103826046	10	102066289	30675	39632	rs281865109	NC_000010.11:102066288:C:T
NM_024747.5(HPS6):c.913C>T (p.Gln305Ter)	HPS6	Q305*	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030673	10	103826144	10	102066387	30673	39630	rs281865110	NC_000010.11:102066386:C:T
NM_024747.5(HPS6):c.1865_1866del (p.Leu622fs)	HPS6	L622fs	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030672	10	103827096 - 103827097	10	102067339 - 102067340	30672	39629	rs281865114	NC_000010.11:102067338:TG:
NM_000519.3(HBD):c.*199G>A	HBD		delta Thalassemia	Pathogenic(Last reviewed: Jan 15, 1992)	no assertion criteria provided	VCV000015068	11	5253995	11	5232765	15068	30107	rs35324967	NC_000011.10:5232764:C:T
NM_024747.5(HPS6):c.1624del (p.Asp542fs)	HPS6	D542fs	Hermansky-Pudlak syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627255	10	103826855	10	102067098	627255	615430		NC_000010.11:102067097:G:
NM_024747.5(HPS6):c.155del (p.Val52fs)	HPS6	V52fs	Hermansky-Pudlak syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627011	10	103825386	10	102065629	627011	615424		NC_000010.11:102065628:T:
NM_003282.4(TNNI2):c.496_498GAG[1] (p.Glu167del)	TNNI2	E167del	Distal arthrogryposis type 2B|not provided	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000012439	11	1862728 - 1862730	11	1841498 - 1841500	12439	27478	rs199474800	NC_000011.10:1841497:GAGGAG:GAG
NM_024747.5(HPS6):c.1714_1717del (p.Leu572fs)	HPS6	L572fs	Hermansky-Pudlak syndrome 6	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000003151	10	103826942 - 103826945	10	102067185 - 102067188	3151	18190	rs281865113	NC_000010.11:102067184:TGTCTGT:TGT
NM_001734.5(C1S):c.880T>C (p.Cys294Arg)	C1S	C279R, C294R, C127R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267349	12	7173830	12	7066526	267349	262484	rs886040975	NC_000012.12:7066525:T:C
NM_001734.5(C1S):c.945_947del (p.Asp315_Val316delinsGlu)	C1S		Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000267348	12	7173895 - 7173897	12	7066591 - 7066593	267348	262483	rs886040974	NC_000012.12:7066590:TGT:
NM_002072.5(GNAQ):c.626A>G (p.Gln209Arg)	GNAQ	Q209R	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375956	9	80409488	9	77794572	375956	362835	rs121913492	NC_000009.12:77794571:T:C
NM_203290.4(POLR1C):c.616del (p.Gln206fs)	POLR1C	Q206fs	Leukodystrophy, hypomyelinating, 11|Leukodystrophy, hypomyelinating, 11|	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000635148	6	43488125	6	43520387	635148	622982		NC_000006.12:43520386:CC:C
NM_006876.3(B4GAT1):c.821_822insTT (p.Glu274fs)	B4GAT1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	no assertion criteria provided	VCV000183334	11	66114195 - 66114196	11	66346724 - 66346725	183334	181432	rs730882237	NC_000011.10:66346724::AA
NM_000823.4(GHRHR):c.57+1G>A	GHRHR		ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000015990	7	31003741	7	30964126	15990	31029		NC_000007.14:30964125:G:A
NM_000823.4(GHRHR):c.214G>T (p.Glu72Ter)	GHRHR	E72*	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000015989	7	31008731	7	30969116	15989	31028	rs121918117	NC_000007.14:30969115:G:T
NM_024747.5(HPS6):c.283del (p.Val95fs)	HPS6	V95fs	Hermansky-Pudlak syndrome|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595731	10	103825513	10	102065756	595731	586793	rs1564899012	NC_000010.11:102065755:GG:G
NM_000301.5(PLG):c.886T>G (p.Cys296Gly)	PLG	C296G	Plasminogen deficiency, type I	Pathogenic(Last reviewed: Jul 29, 2018)	no assertion criteria provided	VCV000830236	6	161139424	6	160718392	830236	818636		NC_000006.12:160718391:T:G
GRCh37/hg19 7p14.1(chr7:40242536-40288569)x1	SUGCT		not provided	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000688860	7	40242536 - 40288569			688860	676452		
GRCh37/hg19 7p14.1(chr7:40473798-40522693)x1	SUGCT		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000688539	7	40473798 - 40522693			688539	676131		
GRCh37/hg19 7p14.1(chr7:40438476-40493996)x1	SUGCT		not provided	Pathogenic(Last reviewed: Mar 2, 2018)	no assertion criteria provided	VCV000687971	7	40438476 - 40493996			687971	675563		
GRCh37/hg19 7p14.1(chr7:40438476-40493996)x1	SUGCT		not provided	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000686995	7	40438476 - 40493996			686995	674587		
GRCh37/hg19 7p14.1(chr7:40438476-40493996)x1	SUGCT		not provided	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000686037	7	40438476 - 40493996			686037	673629		
NM_001168338.1(PLG):c.185+1G>T	PLG		not provided	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000282782	6	161127575	6	160706543	282782	267019	rs886042477	NC_000006.12:160706542:G:T
NM_000301.3(PLG):c.2125+1del	PLG		Plasminogen deficiency, type I	Pathogenic(Last reviewed: May 15, 1999)	no assertion criteria provided	VCV000013582	6	161162449	6	160741417	13582	28621	rs606231210	NC_000006.12:160741416:GG:G
NM_000301.3(PLG):c.2251G>A (p.Gly751Arg)	PLG	G732R, G751R	Dysplasminogenemia	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000013580	6	161173272	6	160752240	13580	28619	rs121918033	NC_000006.12:160752239:G:A
NM_000301.3(PLG):c.1435G>T (p.Glu479Ter)	PLG	E460*, E479*	Plasminogen deficiency, type I	Pathogenic(Last reviewed: Dec 3, 1998)	no assertion criteria provided	VCV000013579	6	161152261	6	160731229	13579	28618	rs121918032	NC_000006.12:160731228:G:T
NM_000301.3(PLG):c.1848G>A (p.Trp616Ter)	PLG	W597*, W616*	Plasminogen deficiency, type I	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000013578	6	161159615	6	160738583	13578	28617	rs121918031	NC_000006.12:160738582:G:A
NM_000301.3(PLG):c.1771T>C (p.Ser591Pro)	PLG	S572P, S591P	Dysplasminogenemia	Pathogenic(Last reviewed: Jul 15, 1993)	no assertion criteria provided	VCV000013576	6	161158008	6	160736976	13576	28615	rs121918029	NC_000006.12:160736975:T:C
NM_000301.3(PLG):c.1120G>T (p.Val374Phe)	PLG	V355F, V374F	Dysplasminogenemia	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000013575	6	161143463	6	160722431	13575	28614	rs121918028	NC_000006.12:160722430:G:T
NM_003550.3(MAD1L1):c.175C>T (p.Arg59Cys)	MAD1L1	R59C	Prostate cancer, somatic	Pathogenic(Last reviewed: May 31, 2001)	no assertion criteria provided	VCV000006920	7	2265161	7	2225526	6920	21959	rs121908982	NC_000007.14:2225525:G:A
NM_003550.3(MAD1L1):c.1947C>G (p.Tyr649Ter)	MAD1L1	Y649*, Y557*, Y105*	Lymphoma, somatic	Pathogenic(Last reviewed: May 31, 2001)	no assertion criteria provided	VCV000006919	7	1937887	7	1898251	6919	21958	rs121908981	NC_000007.14:1898250:G:C
nsv1067861	RB1CC1		Breast adenocarcinoma	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003977	8	53537321 - 53574220	8	52624761 - 52661660	3977	19016		
nsv1067860	RB1CC1		Breast adenocarcinoma	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003976	8	53536328 - 53598019	8	52623768 - 52685459	3976	19015		
NM_024728.2(SUGCT):c.424C>T (p.Arg142Ter)	SUGCT	R142*, R179*	Glutaryl-CoA oxidase deficiency	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000001850	7	40277263	7	40237664	1850	16889	rs137852861	NC_000007.14:40237663:C:T
NM_000301.3(PLG):c.988A>G (p.Lys330Glu)	PLG	K330E	Hereditary angioneurotic edema	Pathogenic(Last reviewed: Aug 6, 2018)	no assertion criteria provided	VCV000590291	6	161139762	6	160718730	590291	581232	rs889957249	NC_000006.12:160718729:A:G
HGF, 10-BP DEL, NT482+1991	HGF		Deafness, autosomal recessive 39	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014951					14951	29990		
HGF, 3-BP DEL, 1986TGA	HGF		Deafness, autosomal recessive 39	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014950					14950	29989		
NM_000601.6(HGF):c.495G>A (p.Ser165=)	HGF	S165S	Deafness, autosomal recessive 39	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014949	7	81381566	7	81752250	14949	29988	rs137853235	NC_000007.14:81752249:C:T
NM_000301.3(PLG):c.687_689GAA[2] (p.Lys231del)	PLG	K212del, K231del	Plasminogen deficiency, type I	Pathogenic(Last reviewed: May 15, 1999)	no assertion criteria provided	VCV000013581	6	161137695 - 161137697	6	160716663 - 160716665	13581	28620	rs121918034	NC_000006.12:160716662:GAAGAAGAA:GAAGAA
NM_000301.3(PLG):c.704G>A (p.Arg235His)	PLG	R216H, R235H	Plasminogen deficiency, type I	Pathogenic(Last reviewed: May 15, 1999)	no assertion criteria provided	VCV000013577	6	161137712	6	160716680	13577	28616	rs121918030	NC_000006.12:160716679:G:A
APOA1, APOA1/APOC3 FUSION	APOA1		High density lipoprotein deficiency, Detroit type|Apolipoproteins a-i and c-iii, combined deficiency of	Pathogenic(Last reviewed: Oct 1, 1987)	no assertion criteria provided	VCV000017918					17918	32957		
NM_003282.4(TNNI2):c.521G>A (p.Arg174Gln)	TNNI2	R174Q	not provided|Distal arthrogryposis type 2B	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012435	11	1862753	11	1841523	12435	27474	rs104894311	NC_000011.10:1841522:G:A
NM_000409.5(GUCA1A):c.359G>T (p.Arg120Leu)	GUCA1A	R120L	Cone dystrophy 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802212	6	42146547	6	42178809	802212	790627		NC_000006.12:42178808:G:T
TNNT3, ARG63CYS	TNNT3	R63C	ARTHROGRYPOSIS, DISTAL, TYPE 2B2	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000631472					631472	619826		
NM_000409.4(GUCA1A):c.359_360delinsTT (p.Arg120Leu)	GUCA1A	R120L	Cone dystrophy 3	Pathogenic(Last reviewed: Dec 15, 2017)	no assertion criteria provided	VCV000453246	6	42146547 - 42146548	6	42178809 - 42178810	453246	446828	rs1554186441	NC_000006.12:42178808:GC:TT
NM_001759.4(CCND2):c.851T>G (p.Val284Gly)	CCND2	V284G	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000273674	12	4409156	12	4299990	273674	263838	rs777786993	NC_000012.12:4299989:T:G
NM_004577.4(PSPH):c.103G>A (p.Ala35Thr)	PSPH	A35T	Deficiency of phosphoserine phosphatase	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000189253	7	56088803	7	56021110	189253	187135	rs786204793	NC_000007.14:56021109:C:T
NM_004577.4(PSPH):c.155T>C (p.Met52Thr)	PSPH	M52T	Deficiency of phosphoserine phosphatase	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000013624	7	56087413	7	56019720	13624	28663	rs104894036	NC_000007.14:56019719:A:G
NM_000409.4(GUCA1A):c.428delinsACAC (p.Ile143delinsAsnThr)	GUCA1A		not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449489	6	42146616	6	42178878	449489	443965	rs1554186463	NC_000006.12:42178877:T:ACAC
NM_000409.4(GUCA1A):c.320T>C (p.Ile107Thr)	GUCA1A	I107T	Cone dystrophy 3	Pathogenic(Last reviewed: Apr 12, 2016)	no assertion criteria provided	VCV000225233	6	42146136	6	42178398	225233	227147	rs869320710	NC_000006.12:42178397:T:C
NM_000409.4(GUCA1A):c.250C>T (p.Leu84Phe)	GUCA1A	L84F	Cone dystrophy 3	Pathogenic(Last reviewed: Apr 12, 2016)	no assertion criteria provided	VCV000225232	6	42146066	6	42178328	225232	227146	rs869320709	NC_000006.12:42178327:C:T
NM_004577.4(PSPH):c.94G>A (p.Asp32Asn)	PSPH	D32N	Deficiency of phosphoserine phosphatase	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000013623	7	56088812	7	56021119	13623	28662	rs104894035	NC_000007.14:56021118:C:T
NM_001759.4(CCND2):c.842C>T (p.Pro281Leu)	CCND2	P281L	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000143986	12	4409147	12	4299981	143986	153716	rs587777622	NC_000012.12:4299980:C:T
NM_001759.4(CCND2):c.842C>G (p.Pro281Arg)	CCND2	P281R	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000143985	12	4409147	12	4299981	143985	153715	rs587777622	NC_000012.12:4299980:C:G
NM_001759.4(CCND2):c.841C>T (p.Pro281Ser)	CCND2	P281S	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000143984	12	4409146	12	4299980	143984	153714	rs587777621	NC_000012.12:4299979:C:T
NM_001759.4(CCND2):c.808A>T (p.Lys270Ter)	CCND2	K270*	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000143982	12	4409113	12	4299947	143982	153712	rs587777619	NC_000012.12:4299946:A:T
NM_203290.4(POLR1C):c.880_882AAG[1] (p.Lys295del)	POLR1C	K295del	Leukodystrophy, hypomyelinating, 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204590	6	43488744 - 43488746	6	43521006 - 43521008	204590	200980	rs875989826	NC_000006.12:43521005:AAGAAG:AAG
NM_000409.4(GUCA1A):c.451C>T (p.Leu151Phe)	GUCA1A	L151F	Cone dystrophy 3|Retinal dystrophy	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000009152	6	42146986	6	42179248	9152	24191	rs121434631	NC_000006.12:42179247:C:T
NM_000197.2(HSD17B3):c.614T>A (p.Val205Glu)	HSD17B3	V205E	Pseudohermaphroditism	Pathogenic(Last reviewed: Oct 25, 2011)	no assertion criteria provided	VCV000492767	9	99006669	9	96244387	492767	485745	rs372027264	NC_000009.12:96244386:A:T
NM_000197.2(HSD17B3):c.397G>A (p.Gly133Arg)	HSD17B3	G133R	Pseudohermaphroditism	Pathogenic(Last reviewed: Sep 28, 2010)	no assertion criteria provided	VCV000492763	9	99013756	9	96251474	492763	485749	rs747724352	NC_000009.12:96251473:C:T
NM_000197.2(HSD17B3):c.121_122del (p.Lys41fs)	HSD17B3	K41fs	Pseudohermaphroditism	Pathogenic(Last reviewed: Dec 16, 2010)	no assertion criteria provided	VCV000492760	9	99064265 - 99064266	9	96301983 - 96301984	492760	485752	rs1554705693	NC_000009.12:96301982:TTT:T
NM_000197.2(HSD17B3):c.202-1G>A	HSD17B3		not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000488878	9	99017226	9	96254944	488878	481861	rs1378603446	NC_000009.12:96254943:C:T
NM_000197.2(HSD17B3):c.803G>A (p.Cys268Tyr)	HSD17B3	C268Y	Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000004881	9	99003059	9	96240777	4881	19920	rs119481080	NC_000009.12:96240776:C:T
NM_000197.2(HSD17B3):c.389A>G (p.Asn130Ser)	HSD17B3	N130S	Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000004880	9	99013764	9	96251482	4880	19919	rs119481079	NC_000009.12:96251481:T:C
NM_000197.2(HSD17B3):c.166G>A (p.Ala56Thr)	HSD17B3	A56T	Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000004879	9	99060733	9	96298451	4879	19918	rs119481078	NC_000009.12:96298450:C:T
HSD17B3, IVS3AS, G-C, -1	HSD17B3		Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000004876					4876	19915		
NM_000197.2(HSD17B3):c.703A>G (p.Met235Val)	HSD17B3	M235V	Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000004873	9	99003159	9	96240877	4873	19912	rs119481074	NC_000009.12:96240876:T:C
NM_000197.2(HSD17B3):c.695C>T (p.Ser232Leu)	HSD17B3	S232L	Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000004872	9	99003167	9	96240885	4872	19911	rs28939085	NC_000009.12:96240884:G:A
NC_000009.12:g.130677193_130686925del	PRDM12		Neuropathy, hereditary sensory and autonomic, type VIII	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000689497					689497	677157		
NM_000197.2(HSD17B3):c.845C>T (p.Pro282Leu)	HSD17B3	P282L	not provided|Pseudohermaphroditism	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000265484	9	98997830	9	96235548	265484	259931	rs144809928	NC_000009.12:96235547:G:A
NM_021619.3(PRDM12):c.866A>T (p.His289Leu)	PRDM12	H289L	Neuropathy, hereditary sensory and autonomic, type VIII	Pathogenic(Last reviewed: Aug 10, 2016)	no assertion criteria provided	VCV000253122	9	133556818	9	130681431	253122	247534	rs879255638	NC_000009.12:130681430:A:T
NM_021619.3(PRDM12):c.305T>A (p.Ile102Asn)	PRDM12	I102N	Neuropathy, hereditary sensory and autonomic, type VIII	Pathogenic(Last reviewed: Aug 10, 2016)	no assertion criteria provided	VCV000253119	9	133542076	9	130666689	253119	247531	rs879255636	NC_000009.12:130666688:T:A
PRDM12, (GCC)n REPEAT EXPANSION	PRDM12		Neuropathy, hereditary sensory and autonomic, type VIII	Pathogenic(Last reviewed: Nov 7, 2019)	no assertion criteria provided	VCV000253118	9	133556993 - 133556995	9	130681606 - 130681608	253118	247530	rs752427775	
NM_021619.3(PRDM12):c.516G>C (p.Glu172Asp)	PRDM12	E172D	Neuropathy, hereditary sensory and autonomic, type VIII	Pathogenic(Last reviewed: Aug 10, 2016)	no assertion criteria provided	VCV000253121	9	133543646	9	130668259	253121	247533	rs755205487	NC_000009.12:130668258:G:C
NM_021619.3(PRDM12):c.91G>T (p.Asp31Tyr)	PRDM12	D31Y	Neuropathy, hereditary sensory and autonomic, type VIII	Pathogenic(Last reviewed: Aug 10, 2016)	no assertion criteria provided	VCV000253120	9	133540131	9	130664744	253120	247532	rs879255637	NC_000009.12:130664743:G:T
NM_000197.2(HSD17B3):c.607-1G>A	HSD17B3		Testosterone 17-beta-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000004878	9	99006677	9	96244395	4878	19917	rs730880305	NC_000009.12:96244394:C:T
NM_177965.4(C8orf37):c.545A>G (p.Gln182Arg)	C8orf37	Q182R, Q150R	Retinitis pigmentosa 64|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000031195	8	96259924	8	95247696	31195	40152	rs387907137	NC_000008.11:95247695:T:C
NM_024079.5(ALG8):c.121C>T (p.Arg41Ter)	ALG8	R41*	not provided	Pathogenic(Last reviewed: Dec 21, 2012)	criteria provided, single submitter	VCV000096090	11	77838457	11	78127411	96090	101984	rs200888240	NC_000011.10:78127410:G:A
NM_018055.5(NODAL):c.446del (p.Gly149fs)	NODAL	G149fs, G16fs	Visceral heterotaxy 5, autosomal	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000663619	10	72195487	10	70435731	663619	639102		NC_000010.11:70435730:CCC:CC
NM_017654.4(SAMD9):c.2470C>T (p.Arg824Ter)	SAMD9	R824*	not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634461	7	92732941	7	93103628	634461	622381	rs1186536794	NC_000007.14:93103627:G:A
NM_024079.5(ALG8):c.535C>T (p.Arg179Ter)	ALG8	R179*	POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS	Pathogenic(Last reviewed: Feb 21, 2018)	no assertion criteria provided	VCV000492977	11	77830239	11	78119193	492977	485927	rs762811727	NC_000011.10:78119192:G:A
NM_024079.5(ALG8):c.1038+1G>T	ALG8		POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS	Pathogenic(Last reviewed: Feb 21, 2018)	no assertion criteria provided	VCV000492976	11	77820487	11	78109441	492976	485926	rs202112771	NC_000011.10:78109440:C:A
NM_017654.4(SAMD9):c.3877C>T (p.Arg1293Trp)	SAMD9	R1293W	Mirage syndrome	Pathogenic(Last reviewed: Jul 25, 2016)	no assertion criteria provided	VCV000253153	7	92731534	7	93102221	253153	247565		NC_000007.14:93102220:G:A
NM_017654.4(SAMD9):c.2305G>A (p.Asp769Asn)	SAMD9	D769N	Mirage syndrome	Pathogenic(Last reviewed: Jul 25, 2016)	no assertion criteria provided	VCV000253152	7	92733106	7	93103793	253152	247564		NC_000007.14:93103792:C:T
NM_017654.4(SAMD9):c.1376G>A (p.Arg459Gln)	SAMD9	R459Q	Mirage syndrome	Pathogenic(Last reviewed: Jul 25, 2016)	no assertion criteria provided	VCV000253151	7	92734035	7	93104722	253151	247563		NC_000007.14:93104721:C:T
NODAL, 9-BP INS/24-BP DEL, NT700	NODAL		Visceral heterotaxy 5, autosomal	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000008270					8270	23309		
NM_017654.4(SAMD9):c.4483A>G (p.Lys1495Glu)	SAMD9	K1495E	Tumoral calcinosis, familial, normophosphatemic	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000001229	7	92730928	7	93101615	1229	16268	rs121918554	NC_000007.14:93101614:T:C
NM_024079.5(ALG8):c.761dup (p.Pro255fs)	ALG8		ALG8-CDG	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000854540	11	77824947 - 77824948	11	78113901 - 78113902	854540	839087		NC_000011.10:78113901:CCC:CCCC
NM_024079.5(ALG8):c.824G>A (p.Gly275Asp)	ALG8	G275D	ALG8-CDG	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002563	11	77823770	11	78112724	2563	17602	rs121908294	NC_000011.10:78112723:C:T
NM_024079.5(ALG8):c.673+4A>G	ALG8		ALG8-CDG	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002562	11	77825308	11	78114262	2562	17601	rs1470636347	NC_000011.10:78114261:T:C
NM_024079.5(ALG8):c.139A>C (p.Thr47Pro)	ALG8	T47P	ALG8-CDG	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002561	11	77838439	11	78127393	2561	17600	rs121908293	NC_000011.10:78127392:T:G
NM_024079.5(ALG8):c.396dup (p.Val133fs)	ALG8		ALG8-CDG	Pathogenic(Last reviewed: Mar 14, 2003)	no assertion criteria provided	VCV000002559	11	77832192 - 77832193	11	78121146 - 78121147	2559	17598	rs753631154	NC_000011.10:78121146:TTTTTTT:TTTTTTTT
NM_024079.5(ALG8):c.413del (p.Thr138fs)	ALG8	T138fs	ALG8-CDG	Pathogenic(Last reviewed: Mar 14, 2003)	no assertion criteria provided	VCV000002558	11	77832176	11	78121130	2558	17597	rs387906277	NC_000011.10:78121129:G:
NM_024079.5(ALG8):c.96-2A>G	ALG8		ALG8-CDG	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002560	11	77838484	11	78127438	2560	17599	rs1555073109	NC_000011.10:78127437:T:C
NM_024079.5(ALG8):c.1090C>T (p.Arg364Ter)	ALG8	R364*	not provided|POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280116	11	77817941	11	78106895	280116	264567	rs376161880	NC_000011.10:78106894:G:A
NM_033500.2(HK1):c.1334C>T (p.Thr445Met)	HK1	T445M, T457M, T456M, T429M, T461M, T425M, T492M	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES|Hemolytic anemia due to hexokinase deficiency|Neuropathy, hereditary motor and sensory, Russe type|Retinitis pigmentosa 79|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372693	10	71142347	10	69382591	372693	359832	rs1057517928	NC_000010.11:69382590:C:T
NM_203290.4(POLR1C):c.326G>A (p.Arg109His)	POLR1C	R109H	|Leukodystrophy, hypomyelinating, 11	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204592	6	43487520	6	43519782	204592	200982	rs796052127	NC_000006.12:43519781:G:A
NM_004188.6(GFI1B):c.784G>A (p.Asp262Asn)	GFI1B	D262N, D216N	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000520664	9	135865264	9	132989877	520664	511812	rs1554724691	NC_000009.12:132989876:G:A
NM_014290.3(TDRD7):c.328dup (p.Thr110fs)	TDRD7		Cataract, autosomal recessive congenital 4	Pathogenic(Last reviewed: Apr 2, 2017)	no assertion criteria provided	VCV000427905	9	100193331 - 100193332	9	97431049 - 97431050	427905	418979	rs1554743428	NC_000009.12:97431049:AAAA:AAAAA
NM_014290.3(TDRD7):c.689dup (p.Tyr230Ter)	TDRD7		Cataract, autosomal recessive congenital 4	Pathogenic(Last reviewed: Apr 2, 2017)	no assertion criteria provided	VCV000427904	9	100203990 - 100203991	9	97441708 - 97441709	427904	418978	rs1554744860	NC_000009.12:97441708:A:AA
NM_001082971.2(DDC):c.823G>A (p.Ala275Thr)	DDC	A275T, A227T, A237T, A182T, A197T	Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Aug 3, 2015)	no assertion criteria provided	VCV000017814	7	50566899	7	50499201	17814	32853	rs137853212	NC_000007.14:50499200:C:T
NM_001082971.2(DDC):c.439A>C (p.Ser147Arg)	DDC	S147R, S109R, S69R	Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Jun 6, 2012)	no assertion criteria provided	VCV000017812	7	50597037	7	50529339	17812	32851	rs137853210	NC_000007.14:50529338:T:G
NM_001082971.2(DDC):c.925T>C (p.Phe309Leu)	DDC	F309L, F231L, F216L, F261L, F271L	Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Jun 6, 2012)	no assertion criteria provided	VCV000017811	7	50563067	7	50495369	17811	32850	rs137853209	NC_000007.14:50495368:A:G
NC_000011.10:g.(?_112226434)_(112226536_?)del	PTS			Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000832307	11	112097157 - 112097259			832307	820336		
NM_000317.3(PTS):c.272A>G (p.Lys91Arg)	PTS	K91R		Pathogenic	criteria provided, single submitter	VCV000813419	11	112103914	11	112233191	813419	801690		NC_000011.10:112233190:A:G
NM_005094.4(SLC27A4):c.1797_1798AG[1] (p.Glu600fs)	SLC27A4		Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802517	9	131122635 - 131122636	9	128360356 - 128360357	802517	790844		NC_000009.12:128360355:AGAG:AG
NM_000317.3(PTS):c.159T>G (p.Tyr53Ter)	PTS	Y53*		Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000638994	11	112099392	11	112228669	638994	639715		NC_000011.10:112228668:T:G
NM_001082971.2(DDC):c.446G>C (p.Ser149Thr)	DDC	S149T, S111T, S71T	Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000636255	7	50597030	7	50529332	636255	624052		NC_000007.14:50529331:C:G
NM_014290.3(TDRD7):c.1129del (p.Ala377fs)	TDRD7	A377fs, A303fs	Cataract, autosomal recessive congenital 4	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000426069	9	100222733	9	97460451	426069	414474	rs765628635	NC_000009.12:97460450:G:
NM_014314.4(DDX58):c.803G>T (p.Cys268Phe)	DDX58	C268F	Singleton-Merten syndrome 2	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000189345	9	32488882	9	32488884	189345	187234	rs786204848	NC_000009.12:32488883:C:A
NM_014314.4(DDX58):c.1118A>C (p.Glu373Ala)	DDX58	E373A	Singleton-Merten syndrome 2	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000189344	9	32488037	9	32488039	189344	187233	rs786204847	NC_000009.12:32488038:T:G
NM_025115.4(TTI2):c.1100C>T (p.Pro367Leu)	TTI2	P367L, P336L	Mental retardation, autosomal recessive 39	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000088867	8	33361281	8	33503763	88867	94436	rs398122366	NC_000008.11:33503762:G:A
TDRD7, 3-BP DEL, VAL618	TDRD7		Cataract, autosomal recessive congenital 4	Pathogenic(Last reviewed: Mar 25, 2011)	no assertion criteria provided	VCV000030903					30903	39860		
DDC, IVS6DS, A-T, +4	DDC		Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Jul 6, 2010)	no assertion criteria provided	VCV000029609					29609	38563		
NM_000317.3(PTS):c.84-323A>T	PTS			Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000000486	11	112098994	11	112228271	486	15525	rs794726657	NC_000011.10:112228270:A:T
NM_000317.3(PTS):c.163+696_163+750del	PTS			Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000000485	11	112100090 - 112100144	11	112229367 - 112229421	485	15524	rs1555198165	
NM_000317.3(PTS):c.139A>G (p.Asn47Asp)	PTS	N47D	Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000000482	11	112099372	11	112228649	482	15521	rs104894278	NC_000011.10:112228648:A:G
NM_000317.3(PTS):c.361_374del (p.Val121fs)	PTS	V121fs	Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000000478	11	112104201 - 112104214	11	112233478 - 112233491	478	15517	rs794726656	NC_000011.10:112233477:GTTCTTCCTGTAGG:
NM_000317.3(PTS):c.74G>A (p.Arg25Gln)	PTS	R25Q		Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000000476	11	112097240	11	112226517	476	15515	rs104894273	NC_000011.10:112226516:G:A
NM_005094.4(SLC27A4):c.1748G>A (p.Arg583His)	SLC27A4	R583H	Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005748	9	131118049	9	128355770	5748	20787	rs137853135	NC_000009.12:128355769:G:A
NM_005094.4(SLC27A4):c.988-2A>G	SLC27A4		Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005747	9	131115302	9	128353023	5747	20786		NC_000009.12:128353022:A:G
NM_005094.4(SLC27A4):c.899A>G (p.Gln300Arg)	SLC27A4	Q300R	Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005746	9	131114938	9	128352659	5746	20785	rs137853134	NC_000009.12:128352658:A:G
NM_005094.4(SLC27A4):c.739T>C (p.Ser247Pro)	SLC27A4	S247P	Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005745	9	131112614	9	128350335	5745	20784	rs137853133	NC_000009.12:128350334:T:C
NM_005094.4(SLC27A4):c.274G>A (p.Ala92Thr)	SLC27A4	A92T	Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005744	9	131107546	9	128345267	5744	20783	rs137853132	NC_000009.12:128345266:G:A
NM_005094.4(SLC27A4):c.716-1G>A	SLC27A4		Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005743	9	131112590	9	128350311	5743	20782		NC_000009.12:128350310:G:A
NM_005094.4(SLC27A4):c.504C>A (p.Cys168Ter)	SLC27A4	C168*	Ichthyosis prematurity syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000005742	9	131107776	9	128345497	5742	20781	rs137853131	NC_000009.12:128345496:C:A
NM_000317.3(PTS):c.73C>T (p.Arg25Ter)	PTS	R25*		Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000859996	11	112097239	11	112226516	859996	837961		NC_000011.10:112226515:C:T
NC_000011.10:g.(?_112226444)_(112233555_?)del	PTS			Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000831225	11	112097167 - 112104278			831225	820337		
NM_001082971.2(DDC):c.1073G>A (p.Arg358His)	DDC	R358H, R310H, R280H, R320H, R265H	not provided|Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000379626	7	50537838	7	50470140	379626	371156	rs771317809	NC_000007.14:50470139:C:T
NM_001082971.2(DDC):c.1040G>A (p.Arg347Gln)	DDC	R347Q, R254Q, R269Q, R299Q, R309Q	Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Aug 28, 2013)	no assertion criteria provided	VCV000202181	7	50544323	7	50476625	202181	198631	rs201951824	NC_000007.14:50476624:C:T
NM_012338.4(TSPAN12):c.542G>T (p.Cys181Phe)	TSPAN12	C181F	Persistent hyperplastic primary vitreous, autosomal recessive|Atrophia bulborum hereditaria|Exudative vitreoretinopathy 5|Familial exudative vitreoretinopathy	Pathogenic(Last reviewed: May 1, 2016)	criteria provided, single submitter	VCV000236067	7	120446673	7	120806619	236067	237630	rs878853243	NC_000007.14:120806618:C:A
NM_001082971.2(DDC):c.714+4A>T	DDC		Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000864024	7	50595831	7	50528133	864024	852366		NC_000007.14:50528132:T:A
NM_001759.4(CCND2):c.839C>A (p.Thr280Asn)	CCND2	T280N	not provided|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143983	12	4409144	12	4299978	143983	153713	rs587777620	NC_000012.12:4299977:C:A
NM_003282.4(TNNI2):c.466C>T (p.Arg156Ter)	TNNI2	R156*	Distal arthrogryposis type 2B|not provided|Congenital finger flexion contractures|Distal arthrogryposis|Ulnar deviation of the wrist|Calcaneovalgus deformity	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, multiple submitters, no conflicts	VCV000012436	11	1862698	11	1841468	12436	27475	rs104894312	NC_000011.10:1841467:C:T
NM_004444.5(EPHB4):c.1180C>T (p.Arg394Ter)	EPHB4	R394*	not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000618629	7	100417296	7	100819674	618629	609635	rs994651018	NC_000007.14:100819673:G:A
NM_032193.3(RNASEH2C):c.451C>T (p.Pro151Ser)	RNASEH2C	P151S	not provided	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000419543	11	65487533	11	65720062	419543	408421	rs78464826	NC_000011.10:65720061:G:A
NM_032193.3(RNASEH2C):c.450G>A (p.Trp150Ter)	RNASEH2C	W150*	not provided	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000419542	11	65487534	11	65720063	419542	408422	rs1064793942	NC_000011.10:65720062:C:T
NM_004444.5(EPHB4):c.2334+1G>C	EPHB4		Hydrops fetalis, nonimmune, and/or atrial septal defect, susceptibility to	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599047	7	100404986	7	100807364	599047	590224	rs1562967463	NC_000007.14:100807363:C:G
NM_021070.4(LTBP3):c.2248G>T (p.Glu750Ter)	LTBP3	E750*, E633*	Dental anomalies and short stature	Pathogenic(Last reviewed: May 11, 2018)	no assertion criteria provided	VCV000523638	11	65314018	11	65546547	523638	514286	rs1554973844	NC_000011.10:65546546:C:A
NM_001164266.1(LTBP3):c.-216del	LTBP3	P45fs	Dental anomalies and short stature	Pathogenic(Last reviewed: May 11, 2018)	no assertion criteria provided	VCV000523637	11	65325299	11	65557828	523637	514285	rs1286042594	NC_000011.10:65557827:CCCCCCC:CCCCCC
NM_004444.5(EPHB4):c.2345T>G (p.Ile782Ser)	EPHB4	I782S	Hydrops fetalis, nonimmune, and/or atrial septal defect, susceptibility to	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000374837	7	100404181	7	100806559	374837	361742	rs1057519264	NC_000007.14:100806558:A:C
NM_004444.5(EPHB4):c.2216G>A (p.Arg739Gln)	EPHB4	R739E, R739Q	Hydrops fetalis, nonimmune, and/or atrial septal defect, susceptibility to	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000374836	7	100405105	7	100807483	374836	361741	rs1057519263	NC_000007.14:100807482:C:T
NM_001130144.2(LTBP3):c.3364C>T (p.Gln1122Ter)	LTBP3	Q1122*	not provided	Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000235446	11	65307505	11	65540034	235446	237129	rs878853036	NC_000011.10:65540033:G:A
NM_021070.4(LTBP3):c.2356del (p.Val786fs)	LTBP3	V786fs, V669fs	Dental anomalies and short stature	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000204497	11	65311018	11	65543547	204497	200884	rs875989824	NC_000011.10:65543546:C:
NM_021070.4(LTBP3):c.1531+1G>T	LTBP3		Dental anomalies and short stature	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000204495	11	65319442	11	65551971	204495	200882	rs875989823	NC_000011.10:65551970:C:A
NM_021070.4(LTBP3):c.421C>T (p.Gln141Ter)	LTBP3	Q141*, Q24*	Dental anomalies and short stature	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000204494	11	65321762	11	65554291	204494	200881	rs796052116	NC_000011.10:65554290:G:A
NM_021070.4(LTBP3):c.2071_2084del (p.Tyr691fs)	LTBP3	Y574fs, Y691fs	Dental anomalies and short stature	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000204493	11	65314933 - 65314946	11	65547462 - 65547475	204493	200880	rs875989822	NC_000011.10:65547461:GCTTTGAGCCGGTAGC:GC
NM_021070.4(LTBP3):c.1859dup (p.Cys620fs)	LTBP3		Dental anomalies and short stature	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000204492	11	65315279 - 65315280	11	65547808 - 65547809	204492	200879	rs878853262	NC_000011.10:65547808:C:CC
NM_021070.4(LTBP3):c.2322C>G (p.Tyr774Ter)	LTBP3	Y744*, Y774*, Y657*	Dental anomalies and short stature	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000007561	11	65313944	11	65546473	7561	22600	rs121909145	NC_000011.10:65546472:G:C
NM_004444.5(EPHB4):c.570dup (p.His191fs)	EPHB4		Capillary malformation-arteriovenous malformation 2	Pathogenic(Last reviewed: Nov 21, 2018)	no assertion criteria provided	VCV000590877	7	100420130 - 100420131	7	100822508 - 100822509	590877	581818	rs1562973614	NC_000007.14:100822508:C:CC
NM_004444.5(EPHB4):c.2484+2dup	EPHB4		Capillary malformation-arteriovenous malformation 2	Pathogenic(Last reviewed: Nov 21, 2018)	no assertion criteria provided	VCV000590876	7	100404039 - 100404040	7	100806417 - 100806418	590876	581817		NC_000007.14:100806417:A:AA
NM_004444.5(EPHB4):c.2484+1G>T	EPHB4		Capillary malformation-arteriovenous malformation 2	Pathogenic(Last reviewed: Nov 26, 2018)	no assertion criteria provided	VCV000590875	7	100404041	7	100806419	590875	581816	rs927772349	NC_000007.14:100806418:C:A
NM_004444.5(EPHB4):c.630_631TG[1] (p.Val211fs)	EPHB4		Capillary malformation-arteriovenous malformation 2	Pathogenic(Last reviewed: Nov 21, 2018)	no assertion criteria provided	VCV000590872	7	100420068 - 100420069	7	100822446 - 100822447	590872	581813	rs1562973541	NC_000007.14:100822445:CACA:CA
NM_021070.4(LTBP3):c.1846+5G>A	LTBP3		GELEOPHYSIC DYSPLASIA 3	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000448913	11	65315386	11	65547915	448913	442501	rs1188540819	NC_000011.10:65547914:C:T
NM_021070.4(LTBP3):c.3771A>T (p.Ter1257Cys)	LTBP3	*1304C, *1257C, *1140C	GELEOPHYSIC DYSPLASIA 3	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000448912	11	65306551	11	65539080	448912	442500	rs1554971742	NC_000011.10:65539079:T:A
NM_021070.4(LTBP3):c.2216del (p.Gly739fs)	LTBP3	G622fs, G739fs	Dental anomalies and short stature	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000204496	11	65314283	11	65546812	204496	200883	rs752375653	NC_000011.10:65546811:CCCCCC:CCCCC
NM_032193.3(RNASEH2C):c.428A>T (p.Lys143Ile)	RNASEH2C	K143I	Aicardi Goutieres syndrome 3	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000001261	11	65487556	11	65720085	1261	16300	rs75146158	NC_000011.10:65720084:T:A
NM_004444.5(EPHB4):c.1123G>T (p.Gly375Ter)	EPHB4	G375*	Capillary malformation-arteriovenous malformation 2	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000691537	7	100417353	7	100819731	691537	679234		NC_000007.14:100819730:C:A
NM_004444.5(EPHB4):c.389G>A (p.Trp130Ter)	EPHB4	W130*	Capillary malformation-arteriovenous malformation 2	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000691531	7	100421288	7	100823666	691531	679236		NC_000007.14:100823665:C:T
NM_004444.5(EPHB4):c.2484+1G>A	EPHB4		Capillary malformation-arteriovenous malformation 2|not specified	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000590874	7	100404041	7	100806419	590874	581815	rs927772349	NC_000007.14:100806418:C:T
NM_000197.1(HSD17B3):c.239G>A	HSD17B3	R80Q	Testosterone 17-beta-dehydrogenase deficiency|Pseudohermaphroditism|not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000004874	9	99017188	9	96254906	4874	19913	rs119481075	NC_000009.12:96254905:C:T
NM_006929.5(SKIV2L):c.1698del (p.Gln566fs)	SKIV2L	Q566fs	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000817878	6	31931740	6	31963963	817878	805496		NC_000006.12:31963962:G:
NM_001159287.1(TPI1):c.680G>A (p.Arg227Gln)	TPI1	R190Q, R227Q, R108Q	Triosephosphate isomerase deficiency	Pathogenic	no assertion criteria provided	VCV000627563	12	6979238	12	6870074	627563	615918	rs1565538350	NC_000012.12:6870073:G:A
NM_006929.5(SKIV2L):c.3561_3581del (p.Ser1189_Leu1195del)	SKIV2L		Trichohepatoenteric syndrome 2	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800925	6	31937310 - 31937330	6	31969533 - 31969553	800925	788797		NC_000006.12:31969532:GGGCTCTCAGGGACCCCTGAGGG:GG
NM_001159287.1(TPI1):c.143dup (p.Asn49fs)	TPI1		Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000136173	12	6976757 - 6976758	12	6867593 - 6867594	136173	139885	rs587777441	NC_000012.12:6867593:GGGGG:GGGGGG
NM_001159287.1(TPI1):c.833T>C (p.Phe278Ser)	TPI1	F240S, F241S, F278S, F159S	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000136172	12	6979519	12	6870355	136172	139884	rs587777440	NC_000012.12:6870354:T:C
IL11RA, 9-BP DUP, NT916	IL11RA		Craniosynostosis and dental anomalies	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030140					30140	39096		
NM_001142784.2(IL11RA):c.475C>T (p.Gln159Ter)	IL11RA	Q159*	Craniosynostosis and dental anomalies	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030139	9	34657328	9	34657331	30139	39095	rs387906787	NC_000009.12:34657330:C:T
NM_001142784.2(IL11RA):c.734C>G (p.Ser245Cys)	IL11RA	S245C	Craniosynostosis and dental anomalies	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030138	9	34658604	9	34658607	30138	39094	rs387906786	NC_000009.12:34658606:C:G
NM_001142784.2(IL11RA):c.662C>G (p.Pro221Arg)	IL11RA	P221R	Craniosynostosis and dental anomalies	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030137	9	34658532	9	34658535	30137	39093	rs387906785	NC_000009.12:34658534:C:G
NM_001142784.2(IL11RA):c.886C>T (p.Arg296Trp)	IL11RA	R296W	Craniosynostosis and dental anomalies	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030136	9	34659831	9	34659834	30136	39092	rs387906784	NC_000009.12:34659833:C:T
NM_005522.4(HOXA1):c.185del (p.Gly62fs)	HOXA1	G62fs	Bosley-Salih-Alorainy syndrome	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000014901	7	27135347	7	27095728	14901	29940	rs1562700083	NC_000007.14:27095727:CC:C
NM_005522.4(HOXA1):c.84C>G (p.Tyr28Ter)	HOXA1	Y28*	Bosley-Salih-Alorainy syndrome	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000014899	7	27135448	7	27095829	14899	29938	rs104894017	NC_000007.14:27095828:G:C
NM_001159287.1(TPI1):c.547G>T (p.Glu183Ter)	TPI1	E145*, E146*, E183*, E64*	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Nov 15, 2001)	no assertion criteria provided	VCV000012473	12	6978533	12	6869369	12473	27512	rs121964850	NC_000012.12:6869368:G:T
NM_001159287.1(TPI1):c.622A>G (p.Ile208Val)	TPI1	I170V, I171V, I208V, I89V	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000012472	12	6978905	12	6869741	12472	27511	rs121964849	NC_000012.12:6869740:A:G
NM_001258026.1(TPI1):c.-122G>A	TPI1	C41Y, C42Y, C79Y	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000012471	12	6978037	12	6868873	12471	27510	rs121964848	NC_000012.12:6868872:G:A
NM_001159287.1(TPI1):c.478G>A (p.Gly160Arg)	TPI1	G122R, G123R, G160R, G41R	Triosephosphate isomerase manchester	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000012469	12	6978464	12	6869300	12469	27508	rs121964846	NC_000012.12:6869299:G:A
NM_001084.5(PLOD3):c.2071del (p.Cys691fs)	PLOD3	C691fs	Bone fragility with contractures, arterial rupture, and deafness	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000006644	7	100849708	7	101206427	6644	21683	rs786205872	NC_000007.14:101206426:A:
NM_001084.5(PLOD3):c.668A>G (p.Asn223Ser)	PLOD3	N223S	Bone fragility with contractures, arterial rupture, and deafness	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000006643	7	100858381	7	101215100	6643	21682	rs121434414	NC_000007.14:101215099:T:C
NM_000317.3(PTS):c.84-291A>G	PTS			Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000649292	11	112099026	11	112228303	649292	652488		NC_000011.10:112228302:A:G
NM_000317.3(PTS):c.84-3C>G	PTS			Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553378	11	112099314	11	112228591	553378	546058	rs1230781262	NC_000011.10:112228590:C:G
NM_004444.5(EPHB4):c.2590C>T (p.Arg864Trp)	EPHB4	R864W	Capillary malformation-arteriovenous malformation 2|not specified	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000691551	7	100403211	7	100805589	691551	679219		NC_000007.14:100805588:G:A
NM_004444.5(EPHB4):c.2418C>G (p.Tyr806Ter)	EPHB4	Y806*	Capillary malformation-arteriovenous malformation 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620197	7	100404108	7	100806486	620197	611667	rs377702127	NC_000007.14:100806485:G:C
NM_001012720.2(RGR):c.*74dup	RGR		Retinal dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438065	10	86018468 - 86018469	10	84258712 - 84258713	438065	431743	rs1554824273	NC_000010.11:84258712:G:GG
NM_006929.5(SKIV2L):c.848G>A (p.Trp283Ter)	SKIV2L	W283*	Trichohepatoenteric syndrome 2	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030069	6	31929382	6	31961605	30069	39024	rs751026211	NC_000006.12:31961604:G:A
NM_005522.4(HOXA1):c.76C>T (p.Arg26Ter)	HOXA1	R26*		Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000014900	7	27135456	7	27095837	14900	29939	rs104894018	NC_000007.14:27095836:G:A
RGR, 1-BP INS	RGR		Retinitis pigmentosa 44	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000009182					9182	24221		
NM_006929.5(SKIV2L):c.2341-2A>G	SKIV2L		Trichohepatoenteric syndrome 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561107	6	31934779	6	31967002	561107	552104	rs781763471	NC_000006.12:31967001:A:G
NM_006929.5(SKIV2L):c.1635_1636insA (p.Gly546fs)	SKIV2L		Trichohepatoenteric syndrome 2|not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000030071	6	31931498 - 31931499	6	31963721 - 31963722	30071	39026	rs1562659544	NC_000006.12:31963721::A
NM_006929.5(SKIV2L):c.2572del (p.Gly857_Val858insTer)	SKIV2L	V341G	Trichohepatoenteric syndrome 2|not provided	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030070	6	31935143	6	31967366	30070	39025	rs281875237	NC_000006.12:31967365:G:
LDHA, 20-BP DEL, EX6	LDHA		Glycogen storage disease XI	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000014566					14566	29605		
NM_001159287.1(TPI1):c.832T>C (p.Phe278Leu)	TPI1	F240L, F159L, F241L, F278L	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Nov 15, 2001)	no assertion criteria provided	VCV000012470	12	6979518	12	6870354	12470	27509	rs121964847	NC_000012.12:6870353:T:C
NM_203290.4(POLR1C):c.835C>T (p.Arg279Trp)	POLR1C	R279W	Leukodystrophy, hypomyelinating, 11||not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000030815	6	43488699	6	43520961	30815	39772	rs141156009	NC_000006.12:43520960:C:T
NM_006757.4(TNNT3):c.187C>T (p.Arg63Cys)	TNNT3	R63C, R62C, R66C, R44C, R55C, R61C, R74C, R59C	ARTHROGRYPOSIS, DISTAL, TYPE 2B2|Arthyrgryposis, distal, type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031874	11	1954966	11	1933736	31874	40534	rs199474721	NC_000011.10:1933735:C:T
NM_000278.5(PAX2):c.364_365dup (p.Ile123fs)	PAX2		not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000817231	10	102510600 - 102510601	10	100750843 - 100750844	817231	805628		NC_000010.11:100750843:GGG:GGGGG
NM_213649.2(SFXN4):c.414+1G>A	SFXN4		Combined oxidative phosphorylation deficiency 18	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000488593	10	120917520	10	119158008	488593	481461	rs1380193482	NC_000010.11:119158007:C:T
NM_003990.5(PAX2):c.240_244dup (p.Val82fs)	PAX2		not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000419192	10	102510477 - 102510478	10	100750720 - 100750721	419192	407799	rs1554856034	NC_000010.11:100750720:GGGTG:GGGTGGGGTG
NM_001385.3(DPYS):c.424-1G>A	DPYS		not provided	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000284276	8	105459732	8	104447504	284276	268513	rs879851088	NC_000008.11:104447503:C:T
NM_213649.2(SFXN4):c.930del (p.Ile310fs)	SFXN4	I310fs	Combined oxidative phosphorylation deficiency 18	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689787	10	120905754	10	119146242	689787	677429		NC_000010.11:119146241:AA:A
NM_213649.2(SFXN4):c.940C>T (p.Gln314Ter)	SFXN4	Q314*	Combined oxidative phosphorylation deficiency 18	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638327	10	120900828	10	119141316	638327	626195		NC_000010.11:119141315:G:A
NM_001385.3(DPYS):c.1423C>T (p.Arg475Ter)	DPYS	R475*	not provided	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000446083	8	105405032	8	104392804	446083	439355	rs61758444	NC_000008.11:104392803:G:A
NM_003990.5(PAX2):c.223_224dup (p.Gly76fs)	PAX2		not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000217289	10	102510460 - 102510461	10	100750703 - 100750704	217289	213940	rs886037757	NC_000010.11:100750703:AC:ACAC
NM_003990.5(PAX2):c.58_64dup (p.Gln22fs)	PAX2		not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000217288	10	102509516 - 102509517	10	100749759 - 100749760	217288	213937	rs886037756	NC_000010.11:100749759:GTGAACC:GTGAACCGTGAACC
NM_003990.5(PAX2):c.187G>A (p.Gly63Ser)	PAX2	G63S, G94S	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000217287	10	102509646	10	100749889	217287	213939	rs886037755	NC_000010.11:100749888:G:A
NM_003990.5(PAX2):c.117_118GC[1] (p.Arg40fs)	PAX2		not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000217286	10	102509576 - 102509577	10	100749819 - 100749820	217286	213938	rs886037754	NC_000010.11:100749818:GCGC:GC
NM_000278.5(PAX2):c.167G>A (p.Arg56Gln)	PAX2	R56Q, R87Q	Focal segmental glomerulosclerosis 7	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000155929	10	102509626	10	100749869	155929	165725	rs587777708	NC_000010.11:100749868:G:A
NM_000278.5(PAX2):c.565G>A (p.Gly189Arg)	PAX2	G189R, G220R	Focal segmental glomerulosclerosis 7	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000155928	10	102541071	10	100781314	155928	165724	rs1131692055	NC_000010.11:100781313:G:A
GRCh38/hg38 10q24.31(chr10:100677717-100764519)x1	PAX2		See cases	Pathogenic(Last reviewed: Aug 19, 2011)	no assertion criteria provided	VCV000148599	10	102437474 - 102524276	10	100677717 - 100764519	148599	158350		
NM_213649.2(SFXN4):c.739dup (p.Arg247fs)	SFXN4		Combined oxidative phosphorylation deficiency 18	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000092099	10	120907365 - 120907366	10	119147853 - 119147854	92099	97530	rs1554886159	NC_000010.11:119147853:T:TT
NM_213649.2(SFXN4):c.233del (p.Pro78fs)	SFXN4	P78fs	Combined oxidative phosphorylation deficiency 18	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000092098	10	120921871	10	119162359	92098	97529	rs398124642	NC_000010.11:119162358:GGG:GG
WDR11, HIS690GLN	WDR11	H690Q	Hypogonadotropic hypogonadism 14 with anosmia	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000037310					37310	45885		
NM_018368.4(LMBRD1):c.1156C>T (p.Arg386Ter)	LMBRD1	R313*, R386*		Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000847318	6	70410689	6	69700797	847318	832284		NC_000006.12:69700796:G:A
NM_001693.4(ATP6V1B2):c.1465A>T (p.Lys489Ter)	ATP6V1B2	K489*	Zimmermann-Laband syndrome with epileptic encephalopathy|Zimmermann-Laband syndrome 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000634920	8	20077842	8	20220331	634920	622759		NC_000008.11:20220330:A:T
NM_001693.4(ATP6V1B2):c.1516C>T (p.Arg506Ter)	ATP6V1B2	R506*	Deafness, congenital, with onychodystrophy, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000203442	8	20077893	8	20220382	203442	199855	rs794729667	NC_000008.11:20220381:C:T
NM_213649.2(SFXN4):c.471+1G>A	SFXN4		Combined oxidative phosphorylation deficiency 18	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000092100	10	120917382	10	119157870	92100	97531	rs367932369	NC_000010.11:119157869:C:T
WDR11, PHE1150LEU	WDR11	F1150L	Hypogonadotropic hypogonadism 14 with or without anosmia	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000037308					37308	45883		
PAX2, 6-BP DEL	PAX2		Renal coloboma syndrome	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000013798					13798	28837		
NM_018368.4(LMBRD1):c.404del (p.Thr135fs)	LMBRD1	T135fs, T62fs		Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000000518	6	70462152	6	69752260	518	15557	rs1562112641	NC_000006.12:69752259:G:
NM_018368.4(LMBRD1):c.515_516del (p.Thr172fs)	LMBRD1	T172fs, T99fs		Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000000517	6	70451727 - 70451728	6	69741835 - 69741836	517	15556	rs779151199	NC_000006.12:69741834:TGT:T
LMBRD1, 1-BP DEL, 1056G	LMBRD1			Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000000516					516	15555		
NM_001385.3(DPYS):c.1235G>T (p.Arg412Met)	DPYS	R412M	Dihydropyrimidinase deficiency	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000000187	8	105436475	8	104424247	187	15226	rs267606774	NC_000008.11:104424246:C:A
NM_001385.3(DPYS):c.1303G>A (p.Gly435Arg)	DPYS	G435R	Dihydropyrimidinase deficiency	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000000185	8	105405152	8	104392924	185	15224	rs267606773	NC_000008.11:104392923:C:T
NM_001385.3(DPYS):c.1001A>G (p.Gln334Arg)	DPYS	Q334R	Dihydropyrimidinase deficiency	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000000184	8	105440299	8	104428071	184	15223	rs121964923	NC_000008.11:104428070:T:C
NM_003990.5(PAX2):c.212G>C (p.Arg71Thr)	PAX2	R71T, R102T	Papillorenal syndrome with macular abnormalities	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000013805	10	102509671	10	100749914	13805	28844	rs104894170	NC_000010.11:100749913:G:C
NM_001385.3(DPYS):c.1078T>C (p.Trp360Arg)	DPYS	W360R	Dihydropyrimidinase deficiency	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000000186	8	105440222	8	104427994	186	15225	rs121964924	NC_000008.11:104427993:A:G
NM_001385.3(DPYS):c.1393C>T (p.Arg465Ter)	DPYS	R465*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000863103	8	105405062	8	104392834	863103	834031		NC_000008.11:104392833:G:A
NM_000278.5(PAX2):c.239C>T (p.Pro80Leu)	PAX2	P80L, P111L	Focal segmental glomerulosclerosis 7|Renal coloboma syndrome	Pathogenic(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000465775	10	102510477	10	100750720	465775	460453	rs1554856032	NC_000010.11:100750719:C:T
NM_018117.12(WDR11):c.1303G>A (p.Ala435Thr)	WDR11	A435T	Hypogonadotropic hypogonadism 14 with or without anosmia|not provided	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000037309	10	122630690	10	120871178	37309	45884	rs318240760	NC_000010.11:120871177:G:A
NM_000278.5(PAX2):c.954C>A (p.Tyr318Ter)	PAX2	Y341*, Y349*, Y318*	Renal coloboma syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000013803	10	102584439	10	100824682	13803	28842	rs78122364	NC_000010.11:100824681:C:A
NM_000278.5(PAX2):c.75_76dup (p.Val26fs)	PAX2		Renal coloboma syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000013802	10	102509528 - 102509529	10	100749771 - 100749772	13802	28841	rs75462234	NC_000010.11:100749771:GGGGGGG:GGGGGGGGG
NM_000278.5(PAX2):c.226G>A (p.Gly76Ser)	PAX2	G76S, G107S	Renal coloboma syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000013799	10	102510464	10	100750707	13799	28838	rs79555199	NC_000010.11:100750706:G:A
NM_000278.5(PAX2):c.131_152del (p.Leu44fs)	PAX2	L75fs, L44fs	Renal coloboma syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000013797	10	102509589 - 102509610	10	100749832 - 100749853	13797	28836	rs76675173	NC_000010.11:100749831:CTGGCCCACCAGGGTGTGCGGCC:C
NM_000317.3(PTS):c.260C>T (p.Pro87Leu)	PTS	P87L		Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553829	11	112103902	11	112233179	553829	545415	rs765406631	NC_000011.10:112233178:C:T
NM_000317.3(PTS):c.317C>T (p.Thr106Met)	PTS	T106M		Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552175	11	112104157	11	112233434	552175	545417	rs200712908	NC_000011.10:112233433:C:T
NM_000317.3(PTS):c.166G>A (p.Val56Met)	PTS	V56M		Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000481	11	112100933	11	112230210	481	15520	rs104894277	NC_000011.10:112230209:G:A
NM_000637.5(GSR):c.1121G>C (p.Gly374Ala)	GSR	G330A, G292A, G321A, G345A, G374A	HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY	Pathogenic(Last reviewed: Dec 2, 2019)	no assertion criteria provided	VCV000694662	8	30541637	8	30684120	694662	682781		NC_000008.11:30684119:C:G
NM_000637.5(GSR):c.993G>A (p.Trp331Ter)	GSR	W287*, W302*, W331*	HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY	Pathogenic(Last reviewed: Nov 26, 2019)	no assertion criteria provided	VCV000694661	8	30546726	8	30689209	694661	682780		NC_000008.11:30689208:C:T
MYORG, ILE655THR	MYORG	I655T	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	VCV000617697					617697	609100		
NM_020702.5(MYORG):c.1233del (p.Phe411fs)	MYORG	F411fs	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	VCV000617695	9	34371709	9	34371711	617695	609098	rs1563981857	NC_000009.12:34371710:G:
NM_002160.4(TNC):c.5386A>T (p.Thr1796Ser)	TNC	T1796S	Deafness, autosomal dominant 56	Pathogenic(Last reviewed: Jul 30, 2013)	no assertion criteria provided	VCV000097009	9	117803226	9	115040947	97009	102918	rs431905513	NC_000009.12:115040946:T:A
NM_002160.4(TNC):c.5317G>A (p.Val1773Met)	TNC	V1773M	Deafness, autosomal dominant 56	Pathogenic(Last reviewed: Jul 30, 2013)	no assertion criteria provided	VCV000097008	9	117803295	9	115041016	97008	102917	rs137933052	NC_000009.12:115041015:C:T
NM_001693.4(ATP6V1B2):c.1454G>C (p.Arg485Pro)	ATP6V1B2	R485P	Zimmermann-Laband syndrome 2|Zimmermann-Laband syndrome 1	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000183414	8	20077831	8	20220320	183414	181522	rs730882177	NC_000008.11:20220319:G:C
NM_000278.5(PAX2):c.561del (p.Asn188fs)	PAX2	N188fs, N219fs	Renal coloboma syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000013795	10	102541067	10	100781310	13795	28834	rs77777862	NC_000010.11:100781309:C:
NM_005522.4(HOXA1):c.175dup (p.Val59fs)	HOXA1		Bosley-Salih-Alorainy syndrome||not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000014898	7	27135356 - 27135357	7	27095737 - 27095738	14898	29937	rs769152039	NC_000007.14:27095737:CCCCCC:CCCCCCC
GSR, 2.246-KB DEL	GSR		HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694660					694660	682779		
NM_020702.5(MYORG):c.225G>A (p.Trp75Ter)	MYORG	W75*	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000617689	9	34372717	9	34372719	617689	609092	rs760451348	NC_000009.12:34372718:C:T
GRCh37/hg19 7q34(chr7:139548076-139680096)x1	TBXAS1		not provided	Pathogenic(Last reviewed: Dec 15, 2017)	no assertion criteria provided	VCV000686007	7	139548076 - 139680096			686007	673599		
NM_015599.3(PGM3):c.398_413del (p.Ser133fs)	PGM3	S52fs, S133fs, S161fs	not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000504123	6	83896771 - 83896786	6	83187052 - 83187067	504123	495538	rs1404084330	NC_000006.12:83187051:TGTGAAAGTTTCTCACTG:TG
NM_001130966.4(TBXAS1):c.1420del (p.Ala474fs)	TBXAS1	A407fs, A413fs, A474fs, A520fs, A455fs	not provided	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000194017	7	139717523	7	140017723	194017	191180	rs794727053	NC_000007.14:140017722:GGGG:GGG
NM_015631.6(TCTN3):c.257-1G>A	TCTN3		Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV000816476	10	97453234	10	95693477	816476	804670		NC_000010.11:95693476:C:T
NM_002161.5(IARS1):c.2215C>T (p.Arg739Cys)	IARS1	R739C	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000559510	9	95015658	9	92253376	559510	550233	rs747311061	NC_000009.12:92253375:G:A
NM_002161.5(IARS1):c.1667T>C (p.Phe556Ser)	IARS1	F556S	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000559509	9	95027244	9	92264962	559509	550232	rs1554728327	NC_000009.12:92264961:A:G
NM_015599.3(PGM3):c.520C>T (p.Arg174Ter)	PGM3	R202*, R174*, R93*	Immunodeficiency 23	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000541844	6	83892635	6	83182916	541844	522243	rs762678772	NC_000006.12:83182915:G:A
NM_013417.3(IARS1):c.2974A>G (p.Asn992Asp)	IARS1	N992D	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000253322	9	95005524	9	92243242	253322	247770	rs886037877	NC_000009.12:92243241:T:C
NM_013417.3(IARS1):c.1109T>G (p.Val370Gly)	IARS1	V370G	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000253321	9	95033819	9	92271537	253321	247769	rs886037876	NC_000009.12:92271536:A:C
NM_013417.3(IARS1):c.760C>T (p.Arg254Ter)	IARS1	R254*	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000253320	9	95040554	9	92278272	253320	247768	rs886037875	NC_000009.12:92278271:G:A
NM_013417.3(IARS1):c.1310C>T (p.Pro437Leu)	IARS1	P437L	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000253319	9	95030577	9	92268295	253319	247767	rs886037874	NC_000009.12:92268294:G:A
NM_013417.3(IARS1):c.3521T>A (p.Ile1174Asn)	IARS1	I1174N	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000253318	9	94985660	9	92223378	253318	247766	rs886037873	NC_000009.12:92223377:A:T
NM_013417.3(IARS1):c.1252C>T (p.Arg418Ter)	IARS1	R418*	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000253317	9	95032219	9	92269937	253317	247765	rs764500338	NC_000009.12:92269936:G:A
NM_015599.3(PGM3):c.1016_1018AAG[1] (p.Glu340del)	PGM3	E340del, E368del	Hyper-IgE syndrome	Pathogenic	no assertion criteria provided	VCV000156471	6	83888400 - 83888402	6	83178681 - 83178683	156471	166237	rs267608259	NC_000006.12:83178680:CTTCTTC:CTTC
NM_015599.3(PGM3):c.1020_1022del (p.Glu340_Val341delinsAsp)	PGM3		Immunodeficiency 23	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000133319	6	83888399 - 83888401	6	83178680 - 83178682	133319	137056	rs587777416	NC_000006.12:83178679:ACT:
NM_015599.3(PGM3):c.891T>G (p.Asp297Glu)	PGM3	D325E, D297E, D216E	Immunodeficiency 23	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000133318	6	83889583	6	83179864	133318	137055	rs587777415	NC_000006.12:83179863:A:C
NM_015631.6(TCTN3):c.1346_1347CT[1] (p.Leu450fs)	TCTN3		Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037060	10	97442511 - 97442512	10	95682754 - 95682755	37060	45740	rs768525869	NC_000010.11:95682753:AGAG:AG
NM_015631.6(TCTN3):c.564_565AG[1] (p.Glu189fs)	TCTN3		Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037059	10	97447409 - 97447410	10	95687652 - 95687653	37059	45739	rs793888507	NC_000010.11:95687651:CTCT:CT
NM_015631.6(TCTN3):c.1327C>T (p.Gln443Ter)	TCTN3	Q443*, Q295*	Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037058	10	97442533	10	95682776	37058	45738	rs387907273	NC_000010.11:95682775:G:A
TCTN3, 4-BP DEL, NT650	TCTN3		Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037057					37057	45737		
TCTN3, GLN480TER	TCTN3	Q480*	Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037056					37056	45736		
NM_001130966.4(TBXAS1):c.1441G>T (p.Gly481Trp)	TBXAS1	G482W, G414W, G528W, G481W, G527W, G462W, G420W	Ghosal hematodiaphyseal syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000011888	7	139717547	7	140017747	11888	26927	rs199422116	NC_000007.14:140017746:G:T
NM_015631.6(TCTN3):c.1423_1429del (p.Arg475fs)	TCTN3	R327fs, R475fs	Joubert syndrome 18|Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000649506	10	97442431 - 97442437	10	95682674 - 95682680	649506	639327		NC_000010.11:95682673:GGATCCTGG:GG
NM_015599.3(PGM3):c.715G>C (p.Asp239His)	PGM3	D239H, D267H, D158H	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000224830	6	83891527	6	83181808	224830	226663	rs869312886	NC_000006.12:83181807:C:G
NM_015631.6(TCTN3):c.877C>T (p.Gln293Ter)	TCTN3	Q293*, Q214*	Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	VCV000208618	10	97446263	10	95686506	208618	205165	rs764091969	NC_000010.11:95686505:G:A
NM_015599.3(PGM3):c.1352A>G (p.Gln451Arg)	PGM3	Q451R, Q479R, Q370R	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000140735	6	83881669	6	83171950	140735	150448	rs587777565	NC_000006.12:83171949:T:C
NM_015599.3(PGM3):c.737dup (p.Asn246fs)	PGM3		Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000140734	6	83891504 - 83891505	6	83181785 - 83181786	140734	150447	rs587777564	NC_000006.12:83181785:TT:TTT
NM_015599.3(PGM3):c.737A>G (p.Asn246Ser)	PGM3	N246S, N274S, N165S	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000140732	6	83891505	6	83181786	140732	150445	rs587777562	NC_000006.12:83181785:T:C
NM_015631.6(TCTN3):c.940G>A (p.Gly314Arg)	TCTN3	G314R	Joubert syndrome 18	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037061	10	97445342	10	95685585	37061	45741	rs793888508	NC_000010.11:95685584:C:T
NM_001130966.4(TBXAS1):c.1460T>C (p.Leu487Pro)	TBXAS1	L488P, L420P, L534P, L487P, L533P, L426P, L468P	Ghosal hematodiaphyseal syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000011886	7	139717566	7	140017766	11886	26925	rs199422114	NC_000007.14:140017765:T:C
NM_001160036.2(RHOBTB2):c.1519C>T (p.Arg507Cys)	RHOBTB2	R507C, R492C, R485C	not provided|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617912	8	22865211	8	23007698	617912	609309	rs1563292586	NC_000008.11:23007697:C:T
NM_001160036.2(RHOBTB2):c.1448G>A (p.Arg483His)	RHOBTB2	R483H, R461H, R468H	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545417	8	22865140	8	23007627	545417	535681	rs1554504663	NC_000008.11:23007626:G:A
NM_000278.5(PAX2):c.706C>T (p.Gln236Ter)	PAX2	Q236*, Q259*, Q267*	Renal coloboma syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000156296	10	102566276	10	100806519	156296	166076	rs75399846	NC_000010.11:100806518:C:T
NM_000278.5(PAX2):c.76del (p.Val26fs)	PAX2	V26fs, V57fs	Renal coloboma syndrome	Pathogenic	criteria provided, single submitter	VCV000013801	10	102509529	10	100749772	13801	28840	rs75462234	NC_000010.11:100749771:GGGGGGG:GGGGGG
NM_015599.3(PGM3):c.1354_1358del (p.Leu452fs)	PGM3	L480fs, L371fs, L452fs	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000133317	6	83881663 - 83881667	6	83171944 - 83171948	133317	137054	rs587777414	NC_000006.12:83171943:TTAAGTT:TT
NM_015599.3(PGM3):c.248T>C (p.Leu83Ser)	PGM3	L83S, L111S, L2S	Hyper-IgE syndrome|Immunodeficiency 23	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000133320	6	83898474	6	83188755	133320	137057	rs267608260	NC_000006.12:83188754:A:G
NM_000317.3(PTS):c.118_121del (p.Phe40fs)	PTS	F40fs	|not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550850	11	112099349 - 112099352	11	112228626 - 112228629	550850	545827	rs747260038	NC_000011.10:112228625:TGTTTG:TG
NM_144585.4(SLC22A12):c.774G>A (p.Trp258Ter)	SLC22A12	W258*, W37*, W224*	Familial renal hypouricemia	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003512	11	64361219	11	64593747	3512	18551	rs121907892	NC_000011.10:64593746:G:A
NM_015631.6(TCTN3):c.3G>A (p.Met1Ile)	TCTN3	M1I	Joubert syndrome 18|Joubert syndrome 18|Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217703	10	97453654	10	95693897	217703	214308	rs745688122	NC_000010.11:95693896:C:T
NM_001160036.2(RHOBTB2):c.1532G>A (p.Arg511Gln)	RHOBTB2	R511Q, R489Q, R496Q	Dystonia|Chorea|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000545418	8	22865224	8	23007711	545418	535682	rs1554504684	NC_000008.11:23007710:G:A
NM_014026.6(DCPS):c.636+1G>A	DCPS		AL-RAQAD SYNDROME	Pathogenic(Last reviewed: Jul 29, 2019)	no assertion criteria provided	VCV000372234	11	126208295	11	126338400	372234	359139	rs770528538	NC_000011.10:126338399:G:A
NM_014026.6(DCPS):c.201+2T>C	DCPS	V68A	AL-RAQAD SYNDROME	Pathogenic(Last reviewed: Jul 29, 2019)	no assertion criteria provided	VCV000372233	11	126174178	11	126304283	372233	359138	rs1057519083	NC_000011.10:126304282:T:C
NM_001136271.2(NKX2-6):c.451T>C (p.Phe151Leu)	NKX2-6	F151L	Persistent truncus arteriosus	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000000791	8	23560419	8	23702906	791	15830	rs267606914	NC_000008.11:23702905:A:G
NM_014026.6(DCPS):c.260C>T (p.Thr87Met)	DCPS	T87M, T94M	AL-RAQAD SYNDROME	Pathogenic(Last reviewed: Jul 29, 2019)	no assertion criteria provided	VCV000638276	11	126176523	11	126306628	638276	626058		NC_000011.10:126306627:C:T
NM_001173990.3(TMEM216):c.230G>C (p.Gly77Ala)	TMEM216	G77A, G16A		Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000000200	11	61165246	11	61397774	200	15239	rs386833830	NC_000011.10:61397773:G:C
NM_001173990.3(TMEM216):c.341T>G (p.Leu114Arg)	TMEM216	L114R, L53R		Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000000199	11	61165357	11	61397885	199	15238	rs386833831	NC_000011.10:61397884:T:G
NM_001173990.3(TMEM216):c.398T>G (p.Leu133Ter)	TMEM216	L133*, L72*	Joubert syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217704	11	61165414	11	61397942	217704	214311	rs755459875	NC_000011.10:61397941:T:G
NM_177965.4(C8orf37):c.529C>T (p.Arg177Trp)	C8orf37	R177W, R145W	Retinitis pigmentosa|Cone-rod dystrophy 16|Bardet-Biedl syndrome 21	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000031194	8	96259940	8	95247712	31194	40151	rs387907136	NC_000008.11:95247711:G:A
NM_173676.2(PNPLA1):c.593_596dup (p.Pro200fs)	PNPLA1		not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000545920	6	36269737 - 36269738	6	36301960 - 36301961	545920	536315	rs1554139129	NC_000006.12:36301960:CAGTCA:CAGTCAGTCA
NM_015160.3(PMPCA):c.554G>A (p.Arg185Gln)	PMPCA	R185Q, R54Q, R85Q	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic	no assertion criteria provided	VCV000375401	9	139310764	9	136416312	375401	362150	rs573267388	NC_000009.12:136416311:G:A
NM_015160.3(PMPCA):c.64C>T (p.Arg22Trp)	PMPCA	R22W	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic	no assertion criteria provided	VCV000375400	9	139305184	9	136410732	375400	362149	rs1057519454	NC_000009.12:136410731:C:T
NM_017909.4(RMND1):c.485del (p.Pro162fs)	RMND1	P162fs	not provided	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000280833	6	151766462	6	151445327	280833	264250	rs759477396	NC_000006.12:151445326:GG:G
NM_173676.2(PNPLA1):c.-80-20703C>G	PNPLA1	S53W	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684647	6	36238394	6	36270617	684647	672243		NC_000006.12:36270616:C:G
NM_173676.2(PNPLA1):c.-80-20704T>C	PNPLA1	S53P	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684646	6	36238393	6	36270616	684646	672242		NC_000006.12:36270615:T:C
NM_173676.2(PNPLA1):c.136A>G (p.Lys46Glu)	PNPLA1	K46E, K141E	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684645	6	36259312	6	36291535	684645	672245		NC_000006.12:36291534:A:G
NM_173676.2(PNPLA1):c.419C>T (p.Pro140Leu)	PNPLA1	P140L, P149L, P235L	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684644	6	36262166	6	36294389	684644	672249		NC_000006.12:36294388:C:T
NM_173676.2(PNPLA1):c.77A>C (p.His26Pro)	PNPLA1	H121P, H26P	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684641	6	36259253	6	36291476	684641	672244		NC_000006.12:36291475:A:C
NM_173676.2(PNPLA1):c.1015del (p.Ala339fs)	PNPLA1	A434fs, A339fs, A348fs	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684640	6	36270158	6	36302381	684640	672252		NC_000006.12:36302380:GGGGG:GGGG
NM_173676.2(PNPLA1):c.163T>C (p.Cys55Arg)	PNPLA1	C150R, C55R	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684639	6	36260847	6	36293070	684639	672246		NC_000006.12:36293069:T:C
NM_173676.2(PNPLA1):c.229G>A (p.Asp77Asn)	PNPLA1	D172N, D77N, D86N	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684638	6	36261976	6	36294199	684638	672248		NC_000006.12:36294198:G:A
NM_173676.2(PNPLA1):c.-80-20769C>A	PNPLA1	A31D	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684637	6	36238328	6	36270551	684637	672241		NC_000006.12:36270550:C:A
NM_173676.2(PNPLA1):c.179C>T (p.Pro60Leu)	PNPLA1	P155L, P60L	Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000684636	6	36260863	6	36293086	684636	672247		NC_000006.12:36293085:C:T
NM_173676.2(PNPLA1):c.442_444TAC[2] (p.Tyr150del)	PNPLA1		Autosomal recessive congenital ichthyosis 10	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633818	6	36263153 - 36263155	6	36295376 - 36295378	633818	622230		NC_000006.12:36295375:TACTACTAC:TACTAC
NM_017909.3(RMND1):c.1003del (p.Ala335Leufs)	RMND1		Combined oxidative phosphorylation deficiency 11	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000374907	6	151742456	6	151421321	374907	361812	rs1057519299	
NM_017909.3(RMND1):c.613G>T	RMND1	D205Y, D35Y	Combined oxidative phosphorylation deficiency 11	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000242631	6	151757581	6	151436446	242631	171704	rs606231472	NC_000006.12:151436445:C:A
NM_015160.3(PMPCA):c.766G>A (p.Val256Met)	PMPCA	V256M, V125M, V156M	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic(Last reviewed: Oct 12, 2016)	no assertion criteria provided	VCV000221566	9	139311535	9	136417083	221566	223295	rs746549806	NC_000009.12:136417082:G:A
NM_015160.3(PMPCA):c.1543G>A (p.Gly515Arg)	PMPCA	G515R, G415R, G384R	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic(Last reviewed: Oct 12, 2016)	no assertion criteria provided	VCV000221565	9	139317681	9	136423229	221565	223294	rs869025293	NC_000009.12:136423228:G:A
NM_015160.3(PMPCA):c.287C>T (p.Ser96Leu)	PMPCA	S96L	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic(Last reviewed: Oct 12, 2016)	no assertion criteria provided	VCV000221564	9	139306954	9	136412502	221564	223293	rs869025292	NC_000009.12:136412501:C:T
NM_015160.3(PMPCA):c.1066G>A (p.Gly356Ser)	PMPCA	G356S, G225S, G256S	Normal pressure hydrocephalus|Hypoventilation|Blindness|Chronic lactic acidosis|Severe global developmental delay|Diffuse cerebellar atrophy|Bilateral ptosis|Failure to thrive|Optic atrophy|Global brain atrophy|Hypertrophic cardiomyopathy|Infantile muscular hypotonia|Restrictive external ophthalmoplegia	Pathogenic(Last reviewed: Jan 22, 2016)	no assertion criteria provided	VCV000221553	9	139313082	9	136418630	221553	223281	rs768643552	NC_000009.12:136418629:G:A
NM_001080413.3(NOBOX):c.1048G>T (p.Val350Leu)	NOBOX	V350L	Premature ovarian failure 5	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000167877	7	144096956	7	144399863	167877	178177	rs193303104	NC_000007.14:144399862:C:A
NM_001080413.3(NOBOX):c.1025G>C (p.Ser342Thr)	NOBOX	S342T	Premature ovarian failure 5	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000167876	7	144097225	7	144400132	167876	178176	rs193303103	NC_000007.14:144400131:C:G
NM_001080413.3(NOBOX):c.907C>T (p.Arg303Ter)	NOBOX	R303*	Premature ovarian failure 5	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000167873	7	144097343	7	144400250	167873	178173	rs193303102	NC_000007.14:144400249:G:A
NM_173676.2(PNPLA1):c.-80-20685C>T	PNPLA1	A59V	Autosomal recessive congenital ichthyosis 10	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000039562	6	36238412	6	36270635	39562	48161	rs1561853847	NC_000006.12:36270634:C:T
NM_173676.2(PNPLA1):c.106G>T (p.Glu36Ter)	PNPLA1	E131*, E36*	Autosomal recessive congenital ichthyosis 10	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000039561	6	36259282	6	36291505	39561	48160	rs1561864453	NC_000006.12:36291504:G:T
NM_001080413.3(NOBOX):c.1064G>A (p.Arg355His)	NOBOX	R355H	Premature ovarian failure 5	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001083	7	144096940	7	144399847	1083	16122	rs201947677	NC_000007.14:144399846:C:T
NM_030653.4(DDX11):c.2457+1G>T	DDX11		Warsaw breakage syndrome	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638411	12	31255955	12	31103021	638411	626314		NC_000012.12:31103020:G:T
NM_017909.4(RMND1):c.504+1G>A	RMND1		Combined oxidative phosphorylation deficiency 11	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039764	6	151766442	6	151445307	39764	48363	rs1562800908	NC_000006.12:151445306:C:T
NM_030653.4(DDX11):c.2271+2T>C	DDX11		Warsaw breakage syndrome	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000008369	12	31255247	12	31102313	8369	23408	rs730880279	NC_000012.12:31102312:T:C
NM_173676.2(PNPLA1):c.102C>A (p.Asp34Glu)	PNPLA1	D34E, D129E	Autosomal recessive congenital ichthyosis 10|Ichthyosis (disease)	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000617846	6	36259278	6	36291501	617846	609204	rs200806519	NC_000006.12:36291500:C:A
NM_030653.4(DDX11):c.1763-1G>C	DDX11		not provided|Warsaw breakage syndrome	Pathogenic(Last reviewed: Oct 11, 2015)	criteria provided, single submitter	VCV000252749	12	31250818	12	31097884	252749	247078	rs148856317	NC_000012.12:31097883:G:C
NM_017909.4(RMND1):c.830+1G>A	RMND1		Mitochondrial diseases	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000225261	6	151748616	6	151427481	225261	227164	rs773470671	NC_000006.12:151427480:C:T
NM_017909.4(RMND1):c.631G>A (p.Val211Met)	RMND1	V211M, V41M	Mitochondrial diseases	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000225260	6	151754348	6	151433213	225260	227165	rs771894262	NC_000006.12:151433212:C:T
NM_017909.4(RMND1):c.1317+1G>T	RMND1		Mitochondrial diseases	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000225259	6	151726854	6	151405719	225259	227162	rs886037773	NC_000006.12:151405718:C:A
NM_017909.4(RMND1):c.533C>A (p.Thr178Lys)	RMND1	T178K, T8K	Mitochondrial diseases	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000225258	6	151757661	6	151436526	225258	227167	rs370863743	NC_000006.12:151436525:G:T
NM_017909.4(RMND1):c.565C>T (p.Gln189Ter)	RMND1	Q189*, Q19*	Mitochondrial diseases	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000225257	6	151757629	6	151436494	225257	227166	rs886037772	NC_000006.12:151436493:G:A
NM_017909.4(RMND1):c.1303C>T (p.Leu435Phe)	RMND1	L435F, L265F	Mitochondrial diseases	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000225256	6	151726869	6	151405734	225256	227163	rs886037771	NC_000006.12:151405733:G:A
NM_030653.4(DDX11):c.788G>A (p.Arg263Gln)	DDX11	R263Q, R237Q	Warsaw breakage syndrome	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039995	12	31242081	12	31089147	39995	48508	rs201968272	NC_000012.12:31089146:G:A
NM_030653.4(DDX11):c.2689_2691del (p.Lys897del)	DDX11	K897del, K871del, E895del, K847del	Warsaw breakage syndrome	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000008370	12	31256661 - 31256663	12	31103727 - 31103729	8370	23409	rs730880280	NC_000012.12:31103726:AGAAG:AG
NM_173676.2(PNPLA1):c.50C>A (p.Ser17Tyr)	PNPLA1	S112Y, S17Y	Congenital ichthyosiform erythroderma|Autosomal recessive congenital ichthyosis 10	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000375258	6	36259226	6	36291449	375258	361959	rs369445146	NC_000006.12:36291448:C:A
NM_012229.4(NT5C2):c.1099C>T (p.Arg367Ter)	NT5C2	R176*, R336*, R338*, R367*, R375*, R129*	Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000834345	10	104852956	10	103093199	834345	836603		NC_000010.11:103093198:G:A
NM_001351176.1(NT5C2):c.-266_-265AC[2]	NT5C2		Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	VCV000541762	10	104865539 - 104865540	10	103105782 - 103105783	541762	525288	rs763305896	NC_000010.11:103105781:GTGTGT:GTGT
NM_012229.4(NT5C2):c.771+573_814-298del	NT5C2		Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Jan 5, 2017)	no assertion criteria provided	VCV000375572	10	104854510 - 104856475	10	103094753 - 103096718	375572	362382		
NM_024915.4(GRHL2):c.1445T>A (p.Ile482Lys)	GRHL2	I482K, I466K	Ectodermal dysplasia/short stature syndrome	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156217	8	102644553	8	101632325	156217	166014	rs587777738	NC_000008.11:101632324:T:A
NM_024915.4(GRHL2):c.1192T>C (p.Tyr398His)	GRHL2	Y398H, Y382H	Ectodermal dysplasia/short stature syndrome	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156216	8	102631860	8	101619632	156216	166013	rs587777737	NC_000008.11:101619631:T:C
NM_012229.4(NT5C2):c.175+1G>A	NT5C2		Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000100908	10	104899162	10	103139405	100908	106770	rs886037658	NC_000010.11:103139404:C:T
NM_012229.4(NT5C2):c.445A>T (p.Arg149Ter)	NT5C2	R149*, R157*, R118*, R120*	Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000100907	10	104861028	10	103101271	100907	106769	rs587777174	NC_000010.11:103101270:T:A
NM_012229.4(NT5C2):c.989-1G>T	NT5C2		Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000100906	10	104853067	10	103093310	100906	106768	rs886037657	NC_000010.11:103093309:C:A
NM_012229.4(NT5C2):c.1225del (p.Ser409fs)	NT5C2	S378fs, S380fs, S409fs, S417fs, S171fs, S218fs	Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000100905	10	104850740	10	103090983	100905	106767	rs886037656	NC_000010.11:103090982:T:
NM_012229.4(NT5C2):c.85C>T (p.Arg29Ter)	NT5C2	R29*	Spastic paraplegia 45, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000100904	10	104934631	10	103174874	100904	106766	rs587777173	NC_000010.11:103174873:G:A
NM_024915.4(GRHL2):c.1258-1G>A	GRHL2		Deafness, autosomal dominant 28	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000092126	8	102643864	8	101631636	92126	97553	rs398123006	NC_000008.11:101631635:G:A
NM_024915.4(GRHL2):c.1609dup (p.Arg537fs)	GRHL2		Deafness, autosomal dominant 28	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000002195	8	102656449 - 102656450	8	101644221 - 101644222	2195	17234	rs398122997	NC_000008.11:101644221:C:CC
NM_173676.2(PNPLA1):c.-80-20761G>A	PNPLA1	A34T	Autosomal recessive congenital ichthyosis 10|Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jun 10, 2019)	no assertion criteria provided	VCV000625427	6	36238336	6	36270559	625427	613741	rs1182312612	NC_000006.12:36270558:G:A
NM_015160.3(PMPCA):c.1129G>A (p.Ala377Thr)	PMPCA	A377T, A277T, A246T	Spinocerebellar ataxia, autosomal recessive 2|Normal pressure hydrocephalus|Hypoventilation|Blindness|Chronic lactic acidosis|Severe global developmental delay|Diffuse cerebellar atrophy|Bilateral ptosis|Failure to thrive|Optic atrophy|Global brain atrophy|Hypertrophic cardiomyopathy|Infantile muscular hypotonia|Restrictive external ophthalmoplegia	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000221552	9	139313299	9	136418847	221552	223282	rs753611141	NC_000009.12:136418846:G:A
NM_000317.3(PTS):c.200C>T (p.Thr67Met)	PTS	T67M		Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000463151	11	112101362	11	112230639	463151	461694	rs370340361	NC_000011.10:112230638:C:T
NM_024915.4(GRHL2):c.20+133del	GRHL2		CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4|Corneal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000489405	8	102505150	8	101492922	489405	482318	rs1554579819	NC_000008.11:101492921:A:
NM_024915.4(GRHL2):c.20+544G>T	GRHL2		CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4|Corneal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000489403	8	102505561	8	101493333	489403	482320	rs1554579878	NC_000008.11:101493332:G:T
NM_001440.4(EXTL3):c.1015C>T (p.Arg339Trp)	EXTL3	R339W	Immunoskeletal dysplasia with neurodevelopmental abnormalities	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000417796	8	28574591	8	28717074	417796	404697	rs747676107	NC_000008.11:28717073:C:T
NM_001440.4(EXTL3):c.1970A>G (p.Asn657Ser)	EXTL3	N657S	Immunoskeletal dysplasia with neurodevelopmental abnormalities	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000417795	8	28575546	8	28718029	417795	404696	rs770842408	NC_000008.11:28718028:A:G
NM_001440.4(EXTL3):c.1382C>T (p.Pro461Leu)	EXTL3	P461L	Immunoskeletal dysplasia with neurodevelopmental abnormalities	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000417794	8	28574958	8	28717441	417794	404695	rs554294508	NC_000008.11:28717440:C:T
NM_173676.2(PNPLA1):c.133T>C (p.Ser45Pro)	PNPLA1	S140P, S45P	Congenital ichthyosiform erythroderma|Autosomal recessive congenital ichthyosis 10	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2019)	no assertion criteria provided	VCV000375256	6	36259309	6	36291532	375256	361957	rs781053760	NC_000006.12:36291531:T:C
NM_017909.4(RMND1):c.1250G>A (p.Arg417Gln)	RMND1	R417Q, R247Q	Mitochondrial diseases|Combined oxidative phosphorylation deficiency 11	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000039765	6	151726922	6	151405787	39765	48364	rs397515421	NC_000006.12:151405786:C:T
GRCh37/hg19 10p12.1(chr10:27005348-27022507)x1	PDSS1		not provided	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000687975	10	27005348 - 27022507			687975	675567		
NM_006624.5(ZMYND11):c.46C>T (p.Gln16Ter)	ZMYND11	Q16*	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000523901	10	225998	10	180058	523901	514606	rs1554767737	NC_000010.11:180057:C:T
NM_001370122.1(ZMYND11):c.448-798_448-797del	ZMYND11	K152fs, K161fs, K170fs, K229fs, K245fs, K246fs, K191fs, K192fs, K215fs, K224fs, K89fs, K206fs	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000504175	10	286034 - 286035	10	240094 - 240095	504175	495458	rs1554789246	NC_000010.11:240093:AAA:A
NM_006624.5(ZMYND11):c.1652dup (p.Gln552fs)	ZMYND11		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000452415	10	294992 - 294993	10	249052 - 249053	452415	444591	rs1554793896	NC_000010.11:249052:AA:AAA
NM_006624.5(ZMYND11):c.82C>T (p.Gln28Ter)	ZMYND11	Q28*	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000451936	10	226034	10	180094	451936	444578	rs1554767754	NC_000010.11:180093:C:T
NM_001330057.1(ZMYND11):c.-125C>T	ZMYND11	R8*	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000393552	10	225974	10	180034	393552	380443	rs1060499626	NC_000010.11:180033:C:T
NM_022726.4(ELOVL4):c.506G>A (p.Trp169Ter)	ELOVL4	W169*	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000391976	6	80631377	6	79921660	391976	369315	rs1057524307	NC_000006.12:79921659:C:T
NM_001370124.1(ZMYND11):c.-12_-9AACA[1]	ZMYND11		not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000373104	10	282796 - 282799	10	236856 - 236859	373104	359845	rs1057518219	NC_000010.11:236855:ACAAACAAACA:ACAAACA
GRCh37/hg19 10p15.3(chr10:136361-274777)x1	ZMYND11		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253634	10	136361 - 274777			253634	248082		
NM_014317.5(PDSS1):c.968del (p.Thr323fs)	PDSS1	T323fs, T153fs	not provided	Pathogenic(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	VCV000214985	10	27024450	10	26735521	214985	211451	rs863224163	NC_000010.11:26735520:C:
NC_000006.12:g.(?_79926194)_(79926381_?)del	ELOVL4		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000831415	6	80635911 - 80636098			831415	819755		
TONSL, EX23 DEL	TONSL		Sponastrime dysplasia	Pathogenic(Last reviewed: Jul 24, 2019)	no assertion criteria provided	VCV000638068					638068	625909		
NM_013432.5(TONSL):c.3589T>C (p.Ser1197Pro)	TONSL	S1197P	Sponastrime dysplasia	Pathogenic(Last reviewed: Jul 24, 2019)	no assertion criteria provided	VCV000638061	8	145657814	8	144432431	638061	625902		NC_000008.11:144432430:A:G
NM_006624.5(ZMYND11):c.383del (p.Ser128fs)	ZMYND11	S128fs, S88fs, S106fs, S111fs	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431092	10	267241	10	221301	431092	424615	rs1135401771	NC_000010.11:221300:C:
NM_001202465.1(ZMYND11):c.354+714del	ZMYND11	M170fs, M30fs, M111fs, M165fs, M116fs, M133fs, M147fs, M187fs, M93fs	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157554	10	283569	10	237629	157554	167417	rs672601341	NC_000010.11:237628:G:
NM_006624.5(ZMYND11):c.1246_1247del (p.Glu416fs)	ZMYND11	E259fs, E340fs, E393fs, E394fs, E415fs, E297fs, E314fs, E331fs, E376fs, E399fs, E416fs, E322fs, E361fs, E362fs, E367fs, E385fs	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157553	10	294293 - 294294	10	248353 - 248354	157553	167416	rs606231268	NC_000010.11:248352:AGA:A
NM_006624.5(ZMYND11):c.976C>T (p.Gln326Ter)	ZMYND11	Q326*, Q232*, Q286*, Q304*, Q169*, Q241*, Q300*, Q309*, Q207*, Q224*, Q250*, Q271*, Q272*, Q295*, Q325*	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157552	10	292731	10	246791	157552	167415	rs672601340	NC_000010.11:246790:C:T
NM_001370124.1(ZMYND11):c.-33-26860dup	ZMYND11		Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157551	10	255917 - 255918	10	209977 - 209978	157551	167414	rs606231267	NC_000010.11:209977:T:TT
NM_006624.5(ZMYND11):c.1756_1758CAG[1] (p.Gln587del)	ZMYND11	Q587del	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157550	10	298357 - 298359	10	252417 - 252419	157550	167413	rs606231266	NC_000010.11:252416:CAGCAG:CAG
NM_022726.4(ELOVL4):c.690del (p.Ile230fs)	ELOVL4	I230fs	Ichthyosis, spastic quadriplegia, and mental retardation	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030495	6	80626580	6	79916863	30495	39452	rs1131690772	NC_000006.12:79916862:AA:A
NM_022726.4(ELOVL4):c.810C>G (p.Tyr270Ter)	ELOVL4	Y270*	Stargardt Disease 3	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000004941	6	80626460	6	79916743	4941	19980	rs104893946	NC_000006.12:79916742:G:C
NM_013432.5(TONSL):c.1480G>A (p.Glu494Lys)	TONSL	E494K	Sponastrime dysplasia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000638065	8	145665404	8	144440021	638065	625906		NC_000008.11:144440020:C:T
NM_013432.5(TONSL):c.1459G>A (p.Glu487Lys)	TONSL	E487K	Sponastrime dysplasia	Pathogenic(Last reviewed: Jul 24, 2019)	no assertion criteria provided	VCV000638062	8	145665425	8	144440042	638062	625903		NC_000008.11:144440041:C:T
NM_022726.4(ELOVL4):c.670-1G>A	ELOVL4		Ichthyosis, spastic quadriplegia, and mental retardation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561003	6	80626601	6	79916884	561003	552107	rs1561982219	NC_000006.12:79916883:C:T
NM_006624.5(ZMYND11):c.76C>T (p.Arg26Trp)	ZMYND11	R26W	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431123	10	226028	10	180088	431123	424656	rs1135401797	NC_000010.11:180087:C:T
NM_014317.5(PDSS1):c.1108A>C (p.Ser370Arg)	PDSS1	S370R, S200R, E306A	Coenzyme Q10 deficiency, primary, 2	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375348	10	27035262	10	26746333	375348	362104	rs1057519354	NC_000010.11:26746332:A:C
NM_014317.5(PDSS1):c.661_662insT (p.Arg221fs)	PDSS1		Coenzyme Q10 deficiency, primary, 2	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375347	10	27012786 - 27012787	10	26723857 - 26723858	375347	362103	rs1057519353	NC_000010.11:26723857::T
NM_022726.4(ELOVL4):c.504G>C (p.Leu168Phe)	ELOVL4	L168F		Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000143056	6	80631379	6	79921662	143056	152775	rs587777598	NC_000006.12:79921661:C:G
NM_022726.4(ELOVL4):c.789_793delinsAAC (p.Asn264fs)	ELOVL4		Stargardt Disease 3	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000004940	6	80626477 - 80626481	6	79916760 - 79916764	4940	19979	rs587776613	NC_000006.12:79916759:AGTTA:GTT
NM_138295.4(PKD1L1):c.6473+2_6473+3del	PKD1L1		Heterotaxy, visceral, 8, autosomal|Situs ambiguus	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000235796	7	47870812 - 47870813	7	47831214 - 47831215	235796	236891	rs528302390	NC_000007.14:47831213:CAC:C
NM_014317.5(PDSS1):c.924T>G (p.Asp308Glu)	PDSS1	D308E, D138E	Coenzyme Q10 deficiency, primary, 2	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003237	10	27024406	10	26735477	3237	18276	rs119463988	NC_000010.11:26735476:T:G
NM_007175.8(ERLIN2):c.353del (p.Asn118fs)	ERLIN2	N118fs	not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000817651	8	37602142	8	37744624	817651	805566		NC_000008.11:37744623:AA:A
NM_007175.8(ERLIN2):c.17del (p.Ala6fs)	ERLIN2	A6fs	not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000280398	8	37595457	8	37737939	280398	264365	rs886041612	NC_000008.11:37737938:C:
NM_007175.8(ERLIN2):c.303T>A (p.Tyr101Ter)	ERLIN2	Y101*	Spastic paraplegia	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000834707	8	37602093	8	37744575	834707	834733		NC_000008.11:37744574:T:A
NM_001606.5(ABCA2):c.4537_4547delinsG (p.Arg1513fs)	ABCA2		INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000828059	9	139907916 - 139907926	9	137013464 - 137013474	828059	816395		NC_000009.12:137013463:TACTCGCGGCG:C
NM_001606.5(ABCA2):c.650dup (p.Gly218fs)	ABCA2		INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000828058	9	139916370 - 139916371	9	137021918 - 137021919	828058	816394		NC_000009.12:137021918:A:AA
NM_001606.5(ABCA2):c.937C>T (p.Gln313Ter)	ABCA2	Q343*, Q313*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000828057	9	139915474	9	137021022	828057	816393		NC_000009.12:137021021:G:A
NM_007175.8(ERLIN2):c.46del (p.Cys16fs)	ERLIN2	C16fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000639125	8	37595483	8	37737965	639125	637194		NC_000008.11:37737964:TTTT:TTT
NM_007175.8(ERLIN2):c.499-1G>T	ERLIN2		Spastic paraplegia 18	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000092113	8	37607311	8	37749793	92113	97545	rs398123002	NC_000008.11:37749792:G:T
NM_007175.8(ERLIN2):c.812_813insAC (p.Asn272fs)	ERLIN2		Spastic paraplegia 18	Pathogenic(Last reviewed: May 15, 2011)	no assertion criteria provided	VCV000030913	8	37611039 - 37611040	8	37753521 - 37753522	30913	39870	rs587776893	NC_000008.11:37753521:C:CAC
NM_033500.2(HK1):c.2503G>A (p.Glu835Lys)	HK1	E847K, E835K, E815K, E851K, E819K, E846K, E882K	Retinal dystrophy|not provided|Retinitis pigmentosa 79	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000424845	10	71158514	10	69398758	424845	411619	rs777849213	NC_000010.11:69398757:G:A
NM_001606.5(ABCA2):c.4903del (p.Val1635fs)	ABCA2	V1665fs, V1635fs	not provided|Ataxia with Dysarthria	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000637957	9	139907342	9	137012890	637957	625778		NC_000009.12:137012889:CC:C
NM_002546.4(TNFRSF11B):c.997C>T (p.Arg333Ter)	TNFRSF11B	R333*	Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802437	8	119936822	8	118924583	802437	790777		NC_000008.11:118924582:G:A
NM_031271.3:c.1425_1432del	TEX15		not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000835432					835432	850689		
NM_001350162.2(TEX15):c.8083C>T (p.Arg2695Ter)	TEX15	R2312*, R2695*	SPERMATOGENIC FAILURE 25	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000523231	8	30699600	8	30842084	523231	513883	rs763654373	NC_000008.11:30842083:G:A
NM_001350162.2(TEX15):c.4189del (p.Ser1397fs)	TEX15	S1397fs	SPERMATOGENIC FAILURE 25	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000523230	8	30703494	8	30845978	523230	513882	rs1554491783	NC_000008.11:30845977:A:
NM_001350162.2(TEX15):c.3568A>T (p.Lys1190Ter)	TEX15	K807*, K1190*	SPERMATOGENIC FAILURE 25	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000523229	8	30704115	8	30846599	523229	513881	rs1554492164	NC_000008.11:30846598:T:A
NM_002546.4(TNFRSF11B):c.226A>C (p.Thr76Pro)	TNFRSF11B	T76P	Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000208809	8	119945344	8	118933105	208809	205370	rs200071478	NC_000008.11:118933104:T:G
TNFRSF11B, 245-KB DEL	TNFRSF11B		Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000208808					208808	205369		
TNFRSF11B, 3-BP DEL AND 2-BP INS	TNFRSF11B		Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000006972					6972	22011		
NM_002546.4(TNFRSF11B):c.349T>C (p.Phe117Leu)	TNFRSF11B	F117L	Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000006971	8	119945221	8	118932982	6971	22010	rs104894092	NC_000008.11:118932981:A:G
NM_002546.4(TNFRSF11B):c.260G>A (p.Cys87Tyr)	TNFRSF11B	C87Y	Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000006970	8	119945310	8	118933071	6970	22009	rs104894091	NC_000008.11:118933070:C:T
NM_002546.4(TNFRSF11B):c.544_546del (p.Asp182del)	TNFRSF11B	D182del	Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000006969	8	119941023 - 119941025	8	118928784 - 118928786	6969	22008	rs796051868	NC_000008.11:118928783:GTCGT:GT
NM_001350162.2(TEX15):c.3279T>G (p.Tyr1093Ter)	TEX15	Y710*, Y1093*	Oligosynaptic infertility|SPERMATOGENIC FAILURE 25	Pathogenic	criteria provided, single submitter	VCV000190036	8	30704404	8	30846888	190036	187894	rs864309485	NC_000008.11:30846887:A:C
NM_001082971.2(DDC):c.749C>T (p.Ser250Phe)	DDC	S250F, S212F, S157F, S172F, S202F	Deficiency of aromatic-L-amino-acid decarboxylase	Pathogenic(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000017810	7	50571723	7	50504025	17810	32849	rs137853208	NC_000007.14:50504024:G:A
NM_006214.4(PHYH):c.530A>G (p.Asp177Gly)	PHYH	D177G, D179G, D77G, D79G	Retinal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000866618	10	13330508	10	13288508	866618	856662		NC_000010.11:13288507:T:C
NM_006214.4(PHYH):c.135-1G>C	PHYH		Refsum syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812375	10	13337607	10	13295607	812375	800692		NC_000010.11:13295606:C:G
NM_014028.4(OSTM1):c.486del (p.Phe162fs)	OSTM1	F162fs	Osteopetrosis, autosomal recessive 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802255	6	108385420	6	108064216	802255	790573		NC_000006.12:108064215:AAAAAA:AAAAA
NM_006214.4(PHYH):c.235C>T (p.Gln79Ter)	PHYH	Q79*	not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000498045	10	13337506	10	13295506	498045	489469	rs1554785113	NC_000010.11:13295505:G:A
NM_006214.4(PHYH):c.840C>A (p.Cys280Ter)	PHYH	C280*, C182*, C192*, C180*, C282*	not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000379919	10	13323099	10	13281099	379919	371203	rs1057520786	NC_000010.11:13281098:G:T
NM_014028.4(OSTM1):c.783+5G>T	OSTM1		Osteopetrosis, autosomal recessive 5	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488566	6	108372230	6	108051026	488566	481434	rs1554250938	NC_000006.12:108051025:C:A
NM_006214.4(PHYH):c.824G>A (p.Arg275Gln)	PHYH	R275Q, R177Q, R175Q, R277Q, R187Q	Refsum disease, adult, 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000007588	10	13325694	10	13283694	7588	22627	rs104894174	NC_000010.11:13283693:C:T
NM_006214.4(PHYH):c.610G>A (p.Gly204Ser)	PHYH	G204S, G106S, G206S, G104S	Refsum disease, adult, 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000007587	10	13330428	10	13288428	7587	22626	rs104894173	NC_000010.11:13288427:C:T
NM_006214.4(PHYH):c.526C>A (p.Gln176Lys)	PHYH	Q176K, Q178K, Q76K, Q78K	Refsum disease, adult, 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000007586	10	13330512	10	13288512	7586	22625	rs28939672	NC_000010.11:13288511:G:T
PHYH, 3-BP INS, 576GCC	PHYH		Refsum disease, adult, 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000007585					7585	22624		
NM_006214.4(PHYH):c.164del (p.Leu55fs)	PHYH	L55fs	Refsum disease, adult, 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000007583	10	13337577	10	13295577	7583	22622	rs730882058	NC_000010.11:13295576:A:
NM_014028.4(OSTM1):c.36T>A (p.Cys12Ter)	OSTM1	C12*	Osteopetrosis, autosomal recessive 5	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000002944	6	108395820	6	108074616	2944	17983	rs119460973	NC_000006.12:108074615:A:T
NM_014028.4(OSTM1):c.949+5G>A	OSTM1		Osteopetrosis, autosomal recessive 5	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002942	6	108370452	6	108049248	2942	17981	rs1562370077	NC_000006.12:108049247:C:T
NM_001128225.3(SLC39A13):c.221G>A (p.Gly74Asp)	SLC39A13	G74D	Spondylocheirodysplasia, Ehlers-Danlos syndrome-like	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002133	11	47431866	11	47410315	2133	17172	rs121434363	NC_000011.10:47410314:G:A
SLC39A13, 9-BP DEL, NT483	SLC39A13		Spondylocheirodysplasia, Ehlers-Danlos syndrome-like	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000002132					2132	17171		
NM_003730.6(RNASET2):c.567G>A (p.Gln189=)	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000417	6	167344532	6	166931044	417	15456		NC_000006.12:166931043:C:T
NM_003730.6(RNASET2):c.50_64del (p.Ala17_Leu21del)	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000416	6	167369607 - 167369621	6	166956119 - 166956133	416	15455		NC_000006.12:166956118:CCAGGCAAAGCAACGCCAGGCA:CCAGGCA
RNASET2, 1-BP DEL, 332+1G	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000415					415	15454		
RNASET2, IVS5AS, A-G, -2	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000414					414	15453		
RNASET2, 2.5-KB DEL	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000413					413	15452		
NM_003730.6(RNASET2):c.550T>C (p.Cys184Arg)	RNASET2	C184R	Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000412	6	167344549	6	166931061	412	15451	rs121918137	NC_000006.12:166931060:A:G
NM_006214.4(PHYH):c.805A>C (p.Asn269His)	PHYH	N269H, N271H, N171H, N169H, N181H	Refsum disease, adult, 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000007584	10	13325713	10	13283713	7584	22623	rs104894179	NC_000010.11:13283712:T:G
GRCh37/hg19 6q21(chr6:107573260-107767076)x1	PDSS2		not provided	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000685834	6	107573260 - 107767076			685834	673426		
NM_020381.4(PDSS2):c.877-2A>G	PDSS2		not provided	Pathogenic(Last reviewed: Nov 28, 2012)	criteria provided, single submitter	VCV000214994	6	107531776	6	107210572	214994	211195	rs863224166	NC_000006.12:107210571:T:C
NM_000144.5(FXN):c.285T>A (p.Tyr95Ter)	FXN	Y95*	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000585889	9	71668077	9	69053161	585889	577128	rs372775073	NC_000009.12:69053160:T:A
NM_014028.4(OSTM1):c.411_412AG[2] (p.Gln140fs)	OSTM1		Osteopetrosis, autosomal recessive 5|not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000195291	6	108385490 - 108385491	6	108064286 - 108064287	195291	192452	rs794727287	NC_000006.12:108064285:CTCTCT:CTCT
NM_000144.5(FXN):c.438C>G (p.Asn146Lys)	FXN	N146K	Friedreich ataxia 1	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549677	9	71679907	9	69064991	549677	540456	rs146818694	NC_000009.12:69064990:C:G
NM_000144.5(FXN):c.157del (p.Arg53fs)	FXN	R53fs	Friedreich's ataxia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000003985	9	71650852	9	69035936	3985	19024	rs141935559	NC_000009.12:69035935:CCCC:CCC
NM_000144.5(FXN):c.3G>T (p.Met1Ile)	FXN	M1I	Friedreich's ataxia	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000003983	9	71650701	9	69035785	3983	19022	rs104894108	NC_000009.12:69035784:G:T
NM_000144.5(FXN):c.385-2A>G	FXN		Friedreich's ataxia	Pathogenic(Last reviewed: Mar 8, 1996)	no assertion criteria provided	VCV000003980	9	71679852	9	69064936	3980	19019	rs140987490	NC_000009.12:69064935:A:G
NM_000144.5(FXN):c.317T>G (p.Leu106Ter)	FXN	L106*	Friedreich's ataxia	Pathogenic(Last reviewed: Mar 8, 1996)	no assertion criteria provided	VCV000003979	9	71668109	9	69053193	3979	19018	rs104894105	NC_000009.12:69053192:T:G
NM_020381.4(PDSS2):c.1145C>T (p.Ser382Leu)	PDSS2	S382L	Coenzyme Q10 deficiency, primary, 3	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000001201	6	107475878	6	107154674	1201	16240	rs118203956	NC_000006.12:107154673:G:A
NM_006757.4(TNNT3):c.188G>A (p.Arg63His)	TNNT3	R63H, R59H, R61H, R66H, R44H, R55H, R62H, R74H	ARTHROGRYPOSIS, DISTAL, TYPE 2B2|Arthyrgryposis, distal, type 2B|not provided	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008913	11	1954967	11	1933737	8913	23952	rs121434638	NC_000011.10:1933736:G:A
NM_004959.5(NR5A1):c.398del (p.Pro133fs)	NR5A1	P133fs	not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000817998	9	127262841	9	124500562	817998	805596		NC_000009.12:124500561:GGGGG:GGGG
NM_004959.5(NR5A1):c.1172_1208dup (p.Asp403delinsGluArgArgSerGlyGluGlyGlnArgArgProAlaTer)	NR5A1		not provided	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000817717	9	127245214 - 127245215	9	124482935 - 124482936	817717	805595		NC_000009.12:124482935:TCAAGCAGGGCGGCGTTGGCCTTCTCCTGAGCGTCTTTCA:TCAAGCAGGGCGGCGTTGGCCTTCTCCTGAGCGTCTTTCAAGCAGGGCGGCGTTGGCCTTCTCCTGAGCGTCTTTCA
NM_138715.3(MSR1):c.1033+1G>C	MSR1		not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000502674	8	16001066	8	16143557	502674	494097	rs1554466908	NC_000008.11:16143556:C:G
NM_004959.5(NR5A1):c.938G>A (p.Arg313His)	NR5A1	R313H	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000449434	9	127255361	9	124493082	449434	444344	rs1554721235	NC_000009.12:124493081:C:T
NM_004959.5(NR5A1):c.634G>A (p.Gly212Ser)	NR5A1	G212S	Spermatogenic failure 8	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000029895	9	127262605	9	124500326	29895	38850	rs201095702	NC_000009.12:124500325:C:T
NM_004959.5(NR5A1):c.392C>T (p.Pro131Leu)	NR5A1	P131L	Spermatogenic failure 8	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000029894	9	127262847	9	124500568	29894	38849	rs387906690	NC_000009.12:124500567:G:A
NM_138715.3(MSR1):c.760C>G (p.Leu254Val)	MSR1	L254V, L272V	Barrett esophagus/esophageal adenocarcinoma	Pathogenic(Last reviewed: Jul 27, 2011)	no assertion criteria provided	VCV000029779	8	16021631	8	16164122	29779	38734	rs387906645	NC_000008.11:16164121:G:C
NM_004959.5(NR5A1):c.682_690CTGCAGCTG[1] (p.228_230LQL[1])	NR5A1		Premature ovarian failure 7	Pathogenic(Last reviewed: Mar 19, 2009)	no assertion criteria provided	VCV000012808	9	127262540 - 127262548	9	124500261 - 124500269	12808	27847	rs606231208	NC_000009.12:124500260:CAGCTGCAGCAGCTGCAG:CAGCTGCAG
NM_004959.5(NR5A1):c.764G>T (p.Arg255Leu)	NR5A1	R255L	ADRENAL INSUFFICIENCY, NR5A1-RELATED	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000012795	9	127262475	9	124500196	12795	27834	rs104894118	NC_000009.12:124500195:C:A
NM_001040167.2(LFNG):c.372del (p.Lys124fs)	LFNG	K124fs		Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000619140	7	2559867	7	2520233	619140	610535	rs1562551396	NC_000007.14:2520232:G:
NM_001040167.2(LFNG):c.601G>A (p.Asp201Asn)	LFNG	D201N, D72N, D130N		Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000619139	7	2565067	7	2525433	619139	610534	rs1211456697	NC_000007.14:2525432:G:A
NM_004959.5(NR5A1):c.34_38delinsGACCTGGACCTGT (p.Leu12fs)	NR5A1		46,XY sex reversal, type 3	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000436032	9	127265637 - 127265641	9	124503358 - 124503362	436032	428910	rs1554721883	NC_000009.12:124503357:CACAG:ACAGGTCCAGGTC
NM_004959.5(NR5A1):c.1210T>G (p.Tyr404Asp)	NR5A1	Y404D	46,XY sex reversal, type 3	Pathogenic(Last reviewed: May 27, 2014)	criteria provided, single submitter	VCV000216976	9	127245213	9	124482934	216976	213584	rs863224904	NC_000009.12:124482933:A:C
NM_004959.5(NR5A1):c.151G>T (p.Glu51Ter)	NR5A1	E51*	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000216975	9	127265451	9	124503172	216975	213585	rs775441984	NC_000009.12:124503171:C:A
NM_004959.5(NR5A1):c.1310T>A (p.Leu437Gln)	NR5A1	L437Q	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000012803	9	127245113	9	124482834	12803	27842	rs104894120	NC_000009.12:124482833:A:T
NM_004959.5(NR5A1):c.271G>A (p.Gly91Ser)	NR5A1	G91S	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000012802	9	127262968	9	124500689	12802	27841	rs104894126	NC_000009.12:124500688:C:T
NM_004959.5(NR5A1):c.234G>A (p.Met78Ile)	NR5A1	M78I	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000012801	9	127265368	9	124503089	12801	27840	rs104894125	NC_000009.12:124503088:C:T
NM_004959.5(NR5A1):c.43G>A (p.Val15Met)	NR5A1	V15M	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000012800	9	127265632	9	124503353	12800	27839	rs104894124	NC_000009.12:124503352:C:T
NM_004959.5(NR5A1):c.18del (p.Asp6fs)	NR5A1	D6fs	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000012799	9	127265657	9	124503378	12799	27838	rs606231205	NC_000009.12:124503377:G:
NM_004959.5(NR5A1):c.48C>A (p.Cys16Ter)	NR5A1	C16*	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000012798	9	127265627	9	124503348	12798	27837	rs104894123	NC_000009.12:124503347:G:T
NR5A1, 8-BP DEL, NT1058	NR5A1		46,XY sex reversal, type 3	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000012797					12797	27836		
NM_000144.5(FXN):c.371_376delinsTACACCTTGAGGACA (p.Asp124_Ser126delinsValHisLeuGluAspThr)	FXN		Friedreich ataxia 1	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000035514	9	71668163 - 71668168	9	69053247 - 69053252	35514	44191	rs886037630	NC_000009.12:69053246:ATGTCT:TACACCTTGAGGACA
NM_020381.4(PDSS2):c.964C>T (p.Gln322Ter)	PDSS2	Q322*	Coenzyme Q10 deficiency, primary, 3	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000001200	6	107531687	6	107210483	1200	16239	rs118203955	NC_000006.12:107210482:G:A
NC_000009.12:g.(?_124481358)_(124505411_?)del	NR5A1		46,XY sex reversal, type 3|Oligosynaptic infertility	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000833100	9	127243637 - 127267690			833100	820046		
NM_004959.5(NR5A1):c.104_105delinsAA (p.Gly35Glu)	NR5A1	G35E	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Oct 24, 2003)	no assertion criteria provided	VCV000012794	9	127265497 - 127265498	9	124503218 - 124503219	12794	27833	rs121918654	NC_000009.12:124503217:GC:TT
NM_001040167.2(LFNG):c.564C>A (p.Phe188Leu)	LFNG	F188L, F59L, F117L		Pathogenic(Last reviewed: Aug 25, 2009)	no assertion criteria provided	VCV000006999	7	2564935	7	2525301	6999	22038	rs104894024	NC_000007.14:2525300:C:A
NM_004959.5(NR5A1):c.129_131CAA[1] (p.Asn44del)	NR5A1		Oligosynaptic infertility|46,XY sex reversal, type 3	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000851632	9	127265468 - 127265470	9	124503189 - 124503191	851632	835435		NC_000009.12:124503188:TTGTTGTT:TTGTT
NM_004959.5(NR5A1):c.390del (p.Pro131fs)	NR5A1	P131fs	Premature ovarian failure 7|46,XY sex reversal, type 3	Pathogenic(Last reviewed: Mar 19, 2009)	no assertion criteria provided	VCV000012807	9	127262849	9	124500570	12807	27846	rs606231207	NC_000009.12:124500569:C:
NM_004959.5(NR5A1):c.3G>A (p.Met1Ile)	NR5A1	M1I	46,XY sex reversal, type 3|Premature ovarian failure 7	Pathogenic(Last reviewed: Mar 19, 2009)	no assertion criteria provided	VCV000012806	9	127265672	9	124503393	12806	27845	rs121918656	NC_000009.12:124503392:C:T
NM_004959.5(NR5A1):c.877G>A (p.Asp293Asn)	NR5A1	D293N	46,XY sex reversal, type 3|Premature ovarian failure 7	Pathogenic(Last reviewed: Mar 19, 2009)	no assertion criteria provided	VCV000012805	9	127255422	9	124493143	12805	27844	rs121918655	NC_000009.12:124493142:C:T
NM_004959.5(NR5A1):c.666del (p.Asn222fs)	NR5A1	N222fs	46,XY sex reversal, type 3|Premature ovarian failure 7	Pathogenic(Last reviewed: Mar 19, 2009)	no assertion criteria provided	VCV000012804	9	127262573	9	124500294	12804	27843	rs606231206	NC_000009.12:124500293:G:
NM_000197.2(HSD17B3):c.238C>T (p.Arg80Trp)	HSD17B3	R80W	Testosterone 17-beta-dehydrogenase deficiency|Pseudohermaphroditism|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004877	9	99017189	9	96254907	4877	19916	rs119481077	NC_000009.12:96254906:G:A
NM_005515.4(MNX1):c.116_117del (p.Ser39fs)	MNX1	S39fs	not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000817990	7	156802928 - 156802929	7	157010234 - 157010235	817990	805536		NC_000007.14:157010233:AGA:A
NM_005515.4(MNX1):c.325_337del (p.Gly109fs)	MNX1	G109fs	not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452317	7	156802708 - 156802720	7	157010014 - 157010026	452317	444106	rs1554594245	NC_000007.14:157010013:GCCCCCCGTGCCCGCC:GCC
NM_005515.4(MNX1):c.77del (p.Ala26fs)	MNX1	A26fs	not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000449412	7	156802968	7	157010274	449412	444107	rs1554594326	NC_000007.14:157010273:G:
NM_177400.3(NKX6-2):c.608G>A (p.Trp203Ter)	NKX6-2	W203*	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000627619	10	134598646	10	132785142	627619	615970	rs1565019928	NC_000010.11:132785141:C:T
NM_177400.3(NKX6-2):c.606delinsTA (p.Lys202fs)	NKX6-2		SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000627618	10	134598648	10	132785144	627618	615971	rs1565019932	NC_000010.11:132785143:C:TA
NM_177400.3(NKX6-2):c.599G>A (p.Arg200Gln)	NKX6-2	R200Q	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000627617	10	134598655	10	132785151	627617	615972	rs1008088032	NC_000010.11:132785150:C:T
NM_177400.3(NKX6-2):c.589C>T (p.Gln197Ter)	NKX6-2	Q197*	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000627616	10	134598665	10	132785161	627616	615973	rs1565019976	NC_000010.11:132785160:G:A
NM_177400.3(NKX6-2):c.565G>T (p.Glu189Ter)	NKX6-2	E189*	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000627615	10	134598798	10	132785294	627615	615974	rs776560015	NC_000010.11:132785293:C:A
NM_005515.4(MNX1):c.53dup (p.Arg19fs)	MNX1		Currarino triad	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000435883	7	156802991 - 156802992	7	157010297 - 157010298	435883	428696	rs1554594329	NC_000007.14:157010297:GGGGGG:GGGGGGG
MNX1, 24-BP DEL/2-BP INS, NT577	MNX1		Currarino triad	Pathogenic(Last reviewed: Jul 30, 2004)	no assertion criteria provided	VCV000014858					14858	29897		
NM_005515.4(MNX1):c.853-2A>G	MNX1		Currarino triad	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000014855	7	156798569	7	157005875	14855	29894	rs1563700090	NC_000007.14:157005874:T:C
NM_005515.4(MNX1):c.492C>A (p.Tyr164Ter)	MNX1	Y166*, Y164*	Currarino triad	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000014853	7	156802553	7	157009859	14853	29892	rs121912547	NC_000007.14:157009858:G:T
MNX1, 1-BP DEL, 414C	MNX1		Currarino triad	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000014852					14852	29891		
NM_002667.4(PLN):c.-97-?_*1344+?del	PLN		Dilated cardiomyopathy 1P	Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	VCV000239214					239214	239866		
PLN, -36A-C	PLN		Dilated cardiomyopathy 1P	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000029838					29838	38793		
PLN, -42C-G	PLN		Familial hypertrophic cardiomyopathy 18	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000029837					29837	38792		
PLN, -77A-G	PLN		Familial hypertrophic cardiomyopathy 18	Pathogenic(Last reviewed: Apr 25, 2003)	no assertion criteria provided	VCV000029836					29836	38791		
MNX1, 1-BP DEL, 652A	MNX1		Currarino triad	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000014850					14850	29889		
NM_177400.3(NKX6-2):c.487C>G (p.Leu163Val)	NKX6-2	L163V	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Aug 15, 2018)	no assertion criteria provided	VCV000430623	10	134598876	10	132785372	430623	423706	rs1131692048	NC_000010.11:132785371:G:C
MNX1, 1-BP INS, 125C	MNX1		Currarino triad	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000014854					14854	29893		
NM_017635.5(KMT5B):c.658C>T (p.Arg220Ter)	KMT5B	R220*, R197*, R48*, R149*	Inborn genetic diseases	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000521728	11	67939172	11	68171705	521728	511930	rs1555028206	NC_000011.10:68171704:G:A
NM_000144.5(FXN):c.460A>T (p.Ile154Phe)	FXN	I154F	Friedreich's ataxia	Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	VCV000003981	9	71679929	9	69065013	3981	19020	rs104894106	NC_000009.12:69065012:A:T
NM_001031710.3(KLHL7):c.565C>T (p.Arg189Ter)	KLHL7	R141*, R189*	PERCHING syndrome	Pathogenic	no assertion criteria provided	VCV000816804	7	23180510	7	23140891	816804	805009		NC_000007.14:23140890:C:T
NM_016729.3(FOLR1):c.34del (p.Leu12fs)	FOLR1	L12fs	not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000501379	11	71903250	11	72192206	501379	492803	rs1555068629	NC_000011.10:72192205:CC:C
NM_000593.5(TAP1):c.1151C>G (p.Ser384Ter)	TAP1	S123*, S384*	Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000642101	6	32818800	6	32851023	642101	634826		NC_000006.12:32851022:G:C
NM_001292022.2(TAP1):c.961C>T (p.Gln321Ter)	TAP1	Q582*, Q321*	Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000839821	6	32816431	6	32848654	839821	831821		NC_000006.12:32848653:G:A
NM_001031710.3(KLHL7):c.1051C>T (p.Arg351Ter)	KLHL7	R351*, R303*	PERCHING syndrome	Pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000804273	7	23205431	7	23165812	804273	792629		NC_000007.14:23165811:C:T
NM_001031710.3(KLHL7):c.249del (p.Phe83fs)	KLHL7	F35fs, F83fs	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000691635	7	23164330	7	23124711	691635	679354		NC_000007.14:23124710:TTT:TT
NM_016729.3(FOLR1):c.257G>A (p.Trp86Ter)	FOLR1	W86*	Cerebral folate deficiency	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000470723	11	71906403	11	72195359	470723	461455	rs1555069069	NC_000011.10:72195358:G:A
FOLR1, SPLICE SITE MUTATION	FOLR1		Cerebral folate deficiency	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000036930					36930	45590		
FOLR1, 18-BP DUP, NT130	FOLR1		Cerebral folate deficiency	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000016257					16257	31296		
NM_016729.3(FOLR1):c.525C>A (p.Cys175Ter)	FOLR1	C175*	Cerebral folate deficiency	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000016256	11	71906972	11	72195928	16256	31295	rs121918406	NC_000011.10:72195927:C:A
TAP1, IVS1, G-A, -1	TAP1		Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000013732					13732	28771		
NM_177400.3(NKX6-2):c.121A>T (p.Lys41Ter)	NKX6-2	K41*	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000430622	10	134599332	10	132785828	430622	423705	rs1131692047	NC_000010.11:132785827:T:A
NM_006659.3(TUBGCP2):c.2025-2A>G	TUBGCP2		PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES|Abnormality of neuronal migration	Pathogenic(Last reviewed: Jan 17, 2020)	no assertion criteria provided	VCV000691862	10	135097508	10	133284004	691862	679577		NC_000010.11:133284003:T:C
NM_001031710.3(KLHL7):c.457G>A (p.Ala153Thr)	KLHL7	A153T, A105T	Retinitis pigmentosa 42	Pathogenic(Last reviewed: Sep 23, 2011)	no assertion criteria provided	VCV000001010	7	23180402	7	23140783	1010	16049	rs137853114	NC_000007.14:23140782:G:A
NM_001031710.3(KLHL7):c.449G>A (p.Ser150Asn)	KLHL7	S150N, S102N	Retinitis pigmentosa 42	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000001008	7	23180394	7	23140775	1008	16047	rs137853112	NC_000007.14:23140774:G:A
NM_001031710.3(KLHL7):c.1115G>A (p.Arg372Gln)	KLHL7	R372Q, R324Q	PERCHING syndrome|Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000226130	7	23205495	7	23165876	226130	227931	rs879255558	NC_000007.14:23165875:G:A
NM_001031710.3(KLHL7):c.1261T>A (p.Cys421Ser)	KLHL7	C421S, C373S	PERCHING syndrome|Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000226127	7	23207538	7	23167919	226127	227933	rs879255556	NC_000007.14:23167918:T:A
NM_006207.2(PDGFRL):c.67C>T (p.His23Tyr)	PDGFRL	H23Y	Carcinoma of colon	Pathogenic(Last reviewed: Mar 2, 1995)	no assertion criteria provided	VCV000005468	8	17446988	8	17589479	5468	20507	rs137853148	NC_000008.11:17589478:C:T
NM_005142.3(CBLIF):c.79+1G>A	CBLIF		Congenital intrinsic factor deficiency|not specified|not provided|Intrinsic factor deficiency	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439755	11	59612847	11	59845374	439755	433589	rs147785187	NC_000011.10:59845373:C:T
NM_000375.3(UROS):c.311C>T (p.Ala104Val)	UROS	A104V	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065601	10	127500791	10	125812222	65601	76509	rs397515528	NC_000010.11:125812221:G:A
NM_000375.3(UROS):c.139T>C (p.Ser47Pro)	UROS	S47P	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065600	10	127504754	10	125816185	65600	76508	rs397515527	NC_000010.11:125816184:A:G
NM_018444.4(PDP1):c.277G>T (p.Glu93Ter)	PDP1	E93*, E118*	Pyruvate dehydrogenase phosphatase deficiency	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000004664	8	94934564	8	93922336	4664	19703	rs267606938	NC_000008.11:93922335:G:T
NM_018444.4(PDP1):c.851_853del (p.Leu284del)	PDP1	L284del, L309del	Pyruvate dehydrogenase phosphatase deficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000004663	8	94935137 - 94935139	8	93922909 - 93922911	4663	19702	rs1554572756	NC_000008.11:93922908:CTTC:C
NM_000375.3(UROS):c.184A>G (p.Thr62Ala)	UROS	T62A	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: May 29, 2019)	no assertion criteria provided	VCV000003753	10	127503663	10	125815094	3753	18792	rs28941775	NC_000010.11:125815093:T:C
NM_000375.3(UROS):c.56A>G (p.Tyr19Cys)	UROS	Y19C	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000694740	10	127505013	10	125816444	694740	682859		NC_000010.11:125816443:T:C
NM_000375.3(UROS):c.661-31T>G	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Feb 4, 2010)	no assertion criteria provided	VCV000030626	10	127477605	10	125789036	30626	39583		NC_000010.11:125789035:A:C
NM_001127666.2(GSN):c.520G>T (p.Asp174Tyr)	GSN	D187Y, D174Y, D214Y, D163Y, D171Y, D180Y, D199Y	Meretoja syndrome	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000016181	9	124073097	9	121310819	16181	31220	rs121909715	NC_000009.12:121310818:G:T
NM_000375.3(UROS):c.743C>A (p.Pro248Gln)	UROS	P248Q, P221Q, P275Q	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000003769	10	127477492	10	125788923	3769	18808	rs121908021	NC_000010.11:125788922:G:T
NM_000375.3(UROS):c.395-1dup	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000003768	10	127486711 - 127486712	10	125798142 - 125798143	3768	18807	rs796051859	NC_000010.11:125798142:CCCC:CCCCC
NM_000375.3(UROS):c.562G>T (p.Gly188Trp)	UROS	G188W, G161W	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003761	10	127483547	10	125794978	3761	18800	rs121908017	NC_000010.11:125794977:C:A
NM_000375.3(UROS):c.243A>T (p.Glu81Asp)	UROS	E81D	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003760	10	127503604	10	125815035	3760	18799	rs121908018	NC_000010.11:125815034:T:A
NM_000375.3(UROS):c.562G>A (p.Gly188Arg)	UROS	G188R, G161R	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000003759	10	127483547	10	125794978	3759	18798	rs121908017	NC_000010.11:125794977:C:T
UROS, 80-BP INS	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000003757					3757	18796		
NM_000375.2(UROS):c.148_244del (p.Leu50Serfs)	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000003756					3756	18795		
NM_000375.3(UROS):c.10C>T (p.Leu4Phe)	UROS	L4F	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000003755	10	127505059	10	125816490	3755	18794	rs121908015	NC_000010.11:125816489:G:A
NM_000375.3(UROS):c.683C>T (p.Thr228Met)	UROS	T228M, T201M, T255M	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000003754	10	127477552	10	125788983	3754	18793	rs121908014	NC_000010.11:125788982:G:A
NM_000375.3(UROS):c.158C>T (p.Pro53Leu)	UROS	P53L	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: May 1, 1990)	no assertion criteria provided	VCV000003751	10	127503689	10	125815120	3751	18790	rs121908013	NC_000010.11:125815119:G:A
NM_000144.5(FXN):c.317T>C (p.Leu106Ser)	FXN	L106S	not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000585891	9	71668109	9	69053193	585891	577130	rs104894105	NC_000009.12:69053192:T:C
NM_000375.3(UROS):c.63+1G>A	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000003767	10	127505005	10	125816436	3767	18806	rs373864821	NC_000010.11:125816435:C:T
NM_000375.3(UROS):c.673G>A (p.Gly225Ser)	UROS	G225S, G198S, G252S	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000003766	10	127477562	10	125788993	3766	18805	rs121908020	NC_000010.11:125788992:C:T
NM_000375.3(UROS):c.-26-193C>A	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000003764	10	127505287	10	125816718	3764	18803	rs397515350	NC_000010.11:125816717:G:T
NM_000375.3(UROS):c.197C>T (p.Ala66Val)	UROS	A66V	Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000003752	10	127503650	10	125815081	3752	18791	rs28941774	NC_000010.11:125815080:G:A
NM_001031710.3(KLHL7):c.1022del (p.Leu341fs)	KLHL7	L293fs, L341fs	PERCHING syndrome|Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000226129	7	23205399	7	23165780	226129	227930	rs879255557	NC_000007.14:23165779:TTTT:TTT
NM_001031710.3(KLHL7):c.1258C>T (p.Arg420Cys)	KLHL7	R420C, R372C	PERCHING syndrome|Cold-induced sweating syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000226128	7	23207535	7	23167916	226128	227932	rs780705654	NC_000007.14:23167915:C:T
NM_000375.3(UROS):c.-26-197C>A	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Apr 7, 2016)	no assertion criteria provided	VCV000003765	10	127505291	10	125816722	3765	18804	rs397515351	NC_000010.11:125816721:G:T
NM_000375.3(UROS):c.-26-183G>A	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Apr 7, 2016)	no assertion criteria provided	VCV000003763	10	127505277	10	125816708	3763	18802	rs397515349	NC_000010.11:125816707:C:T
NM_000375.3(UROS):c.-203T>C	UROS		Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Apr 7, 2016)	no assertion criteria provided	VCV000003762	10	127511774	10	125823205	3762	18801	rs397515348	NC_000010.11:125823204:A:G
NM_000474.4(TWIST1):c.309C>G (p.Tyr103Ter)	TWIST1	Y103*	Craniosynostosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802300	7	19156636	7	19117013	802300	790715		NC_000007.14:19117012:G:C
NM_000474.4(TWIST1):c.362C>T (p.Thr121Ile)	TWIST1	T121I	TWIST1-related disorder	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800915	7	19156583	7	19116960	800915	788814		NC_000007.14:19116959:G:A
NM_001145308.4(LRTOMT):c.358+1G>A	LRTOMT		not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000596783	11	71817257	11	72106211	596783	587844	rs1565330066	NC_000011.10:72106210:G:A
NM_000474.4(TWIST1):c.419C>A (p.Ser140Ter)	TWIST1	S140*	not provided	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000489149	7	19156526	7	19116903	489149	481785	rs1554441987	NC_000007.14:19116902:G:T
NM_152416.4(NDUFAF6):c.420+2dup	NDUFAF6		not provided	Pathogenic(Last reviewed: Apr 27, 2012)	criteria provided, single submitter	VCV000214214	8	96047805 - 96047806	8	95035577 - 95035578	214214	211344	rs1554669910	NC_000008.11:95035577:T:TT
NM_000474.4(TWIST1):c.350A>G (p.Glu117Gly)	TWIST1	E117G	SWEENEY-COX SYNDROME	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444876	7	19156595	7	19116972	444876	438517	rs1554442016	NC_000007.14:19116971:T:C
NM_152416.4(NDUFAF6):c.820A>G (p.Arg274Gly)	NDUFAF6	R274G, R122G, R163G, R182G, R222G	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000372259	8	96064405	8	95052177	372259	359164	rs1057519086	NC_000008.11:95052176:A:G
NM_152416.4(NDUFAF6):c.206A>T (p.Asp69Val)	NDUFAF6	D69V, D17V	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000372258	8	96044231	8	95032003	372258	359163	rs1057519085	NC_000008.11:95032002:A:T
NM_152416.4(NDUFAF6):c.226T>C (p.Ser76Pro)	NDUFAF6	S76P, S24P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000372256	8	96044251	8	95032023	372256	359161	rs1057519084	NC_000008.11:95032022:T:C
NM_152416.4(NDUFAF6):c.805C>G (p.His269Asp)	NDUFAF6	H269D, H217D, H158D, H177D, H117D	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000372255	8	96060775	8	95048547	372255	359160	rs768273248	NC_000008.11:95048546:C:G
NM_152416.4(NDUFAF6):c.532G>C (p.Ala178Pro)	NDUFAF6	A178P, A126P, A67P, A86P, A26P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000372254	8	96057827	8	95045599	372254	359159	rs201088736	NC_000008.11:95045598:G:C
NM_000474.4(TWIST1):c.563C>T (p.Ser188Leu)	TWIST1	S188L	Craniosynostosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007986	7	19156382	7	19116759	7986	23025	rs121909191	NC_000007.14:19116758:G:A
NM_000474.4(TWIST1):c.556G>A (p.Ala186Thr)	TWIST1	A186T	Craniosynostosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007985	7	19156389	7	19116766	7985	23024	rs121909190	NC_000007.14:19116765:C:T
NM_000474.4(TWIST1):c.397A>T (p.Lys133Ter)	TWIST1	K133*	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Aug 21, 2019)	no assertion criteria provided	VCV000827827	7	19156548	7	19116925	827827	815986		NC_000007.14:19116924:T:A
NM_000474.4(TWIST1):c.277dup (p.Ser93fs)	TWIST1		Craniosynostosis 1|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000648741	7	19156667 - 19156668	7	19117044 - 19117045	648741	635974		NC_000007.14:19117044:T:TT
NM_000474.4(TWIST1):c.197del (p.Pro66fs)	TWIST1	P66fs	Saethre-Chotzen syndrome|Craniosynostosis 1	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000645450	7	19156748	7	19117125	645450	635975		NC_000007.14:19117124:GG:G
NM_000474.4(TWIST1):c.68_75dup (p.Arg26fs)	TWIST1		Craniosynostosis 1|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000642695	7	19156869 - 19156870	7	19117246 - 19117247	642695	635976		NC_000007.14:19117246:GTCTGGCT:GTCTGGCTGTCTGGCT
NM_000474.4(TWIST1):c.90_111del (p.Lys33fs)	TWIST1	K33fs	Craniosynostosis 1|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000573378	7	19156834 - 19156855	7	19117211 - 19117232	573378	566659	rs1563160337	NC_000007.14:19117210:GCGTCCCCCGCGCTTGCCGCTCG:G
NM_000474.4(TWIST1):c.398_418dup (p.Ser140Ter)	TWIST1		Craniosynostosis 1|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000567420	7	19156526 - 19156527	7	19116903 - 19116904	567420	566649	rs1563159980	NC_000007.14:19116903:AGGGCAGCGTGGGGATGATCT:AGGGCAGCGTGGGGATGATCTAGGGCAGCGTGGGGATGATCT
NM_000474.4(TWIST1):c.397_417dup (p.Lys133_Pro139dup)	TWIST1		Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000458686	7	19156527 - 19156528	7	19116904 - 19116905	458686	457165	rs1554441989	NC_000007.14:19116904:GGGCAGCGTGGGGATGATCTT:GGGCAGCGTGGGGATGATCTTGGGCAGCGTGGGGATGATCTT
NM_000474.4(TWIST1):c.350A>T (p.Glu117Val)	TWIST1	E117V	SWEENEY-COX SYNDROME	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444875	7	19156595	7	19116972	444875	438516	rs1554442016	NC_000007.14:19116971:T:A
NM_000474.4(TWIST1):c.466A>G (p.Ile156Val)	TWIST1	I156V	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Dec 15, 2001)	no assertion criteria provided	VCV000007982	7	19156479	7	19116856	7982	23021	rs104894059	NC_000007.14:19116855:T:C
NM_000474.4(TWIST1):c.460dup (p.Arg154fs)	TWIST1			Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000007981	7	19156484 - 19156485	7	19116861 - 19116862	7981	23020		NC_000007.14:19116861:T:TT
NM_000474.4(TWIST1):c.541G>T (p.Glu181Ter)	TWIST1	E181*	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jan 15, 1999)	no assertion criteria provided	VCV000007980	7	19156404	7	19116781	7980	23019	rs104894058	NC_000007.14:19116780:C:A
NM_000474.4(TWIST1):c.392T>C (p.Leu131Pro)	TWIST1	L135P, L131P	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000007978	7	19156553	7	19116930	7978	23017	rs121909189	NC_000007.14:19116929:A:G
NM_000474.4(TWIST1):c.368C>A (p.Ser123Ter)	TWIST1	S127*, S123*	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000007976	7	19156577	7	19116954	7976	23015	rs121909187	NC_000007.14:19116953:G:T
NM_000474.4(TWIST1):c.309C>A (p.Tyr103Ter)	TWIST1	Y107*, Y103*	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000007975	7	19156636	7	19117013	7975	23014	rs104894054	NC_000007.14:19117012:G:T
NM_000474.4(TWIST1):c.356A>C (p.Gln119Pro)	TWIST1	Q119P	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007974	7	19156589	7	19116966	7974	23013	rs104894057	NC_000007.14:19116965:T:G
NM_000474.4(TWIST1):c.308dup (p.Tyr103Ter)	TWIST1	Y103*	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007973	7	19156636 - 19156637	7	19117013 - 19117014	7973	23012	rs121909186	NC_000007.14:19117013:T:TT
NM_152416.4(NDUFAF6):c.296A>G (p.Gln99Arg)	NDUFAF6	Q99R, R6G, Q47R	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Pathogenic(Last reviewed: Jul 11, 2008)	no assertion criteria provided	VCV000000547	8	96044321	8	95032093	547	15586	rs137853184	NC_000008.11:95032092:A:G
NM_001145308.4(LRTOMT):c.333C>G (p.Tyr111Ter)	LRTOMT	Y71*, Y111*	Deafness, autosomal recessive 63	Pathogenic(Last reviewed: Sep 23, 2008)	no assertion criteria provided	VCV000000546	11	71817231	11	72106185	546	15585	rs137853188	NC_000011.10:72106184:C:G
NM_001145308.4(LRTOMT):c.328G>A (p.Glu110Lys)	LRTOMT	E110K, E70K	Deafness, autosomal recessive 63	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000545	11	71817226	11	72106180	545	15584	rs137853187	NC_000011.10:72106179:G:A
NM_001145308.4(LRTOMT):c.313T>C (p.Trp105Arg)	LRTOMT	W105R, W65R	Deafness, autosomal recessive 63	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000544	11	71817211	11	72106165	544	15583	rs137853186	NC_000011.10:72106164:T:C
NM_000474.4(TWIST1):c.306_307del (p.Tyr103fs)	TWIST1	Y103fs	Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000691563	7	19156638 - 19156639	7	19117015 - 19117016	691563	679249		NC_000007.14:19117014:AA:
NM_000474.4(TWIST1):c.82C>T (p.Gln28Ter)	TWIST1	Q28*	Saethre-Chotzen syndrome with eyelid anomalies	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000007983	7	19156863	7	19117240	7983	23022	rs104894055	NC_000007.14:19117239:G:A
TWIST1, 21-BP DUP	TWIST1		Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000007979					7979	23018		
NM_001031710.3(KLHL7):c.976C>T (p.Arg326Ter)	KLHL7	R326*, R278*	PERCHING syndrome|Bohring-Opitz-like syndrome|not provided|PERCHING syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279824	7	23205356	7	23165737	279824	264323	rs77078070	NC_000007.14:23165736:C:T
NM_000474.4(TWIST1):c.301C>T (p.Gln101Ter)	TWIST1	Q101*	Craniosynostosis 1|Saethre-Chotzen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000575739	7	19156644	7	19117021	575739	561768	rs1563160116	NC_000007.14:19117020:G:A
NM_000474.4(TWIST1):c.132_142del (p.Ser45fs)	TWIST1	S45fs	Craniosynostosis 1|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000543077	7	19156803 - 19156813	7	19117180 - 19117190	543077	522830	rs1554442082	NC_000007.14:19117179:CGCCCGCGCTGCGCC:CGCC
NM_017649.5(CNNM2):c.1069G>A (p.Glu357Lys)	CNNM2	E357K	Hypomagnesemia, seizures, and mental retardation 1	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000192324	10	104679306	10	102919549	192324	190116	rs786205910	NC_000010.11:102919548:G:A
NM_017649.5(CNNM2):c.1703C>T (p.Thr568Ile)	CNNM2	T568I	Hypomagnesemia 6, renal	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000030684	10	104809545	10	103049788	30684	39641	rs387906975	NC_000010.11:103049787:C:T
NM_017649.5(CNNM2):c.117del (p.Ile40fs)	CNNM2	I40fs	Hypomagnesemia 6, renal	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000030683	10	104678350	10	102918593	30683	39640	rs1564803221	NC_000010.11:102918592:GGGGG:GGGG
NM_017649.5(CNNM2):c.364G>A (p.Glu122Lys)	CNNM2	E122K	Hypomagnesemia, seizures, and mental retardation 1	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000192323	10	104678601	10	102918844	192323	190115	rs786205909	NC_000010.11:102918843:G:A
NM_022726.4(ELOVL4):c.790_794del (p.Asn264fs)	ELOVL4	N264fs	not provided|Stargardt Disease 3|Retinal dystrophy	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004939	6	80626476 - 80626480	6	79916759 - 79916763	4939	19978	rs1131690770	NC_000006.12:79916758:AAGTTAAG:AAG
NM_000474.4(TWIST1):c.358C>T (p.Arg120Cys)	TWIST1	R120C	Saethre-Chotzen syndrome|Craniosynostosis 1	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000652940	7	19156587	7	19116964	652940	635972		NC_000007.14:19116963:G:A
NM_000474.4(TWIST1):c.395G>C (p.Arg132Pro)	TWIST1	R132P	Saethre-Chotzen syndrome|Craniosynostosis 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000476634	7	19156550	7	19116927	476634	456538	rs1554441995	NC_000007.14:19116926:C:G
NC_000007.13:g.(?_19156316)_(19156964_?)del	TWIST1		Saethre-Chotzen syndrome|Craniosynostosis 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000458685			7	19116693 - 19117341	458685	456820		
NM_001012393.3(OPCML):c.263C>G (p.Pro88Arg)	OPCML	P95R, P88R, P54R	Neoplasm of ovary	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000008983	11	132527098	11	132657203	8983	24022	rs137852691	NC_000011.10:132657202:G:C
NM_000207.2(INS):c.-187_-164del	INS		Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000431441	11	2182544 - 2182567	11	2161314 - 2161337	431441	424960	rs1135401727	NC_000011.10:2161313:AGATGGCTGGGGGCTGAGGCTGCAA:A
NM_020680.4(SCYL1):c.2066_2067del (p.Pro689fs)	SCYL1	P689fs, P672fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000521096	11	65305472 - 65305473	11	65538001 - 65538002	521096	511920	rs759830598	NC_000011.10:65538000:CA:
NM_000207.2(INS):c.-152C>A	INS		Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000431442	11	2182532	11	2161302	431442	424959	rs748749585	NC_000011.10:2161301:G:T
NM_004959.5(NR5A1):c.275G>A (p.Arg92Gln)	NR5A1	R92Q	46,XY sex reversal, type 3|46,XX sex reversal 4|ADRENAL INSUFFICIENCY, NR5A1-RELATED	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000012796	9	127262964	9	124500685	12796	27835	rs104894119	NC_000009.12:124500684:C:T
NM_000165.5(GJA1):c.917G>A (p.Ser306Asn)	GJA1	S306N	Syndactyly, type V	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000829870	6	121768910	6	121447764	829870	818241		NC_000006.12:121447763:G:A
NM_000165.5(GJA1):c.389T>C (p.Ile130Thr)	GJA1	I130T	Oculodentodigital dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000470215	6	121768382	6	121447236	470215	456047	rs1554201017	NC_000006.12:121447235:T:C
NM_000165.5(GJA1):c.646G>T (p.Val216Leu)	GJA1	V216L	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000435325	6	121768639	6	121447493	435325	428502	rs1554201043	NC_000006.12:121447492:G:T
NM_000165.5(GJA1):c.119C>T (p.Ala40Val)	GJA1	A40V	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000435323	6	121768112	6	121446966	435323	428500	rs1554200992	NC_000006.12:121446965:C:T
NM_000165.5(GJA1):c.23G>T (p.Gly8Val)	GJA1	G8V	Alopecia congenita keratosis palmoplantaris	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000203467	6	121768016	6	121446870	203467	199878	rs864309644	NC_000006.12:121446869:G:T
NM_000165.5(GJA1):c.617A>G (p.Lys206Arg)	GJA1	K206R	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000088726	6	121768610	6	121447464	88726	94303	rs397518464	NC_000006.12:121447463:A:G
GJA1, 12-BP DEL, NT120	GJA1		Oculodentodigital dysplasia	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029667					29667	38622		
NM_000165.5(GJA1):c.97C>T (p.Arg33Ter)	GJA1	R33*	Oculodentodigital dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000016995	6	121768090	6	121446944	16995	32034	rs121912970	NC_000006.12:121446943:C:T
NM_000165.5(GJA1):c.32T>C (p.Leu11Pro)	GJA1	L11P	Oculodentodigital dysplasia	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000016993	6	121768025	6	121446879	16993	32032	rs121912969	NC_000006.12:121446878:T:C
NM_000165.5(GJA1):c.778_779TG[1] (p.Cys260fs)	GJA1		Oculodentodigital dysplasia	Pathogenic(Last reviewed: Jan 15, 2005)	no assertion criteria provided	VCV000016989	6	121768771 - 121768772	6	121447625 - 121447626	16989	32028		NC_000006.12:121447624:TGTG:TG
NM_000165.5(GJA1):c.286G>A (p.Val96Met)	GJA1	V96M	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000016988	6	121768279	6	121447133	16988	32027	rs28931601	NC_000006.12:121447132:G:A
NM_000165.5(GJA1):c.61G>A (p.Gly21Arg)	GJA1	G21R	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000016984	6	121768054	6	121446908	16984	32023	rs104893963	NC_000006.12:121446907:G:A
NM_000165.5(GJA1):c.306G>C (p.Lys102Asn)	GJA1	K102N	Oculodentodigital dysplasia, autosomal recessive	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000537755	6	121768299	6	121447153	537755	521976	rs1554201011	NC_000006.12:121447152:G:C
NM_000165.5(GJA1):c.440T>C (p.Met147Thr)	GJA1	M147T	Cutaneous finger syndactyly|Anteverted nares|Bilateral microphthalmos|Intellectual disability	Pathogenic(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	VCV000374068	6	121768433	6	121447287	374068	360871	rs1057518872	NC_000006.12:121447286:T:C
NM_000165.5(GJA1):c.131C>T (p.Ala44Val)	GJA1	A44V	Erythrokeratodermia variabilis et progressiva 3	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000203469	6	121768124	6	121446978	203469	199880	rs794729675	NC_000006.12:121446977:C:T
NM_000165.5(GJA1):c.31C>T (p.Leu11Phe)	GJA1	L11F	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029668	6	121768024	6	121446878	29668	38623	rs387906616	NC_000006.12:121446877:C:T
NM_000165.5(GJA1):c.227G>A (p.Arg76His)	GJA1	R76H	Oculodentodigital dysplasia, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000016996	6	121768220	6	121447074	16996	32035	rs267606844	NC_000006.12:121447073:G:A
NM_000165.5(GJA1):c.689_690del (p.Tyr230fs)	GJA1	Y230fs	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Feb 15, 2007)	no assertion criteria provided	VCV000016994	6	121768681 - 121768682	6	121447535 - 121447536	16994	32033		NC_000006.12:121447534:TAT:T
NM_000165.5(GJA1):c.581A>C (p.His194Pro)	GJA1	H194P	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Feb 15, 2005)	no assertion criteria provided	VCV000016992	6	121768574	6	121447428	16992	32031	rs104893966	NC_000006.12:121447427:A:C
NM_000165.5(GJA1):c.427G>A (p.Gly143Ser)	GJA1	G143S	Syndactyly type 3	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000016987	6	121768420	6	121447274	16987	32026	rs28931600	NC_000006.12:121447273:G:A
NM_000165.5(GJA1):c.52T>C (p.Ser18Pro)	GJA1	S18P	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000016983	6	121768045	6	121446899	16983	32022	rs104893962	NC_000006.12:121446898:T:C
NM_000165.5(GJA1):c.50A>C (p.Tyr17Ser)	GJA1	Y17S	Oculodentodigital dysplasia	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000016982	6	121768043	6	121446897	16982	32021	rs104893961	NC_000006.12:121446896:A:C
NM_000165.5(GJA1):c.64G>A (p.Gly22Arg)	GJA1	G22R	Oculodentodigital dysplasia, autosomal recessive	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000844190	6	121768057	6	121446911	844190	831472		NC_000006.12:121446910:G:A
NM_000165.5(GJA1):c.140A>T (p.Asp47Val)	GJA1	D47V	Oculodentodigital dysplasia, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000470213	6	121768133	6	121446987	470213	455825	rs1554200995	NC_000006.12:121446986:A:T
NM_000165.5(GJA1):c.154_156dup (p.Phe52dup)	GJA1		Oculodentodigital dysplasia	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000016986	6	121768146 - 121768147	6	121447000 - 121447001	16986	32025		NC_000006.12:121447000:TTT:TTTTTT
NM_138425.4(C12orf57):c.182del (p.Ile61fs)	C12orf57	I48fs, I61fs, I26fs	Temtamy syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802816	12	7053768	12	6944605	802816	791273		NC_000012.12:6944604:T:
NC_000012.11:g.(?_7053265)_(7055105_?)del	C12orf57		Temtamy syndrome	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000583666	12	7053265 - 7055105			583666	564991		
NM_138425.4(C12orf57):c.152T>A (p.Leu51Gln)	C12orf57	L51Q, L16Q, L38Q	Temtamy syndrome	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000041943	12	7053738	12	6944575	41943	51109	rs587776955	NC_000012.12:6944574:T:A
NM_001365308.1(BMPER):c.1638T>A (p.Cys546Ter)	BMPER	C546*	Diaphanospondylodysostosis	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000030746	7	34125597	7	34085985	30746	39703	rs387906994	NC_000007.14:34085984:T:A
NM_001365308.1(BMPER):c.1109C>T (p.Pro370Leu)	BMPER	P370L	Diaphanospondylodysostosis	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000030745	7	34118499	7	34078887	30745	39702	rs387906993	NC_000007.14:34078886:C:T
BMPER, IVS11DS, G-A, +5	BMPER		Diaphanospondylodysostosis	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000030744					30744	39701		
BMPER, 10-BP DEL/14-BP INS, NT26	BMPER		Diaphanospondylodysostosis	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000030743					30743	39700		
NM_001365308.1(BMPER):c.925C>T (p.Gln309Ter)	BMPER	Q309*	Diaphanospondylodysostosis	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000030742	7	34094913	7	34055301	30742	39699	rs387906992	NC_000007.14:34055300:C:T
NM_138425.4(C12orf57):c.161_162del (p.Val54fs)	C12orf57	V19fs, V41fs, V54fs	Temtamy syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000662818	12	7053746 - 7053747	12	6944583 - 6944584	662818	641374		NC_000012.12:6944582:GTG:G
NM_001365308.1(BMPER):c.410T>A (p.Val137Asp)	BMPER	V137D	Diaphanospondylodysostosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	no assertion criteria provided	VCV000559441	7	34009948	7	33970336	559441	550165	rs1554300601	NC_000007.14:33970335:T:A
NM_138425.4(C12orf57):c.53-2A>G	C12orf57		Renal atrophy|Intellectual disability|Hydronephrosis|Vesicoureteral reflux|Attention deficit hyperactivity disorder|Global developmental delay|Temtamy syndrome	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000242885	12	7053637	12	6944474	242885	243991	rs1114167293	NC_000012.12:6944473:A:G
NM_002072.5(GNAQ):c.626A>C (p.Gln209Pro)	GNAQ	Q209P	Susceptibility to uveal melanoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375957	9	80409488	9	77794572	375957	362836	rs121913492	NC_000009.12:77794571:T:G
NM_002072.5(GNAQ):c.626A>T (p.Gln209Leu)	GNAQ	Q209L	Cutaneous melanoma|Susceptibility to uveal melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375955	9	80409488	9	77794572	375955	362834	rs121913492	NC_000009.12:77794571:T:A
NM_001145308.4(LRTOMT):c.242G>A (p.Arg81Gln)	LRTOMT	R81Q, R41Q	Deafness, autosomal recessive 63|Rare genetic deafness	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000000543	11	71817140	11	72106094	543	15582	rs137853185	NC_000011.10:72106093:G:A
NM_138425.4(C12orf57):c.43C>T (p.Gln15Ter)	C12orf57	Q15*	Temtamy syndrome|not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620193	12	7053327	12	6944164	620193	611776	rs1565574197	NC_000012.12:6944163:C:T
NM_032801.5(JAM3):c.1A>G (p.Met1Val)	JAM3	M1V	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000827781	11	133938979	11	134069084	827781	815993		NC_000011.10:134069083:A:G
NM_182548.4(LHFPL5):c.452G>T (p.Gly151Val)	LHFPL5	G151V	Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562086	6	35782362	6	35814585	562086	553258	rs762876554	NC_000006.12:35814584:G:T
NM_013352.4(DSE):c.799A>G (p.Arg267Gly)	DSE	R267G, R80G, R286G	Ehlers-Danlos syndrome, musculocontractural type 2	Pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000446171	6	116752245	6	116431082	446171	439518	rs1554227382	NC_000006.12:116431081:A:G
NM_182548.4(LHFPL5):c.1A>G (p.Met1Val)	LHFPL5	M1V	Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402282	6	35773448	6	35805671	402282	389224	rs1060499810	NC_000006.12:35805670:A:G
NM_013352.4(DSE):c.803C>T (p.Ser268Leu)	DSE	S268L, S81L, S287L	Ehlers-Danlos syndrome, musculocontractural type 2	Pathogenic(Last reviewed: Sep 15, 2013)	no assertion criteria provided	VCV000088848	6	116752249	6	116431086	88848	94417	rs398122361	NC_000006.12:116431085:C:T
NM_032801.5(JAM3):c.2T>G (p.Met1Arg)	JAM3	M1R	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000041883	11	133938980	11	134069085	41883	50321	rs397514678	NC_000011.10:134069084:T:G
NM_032801.5(JAM3):c.346G>A (p.Glu116Lys)	JAM3	E116K	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000041882	11	134014225	11	134144330	41882	50320	rs397515439	NC_000011.10:134144329:G:A
NM_032801.5(JAM3):c.656G>A (p.Cys219Tyr)	JAM3	C219Y, C168Y	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000041881	11	134015884	11	134145989	41881	50319	rs397515438	NC_000011.10:134145988:G:A
NM_032801.5(JAM3):c.612+1G>T	JAM3		Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030607	11	134014890	11	134144995	30607	39564		NC_000011.10:134144994:G:T
NM_182548.4(LHFPL5):c.575T>C (p.Leu192Pro)	LHFPL5	L192P	Autosomal recessive non-syndromic intellectual disability|Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Feb 12, 2017)	criteria provided, single submitter	VCV000375705	6	35782485	6	35814708	375705	362595	rs1554147220	NC_000006.12:35814707:T:C
NM_182548.4(LHFPL5):c.494C>T (p.Thr165Met)	LHFPL5	T165M	Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001697	6	35782404	6	35814627	1697	16736	rs104893976	NC_000006.12:35814626:C:T
NM_182548.4(LHFPL5):c.649+1del	LHFPL5		Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001696	6	35782559	6	35814782	1696	16735		NC_000006.12:35814781:GG:G
NM_182548.4(LHFPL5):c.380A>G (p.Tyr127Cys)	LHFPL5	Y127C	Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000001695	6	35773827	6	35806050	1695	16734	rs104893975	NC_000006.12:35806049:A:G
NM_182548.4(LHFPL5):c.250del (p.Pro83_Leu84insTer)	LHFPL5		Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000001694	6	35773693	6	35805916	1694	16733		NC_000006.12:35805915:CCCCC:CCCC
NM_014797.2(ZBTB24):c.1492_1493del (p.Gln498fs)	ZBTB24	Q498fs	not provided	Pathogenic(Last reviewed: Aug 29, 2015)	criteria provided, single submitter	VCV000429892	6	109787655 - 109787656	6	109466452 - 109466453	429892	421563	rs1131691654	NC_000006.12:109466451:TGT:T
NM_014797.2(ZBTB24):c.1192C>T (p.Arg398Ter)	ZBTB24	R398*	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000650017	6	109797390	6	109476187	650017	634469		NC_000006.12:109476186:G:A
NM_000102.4(CYP17A1):c.1162A>T (p.Lys388Ter)	CYP17A1	K388*	Deficiency of steroid 17-alpha-monooxygenase	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000417889	10	104591346	10	102831589	417889	404785	rs1060499582	NC_000010.11:102831588:T:A
NM_014797.2(ZBTB24):c.396_397del (p.His132fs)	ZBTB24	H132fs	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000040181	6	109802833 - 109802834	6	109481630 - 109481631	40181	48678		NC_000006.12:109481629:TAT:T
NM_014797.2(ZBTB24):c.1369C>T (p.Arg457Ter)	ZBTB24	R457*	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031097	6	109788857	6	109467654	31097	40054	rs387907106	NC_000006.12:109467653:G:A
NM_014797.2(ZBTB24):c.1222T>G (p.Cys408Gly)	ZBTB24	C408G	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031096	6	109796668	6	109475465	31096	40053	rs387907105	NC_000006.12:109475464:A:C
NM_014797.2(ZBTB24):c.833C>G (p.Ser278Ter)	ZBTB24	S278*	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031095	6	109802397	6	109481194	31095	40052		NC_000006.12:109481193:G:C
NM_014797.2(ZBTB24):c.958C>T (p.Arg320Ter)	ZBTB24	R320*	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031093	6	109798128	6	109476925	31093	40050	rs387907104	NC_000006.12:109476924:G:A
CYP17A1, IVS3AS, 4-BP DEL	CYP17A1		Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000001808					1808	16847		
NM_000102.4(CYP17A1):c.437-2A>C	CYP17A1		Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000001807	10	104594773	10	102835016	1807	16846	rs1395913655	NC_000010.11:102835015:T:G
NM_000102.4(CYP17A1):c.1358T>C (p.Phe453Ser)	CYP17A1	F453S	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000001806	10	104590628	10	102830871	1806	16845	rs104894151	NC_000010.11:102830870:A:G
CYP17A1, 9-BP DEL	CYP17A1		Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000001805					1805	16844		
NM_000102.4(CYP17A1):c.374G>A (p.Arg125Gln)	CYP17A1	R125Q	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000001803	10	104595073	10	102835316	1803	16842	rs104894154	NC_000010.11:102835315:C:T
NM_000102.4(CYP17A1):c.81C>A (p.Tyr27Ter)	CYP17A1	Y27*	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000001801	10	104597038	10	102837281	1801	16840	rs104894152	NC_000010.11:102837280:G:T
NM_000102.4(CYP17A1):c.601T>A (p.Tyr201Asn)	CYP17A1	Y201N	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000001800	10	104594607	10	102834850	1800	16839	rs104894150	NC_000010.11:102834849:A:T
NM_000102.4(CYP17A1):c.1283C>T (p.Pro428Leu)	CYP17A1	P428L	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000001799	10	104590703	10	102830946	1799	16838	rs104894145	NC_000010.11:102830945:G:A
NM_000102.4(CYP17A1):c.985T>G (p.Tyr329Asp)	CYP17A1	Y329D	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000001798	10	104592422	10	102832665	1798	16837	rs104894144	NC_000010.11:102832664:A:C
NM_000102.4(CYP17A1):c.206_230del (p.Gly69fs)	CYP17A1	G69fs	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000001795	10	104596889 - 104596913	10	102837132 - 102837156	1795	16834	rs786205062	NC_000010.11:102837131:CCGACAATCACTGTAGTCTTGGTGCCC:CC
NM_000102.4(CYP17A1):c.1039C>T (p.Arg347Cys)	CYP17A1	R347C	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000001794	10	104592368	10	102832611	1794	16833	rs104894149	NC_000010.11:102832610:G:A
NM_000102.4(CYP17A1):c.347A>T (p.Asp116Val)	CYP17A1	D116V	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000001793	10	104595100	10	102835343	1793	16832	rs104894148	NC_000010.11:102835342:T:A
NM_000102.4(CYP17A1):c.340T>G (p.Phe114Val)	CYP17A1	F114V	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000001792	10	104595107	10	102835350	1792	16831	rs104894147	NC_000010.11:102835349:A:C
NM_000102.4(CYP17A1):c.278T>G (p.Phe93Cys)	CYP17A1	F93C	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000001791	10	104596841	10	102837084	1791	16830	rs104894146	NC_000010.11:102837083:A:C
NM_000102.4(CYP17A1):c.436+5G>T	CYP17A1		Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000001790	10	104595006	10	102835249	1790	16829	rs786205061	NC_000010.11:102835248:C:A
NM_000102.4(CYP17A1):c.51G>A (p.Trp17Ter)	CYP17A1	W17*	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000001789	10	104597068	10	102837311	1789	16828	rs104894141	NC_000010.11:102837310:C:T
NM_000102.4(CYP17A1):c.1073G>A (p.Arg358Gln)	CYP17A1	R358Q	Isolated 17,20-lyase deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000001788	10	104592334	10	102832577	1788	16827	rs104894139	NC_000010.11:102832576:C:T
CYP17A1, 1-BP DEL	CYP17A1		Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000001784					1784	16823		
NM_000102.4(CYP17A1):c.1024C>A (p.Pro342Thr)	CYP17A1	P342T	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000001783	10	104592383	10	102832626	1783	16822	rs104894137	NC_000010.11:102832625:G:T
CYP17A1, 469-BP INS, 518-BP DEL	CYP17A1		Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000001781					1781	16820		
CYP17A1, 7-BP DUP, EX2	CYP17A1		Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: May 1, 1990)	no assertion criteria provided	VCV000001779					1779	16818		
NM_000102.4(CYP17A1):c.297+2T>C	CYP17A1		not provided|Deficiency of steroid 17-alpha-monooxygenase	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000431980	10	104596820	10	102837063	431980	425860	rs764723654	NC_000010.11:102837062:A:G
NM_000102.4(CYP17A1):c.1216T>C (p.Trp406Arg)	CYP17A1	W406R	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000001797	10	104591292	10	102831535	1797	16836	rs104894143	NC_000010.11:102831534:A:G
NM_000102.4(CYP17A1):c.1243+5G>A	CYP17A1		Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000001786	10	104591260	10	102831503	1786	16825	rs1564777724	NC_000010.11:102831502:C:T
NM_000102.4(CYP17A1):c.157_159TTC[1] (p.Phe54del)	CYP17A1	F53del, F54del	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000001778	10	104596957 - 104596959	10	102837200 - 102837202	1778	16817	rs121434319	NC_000010.11:102837199:GAAGAAG:GAAG
NM_014797.2(ZBTB24):c.47C>G (p.Ser16Ter)	ZBTB24	S16*	not provided|Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000598541	6	109803183	6	109481980	598541	589602	rs370370334	NC_000006.12:109481979:G:C
NM_005094.4(SLC27A4):c.1774G>A (p.Gly592Arg)	SLC27A4	G592R	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 24, 2013)	criteria provided, single submitter	VCV000225105	9	131118075	9	128355796	225105	226913	rs869312967	NC_000009.12:128355795:G:A
NM_005094.4(SLC27A4):c.556+2T>G	SLC27A4		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	VCV000225061	9	131107830	9	128345551	225061	226912	rs368207076	NC_000009.12:128345550:T:G
NM_000317.3(PTS):c.155A>G (p.Asn52Ser)	PTS	N52S		Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000000479	11	112099388	11	112228665	479	15518	rs104894275	NC_000011.10:112228664:A:G
NM_000102.4(CYP17A1):c.1118A>T (p.His373Leu)	CYP17A1	H373L	not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000654004	10	104592289	10	102832532	654004	638706		NC_000010.11:102832531:T:A
NM_003718.5(CDK13):c.2141G>A (p.Gly714Asp)	CDK13	G714D	not provided	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000449224	7	40039058	7	39999459	449224	444125	rs1554326755	NC_000007.14:39999458:G:A
NM_003718.5(CDK13):c.2209C>T (p.Arg737Cys)	CDK13	R737C	not provided	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000423480	7	40041486	7	40001887	423480	407132	rs1064796451	NC_000007.14:40001886:C:T
NM_012301.4(MAGI2):c.3526_3533dup (p.Glu1178fs)	MAGI2		Nephrotic syndrome type 15	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000431757	7	77755044 - 77755045	7	78125727 - 78125728	431757	425261	rs1135402913	NC_000007.14:78125727:TCTGCCAGTCT:TCTGCCAGTCTGCCAGTCT
NM_012301.4(MAGI2):c.3998del (p.Gly1333fs)	MAGI2	G1333fs, G1319fs	Nephrotic syndrome type 15	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000431755	7	77649002	7	78019685	431755	425259	rs1135402911	NC_000007.14:78019684:CC:C
CDK13, VAL874LEU	CDK13	V874L	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488422					488422	481278		
CDK13, ASN842ASP	CDK13	N842D	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488421					488421	481277		
NM_003718.5(CDK13):c.2140G>C (p.Gly714Arg)	CDK13	G714R	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic(Last reviewed: Feb 24, 2017)	no assertion criteria provided	VCV000375738	7	40039057	7	39999458	375738	362623	rs1057519633	NC_000007.14:39999457:G:C
NM_000474.4(TWIST1):c.211C>T (p.Gln71Ter)	TWIST1	Q71*	Craniosynostosis 1|Saethre-Chotzen syndrome|	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000007984	7	19156734	7	19117111	7984	23023	rs104894065	NC_000007.14:19117110:G:A
NM_000102.4(CYP17A1):c.1040G>A (p.Arg347His)	CYP17A1	R347H	Isolated 17,20-lyase deficiency|Deficiency of steroid 17-alpha-monooxygenase	Pathogenic(Last reviewed: Jun 10, 2015)	no assertion criteria provided	VCV000001787	10	104592367	10	102832610	1787	16826	rs61754278	NC_000010.11:102832609:C:T
NM_000165.5(GJA1):c.412G>A (p.Gly138Ser)	GJA1	G138S	Oculodentodigital dysplasia, autosomal recessive	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000537756	6	121768405	6	121447259	537756	521345	rs1554201018	NC_000006.12:121447258:G:A
NM_003718.5(CDK13):c.2252G>A (p.Arg751Gln)	CDK13	R751Q	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000375739	7	40041529	7	40001930	375739	362624	rs1057519634	NC_000007.14:40001929:G:A
GRCh37/hg19 9q22.31(chr9:94117511-94122902)x1	AUH		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	no assertion criteria provided	VCV000685654	9	94117511 - 94122902			685654	673246		
NM_001698.3(AUH):c.197del (p.Gly66fs)	AUH	G66fs	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000850052	9	94123975	9	91361693	850052	836282		NC_000009.12:91361692:CCCC:CCC
NC_000009.12:g.(?_91220785)_(91221012_?)del	AUH		3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000831476	9	93983067 - 93983294			831476	820168		
NM_178443.2(FERMT3):c.814dup (p.Tyr272fs)	FERMT3		Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000652864	11	63986749 - 63986750	11	64219277 - 64219278	652864	640241		NC_000011.10:64219277:T:TT
NM_178443.2(FERMT3):c.664_665del (p.Lys222fs)	FERMT3	K222fs	Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000643472	11	63978896 - 63978897	11	64211424 - 64211425	643472	640240		NC_000011.10:64211423:AA:
NM_178443.2(FERMT3):c.161-2A>C	FERMT3		Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000031528	11	63978081	11	64210609	31528	40201	rs1286499329	NC_000011.10:64210608:A:C
NM_178443.2(FERMT3):c.1287del (p.Glu430fs)	FERMT3	E430fs, E426fs	Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: Jun 10, 2010)	no assertion criteria provided	VCV000030687	11	63987762	11	64220290	30687	39644	rs775138431	NC_000011.10:64220289:T:
NM_001698.2(AUH):c.650G>A (p.Gly217Asp)	AUH	G217D, G108D, G188D	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000030080	9	94058308	9	91296026	30080	39035	rs387906756	NC_000009.12:91296025:C:T
NM_178443.2(FERMT3):c.687G>A (p.Trp229Ter)	FERMT3	W229*	Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: May 7, 2009)	no assertion criteria provided	VCV000002711	11	63979120	11	64211648	2711	17750	rs121918298	NC_000011.10:64211647:G:A
NM_178443.2(FERMT3):c.1729C>T (p.Arg577Ter)	FERMT3	R573*, R577*	Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: May 7, 2009)	no assertion criteria provided	VCV000002710	11	63990566	11	64223094	2710	17749	rs121918297	NC_000011.10:64223093:C:T
NM_178443.2(FERMT3):c.48G>A (p.Trp16Ter)	FERMT3	W16*	Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000002709	11	63974884	11	64207412	2709	17748	rs121918296	NC_000011.10:64207411:G:A
NM_001698.2(AUH):c.(?_1)_(418_?)+1del	AUH		3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000619968			9	91355882 - 91361889	619968	611362		
RAB18, EX2DEL	RAB18		Warburg micro syndrome 3	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030248					30248	39204		
NM_001698.2(AUH):c.943-2A>G	AUH		3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000009060	9	93976709	9	91214427	9060	24099	rs730880312	NC_000009.12:91214426:T:C
NM_001698.2(AUH):c.263-2A>G	AUH		3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000009059	9	94118439	9	91356157	9059	24098	rs730880311	NC_000009.12:91356156:T:C
FERMT3, IVS13AS, A-G, -2	FERMT3		Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000002708					2708	17747		
NM_021252.5(RAB18):c.284C>G (p.Thr95Arg)	RAB18	T95R, T71R, T124R	Warburg micro syndrome 3	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000100768	10	27822688	10	27533759	100768	106634	rs587777151	NC_000010.11:27533758:C:G
NM_021252.5(RAB18):c.619T>C (p.Ter207Gln)	RAB18	*143Q, *207Q, *183Q, *236Q	Warburg micro syndrome 3	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000030250	10	27826978	10	27538049	30250	39206	rs387906833	NC_000010.11:27538048:T:C
NM_021252.5(RAB18):c.71T>A (p.Leu24Gln)	RAB18	L24Q	Warburg micro syndrome 3	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000030247	10	27798806	10	27509877	30247	39203	rs387906832	NC_000010.11:27509876:T:A
NM_001698.2(AUH):c.559G>A (p.Gly187Ser)	AUH	G187S, G158S, G78S	not provided|3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	VCV000030079	9	94060305	9	91298023	30079	39034	rs387906755	NC_000009.12:91298022:C:T
NM_001351431.1(AUH):c.-318del	AUH	S27fs	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000009058	9	94124092	9	91361810	9058	24097	rs730880310	NC_000009.12:91361809:C:
NM_178443.2(FERMT3):c.1537C>T (p.Arg513Ter)	FERMT3	R513*, R509*	Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: May 7, 2009)	no assertion criteria provided	VCV000002712	11	63988121	11	64220649	2712	17751	rs121918295	NC_000011.10:64220648:C:T
NM_178443.2(FERMT3):c.1029+2T>C	FERMT3		Leukocyte adhesion deficiency, type III	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000646802	11	63987132	11	64219660	646802	652554		NC_000011.10:64219659:T:C
NM_021252.5(RAB18):c.274_276AGA[1] (p.Arg93del)	RAB18	R93del	Warburg micro syndrome 3	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000030249	10	27822677 - 27822679	10	27533748 - 27533750	30249	39205	rs587776875	NC_000010.11:27533747:AAGAAGA:AAGA
NM_001698.2(AUH):c.895-1G>A	AUH		3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Nov 28, 2006)	no assertion criteria provided	VCV000009057	9	93978389	9	91216107	9057	24096	rs730880309	NC_000009.12:91216106:C:T
NM_016729.3(FOLR1):c.352C>T (p.Gln118Ter)	FOLR1	Q118*	not provided|Cerebral folate deficiency	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016255	11	71906498	11	72195454	16255	31294	rs121918405	NC_000011.10:72195453:C:T
NM_014679.5(CEP57):c.724del (p.Arg242fs)	CEP57	R233fs, R215fs, R242fs	Mosaic variegated aneuploidy syndrome	Pathogenic	no assertion criteria provided	VCV000431798	11	95555059	11	95821895	431798	425300	rs1555052278	NC_000011.10:95821894:A:
NM_001330691.3(CEP78):c.58G>T (p.Glu20Ter)	CEP78	E20*	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000844273	9	80851324	9	78236408	844273	836251		NC_000009.12:78236407:G:T
NM_014679.5(CEP57):c.451C>T (p.Arg151Ter)	CEP57	R124*, R142*, R151*	Mosaic variegated aneuploidy syndrome 2	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000643769	11	95546700	11	95813536	643769	640528		NC_000011.10:95813535:C:T
NM_018947.5(CYCS):c.301_303del (p.Lys101del)	CYCS	K101del	Thrombocytopenia 4	Pathogenic(Last reviewed: Jan 16, 2019)	no assertion criteria provided	VCV000599385	7	25163335 - 25163337	7	25123716 - 25123718	599385	590721	rs1562515878	NC_000007.14:25123715:TTTTTT:TTT
NM_005002.5(NDUFA9):c.1078C>T (p.Arg360Cys)	NDUFA9	R360C	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000587683	12	4796218	12	4687052	587683	578641	rs3210083	NC_000012.12:4687051:C:T
46,XX,der(9)(q21.2,q21.2).seq[GRCh37/hg19]der(9)(9pter->9q21.2(+)(8084369{7-8})::q21.2(-)(808497{60-59}),q21.2(-)(8084946{5-3})::q21.2(+)(808596{79-81}->9qter)	CEP78		Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000561260	9	80843698 - 80859679			561260	552398		
NM_015261.2(NCAPD3):c.3458A>C (p.Glu1153Ala)	NCAPD3	E1153A	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000524199	11	134038006	11	134168111	524199	514847	rs1350194762	NC_000011.10:134168110:T:G
NM_015261.2(NCAPD3):c.382+14A>G	NCAPD3		MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000524198	11	134086816	11	134216922	524198	514846	rs1555143325	NC_000011.10:134216921:T:C
NM_015261.2(NCAPD3):c.1783del (p.Val595Serfs)	NCAPD3	V595fs	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000524197	11	134063952	11	134194057	524197	514845	rs1555139372	NC_000011.10:134194056:C:
NM_001330691.3(CEP78):c.1626-2A>G	CEP78		Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: May 18, 2017)	no assertion criteria provided	VCV000372272	9	80880286	9	78265370	372272	359180	rs1057518753	NC_000009.12:78265369:A:G
NM_001330691.3(CEP78):c.1251+5G>A	CEP78		Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: May 18, 2017)	no assertion criteria provided	VCV000372271	9	80868198	9	78253282	372271	359179	rs745750156	NC_000009.12:78253281:G:A
NM_001330691.3(CEP78):c.499+5G>A	CEP78		Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000372268	9	80855285	9	78240369	372268	359176	rs1057517693	NC_000009.12:78240368:G:A
NM_001330691.3(CEP78):c.633del (p.Trp212fs)	CEP78	W212fs	Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000372267	9	80858406	9	78243490	372267	359175	rs1057517692	NC_000009.12:78243489:CC:C
NM_001330691.3(CEP78):c.499+1G>T	CEP78		Cone-rod dystrophy and hearing loss 1	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000372266	9	80855281	9	78240365	372266	359174	rs1057517691	NC_000009.12:78240364:G:T
NM_018947.5(CYCS):c.145T>C (p.Tyr49His)	CYCS	Y48H, Y49H	Thrombocytopenia 4	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000180656	7	25163594	7	25123975	180656	178822	rs886037737	NC_000007.14:25123974:A:G
NM_001289808.2(CRYAB):c.166C>T (p.Arg56Trp)	CRYAB	R56W	Cataract 16, multiple types	Pathogenic(Last reviewed: May 15, 2009)	no assertion criteria provided	VCV000041929	11	111782283	11	111911559	41929	51098	rs387907338	NC_000011.10:111911558:G:A
NM_001289808.2(CRYAB):c.58C>T (p.Pro20Ser)	CRYAB	P20S	Cataract 16, multiple types	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000041928	11	111782391	11	111911667	41928	51097	rs387907337	NC_000011.10:111911666:G:A
NM_001289808.2(CRYAB):c.418G>A (p.Asp140Asn)	CRYAB	D140N, D73N	Cataract 16, multiple types	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000041927	11	111779598	11	111908874	41927	51096	rs387907336	NC_000011.10:111908873:C:T
NM_005002.5(NDUFA9):c.962G>C (p.Arg321Pro)	NDUFA9	R321P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030391	12	4794490	12	4685324	30391	39348	rs199592341	NC_000012.12:4685323:G:C
NM_001289808.2(CRYAB):c.450del (p.Lys150fs)	CRYAB	K83fs, K150fs	Cataract 16, multiple types	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000016954	11	111779566	11	111908842	16954	31993	rs1566402656	NC_000011.10:111908841:TTT:TT
NM_001289808.2(CRYAB):c.325G>C (p.Asp109His)	CRYAB	D109H, D42H	Alpha-B crystallinopathy	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000041930	11	111779691	11	111908967	41930	51099	rs387907339	NC_000011.10:111908966:C:G
NM_014679.5(CEP57):c.518_519GA[1] (p.Glu174fs)	CEP57		Mosaic variegated aneuploidy syndrome 2	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030690	11	95550963 - 95550964	11	95817799 - 95817800	30690	39647	rs1565326373	NC_000011.10:95817798:AGAGA:AGA
NM_001289808.2(CRYAB):c.451C>T (p.Gln151Ter)	CRYAB	Q151*, Q84*	Alpha-B crystallinopathy	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000016956	11	111779565	11	111908841	16956	31995	rs104894202	NC_000011.10:111908840:G:A
NM_001289808.2(CRYAB):c.464_465del (p.Pro155fs)	CRYAB	P88fs, P155fs	Alpha-B crystallinopathy	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000016955	11	111779551 - 111779552	11	111908827 - 111908828	16955	31994	rs1566402514	NC_000011.10:111908826:AG:
NM_001330691.3(CEP78):c.534del (p.Lys179fs)	CEP78	K179fs	Cone-rod dystrophy and hearing loss 1|Sensorineural hearing loss|Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000372270	9	80856645	9	78241729	372270	359178	rs1057517695	NC_000009.12:78241728:TT:T
NM_001330691.3(CEP78):c.893-1G>A	CEP78		Cone-rod dystrophy and hearing loss 1|Sensorineural hearing loss|Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000372269	9	80863206	9	78248290	372269	359177	rs1057517694	NC_000009.12:78248289:G:A
NM_014679.5(CEP57):c.241C>T (p.Arg81Ter)	CEP57	R81*, R72*, R54*	Mosaic variegated aneuploidy syndrome 2	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000030692	11	95546134	11	95812970	30692	39649	rs387906977	NC_000011.10:95812969:C:T
NM_001289808.2(CRYAB):c.60del (p.Ser21fs)	CRYAB	S21fs	Alpha-B crystallinopathy	Pathogenic(Last reviewed: Oct 29, 2012)	no assertion criteria provided	VCV000029669	11	111782389	11	111911665	29669	38624	rs281865141	NC_000011.10:111911664:GGGGG:GGGG
NM_001168338.1(PLG):c.112A>G (p.Lys38Glu)	PLG	K19E, K38E	Plasminogen deficiency, type I|not provided|Otitis media, susceptibility to	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013583	6	161127501	6	160706469	13583	28622	rs73015965	NC_000006.12:160706468:A:G
NC_000006.11:g.(?_159401786)_(159407473_?)del	RSPH3		Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000665656	6	159401786 - 159407473	6	158980754 - 158986441	665656	651532		
NM_031924.4:c.595C>T	RSPH3	R199*	Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000650363	6	159414906	6	158993874	650363	634756		NC_000006.12:158993873:G:A
NM_001346418.1(RSPH3):c.220_221TG[1] (p.Cys74fs)	RSPH3		Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000646115	6	159420786 - 159420787	6	158999754 - 158999755	646115	634757		NC_000006.12:158999753:CACA:CA
NM_031924.5(RSPH3):c.1111C>T (p.Arg371Ter)	RSPH3	R371*, R275*	Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000570047	6	159403528	6	158982496	570047	565499	rs1158185476	NC_000006.12:158982495:G:A
NM_001346418.1(RSPH3):c.817C>T (p.Arg273Ter)	RSPH3	R369*, R273*	Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204502	6	159403534	6	158982502	204502	200889	rs796052119	NC_000006.12:158982501:G:A
NM_001346418.1(RSPH3):c.1028_1031TGAA[1] (p.Asn344fs)	RSPH3		Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204501	6	159399341 - 159399344	6	158978309 - 158978312	204501	200888	rs875989825	NC_000006.12:158978308:TTCATTCATT:TTCATT
NM_001346418.1(RSPH3):c.904C>T (p.Arg302Ter)	RSPH3	R398*, R302*	Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204500	6	159401899	6	158980867	204500	200887	rs796052118	NC_000006.12:158980866:G:A
NM_001346418.1(RSPH3):c.616C>T (p.Gln206Ter)	RSPH3	Q206*	Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204498	6	159414885	6	158993853	204498	200885	rs796052117	NC_000006.12:158993852:G:A
NM_001001557.4(GDF6):c.169G>C (p.Asp57His)	GDF6	D57H	Leber congenital amaurosis 17	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060534	8	97172752	8	96160524	60534	75115	rs397514725	NC_000008.11:96160523:C:G
NM_001001557.4(GDF6):c.876G>Y (p.Glu292Asp)	GDF6	E292D	Leber congenital amaurosis 17	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060533	8	97157283	8	96145055	60533	75114	rs1401531865	NC_000008.11:96145054:C:R
NM_001001557.4(GDF6):c.980C>A (p.Pro327His)	GDF6	P327H	Microphthalmia, isolated 4	Pathogenic(Last reviewed: Mar 15, 2009)	no assertion criteria provided	VCV000008376	8	97157179	8	96144951	8376	23415	rs121909356	NC_000008.11:96144950:G:T
NM_001001557.4(GDF6):c.758A>T (p.Gln253Leu)	GDF6	Q253L	Microphthalmia, isolated 4	Pathogenic(Last reviewed: Mar 15, 2009)	no assertion criteria provided	VCV000008375	8	97157401	8	96145173	8375	23414	rs121909355	NC_000008.11:96145172:T:A
NM_001001557.4(GDF6):c.125G>T (p.Gly42Val)	GDF6	G42V	Klippel-Feil syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Mar 15, 2009)	no assertion criteria provided	VCV000008374	8	97172796	8	96160568	8374	23413	rs121909354	NC_000008.11:96160567:C:A
NM_001001557.4(GDF6):c.1330T>A (p.Tyr444Asn)	GDF6	Y444N	MULTIPLE SYNOSTOSES SYNDROME 4	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000495116	8	97156829	8	96144601	495116	486670	rs1554571213	NC_000008.11:96144600:A:T
NM_014679.5(CEP57):c.915_925dup (p.Leu309fs)	CEP57		Mosaic variegated aneuploidy syndrome 2|Mosaic variegated aneuploidy syndrome 1	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000030691	11	95560979 - 95560989	11	95827811 - 95827812	30691	39648	rs1166323407	NC_000011.10:95827811:AGCCAATGTTCAGC:AGCCAATGTTCAGCCAATGTTCAGC
NM_000102.4(CYP17A1):c.316T>C (p.Ser106Pro)	CYP17A1	S106P	not provided|Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency|Deficiency of steroid 17-alpha-monooxygenase	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001780	10	104595131	10	102835374	1780	16819	rs104894135	NC_000010.11:102835373:A:G
NM_198488.4(FAM83H):c.926_927del (p.Val309fs)	FAM83H	V309fs	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488513	8	144810704 - 144810705	8	143728534 - 143728535	488513	481381	rs1554623490	NC_000008.11:143728533:CAC:C
NM_020638.3(FGF23):c.367G>T (p.Gly123Trp)	FGF23	G123W	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000444062	12	4479898	12	4370732	444062	437706	rs1220533001	NC_000012.12:4370731:C:A
NM_020638.3(FGF23):c.385T>C (p.Ser129Pro)	FGF23	S129P	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444061	12	4479880	12	4370714	444061	437705	rs1555096583	NC_000012.12:4370713:A:G
NM_001273.5(CHD4):c.3443G>T (p.Trp1148Leu)	CHD4	W1148L, W1135L, W1141L	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266128	12	6697486	12	6588320	266128	260983	rs886039919	NC_000012.12:6588319:C:A
NM_001273.5(CHD4):c.3518G>T (p.Arg1173Leu)	CHD4	R1173L, R1166L, R1160L	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266127	12	6697063	12	6587897	266127	260982	rs886039918	NC_000012.12:6587896:C:A
NM_001273.5(CHD4):c.3380G>A (p.Arg1127Gln)	CHD4	R1127Q, R1114Q, R1120Q	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266126	12	6697549	12	6588383	266126	260981	rs886039917	NC_000012.12:6588382:C:T
NM_001273.5(CHD4):c.2552C>A (p.Ser851Tyr)	CHD4	S851Y, S838Y, S844Y	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266125	12	6702357	12	6593191	266125	260980	rs886039916	NC_000012.12:6593190:G:T
NM_020442.5(VARS2):c.1787C>A (p.Ala596Asp)	VARS2	A626D, A596D, A456D	Combined oxidative phosphorylation deficiency 20	Pathogenic(Last reviewed: Jul 2, 2014)	no assertion criteria provided	VCV000141426	6	30889753	6	30921976	141426	151140	rs587777584	NC_000006.12:30921975:C:A
NM_020442.5(VARS2):c.1045G>A (p.Ala349Thr)	VARS2	A379T, A349T, A209T	Combined oxidative phosphorylation deficiency 20	Pathogenic(Last reviewed: Jul 2, 2014)	no assertion criteria provided	VCV000141424	6	30886663	6	30918886	141424	151138	rs587777583	NC_000006.12:30918885:G:A
NM_198488.4(FAM83H):c.1366C>T (p.Gln456Ter)	FAM83H	Q456*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000030930	8	144810265	8	143728095	30930	39887	rs387907056	NC_000008.11:143728094:G:A
NM_020638.3(FGF23):c.386C>T (p.Ser129Phe)	FGF23	S129F	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000005029	12	4479879	12	4370713	5029	20068	rs104894344	NC_000012.12:4370712:G:A
NM_020638.3(FGF23):c.287T>C (p.Met96Thr)	FGF23	M96T	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000005028	12	4481788	12	4372622	5028	20067	rs104894343	NC_000012.12:4372621:A:G
NM_198488.4(FAM83H):c.921_922TC[1] (p.Leu308fs)	FAM83H		Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000000780	8	144810707 - 144810708	8	143728537 - 143728538	780	15819	rs796065023	NC_000008.11:143728536:GAGAG:GAG
NM_198488.4(FAM83H):c.1872_1873del (p.Leu625fs)	FAM83H	L625fs	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000000779	8	144809758 - 144809759	8	143727588 - 143727589	779	15818	rs796065022	NC_000008.11:143727587:GG:
NM_198488.4(FAM83H):c.2080G>T (p.Glu694Ter)	FAM83H	E694*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000000778	8	144809551	8	143727381	778	15817	rs137854443	NC_000008.11:143727380:C:A
NM_198488.4(FAM83H):c.860C>A (p.Ser287Ter)	FAM83H	S287*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000000777	8	144810771	8	143728601	777	15816	rs137854442	NC_000008.11:143728600:G:T
NM_198488.4(FAM83H):c.1408C>T (p.Gln470Ter)	FAM83H	Q470*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000000776	8	144810223	8	143728053	776	15815	rs137854441	NC_000008.11:143728052:G:A
NM_198488.4(FAM83H):c.1380G>A (p.Trp460Ter)	FAM83H	W460*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000774	8	144810251	8	143728081	774	15813	rs137854439	NC_000008.11:143728080:C:T
NM_198488.4(FAM83H):c.891T>A (p.Tyr297Ter)	FAM83H	Y297*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000773	8	144810740	8	143728570	773	15812	rs137854438	NC_000008.11:143728569:A:T
NM_198488.4(FAM83H):c.1243G>T (p.Glu415Ter)	FAM83H	E415*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000772	8	144810388	8	143728218	772	15811	rs137854437	NC_000008.11:143728217:C:A
NM_198488.4(FAM83H):c.1192C>T (p.Gln398Ter)	FAM83H	Q398*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000000771	8	144810439	8	143728269	771	15810	rs137854436	NC_000008.11:143728268:G:A
NM_000474.4(TWIST1):c.396_416dup (p.Lys133_Pro139dup)	TWIST1		Craniosynostosis 1|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000543075	7	19156528 - 19156529	7	19116905 - 19116906	543075	523183	rs1554441991	NC_000007.14:19116905:GGCAGCGTGGGGATGATCTTC:GGCAGCGTGGGGATGATCTTCGGCAGCGTGGGGATGATCTTC
NM_198488.4(FAM83H):c.1379G>A (p.Trp460Ter)	FAM83H	W460*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000000781	8	144810252	8	143728082	781	15820	rs137854444	NC_000008.11:143728081:C:T
NM_198488.4(FAM83H):c.2029C>T (p.Gln677Ter)	FAM83H	Q677*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000000775	8	144809602	8	143727432	775	15814	rs137854440	NC_000008.11:143727431:G:A
NM_198488.4(FAM83H):c.973C>T (p.Arg325Ter)	FAM83H	R325*	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000000770	8	144810658	8	143728488	770	15809	rs137854435	NC_000008.11:143728487:G:A
NM_001001557.4(GDF6):c.595G>A (p.Ala199Thr)	GDF6	A199T	Leber congenital amaurosis 17|Microphthalmia, isolated, with coloboma 6	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000030159	8	97157564	8	96145336	30159	39115	rs387906794	NC_000008.11:96145335:C:T
NM_003816.3(ADAM9):c.1455C>A (p.Tyr485Ter)	ADAM9	Y485*	Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812214	8	38913155	8	39055636	812214	800535		NC_000008.11:39055635:C:A
NM_078480.3(PUF60):c.219del (p.Lys72_Tyr73insTer)	PUF60		Verheij syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802445	8	144903845	8	143821675	802445	790785		NC_000008.11:143821674:G:
NM_078480.3(PUF60):c.993del (p.Lys332fs)	PUF60	K314fs, K286fs, K303fs, K272fs, K289fs, K331fs, K332fs, K369fs, K315fs, K352fs	not provided	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000430000	8	144899777	8	143817607	430000	421660	rs1131691721	NC_000008.11:143817606:GG:G
NM_003816.3(ADAM9):c.196-1G>A	ADAM9		not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000373092	8	38869176	8	39011657	373092	359851	rs1057518208	NC_000008.11:39011656:G:A
NM_078480.3(PUF60):c.485G>A (p.Trp162Ter)	PUF60	W162*, W144*, W161*, W116*, W119*, W133*, W182*, W102*, W145*, W199*	not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000280867	8	144900568	8	143818398	280867	264395	rs886041995	NC_000008.11:143818397:C:T
NM_003816.3(ADAM9):c.1968T>A (p.Cys656Ter)	ADAM9	C656*	not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000862925	8	38940492	8	39082973	862925	834751		NC_000008.11:39082972:T:A
NM_078480.3(PUF60):c.51dup (p.Ser18fs)	PUF60		not provided	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000853320	8	144906542 - 144906543	8	143824372 - 143824373	853320	834167		NC_000008.11:143824372:CCCCCC:CCCCCCC
NM_078480.3(PUF60):c.1448T>C (p.Val483Ala)	PUF60	V483A, V440A, V466A, V482A, V423A, V454A, V503A, V520A, V437A, V465A	Verheij syndrome	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599208	8	144898922	8	143816752	599208	590430	rs1563818514	NC_000008.11:143816751:A:G
NM_078480.3(PUF60):c.901A>T (p.Lys301Ter)	PUF60	K301*, K255*, K258*, K241*, K283*, K284*, K272*, K321*, K338*, K300*	Verheij syndrome	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599207	8	144899869	8	143817699	599207	590429	rs1563823411	NC_000008.11:143817698:T:A
NM_078480.3(PUF60):c.1342C>T (p.Arg448Ter)	PUF60	R448*, R402*, R405*, R485*, R388*, R419*, R431*, R447*, R430*, R468*	Verheij syndrome	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599206	8	144899118	8	143816948	599206	590428	rs1563819620	NC_000008.11:143816947:G:A
NM_078480.3(PUF60):c.403_406TCTA[1] (p.Ile136fs)	PUF60		Verheij syndrome	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599205	8	144900643 - 144900646	8	143818473 - 143818476	599205	590427	rs1563826453	NC_000008.11:143818472:TAGATAGA:TAGA
NM_078480.3(PUF60):c.1309C>T (p.Gln437Ter)	PUF60	Q437*, Q391*, Q394*, Q457*, Q377*, Q408*, Q474*, Q419*, Q420*, Q436*	Verheij syndrome	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000545569	8	144899151	8	143816981	545569	536072	rs1554642022	NC_000008.11:143816980:G:A
NM_078480.3(PUF60):c.1072_1073delinsTTGACCCTGGCCCAGCCCC (p.Leu364fs)	PUF60		Verheij syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000520432	8	144899572 - 144899573	8	143817402 - 143817403	520432	511028	rs1554642573	NC_000008.11:143817401:AG:GGGGCTGGGCCAGGGTCAA
NM_003816.3(ADAM9):c.1396-2A>G	ADAM9		Cone-rod dystrophy 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000189795	8	38913094	8	39055575	189795	187665	rs786205151	NC_000008.11:39055574:A:G
NM_015459.5(ATL3):c.575A>G (p.Tyr192Cys)	ATL3	Y192C, Y174C	Hereditary sensory neuropathy type IF	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000097070	11	63414022	11	63646550	97070	102969	rs587777108	NC_000011.10:63646549:T:C
NM_078480.3(PUF60):c.505C>T (p.His169Tyr)	PUF60	H169Y, H109Y, H189Y, H126Y, H140Y, H151Y, H168Y, H123Y, H152Y, H206Y	Verheij syndrome	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000092112	8	144900548	8	143818378	92112	97544	rs398123001	NC_000008.11:143818377:G:A
NM_005157.6(ABL1):c.707A>T (p.Glu236Val)	ABL1	E255V, E236V	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	Pathogenic(Last reviewed: Feb 9, 2002)	no assertion criteria provided	VCV000012625	9	133738307	9	130862920	12625	27664	rs387906516	NC_000009.12:130862919:A:T
NM_003816.3(ADAM9):c.766C>T (p.Arg256Ter)	ADAM9	R256*	Cone-rod dystrophy 9	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006877	8	38880696	8	39023177	6877	21916	rs137853040	NC_000008.11:39023176:C:T
Single allele	ABL1		T-cell acute lymphoblastic leukemia	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000617566	9	133709770 - 133709771			617566	608935		
NM_078480.3(PUF60):c.619_637del (p.Asn207fs)	PUF60	N189fs, N206fs, N244fs, N161fs, N227fs, N147fs, N164fs, N178fs, N190fs, N207fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000425573	8	144900212 - 144900230	8	143818042 - 143818060	425573	413924	rs1554643142	NC_000008.11:143818041:GCTGGGCCTGCCCTATGTTGCTGGG:GCTGGG
NM_005271.5(GLUD1):c.1496G>T (p.Gly499Val)	GLUD1	G499V, G332V, G366V	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000226111	10	88813160	10	87053403	226111	227919	rs121909734	NC_000010.11:87053402:C:A
NM_005271.5(GLUD1):c.820C>T (p.Arg274Cys)	GLUD1	R221C, R274C, R107C, R141C	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000016128	10	88822514	10	87062757	16128	31167	rs56275071	NC_000010.11:87062756:G:A
NM_005271.5(GLUD1):c.953G>A (p.Arg318Lys)	GLUD1	R265K, R318K, R185K, R151K	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000016127	10	88820778	10	87061021	16127	31166	rs121909736	NC_000010.11:87061020:C:T
NM_005271.5(GLUD1):c.1046A>C (p.Glu349Ala)	GLUD1	E296A, E349A, E216A, E182A	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000016126	10	88820685	10	87060928	16126	31165	rs121909735	NC_000010.11:87060927:T:G
NM_005271.5(GLUD1):c.1495G>A (p.Gly499Ser)	GLUD1	G446S, G499S, G366S, G332S	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: May 7, 1998)	no assertion criteria provided	VCV000016124	10	88813161	10	87053404	16124	31163	rs121909733	NC_000010.11:87053403:C:T
NM_005157.6(ABL1):c.931T>C (p.Phe311Leu)	ABL1	F311L, F330L	Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000012628	9	133748270	9	130872883	12628	27667	rs137853304	NC_000009.12:130872882:T:C
NM_003816.3(ADAM9):c.1130+1G>A	ADAM9		Cone-rod dystrophy 9	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006876	8	38884330	8	39026811	6876	21915	rs786205085	NC_000008.11:39026810:G:A
NM_003816.3(ADAM9):c.1087T>A (p.Cys363Ser)	ADAM9	C363S	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812213	8	38884286	8	39026767	812213	800534		NC_000008.11:39026766:T:A
NM_003816.3(ADAM9):c.411-8A>G	ADAM9		Cone-rod dystrophy 9|Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000006879	8	38874730	8	39017211	6879	21918	rs786205086	NC_000008.11:39017210:A:G
NM_020638.3(FGF23):c.535C>T (p.Arg179Trp)	FGF23	R179W	not provided|Autosomal dominant hypophosphatemic rickets	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000005026	12	4479730	12	4370564	5026	20065	rs28937882	NC_000012.12:4370563:G:A
NM_020638.3(FGF23):c.527G>A (p.Arg176Gln)	FGF23	R176Q	not provided|Autosomal dominant hypophosphatemic rickets	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000005025	12	4479738	12	4370572	5025	20064	rs104894347	NC_000012.12:4370571:C:T
NM_005157.6(ABL1):c.677A>G (p.Tyr226Cys)	ABL1	Y226C, Y245C	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME|Failure to thrive|Abnormality of skeletal morphology|Congenital heart disease	Pathogenic(Last reviewed: Dec 11, 2016)	criteria provided, single submitter	VCV000374795	9	133738277	9	130862890	374795	361696	rs1060499547	NC_000009.12:130862889:A:G
NM_005271.5(GLUD1):c.1496G>A (p.Gly499Asp)	GLUD1	G446D, G499D, G332D, G366D	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000016125	10	88813160	10	87053403	16125	31164	rs121909734	NC_000010.11:87053402:C:T
NM_005271.5(GLUD1):c.1501T>C (p.Ser501Pro)	GLUD1	S448P, S501P, S334P, S368P	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000016123	10	88813155	10	87053398	16123	31162	rs121909732	NC_000010.11:87053397:A:G
NM_001698.2(AUH):c.589C>T (p.Arg197Ter)	AUH	R197*, R168*, R88*	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009056	9	94060275	9	91297993	9056	24095	rs121434636	NC_000009.12:91297992:G:A
NM_031924.5(RSPH3):c.631-2A>G	RSPH3		Kartagener syndrome|Ciliary dyskinesia, primary, 32	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000209010	6	159407455	6	158986423	209010	205558	rs142800871	NC_000006.12:158986422:T:C
NM_001278064.2(GRM1):c.26dup (p.Ala11fs)	GRM1		Spinocerebellar ataxia, autosomal recessive 13	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000818224	6	146350671 - 146350672	6	146029535 - 146029536	818224	806437	rs758809498	NC_000006.12:146029535:TTTTTTTT:TTTTTTTTT
NM_001278064.2(GRM1):c.889C>T (p.Arg297Ter)	GRM1	R297*	Spinocerebellar ataxia, autosomal recessive 13	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000626248	6	146480672	6	146159536	626248	614542	rs774214806	NC_000006.12:146159535:C:T
NM_001278064.2(GRM1):c.3165dup (p.Gly1056fs)	GRM1		SPINOCEREBELLAR ATAXIA 44	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	VCV000438857	6	146755508 - 146755509	6	146434372 - 146434373	438857	432487	rs1554317158	NC_000006.12:146434372:CCCC:CCCCC
NM_001278064.2(GRM1):c.785A>G (p.Tyr262Cys)	GRM1	Y262C	SPINOCEREBELLAR ATAXIA 44	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000438856	6	146480568	6	146159432	438856	432486	rs1554274719	NC_000006.12:146159431:A:G
NM_001278064.2(GRM1):c.2375A>G (p.Tyr792Cys)	GRM1	Y792C	SPINOCEREBELLAR ATAXIA 44	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	VCV000438855	6	146720550	6	146399414	438855	432485	rs1554308513	NC_000006.12:146399413:A:G
NM_031418.4(ANO3):c.2586G>T (p.Lys862Asn)	ANO3	K862N, K923N, K716N	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039499	11	26677681	11	26656134	39499	48098	rs1277790116	NC_000011.10:26656133:G:T
NM_031418.4(ANO3):c.2053A>G (p.Ser685Gly)	ANO3	S685G, S746G, S539G	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039498	11	26660700	11	26639153	39498	48097	rs587776923	NC_000011.10:26639152:A:G
NM_031418.4(ANO3):c.1470G>T (p.Trp490Cys)	ANO3	W490C, W551C, W344C	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039497	11	26619934	11	26598387	39497	48096	rs1565132917	NC_000011.10:26598386:G:T
NM_031418.4(ANO3):c.1480A>T (p.Arg494Trp)	ANO3	R494W, R555W, R348W	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039496	11	26619944	11	26598397	39496	48095	rs587776922	NC_000011.10:26598396:A:T
NM_005271.5(GLUD1):c.1519C>T (p.His507Tyr)	GLUD1	H454Y, H507Y, H340Y, H374Y	Hyperinsulinism-hyperammonemia syndrome|Familial hyperinsulinemia	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000016121	10	88813137	10	87053380	16121	31160	rs121909730	NC_000010.11:87053379:G:A
NM_003816.3(ADAM9):c.490C>T (p.Arg164Ter)	ADAM9	R490*, R164*	not provided|Cone-rod degeneration|Cone-rod dystrophy 9	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000006878	8	38874817	8	39017298	6878	21917	rs137853041	NC_000008.11:39017297:C:T
NM_000102.4(CYP17A1):c.1084C>T (p.Arg362Cys)	CYP17A1	R362C	not provided|Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000001796	10	104592323	10	102832566	1796	16835	rs104894142	NC_000010.11:102832565:G:A
NM_000102.4(CYP17A1):c.286C>T (p.Arg96Trp)	CYP17A1	R96W	not provided|Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency|Deficiency of steroid 17-alpha-monooxygenase	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001785	10	104596833	10	102837076	1785	16824	rs104894138	NC_000010.11:102837075:G:A
NM_006446.5(SLCO1B1):c.757C>T (p.Arg253Ter)	SLCO1B1	R253*	not provided|Rotor syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000030439	12	21349909	12	21196975	30439	39396	rs183501729	NC_000012.12:21196974:C:T
NM_017570.5(OPLAH):c.587+1G>C	OPLAH		not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000504164	8	145113675	8	144058772	504164	495355	rs1272869557	NC_000008.11:144058771:C:G
NM_017570.5(OPLAH):c.493C>T (p.Gln165Ter)	OPLAH	Q165*	5-Oxoprolinase deficiency	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000856398	8	145113770	8	144058867	856398	834298		NC_000008.11:144058866:G:A
NM_000370.3(TTPA):c.182del (p.Phe61fs)	TTPA	F61fs	not provided	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000840876	8	63998399	8	63085840	840876	834981		NC_000008.11:63085839:AAA:AA
NM_000370.3(TTPA):c.595G>T (p.Glu199Ter)	TTPA	E199*	not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000586912	8	63976833	8	63064274	586912	577064	rs1563678790	NC_000008.11:63064273:C:A
NM_017570.5(OPLAH):c.2557C>T (p.Arg853Ter)	OPLAH	R853*	5-Oxoprolinase deficiency	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000572337	8	145109593	8	144054690	572337	564811	rs543486699	NC_000008.11:144054689:G:A
NM_000370.3(TTPA):c.366G>A (p.Trp122Ter)	TTPA	W122*	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000448839	8	63978649	8	63066090	448839	441240	rs1554523526	NC_000008.11:63066089:C:T
NM_017570.5(OPLAH):c.969C>A (p.Ser323Arg)	OPLAH	S323R	5-Oxoprolinase deficiency	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039635	8	145113032	8	144058129	39635	48234	rs398122906	NC_000008.11:144058128:G:T
NM_017570.5(OPLAH):c.2608dup (p.His870fs)	OPLAH		5-Oxoprolinase deficiency	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000031133	8	145109541 - 145109542	8	144054638 - 144054639	31133	40090	rs781956288	NC_000008.11:144054638:GGGGGGG:GGGGGGGG
TTPA, 552G-A	TTPA		Ataxia, Friedreich-like, with isolated vitamin E deficiency	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000009142					9142	24181		
NM_144585.4(SLC22A12):c.269G>A (p.Arg90His)	SLC22A12	R90H	Hereditary renal hypouricemia|Familial renal hypouricemia	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003516	11	64359297	11	64591825	3516	18555	rs121907896	NC_000011.10:64591824:G:A
NM_000370.3(TTPA):c.726del (p.Leu243fs)	TTPA	L243fs	not provided	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000863591	8	63973922	8	63061363	863591	834980		NC_000008.11:63061362:A:
NM_017570.5(OPLAH):c.587+1G>A	OPLAH		5-Oxoprolinase deficiency	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000861806	8	145113675	8	144058772	861806	852419		NC_000008.11:144058771:C:T
NM_031418.4(ANO3):c.1528G>A (p.Glu510Lys)	ANO3	E364K, E510K, E571K	Dystonia|Dystonia 24	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000641954	11	26619992	11	26598445	641954	639919		NC_000011.10:26598444:G:A
NM_000370.3(TTPA):c.736G>C (p.Gly246Arg)	TTPA	G246R	Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065598	8	63973912	8	63061353	65598	76506	rs397515526	NC_000008.11:63061352:C:G
NM_000370.3(TTPA):c.548T>C (p.Leu183Pro)	TTPA	L183P	Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065596	8	63978467	8	63065908	65596	76504	rs397515525	NC_000008.11:63065907:A:G
NM_000370.3(TTPA):c.530_531delinsGTAAGT (p.Lys177fs)	TTPA		Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065595	8	63978484 - 63978485	8	63065925 - 63065926	65595	76503	rs1554605631	NC_000008.11:63065924:CT:ACTTAC
NM_000370.3(TTPA):c.421G>A (p.Glu141Lys)	TTPA	E141K	Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065592	8	63978594	8	63066035	65592	76500	rs397515524	NC_000008.11:63066034:C:T
NM_000370.3(TTPA):c.191A>G (p.Asp64Gly)	TTPA	D64G	Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065590	8	63998390	8	63085831	65590	76498	rs397515523	NC_000008.11:63085830:T:C
NM_005271.5(GLUD1):c.956A>G (p.Tyr319Cys)	GLUD1	Y319C, Y186C, Y152C	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000447454	10	88820775	10	87061018	447454	441384	rs1554906133	NC_000010.11:87061017:T:C
NM_005157.6(ABL1):c.1009G>A (p.Ala337Thr)	ABL1	A337T, A356T	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME|not provided|Failure to thrive|Abnormality of skeletal morphology|Congenital heart disease	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374794	9	133748348	9	130872961	374794	361695	rs1060499548	NC_000009.12:130872960:G:A
GRCh37/hg19 11q14.2(chr11:88023054-88100191)x1	CTSC		not provided	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000687705	11	88023054 - 88100191			687705	675297		
NM_016042.4(EXOSC3):c.619_622dup (p.Arg208delinsAsnTer)	EXOSC3		not provided	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000594188	9	37781986 - 37781987	9	37781989 - 37781990	594188	585251	rs1564014225	NC_000009.12:37781989:TAATTAA:TAATTAATTAA
NM_001814.6(CTSC):c.1141del (p.Leu381fs)	CTSC	L381fs	not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000523939	11	88027425	11	88294257	523939	514633	rs772132996	NC_000011.10:88294256:GG:G
NM_001286577.1(C2CD3):c.3910+1G>A	C2CD3		not provided	Pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	VCV000419541	11	73796662	11	74085617	419541	408472	rs1064793941	NC_000011.10:74085616:C:T
NM_001286577.1(C2CD3):c.708-2_708-1del	C2CD3		not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000418736	11	73850013 - 73850014	11	74138968 - 74138969	418736	408473	rs769076549	NC_000011.10:74138967:CT:
NM_001814.6(CTSC):c.861_863delinsTTGGGCTTAGCCCAA (p.Glu287_Val288delinsAspTrpAlaTer)	CTSC		Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000690367	11	88029327 - 88029329	11	88296159 - 88296161	690367	678052		NC_000011.10:88296158:ACC:TTGGGCTAAGCCCAA
NM_015531.6(C2CD3):c.5090+5G>C	C2CD3		Orofaciodigital syndrome xiv	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000625150	11	73768446	11	74057401	625150	613494	rs1565237232	NC_000011.10:74057400:C:G
NM_015531.6(C2CD3):c.1365+1G>A	C2CD3		Orofaciodigital syndrome xiv	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000625149	11	73834032	11	74122987	625149	613493	rs1174615027	NC_000011.10:74122986:C:T
FDFT1, 120-KB DEL	FDFT1		SQUALENE SYNTHASE DEFICIENCY	Pathogenic(Last reviewed: Oct 25, 2018)	no assertion criteria provided	VCV000587360					587360	578310		
NM_015531.6(C2CD3):c.3911-2A>T	C2CD3		Orofaciodigital syndrome xiv	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144040	11	73796017	11	74084972	144040	153779	rs149366137	NC_000011.10:74084971:T:A
NM_015531.6(C2CD3):c.3085T>G (p.Cys1029Gly)	C2CD3	C1029G	Orofaciodigital syndrome xiv	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144039	11	73806348	11	74095303	144039	153778	rs587777654	NC_000011.10:74095302:A:C
NM_001814.6(CTSC):c.1056del (p.Phe351_Tyr352insTer)	CTSC		Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000139654	11	88027510	11	88294342	139654	150118		NC_000011.10:88294341:A:
NM_001814.6(CTSC):c.1235A>G (p.Tyr412Cys)	CTSC	Y412C	Periodontitis, aggressive, 1	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000007300	11	88027331	11	88294163	7300	22339	rs28937571	NC_000011.10:88294162:T:C
NM_001814.6(CTSC):c.380A>C (p.His127Pro)	CTSC	H127P	Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000007299	11	88045661	11	88312493	7299	22338		NC_000011.10:88312492:T:G
NM_001814.6(CTSC):c.1287G>C (p.Trp429Cys)	CTSC	W429C	Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000007298	11	88027279	11	88294111	7298	22337		NC_000011.10:88294110:C:G
NM_001814.6(CTSC):c.901G>A (p.Gly301Ser)	CTSC	G301S	Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000007297	11	88027665	11	88294497	7297	22336		NC_000011.10:88294496:C:T
NM_001814.6(CTSC):c.116G>C (p.Trp39Ser)	CTSC	W39S	Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000007296	11	88070725	11	88337557	7296	22335		NC_000011.10:88337556:C:G
NM_001814.6(CTSC):c.1047del (p.Gly350fs)	CTSC	G350fs	Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000007293	11	88027519	11	88294351	7293	22332		NC_000011.10:88294350:T:
NM_001814.6(CTSC):c.856C>T (p.Gln286Ter)	CTSC	E286*, Q286*	Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000007292	11	88029334	11	88296166	7292	22331		NC_000011.10:88296165:G:A
NM_001814.6(CTSC):c.890-1G>A	CTSC		Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000007290	11	88027677	11	88294509	7290	22329		NC_000011.10:88294508:C:T
NM_021978.4(ST14):c.3G>A (p.Met1Ile)	ST14	M1I	Ichthyosis, congenital, autosomal recessive 11	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000004039	11	130029877	11	130159982	4039	19078	rs137852932	NC_000011.10:130159981:G:A
NM_021978.4(ST14):c.2479G>A (p.Gly827Arg)	ST14	G827R	Ichthyosis, congenital, autosomal recessive 11	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000004038	11	130079629	11	130209734	4038	19077	rs137852931	NC_000011.10:130209733:G:A
NM_001814.6(CTSC):c.203T>G (p.Leu68Arg)	CTSC	L68R	Periodontitis, aggressive, 1|Papillon-Lefèvre syndrome|Haim-Munk syndrome	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000839668	11	88068220	11	88335052	839668	839161		NC_000011.10:88335051:A:C
NM_016042.4(EXOSC3):c.571G>T (p.Gly191Cys)	EXOSC3	G191C	Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000183048	9	37782038	9	37782041	183048	181189	rs730882145	NC_000009.12:37782040:C:A
NM_016042.4(EXOSC3):c.112del (p.Glu38fs)	EXOSC3	E38fs	Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	VCV000129023	9	37784930	9	37784933	129023	134469	rs587780333	NC_000009.12:37784932:CC:C
NM_021978.4(ST14):c.2034del (p.Leu678fs)	ST14	L678fs	Ichthyosis, congenital, autosomal recessive 11	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000126420	11	130078344	11	130208449	126420	131952	rs587777263	NC_000011.10:130208448:G:
NM_021978.4(ST14):c.2269+1G>A	ST14		Ichthyosis, congenital, autosomal recessive 11	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000126419	11	130078580	11	130208685	126419	131951	rs587777262	NC_000011.10:130208684:G:A
NM_016042.4(EXOSC3):c.712T>C (p.Trp238Arg)	EXOSC3	W238R	Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Apr 29, 2012)	no assertion criteria provided	VCV000031692	9	37780792	9	37780795	31692	40352	rs672601332	NC_000009.12:37780794:A:G
NM_016042.4(EXOSC3):c.294_303del (p.Val99fs)	EXOSC3	V99fs	Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Apr 29, 2012)	no assertion criteria provided	VCV000031690	9	37784739 - 37784748	9	37784742 - 37784751	31690	40350	rs672601331	NC_000009.12:37784741:CCAGTAAACACC:CC
NM_016042.4(EXOSC3):c.415G>C (p.Ala139Pro)	EXOSC3	A139P	Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Apr 29, 2012)	no assertion criteria provided	VCV000031689	9	37783970	9	37783973	31689	40349	rs387907195	NC_000009.12:37783972:C:G
NM_001286577.1(C2CD3):c.4951+1G>T	C2CD3		Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217559	11	73785297	11	74074252	217559	214313	rs863225151	NC_000011.10:74074251:C:A
NM_001814.6(CTSC):c.857A>G (p.Gln286Arg)	CTSC	Q286R	not provided|Haim-Munk syndrome	Pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	VCV000007294	11	88029333	11	88296165	7294	22333	rs104894208	NC_000011.10:88296164:T:C
NM_001173990.3(TMEM216):c.218G>A (p.Arg73His)	TMEM216	R73H, R12H	Joubert syndrome 2||Joubert syndrome	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000000198	11	61161437	11	61393965	198	15237	rs201108965	NC_000011.10:61393964:G:A
NM_000370.3(TTPA):c.552+2T>A	TTPA		Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000267262	8	63978461	8	63065902	267262	262263	rs886040964	NC_000008.11:63065901:A:T
NM_000370.3(TTPA):c.205-1G>T	TTPA		Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000267261	8	63985648	8	63073089	267261	262264	rs886040963	NC_000008.11:63073088:C:A
NM_016042.4(EXOSC3):c.155del (p.Pro52fs)	EXOSC3	P52fs	Pontocerebellar hypoplasia, type 1b|not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280004	9	37784887	9	37784890	280004	264333	rs886041316	NC_000009.12:37784889:GG:G
NM_001814.6(CTSC):c.1040A>G (p.Tyr347Cys)	CTSC	Y347C	Periodontitis, aggressive, 1|Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000007301	11	88027526	11	88294358	7301	22340	rs104894211	NC_000011.10:88294357:T:C
NM_017760.7(NCAPG2):c.2548A>C (p.Thr850Pro)	NCAPG2	T850P	KHAN-KHAN-KATSANIS SYNDROME	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000633700	7	158447908	7	158655216	633700	622132	rs1563515856	NC_000007.14:158655215:T:G
NM_017760.7(NCAPG2):c.2078C>T (p.Thr693Met)	NCAPG2	T693M	KHAN-KHAN-KATSANIS SYNDROME	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000633699	7	158449380	7	158656688	633699	622131	rs772209292	NC_000007.14:158656687:G:A
NM_017760.7(NCAPG2):c.1825A>G (p.Lys609Glu)	NCAPG2	K609E	KHAN-KHAN-KATSANIS SYNDROME	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000633698	7	158455050	7	158662358	633698	622130	rs1299537743	NC_000007.14:158662357:T:C
NM_002017.5(FLI1):c.1033A>G (p.Lys345Glu)	FLI1	K345E, K152E, K279E, K312E	Bleeding disorder, platelet-type, 21	Pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000424636	11	128680557	11	128810662	424636	411537	rs1064797087	NC_000011.10:128810661:A:G
NM_002017.5(FLI1):c.1028A>G (p.Tyr343Cys)	FLI1	Y343C, Y150C, Y277C, Y310C	Bleeding disorder, platelet-type, 21	Pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000424633	11	128680552	11	128810657	424633	411534	rs1064797084	NC_000011.10:128810656:A:G
NM_003221.4(TFAP2B):c.435_438CCGG[1] (p.Pro147fs)	TFAP2B		Patent ductus arteriosus 2	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000243019	6	50791472 - 50791475	6	50823759 - 50823762	243019	244101	rs879253871	NC_000006.12:50823758:GCCGGCCGG:GCCGG
NM_003221.4(TFAP2B):c.541-2A>T	TFAP2B		Patent ductus arteriosus 2	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000243018	6	50796330	6	50828617	243018	244100	rs879253870	NC_000006.12:50828616:A:T
NM_003221.4(TFAP2B):c.650del (p.Gly217fs)	TFAP2B	G217fs	Char syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000599040	6	50803821	6	50836108	599040	590168	rs1561964103	NC_000006.12:50836107:GG:G
NM_003221.4(TFAP2B):c.822-1G>C	TFAP2B		Char syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000021361	6	50805687	6	50837974	21361	34213	rs80338916	NC_000006.12:50837973:G:C
NM_002017.5(FLI1):c.992_995del (p.Asn331fs)	FLI1	N298fs, N138fs, N265fs, N331fs	Bleeding disorder, platelet-type, 21|Thrombocytopenia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000424634	11	128680515 - 128680518	11	128810620 - 128810623	424634	411535	rs1064797085	NC_000011.10:128810619:AATTA:A
NM_003221.4(TFAP2B):c.706C>T (p.Arg236Cys)	TFAP2B	R225C, R236C	Char syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000008041	6	50803878	6	50836165	8041	23080	rs80338912	NC_000006.12:50836164:C:T
ARG1, IVS4AS, A-G, -2	ARG1		Arginase deficiency	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000002396					2396	17435		
ARG1, 1-BP DEL, NT72	ARG1		Arginase deficiency	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000002387					2387	17426		
ARG1, 4-BP DEL, 262AAGA	ARG1		Arginase deficiency	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000002386					2386	17425		
NM_000474.4(TWIST1):c.376G>T (p.Glu126Ter)	TWIST1	E130*, E126*	Craniosynostosis 1|Saethre-Chotzen syndrome|Saethre-Chotzen syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000007977	7	19156569	7	19116946	7977	23016	rs121909188	NC_000007.14:19116945:C:A
NM_001814.6(CTSC):c.628C>T (p.Arg210Ter)	CTSC	R210*	Haim-Munk syndrome|Periodontitis, aggressive, 1|Papillon-Lefèvre syndrome|Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000007289	11	88042344	11	88309176	7289	22328		NC_000011.10:88309175:G:A
NM_002017.5(FLI1):c.970C>T (p.Arg324Trp)	FLI1	R131W, R258W, R291W, R324W	Bleeding disorder platelet type macrothrombocytopenia|Bleeding disorder, platelet-type, 21	Pathogenic(Last reviewed: Jan 21, 2015)	criteria provided, single submitter	VCV000217031	11	128680494	11	128810599	217031	213674	rs773148506	NC_000011.10:128810598:C:T
NM_003221.4(TFAP2B):c.218C>G (p.Pro73Arg)	TFAP2B	P62R, P73R	Char syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000008044	6	50791256	6	50823543	8044	23083	rs80338910	NC_000006.12:50823542:C:G
NM_003221.4(TFAP2B):c.706C>A (p.Arg236Ser)	TFAP2B	R225S, R236S	Char syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000008042	6	50803878	6	50836165	8042	23081	rs80338912	NC_000006.12:50836164:C:A
NM_003221.4(TFAP2B):c.898C>T (p.Arg300Cys)	TFAP2B	R289C, R300C	Char syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000008040	6	50805764	6	50838051	8040	23079	rs80338917	NC_000006.12:50838050:C:T
NM_003221.4(TFAP2B):c.824C>A (p.Ala275Asp)	TFAP2B	A264D, A275D	Char syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000008039	6	50805690	6	50837977	8039	23078	rs80338914	NC_000006.12:50837976:C:A
NM_001289808.2(CRYAB):c.358A>G (p.Arg120Gly)	CRYAB	R120G, R53G	Alpha-B crystallinopathy	Pathogenic(Last reviewed: Oct 29, 2012)	no assertion criteria provided	VCV000016953	11	111779658	11	111908934	16953	31992	rs104894201	NC_000011.10:111908933:T:C
NM_005157.6(ABL1):c.706G>A (p.Glu236Lys)	ABL1	E255K, E236K	Leukemia, Philadelphia chromosome-positive, resistant to imatinib|Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	VCV000012626	9	133738306	9	130862919	12626	27665	rs387906517	NC_000009.12:130862918:G:A
NM_207111.4(RNF216):c.930del (p.Glu310fs)	RNF216	E310fs, E253fs	not provided	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000817880	7	5780718	7	5741087	817880	805543		NC_000007.14:5741086:C:
NM_207111.4(RNF216):c.687G>A (p.Trp229Ter)	RNF216	W172*, W229*	not provided	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000841220	7	5780961	7	5741330	841220	833729		NC_000007.14:5741329:C:T
NC_000009.12:g.128634800_128634801TC[1]	WDR34		Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000838321	9	131397078 - 131397079	9	128634799 - 128634800	838321	835550		NC_000009.12:128634798:CTCTC:CTC
GRCh37/hg19 7p22.1(chr7:5692044-5692141)	RNF216		Gordon Holmes syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000813323	7	5692044 - 5692141			813323	801572		
NM_052844.3(WDR34):c.26del (p.Pro9fs)	WDR34	P9fs	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000576613	9	131418980	9	128656701	576613	562828	rs763975565	NC_000009.12:128656700:GG:G
NM_000544.3(TAP2):c.958del (p.Glu320fs)	TAP2	E320fs	Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000571072	6	32800589	6	32832812	571072	565555	rs1562331529	NC_000006.12:32832811:CCC:CC
NM_052844.3(WDR34):c.935T>C (p.Phe312Ser)	WDR34	F312S	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446626	9	131397417	9	128635138	446626	440114	rs1554771175	NC_000009.12:128635137:A:G
NM_052844.3(WDR34):c.544C>T (p.Arg182Trp)	WDR34	R182W	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446625	9	131399198	9	128636919	446625	440115	rs555811074	NC_000009.12:128636918:G:A
NM_052844.3(WDR34):c.1397A>C (p.Gln466Pro)	WDR34	Q466P	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446624	9	131396237	9	128633958	446624	440112	rs1554770620	NC_000009.12:128633957:T:G
NM_052844.3(WDR34):c.1060A>G (p.Thr354Ala)	WDR34	T354A	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446623	9	131397122	9	128634843	446623	440113	rs1554771066	NC_000009.12:128634842:T:C
NM_052844.3(WDR34):c.1567_1582del (p.Glu523fs)	WDR34	E523fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446622	9	131396052 - 131396067	9	128633773 - 128633788	446622	440110	rs1554770453	NC_000009.12:128633772:CCAGGTCCTCAGCTTCCC:CC
NM_052844.3(WDR34):c.1480C>T (p.Gln494Ter)	WDR34	Q494*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446621	9	131396154	9	128633875	446621	440111	rs751323441	NC_000009.12:128633874:G:A
NM_052844.3(WDR34):c.1307A>G (p.Lys436Arg)	WDR34	K436R	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097045	9	131396570	9	128634291	97045	102950	rs587777098	NC_000009.12:128634290:T:C
NM_052844.3(WDR34):c.472C>T (p.Gln158Ter)	WDR34	Q158*	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097044	9	131399270	9	128636991	97044	102949	rs587777097	NC_000009.12:128636990:G:A
NM_052844.3(WDR34):c.1539_1540CA[1] (p.Thr514fs)	WDR34		Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097043	9	131396092 - 131396093	9	128633813 - 128633814	97043	102948	rs431905519	NC_000009.12:128633812:TGTG:TG
NM_052844.3(WDR34):c.982-2A>C	WDR34		Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097041	9	131397202	9	128634923	97041	102946	rs587777095	NC_000009.12:128634922:T:G
NM_052844.3(WDR34):c.1340G>A (p.Arg447Gln)	WDR34	R447Q	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097040	9	131396537	9	128634258	97040	102945	rs587777094	NC_000009.12:128634257:C:T
NM_052844.3(WDR34):c.1061C>T (p.Thr354Met)	WDR34	T345M, T354M	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097038	9	131397121	9	128634842	97038	102943	rs587777092	NC_000009.12:128634841:G:A
NM_052844.3(WDR34):c.1022C>T (p.Ala341Val)	WDR34	A314V, A341V	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097037	9	131397160	9	128634881	97037	102942	rs587777091	NC_000009.12:128634880:G:A
TAP2, 1-BP DEL	TAP2		Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Nov 6, 1999)	no assertion criteria provided	VCV000013728					13728	28767		
NM_000544.3(TAP2):c.817C>T (p.Arg273Ter)	TAP2	R253*, R273*	Bare lymphocyte syndrome type 1	Pathogenic(Last reviewed: Jul 8, 1994)	no assertion criteria provided	VCV000013727	6	32803059	6	32835282	13727	28766		NC_000006.12:32835281:G:A
NM_207111.4(RNF216):c.202-1G>C	RNF216		Gordon Holmes syndrome	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587594	7	5781447	7	5741816	587594	578460	rs1562451985	NC_000007.14:5741815:C:G
NM_207111.4(RNF216):c.1616A>G (p.Tyr539Cys)	RNF216	Y539C, Y482C	Gordon Holmes syndrome	Pathogenic(Last reviewed: Apr 28, 2015)	no assertion criteria provided	VCV000199656	7	5760692	7	5721061	199656	196434	rs148642312	NC_000007.14:5721060:T:C
NM_207111.4(RNF216):c.904C>T (p.Gln302Ter)	RNF216	Q302*, Q245*	Gordon Holmes syndrome	Pathogenic(Last reviewed: Apr 28, 2015)	no assertion criteria provided	VCV000199655	7	5780744	7	5741113	199655	196433	rs373785974	NC_000007.14:5741112:G:A
NM_207111.4(RNF216):c.1367G>A (p.Gly456Glu)	RNF216	G456E, G399E	Gordon Holmes syndrome	Pathogenic(Last reviewed: Apr 28, 2015)	no assertion criteria provided	VCV000199654	7	5769085	7	5729454	199654	196432	rs794728000	NC_000007.14:5729453:C:T
NM_052844.3(WDR34):c.1339C>T (p.Arg447Trp)	WDR34	R447W	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097039	9	131396538	9	128634259	97039	102944	rs587777093	NC_000009.12:128634258:G:A
NM_207111.4(RNF216):c.613_614GA[1] (p.Glu205fs)	RNF216		Gordon Holmes syndrome	Pathogenic(Last reviewed: May 23, 2013)	no assertion criteria provided	VCV000050914	7	5781032 - 5781033	7	5741401 - 5741402	50914	65576	rs387907370	NC_000007.14:5741400:TCTCT:TCT
NM_207111.4(RNF216):c.1791T>A (p.Cys597Ter)	RNF216	C597*, C540*	Gordon Holmes syndrome	Pathogenic(Last reviewed: May 23, 2013)	no assertion criteria provided	VCV000050913	7	5754726	7	5715095	50913	65575	rs387907369	NC_000007.14:5715094:A:T
NM_052844.3(WDR34):c.1312_1313del (p.Leu438fs)	WDR34	L438fs	Short-rib thoracic dysplasia 11 with or without polydactyly	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000665979	9	131396564 - 131396565	9	128634285 - 128634286	665979	637768		NC_000009.12:128634284:AGA:A
NM_207111.4(RNF216):c.2251C>T (p.Arg751Cys)	RNF216	R751C, R694C	Gordon Holmes syndrome	Pathogenic(Last reviewed: May 23, 2013)	no assertion criteria provided	VCV000050912	7	5680916	7	5641285	50912	65574	rs387907368	NC_000007.14:5641284:G:A
NM_203290.4(POLR1C):c.836G>A (p.Arg279Gln)	POLR1C	R279Q	Leukodystrophy, hypomyelinating, 11||not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030811	6	43488700	6	43520962	30811	39768	rs191582628	NC_000006.12:43520961:G:A
NM_000102.4(CYP17A1):c.1459_1467del (p.Asp487_Phe489del)	CYP17A1		Deficiency of steroid 17-alpha-monooxygenase|not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000631622	10	104590519 - 104590527	10	102830762 - 102830770	631622	620342	rs756135168	NC_000010.11:102830761:GAAAGAGTCGA:GA
NM_001286577.1(C2CD3):c.184C>T (p.Arg62Ter)	C2CD3	R62*	Joubert syndrome|Orofaciodigital syndrome xiv	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000144038	11	73879530	11	74168485	144038	153777	rs587777653	NC_000011.10:74168484:G:A
NM_001814.6(CTSC):c.96T>G (p.Tyr32Ter)	CTSC	Y32*	Periodontitis, aggressive, 1|Papillon-Lefèvre syndrome|Haim-Munk syndrome|Papillon-Lefèvre syndrome	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000139655	11	88070745	11	88337577	139655	150119		NC_000011.10:88337576:A:C
NM_000111.3(SLC26A3):c.1696C>T (p.Arg566Ter)	SLC26A3	R566*	Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802343	7	107415299	7	107774854	802343	790671		NC_000007.14:107774853:G:A
NM_020661.4(AICDA):c.416T>C (p.Met139Thr)	AICDA	M139T	not provided	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000636339	12	8757822	12	8605226	636339	624464		NC_000012.12:8605225:A:G
PEX16, DEL, EX11	PEX16		Peroxisome biogenesis disorder 8B	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030353					30353	39309		
NM_057174.2(PEX16):c.953-96A>G	PEX16	Y331C	Peroxisome biogenesis disorder 8B	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030352	11	45931824	11	45910273	30352	39308	rs397514472	NC_000011.10:45910272:T:C
NM_057174.2(PEX16):c.953-104del	PEX16	I330fs	Peroxisome biogenesis disorder 8B	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030351	11	45931832	11	45910281	30351	39307		NC_000011.10:45910280:C:
NM_000111.2(SLC26A3):c.1386G>A (p.Trp462Ter)	SLC26A3	W462*	Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000016761	7	107420134	7	107779689	16761	31800	rs121913033	NC_000007.14:107779688:C:T
SLC26A3, 13-BP DEL	SLC26A3		Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000016760					16760	31799		
SLC26A3, 1-BP DEL, T344	SLC26A3		Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000016756					16756	31795		
NM_000111.2(SLC26A3):c.371A>T (p.His124Leu)	SLC26A3	H124L	Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000016755	7	107432286	7	107791841	16755	31794	rs121913030	NC_000007.14:107791840:T:A
NM_057174.2(PEX16):c.952+2T>C	PEX16		Peroxisome biogenesis disorder 8A	Pathogenic(Last reviewed: Mar 22, 2002)	no assertion criteria provided	VCV000006467	11	45932447	11	45910896	6467	21506		NC_000011.10:45910895:A:G
NM_020661.4(AICDA):c.177_185del (p.Leu59_Leu62delinsPhe)	AICDA			Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005130	12	8758053 - 8758061	12	8605457 - 8605465	5130	20169	rs387906329	NC_000012.12:8605456:AGGAAGAGCA:A
NM_020661.4(AICDA):c.22_40del (p.Arg8fs)	AICDA	R8fs		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005129	12	8759577 - 8759595	12	8606981 - 8606999	5129	20168	rs387906328	NC_000012.12:8606980:GGTAAAGAAACTTCCTCCGG:G
NM_020661.4(AICDA):c.452T>C (p.Phe151Ser)	AICDA	F151S		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005128	12	8757494	12	8604898	5128	20167	rs104894327	NC_000012.12:8604897:A:G
NM_020661.4(AICDA):c.441C>A (p.Cys147Ter)	AICDA	C147*		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005127	12	8757505	12	8604909	5127	20166	rs104894323	NC_000012.12:8604908:G:T
NM_020661.4(AICDA):c.415A>G (p.Met139Val)	AICDA	M139V		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005126	12	8757823	12	8605227	5126	20165	rs104894322	NC_000012.12:8605226:T:C
NM_020661.4(AICDA):c.317T>C (p.Leu106Pro)	AICDA	L106P		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005125	12	8757921	12	8605325	5125	20164	rs104894321	NC_000012.12:8605324:A:G
NM_020661.4(AICDA):c.238T>C (p.Trp80Arg)	AICDA	W80R		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005124	12	8758000	12	8605404	5124	20163	rs104894320	NC_000012.12:8605403:A:G
NM_020661.4(AICDA):c.203G>A (p.Trp68Ter)	AICDA	W68*		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005123	12	8758035	12	8605439	5123	20162	rs104894325	NC_000012.12:8605438:C:T
NM_020661.4(AICDA):c.70C>T (p.Arg24Trp)	AICDA	R24W		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005122	12	8759547	12	8606951	5122	20161	rs104894324	NC_000012.12:8606950:G:A
NC_000012.11:g.(?_8756860)_(8765383_?)del	AICDA			Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000657907	12	8756860 - 8765383	12	8604264 - 8612787	657907	652271		
NM_020661.4(AICDA):c.251G>A (p.Trp84Ter)	AICDA	W84*	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000035655	12	8757987	12	8605391	35655	44320	rs193922703	NC_000012.12:8605390:C:T
SLC26A3, 3.5-KB DEL	SLC26A3		Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000016757					16757	31796		
NM_020661.4(AICDA):c.334C>T (p.Arg112Cys)	AICDA	R112C	not provided|	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379250	12	8757904	12	8605308	379250	372576	rs1057520542	NC_000012.12:8605307:G:A
NM_057174.2(PEX16):c.526C>T (p.Arg176Ter)	PEX16	R176*	Peroxisome biogenesis disorder 8A|not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000006466	11	45936170	11	45914619	6466	21505	rs61752117	NC_000011.10:45914618:G:A
NM_000111.2(SLC26A3):c.951_953del (p.Val318del)	SLC26A3	V318del	Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000016754	7	107427290 - 107427292	7	107786845 - 107786847	16754	31793	rs386833491	NC_000007.14:107786844:ACCAC:AC
NM_003221.4(TFAP2B):c.601+5G>A	TFAP2B		Char syndrome|Patent ductus arteriosus 2	Pathogenic(Last reviewed: Jan 2, 2013)	no assertion criteria provided	VCV000021359	6	50796397	6	50828684	21359	34211	rs80338911	NC_000006.12:50828683:G:A
NM_003221.4(TFAP2B):c.854G>A (p.Arg285Gln)	TFAP2B	R274Q, R285Q	Char syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000008043	6	50805720	6	50838007	8043	23082	rs80338915	NC_000006.12:50838006:G:A
NM_000045.4(ARG1):c.32T>C (p.Ile11Thr)	ARG1	I11T	Arginase deficiency	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000002393	6	131894454	6	131573314	2393	17432	rs28941474	NC_000006.12:131573313:T:C
NM_000370.3(TTPA):c.88_118del (p.Ala30fs)	TTPA	A30fs	not provided|Familial isolated deficiency of vitamin E	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550204	8	63998463 - 63998493	8	63085904 - 63085934	550204	544457	rs1554525125	NC_000008.11:63085903:CGCCAGCTTCCCGGGCCCGGCGCCGCAGCGCCGCCAG:CGCCAG
NM_001080453.3(INTS1):c.5881C>T (p.Gln1961Ter)	INTS1	Q1961*	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Jan 24, 2020)	no assertion criteria provided	VCV000689525	7	1513278	7	1473642	689525	677203		NC_000007.14:1473641:G:A
NM_001080453.3(INTS1):c.1645A>G (p.Met549Val)	INTS1	M549V	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Jan 24, 2020)	no assertion criteria provided	VCV000689524	7	1535858	7	1496222	689524	677202		NC_000007.14:1496221:T:C
NM_001080453.3(INTS1):c.5621C>T (p.Pro1874Leu)	INTS1	P1874L	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Sep 11, 2019)	no assertion criteria provided	VCV000689523	7	1514356	7	1474720	689523	677201		NC_000007.14:1474719:G:A
NM_001080453.3(INTS1):c.5398dup (p.Arg1800fs)	INTS1		NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Sep 11, 2019)	no assertion criteria provided	VCV000689522	7	1515687 - 1515688	7	1476051 - 1476052	689522	677200		NC_000007.14:1476051:GG:GGG
NM_001080453.3(INTS1):c.229C>T (p.Arg77Cys)	INTS1	R77C	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Sep 11, 2019)	no assertion criteria provided	VCV000689521	7	1542657	7	1503021	689521	677199		NC_000007.14:1503020:G:A
NM_001080453.3(INTS1):c.5351C>A (p.Ser1784Ter)	INTS1	S1784*	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Sep 11, 2019)	no assertion criteria provided	VCV000689520	7	1515892	7	1476256	689520	677198		NC_000007.14:1476255:G:T
NM_001080453.3(INTS1):c.6381C>G (p.Tyr2127Ter)	INTS1	Y2127*	not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000643062	7	1510558	7	1470922	643062	635851		NC_000007.14:1470921:G:C
NM_003018.4(SFTPC):c.581T>C (p.Leu194Pro)	SFTPC	L194P, L141P, L188P	Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000013214	8	22021541	8	22164028	13214	28253	rs121918560	NC_000008.11:22164027:T:C
NM_003018.4(SFTPC):c.196G>A (p.Glu66Lys)	SFTPC	E66K	Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000013213	8	22020240	8	22162727	13213	28252	rs121917836	NC_000008.11:22162726:G:A
NM_003018.4(SFTPC):c.347C>A (p.Ala116Asp)	SFTPC	A116D, A63D	Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: Jan 13, 2005)	no assertion criteria provided	VCV000013212	8	22020971	8	22163458	13212	28251	rs121918559	NC_000008.11:22163457:C:A
NM_003018.4(SFTPC):c.435+1G>T	SFTPC		Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: Feb 22, 2001)	no assertion criteria provided	VCV000013211	8	22021060	8	22163547	13211	28250		NC_000008.11:22163546:G:T
SFTPC, IVS4DS, G-A, +1	SFTPC		Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: Feb 15, 2003)	no assertion criteria provided	VCV000013207					13207	28246		
NM_003018.4(SFTPC):c.563T>A (p.Leu188Gln)	SFTPC	L188Q, L135Q, L182Q	Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000013210	8	22021523	8	22164010	13210	28249	rs121917835	NC_000008.11:22164009:T:A
NM_000111.2(SLC26A3):c.2024_2026dup (p.Ile675dup)	SLC26A3		Congenital secretory diarrhea, chloride type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000055988	7	107412534 - 107412535	7	107772089 - 107772090	55988	70627	rs121913031	NC_000007.14:107772089:TGAT:TGATGAT
NM_000278.5(PAX2):c.890C>G (p.Ser297Ter)	PAX2	S320*, S328*, S297*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000522066	10	102568964	10	100809207	522066	511851	rs1554865146	NC_000010.11:100809206:C:G
NM_182746.3(MCM4):c.71-2A>G	MCM4		Natural killer cell and glucocorticoid deficiency with DNA repair defect	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000037234	8	48874074	8	47961514	37234	45829	rs1563829725	NC_000008.11:47961513:A:G
NM_078480.3(PUF60):c.389G>A (p.Arg130His)	PUF60	R130H, R101H, R129H, R87H, R150H, R70H, R112H, R113H, R167H, R84H	Verheij syndrome|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488376	8	144900664	8	143818494	488376	481211	rs1554643584	NC_000008.11:143818493:C:T
NM_005271.5(GLUD1):c.965G>A (p.Arg322His)	GLUD1	R269H, R322H, R155H, R189H	Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016129	10	88820766	10	87061009	16129	31168	rs121909737	NC_000010.11:87061008:C:T
NM_001701.4(BAAT):c.226A>G (p.Met76Val)	BAAT	M76V	Hypercholanemia, familial	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000006720	9	104133461	9	101371179	6720	21759	rs28937579	NC_000009.12:101371178:T:C
NM_001142459.2(ASB10):c.619G>C (p.Val207Leu)	ASB10	V192L, V207L	Glaucoma 1, open angle, F	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000050953	7	150878511	7	151181424	50953	65620	rs104886474	NC_000007.14:151181423:C:G
NM_001142459.2(ASB10):c.564C>A (p.Cys188Ter)	ASB10	C173*, C188*	Glaucoma 1, open angle, F	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000050952	7	150883499	7	151186412	50952	65619	rs151344606	NC_000007.14:151186411:G:T
NM_001142459.2(ASB10):c.810C>T (p.Thr270=)	ASB10	T255T	Glaucoma 1, open angle, F	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000050951	7	150878320	7	151181233	50951	65618	rs104886478	NC_000007.14:151181232:G:A
NM_001701.4(BAAT):c.967A>G (p.Ile323Val)	BAAT	I323V	Atypical hemolytic-uremic syndrome 1	Pathogenic(Last reviewed: Mar 10, 2011)	no assertion criteria provided	VCV000021301	9	104125000	9	101362718	21301	34153	rs80356747	NC_000009.12:101362717:T:C
NM_001701.4(BAAT):c.858C>G (p.Ser286=)	BAAT		Atypical hemolytic-uremic syndrome 1	Pathogenic(Last reviewed: Mar 10, 2011)	no assertion criteria provided	VCV000021300	9	104125109	9	101362827	21300	34152	rs80356746	NC_000009.12:101362826:G:C
NM_001031710.3(KLHL7):c.458C>T (p.Ala153Val)	KLHL7	A153V, A105V	Retinal dystrophy|not provided|Retinitis pigmentosa|Retinitis pigmentosa 42	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001009	7	23180403	7	23140784	1009	16048	rs137853113	NC_000007.14:23140783:C:T
NM_001289808.2(CRYAB):c.343del (p.Ser115fs)	CRYAB	S48fs, S115fs	Dilated cardiomyopathy 1II|not provided|Alpha-B crystallinopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038963	11	111779673	11	111908949	38963	47566	rs281865142	NC_000011.10:111908948:A:
NM_000045.4(ARG1):c.57+1G>A	ARG1		Arginase deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002395	6	131894480	6	131573340	2395	17434	rs587776539	NC_000006.12:131573339:G:A
NM_006734.4(HIVEP2):c.3528del (p.Tyr1177fs)	HIVEP2	Y1177fs	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817430	6	143092348	6	142771211	817430	805470		NC_000006.12:142771210:GG:G
NM_006734.4(HIVEP2):c.5953_5954AC[1] (p.Pro1986fs)	HIVEP2		not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000817285	6	143081469 - 143081470	6	142760332 - 142760333	817285	805468		NC_000006.12:142760331:GTGT:GT
NM_006734.4(HIVEP2):c.5819del (p.Pro1940fs)	HIVEP2	P1940fs	not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000817181	6	143081606	6	142760469	817181	805469		NC_000006.12:142760468:GG:G
NM_006734.4(HIVEP2):c.3742C>T (p.Gln1248Ter)	HIVEP2	Q1248*	not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000620259	6	143092134	6	142770997	620259	611647	rs1562505335	NC_000006.12:142770996:G:A
NM_006734.4(HIVEP2):c.6667C>T (p.Arg2223Ter)	HIVEP2	R2223*	not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000620226	6	143074918	6	142753781	620226	611646	rs1562493608	NC_000006.12:142753780:G:A
NM_133645.3(MTO1):c.1537C>T (p.Arg513Ter)	MTO1	R488*, R513*, R528*	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000488996	6	74191964	6	73482241	488996	481769	rs771939280	NC_000006.12:73482240:C:T
NM_000507.4(FBP1):c.267del (p.Phe90fs)	FBP1	F90fs	not provided	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000427178	9	97382677	9	94620395	427178	415206	rs1085308003	NC_000009.12:94620394:GG:G
NM_006734.4(HIVEP2):c.5900del (p.Ser1967fs)	HIVEP2	S1967fs	not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000422837	6	143081525	6	142760388	422837	406822	rs1064796034	NC_000006.12:142760387:G:
NM_000507.4(FBP1):c.114_119dup (p.Cys39_Thr40dup)	FBP1		not provided	Pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	VCV000419848	9	97401473 - 97401474	9	94639191 - 94639192	419848	407727	rs1554682769	NC_000009.12:94639191:GTGCAG:GTGCAGGTGCAG
NM_000507.4(FBP1):c.960delinsGG (p.Ser321fs)	FBP1		not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000372364	9	97365720	9	94603438	372364	359779	rs1057517733	NC_000009.12:94603437:T:CC
NM_006734.4(HIVEP2):c.2905C>T (p.Gln969Ter)	HIVEP2	Q969*	not provided	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000224792	6	143092971	6	142771834	224792	226611	rs869312842	NC_000006.12:142771833:G:A
NM_006734.4(HIVEP2):c.5744del (p.Asp1915fs)	HIVEP2	D1915fs	not provided	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000861448	6	143081681	6	142760544	861448	831619		NC_000006.12:142760543:T:
NM_012123.4(MTO1):c.1201C>T (p.Arg401Ter)	MTO1	R401*, R426*	Combined oxidative phosphorylation deficiency 10	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000840849	6	74190469	6	73480746	840849	832341		NC_000006.12:73480745:C:T
NM_012123.4(MTO1):c.97del (p.Arg33fs)	MTO1	R33fs	Combined oxidative phosphorylation deficiency 10	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638475	6	74171671	6	73461948	638475	626167		NC_000006.12:73461947:CCCC:CCC
NM_006734.4(HIVEP2):c.3461_3492dup (p.Glu1165fs)	HIVEP2		Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000620051	6	143092383 - 143092384	6	142771246 - 142771247	620051	611391	rs1562505675	NC_000006.12:142771246:CTGACTGTCCATGTGCATGATCTGTGGCTGGGC:CTGACTGTCCATGTGCATGATCTGTGGCTGGGCTGACTGTCCATGTGCATGATCTGTGGCTGGGC
NM_012123.4(MTO1):c.1822del (p.Leu608fs)	MTO1	L608fs, L648fs, L633fs	Combined oxidative phosphorylation deficiency 10	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000574880	6	74207524	6	73497801	574880	560961	rs1561954433	NC_000006.12:73497800:C:
NM_006734.4(HIVEP2):c.3556C>T (p.Gln1186Ter)	HIVEP2	Q1186*	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000236212	6	143092320	6	142771183	236212	237780	rs878853269	NC_000006.12:142771182:G:A
NM_006734.4(HIVEP2):c.2857G>T (p.Glu953Ter)	HIVEP2	E953*	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000224794	6	143093019	6	142771882	224794	226612	rs869312843	NC_000006.12:142771881:C:A
NM_006734.4(HIVEP2):c.6475G>T (p.Gly2159Ter)	HIVEP2	G2159*	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000224793	6	143080950	6	142759813	224793	226609	rs761993070	NC_000006.12:142759812:C:A
NM_012123.4(MTO1):c.1232C>T (p.Thr411Ile)	MTO1	T411I, T436I	Combined oxidative phosphorylation deficiency 10	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089038	6	74190500	6	73480777	89038	94579	rs398122419	NC_000006.12:73480776:C:T
NM_012123.4(MTO1):c.1858dup (p.Arg620fs)	MTO1		Combined oxidative phosphorylation deficiency 10	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000035495	6	74207559 - 74207560	6	73497836 - 73497837	35495	44168	rs397518449	NC_000006.12:73497836:A:AA
NM_000507.4(FBP1):c.577G>T (p.Glu193Ter)	FBP1	E193*	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000853649	9	97369225	9	94606943	853649	836329		NC_000009.12:94606942:C:A
NM_000507.4(FBP1):c.544del (p.Val182fs)	FBP1	V182fs	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000835572	9	97372226	9	94609944	835572	836330		NC_000009.12:94609943:CCCC:CCC
NM_012472.6(LRRC6):c.538C>T (p.Arg180Ter)	LRRC6	R98*, R180*, R60*	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000834793	8	133645101	8	132632855	834793	834143		NC_000008.11:132632854:G:A
NM_012472.6(LRRC6):c.936_937del (p.Asp312fs)	LRRC6	D312fs, D230fs, D192fs	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000654068	8	133627321 - 133627322	8	132615075 - 132615076	654068	636608		NC_000008.11:132615074:TAT:T
NM_002906.3(RDX):c.551+2T>C	RDX		Deafness, autosomal recessive 24	Pathogenic	criteria provided, single submitter	VCV000638047	11	110128829	11	110258104	638047	625873		NC_000011.10:110258103:A:G
NM_000507.4(FBP1):c.778G>A (p.Gly260Arg)	FBP1	G260R	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Jul 12, 2014)	criteria provided, single submitter	VCV000561989	9	97367786	9	94605504	561989	553126	rs780803192	NC_000009.12:94605503:C:T
NM_000507.4(FBP1):c.841G>T (p.Glu281Ter)	FBP1	E281*	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548480	9	97365839	9	94603557	548480	539025	rs566453434	NC_000009.12:94603556:C:A
NM_012472.6(LRRC6):c.1050del (p.Gln351fs)	LRRC6	Q211fs, Q231fs, Q331fs, Q351fs, Q269fs	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000540328	8	133622502	8	132610256	540328	523502	rs763900107	NC_000008.11:132610255:AAA:AA
NM_012472.6(LRRC6):c.633C>A (p.Tyr211Ter)	LRRC6	Y211*, Y129*, Y91*	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000540325	8	133645006	8	132632760	540325	523011	rs750603177	NC_000008.11:132632759:G:T
NM_000507.4(FBP1):c.704del (p.Pro235fs)	FBP1	P235fs	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000403705	9	97369098	9	94606816	403705	390675	rs774362519	NC_000009.12:94606815:GGGGGG:GGGGG
NM_000507.4(FBP1):c.720_729del (p.Tyr241fs)	FBP1	Y241fs	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000403701	9	97367835 - 97367844	9	94605553 - 94605562	403701	390671	rs1060499726	NC_000009.12:94605552:GGCCCCATAAGG:GG
NM_006734.4(HIVEP2):c.5737del (p.Asp1913fs)	HIVEP2	D1913fs	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Nov 10, 2012)	no assertion criteria provided	VCV000236210	6	143081688	6	142760551	236210	237778	rs878853251	NC_000006.12:142760550:C:
NM_001260496.1(RDX):c.405-4131del	RDX	K438fs, K91fs, K302fs	Rare genetic deafness	Pathogenic(Last reviewed: Sep 7, 2013)	criteria provided, single submitter	VCV000179207	11	110106860	11	110236135	179207	175338	rs727504709	NC_000011.10:110236134:C:
NM_012472.6(LRRC6):c.562C>T (p.Gln188Ter)	LRRC6	Q188*, Q106*, Q68*	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000066028	8	133645077	8	132632831	66028	76938	rs397515461	NC_000008.11:132632830:G:A
NM_002906.3(RDX):c.698+1G>A	RDX		Deafness, autosomal recessive 24	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000013187	11	110128491	11	110257766	13187	28226		NC_000011.10:110257765:C:T
NM_001260494.1(RDX):c.60-5775C>T	RDX	Q155*, Q123*	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000013186	11	110134689	11	110263964	13186	28225	rs121918380	NC_000011.10:110263963:G:A
NM_001260496.1(RDX):c.405-1415dup	RDX		Deafness, autosomal recessive 24	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000013185	11	110104143 - 110104144	11	110233418 - 110233419	13185	28224		NC_000011.10:110233418:C:CC
NM_002906.3(RDX):c.1732G>A (p.Asp578Asn)	RDX	D578N, D231N, D174N, D442N	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000013184	11	110102614	11	110231889	13184	28223	rs121918379	NC_000011.10:110231888:C:T
NM_000507.4(FBP1):c.851C>G (p.Pro284Arg)	FBP1	P284R	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000000872	9	97365829	9	94603547	872	15911	rs121918192	NC_000009.12:94603546:G:C
NM_000507.4(FBP1):c.581T>C (p.Phe194Ser)	FBP1	F194S	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000000871	9	97369221	9	94606939	871	15910	rs121918191	NC_000009.12:94606938:A:G
NM_000507.4(FBP1):c.88G>T (p.Glu30Ter)	FBP1	E30*	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000000870	9	97401505	9	94639223	870	15909	rs121918190	NC_000009.12:94639222:C:A
NM_000507.4(FBP1):c.530C>A (p.Ala177Asp)	FBP1	A177D	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000000869	9	97372240	9	94609958	869	15908	rs121918189	NC_000009.12:94609957:G:T
NM_012472.6(LRRC6):c.1226+1G>A	LRRC6		Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000860454	8	133595940	8	132583693	860454	851181		NC_000008.11:132583692:C:T
NC_000009.12:g.(?_94639121)_(94639330_?)del	FBP1		Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV000831512	9	97401403 - 97401612			831512	820170		
NM_012472.6(LRRC6):c.10+1G>A	LRRC6		Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000652985	8	133687729	8	132675483	652985	651932		NC_000008.11:132675482:C:T
NM_017637.6(BNC2):c.2636+499C>T	BNC2	R853*	LOWER URINARY TRACT OBSTRUCTION, CONGENITAL|Lower Urinary Tract Obstruction	Pathogenic(Last reviewed: Oct 4, 2019)	no assertion criteria provided	VCV000624566	9	16435054	9	16435056	624566	613398	rs1350162888	NC_000009.12:16435055:G:A
NM_000507.4(FBP1):c.1_170del (p.Met1fs)	FBP1	M1fs	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000619962	9	97401423 - 97401592	9	94639141 - 94639310	619962	611364	rs1563991556	
NM_017637.6(BNC2):c.2663A>G (p.His888Arg)	BNC2	H888R, H793R	LOWER URINARY TRACT OBSTRUCTION, CONGENITAL|Lower Urinary Tract Obstruction	Pathogenic(Last reviewed: Oct 4, 2019)	no assertion criteria provided	VCV000599348	9	16419624	9	16419626	599348	590642	rs1563774686	NC_000009.12:16419625:T:C
NM_000507.4(FBP1):c.472C>T (p.Arg158Trp)	FBP1	R158W	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561988	9	97372298	9	94610016	561988	553128	rs766005419	NC_000009.12:94610015:G:A
NM_012472.6(LRRC6):c.299T>C (p.Ile100Thr)	LRRC6	I100T, I18T	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000540329	8	133650311	8	132638065	540329	523278	rs139008774	NC_000008.11:132638064:A:G
NM_006734.4(HIVEP2):c.5935C>T (p.Arg1979Ter)	HIVEP2	R1979*	not provided|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523775	6	143081490	6	142760353	523775	514525	rs1554275163	NC_000006.12:142760352:G:A
NM_000507.4(FBP1):c.825+1G>A	FBP1		Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000403706	9	97367738	9	94605456	403706	390676	rs111437558	NC_000009.12:94605455:C:T
NM_006734.4(HIVEP2):c.5614dup (p.Glu1872fs)	HIVEP2		not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000224795	6	143082606 - 143082607	6	142761469 - 142761470	224795	226610	rs869312844	NC_000006.12:142761469:CC:CCC
NM_006734.4(HIVEP2):c.2827C>T (p.Arg943Ter)	HIVEP2	R943*	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000224791	6	143093049	6	142771912	224791	226613	rs869312841	NC_000006.12:142771911:G:A
NM_012472.6(LRRC6):c.220G>C (p.Ala74Pro)	LRRC6	A74P	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039797	8	133669112	8	132656866	39797	48396	rs397514596	NC_000008.11:132656865:C:G
NM_012472.6(LRRC6):c.576dup (p.Glu193fs)	LRRC6		Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039796	8	133645062 - 133645063	8	132632816 - 132632817	39796	48395	rs397515425	NC_000008.11:132632816:TT:TTT
NM_006734.4(HIVEP2):c.2954_2955GA[1] (p.Glu986fs)	HIVEP2		not provided|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000625161	6	143092919 - 143092920	6	142771782 - 142771783	625161	613504		NC_000006.12:142771781:TCTCT:TCT
NM_000507.4(FBP1):c.355G>A (p.Asp119Asn)	FBP1	D119N	Fructose-biphosphatase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000214364	9	97380121	9	94617839	214364	211421	rs758609113	NC_000009.12:94617838:C:T
NM_000370.3(TTPA):c.19del (p.Gln7fs)	TTPA	Q7fs	not provided|Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208623	8	63998562	8	63086003	208623	205158	rs760014795	NC_000008.11:63086002:GGG:GG
NM_018105.3(THAP1):c.135_139delinsGGGTTTA (p.Phe45fs)	THAP1		not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000817036	8	42694457 - 42694461	8	42839314 - 42839318	817036	805577		NC_000008.11:42839313:GTTTA:TAAACCC
NM_017866.6(TMEM70):c.378dup (p.Thr127fs)	TMEM70		Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488624	8	74893446 - 74893447	8	73981211 - 73981212	488624	481492	rs1554599411	NC_000008.11:73981211:TTTTT:TTTTTT
NM_001358530.2(MOCS1):c.604_624del (p.Gly202_Glu208del)	MOCS1		not provided	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000280910	6	39881539 - 39881559	6	39913795 - 39913815	280910	264261	rs886042028	NC_000006.12:39913794:CTCGATGGCCTTGTGGATGCCCTC:CTC
NM_001358530.2(MOCS1):c.1102+1G>A	MOCS1		not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000265444	6	39877578	6	39909834	265444	259844	rs146075796	NC_000006.12:39909833:C:T
NC_000008.10:g.(?_74888497)_(74893876_?)del	TMEM70		Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000583679	8	74888497 - 74893876	8	73976262 - 73981641	583679	561847		
TMEM70, 2-BP DEL, 578CA	TMEM70		Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030959					30959	39916		
NM_017866.6(TMEM70):c.238C>T (p.Arg80Ter)	TMEM70	R80*	Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030958	8	74891018	8	73978783	30958	39915	rs387907070	NC_000008.11:73978782:C:T
NM_017866.6(TMEM70):c.336T>A (p.Tyr112Ter)	TMEM70	Y112*	Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030957	8	74893409	8	73981174	30957	39914		NC_000008.11:73981173:T:A
NM_001358530.2(MOCS1):c.217C>T (p.Arg73Trp)	MOCS1	R73W	Molybdenum cofactor deficiency, complementation group A	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000006121	6	39895101	6	39927362	6121	21160	rs104893970	NC_000006.12:39927361:G:A
NM_001358530.2(MOCS1):c.956G>A (p.Arg319Gln)	MOCS1	R319Q, R232Q	Molybdenum cofactor deficiency, complementation group A	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000006119	6	39880033	6	39912289	6119	21158	rs104893969	NC_000006.12:39912288:C:T
TMEM70, 2-BP INS, 118GT	TMEM70		Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000541					541	15580		
NM_001358530.2(MOCS1):c.1000dup (p.Ser334fs)	MOCS1		Molybdenum cofactor deficiency, complementation group A	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000838147	6	39877680 - 39877681	6	39909936 - 39909937	838147	831936		NC_000006.12:39909936:A:AA
NM_018105.3(THAP1):c.112del (p.Ala38fs)	THAP1	A38fs		Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807516	8	42694484	8	42839341	807516	798600		NC_000008.11:42839340:CC:C
NM_018105.3(THAP1):c.25G>T (p.Gly9Cys)	THAP1	G9C		Pathogenic(Last reviewed: Sep 18, 2019)	no assertion criteria provided	VCV000001651	8	42698213	8	42843070	1651	16690	rs267607112	NC_000008.11:42843069:C:A
NM_018105.3(THAP1):c.71del (p.Lys24fs)	THAP1	K25fs, K24fs		Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000845954	8	42698167	8	42843024	845954	834770		NC_000008.11:42843023:TT:T
NM_018105.3(THAP1):c.331C>T (p.Gln111Ter)	THAP1	Q111*		Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000654563	8	42693416	8	42838273	654563	637218		NC_000008.11:42838272:G:A
NM_018105.3(THAP1):c.131del (p.Asn44fs)	THAP1	N44fs		Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000532261	8	42694465	8	42839322	532261	524172	rs1554599712	NC_000008.11:42839321:TTTTTT:TTTTT
NM_018105.3(THAP1):c.68A>C (p.His23Pro)	THAP1	H23P		Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000031632	8	42698170	8	42843027	31632	40311	rs387907177	NC_000008.11:42843026:T:G
NM_018105.3(THAP1):c.70A>G (p.Lys24Glu)	THAP1	K24E		Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000031631	8	42698168	8	42843025	31631	40310	rs387907176	NC_000008.11:42843024:T:C
NM_001358530.2(MOCS1):c.722del (p.Leu241fs)	MOCS1	L241fs, L154fs	Molybdenum cofactor deficiency, complementation group A	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000006117	6	39881096	6	39913352	6117	21156	rs397518418	NC_000006.12:39913351:A:
NM_018105.3(THAP1):c.474del (p.Lys158fs)	THAP1	K158fs		Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001650	8	42693273	8	42838130	1650	16689		NC_000008.11:42838129:TTTTT:TTTT
NM_018105.3(THAP1):c.384_385TC[2] (p.Val131fs)	THAP1			Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001649	8	42693358 - 42693359	8	42838215 - 42838216	1649	16688		NC_000008.11:42838214:GAGAGA:GAGA
NM_018105.3(THAP1):c.266A>G (p.Lys89Arg)	THAP1	K89R		Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001648	8	42694330	8	42839187	1648	16687	rs267607111	NC_000008.11:42839186:T:C
NM_018105.3(THAP1):c.460del (p.Gln154fs)	THAP1	Q154fs		Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001647	8	42693287	8	42838144	1647	16686		NC_000008.11:42838143:G:
THAP1, 5-BP INS/3-BP DEL, NT134	THAP1			Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001645					1645	16684		
NM_000507.4(FBP1):c.611_614del (p.Lys204fs)	FBP1	K204fs	Fructose-biphosphatase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561985	9	97369188 - 97369191	9	94606906 - 94606909	561985	553127	rs761470205	NC_000009.12:94606905:TTTTTT:TT
NM_012472.6(LRRC6):c.574C>T (p.Gln192Ter)	LRRC6	Q192*, Q110*, Q72*	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000039795	8	133645065	8	132632819	39795	48394	rs141945265	NC_000008.11:132632818:G:A
NM_018105.3(THAP1):c.7C>T (p.Gln3Ter)	THAP1	Q3*		Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000532263	8	42698231	8	42843088	532263	523907	rs1554599983	NC_000008.11:42843087:G:A
NM_001358530.2(MOCS1):c.418+1G>A	MOCS1		Molybdenum cofactor deficiency, complementation group A|not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000006120	6	39893421	6	39925677	6120	21159	rs141982812	NC_000006.12:39925676:C:T
NM_000062.3(SERPING1):c.164del (p.Phe55fs)	SERPING1	F55fs	not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000817621	11	57367463	11	57599990	817621	805698		NC_000011.10:57599989:TT:T
NM_000062.2(SERPING1):c.615dup (p.Val206fs)	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559595	11	57369571 - 57369572	11	57602098 - 57602099	559595	550316	rs1554995260	NC_000011.10:57602098:T:TT
NM_000062.2(SERPING1):c.166del (p.Val56fs)	SERPING1	V56fs	not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000503648	11	57367466	11	57599993	503648	495719	rs1554994909	NC_000011.10:57599992:G:
NM_000062.2(SERPING1):c.936del (p.His314fs)	SERPING1	H314fs	not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000426410	11	57373925	11	57606452	426410	415278	rs1085307611	NC_000011.10:57606451:CCC:CC
NM_000062.2(SERPING1):c.1397G>C (p.Arg466Pro)	SERPING1	R466P	not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000426171	11	57381948	11	57614475	426171	415280	rs121907948	NC_000011.10:57614474:G:C
NM_000062.2(SERPING1):c.1169_1175del (p.Lys390fs)	SERPING1	K390fs	not provided	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000419503	11	57379325 - 57379331	11	57611852 - 57611858	419503	408389	rs1064793917	NC_000011.10:57611851:TCCAAGTTCCA:TCCA
NM_000062.2(SERPING1):c.856del (p.Arg286fs)	SERPING1	R286fs	not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000419322	11	57373651	11	57606178	419322	408388	rs1064793792	NC_000011.10:57606177:CCC:CC
NM_000062.2(SERPING1):c.52-1G>A	SERPING1		not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000280064	11	57367351	11	57599878	280064	264611	rs886041353	NC_000011.10:57599877:G:A
NM_005618.4(DLL1):c.54+1G>A	DLL1		NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000800564	6	170599173	6	170290085	800564	789165		NC_000006.12:170290084:C:T
NM_005618.4(DLL1):c.2013_2014del (p.Glu673fs)	DLL1	E673fs	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000800563	6	170592353 - 170592354	6	170283265 - 170283266	800563	789164		NC_000006.12:170283264:CT:
NM_005618.4(DLL1):c.1525C>T (p.Arg509Ter)	DLL1	R509*	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000800562	6	170592842	6	170283754	800562	789163		NC_000006.12:170283753:G:A
NM_005618.4(DLL1):c.231C>A (p.Cys77Ter)	DLL1	C77*	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000800561	6	170598720	6	170289632	800561	789162		NC_000006.12:170289631:G:T
NM_005618.4(DLL1):c.1492G>T (p.Glu498Ter)	DLL1	E498*	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000800560	6	170592875	6	170283787	800560	789161		NC_000006.12:170283786:C:A
NM_000062.3(SERPING1):c.124G>T (p.Glu42Ter)	SERPING1	E42*	Hereditary angioedema type 1	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000694737	11	57367424	11	57599951	694737	682856		NC_000011.10:57599950:G:T
NM_006918.5(SC5D):c.223C>T (p.Arg75Ter)	SC5D	R75*	Lathosterolosis	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638393	11	121175082	11	121304373	638393	626203		NC_000011.10:121304372:C:T
NM_000062.2(SERPING1):c.342_345del (p.Thr115fs)	SERPING1	T115fs	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626351	11	57367640 - 57367643	11	57600167 - 57600170	626351	614682	rs1565169621	NC_000011.10:57600166:CCTACC:CC
NM_001032295.2(SERPING1):c.102_103AG[2] (p.Ser36fs)	SERPING1		Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626349	11	57367402 - 57367403	11	57599929 - 57599930	626349	614681		NC_000011.10:57599928:AGAGAG:AGAG
NM_000062.2(SERPING1):c.1247T>A (p.Leu416Ter)	SERPING1	L416*	Hereditary angioedema type 1	Pathogenic(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000619176	11	57379407	11	57611934	619176	610571	rs1565173405	NC_000011.10:57611933:T:A
NM_000062.2(SERPING1):c.55A>T (p.Arg19Ter)	SERPING1	R19*	Hereditary angioedema type 1	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000619175	11	57367355	11	57599882	619175	610570	rs1565169419	NC_000011.10:57599881:A:T
NM_000062.2(SERPING1):c.646delinsTCAGTGTCGTG (p.Lys216delinsSerValSerTer)	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Feb 14, 2018)	no assertion criteria provided	VCV000487526	11	57369603	11	57602130	487526	480577	rs1554995271	NC_000011.10:57602129:A:TCAGTGTCGTG
NM_000062.2(SERPING1):c.1198C>T (p.Arg400Cys)	SERPING1	R378C, R400C	Hereditary angioedema type 1	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000487525	11	57379358	11	57611885	487525	480576	rs201363394	NC_000011.10:57611884:C:T
NM_000062.2(SERPING1):c.1385T>G (p.Ile462Ser)	SERPING1	I462S	Hereditary angioedema type 1	Pathogenic(Last reviewed: Oct 4, 2018)	no assertion criteria provided	VCV000487524	11	57381936	11	57614463	487524	480575	rs763451792	NC_000011.10:57614462:T:G
NM_000062.2(SERPING1):c.953C>G (p.Ser318Ter)	SERPING1	S318*	Hereditary angioedema type 1	Pathogenic(Last reviewed: Oct 7, 2013)	no assertion criteria provided	VCV000252942	11	57373944	11	57606471	252942	247344	rs1554995860	NC_000011.10:57606470:C:G
NM_000062.2(SERPING1):c.550+745_685+308del	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Oct 7, 2013)	no assertion criteria provided	VCV000252941	11	57368540 - 57369895	11	57601067 - 57602422	252941	247342		
NM_006918.5(SC5D):c.137A>C (p.Tyr46Ser)	SC5D	Y46S	Lathosterolosis	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000007356	11	121174221	11	121303512	7356	22395	rs104894297	NC_000011.10:121303511:A:C
NM_006918.5(SC5D):c.632G>A (p.Gly211Asp)	SC5D	G211D	Lathosterolosis	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007355	11	121177953	11	121307244	7355	22394	rs104894296	NC_000011.10:121307243:G:A
NM_006918.5(SC5D):c.86G>A (p.Arg29Gln)	SC5D	R29Q	Lathosterolosis	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007354	11	121174170	11	121303461	7354	22393	rs104894295	NC_000011.10:121303460:G:A
NM_000062.2(SERPING1):c.597C>G (p.Tyr199Ter)	SERPING1	Y199*	Hereditary angioedema type 1	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000003957	11	57369554	11	57602081	3957	18996	rs121907951	NC_000011.10:57602080:C:G
SERPING1, C-T, -103, PROMOTER	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Aug 1, 1996)	no assertion criteria provided	VCV000003956					3956	18995		
NM_000062.2(SERPING1):c.1394C>T (p.Ala465Val)	SERPING1	A465V	Complement component 4, partial deficiency of, due to dysfunctional c1 inhibitor	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000003955	11	57381945	11	57614472	3955	18994	rs121907950	NC_000011.10:57614471:C:T
NM_000062.2(SERPING1):c.1357_1358insTGT (p.Gly453delinsValTrp)	SERPING1		Hereditary C1 esterase inhibitor deficiency - dysfunctional factor	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000003954	11	57381908 - 57381909	11	57614435 - 57614436	3954	18993	rs606231141	NC_000011.10:57614435::TGT
NM_000062.2(SERPING1):c.1361T>A (p.Val454Glu)	SERPING1	V432E, V454E	Hereditary C1 esterase inhibitor deficiency - dysfunctional factor	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000003953	11	57381912	11	57614439	3953	18992	rs121907949	NC_000011.10:57614438:T:A
SERPING1, 1-BP DEL, 11698C	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000003952					3952	18991		
NM_000062.2(SERPING1):c.1249+1G>T	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000003951	11	57379410	11	57611937	3951	18990	rs112565881	NC_000011.10:57611936:G:T
NM_000062.2(SERPING1):c.1264del (p.Ser422fs)	SERPING1	S422fs	Hereditary angioedema type 1	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000003950	11	57381811	11	57614338	3950	18989	rs1554996817	NC_000011.10:57614337:TTTTT:TTTT
NM_000062.3(SERPING1):c.1268dup (p.Tyr423Ter)	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000003949	11	57381818 - 57381819	11	57614345 - 57614346	3949	18988	rs1554996819	NC_000011.10:57614345:A:AA
NM_000062.3(SERPING1):c.1373C>T (p.Ala458Val)	SERPING1	A458V	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690357	11	57381924	11	57614451	690357	678035		NC_000011.10:57614450:C:T
NM_000062.3(SERPING1):c.1180del (p.Thr394fs)	SERPING1	T394fs	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690356	11	57379340	11	57611867	690356	678033		NC_000011.10:57611866:A:
NM_000062.3(SERPING1):c.1417G>A (p.Val473Met)	SERPING1	V473M	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690355	11	57381968	11	57614495	690355	678036		NC_000011.10:57614494:G:A
NM_000062.3(SERPING1):c.508del (p.Ser170fs)	SERPING1	S170fs	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690354	11	57367805	11	57600332	690354	678027		NC_000011.10:57600331:TTTT:TTT
NM_000062.3(SERPING1):c.347del (p.Gln116fs)	SERPING1	Q116fs	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690353	11	57367647	11	57600174	690353	678026		NC_000011.10:57600173:A:
NM_000062.3(SERPING1):c.1446G>A (p.Trp482Ter)	SERPING1	W482*	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690351	11	57381997	11	57614524	690351	678037		NC_000011.10:57614523:G:A
NM_000062.3(SERPING1):c.600dup (p.Lys201fs)	SERPING1		Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690350	11	57369553 - 57369554	11	57602080 - 57602081	690350	678028		NC_000011.10:57602080:CCCC:CCCCC
NM_000062.3(SERPING1):c.1342_1349dup (p.Glu451_Thr452insAsnTer)	SERPING1		Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690349	11	57381892 - 57381893	11	57614419 - 57614420	690349	678034		NC_000011.10:57614419:GAACTGAC:GAACTGACGAACTGAC
NM_000062.3(SERPING1):c.1036C>T (p.Gln346Ter)	SERPING1	Q346*	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690348	11	57379196	11	57611723	690348	678031		NC_000011.10:57611722:C:T
NM_000062.3(SERPING1):c.908T>C (p.Phe303Ser)	SERPING1	F303S	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000690347	11	57373899	11	57606426	690347	678030		NC_000011.10:57606425:T:C
NM_000062.2(SERPING1):c.586_589del (p.Ile196fs)	SERPING1	I196fs	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626356	11	57369542 - 57369545	11	57602069 - 57602072	626356	614683	rs1565170287	NC_000011.10:57602068:CATCC:C
NM_000062.2(SERPING1):c.1106del (p.Asp369fs)	SERPING1	D369fs	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626355	11	57379266	11	57611793	626355	614686	rs1565173309	NC_000011.10:57611792:A:
NM_000062.2(SERPING1):c.1420C>T (p.Gln474Ter)	SERPING1	Q474*	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626354	11	57381971	11	57614498	626354	614687	rs1565174105	NC_000011.10:57614497:C:T
NM_000062.2(SERPING1):c.1A>C (p.Met1Leu)	SERPING1	M1L	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626353	11	57365744	11	57598271	626353	614679	rs1565168898	NC_000011.10:57598270:A:C
NM_000062.2(SERPING1):c.1A>G (p.Met1Val)	SERPING1	M1V	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626352	11	57365744	11	57598271	626352	614680	rs1565168898	NC_000011.10:57598270:A:G
NM_000062.2(SERPING1):c.674_675delinsAA (p.Phe225Ter)	SERPING1		Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626350	11	57369631 - 57369632	11	57602158 - 57602159	626350	614684	rs1565170364	NC_000011.10:57602157:TC:AA
NM_000062.2(SERPING1):c.1012C>T (p.Gln338Ter)	SERPING1	Q338*	Hereditary angioedema type 1	Pathogenic	criteria provided, single submitter	VCV000626348	11	57374003	11	57606530	626348	614685	rs1565171906	NC_000011.10:57606529:C:T
NM_000062.2(SERPING1):c.1372G>A (p.Ala458Thr)	SERPING1	A436T, A458T	Hereditary C1 esterase inhibitor deficiency - dysfunctional factor	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000003945	11	57381923	11	57614450	3945	18984	rs121907947	NC_000011.10:57614449:G:A
SERPING1, EX7DEL	SERPING1		Hereditary angioedema type 1	Pathogenic(Last reviewed: Jun 1, 1989)	no assertion criteria provided	VCV000003944					3944	18983		
NM_018105.3(THAP1):c.201_203CAA[2] (p.Asn69del)	THAP1	N69del		Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000569769	8	42694387 - 42694389	8	42839244 - 42839246	569769	567930	rs1563644810	NC_000008.11:42839243:TTGTTGTTG:TTGTTG
NM_018105.3(THAP1):c.289C>T (p.Gln97Ter)	THAP1	Q97*		Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000532262	8	42693458	8	42838315	532262	523898	rs1554599616	NC_000008.11:42838314:G:A
NM_000062.2(SERPING1):c.1480C>T (p.Arg494Ter)	SERPING1	R494*	not provided|Hereditary angioedema type 1	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000626347	11	57382031	11	57614558	626347	614688	rs922149386	NC_000011.10:57614557:C:T
NM_001032295.2(SERPING1):c.1351_1352GA[1] (p.Glu451fs)	SERPING1		not provided|Hereditary angioedema type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000503707	11	57381901 - 57381902	11	57614428 - 57614429	503707	495533	rs1554996833	NC_000011.10:57614427:AGAGA:AGA
NM_000062.2(SERPING1):c.1396C>A (p.Arg466Ser)	SERPING1	R444S, R466S	Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided	Pathogenic(Last reviewed: Jun 18, 1990)	no assertion criteria provided	VCV000003948	11	57381947	11	57614474	3948	18987	rs28940870	NC_000011.10:57614473:C:A
NM_000507.4(FBP1):c.960_961insG (p.Ser321fs)	FBP1		Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000867	9	97365719 - 97365720	9	94603437 - 94603438	867	15906	rs757653154	NC_000009.12:94603437::C
NM_000349.3(STAR):c.290del (p.Lys97fs)	STAR	K97fs	not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000860815	8	38005734	8	38148216	860815	834735		NC_000008.11:38148215:TT:T
NM_001003722.2(GLE1):c.1768C>T (p.Arg590Ter)	GLE1	R590*	not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000835117	9	131298755	9	128536476	835117	835517		NC_000009.12:128536475:C:T
NC_000009.12:g.(?_128515519)_(128533961_?)del	GLE1		not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000833204	9	131277798 - 131296240			833204	820071		
NC_000009.12:g.(?_128522658)_(128527535_?)del	GLE1		not provided	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000832435	9	131284937 - 131289814			832435	820072		
NM_001499.2(GLE1):c.1750C>T (p.Arg584Trp)	GLE1	R584W	Lethal arthrogryposis with anterior horn cell disease	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000619144	9	131298737	9	128536458	619144	610539	rs765269946	NC_000009.12:128536457:C:T
NM_001003722.1(GLE1):c.2078C>T (p.Ser693Phe)	GLE1	S693F	Lethal arthrogryposis with anterior horn cell disease	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000619143	9	131303430	9	128541151	619143	610538	rs1564162129	NC_000009.12:128541150:C:T
NM_001003722.1(GLE1):c.100-7_100-3del	GLE1		Lethal arthrogryposis with anterior horn cell disease	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000619142	9	131271147 - 131271151	9	128508868 - 128508872	619142	610537		NC_000009.12:128508867:TTCTCT:T
NM_001499.2(GLE1):c.1882-2A>G	GLE1		Lethal arthrogryposis with anterior horn cell disease	Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000619141	9	131301893	9	128539614	619141	610536	rs1336481358	NC_000009.12:128539613:A:G
NM_000349.3(STAR):c.653C>T (p.Ala218Val)	STAR	R218V, A218V	Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000008993	8	38002831	8	38145313	8993	24032	rs137852690	NC_000008.11:38145312:G:A
NM_000349.3(STAR):c.650G>C (p.Arg217Thr)	STAR	R217T	Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000008992	8	38003481	8	38145963	8992	24031	rs137852689	NC_000008.11:38145962:C:G
NM_000349.3(STAR):c.178+2dup	STAR		Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000008990	8	38006156 - 38006157	8	38148638 - 38148639	8990	24029	rs1563268785	NC_000008.11:38148638:A:AA
STAR, 1-BP DEL, 261T	STAR		Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000008989					8989	24028		
NM_001499.2(GLE1):c.1849G>A (p.Val617Met)	GLE1	V617M	Lethal arthrogryposis with anterior horn cell disease	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000006464	9	131300337	9	128538058	6464	21503	rs121434408	NC_000009.12:128538057:G:A
NM_000349.3(STAR):c.545G>T (p.Arg182Leu)	STAR	R182L	Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000008988	8	38003586	8	38146068	8988	24027	rs104894086	NC_000008.11:38146067:C:A
NM_001003722.1(GLE1):c.2051T>C (p.Ile684Thr)	GLE1	I684T	Lethal arthrogryposis with anterior horn cell disease	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000006465	9	131303403	9	128541124	6465	21504	rs121434409	NC_000009.12:128541123:T:C
NM_000349.3(STAR):c.811del (p.Leu271fs)	STAR	L271fs	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556387	8	38001838	8	38144320	556387	544724	rs1350908961	NC_000008.11:38144319:GG:G
NM_000349.3(STAR):c.577C>T (p.Arg193Ter)	STAR	R193*	Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000035553	8	38003554	8	38146036	35553	44226	rs387907235	NC_000008.11:38146035:G:A
NM_018105.3(THAP1):c.305dup (p.Pro103fs)	THAP1			Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000568461	8	42693441 - 42693442	8	42838298 - 42838299	568461	562420	rs1563644456	NC_000008.11:42838298:GGGGG:GGGGGG
NM_000181.4(GUSB):c.1A>C (p.Met1Leu)	GUSB	M1L	not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000618670	7	65447170	7	65982183	618670	609663	rs1382654122	NC_000007.14:65982182:T:G
NM_000181.4(GUSB):c.328C>T (p.Arg110Ter)	GUSB	R110*	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000501147	7	65445279	7	65980292	501147	492571	rs1053785648	NC_000007.14:65980291:G:A
NM_173689.7(CRB2):c.3291_3292del (p.Cys1098fs)	CRB2	C1098fs	not provided	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000419404	9	126136101 - 126136102	9	123373822 - 123373823	419404	407523	rs1064793849	NC_000009.12:123373821:CT:
NM_000181.4(GUSB):c.530C>T (p.Thr177Ile)	GUSB	T177I	Mucopolysaccharidosis type 7	Pathogenic	no assertion criteria provided	VCV000100722	7	65444765	7	65979778	100722	106587	rs587779400	NC_000007.14:65979777:G:A
NM_000181.4(GUSB):c.866G>A (p.Trp289Ter)	GUSB	W289*, W70*, W99*	not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000092592	7	65441048	7	65976061	92592	98500	rs398123238	NC_000007.14:65976060:C:T
NM_000181.4(GUSB):c.1084G>A (p.Asp362Asn)	GUSB	D362N, D143N, D172N, D216N	not provided	Pathogenic(Last reviewed: Jun 26, 2013)	criteria provided, single submitter	VCV000092584	7	65439673	7	65974686	92584	98492	rs398123234	NC_000007.14:65974685:C:T
NC_000007.14:g.(?_65970262)_(65970386_?)del	GUSB		Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000832741	7	65435249 - 65435373			832741	819907		
NC_000007.14:g.(?_65967711)_(65970386_?)del	GUSB		Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000832740	7	65432698 - 65435373			832740	819906		
NM_000181.4(GUSB):c.1429C>T (p.Arg477Trp)	GUSB	R477W, R331W, R258W, R287W	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Dec 3, 2018)	no assertion criteria provided	VCV000599019	7	65435316	7	65970329	599019	590118	rs774393243	NC_000007.14:65970328:G:A
NC_000007.13:g.(?_65439262)_(65447190_?)del	GUSB		Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000583875	7	65439262 - 65447190	7	65974275 - 65982203	583875	566129		
NM_173689.7(CRB2):c.1897C>T (p.Arg633Trp)	CRB2	R633W	Ventriculomegaly with cystic kidney disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180707	9	126133229	9	123370950	180707	178872	rs730880377	NC_000009.12:123370949:C:T
NM_173689.7(CRB2):c.1886G>C (p.Cys629Ser)	CRB2	C629S	Focal segmental glomerulosclerosis 9	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180702	9	126133218	9	123370939	180702	178867	rs879255252	NC_000009.12:123370938:G:C
NM_173689.7(CRB2):c.1859G>C (p.Cys620Ser)	CRB2	C620S	Focal segmental glomerulosclerosis 9	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180699	9	126133191	9	123370912	180699	178864	rs879255250	NC_000009.12:123370911:G:C
NM_152415.3(VPS37A):c.1146A>T (p.Lys382Asn)	VPS37A	K382N, K292N, K286N, K357N, K376N	Spastic paraplegia 53, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000039741	8	17143888	8	17286379	39741	48340	rs211694394	NC_000008.11:17286378:A:T
NM_020223.4(FAM20C):c.982C>T (p.Pro328Ser)	FAM20C	P314S, P328S	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030878	7	288306	7	248340	30878	39835	rs797044462	NC_000007.14:248339:C:T
NM_020223.4(FAM20C):c.796G>A (p.Gly266Arg)	FAM20C	G266R	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000030877	7	208909	7	208909	30877	39834	rs796051875	NC_000007.14:208908:G:A
NM_020223.4(FAM20C):c.737T>A (p.Ile246Asn)	FAM20C	I244N, I246N	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000030876	7	195685	7	195685	30876	39833	rs796051874	NC_000007.14:195684:T:A
FAM20C, ASP437ASN	FAM20C	D437N	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000030875					30875	39832		
NM_020223.4(FAM20C):c.1446-1G>A	FAM20C		Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001030	7	298611	7	258645	1030	16069	rs796051855	NC_000007.14:258644:G:A
NM_020223.4(FAM20C):c.956+5G>C	FAM20C		Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001029	7	286478	7	246512	1029	16068	rs796051854	NC_000007.14:246511:G:C
NM_020223.4(FAM20C):c.1364-2A>G	FAM20C		Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001028	7	296969	7	257003	1028	16067	rs796051853	NC_000007.14:257002:A:G
NM_020223.4(FAM20C):c.1136G>A (p.Gly379Glu)	FAM20C	G365E, G379E	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001027	7	295878	7	255912	1027	16066	rs796051852	NC_000007.14:255911:G:A
NM_020223.4(FAM20C):c.1093G>C (p.Gly365Arg)	FAM20C	G365R	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001023	7	295835	7	255869	1023	16062	rs267606795	NC_000007.14:255868:G:C
NM_000181.4(GUSB):c.1338G>A (p.Trp446Ter)	GUSB	W446*, W300*, W256*, W227*	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000000904	7	65439335	7	65974348	904	15943	rs121918180	NC_000007.14:65974347:C:T
NM_000181.4(GUSB):c.1730G>T (p.Arg577Leu)	GUSB	R577L, R358L, R387L, R431L	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000902	7	65429369	7	65964382	902	15941	rs121918183	NC_000007.14:65964381:C:A
NM_000181.4(GUSB):c.1617C>T (p.Ser539=)	GUSB		Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000000901	7	65432754	7	65967767	901	15940	rs377519272	NC_000007.14:65967766:G:A
NM_000181.4(GUSB):c.1484A>G (p.Tyr495Cys)	GUSB	Y495C, Y276C, Y305C, Y349C	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000000899	7	65432887	7	65967900	899	15938	rs121918178	NC_000007.14:65967899:T:C
NM_000181.4(GUSB):c.442C>T (p.Pro148Ser)	GUSB	P148S	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000000898	7	65444853	7	65979866	898	15937	rs121918177	NC_000007.14:65979865:G:A
NM_000181.4(GUSB):c.1831C>T (p.Arg611Trp)	GUSB	R611W, R392W, R421W, R465W	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000000897	7	65426009	7	65961022	897	15936	rs121918176	NC_000007.14:65961021:G:A
NM_000181.4(GUSB):c.1856C>T (p.Ala619Val)	GUSB	A619V, A400V, A429V, A473V	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000000893	7	65425984	7	65960997	893	15932	rs121918172	NC_000007.14:65960996:G:A
NM_000181.4(GUSB):c.1868_1869GA[3] (p.Arg625fs)	GUSB		Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000633257	7	65425965 - 65425966	7	65960978 - 65960979	633257	621278		NC_000007.14:65960977:TCTCTCTC:TCTCTC
GRCh38/hg38 9p23-22.3(chr9:13974416-14286260)x1	NFIB		Dolichocephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	VCV000562127	9	13974415 - 14286259	9	13974416 - 14286260	562127	553301		
GRCh38/hg38 9p23-22.3(chr9:14102176-14386039)x1	NFIB		Relative macrocephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	VCV000562126	9	14102175 - 14386038	9	14102176 - 14386039	562126	553300		
GRCh38/hg38 9p23-22.3(chr9:14098660-14324148)x1	NFIB		Macrocephalus|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	VCV000562125	9	14098659 - 14324147	9	14098660 - 14324148	562125	553299		
NM_020223.4(FAM20C):c.957-3C>G	FAM20C		Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001026	7	288278	7	248312	1026	16065	rs796051851	NC_000007.14:248311:C:G
NM_020223.4(FAM20C):c.1645C>T (p.Arg549Trp)	FAM20C	R535W, R549W	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001025	7	299836	7	259870	1025	16064	rs796051850	NC_000007.14:259869:C:T
NM_020223.4(FAM20C):c.1163T>G (p.Leu388Arg)	FAM20C	L374R, L388R	Lethal osteosclerotic bone dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001024	7	295905	7	255939	1024	16063	rs796051849	NC_000007.14:255938:T:G
NM_000181.4(GUSB):c.1881G>T (p.Trp627Cys)	GUSB	W627C, W437C, W481C, W408C	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000000907	7	65425959	7	65960972	907	15946	rs121918184	NC_000007.14:65960971:C:A
NM_000181.4(GUSB):c.1050G>C (p.Lys350Asn)	GUSB	K350N, K204N, K131N, K160N	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000906	7	65439921	7	65974934	906	15945	rs121918182	NC_000007.14:65974933:C:G
NM_000181.4(GUSB):c.1061C>T (p.Ala354Val)	GUSB	A354V, A164V, A135V, A208V	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000000896	7	65439910	7	65974923	896	15935	rs121918175	NC_000007.14:65974922:G:A
NM_000181.4(GUSB):c.646C>T (p.Arg216Trp)	GUSB	R216W, R26W	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000000895	7	65444464	7	65979477	895	15934	rs121918174	NC_000007.14:65979476:G:A
NM_173689.7(CRB2):c.2277G>A (p.Trp759Ter)	CRB2	W759*	Ventriculomegaly with cystic kidney disease|not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000180704	9	126133698	9	123371419	180704	178869	rs375072557	NC_000009.12:123371418:G:A
NM_173689.7(CRB2):c.1882C>T (p.Arg628Cys)	CRB2	R628C	Focal segmental glomerulosclerosis 9|Steroid-resistant nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180700	9	126133214	9	123370935	180700	178865	rs202128397	NC_000009.12:123370934:C:T
NM_000181.4(GUSB):c.1337G>A (p.Trp446Ter)	GUSB	W446*, W256*, W300*, W227*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000495724	7	65439336	7	65974349	495724	487321	rs1434169374	NC_000007.14:65974348:C:T
NM_000181.4(GUSB):c.1391+618_1391+619del	GUSB		Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000000903	7	65438663 - 65438664	7	65973676 - 65973677	903	15942	rs786200863	NC_000007.14:65973675:GA:
NM_000062.2(SERPING1):c.550G>A (p.Gly184Arg)	SERPING1	G184R	Hereditary angioedema type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000068253	11	57367850	11	57600377	68253	79144	rs281875170	NC_000011.10:57600376:G:A
NM_003880.3(CCN6):c.879dup (p.Thr294fs)	CCN6		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000521956	6	112390634 - 112390635	6	112069431 - 112069432	521956	511618	rs1554314738	NC_000006.12:112069431:CCC:CCCC
NM_007103.4(NDUFV1):c.1157G>A (p.Arg386His)	NDUFV1	R386H, R377H	not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000496918	11	67379444	11	67611973	496918	488342	rs536758576	NC_000011.10:67611972:G:A
NM_007103.4(NDUFV1):c.51_52TG[1] (p.Val18fs)	NDUFV1		not provided	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000280782	11	67374526 - 67374527	11	67607055 - 67607056	280782	264449	rs746745725	NC_000011.10:67607054:TGTG:TG
NM_007103.4(NDUFV1):c.617G>A (p.Cys206Tyr)	NDUFV1	C206Y, C197Y	not provided	Pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000214863	11	67377958	11	67610487	214863	211553	rs863224120	NC_000011.10:67610486:G:A
NM_007103.4(NDUFV1):c.1256_1259del (p.Ile419fs)	NDUFV1	I410fs, I419fs	not provided	Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	VCV000214862	11	67379681 - 67379684	11	67612210 - 67612213	214862	211562	rs863224119	NC_000011.10:67612209:AGATAGA:AGA
NM_007103.4(NDUFV1):c.1132A>C (p.Ser378Arg)	NDUFV1	S378R, S369R	not provided	Pathogenic(Last reviewed: Jun 8, 2012)	criteria provided, single submitter	VCV000214861	11	67379419	11	67611948	214861	211560	rs863224118	NC_000011.10:67611947:A:C
NM_007103.4(NDUFV1):c.349G>A (p.Ala117Thr)	NDUFV1	A117T, A108T	not provided	Pathogenic(Last reviewed: Jun 8, 2012)	criteria provided, single submitter	VCV000214851	11	67376945	11	67609474	214851	211548	rs757486575	NC_000011.10:67609473:G:A
NM_007103.4(NDUFV1):c.1118T>C (p.Phe373Ser)	NDUFV1	F373S, F364S	Mitochondrial complex I deficiency	Pathogenic	no assertion criteria provided	VCV000431452	11	67379405	11	67611934	431452	424968	rs1135402749	NC_000011.10:67611933:T:C
NM_012472.6(LRRC6):c.436G>C (p.Asp146His)	LRRC6	D146H, D64H, D26H	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000039798	8	133645203	8	132632957	39798	48397	rs200321595	NC_000008.11:132632956:C:G
NM_012472.6(LRRC6):c.598_599del (p.Lys200fs)	LRRC6	K80fs, K118fs, K200fs	Ciliary dyskinesia, primary, 19	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000039794	8	133645040 - 133645041	8	132632794 - 132632795	39794	48393	rs397515424	NC_000008.11:132632793:TT:
NM_007103.4(NDUFV1):c.175C>T (p.Arg59Ter)	NDUFV1	R59*, R50*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4|not provided	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000014057	11	67376042	11	67608571	14057	29096	rs768050261	NC_000011.10:67608570:C:T
NM_000370.3(TTPA):c.2T>C (p.Met1Thr)	TTPA	M1T	not provided|Familial isolated deficiency of vitamin E	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189186	8	63998579	8	63086020	189186	186763	rs786204758	NC_000008.11:63086019:A:G
NM_000370.3(TTPA):c.303T>G (p.His101Gln)	TTPA	H101Q	Ataxia and retinitis pigmentosa with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000009137	8	63985549	8	63072990	9137	24176	rs121917849	NC_000008.11:63072989:A:C
NM_000317.3(PTS):c.286G>A (p.Asp96Asn)	PTS	D96N		Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000484	11	112103928	11	112233205	484	15523	rs104894280	NC_000011.10:112233204:G:A
NM_001190737.2(NFIB):c.1063_1076del (p.Ile355fs)	NFIB	I103fs, I176fs, I354fs, I336fs, I346fs, I377fs, I276fs, I307fs, I349fs, I351fs, I381fs, I280fs, I350fs, I355fs	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT|Macrocephalus|Intellectual disability	Pathogenic	criteria provided, single submitter	VCV000560029	9	14120608 - 14120621	9	14120609 - 14120622	560029	550745	rs1554639173	NC_000009.12:14120608:GTTCGAGTTGAGATG:G
NM_001190737.2(NFIB):c.758_759dup (p.Asn254Ter)	NFIB		MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT|Macrocephalus|Intellectual disability	Pathogenic	criteria provided, single submitter	VCV000560028	9	14150190 - 14150191	9	14150191 - 14150192	560028	550744	rs1554649366	NC_000009.12:14150191:CA:CACA
NM_001190737.2(NFIB):c.341A>C (p.Lys114Thr)	NFIB	K114T, K105T, K136T, K140T, K66T, K109T, K110T	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT|Macrocephalus|Intellectual disability	Pathogenic	criteria provided, single submitter	VCV000560025	9	14307209	9	14307210	560025	550741	rs1554709683	NC_000009.12:14307209:T:G
NM_000181.4(GUSB):c.1521G>A (p.Trp507Ter)	GUSB	W507*, W288*, W317*, W361*	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000000900	7	65432850	7	65967863	900	15939	rs121918179	NC_000007.14:65967862:C:T
NM_007103.4(NDUFV1):c.1207dup (p.Asp403fs)	NDUFV1		Leigh syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802694	11	67379629 - 67379630	11	67612158 - 67612159	802694	791162		NC_000011.10:67612158:GGGGGG:GGGGGGG
NM_007103.4(NDUFV1):c.365C>T (p.Pro122Leu)	NDUFV1	P122L, P113L	not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214852	11	67376961	11	67609490	214852	211549	rs750831299	NC_000011.10:67609489:C:T
NM_000349.3(STAR):c.125dup (p.Thr44fs)	STAR		not provided|Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000632520	8	38006211 - 38006212	8	38148693 - 38148694	632520	620299	rs750549499	NC_000008.11:38148693:CCCCCC:CCCCCCC
NM_000349.3(STAR):c.135del (p.Ser46fs)	STAR	S46fs	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036782	8	38006202	8	38148684	36782	45443	rs193922393	NC_000008.11:38148683:A:
NM_004523.4(KIF11):c.2018del (p.Lys673fs)	KIF11	K673fs	not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000817966	10	94397154	10	92637397	817966	805656		NC_000010.11:92637396:AAAAAAA:AAAAAA
NM_004523.4(KIF11):c.2649del (p.Gln883_Met884insTer)	KIF11		not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000817004	10	94408070	10	92648313	817004	805657		NC_000010.11:92648312:G:
NM_004523.4(KIF11):c.2782C>T (p.Gln928Ter)	KIF11	Q928*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802621	10	94409603	10	92649846	802621	791015		NC_000010.11:92649845:C:T
NM_006940.6(SOX5):c.1819G>T (p.Glu607Ter)	SOX5	E486*, E221*, E572*, E594*, E597*, E607*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695088	12	23689556	12	23536622	695088	683189		NC_000012.12:23536621:C:A
NM_006940.6(SOX5):c.1814A>G (p.Tyr605Cys)	SOX5	Y605C, Y219C, Y484C, Y570C, Y592C, Y595C	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695087	12	23689561	12	23536627	695087	683190		NC_000012.12:23536626:T:C
NM_006940.6(SOX5):c.1782G>A (p.Trp594Ter)	SOX5	W208*, W559*, W581*, W473*, W584*, W594*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695086	12	23689593	12	23536659	695086	683191		NC_000012.12:23536658:C:T
NM_006940.6(SOX5):c.1613C>G (p.Ser538Ter)	SOX5	S417*, S503*, S525*, S538*, S152*, S528*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695082	12	23696303	12	23543369	695082	683195		NC_000012.12:23543368:G:C
NM_006940.6(SOX5):c.1465dup (p.Leu489fs)	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695080	12	23716214 - 23716215	12	23563280 - 23563281	695080	683197		NC_000012.12:23563280:G:GG
NM_006940.6(SOX5):c.1411C>T (p.Arg471Ter)	SOX5	R436*, R471*, R461*, R85*, R458*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695079	12	23716269	12	23563335	695079	683198		NC_000012.12:23563334:G:A
NM_006940.6(SOX5):c.820C>T (p.Gln274Ter)	SOX5	Q261*, Q274*, Q239*, Q264*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695078	12	23818489	12	23665555	695078	683200		NC_000012.12:23665554:G:A
NM_006940.6(SOX5):c.518G>A (p.Trp173Ter)	SOX5	W163*, W138*, W160*, W173*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695077	12	23908622	12	23755688	695077	683202		NC_000012.12:23755687:C:T
GRCh37/hg19 12p12.1(chr12:23685093-23728869)x1	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695076	12	23685093 - 23728869			695076	683209		
GRCh37/hg19 12p12.1(chr12:23718347-23769414)x1	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695075	12	23718347 - 23769414			695075	683208		
GRCh37/hg19 12p12.1(chr12:23773664-23893799)x1	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695074	12	23773664 - 23893799			695074	683207		
GRCh37/hg19 12p12.1(chr12:23147341-23893799)x1	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695072	12	23147341 - 23893799			695072	683205		
GRCh37/hg19 12p12.1(chr12:23723120-23908799)x1	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695071	12	23723120 - 23908799			695071	683204		
GRCh37/hg19 12p12.1(chr12:24102502-24173232)x1	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000695070	12	24102502 - 24173232			695070	683203		
GRCh37/hg19 12p12.1(chr12:23689580-23783298)x1	SOX5		not provided	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000687389	12	23689580 - 23783298			687389	674981		
NM_004523.4(KIF11):c.274G>T (p.Glu92Ter)	KIF11	E92*	not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000489054	10	94366439	10	92606682	489054	481973	rs1554859344	NC_000010.11:92606681:G:T
NM_004523.4(KIF11):c.139C>T (p.Arg47Ter)	KIF11	R47*	not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000488844	10	94366083	10	92606326	488844	481972	rs1227480400	NC_000010.11:92606325:C:T
NM_004523.4(KIF11):c.2T>C (p.Met1Thr)	KIF11	M1T	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000488843	10	94353134	10	92593377	488843	481971	rs1554858130	NC_000010.11:92593376:T:C
NM_032861.4(SERAC1):c.1102C>T (p.Arg368Ter)	SERAC1	R368*	not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000452315	6	158541521	6	158120489	452315	443929	rs758745099	NC_000006.12:158120488:G:A
NM_004523.4(KIF11):c.77+1G>A	KIF11		not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000392999	10	94353210	10	92593453	392999	370991	rs1057524736	NC_000010.11:92593452:G:A
NM_032861.4(SERAC1):c.493C>T (p.Gln165Ter)	SERAC1	Q165*	not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000391193	6	158565447	6	158144415	391193	368490	rs1057523999	NC_000006.12:158144414:G:A
NM_004523.4(KIF11):c.1040dup (p.Ser348fs)	KIF11		not provided	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000373017	10	94376500 - 94376501	10	92616743 - 92616744	373017	359976	rs1057518144	NC_000010.11:92616743:T:TT
NM_004523.4(KIF11):c.2341C>T (p.Gln781Ter)	KIF11	Q781*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic	no assertion criteria provided	VCV000369969	10	94405193	10	92645436	369969	354170	rs1057516208	NC_000010.11:92645435:C:T
NM_032861.4(SERAC1):c.219_220AT[6] (p.Val77fs)	SERAC1		not provided	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000280568	6	158571521 - 158571522	6	158150489 - 158150490	280568	264257	rs886041750	NC_000006.12:158150489:ATATATATAT:ATATATATATAT
NM_004523.4(KIF11):c.24_26delinsAG (p.Ala9fs)	KIF11		not provided	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000280235	10	94353156 - 94353158	10	92593399 - 92593401	280235	264379	rs886041477	NC_000010.11:92593398:TGC:AG
NM_004523.4(KIF11):c.1702+1G>A	KIF11		not provided	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000280215	10	94392451	10	92632694	280215	264498	rs886041462	NC_000010.11:92632693:G:A
NM_032861.4(SERAC1):c.1916G>C (p.Arg639Pro)	SERAC1	R639P	not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000215146	6	158532447	6	158111415	215146	211204	rs768913919	NC_000006.12:158111414:C:G
NM_032861.4(SERAC1):c.1347_1350dup (p.Val451fs)	SERAC1		not provided	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000215144	6	158538811 - 158538812	6	158117779 - 158117780	215144	211210	rs780275814	NC_000006.12:158117779:AGATA:AGATAGATA
NM_032861.4(SERAC1):c.1126C>T (p.Gln376Ter)	SERAC1	Q376*	not provided	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000215142	6	158541497	6	158120465	215142	211211	rs199632531	NC_000006.12:158120464:G:A
NM_004523.4(KIF11):c.2494C>T (p.Gln832Ter)	KIF11	Q832*	not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000849766	10	94405346	10	92645589	849766	837487		NC_000010.11:92645588:C:T
NM_004523.4(KIF11):c.476_477CT[1] (p.Leu160fs)	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812110	10	94368864 - 94368865	10	92609107 - 92609108	812110	800359		NC_000010.11:92609106:TCTCT:TCT
NM_004523.4(KIF11):c.1116dup (p.Ala373fs)	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic	no assertion criteria provided	VCV000694001	10	94376571 - 94376572	10	92616814 - 92616815	694001	681828		NC_000010.11:92616814:AAAAAA:AAAAAAA
NC_000010.10:g.(?_94368777)_(94369266_?)del	KIF11		not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000659601	10	94368777 - 94369266	10	92609020 - 92609509	659601	652023		
NM_004523.4(KIF11):c.2230C>T (p.Gln744Ter)	KIF11	Q744*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453264	10	94399620	10	92639863	453264	446859	rs1554862427	NC_000010.11:92639862:C:T
GRCh37/hg19 12p12.1(chr12:23674558-23735393)x1	SOX5		See cases	Pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	VCV000443533	12	23674558 - 23735393			443533	437195		
GRCh37/hg19 12p12.1(chr12:23899592-24266672)x1	SOX5		See cases	Pathogenic(Last reviewed: Aug 26, 2015)	no assertion criteria provided	VCV000442608	12	23899592 - 24266672			442608	436270		
NM_004523.4(KIF11):c.868C>T (p.Gln290Ter)	KIF11	Q290*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000435617	10	94373212	10	92613455	435617	429140	rs1554859966	NC_000010.11:92613454:C:T
NM_004523.4(KIF11):c.2160+1G>T	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000435613	10	94397303	10	92637546	435613	429146	rs1554862218	NC_000010.11:92637545:G:T
NM_004523.4(KIF11):c.112del (p.His38fs)	KIF11	H38fs	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000435609	10	94366054	10	92606297	435609	429138	rs1554859309	NC_000010.11:92606296:CCC:CC
NM_032861.4(SERAC1):c.1643_1646dup (p.Leu550fs)	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic	no assertion criteria provided	VCV000430608	6	158535858 - 158535859	6	158114826 - 158114827	430608	423256	rs761964407	NC_000006.12:158114826:AGATAG:AGATAGATAG
NC_000012.11:g.23979791_24033225del	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Feb 12, 2016)	no assertion criteria provided	VCV000222021	12	23979791 - 24033225	12	23826857 - 23880291	222021	223712		
NC_000012.12:g.23771866_23888764del	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Feb 12, 2016)	no assertion criteria provided	VCV000222020	12	23924800 - 24041698	12	23771866 - 23888764	222020	223711		
NC_000012.12:g.23488792_23626279del	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Feb 12, 2016)	no assertion criteria provided	VCV000222019	12	23641726 - 23779213	12	23488792 - 23626279	222019	223710		
NC_000012.12:g.23484745_23564581del	SOX5		Lamb-shaffer syndrome	Pathogenic(Last reviewed: Feb 17, 2016)	no assertion criteria provided	VCV000222018	12	23637679 - 23717515	12	23484745 - 23564581	222018	223709		
NM_004523.4(KIF11):c.699-7_705del	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000211275	10	94372790 - 94372803	10	92613033 - 92613046	211275	207801	rs797045651	NC_000010.11:92613032:TTTCTAGTCGTTCC:
NM_004523.4(KIF11):c.436A>T (p.Lys146Ter)	KIF11	K146*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000211274	10	94368825	10	92609068	211274	207800	rs797045650	NC_000010.11:92609067:A:T
NM_004523.4(KIF11):c.-1_2delinsAA (p.Met1fs)	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000211271	10	94353132 - 94353134	10	92593375 - 92593377	211271	207799	rs797045649	NC_000010.11:92593374:CAT:AA
NM_004523.4(KIF11):c.790-1G>T	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000192301	10	94373133	10	92613376	192301	190094	rs730882122	NC_000010.11:92613375:G:T
NM_004523.4(KIF11):c.1408G>T (p.Glu470Ter)	KIF11	E470*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000192300	10	94390035	10	92630278	192300	190093	rs786205900	NC_000010.11:92630277:G:T
NM_004523.4(KIF11):c.790-1G>A	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000183017	10	94373133	10	92613376	183017	181168	rs730882122	NC_000010.11:92613375:G:A
NM_004523.4(KIF11):c.2300_2301del (p.Phe767fs)	KIF11	F767fs	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000183016	10	94405150 - 94405151	10	92645393 - 92645394	183016	181167	rs730882121	NC_000010.11:92645392:TTTT:TT
NM_001556.3(IKBKB):c.814C>T (p.Arg272Ter)	IKBKB	R272*, R213*, R270*	Immunodeficiency 15	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000157663	8	42173741	8	42316223	157663	167509	rs200296680	NC_000008.11:42316222:C:T
NM_004523.4(KIF11):c.704C>G (p.Ser235Cys)	KIF11	S235C	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029773	10	94372802	10	92613045	29773	38728	rs387906643	NC_000010.11:92613044:C:G
NM_004523.4(KIF11):c.2547+2T>C	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029772	10	94405401	10	92645644	29772	38727	rs730882063	NC_000010.11:92645643:T:C
NM_004523.4(KIF11):c.1592del (p.Gln531fs)	KIF11	Q531fs	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029771	10	94392340	10	92632583	29771	38726	rs730882062	NC_000010.11:92632582:A:
NM_004523.4(KIF11):c.1037_1038CT[1] (p.Leu347fs)	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029769	10	94376498 - 94376499	10	92616741 - 92616742	29769	38724	rs730882061	NC_000010.11:92616740:CTCT:CT
NM_004523.4(KIF11):c.1159C>T (p.Arg387Ter)	KIF11	R387*	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029768	10	94381172	10	92621415	29768	38723	rs387906641	NC_000010.11:92621414:C:T
NM_012082.4(ZFPM2):c.334C>T (p.Arg112Ter)	ZFPM2	R112*, R59*	Diaphragmatic hernia 3	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000006129	8	106573623	8	105561395	6129	21168	rs121908602	NC_000008.11:105561394:C:T
NM_006940.6(SOX5):c.1477C>T (p.Arg493Ter)	SOX5	R107*, R458*, R480*, R483*, R493*	not provided|Lamb-shaffer syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000695081	12	23716203	12	23563269	695081	683196		NC_000012.12:23563268:G:A
NM_032861.4(SERAC1):c.92-165C>T	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000587699	6	158576548	6	158155516	587699	578657	rs1562458862	NC_000006.12:158155515:G:A
NM_032861.4(SERAC1):c.92-239G>C	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000587693	6	158576622	6	158155590	587693	578651	rs1562458915	NC_000006.12:158155589:C:G
NM_006940.6(SOX5):c.622C>T (p.Gln208Ter)	SOX5	Q195*, Q198*, Q208*, Q173*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000545592	12	23893920	12	23740986	545592	536093	rs1555307370	NC_000012.12:23740985:G:A
Single allele	SOX5		Optic nerve hypoplasia	Pathogenic	criteria provided, single submitter	VCV000496727	12	23432684 - 23773692	12	23279750 - 23620758	496727	488177		
NM_006940.6(SOX5):c.1597+2T>A	SOX5		Lamb-shaffer syndrome|not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000449233	12	23699248	12	23546314	449233	444967	rs1555141265	NC_000012.12:23546313:A:T
NM_004523.4(KIF11):c.2548-1G>A	KIF11		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000435615	10	94407968	10	92648211	435615	429148	rs1554863016	NC_000010.11:92648210:G:A
NM_032861.4(SERAC1):c.202C>T (p.Arg68Ter)	SERAC1	R68*	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000120184	6	158571548	6	158150516	120184	125792	rs529232938	NC_000006.12:158150515:G:A
NM_001556.3(IKBKB):c.1292dup (p.Gln432fs)	IKBKB		Immunodeficiency 15	Pathogenic(Last reviewed: Dec 26, 2013)	no assertion criteria provided	VCV000102445	8	42176117 - 42176118	8	42318599 - 42318600	102445	108187	rs886041036	NC_000008.11:42318599:GGGG:GGGGG
NM_004523.4(KIF11):c.381G>A (p.Trp127Ter)	KIF11	W127*	|Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810629	10	94366988	10	92607231	810629	798919		NC_000010.11:92607230:G:A
NM_001556.3(IKBKB):c.607G>A (p.Val203Ile)	IKBKB	V203I, V144I, V201I	IMMUNODEFICIENCY 15A	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000590941	8	42166458	8	42308940	590941	581885	rs1563340753	NC_000008.11:42308939:G:A
NM_006940.6(SOX5):c.1060G>T (p.Gly354Ter)	SOX5	G341*, G354*, G319*, G344*	Lamb-shaffer syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000222022	12	23757425	12	23604491	222022	223713	rs869025321	NC_000012.12:23604490:C:A
NM_032861.4(SERAC1):c.1432_1434CTT[1] (p.Leu479del)	SERAC1	L479del	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Jun 10, 2012)	no assertion criteria provided	VCV000035559	6	158537281 - 158537283	6	158116249 - 158116251	35559	44232	rs1199625391	NC_000006.12:158116248:AAGAAG:AAG
NM_032861.3(SERAC1):c.1167_1170del (p.Gln390Profs)	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Jun 10, 2012)	no assertion criteria provided	VCV000035558	6	158540199 - 158540202	6	158119167 - 158119170	35558	44231	rs772296795	NC_000006.12:158119166:CTGACT:CT
NM_016042.4(EXOSC3):c.92G>C (p.Gly31Ala)	EXOSC3	G31A	Lissencephaly|Paucity of anterior horn motor neurons|Abnormality of the cerebellum|Severe intrauterine growth retardation|Microcephaly|Hypoplasia of the pons|Fetal akinesia sequence|Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031691	9	37784950	9	37784953	31691	40351	rs387907196	NC_000009.12:37784952:C:G
NM_004523.4(KIF11):c.2434_2438del (p.Ser812fs)	KIF11	S812fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000848431	10	94405285 - 94405289	10	92645528 - 92645532	848431	837486		NC_000010.11:92645527:ATCTCA:A
NM_032861.4(SERAC1):c.438del (p.Thr147fs)	SERAC1	T147fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689786	6	158567863	6	158146831	689786	677424		NC_000006.12:158146830:GG:G
NM_006940.6(SOX5):c.637C>T (p.Arg213Ter)	SOX5	R200*, R213*, R178*, R203*	not provided|Lamb-shaffer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503755	12	23893905	12	23740971	503755	495732	rs767241917	NC_000012.12:23740970:G:A
NM_032193.3(RNASEH2C):c.205C>T (p.Arg69Trp)	RNASEH2C	R69W	not provided|Aicardi Goutieres syndrome 3|Neurodevelopmental delay	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001260	11	65487856	11	65720385	1260	16299	rs78635798	NC_000011.10:65720384:G:A
NM_001190737.2(NFIB):c.395T>C (p.Leu132Pro)	NFIB	L132P, L128P, L84P, L123P, L127P, L158P, L154P	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT|Macrocephalus|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560027	9	14307155	9	14307156	560027	550743	rs1554709654	NC_000009.12:14307155:A:G
NM_001190737.2(NFIB):c.109C>T (p.Arg37Ter)	NFIB	R37*, R28*, R32*, R59*, R33*, R63*	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT|Macrocephalus|Intellectual disability	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560024	9	14307441	9	14307442	560024	550740	rs1554709792	NC_000009.12:14307441:G:A
NM_173689.7(CRB2):c.3089_3104dup (p.Gly1036fs)	CRB2		Focal segmental glomerulosclerosis 9|not provided|Steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000180701	9	126135887 - 126135888	9	123373608 - 123373609	180701	178866	rs879255251	NC_000009.12:123373608:GGCGCGGCCCCGGCCCGGCGCGGCCCC:GGCGCGGCCCCGGCCCGGCGCGGCCCCGGCCCGGCGCGGCCCC
NM_016035.5(COQ4):c.23_33del (p.Val8fs)	COQ4	V8fs	not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000280320	9	131085159 - 131085169	9	128322880 - 128322890	280320	264313	rs886041549	NC_000009.12:128322879:GTCCTCCGTCGG:G
NM_004211.5(SLC6A5):c.1430del (p.Ser477fs)	SLC6A5	S477fs, S243fs	Exaggerated startle response	Pathogenic	no assertion criteria provided	VCV000624831	11	20649560	11	20628014	624831	613457		NC_000011.10:20628013:C:
NM_004211.4(SLC6A5):c.1429T>C (p.Ser477Pro)	SLC6A5	S477P, S243P	Exaggerated startle response	Pathogenic	no assertion criteria provided	VCV000624830	11	20649559	11	20628013	624830	613456		NC_000011.10:20628012:T:C
NM_004211.4(SLC6A5):c.323del (p.Pro108Leufs)	SLC6A5	P108fs	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038371	11	20622990	11	20601444	38371	46932	rs281864923	NC_000011.10:20601443:CCCCC:CCCC
NM_004211.4(SLC6A5):c.1444T>C (p.Trp482Arg)	SLC6A5	W482R, W248R	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038370	11	20649574	11	20628028	38370	46931	rs281864925	NC_000011.10:20628027:T:C
NM_005989.4(AKR1D1):c.781C>T (p.Arg261Cys)	AKR1D1	R261C, R220C		Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000005378	7	137792252	7	138107506	5378	20417	rs267606650	NC_000007.14:138107505:C:T
NM_005989.4(AKR1D1):c.316C>T (p.Leu106Phe)	AKR1D1	L106F		Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000005376	7	137776568	7	138091822	5376	20415	rs121918343	NC_000007.14:138091821:C:T
AKR1D1, 1-BP DEL, 511T	AKR1D1			Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000005375					5375	20414		
NM_018389.5(SLC35C1):c.367del (p.Val123fs)	SLC35C1	V110fs, V123fs		Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000836912	11	45827718	11	45806167	836912	838444		NC_000011.10:45806166:GG:G
NM_004211.3:c.808C>T	SLC6A5	Q270*, Q36*	Hyperekplexia 3	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000658045	11	20628681	11	20607135	658045	639857		NC_000011.10:20607134:C:T
NM_016035.5(COQ4):c.371G>T (p.Gly124Val)	COQ4	G124V, V92F	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000638639	9	131088129	9	128325850	638639	626414		NC_000009.12:128325849:G:T
NM_016035.5(COQ4):c.197_198delinsAA (p.Arg66Gln)	COQ4	R66Q	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Oct 27, 2016)	no assertion criteria provided	VCV000267346	9	131085421 - 131085422	9	128323142 - 128323143	267346	262448	rs886040973	NC_000009.12:128323141:GC:AA
NM_005989.4(AKR1D1):c.398C>G (p.Pro133Arg)	AKR1D1	P133R		Pathogenic(Last reviewed: Aug 6, 2010)	no assertion criteria provided	VCV000005377	7	137782631	7	138097885	5377	20416	rs267606649	NC_000007.14:138097884:C:G
NM_000062.2(SERPING1):c.1397G>A (p.Arg466His)	SERPING1	R444H, R466H	Hereditary angioedema type 1|Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003946	11	57381948	11	57614475	3946	18985	rs121907948	NC_000011.10:57614474:G:A
NM_004211.4(SLC6A5):c.571C>T (p.Arg191Ter)	SLC6A5	R191*	Hyperekplexia 3	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000579017	11	20625862	11	20604316	579017	570423	rs376783257	NC_000011.10:20604315:C:T
NM_004211.3(SLC6A5):c.1640T>C (p.Phe547Ser)	SLC6A5	F547S, F313S	Hyperekplexia 3	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000540366	11	20657868	11	20636322	540366	526096	rs772652517	NC_000011.10:20636321:T:C
NM_016035.5(COQ4):c.190C>T (p.Pro64Ser)	COQ4	P64S	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000189204	9	131085414	9	128323135	189204	187095	rs766317663	NC_000009.12:128323134:C:T
NM_016035.5(COQ4):c.518_520CCA[1] (p.Thr174del)	COQ4	T174del	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000189203	9	131094547 - 131094549	9	128332268 - 128332270	189203	187094	rs786204771	NC_000009.12:128332267:CCACCA:CCA
NM_016035.5(COQ4):c.155T>C (p.Leu52Ser)	COQ4	L52S	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000189202	9	131085379	9	128323100	189202	187093	rs786204770	NC_000009.12:128323099:T:C
NM_016035.5(COQ4):c.421C>T (p.Arg141Ter)	COQ4	R141*	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000189200	9	131094450	9	128332171	189200	187091	rs775607037	NC_000009.12:128332170:C:T
NM_016035.5(COQ4):c.433C>G (p.Arg145Gly)	COQ4	R145G	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000189199	9	131094462	9	128332183	189199	187090	rs774395996	NC_000009.12:128332182:C:G
NM_004211.4(SLC6A5):c.1530T>G (p.Ser510Arg)	SLC6A5	S510R, S276R	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000031540	11	20652267	11	20630721	31540	40212	rs281864926	NC_000011.10:20630720:T:G
NM_004211.4(SLC6A5):c.1274C>T (p.Thr425Met)	SLC6A5	T425M, T191M	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000005767	11	20648267	11	20626721	5767	20806	rs121908498	NC_000011.10:20626720:C:T
NM_004211.4(SLC6A5):c.1526A>G (p.Asn509Ser)	SLC6A5	N509S, N275S	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000005766	11	20652263	11	20630717	5766	20805	rs121908497	NC_000011.10:20630716:A:G
NM_004211.4(SLC6A5):c.916C>G (p.Leu306Val)	SLC6A5	L306V, L72V	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000005765	11	20629129	11	20607583	5765	20804	rs121908496	NC_000011.10:20607582:C:G
NM_004211.4(SLC6A5):c.1888C>T (p.Gln630Ter)	SLC6A5	Q630*, Q396*	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000005764	11	20660023	11	20638477	5764	20803	rs121908495	NC_000011.10:20638476:C:T
NM_004211.4(SLC6A5):c.1472A>G (p.Tyr491Cys)	SLC6A5	Y491C, Y257C	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000005763	11	20649602	11	20628056	5763	20802	rs121908494	NC_000011.10:20628055:A:G
NM_018389.4(SLC35C1):c.439C>T (p.Arg147Cys)	SLC35C1	R147C, R134C		Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000004739	11	45827791	11	45806240	4739	19778	rs28939087	NC_000011.10:45806239:C:T
NM_032861.4(SERAC1):c.1626_1627CT[3] (p.Val544fs)	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome|not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000215148	6	158535875 - 158535876	6	158114843 - 158114844	215148	211206	rs767780913	NC_000006.12:158114843:AGAG:AGAGAG
NM_016035.5(COQ4):c.67dup (p.Ala23fs)	COQ4		Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000476186	9	131085202 - 131085203	9	128322923 - 128322924	476186	459342	rs1554796655	NC_000009.12:128322923:GG:GGG
NM_016035.5(COQ4):c.402+1G>C	COQ4		Coenzyme Q10 deficiency, primary, 7|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379740	9	131088161	9	128325882	379740	370612	rs747779231	NC_000009.12:128325881:G:C
NM_018389.4(SLC35C1):c.91G>T (p.Glu31Ter)	SLC35C1	E31*, E18*	not provided|	Pathogenic(Last reviewed: Aug 14, 2012)	criteria provided, single submitter	VCV000095906	11	45827443	11	45805892	95906	101802	rs398124345	NC_000011.10:45805891:G:T
NM_001112741.1(KCNC1):c.1262C>T (p.Ala421Val)	KCNC1	A421V	not provided|Epilepsy, progressive myoclonic 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488536	11	17793903	11	17772356	488536	481404	rs1554991378	NC_000011.10:17772355:C:T
NM_007103.4(NDUFV1):c.1156C>T (p.Arg386Cys)	NDUFV1	R386C, R377C	Mitochondrial complex I deficiency, nuclear type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419230	11	67379443	11	67611972	419230	408448	rs150966634	NC_000011.10:67611971:C:T
NM_007103.4(NDUFV1):c.1162+4A>C	NDUFV1		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4|Mitochondrial complex I deficiency, nuclear type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372716	11	67379453	11	67611982	372716	359994	rs199683937	NC_000011.10:67611981:A:C
NM_020361.5(CPA6):c.587A>G (p.His196Arg)	CPA6	H196R	Epilepsy, familial temporal lobe, 5	Pathogenic(Last reviewed: Dec 14, 2012)	no assertion criteria provided	VCV000393468	8	68419071	8	67506836	393468	380290	rs376266840	NC_000008.11:67506835:T:C
NM_001010892.3(RSPH4A):c.1490dup (p.Ser498fs)	RSPH4A		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000838557	6	116949359 - 116949360	6	116628196 - 116628197	838557	831467		NC_000006.12:116628196:T:TT
NM_001010892.3(RSPH4A):c.1103T>G (p.Val368Gly)	RSPH4A	V368G	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000650407	6	116948973	6	116627810	650407	634515		NC_000006.12:116627809:T:G
NM_001010892.3(RSPH4A):c.1391G>A (p.Gly464Glu)	RSPH4A	G464E	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000640175	6	116949261	6	116628098	640175	634517		NC_000006.12:116628097:G:A
NM_024740.2(ALG9):c.681G>A (p.Trp227Ter)	ALG9	W227*, W31*, W56*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631494	11	111728345	11	111857622	631494	619857		NC_000011.10:111857621:C:T
NM_001010892.3(RSPH4A):c.1690C>T (p.Gln564Ter)	RSPH4A	Q564*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000525321	6	116950757	6	116629594	525321	521967	rs1554249521	NC_000006.12:116629593:C:T
NM_001010892.3(RSPH4A):c.11C>G (p.Ser4Ter)	RSPH4A	S4*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000525311	6	116937797	6	116616634	525311	521336	rs1554247978	NC_000006.12:116616633:C:G
NM_001010892.3(RSPH4A):c.690T>G (p.Tyr230Ter)	RSPH4A	Y230*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000525252	6	116943934	6	116622771	525252	521703	rs1554248617	NC_000006.12:116622770:T:G
ALG9, GLU359LYS	ALG9	E530K	ALG9 congenital disorder of glycosylation	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000488404					488404	481251		
NM_001010892.3(RSPH4A):c.1707del (p.Glu570fs)	RSPH4A	E570fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000454522	6	116950773	6	116629610	454522	455814	rs902750903	NC_000006.12:116629609:AA:A
NM_001010892.3(RSPH4A):c.1453C>T (p.Arg485Ter)	RSPH4A	R485*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000454521	6	116949323	6	116628160	454521	455810	rs1034327724	NC_000006.12:116628159:C:T
NM_001010892.3(RSPH4A):c.166dup (p.Arg56fs)	RSPH4A		Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000208994	6	116937949 - 116937950	6	116616786 - 116616787	208994	205557	rs797045147	NC_000006.12:116616786:CCC:CCCC
NM_001010892.3(RSPH4A):c.1270del (p.Thr424fs)	RSPH4A	T424fs	Ciliary dyskinesia, primary, 11	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066993	6	116949139	6	116627976	66993	77878	rs397518456	NC_000006.12:116627975:AA:A
NM_001010892.3(RSPH4A):c.667del (p.Ser223fs)	RSPH4A	S223fs	Ciliary dyskinesia, primary, 11	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066992	6	116938453	6	116617290	66992	77877	rs397518455	NC_000006.12:116617289:A:
NM_024740.2(ALG9):c.860A>G (p.Tyr287Cys)	ALG9	Y286C, Y287C, Y116C, Y91C	ALG9 congenital disorder of glycosylation	Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	VCV000003749	11	111724138	11	111853415	3749	18788	rs121908023	NC_000011.10:111853414:T:C
NM_024740.2(ALG9):c.1588G>A (p.Glu530Lys)	ALG9	E523K, E530K, E352K, E327K, E359K, E311K, E482K	ALG9 congenital disorder of glycosylation	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000003748	11	111706902	11	111836179	3748	18787	rs121908022	NC_000011.10:111836178:C:T
NM_000349.3(STAR):c.64+1G>T	STAR		not provided|Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550998	8	38008272	8	38150754	550998	544814	rs765968701	NC_000008.11:38150753:C:A
NM_000349.3(STAR):c.505G>A (p.Glu169Lys)	STAR	E169K	not provided|Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448533	8	38003626	8	38146108	448533	441232	rs747169620	NC_000008.11:38146107:C:T
NM_000349.3(STAR):c.559G>A (p.Val187Met)	STAR	V187M	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008996	8	38003572	8	38146054	8996	24035	rs104894089	NC_000008.11:38146053:C:T
NM_001010892.3(RSPH4A):c.522dup (p.Glu175fs)	RSPH4A		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000580401	6	116938305 - 116938306	6	116617142 - 116617143	580401	560546	rs1444391928	NC_000006.12:116617142:AAA:AAAA
NM_001010892.3(RSPH4A):c.1393C>T (p.Arg465Ter)	RSPH4A	R465*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000577068	6	116949263	6	116628100	577068	563345	rs755782051	NC_000006.12:116628099:C:T
NM_001010892.3(RSPH4A):c.1351C>T (p.Gln451Ter)	RSPH4A	Q451*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000454520	6	116949221	6	116628058	454520	456043	rs750528020	NC_000006.12:116628057:C:T
NM_001010892.3(RSPH4A):c.1068G>A (p.Trp356Ter)	RSPH4A	W356*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000409228	6	116948938	6	116627775	409228	395662	rs371374918	NC_000006.12:116627774:G:A
NM_004211.4(SLC6A5):c.1294delGinsTT (p.Val432Phefs)	SLC6A5	V432F	Hyperekplexia 3	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000005762	11	20648287	11	20626741	5762	20801	rs281864924	NC_000011.10:20626740:G:TT
NM_004211.3(SLC6A5):c.1131C>A (p.Tyr377Ter)	SLC6A5	Y377*, Y143*	Hyperekplexia 3	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000005761	11	20639301	11	20617755	5761	20800	rs121908493	NC_000011.10:20617754:C:A
NM_018389.4(SLC35C1):c.923C>G (p.Thr308Arg)	SLC35C1	T308R, T295R		Pathogenic(Last reviewed: Jun 15, 2002)	no assertion criteria provided	VCV000004740	11	45832714	11	45811163	4740	19779	rs28937886	NC_000011.10:45811162:C:G
NM_032861.4(SERAC1):c.1403+1G>C	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Jan 31, 2017)	no assertion criteria provided	VCV000430610	6	158538758	6	158117726	430610	423258	rs1131690799	NC_000006.12:158117725:C:G
NM_004523.4(KIF11):c.247C>T (p.Arg83Ter)	KIF11	R83*	not provided|Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424002	10	94366412	10	92606655	424002	408021	rs1064796738	NC_000010.11:92606654:C:T
NM_012120.3(CD2AP):c.1045+1G>A	CD2AP		Focal segmental glomerulosclerosis 3, susceptibility to	Pathogenic(Last reviewed: Oct 16, 2017)	no assertion criteria provided	VCV000522522	6	47548637	6	47580901	522522	513063	rs1393955970	NC_000006.12:47580900:G:A
NM_020632.3(ATP6V0A4):c.1180+1del	ATP6V0A4		not provided	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000423162	7	138433911	7	138749166	423162	406982	rs1064796270	NC_000007.14:138749165:CC:C
NM_020632.3(ATP6V0A4):c.1006_1007del (p.Lys336fs)	ATP6V0A4	K336fs	not provided	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000422991	7	138437392 - 138437393	7	138752647 - 138752648	422991	406983	rs1064796145	NC_000007.14:138752646:TT:
NM_020632.3(ATP6V0A4):c.334C>T (p.Gln112Ter)	ATP6V0A4	Q112*	not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000280715	7	138447728	7	138762983	280715	264310	rs779869631	NC_000007.14:138762982:G:A
NM_020632.3(ATP6V0A4):c.369_373del (p.Glu123fs)	ATP6V0A4	E123fs	Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802371	7	138447689 - 138447693	7	138762944 - 138762948	802371	790699		NC_000007.14:138762943:TCAGTTC:TC
NM_020632.3(ATP6V0A4):c.816+1G>A	ATP6V0A4		Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 24, 2018)	no assertion criteria provided	VCV000635428	7	138440433	7	138755688	635428	623297		NC_000007.14:138755687:C:T
NM_014694.4(ADAMTSL2):c.234-2A>G	ADAMTSL2		Geleophysic dysplasia 1	Pathogenic(Last reviewed: Jun 17, 2017)	no assertion criteria provided	VCV000427943	9	136403469	9	133538347	427943	419138	rs775621284	NC_000009.12:133538346:A:G
NM_012120.3(CD2AP):c.1834C>T (p.Arg612Ter)	CD2AP	R612*	Focal segmental glomerulosclerosis 3	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000005704	6	47580228	6	47612492	5704	20743	rs267606710	NC_000006.12:47612491:C:T
NM_012120.3(CD2AP):c.730-1_730delinsCT	CD2AP		Focal segmental glomerulosclerosis 3	Pathogenic(Last reviewed: May 23, 2003)	no assertion criteria provided	VCV000005703	6	47544259 - 47544260	6	47576523 - 47576524	5703	20742	rs1554181304	NC_000006.12:47576522:GC:CT
NM_020632.3(ATP6V0A4):c.2420G>A (p.Arg807Gln)	ATP6V0A4	R807Q	Renal tubular acidosis, distal, autosomal recessive, with late-onset sensorineural hearing loss	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005159	7	138394378	7	138709633	5159	20198	rs28939081	NC_000007.14:138709632:C:T
NM_020632.3(ATP6V0A4):c.1506T>A (p.Tyr502Ter)	ATP6V0A4	Y502*	Renal tubular acidosis, distal, autosomal recessive, with late-onset sensorineural hearing loss	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005158	7	138424351	7	138739606	5158	20197	rs121908369	NC_000007.14:138739605:A:T
ATP6V0A4, 1-BP DEL, GLN276	ATP6V0A4		Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005156					5156	20195		
NM_014694.4(ADAMTSL2):c.499G>A (p.Asp167Asn)	ADAMTSL2	D167N	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Mar 27, 2019)	no assertion criteria provided	VCV000624558	9	136405806	9	133540684	624558	613383	rs761886575	NC_000009.12:133540683:G:A
NM_014694.4(ADAMTSL2):c.661C>T (p.Arg221Cys)	ADAMTSL2	R221C	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030945	9	136406102	9	133540980	30945	39902	rs387907065	NC_000009.12:133540979:C:T
NM_014694.4(ADAMTSL2):c.215G>A (p.Arg72Gln)	ADAMTSL2	R72Q	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030944	9	136402651	9	133537529	30944	39901	rs387907064	NC_000009.12:133537528:G:A
NM_020632.3(ATP6V0A4):c.418-1G>A	ATP6V0A4		Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005155	7	138447180	7	138762435	5155	20194	rs587776617	NC_000007.14:138762434:C:T
NM_020632.3(ATP6V0A4):c.105del (p.Gln36fs)	ATP6V0A4	Q36fs	Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005153	7	138455888	7	138771143	5153	20192	rs587776616	NC_000007.14:138771142:AA:A
NM_020632.3(ATP6V0A4):c.1691+1G>A	ATP6V0A4		Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005152	7	138418880	7	138734135	5152	20191	rs587776615	NC_000007.14:138734134:C:T
NM_020632.3(ATP6V0A4):c.2458G>A (p.Gly820Arg)	ATP6V0A4	G820R	Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005151	7	138391434	7	138706689	5151	20190	rs267606671	NC_000007.14:138706688:C:T
NM_020632.3(ATP6V0A4):c.2257C>T (p.Gln753Ter)	ATP6V0A4	E753*, Q753*	Renal tubular acidosis, distal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005150	7	138400509	7	138715764	5150	20189	rs121908367	NC_000007.14:138715763:G:A
NM_014694.4(ADAMTSL2):c.2586G>A (p.Trp862Ter)	ADAMTSL2	W862*	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Mar 26, 2019)	no assertion criteria provided	VCV000000697	9	136435623	9	133570501	697	15736	rs113994125	NC_000009.12:133570500:G:A
NM_014694.4(ADAMTSL2):c.2431G>A (p.Gly811Arg)	ADAMTSL2	E811R, G811R	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Mar 26, 2019)	no assertion criteria provided	VCV000000696	9	136435468	9	133570346	696	15735	rs113994124	NC_000009.12:133570345:G:A
NM_014694.4(ADAMTSL2):c.338G>A (p.Arg113His)	ADAMTSL2	R113H	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Mar 26, 2019)	no assertion criteria provided	VCV000000694	9	136404921	9	133539799	694	15733	rs113994122	NC_000009.12:133539798:G:A
NM_014694.4(ADAMTSL2):c.440C>T (p.Pro147Leu)	ADAMTSL2	P147L	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Mar 26, 2019)	no assertion criteria provided	VCV000000693	9	136405747	9	133540625	693	15732	rs113994121	NC_000009.12:133540624:C:T
NM_024740.2(ALG9):c.[1173+2T>A];[1173+2T>A]	ALG9		Gillessen-Kaesbach-Nishimura dysplasia|Gillessen-Kaesbach-Nishimura syndrome	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000162619	11	111711376	11	111840653	162619	172295	rs786205134	NC_000011.10:111840652:A:T
NM_020661.4(AICDA):c.259T>C (p.Cys87Arg)	AICDA	C87R	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617969	12	8757979	12	8605383	617969	609861	rs762590894	NC_000012.12:8605382:A:G
SLCO1B3, ARG253TER	SLCO1B3	R253*	Rotor syndrome	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000030488					30488	39445		
SLCO1B3, 7.2-KB DEL	SLCO1B3		Rotor syndrome	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000030487					30487	39444		
NM_001010892.3(RSPH4A):c.325C>T (p.Gln109Ter)	RSPH4A	Q109*	Ciliary dyskinesia, primary, 11|Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 27, 2017)	criteria provided, single submitter	VCV000000504	6	116938111	6	116616948	504	15543	rs118204042	NC_000006.12:116616947:C:T
NM_001010892.3(RSPH4A):c.460C>T (p.Gln154Ter)	RSPH4A	Q154*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 11	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000000503	6	116938246	6	116617083	503	15542	rs118204041	NC_000006.12:116617082:C:T
NM_001300895.2(CABP4):c.-323_-322delinsA	CABP4		Congenital stationary night blindness, type 2B	Pathogenic(Last reviewed: Jan 25, 2019)	no assertion criteria provided	VCV000635475	11	67222955 - 67222956	11	67455484 - 67455485	635475	623308		NC_000011.10:67455483:CC:A
NM_001128228.3(TPRN):c.53G>A (p.Trp18Ter)	TPRN	W18*	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627483	9	140095111	9	137200659	627483	615806	rs1564386891	NC_000009.12:137200658:C:T
NM_001128228.3(TPRN):c.1530del (p.Thr511fs)	TPRN	T511fs	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000138	9	140093634	9	137199182	138	15177	rs387906222	NC_000009.12:137199181:CCC:CC
NM_001128228.3(TPRN):c.1427del (p.Pro476fs)	TPRN	P476fs	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000135	9	140093737	9	137199285	135	15174	rs387906219	NC_000009.12:137199284:GGG:GG
NM_001128228.3(TPRN):c.1239G>A (p.Trp413Ter)	TPRN	W352*, W413*	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000134	9	140093925	9	137199473	134	15173	rs267607135	NC_000009.12:137199472:C:T
NM_001300895.2(CABP4):c.-303_-302insA	CABP4		Congenital stationary night blindness, type 2B	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000190960	11	67222975 - 67222976	11	67455504 - 67455505	190960	188767	rs786205852	NC_000011.10:67455504::A
NM_001128228.3(TPRN):c.227_237dup (p.Leu80fs)	TPRN		Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000136	9	140094926 - 140094927	9	137200474 - 137200475	136	15175	rs387906220	NC_000009.12:137200474:CAGCCGCGCCCC:CAGCCGCGCCCCAGCCGCGCCCC
NM_145200.4(CABP4):c.673C>T (p.Arg225Ter)	CABP4	R225*, R120*	Retinal dystrophy|Cone/cone-rod dystrophy	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000438047	11	67225863	11	67458392	438047	431757	rs531851447	NC_000011.10:67458391:C:T
NM_000349.3(STAR):c.714del (p.Lys238fs)	STAR	K238fs	not provided|Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558171	8	38002770	8	38145252	558171	544771	rs1417088430	NC_000008.11:38145251:TTT:TT
NM_001128228.3(TPRN):c.214_224GGGGGCGCGGC[1] (p.Gly76fs)	TPRN		Deafness, autosomal recessive 79|not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000000137	9	140094929 - 140094939	9	137200477 - 137200487	137	15176	rs387906221	NC_000009.12:137200476:GCCGCGCCCCCGCCGCGCCCCCGCCGCGCC:GCCGCGCCCCCGCCGCGCC
NM_017813.5(BPNT2):c.547A>C (p.Thr183Pro)	BPNT2	T183P	Chondrodysplasia with joint dislocations, GPAPP type	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000031091	8	57892597	8	56980038	31091	40048	rs387907102	NC_000008.11:56980037:T:G
NM_017813.5(BPNT2):c.529G>A (p.Asp177Asn)	BPNT2	D177N	Chondrodysplasia with joint dislocations, GPAPP type	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000031090	8	57892615	8	56980056	31090	40047	rs387907101	NC_000008.11:56980055:C:T
NM_014694.4(ADAMTSL2):c.340G>A (p.Glu114Lys)	ADAMTSL2	E114K	Geleophysic dysplasia 1	Pathogenic(Last reviewed: Jun 17, 2017)	no assertion criteria provided	VCV000000695	9	136404923	9	133539801	695	15734	rs113994123	NC_000009.12:133539800:G:A
NM_017813.5(BPNT2):c.324del (p.Ser108fs)	BPNT2	S108fs	Chondrodysplasia with joint dislocations, GPAPP type	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000162436	8	57905821	8	56993262	162436	172127	rs724160003	NC_000008.11:56993261:G:
NM_001190737.2(NFIB):c.376A>G (p.Lys126Glu)	NFIB	K126E, K122E, K117E, K148E, K152E, K121E, K78E	Marfanoid habitus and intellectual disability|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT|Macrocephalus|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560026	9	14307174	9	14307175	560026	550742	rs1554709662	NC_000009.12:14307174:T:C
NM_017813.5(BPNT2):c.559C>T (p.Arg187Ter)	BPNT2	R187*	Chondrodysplasia with joint dislocations, GPAPP type|not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000031092	8	57890696	8	56978137	31092	40049	rs387907103	NC_000008.11:56978136:G:A
NM_012123.4(MTO1):c.1430G>A (p.Arg477His)	MTO1	R477H, R502H, R517H	not provided|Combined oxidative phosphorylation deficiency 10	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000089037	6	74191932	6	73482209	89037	94578	rs201544686	NC_000006.12:73482208:G:A
NM_000507.4(FBP1):c.490G>A (p.Gly164Ser)	FBP1	G164S	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000868	9	97372280	9	94609998	868	15907	rs121918188	NC_000009.12:94609997:C:T
NM_004722.4(AP4M1):c.694dup (p.Glu232fs)	AP4M1		not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000818030	7	99702686 - 99702687	7	100105063 - 100105064	818030	805519		NC_000007.14:100105063:GG:GGG
NM_003764.4(STX11):c.687dup (p.Gln230fs)	STX11		not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000545749	6	144508450 - 144508451	6	144187313 - 144187314	545749	536312	rs1554294422	NC_000006.12:144187313:G:GG
NM_004722.4(AP4M1):c.737del (p.Pro246fs)	AP4M1	P246fs, P253fs	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000496933	7	99702871	7	100105248	496933	488357	rs1191415115	NC_000007.14:100105247:CC:C
NM_004722.4(AP4M1):c.218dup (p.Asn73fs)	AP4M1		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000450739	7	99700364 - 99700365	7	100102741 - 100102742	450739	444024	rs1321353475	NC_000007.14:100102741:AAAA:AAAAA
NM_004722.4(AP4M1):c.923C>G (p.Ser308Ter)	AP4M1	S308*, S315*	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000429735	7	99703156	7	100105533	429735	421608	rs1131691556	NC_000007.14:100105532:C:G
NM_001024630.4(RUNX2):c.1275dup (p.Tyr426fs)	RUNX2		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000423643	6	45514748 - 45514749	6	45547011 - 45547012	423643	406879	rs1554125882	NC_000006.12:45547011:CCC:CCCC
NM_001024630.4(RUNX2):c.569G>A (p.Arg190Gln)	RUNX2	R190Q, R176Q	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000381546	6	45399745	6	45432008	381546	368950	rs1057521068	NC_000006.12:45432007:G:A
NM_004722.4(AP4M1):c.330C>G (p.Tyr110Ter)	AP4M1	Y110*, Y117*	not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000280192	7	99700562	7	100102939	280192	264219	rs752598529	NC_000007.14:100102938:C:G
NM_004722.4(AP4M1):c.1321C>T (p.Arg441Ter)	AP4M1	R441*, R448*	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000279679	7	99704464	7	100106841	279679	264224	rs886041126	NC_000007.14:100106840:C:T
NC_000011.9:g.(?_111896177)_(111922093_?)del	DLAT		Pyruvate dehydrogenase E2 deficiency	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000832069	11	111896177 - 111922093			832069	820427		
NM_001024630.4(RUNX2):c.577C>T (p.Arg193Ter)	RUNX2	R179*, R193*	Cleidocranial dysostosis	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000829868	6	45399753	6	45432016	829868	818248		NC_000006.12:45432015:C:T
NM_003764.4(STX11):c.581_584del (p.Leu194fs)	STX11	L194fs		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802280	6	144508343 - 144508346	6	144187206 - 144187209	802280	790598		NC_000006.12:144187205:GCTGGC:GC
NM_001024630.4(RUNX2):c.371C>A (p.Ser124Ter)	RUNX2	S124*, S110*	Cleidocranial dysostosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802220	6	45390642	6	45422905	802220	790635		NC_000006.12:45422904:C:A
RUNX2, EX3-6DUP	RUNX2		Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000691870					691870	679584		
NM_014334.3(FRRS1L):c.670C>T (p.Gln224Ter)	FRRS1L	Q224*	Epileptic encephalopathy, early infantile, 37	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000659759	9	111903815	9	109141535	659759	637608		NC_000009.12:109141534:G:A
NM_014334.3(FRRS1L):c.639C>A (p.Cys213Ter)	FRRS1L	C213*	Epileptic encephalopathy, early infantile, 37	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000575860	9	111903846	9	109141566	575860	565408	rs779716535	NC_000009.12:109141565:G:T
NM_014334.3(FRRS1L):c.451_452TG[1] (p.Cys151fs)	FRRS1L		Epileptic encephalopathy, early infantile, 37	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000569279	9	111911938 - 111911939	9	109149658 - 109149659	569279	565409	rs1564232243	NC_000009.12:109149657:CACA:CA
Single allele	RUNX2		Cleidocranial dysostosis	Pathogenic(Last reviewed: Aug 31, 2016)	no assertion criteria provided	VCV000437934			6	45512244	437934	431555		
NM_001024630.4(RUNX2):c.90dup (p.Ser31fs)	RUNX2		Cleidocranial dysostosis	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065626	6	45390354 - 45390355	6	45422617 - 45422618	65626	76534	rs397515538	NC_000006.12:45422617:CCCCCCC:CCCCCCCC
NM_001024630.4(RUNX2):c.1171C>T (p.Arg391Ter)	RUNX2	R391*, R369*, R377*, R355*	Cleidocranial dysostosis	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065625	6	45514647	6	45546910	65625	76533	rs397515537	NC_000006.12:45546909:C:T
NM_001024630.4(RUNX2):c.1205dup (p.Pro403fs)	RUNX2		Cleidocranial dysplasia, severe, with osteoporosis and scoliosis	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000009301	6	45514677 - 45514678	6	45546940 - 45546941	9301	24340	rs730880314	NC_000006.12:45546940:CCCC:CCCCC
NM_001024630.4(RUNX2):c.1379dup (p.Asp463fs)	RUNX2		Cleidocranial dysplasia, forme fruste	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000009300	6	45514853 - 45514854	6	45547116 - 45547117	9300	24339		NC_000006.12:45547116:CC:CCC
DLAT, 3-BP DEL, 361GAA	DLAT		Pyruvate dehydrogenase E2 deficiency	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000002109					2109	17148		
NC_000009.12:g.(?_109147031)_(109147209_?)del	FRRS1L		Epileptic encephalopathy, early infantile, 37	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000831493	9	111909311 - 111909489			831493	820041		
NM_001024630.4(RUNX2):c.738C>T (p.Leu246=)	RUNX2		Cleidocranial dysostosis	Pathogenic	criteria provided, single submitter	VCV000694720	6	45459730	6	45491993	694720	682807		NC_000006.12:45491992:C:T
NM_014334.3(FRRS1L):c.298del (p.Asp100fs)	FRRS1L	D100fs	Epileptic encephalopathy, early infantile, 37	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000476302	9	111929274	9	109166994	476302	458713	rs933379958	NC_000009.12:109166993:CCCCCC:CCCCC
NM_001024630.4(RUNX2):c.476G>A (p.Gly159Asp)	RUNX2	G159D, G145D	Cleidocranial dysostosis	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208165	6	45399652	6	45431915	208165	204425	rs864621970	NC_000006.12:45431914:G:A
NM_001024630.4(RUNX2):c.1228dup (p.Leu410fs)	RUNX2		Cleidocranial dysostosis	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000009307	6	45514701 - 45514702	6	45546964 - 45546965	9307	24346	rs730880315	NC_000006.12:45546964:CCC:CCCC
NM_001024630.4(RUNX2):c.506G>C (p.Arg169Pro)	RUNX2	R169P, R155P	Cleidocranial dysostosis	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000009306	6	45399682	6	45431945	9306	24345	rs104893995	NC_000006.12:45431944:G:C
NM_001024630.4(RUNX2):c.1565G>C (p.Ter522Ser)	RUNX2	*522S, *508S, *500S, *486S	Cleidocranial dysostosis	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000009305	6	45515041	6	45547304	9305	24344	rs104893994	NC_000006.12:45547303:G:C
NM_001024630.4(RUNX2):c.572G>A (p.Ser191Asn)	RUNX2	S191N, S177N	Cleidocranial dysostosis	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000009299	6	45399748	6	45432011	9299	24338	rs104893990	NC_000006.12:45432010:G:A
NM_001024630.4(RUNX2):c.524T>G (p.Met175Arg)	RUNX2	M175R, M161R	Cleidocranial dysostosis	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000009298	6	45399700	6	45431963	9298	24337	rs104893989	NC_000006.12:45431962:T:G
NM_001024630.4(RUNX2):c.891G>A (p.Trp297Ter)	RUNX2	W283*, W297*	Cleidocranial dysostosis	Pathogenic(Last reviewed: May 30, 1997)	no assertion criteria provided	VCV000009296	6	45480014	6	45512277	9296	24335	rs104893988	NC_000006.12:45512276:G:A
NC_000006.12:g.144176889_144196077del	STX11			Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000005264	6	144498026 - 144517214	6	144176889 - 144196077	5264	20303		
NM_004722.4(AP4M1):c.802C>T (p.Arg268Ter)	AP4M1	R268*, R275*	Spastic paraplegia 50, autosomal recessive	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522944	7	99702937	7	100105314	522944	513571	rs780030221	NC_000007.14:100105313:C:T
NM_004722.4(AP4M1):c.1225T>C (p.Phe409Leu)	AP4M1	F409L, F416L	Spastic paraplegia 50, autosomal recessive	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522649	7	99704368	7	100106745	522649	513289	rs760907496	NC_000007.14:100106744:T:C
NM_014334.3(FRRS1L):c.874C>T (p.Arg292Ter)	FRRS1L	R292*	Epileptic encephalopathy, early infantile, 37	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000476309	9	111899896	9	109137616	476309	459217	rs1054228594	NC_000009.12:109137615:G:A
NM_004722.4(AP4M1):c.1012C>T (p.Arg338Ter)	AP4M1	R338*, R345*	Spastic paraplegia 50, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000209980	7	99703901	7	100106278	209980	206566	rs146262009	NC_000007.14:100106277:C:T
NM_001024630.4(RUNX2):c.673C>T (p.Arg225Trp)	RUNX2	R225W, R211W	Cleidocranial dysostosis	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000009303	6	45405776	6	45438039	9303	24342	rs104893992	NC_000006.12:45438038:C:T
AP4M1, IVS14DS, G-T, +1	AP4M1		Spastic paraplegia 50, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000007349					7349	22388		
NM_003764.4(STX11):c.802C>T (p.Gln268Ter)	STX11	Q268*		Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000005265	6	144508566	6	144187429	5265	20304	rs104893996	NC_000006.12:144187428:C:T
NM_003764.4(STX11):c.369_376delinsTGG (p.Val124fs)	STX11			Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000005263	6	144508133 - 144508140	6	144186996 - 144187003	5263	20302	rs483352901	NC_000006.12:144186995:AGTGGCGC:TGG
NM_001010892.3(RSPH4A):c.1662+2_1662+5del	RSPH4A		Ciliary dyskinesia, primary, 11|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000441117	6	116949531 - 116949534	6	116628368 - 116628371	441117	434602	rs768986129	NC_000006.12:116628367:AGGTAGG:AGG
NM_001010892.3(RSPH4A):c.1468C>T (p.Arg490Ter)	RSPH4A	R490*	Ciliary dyskinesia, primary, 11|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000000505	6	116949338	6	116628175	505	15544	rs118204043	NC_000006.12:116628174:C:T
NM_001112741.1(KCNC1):c.959G>A (p.Arg320His)	KCNC1	R320H	Epilepsy, progressive myoclonic 7	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162519	11	17793600	11	17772053	162519	172192	rs727502818	NC_000011.10:17772052:G:A
NC_000006.11:g.(?_144507745)_(144508648_?)del	STX11			Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000583514	6	144507745 - 144508648	6	144186608 - 144187511	583514	560397		
NM_014334.3(FRRS1L):c.436dup (p.Ile146fs)	FRRS1L		Epileptic encephalopathy, early infantile, 37|Seizures|Chorea|Progressive encephalopathy	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000218154	9	111911955 - 111911956	9	109149675 - 109149676	218154	214802	rs878853283	NC_000009.12:109149675:TTTT:TTTTT
NM_001024630.4(RUNX2):c.674G>A (p.Arg225Gln)	RUNX2	R225Q, R211Q	not provided|Cleidocranial dysostosis	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000009302	6	45405777	6	45438040	9302	24341	rs104893991	NC_000006.12:45438039:G:A
NM_001005463.3(EBF3):c.806dup (p.Ala270fs)	EBF3		not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000817501	10	131666124 - 131666125	10	129867860 - 129867861	817501	805634		NC_000010.11:129867860:CCCCCC:CCCCCCC
NM_001005463.3(EBF3):c.556_559TTCT[1] (p.Phe186_Phe187insTer)	EBF3		not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000816997	10	131676105 - 131676108	10	129877841 - 129877844	816997	805635		NC_000010.11:129877840:AGAAAGAA:AGAA
NM_001005463.3(EBF3):c.1101+1G>C	EBF3		Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802637	10	131646655	10	129848391	802637	790944		NC_000010.11:129848390:C:G
NM_001005463.3(EBF3):c.86C>A (p.Ser29Ter)	EBF3	S29*	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000620368	10	131761947	10	129963683	620368	611730	rs778076484	NC_000010.11:129963682:G:T
NM_001005463.3(EBF3):c.469_477dup (p.His157_Ile159dup)	EBF3		not provided	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000545060	10	131757205 - 131757206	10	129958941 - 129958942	545060	535317	rs1554935456	NC_000010.11:129958941:GATCTCGTGG:GATCTCGTGGATCTCGTGG
NM_001005463.3(EBF3):c.421_422insC (p.Tyr141fs)	EBF3		not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000524128	10	131757261 - 131757262	10	129958997 - 129958998	524128	514605	rs1554935484	NC_000010.11:129958997::G
NM_001005463.3(EBF3):c.171del (p.Gln57fs)	EBF3	Q57fs	not provided	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000504040	10	131761751	10	129963487	504040	495665	rs1554937243	NC_000010.11:129963486:C:
NM_001005463.3(EBF3):c.151_153delinsTGA (p.Arg51Ter)	EBF3		not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503921	10	131761769 - 131761771	10	129963505 - 129963507	503921	495667	rs1554937249	NC_000010.11:129963504:CCG:TCA
NM_173551.5(ANKS6):c.1301del (p.Leu434fs)	ANKS6	L434fs	not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000503782	9	101542538	9	98780256	503782	495440	rs1554746855	NC_000009.12:98780255:A:
NM_001005463.3(EBF3):c.469C>T (p.His157Tyr)	EBF3	H157Y	not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000451021	10	131757214	10	129958950	451021	444572	rs1554935464	NC_000010.11:129958949:G:A
NM_001005463.3(EBF3):c.244del (p.Val82fs)	EBF3	V82fs	not provided	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000430928	10	131761678	10	129963414	430928	424473	rs1131692259	NC_000010.11:129963413:CC:C
NM_001005463.3(EBF3):c.286_287GA[1] (p.Lys97fs)	EBF3		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000426170	10	131761633 - 131761634	10	129963369 - 129963370	426170	415216	rs1085307482	NC_000010.11:129963368:TCTCT:TCT
NM_001005463.3(EBF3):c.341T>G (p.Leu114Ter)	EBF3	L114*	not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000424047	10	131761220	10	129962956	424047	407830	rs1064796766	NC_000010.11:129962955:A:C
NM_001005463.3(EBF3):c.907C>T (p.Arg303Ter)	EBF3	R303*	not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000423864	10	131665510	10	129867246	423864	407829	rs1064796669	NC_000010.11:129867245:G:A
NM_001005463.3(EBF3):c.370C>T (p.Gln124Ter)	EBF3	Q124*	not provided	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000391200	10	131760476	10	129962212	391200	373328	rs1057524002	NC_000010.11:129962211:G:A
NM_001005463.3(EBF3):c.512G>A (p.Gly171Asp)	EBF3	G171D	Renal dysplasia|Generalized hypotonia|Developmental regression|Broad-based gait|Neurogenic bladder	Pathogenic	no assertion criteria provided	VCV000375375	10	131755564	10	129957300	375375	362152	rs1057519437	NC_000010.11:129957299:C:T
NM_001005463.3(EBF3):c.1101+1G>T	EBF3		Muscular hypotonia|Intellectual disability (severe)	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000212723	10	131646655	10	129848391	212723	209338	rs797046136	NC_000010.11:129848390:C:A
NM_001005463.3(EBF3):c.1232_1233insT (p.Gln412fs)	EBF3		not provided	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000844228	10	131640492 - 131640493	10	129842228 - 129842229	844228	836693		NC_000010.11:129842228::A
NM_001005463.3(EBF3):c.636+1G>A	EBF3		Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000828034	10	131676031	10	129877767	828034	816373		NC_000010.11:129877766:C:T
NM_001005463.3(EBF3):c.163G>T (p.Glu55Ter)	EBF3	E55*	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000692039	10	131761759	10	129963495	692039	679767		NC_000010.11:129963494:C:A
NM_001005463.3(EBF3):c.593G>A (p.Cys198Tyr)	EBF3	C198Y	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000545444	10	131676075	10	129877811	545444	535703	rs1554904330	NC_000010.11:129877810:C:T
NM_001005463.3(EBF3):c.486-1G>A	EBF3		not provided	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000430927	10	131755591	10	129957327	430927	424471	rs1131692258	NC_000010.11:129957326:C:T
NM_001005463.3(EBF3):c.1402_1414del (p.Thr468fs)	EBF3	T468fs	not provided	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000421178	10	131639228 - 131639240	10	129840964 - 129840976	421178	407828	rs1064794961	NC_000010.11:129840963:ACTGCTGGGGAGTACTGCTGGGGA:ACTGCTGGGGA
NM_001005463.3(EBF3):c.579G>T (p.Lys193Asn)	EBF3	K193N	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	no assertion criteria provided	VCV000375501	10	131676089	10	129877825	375501	362311	rs1057519520	NC_000010.11:129877824:C:A
NM_001005463.3(EBF3):c.488G>C (p.Arg163Pro)	EBF3	R163P	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	no assertion criteria provided	VCV000375500	10	131755588	10	129957324	375500	362310	rs1057519389	NC_000010.11:129957323:C:G
NM_001005463.3(EBF3):c.196A>G (p.Asn66Asp)	EBF3	N66D	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	no assertion criteria provided	VCV000375495	10	131761726	10	129963462	375495	362305	rs1057519518	NC_000010.11:129963461:T:C
NM_001005463.3(EBF3):c.625C>T (p.Arg209Trp)	EBF3	R209W	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	no assertion criteria provided	VCV000375494	10	131676043	10	129877779	375494	362304	rs779003155	NC_000010.11:129877778:G:A
NM_173551.5(ANKS6):c.539_540del (p.Leu180fs)	ANKS6	L180fs	Nephronophthisis 16	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000661012	9	101552708 - 101552709	9	98790426 - 98790427	661012	638610		NC_000009.12:98790425:CA:
NM_173551.5(ANKS6):c.1381C>T (p.Arg461Ter)	ANKS6	R461*	Nephronophthisis 16	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000579608	9	101540694	9	98778412	579608	563458	rs369437168	NC_000009.12:98778411:G:A
NM_173551.5(ANKS6):c.694_718dup (p.Val240fs)	ANKS6		Nephronophthisis 16	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000574976	9	101552529 - 101552530	9	98790247 - 98790248	574976	569375	rs1564228101	NC_000009.12:98790247:CTCCAAGCCGCCCAGTGAGTGCGGCC:CTCCAAGCCGCCCAGTGAGTGCGGCCTCCAAGCCGCCCAGTGAGTGCGGCC
NM_173551.5(ANKS6):c.727C>T (p.Gln243Ter)	ANKS6	Q243*	Nephronophthisis 16	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000571622	9	101552521	9	98790239	571622	569366	rs756090222	NC_000009.12:98790238:G:A
NM_173551.5(ANKS6):c.2512-2A>C	ANKS6		Nephronophthisis 16	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000064359	9	101498907	9	98736625	64359	75325	rs397514258	NC_000009.12:98736624:T:G
NM_173551.5(ANKS6):c.2370_2372del (p.Tyr790_Gln791delinsTer)	ANKS6	Y790*	Nephronophthisis 16	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000064358	9	101513333 - 101513335	9	98751051 - 98751053	64358	75324	rs587777025	NC_000009.12:98751050:TGAT:T
NM_173551.5(ANKS6):c.2054_2064del (p.His685fs)	ANKS6	H685fs	Nephronophthisis 16	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000064357	9	101530441 - 101530451	9	98768159 - 98768169	64357	75323	rs587777024	NC_000009.12:98768158:GCTTGACCGATG:G
NM_001005463.3(EBF3):c.530C>T (p.Pro177Leu)	EBF3	P177L	Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000224085	10	131755546	10	129957282	224085	225815	rs869312668	NC_000010.11:129957281:G:A
NM_004722.4(AP4M1):c.840_841TG[1] (p.Val281fs)	AP4M1		not provided|Spastic paraplegia 50, autosomal recessive	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450738	7	99703073 - 99703074	7	100105450 - 100105451	450738	444025	rs776788025	NC_000007.14:100105449:TGTG:TG
NM_014334.3(FRRS1L):c.845G>A (p.Trp282Ter)	FRRS1L	W282*	Epileptic encephalopathy, early infantile, 37|Seizures|Chorea|Progressive encephalopathy	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000218152	9	111903640	9	109141360	218152	214800	rs878853281	NC_000009.12:109141359:C:T
NM_014334.3(FRRS1L):c.961C>T (p.Gln321Ter)	FRRS1L	Q321*	Epileptic encephalopathy, early infantile, 37|Seizures|Chorea|Progressive encephalopathy	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000218151	9	111899809	9	109137529	218151	214799	rs878853280	NC_000009.12:109137528:G:A
NM_004722.4(AP4M1):c.32del (p.Lys11fs)	AP4M1	K11fs	Spastic paraplegia 50, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210211	7	99699368	7	100101745	210211	207426	rs797045249	NC_000007.14:100101744:AA:A
NM_001024630.4(RUNX2):c.598A>G (p.Thr200Ala)	RUNX2	T200A, T186A	Cleidocranial dysplasia, forme fruste, dental anomalies only|Cleidocranial dysostosis	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000009304	6	45405701	6	45437964	9304	24343	rs104893993	NC_000006.12:45437963:A:G
NM_001005463.3(EBF3):c.280_283del (p.Glu94fs)	EBF3	E94fs	Vesicoureteral reflux|Recurrent urinary tract infections|Global developmental delay|Generalized hypotonia|Constipation|Abnormal facial shape|Growth abnormality|Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	no assertion criteria provided	VCV000375502	10	131761639 - 131761642	10	129963375 - 129963378	375502	362312	rs1057519521	NC_000010.11:129963374:TCTC:
GRCh37/hg19 7q35(chr7:144319985-144446894)x1	TPK1		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000689063	7	144319985 - 144446894			689063	676655		
GRCh37/hg19 7q35(chr7:144272015-144331634)x1	TPK1		not provided	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000687273	7	144272015 - 144331634			687273	674865		
GRCh37/hg19 7q35(chr7:144318728-144425718)x1	TPK1		not provided	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000686732	7	144318728 - 144425718			686732	674324		
GRCh37/hg19 7q35(chr7:144274734-144331634)x1	TPK1		not provided	Pathogenic(Last reviewed: Sep 18, 2018)	no assertion criteria provided	VCV000686209	7	144274734 - 144331634			686209	673801		
NM_000380.3(XPA):c.327_340dup (p.Asp114fs)	XPA		not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000524024	9	100451864 - 100451865	9	97689582 - 97689583	524024	514599	rs1554701945	NC_000009.12:97689582:CCATAAATTCTTTCCCA:CCATAAATTCTTTCCCATAAATTCTTTCCCA
NM_000380.3(XPA):c.266_267dup (p.Val90fs)	XPA		not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000524023	9	100455946 - 100455947	9	97693664 - 97693665	524023	514600	rs759052378	NC_000009.12:97693664:TTTT:TTTTTT
NM_022445.4(TPK1):c.614-1G>A	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438735	7	144150757	7	144453664	438735	432357	rs776874412	NC_000007.14:144453663:C:T
NM_022445.4(TPK1):c.395T>C (p.Phe132Ser)	TPK1	F132S, F15S, F127S, F26S	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438734	7	144288622	7	144591529	438734	432358	rs1417315589	NC_000007.14:144591528:A:G
NM_022445.4(TPK1):c.664G>C (p.Asp222His)	TPK1	D222H, D105H, D217H, D173H, D116H	not provided	Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	VCV000419232	7	144150706	7	144453613	419232	406999	rs368458768	NC_000007.14:144453612:C:G
NM_022445.4(TPK1):c.311del (p.Cys104fs)	TPK1	C104fs, C99fs	not provided	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000215277	7	144320302	7	144623209	215277	211316	rs863224238	NC_000007.14:144623208:C:
NM_000380.4(XPA):c.306_309del (p.Asp101_Tyr102insTer)	XPA		not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000852034	9	100451896 - 100451899	9	97689614 - 97689617	852034	836461		NC_000009.12:97689613:TACATA:TA
NC_000007.14:g.(?_144591403)_(144835622_?)del	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000833116	7	144288496 - 144532715			833116	819838		
NC_000007.14:g.(?_144682889)_(144765971_?)del	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832084	7	144379982 - 144463064			832084	819839		
NC_000007.13:g.(?_144379982)_(144380091_?)del	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000665627	7	144379982 - 144380091	7	144682889 - 144682998	665627	651645		
NM_000380.4(XPA):c.667del (p.Lys222_Val223insTer)	XPA		not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000646282	9	100447211	9	97684929	646282	638597		NC_000009.12:97684928:C:
NM_022445.4(TPK1):c.185+1G>A	TPK1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215274	7	144380001	7	144682908	215274	211317	rs747753388	NC_000007.14:144682907:C:T
TPK1, 4-BP DEL, 179GAGA	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030571					30571	39528		
TPK1, IVS7DS, A-T, +4	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030569					30569	39526		
NM_022445.4(TPK1):c.148A>C (p.Asn50His)	TPK1	N50H	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030568	7	144380039	7	144682946	30568	39525	rs387906935	NC_000007.14:144682945:T:G
NM_000380.3(XPA):c.335_338delinsCATAAGAAA (p.Phe112_Met113delinsSerTer)	XPA			Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264683	9	100451867 - 100451870	9	97689585 - 97689588	264683	259253	rs886039226	NC_000009.12:97689584:ATAA:TTTCTTATG
NM_000380.3(XPA):c.545_546insTA (p.Leu182fs)	XPA			Pathogenic(Last reviewed: Dec 29, 2009)	criteria provided, single submitter	VCV000190207	9	100449387 - 100449388	9	97687105 - 97687106	190207	187984	rs786205205	NC_000009.12:97687105::TA
NM_001382.4(DPAGT1):c.503T>C (p.Leu168Pro)	DPAGT1	L168P	DPAGT1-CDG	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065471	11	118971112	11	119100402	65471	76383	rs397515329	NC_000011.10:119100401:A:G
NM_001382.4(DPAGT1):c.85A>T (p.Ile29Phe)	DPAGT1	I29F	DPAGT1-CDG	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065470	11	118972281	11	119101571	65470	76382	rs397515328	NC_000011.10:119101570:T:A
NM_001382.4(DPAGT1):c.341C>G (p.Ala114Gly)	DPAGT1	A114G	DPAGT1-CDG	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000065469	11	118971495	11	119100785	65469	76381	rs397515327	NC_000011.10:119100784:G:C
NM_001382.4(DPAGT1):c.161+5G>A	DPAGT1		DPAGT1-CDG	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039774	11	118972200	11	119101490	39774	48373	rs397515322	NC_000011.10:119101489:C:T
NM_001382.4(DPAGT1):c.206T>A (p.Ile69Asn)	DPAGT1	I69N	DPAGT1-CDG	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039773	11	118971804	11	119101094	39773	48372	rs397514586	NC_000011.10:119101093:A:T
NM_001382.4(DPAGT1):c.791T>G (p.Val264Gly)	DPAGT1	V264G	Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000036922	11	118968691	11	119097981	36922	45583	rs387907245	NC_000011.10:119097980:A:C
NM_001382.4(DPAGT1):c.358C>A (p.Leu120Met)	DPAGT1	L120M	Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000036921	11	118971478	11	119100768	36921	45582	rs387907244	NC_000011.10:119100767:G:T
NM_001382.4(DPAGT1):c.699dup (p.Thr234fs)	DPAGT1		Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000036920	11	118969141 - 118969142	11	119098431 - 119098432	36920	45581	rs397515321	NC_000011.10:119098431:G:GG
NM_001382.4(DPAGT1):c.324G>C (p.Met108Ile)	DPAGT1	M108I	Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000036919	11	118971512	11	119100802	36919	45580	rs376039938	NC_000011.10:119100801:C:G
NM_001382.4(DPAGT1):c.349G>A (p.Val117Ile)	DPAGT1	V117I	Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000036918	11	118971487	11	119100777	36918	45579	rs387907243	NC_000011.10:119100776:C:T
COL10A1, TYR663TER	COL10A1	Y663*	Metaphyseal chondrodysplasia, Schmid type	Pathogenic(Last reviewed: May 15, 2007)	no assertion criteria provided	VCV000029632					29632	38586		
COL10A1, 2-BP DEL, FS665TER	COL10A1		Metaphyseal chondrodysplasia, Schmid type	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000017469					17469	32508		
COL10A1, 13-BP DEL, NT1856	COL10A1		Metaphyseal chondrodysplasia, Schmid type	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000017464					17464	32503		
NM_000380.3(XPA):c.172+2T>G	XPA			Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000000998	9	100459401	9	97697119	998	16037		NC_000009.12:97697118:A:C
NM_000062.2(SERPING1):c.1396C>T (p.Arg466Cys)	SERPING1	R444C, R466C	Hereditary angioedema type 1|Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003947	11	57381947	11	57614474	3947	18986	rs28940870	NC_000011.10:57614473:C:T
NM_001382.4(DPAGT1):c.398C>G (p.Ser133Ter)	DPAGT1	S133*	Congenital myasthenic syndrome 13|DPAGT1-CDG	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000640003	11	118971438	11	119100728	640003	639798		NC_000011.10:119100727:G:C
NM_001382.4(DPAGT1):c.26dup (p.Met9fs)	DPAGT1		DPAGT1-CDG|Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000567578	11	118972339 - 118972340	11	119101629 - 119101630	567578	565535	rs768656482	NC_000011.10:119101629:A:AA
NM_000380.3(XPA):c.772_785del (p.Arg258fs)	XPA	R216fs, R258fs		Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523608	9	100437758 - 100437771	9	97675476 - 97675489	523608	514259	rs778543124	NC_000009.12:97675475:GTACAAGTCTTACGGTACA:GTACA
NM_001382.4(DPAGT1):c.584C>G (p.Ala195Gly)	DPAGT1	A195G	DPAGT1-CDG	Pathogenic	criteria provided, single submitter	VCV000218096	11	118971031	11	119100321	218096	214748	rs863225088	NC_000011.10:119100320:G:C
NM_022445.4(TPK1):c.656A>G (p.Asn219Ser)	TPK1	N219S, N102S, N113S, N214S, N170S	not provided|Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000030572	7	144150714	7	144453621	30572	39529	rs371271054	NC_000007.14:144453620:T:C
COL10A1, 10-BP DEL, NT1867	COL10A1		Metaphyseal chondrodysplasia, Schmid type	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000017470					17470	32509		
COL10A1, 1-BP DEL, 1856C	COL10A1		Metaphyseal chondrodysplasia, Schmid type	Pathogenic(Last reviewed: May 15, 2007)	no assertion criteria provided	VCV000017468					17468	32507		
NM_000380.3(XPA):c.348T>A (p.Tyr116Ter)	XPA	Y116*, Y74*		Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000000997	9	100451857	9	97689575	997	16036	rs104894134	NC_000009.12:97689574:A:T
NM_001005463.3(EBF3):c.422A>G (p.Tyr141Cys)	EBF3	Y141C	not provided|Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375497	10	131757261	10	129958997	375497	362307	rs1057519519	NC_000010.11:129958996:T:C
NM_001354975.1(XPA):c.-1140del	XPA	A4fs	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551362	9	100459565	9	97697283	551362	545426	rs779161471	NC_000009.12:97697282:CC:C
NM_004959.5(NR5A1):c.937C>T (p.Arg313Cys)	NR5A1	R313C	46,XY sex reversal, type 3|Oligosynaptic infertility|not provided|46,XY sex reversal, type 3	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372437	9	127255362	9	124493083	372437	359757	rs1057517779	NC_000009.12:124493082:G:A
NM_001322934.2(NFKB2):c.1469+1G>T	NFKB2		Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827730	10	104159476	10	102399719	827730	815952		NC_000010.11:102399718:G:T
NM_001322934.2(NFKB2):c.1903C>T (p.Arg635Ter)	NFKB2	R593*, R635*	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827731	10	104160516	10	102400759	827731	815924		NC_000010.11:102400758:C:T
NM_004722.4(AP4M1):c.916C>T (p.Arg306Ter)	AP4M1	R306*, R313*	Spastic paraplegia 50, autosomal recessive|not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561150	7	99703149	7	100105526	561150	552111	rs369459721	NC_000007.14:100105525:C:T
NM_000349.3(STAR):c.197_198CT[2] (p.Tyr68fs)	STAR		not provided|Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000586680	8	38005822 - 38005823	8	38148304 - 38148305	586680	577060	rs1563268652	NC_000008.11:38148303:AGAGAG:AGAG
NM_001322934.2(NFKB2):c.2556_2563del (p.Arg853fs)	NFKB2	R811fs, R853fs	Common variable immunodeficiency 10	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000155764	10	104161894 - 104161901	10	102402137 - 102402144	155764	165517	rs727502786	NC_000010.11:102402136:CCGAGACA:
NM_001322934.2(NFKB2):c.2564del (p.Lys855fs)	NFKB2	K813fs, K855fs	Common variable immunodeficiency 10|Common variable immunodeficiency 1	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000065386	10	104161901	10	102402144	65386	76320	rs397514331	NC_000010.11:102402143:AA:A
NM_000380.4(XPA):c.555+8A>G	XPA		not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000852033	9	100449370	9	97687088	852033	852536		NC_000009.12:97687087:T:C
NM_000380.3(XPA):c.331G>T (p.Glu111Ter)	XPA	E111*, E69*		Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557900	9	100451874	9	97689592	557900	545406	rs769255883	NC_000009.12:97689591:C:A
NM_022445.4(TPK1):c.44-2A>G	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215276	7	144463046	7	144765953	215276	211318	rs863224237	NC_000007.14:144765952:T:C
NM_022445.4(TPK1):c.501+4A>T	TPK1		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215275	7	144288512	7	144591419	215275	211314	rs375169579	NC_000007.14:144591418:T:A
NM_001322934.2(NFKB2):c.2594A>G (p.Asp865Gly)	NFKB2	D864G, D865G, D823G	Common variable immunodeficiency 10	Pathogenic(Last reviewed: Dec 19, 2014)	no assertion criteria provided	VCV000155765	10	104162024	10	102402267	155765	165518	rs727502787	NC_000010.11:102402266:A:G
NM_001005463.3(EBF3):c.616C>T (p.Arg206Ter)	EBF3	R206*	not provided|Neurodevelopmental disorder|Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000375503	10	131676052	10	129877788	375503	362313	rs1057519522	NC_000010.11:129877787:G:A
NM_016616.5(NME8):c.1277T>A (p.Leu426Ter)	NME8	L426*	Ciliary dyskinesia, primary, 6	Pathogenic(Last reviewed: Sep 15, 2011)	no assertion criteria provided	VCV000003256	7	37927908	7	37888306	3256	18295	rs121918300	NC_000007.14:37888305:T:A
NM_015214.3(DDHD2):c.94_101dup (p.Ser35fs)	DDHD2		not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000523988	8	38090604 - 38090605	8	38233086 - 38233087	523988	514567	rs1554510884	NC_000008.11:38233086:GGATGCTGG:GGATGCTGGGATGCTGG
NM_015214.3(DDHD2):c.1386dup (p.Ile463fs)	DDHD2		not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503722	8	38109470 - 38109471	8	38251952 - 38251953	503722	495380	rs867389476	NC_000008.11:38251952:C:CC
NM_000536.4(RAG2):c.955G>T (p.Gly319Ter)	RAG2	G319*	not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000500475	11	36614764	11	36593214	500475	491899	rs879541124	NC_000011.10:36593213:C:A
NM_004376.5(COX15):c.281_282delAG (p.Glu94Valfs)	COX15		not provided	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000429754	10	101487311 - 101487312	10	99727554 - 99727555	429754	421813	rs748468371	NC_000010.11:99727553:CTCT:CT
NM_000536.4(RAG2):c.629T>C (p.Ile210Thr)	RAG2	I210T	Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827734	11	36615090	11	36593540	827734	815925		NC_000011.10:36593539:A:G
NC_000008.10:g.(?_38099748)_(38105373_?)del	DDHD2		Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000655242	8	38099748 - 38105373	8	38242230 - 38247855	655242	651724		
NM_015214.3(DDHD2):c.420C>A (p.Tyr140Ter)	DDHD2	Y140*	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000653596	8	38095064	8	38237546	653596	637197		NC_000008.11:38237545:C:A
NM_015214.3(DDHD2):c.334C>T (p.Arg112Ter)	DDHD2	R112*	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638323	8	38092025	8	38234507	638323	626175		NC_000008.11:38234506:C:T
NM_015214.3(DDHD2):c.694C>T (p.Arg232Ter)	DDHD2	R232*	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634496	8	38097864	8	38240346	634496	622389	rs1249841130	NC_000008.11:38240345:C:T
NM_015214.3(DDHD2):c.1803del (p.Phe601fs)	DDHD2	F571fs, F601fs	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000540287	8	38110554	8	38253036	540287	524154	rs1312739762	NC_000008.11:38253035:TTTT:TTT
NM_015214.3(DDHD2):c.371del (p.Lys124fs)	DDHD2	K124fs	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000473074	8	38092061	8	38234543	473074	457833	rs1475369039	NC_000008.11:38234542:AA:A
NM_015214.3(DDHD2):c.1057+5C>G	DDHD2		Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000101083	8	38103473	8	38245955	101083	106844	rs886037659	NC_000008.11:38245954:C:G
NM_015214.3(DDHD2):c.1982_1983del (p.Tyr661fs)	DDHD2	Y661fs, Y631fs	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000091400	8	38111163 - 38111164	8	38253645 - 38253646	91400	96876	rs398122837	NC_000008.11:38253644:TAT:T
DDHD2, 1-BP DUP, 138C	DDHD2		Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039678					39678	48277		
NM_015214.3(DDHD2):c.2057del (p.Glu686fs)	DDHD2	E686fs, E656fs	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039677	8	38117560	8	38260042	39677	48276		NC_000008.11:38260041:A:
NM_015214.3(DDHD2):c.1803dup (p.Thr602fs)	DDHD2		Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039676	8	38110553 - 38110554	8	38253035 - 38253036	39676	48275		NC_000008.11:38253035:TTTT:TTTTT
RAG2, 3-BP DEL, NT2018	RAG2		Severe combined immunodeficiency, B cell-negative	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000013134					13134	28173		
NM_178138.6(LHX3):c.133A>T (p.Lys45Ter)	LHX3	K50*, K45*, K34*	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000009029	9	139092546	9	136200700	9029	24068	rs137854506	NC_000009.12:136200699:T:A
NM_178138.6(LHX3):c.80-530_776-454del	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000009028	9	139090043 - 139093129	9	136198197 - 136201283	9028	24067		
NM_178138.6(LHX3):c.672G>A (p.Trp224Ter)	LHX3	W224*, W213*, W229*	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009027	9	139090601	9	136198755	9027	24066	rs137854505	NC_000009.12:136198754:C:T
NC_000009.12:g.(?_136197325)_(136205012_?)del	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009026			9	136197325 - 136205012	9026	24065		
NM_178138.6(LHX3):c.287_288delinsTCCT (p.Gly96fs)	LHX3	E173*	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009025	9	139091690 - 139091691	9	136199844 - 136199845	9025	24064	rs137854504	NC_000009.12:136199843:GC:AGGA
NM_178138.6(LHX3):c.629C>T (p.Ala210Val)	LHX3	A210V, A199V, A215V	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009024	9	139090644	9	136198798	9024	24063	rs137854503	NC_000009.12:136198797:G:A
NM_178138.6(LHX3):c.96del (p.Gly33fs)	LHX3	G38fs, G22fs, G33fs	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000009023	9	139092583	9	136200737	9023	24062	rs587776712	NC_000009.12:136200736:A:
NM_178138.6(LHX3):c.332A>G (p.Tyr111Cys)	LHX3	Y116C, Y111C, Y100C	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000009021	9	139091646	9	136199800	9021	24060	rs104894117	NC_000009.12:136199799:T:C
NM_000380.3(XPA):c.677T>A (p.Leu226Ter)	XPA	L226*, L184*	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554689	9	100437866	9	97675584	554689	545383	rs1554699334	NC_000009.12:97675583:A:T
XPA, IVS3AS, G-C	XPA			Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000000992					992	16031		
NM_000536.4(RAG2):c.2T>C (p.Met1Thr)	RAG2	M1T	Primary immunodeficiency|Recombinase activating gene 2 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488726	11	36615717	11	36594167	488726	481991	rs1554947410	NC_000011.10:36594166:A:G
NM_015214.3(DDHD2):c.985C>T (p.Arg329Ter)	DDHD2	R329*, R299*	Spastic paraplegia 54, autosomal recessive|not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000452548	8	38103396	8	38245878	452548	444273	rs201258800	NC_000008.11:38245877:C:T
NM_000536.4(RAG2):c.539C>A (p.Pro180His)	RAG2	P180H	Recombinase activating gene 2 deficiency|Primary immunodeficiency|Atypical severe combined immunodeficiency due to complete RAG1/2 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418453	11	36615180	11	36593630	418453	408345	rs1064793251	NC_000011.10:36593629:G:T
NM_015214.3(DDHD2):c.859C>T (p.Arg287Ter)	DDHD2	R287*, R257*	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000039681	8	38103270	8	38245752	39681	48280	rs398122826	NC_000008.11:38245751:C:T
NM_015214.3(DDHD2):c.1546C>T (p.Arg516Ter)	DDHD2	R516*, R486*	Spastic paraplegia 54, autosomal recessive	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000039680	8	38109734	8	38252216	39680	48279	rs373856119	NC_000008.11:38252215:C:T
NM_178138.6(LHX3):c.452_454+20del	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000009022	9	139091504 - 139091526	9	136199658 - 136199680	9022	24061	rs587776711	NC_000009.12:136199657:GCGTCGTCCCCTCGGCTGACCTCGC:GC
NM_014334.3(FRRS1L):c.737_739del (p.Gly246del)	FRRS1L	G246del	Epileptic encephalopathy, early infantile, 37|Seizures|Chorea|Progressive encephalopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218153	9	111903746 - 111903748	9	109141466 - 109141468	218153	214801	rs878853282	NC_000009.12:109141465:CTCCT:CT
NM_004722.4(AP4M1):c.952C>T (p.Arg318Ter)	AP4M1	R318*, R325*	Microcephaly|CNS hypomyelination|Brain atrophy|Hypoplasia of the corpus callosum|Global developmental delay|Spastic paraplegia 50, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183357	7	99703604	7	100105981	183357	181423	rs730882249	NC_000007.14:100105980:C:T
NM_000317.3(PTS):c.259C>T (p.Pro87Ser)	PTS	P87S		Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000480	11	112103901	11	112233178	480	15519	rs104894276	NC_000011.10:112233177:C:T
NM_000536.4(RAG2):c.243del (p.Gly82fs)	RAG2	G82fs	Combined cellular and humoral immune defects with granulomas|	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000857371	11	36615476	11	36593926	857371	838401		NC_000011.10:36593925:TTT:TT
NM_000536.4(RAG2):c.193G>T (p.Asp65Tyr)	RAG2	D65Y	Primary immunodeficiency|Recombinase activating gene 2 deficiency||not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000427020	11	36615526	11	36593976	427020	415267	rs909264507	NC_000011.10:36593975:C:A
NM_000507.4(FBP1):c.841G>A (p.Glu281Lys)	FBP1	E281K	Fructose-biphosphatase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381580	9	97365839	9	94603557	381580	370993	rs566453434	NC_000009.12:94603556:C:T
NC_000010.11:g.27100454C>T	ANKRD26		Thrombocytopenia	Pathogenic	no assertion criteria provided	VCV000812727	10	27389383	10	27100454	812727	801119		NC_000010.11:27100453:C:T
NM_001002295.2(GATA3):c.708del (p.Ser237fs)	GATA3	S237fs	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802559	10	8100728	10	8058765	802559	790986		NC_000010.11:8058764:CCCCCCC:CCCCCC
NM_001002295.2(GATA3):c.646dup (p.His216fs)	GATA3		not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000503787	10	8100669 - 8100670	10	8058706 - 8058707	503787	495448	rs1554794885	NC_000010.11:8058706:CCC:CCCC
NM_001002295.2(GATA3):c.681dup (p.Glu228fs)	GATA3		not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000280652	10	8100704 - 8100705	10	8058741 - 8058742	280652	264372	rs1554794901	NC_000010.11:8058741:CCC:CCCC
NM_001002295.2(GATA3):c.681_682insACCACCCCATCAGCACTCACCCGCCCTACGTGCCC (p.Glu228fs)	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236031	10	8100690 - 8100691	10	8058727 - 8058728	236031	237608	rs878853222	NC_000010.11:8058727:ACCCGCCCTACGTGCCC:ACCCGCCCTACGTGCCCACCACCCCATCAGCACTCACCCGCCCTACGTGCCC
NM_001002295.2(GATA3):c.832G>A (p.Asp278Asn)	GATA3	D278N, D277N	Dominant congenital non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813823	10	8106009	10	8064046	813823	802075		NC_000010.11:8064045:G:A
NM_001002295.2(GATA3):c.1051-1G>C	GATA3		Stage 5 chronic kidney disease	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000430696	10	8115701	10	8073738	430696	424227	rs112417755	NC_000010.11:8073737:G:C
NM_001002295.2(GATA3):c.1025G>A (p.Cys342Tyr)	GATA3	C342Y, C341Y	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000029693	10	8111536	10	8069573	29693	38648	rs387906621	NC_000010.11:8069572:G:A
NM_001002295.2(GATA3):c.108_109del (p.Met36fs)	GATA3	M36fs	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000029692	10	8097726 - 8097727	10	8055763 - 8055764	29692	38647		NC_000010.11:8055762:GG:
NM_001002295.2(GATA3):c.1059A>T (p.Arg353Ser)	GATA3	R353S, R352S	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016630	10	8115710	10	8073747	16630	31669	rs104894165	NC_000010.11:8073746:A:T
NM_001002295.2(GATA3):c.924+2delinsGCTTACTTCCC	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016629	10	8106103	10	8064140	16629	31668	rs387906551	NC_000010.11:8064139:T:GCTTACTTCCC
NM_001002295.2(GATA3):c.478del (p.Asp160fs)	GATA3	D160fs	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016628	10	8100503	10	8058540	16628	31667		NC_000010.11:8058539:GG:G
NM_001002295.2(GATA3):c.431del (p.Gly144fs)	GATA3	G144fs	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000016627	10	8100452	10	8058489	16627	31666		NC_000010.11:8058488:GGGGGG:GGGGG
GATA3, 2-BP INS, 3-BP INS	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000016625					16625	31664		
NM_001002295.2(GATA3):c.823T>A (p.Trp275Arg)	GATA3	W275R, W274R	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000016624	10	8106000	10	8064037	16624	31663	rs104894163	NC_000010.11:8064036:T:A
NM_001002295.2(GATA3):c.829C>T (p.Arg277Ter)	GATA3	R277*, R276*	Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016623	10	8106006	10	8064043	16623	31662	rs104894162	NC_000010.11:8064042:C:T
GATA3, 12-BP DEL, NT946-957	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016622					16622	31661		
GATA3, 49-BP DEL, NT465-513	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016621					16621	31660		
GATA3, 250-KB DEL	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016620					16620	31659		
GATA3, 900-KB DEL	GATA3		Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016619					16619	31658		
NM_000375.3(UROS):c.217T>C (p.Cys73Arg)	UROS	C73R	not provided|Congenital erythropoietic porphyria	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003750	10	127503630	10	125815061	3750	18789	rs121908012	NC_000010.11:125815060:A:G
NM_014915.2(ANKRD26):c.-127A>G	ANKRD26		Thrombocytopenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626942	10	27389382	10	27100453	626942	615438		NC_000010.11:27100452:T:C
NM_000883.4(IMPDH1):c.984G>C (p.Gln328His)	IMPDH1	Q318H, Q328H, Q259H, Q295H, Q238H, Q218H, Q243H, Q292H	Retinitis pigmentosa 10	Pathogenic(Last reviewed: Sep 7, 2016)	no assertion criteria provided	VCV000254167	7	128038558	7	128398504	254167	248646	rs886037911	NC_000007.14:128398503:C:G
ANKRD26, -128G-A	ANKRD26		Thrombocytopenia 2	Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000030855					30855	39812		
ANKRD26, -127A-T	ANKRD26		Thrombocytopenia 2	Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000030854					30854	39811		
NM_000883.4(IMPDH1):c.926G>C (p.Arg309Pro)	IMPDH1	R224P, R199P, R219P, R273P, R276P, R299P, R309P, R240P	Retinitis pigmentosa 10	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000014836	7	128038616	7	128398562	14836	29875	rs121912552	NC_000007.14:128398561:C:G
NM_000883.4(IMPDH1):c.1057G>A (p.Val353Ile)	IMPDH1	V268I, V243I, V263I, V317I, V320I, V343I, V353I, V284I	Retinitis pigmentosa 10	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000014835	7	128038485	7	128398431	14835	29874	rs121912551	NC_000007.14:128398430:C:T
NM_000883.4(IMPDH1):c.849T>G (p.Asn283Lys)	IMPDH1	N198K, N173K, N193K, N247K, N250K, N273K, N283K, N214K	Leber congenital amaurosis 11	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000014838	7	128040174	7	128400120	14838	29877	rs121912554	NC_000007.14:128400119:A:C
NM_016035.5(COQ4):c.718C>T (p.Arg240Cys)	COQ4	R240C	Coenzyme Q10 deficiency, primary, 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189201	9	131095844	9	128333565	189201	187092	rs143441644	NC_000009.12:128333564:C:T
NM_001002295.2(GATA3):c.1099C>T (p.Arg367Ter)	GATA3	R367*, R366*	not provided|Hypoparathyroidism-deafness-renal disease syndrome	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000016626	10	8115750	10	8073787	16626	31665	rs104894164	NC_000010.11:8073786:C:T
NM_001029835.2(CCM2):c.237dup (p.Leu80fs)	CCM2		not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000524145	7	45077994 - 45077995	7	45038395 - 45038396	524145	514558	rs1554365577	NC_000007.14:45038395:G:GG
NM_000429.3(MAT1A):c.524G>A (p.Trp175Ter)	MAT1A	W175*	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000503624	10	82039954	10	80280198	503624	495472	rs1203137107	NC_000010.11:80280197:C:T
NM_001029835.2(CCM2):c.746_749del (p.Phe249fs)	CCM2	F170fs, F228fs, F249fs	not provided	Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000429700	7	45109496 - 45109499	7	45069897 - 45069900	429700	421637	rs1131691538	NC_000007.14:45069896:CTTTCT:CT
NM_001029835.2(CCM2):c.257_258dup (p.Glu87fs)	CCM2		not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000429309	7	45078014 - 45078015	7	45038415 - 45038416	429309	421636	rs1131691312	NC_000007.14:45038415:AG:AGAG
NM_001029835.2(CCM2):c.277C>T (p.Gln93Ter)	CCM2	Q72*, Q93*, Q14*	not provided	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	VCV000279739	7	45103526	7	45063927	279739	264232	rs886041157	NC_000007.14:45063926:C:T
GRCh37/hg19 7p13(chr7:45065944-45115876)x1	CCM2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253618	7	45065944 - 45115876			253618	248066		
NM_031443.4(CCM2):c.98_123del (p.His33fs)	CCM2	H54fs, H33fs	not provided	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000804670	7	45077919 - 45077944	7	45038320 - 45038345	804670	793243		NC_000007.14:45038319:ATGAGAAGGTGACAGAGAGGCGCCCT:
NM_001029835.2(CCM2):c.377del (p.His125_Leu126insTer)	CCM2		not provided	Pathogenic(Last reviewed: Oct 7, 2013)	criteria provided, single submitter	VCV000590657	7	45104086	7	45064487	590657	581324	rs1562907455	NC_000007.14:45064486:TT:T
NM_031443.3(CCM2):c.289-1G>T	CCM2		not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000590653	7	45104061	7	45064462	590653	581322	rs1562907365	NC_000007.14:45064461:G:T
NM_001029835.2(CCM2):c.228_231AGAC[1] (p.Arg78fs)	CCM2		not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000590649	7	45077985 - 45077988	7	45038386 - 45038389	590649	581319	rs1562882045	NC_000007.14:45038385:CAGACAGAC:CAGAC
NM_001029835.2(CCM2):c.358del (p.His120fs)	CCM2	H120fs, H41fs, H99fs	not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000447027	7	45104066	7	45064467	447027	441132	rs1554375233	NC_000007.14:45064466:CCC:CC
NM_001029835.2(CCM2):c.185del (p.Pro62fs)	CCM2	P41fs, P62fs	not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000376845	7	45077941	7	45038342	376845	363723	rs1057520070	NC_000007.14:45038341:CCC:CC
NM_001029835.2(CCM2):c.417C>G (p.Tyr139Ter)	CCM2	Y118*, Y139*, Y60*	Cavernous hemangioma	Pathogenic(Last reviewed: Oct 15, 2014)	criteria provided, single submitter	VCV000374160	7	45104127	7	45064528	374160	360893	rs765548101	NC_000007.14:45064527:C:G
NM_000429.3(MAT1A):c.1006G>A (p.Gly336Arg)	MAT1A	G336R	Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000001211	10	82034355	10	80274599	1211	16250	rs118204006	NC_000010.11:80274598:C:T
MAT1A, 2-BP DEL, 1043TG	MAT1A		Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Aug 15, 1996)	no assertion criteria provided	VCV000001207					1207	16246		
NM_000429.3(MAT1A):c.914T>C (p.Leu305Pro)	MAT1A	L305P	Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000001205	10	82034810	10	80275054	1205	16244	rs118204004	NC_000010.11:80275053:A:G
MAT1A, 1-BP INS, 827G	MAT1A		Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Aug 15, 1996)	no assertion criteria provided	VCV000001206					1206	16245		
NM_000429.3(MAT1A):c.164C>A (p.Ala55Asp)	MAT1A	A55D	Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000001203	10	82045273	10	80285517	1203	16242	rs118204002	NC_000010.11:80285516:G:T
NM_000429.3(MAT1A):c.966T>G (p.Ile322Met)	MAT1A	I322M	Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000001202	10	82034395	10	80274639	1202	16241	rs118204001	NC_000010.11:80274638:A:C
NM_000429.3(MAT1A):c.895C>T (p.Arg299Cys)	MAT1A	R299C	Hepatic methionine adenosyltransferase deficiency|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418870	10	82034829	10	80275073	418870	407916	rs376993881	NC_000010.11:80275072:G:A
MAT1A, 2-BP INS, 539TG	MAT1A		Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Feb 3, 1998)	no assertion criteria provided	VCV000001209					1209	16248		
NM_001010892.3(RSPH4A):c.921+3_921+6del	RSPH4A		Primary ciliary dyskinesia|Kartagener syndrome|not provided|Ciliary dyskinesia, primary, 11	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000088863	6	116944165 - 116944168	6	116623002 - 116623005	88863	94432	rs869320683	NC_000006.12:116623001:AGTAAGT:AGT
NM_031443.4(CCM2):c.970G>T (p.Glu324Ter)	CCM2	E365*, E345*, E233*, E266*, E307*, E324*	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000862971	7	45113923	7	45074324	862971	833624		NC_000007.14:45074323:G:T
NM_031443.4(CCM2):c.354C>A (p.Tyr118Ter)	CCM2	Y118*, Y60*, Y139*	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000857759	7	45104127	7	45064528	857759	833621		NC_000007.14:45064527:C:A
NM_000429.3(MAT1A):c.1066C>T (p.Arg356Trp)	MAT1A	R356W	Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000834512	10	82034295	10	80274539	834512	837334		NC_000010.11:80274538:G:A
NM_031443.3(CCM2):c.30G>A (p.Lys10=)	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000662968	7	45039962	7	45000363	662968	636170		NC_000007.14:45000362:G:A
NM_001029835.2(CCM2):c.465_468dup (p.Ile157fs)	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000661878	7	45104174 - 45104175	7	45064575 - 45064576	661878	636172		NC_000007.14:45064575:GCCC:GCCCGCCC
NM_001029835.2(CCM2):c.282_283del (p.Leu94fs)	CCM2	L73fs, L15fs, L94fs	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000570247	7	45103531 - 45103532	7	45063932 - 45063933	570247	561954	rs1562906798	NC_000007.14:45063931:AA:
NM_001029835.2(CCM2):c.105_106insATTTAAACGAGTATTTAAA (p.Ser36delinsIleTer)	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000468336	7	45077863 - 45077864	7	45038264 - 45038265	468336	456738	rs1554365511	NC_000007.14:45038264::ATTTAAACGAGTATTTAAA
NC_000007.13:g.(?_45077852)_(45116069_?)del	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000468334	7	45077852 - 45116069	7	45038253 - 45076470	468334	456824		
CCM2, IVS1, GC-TT, +5	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000030688					30688	39645		
NM_001029835.2(CCM2):c.656T>G (p.Leu219Arg)	CCM2	L198R, L219R, L140R	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000002686	7	45108162	7	45068563	2686	17725	rs137852843	NC_000007.14:45068562:T:G
NM_001029835.2(CCM2):c.351+1G>A	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000002685	7	45103601	7	45064002	2685	17724	rs1562906981	NC_000007.14:45064001:G:A
CCM2, 4-BP DEL, NT169	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000002683					2683	17722		
NM_031443.3(CCM2):c.23del (p.Gly8fs)	CCM2	G8fs	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000002680	7	45039953	7	45000354	2680	17719	rs1562848466	NC_000007.14:45000353:GGG:GG
NM_032581.4(FAM126A):c.125dup (p.Tyr42Ter)	FAM126A		not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000450984	7	23023590 - 23023591	7	22983971 - 22983972	450984	444112	rs780540757	NC_000007.14:22983971:T:TT
NM_032581.4(FAM126A):c.415-1G>A	FAM126A		not provided	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000285562	7	23016428	7	22976809	285562	269799	rs886043139	NC_000007.14:22976808:C:T
NM_138413.4(HOGA1):c.653del (p.Gln218fs)	HOGA1	Q218fs	not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000855900	10	99359873	10	97600116	855900	837568		NC_000010.11:97600115:A:
NM_138413.4(HOGA1):c.75G>A (p.Trp25Ter)	HOGA1	W25*	not provided	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000848856	10	99344535	10	97584778	848856	837565		NC_000010.11:97584777:G:A
NM_138413.4(HOGA1):c.122_135del (p.Pro41fs)	HOGA1	P41fs	not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000652071	10	99344576 - 99344589	10	97584819 - 97584832	652071	639349		NC_000010.11:97584818:ACCCCCCTGTGACCACCCCC:ACCCCC
NM_138413.4(HOGA1):c.158del (p.Asp53fs)	HOGA1	D53fs	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204287	10	99344618	10	97584861	204287	200685	rs796052091	NC_000010.11:97584860:A:
NM_138413.4(HOGA1):c.134C>T (p.Pro45Leu)	HOGA1	P45L	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204266	10	99344594	10	97584837	204266	200654	rs764396564	NC_000010.11:97584836:C:T
NM_181507.1(HPS5):c.1871T>G (p.Leu624Arg)	HPS5	L624R, L510R	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021817	11	18313558	11	18292011	21817	34669	rs281865102	NC_000011.10:18292010:A:C
NM_181507.1(HPS5):c.107del (p.Lys36fs)	HPS5	K36fs	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000435459	11	18339299	11	18317752	435459	429224	rs1554948134	NC_000011.10:18317751:TTT:TT
NM_007216.4(HPS5):c.-58-10A>G	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000431165	11	18332490	11	18310943	431165	424688	rs200449378	NC_000011.10:18310942:T:C
11p15.1 deletion	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427885					427885	418960		
NM_181507.1(HPS5):c.719G>C (p.Arg240Pro)	HPS5	R240P, R126P	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427884	11	18327787	11	18306240	427884	418958	rs764296457	NC_000011.10:18306239:C:G
NM_007216.4(HPS5):c.2406_2407AG[1] (p.Glu803fs)	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427883	11	18308224 - 18308225	11	18286677 - 18286678	427883	418953	rs1131692151	NC_000011.10:18286676:CTCT:CT
NM_181507.1(HPS5):c.3058+3A>G	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427882	11	18305339	11	18283792	427882	418952	rs113304476	NC_000011.10:18283791:T:C
NM_181507.1(HPS5):c.219G>A (p.Arg73=)	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427881	11	18333461	11	18311914	427881	418959	rs1131692150	NC_000011.10:18311913:C:T
NM_181507.1(HPS5):c.2219T>C (p.Leu740Ser)	HPS5	L740S, L626S	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427880	11	18313210	11	18291663	427880	418954	rs1131692149	NC_000011.10:18291662:A:G
NM_181507.1(HPS5):c.1417C>T (p.Gln473Ter)	HPS5	Q473*, Q359*	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427879	11	18318438	11	18296891	427879	418956	rs1131692148	NC_000011.10:18296890:G:A
NM_007216.4(HPS5):c.476_480del (p.Thr159fs)	HPS5	T159fs, T273fs	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427878	11	18327684 - 18327688	11	18306137 - 18306141	427878	418957	rs1131692147	NC_000011.10:18306136:GAGAG:
NM_007216.4(HPS5):c.2754_2756del (p.Leu919del)	HPS5	L1033del, L919del	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427877	11	18303728 - 18303730	11	18282181 - 18282183	427877	418951	rs753928208	NC_000011.10:18282180:AGGAG:AG
NM_007216.4(HPS5):c.1558del (p.Glu520fs)	HPS5	E520fs, E634fs	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000427876	11	18313529	11	18291982	427876	418955	rs1131692146	NC_000011.10:18291981:C:
NM_138413.4(HOGA1):c.803_805del (p.Leu268del)	HOGA1	L268del, L105del	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204288	10	99361715 - 99361717	10	97601958 - 97601960	204288	200686	rs796052092	NC_000010.11:97601957:CTGC:C
NM_138413.4(HOGA1):c.973G>A (p.Gly325Ser)	HOGA1	G325S, G162S	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204284	10	99371405	10	97611648	204284	200684	rs777046879	NC_000010.11:97611647:G:A
NM_138413.4(HOGA1):c.533T>C (p.Leu178Pro)	HOGA1	L178F, L178P	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204282	10	99359501	10	97599744	204282	200668	rs796052090	NC_000010.11:97599743:T:C
NM_138413.4(HOGA1):c.308A>T (p.Asn103Ile)	HOGA1	N103I	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204281	10	99358628	10	97598871	204281	200659	rs796052089	NC_000010.11:97598870:A:T
NM_138413.4(HOGA1):c.227G>A (p.Gly76Asp)	HOGA1	G76D	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204280	10	99358547	10	97598790	204280	200658	rs796052088	NC_000010.11:97598789:G:A
NM_138413.4(HOGA1):c.907C>T (p.Arg303Cys)	HOGA1	R303C, R140C	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204279	10	99371339	10	97611582	204279	200682	rs149150736	NC_000010.11:97611581:C:T
NM_138413.4(HOGA1):c.875T>C (p.Met292Thr)	HOGA1	M292T, M129T	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204278	10	99371307	10	97611550	204278	200681	rs796052087	NC_000010.11:97611549:T:C
NM_138413.4(HOGA1):c.839C>T (p.Thr280Ile)	HOGA1	T280I, T117I	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204277	10	99371271	10	97611514	204277	200680	rs756489804	NC_000010.11:97611513:C:T
NM_138413.4(HOGA1):c.763C>T (p.Arg255Ter)	HOGA1	R255*, R92*	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204276	10	99361676	10	97601919	204276	200677	rs796052086	NC_000010.11:97601918:C:T
NM_138413.4(HOGA1):c.733G>A (p.Val245Ile)	HOGA1	V245I, V82I	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204275	10	99361646	10	97601889	204275	200675	rs755562733	NC_000010.11:97601888:G:A
NM_138413.4(HOGA1):c.728C>A (p.Ala243Asp)	HOGA1	A243D, A80D	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204274	10	99361641	10	97601884	204274	200674	rs796052085	NC_000010.11:97601883:C:A
NM_138413.4(HOGA1):c.346C>T (p.Gln116Ter)	HOGA1	Q116*	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204271	10	99358851	10	97599094	204271	200662	rs767405535	NC_000010.11:97599093:C:T
FAM126A:c.627-439_831+348del	FAM126A		Hypomyelination and Congenital Cataract	Pathogenic(Last reviewed: Nov 16, 2010)	no assertion criteria provided	VCV000021725	7	23000506 - 23004589	7	22960887 - 22964970	21725	34577		
FAM126A, 4-KB DEL	FAM126A		Hypomyelination and Congenital Cataract	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000001217					1217	16256		
NM_138413.4(HOGA1):c.700+4G>T	HOGA1		Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000000032	10	99359924	10	97600167	32	15071		NC_000010.11:97600166:G:T
NM_007216.4(HPS5):c.201del (p.Gln67fs)	HPS5	Q181fs, Q67fs	Hermansky-Pudlak syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627333	11	18330561	11	18309014	627333	615443		NC_000011.10:18309013:C:
NM_007216.4(HPS5):c.1684_1687del (p.Val562fs)	HPS5	V562fs, V676fs	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000003152	11	18313400 - 18313403	11	18291853 - 18291856	3152	18191	rs281865103	NC_000011.10:18291852:TAACTAA:TAA
NM_032581.4(FAM126A):c.158T>C (p.Leu53Pro)	FAM126A	L53P	Hypomyelination and Congenital Cataract	Pathogenic(Last reviewed: Nov 16, 2010)	no assertion criteria provided	VCV000001216	7	23018063	7	22978444	1216	16255	rs72549407	NC_000007.14:22978443:A:G
NM_032581.4(FAM126A):c.51+1G>A	FAM126A		Hypomyelination and Congenital Cataract	Pathogenic(Last reviewed: Nov 16, 2010)	no assertion criteria provided	VCV000001214	7	23030679	7	22991060	1214	16253	rs72549405	NC_000007.14:22991059:C:T
NM_138413.4(HOGA1):c.209G>C (p.Arg70Pro)	HOGA1	R70P	Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000000033	10	99344669	10	97584912	33	15072	rs267606763	NC_000010.11:97584911:G:C
NM_000349.3(STAR):c.562C>T (p.Arg188Cys)	STAR	R188C	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008997	8	38003569	8	38146051	8997	24036	rs104894090	NC_000008.11:38146050:G:A
NM_001499.2(GLE1):c.433-10A>G	GLE1		Lethal arthrogryposis with anterior horn cell disease|Lethal congenital contracture syndrome 1|not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000006462	9	131284937	9	128522658	6462	21501	rs386833693	NC_000009.12:128522657:A:G
NM_031443.4(CCM2):c.1078A>T (p.Lys360Ter)	CCM2	K343*, K269*, K360*, K302*, K381*, K401*	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000849329	7	45115399	7	45075800	849329	833625		NC_000007.14:45075799:A:T
7p13 deletion (77.6 kb)	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Aug 4, 2016)	no assertion criteria provided	VCV000253004					253004	247409		
nsv513784	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000002688					2688	17727		
NM_000429.3(MAT1A):c.790C>T (p.Arg264Cys)	MAT1A	R264C	Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000001210	10	82034934	10	80275178	1210	16249	rs118204005	NC_000010.11:80275177:G:A
NM_000429.3(MAT1A):c.1070C>T (p.Pro357Leu)	MAT1A	P357L	not provided|Hepatic methionine adenosyltransferase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001204	10	82034291	10	80274535	1204	16243	rs118204003	NC_000010.11:80274534:G:A
NM_007216.4(HPS5):c.537dup (p.Lys180fs)	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021822	11	18326985 - 18326986	11	18305438 - 18305439	21822	34674	rs281865101	NC_000011.10:18305438:GGGG:GGGGG
NM_007216.4(HPS5):c.2586_2587dup (p.Thr863fs)	HPS5		Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021820	11	18306914 - 18306915	11	18285367 - 18285368	21820	34672	rs397507169	NC_000011.10:18285367:TC:TCTC
NM_007216.4(HPS5):c.2282del (p.Leu761fs)	HPS5	L875fs, L761fs	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021819	11	18309175	11	18287628	21819	34671	rs281865105	NC_000011.10:18287627:AAAA:AAA
NM_181507.1(HPS5):c.2593C>T (p.Arg865Ter)	HPS5	R865*, R751*	Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021818	11	18309206	11	18287659	21818	34670	rs281865104	NC_000011.10:18287658:G:A
NM_032581.4(FAM126A):c.414+1G>T	FAM126A		Hypomyelination and Congenital Cataract	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000001215	7	23016959	7	22977340	1215	16254	rs72549406	NC_000007.14:22977339:C:A
NM_001005463.3(EBF3):c.488G>T (p.Arg163Leu)	EBF3	R163L	Hypotonia, ataxia, and delayed development syndrome|not provided|Intellectual disability|Ataxia|Expressive language delay|Global developmental delay|Muscular hypotonia	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000268155	10	131755588	10	129957324	268155	263782	rs1057519389	NC_000010.11:129957323:C:A
NM_138413.4(HOGA1):c.123del (p.Pro41_Val42insTer)	HOGA1		Primary hyperoxaluria, type III|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522533	10	99344583	10	97584826	522533	513085	rs1419840309	NC_000010.11:97584825:T:
NM_138413.4(HOGA1):c.117C>A (p.Tyr39Ter)	HOGA1	Y39*	not provided|Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000204268	10	99344577	10	97584820	204268	200653	rs746419489	NC_000010.11:97584819:C:A
NM_000536.4(RAG2):c.293del (p.Thr98fs)	RAG2	T98fs	|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000839979	11	36615426	11	36593876	839979	838400		NC_000011.10:36593875:G:
NM_000536.4(RAG2):c.595G>T (p.Glu199Ter)	RAG2	E199*	|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000463972	11	36615124	11	36593574	463972	461304	rs748727021	NC_000011.10:36593573:C:A
NM_004376.6(COX15):c.649C>T (p.Arg217Trp)	COX15	R217W, R38W	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2|Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000006175	10	101483814	10	99724057	6175	21214	rs28939711	NC_000010.11:99724056:G:A
NM_018718.3(CEP41):c.418C>T (p.Gln140Ter)	CEP41	Q140*, Q124*	not provided	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000280165	7	130044409	7	130404568	280165	264302	rs781848162	NC_000007.14:130404567:G:A
NM_018718.3(CEP41):c.1078C>T (p.Arg360Cys)	CEP41	R360C, R272C, R288C	Joubert syndrome 9/15, digenic	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030843	7	130038776	7	130398935	30843	39800	rs371812716	NC_000007.14:130398934:G:A
NM_018718.3(CEP41):c.536G>A (p.Arg179His)	CEP41	R179H, R163H	Joubert syndrome 12/15, digenic	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030841	7	130042527	7	130402686	30841	39798	rs140259402	NC_000007.14:130402685:C:T
NM_018718.3(CEP41):c.83C>A (p.Ser28Ter)	CEP41	S28*	Joubert syndrome 15	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030844	7	130067810	7	130427969	30844	39801		NC_000007.14:130427968:G:T
CEP41, 3-BP DEL, IVS1DS, 97GAG	CEP41		Joubert syndrome 15	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030839					30839	39796		
NM_018718.3(CEP41):c.33+2T>G	CEP41		Joubert syndrome 15	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030838	7	130080773	7	130440932	30838	39795		NC_000007.14:130440931:A:C
NM_004403.3(GSDME):c.1183+4A>G	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000002093	7	24745799	7	24706180	2093	17132	rs1562687295	NC_000007.14:24706179:T:C
NM_004403.3(GSDME):c.991-6C>G	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000002092	7	24746001	7	24706382	2092	17131	rs1562687726	NC_000007.14:24706381:G:C
GSDME, INS/DEL, EX8DEL	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000002090					2090	17129		
NM_000380.3(XPA):c.619C>T (p.Arg207Ter)	XPA	R207*, R165*	|not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000996	9	100447259	9	97684977	996	16035	rs104894133	NC_000009.12:97684976:G:A
NM_031443.4(CCM2):c.839C>G (p.Ser280Ter)	CCM2	S222*, S321*, S263*, S189*, S301*, S280*	Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000838138	7	45113094	7	45073495	838138	833623		NC_000007.14:45073494:C:G
NC_000007.14:g.(?_45038233)_(45038446_?)del	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000832896	7	45077832 - 45078045			832896	819876		
NM_001029835.2(CCM2):c.808+1G>C	CCM2		Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000650894	7	45109561	7	45069962	650894	651809		NC_000007.14:45069961:G:C
NM_001029835.2(CCM2):c.134del (p.Gly45fs)	CCM2	G45fs, G24fs	Cerebral cavernous malformations 2|not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618554	7	45077891	7	45038292	618554	609662	rs1562881854	NC_000007.14:45038291:GG:G
NM_001029835.2(CCM2):c.382C>T (p.Gln128Ter)	CCM2	Q107*, Q128*, Q49*	Cerebral cavernous malformations 2|not provided	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000002681	7	45104092	7	45064493	2681	17720	rs137852841	NC_000007.14:45064492:C:T
GSMDE, 3-BP DEL, IVS7, -17CTT	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000002091					2091	17130		
NM_003018.4(SFTPC):c.218T>C (p.Ile73Thr)	SFTPC	I73T, I20T	not provided|Surfactant metabolism dysfunction, pulmonary, 2	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013208	8	22020609	8	22163096	13208	28247	rs121917834	NC_000008.11:22163095:T:C
NM_018718.3(CEP41):c.423-2A>C	CEP41		Joubert syndrome 15	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000030840	7	130042642	7	130402801	30840	39797		NC_000007.14:130402800:T:G
NM_001257180.2(SLC20A2):c.1399C>T (p.Arg467Ter)	SLC20A2	R467*	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000620147	8	42294631	8	42437113	620147	611699	rs1563452873	NC_000008.11:42437112:G:A
NM_001257180.2(SLC20A2):c.1604G>A (p.Trp535Ter)	SLC20A2	W535*	not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000489160	8	42287687	8	42430169	489160	481818	rs1554546830	NC_000008.11:42430168:C:T
NM_001257180.2(SLC20A2):c.458dup (p.Leu153fs)	SLC20A2		not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000452417	8	42320580 - 42320581	8	42463062 - 42463063	452417	444285	rs1554557554	NC_000008.11:42463062:AA:AAA
NM_153767.3(KCNJ1):c.262A>T (p.Lys88Ter)	KCNJ1	K88*, K107*, K105*	Bartter syndrome, type 2, antenatal	Pathogenic	no assertion criteria provided	VCV000373897	11	128709877	11	128839982	373897	360797	rs185212943	NC_000011.10:128839981:T:A
NM_001257180.2(SLC20A2):c.971C>A (p.Ser324Ter)	SLC20A2	S324*	not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000280572	8	42295059	8	42437541	280572	264362	rs886041752	NC_000008.11:42437540:G:T
NM_001257180.2(SLC20A2):c.338C>G (p.Ser113Ter)	SLC20A2	S113*	not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000280122	8	42323387	8	42465869	280122	264390	rs886041397	NC_000008.11:42465868:G:C
NM_000220.5(KCNJ1):c.924C>A (p.Cys308Ter)	KCNJ1	C289*, C308*, C306*	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000586076	11	128709272	11	128839377	586076	577171	rs746509804	NC_000011.10:128839376:G:T
NM_000220.5(KCNJ1):c.372T>A (p.Asn124Lys)	KCNJ1	K124N, N105K, N124K, N122K	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Sep 11, 1998)	no assertion criteria provided	VCV000009162	11	128709824	11	128839929	9162	24201	rs104894251	NC_000011.10:128839928:A:T
NM_000220.5(KCNJ1):c.500G>A (p.Gly167Glu)	KCNJ1	G167E, G148E, G165E	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000009160	11	128709696	11	128839801	9160	24199	rs104894254	NC_000011.10:128839800:C:T
NM_000220.5(KCNJ1):c.592G>A (p.Ala198Thr)	KCNJ1	A198T, A179T, A196T	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000009159	11	128709604	11	128839709	9159	24198	rs104894253	NC_000011.10:128839708:C:T
KCNJ1, TRP58TER	KCNJ1	W58*	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000009156					9156	24195		
KCNJ1, 1-BP INS, CODON 15	KCNJ1		Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000009154					9154	24193		
NM_000220.5(KCNJ1):c.237C>G (p.Tyr79Ter)	KCNJ1	Y60*, Y77*, Y79*	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000009153	11	128709959	11	128840064	9153	24192	rs104894244	NC_000011.10:128840063:G:C
NM_001257180.2(SLC20A2):c.935-2A>G	SLC20A2		Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000636249	8	42295097	8	42437579	636249	624067		NC_000008.11:42437578:T:C
NM_001257180.2(SLC20A2):c.1375G>T (p.Glu459Ter)	SLC20A2	E459*	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000584447	8	42294655	8	42437137	584447	575491	rs1563452941	NC_000008.11:42437136:C:A
NM_001257180.2(SLC20A2):c.1723G>T (p.Glu575Ter)	SLC20A2	E575*	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000522850	8	42286347	8	42428829	522850	513426	rs387906653	NC_000008.11:42428828:C:A
NM_001257180.2(SLC20A2):c.136C>T (p.Gln46Ter)	SLC20A2	Q46*	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000522849	8	42329773	8	42472255	522849	513427	rs751093906	NC_000008.11:42472254:G:A
NM_001257180.2(SLC20A2):c.1784C>T (p.Thr595Met)	SLC20A2	T595M	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Feb 12, 2012)	no assertion criteria provided	VCV000029797	8	42286286	8	42428768	29797	38752	rs387906654	NC_000008.11:42428767:G:A
NM_000220.5(KCNJ1):c.322G>C (p.Asp108His)	KCNJ1	D108H, D89H, D106H	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Jan 23, 1997)	no assertion criteria provided	VCV000009161	11	128709874	11	128839979	9161	24200	rs104894250	NC_000011.10:128839978:C:G
NM_000220.5(KCNJ1):c.641C>T (p.Ala214Val)	KCNJ1	A195V, A212V, A214V	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000009157	11	128709555	11	128839660	9157	24196	rs104894246	NC_000011.10:128839659:G:A
NM_000220.5(KCNJ1):c.657C>G (p.Ser219Arg)	KCNJ1	S200R, S219R, S217R	Bartter syndrome, type 2, antenatal	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000009155	11	128709539	11	128839644	9155	24194	rs104894245	NC_000011.10:128839643:G:C
NM_138413.4(HOGA1):c.834_834+1delinsTT	HOGA1		not provided|Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000625169	10	99361747 - 99361748	10	97601990 - 97601991	625169	613512	rs1564760008	NC_000010.11:97601989:GG:TT
NM_138413.4(HOGA1):c.834G>A (p.Ala278=)	HOGA1		not provided|Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000204286	10	99361747	10	97601990	204286	200678	rs770050262	NC_000010.11:97601989:G:A
SLC20A2, EX6-10DEL	SLC20A2		Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Oct 15, 2019)	no assertion criteria provided	VCV000691908					691908	679656		
NM_000220.5(KCNJ1):c.1058dup (p.His354fs)	KCNJ1		not provided	Pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	VCV000586075	11	128709137 - 128709138	11	128839242 - 128839243	586075	577170	rs768286324	NC_000011.10:128839242:GGGG:GGGGG
NM_001257180.2(SLC20A2):c.1828_1831del (p.Ser610fs)	SLC20A2	S610fs	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000075231	8	42275449 - 42275452	8	42417931 - 42417934	75231	86122	rs398122396	NC_000008.11:42417930:GGGAG:G
NM_001257180.2(SLC20A2):c.1802C>G (p.Ser601Trp)	SLC20A2	S601W	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000029794	8	42275478	8	42417960	29794	38749	rs387906652	NC_000008.11:42417959:G:C
NM_001257180.2(SLC20A2):c.1492G>A (p.Gly498Arg)	SLC20A2	G498R	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Feb 12, 2012)	no assertion criteria provided	VCV000029793	8	42294538	8	42437020	29793	38748		NC_000008.11:42437019:C:T
NM_001257180.2(SLC20A2):c.1802C>T (p.Ser601Leu)	SLC20A2	S601L	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000029795	8	42275478	8	42417960	29795	38750	rs387906652	NC_000008.11:42417959:G:A
NM_014915.2(ANKRD26):c.-126T>C	ANKRD26		Thrombocytopenia|Inherited bleeding disorder, platelet-type|Thrombocytopenia 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000626941	10	27389381	10	27100452	626941	615436		NC_000010.11:27100451:A:G
NM_006214.4(PHYH):c.135-2A>G	PHYH		not provided|Refsum disease, adult, 1|Phytanic acid storage disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007581	10	13337608	10	13295608	7581	22620	rs201578674	NC_000010.11:13295607:T:C
NM_032861.4(SERAC1):c.442C>T (p.Arg148Ter)	SERAC1	R148*	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome|not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035556	6	158567859	6	158146827	35556	44229	rs387907236	NC_000006.12:158146826:G:A
NM_001257180.2(SLC20A2):c.509del (p.Ile169_Leu170insTer)	SLC20A2		Idiopathic basal ganglia calcification 1|not provided	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000280118	8	42320530	8	42463012	280118	264277	rs398122395	NC_000008.11:42463011:AA:A
NM_001029835.2(CCM2):c.673-1G>A	CCM2		Cerebral cavernous malformations 2|not provided	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000590663	7	45109424	7	45069825	590663	581330	rs1562913873	NC_000007.14:45069824:G:A
NM_001029835.2(CCM2):c.232A>T (p.Arg78Ter)	CCM2	R57*, R78*	Cerebral cavernous malformations 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590650	7	45077990	7	45038391	590650	581318	rs1562882049	NC_000007.14:45038390:A:T
NM_031443.3(CCM2):c.1A>G (p.Met1Val)	CCM2	M1V	not provided|Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000002684	7	45039933	7	45000334	2684	17723	rs137852842	NC_000007.14:45000333:A:G
NM_003322.6(TULP1):c.525dup (p.Pro176fs)	TULP1		Retinal dystrophy	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000866284	6	35477679 - 35477680	6	35509902 - 35509903	866284	856432		NC_000006.12:35509902:T:TT
NM_152722.5(HEPACAM):c.980del (p.Pro327fs)	HEPACAM	P327fs	not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000419081	11	124791305	11	124921409	419081	408299	rs1064793629	NC_000011.10:124921408:GGGG:GGG
NM_003322.6(TULP1):c.845del (p.Pro282fs)	TULP1	P282fs, P229fs	not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280920	6	35473934	6	35506157	280920	264216	rs886042038	NC_000006.12:35506156:GGGG:GGG
NM_003322.6(TULP1):c.725_728del (p.Pro242fs)	TULP1	P189fs, P242fs	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000198784	6	35477080 - 35477083	6	35509303 - 35509306	198784	195944	rs771723580	NC_000006.12:35509302:TTGG:
NM_003322.6(TULP1):c.528_529insT (p.Lys177Ter)	TULP1		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812443	6	35477676 - 35477677	6	35509899 - 35509900	812443	800514		NC_000006.12:35509899::A
NM_003322.6(TULP1):c.781_782insCTCC (p.Lys261fs)	TULP1		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812442	6	35477026 - 35477027	6	35509249 - 35509250	812442	800513		NC_000006.12:35509249::GGAG
NM_003322.6(TULP1):c.832_833insTCCC (p.Glu278fs)	TULP1		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812441	6	35473946 - 35473947	6	35506169 - 35506170	812441	800512		NC_000006.12:35506169::GGGA
NM_003322.6(TULP1):c.1349G>A (p.Trp450Ter)	TULP1	W450*, W397*	Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812438	6	35467904	6	35500127	812438	800509		NC_000006.12:35500126:C:T
NM_003322.6(TULP1):c.1495+2dup	TULP1		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812437	6	35467755 - 35467756	6	35499978 - 35499979	812437	800690		NC_000006.12:35499978:A:AA
NM_003322.6(TULP1):c.794del (p.Lys265fs)	TULP1	K265fs, K212fs	Leber congenital amaurosis 15	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000829968	6	35477014	6	35509237	829968	818245		NC_000006.12:35509236:TTTT:TTT
NM_003322.6(TULP1):c.1388del (p.Asn463fs)	TULP1	N410fs, N463fs	Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802208	6	35467865	6	35500088	802208	790623		NC_000006.12:35500087:TT:T
NM_003322.6(TULP1):c.1560C>A (p.Tyr520Ter)	TULP1	Y467*, Y520*	Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802207	6	35466173	6	35498396	802207	790622		NC_000006.12:35498395:G:T
NM_152722.5(HEPACAM):c.266G>A (p.Gly89Asp)	HEPACAM	G89D	Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with mental retardation	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030920	11	124794785	11	124924889	30920	39877	rs387907054	NC_000011.10:124924888:C:T
NM_152722.5(HEPACAM):c.292C>T (p.Arg98Cys)	HEPACAM	R98C	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030918	11	124794759	11	124924863	30918	39875	rs387907052	NC_000011.10:124924862:G:A
NM_152722.5(HEPACAM):c.631G>A (p.Asp211Asn)	HEPACAM	D211N	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030917	11	124793703	11	124923807	30917	39874	rs387907051	NC_000011.10:124923806:C:T
HEPACAM, TRP263TER	HEPACAM	W263*	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030915					30915	39872		
NM_152722.5(HEPACAM):c.587C>A (p.Ser196Tyr)	HEPACAM	S196Y	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030914	11	124793747	11	124923851	30914	39871	rs387907049	NC_000011.10:124923850:G:T
NM_003322.6(TULP1):c.718+2T>C	TULP1		Retinitis pigmentosa 14	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000007365	6	35477409	6	35509632	7365	22404		NC_000006.12:35509631:A:G
NM_003322.6(TULP1):c.1511_1521del (p.Leu504fs)	TULP1	L451fs, L504fs	Retinitis pigmentosa 14	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000007364	6	35466212 - 35466222	6	35498435 - 35498445	7364	22403		NC_000006.12:35498434:GCCGAACTGCAGC:GC
NM_003322.6(TULP1):c.1444C>T (p.Arg482Trp)	TULP1	R482W, R429W	Retinitis pigmentosa 14	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000007363	6	35467809	6	35500032	7363	22402	rs121909077	NC_000006.12:35500031:G:A
TULP1, IVS14DS, G-A, +1	TULP1		Retinitis pigmentosa 14	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000007361					7361	22400		
NM_003322.6(TULP1):c.1376T>A (p.Ile459Lys)	TULP1	I459K, I406K	Retinitis pigmentosa 14	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000007359	6	35467877	6	35500100	7359	22398	rs121909075	NC_000006.12:35500099:A:T
NM_021922.3(FANCE):c.940C>T (p.Gln314Ter)	FANCE	Q314*	Fanconi anemia, complementation group E	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000859286	6	35425732	6	35457955	859286	831875		NC_000006.12:35457954:C:T
NM_003322.6(TULP1):c.1301G>A (p.Arg434Lys)	TULP1	R381K, R434K	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812439	6	35471358	6	35503581	812439	800510		NC_000006.12:35503580:C:T
NM_021922.3(FANCE):c.929dup (p.Val311fs)	FANCE		Fanconi anemia, complementation group E	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000655390	6	35425714 - 35425715	6	35457937 - 35457938	655390	634875		NC_000006.12:35457937:CCCCCCC:CCCCCCCC
NM_152722.5(HEPACAM):c.275G>A (p.Arg92Gln)	HEPACAM	R92Q	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000030916	11	124794776	11	124924880	30916	39873	rs387907050	NC_000011.10:124924879:C:T
TULP1, 6-BP DUP, NT1593	TULP1		Leber congenital amaurosis 15	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000030263					30263	39219		
NM_003322.6(TULP1):c.1102G>T (p.Gly368Trp)	TULP1	G368W, G315W	Leber congenital amaurosis 15	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000030262	6	35473528	6	35505751	30262	39218	rs387906837	NC_000006.12:35505750:C:A
NM_003322.6(TULP1):c.1204G>T (p.Glu402Ter)	TULP1	E402*, E349*	Leber congenital amaurosis 15	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000030260	6	35471534	6	35503757	30260	39216	rs387906835	NC_000006.12:35503756:C:A
NM_021922.2(FANCE):c.421C>T (p.Arg141Ter)	FANCE	R141*	Fanconi anemia, complementation group E	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000008710	6	35423696	6	35455919	8710	23749	rs121434506	NC_000006.12:35455918:C:T
NM_152722.5(HEPACAM):c.274C>T (p.Arg92Trp)	HEPACAM	R92W	Megalencephalic leukoencephalopathy with subcortical cysts 2a|Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000030921	11	124794777	11	124924881	30921	39878	rs387907055	NC_000011.10:124924880:G:A
NM_003322.6(TULP1):c.1259G>C (p.Arg420Pro)	TULP1	R420P, R367P	not provided|Retinitis pigmentosa 14	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000007357	6	35471400	6	35503623	7357	22396	rs121909073	NC_000006.12:35503622:C:G
NM_003322.6(TULP1):c.1047T>G (p.Asn349Lys)	TULP1	N296K, N349K	Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000812440	6	35473583	6	35505806	812440	800511		NC_000006.12:35505805:A:C
NM_003322.6(TULP1):c.524dup (p.Pro176fs)	TULP1		Leber congenital amaurosis 1	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000547179	6	35477680 - 35477681	6	35509903 - 35509904	547179	537666	rs1327062642	NC_000006.12:35509903:GGGGGG:GGGGGGG
NM_021922.2(FANCE):c.1114-8G>A	FANCE		Fanconi anemia, complementation group E	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000008711	6	35427100	6	35459323	8711	23750	rs878854342	NC_000006.12:35459322:G:A
NM_003114.4(SPAG1):c.897_901del (p.Lys301fs)	SPAG1	K301fs	not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000445743	8	101203682 - 101203686	8	100191454 - 100191458	445743	439015	rs751845138	NC_000008.11:100191453:GAGTA:
NM_003114.5(SPAG1):c.1637_1638del (p.Thr546fs)	SPAG1	T546fs	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000848748	8	101232607 - 101232608	8	100220379 - 100220380	848748	834024		NC_000008.11:100220378:ACA:A
NM_003114.5(SPAG1):c.1282_1294del (p.Ala428fs)	SPAG1	A428fs	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000848747	8	101225493 - 101225505	8	100213265 - 100213277	848747	834023		NC_000008.11:100213264:GGCGGCGGCGGCGGGCGGCGGCG:GGCGGCGGCG
NC_000008.10:g.(?_101199328)_(101199498_?)del	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000666216	8	101199328 - 101199498	8	100187100 - 100187270	666216	651756		
NM_172218.2(SPAG1):c.427-1065_630del	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000662557	8	101194532 - 101196884	8	100182304 - 100184656	662557	651882		
NM_172218.2(SPAG1):c.1663C>T (p.Gln555Ter)	SPAG1	Q555*	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648143	8	101232634	8	100220406	648143	636527		NC_000008.11:100220405:C:T
NM_003114.4(SPAG1):c.2083_2084TA[1] (p.Tyr695_Arg696delinsTer)	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000575027	8	101245733 - 101245734	8	100233505 - 100233506	575027	561881	rs1563815206	NC_000008.11:100233504:TATA:TA
NM_003114.4(SPAG1):c.1864dup (p.Thr622fs)	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000541532	8	101243386 - 101243387	8	100231158 - 100231159	541532	523186	rs1380083184	NC_000008.11:100231158:AAAAAA:AAAAAAA
NM_172218.2(SPAG1):c.311C>A (p.Ser104Ter)	SPAG1	S104*	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	VCV000474661	8	101190054	8	100177826	474661	457759	rs1275662909	NC_000008.11:100177825:C:A
NM_172218.2(SPAG1):c.1156C>T (p.Gln386Ter)	SPAG1	Q386*	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Apr 2, 2017)	criteria provided, single submitter	VCV000474648	8	101225377	8	100213149	474648	457761	rs1229952265	NC_000008.11:100213148:C:T
NC_000008.10:g.(?_101174507)_(101174648_?)del	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000417543	8	101174507 - 101174648	8	100162279 - 100162420	417543	396234		
NM_003114.4(SPAG1):c.325_326del (p.Glu109fs)	SPAG1	E109fs	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000411002	8	101190067 - 101190068	8	100177839 - 100177840	411002	395838	rs1060503107	NC_000008.11:100177838:AGA:A
NM_003114.4(SPAG1):c.1519dup (p.Ile507fs)	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000410993	8	101226129 - 101226130	8	100213901 - 100213902	410993	396529	rs763569711	NC_000008.11:100213901:A:AA
NM_172218.2(SPAG1):c.319A>T (p.Lys107Ter)	SPAG1	K107*	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000410980	8	101190062	8	100177834	410980	396242	rs752479330	NC_000008.11:100177833:A:T
NM_003114.4(SPAG1):c.902_906del (p.Lys301fs)	SPAG1	K301fs	Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000209000	8	101203683 - 101203687	8	100191455 - 100191459	209000	205559	rs797045149	NC_000008.11:100191454:AGTAAAGTA:AGTA
NM_003114.4(SPAG1):c.2T>G (p.Met1Arg)	SPAG1	M1R	Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088680	8	101174510	8	100162282	88680	94260	rs397518458	NC_000008.11:100162281:T:G
NM_003114.4(SPAG1):c.679G>T (p.Glu227Ter)	SPAG1	E227*	Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088682	8	101196939	8	100184711	88682	94262	rs397518459	NC_000008.11:100184710:G:T
NM_000409.4(GUCA1A):c.296A>G (p.Tyr99Cys)	GUCA1A	Y99C	Retinitis pigmentosa|Macular dystrophy|not provided|Cone dystrophy 3|Retinal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009150	6	42146112	6	42178374	9150	24189	rs104893967	NC_000006.12:42178373:A:G
NC_000008.10:g.(?_101174489)_(101174668_?)del	SPAG1		Ciliary dyskinesia, primary, 28	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000474645			8	100162261 - 100162440	474645	457741		
NM_004403.3(GSDME):c.991-21TTC[2]	GSDME		Rare genetic deafness	Pathogenic(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	VCV000179997	7	24746008 - 24746010	7	24706389 - 24706391	179997	174221	rs727505273	NC_000007.14:24706388:GAAGAAGAAG:GAAGAAG
NM_003322.6(TULP1):c.901C>T (p.Gln301Ter)	TULP1	Q248*, Q301*	not provided|Retinitis pigmentosa 14	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000828151	6	35473878	6	35506101	828151	816462		NC_000006.12:35506100:G:A
NM_152722.5(HEPACAM):c.265G>A (p.Gly89Ser)	HEPACAM	G89S	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 2a|Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000030919	11	124794786	11	124924890	30919	39876	rs387907053	NC_000011.10:124924889:C:T
NM_003322.6(TULP1):c.1198C>T (p.Arg400Trp)	TULP1	R400W, R347W	Leber congenital amaurosis 15|Brachydactyly|Retinal degeneration|Non-syndromic syndactyly|Postaxial polydactyly type A1	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000030261	6	35471540	6	35503763	30261	39217	rs387906836	NC_000006.12:35503762:G:A
NM_021922.2(FANCE):c.355C>T (p.Gln119Ter)	FANCE	Q119*	Fanconi anemia, complementation group E	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000008709	6	35423630	6	35455853	8709	23748	rs121434505	NC_000006.12:35455852:C:T
NM_001029835.2(CCM2):c.1297dup (p.Arg433fs)	CCM2		Cerebral cavernous malformations 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000590645	7	45115553 - 45115554	7	45075954 - 45075955	590645	581333	rs1331484727	NC_000007.14:45075954:CC:CCC
NM_000349.3(STAR):c.749G>A (p.Trp250Ter)	STAR	W250*	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000008991	8	38001900	8	38144382	8991	24030	rs104894087	NC_000008.11:38144381:C:T
NM_001257180.2(SLC20A2):c.583_584del (p.Val195fs)	SLC20A2	V195fs	Idiopathic basal ganglia calcification 1|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000075233	8	42317443 - 42317444	8	42459925 - 42459926	75233	86124	rs398122397	NC_000008.11:42459924:ACA:A
NM_006412.4(AGPAT2):c.662-2A>C	AGPAT2		not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430117	9	139568381	9	136673929	430117	421737	rs1131691791	NC_000009.12:136673928:T:G
NM_018238.4(AGK):c.297+2T>C	AGK		not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000429694	7	141301082	7	141601282	429694	421621	rs765471424	NC_000007.14:141601281:T:C
NM_006412.4(AGPAT2):c.282del (p.Ile94fs)	AGPAT2	I94fs	not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000285946	9	139571909	9	136677457	285946	270183	rs886043265	NC_000009.12:136677456:G:
NM_018238.4(AGK):c.102-1G>T	AGK		not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000280668	7	141292945	7	141593145	280668	264332	rs886041835	NC_000007.14:141593144:G:T
NM_018238.4(AGK):c.1047-2A>T	AGK		not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000280255	7	141351323	7	141651523	280255	264334	rs886041491	NC_000007.14:141651522:A:T
NM_001195248.2(APTX):c.667C>T (p.Leu223Phe)	APTX	L223F, L237F, L135F, L151F, L169F	not provided	Pathogenic(Last reviewed: Jul 18, 2012)	criteria provided, single submitter	VCV000214128	9	32984732	9	32984734	214128	211377	rs754477154	NC_000009.12:32984733:G:A
NM_006412.4(AGPAT2):c.622_626del (p.Ser208fs)	AGPAT2	S208fs, S176fs	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 11, 2018)	no assertion criteria provided	VCV000549712	9	139569222 - 139569226	9	136674770 - 136674774	549712	540478	rs1564290079	NC_000009.12:136674769:GAGGAGA:GA
NM_006412.4(AGPAT2):c.513del (p.Glu172fs)	AGPAT2	E172fs	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 11, 2018)	no assertion criteria provided	VCV000549711	9	139571112	9	136676660	549711	540479	rs1564290914	NC_000009.12:136676659:GGG:GG
NM_018238.4(AGK):c.298-2A>G	AGK		Sengers syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488464	7	141310993	7	141611193	488464	481332	rs1554401640	NC_000007.14:141611192:A:G
NM_006412.4(AGPAT2):c.503G>A (p.Trp168Ter)	AGPAT2	W168*	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374338	9	139571122	9	136676670	374338	361196	rs1057518714	NC_000009.12:136676669:C:T
NM_006412.4(AGPAT2):c.755_763del (p.Met252_Thr254del)	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372113	9	139568278 - 139568286	9	136673826 - 136673834	372113	359009	rs1057517656	NC_000009.12:136673825:TGGTCCTCATGG:TGG
NM_006412.4(AGPAT2):c.713C>G (p.Ala238Gly)	AGPAT2	A238G, A206G	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372112	9	139568328	9	136673876	372112	359010	rs200656731	NC_000009.12:136673875:G:C
NM_006412.4(AGPAT2):c.676C>T (p.Gln226Ter)	AGPAT2	Q226*, Q194*	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372111	9	139568365	9	136673913	372111	359011	rs1057517655	NC_000009.12:136673912:G:A
NM_006412.4(AGPAT2):c.661+2T>G	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372110	9	139569185	9	136674733	372110	359012	rs1057517654	NC_000009.12:136674732:A:C
NM_006412.4(AGPAT2):c.538del (p.Asp180fs)	AGPAT2	D180fs	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372109	9	139571087	9	136676635	372109	359013	rs1057517653	NC_000009.12:136676634:CCCC:CCC
NM_006412.3(AGPAT2):c.(316+1_317-1)_(588+1_589-1)del (p.Leu107AlafsTer279)	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372107					372107	359027		
NM_006412.4(AGPAT2):c.492+1G>A	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372106	9	139571412	9	136676960	372106	359015	rs933422777	NC_000009.12:136676959:C:T
NM_006412.4(AGPAT2):c.194G>A (p.Trp65Ter)	AGPAT2	W65*	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372104	9	139571997	9	136677545	372104	359017	rs1057517651	NC_000009.12:136677544:C:T
NM_006412.4(AGPAT2):c.182+1G>A	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372103	9	139581627	9	136687175	372103	359019	rs1057517650	NC_000009.12:136687174:C:T
NM_006412.4(AGPAT2):c.183-2A>G	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372102	9	139572010	9	136677558	372102	359018	rs1057517649	NC_000009.12:136677557:T:C
NM_006412.4(AGPAT2):c.406G>A (p.Gly136Arg)	AGPAT2	G136R	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000210104	9	139571499	9	136677047	210104	207660	rs797045222	NC_000009.12:136677046:C:T
NM_018238.4(AGK):c.672C>G (p.Tyr224Ter)	AGK	Y224*	Sengers syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030830	7	141336763	7	141636963	30830	39787	rs771945804	NC_000007.14:141636962:C:G
NM_018238.4(AGK):c.306T>G (p.Tyr102Ter)	AGK	Y102*	Sengers syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030828	7	141311003	7	141611203	30828	39785	rs1554401641	NC_000007.14:141611202:T:G
NM_018238.4(AGK):c.517C>T (p.Gln173Ter)	AGK	Q173*	Sengers syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030827	7	141315364	7	141615564	30827	39784	rs387907024	NC_000007.14:141615563:C:T
NM_018238.4(AGK):c.975+1G>T	AGK		Sengers syndrome	Pathogenic(Last reviewed: Jan 25, 2012)	no assertion criteria provided	VCV000030825	7	141341709	7	141641909	30825	39782	rs868431923	NC_000007.14:141641908:G:T
NM_018238.4(AGK):c.141+2T>C	AGK		Sengers syndrome	Pathogenic(Last reviewed: Jan 25, 2012)	no assertion criteria provided	VCV000030823	7	141292987	7	141593187	30823	39780	rs1554399572	NC_000007.14:141593186:T:C
NM_006412.4(AGPAT2):c.570C>A (p.Tyr190Ter)	AGPAT2	F189*, Y190*	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000006631	9	139571055	9	136676603	6631	21670	rs121908926	NC_000009.12:136676602:G:T
NM_006412.4(AGPAT2):c.643A>T (p.Lys215Ter)	AGPAT2	K215*, K183*	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000006629	9	139569205	9	136674753	6629	21668	rs121908925	NC_000009.12:136674752:T:A
NM_006412.4(AGPAT2):c.415_417TTC[1] (p.Phe140del)	AGPAT2	F140del	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000006628	9	139571485 - 139571487	9	136677033 - 136677035	6628	21667	rs387906356	NC_000009.12:136677032:GAAGAAGA:GAAGA
NM_006412.4(AGPAT2):c.683T>C (p.Leu228Pro)	AGPAT2	L228P, L196P	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000006627	9	139568358	9	136673906	6627	21666	rs104894100	NC_000009.12:136673905:A:G
NM_006412.4(AGPAT2):c.377dup (p.Pro128fs)	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000006626	9	139571527 - 139571528	9	136677075 - 136677076	6626	21665	rs387906355	NC_000009.12:136677075:A:AA
NM_006412.4(AGPAT2):c.299G>A (p.Ser100Asn)	AGPAT2	S100N	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	VCV000372105	9	139571892	9	136677440	372105	359016	rs764260414	NC_000009.12:136677439:C:T
NM_018238.4(AGK):c.1131+5G>A	AGK		Sengers syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030831	7	141351414	7	141651614	30831	39788	rs542547163	NC_000007.14:141651613:G:A
NM_006412.4(AGPAT2):c.366_588+534del	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000006632	9	139570503 - 139571539	9	136676051 - 136677087	6632	21671		
NM_006412.4(AGPAT2):c.202C>T (p.Arg68Ter)	AGPAT2	R68*	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000006624	9	139571989	9	136677537	6624	21663	rs104894093	NC_000009.12:136677536:G:A
NM_007216.4(HPS5):c.2637_2640del (p.Cys879fs)	HPS5	C879fs, C993fs	Hermansky-Pudlak syndrome|not provided|Hermansky-Pudlak syndrome 5	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280536	11	18305418 - 18305421	11	18283871 - 18283874	280536	264420	rs886041723	NC_000011.10:18283870:CAAACA:CA
NM_018238.4(AGK):c.841C>T (p.Arg281Ter)	AGK	R281*	Sengers syndrome|not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000030829	7	141341162	7	141641362	30829	39786	rs387907025	NC_000007.14:141641361:C:T
NM_203395.3(IYD):c.658G>A (p.Ala220Thr)	IYD	A220T, A138T	Iodotyrosine deiodination defect	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000740	6	150715362	6	150394226	740	15779	rs121918140	NC_000006.12:150394225:G:A
NM_203395.3(IYD):c.347T>C (p.Ile116Thr)	IYD	I116T	Iodotyrosine deiodination defect	Pathogenic(Last reviewed: Apr 24, 2008)	no assertion criteria provided	VCV000000739	6	150710656	6	150389520	739	15778	rs121918139	NC_000006.12:150389519:T:C
NM_203395.3(IYD):c.301C>T (p.Arg101Trp)	IYD	R101W	Iodotyrosine deiodination defect	Pathogenic(Last reviewed: Apr 24, 2008)	no assertion criteria provided	VCV000000737	6	150710610	6	150389474	737	15776	rs121918138	NC_000006.12:150389473:C:T
NM_203395.3(IYD):c.315_317del (p.Phe105_Ile106delinsLeu)	IYD		Iodotyrosine deiodination defect	Pathogenic(Last reviewed: Apr 24, 2008)	no assertion criteria provided	VCV000000738	6	150710623 - 150710625	6	150389487 - 150389489	738	15777	rs863223276	NC_000006.12:150389486:TCAT:T
NM_000536.4(RAG2):c.283G>A (p.Gly95Arg)	RAG2	G95R	|Combined cellular and humoral immune defects with granulomas|Histiocytic medullary reticulosis||Combined cellular and humoral immune defects with granulomas|Histiocytic medullary reticulosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013133	11	36615436	11	36593886	13133	28172	rs36001797	NC_000011.10:36593885:C:T
NM_001195248.2(APTX):c.776del (p.Val259fs)	APTX	V187fs, V171fs, V259fs, V205fs	Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000635168	9	32974554	9	32974556	635168	623002	rs1563945076	NC_000009.12:32974555:A:
NM_001195248.2(APTX):c.484-1G>T	APTX		Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634641	9	32986029	9	32986031	634641	622509	rs1563963464	NC_000009.12:32986030:C:A
NM_001195248.2(APTX):c.875-2A>G	APTX		Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000434253	9	32973652	9	32973654	434253	429011	rs904293109	NC_000009.12:32973653:T:C
NM_001195248.2(APTX):c.697A>T (p.Lys233Ter)	APTX	K233*, K247*, K161*, K145*, K179*	Ataxia-oculomotor apraxia type 1	Pathogenic	no assertion criteria provided	VCV000426093	9	32984702	9	32984704	426093	414697	rs1114167423	NC_000009.12:32984703:T:A
NM_018238.4(AGK):c.3G>C (p.Met1Ile)	AGK	M1I	Sengers syndrome|not provided	Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	VCV000214076	7	141255269	7	141555469	214076	211298	rs863223895	NC_000007.14:141555468:G:C
NM_006412.4(AGPAT2):c.493-1G>C	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	VCV000006630	9	139571133	9	136676681	6630	21669	rs606231168	NC_000009.12:136676680:C:G
NM_001195248.2(APTX):c.668T>C (p.Leu223Pro)	APTX	L223P, L165P, L169P, L183P, L237P, L135P, L151P	Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000004433	9	32984731	9	32984733	4433	19472	rs267606665	NC_000009.12:32984732:A:G
NC_000009.12:g.(?_32973498)_(33001604_?)del	APTX		Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Sep 14, 2004)	no assertion criteria provided	VCV000004432			9	32973498 - 33001604	4432	19471		
NM_001195248.2(APTX):c.875-1G>A	APTX		Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Sep 14, 2004)	no assertion criteria provided	VCV000004430	9	32973651	9	32973653	4430	19469		NC_000009.12:32973652:C:T
NM_001195248.2(APTX):c.602A>G (p.His201Arg)	APTX	H27R, H215R, H201R, H129R, H113R, H147R	Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Aug 27, 2002)	no assertion criteria provided	VCV000004429	9	32984797	9	32984799	4429	19468	rs121908133	NC_000009.12:32984798:T:C
NM_001195248.2(APTX):c.788T>G (p.Val263Gly)	APTX	V277G, V263G, V209G, V191G, V175G	Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004428	9	32974542	9	32974544	4428	19467	rs121908132	NC_000009.12:32974543:A:C
NM_001195248.2(APTX):c.841del (p.Ser281fs)	APTX	S209fs, S193fs, S281fs, S227fs	Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004427	9	32974489	9	32974491	4427	19466	rs587776594	NC_000009.12:32974490:AA:A
NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)	NDUFV1	T423M, T414M	Mitochondrial complex I deficiency|Mitochondrial complex I deficiency, nuclear type 1|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014056	11	67379696	11	67612225	14056	29095	rs121913659	NC_000011.10:67612224:C:T
GRCh37/hg19 7q22.3(chr7:106868531-106927676)x1	COG5		not provided	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000687032	7	106868531 - 106927676			687032	674624		
NM_003322.6(TULP1):c.1145T>C (p.Phe382Ser)	TULP1	F382S, F329S	Retinitis pigmentosa|Retinitis pigmentosa 14	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000007362	6	35471593	6	35503816	7362	22401	rs121909076	NC_000006.12:35503815:A:G
TULP1, IVS2DS, G-A, +1	TULP1		Retinitis pigmentosa 14|Leber congenital amaurosis 15	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000007360					7360	22399		
NM_017654.4(SAMD9):c.2920G>A (p.Glu974Lys)	SAMD9	E974K	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000521232	7	92732491	7	93103178	521232	511728	rs1554336981	NC_000007.14:93103177:C:T
NM_006348.4(COG5):c.1159del (p.Arg387fs)	COG5	R418fs, R387fs	Congenital disorder of glycosylation type 2i	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000651291	7	106938741	7	107298296	651291	635442		NC_000007.14:107298295:G:
NM_006348.3(COG5):c.580C>T (p.Gln194Ter)	COG5	Q194*	Congenital disorder of glycosylation type 2i	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634487	7	107167733	7	107527288	634487	622373	rs1231928102	NC_000007.14:107527287:G:A
NM_016204.4(GDF2):c.203G>T (p.Arg68Leu)	GDF2	R68L	Telangiectasia, hereditary hemorrhagic, type 5	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000088651	10	48416491	10	47322871	88651	94239	rs200330818	NC_000010.11:47322870:G:T
NM_016204.4(GDF2):c.254C>T (p.Pro85Leu)	GDF2	P85L	Telangiectasia, hereditary hemorrhagic, type 5	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000088650	10	48416440	10	47322922	88650	94238	rs199804679	NC_000010.11:47322921:C:T
NM_006348.3(COG5):c.1669-15A>G	COG5		Congenital disorder of glycosylation type 2i	Pathogenic(Last reviewed: Nov 15, 2009)	no assertion criteria provided	VCV000004001	7	106898843	7	107258398	4001	19040	rs1562937199	NC_000007.14:107258397:T:C
NM_006348.3(COG5):c.1508dup (p.Gly505fs)	COG5		Congenital disorder of glycosylation type 2i	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431150	7	106924075 - 106924076	7	107283630 - 107283631	431150	424653	rs773281248	NC_000007.14:107283630:GGGGG:GGGGGG
NM_004621.6(TRPC6):c.524G>A (p.Arg175Gln)	TRPC6	R175Q	Focal segmental glomerulosclerosis 2	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000829823	11	101375176	11	101504445	829823	818286		NC_000011.10:101504444:C:T
NM_000399.5(EGR2):c.1151A>G (p.His384Arg)	EGR2	H384R, H334R	not provided	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	VCV000246474	10	64573247	10	62813487	246474	244556	rs879254278	NC_000010.11:62813486:T:C
NM_000399.5(EGR2):c.1234G>A (p.Glu412Lys)	EGR2	E412K, E362K	Dejerine-sottas neuropathy, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000016753	10	64573164	10	62813404	16753	31792	rs121434563	NC_000010.11:62813403:C:T
NM_004621.6(TRPC6):c.2620A>T (p.Lys874Ter)	TRPC6	K874*	Focal segmental glomerulosclerosis 2	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000006154	11	101324405	11	101453674	6154	21193	rs121434393	NC_000011.10:101453673:T:A
NM_004621.6(TRPC6):c.808T>A (p.Ser270Thr)	TRPC6	S270T	Focal segmental glomerulosclerosis 2	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000006153	11	101374892	11	101504161	6153	21192	rs121434392	NC_000011.10:101504160:A:T
NM_000399.5(EGR2):c.1147G>T (p.Asp383Tyr)	EGR2	D383Y, D333Y	Congenital hypomyelinating neuropathy 1, autosomal recessive	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000038874	10	64573251	10	62813491	38874	38481	rs104894160	NC_000010.11:62813490:C:A
NM_000399.5(EGR2):c.1146T>G (p.Ser382Arg)	EGR2	S382R, S332R	Congenital hypomyelinating neuropathy 1, autosomal recessive	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000038873	10	64573252	10	62813492	38873	31790	rs281865138	NC_000010.11:62813491:A:C
NM_004621.6(TRPC6):c.335C>A (p.Pro112Gln)	TRPC6	P112Q	Focal segmental glomerulosclerosis 2	Pathogenic(Last reviewed: Jun 17, 2005)	no assertion criteria provided	VCV000006151	11	101375365	11	101504634	6151	21190	rs121434390	NC_000011.10:101504633:G:T
NM_006412.4(AGPAT2):c.589-2A>G	AGPAT2		Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000006625	9	139569261	9	136674809	6625	21664	rs116807569	NC_000009.12:136674808:T:C
NM_001195248.2(APTX):c.617C>T (p.Pro206Leu)	APTX	P32L, P220L, P206L, P152L, P118L, P134L	Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004426	9	32984782	9	32984784	4426	19465	rs121908131	NC_000009.12:32984783:G:A
NM_001195248.2(APTX):c.689dup (p.Glu232fs)	APTX		Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004425	9	32984709 - 32984710	9	32984711 - 32984712	4425	19464	rs587776593	NC_000009.12:32984711:A:AA
NM_006348.3(COG5):c.189delG	COG5		not provided|Congenital disorder of glycosylation type 2i	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523949	7	107198559	7	107558114	523949	514549	rs1554464495	NC_000007.14:107558113:CCC:CC
NM_004621.6(TRPC6):c.2689G>A (p.Glu897Lys)	TRPC6	E897K	Focal segmental glomerulosclerosis 2|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000006156	11	101323793	11	101453062	6156	21195	rs121434395	NC_000011.10:101453061:C:T
NM_004621.6(TRPC6):c.2683C>T (p.Arg895Cys)	TRPC6	R895C	Focal segmental glomerulosclerosis 2|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000006155	11	101323799	11	101453068	6155	21194	rs121434394	NC_000011.10:101453067:G:A
NM_001558.4(IL10RA):c.634C>T (p.Arg212Ter)	IL10RA	R212*	Inflammatory bowel disease 28, autosomal recessive	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830052	11	117864810	11	117994095	830052	818394		NC_000011.10:117994094:C:T
NM_001558.4(IL10RA):c.537G>A (p.Thr179=)	IL10RA		Inflammatory bowel disease 28, autosomal recessive	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830051	11	117864125	11	117993410	830051	818393		NC_000011.10:117993409:G:A
NM_001558.3(IL10RA):c.301C>T (p.Arg101Trp)	IL10RA	R101W	Inflammatory bowel disease 28	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000039432	11	117860269	11	117989554	39432	48031	rs368287711	NC_000011.10:117989553:C:T
NM_001558.3(IL10RA):c.784C>T (p.Arg262Cys)	IL10RA	R262C	Inflammatory bowel disease 28	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000039430	11	117866399	11	117995684	39430	48029	rs149491038	NC_000011.10:117995683:C:T
NM_001558.3(IL10RA):c.251C>T (p.Thr84Ile)	IL10RA	T84I	Inflammatory bowel disease 28	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000014815	11	117860219	11	117989504	14815	29854	rs137853580	NC_000011.10:117989503:C:T
NM_001558.3(IL10RA):c.421G>A (p.Gly141Arg)	IL10RA	G141R	Inflammatory bowel disease 28	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000014814	11	117864009	11	117993294	14814	29853	rs137853579	NC_000011.10:117993293:G:A
NM_172218.2(SPAG1):c.2542del (p.Asp848fs)	SPAG1	D848fs	Ciliary dyskinesia, primary, 28|Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000088684	8	101252889	8	100240661	88684	94264	rs886037653	NC_000008.11:100240660:GGGG:GGG
NM_000399.5(EGR2):c.803T>A (p.Ile268Asn)	EGR2	I268N, I218N	Congenital hypomyelinating neuropathy 1, autosomal recessive	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000016749	10	64573595	10	62813835	16749	31788	rs104894158	NC_000010.11:62813834:A:T
NM_018344.6(SLC29A3):c.300+1G>C	SLC29A3		not provided	Pathogenic(Last reviewed: Aug 22, 2015)	criteria provided, single submitter	VCV000427021	10	73082812	10	71323055	427021	415229	rs587780463	NC_000010.11:71323054:G:C
NM_018344.6(SLC29A3):c.139G>T (p.Glu47Ter)	SLC29A3	E47*	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000862781	10	73082650	10	71322893	862781	837184		NC_000010.11:71322892:G:T
NM_018344.6(SLC29A3):c.479G>A (p.Trp160Ter)	SLC29A3	W160*, W82*	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000573984	10	73111414	10	71351657	573984	566470	rs776960135	NC_000010.11:71351656:G:A
NM_018344.6(SLC29A3):c.300+1G>A	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000130339	10	73082812	10	71323055	130339	135786	rs587780463	NC_000010.11:71323054:G:A
NM_018344.6(SLC29A3):c.1228C>T (p.Gln410Ter)	SLC29A3	Q410*, Q332*	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000130338	10	73122165	10	71362408	130338	135785	rs587780462	NC_000010.11:71362407:C:T
NM_018344.6(SLC29A3):c.607T>C (p.Ser203Pro)	SLC29A3	S203P, S125P	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039871	10	73111542	10	71351785	39871	48470	rs397514626	NC_000010.11:71351784:T:C
NM_018344.6(SLC29A3):c.308_309del (p.Tyr102_Phe103insTer)	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 5, 2010)	no assertion criteria provided	VCV000030947	10	73103972 - 73103973	10	71344215 - 71344216	30947	39904	rs796052139	NC_000010.11:71344214:TTT:T
NC_000011.10:g.(?_65871960)_(65872944_?)del	EFEMP2		Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000832127	11	65639431 - 65640415			832127	820404		
NM_016938.5(EFEMP2):c.679C>T (p.Arg227Cys)	EFEMP2	R227C	Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: Sep 3, 2012)	no assertion criteria provided	VCV000042041	11	65637376	11	65869905	42041	51205	rs397514683	NC_000011.10:65869904:G:A
NM_018344.6(SLC29A3):c.1157G>A (p.Arg386Gln)	SLC29A3	R386Q, R308Q	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039870	10	73122094	10	71362337	39870	48469	rs397515429	NC_000010.11:71362336:G:A
SLC29A3, IVS2, G-A, +1	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 5, 2010)	no assertion criteria provided	VCV000030946					30946	39903		
NM_018344.6(SLC29A3):c.1088G>A (p.Arg363Gln)	SLC29A3	R363Q, R285Q	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000030948	10	73122025	10	71362268	30948	39905	rs387907066	NC_000010.11:71362267:G:A
NM_022725.3(FANCF):c.327C>G (p.Tyr109Ter)	FANCF	Y109*	Fanconi anemia, complementation group F	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006344	11	22647030	11	22625484	6344	21383	rs104894222	NC_000011.10:22625483:G:C
NM_022725.3(FANCF):c.16C>T (p.Gln6Ter)	FANCF	Q6*	Fanconi anemia, complementation group F	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006342	11	22647341	11	22625795	6342	21381	rs104894221	NC_000011.10:22625794:G:A
NM_018344.6(SLC29A3):c.347T>G (p.Met116Arg)	SLC29A3	M116R, M38R	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Sep 3, 2010)	no assertion criteria provided	VCV000000568	10	73104012	10	71344255	568	15607	rs267607057	NC_000010.11:71344254:T:G
NM_018344.6(SLC29A3):c.940del (p.Tyr314fs)	SLC29A3	Y236fs, Y314fs	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Sep 3, 2010)	no assertion criteria provided	VCV000000567	10	73121877	10	71362120	567	15606	rs869025177	NC_000010.11:71362119:T:
NM_018344.6(SLC29A3):c.1045del (p.Leu349fs)	SLC29A3	L349fs, L271fs	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000000566	10	73121978	10	71362221	566	15605	rs869025176	NC_000010.11:71362220:CCCCC:CCCC
NM_018344.6(SLC29A3):c.243del (p.Lys81fs)	SLC29A3	K81fs, K3fs	not provided|Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000636986	10	73082752	10	71322995	636986	624410		NC_000010.11:71322994:AAA:AA
NM_022725.3(FANCF):c.351_397del (p.Gly120fs)	FANCF	G120fs	Fanconi anemia, complementation group F	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006341	11	22646960 - 22647006	11	22625414 - 22625460	6341	21380	rs730880278	NC_000011.10:22625413:GGCTCTCTTGGAGTGTCTCCTCATCGGCGTCCCGGACGCCCGGGCCGGG:GG
NM_018344.6(SLC29A3):c.1346C>G (p.Thr449Arg)	SLC29A3	T449R, T371R	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000000569	10	73122283	10	71362526	569	15608	rs267607058	NC_000010.11:71362525:C:G
NM_017547.4(FOXRED1):c.86-1G>A	FOXRED1		not provided	Pathogenic(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	VCV000214454	11	126141331	11	126271436	214454	211503	rs768720209	NC_000011.10:126271435:G:A
NM_000718.4(CACNA1B):c.1147C>T (p.Arg383Ter)	CACNA1B	R383*	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635836	9	140850226	9	137955774	635836	623651		NC_000009.12:137955773:C:T
NM_000718.4(CACNA1B):c.4857+1G>C	CACNA1B		NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635835	9	140968519	9	138074067	635835	623650		NC_000009.12:138074066:G:C
NM_000718.4(CACNA1B):c.3573_3574del (p.Gly1192fs)	CACNA1B	G1192fs	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635834	9	140941880 - 140941881	9	138047428 - 138047429	635834	623649		NC_000009.12:138047427:TG:
NM_000718.4(CACNA1B):c.3665del (p.Leu1222fs)	CACNA1B	L1222fs	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635833	9	140943722	9	138049270	635833	623648		NC_000009.12:138049269:T:
NM_017547.4(FOXRED1):c.1289A>G (p.Asn430Ser)	FOXRED1	N430S	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000000006	11	126147412	11	126277517	6	15045	rs267606830	NC_000011.10:126277516:A:G
NM_017547.4(FOXRED1):c.406C>T (p.Arg136Trp)	FOXRED1	R136W	Mitochondrial complex I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372745	11	126142963	11	126273068	372745	360002	rs373075574	NC_000011.10:126273067:C:T
NM_001497.3(B4GALT1):c.1031dup (p.Arg345fs)	B4GALT1		B4GALT1-CDG	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000016229	9	33113804 - 33113805	9	33113806 - 33113807	16229	31268	rs1564035076	NC_000009.12:33113806:G:GG
NM_012123.4(MTO1):c.1282G>A (p.Ala428Thr)	MTO1	A428T, A453T, A468T	Combined oxidative phosphorylation deficiency 10|Mitochondrial oxidative phosphorylation disorder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000035496	6	74191784	6	73482061	35496	44169	rs143747297	NC_000006.12:73482060:G:A
NM_017547.4(FOXRED1):c.694C>T (p.Gln232Ter)	FOXRED1	Q232*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19|not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000000005	11	126145284	11	126275389	5	15044	rs267606829	NC_000011.10:126275388:C:T
NM_016938.5(EFEMP2):c.608A>C (p.Asp203Ala)	EFEMP2	D203A	Autosomal recessive cutis laxa type IA|Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: Sep 3, 2012)	no assertion criteria provided	VCV000039014	11	65637447	11	65869976	39014	47617	rs193302864	NC_000011.10:65869975:T:G
NM_016938.5(EFEMP2):c.577del (p.Gln193fs)	EFEMP2	Q193fs	Autosomal recessive cutis laxa type IA|Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000039013	11	65637622	11	65870151	39013	47616	rs193302870	NC_000011.10:65870150:GG:G
NM_016938.5(EFEMP2):c.377A>T (p.Glu126Val)	EFEMP2	E126V	Autosomal recessive cutis laxa type IA|Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000039012	11	65638120	11	65870649	39012	47615	rs193302869	NC_000011.10:65870648:T:A
NM_016938.5(EFEMP2):c.1070_1073dup (p.Asp359fs)	EFEMP2		Autosomal recessive cutis laxa type 1B|Autosomal recessive cutis laxa type IA	Pathogenic(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000005425	11	65635428 - 65635429	11	65867957 - 65867958	5425	20464	rs193302865	NC_000011.10:65867957:GCGGGC:GCGGGCGGGC
NM_016938.5(EFEMP2):c.169G>A (p.Glu57Lys)	EFEMP2	E57K	Autosomal recessive cutis laxa type 1B|Autosomal recessive cutis laxa type IA	Pathogenic(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000005423	11	65638826	11	65871355	5423	20462	rs119489101	NC_000011.10:65871354:C:T
NM_017866.6(TMEM70):c.117_118dup (p.Ser40fs)	TMEM70		not provided|Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2|Mitochondrial proton-transporting ATP synthase complex deficiency	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203989	8	74888632 - 74888633	8	73976397 - 73976398	203989	200167	rs796052056	NC_000008.11:73976397:GT:GTGT
NM_182643.3(DLC1):c.2875A>G (p.Thr959Ala)	DLC1	T522A, T959A, T448A, T556A	Carcinoma of colon	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005699	8	12956971	8	13099462	5699	20738	rs121908500	NC_000008.11:13099461:T:C
NM_017866.6(TMEM70):c.317-2A>G	TMEM70		not provided|Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000540	8	74893388	8	73981153	540	15579	rs183973249	NC_000008.11:73981152:A:G
NM_012434.5(SLC17A5):c.1259+2T>C	SLC17A5		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000420186	6	74320121	6	73610398	420186	406899	rs1064794334	NC_000006.12:73610397:A:G
NM_000318.3(PEX2):c.740G>A (p.Cys247Tyr)	PEX2	C247Y	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000265330	8	77895675	8	76983439	265330	259907	rs886039481	NC_000008.11:76983438:C:T
NM_012434.5(SLC17A5):c.43G>T (p.Glu15Ter)	SLC17A5	E15*	not provided	Pathogenic(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	VCV000167694	6	74363567	6	73653844	167694	177111	rs727504157	NC_000006.12:73653843:C:A
NM_006204.4(PDE6C):c.633G>C (p.Glu211Asp)	PDE6C	E211D	Achromatopsia 5	Pathogenic(Last reviewed: Mar 15, 2019)	no assertion criteria provided	VCV000008768	10	95380541	10	93620784	8768	23807	rs387906401	NC_000010.11:93620783:G:C
NM_006204.4(PDE6C):c.1363A>G (p.Met455Val)	PDE6C	M455V	Achromatopsia 5	Pathogenic(Last reviewed: Mar 15, 2019)	no assertion criteria provided	VCV000008767	10	95395347	10	93635590	8767	23806	rs121918539	NC_000010.11:93635589:A:G
NM_006204.4(PDE6C):c.254_255AG[3] (p.Leu87fs)	PDE6C		Achromatopsia 5	Pathogenic(Last reviewed: Mar 15, 2019)	no assertion criteria provided	VCV000008765	10	95372735 - 95372736	10	93612978 - 93612979	8765	23804	rs786200908	NC_000010.11:93612978:AGAG:AGAGAG
NM_006204.4(PDE6C):c.967T>A (p.Tyr323Asn)	PDE6C	Y323N	Achromatopsia 5	Pathogenic(Last reviewed: Mar 15, 2019)	no assertion criteria provided	VCV000008764	10	95386424	10	93626667	8764	23803	rs121918538	NC_000010.11:93626666:T:A
NM_006204.4(PDE6C):c.1292G>A (p.Trp431Ter)	PDE6C	W431*	not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000858833	10	95395276	10	93635519	858833	837503		NC_000010.11:93635518:G:A
NM_006204.4(PDE6C):c.435G>A (p.Trp145Ter)	PDE6C	W145*	Cone dystrophy 4	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000829826	10	95372917	10	93613160	829826	818284		NC_000010.11:93613159:G:A
NM_006204.4(PDE6C):c.2036+2T>G	PDE6C		Cone dystrophy 4	Pathogenic(Last reviewed: Mar 13, 2019)	no assertion criteria provided	VCV000829820	10	95415619	10	93655862	829820	818285		NC_000010.11:93655861:T:G
NM_006204.4(PDE6C):c.2192G>A (p.Trp731Ter)	PDE6C	W731*	Cone dystrophy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802622	10	95418908	10	93659151	802622	791016		NC_000010.11:93659150:G:A
NM_000318.3(PEX2):c.497T>A (p.Leu166Ter)	PEX2	L166*	Peroxisome biogenesis disorder 5a (zellweger)	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000662902	8	77895918	8	76983682	662902	637403		NC_000008.11:76983681:A:T
NM_000318.3(PEX2):c.218del (p.Asn73fs)	PEX2	N73fs	Peroxisome biogenesis disorder 5a (zellweger)	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000653188	8	77896197	8	76983961	653188	637405		NC_000008.11:76983960:TTTTT:TTTT
NM_000318.3(PEX2):c.624dup (p.Pro209fs)	PEX2		not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504137	8	77895790 - 77895791	8	76983554 - 76983555	504137	495382	rs1438831421	NC_000008.11:76983554:T:TT
NM_000318.3(PEX2):c.310dup (p.Ile104fs)	PEX2		not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504136	8	77896104 - 77896105	8	76983868 - 76983869	504136	495238	rs1235008965	NC_000008.11:76983868:TTTTTT:TTTTTTT
NM_000318.3(PEX2):c.739T>C (p.Cys247Arg)	PEX2	C247R	Peroxisome biogenesis disorder 5a (zellweger)	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000139589	8	77895676	8	76983440	139589	143214	rs61752128	NC_000008.11:76983439:A:G
NM_000318.3(PEX2):c.163G>A (p.Glu55Lys)	PEX2	E55K	Peroxisome biogenesis disorder 5B	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000013705	8	77896252	8	76984016	13705	28744	rs61752119	NC_000008.11:76984015:C:T
NM_006204.4(PDE6C):c.1682dup (p.Tyr561Ter)	PDE6C		Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008775	10	95400258 - 95400259	10	93640501 - 93640502	8775	23814	rs786200911	NC_000010.11:93640501:A:AA
NM_006204.4(PDE6C):c.2457T>A (p.Tyr819Ter)	PDE6C	Y819*	Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008774	10	95422874	10	93663117	8774	23813	rs267606935	NC_000010.11:93663116:T:A
NM_006204.4(PDE6C):c.826C>T (p.Arg276Ter)	PDE6C	R276*	Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008773	10	95381791	10	93622034	8773	23812	rs267606937	NC_000010.11:93622033:C:T
NM_006204.4(PDE6C):c.1805A>T (p.His602Leu)	PDE6C	H602L	Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008772	10	95400744	10	93640987	8772	23811	rs267606934	NC_000010.11:93640986:A:T
NM_006204.4(PDE6C):c.1483-2A>G	PDE6C		Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008771	10	95399825	10	93640068	8771	23810	rs786200910	NC_000010.11:93640067:A:G
NM_006204.4(PDE6C):c.481-12T>A	PDE6C		Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008770	10	95380377	10	93620620	8770	23809	rs786200909	NC_000010.11:93620619:T:A
NM_006204.4(PDE6C):c.2368G>A (p.Glu790Lys)	PDE6C	E790K	Achromatopsia 5	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000008769	10	95422785	10	93663028	8769	23808	rs267606936	NC_000010.11:93663027:G:A
NM_012434.5(SLC17A5):c.923T>G (p.Leu308Ter)	SLC17A5	L308*	Salla disease	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000841274	6	74331582	6	73621859	841274	832349		NC_000006.12:73621858:A:C
NC_000006.12:g.(?_73644397)_(73644613_?)del	SLC17A5		Salla disease	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000832233	6	74354120 - 74354336			832233	819748		
NC_000006.11:g.(?_74351404)_(74354336_?)del	SLC17A5		Salla disease	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000649623	6	74351404 - 74354336	6	73641681 - 73644613	649623	651595		
NM_012434.5(SLC17A5):c.221T>A (p.Leu74Ter)	SLC17A5	L74*	Salla disease	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000644884	6	74354200	6	73644477	644884	635138		NC_000006.12:73644476:A:T
NM_012434.5(SLC17A5):c.526-2A>G	SLC17A5		Salla disease	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000555734	6	74348224	6	73638501	555734	544319	rs1554164096	NC_000006.12:73638500:T:C
NM_006204.4(PDE6C):c.857del (p.Lys286fs)	PDE6C	K286fs	Achromatopsia	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000487695	10	95381821	10	93622064	487695	480777	rs1554888978	NC_000010.11:93622063:AA:A
NM_006204.4(PDE6C):c.497del (p.Asp166fs)	PDE6C	D166fs	Achromatopsia	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000487694	10	95380405	10	93620648	487694	480774	rs1554888848	NC_000010.11:93620647:A:
NM_006204.4(PDE6C):c.78del (p.Lys27fs)	PDE6C	K27fs	Achromatopsia	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000487693	10	95372559	10	93612802	487693	480771	rs1554888353	NC_000010.11:93612801:GG:G
NM_006204.4(PDE6C):c.775C>T (p.Arg259Ter)	PDE6C	R259*	Achromatopsia	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000487691	10	95381740	10	93621983	487691	480775	rs757622521	NC_000010.11:93621982:C:T
NM_006204.4(PDE6C):c.211G>T (p.Glu71Ter)	PDE6C	E71*	Achromatopsia	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000487690	10	95372693	10	93612936	487690	480772	rs756324901	NC_000010.11:93612935:G:T
NM_000318.3(PEX2):c.865dup (p.Ser289fs)	PEX2		Peroxisome biogenesis disorder 5B	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000162495	8	77895549 - 77895550	8	76983313 - 76983314	162495	172169	rs724160029	NC_000008.11:76983313:T:TT
NM_000318.3(PEX2):c.669G>A (p.Trp223Ter)	PEX2	W223*	Peroxisome biogenesis disorder 5B	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000139590	8	77895746	8	76983510	139590	143215	rs61752127	NC_000008.11:76983509:C:T
NM_012434.5(SLC17A5):c.1001C>G (p.Pro334Arg)	SLC17A5	P334R	Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000005619	6	74325148	6	73615425	5619	20658	rs119491110	NC_000006.12:73615424:G:C
NM_012434.5(SLC17A5):c.819+1G>A	SLC17A5		not provided|Salla disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371127	6	74345104	6	73635381	371127	357507	rs1057517028	NC_000006.12:73635380:C:T
SLC17A5, 500-BP INS, NT978	SLC17A5		Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000005620					5620	20659		
NM_012434.5(SLC17A5):c.548A>G (p.His183Arg)	SLC17A5	H183R	Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000005618	6	74348200	6	73638477	5618	20657	rs119491109	NC_000006.12:73638476:T:C
SLC17A5, 148-BP DEL, NT1112	SLC17A5		Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000005617					5617	20656		
SLC17A5, 1-BP DEL, 533C	SLC17A5		Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000005616					5616	20655		
NM_015214.3(DDHD2):c.1978G>C (p.Asp660His)	DDHD2	D660H, D630H	Spastic paraplegia 54, autosomal recessive|Obesity|Global developmental delay|Generalized epilepsy	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000039679	8	38111160	8	38253642	39679	48278	rs375168720	NC_000008.11:38253641:G:C
NM_016938.5(EFEMP2):c.800G>A (p.Cys267Tyr)	EFEMP2	C267Y	Autosomal recessive cutis laxa type IA|Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000039016	11	65636028	11	65868557	39016	47619	rs193302866	NC_000011.10:65868556:C:T
NM_016938.5(EFEMP2):c.835C>T (p.Arg279Cys)	EFEMP2	R279C	Autosomal recessive cutis laxa type 1B|Autosomal recessive cutis laxa type IA	Pathogenic(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000005424	11	65635993	11	65868522	5424	20463	rs119489102	NC_000011.10:65868521:G:A
NM_018344.6(SLC29A3):c.1279G>A (p.Gly427Ser)	SLC29A3	G427S, G349S	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000000563	10	73122216	10	71362459	563	15602	rs121912583	NC_000010.11:71362458:G:A
NM_000318.3(PEX2):c.547_548AT[1] (p.Ile183fs)	PEX2		Peroxisome biogenesis disorder 5a (zellweger)	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000858381	8	77895865 - 77895866	8	76983629 - 76983630	858381	835051		NC_000008.11:76983628:ATAT:AT
NM_000318.3(PEX2):c.550del (p.Cys184fs)	PEX2	R184fs, C184fs	Peroxisome biogenesis disorder 5a (zellweger)	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000641647	8	77895865	8	76983629	641647	637402		NC_000008.11:76983628:A:
NM_012434.5(SLC17A5):c.1007_1008del (p.Leu336fs)	SLC17A5	L336fs	Salla disease	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000056551	6	74325141 - 74325142	6	73615418 - 73615419	56551	71190	rs386833987	NC_000006.12:73615417:TA:
NM_003477.3(PDHX):c.711dup (p.Thr238fs)	PDHX		not provided	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000418869	11	34988251 - 34988252	11	34966704 - 34966705	418869	408339	rs776567343	NC_000011.10:34966704:CCCCC:CCCCCC
NM_003477.3(PDHX):c.793dup (p.Thr265fs)	PDHX		not provided	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000373059	11	34988336 - 34988337	11	34966789 - 34966790	373059	360042	rs1057518180	NC_000011.10:34966789:AA:AAA
NM_021830.5(TWNK):c.1462_1463del (p.Phe488fs)	TWNK	F34fs, F488fs	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000214190	10	102749618 - 102749619	10	100989861 - 100989862	214190	211437	rs863223925	NC_000010.11:100989860:TTT:T
NM_021830.5(TWNK):c.1110C>G (p.Phe370Leu)	TWNK	F370L	not provided	Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	VCV000214184	10	102749077	10	100989320	214184	211432	rs863223920	NC_000010.11:100989319:C:G
NM_021830.5(TWNK):c.967C>T (p.Arg323Ter)	TWNK	R323*	not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000214183	10	102748934	10	100989177	214183	211430	rs863223919	NC_000010.11:100989176:C:T
NM_004830.4(MED23):c.3988C>T (p.Arg1330Ter)	MED23	R1330*, R1336*	Mental retardation, autosomal recessive 18	Pathogenic	no assertion criteria provided	VCV000143193	6	131908938	6	131587798	143193	152911	rs527236036	NC_000006.12:131587797:G:A
NM_004830.4(MED23):c.3638A>G (p.His1213Arg)	MED23	H1213R, H1219R	Mental retardation, autosomal recessive 18	Pathogenic	no assertion criteria provided	VCV000143192	6	131912501	6	131591361	143192	152910	rs527236035	NC_000006.12:131591360:T:C
NM_003477.3(PDHX):c.211G>T (p.Gly71Ter)	PDHX	G56*, G71*	not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000660921	11	34953001	11	34931454	660921	639999		NC_000011.10:34931453:G:T
NM_003477.3(PDHX):c.850C>T (p.Arg284Ter)	PDHX	R269*, R284*	not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000650650	11	34991719	11	34970172	650650	640002		NC_000011.10:34970171:C:T
NM_021830.5(TWNK):c.874C>A (p.Pro292Thr)	TWNK	P292T	Perrault syndrome 5	Pathogenic	no assertion criteria provided	VCV000488187	10	102748841	10	100989084	488187	481146	rs759603316	NC_000010.11:100989083:C:A
NM_017662.5(TRPM6):c.3357C>A (p.Cys1119Ter)	TRPM6	C1119*, C1114*	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000427900	9	77390845	9	74775929	427900	418974	rs1114167360	NC_000009.12:74775928:G:T
NM_017662.5(TRPM6):c.3173A>G (p.Tyr1058Cys)	TRPM6	Y1053C, Y1058C	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000210059	9	77397314	9	74782398	210059	206682	rs797045204	NC_000009.12:74782397:T:C
TRPM6, IVS23AS, A-G, -68	TRPM6		Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003584					3584	18623		
NM_017662.5(TRPM6):c.1010+5G>C	TRPM6		Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003583	9	77436580	9	74821664	3583	18622		NC_000009.12:74821663:C:G
NM_017662.5(TRPM6):c.166C>T (p.Arg56Ter)	TRPM6	R56*, R51*	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003582	9	77457246	9	74842330	3582	18621	rs121912624	NC_000009.12:74842329:G:A
NM_017662.5(TRPM6):c.1420C>T (p.Arg474Ter)	TRPM6	R484*, R469*, R474*	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003581	9	77427238	9	74812322	3581	18620	rs121912623	NC_000009.12:74812321:G:A
NM_017662.5(TRPM6):c.2208del (p.Arg736fs)	TRPM6	R736fs, R731fs	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003579	9	77415200	9	74800284	3579	18618		NC_000009.12:74800283:CC:C
TRPM6, 13-BP DEL, NT3779	TRPM6		Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003578					3578	18617		
NM_017662.5(TRPM6):c.1280del (p.His427fs)	TRPM6	H427fs, H422fs	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003577	9	77431613	9	74816697	3577	18616		NC_000009.12:74816696:T:
NM_017662.5(TRPM6):c.1769C>G (p.Ser590Ter)	TRPM6	S590*, S585*	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003575	9	77417054	9	74802138	3575	18614	rs121912622	NC_000009.12:74802137:G:C
NM_003477.3(PDHX):c.1183-3088_1247+760del	PDHX		Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000002119	11	35010771 - 35014683	11	34989224 - 34993136	2119	17158		
NM_003477.3(PDHX):c.742C>T (p.Gln248Ter)	PDHX	Q248*, Q233*	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000002118	11	34988287	11	34966740	2118	17157	rs113309941	NC_000011.10:34966739:C:T
AJ298105.1:g.61273_107768delins6086	PDHX		Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000002117					2117	17156		
NM_003477.3(PDHX):c.620del (p.Pro207fs)	PDHX	P192fs, P207fs	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000002116	11	34982042	11	34960495	2116	17155	rs724159979	NC_000011.10:34960494:CCC:CC
NM_003477.3(PDHX):c.1024-1G>A	PDHX		Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000002115	11	35006116	11	34984569	2115	17154	rs724159830	NC_000011.10:34984568:G:A
NM_003477.3(PDHX):c.641+1G>A	PDHX		Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000002114	11	34982066	11	34960519	2114	17153	rs724159829	NC_000011.10:34960518:G:A
NM_003477.3(PDHX):c.88_91del (p.Lys30fs)	PDHX	K30fs	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000002113	11	34938289 - 34938292	11	34916742 - 34916745	2113	17152	rs724159828	NC_000011.10:34916741:GAAGG:G
NM_004830.4(MED23):c.670C>G (p.Arg224Gly)	MED23	R224G	Mental retardation, autosomal recessive 18	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437437	6	131939657	6	131618517	437437	430994	rs1293450628	NC_000006.12:131618516:G:C
NM_003477.3(PDHX):c.1336C>T (p.Arg446Ter)	PDHX	R446*, R219*, R431*	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000162202	11	35016549	11	34995002	162202	171910	rs1135402725	NC_000011.10:34995001:C:T
NM_021830.5(TWNK):c.1321T>G (p.Trp441Gly)	TWNK	W441G	Perrault syndrome 5	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000162050	10	102749478	10	100989721	162050	171769	rs672601361	NC_000010.11:100989720:T:G
NM_021830.5(TWNK):c.1754A>G (p.Asn585Ser)	TWNK	N585S, N131S	Perrault syndrome 5	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000162049	10	102752966	10	100993209	162049	171768	rs672601360	NC_000010.11:100993208:A:G
NM_021830.5(TWNK):c.908G>A (p.Arg303Gln)	TWNK	R303Q	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004628	10	102748875	10	100989118	4628	19667	rs137852956	NC_000010.11:100989117:G:A
NM_021830.5(TWNK):c.1106C>A (p.Ser369Tyr)	TWNK	S369Y	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000004624	10	102749073	10	100989316	4624	19663	rs111033579	NC_000010.11:100989315:C:A
NM_021830.5(TWNK):c.1061G>C (p.Arg354Pro)	TWNK	R354P	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000004621	10	102749028	10	100989271	4621	19660	rs111033576	NC_000010.11:100989270:G:C
NM_021830.5(TWNK):c.944G>T (p.Trp315Leu)	TWNK	W315L	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000004620	10	102748911	10	100989154	4620	19659	rs111033575	NC_000010.11:100989153:G:T
NM_021830.5(TWNK):c.1422G>A (p.Trp474Ter)	TWNK	W474C, W474*, W20*	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000004619	10	102749579	10	100989822	4619	19658	rs111033574	NC_000010.11:100989821:G:A
NM_017662.5(TRPM6):c.422C>T (p.Ser141Leu)	TRPM6	S141L, S136L	Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Mar 2, 2004)	no assertion criteria provided	VCV000003585	9	77455062	9	74840146	3585	18624	rs121912625	NC_000009.12:74840145:G:A
NM_017662.5(TRPM6):c.2009+1G>A	TRPM6		Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000003580	9	77416813	9	74801897	3580	18619		NC_000009.12:74801896:C:T
NM_003477.3(PDHX):c.965_1023del (p.Asp322fs)	PDHX	D322fs, D307fs	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000002112	11	34999671 - 34999729	11	34978124 - 34978182	2112	17151	rs1554989996	
NG_013368.1:g.5604_20276del	PDHX		Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000002111	11	34938280 - 34952952	11	34916733 - 34931405	2111	17150		
NM_021830.5(TWNK):c.1422G>C (p.Trp474Cys)	TWNK	W20C, W474C	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694438	10	102749579	10	100989822	694438	682353		NC_000010.11:100989821:G:C
NM_021830.5(TWNK):c.49del (p.Leu17fs)	TWNK	L17fs	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694436	10	102748013	10	100988256	694436	682347		NC_000010.11:100988255:CCCC:CCC
NM_021830.5(TWNK):c.1391T>C (p.Leu464Pro)	TWNK	L464P, L10P	Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000426105	10	102749548	10	100989791	426105	414706	rs1554887222	NC_000010.11:100989790:T:C
NM_021830.5(TWNK):c.1374G>T (p.Gln458His)	TWNK	Q458H, Q4H	Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000426104	10	102749531	10	100989774	426104	414705	rs1554887213	NC_000010.11:100989773:G:T
NM_021830.5(TWNK):c.333del (p.Leu112fs)	TWNK	L112fs	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	Pathogenic(Last reviewed: Mar 20, 2016)	no assertion criteria provided	VCV000225837	10	102748298	10	100988541	225837	227652	rs886037832	NC_000010.11:100988540:TTT:TT
NM_021830.5(TWNK):c.1287C>T (p.Ala429=)	TWNK		Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	Pathogenic(Last reviewed: Jul 22, 2010)	no assertion criteria provided	VCV000021673	10	102749444	10	100989687	21673	34525	rs80356541	NC_000010.11:100989686:C:T
NM_021830.5(TWNK):c.1423G>C (p.Ala475Pro)	TWNK	A475P, A21P	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000004617	10	102749580	10	100989823	4617	19656	rs111033572	NC_000010.11:100989822:G:C
TWNK, 39-BP DUP	TWNK		Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000004616					4616	19655		
NM_021830.5(TWNK):c.952G>A (p.Ala318Thr)	TWNK	A318T	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	Pathogenic(Last reviewed: Jul 22, 2010)	no assertion criteria provided	VCV000004630	10	102748919	10	100989162	4630	19669	rs80356542	NC_000010.11:100989161:G:A
NM_006204.4(PDE6C):c.1483-1G>T	PDE6C		not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000863605	10	95399826	10	93640069	863605	852559		NC_000010.11:93640068:G:T
NM_000318.3(PEX2):c.279_283del (p.Arg94fs)	PEX2	R94fs	Peroxisome biogenesis disorder 5a (zellweger)|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000139588	8	77896132 - 77896136	8	76983896 - 76983900	139588	143213	rs61752122	NC_000008.11:76983895:ATCTCA:A
NM_012434.5(SLC17A5):c.719G>A (p.Trp240Ter)	SLC17A5	W240*	Salla disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056557	6	74345205	6	73635482	56557	71196	rs386833993	NC_000006.12:73635481:C:T
NM_006204.4(PDE6C):c.85C>T (p.Arg29Trp)	PDE6C	R29W	Achromatopsia 5|Cone dystrophy 4	Pathogenic(Last reviewed: Mar 15, 2019)	no assertion criteria provided	VCV000008763	10	95372567	10	93612810	8763	23802	rs121918537	NC_000010.11:93612809:C:T
MTAP, 885A-G, ARG100ARG	MTAP	R100R	Diaphyseal medullary stenosis-bone malignancy syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000029790					29790	38745		
NM_017662.5(TRPM6):c.2667+1G>A	TRPM6		Hypomagnesemia 1, intestinal	Pathogenic(Last reviewed: Sep 1, 2013)	criteria provided, single submitter	VCV000218238	9	77403529	9	74788613	218238	214870	rs869025214	NC_000009.12:74788612:C:T
NM_016341.4(PLCE1):c.3058C>T (p.Gln1020Ter)	PLCE1	Q712*, Q1020*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800845	10	96006340	10	94246583	800845	788843		NC_000010.11:94246582:C:T
NM_016341.4(PLCE1):c.5890C>T (p.Arg1964Ter)	PLCE1	R1964*, R1656*, R1948*	not provided	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000499215	10	96068343	10	94308586	499215	490639	rs775052849	NC_000010.11:94308585:C:T
NM_016341.4(PLCE1):c.3736C>T (p.Arg1246Ter)	PLCE1	R1246*, R1230*, R938*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000018424	10	96018829	10	94259072	18424	33463	rs267606955	NC_000010.11:94259071:C:T
NM_016341.4(PLCE1):c.4451C>T (p.Ser1484Leu)	PLCE1	S1484L, S1176L, S1468L	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002350	10	96030304	10	94270547	2350	17389	rs121912605	NC_000010.11:94270546:C:T
NM_016341.4(PLCE1):c.5560C>T (p.Gln1854Ter)	PLCE1	Q1854*, Q1546*, Q1838*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002349	10	96064340	10	94304583	2349	17388	rs121912604	NC_000010.11:94304582:C:T
NM_016341.4(PLCE1):c.3846del (p.Leu1283fs)	PLCE1	L1267fs, L1283fs, L975fs	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002347	10	96022279	10	94262522	2347	17386	rs876657370	NC_000010.11:94262521:GGGG:GGG
NM_016341.4(PLCE1):c.3346C>T (p.Arg1116Ter)	PLCE1	R1116*, R808*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002346	10	96014013	10	94254256	2346	17385	rs121912602	NC_000010.11:94254255:C:T
NM_016341.4(PLCE1):c.1477C>T (p.Arg493Ter)	PLCE1	R493*, R185*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002345	10	95892201	10	94132444	2345	17384	rs121912601	NC_000010.11:94132443:C:T
NM_016341.4(PLCE1):c.1146del (p.Ser383fs)	PLCE1	S383fs	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002344	10	95791949	10	94032192	2344	17383	rs876657369	NC_000010.11:94032191:G:
NM_016341.4(PLCE1):c.3065G>A (p.Trp1022Ter)	PLCE1	W1022*, W714*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635315	10	96006347	10	94246590	635315	623151		NC_000010.11:94246589:G:A
NM_016341.4(PLCE1):c.961C>T (p.Arg321Ter)	PLCE1	R321*	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000018423	10	95791764	10	94032007	18423	33462	rs267606954	NC_000010.11:94032006:C:T
NM_000181.4(GUSB):c.1069C>T (p.Arg357Ter)	GUSB	R356*, R357*, R211*, R138*, R167*	Non-immune hydrops fetalis|Mucopolysaccharidosis type 7	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000908	7	65439688	7	65974701	908	15947	rs121918185	NC_000007.14:65974700:G:A
NM_022725.4(FANCF):c.123dup (p.Arg42fs)	FANCF		Fanconi anemia	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000847349	11	22647233 - 22647234	11	22625687 - 22625688	847349	838229		NC_000011.10:22625687:C:CC
NM_001029835.2(CCM2):c.1311_1312AG[1] (p.Glu438fs)	CCM2		Cerebral cavernous malformations 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000585627	7	45115569 - 45115570	7	45075970 - 45075971	585627	577001	rs1562921605	NC_000007.14:45075969:AGAG:AG
NM_000429.3(MAT1A):c.776C>T (p.Ala259Val)	MAT1A	A259V	not provided|Hepatic methionine adenosyltransferase deficiency	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279845	10	82034948	10	80275192	279845	264435	rs138556525	NC_000010.11:80275191:G:A
MTAP, IVS9AS, A-G, -2	MTAP		Diaphyseal medullary stenosis-bone malignancy syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000029791					29791	38746		
NM_003172.4(SURF1):c.534_535del (p.Asn178fs)	SURF1	N178fs, N69fs	not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000432819	9	136219602 - 136219603	9	133352747 - 133352748	432819	425830	rs1242159511	NC_000009.12:133352746:TAT:T
NM_003172.4(SURF1):c.574_575insCTGC (p.Arg192fs)	SURF1		not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000419973	9	136219562 - 136219563	9	133352707 - 133352708	419973	407585	rs782289759	NC_000009.12:133352707:G:GCAGG
NM_003172.4(SURF1):c.681G>A (p.Trp227Ter)	SURF1	W227*, W118*	not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000379686	9	136219371	9	133352516	379686	369990	rs1057520688	NC_000009.12:133352515:C:T
NM_003172.4(SURF1):c.240+1G>T	SURF1		not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000379506	9	136221678	9	133354823	379506	370005	rs781948238	NC_000009.12:133354822:C:A
NM_003172.4(SURF1):c.532_535del (p.Asn178fs)	SURF1	N69fs, N178fs	not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000372719	9	136219602 - 136219605	9	133352747 - 133352750	372719	359910	rs1057517942	NC_000009.12:133352746:TATTTA:TA
NM_003172.4(SURF1):c.589-1G>T	SURF1		not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000215236	9	136219464	9	133352609	215236	211360	rs863224227	NC_000009.12:133352608:C:A
NM_003172.4(SURF1):c.324-11T>G	SURF1		not provided	Pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000215232	9	136220806	9	133353951	215232	211366	rs375398247	NC_000009.12:133353950:A:C
NM_003172.4(SURF1):c.797_798CT[1] (p.Leu267fs)	SURF1		Charcot-Marie-Tooth disease, type 4k	Pathogenic(Last reviewed: Oct 22, 2013)	no assertion criteria provided	VCV000218303	9	136218949 - 136218950	9	133352094 - 133352095	218303	214999	rs864309500	NC_000009.12:133352093:AGAG:AG
NM_003172.4(SURF1):c.107-2A>G	SURF1		Charcot-Marie-Tooth disease, type 4k	Pathogenic(Last reviewed: Oct 22, 2013)	no assertion criteria provided	VCV000218301	9	136221814	9	133354959	218301	214997	rs782726390	NC_000009.12:133354958:T:C
NM_003172.4(SURF1):c.516-2A>G	SURF1		not specified	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000633010	9	136219623	9	133352768	633010	621785	rs782682492	NC_000009.12:133352767:T:C
NM_003172.4(SURF1):c.679T>C (p.Trp227Arg)	SURF1	W227R, W118R	Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000029897	9	136219373	9	133352518	29897	38852	rs398122806	NC_000009.12:133352517:A:G
SURF1, 4-BP INS, 572CCCT	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Jul 15, 2004)	no assertion criteria provided	VCV000012769					12769	27808		
NM_003172.4(SURF1):c.371G>A (p.Gly124Glu)	SURF1	G124E, G15E	Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000012768	9	136220748	9	133353893	12768	27807	rs28933402	NC_000009.12:133353892:C:T
NM_003172.4(SURF1):c.820T>G (p.Tyr274Asp)	SURF1	Y274D, Y165D	Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000012766	9	136218929	9	133352074	12766	27805	rs121918658	NC_000009.12:133352073:A:C
NM_003172.4(SURF1):c.550_551del (p.Arg184fs)	SURF1	R75fs, R184fs	Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012765	9	136219586 - 136219587	9	133352731 - 133352732	12765	27804		NC_000009.12:133352730:CT:
NM_003172.4(SURF1):c.515+2T>G	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012764	9	136220602	9	133353747	12764	27803		NC_000009.12:133353746:A:C
SURF1, 1-BP INS, 868T	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012763					12763	27802		
SURF1, 1-BP INS, 882T	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012761					12761	27800		
SURF1, 2-BP DEL, 855CT	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012760					12760	27799		
NM_003172.4(SURF1):c.323+2T>C	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012758	9	136221512	9	133354657	12758	27797		NC_000009.12:133354656:A:G
SURF1, 765C-T	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012757					12757	27796		
NM_021830.5(TWNK):c.1370C>T (p.Thr457Ile)	TWNK	T457I, T3I	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)|Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Jul 22, 2010)	no assertion criteria provided	VCV000004626	10	102749527	10	100989770	4626	19665	rs80356544	NC_000010.11:100989769:C:T
NM_021830.5(TWNK):c.955A>G (p.Lys319Glu)	TWNK	K319E	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	Pathogenic(Last reviewed: Jul 22, 2010)	no assertion criteria provided	VCV000004625	10	102748922	10	100989165	4625	19664	rs80356543	NC_000010.11:100989164:A:G
NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	R334Q	Mitochondrial diseases|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000004623	10	102748968	10	100989211	4623	19662	rs28937887	NC_000010.11:100989210:G:A
NM_003172.4(SURF1):c.11_27dup (p.Gly10fs)	SURF1		Leigh syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802530	9	136223302 - 136223303	9	133356426 - 133356427	802530	790857		NC_000009.12:133356426:CAGCTGCAACGCAGCCAC:CAGCTGCAACGCAGCCACAGCTGCAACGCAGCCAC
NM_003172.4(SURF1):c.236G>A (p.Trp79Ter)	SURF1	W79*	Leigh syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802529	9	136221683	9	133354828	802529	790856		NC_000009.12:133354827:C:T
NM_003172.4(SURF1):c.465_466del (p.Thr156fs)	SURF1	T156fs, T47fs	Leigh syndrome	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000520391	9	136220653 - 136220654	9	133353798 - 133353799	520391	510988	rs1564349176	NC_000009.12:133353797:TT:
NM_003172.4(SURF1):c.532A>T (p.Asn178Tyr)	SURF1	N178Y, N69Y	Leigh syndrome	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000520389	9	136219605	9	133352750	520389	510987	rs587753385	NC_000009.12:133352749:T:A
NM_003172.4(SURF1):c.772C>T (p.Pro258Ser)	SURF1	P258S, P149S	Leigh syndrome	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000520388	9	136218977	9	133352122	520388	510986	rs1053850536	NC_000009.12:133352121:G:A
NM_003172.4(SURF1):c.752-1G>C	SURF1		Leigh syndrome	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000488613	9	136218998	9	133352143	488613	481481	rs1391748504	NC_000009.12:133352142:C:G
NM_138413.4(HOGA1):c.769T>G (p.Cys257Gly)	HOGA1	C257G, C94G	Primary hyperoxaluria, type III|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000034	10	99361682	10	97601925	34	15073	rs267606764	NC_000010.11:97601924:T:G
NM_000787.4(DBH):c.1085C>A (p.Ala362Glu)	DBH	C1043A, A348E, A362E	Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000217765	9	136513028	9	133647906	217765	214413	rs75215331	NC_000009.12:133647905:C:A
NM_000787.4(DBH):c.1033G>A (p.Asp345Asn)	DBH	D331N, D345N	Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000217764	9	136512976	9	133647854	217764	38418	rs267606761	NC_000009.12:133647853:G:A
NM_000787.4(DBH):c.806G>T (p.Cys269Phe)	DBH	G764T, C255F, C269F	Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000217763	9	136508596	9	133643474	217763	214412	rs863225245	NC_000009.12:133643473:G:T
NM_000787.4(DBH):c.617del (p.Glu206fs)	DBH	E206fs	Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000217762	9	136507459	9	133642337	217762	214411	rs863225244	NC_000009.12:133642336:A:
NM_000787.4(DBH):c.301G>A (p.Val101Met)	DBH	V87M, V101M	Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000217761	9	136501794	9	133636672	217761	16791	rs267606760	NC_000009.12:133636671:G:A
NM_000787.4(DBH):c.468dup (p.Lys157fs)	DBH		Orthostatic hypotension 1	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000846731	9	136505092 - 136505093	9	133639970 - 133639971	846731	835738		NC_000009.12:133639970:CCCC:CCCCC
NM_000787.4(DBH):c.342C>A (p.Asp114Glu)	DBH	D114E, C300A	Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000001751	9	136504970	9	133639848	1751	16790	rs77576840	NC_000009.12:133639847:C:A
NM_003172.4(SURF1):c.281dup (p.Leu94fs)	SURF1		Leigh syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000643552	9	136221555 - 136221556	9	133354700 - 133354701	643552	637934		NC_000009.12:133354700:AA:AAA
NM_003172.4(SURF1):c.32_38dup (p.Leu16fs)	SURF1		Leigh syndrome	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000456665	9	136223291 - 136223292	9	133356415 - 133356416	456665	459618	rs1410388157	NC_000009.12:133356415:GCCCGCAGCCC:GCCCGCAGCCCGCAGCCC
NM_006204.4(PDE6C):c.1579C>T (p.Arg527Ter)	PDE6C	R527*	not provided|Achromatopsia	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487692	10	95399923	10	93640166	487692	480779	rs1028838062	NC_000010.11:93640165:C:T
NM_007214.5(SEC63):c.514+1G>A	SEC63		Polycystic liver disease 2	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522474	6	108234569	6	107913365	522474	513061	rs1554236269	NC_000006.12:107913364:C:T
NM_000288.4(PEX7):c.213del (p.Phe71fs)	PEX7	F71fs	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000502657	6	137147479	6	136826341	502657	494080	rs1190462422	NC_000006.12:136826340:TTT:TT
NM_018076.5(ARMC4):c.853_854GA[2] (p.Arg286fs)	ARMC4		not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000280673	10	28270473 - 28270474	10	27981544 - 27981545	280673	264559	rs769346541	NC_000010.11:27981543:TCTCTC:TCTC
NM_018076.5(ARMC4):c.2406del (p.Leu802_Val803insTer)	ARMC4		not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000280292	10	28224028	10	27935099	280292	264428	rs886041523	NC_000010.11:27935098:AA:A
NM_007214.5(SEC63):c.220del (p.Thr73_Val74insTer)	SEC63		Polycystic liver disease 1	Pathogenic	no assertion criteria provided	VCV000225125	6	108250623	6	107929419	225125	227011	rs869312978	NC_000006.12:107929418:C:
NM_007214.5(SEC63):c.1605dup (p.Pro536fs)	SEC63		not provided	Pathogenic(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	VCV000194646	6	108214754 - 108214755	6	107893550 - 107893551	194646	191809	rs752868449	NC_000006.12:107893550:TTTTTTTTTT:TTTTTTTTTTT
NM_007214.5(SEC63):c.109del (p.Arg37fs)	SEC63	R37fs	not provided	Pathogenic(Last reviewed: Dec 4, 2013)	criteria provided, single submitter	VCV000167671	6	108279105	6	107957901	167671	178063	rs727504146	NC_000006.12:107957900:GGGG:GGG
NM_018076.5(ARMC4):c.2097+1G>A	ARMC4		Male infertility|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000812721	10	28228825	10	27939896	812721	800972		NC_000010.11:27939895:C:T
NM_003737.4(DCHS1):c.6988C>T (p.Arg2330Cys)	DCHS1	R2330C	Mitral valve prolapse 2	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000217871	11	6646587	11	6625356	217871	214527	rs768737101	NC_000011.10:6625355:G:A
NM_007214.5(SEC63):c.733+1G>A	SEC63		Polycystic liver disease 2	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002169	6	108230130	6	107908926	2169	17208	rs886041028	NC_000006.12:107908925:C:T
NM_007214.5(SEC63):c.442_443insA (p.Ala148fs)	SEC63		Polycystic liver disease 2	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002168	6	108243010 - 108243011	6	107921806 - 107921807	2168	17207	rs886041027	NC_000006.12:107921806::T
NM_007214.5(SEC63):c.173G>A (p.Trp58Ter)	SEC63	W58*	Polycystic liver disease 2	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002167	6	108250670	6	107929466	2167	17206	rs119103233	NC_000006.12:107929465:C:T
NM_000288.4(PEX7):c.49_70dup (p.Phe24fs)	PEX7		Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000846733	6	137143851 - 137143852	6	136822713 - 136822714	846733	831608		NC_000006.12:136822713:CGCCACGGCTACGCCGCCGAGT:CGCCACGGCTACGCCGCCGAGTCGCCACGGCTACGCCGCCGAGT
NC_000010.11:g.(?_27935000)_(28000048_?)del	ARMC4		Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000832042	10	28223929 - 28288977			832042	820203		
NM_000288.4(PEX7):c.188+1G>A	PEX7		Rhizomelic chondrodysplasia punctata type 1	Pathogenic	criteria provided, single submitter	VCV000813363	6	137146410	6	136825272	813363	801610		NC_000006.12:136825271:G:A
NM_018076.5(ARMC4):c.724C>T (p.Gln242Ter)	ARMC4	Q242*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000659262	10	28272867	10	27983938	659262	638852		NC_000010.11:27983937:G:A
NM_018076.5(ARMC4):c.564dup (p.His189fs)	ARMC4		Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000653813	10	28273958 - 28273959	10	27985029 - 27985030	653813	638854		NC_000010.11:27985029:TTTT:TTTTT
NC_000010.10:g.(?_28101421)_(28101574_?)del	ARMC4		Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000642637	10	28101421 - 28101574	10	27812492 - 27812645	642637	651961		
NM_000941.3(POR):c.1571_1619dup (p.Ala541fs)	POR		Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency	Pathogenic(Last reviewed: Feb 25, 2018)	criteria provided, single submitter	VCV000580516	7	75615068 - 75615069	7	75985750 - 75985751	580516	562165	rs1563435458	NC_000007.14:75985750:CCTTCAAGGCCACCACGCCTGTCATCATGGTGGGCCCCGGCACCGGGGT:CCTTCAAGGCCACCACGCCTGTCATCATGGTGGGCCCCGGCACCGGGGTCCTTCAAGGCCACCACGCCTGTCATCATGGTGGGCCCCGGCACCGGGGT
NM_018076.5(ARMC4):c.1076G>A (p.Trp359Ter)	ARMC4	W359*, W51*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000571362	10	28260103	10	27971174	571362	564556	rs768447289	NC_000010.11:27971173:C:T
NM_018076.5(ARMC4):c.1267_1268del (p.Thr422_Val423insTer)	ARMC4		Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000474571	10	28250615 - 28250616	10	27961686 - 27961687	474571	460651	rs1409069267	NC_000010.11:27961685:ACA:A
NM_000288.4(PEX7):c.538del (p.Thr179_Leu180insTer)	PEX7		Rhizomelic chondrodysplasia punctata type 1	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000436288	6	137187776	6	136866638	436288	428525	rs1554333636	NC_000006.12:136866637:C:
NM_000288.4(PEX7):c.357G>A (p.Trp119Ter)	PEX7	W119*	Rhizomelic chondrodysplasia punctata type 1	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000436286	6	137166770	6	136845632	436286	428524	rs1554331461	NC_000006.12:136845631:G:A
NM_003737.4(DCHS1):c.7109A>T (p.Asn2370Ile)	DCHS1	N2370I	Van Maldergem syndrome 1	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088999	11	6646466	11	6625235	88999	94553	rs483352919	NC_000011.10:6625234:T:A
NM_003737.4(DCHS1):c.2543del (p.Thr848fs)	DCHS1	T848fs	Van Maldergem syndrome 1	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088998	11	6654200	11	6632969	88998	94552	rs483352918	NC_000011.10:6632968:G:
NM_003737.4(DCHS1):c.2503G>T (p.Gly835Ter)	DCHS1	G835*	Van Maldergem syndrome 1	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088997	11	6654240	11	6633009	88997	94551	rs483352917	NC_000011.10:6633008:C:A
NM_000288.4(PEX7):c.-45C>T	PEX7		Phytanic acid storage disease	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000038871	6	137143759	6	136822621	38871	47476	rs267608252	NC_000006.12:136822620:C:T
NM_000941.3(POR):c.1835_1858del (p.Leu612_Trp620delinsArg)	POR		Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000016912	7	75615496 - 75615519	7	75986178 - 75986201	16912	31951	rs786205876	NC_000007.14:75986177:TAAAGCAAGACCGAGAGCACCTGT:
NM_000941.3(POR):c.1733A>G (p.Tyr578Cys)	POR	Y578C	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000016911	7	75615304	7	75985986	16911	31950	rs121912975	NC_000007.14:75985985:A:G
NM_000941.3(POR):c.541T>G (p.Tyr181Asp)	POR	Y181D	Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency	Pathogenic(Last reviewed: Jun 26, 2004)	no assertion criteria provided	VCV000016906	7	75610390	7	75981072	16906	31945	rs72552771	NC_000007.14:75981071:T:G
NM_000941.3(POR):c.731+1G>A	POR		Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000016905	7	75610925	7	75981607	16905	31944	rs786205099	NC_000007.14:75981606:G:A
NM_000941.3(POR):c.1822G>T (p.Val608Phe)	POR	V608F	Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000016904	7	75615483	7	75986165	16904	31943	rs72552772	NC_000007.14:75986164:G:T
NM_000941.3(POR):c.1475T>A (p.Val492Glu)	POR	V492E	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000016901	7	75614973	7	75985655	16901	31940	rs28931606	NC_000007.14:75985654:T:A
NM_000941.3(POR):c.1443C>A (p.Tyr481Ter)	POR	Y481*	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000691923	7	75614941	7	75985623	691923	679662		NC_000007.14:75985622:C:A
NM_000288.4(PEX7):c.854A>G (p.His285Arg)	PEX7	H285R	not provided|Rhizomelic chondrodysplasia punctata type 1	Pathogenic(Last reviewed: Aug 26, 2016)	no assertion criteria provided	VCV000038872	6	137219330	6	136898192	38872	47477	rs62653611	NC_000006.12:136898191:A:G
NM_000941.3(POR):c.568_580dup (p.Arg194fs)	POR		Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000016914	7	75610416 - 75610417	7	75981098 - 75981099	16914	31953	rs786205878	NC_000007.14:75981098:TACGTGGACAAGC:TACGTGGACAAGCTACGTGGACAAGC
NM_000941.3(POR):c.1706G>A (p.Cys569Tyr)	POR	C569Y	Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency	Pathogenic(Last reviewed: Jun 26, 2004)	no assertion criteria provided	VCV000016903	7	75615277	7	75985959	16903	31942	rs28931607	NC_000007.14:75985958:G:A
NM_003172.4(SURF1):c.555_556del (p.Lys186fs)	SURF1	K186fs, K77fs	Leigh syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000847821	9	136219581 - 136219582	9	133352726 - 133352727	847821	835735		NC_000009.12:133352725:TCT:T
NM_003172.4(SURF1):c.631_632del (p.Glu211fs)	SURF1	E102fs, E211fs	Leigh syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496203	9	136219420 - 136219421	9	133352565 - 133352566	496203	487251	rs1554768333	NC_000009.12:133352564:TCT:T
NM_018076.5(ARMC4):c.2014G>T (p.Glu672Ter)	ARMC4	E672*, E197*, E364*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	VCV000242860	10	28228909	10	27939980	242860	243963	rs771920114	NC_000010.11:27939979:C:A
NM_018076.5(ARMC4):c.1972G>T (p.Glu658Ter)	ARMC4	E658*, E183*, E350*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000101070	10	28229506	10	27940577	101070	106835	rs587777199	NC_000010.11:27940576:C:A
NM_000941.3(POR):c.1329dup (p.Ile444fs)	POR		not provided|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000016910	7	75614450 - 75614451	7	75985132 - 75985133	16910	31949	rs786205875	NC_000007.14:75985132:CCCCCC:CCCCCCC
NM_000108.5(DLD):c.1340_1343CAGA[1] (p.Asp448fs)	DLD		Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000856335	7	107558470 - 107558473	7	107918025 - 107918028	856335	832783		NC_000007.14:107918024:GACAGACAGA:GACAGA
NM_000108.5(DLD):c.946C>T (p.Arg316Ter)	DLD	R217*, R293*, R268*, R316*	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000854640	7	107557309	7	107916864	854640	832782		NC_000007.14:107916863:C:T
NC_000007.14:g.(?_107901728)_(107906378_?)del	DLD		Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000831013	7	107542173 - 107546823			831013	819779		
NM_000108.5(DLD):c.12G>A (p.Trp4Ter)	DLD	W4*	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000572549	7	107531707	7	107891262	572549	563929	rs1562908173	NC_000007.14:107891261:G:A
NM_000108.5(DLD):c.105del (p.Thr34_Tyr35insTer)	DLD		Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000553084	7	107533710	7	107893265	553084	544459	rs1554396895	NC_000007.14:107893264:C:
NM_000108.5(DLD):c.140T>C (p.Ile47Thr)	DLD	I47T	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Jul 15, 2006)	no assertion criteria provided	VCV000040188	7	107542204	7	107901759	40188	48685	rs397514651	NC_000007.14:107901758:T:C
NM_000108.5(DLD):c.1081A>G (p.Met361Val)	DLD	M361V, M313V, M338V, M262V	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000011972	7	107557752	7	107917307	11972	27011	rs121964993	NC_000007.14:107917306:A:G
NM_000108.5(DLD):c.1483A>G (p.Arg495Gly)	DLD	R495G, R447G, R396G, R472G	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000011968	7	107559657	7	107919212	11968	27007	rs121964989	NC_000007.14:107919211:A:G
NM_000108.5(DLD):c.1463C>T (p.Pro488Leu)	DLD	P488L, P465L, P389L, P440L	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000011965	7	107559543	7	107919098	11965	27004	rs121964988	NC_000007.14:107919097:C:T
NM_000108.5(DLD):c.803_804del (p.Gln268fs)	DLD	Q220fs, Q245fs, Q268fs, Q169fs	Maple syrup urine disease, type 3|not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424264	7	107556069 - 107556070	7	107915624 - 107915625	424264	406957	rs764611160	NC_000007.14:107915623:AG:
NM_000108.5(DLD):c.633dup (p.Val212fs)	DLD		Maple syrup urine disease, type 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371111	7	107546755 - 107546756	7	107906310 - 107906311	371111	357560	rs1040811473	NC_000007.14:107906310:AAAAAAA:AAAAAAAA
NM_000108.5(DLD):c.1444A>G (p.Arg482Gly)	DLD	R482G, R459G, R383G, R434G	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000040187	7	107559524	7	107919079	40187	48684	rs397514650	NC_000007.14:107919078:A:G
NM_000108.5(DLD):c.1178T>C (p.Ile393Thr)	DLD	I393T, I345T, I370T, I294T	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000011969	7	107557849	7	107917404	11969	27008	rs121964991	NC_000007.14:107917403:T:C
NM_000108.5(DLD):c.1436A>T (p.Asp479Val)	DLD	D479V, D456V, D431V, D380V	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Apr 10, 2007)	no assertion criteria provided	VCV000040186	7	107559516	7	107919071	40186	48683	rs397514649	NC_000007.14:107919070:A:T
NM_018076.5(ARMC4):c.2712del (p.Ile905fs)	ARMC4	I597fs, I430fs, I905fs	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	VCV000066046	10	28151450	10	27862521	66046	76952	rs587777048	NC_000010.11:27862520:GG:G
nsv1067903	ARMC4		Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	VCV000066044	10	28270060 - 28275320	10	27981131 - 27986391	66044	76950		
NM_000288.4(PEX7):c.40A>C (p.Thr14Pro)	PEX7	T14P	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000007790	6	137143843	6	136822705	7790	22829	rs61753233	NC_000006.12:136822704:A:C
GRCh37/hg19 12p12.1(chr12:21685107-21774521)x1	GYS2		not provided	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000686518	12	21685107 - 21774521			686518	674110		
NM_021957.4(GYS2):c.457del (p.Met152_Leu153insTer)	GYS2		not provided	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000498897	12	21728838	12	21575904	498897	490321	rs1307281520	NC_000012.12:21575903:G:
NM_001122769.3(LCA5):c.1062C>G (p.Tyr354Ter)	LCA5	Y354*	not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000287456	6	80201341	6	79491624	287456	271693	rs183261547	NC_000006.12:79491623:G:C
NM_021957.4(GYS2):c.942-42_974del	GYS2		not provided	Pathogenic(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	VCV000214537	12	21715940 - 21716014	12	21563006 - 21563080	214537	211605	rs1555156695	
NM_001122769.3(LCA5):c.149dup (p.Asn50fs)	LCA5		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000863636	6	80228462 - 80228463	6	79518745 - 79518746	863636	832575		NC_000006.12:79518745:TTTTTT:TTTTTTT
NM_001122769.3(LCA5):c.30dup (p.Asp11Ter)	LCA5		not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000855636	6	80228581 - 80228582	6	79518864 - 79518865	855636	832579		NC_000006.12:79518864:A:AA
NC_000006.12:g.(?_79513202)_(79518904_?)del	LCA5		not provided	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000832789	6	80222919 - 80228621			832789	819754		
NM_001122769.3(LCA5):c.1171A>T (p.Lys391Ter)	LCA5	K391*	Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812346	6	80198861	6	79489144	812346	800531		NC_000006.12:79489143:T:A
NM_021957.4(GYS2):c.122-8_141del	GYS2		Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000569698	12	21733438 - 21733465	12	21580504 - 21580531	569698	566747	rs746120293	NC_000012.12:21580503:CACAGTATAGATGCCTCCAACTGTTAAA:
NM_021957.4(GYS2):c.925C>T (p.Arg309Ter)	GYS2	R309*	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000078954	12	21716178	12	21563244	78954	89845	rs267603422	NC_000012.12:21563243:G:A
NM_021957.4(GYS2):c.1447T>C (p.Ser483Pro)	GYS2	S483P	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000016055	12	21699380	12	21546446	16055	31094	rs121918424	NC_000012.12:21546445:A:G
NM_021957.4(GYS2):c.116A>G (p.Asn39Ser)	GYS2	N39S	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000016054	12	21757411	12	21604477	16054	31093	rs121918423	NC_000012.12:21604476:T:C
NM_021957.4(GYS2):c.1015G>C (p.Ala339Pro)	GYS2	A339P	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000016052	12	21715899	12	21562965	16052	31091	rs121918421	NC_000012.12:21562964:C:G
NM_005802.5(TOPORS):c.2422G>T (p.Glu808Ter)	TOPORS	E743*, E808*	not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000861205	9	32542101	9	32542103	861205	836052		NC_000009.12:32542102:C:A
NM_001122769.3(LCA5):c.142A>T (p.Arg48Ter)	LCA5	R48*	not provided	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000842687	6	80228470	6	79518753	842687	832576		NC_000006.12:79518752:T:A
NM_001122769.3(LCA5):c.955G>A (p.Ala319Thr)	LCA5	A319T	Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802243	6	80202268	6	79492551	802243	790659		NC_000006.12:79492550:C:T
NM_021957.4(GYS2):c.495+1G>T	GYS2		Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000665082	12	21728799	12	21575865	665082	652231		NC_000012.12:21575864:C:A
NM_001122769.3(LCA5):c.1458C>A (p.Tyr486Ter)	LCA5	Y486*	not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000855833	6	80197357	6	79487640	855833	832560		NC_000006.12:79487639:G:T
NM_001122769.3(LCA5):c.103C>T (p.Arg35Ter)	LCA5	R35*	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000844114	6	80228509	6	79518792	844114	832577		NC_000006.12:79518791:G:A
NM_001122769.3(LCA5):c.1173del (p.Lys391fs)	LCA5	K391fs	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000838424	6	80198859	6	79489142	838424	832563		NC_000006.12:79489141:TTTTT:TTTT
NM_005802.5(TOPORS):c.2524dup (p.Thr842fs)	TOPORS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812433	9	32541998 - 32541999	9	32542000 - 32542001	812433	800553		NC_000009.12:32542000:T:TT
NM_021957.4(GYS2):c.1081del (p.Thr361fs)	GYS2	T361fs	not provided|Glycogen storage disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000667422	12	21713408	12	21560474	667422	654717		NC_000012.12:21560473:T:
NM_001122769.3(LCA5):c.1243G>T (p.Glu415Ter)	LCA5	E415*	not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000641484	6	80197572	6	79487855	641484	635308		NC_000006.12:79487854:C:A
NM_021957.4(GYS2):c.1156C>T (p.Arg386Ter)	GYS2	R386*	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569452	12	21713333	12	21560399	569452	565368	rs146195866	NC_000012.12:21560398:G:A
NM_005802.5(TOPORS):c.2546_2549CAGA[1] (p.Asp850fs)	TOPORS		Retinitis pigmentosa 31|Retinal dystrophy	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000560511	9	32541970 - 32541973	9	32541972 - 32541975	560511	551560	rs1563983151	NC_000009.12:32541971:TCTGTCTG:TCTG
NM_001122769.3(LCA5):c.1676C>A (p.Ser559Ter)	LCA5	S559*	Leber congenital amaurosis	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438152	6	80197139	6	79487422	438152	431717	rs766143193	NC_000006.12:79487421:G:T
NM_021957.4(GYS2):c.574C>T (p.Arg192Ter)	GYS2	R192*	Glycogen storage disease due to hepatic glycogen synthase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214530	12	21727182	12	21574248	214530	211606	rs150382575	NC_000012.12:21574247:G:A
NM_021957.4(GYS2):c.941+1G>C	GYS2		Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000016050	12	21716161	12	21563227	16050	31089	rs587776831	NC_000012.12:21563226:C:G
NM_005802.5(TOPORS):c.2474dup (p.Tyr825Ter)	TOPORS		Retinitis pigmentosa 31	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001656	9	32542048 - 32542049	9	32542050 - 32542051	1656	16695		NC_000009.12:32542050:T:TT
NM_020632.3(ATP6V0A4):c.777del (p.Met259fs)	ATP6V0A4	M259fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 26, 2015)	criteria provided, single submitter	VCV000520733	7	138440473	7	138755728	520733	511700	rs1445362077	NC_000007.14:138755727:C:
NM_020632.3(ATP6V0A4):c.1987dup (p.Arg663fs)	ATP6V0A4		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 25, 2015)	criteria provided, single submitter	VCV000520732	7	138413528 - 138413529	7	138728783 - 138728784	520732	511699	rs1252623454	NC_000007.14:138728783:T:TT
NM_030653.4(DDX11):c.223C>T (p.Arg75Ter)	DDX11	R75*, R49*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000521211	12	31236825	12	31083891	521211	511989	rs781413815	NC_000012.12:31083890:C:T
NM_001122769.3(LCA5):c.1466del (p.Leu489fs)	LCA5	L489fs	not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000864411	6	80197349	6	79487632	864411	832559		NC_000006.12:79487631:AAAA:AAA
NM_001122769.3(LCA5):c.1062_1068del (p.Cys353_Tyr354insTer)	LCA5		Leber congenital amaurosis 5	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810630	6	80201335 - 80201341	6	79491618 - 79491624	810630	798916		NC_000006.12:79491617:GTTTTCG:
NM_001122769.3(LCA5):c.633_639del (p.Glu211fs)	LCA5	E211fs	Retinal dystrophy	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000236493	6	80223010 - 80223016	6	79513293 - 79513299	236493	238033	rs878853382	NC_000006.12:79513292:TCTAGCTTC:TC
NM_021957.4(GYS2):c.547C>T (p.Gln183Ter)	GYS2	Q183*	Glycogen storage disease due to hepatic glycogen synthase deficiency|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214529	12	21727209	12	21574275	214529	211608	rs201157731	NC_000012.12:21574274:G:A
NM_021957.4(GYS2):c.1336C>G (p.His446Asp)	GYS2	H446D	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000016056	12	21711220	12	21558286	16056	31095	rs121918425	NC_000012.12:21558285:G:C
NM_001122769.3(LCA5):c.1476dup (p.Pro493fs)	LCA5		Leber congenital amaurosis 5	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000000967	6	80197338 - 80197339	6	79487621 - 79487622	967	16006	rs386834253	NC_000006.12:79487621:T:TT
NM_000108.5(DLD):c.214A>G (p.Lys72Glu)	DLD	K72E	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000011964	7	107542785	7	107902340	11964	27003	rs121964987	NC_000007.14:107902339:A:G
NM_012434.5(SLC17A5):c.409del (p.Met137fs)	SLC17A5	M137fs	Salla disease|Sialic acid storage disease, severe infantile type	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203395	6	74351530	6	73641807	203395	199786	rs794729653	NC_000006.12:73641806:TTTT:TTT
NM_012434.5(SLC17A5):c.291G>A (p.Thr97=)	SLC17A5		not provided|Salla disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056554	6	74354130	6	73644407	56554	71193	rs386833990	NC_000006.12:73644406:C:T
SLC17A5, 15-BP DEL, NT802	SLC17A5		Salla disease|Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000005621					5621	20660		
NM_003322.6(TULP1):c.1495+1G>A	TULP1		Retinal dystrophy|not provided|Retinitis pigmentosa 14|Leber congenital amaurosis 15	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000099665	6	35467757	6	35499980	99665	105554	rs281865168	NC_000006.12:35499979:C:T
NM_000288.4(PEX7):c.429del (p.Val144fs)	PEX7	V144fs	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554785	6	137167222	6	136846084	554785	543938	rs61753248	NC_000006.12:136846083:T:
NM_018076.5(ARMC4):c.2219G>A (p.Trp740Ter)	ARMC4	W740*, W265*, W432*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242859	10	28225688	10	27936759	242859	243962	rs201213030	NC_000010.11:27936758:C:T
NM_018076.5(ARMC4):c.1969C>T (p.Gln657Ter)	ARMC4	Q657*, Q182*, Q349*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000242858	10	28229509	10	27940580	242858	243964	rs868755574	NC_000010.11:27940579:G:A
NM_018076.5(ARMC4):c.2675C>A (p.Ser892Ter)	ARMC4	S892*, S417*, S584*	Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	VCV000066047	10	28151487	10	27862558	66047	76953	rs587777049	NC_000010.11:27862557:G:T
NM_000941.3(POR):c.1615G>A (p.Gly539Arg)	POR	G539R	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000016915	7	75615113	7	75985795	16915	31954	rs121912976	NC_000007.14:75985794:G:A
NM_001122769.3(LCA5):c.238C>T (p.Arg80Ter)	LCA5	R80*	not provided|Leber congenital amaurosis	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000662038	6	80223411	6	79513694	662038	635309		NC_000006.12:79513693:G:A
NM_005802.5(TOPORS):c.2569del (p.Arg857fs)	TOPORS	R792fs, R857fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438067	9	32541954	9	32541956	438067	431737	rs1554671407	NC_000009.12:32541955:TTTT:TTT
NM_005097.4(LGI1):c.931C>T (p.Arg311Ter)	LGI1	R311*, R263*	not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000265352	10	95556817	10	93797060	265352	259946	rs886039496	NC_000010.11:93797059:C:T
NM_004092.4(ECHS1):c.121_122AG[1] (p.Gly42fs)	ECHS1		Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802643	10	135184226 - 135184227	10	133370722 - 133370723	802643	790951		NC_000010.11:133370721:CTCT:CT
NM_004092.4(ECHS1):c.161G>A (p.Arg54His)	ECHS1	R54H	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802642	10	135184189	10	133370685	802642	790950		NC_000010.11:133370684:C:T
NM_004092.4(ECHS1):c.583G>A (p.Gly195Ser)	ECHS1	G195S	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802641	10	135180429	10	133366925	802641	790949		NC_000010.11:133366924:C:T
NM_004092.4(ECHS1):c.538A>G (p.Thr180Ala)	ECHS1	T180A	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Jun 17, 2019)	no assertion criteria provided	VCV000691284	10	135180474	10	133366970	691284	678970		NC_000010.11:133366969:T:C
NM_004092.4(ECHS1):c.74G>C (p.Arg25Pro)	ECHS1	R25P	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488500	10	135186764	10	133373260	488500	481368	rs1554886769	NC_000010.11:133373259:C:G
NM_004092.4(ECHS1):c.856_857dup (p.Asn286fs)	ECHS1		Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000488496	10	135176387 - 135176388	10	133362883 - 133362884	488496	481364	rs1554885530	NC_000010.11:133362883:TT:TTTT
NM_005097.4(LGI1):c.1580_1581del (p.His527fs)	LGI1	H479fs, H527fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000641538	10	95557466 - 95557467	10	93797709 - 93797710	641538	639318		NC_000010.11:93797708:AT:
NM_005097.4(LGI1):c.386C>G (p.Ser129Ter)	LGI1	S129*	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000583153	10	95537329	10	93777572	583153	569896	rs1564845068	NC_000010.11:93777571:C:G
NM_004092.4(ECHS1):c.394G>A (p.Ala132Thr)	ECHS1	A132T	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488499	10	135183428	10	133369924	488499	481367	rs770931871	NC_000010.11:133369923:C:T
NM_005097.4(LGI1):c.1256T>G (p.Leu419Ter)	LGI1	L419*, L371*	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000464744	10	95557142	10	93797385	464744	460414	rs1554907787	NC_000010.11:93797384:T:G
NM_005097.4(LGI1):c.688C>T (p.Gln230Ter)	LGI1	Q230*, Q182*	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000408592	10	95552957	10	93793200	408592	397976	rs1060502054	NC_000010.11:93793199:C:T
NM_005097.4(LGI1):c.1128G>A (p.Trp376Ter)	LGI1	W376*, W328*	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000408590	10	95557014	10	93797257	408590	398102	rs1060502053	NC_000010.11:93797256:G:A
NC_000010.10:g.(?_135175966)_(135180498_135182426)del	ECHS1		Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000397547	10	135175966 - 135182426	10	133362462 - 133368922	397547	384437		
NM_004092.4(ECHS1):c.413C>T (p.Ala138Val)	ECHS1	A138V	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218891	10	135183409	10	133369905	218891	215650	rs864309656	NC_000010.11:133369904:G:A
NM_004092.4(ECHS1):c.176A>G (p.Asn59Ser)	ECHS1	N59S	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218890	10	135184174	10	133370670	218890	215649	rs201865375	NC_000010.11:133370669:T:C
NM_005097.4(LGI1):c.1418C>T (p.Ser473Leu)	LGI1	S473L, S425L	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208480	10	95557304	10	93797547	208480	205004	rs797044999	NC_000010.11:93797546:C:T
NC_000010.11:g.(93704377_?)_(?_93785620)del	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208479	10	95464133 - 95545376	10	93704377 - 93785620	208479	205006		
NM_005097.4(LGI1):c.1013T>C (p.Phe338Ser)	LGI1	F338S, F290S	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000208125	10	95556899	10	93797142	208125	204392	rs869025201	NC_000010.11:93797141:T:C
NM_004092.4(ECHS1):c.414+3G>C	ECHS1		Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000187860	10	135183405	10	133369901	187860	185752	rs786204002	NC_000010.11:133369900:C:G
NM_004092.4(ECHS1):c.473C>A (p.Ala158Asp)	ECHS1	A158D	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000187859	10	135182468	10	133368964	187859	185751	rs786204001	NC_000010.11:133368963:G:T
LGI1, 81-KB DEL	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Apr 24, 2012)	no assertion criteria provided	VCV000040218					40218	48703		
NM_005097.4(LGI1):c.365T>A (p.Ile122Lys)	LGI1	I122K	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000005439	10	95537308	10	93777551	5439	20478	rs119488100	NC_000010.11:93777550:T:A
NM_005097.4(LGI1):c.695T>C (p.Leu232Pro)	LGI1	L232P, L184P	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000005437	10	95552964	10	93793207	5437	20476	rs104894167	NC_000010.11:93793206:T:C
LGI1, IVS5DS, G-A, +1	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000005436					5436	20475		
NM_005097.4(LGI1):c.953T>G (p.Phe318Cys)	LGI1	F318C, F270C	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: May 27, 2003)	no assertion criteria provided	VCV000005435	10	95556839	10	93797082	5435	20474	rs28939075	NC_000010.11:93797081:T:G
NM_005097.4(LGI1):c.360-3C>A	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005432	10	95537300	10	93777543	5432	20471		NC_000010.11:93777542:C:A
NM_004092.4(ECHS1):c.476A>G (p.Gln159Arg)	ECHS1	Q159R	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379794	10	135182465	10	133368961	379794	370650	rs375032130	NC_000010.11:133368960:T:C
NM_004092.4(ECHS1):c.817A>G (p.Lys273Glu)	ECHS1	K273E	not provided|Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372596	10	135176428	10	133362924	372596	359810	rs565090080	NC_000010.11:133362923:T:C
NM_005097.4(LGI1):c.1420C>T (p.Arg474Ter)	LGI1	R474*, R426*	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208478	10	95557306	10	93797549	208478	205005	rs797044998	NC_000010.11:93797548:C:T
NM_005097.4(LGI1):c.758del (p.Ala253fs)	LGI1	A205fs, A253fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208477	10	95553027	10	93793270	208477	205003	rs797044997	NC_000010.11:93793269:C:
NM_005097.4(LGI1):c.124T>G (p.Cys42Gly)	LGI1	C42G	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208476	10	95518025	10	93758268	208476	205002	rs797044996	NC_000010.11:93758267:T:G
NM_005097.4(LGI1):c.124T>C (p.Cys42Arg)	LGI1	C42R	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208475	10	95518025	10	93758268	208475	205001	rs797044996	NC_000010.11:93758267:T:C
LGI1, 1320C-T	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000005434					5434	20473		
LGI1, 1-BP DEL, 835C	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jun 15, 2005)	no assertion criteria provided	VCV000005431					5431	20470		
NM_005097.4(LGI1):c.1148A>C (p.Glu383Ala)	LGI1	E383A, E335A	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000005430	10	95557034	10	93797277	5430	20469	rs28937874	NC_000010.11:93797276:A:C
NM_006415.4(SPTLC1):c.1055C>T (p.Ala352Val)	SPTLC1	A352V, A230V, A197V	Neuropathy hereditary sensory and autonomic type 1	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000004805	9	94809480	9	92047198	4805	19844	rs267607088	NC_000009.12:92047197:G:A
NM_152416.4(NDUFAF6):c.485dup (p.Asn162fs)	NDUFAF6		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000521473	8	96057773 - 96057774	8	95045545 - 95045546	521473	511774	rs762093523	NC_000008.11:95045545:AAAAAAA:AAAAAAAA
NM_021830.5(TWNK):c.1523A>G (p.Tyr508Cys)	TWNK	Y508C, Y54C	not provided|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004627	10	102750231	10	100990474	4627	19666	rs80356540	NC_000010.11:100990473:A:G
NM_021830.5(TWNK):c.1142T>C (p.Leu381Pro)	TWNK	L381P	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000004622	10	102749109	10	100989352	4622	19661	rs111033577	NC_000010.11:100989351:T:C
NM_021830.5(TWNK):c.1075G>A (p.Ala359Thr)	TWNK	A359T	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000004618	10	102749042	10	100989285	4618	19657	rs111033573	NC_000010.11:100989284:G:A
NM_000883.4(IMPDH1):c.931G>A (p.Asp311Asn)	IMPDH1	D226N, D201N, D221N, D275N, D278N, D301N, D311N, D242N	Retinitis pigmentosa 10|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014834	7	128038611	7	128398557	14834	29873	rs121912550	NC_000007.14:128398556:C:T
NM_005097.4(LGI1):c.136T>C (p.Cys46Arg)	LGI1	C46R	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000005433	10	95518037	10	93758280	5433	20472	rs104894166	NC_000010.11:93758279:T:C
NM_006415.4(SPTLC1):c.992C>T (p.Ser331Phe)	SPTLC1	S331F, S176F, S209F	Neuropathy hereditary sensory and autonomic type 1	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000004804	9	94809543	9	92047261	4804	19843	rs267607087	NC_000009.12:92047260:G:A
NM_145200.4(CABP4):c.646C>T (p.Arg216Ter)	CABP4	R216*, R111*	Achromatopsia|not provided|Cone-rod dystrophy|Congenital stationary night blindness, type 2B	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000190959	11	67225148	11	67457677	190959	188766	rs150115958	NC_000011.10:67457676:C:T
NM_004820.5(CYP7B1):c.1091C>T (p.Ser364Leu)	CYP7B1	S364L	Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807591	8	65517381	8	64604824	807591	798602		NC_000008.11:64604823:G:A
NM_000035.4(ALDOB):c.302del (p.Lys101fs)	ALDOB	K101fs	not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000595944	9	104192059	9	101429777	595944	587005	rs974582114	NC_000009.12:101429776:TTTT:TTT
NM_004820.5(CYP7B1):c.793C>T (p.Gln265Ter)	CYP7B1	Q265*	not provided	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000280294	8	65528305	8	64615748	280294	264373	rs886041525	NC_000008.11:64615747:G:A
NC_000008.11:g.(?_64624393)_(64624549_?)del	CYP7B1		Spastic paraplegia	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000830649	8	65536950 - 65537106			830649	819973		
NM_004820.5(CYP7B1):c.823del (p.Tyr275fs)	CYP7B1	Y275fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000663703	8	65528275	8	64615718	663703	637364		NC_000008.11:64615717:AA:A
NM_004820.5(CYP7B1):c.1286dup (p.Lys430fs)	CYP7B1		Spastic paraplegia	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000409026	8	65509433 - 65509434	8	64596876 - 64596877	409026	396264	rs1060502224	NC_000008.11:64596876:AAAAA:AAAAAA
NM_004820.5(CYP7B1):c.525G>A (p.Trp175Ter)	CYP7B1	W175*	Spastic paraplegia	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000240074	8	65528573	8	64616016	240074	240397	rs794727501	NC_000008.11:64616015:C:T
NM_004820.5(CYP7B1):c.321_324del (p.Lys107fs)	CYP7B1	K107fs	Spastic paraplegia	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	VCV000240073	8	65528774 - 65528777	8	64616217 - 64616220	240073	240398	rs770285398	NC_000008.11:64616216:TTGTTT:TT
NM_174934.3(SCN4B):c.496A>C (p.Ile166Leu)	SCN4B	I166L, I32L, I56L	Atrial fibrillation, familial, 17	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000140601	11	118012019	11	118141304	140601	150293	rs587777560	NC_000011.10:118141303:T:G
NM_174934.3(SCN4B):c.485T>G (p.Val162Gly)	SCN4B	V162G, V52G, V28G	Atrial fibrillation, familial, 17	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000140600	11	118012030	11	118141315	140600	150292	rs587777559	NC_000011.10:118141314:A:C
NM_004820.5(CYP7B1):c.260G>T (p.Gly87Val)	CYP7B1	G87V	Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000120178	8	65528838	8	64616281	120178	125786	rs587777221	NC_000008.11:64616280:C:A
NM_004820.5(CYP7B1):c.1408T>A (p.Phe470Ile)	CYP7B1	F470I	Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000006106	8	65509312	8	64596755	6106	21145	rs267606758	NC_000008.11:64596754:A:T
NM_004820.5(CYP7B1):c.647T>C (p.Phe216Ser)	CYP7B1	F216S	Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000006104	8	65528451	8	64615894	6104	21143	rs121908612	NC_000008.11:64615893:A:G
NM_004820.5(CYP7B1):c.392dup (p.Asn131fs)	CYP7B1		Spastic paraplegia	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000850629	8	65528705 - 65528706	8	64616148 - 64616149	850629	834984		NC_000008.11:64616148:TTTTTTT:TTTTTTTT
NM_004820.5(CYP7B1):c.650dup (p.Leu217fs)	CYP7B1		Spastic paraplegia	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000849738	8	65528447 - 65528448	8	64615890 - 64615891	849738	834983		NC_000008.11:64615890:AAAAAA:AAAAAAA
NC_000009.12:g.(?_101424833)_(101437751_?)del	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000832157	9	104187115 - 104200033			832157	820034		
NM_000035.4(ALDOB):c.522C>G (p.Tyr174Ter)	ALDOB	Y174*	Hereditary fructosuria	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000555545	9	104189782	9	101427500	555545	545030	rs752902486	NC_000009.12:101427499:G:C
NM_004820.5(CYP7B1):c.914dup (p.Met305fs)	CYP7B1		Hereditary spastic paraplegia	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424649	8	65527725 - 65527726	8	64615168 - 64615169	424649	411568	rs1554524697	NC_000008.11:64615168:A:AA
NM_004820.5(CYP7B1):c.259+2T>C	CYP7B1		Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225337	8	65536958	8	64624401	225337	227324	rs751713917	NC_000008.11:64624400:A:G
NM_000035.3(ALDOB):c.-10-2043_624+62del	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030978	9	104188775 - 104195222	9	101426493 - 101432940	30978	39935		
NM_004820.5(CYP7B1):c.1088C>T (p.Ser363Phe)	CYP7B1	S363F	Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000006101	8	65517384	8	64604827	6101	21140	rs121908610	NC_000008.11:64604826:G:A
NM_174934.3(SCN4B):c.535C>T (p.Leu179Phe)	SCN4B	L179F, L45F, L69F	Long QT syndrome 10	Pathogenic(Last reviewed: Jul 10, 2007)	no assertion criteria provided	VCV000002459	11	118011980	11	118141265	2459	17498	rs121434386	NC_000011.10:118141264:G:A
NM_000035.4(ALDOB):c.442T>C (p.Trp148Arg)	ALDOB	W147R, W148R	Hereditary fructosuria	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000000475	9	104189862	9	101427580	475	15514	rs118204430	NC_000009.12:101427579:A:G
NM_000035.4(ALDOB):c.548_553del (p.Leu183_Val184del)	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000000474	9	104188908 - 104188913	9	101426626 - 101426631	474	15513	rs387906226	NC_000009.12:101426625:GTACCAGT:GT
NM_000035.4(ALDOB):c.625-1G>A	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000000473	9	104187910	9	101425628	473	15512	rs1564077542	NC_000009.12:101425627:C:T
ALDOB, 7-BP DEL/1-BP INS, 3-PRIME IVS8	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000000470					470	15509		
NM_000035.4(ALDOB):c.720C>A (p.Cys240Ter)	ALDOB	C240*	Hereditary fructosuria	Pathogenic(Last reviewed: Sep 1, 1990)	no assertion criteria provided	VCV000000468	9	104187814	9	101425532	468	15507	rs118204426	NC_000009.12:101425531:G:T
NM_000035.4(ALDOB):c.865_867del (p.Leu289del)	ALDOB	L288del, L289del	Hereditary fructosuria	Pathogenic(Last reviewed: Feb 10, 1990)	no assertion criteria provided	VCV000000466	9	104187257 - 104187259	9	101424975 - 101424977	466	15505	rs118204425	NC_000009.12:101424974:AAG:
NM_000035.4(ALDOB):c.324+2T>A	ALDOB		Hereditary fructosuria	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370293	9	104192035	9	101429753	370293	357762	rs1057516379	NC_000009.12:101429752:A:T
NM_004820.5(CYP7B1):c.169G>A (p.Gly57Arg)	CYP7B1	G57R	Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000006102	8	65537050	8	64624493	6102	21141	rs121908614	NC_000008.11:64624492:C:T
NM_181714.4(LCA5):c.0_-298+211del	LCA5		Leber congenital amaurosis 5	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000000969	6	80246622 - 80248219	6	79536905 - 79538502	969	16008		
NM_000035.4(ALDOB):c.612T>G (p.Tyr204Ter)	ALDOB	Y204*	Hereditary fructosuria	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000632627	9	104188849	9	101426567	632627	621289	rs370793608	NC_000009.12:101426566:A:C
NM_005271.5(GLUD1):c.1493C>T (p.Ser498Leu)	GLUD1	S445L, S498L, S331L, S365L	not provided|Hyperinsulinism-hyperammonemia syndrome	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016122	10	88817449	10	87057692	16122	31161	rs121909731	NC_000010.11:87057691:G:A
NM_005097.4(LGI1):c.1158_1168dup (p.Thr390delinsLysTer)	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000533337	10	95557042 - 95557043	10	93797285 - 93797286	533337	525624	rs1554907767	NC_000010.11:93797285:AAATAGTCAGAA:AAATAGTCAGAAAATAGTCAGAA
NM_016938.5(EFEMP2):c.376G>A (p.Glu126Lys)	EFEMP2	E126K	Autosomal recessive cutis laxa type IA|not provided|Autosomal recessive cutis laxa type 1B	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000039011	11	65638121	11	65870650	39011	47614	rs193302867	NC_000011.10:65870649:C:T
NM_022725.3(FANCF):c.230_252del (p.Val77fs)	FANCF	V77fs	Fanconi anemia, complementation group F|Fanconi anemia	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000006340	11	22647105 - 22647127	11	22625559 - 22625581	6340	21379	rs730880277	NC_000011.10:22625558:CTGGAAGTTCGCTAATCCCGGAACTGGA:CTGGA
NM_000288.4(PEX7):c.130+1G>A	PEX7		Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000639671	6	137143934	6	136822796	639671	651523		NC_000006.12:136822795:G:A
NM_000288.4(PEX7):c.45_52dup (p.His18fs)	PEX7		Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000007784	6	137143840 - 137143841	6	136822702 - 136822703	7784	22823	rs63535662	NC_000006.12:136822702:GGACGCCGGGACGCC:GGACGCCGGGACGCCGGGACGCC
NC_000009.12:g.(?_101426493)_(101437751_?)del	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000832254	9	104188775 - 104200033			832254	820035		
NM_000035.4(ALDOB):c.-11+1G>C	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495347	9	104197990	9	101435708	495347	487350	rs181639417	NC_000009.12:101435707:C:G
NM_003995.4(NPR2):c.2527del (p.Ala843fs)	NPR2	A843fs	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000817489	9	35807026	9	35807029	817489	805623		NC_000009.12:35807028:GG:G
NC_000009.12:g.(?_27157831)_(27220145_?)del	TEK		not provided	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000832541	9	27157829 - 27220143			832541	820124		
NM_003995.3(NPR2):c.560T>A (p.Val187Asp)	NPR2	V187D		Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, single submitter	VCV000375293	9	35792965	9	35792968	375293	362063	rs1057519335	NC_000009.12:35792967:T:A
NM_003995.3(NPR2):c.1758delC (p.Cys586Terfs)	NPR2	C586*		Pathogenic(Last reviewed: Mar 30, 2013)	criteria provided, single submitter	VCV000375292	9	35802547	9	35802550	375292	362064	rs1057519334	NC_000009.12:35802549:C:
NM_003995.3(NPR2):c.2302T>C (p.Cys768Arg)	NPR2	C768R		Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000375291	9	35806160	9	35806163	375291	362065	rs1057519333	NC_000009.12:35806162:T:C
NM_003995.3(NPR2):c.1249C>G (p.Gln417Glu)	NPR2	Q417E	Short stature with nonspecific skeletal abnormalities	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000208360	9	35800736	9	35800739	208360	204588	rs796065356	NC_000009.12:35800738:C:G
NM_003995.3(NPR2):c.328C>T (p.Arg110Cys)	NPR2	R110C	Short stature with nonspecific skeletal abnormalities	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000208359	9	35792733	9	35792736	208359	204587	rs758478717	NC_000009.12:35792735:C:T
NM_003995.3(NPR2):c.788G>C (p.Arg263Pro)	NPR2	R263P	Short stature with nonspecific skeletal abnormalities	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000208358	9	35794015	9	35794018	208358	204586	rs139036657	NC_000009.12:35794017:G:C
NM_003995.3(NPR2):c.226T>C (p.Ser76Pro)	NPR2	S76P	Short stature with nonspecific skeletal abnormalities	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000208357	9	35792631	9	35792634	208357	204585	rs796065355	NC_000009.12:35792633:T:C
NM_003995.3(NPR2):c.2455C>T (p.Arg819Cys)	NPR2	R819C	Short stature with nonspecific skeletal abnormalities	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000208356	9	35806471	9	35806474	208356	204584	rs766256429	NC_000009.12:35806473:C:T
NM_003995.3(NPR2):c.1462G>C (p.Ala488Pro)	NPR2	A488P	Epiphyseal chondrodysplasia, miura type	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000143055	9	35801665	9	35801668	143055	152774	rs587777597	NC_000009.12:35801667:G:C
NM_003995.3(NPR2):c.1963C>T (p.Arg655Cys)	NPR2	R655C	Epiphyseal chondrodysplasia, miura type	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000143054	9	35805583	9	35805586	143054	152773	rs587777596	NC_000009.12:35805585:C:T
KLLN, PROMOTER HYPERMETHYLATION	KLLN		Cowden syndrome 4	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000040164					40164	48664		
NM_003995.3(NPR2):c.1162C>T (p.Arg388Ter)	NPR2	R388*		Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000017787	9	35800424	9	35800427	17787	32826	rs121912739	NC_000009.12:35800426:C:T
NM_003995.3(NPR2):c.528T>A (p.Asp176Glu)	NPR2	D176E		Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000017786	9	35792933	9	35792936	17786	32825	rs28929479	NC_000009.12:35792935:T:A
NM_003995.3(NPR2):c.343T>G (p.Trp115Gly)	NPR2	W115G		Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000017785	9	35792748	9	35792751	17785	32824	rs28931582	NC_000009.12:35792750:T:G
NM_003995.3(NPR2):c.94C>A (p.Pro32Thr)	NPR2	P32T		Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000017784	9	35792499	9	35792502	17784	32823	rs28931581	NC_000009.12:35792501:C:A
NM_003995.3(NPR2):c.1435C>T (p.Arg479Ter)	NPR2	R479*		Pathogenic(Last reviewed: Mar 1, 2015)	criteria provided, single submitter	VCV000375290	9	35801150	9	35801153	375290	362062	rs1057519324	NC_000009.12:35801152:C:T
NM_000459.4(TEK):c.448G>T (p.Glu150Ter)	TEK	E150*, E46*	Glaucoma 3, primary congenital, E	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000374839	9	27168576	9	27168578	374839	361744	rs753021890	NC_000009.12:27168577:G:T
NM_001290077.1(TEK):c.902-3200C>A	TEK	Y307*	Glaucoma 3, primary congenital, E	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000374838	9	27180257	9	27180259	374838	361743	rs541217363	NC_000009.12:27180258:C:A
NM_000459.4(TEK):c.2744G>A (p.Arg915His)	TEK	R915H, R767H, R872H	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000030054	9	27212762	9	27212764	30054	39009	rs387906745	NC_000009.12:27212763:G:A
NM_003995.3(NPR2):c.2647G>A (p.Val883Met)	NPR2	V833M, V883M	Epiphyseal chondrodysplasia, miura type	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000143053	9	35807330	9	35807333	143053	152772	rs587777595	NC_000009.12:35807332:G:A
NM_000459.4(TEK):c.2690A>C (p.Tyr897Ser)	TEK	Y897S, Y854S, Y749S	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000009294	9	27212708	9	27212710	9294	24333	rs80338909	NC_000009.12:27212709:A:C
NM_003172.4(SURF1):c.833+1G>A	SURF1		Leigh syndrome|not specified	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000599351	9	136218915	9	133352060	599351	590645	rs782609482	NC_000009.12:133352059:C:T
NM_003995.3(NPR2):c.1092del (p.Ile364fs)	NPR2	I364fs	|Short stature with nonspecific skeletal abnormalities	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000208355	9	35800122	9	35800125	208355	204583	rs879255257	NC_000009.12:35800124:TT:T
NM_000459.4(TEK):c.2690A>G (p.Tyr897Cys)	TEK	Y897C, Y749C, Y854C	not provided|Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000030053	9	27212708	9	27212710	30053	39008	rs80338909	NC_000009.12:27212709:A:G
GRCh37/hg19 8p22(chr8:15241652-15413345)x1	TUSC3		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000686619	8	15241652 - 15413345			686619	674211		
GRCh37/hg19 8p22(chr8:15282408-15423270)x1	TUSC3		not provided	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000686462	8	15282408 - 15423270			686462	674054		
NM_020944.3(GBA2):c.1153G>T (p.Gly385Ter)	GBA2	G385*	not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000596782	9	35740336	9	35740339	596782	587843	rs756503362	NC_000009.12:35740338:C:A
NM_014956.5(CEP164):c.1946del (p.Glu649fs)	CEP164	E652fs, E649fs	not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000280343	11	117261504	11	117390788	280343	264445	rs886041567	NC_000011.10:117390787:A:
NM_020944.3(GBA2):c.2101C>T (p.Gln701Ter)	GBA2	Q701*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 8, 2018)	criteria provided, single submitter	VCV000652834	9	35738325	9	35738328	652834	638305		NC_000009.12:35738327:G:A
NM_020944.3(GBA2):c.2202del (p.Tyr735fs)	GBA2	Y735fs	Spastic paraplegia	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000567447	9	35738145	9	35738148	567447	569076	rs1448182827	NC_000009.12:35738147:G:
NM_020944.3(GBA2):c.1471_1474dup (p.Thr492fs)	GBA2		Spastic paraplegia 46, autosomal recessive	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000041488	9	35739732 - 35739733	9	35739735 - 35739736	41488	49927		NC_000009.12:35739735:TGCCT:TGCCTGCCT
NM_018238.4(AGK):c.409C>T (p.Arg137Ter)	AGK	R137*	not provided|Trichohepatoenteric syndrome 1|Sengers syndrome	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000209130	7	141313964	7	141614164	209130	205750	rs746709222	NC_000007.14:141614163:C:T
NM_014956.5(CEP164):c.3739C>T (p.Gln1247Ter)	CEP164	Q1247*	Nephronophthisis 15	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000862771	11	117279735	11	117409019	862771	837994		NC_000011.10:117409018:C:T
NM_014956.5(CEP164):c.381dup (p.Lys128fs)	CEP164		Nephronophthisis 15	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000581067	11	117222685 - 117222686	11	117351969 - 117351970	581067	565520	rs747914869	NC_000011.10:117351969:CCCCCCC:CCCCCCCC
NM_014956.5(CEP164):c.2689C>T (p.Arg897Ter)	CEP164	R897*, R900*	Nephronophthisis 15	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000571715	11	117265138	11	117394422	571715	564431	rs764893412	NC_000011.10:117394421:C:T
NM_006765.4(TUSC3):c.225del (p.Lys75fs)	TUSC3	K75fs	Mental retardation, autosomal recessive 7	Pathogenic(Last reviewed: Mar 5, 2018)	no assertion criteria provided	VCV000495148	8	15480672	8	15623163	495148	486702	rs1554461593	NC_000008.11:15623162:AAAA:AAA
NM_014956.5(CEP164):c.1726C>T (p.Arg576Ter)	CEP164	R576*, R579*	Nephronophthisis 15	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037298	11	117257920	11	117387204	37298	45871	rs145646425	NC_000011.10:117387203:C:T
NM_014956.5(CEP164):c.1573C>T (p.Gln525Ter)	CEP164	Q525*, Q528*	Nephronophthisis 15	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037297	11	117252580	11	117381864	37297	45870	rs387907311	NC_000011.10:117381863:C:T
NM_014956.5(CEP164):c.277C>T (p.Arg93Trp)	CEP164	R93W	Nephronophthisis 15	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037296	11	117222588	11	117351872	37296	45869	rs387907310	NC_000011.10:117351871:C:T
NM_014956.5(CEP164):c.32A>C (p.Gln11Pro)	CEP164	Q11P	Nephronophthisis 15	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037295	11	117209334	11	117338618	37295	45868	rs387907309	NC_000011.10:117338617:A:C
NM_014956.5(CEP164):c.4381T>C (p.Ter1461Arg)	CEP164	*1461R, *1456R	Nephronophthisis 15	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037294	11	117282882	11	117412166	37294	45867	rs1565649749	NC_000011.10:117412165:T:C
NM_006765.4(TUSC3):c.163C>T (p.Gln55Ter)	TUSC3	Q55*	Mental retardation, autosomal recessive 7	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030177	8	15480613	8	15623104	30177	39133	rs387906804	NC_000008.11:15623103:C:T
NM_006765.4(TUSC3):c.786dup (p.Asn263fs)	TUSC3		Mental retardation, autosomal recessive 7	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000008183	8	15531332 - 15531333	8	15673823 - 15673824	8183	23222		NC_000008.11:15673823:C:CC
NM_004820.5(CYP7B1):c.1249C>T (p.Arg417Cys)	CYP7B1	R417C	not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000586668	8	65509471	8	64596914	586668	577067	rs367916692	NC_000008.11:64596913:G:A
NM_004820.5(CYP7B1):c.187C>T (p.Arg63Ter)	CYP7B1	R63*	not provided|Spastic paraplegia	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488846	8	65537032	8	64624475	488846	481826	rs746979262	NC_000008.11:64624474:G:A
NM_000035.4(ALDOB):c.865del (p.Leu289fs)	ALDOB	L289fs	Hereditary fructosuria	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000218381	9	104187259	9	101424977	218381	215107	rs864309533	NC_000009.12:101424976:GG:G
NM_000035.4(ALDOB):c.324+1G>A	ALDOB		Hereditary fructosuria	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218380	9	104192036	9	101429754	218380	215108	rs764826805	NC_000009.12:101429753:C:T
NM_020944.3(GBA2):c.363C>A (p.Tyr121Ter)	GBA2	Y121*	Spastic paraplegia 46, autosomal recessive	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000638293	9	35744700	9	35744703	638293	626076		NC_000009.12:35744702:G:T
NM_000318.3(PEX2):c.232C>T (p.Gln78Ter)	PEX2	Q78*	Peroxisome biogenesis disorder 5a (zellweger)	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000649982	8	77896183	8	76983947	649982	637404		NC_000008.11:76983946:G:A
NM_006204.4(PDE6C):c.1269+1G>A	PDE6C		Achromatopsia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487689	10	95394665	10	93634908	487689	480778	rs1554889905	NC_000010.11:93634907:G:A
NM_000380.3(XPA):c.631C>T (p.Arg211Ter)	XPA	R211*, R169*	|Xeroderma pigmentosum|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551809	9	100447247	9	97684965	551809	545299	rs149226993	NC_000009.12:97684964:G:A
NM_001354975.1(XPA):c.218_222CTTAT[1] (p.Leu75fs)	XPA		Xeroderma pigmentosum||not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000994	9	100451852 - 100451856	9	97689570 - 97689574	994	16033	rs1200172747	NC_000009.12:97689569:ATAAGATAAGA:ATAAGA
NM_020944.3(GBA2):c.518G>A (p.Trp173Ter)	GBA2	W173*	Spastic paraplegia 46, autosomal recessive	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000638294	9	35744343	9	35744346	638294	626075		NC_000009.12:35744345:C:T
Single allele	TUSC3		Mental retardation, autosomal recessive 7	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000560138	8	15427697 - 15531804	8	15570188 - 15674295	560138	550854		
NM_020944.3(GBA2):c.700C>T (p.Arg234Ter)	GBA2	R234*	Spastic paraplegia 46, autosomal recessive	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000041486	9	35741755	9	35741758	41486	49925	rs398123013	NC_000009.12:35741757:G:A
NM_022370.4(ROBO3):c.2427G>A (p.Trp809Ter)	ROBO3	W809*	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000501316	11	124745855	11	124875959	501316	492740	rs372821877	NC_000011.10:124875958:G:A
NM_001291970.2(POLH):c.*2_*6del (p.Ter415=)	POLH	I316fs, I440fs	not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000449225	6	43581468 - 43581472	6	43613731 - 43613735	449225	443968	rs1554141842	NC_000006.12:43613730:ACATCAC:AC
NM_022370.4(ROBO3):c.3467_3476del (p.Leu1156fs)	ROBO3	L1156fs, L140fs, L205fs	not provided	Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	VCV000419194	11	124748623 - 124748632	11	124878727 - 124878736	419194	408298	rs754162997	NC_000011.10:124878726:CTCTTACACCCTC:CTC
NM_006502.2(POLH):c.1075-?_1244+?del	POLH			Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264682	6	43573056 - 43581397	6	43607987 - 43611911	264682	259256		
NM_022370.4(ROBO3):c.2317C>T (p.Gln773Ter)	ROBO3	Q773*	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000002185	11	124745477	11	124875581	2185	17224	rs121918278	NC_000011.10:124875580:C:T
NM_022370.4(ROBO3):c.1886_1887del (p.Val629fs)	ROBO3	V629fs	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000002183	11	124744067 - 124744068	11	124874171 - 124874172	2183	17222	rs1565312182	NC_000011.10:124874170:TT:
NM_022370.4(ROBO3):c.1838_1839CA[3] (p.Thr615fs)	ROBO3		Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000002182	11	124744018 - 124744019	11	124874122 - 124874123	2182	17221	rs775068146	NC_000011.10:124874121:ACACACACA:ACACACA
NM_022370.4(ROBO3):c.2073+1G>A	ROBO3		Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002181	11	124744806	11	124874910	2181	17220	rs1565312616	NC_000011.10:124874909:G:A
NM_022370.4(ROBO3):c.196A>C (p.Ile66Leu)	ROBO3	I66L	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002180	11	124738733	11	124868837	2180	17219	rs121918276	NC_000011.10:124868836:A:C
NM_022370.4(ROBO3):c.14T>C (p.Leu5Pro)	ROBO3	L5P	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002179	11	124735487	11	124865591	2179	17218	rs121918275	NC_000011.10:124865590:T:C
ROBO3, 1-BP INS, 2310C	ROBO3		Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002178					2178	17217		
NM_022370.4(ROBO3):c.955G>A (p.Glu319Lys)	ROBO3	E319K	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002177	11	124740546	11	124870650	2177	17216	rs121918274	NC_000011.10:124870649:G:A
NM_022370.4(ROBO3):c.1366G>T (p.Gly456Ter)	ROBO3	G456*	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002176	11	124742815	11	124872919	2176	17215	rs121918273	NC_000011.10:124872918:G:T
NM_022370.4(ROBO3):c.2113T>C (p.Ser705Pro)	ROBO3	S705P	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002175	11	124745046	11	124875150	2175	17214	rs121918272	NC_000011.10:124875149:T:C
NM_022370.4(ROBO3):c.2108G>C (p.Arg703Pro)	ROBO3	R703P	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002174	11	124745041	11	124875145	2174	17213	rs121918271	NC_000011.10:124875144:G:C
ROBO3, 1-BP INS, 3325G	ROBO3		Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002173					2173	17212		
NM_022370.4(ROBO3):c.1082G>A (p.Gly361Glu)	ROBO3	G361E	Gaze palsy, familial horizontal, with progressive scoliosis 1	Pathogenic(Last reviewed: Jun 4, 2004)	no assertion criteria provided	VCV000002172	11	124740958	11	124871062	2172	17211	rs121918270	NC_000011.10:124871061:G:A
NM_001291970.2(POLH):c.*348del	POLH	N431fs, N555fs		Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264681	6	43581813	6	43614076	264681	259251	rs886039225	NC_000006.12:43614075:AAAA:AAA
NM_006502.2(POLH):c.725C>G (p.Ser242Ter)	POLH	S242*, S118*		Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264680	6	43568789	6	43601052	264680	259250	rs745778317	NC_000006.12:43601051:C:G
NM_006502.2(POLH):c.907C>T (p.Arg303Ter)	POLH	R303*, R179*		Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000224063	6	43572374	6	43604637	224063	225791	rs759607901	NC_000006.12:43604636:C:T
NM_001291969.2(POLH):c.68_70TCT[1] (p.Phe24del)	POLH	L77del		Pathogenic(Last reviewed: Jul 9, 1999)	no assertion criteria provided	VCV000005893	6	43550828 - 43550830	6	43583091 - 43583093	5893	20932	rs1426687865	NC_000006.12:43583090:TCTTCT:TCT
NM_006502.2(POLH):c.207del (p.Lys70fs)	POLH	K70fs, R18fs		Pathogenic(Last reviewed: Jul 9, 1999)	no assertion criteria provided	VCV000005892	6	43550813	6	43583076	5892	20931	rs1176350430	NC_000006.12:43583075:G:
POLH, 104-BP DEL, NT661	POLH			Pathogenic(Last reviewed: Jul 9, 1999)	no assertion criteria provided	VCV000005891					5891	20930		
NM_006502.2(POLH):c.1117C>T (p.Gln373Ter)	POLH	V372*, Q373*, Q249*		Pathogenic(Last reviewed: Jul 9, 1999)	no assertion criteria provided	VCV000005890	6	43578333	6	43610596	5890	20929	rs121908564	NC_000006.12:43610595:C:T
NM_001291969.2(POLH):c.118+4234C>T	POLH	V125*, Q126*		Pathogenic(Last reviewed: Jul 9, 1999)	no assertion criteria provided	VCV000005889	6	43555112	6	43587375	5889	20928	rs121908563	NC_000006.12:43587374:C:T
POLH, DEL AND TRP297TER	POLH	W297*		Pathogenic(Last reviewed: Jun 17, 1999)	no assertion criteria provided	VCV000005888					5888	20927		
POLH, 2-BP DEL, NT770	POLH			Pathogenic(Last reviewed: Jun 17, 1999)	no assertion criteria provided	VCV000005886					5886	20925		
POLH, 4-BP DEL, NT289	POLH			Pathogenic(Last reviewed: Jun 17, 1999)	no assertion criteria provided	VCV000005885					5885	20924		
NM_006502.2(POLH):c.764+1G>A	POLH			Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000224062	6	43568829	6	43601092	224062	225790	rs772570523	NC_000006.12:43601091:G:A
NM_001291970.2(POLH):c.*450A>C	POLH	K589T, K465T		Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000005895	6	43581918	6	43614181	5895	20934	rs121908565	NC_000006.12:43614180:A:C
POLH, 13-BP DEL, NT343	POLH			Pathogenic(Last reviewed: Jul 9, 1999)	no assertion criteria provided	VCV000005884					5884	20923		
NM_004092.4(ECHS1):c.518C>T (p.Ala173Val)	ECHS1	A173V	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377257	10	135180494	10	133366990	377257	364135	rs150321966	NC_000010.11:133366989:G:A
NM_006502.2(POLH):c.916G>T (p.Glu306Ter)	POLH	E306*, E182*		Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000005887	6	43572383	6	43604646	5887	20926	rs121908562	NC_000006.12:43604645:G:T
NM_000190.4(HMBS):c.535del (p.Glu179fs)	HMBS	E162fs, E179fs	Abnormality of the heme biosynthetic pathway	Pathogenic	no assertion criteria provided	VCV000812773	11	118962159	11	119091449	812773	801122		NC_000011.10:119091448:G:
NM_005055.5(RAPSN):c.61C>T (p.Gln21Ter)	RAPSN	Q21*	Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802677	11	47470456	11	47448904	802677	791143		NC_000011.10:47448903:G:A
NM_005055.5(RAPSN):c.1177_1178del (p.Asn393fs)	RAPSN	N393fs, N334fs	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000545747	11	47459587 - 47459588	11	47438036 - 47438037	545747	536399	rs1555142142	NC_000011.10:47438035:TT:
NM_005055.5(RAPSN):c.149_153delinsAGATGGGCCGCTACAAGGAGATGG (p.Val50fs)	RAPSN		not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000430474	11	47470364 - 47470368	11	47448812 - 47448816	430474	421861	rs1131691986	NC_000011.10:47448811:TGTGA:CCATCTCCTTGTAGCGGCCCATCT
NM_005055.5(RAPSN):c.853_855delinsTAA (p.Gln285Ter)	RAPSN		not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000280676	11	47463220 - 47463222	11	47441668 - 47441670	280676	264555	rs886041841	NC_000011.10:47441667:CTG:TTA
NM_000190.4(HMBS):c.544dup (p.Glu182fs)	HMBS		not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000657634	11	118962166 - 118962167	11	119091456 - 119091457	657634	639783		NC_000011.10:119091456:GG:GGG
NM_000190.4(HMBS):c.323del (p.Phe108fs)	HMBS	F91fs, F108fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000657255	11	118960448	11	119089738	657255	639779		NC_000011.10:119089737:TT:T
NM_000190.4(HMBS):c.457C>T (p.Gln153Ter)	HMBS	Q153*, Q136*	not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000652216	11	118960934	11	119090224	652216	639781		NC_000011.10:119090223:C:T
NM_000190.4(HMBS):c.623_624del (p.Pro208fs)	HMBS	P191fs, P208fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000651426	11	118962845 - 118962846	11	119092135 - 119092136	651426	639785		NC_000011.10:119092134:CT:
NM_000190.4(HMBS):c.168_169del (p.Met56fs)	HMBS	M39fs, M56fs	not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000643733	11	118959798 - 118959799	11	119089088 - 119089089	643733	639776		NC_000011.10:119089087:TGT:T
NM_000190.4(HMBS):c.716del (p.His239fs)	HMBS	H222fs, H239fs	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000641071	11	118963178	11	119092468	641071	639788		NC_000011.10:119092467:A:
NM_000190.4(HMBS):c.400del (p.Thr133_Leu134insTer)	HMBS		Vomiting|Abdominal pain|Fever|Visual loss|Mood changes	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000374084	11	118960753	11	119090043	374084	360926	rs1057518886	NC_000011.10:119090042:CCC:CC
NM_005055.5(RAPSN):c.566C>T (p.Ala189Val)	RAPSN	A189V	FETAL AKINESIA DEFORMATION SEQUENCE 2	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000008059	11	47464332	11	47442780	8059	23098	rs121909257	NC_000011.10:47442779:G:A
NM_005055.5(RAPSN):c.416T>C (p.Phe139Ser)	RAPSN	F139S	FETAL AKINESIA DEFORMATION SEQUENCE 2	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000008058	11	47469479	11	47447927	8058	23097	rs121909256	NC_000011.10:47447926:A:G
NM_000190.4(HMBS):c.1A>G (p.Met1Val)	HMBS	M1V	Porphyria, acute intermittent, nonerythroid variant	Pathogenic(Last reviewed: Nov 1, 1994)	no assertion criteria provided	VCV000001484	11	118955744	11	119085034	1484	16523	rs118204118	NC_000011.10:119085033:A:G
NM_000190.4(HMBS):c.41del (p.Asn14fs)	HMBS	N14fs	Porphyria, acute intermittent, nonerythroid variant	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000001482	11	118958969	11	119088259	1482	16521		NC_000011.10:119088258:AAAA:AAA
HMBS, 1-BP DEL, -154G	HMBS		Porphyria, acute intermittent, nonerythroid variant	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000001481					1481	16520		
NC_000011.10:g.(?_47447802)_(47449175_?)del	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832215	11	47469354 - 47470727			832215	820381		
NC_000011.10:g.(?_119084613)_(119085735_?)del	HMBS		not provided	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000831113	11	118955323 - 118956445			831113	820340		
NC_000011.10:g.(?_119088234)_(119093560_?)del	HMBS		not provided	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000830732	11	118958944 - 118964270			830732	820341		
NM_005055.5(RAPSN):c.193-2A>C	RAPSN		Congenital myasthenic syndrome 4C	Pathogenic	criteria provided, single submitter	VCV000813472	11	47469704	11	47448152	813472	801691		NC_000011.10:47448151:T:G
NM_000190.4(HMBS):c.160+5G>C	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000694280	11	118959422	11	119088712	694280	682125		NC_000011.10:119088711:G:C
NM_000190.4(HMBS):c.215_216GA[2] (p.Ser75fs)	HMBS		not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000653427	11	118959931 - 118959932	11	119089221 - 119089222	653427	639777		NC_000011.10:119089220:GAGAGA:GAGA
NM_000190.4(HMBS):c.1078_*46del (p.Ala360fs)	HMBS	A303fs, A320fs, A343fs, A360fs	Acute intermittent porphyria	Pathogenic(Last reviewed: May 20, 2017)	criteria provided, single submitter	VCV000549662	11	118963984 - 118964038	11	119093274 - 119093328	549662	540142	rs1555206402	
NM_000190.4(HMBS):c.669_698del (p.Glu223_Leu232del)	HMBS		Acute intermittent porphyria	Pathogenic	criteria provided, single submitter	VCV000522578	11	118963127 - 118963156	11	119092417 - 119092446	522578	513190	rs1555206128	NC_000011.10:119092416:TGGAAGTGCGAGCCAAGGACCAGGACATCTTGGA:TGGA
NM_005055.5(RAPSN):c.853C>T (p.Gln285Ter)	RAPSN	Q285*	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000476126	11	47463222	11	47441670	476126	461705	rs1555142603	NC_000011.10:47441669:G:A
NM_005055.4(RAPSN):c.-199C>G	RAPSN		Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000264677	11	47470715	11	47449163	264677	259249	rs886037842	NC_000011.10:47449162:G:C
NM_005055.5(RAPSN):c.484G>A (p.Glu162Lys)	RAPSN	E162K	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000008056	11	47469411	11	47447859	8056	23095	rs121909255	NC_000011.10:47447858:C:T
NM_005055.5(RAPSN):c.193-15C>A	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Oct 10, 2006)	no assertion criteria provided	VCV000008053	11	47469717	11	47448165	8053	23092	rs45547231	NC_000011.10:47448164:G:T
NM_005055.5(RAPSN):c.807C>A (p.Tyr269Ter)	RAPSN	Y269*	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000008050	11	47463268	11	47441716	8050	23089	rs104894301	NC_000011.10:47441715:G:T
RAPSN, 1-BP INS, 46C	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000008049					8049	23088		
NM_005055.5(RAPSN):c.549_553dup (p.Phe185fs)	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000008048	11	47464344 - 47464345	11	47442792 - 47442793	8048	23087	rs786200904	NC_000011.10:47442792:AGAACAG:AGAACAGAACAG
NM_000190.4(HMBS):c.242T>C (p.Leu81Pro)	HMBS	L81P, L64P	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000001485	11	118959958	11	119089248	1485	16524	rs118204119	NC_000011.10:119089247:T:C
HMBS, ALU INS	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000001480					1480	16519		
NM_000190.4(HMBS):c.847_848del (p.Trp283fs)	HMBS	W283fs, W226fs, W243fs, W266fs	Acute intermittent porphyria	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000001479	11	118963666 - 118963667	11	119092956 - 119092957	1479	16518		NC_000011.10:119092955:TG:
NM_000190.4(HMBS):c.647G>A (p.Gly216Asp)	HMBS	G216D, G199D	Acute intermittent porphyria	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000001478	11	118962869	11	119092159	1478	16517	rs118204116	NC_000011.10:119092158:G:A
NM_000190.4(HMBS):c.266+1G>C	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000001477	11	118959983	11	119089273	1477	16516	rs1565754565	NC_000011.10:119089272:G:C
HMBS, IVS14DS, G-A, +1	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000001476					1476	16515		
NM_000190.4(HMBS):c.771+1G>C	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001475	11	118963234	11	119092524	1475	16514	rs1565758008	NC_000011.10:119092523:G:C
NM_000190.4(HMBS):c.766C>A (p.His256Asn)	HMBS	H256N, H239N	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001474	11	118963228	11	119092518	1474	16513	rs118204115	NC_000011.10:119092517:C:A
NM_000190.4(HMBS):c.755C>T (p.Ala252Val)	HMBS	A252V, A235V	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001473	11	118963217	11	119092507	1473	16512	rs118204114	NC_000011.10:119092506:C:T
NM_000190.4(HMBS):c.754G>A (p.Ala252Thr)	HMBS	A252T, A235T	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001472	11	118963216	11	119092506	1472	16511	rs118204113	NC_000011.10:119092505:G:A
NM_000190.4(HMBS):c.748G>A (p.Glu250Lys)	HMBS	E250K, E233K	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001471	11	118963210	11	119092500	1471	16510	rs118204112	NC_000011.10:119092499:G:A
NM_000190.4(HMBS):c.734_741dup (p.Ile248fs)	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001470	11	118963191 - 118963192	11	119092481 - 119092482	1470	16509	rs1565757857	NC_000011.10:119092481:CTGCTTCGCTGC:CTGCTTCGCTGCTTCGCTGC
NM_000190.4(HMBS):c.739T>C (p.Cys247Arg)	HMBS	C247R, C230R	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001469	11	118963201	11	119092491	1469	16508	rs118204111	NC_000011.10:119092490:T:C
NM_000190.4(HMBS):c.499-1G>A	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001465	11	118962122	11	119091412	1465	16504	rs1565756481	NC_000011.10:119091411:G:A
HMBS, 2-BP DEL, 218AG	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001463					1463	16502		
NM_000190.4(HMBS):c.211-1G>A	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001461	11	118959926	11	119089216	1461	16500	rs1565754452	NC_000011.10:119089215:G:A
NM_000190.4(HMBS):c.181dup (p.Asp61fs)	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001460	11	118959808 - 118959809	11	119089098 - 119089099	1460	16499	rs1565754296	NC_000011.10:119089098:GGGG:GGGGG
NM_000190.4(HMBS):c.174del (p.Thr59fs)	HMBS	T59fs, T42fs	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001459	11	118959804	11	119089094	1459	16498	rs1565754285	NC_000011.10:119089093:CC:C
NM_000190.4(HMBS):c.163G>T (p.Ala55Ser)	HMBS	A55S, A38S	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001458	11	118959794	11	119089084	1458	16497	rs118204106	NC_000011.10:119089083:G:T
NM_000190.4(HMBS):c.500G>T (p.Arg167Leu)	HMBS	R167L, R150L	Acute intermittent porphyria	Pathogenic(Last reviewed: Apr 15, 1991)	no assertion criteria provided	VCV000001457	11	118962124	11	119091414	1457	16496	rs118204095	NC_000011.10:119091413:G:T
NM_000190.4(HMBS):c.100C>A (p.Gln34Lys)	HMBS	Q34K, Q17K	Acute intermittent porphyria	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000001455	11	118959357	11	119088647	1455	16494	rs118204105	NC_000011.10:119088646:C:A
NM_000190.4(HMBS):c.91G>A (p.Ala31Thr)	HMBS	A31T, A14T	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001454	11	118959348	11	119088638	1454	16493	rs118204104	NC_000011.10:119088637:G:A
NM_000190.4(HMBS):c.593G>A (p.Trp198Ter)	HMBS	W198*, W181*	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000001453	11	118962217	11	119091507	1453	16492	rs118204100	NC_000011.10:119091506:G:A
HMBS, 9-BP DEL, EX10	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000001452					1452	16491		
NM_000190.4(HMBS):c.900del (p.His300fs)	HMBS	H243fs, H260fs, H300fs, H283fs	Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000001451	11	118963719	11	119093009	1451	16490	rs1565758825	NC_000011.10:119093008:T:
NM_000190.4(HMBS):c.734T>G (p.Leu245Arg)	HMBS	L245R, L228R	Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000001450	11	118963196	11	119092486	1450	16489	rs118204099	NC_000011.10:119092485:T:G
NM_000190.4(HMBS):c.446G>A (p.Arg149Gln)	HMBS	R149Q, R132Q	Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000001449	11	118960923	11	119090213	1449	16488	rs118204098	NC_000011.10:119090212:G:A
NM_000190.4(HMBS):c.463C>T (p.Gln155Ter)	HMBS	Q155*, Q138*	Acute intermittent porphyria	Pathogenic(Last reviewed: Oct 1, 1990)	no assertion criteria provided	VCV000001448	11	118960940	11	119090230	1448	16487	rs118204097	NC_000011.10:119090229:C:T
NM_000190.4(HMBS):c.346C>T (p.Arg116Trp)	HMBS	R116W, R99W	Acute intermittent porphyria	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000001445	11	118960701	11	119089991	1445	16484	rs118204094	NC_000011.10:119089990:C:T
NM_000190.4(HMBS):c.33+1G>T	HMBS		Porphyria, acute intermittent, nonerythroid variant	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000001444	11	118955777	11	119085067	1444	16483	rs1565750784	NC_000011.10:119085066:G:T
HMBS, EX12DEL	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 25, 1989)	no assertion criteria provided	VCV000001442					1442	16481		
NM_005055.5(RAPSN):c.997G>T (p.Glu333Ter)	RAPSN	E333*, E274*	Pena-Shokeir syndrome type I|Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000664620	11	47460452	11	47438901	664620	640138		NC_000011.10:47438900:C:A
NM_000190.4(HMBS):c.874C>T (p.Gln292Ter)	HMBS	Q235*, Q252*, Q292*, Q275*	not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000652166	11	118963693	11	119092983	652166	639790		NC_000011.10:119092982:C:T
NM_005055.5(RAPSN):c.41T>C (p.Leu14Pro)	RAPSN	L14P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000008047	11	47470476	11	47448924	8047	23086	rs104894300	NC_000011.10:47448923:A:G
NM_000190.4(HMBS):c.728_729CT[1] (p.Leu244fs)	HMBS		Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001468	11	118963190 - 118963191	11	119092480 - 119092481	1468	16507	rs1565757839	NC_000011.10:119092479:CTCT:CT
NM_000190.4(HMBS):c.331G>A (p.Gly111Arg)	HMBS	G111R, G94R	Acute intermittent porphyria	Pathogenic(Last reviewed: Oct 8, 1999)	no assertion criteria provided	VCV000001464	11	118960457	11	119089747	1464	16503	rs118204107	NC_000011.10:119089746:G:A
NM_000190.4(HMBS):c.518G>A (p.Arg173Gln)	HMBS	R173Q, R156Q	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000001447	11	118962142	11	119091432	1447	16486	rs118204096	NC_000011.10:119091431:G:A
NM_000399.5(EGR2):c.1141C>T (p.Arg381Cys)	EGR2	R381C, R331C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000637524	10	64573257	10	62813497	637524	625202		NC_000010.11:62813496:G:A
NM_000035.4(ALDOB):c.324G>A (p.Lys108=)	ALDOB		Hereditary fructosuria	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188779	9	104192037	9	101429755	188779	186779	rs750026492	NC_000009.12:101429754:C:T
NM_005055.5(RAPSN):c.1116_1118GAA[1] (p.Lys373del)	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000847394	11	47460328 - 47460330	11	47438777 - 47438779	847394	838547		NC_000011.10:47438776:TTCTTCT:TTCT
NM_000190.4(HMBS):c.161-1G>C	HMBS		not provided	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000842813	11	118959791	11	119089081	842813	852605		NC_000011.10:119089080:G:C
NM_000190.4(HMBS):c.771+2T>C	HMBS		not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000841292	11	118963235	11	119092525	841292	852333		NC_000011.10:119092524:T:C
NC_000011.10:g.(?_47437965)_(47438941_?)del	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000832988	11	47459516 - 47460492			832988	820380		
NM_000190.4(HMBS):c.612G>T (p.Gln204His)	HMBS	Q187H, Q204H	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000652314	11	118962236	11	119091526	652314	639784		NC_000011.10:119091525:G:T
NM_000190.4(HMBS):c.612+1G>A	HMBS		not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000645478	11	118962237	11	119091527	645478	652112		NC_000011.10:119091526:G:A
NC_000011.9:g.(?_47459506)_(47460502_?)del	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000542739	11	47459506 - 47460502	11	47437955 - 47438951	542739	525851		
NM_005055.5(RAPSN):c.370C>T (p.Gln124Ter)	RAPSN	Q124*	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000476121	11	47469525	11	47447973	476121	462028	rs1479498379	NC_000011.10:47447972:G:A
NM_005055.5(RAPSN):c.1081_1082CT[3] (p.Tyr362fs)	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000190252	11	47460364 - 47460365	11	47438813 - 47438814	190252	188076	rs786205885	NC_000011.10:47438813:AGAG:AGAGAG
NM_000190.4(HMBS):c.33+1G>A	HMBS		Porphyria, acute intermittent, nonerythroid variant	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000001441	11	118955777	11	119085067	1441	16480	rs1565750784	NC_000011.10:119085066:G:A
NM_001540.5(HSPB1):c.560C>T (p.Ser187Leu)	HSPB1	S187L	Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000560409	7	75933432	7	76304115	560409	551462	rs774585320	NC_000007.14:76304114:C:T
NM_001540.5(HSPB1):c.171_172insGCGCCCT (p.Leu58fs)	HSPB1		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637505	7	75932200 - 75932201	7	76302883 - 76302884	637505	625147		NC_000007.14:76302883::GCGCCCT
NM_001540.5(HSPB1):c.505del (p.Met169fs)	HSPB1	M169fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637259	7	75933377	7	76304060	637259	625152		NC_000007.14:76304059:A:
NM_001540.5(HSPB1):c.545C>T (p.Pro182Leu)	HSPB1	P182L	Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000007481	7	75933417	7	76304100	7481	22520	rs28937569	NC_000007.14:76304099:C:T
NM_000190.4(HMBS):c.913-2A>G	HMBS		not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000855310	11	118963818	11	119093108	855310	851429		NC_000011.10:119093107:A:G
NM_000190.4(HMBS):c.613-1G>T	HMBS		not provided	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000845819	11	118962834	11	119092124	845819	851820		NC_000011.10:119092123:G:T
RAPSN, 2-BP DEL, 1177AA	RAPSN		FETAL AKINESIA DEFORMATION SEQUENCE 2|Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000008057					8057	23096		
NM_003289.4(TPM2):c.620_631dup (p.Ala211_Asp212insValGluAlaGln)	TPM2		Distal arthrogryposis type 1A	Pathogenic	no assertion criteria provided	VCV000816832	9	35684736 - 35684737	9	35684739 - 35684740	816832	805017		NC_000009.12:35684739:CCTGGGCCTCCA:CCTGGGCCTCCACCTGGGCCTCCA
NM_213674.1(TPM2):c.210del (p.Lys70fs)	TPM2	K70fs	not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000452383	9	35689173	9	35689176	452383	444490	rs1554659545	NC_000009.12:35689175:TTT:TT
NM_213674.1(TPM2):c.320del (p.Ala107fs)	TPM2	A107fs	not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000451987	9	35685698	9	35685701	451987	444489	rs775399371	NC_000009.12:35685700:G:
NM_213674.1(TPM2):c.374+2T>C	TPM2		ARTHROGRYPOSIS, DISTAL, TYPE 2B4	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000631480	9	35685642	9	35685645	631480	619843	rs113612402	NC_000009.12:35685644:A:G
NM_213674.1(TPM2):c.308A>G (p.Gln103Arg)	TPM2	N103R, Q103R	ARTHROGRYPOSIS, DISTAL, TYPE 2B4	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000631479	9	35685710	9	35685713	631479	619842	rs1563929383	NC_000009.12:35685712:T:C
NM_001083116.3(PRF1):c.1163G>T (p.Ser388Ile)	PRF1	S388I	Aplastic anemia	Pathogenic(Last reviewed: Jun 15, 2007)	no assertion criteria provided	VCV000013719	10	72358314	10	70598558	13719	28758	rs193302875	NC_000010.11:70598557:C:A
NC_000010.11:g.(?_70598033)_(70600922_?)del	PRF1			Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000831689	10	72357789 - 72360678			831689	820232		
NM_003227.4(TFR2):c.949C>T (p.Gln317Ter)	TFR2	Q317*, Q146*	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021379	7	100229722	7	100632099	21379	34231	rs80338881	NC_000007.14:100632098:G:A
NM_003227.4(TFR2):c.64G>A (p.Val22Ile)	TFR2	V22I	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021377	7	100238821	7	100641198	21377	34229	rs80338876	NC_000007.14:100641197:C:T
NM_003227.4(TFR2):c.313C>T (p.Arg105Ter)	TFR2	R105*	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021375	7	100238469	7	100640846	21375	34227	rs80338878	NC_000007.14:100640845:G:A
NM_003227.4(TFR2):c.2137-1G>A	TFR2		Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021371	7	100218750	7	100621127	21371	34223	rs80338890	NC_000007.14:100621126:C:T
NM_003227.4(TFR2):c.1849_1860GCCGTGGCCCAG[1] (p.617_620AVAQ[1])	TFR2		Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021370	7	100225010 - 100225021	7	100627387 - 100627398	21370	34222	rs80338888	NC_000007.14:100627386:CTGGGCCACGGCCTGGGCCACGGC:CTGGGCCACGGC
NM_003227.4(TFR2):c.1665del (p.Ser556fs)	TFR2	S556fs, S385fs	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021367	7	100225384	7	100627761	21367	34219	rs80338887	NC_000007.14:100627760:GGG:GG
NM_003227.4(TFR2):c.1469T>G (p.Leu490Arg)	TFR2	L490R, L319R	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021366	7	100225851	7	100628228	21366	34218	rs80338886	NC_000007.14:100628227:A:C
NM_003227.4(TFR2):c.1330G>A (p.Ala444Thr)	TFR2	A444T, A273T	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021364	7	100226936	7	100629313	21364	34216	rs80338884	NC_000007.14:100629312:C:T
NM_003227.4(TFR2):c.1232_1234ACA[1] (p.Asn412del)	TFR2	N411del, N412del	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021363	7	100228545 - 100228547	7	100630922 - 100630924	21363	34215	rs80338883	NC_000007.14:100630921:TGTTGTTG:TGTTG
NM_003227.4(TFR2):c.1186C>T (p.Arg396Ter)	TFR2	R396*, R225*	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021362	7	100228596	7	100630973	21362	34214	rs80338882	NC_000007.14:100630972:G:A
NM_001083116.3(PRF1):c.1246C>T (p.Gln416Ter)	PRF1	Q416*		Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000013723	10	72358231	10	70598475	13723	28762	rs193302876	NC_000010.11:70598474:G:A
NM_001083116.3(PRF1):c.207del (p.Asp70fs)	PRF1	D70fs		Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000013722	10	72360452	10	70600696	13722	28761	rs786205093	NC_000010.11:70600695:GGG:GG
NM_001083116.3(PRF1):c.1090_1091del (p.Leu364fs)	PRF1	L364fs		Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000013721	10	72358386 - 72358387	10	70598630 - 70598631	13721	28760	rs771552960	NC_000010.11:70598629:AG:
NM_001083116.3(PRF1):c.548T>G (p.Val183Gly)	PRF1	V183G		Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000013715	10	72358929	10	70599173	13715	28754	rs104894183	NC_000010.11:70599172:A:C
NM_001083116.3(PRF1):c.836G>A (p.Cys279Tyr)	PRF1	C279Y		Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000013714	10	72358641	10	70598885	13714	28753	rs104894182	NC_000010.11:70598884:C:T
NM_001083116.3(PRF1):c.1034C>T (p.Pro345Leu)	PRF1	P345L		Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000013713	10	72358443	10	70598687	13713	28752	rs28933374	NC_000010.11:70598686:G:A
NM_001083116.3(PRF1):c.1286G>A (p.Gly429Glu)	PRF1	G429E		Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000013712	10	72358191	10	70598435	13712	28751	rs104894181	NC_000010.11:70598434:C:T
PRF1, 1-BP DEL, 50T	PRF1			Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000013708					13708	28747		
NM_003227.4(TFR2):c.1811dup (p.Tyr604Ter)	TFR2		Hereditary hemochromatosis	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000857035	7	100225070 - 100225071	7	100627447 - 100627448	857035	832627		NC_000007.14:100627447:T:TT
NM_003227.4(TFR2):c.1163del (p.Pro388fs)	TFR2	P217fs, P388fs	Hereditary hemochromatosis	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000850883	7	100228619	7	100630996	850883	832629		NC_000007.14:100630995:GGGG:GGG
NM_003227.4(TFR2):c.1629del (p.Gln544fs)	TFR2	Q373fs, Q544fs	Hereditary hemochromatosis	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000834979	7	100225420	7	100627797	834979	832628		NC_000007.14:100627796:CCC:CC
NC_000007.14:g.(?_100640676)_(100641519_?)del	TFR2		Hereditary hemochromatosis	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000831039	7	100238299 - 100239142			831039	819770		
NM_003227.4(TFR2):c.401_402dup (p.Leu135fs)	TFR2		Hereditary hemochromatosis	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000652249	7	100238379 - 100238380	7	100640756 - 100640757	652249	635339		NC_000007.14:100640756:TCT:TCTCT
NC_000007.13:g.(?_100238303)_(100239138_?)del	TFR2		Hereditary hemochromatosis	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000583971	7	100238303 - 100239138	7	100640680 - 100641515	583971	561136		
NM_003227.4(TFR2):c.1870C>T (p.Gln624Ter)	TFR2	Q624*, Q453*	Hereditary hemochromatosis	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000582071	7	100225012	7	100627389	582071	561113	rs1220336558	NC_000007.14:100627388:G:A
NM_003227.4(TFR2):c.1746del (p.Val583fs)	TFR2	V412fs, V583fs	Hereditary hemochromatosis	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000581375	7	100225221	7	100627598	581375	563903	rs1562838535	NC_000007.14:100627597:GG:G
NM_003227.4(TFR2):c.1409G>T (p.Ser470Ile)	TFR2	S470I, S299I	Hereditary hemochromatosis	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000577309	7	100225911	7	100628288	577309	566173	rs772104483	NC_000007.14:100628287:C:A
NM_001083116.3(PRF1):c.1385C>A (p.Ser462Ter)	PRF1	S462*		Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561093	10	72358092	10	70598336	561093	552144	rs1564723653	NC_000010.11:70598335:G:T
NM_001083116.3(PRF1):c.1081A>T (p.Arg361Trp)	PRF1	R361W	not provided|	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000502548	10	72358396	10	70598640	502548	493972	rs752858869	NC_000010.11:70598639:T:A
NM_003227.4(TFR2):c.253del (p.Leu85fs)	TFR2	L85fs	Hereditary hemochromatosis	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000461198	7	100238632	7	100641009	461198	456865	rs1426704853	NC_000007.14:100641008:GG:G
NM_003227.4(TFR2):c.1398del (p.Arg468fs)	TFR2	R468fs, R297fs	Hereditary hemochromatosis	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000461197	7	100225922	7	100628299	461197	455888	rs773050231	NC_000007.14:100628298:CC:C
NM_001083116.3(PRF1):c.1304C>T (p.Thr435Met)	PRF1	T435M		Pathogenic(Last reviewed: Mar 15, 2003)	no assertion criteria provided	VCV000013717	10	72358173	10	70598417	13717	28756	rs28933376	NC_000010.11:70598416:G:A
NM_001083116.3(PRF1):c.190C>T (p.Gln64Ter)	PRF1	Q64*		Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000013710	10	72360469	10	70600713	13710	28749	rs104894180	NC_000010.11:70600712:G:A
NM_213674.1(TPM2):c.640-215C>G	TPM2	N202K	Cap myopathy 2|not provided	Pathogenic(Last reviewed: Dec 2, 2008)	no assertion criteria provided	VCV000012467	9	35684762	9	35684765	12467	27506	rs137853307	NC_000009.12:35684764:G:C
NM_213674.1(TPM2):c.142_144AAG[1] (p.Lys49del)	TPM2	K49del	Cap myopathy 2|not provided	Pathogenic(Last reviewed: Dec 2, 2008)	no assertion criteria provided	VCV000012466	9	35689236 - 35689238	9	35689239 - 35689241	12466	27505	rs199476147	NC_000009.12:35689238:CTTCTTCT:CTTCT
NM_003227.4(TFR2):c.515T>A (p.Met172Lys)	TFR2	M172K, M1K	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000005382	7	100231138	7	100633515	5382	20421	rs80338879	NC_000007.14:100633514:A:T
NM_003227.4(TFR2):c.88dup (p.Arg30fs)	TFR2		Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000005381	7	100238796 - 100238797	7	100641173 - 100641174	5381	20420	rs80338877	NC_000007.14:100641173:GGGGG:GGGGGG
NM_003227.4(TFR2):c.750C>G (p.Tyr250Ter)	TFR2	Y250*, Y79*	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000005380	7	100230723	7	100633100	5380	20419	rs80338880	NC_000007.14:100633099:G:C
NM_003172.4(SURF1):c.586C>T (p.Gln196Ter)	SURF1	Q196*, Q87*	not provided|Leigh syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000243077	9	136219551	9	133352696	243077	244160	rs147816470	NC_000009.12:133352695:G:A
NM_003172.4(SURF1):c.-11_13del (p.Met1_Ala5del)	SURF1		not provided|Leigh syndrome	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000215241	9	136223317 - 136223340	9	133356441 - 133356464	215241	211371	rs863224229	NC_000009.12:133356440:CCACCGCCGCCATCGCACCCGGCCCC:CC
NM_001258392.3(CLPB):c.829C>T (p.Arg277Ter)	CLPB	R307*, R277*, R262*, R248*	not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000489055	11	72040795	11	72329751	489055	482003	rs1466435969	NC_000011.10:72329750:G:A
NM_001258392.3(CLPB):c.873+1G>A	CLPB		not provided	Pathogenic(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	VCV000449301	11	72040750	11	72329706	449301	444887	rs974377052	NC_000011.10:72329705:C:T
NM_014384.2(ACAD8):c.46_52del (p.Leu16fs)	ACAD8	L16fs	not provided	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000418783	11	134123540 - 134123546	11	134253646 - 134253652	418783	408307	rs1064793430	NC_000011.10:134253645:CTGCCCG:
NM_014384.2(ACAD8):c.567+1G>A	ACAD8		not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000372296	11	134128979	11	134259085	372296	360014	rs777756488	NC_000011.10:134259084:G:A
NM_001330174.2(ACADSB):c.-3-2627C>T	ACADSB	Q99*	not provided	Pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, single submitter	VCV000281177	10	124797355	10	123037839	281177	265414	rs760791287	NC_000010.11:123037838:C:T
NM_001609.4(ACADSB):c.653dup (p.Val219fs)	ACADSB		Deficiency of 2-methylbutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000859736	10	124800866 - 124800867	10	123041350 - 123041351	859736	836687		NC_000010.11:123041350:T:TT
NM_001258392.3(CLPB):c.934C>T (p.Arg312Ter)	CLPB	R342*, R283*, R297*, R312*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802698	11	72028204	11	72317160	802698	791169		NC_000011.10:72317159:G:A
NM_001609.4(ACADSB):c.375dup (p.Glu126fs)	ACADSB		Deficiency of 2-methylbutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000659271	10	124800052 - 124800053	10	123040536 - 123040537	659271	638765		NC_000010.11:123040536:A:AA
NM_014384.2(ACAD8):c.133C>T (p.Gln45Ter)	ACAD8	Q45*	Deficiency of isobutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000645496	11	134126465	11	134256571	645496	639823		NC_000011.10:134256570:C:T
NM_014384.2(ACAD8):c.445_446CT[3] (p.Cys150fs)	ACAD8		not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000095587	11	134128472 - 134128473	11	134258578 - 134258579	95587	101485	rs398124269	NC_000011.10:134258578:CTCT:CTCTCT
NM_001609.3(ACADSB):c.1228G>A (p.Gly410Ser)	ACADSB	G410S, G308S	Deficiency of 2-methylbutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000009199	10	124812676	10	123053160	9199	24238	rs387906409	NC_000010.11:123053159:G:A
NM_014384.2(ACAD8):c.867C>A (p.His289Gln)	ACAD8	H267Q, H289Q	Deficiency of isobutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000005358	11	134131194	11	134261300	5358	20397	rs121908421	NC_000011.10:134261299:C:A
NM_014384.2(ACAD8):c.455T>C (p.Met152Thr)	ACAD8	M103T, M152T	Deficiency of isobutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000005355	11	134128483	11	134258589	5355	20394	rs121908418	NC_000011.10:134258588:T:C
NM_001258392.3(CLPB):c.193G>T (p.Gly65Ter)	CLPB	G65*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000856343	11	72145326	11	72434282	856343	839004		NC_000011.10:72434281:C:A
NM_001258392.3(CLPB):c.646+7310G>A	CLPB	W230*, W185*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000851107	11	72084015	11	72372971	851107	839000		NC_000011.10:72372970:C:T
NM_014384.3(ACAD8):c.348C>A (p.Cys116Ter)	ACAD8	C116*	Deficiency of isobutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000848313	11	134127119	11	134257225	848313	838124		NC_000011.10:134257224:C:A
NC_000011.10:g.(?_72372905)_(72380404_?)del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000830973	11	72083949 - 72091448			830973	820416		
NC_000011.9:g.(?_72004391)_(72145538_?)del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000642638	11	72004391 - 72145538	11	72293347 - 72434494	642638	652395		
NM_001258392.3(CLPB):c.1167+5G>T	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000574472	11	72013343	11	72302299	574472	570997	rs1565424666	NC_000011.10:72302298:C:A
NM_001258392.3(CLPB):c.646+7323G>T	CLPB	E235*, E190*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000571241	11	72084002	11	72372958	571241	567536	rs374473067	NC_000011.10:72372957:C:A
NM_001258392.3(CLPB):c.1955T>A (p.Ile652Asn)	CLPB	I682N, I652N, I637N, I623N	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279613	11	72004490	11	72293446	279613	263872	rs886041120	NC_000011.10:72293445:A:T
NM_001258392.3(CLPB):c.1847dup (p.Cys617fs)	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279612	11	72004597 - 72004598	11	72293553 - 72293554	279612	263873	rs886041119	NC_000011.10:72293553:CCCCC:CCCCCC
NM_001258392.3(CLPB):c.1825G>A (p.Glu609Lys)	CLPB	E639K, E609K, E594K, E580K	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279611	11	72004620	11	72293576	279611	263874	rs375934856	NC_000011.10:72293575:C:T
NM_001258392.3(CLPB):c.1411G>A (p.Glu471Lys)	CLPB	E501K, E471K, E456K, E442K	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279608	11	72006611	11	72295567	279608	263877	rs748915609	NC_000011.10:72295566:C:T
NM_001258392.3(CLPB):c.1366T>C (p.Cys456Arg)	CLPB	C486R, C456R, C427R, C441R	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279607	11	72006656	11	72295612	279607	263878	rs886041118	NC_000011.10:72295611:A:G
NM_001258392.3(CLPB):c.715G>A (p.Ala239Thr)	CLPB	A269T, A239T, A224T, A210T	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279605	11	72069984	11	72358940	279605	263880	rs886041117	NC_000011.10:72358939:C:T
NM_001258392.3(CLPB):c.658C>T (p.Arg220Ter)	CLPB	R250*, R220*, R205*, R191*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279604	11	72070041	11	72358997	279604	263881	rs777202372	NC_000011.10:72358996:G:A
NM_001609.3(ACADSB):c.763C>T (p.Leu255Phe)	ACADSB	L222F, L255F, L153F	Deficiency of 2-methylbutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000009200	10	124802643	10	123043127	9200	24239	rs137852649	NC_000010.11:123043126:C:T
NM_001609.3(ACADSB):c.1165A>G (p.Met389Val)	ACADSB	M287V, M389V	Deficiency of 2-methylbutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000664690	10	124812613	10	123053097	664690	638768		NC_000010.11:123053096:A:G
NM_001258392.3(CLPB):c.725A>G (p.Tyr242Cys)	CLPB	Y272C, Y242C, Y227C, Y213C	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279606	11	72069974	11	72358930	279606	263879	rs777313457	NC_000011.10:72358929:T:C
NM_001258392.3(CLPB):c.1595del (p.Ile532fs)	CLPB	I503fs, I532fs, I562fs, I517fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000192392	11	72005454	11	72294410	192392	190178	rs876657402	NC_000011.10:72294409:A:
NM_001258392.3(CLPB):c.871A>T (p.Lys291Ter)	CLPB	K321*, K291*, K262*, K276*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000187788	11	72040753	11	72329709	187788	185686	rs786205139	NC_000011.10:72329708:T:A
NM_001258392.3(CLPB):c.1760A>G (p.Tyr587Cys)	CLPB	Y617C, Y587C, Y558C, Y572C	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000187784	11	72005091	11	72294047	187784	185682	rs786205138	NC_000011.10:72294046:T:C
NM_001258392.3(CLPB):c.1143G>A (p.Met381Ile)	CLPB	M411I, M381I, M352I, M366I	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000187783	11	72013372	11	72302328	187783	185681	rs786205137	NC_000011.10:72302327:C:T
NM_001258392.3(CLPB):c.1682C>T (p.Ala561Val)	CLPB	A591V, A561V, A546V, A532V	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000187782	11	72005169	11	72294125	187782	185680	rs748010262	NC_000011.10:72294124:G:A
NM_001258392.3(CLPB):c.1847G>T (p.Gly616Val)	CLPB	G646V, G616V, G601V, G587V	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000187781	11	72004598	11	72293554	187781	185679	rs759500860	NC_000011.10:72293553:C:A
NM_001258392.3(CLPB):c.1215_1217inv (p.Glu405_Gly406delinsAspPro)	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000187780	11	72012959 - 72012961	11	72301915 - 72301917	187780	185678		NC_000011.10:72301914:CCC:GGG
NM_001609.3(ACADSB):c.303+3A>G	ACADSB		not provided|Deficiency of 2-methylbutyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000448980	10	124797366	10	123037850	448980	444567	rs1345480688	NC_000010.11:123037849:A:G
NM_020944.3(GBA2):c.1018C>T (p.Arg340Ter)	GBA2	R340*	Spastic paraplegia|Spastic paraplegia 46, autosomal recessive	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041489	9	35740830	9	35740833	41489	49928	rs398123014	NC_000009.12:35740832:G:A
NM_000190.4(HMBS):c.345-1G>A	HMBS		not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000664103	11	118960699	11	119089989	664103	652103		NC_000011.10:119089988:G:A
NM_000190.4(HMBS):c.517C>T (p.Arg173Trp)	HMBS	R173W, R156W	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000649348	11	118962141	11	119091431	649348	639782		NC_000011.10:119091430:C:T
NM_000190.4(HMBS):c.673C>T (p.Arg225Ter)	HMBS	R208*, R225*	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000642877	11	118963135	11	119092425	642877	639787		NC_000011.10:119092424:C:T
NM_000190.4(HMBS):c.445C>T (p.Arg149Ter)	HMBS	R149*, R132*	Acute intermittent porphyria	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	VCV000001486	11	118960922	11	119090212	1486	16525	rs118204120	NC_000011.10:119090211:C:T
NM_005670.4(EPM2A):c.466_469dup (p.Tyr157fs)	EPM2A		not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000423471	6	146007264 - 146007265	6	145686128 - 145686129	423471	406824	rs1554263320	NC_000006.12:145686128:AATG:AATGAATG
NM_005445.3(SMC3):c.1539del (p.Asn513fs)	SMC3	N513fs	not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000419035	10	112350199	10	110590441	419035	407811	rs1064793598	NC_000010.11:110590440:C:
NM_005670.4(EPM2A):c.303_476+1del	EPM2A		not provided	Pathogenic(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	VCV000205446	6	146007257 - 146007431	6	145686121 - 145686295	205446	201932	rs1554263318	
NM_005670.4(EPM2A):c.878A>T (p.Gln293Leu)	EPM2A	Q293L, Q139L, Q155L	not provided	Pathogenic(Last reviewed: May 23, 2013)	criteria provided, single submitter	VCV000205434	6	145948670	6	145627534	205434	201924	rs796052427	NC_000006.12:145627533:T:A
NM_001083116.3(PRF1):c.1337A>C (p.Gln446Pro)	PRF1	Q446P		Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216986	10	72358140	10	70598384	216986	213598	rs751161742	NC_000010.11:70598383:T:G
NM_213674.1(TPM2):c.397C>T (p.Arg133Trp)	TPM2	R133W	ARTHROGRYPOSIS, DISTAL, TYPE 2B4|not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000012463	9	35685526	9	35685529	12463	27502	rs137853305	NC_000009.12:35685528:G:A
NM_213674.1(TPM2):c.440A>C (p.Gln147Pro)	TPM2	Q147P	Nemaline myopathy 4|not provided	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000012461	9	35685483	9	35685486	12461	27500	rs104894128	NC_000009.12:35685485:T:G
NM_213674.1(TPM2):c.271C>G (p.Arg91Gly)	TPM2	R91G	Distal arthrogryposis type 1A|not provided	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000012460	9	35685747	9	35685750	12460	27499	rs104894127	NC_000009.12:35685749:G:C
NM_005144.5(HR):c.-319G>A	HR	M1I	Hypotrichosis 4	Pathogenic(Last reviewed: Mar 30, 2020)	no assertion criteria provided	VCV000830233	8	21988219	8	22130706	830233	818633		NC_000008.11:22130705:C:T
NM_005670.4(EPM2A):c.314A>G (p.His105Arg)	EPM2A	H105R	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433103	6	146007420	6	145686284	433103	426666	rs1554263366	NC_000006.12:145686283:T:C
NM_005144.4(HR):c.3526C>T (p.Gln1176Ter)	HR	Q1176*, Q1121*	Atrichia with papular lesions	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007339	8	21973257	8	22115744	7339	22378	rs121434450	NC_000008.11:22115743:G:A
HR, 2-BP DEL, 2847AG	HR		Atrichia with papular lesions	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007338					7338	22377		
HR, 21-BP DEL, NT1261	HR		Atrichia with papular lesions	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000007337					7337	22376		
HR, 1-BP DEL, 1256C	HR		Atrichia with papular lesions	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000007336					7336	22375		
HR, 1-BP DEL, 2147C	HR		Atrichia with papular lesions	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000007333					7333	22372		
HR, IVS12DS, G-A, +1	HR		Alopecia universalis congenita	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000007332					7332	22371		
NM_005144.4(HR):c.3407T>A (p.Val1136Asp)	HR	V1136D, V1081D	Alopecia universalis congenita	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000007331	8	21973913	8	22116400	7331	22370	rs121434448	NC_000008.11:22116399:A:T
NM_005445.4(SMC3):c.1138_1152del (p.Gly380_Gln384del)	SMC3		Cornelia de Lange syndrome 3	Pathogenic(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000864833	10	112343984 - 112343998	10	110584226 - 110584240	864833	855081		NC_000010.11:110584225:CAGGGTCGAGGAAGCCAG:CAG
NM_005670.4(EPM2A):c.835G>T (p.Gly279Cys)	EPM2A	G279C, G125C, G141C, R198L	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000834981	6	145948713	6	145627577	834981	831636		NC_000006.12:145627576:C:A
NM_018411.4(HR):c.1997_2000CCAG[1] (p.Ser667fs)	HR		Atrichia with papular lesions	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000667396	8	21980304 - 21980307	8	22122791 - 22122794	667396	654506		NC_000008.11:22122790:CTGGCTGG:CTGG
NM_005445.3(SMC3):c.1067_1070AGAA[1] (p.Glu358fs)	SMC3		Cornelia de Lange syndrome 3	Pathogenic	no assertion criteria provided	VCV000626275	10	112343696 - 112343699	10	110583938 - 110583941	626275	614602		NC_000010.11:110583937:AGAAAGAA:AGAA
NM_005144.4(HR):c.2776+1G>A	HR		Alopecia universalis congenita	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623309	8	21977854	8	22120341	623309	612353	rs773764015	NC_000008.11:22120340:C:T
NM_005445.3(SMC3):c.1997G>C (p.Gly666Ala)	SMC3	G666A	Cornelia de Lange syndrome 3	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000217804	10	112356189	10	110596431	217804	214460	rs863225261	NC_000010.11:110596430:G:C
NM_005445.3(SMC3):c.1462G>A (p.Glu488Lys)	SMC3	E488K	Cornelia de Lange syndrome 3	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000217802	10	112349702	10	110589944	217802	214458	rs863225260	NC_000010.11:110589943:G:A
NM_005445.3(SMC3):c.2536-5_2541del	SMC3		Cornelia de Lange syndrome 3|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180199	10	112360774 - 112360784	10	110601016 - 110601026	180199	178382	rs727503775	NC_000010.11:110601015:TTACAGGAACTT:T
NM_005144.4(HR):c.-218A>G	HR		Hypotrichosis 4	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000007344	8	21988118	8	22130605	7344	22383	rs267606869	NC_000008.11:22130604:T:C
NM_005144.4(HR):c.-315C>T	HR	Q3*	Hypotrichosis 4	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000007342	8	21988215	8	22130702	7342	22381	rs267606867	NC_000008.11:22130701:G:A
NM_005144.4(HR):c.3034G>A (p.Asp1012Asn)	HR	D1012N	Alopecia universalis congenita	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007340	8	21976740	8	22119227	7340	22379	rs121434451	NC_000008.11:22119226:C:T
NM_005144.4(HR):c.1837C>T (p.Arg613Ter)	HR	R613*	Atrichia with papular lesions	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000007335	8	21981240	8	22123727	7335	22374	rs121434449	NC_000008.11:22123726:G:A
HR, 1-BP DEL, 3434C	HR		Atrichia with papular lesions	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000007334					7334	22373		
NM_004092.4(ECHS1):c.2T>G (p.Met1Arg)	ECHS1	M1R	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency|Leigh syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000156433	10	135186836	10	133373332	156433	166206	rs587776497	NC_000010.11:133373331:A:C
NM_005097.4(LGI1):c.406C>T (p.Arg136Trp)	LGI1	R136W	Familial temporal lobe epilepsy 1|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005438	10	95537349	10	93777592	5438	20477	rs119488099	NC_000010.11:93777591:C:T
NC_000006.12:g.(?_145625675)_(145635506_?)del	EPM2A		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000830902	6	145946811 - 145956642			830902	819669		
NM_005445.3(SMC3):c.1942A>G (p.Met648Val)	SMC3	M648V	not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279893	10	112352960	10	110593202	279893	264423	rs886041239	NC_000010.11:110593201:A:G
NM_005445.3(SMC3):c.703_705del (p.Thr235del)	SMC3	T235del	Cornelia de Lange syndrome 3	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000217800	10	112341836 - 112341838	10	110582078 - 110582080	217800	214456	rs863225259	NC_000010.11:110582077:ACT:
NM_005445.3(SMC3):c.139T>C (p.Phe47Leu)	SMC3	F47L	Cornelia de Lange syndrome 3	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000217799	10	112335102	10	110575344	217799	214455	rs863225258	NC_000010.11:110575343:T:C
NM_005144.4(HR):c.-249C>G	HR	P25A	Hypotrichosis 4	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000007343	8	21988149	8	22130636	7343	22382	rs267606868	NC_000008.11:22130635:G:C
NM_005670.4(EPM2A):c.953dup (p.Gln319fs)	EPM2A		Lafora disease	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000003106	6	145948594 - 145948595	6	145627458 - 145627459	3106	18145	rs587776554	NC_000006.12:145627458:AAAAAA:AAAAAAA
NM_005670.4(EPM2A):c.335dup (p.Tyr112Ter)	EPM2A		Lafora disease	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000003101	6	146007398 - 146007399	6	145686262 - 145686263	3101	18140	rs587776553	NC_000006.12:145686262:T:TT
NM_005670.4(EPM2A):c.322C>T (p.Arg108Cys)	EPM2A	R108C	Lafora disease	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000003100	6	146007412	6	145686276	3100	18139	rs137852915	NC_000006.12:145686275:G:A
NM_005670.4(EPM2A):c.495G>A (p.Trp165Ter)	EPM2A	W165*, W27*, W11*	Progressive myoclonic epilepsy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381553	6	145956604	6	145635468	381553	368890	rs781291421	NC_000006.12:145635467:C:T
NM_005445.3(SMC3):c.1461_1463AGA[1] (p.Glu488del)	SMC3	E488del	Cornelia de Lange syndrome 3	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000004631	10	112349701 - 112349703	10	110589943 - 110589945	4631	19670	rs863223279	NC_000010.11:110589942:AGAAGA:AGA
NC_000007.14:g.(?_76303789)_(76304183_?)del	HSPB1			Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000831819	7	75933106 - 75933500			831819	819917		
NC_000007.13:g.(?_75933119)_(75933490_?)del	HSPB1			Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000584236	7	75933119 - 75933490	7	76303802 - 76304173	584236	566153		
NM_001540.5(HSPB1):c.544C>T (p.Pro182Ser)	HSPB1	P182S	|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000007483	7	75933416	7	76304099	7483	22522	rs104894020	NC_000007.14:76304098:C:T
NM_015713.5(RRM2B):c.109_110del (p.Lys37fs)	RRM2B	K109fs, K37fs	not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000817116	8	103244471 - 103244472	8	102232243 - 102232244	817116	805554		NC_000008.11:102232242:TTT:T
NM_001172477.1(RRM2B):c.421-2A>G	RRM2B		not provided	Pathogenic(Last reviewed: Jun 14, 2012)	criteria provided, single submitter	VCV000215099	8	103238264	8	102226036	215099	211329	rs863224194	NC_000008.11:102226035:T:C
NM_001172477.1(RRM2B):c.815G>A (p.Gly272Glu)	RRM2B	G200E, G272E, G148E	not provided	Pathogenic(Last reviewed: Mar 23, 2012)	criteria provided, single submitter	VCV000215092	8	103231127	8	102218899	215092	211322	rs863224192	NC_000008.11:102218898:C:T
NM_001172477.1(RRM2B):c.736C>T (p.Arg246Ter)	RRM2B	R174*, R246*, R122*	not provided	Pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	VCV000215091	8	103236304	8	102224076	215091	211325	rs863224191	NC_000008.11:102224075:G:A
NM_001172477.1(RRM2B):c.1262C>G (p.Ala421Gly)	RRM2B	A349G, A421G, A297G	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132129	8	103220371	8	102208143	132129	136351	rs515726202	NC_000008.11:102208142:G:C
NM_001172477.1(RRM2B):c.1168G>T (p.Glu390Ter)	RRM2B	E318*, E390*, E266*	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132127	8	103220465	8	102208237	132127	136349	rs515726200	NC_000008.11:102208236:C:A
NM_001172477.1(RRM2B):c.1165T>G (p.Leu389Val)	RRM2B	L317V, L389V, L265V	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132125	8	103220468	8	102208240	132125	136347	rs515726198	NC_000008.11:102208239:A:C
NM_001172477.1(RRM2B):c.1136del (p.Asn379fs)	RRM2B	N255fs, N307fs, N379fs	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132124	8	103220497	8	102208269	132124	136346	rs515726197	NC_000008.11:102208268:TTTT:TTT
NM_001172477.1(RRM2B):c.1062G>C (p.Met354Ile)	RRM2B	M282I, M354I, M230I	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132123	8	103225061	8	102212833	132123	136345	rs182614164	NC_000008.11:102212832:C:G
NM_001172477.1(RRM2B):c.848G>A (p.Arg283Lys)	RRM2B	R211K, R283K, R159K	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132121	8	103231094	8	102218866	132121	136343	rs515726195	NC_000008.11:102218865:C:T
NM_001172477.1(RRM2B):c.800del (p.Gly267fs)	RRM2B	G195fs, G267fs, G143fs	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132119	8	103231142	8	102218914	132119	136341	rs515726193	NC_000008.11:102218913:CC:C
NM_001172477.1(RRM2B):c.799G>A (p.Gly267Arg)	RRM2B	G195R, G267R, G143R	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132118	8	103231143	8	102218915	132118	136340	rs515726192	NC_000008.11:102218914:C:T
NM_001172477.1(RRM2B):c.797A>G (p.Glu266Gly)	RRM2B	E194G, E266G, E142G	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132117	8	103231145	8	102218917	132117	136339	rs515726191	NC_000008.11:102218916:T:C
NM_001172477.1(RRM2B):c.772A>G (p.Arg258Gly)	RRM2B	R186G, R258G, R134G	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132116	8	103231170	8	102218942	132116	136338	rs515726190	NC_000008.11:102218941:T:C
NM_001172477.1(RRM2B):c.607G>A (p.Glu203Lys)	RRM2B	E131K, E203K, E79K	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132114	8	103237177	8	102224949	132114	136336	rs515726188	NC_000008.11:102224948:C:T
NM_001172477.1(RRM2B):c.584T>C (p.Phe195Ser)	RRM2B	F123S, F195S, F71S	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132113	8	103237200	8	102224972	132113	136335	rs515726187	NC_000008.11:102224971:A:G
NM_001172477.1(RRM2B):c.544C>T (p.Arg182Cys)	RRM2B	R110C, R182C, R58C	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132112	8	103237240	8	102225012	132112	136334	rs515726186	NC_000008.11:102225011:G:A
NM_001172477.1(RRM2B):c.538-2A>C	RRM2B		RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132110	8	103237248	8	102225020	132110	136332	rs515726185	NC_000008.11:102225019:T:G
NM_001172477.1(RRM2B):c.424G>A (p.Asp142Asn)	RRM2B	D142N, D70N, D18N	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132108	8	103238259	8	102226031	132108	136330	rs515726183	NC_000008.11:102226030:C:T
NM_001172477.1(RRM2B):c.406T>C (p.Trp136Arg)	RRM2B	W136R, W64R	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132107	8	103244391	8	102232163	132107	136329	rs515726182	NC_000008.11:102232162:A:G
NM_001172477.1(RRM2B):c.338G>C (p.Arg113Pro)	RRM2B	R113P, R41P	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132106	8	103244459	8	102232231	132106	136328	rs200273673	NC_000008.11:102232230:C:G
NM_001172477.1(RRM2B):c.338G>A (p.Arg113Gln)	RRM2B	R113Q, R41Q	RRM2B-related mitochondrial disease	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000132105	8	103244459	8	102232231	132105	136327	rs200273673	NC_000008.11:102232230:C:T
NM_015713.5(RRM2B):c.527_528insG (p.Ile176fs)	RRM2B		Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830053	8	103236296 - 103236297	8	102224068 - 102224069	830053	818390		NC_000008.11:102224068::C
RRM2B, 3-BP DEL, 253GAG	RRM2B		Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000005389					5389	20428		
NM_000035.4(ALDOB):c.113-1_115del	ALDOB		Hereditary fructosuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188974	9	104192246 - 104192249	9	101429964 - 101429967	188974	186780	rs786204598	NC_000009.12:101429963:TACCTA:TA
NM_004820.5(CYP7B1):c.1162C>T (p.Arg388Ter)	CYP7B1	R388*	Spastic paraplegia|Bile acid synthesis defect, congenital, 3|Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000006100	8	65517310	8	64604753	6100	21139	rs72554620	NC_000008.11:64604752:G:A
NM_001172477.1(RRM2B):c.337C>T (p.Arg113Trp)	RRM2B	R113W, R41W	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000132104	8	103244460	8	102232232	132104	136326	rs515726181	NC_000008.11:102232231:G:A
NM_001172477.1(RRM2B):c.1181dup (p.Asn394fs)	RRM2B		RRM2B-related mitochondrial disease|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000030433	8	103220451 - 103220452	8	102208223 - 102208224	30433	39390	rs515726201	NC_000008.11:102208223:TTT:TTTT
NM_001172477.1(RRM2B):c.578G>A (p.Arg193His)	RRM2B	R121H, R193H, R69H	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome 8B (MNGIE type)	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005394	8	103237206	8	102224978	5394	20433	rs267607024	NC_000008.11:102224977:C:T
NM_001172477.1(RRM2B):c.545G>A (p.Arg182His)	RRM2B	R110H, R182H, R58H	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome 8B (MNGIE type)	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005393	8	103237239	8	102225011	5393	20432	rs267607025	NC_000008.11:102225010:C:T
NM_001172477.1(RRM2B):c.902G>T (p.Gly301Val)	RRM2B	G229V, G301V, G177V	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005392	8	103226385	8	102214157	5392	20431	rs121918311	NC_000008.11:102214156:C:A
NM_001172477.1(RRM2B):c.923G>T (p.Cys308Phe)	RRM2B	C236F, C308F, C184F	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005390	8	103226364	8	102214136	5390	20429	rs121918309	NC_000008.11:102214135:C:A
NM_001172477.1(RRM2B):c.796G>A (p.Glu266Lys)	RRM2B	E194K, E266K, E142K	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005388	8	103231146	8	102218918	5388	20427	rs121918308	NC_000008.11:102218917:C:T
NM_001172477.1(RRM2B):c.538-2A>G	RRM2B		RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005387	8	103237248	8	102225020	5387	20426	rs515726185	NC_000008.11:102225019:T:C
NM_001172477.1(RRM2B):c.1066C>T (p.Gln356Ter)	RRM2B	Q284*, Q356*, Q232*	RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000005386	8	103225057	8	102212829	5386	20425	rs121918307	NC_000008.11:102212828:G:A
NM_018076.5(ARMC4):c.2495+1G>A	ARMC4		Primary ciliary dyskinesia|Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242857	10	28223938	10	27935009	242857	243961	rs879253744	NC_000010.11:27935008:C:T
NM_000288.4(PEX7):c.183del (p.Phe61fs)	PEX7	F61fs	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225436	6	137146400	6	136825262	225436	227291	rs774131564	NC_000006.12:136825261:TTTTT:TTTT
NM_000288.4(PEX7):c.188+1G>C	PEX7		Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188975	6	137146410	6	136825272	188975	186700	rs267608254	NC_000006.12:136825271:G:C
NM_018076.5(ARMC4):c.2780T>G (p.Leu927Trp)	ARMC4	L927W, L452W, L619W	Primary ciliary dyskinesia 23|Kartagener syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066045	10	28151382	10	27862453	66045	76951	rs587777047	NC_000010.11:27862452:A:C
NM_213674.1(TPM2):c.121G>A (p.Glu41Lys)	TPM2	E41K	Nemaline myopathy 4|not provided	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000012464	9	35689262	9	35689265	12464	27503	rs137853306	NC_000009.12:35689264:C:T
NM_000274.4(OAT):c.900+1G>A	OAT		Gyrate atrophy	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812363	10	126091495	10	124402926	812363	800691		NC_000010.11:124402925:C:T
NM_000274.3(OAT):c.899C>T (p.Pro300Leu)	OAT	P300L, P162L, P100L, P193L	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000599083	10	126091497	10	124402928	599083	590288	rs759979499	NC_000010.11:124402927:G:A
OAT, ALU INS	OAT		Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000000166					166	15205		
NM_017841.4(SDHAF2):c.201_205dup (p.Arg69fs)	SDHAF2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000820509	11	61205260 - 61205261	11	61437788 - 61437789	820509	810777		NC_000011.10:61437788:AGCCC:AGCCCAGCCC
NM_001164665.2(KIAA1549):c.4686C>A (p.His1562Gln)	KIAA1549	H1562Q	RETINITIS PIGMENTOSA 86	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691598	7	138554373	7	138869627	691598	679318		NC_000007.14:138869626:G:T
NM_001164665.2(KIAA1549):c.52del (p.Arg18fs)	KIAA1549	R18fs	RETINITIS PIGMENTOSA 86	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691597	7	138665964	7	138981218	691597	679317		NC_000007.14:138981217:GGGG:GGG
NM_001171814.1(OAT):c.-215-3158_-215-3155dup	OAT		Gyrate atrophy	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000456522	10	126100688 - 126100689	10	124412119 - 124412120	456522	459717	rs1554867854	NC_000010.11:124412119:CTCC:CTCCCTCC
NM_000274.3(OAT):c.1192C>T (p.Arg398Ter)	OAT	R398*, R291*, R198*, R260*	Gyrate atrophy	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000456519	10	126086639	10	124398070	456519	460162	rs200068769	NC_000010.11:124398069:G:A
NM_001171814.1(OAT):c.-147C>G	OAT	Q90E	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000000182	10	126097466	10	124408897	182	15221	rs121965060	NC_000010.11:124408896:G:C
NM_000274.3(OAT):c.677C>T (p.Ala226Val)	OAT	A226V, A88V, A119V, A26V	Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000000181	10	126092461	10	124403892	181	15220	rs121965059	NC_000010.11:124403891:G:A
NM_000274.3(OAT):c.824G>A (p.Trp275Ter)	OAT	W275*, W137*, W75*, W168*	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jan 29, 1993)	no assertion criteria provided	VCV000000180	10	126091572	10	124403003	180	15219	rs267606924	NC_000010.11:124403002:C:T
NM_001322974.2(OAT):c.-68G>A	OAT	W178*, W40*, W71*	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jan 29, 1993)	no assertion criteria provided	VCV000000179	10	126094120	10	124405551	179	15218	rs267606923	NC_000010.11:124405550:C:T
NM_000274.3(OAT):c.1201G>T (p.Gly401Ter)	OAT	G401*, G263*, G294*, G201*	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000173	10	126086630	10	124398061	173	15212	rs121965055	NC_000010.11:124398060:C:A
NM_000274.3(OAT):c.1180T>C (p.Cys394Arg)	OAT	C394R, C256R, C287R, C194R	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000172	10	126086651	10	124398082	172	15211	rs121965054	NC_000010.11:124398081:A:G
NM_000274.3(OAT):c.1058G>A (p.Gly353Asp)	OAT	G353D, G215D, G153D, G246D	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000170	10	126089510	10	124400941	170	15209	rs121965053	NC_000010.11:124400940:C:T
NM_000274.3(OAT):c.749G>C (p.Arg250Pro)	OAT	R250P, R112P, R143P, R50P	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000169	10	126092389	10	124403820	169	15208	rs121965052	NC_000010.11:124403819:C:G
NM_000274.3(OAT):c.955C>T (p.His319Tyr)	OAT	H319Y, H181Y, H119Y, H212Y	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Oct 15, 1989)	no assertion criteria provided	VCV000000164	10	126090354	10	124401785	164	15203	rs121965049	NC_000010.11:124401784:G:A
NM_001171814.1(OAT):c.-215-3045C>A	OAT	N54K	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1988)	no assertion criteria provided	VCV000000163	10	126100579	10	124412010	163	15202	rs121965048	NC_000010.11:124412009:G:T
NM_000274.3(OAT):c.1205T>C (p.Leu402Pro)	OAT	L402P, L264P, L295P, L202P	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000000156	10	126086626	10	124398057	156	15195	rs121965043	NC_000010.11:124398056:A:G
NM_001322974.2(OAT):c.-62G>C	OAT	R180T, R42T, R73T	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000000153	10	126094114	10	124405545	153	15192	rs121965040	NC_000010.11:124405544:C:G
NM_001171814.1(OAT):c.-137G>T	OAT	C93F	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000151	10	126097456	10	124408887	151	15190	rs121965038	NC_000010.11:124408886:C:A
NM_001171814.1(OAT):c.-215-3044T>C	OAT	Y55H	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000150	10	126100578	10	124412009	150	15189	rs121965037	NC_000010.11:124412008:A:G
NM_001322974.2(OAT):c.-5C>A	OAT	P199Q, P61Q, P92Q	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000000183	10	126094057	10	124405488	183	15222	rs267606925	NC_000010.11:124405487:G:T
NM_000274.3(OAT):c.1172G>A (p.Trp391Ter)	OAT	W391*, W253*, W284*, W191*	Ornithine aminotransferase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000171	10	126086659	10	124398090	171	15210	rs386833596	NC_000010.11:124398089:C:T
NM_001322974.2(OAT):c.-51G>A	OAT	R184T, A184T, A46T, A77T	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000167	10	126094103	10	124405534	167	15206	rs121965050	NC_000010.11:124405533:C:T
NM_001171814.1(OAT):c.11-4_15del	OAT		Ornithine aminotransferase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 1990)	no assertion criteria provided	VCV000000165	10	126097202 - 126097210	10	124408633 - 124408641	165	15204	rs386833609	NC_000010.11:124408632:CACTCCTATCA:CA
NM_000274.3(OAT):c.734A>G (p.Tyr245Cys)	OAT	Y245C, Y107C, Y45C, Y138C	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000160	10	126092404	10	124403835	160	15199	rs121965046	NC_000010.11:124403834:T:C
NM_000274.3(OAT):c.812G>A (p.Arg271Lys)	OAT	R271K, R133K, R71K, R164K	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000155	10	126091584	10	124403015	155	15194	rs121965042	NC_000010.11:124403014:C:T
NM_000274.3(OAT):c.808G>C (p.Ala270Pro)	OAT	A270P, A132P, A163P, A70P	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000154	10	126091588	10	124403019	154	15193	rs121965041	NC_000010.11:124403018:C:G
NM_001322971.2(OAT):c.200-3038G>T	OAT	R154L, R16L	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000152	10	126097170	10	124408601	152	15191	rs121965039	NC_000010.11:124408600:C:A
NM_001322974.2(OAT):c.-51_-49del	OAT	A184del, A46del, A77del	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000000148	10	126094101 - 126094103	10	124405532 - 124405534	148	15187	rs121965035	NC_000010.11:124405531:AGCAG:AG
NM_001171814.1(OAT):c.-215-3204G>A	OAT	M1I	Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Feb 1, 1991)	no assertion criteria provided	VCV000000146	10	126100738	10	124412169	146	15185	rs121965034	NC_000010.11:124412168:C:T
NM_000318.3(PEX2):c.339_345del (p.Gly113_Arg114insTer)	PEX2		Peroxisome biogenesis disorder 5a (zellweger)|Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000287499	8	77896070 - 77896076	8	76983834 - 76983840	287499	271736	rs764771123	NC_000008.11:76983833:CCACCTGCCACC:CCACC
NM_012434.5(SLC17A5):c.1138_1139del (p.Val380fs)	SLC17A5	V380fs	Salla disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056552	6	74320243 - 74320244	6	73610520 - 73610521	56552	71191	rs386833988	NC_000006.12:73610519:AC:
NC_000010.11:g.(124404664_124404669)_(124404736_124405741)del	OAT		Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 25, 1992)	no assertion criteria provided	VCV000000174	10	126093233 - 126094310	10	124404664 - 124405741	174	15213		
NM_031443.3(CCM2):c.30+1G>A	CCM2		Cerebral cavernous malformations 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000590655	7	45039963	7	45000364	590655	581314	rs1562848479	NC_000007.14:45000363:G:A
NM_005055.5(RAPSN):c.493G>A (p.Val165Met)	RAPSN	V165M	Pena-Shokeir syndrome type I|Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000856323	11	47469402	11	47447850	856323	838552		NC_000011.10:47447849:C:T
NM_000190.4(HMBS):c.849G>A (p.Trp283Ter)	HMBS	W283*, W266*, W226*, W243*	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001483	11	118963668	11	119092958	1483	16522	rs118204117	NC_000011.10:119092957:G:A
NM_000190.4(HMBS):c.530T>G (p.Leu177Arg)	HMBS	L177R, L160R	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000001466	11	118962154	11	119091444	1466	16505	rs118204108	NC_000011.10:119091443:T:G
NM_014908.3(DOLK):c.1447C>A (p.Gln483Lys)	DOLK	Q483K	not provided	Pathogenic(Last reviewed: Dec 16, 2013)	criteria provided, single submitter	VCV000167005	9	131708136	9	128945857	167005	177390	rs727503904	NC_000009.12:128945856:G:T
NC_000006.11:g.(?_146007238)_(146007452_?)del	EPM2A		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000462911			6	145686102 - 145686316	462911	455759		
NM_005144.4(HR):c.-320T>C	HR		Hypotrichosis 4	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007341	8	21988220	8	22130707	7341	22380	rs387906382	NC_000008.11:22130706:A:G
NM_005670.4(EPM2A):c.835G>A (p.Gly279Ser)	EPM2A	G279S, G125S, R198Q, G141S	not provided|Lafora disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2017)	no assertion criteria provided	VCV000003099	6	145948713	6	145627577	3099	18138	rs137852917	NC_000006.12:145627576:C:T
NM_006129.5(BMP1):c.1297G>T (p.Ala433Ser)	BMP1	A433S	Osteogenesis imperfecta, type xiii	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000190234	8	22051687	8	22194174	190234	188063	rs786205220	NC_000008.11:22194173:G:T
NM_006129.5(BMP1):c.808A>G (p.Met270Val)	BMP1	M270V	Osteogenesis imperfecta, type xiii	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000190233	8	22035442	8	22177929	190233	188062	rs786205219	NC_000008.11:22177928:A:G
NM_006129.5(BMP1):c.2107G>C (p.Asp703His)	BMP1	D703H, E703Q	Osteogenesis imperfecta, type xiii	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000190232	8	22054933	8	22197420	190232	188061	rs786205218	NC_000008.11:22197419:G:C
NM_017841.4(SDHAF2):c.199del (p.Arg67fs)	SDHAF2	R67fs	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000835577	11	61205256	11	61437784	835577	838589		NC_000011.10:61437783:AAAA:AAA
NM_017841.2(SDHAF2):c.177dup (p.Asp60Ter)	SDHAF2		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000532513	11	61205236 - 61205237	11	61437764 - 61437765	532513	526779	rs1554984631	NC_000011.10:61437764:T:TT
NM_000274.3(OAT):c.994G>A (p.Val332Met)	OAT	V332M, V194M, V225M, V132M	Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000000162	10	126090315	10	124401746	162	15201	rs121965047	NC_000010.11:124401745:C:T
NM_006129.5(BMP1):c.2108-359T>C	BMP1		Osteogenesis imperfecta, type xiii	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000190231	8	22058957	8	22201444	190231	188060	rs786205217	NC_000008.11:22201443:T:C
NM_014908.3(DOLK):c.2T>C (p.Met1Thr)	DOLK	M1T	Congenital disorder of glycosylation type 1M	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000100664	9	131709581	9	128947302	100664	106536	rs587777137	NC_000009.12:128947301:A:G
NM_006129.5(BMP1):c.747C>G (p.Phe249Leu)	BMP1	F249L	Osteogenesis imperfecta, type xiii	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000037306	8	22035381	8	22177868	37306	45881	rs398122891	NC_000008.11:22177867:C:G
NM_014908.3(DOLK):c.3G>A (p.Met1Ile)	DOLK	M1I	Congenital disorder of glycosylation type 1M	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030852	9	131709580	9	128947301	30852	39809	rs1564546510	NC_000009.12:128947300:C:T
NM_014908.3(DOLK):c.912G>T (p.Trp304Cys)	DOLK	W304C	Congenital disorder of glycosylation type 1M	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030851	9	131708671	9	128946392	30851	39808	rs1564545929	NC_000009.12:128946391:C:A
NM_014908.3(DOLK):c.1222C>G (p.His408Asp)	DOLK	H408D	Congenital disorder of glycosylation type 1M	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030850	9	131708361	9	128946082	30850	39807	rs387907030	NC_000009.12:128946081:G:C
NM_014908.3(DOLK):c.1322A>C (p.Tyr441Ser)	DOLK	Y441S	Congenital disorder of glycosylation type 1M	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000001132	9	131708261	9	128945982	1132	16171	rs137853110	NC_000009.12:128945981:T:G
NM_014908.3(DOLK):c.295T>A (p.Cys99Ser)	DOLK	C99S	Congenital disorder of glycosylation type 1M	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000001131	9	131709288	9	128947009	1131	16170	rs137853109	NC_000009.12:128947008:A:T
NM_020944.3(GBA2):c.2618G>A (p.Arg873His)	GBA2	R873H	Hereditary spastic paraplegia|Spastic paraplegia 46, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041490	9	35737332	9	35737335	41490	49929	rs398123015	NC_000009.12:35737334:C:T
NM_006129.5(BMP1):c.34G>C (p.Gly12Arg)	BMP1	G12R	not provided|Osteogenesis imperfecta, type xiii	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000037307	8	22022952	8	22165439	37307	45882	rs318240762	NC_000008.11:22165438:G:C
NM_001017420.3(ESCO2):c.1433_1437CTTTT[1] (p.Leu480fs)	ESCO2		not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000545908	8	27650264 - 27650268	8	27792747 - 27792751	545908	536336	rs1554556417	NC_000008.11:27792746:CTTTTCTTTT:CTTTT
NM_001017420.3(ESCO2):c.151C>T (p.Gln51Ter)	ESCO2	Q51*	not provided	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000857598	8	27633976	8	27776459	857598	834588		NC_000008.11:27776458:C:T
NM_001017420.3(ESCO2):c.1024G>T (p.Glu342Ter)	ESCO2	E342*	not provided	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000839047	8	27645412	8	27787895	839047	834589		NC_000008.11:27787894:G:T
NM_001172477.1(RRM2B):c.887T>G (p.Ile296Ser)	RRM2B	I224S, I296S, I172S	not provided|RRM2B-related mitochondrial disease|Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132122	8	103231055	8	102218827	132122	136344	rs515726196	NC_000008.11:102218826:A:C
NM_001172477.1(RRM2B):c.-5G>A	RRM2B	E16E	RRM2B-related mitochondrial disease|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000132103	8	103251055	8	102238827	132103	136325	rs515726180	NC_000008.11:102238826:C:T
NM_001172477.1(RRM2B):c.1195C>T (p.Arg399Ter)	RRM2B	R327*, R399*, R275*	RRM2B-related mitochondrial disease|not provided|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000005391	8	103220438	8	102208210	5391	20430	rs121918310	NC_000008.11:102208209:G:A
NM_001083116.3(PRF1):c.160C>T (p.Arg54Cys)	PRF1	R54C		Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802583	10	72360499	10	70600743	802583	790975		NC_000010.11:70600742:G:A
NM_001017420.3(ESCO2):c.1268G>A (p.Trp423Ter)	ESCO2	W423*	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000861126	8	27649484	8	27791967	861126	834590		NC_000008.11:27791966:G:A
NM_001017420.3(ESCO2):c.911dup (p.Asn304fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Feb 21, 2013)	criteria provided, single submitter	VCV000210962	8	27637735 - 27637736	8	27780218 - 27780219	210962	207540	rs797045566	NC_000008.11:27780218:AAAAA:AAAAAA
NM_001017420.3(ESCO2):c.894delinsTTTTAT (p.Glu298fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Feb 21, 2013)	criteria provided, single submitter	VCV000210961	8	27637723	8	27780206	210961	207539	rs797045565	NC_000008.11:27780205:A:TTTTAT
NM_001017420.3(ESCO2):c.955+2_955+5del	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021252	8	27637783 - 27637786	8	27780266 - 27780269	21252	34104	rs80359858	NC_000008.11:27780265:AAGTAAG:AAG
NM_001017420.3(ESCO2):c.876_879del (p.Asp292fs)	ESCO2	D292fs	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021250	8	27637703 - 27637706	8	27780186 - 27780189	21250	34102	rs80359856	NC_000008.11:27780185:GACAGA:GA
NM_001017420.3(ESCO2):c.764_765del (p.Phe255fs)	ESCO2	F255fs	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021249	8	27634587 - 27634588	8	27777070 - 27777071	21249	34101	rs80359855	NC_000008.11:27777069:TTTT:TT
NM_001017420.3(ESCO2):c.745_746del (p.Val249fs)	ESCO2	V249fs	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021246	8	27634569 - 27634570	8	27777052 - 27777053	21246	34098	rs80359851	NC_000008.11:27777051:TGT:T
NM_001017420.3(ESCO2):c.417dup (p.Pro140fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021245	8	27634236 - 27634237	8	27776719 - 27776720	21245	34097	rs80359848	NC_000008.11:27776719:AAAAAA:AAAAAAA
NM_001017420.3(ESCO2):c.308_309del (p.Lys103fs)	ESCO2	K103fs	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021244	8	27634131 - 27634132	8	27776614 - 27776615	21244	34096	rs80359847	NC_000008.11:27776613:AAAA:AA
NM_001017420.3(ESCO2):c.307_311del (p.Lys103fs)	ESCO2	K103fs	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021243	8	27634131 - 27634135	8	27776614 - 27776618	21243	34095	rs80359846	NC_000008.11:27776613:AAAAGA:A
NM_001017420.3(ESCO2):c.252_253del (p.Ser85fs)	ESCO2	S85fs	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021241	8	27634076 - 27634077	8	27776559 - 27776560	21241	34093	rs80359844	NC_000008.11:27776558:TAT:T
NM_001017420.3(ESCO2):c.1674-2A>G	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021239	8	27660821	8	27803304	21239	34091	rs80359869	NC_000008.11:27803303:A:G
NM_001017420.3(ESCO2):c.1597dup (p.Cys533fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021238	8	27657156 - 27657157	8	27799639 - 27799640	21238	34090	rs80359867	NC_000008.11:27799639:T:TT
NM_001017420.3(ESCO2):c.1457_1458AG[2] (p.Arg487fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021237	8	27650288 - 27650289	8	27792771 - 27792772	21237	34089	rs80359866	NC_000008.11:27792770:AGAGAG:AGAG
NM_001017420.3(ESCO2):c.1354-18G>A	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021236	8	27650167	8	27792650	21236	34088	rs80359865	NC_000008.11:27792649:G:A
NM_001017420.3(ESCO2):c.1263+1G>C	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021235	8	27646496	8	27788979	21235	34087	rs80359863	NC_000008.11:27788978:G:C
NM_001017420.3(ESCO2):c.1131+1G>A	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021233	8	27645520	8	27788003	21233	34085	rs80359861	NC_000008.11:27788002:G:A
NM_001017420.3(ESCO2):c.1111_1112insG (p.Thr371fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021231	8	27645499 - 27645500	8	27787982 - 27787983	21231	34083	rs1554555716	NC_000008.11:27787982::G
NM_001017420.3(ESCO2):c.1269G>A (p.Trp423Ter)	ESCO2	W423*	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000001739	8	27649485	8	27791968	1739	16778	rs80359864	NC_000008.11:27791967:G:A
NM_001017420.3(ESCO2):c.751dup (p.Glu251fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000001737	8	27634575 - 27634576	8	27777058 - 27777059	1737	16776	rs1554554098	NC_000008.11:27777058:G:GG
NM_001017420.3(ESCO2):c.505C>T (p.Arg169Ter)	ESCO2	R169*	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000001736	8	27634330	8	27776813	1736	16775	rs80359849	NC_000008.11:27776812:C:T
NM_001017420.3(ESCO2):c.877_878AG[1] (p.Arg293fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000021251	8	27637706 - 27637707	8	27780189 - 27780190	21251	34103	rs80359857	NC_000008.11:27780188:AGAG:AG
NM_001017420.3(ESCO2):c.604C>T (p.Gln202Ter)	ESCO2	Q202*	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000001740	8	27634429	8	27776912	1740	16779	rs80359850	NC_000008.11:27776911:C:T
NM_001017420.3(ESCO2):c.1615T>G (p.Trp539Gly)	ESCO2	W539G	Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000001735	8	27657175	8	27799658	1735	16774	rs80359868	NC_000008.11:27799657:T:G
NM_052813.5(CARD9):c.766del (p.Leu256fs)	CARD9	L256fs	Candidiasis, familial, 2	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000836732	9	139265015	9	136370563	836732	835840		NC_000009.12:136370562:GGG:GG
NM_052813.5(CARD9):c.638del (p.Leu213fs)	CARD9	L213fs	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827689	9	139265143	9	136370691	827689	815921		NC_000009.12:136370690:A:
NM_052813.4(CARD9):c.1351_1354del (p.Asp451fs)	CARD9	D451fs	Candidiasis, familial, 2	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000575157	9	139261255 - 139261258	9	136366803 - 136366806	575157	565756	rs746470735	NC_000009.12:136366802:TGTCTG:TG
NM_052813.4(CARD9):c.1289dup (p.Ser431fs)	CARD9		Candidiasis, familial, 2	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000567137	9	139261689 - 139261690	9	136367237 - 136367238	567137	565757	rs1564367364	NC_000009.12:136367237:CC:CCC
NC_000009.11:g.(?_139258557)_(139266550_?)del	CARD9		Candidiasis, familial, 2	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000535824	9	139258557 - 139266550	9	136364105 - 136372098	535824	524447		
NM_052813.4(CARD9):c.301C>T (p.Arg101Cys)	CARD9	R101C	Candidiasis, familial, 2	Pathogenic(Last reviewed: Oct 31, 2013)	no assertion criteria provided	VCV000088853	9	139265797	9	136371345	88853	94422	rs398122364	NC_000009.12:136371344:G:A
NM_052813.4(CARD9):c.1118G>C (p.Arg373Pro)	CARD9	R373P	Candidiasis, familial, 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000088851	9	139262240	9	136367788	88851	94420	rs149712114	NC_000009.12:136367787:C:G
NM_052813.4(CARD9):c.214G>A (p.Gly72Ser)	CARD9	G72S	Candidiasis, familial, 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000088850	9	139265884	9	136371432	88850	94419	rs398122362	NC_000009.12:136371431:C:T
NM_052813.4(CARD9):c.883C>T (p.Gln295Ter)	CARD9	Q295*	Candidiasis, familial, 2	Pathogenic(Last reviewed: Oct 29, 2009)	no assertion criteria provided	VCV000003406	9	139264814	9	136370362	3406	18445	rs121918338	NC_000009.12:136370361:G:A
NM_000274.3(OAT):c.1276C>T (p.Arg426Ter)	OAT	R426*, R288*, R226*, R319*	Gyrate atrophy|Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000000177	10	126086555	10	124397986	177	15216	rs121965058	NC_000010.11:124397985:G:A
NM_000274.3(OAT):c.627T>A (p.Tyr209Ter)	OAT	Y209*, Y71*, Y9*, Y102*	Gyrate atrophy|Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000175	10	126094026	10	124405457	175	15214	rs121965056	NC_000010.11:124405456:A:T
NM_052813.4(CARD9):c.865C>T (p.Gln289Ter)	CARD9	Q289*	Candidiasis, familial, 2	Pathogenic(Last reviewed: Oct 31, 2013)	no assertion criteria provided	VCV000088852	9	139264832	9	136370380	88852	94421	rs398122363	NC_000009.12:136370379:G:A
NM_014384.2(ACAD8):c.1129G>A (p.Gly377Ser)	ACAD8	G355S, G377S	Deficiency of isobutyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005356	11	134132450	11	134262556	5356	20395	rs121908419	NC_000011.10:134262555:G:A
NM_000399.5(EGR2):c.1226G>A (p.Arg409Gln)	EGR2	R409Q, R359Q	not specified|not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219844	10	64573172	10	62813412	219844	221982	rs864622273	NC_000010.11:62813411:C:T
GRCh38/hg38 6q13(chr6:71845502-72098192)x1	RIMS1		See cases	Pathogenic(Last reviewed: Oct 19, 2010)	no assertion criteria provided	VCV000146598	6	72555205 - 72807895	6	71845502 - 72098192	146598	156349		
NM_001017420.3(ESCO2):c.760dup (p.Thr254fs)	ESCO2		Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Oct 2, 2008)	no assertion criteria provided	VCV000001738	8	27634576 - 27634577	8	27777059 - 27777060	1738	16777	rs80359852	NC_000008.11:27777059:AAAAAAAAA:AAAAAAAAAA
NM_000035.4(ALDOB):c.612T>A (p.Tyr204Ter)	ALDOB	Y204*	not provided|Hereditary fructosuria	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, multiple submitters, no conflicts	VCV000188782	9	104188849	9	101426567	188782	186777	rs370793608	NC_000009.12:101426566:A:T
NM_004820.5(CYP7B1):c.889A>G (p.Thr297Ala)	CYP7B1	T297A	Spastic paraplegia|not provided|Hereditary spastic paraplegia 5A	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000120179	8	65527751	8	64615194	120179	125787	rs587777222	NC_000008.11:64615193:T:C
NM_000349.3(STAR):c.772C>T (p.Gln258Ter)	STAR	Q258*	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008987	8	38001877	8	38144359	8987	24026	rs104894085	NC_000008.11:38144358:G:A
NM_001987.4(ETV6):c.1153-5_1153-1del	ETV6		Acute lymphoid leukemia|Thrombocytopenia|Thrombocytopenia|See cases|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000190240	12	12038855 - 12038859	12	11885921 - 11885925	190240	188069	rs786205154	NC_000012.12:11885920:AACAGAACAGAACA:AACAGAACA
NM_000380.3(XPA):c.390-1G>C	XPA		not provided|	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000264684	9	100449544	9	97687262	264684	259252	rs750218942	NC_000009.12:97687261:C:G
NM_001715.3(BLK):c.1075C>T (p.Arg359Cys)	BLK	R359C, R288C	Systemic lupus erythematosus	Pathogenic	no assertion criteria provided	VCV000619205	8	11418856	8	11561347	619205	610608	rs146505280	NC_000008.11:11561346:C:T
NM_001715.3(BLK):c.1048T>C (p.Tyr350His)	BLK	Y350H, Y279H	Systemic lupus erythematosus	Pathogenic	no assertion criteria provided	VCV000619204	8	11418829	8	11561320	619204	610607	rs758750492	NC_000008.11:11561319:T:C
NM_001715.3(BLK):c.919C>G (p.Pro307Ala)	BLK	P307A, P236A	Systemic lupus erythematosus	Pathogenic	no assertion criteria provided	VCV000619203	8	11414313	8	11556804	619203	610606	rs1307379746	NC_000008.11:11556803:C:G
NM_001715.3(BLK):c.391C>T (p.Arg131Trp)	BLK	R131W, R60W	Systemic lupus erythematosus	Pathogenic	no assertion criteria provided	VCV000619201	8	11407690	8	11550181	619201	610604	rs73663163	NC_000008.11:11550180:C:T
NM_018051.5(WDR60):c.1321C>T (p.Arg441Ter)	WDR60	R441*, R250*, R395*	Short-rib thoracic dysplasia 8 with or without polydactyly	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000577342	7	158695250	7	158902559	577342	564180	rs766663693	NC_000007.14:158902558:C:T
NM_018051.5(WDR60):c.2503_2505dup (p.Arg835dup)	WDR60		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446630	7	158723160 - 158723161	7	158930469 - 158930470	446630	440108	rs1554478948	NC_000007.14:158930469:GGAGG:GGAGGAGG
NM_018051.5(WDR60):c.2284C>T (p.Arg762Ter)	WDR60	R762*, R346*, R571*, R275*, R716*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446629	7	158718904	7	158926213	446629	440106	rs1456300819	NC_000007.14:158926212:C:T
NM_018051.5(WDR60):c.2841del (p.Gln947fs)	WDR60	Q756fs, Q947fs, Q460fs, Q901fs, Q531fs	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446628	7	158734678	7	158941987	446628	440109	rs748645101	NC_000007.14:158941986:G:
NM_018051.5(WDR60):c.1703-3T>A	WDR60		Short-rib thoracic dysplasia 8 with or without polydactyly	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000088646	7	158706921	7	158914230	88646	94234	rs587777066	NC_000007.14:158914229:T:A
NM_018051.5(WDR60):c.2246C>T (p.Thr749Met)	WDR60	T749M, T262M, T558M, T703M, T333M	Short-rib thoracic dysplasia 8 with or without polydactyly	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000088645	7	158716413	7	158923722	88645	94233	rs587777065	NC_000007.14:158923721:C:T
NM_018051.5(WDR60):c.1891C>T (p.Gln631Ter)	WDR60	Q631*, Q585*, Q144*, Q215*, Q440*	Short-rib thoracic dysplasia 8 with or without polydactyly	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000088644	7	158711530	7	158918839	88644	94232	rs587777064	NC_000007.14:158918838:C:T
NM_001715.2(BLK):c.*505G>T	BLK		Maturity-onset diabetes of the young, type 11	Pathogenic(Last reviewed: Aug 25, 2009)	no assertion criteria provided	VCV000012323	8	11422122	8	11564613	12323	27362	rs886037621	NC_000008.11:11564612:G:T
NM_130849.4(SLC39A4):c.909G>C (p.Gln303His)	SLC39A4	Q303H, Q278H	Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000003545	8	145640176	8	144414792	3545	18584	rs121434293	NC_000008.11:144414791:C:G
NM_130849.4(SLC39A4):c.283C>T (p.Arg95Cys)	SLC39A4	R95C, R70C	Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000003544	8	145641385	8	144416001	3544	18583	rs121434292	NC_000008.11:144416000:G:A
SLC39A4, 53-BP INS, NT1017	SLC39A4		Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000003543					3543	18582		
SLC39A4, 2-KB DEL, UPSTREAM REGION	SLC39A4		Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003541					3541	18580		
NM_130849.4(SLC39A4):c.318C>A (p.Asn106Lys)	SLC39A4	N106K, N81K	Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003540	8	145641350	8	144415966	3540	18579	rs121434290	NC_000008.11:144415965:G:T
NM_130849.4(SLC39A4):c.1120G>A (p.Gly374Arg)	SLC39A4	G374R, G349R	Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003539	8	145639675	8	144414291	3539	18578	rs121434289	NC_000008.11:144414290:C:T
SLC39A4, IVS1AS, G-A, -19	SLC39A4		Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003536					3536	18575		
SLC39A4, 4-BP DEL	SLC39A4		Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003535					3535	18574		
SLC39A4, 5-BP DEL	SLC39A4		Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003534					3534	18573		
NM_000274.3(OAT):c.772-1G>A	OAT		Gyrate atrophy|not provided|Ornithine aminotransferase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000444240	10	126091625	10	124403056	444240	437880	rs770390524	NC_000010.11:124403055:C:T
NM_000274.3(OAT):c.897C>G (p.Tyr299Ter)	OAT	Y299*, Y161*, Y99*, Y192*	Ornithine aminotransferase deficiency|Retinal dystrophy|Gyrate atrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000176	10	126091499	10	124402930	176	15215	rs121965057	NC_000010.11:124402929:G:C
NM_001171814.1(OAT):c.-215-3048del	OAT	H53fs	Gyrate atrophy|Ornithine aminotransferase deficiency	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000000147	10	126100582	10	124412013	147	15186	rs386833599	NC_000010.11:124412012:G:
NM_018051.5(WDR60):c.2305G>A (p.Glu769Lys)	WDR60	E769K, E353K, E723K, E282K, E578K	Jeune thoracic dystrophy|Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446627	7	158718925	7	158926234	446627	440107	rs193204571	NC_000007.14:158926233:G:A
NM_130849.4(SLC39A4):c.989G>A (p.Gly330Asp)	SLC39A4	G330D, G305D	Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003542	8	145639806	8	144414422	3542	18581	rs121434291	NC_000008.11:144414421:C:T
NM_130849.4(SLC39A4):c.1576G>A (p.Gly526Arg)	SLC39A4	G526R, G28R, G501R	Hereditary acrodermatitis enteropathica	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003538	8	145638672	8	144413288	3538	18577	rs121434288	NC_000008.11:144413287:C:T
NM_001083116.3(PRF1):c.133G>A (p.Gly45Arg)	PRF1	G45R		Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000468300	10	72360526	10	70600770	468300	460232	rs578092914	NC_000010.11:70600769:C:T
NM_001322934.2(NFKB2):c.2557C>T (p.Arg853Ter)	NFKB2	R853*, R811*	Common variable immunodeficiency 10|Inherited Immunodeficiency Diseases|not specified	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065385	10	104161895	10	102402138	65385	76319	rs397514332	NC_000010.11:102402137:C:T
NM_000288.4(PEX7):c.6_12TGCGGTG[3] (p.Gly7fs)	PEX7		Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370629	6	137143807 - 137143808	6	136822669 - 136822670	370629	357420	rs62636519	NC_000006.12:136822669:GTGCGGTGTGCGGTG:GTGCGGTGTGCGGTGTGCGGTG
NM_001290020.2(ARMC4):c.1669G>T (p.Glu557Ter)	ARMC4	E557*, E82*, E249*	Primary ciliary dyskinesia 23|not provided|Kartagener syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208997	10	28233225	10	27944296	208997	205561	rs145742175	NC_000010.11:27944295:C:A
NM_000288.4(PEX7):c.618G>A (p.Trp206Ter)	PEX7	W206*	not provided|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189076	6	137187856	6	136866718	189076	186702	rs61753245	NC_000006.12:136866717:G:A
NM_000941.3(POR):c.859G>C (p.Ala287Pro)	POR	A287P, A284P	not provided|Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000016902	7	75612866	7	75983548	16902	31941	rs121912974	NC_000007.14:75983547:G:C
NM_000288.4(PEX7):c.345T>G (p.Tyr115Ter)	PEX7	Y115*	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007786	6	137166758	6	136845620	7786	22825	rs121909154	NC_000006.12:136845619:T:G
NM_000494.4(COL17A1):c.662G>A (p.Trp221Ter)	COL17A1	W221*	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000489231	10	105824300	10	104064542	489231	481864	rs1554850239	NC_000010.11:104064541:C:T
NM_002778.4(PSAP):c.607C>T (p.Gln203Ter)	PSAP	Q203*	not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000489144	10	73587884	10	71828127	489144	481874	rs1554880848	NC_000010.11:71828126:G:A
NM_000494.4(COL17A1):c.1424G>A (p.Trp475Ter)	COL17A1	W475*	not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000489069	10	105816774	10	104057016	489069	481863	rs1554849445	NC_000010.11:104057015:C:T
NM_000494.4(COL17A1):c.3046C>T (p.Gln1016Ter)	COL17A1	Q1016*	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000488824	10	105798188	10	104038430	488824	481862	rs1240465846	NC_000010.11:104038429:G:A
NM_000494.4(COL17A1):c.994del (p.Val332fs)	COL17A1	V332fs	not provided	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000430046	10	105820024	10	104060266	430046	421773	rs1131691753	NC_000010.11:104060265:C:
NM_000494.4(COL17A1):c.4000del (p.Arg1334fs)	COL17A1	R1334fs	not provided	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000422593	10	105793859	10	104034101	422593	407809	rs775251483	NC_000010.11:104034100:T:
NM_000494.4(COL17A1):c.1906G>A (p.Gly636Arg)	COL17A1	G636R	not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000390382	10	105812822	10	104053064	390382	371525	rs767083273	NC_000010.11:104053063:C:T
NM_000494.4(COL17A1):c.332-1G>A	COL17A1		not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000379785	10	105833990	10	104074232	379785	373270	rs754289857	NC_000010.11:104074231:C:T
NM_000494.4(COL17A1):c.4050del (p.Ala1351fs)	COL17A1	A1351fs	not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000280329	10	105793809	10	104034051	280329	264554	rs886041555	NC_000010.11:104034050:T:
NC_000009.12:g.(?_37429722)_(37430656_?)del	GRHPR		not provided	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832046	9	37429719 - 37430653			832046	820144		
NM_012203.2(GRHPR):c.13C>T (p.Arg5Ter)	GRHPR	R5*	not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000649477	9	37422760	9	37422763	649477	638334		NC_000009.12:37422762:C:T
NM_012203.2(GRHPR):c.591_592AG[1] (p.Glu198fs)	GRHPR		not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000645622	9	37429826 - 37429827	9	37429829 - 37429830	645622	638335		NC_000009.12:37429828:AGAG:AG
NM_000494.4(COL17A1):c.4143_4144AG[1] (p.Glu1382fs)	COL17A1		Nail dystrophy|Failure to thrive|Constipation|Anonychia|Hyperkeratotic papule|Abnormal blistering of the skin|Discolored lateral incisors|Pterygium of nails|Irregular dentition|Generalized abnormality of skin|Abnormality of the skin|Abnormality of skin morphology|Sparse scalp hair|Abnormality of the dentition	Pathogenic	criteria provided, single submitter	VCV000599000	10	105793711 - 105793714	10	104033953 - 104033956	599000	590063	rs765243124	NC_000010.11:104033952:CTCTCT:CT
NM_002778.4(PSAP):c.1369G>T (p.Glu457Ter)	PSAP	E460*, E459*, E457*	Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|	Pathogenic(Last reviewed: Jun 18, 2013)	no assertion criteria provided	VCV000438801	10	73578850	10	71819093	438801	432427	rs1554879741	NC_000010.11:71819092:C:A
NM_000494.4(COL17A1):c.2816C>T (p.Thr939Ile)	COL17A1	T939I	Epithelial recurrent erosion dystrophy	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000208977	10	105799371	10	104039613	208977	205532	rs797045142	NC_000010.11:104039612:G:A
NM_012203.2(GRHPR):c.356_369dup (p.Arg124fs)	GRHPR		Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204248	9	37426597 - 37426598	9	37426600 - 37426601	204248	200651	rs1554746962	NC_000009.12:37426600:CCTGCTACTTACCACCTGC:CCTGCTACTTACCACCTGCTACTTACCACCTGC
NM_012203.2(GRHPR):c.288-2_288del	GRHPR		Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204247	9	37426531 - 37426533	9	37426534 - 37426536	204247	200626	rs796052081	NC_000009.12:37426533:GTAGT:GT
NM_012203.2(GRHPR):c.45del (p.Ala17fs)	GRHPR	A17fs	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204245	9	37422792	9	37422795	204245	200616	rs180177311	NC_000009.12:37422794:A:
NM_012203.2(GRHPR):c.965T>C (p.Met322Thr)	GRHPR	M322T	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204240	9	37436757	9	37436760	204240	200648	rs180177325	NC_000009.12:37436759:T:C
NM_012203.2(GRHPR):c.905G>A (p.Arg302His)	GRHPR	R302H	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204237	9	37436697	9	37436700	204237	200645	rs180177323	NC_000009.12:37436699:G:A
NM_012203.2(GRHPR):c.743T>A (p.Val248Asp)	GRHPR	V248D	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204236	9	37432013	9	37432016	204236	200643	rs796052079	NC_000009.12:37432015:T:A
NM_012203.2(GRHPR):c.478G>A (p.Gly160Arg)	GRHPR	G160R	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204234	9	37428554	9	37428557	204234	200630	rs180177312	NC_000009.12:37428556:G:A
NM_012203.2(GRHPR):c.287G>T (p.Arg96Leu)	GRHPR	R96L	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204233	9	37425991	9	37425994	204233	200624	rs796052078	NC_000009.12:37425993:G:T
NM_012203.2(GRHPR):c.203T>C (p.Leu68Pro)	GRHPR	L68P	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204232	9	37424961	9	37424964	204232	200622	rs180177305	NC_000009.12:37424963:T:C
NM_000494.4(COL17A1):c.3908G>A (p.Arg1303Gln)	COL17A1	R1303Q	Epidermolysis bullosa, junctional, localisata variant	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000017650	10	105793951	10	104034193	17650	32689	rs121912771	NC_000010.11:104034192:C:T
NM_002778.4(PSAP):c.826_827GA[1] (p.Glu276fs)	PSAP		Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000013375	10	73581713 - 73581714	10	71821956 - 71821957	13375	28414		NC_000010.11:71821955:TCTCT:TCT
NM_002778.4(PSAP):c.577-2A>G	PSAP		Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000013374	10	73587916	10	71828159	13374	28413		NC_000010.11:71828158:T:C
NM_002778.4(PSAP):c.1006-2A>G	PSAP		Combined saposin deficiency	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000013373	10	73579659	10	71819902	13373	28412		NC_000010.11:71819901:T:C
NM_002778.4(PSAP):c.1046T>C (p.Leu349Pro)	PSAP	L349P, L352P, L351P	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000013372	10	73579617	10	71819860	13372	28411	rs121918110	NC_000010.11:71819859:A:G
NM_002778.4(PSAP):c.207_209del (p.Val70del)	PSAP	V70del		Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000013369	10	73591643 - 73591645	10	71831886 - 71831888	13369	28408		NC_000010.11:71831885:ACAAC:AC
PSAP, 1-BP DEL, 803G	PSAP		Combined saposin deficiency	Pathogenic(Last reviewed: Apr 15, 2001)	no assertion criteria provided	VCV000013368					13368	28407		
NM_002778.4(PSAP):c.577-1G>T	PSAP		Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000013366	10	73587915	10	71828158	13366	28405		NC_000010.11:71828157:C:A
NM_002778.4(PSAP):c.1268del (p.Leu423fs)	PSAP	L423fs, L425fs, L426fs	Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562227	10	73579304	10	71819547	562227	553410	rs1564815053	NC_000010.11:71819546:A:
NM_012203.2(GRHPR):c.540del (p.Leu181fs)	GRHPR	L181fs	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204251	9	37429773	9	37429776	204251	200635	rs180177315	NC_000009.12:37429775:TTT:TT
NM_012203.2(GRHPR):c.375del (p.Leu126fs)	GRHPR	L126fs	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204249	9	37426621	9	37426624	204249	200627	rs180177308	NC_000009.12:37426623:GG:G
NM_012203.2(GRHPR):c.965T>G (p.Met322Arg)	GRHPR	M322R	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204239	9	37436757	9	37436760	204239	200649	rs180177325	NC_000009.12:37436759:T:G
NM_012203.2(GRHPR):c.934A>G (p.Asn312Asp)	GRHPR	N312D	Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204238	9	37436726	9	37436729	204238	200646	rs180177324	NC_000009.12:37436728:A:G
NM_012203.2(GRHPR):c.-4_-3delinsAT	GRHPR		Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204230	9	37422744 - 37422745	9	37422747 - 37422748	204230	200615	rs796052077	NC_000009.12:37422746:GC:AT
NM_002778.4(PSAP):c.643A>C (p.Asn215His)	PSAP	N215H	Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000013367	10	73587848	10	71828091	13367	28406	rs121918107	NC_000010.11:71828090:T:G
NM_002778.4(PSAP):c.1145G>T (p.Cys382Phe)	PSAP	C385F, C382F, C384F	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Jun 17, 1991)	no assertion criteria provided	VCV000013364	10	73579518	10	71819761	13364	28403	rs121918105	NC_000010.11:71819760:C:A
PSAP, IVS4AS, C-A	PSAP		Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000013362					13362	28401		
NM_000494.4(COL17A1):c.779del (p.Pro260fs)	COL17A1	P260fs	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000804336	10	105823564	10	104063806	804336	792673		NC_000010.11:104063805:GG:G
NM_000494.4(COL17A1):c.214C>T (p.Arg72Ter)	COL17A1	R72*	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000585309	10	105836176	10	104076418	585309	576350	rs760094345	NC_000010.11:104076417:G:A
NM_000494.4(COL17A1):c.433C>T (p.Arg145Ter)	COL17A1	R145*	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000017658	10	105831820	10	104072062	17658	32697	rs121912774	NC_000010.11:104072061:G:A
NM_000494.4(COL17A1):c.1898G>A (p.Gly633Asp)	COL17A1	G633D	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000017657	10	105812830	10	104053072	17657	32696	rs121912773	NC_000010.11:104053071:C:T
NM_000494.4(COL17A1):c.2564T>G (p.Leu855Ter)	COL17A1	L855*	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000017656	10	105801284	10	104041526	17656	32695	rs121912772	NC_000010.11:104041525:A:C
COL17A1, 1-BP DEL, 2965G	COL17A1		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000017655					17655	32694		
COL17A1, 2-BP DEL, 520AG	COL17A1		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000017654					17654	32693		
NM_000494.4(COL17A1):c.2336-1G>T	COL17A1		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000017652	10	105806532	10	104046774	17652	32691		NC_000010.11:104046773:C:A
NM_000494.4(COL17A1):c.1601del (p.Asp534fs)	COL17A1	D534fs	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000017649	10	105815626	10	104055868	17649	32688		NC_000010.11:104055867:T:
NM_000494.4(COL17A1):c.3067C>T (p.Gln1023Ter)	COL17A1	Q1023*	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000017648	10	105798167	10	104038409	17648	32687	rs121912770	NC_000010.11:104038408:G:A
COL17A1, 5-BP DEL, NT2944	COL17A1		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000017647					17647	32686		
COL17A1, 1-BP INS, 4150G	COL17A1		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000017646					17646	32685		
NM_002778.4(PSAP):c.1288C>T (p.Gln430Ter)	PSAP	Q430*, Q433*, Q432*	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000013371	10	73579284	10	71819527	13371	28410	rs121918109	NC_000010.11:71819526:G:A
NM_002778.4(PSAP):c.1144T>G (p.Cys382Gly)	PSAP	C382G, C385G, C384G	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000013370	10	73579519	10	71819762	13370	28409	rs121918108	NC_000010.11:71819761:A:C
NM_020944.3(GBA2):c.1888C>T (p.Arg630Trp)	GBA2	R630W	Hereditary spastic paraplegia|Spastic paraplegia 46, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041485	9	35738808	9	35738811	41485	49924	rs398123012	NC_000009.12:35738810:G:A
NM_002778.4(PSAP):c.1A>G (p.Met1Val)	PSAP	M1V	Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000860182	10	73610978	10	71851221	860182	837277		NC_000010.11:71851220:T:C
NM_012203.2(GRHPR):c.617_671del (p.Ala206fs)	GRHPR	A206fs	not provided|Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000599224	9	37430524 - 37430578	9	37430527 - 37430581	599224	590449	rs1564300888	
NM_012203.2(GRHPR):c.781_782delinsTAC (p.Gly261fs)	GRHPR		Primary hyperoxaluria, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551312	9	37432051 - 37432052	9	37432054 - 37432055	551312	545292	rs1554748528	NC_000009.12:37432053:GG:TAC
NM_000494.4(COL17A1):c.3922del (p.Ser1308fs)	COL17A1	S1308fs	Adult junctional epidermolysis bullosa|not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419270	10	105793937	10	104034179	419270	407810	rs1064793760	NC_000010.11:104034178:T:
NM_012203.2(GRHPR):c.246_247TG[1] (p.Val83fs)	GRHPR		Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000162021	9	37425950 - 37425951	9	37425953 - 37425954	162021	171742	rs672601351	NC_000009.12:37425952:TGTG:TG
COL17A1, 2-BP DEL, 4003TC	COL17A1		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000017653					17653	32692		
NM_000193.4(SHH):c.413_414CT[1] (p.Leu139fs)	SHH		not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000817047	7	155599136 - 155599137	7	155806442 - 155806443	817047	805535		NC_000007.14:155806441:AGAGA:AGA
NM_000193.4(SHH):c.1018G>T (p.Glu340Ter)	SHH	E340*	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000597652	7	155595965	7	155803271	597652	588713	rs1563198990	NC_000007.14:155803270:C:A
NM_000193.4(SHH):c.1258dup (p.Ala420fs)	SHH		not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000449796	7	155595724 - 155595725	7	155803030 - 155803031	449796	444104	rs1554493633	NC_000007.14:155803030:C:CC
NM_000193.4(SHH):c.592T>C (p.Cys198Arg)	SHH	C198R	not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000430482	7	155596391	7	155803697	430482	421627	rs1131691989	NC_000007.14:155803696:A:G
NM_000193.4(SHH):c.423C>A (p.Tyr141Ter)	SHH	Y141*, Y54*	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000379347	7	155599129	7	155806435	379347	369097	rs763132615	NC_000007.14:155806434:G:T
GRCh37/hg19 7q36.3(chr7:155594374-156069411)x1	SHH		See cases	Pathogenic	no assertion criteria provided	VCV000395377	7	155594374 - 156069411			395377	382270		
NM_000193.4(SHH):c.995T>C (p.Val332Ala)	SHH	V332A	Solitary median maxillary central incisor syndrome	Pathogenic(Last reviewed: May 15, 2004)	no assertion criteria provided	VCV000008894	7	155595988	7	155803294	8894	23933	rs104894052	NC_000007.14:155803293:A:G
NM_004273.5(CHST3):c.503T>G (p.Ile168Ser)	CHST3	I168S	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828155	10	73767292	10	72007534	828155	816473		NC_000010.11:72007533:T:G
NM_004273.5(CHST3):c.1254_1256GAA[1] (p.Lys419del)	CHST3		Larsen syndrome, dominant type	Pathogenic	criteria provided, single submitter	VCV000694680	10	73768042 - 73768044	10	72008284 - 72008286	694680	682815		NC_000010.11:72008283:AGAAGAA:AGAA
NM_000193.4(SHH):c.1284del (p.Thr429fs)	SHH	T429fs	Holoprosencephaly 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000374270	7	155595699	7	155803005	374270	361187	rs1057518660	NC_000007.14:155803004:GG:G
NM_000193.4(SHH):c.331A>T (p.Ile111Phe)	SHH	I111F, I24F	Solitary median maxillary central incisor syndrome	Pathogenic(Last reviewed: May 15, 2004)	no assertion criteria provided	VCV000008890	7	155599221	7	155806527	8890	23929	rs104894049	NC_000007.14:155806526:T:A
NM_000108.5(DLD):c.104dup (p.Tyr35Ter)	DLD		Maple syrup urine disease, type 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370072	7	107533708 - 107533709	7	107893263 - 107893264	370072	357557	rs753234219	NC_000007.14:107893263:A:AA
NM_000193.4(SHH):c.100_101del (p.Arg34fs)	SHH	R34fs	Holoprosencephaly 3	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000689618	7	155604716 - 155604717	7	155812022 - 155812023	689618	677292		NC_000007.14:155812021:CTC:C
NM_000193.4(SHH):c.419_423dup (p.Glu142fs)	SHH		Holoprosencephaly 3	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000646865	7	155599128 - 155599129	7	155806434 - 155806435	646865	635957		NC_000007.14:155806434:GTAGTG:GTAGTGTAGTG
NM_000193.4(SHH):c.214C>T (p.Arg72Ter)	SHH	R72*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000545582	7	155604603	7	155811909	545582	536081	rs779093031	NC_000007.14:155811908:G:A
NM_000193.4(SHH):c.1307C>A (p.Ser436Ter)	SHH	S436*	Holoprosencephaly 3	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000545579	7	155595676	7	155802982	545579	536077	rs1554493607	NC_000007.14:155802981:G:T
NM_000193.4(SHH):c.1040C>T (p.Pro347Leu)	SHH	P347L	Holoprosencephaly 3	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000545575	7	155595943	7	155803249	545575	536078	rs886042458	NC_000007.14:155803248:G:A
NM_004273.5(CHST3):c.1312C>T (p.Gln438Ter)	CHST3	Q438*	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522996	10	73768101	10	72008343	522996	513597	rs1416783446	NC_000010.11:72008342:C:T
NM_000193.4(SHH):c.851_873del (p.Glu284fs)	SHH	E284fs	Holoprosencephaly 3	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000464839	7	155596110 - 155596132	7	155803416 - 155803438	464839	456902	rs1554493810	NC_000007.14:155803415:CGAGCCCGAGGACGCCTCGGGCTC:C
NM_004273.5(CHST3):c.1063G>A (p.Gly355Arg)	CHST3	G355R	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: May 3, 2016)	no assertion criteria provided	VCV000225684	10	73767852	10	72008094	225684	227499	rs747171013	NC_000010.11:72008093:G:A
NM_000193.4(SHH):c.708C>A (p.Ser236Arg)	SHH	S236R	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065892	7	155596275	7	155803581	65892	76800	rs587778806	NC_000007.14:155803580:G:T
NM_000193.4(SHH):c.664G>A (p.Asp222Asn)	SHH	D222N	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065887	7	155596319	7	155803625	65887	76795	rs587778805	NC_000007.14:155803624:C:T
NM_000193.4(SHH):c.625C>T (p.Gln209Ter)	SHH	Q209*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065883	7	155596358	7	155803664	65883	76791	rs587778803	NC_000007.14:155803663:G:A
NM_000193.4(SHH):c.562G>C (p.Glu188Gln)	SHH	E188Q, G101R	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065876	7	155598990	7	155806296	65876	76784	rs587778799	NC_000007.14:155806295:C:G
NM_000193.4(SHH):c.474C>G (p.Tyr158Ter)	SHH	Y158*, Y71*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065872	7	155599078	7	155806384	65872	76780	rs146990376	NC_000007.14:155806383:G:C
NM_000193.4(SHH):c.300G>C (p.Gln100His)	SHH	Q100H	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065860	7	155604517	7	155811823	65860	76768	rs587778792	NC_000007.14:155811822:C:G
NM_000193.4(SHH):c.38_45del (p.Val13fs)	SHH	V13fs	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065854	7	155604772 - 155604779	7	155812078 - 155812085	65854	76762	rs587778789	NC_000007.14:155812077:CGAGGAGACGAGGA:CGAGGA
NM_000193.4(SHH):c.6_9dup (p.Leu4fs)	SHH		Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065853	7	155604807 - 155604808	7	155812113 - 155812114	65853	76761	rs587778788	NC_000007.14:155812113:CAGC:CAGCCAGC
NM_000193.4(SHH):c.1212_1226del (p.Asp405_Gly409del)	SHH		Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065849	7	155595757 - 155595771	7	155803063 - 155803077	65849	76757	rs587778786	NC_000007.14:155803062:CCGCCCCCGCGGTCCCCGCC:CCGCC
NM_004273.5(CHST3):c.988C>T (p.Gln330Ter)	CHST3	Q330*	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000006051	10	73767777	10	72008019	6051	21090	rs267606732	NC_000010.11:72008018:C:T
NM_004273.5(CHST3):c.481C>T (p.Leu161Phe)	CHST3	L161F	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000006050	10	73767270	10	72007512	6050	21089	rs267606733	NC_000010.11:72007511:C:T
NM_004273.5(CHST3):c.422C>T (p.Thr141Met)	CHST3	T141M	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000006048	10	73767211	10	72007453	6048	21087	rs267606735	NC_000010.11:72007452:C:T
NM_004273.5(CHST3):c.857T>C (p.Leu286Pro)	CHST3	L286P	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Sep 15, 2008)	no assertion criteria provided	VCV000006047	10	73767646	10	72007888	6047	21086	rs121908620	NC_000010.11:72007887:T:C
NM_004273.5(CHST3):c.603C>A (p.Tyr201Ter)	CHST3	Y201*	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006046	10	73767392	10	72007634	6046	21085	rs121908619	NC_000010.11:72007633:C:A
NM_004273.5(CHST3):c.1114G>A (p.Glu372Lys)	CHST3	E372K	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006042	10	73767903	10	72008145	6042	21081	rs267606734	NC_000010.11:72008144:G:A
NM_004273.5(CHST3):c.491C>T (p.Pro164Leu)	CHST3	P164L	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic	criteria provided, single submitter	VCV000478823	10	73767280	10	72007522	478823	472249	rs771866012	NC_000010.11:72007521:C:T
NM_004273.5(CHST3):c.904G>C (p.Asp302His)	CHST3	D302H	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic	criteria provided, single submitter	VCV000478822	10	73767693	10	72007935	478822	472248	rs1316347883	NC_000010.11:72007934:G:C
NM_000193.4(SHH):c.766G>T (p.Glu256Ter)	SHH	E256*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008893	7	155596217	7	155803523	8893	23932	rs104894051	NC_000007.14:155803522:C:A
SHH, 24-BP DEL, NT1353	SHH		Microphthalmia, isolated, with coloboma 5	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000008892					8892	23931		
NM_000193.4(SHH):c.1132_1140del (p.Ala378_Phe380del)	SHH		Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008889	7	155595843 - 155595851	7	155803149 - 155803157	8889	23928	rs397515376	NC_000007.14:155803148:GAAGGGCGCGAAGG:GAAGG
NM_000193.4(SHH):c.1270C>G (p.Pro424Ala)	SHH	P424A	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008888	7	155595713	7	155803019	8888	23927	rs104894048	NC_000007.14:155803018:G:C
NM_000193.4(SHH):c.313A>T (p.Lys105Ter)	SHH	K105*, K18*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008879	7	155599239	7	155806545	8879	23918	rs104894045	NC_000007.14:155806544:T:A
NM_000193.4(SHH):c.298C>T (p.Gln100Ter)	SHH	Q100*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008878	7	155604519	7	155811825	8878	23917	rs104894044	NC_000007.14:155811824:G:A
NM_004273.5(CHST3):c.1086del (p.Arg363fs)	CHST3	R363fs	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006045	10	73767875	10	72008117	6045	21084		NC_000010.11:72008116:G:
NM_004273.5(CHST3):c.664C>T (p.Arg222Trp)	CHST3	R222W	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000006043	10	73767453	10	72007695	6043	21082	rs121908617	NC_000010.11:72007694:C:T
NM_014251.3(SLC25A13):c.1631del (p.Ile544fs)	SLC25A13	I544fs, I545fs	not provided	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000593892	7	95751270	7	96121958	593892	584955	rs1562774778	NC_000007.14:96121957:A:
NM_014251.3(SLC25A13):c.70-1G>A	SLC25A13		not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000593512	7	95906651	7	96277339	593512	584576	rs962082210	NC_000007.14:96277338:C:T
NM_014251.3(SLC25A13):c.493C>T (p.Gln165Ter)	SLC25A13	Q165*	Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000590804	7	95822471	7	96193159	590804	581761	rs1562831765	NC_000007.14:96193158:G:A
NM_014251.3(SLC25A13):c.1664_1665insAGATTACAGGTGGCTGCCCGGGG (p.Gln556fs)	SLC25A13		Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000590803	7	95751236 - 95751237	7	96121924 - 96121925	590803	581759	rs1562774655	NC_000007.14:96121924:CC:CCCCGGGCAGCCACCTGTAATCTCC
NM_002234.4(KCNA5):c.143A>G (p.Glu48Gly)	KCNA5	E48G	Atrial fibrillation, familial, 7	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000127137	12	5153456	12	5044290	127137	132635	rs587777336	NC_000012.12:5044289:A:G
NM_002234.4(KCNA5):c.1828G>A (p.Glu610Lys)	KCNA5	E610K	Atrial fibrillation, familial, 7	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000013472	12	5155141	12	5045975	13472	28511	rs121908593	NC_000012.12:5045974:G:A
NM_002234.4(KCNA5):c.1727C>T (p.Ala576Val)	KCNA5	A576V	Atrial fibrillation, familial, 7	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000013471	12	5155040	12	5045874	13471	28510	rs121908592	NC_000012.12:5045873:C:T
NM_002234.4(KCNA5):c.1123G>T (p.Glu375Ter)	KCNA5	E375*	Atrial fibrillation, familial, 7	Pathogenic(Last reviewed: Jul 15, 2006)	no assertion criteria provided	VCV000013469	12	5154436	12	5045270	13469	28508	rs121908590	NC_000012.12:5045269:G:T
NM_014251.3(SLC25A13):c.1196T>A (p.Leu399Ter)	SLC25A13	L399*, L400*	Citrin deficiency	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000860951	7	95800818	7	96171506	860951	833999		NC_000007.14:96171505:A:T
NM_014251.3(SLC25A13):c.571del (p.Arg191fs)	SLC25A13	R191fs	Citrin deficiency	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000838520	7	95822393	7	96193081	838520	834002		NC_000007.14:96193080:GG:G
NC_000007.14:g.(?_96191099)_(96193193_?)del	SLC25A13		Citrin deficiency	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000831578	7	95820411 - 95822505			831578	819927		
NC_000007.14:g.(?_96234792)_(96234927_?)del	SLC25A13		Citrin deficiency	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000830502	7	95864104 - 95864239			830502	819928		
NM_014251.3(SLC25A13):c.1762C>T (p.Arg588Ter)	SLC25A13	R589*, R588*	Citrin deficiency	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000664925	7	95751046	7	96121734	664925	636492		NC_000007.14:96121733:G:A
NM_014251.3(SLC25A13):c.978_979AG[1] (p.Glu327fs)	SLC25A13		Citrin deficiency	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000643067	7	95814276 - 95814277	7	96184964 - 96184965	643067	636494		NC_000007.14:96184963:CTCT:CT
NM_014251.3(SLC25A13):c.1712del (p.Arg571fs)	SLC25A13	R572fs, R571fs	Citrin deficiency	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000469032	7	95751189	7	96121877	469032	458113	rs1554335461	NC_000007.14:96121876:C:
NM_014251.3(SLC25A13):c.495del (p.Ala166fs)	SLC25A13	A166fs	Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000252924	7	95822469	7	96193157	252924	247326	rs879255504	NC_000007.14:96193156:TT:T
NM_014251.3(SLC25A13):c.775C>T (p.Gln259Ter)	SLC25A13	Q259*	Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Feb 23, 2010)	no assertion criteria provided	VCV000252920	7	95818966	7	96189654	252920	247324	rs746155190	NC_000007.14:96189653:G:A
NM_014251.3(SLC25A13):c.615+1G>C	SLC25A13		Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jan 5, 2012)	no assertion criteria provided	VCV000021516	7	95822348	7	96193036	21516	34368	rs80338718	NC_000007.14:96193035:C:G
NM_014251.3(SLC25A13):c.1801G>T (p.Glu601Ter)	SLC25A13	E601*, E602*	Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jan 5, 2012)	no assertion criteria provided	VCV000021513	7	95751007	7	96121695	21513	34365	rs80338727	NC_000007.14:96121694:C:A
NM_014251.2(SLC25A13):c.1750_1751[insNM_138459.3:2672_24;1750+72_1751-4dup]	SLC25A13		Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jan 5, 2012)	no assertion criteria provided	VCV000021511					21511	34363		
NM_014251.3(SLC25A13):c.15G>A (p.Lys5=)	SLC25A13		Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jan 5, 2012)	no assertion criteria provided	VCV000021510	7	95951254	7	96321942	21510	34362	rs80338715	NC_000007.14:96321941:C:T
NM_014251.3(SLC25A13):c.1592G>A (p.Gly531Asp)	SLC25A13	G531D, G532D	Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Jan 5, 2012)	no assertion criteria provided	VCV000021509	7	95751309	7	96121997	21509	34361	rs80338724	NC_000007.14:96121996:C:T
NM_005802.5(TOPORS):c.2552_2553GA[2] (p.Glu852fs)	TOPORS		Retinitis pigmentosa 31|Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438066	9	32541966 - 32541967	9	32541968 - 32541969	438066	431738	rs527236116	NC_000009.12:32541967:TCTCTCT:TCTCT
NM_005802.5(TOPORS):c.2552_2553GA[1] (p.Glu852fs)	TOPORS		Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143130	9	32541966 - 32541969	9	32541968 - 32541971	143130	152848	rs527236116	NC_000009.12:32541967:TCTCTCT:TCT
NM_001017420.3(ESCO2):c.292_293GA[1] (p.Arg99fs)	ESCO2		not provided|Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021242	8	27634117 - 27634120	8	27776600 - 27776603	21242	34094	rs80359845	NC_000008.11:27776599:GAGAGA:GA
NM_014251.3(SLC25A13):c.848+3A>C	SLC25A13		Citrin deficiency	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000850379	7	95818890	7	96189578	850379	852395		NC_000007.14:96189577:T:G
NM_014251.3(SLC25A13):c.1375del (p.Ala459fs)	SLC25A13	A459fs, A460fs	Citrin deficiency	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000638891	7	95775945	7	96146633	638891	636493		NC_000007.14:96146632:CC:C
NM_014251.3(SLC25A13):c.955C>T (p.Arg319Ter)	SLC25A13	R319*, R320*	Citrin deficiency|not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372748	7	95814302	7	96184990	372748	359822	rs763191789	NC_000007.14:96184989:G:A
NM_014251.3(SLC25A13):c.1813C>T (p.Arg605Ter)	SLC25A13	R605*, R606*	not provided|Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	VCV000021514	7	95750995	7	96121683	21514	34366	rs80338729	NC_000007.14:96121682:G:A
NM_020320.5(RARS2):c.-2A>G	RARS2		Pontocerebellar hypoplasia type 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802251	6	88299677	6	87589959	802251	790667		NC_000006.12:87589958:T:C
NM_138691.2(TMC1):c.530T>C (p.Ile177Thr)	TMC1	I177T	Intellectual disability, moderate|Bilateral sensorineural hearing impairment|Delayed speech and language development	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000690365	9	75357436	9	72742520	690365	678050		NC_000009.12:72742519:T:C
GRCh37/hg19 9q21.13(chr9:75274024-75318551)x1	TMC1		not provided	Pathogenic(Last reviewed: May 31, 2017)	no assertion criteria provided	VCV000686078	9	75274024 - 75318551			686078	673670		
NM_020320.5(RARS2):c.685C>T (p.Arg229Ter)	RARS2	R229*, R54*	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000620219	6	88240588	6	87530870	620219	611666	rs769473411	NC_000006.12:87530869:G:A
NM_138691.2(TMC1):c.945G>A (p.Trp315Ter)	TMC1	W315*	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560916	9	75403315	9	72788399	560916	552008	rs1564554255	NC_000009.12:72788398:G:A
NM_138691.2(TMC1):c.1728C>G (p.Asn576Lys)	TMC1	N576K	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560915	9	75431091	9	72816175	560915	552011	rs761261855	NC_000009.12:72816174:C:G
NM_138691.2(TMC1):c.1209G>A (p.Trp403Ter)	TMC1	W403*	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560914	9	75404218	9	72789302	560914	552009	rs773851192	NC_000009.12:72789301:G:A
NM_138691.2(TMC1):c.1224+2T>C	TMC1		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560913	9	75404235	9	72789319	560913	552010	rs1564555240	NC_000009.12:72789318:T:C
NM_138691.2(TMC1):c.1534C>T (p.Arg512Ter)	TMC1	R512*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000545971	9	75407236	9	72792320	545971	536351	rs200171616	NC_000009.12:72792319:C:T
NM_138691.2(TMC1):c.2130-1del	TMC1		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000503746	9	75445366	9	72830450	503746	495429	rs1554731002	NC_000009.12:72830449:G:
NM_020320.5(RARS2):c.1237+1G>A	RARS2		Pontocerebellar hypoplasia type 6	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488586	6	88229300	6	87519582	488586	481454	rs759922477	NC_000006.12:87519581:C:T
NM_020320.5(RARS2):c.1423G>T (p.Glu475Ter)	RARS2	E475*, E300*	not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000280430	6	88227975	6	87518257	280430	264299	rs886041639	NC_000006.12:87518256:C:A
GRCh37/hg19 9q21.13(chr9:75161655-75429310)x1	TMC1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253561	9	75161655 - 75429310			253561	248009		
NM_020320.5(RARS2):c.1582_1583dup (p.Leu528fs)	RARS2		not provided	Pathogenic(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	VCV000215076	6	88226526 - 88226527	6	87516808 - 87516809	215076	211267	rs863224183	NC_000006.12:87516808:AAA:AAAAA
NM_020320.5(RARS2):c.898dup (p.Asp300fs)	RARS2		not provided	Pathogenic(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	VCV000215075	6	88234350 - 88234351	6	87524632 - 87524633	215075	211279	rs863224182	NC_000006.12:87524632:C:CC
NM_020320.5(RARS2):c.839T>G (p.Leu280Ter)	RARS2	L280*, L105*	not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000858420	6	88239299	6	87529581	858420	832597		NC_000006.12:87529580:A:C
NM_020320.5(RARS2):c.474_477del (p.Glu159fs)	RARS2	E159fs	not provided	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000840886	6	88255392 - 88255395	6	87545674 - 87545677	840886	832598		NC_000006.12:87545673:TTCTTT:TT
NC_000006.12:g.(?_87555398)_(87555515_?)del	RARS2		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000833491	6	88265116 - 88265233			833491	819761		
NC_000006.12:g.(?_87585036)_(87590042_?)del	RARS2		not provided	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000833127	6	88294754 - 88299760			833127	819762		
NC_000006.12:g.(?_87529532)_(87529658_?)del	RARS2		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832483	6	88239250 - 88239376			832483	819760		
NM_020320.5(RARS2):c.1156C>T (p.Arg386Ter)	RARS2	R386*, R211*	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000653657	6	88229382	6	87519664	653657	635326		NC_000006.12:87519663:G:A
NM_020320.5(RARS2):c.233_234del (p.Val78fs)	RARS2	V78fs	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000652283	6	88272483 - 88272484	6	87562765 - 87562766	652283	635328		NC_000006.12:87562764:CAC:C
NM_020320.5(RARS2):c.1430_1431del (p.Phe477fs)	RARS2	F302fs, F477fs	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000652213	6	88227967 - 88227968	6	87518249 - 87518250	652213	635324		NC_000006.12:87518248:AAAA:AA
NM_020320.5(RARS2):c.1387del (p.Leu463fs)	RARS2	L288fs, L463fs	not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000641349	6	88228376	6	87518658	641349	635325		NC_000006.12:87518657:GG:G
NM_020320.5(RARS2):c.959_960CT[2] (p.Tyr322fs)	RARS2		not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000641283	6	88234285 - 88234286	6	87524567 - 87524568	641283	635327		NC_000006.12:87524566:AGAGAGA:AGAGA
NM_138691.2(TMC1):c.2218G>T (p.Glu740Ter)	TMC1	E740*	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627481	9	75445556	9	72830640	627481	615807	rs1564583413	NC_000009.12:72830639:G:T
NM_138691.2(TMC1):c.1259G>A (p.Cys420Tyr)	TMC1	C420Y	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619172	9	75406836	9	72791920	619172	610566	rs1564556995	NC_000009.12:72791919:G:A
NM_138691.2(TMC1):c.1143C>G (p.Tyr381Ter)	TMC1	Y381*	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562098	9	75404152	9	72789236	562098	553259	rs757327146	NC_000009.12:72789235:C:G
NM_138691.2(TMC1):c.1220dup (p.Asn407fs)	TMC1		Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562091	9	75404222 - 75404223	9	72789306 - 72789307	562091	553260	rs1564555185	NC_000009.12:72789306:AAAAAAA:AAAAAAAA
NM_020320.5(RARS2):c.1612del (p.Thr538fs)	RARS2	T363fs, T538fs	Pontocerebellar hypoplasia type 6	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000522857	6	88224713	6	87514995	522857	513424	rs781417096	NC_000006.12:87514994:TTTT:TTT
NM_138691.2(TMC1):c.1532C>T (p.Pro511Leu)	TMC1	P511L	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402278	9	75407234	9	72792318	402278	389230	rs727503483	NC_000009.12:72792317:C:T
NM_138691.2(TMC1):c.229del (p.Arg77fs)	TMC1	R77fs	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236042	9	75309623	9	72694707	236042	237605	rs878853230	NC_000009.12:72694706:A:
NM_138691.2(TMC1):c.15dup (p.Val6fs)	TMC1		Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236041	9	75263573 - 75263574	9	72648657 - 72648658	236041	237604	rs878853229	NC_000009.12:72648657:AAAAAA:AAAAAAA
NM_138691.2(TMC1):c.1677G>A (p.Trp559Ter)	TMC1	W559*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000228407	9	75420408	9	72805492	228407	229706	rs876657729	NC_000009.12:72805491:G:A
NM_138691.2(TMC1):c.1676G>A (p.Trp559Ter)	TMC1	W559*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000228406	9	75420407	9	72805491	228406	229705	rs876657728	NC_000009.12:72805490:G:A
RARS2, -2A-G	RARS2		Pontocerebellar hypoplasia type 6	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208208					208208	204466		
NM_138691.2(TMC1):c.215_219dup (p.Arg74fs)	TMC1		Rare genetic deafness	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	VCV000179431	9	75309608 - 75309609	9	72694692 - 72694693	179431	178278	rs730880359	NC_000009.12:72694692:GGAGG:GGAGGGGAGG
NM_138691.2(TMC1):c.22del (p.Ile8fs)	TMC1	I8fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	VCV000178942	9	75303628	9	72688712	178942	174844	rs727504554	NC_000009.12:72688711:AAA:AA
LMBR1, 406A-G	LMBR1		Tibia, hypoplasia or aplasia of, with polydactyly	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000155923					155923	165719		
NM_000500.5:c.293-13A>G(659A>G)	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065606					65606	76514		
NM_020320.5(RARS2):c.1024A>G (p.Met342Val)	RARS2	M342V, M167V	Pontocerebellar hypoplasia type 6	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000030911	6	88231193	6	87521475	30911	39868	rs387907048	NC_000006.12:87521474:T:C
CYP21A2, VAL304MET	CYP21A2	V304M	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000012180					12180	27219		
LMBR1, 235-KB DUP, IVS5	LMBR1		Syndactyly, type IV	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000004905					4905	19944		
LMBR1, 589-KB DUP, IVS5	LMBR1		Triphalangeal thumb polysyndactyly syndrome	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000004904					4904	19943		
NM_022458.3(LMBR1):c.180-2465_319+2696del	LMBR1		Acheiropodia	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004896	7	156615803 - 156621903	7	156823109 - 156829209	4896	19935		
NM_020320.5(RARS2):c.110+5A>G	RARS2		Pontocerebellar hypoplasia type 6	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000000891	6	88279230	6	87569512	891	15930		NC_000006.12:87569511:T:C
NM_138691.2:c.(?_-52-7)_(16+6_?)del	TMC1		Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000666999	9	75263506 - 75263586			666999	654978		
NM_138691.2(TMC1):c.885-2A>C	TMC1		Deafness, autosomal recessive 7	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000620585	9	75403253	9	72788337	620585	611985	rs1564554148	NC_000009.12:72788336:A:C
NM_020320.5(RARS2):c.42del (p.Arg15fs)	RARS2	R15fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430500	6	88279303	6	87569585	430500	421606	rs777942571	NC_000006.12:87569584:GG:G
NM_020320.5(RARS2):c.943C>T (p.Arg315Ter)	RARS2	R315*, R140*	Pontocerebellar hypoplasia type 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215061	6	88234306	6	87524588	215061	211277	rs199835443	NC_000006.12:87524587:G:A
NM_138691.2(TMC1):c.1253T>A (p.Met418Lys)	TMC1	M418K	Deafness, autosomal dominant 36	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000183668	9	75406830	9	72791914	183668	181568	rs786201027	NC_000009.12:72791913:T:A
LMBR1, 73-KB DUP	LMBR1		Syndactyly, type IV	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000155922					155922	165718		
LMBR1, 404G-C	LMBR1		Tibia, hypoplasia or aplasia of, with polydactyly	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000155921					155921	165717		
CYP21A2, 1-BP INS, 1003A	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000012178					12178	27217		
CYP21A2, GLY424SER	CYP21A2	G424S	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000012174					12174	27213		
CYP21A2, GLU380ASP	CYP21A2	E380D	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000012172					12172	27211		
CYP21A2, ARG339HIS AND PRO453SER	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000012170					12170	27209		
CYP21A2, IVS7DS, G-C, +1	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000012168					12168	27207		
CYP21A2, GENE CONVERSION CYP21 FROM CYP21P	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 1, 1988)	no assertion criteria provided	VCV000012161					12161	27200		
CYP21A2, 30-KB DEL	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jun 1, 1988)	no assertion criteria provided	VCV000012160					12160	27199		
NM_138691.2(TMC1):c.1543T>C (p.Cys515Arg)	TMC1	C515R	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000004107	9	75407245	9	72792329	4107	19146	rs121908076	NC_000009.12:72792328:T:C
NM_138691.2(TMC1):c.16+1G>T	TMC1		Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000004106	9	75263581	9	72648665	4106	19145		NC_000009.12:72648664:G:T
NM_138691.2(TMC1):c.1714G>C (p.Asp572His)	TMC1	D572H	Deafness, autosomal dominant 36	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000004105	9	75431077	9	72816161	4105	19144	rs121908072	NC_000009.12:72816160:G:C
NM_138691.2(TMC1):c.1960A>G (p.Met654Val)	TMC1	M654V	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004104	9	75435954	9	72821038	4104	19143	rs121908074	NC_000009.12:72821037:A:G
NM_000193.4(SHH):c.345C>A (p.Asn115Lys)	SHH	N115K, N28K	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008896	7	155599207	7	155806513	8896	23935	rs267607047	NC_000007.14:155806512:G:T
NM_000193.4(SHH):c.850G>T (p.Glu284Ter)	SHH	E284*	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008885	7	155596133	7	155803439	8885	23924	rs104894046	NC_000007.14:155803438:C:A
NM_000193.4(SHH):c.671T>A (p.Val224Glu)	SHH	V224E	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008882	7	155596312	7	155803618	8882	23921	rs104894042	NC_000007.14:155803617:A:T
NM_000193.4(SHH):c.349T>C (p.Trp117Arg)	SHH	W117R, W30R	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008881	7	155599203	7	155806509	8881	23920	rs104894040	NC_000007.14:155806508:A:G
NM_000193.4(SHH):c.349T>G (p.Trp117Gly)	SHH	W117G, W30G	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008880	7	155599203	7	155806509	8880	23919	rs104894040	NC_000007.14:155806508:A:C
NM_000193.4(SHH):c.91G>A (p.Gly31Arg)	SHH	G31R	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008877	7	155604726	7	155812032	8877	23916	rs28936675	NC_000007.14:155812031:C:T
NM_004273.5(CHST3):c.920T>C (p.Leu307Pro)	CHST3	L307P	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000006044	10	73767709	10	72007951	6044	21083	rs121908618	NC_000010.11:72007950:T:C
NM_004273.5(CHST3):c.776T>C (p.Leu259Pro)	CHST3	L259P	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000006041	10	73767565	10	72007807	6041	21080	rs121908616	NC_000010.11:72007806:T:C
NM_138691.2(TMC1):c.1236del (p.Met413fs)	TMC1	M413fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000228405	9	75406812	9	72791896	228405	229703	rs876657727	NC_000009.12:72791895:TT:T
NM_017841.2(SDHAF2):c.305_306insA (p.Asn103fs)	SDHAF2		Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000532508	11	61205520 - 61205521	11	61438048 - 61438049	532508	526281	rs753554501	NC_000011.10:61438048::A
NM_000274.3(OAT):c.1250C>T (p.Pro417Leu)	OAT	P417L, P279L, P310L, P217L	Ornithine aminotransferase deficiency|Gyrate atrophy	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000157	10	126086581	10	124398012	157	15196	rs121965044	NC_000010.11:124398011:G:A
NM_000190.4(HMBS):c.583C>T (p.Arg195Cys)	HMBS	R178C, R195C	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000161251	11	118962207	11	119091497	161251	171129	rs34413634	NC_000011.10:119091496:C:T
NM_000500.7:c.*28697972C>G	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000189131					189131	187078		
NM_006766.5(KAT6A):c.1473_1476dup (p.Leu493fs)	KAT6A		not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000817975	8	41832227 - 41832228	8	41974709 - 41974710	817975	805575		NC_000008.11:41974709:TGCTTG:TGCTTGCTTG
NM_006766.5(KAT6A):c.5566del (p.Ser1856fs)	KAT6A	S1856fs	not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000817973	8	41790172	8	41932654	817973	805571		NC_000008.11:41932653:AAA:AA
NM_006766.5(KAT6A):c.4370_4371AG[1] (p.Ser1458fs)	KAT6A		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000817759	8	41791365 - 41791366	8	41933847 - 41933848	817759	805572		NC_000008.11:41933846:CTCT:CT
NM_006766.5(KAT6A):c.4256_4260dup (p.Asp1421fs)	KAT6A		not provided	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000817328	8	41791477 - 41791478	8	41933959 - 41933960	817328	805573		NC_000008.11:41933959:CAGCTCA:CAGCTCAGCTCA
NM_006766.5(KAT6A):c.3306del (p.Lys1103fs)	KAT6A	K1103fs	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807616	8	41794820	8	41937302	807616	798599		NC_000008.11:41937301:CC:C
NM_006766.5(KAT6A):c.3318_3319insCT (p.Glu1107fs)	KAT6A		Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807615	8	41794807 - 41794808	8	41937289 - 41937290	807615	798598		NC_000008.11:41937289:A:AGA
NM_006766.5(KAT6A):c.805C>T (p.Arg269Ter)	KAT6A	R269*	not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000620554	8	41839377	8	41981859	620554	611697	rs1564039543	NC_000008.11:41981858:G:A
NM_006766.5(KAT6A):c.658C>T (p.Arg220Ter)	KAT6A	R220*	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000620356	8	41845024	8	41987506	620356	611698	rs1395351821	NC_000008.11:41987505:G:A
NM_006766.5(KAT6A):c.1096C>T (p.Arg366Ter)	KAT6A	R366*	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000620229	8	41834793	8	41977275	620229	611696	rs1564034820	NC_000008.11:41977274:G:A
NM_006766.5(KAT6A):c.442C>T (p.Arg148Ter)	KAT6A	R148*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000589472	8	41906054	8	42048536	589472	579438	rs759900272	NC_000008.11:42048535:G:A
NM_006766.5(KAT6A):c.3780del (p.Pro1261fs)	KAT6A	P1261fs	not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000545910	8	41791958	8	41934440	545910	536338	rs1554680115	NC_000008.11:41934439:A:
NM_006766.5(KAT6A):c.3782del (p.Pro1261fs)	KAT6A	P1261fs	not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000524127	8	41791956	8	41934438	524127	514571	rs1554680113	NC_000008.11:41934437:GG:G
NM_006766.5(KAT6A):c.1176del (p.Cys393fs)	KAT6A	C393fs	not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000504378	8	41834713	8	41977195	504378	495367	rs1554688473	NC_000008.11:41977194:G:
NM_006766.5(KAT6A):c.949C>T (p.Arg317Ter)	KAT6A	R317*	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000489323	8	41836254	8	41978736	489323	481817	rs1554688879	NC_000008.11:41978735:G:A
NM_006766.5(KAT6A):c.3055C>T (p.Arg1019Ter)	KAT6A	R1019*	not provided	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000489088	8	41795071	8	41937553	489088	481816	rs1554680902	NC_000008.11:41937552:G:A
NM_006766.5(KAT6A):c.5639C>A (p.Ser1880Ter)	KAT6A	S1880*	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000489019	8	41790099	8	41932581	489019	481815	rs201870299	NC_000008.11:41932580:G:T
NM_006766.5(KAT6A):c.3412del (p.Glu1139fs)	KAT6A	E1139fs	not provided	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000452579	8	41792326	8	41934808	452579	444280	rs1554680267	NC_000008.11:41934807:G:
NM_006766.5(KAT6A):c.1085_1089dup (p.Arg364fs)	KAT6A		not provided	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000451609	8	41834799 - 41834800	8	41977281 - 41977282	451609	444284	rs1554688570	NC_000008.11:41977281:ACCCC:ACCCCACCCC
NM_006766.5(KAT6A):c.3353-3_3353dup	KAT6A		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000450319	8	41792384 - 41792385	8	41934866 - 41934867	450319	444281	rs1554680316	NC_000008.11:41934866:TCTAT:TCTATCTAT
NM_006766.5(KAT6A):c.3353-1G>A	KAT6A		not provided	Pathogenic(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	VCV000449582	8	41792386	8	41934868	449582	444282	rs1351334408	NC_000008.11:41934867:C:T
NM_006766.5(KAT6A):c.4645G>A (p.Gly1549Ser)	KAT6A	G1549S	not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000419627	8	41791093	8	41933575	419627	407383	rs1064794000	NC_000008.11:41933574:C:T
NM_006766.5(KAT6A):c.4361dup (p.Thr1455fs)	KAT6A		not provided	Pathogenic(Last reviewed: Aug 22, 2015)	criteria provided, single submitter	VCV000419571	8	41791376 - 41791377	8	41933858 - 41933859	419571	407385	rs1554679835	NC_000008.11:41933858:T:TT
NM_006766.5(KAT6A):c.4025del (p.Lys1342fs)	KAT6A	K1342fs	not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000419562	8	41791713	8	41934195	419562	407386	rs1064793955	NC_000008.11:41934194:TT:T
NM_006766.5(KAT6A):c.931C>T (p.Arg311Ter)	KAT6A	R311*	not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000419207	8	41836272	8	41978754	419207	407387	rs1064793721	NC_000008.11:41978753:G:A
NM_006766.5(KAT6A):c.4381C>T (p.Gln1461Ter)	KAT6A	Q1461*	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000391696	8	41791357	8	41933839	391696	369472	rs1057524195	NC_000008.11:41933838:G:A
NM_006766.5(KAT6A):c.4210dup (p.Glu1404fs)	KAT6A		not provided	Pathogenic(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000373672	8	41791527 - 41791528	8	41934009 - 41934010	373672	359737	rs1057518543	NC_000008.11:41934009:CC:CCC
NM_006766.5(KAT6A):c.3182T>G (p.Leu1061Ter)	KAT6A	L1061*	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000280659	8	41794944	8	41937426	280659	264360	rs886041825	NC_000008.11:41937425:A:C
NM_006766.5(KAT6A):c.1536dup (p.Glu513Ter)	KAT6A		not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000280641	8	41812875 - 41812876	8	41955357 - 41955358	280641	264401	rs886041809	NC_000008.11:41955357:AA:AAA
NM_006766.5(KAT6A):c.3432dup (p.Pro1145fs)	KAT6A		not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000280545	8	41792305 - 41792306	8	41934787 - 41934788	280545	264382	rs886041731	NC_000008.11:41934787:T:TT
NM_006766.5(KAT6A):c.3553C>T (p.Gln1185Ter)	KAT6A	Q1185*	not provided	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000280462	8	41792185	8	41934667	280462	264358	rs374290942	NC_000008.11:41934666:G:A
NM_006766.5(KAT6A):c.3661G>T (p.Glu1221Ter)	KAT6A	E1221*	not provided	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000280246	8	41792077	8	41934559	280246	264264	rs139494583	NC_000008.11:41934558:C:A
NM_006766.5(KAT6A):c.5546_5555del (p.Met1849fs)	KAT6A	M1849fs	not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000280240	8	41790183 - 41790192	8	41932665 - 41932674	280240	264377	rs886041480	NC_000008.11:41932664:TTCACTGGCATT:TT
NM_006766.5(KAT6A):c.1903-5_1903-2del	KAT6A		Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000692079	8	41804204 - 41804207	8	41946686 - 41946689	692079	679827		NC_000008.11:41946685:TGGT:
KAT6A, ASN643SER	KAT6A	N643S	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Mar 3, 2020)	no assertion criteria provided	VCV000626907					626907	615239		
NM_006766.5(KAT6A):c.907+1del	KAT6A		Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000620010	8	41838363	8	41980845	620010	611467	rs1564038389	NC_000008.11:41980844:CC:C
NM_006766.5(KAT6A):c.856C>T (p.Arg286Ter)	KAT6A	R286*	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000598767	8	41838415	8	41980897	598767	589839	rs1564038539	NC_000008.11:41980896:G:A
NM_006766.5(KAT6A):c.3443del (p.Lys1148fs)	KAT6A	K1148fs	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Mar 22, 2018)	no assertion criteria provided	VCV000559638	8	41792295	8	41934777	559638	550362	rs1554680245	NC_000008.11:41934776:TTTTT:TTTT
NM_006766.5(KAT6A):c.4254_4257del (p.Glu1419fs)	KAT6A	E1419fs	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, single submitter	VCV000369686	8	41791481 - 41791484	8	41933963 - 41933966	369686	353897	rs1057516049	NC_000008.11:41933962:CTCACT:CT
NM_006766.5(KAT6A):c.3505C>T (p.Arg1169Ter)	KAT6A	R1169*	not provided|Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000280873	8	41792233	8	41934715	280873	264380	rs886042000	NC_000008.11:41934714:G:A
NM_000494.4(COL17A1):c.25C>T (p.Arg9Ter)	COL17A1	R9*	Adult junctional epidermolysis bullosa|not provided	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427173	10	105840407	10	104080649	427173	415214	rs775196743	NC_000010.11:104080648:G:A
NM_012203.2(GRHPR):c.454dup (p.Thr152fs)	GRHPR		Primary hyperoxaluria, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371016	9	37428529 - 37428530	9	37428532 - 37428533	371016	357813	rs771019056	NC_000009.12:37428532:A:AA
NM_000494.4(COL17A1):c.3156C>T (p.Gly1052=)	COL17A1	G1052G	Epithelial recurrent erosion dystrophy	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000208978	10	105797446	10	104037688	208978	205533	rs760714959	NC_000010.11:104037687:G:A
NM_012203.2(GRHPR):c.84-2A>G	GRHPR		Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000204241	9	37424840	9	37424843	204241	200620	rs180177319	NC_000009.12:37424842:A:G
NM_002778.4(PSAP):c.1A>T (p.Met1Leu)	PSAP	M1L	Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000013365	10	73610978	10	71851221	13365	28404	rs121918106	NC_000010.11:71851220:T:A
NM_006766.5(KAT6A):c.4038del (p.Val1347fs)	KAT6A	V1347fs	not provided|Mental retardation, autosomal dominant 32	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617516	8	41791700	8	41934182	617516	608878	rs1564005155	NC_000008.11:41934181:A:
NM_006766.5(KAT6A):c.3879dup (p.Glu1294fs)	KAT6A		Mental retardation, autosomal dominant 32|Syndromic intellectual disability	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000180678	8	41791858 - 41791859	8	41934340 - 41934341	180678	178847	rs786200952	NC_000008.11:41934340:T:TT
NM_006766.5(KAT6A):c.3116_3117del (p.Ile1038_Ser1039insTer)	KAT6A		Mental retardation, autosomal dominant 32|Syndromic intellectual disability	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000162616	8	41795009 - 41795010	8	41937491 - 41937492	162616	172292	rs786200959	NC_000008.11:41937490:AGA:A
NM_001540.5(HSPB1):c.452C>T (p.Thr151Ile)	HSPB1	T151I	|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000007480	7	75933324	7	76304007	7480	22519	rs28937568	NC_000007.14:76304006:C:T
NM_138691.2(TMC1):c.1939T>C	TMC1	S647P	Rare genetic deafness|Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000228408	9	75435933	9	72821017	228408	229709	rs138527651	NC_000009.12:72821016:T:C
NM_000500.7:c.*28699312C>T	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000189135					189135	187082		
-4C-T, PRO105LEU, AND PRO453SER	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000012158					12158	27197		
NM_004273.5(CHST3):c.533dup (p.Ala179fs)	CHST3		not provided|Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000432012	10	73767316 - 73767317	10	72007558 - 72007559	432012	425884	rs769540174	NC_000010.11:72007558:GGGGGG:GGGGGGG
NM_000193.4(SHH):c.263A>T (p.Asp88Val)	SHH	D88V	Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008891	7	155604554	7	155811860	8891	23930	rs104894050	NC_000007.14:155811859:T:A
NM_000193.4(SHH):c.788_808del (p.Arg263_Ala269del)	SHH		Holoprosencephaly 3	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000008884	7	155596175 - 155596195	7	155803481 - 155803501	8884	23923	rs397515375	NC_000007.14:155803480:GCGCGGCGGTGAGCAGCAGGCGC:GC
NM_080877.2(SLC34A3):c.1639_1652del (p.Arg547fs)	SLC34A3	R547fs	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	VCV000444096	9	140130702 - 140130715	9	137236250 - 137236263	444096	437704	rs1554785389	NC_000009.12:137236249:GCCTGCGCTCCTGGGCCTG:GCCTG
NM_080877.2(SLC34A3):c.575C>G (p.Ser192Trp)	SLC34A3	S192W	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	VCV000444094	9	140127675	9	137233223	444094	437702	rs199690076	NC_000009.12:137233222:C:G
NM_080877.2(SLC34A3):c.1556dup (p.Pro520fs)	SLC34A3		Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438692	9	140130619 - 140130620	9	137236167 - 137236168	438692	432302	rs1554785333	NC_000009.12:137236167:GGGGG:GGGGGG
NM_080877.2(SLC34A3):c.210del (p.Gly71fs)	SLC34A3	G71fs	not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000423399	9	140127060	9	137232608	423399	407635	rs1064796402	NC_000009.12:137232607:CC:C
NM_153033.4(KCTD7):c.631C>T (p.Arg211Ter)	KCTD7	R211*	not provided	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000379332	7	66103980	7	66638993	379332	369575	rs750811871	NC_000007.14:66638992:C:T
GRCh37/hg19 7q11.21(chr7:66103208-66105624)x3	KCTD7		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253379	7	66103208 - 66105624			253379	247827		
NM_153033.4(KCTD7):c.536_543del (p.Val179fs)	KCTD7	V179fs	not provided	Pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	VCV000206016	7	66103881 - 66103888	7	66638894 - 66638901	206016	202141	rs796052688	NC_000007.14:66638893:GCGGTCCAGCGG:GCGG
NM_001177316.2(SLC34A3):c.711dup (p.Ile238fs)	SLC34A3		not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000852891	9	140127810 - 140127811	9	137233358 - 137233359	852891	835944		NC_000009.12:137233358:C:CC
NM_001177316.2(SLC34A3):c.143del (p.Pro48fs)	SLC34A3	P48fs	not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000835431	9	140126579	9	137232127	835431	835942		NC_000009.12:137232126:CCC:CC
NM_002291.3(LAMB1):c.1442G>T (p.Cys481Phe)	LAMB1	C481F	Lissencephaly 5	Pathogenic(Last reviewed: May 4, 2016)	no assertion criteria provided	VCV000225688	7	107615471	7	107975026	225688	227503	rs879255267	NC_000007.14:107975025:C:A
NM_002291.3(LAMB1):c.2931del (p.Gln977fs)	LAMB1	Q977fs	Lissencephaly 5	Pathogenic(Last reviewed: May 4, 2016)	no assertion criteria provided	VCV000225687	7	107594123	7	107953678	225687	227502	rs879255266	NC_000007.14:107953677:C:
NM_002291.3(LAMB1):c.2109+1G>T	LAMB1		Lissencephaly 5	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000042015	7	107601650	7	107961205	42015	51183	rs387907344	NC_000007.14:107961204:C:A
NM_002291.3(LAMB1):c.3145_3158delinsCCAGTGCTTGTGTCTTCCTAATGTGCTTGTGTCTTCCTAAT (p.Lys1049_Gln1053delinsProValLeuValSerSerTer)	LAMB1		Lissencephaly 5	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000042014	7	107592590 - 107592603	7	107952145 - 107952158	42014	51182	rs387907343	NC_000007.14:107952144:TGACCAGTGGCTTT:ATTAGGAAGACACAAGCACATTAGGAAGACACAAGCACTGG
NM_080877.2(SLC34A3):c.1093+41_1094-15del	SLC34A3		Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000001435	9	140128753 - 140128837	9	137234301 - 137234385	1435	16474	rs1554784508	
NM_001083116.3(PRF1):c.1122G>A (p.Trp374Ter)	PRF1	W374*	not provided|	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013709	10	72358355	10	70598599	13709	28748	rs104894176	NC_000010.11:70598598:C:T
NM_001167961.2(KCTD7):c.331del (p.Leu111fs)	KCTD7	L111fs	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV000860762	7	66103255	7	66638268	860762	833812		NC_000007.14:66638267:CC:C
NM_001177316.2(SLC34A3):c.1502del (p.Leu501fs)	SLC34A3	L501fs	not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000855268	9	140130570	9	137236118	855268	835950		NC_000009.12:137236117:T:
NC_000007.14:g.(?_66629045)_(66640414_?)del	KCTD7		Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000831752	7	66094032 - 66105401			831752	819912		
NM_080877.2(SLC34A3):c.1561dup (p.Leu521fs)	SLC34A3		not provided|Autosomal recessive hypophosphatemic bone disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000444095	9	140130625 - 140130626	9	137236173 - 137236174	444095	437703	rs765816079	NC_000009.12:137236173:CCCC:CCCCC
NM_153033.4(KCTD7):c.322C>A (p.Leu108Met)	KCTD7	L108M	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037013	7	66103247	7	66638260	37013	45679	rs387907263	NC_000007.14:66638259:C:A
NM_153033.4(KCTD7):c.343G>T (p.Asp115Tyr)	KCTD7	D115Y	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037012	7	66103268	7	66638281	37012	45678	rs387907262	NC_000007.14:66638280:G:T
NM_153033.4(KCTD7):c.818A>T (p.Asn273Ile)	KCTD7	N273I	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037011	7	66104167	7	66639180	37011	45677	rs387907261	NC_000007.14:66639179:A:T
NM_153033.4(KCTD7):c.594del (p.Ile199fs)	KCTD7	I199fs	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037009	7	66103941	7	66638954	37009	45675	rs727502785	NC_000007.14:66638953:CCC:CC
NM_080877.2(SLC34A3):c.228del (p.Cys77fs)	SLC34A3	C77fs	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000001430	9	140127078	9	137232626	1430	16469	rs794729659	NC_000009.12:137232625:CC:C
NM_080877.2(SLC34A3):c.846G>A (p.Pro282=)	SLC34A3	P282P	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	VCV000001429	9	140128174	9	137233722	1429	16468	rs121918236	NC_000009.12:137233721:G:A
NM_080877.2(SLC34A3):c.1238C>A (p.Ala413Glu)	SLC34A3	A413E	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	VCV000001428	9	140129086	9	137234634	1428	16467	rs121918235	NC_000009.12:137234633:C:A
NM_080877.2(SLC34A3):c.1058G>T (p.Arg353Leu)	SLC34A3	R353L	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000001427	9	140128693	9	137234241	1427	16466	rs121918234	NC_000009.12:137234240:G:T
NM_080877.2(SLC34A3):c.908del (p.Pro303fs)	SLC34A3	P303fs	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	VCV000001426	9	140128373	9	137233921	1426	16465	rs794729658	NC_000009.12:137233920:CCCC:CCC
NM_153033.4(KCTD7):c.295C>T (p.Arg99Ter)	KCTD7	R99*	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000000843	7	66098412	7	66633425	843	15882	rs267607199	NC_000007.14:66633424:C:T
NM_006766.5(KAT6A):c.4228_4232del (p.Lys1410fs)	KAT6A	K1410fs	Mental retardation, autosomal dominant 32|History of neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000524135	8	41791506 - 41791510	8	41933988 - 41933992	524135	514570	rs1554679889	NC_000008.11:41933987:TCTTTT:T
NM_014251.3(SLC25A13):c.550C>T (p.Arg184Ter)	SLC25A13	R184*	Neonatal intrahepatic cholestasis caused by citrin deficiency|Citrin deficiency	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000021515	7	95822414	7	96193102	21515	34367	rs80338716	NC_000007.14:96193101:G:A
NM_014251.3(SLC25A13):c.1078C>T (p.Arg360Ter)	SLC25A13	R360*, R361*	Neonatal intrahepatic cholestasis caused by citrin deficiency|Citrin deficiency	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000021508	7	95813688	7	96184376	21508	34360	rs80338721	NC_000007.14:96184375:G:A
NM_080877.2(SLC34A3):c.925+20_926-48del	SLC34A3		Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	VCV000001433	9	140128413 - 140128513	9	137233910 - 137234010	1433	16472	rs1554784044	
NM_003172.4(SURF1):c.756_757CA[1] (p.Thr253fs)	SURF1		Leigh syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000372717	9	136218990 - 136218991	9	133352135 - 133352136	372717	359786	rs782349178	NC_000009.12:133352134:TGTG:TG
NM_003172.4(SURF1):c.751C>T (p.Gln251Ter)	SURF1	Q251*, Q142*	Leigh syndrome|Leigh syndrome due to mitochondrial complex IV deficiency|not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012762	9	136219301	9	133352446	12762	27801	rs121918657	NC_000009.12:133352445:G:A
NC_000007.13:g.(?_66103220)_(66104239_?)del	KCTD7		Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000583587	7	66103220 - 66104239	7	66638233 - 66639252	583587	561099		
NM_153033.4(KCTD7):c.335G>A (p.Arg112His)	KCTD7	R112H	not provided|Epilepsy, progressive myoclonic 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000206015	7	66103260	7	66638273	206015	202134	rs774026720	NC_000007.14:66638272:G:A
NM_014780.4(CUL7):c.2710C>T (p.Arg904Ter)	CUL7	R904*, R988*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000595100	6	43013780	6	43046042	595100	586162	rs760910667	NC_000006.12:43046041:G:A
NM_014780.4(CUL7):c.2559del (p.Ser854fs)	CUL7	S938fs, S854fs	not provided	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000498090	6	43014075	6	43046337	498090	489514	rs1554137913	NC_000006.12:43046336:GG:G
NM_014780.4(CUL7):c.2112G>A (p.Trp704Ter)	CUL7	W704*, W788*	not provided	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000498089	6	43015943	6	43048205	498089	489513	rs1554138577	NC_000006.12:43048204:C:T
NM_014780.4(CUL7):c.1648C>T (p.Arg550Ter)	CUL7	R550*, R634*	not provided	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000497425	6	43017322	6	43049584	497425	488849	rs746333044	NC_000006.12:43049583:G:A
NM_014780.4(CUL7):c.4476del (p.Leu1493fs)	CUL7	L1493fs, L1577fs	not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000450652	6	43006395	6	43038657	450652	443966	rs1554135458	NC_000006.12:43038656:CCC:CC
NM_014780.4(CUL7):c.2130_2131delinsTGCCTG (p.Cys711fs)	CUL7		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000450651	6	43015924 - 43015925	6	43048186 - 43048187	450651	443967	rs1554138553	NC_000006.12:43048185:AG:CAGGCA
NM_014780.4(CUL7):c.2848A>T (p.Lys950Ter)	CUL7	K950*, K1034*	not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000290242	6	43013339	6	43045601	290242	274479	rs886044397	NC_000006.12:43045600:T:A
NM_014780.4(CUL7):c.4318C>T (p.Arg1440Ter)	CUL7	R1440*, R1524*	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000288359	6	43006702	6	43038964	288359	272596	rs748555538	NC_000006.12:43038963:G:A
NM_014780.4(CUL7):c.2787del (p.Ser930fs)	CUL7	S1014fs, S930fs	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000288357	6	43013400	6	43045662	288357	272594	rs886043872	NC_000006.12:43045661:GG:G
NM_014780.4(CUL7):c.2164C>T (p.Arg722Ter)	CUL7	R722*, R806*	not provided	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000282301	6	43015891	6	43048153	282301	266538	rs886042376	NC_000006.12:43048152:G:A
NM_014780.4(CUL7):c.898_919del (p.Met300fs)	CUL7	M384fs, M300fs	not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000197297	6	43019020 - 43019041	6	43051282 - 43051303	197297	194458	rs794727644	NC_000006.12:43051281:GCTCCGAGATCAGGGTGCCCATG:G
NC_000011.10:g.(?_4059271)_(4059406_?)del	STIM1		Combined immunodeficiency due to STIM1 deficiency|Myopathy with tubular aggregates|Stormorken syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000832877	11	4080501 - 4080636			832877	820366		
NM_003156.3(STIM1):c.700_707del (p.Asn234fs)	STIM1	N234fs	Myopathy, tubular aggregate, 1|Combined immunodeficiency due to STIM1 deficiency|Stormorken syndrome	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000643831	11	4091342 - 4091349	11	4070112 - 4070119	643831	640037		NC_000011.10:4070111:AACCGTTA:
NM_003156.3(STIM1):c.1452del (p.Ile484fs)	STIM1	I484fs	Combined immunodeficiency due to STIM1 deficiency|Stormorken syndrome|Myopathy, tubular aggregate, 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000572186	11	4104705	11	4083475	572186	570639	rs1565171115	NC_000011.10:4083474:TT:T
NM_001168370.1(CUL7):c.3193_3194CT[1] (p.Cys1066fs)	CUL7		Three M syndrome	Pathogenic(Last reviewed: Oct 14, 2016)	no assertion criteria provided	VCV000425545	6	43013059 - 43013060	6	43045321 - 43045322	425545	413879	rs1064792895	NC_000006.12:43045320:AGAG:AG
NM_003156.3(STIM1):c.221T>C (p.Leu74Pro)	STIM1	L74P	Combined immunodeficiency due to STIM1 deficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000375471	11	3988863	11	3967633	375471	362276	rs1057519506	NC_000011.10:3967632:T:C
NM_003156.3(STIM1):c.216C>A (p.His72Gln)	STIM1	H72Q	Myopathy, tubular aggregate, 1	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000041484	11	3988858	11	3967628	41484	49923	rs397515436	NC_000011.10:3967627:C:A
NM_003156.3(STIM1):c.251A>G (p.Asp84Gly)	STIM1	D84G	Myopathy, tubular aggregate, 1	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000041481	11	3988893	11	3967663	41481	49920	rs397514675	NC_000011.10:3967662:A:G
NM_003156.3(STIM1):c.970-1G>A	STIM1		Combined immunodeficiency due to STIM1 deficiency	Pathogenic(Last reviewed: Oct 25, 2010)	no assertion criteria provided	VCV000030540	11	4103413	11	4082183	30540	39497	rs397515390	NC_000011.10:4082182:G:A
NM_003156.3(STIM1):c.381dup (p.Glu128fs)	STIM1		Combined immunodeficiency due to STIM1 deficiency	Pathogenic(Last reviewed: May 7, 2009)	no assertion criteria provided	VCV000004711	11	4045212 - 4045213	11	4023982 - 4023983	4711	19750	rs397515357	NC_000011.10:4023982:A:AA
NM_014780.4(CUL7):c.4581dup (p.Arg1528fs)	CUL7		Yakut short stature syndrome	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000001616	6	43006196 - 43006197	6	43038458 - 43038459	1616	16655	rs730880301	NC_000006.12:43038458:AA:AAA
NM_014780.5(CUL7):c.2988G>A (p.Trp996Ter)	CUL7	W996*, W1028*	Three M syndrome 1	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828132	6	43013015	6	43045277	828132	816463		NC_000006.12:43045276:C:T
NM_014780.5(CUL7):c.652del (p.Arg218fs)	CUL7	R218fs, R250fs	Three M syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802219	6	43019430	6	43051692	802219	790634		NC_000006.12:43051691:GG:G
NM_003156.3(STIM1):c.1276C>T (p.Arg426Cys)	STIM1	R426C	Combined immunodeficiency due to STIM1 deficiency	Pathogenic(Last reviewed: Mar 12, 2014)	no assertion criteria provided	VCV000375470	11	4104530	11	4083300	375470	362275	rs1057519505	NC_000011.10:4083299:C:T
NM_014780.4(CUL7):c.3173-1G>C	CUL7		Three M syndrome 1	Pathogenic(Last reviewed: Dec 17, 2015)	no assertion criteria provided	VCV000218361	6	43011369	6	43043631	218361	215088	rs864309521	NC_000006.12:43043630:C:G
NM_003156.3(STIM1):c.325C>A (p.His109Asn)	STIM1	H109N	Myopathy, tubular aggregate, 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000041482	11	4045157	11	4023927	41482	49921	rs397514676	NC_000011.10:4023926:C:A
NM_001258392.3(CLPB):c.1159C>T (p.Arg387Ter)	CLPB	R417*, R387*, R358*, R372*	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187786	11	72013356	11	72302312	187786	185684	rs200203460	NC_000011.10:72302311:G:A
NM_000500.7:c.*28698024_*28698031del8	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000189142					189142	187085		
NM_000500.7:c.*28699426C>T	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000189136					189136	187083		
NM_138691.2(TMC1):c.1165C>T	TMC1	R389*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000047856	9	75404174	9	72789258	47856	57020	rs151001642	NC_000009.12:72789257:C:T
NM_014780.4(CUL7):c.1570-3C>A	CUL7		Three M syndrome 1	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001619	6	43017403	6	43049665	1619	16658	rs730880263	NC_000006.12:43049664:G:T
NM_014780.4(CUL7):c.3379_3380del (p.Trp1127fs)	CUL7	W1127fs, W1211fs	Three M syndrome 1	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001618	6	43010894 - 43010895	6	43043156 - 43043157	1618	16657	rs730880262	NC_000006.12:43043155:CA:
NM_014780.4(CUL7):c.4391A>C (p.His1464Pro)	CUL7	H1464P, H1548P	Three M syndrome 1	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000001614	6	43006629	6	43038891	1614	16653	rs121918229	NC_000006.12:43038890:T:G
NM_000494.4(COL17A1):c.2407G>T (p.Gly803Ter)	COL17A1	G803*	not provided|Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000298713	10	105803610	10	104043852	298713	309402	rs752317971	NC_000010.11:104043851:C:A
NM_012203.2(GRHPR):c.694del (p.Gln232fs)	GRHPR	Q232fs	not provided|Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204253	9	37430602	9	37430605	204253	200639	rs796052082	NC_000009.12:37430604:CC:C
NM_002778.4(PSAP):c.722G>C (p.Cys241Ser)	PSAP	C241S	Combined saposin deficiency|Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013363	10	73585649	10	71825892	13363	28402	rs121918104	NC_000010.11:71825891:C:G
NM_000111.2(SLC26A3):c.559G>T (p.Gly187Ter)	SLC26A3	G187*	Congenital secretory diarrhea, chloride type|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016759	7	107431504	7	107791059	16759	31798	rs121913032	NC_000007.14:107791058:C:A
NM_000459.4(TEK):c.2545C>T (p.Arg849Trp)	TEK	R849W, R701W, R806W	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000009293	9	27206760	9	27206762	9293	24332	rs80338908	NC_000009.12:27206761:C:T
NM_138413.4(HOGA1):c.860G>T (p.Gly287Val)	HOGA1	G287V, G124V	Primary hyperoxaluria, type III|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000030	10	99371292	10	97611535	30	15069	rs138207257	NC_000010.11:97611534:G:T
NM_001168370.1(CUL7):c.4701_4702TG[1] (p.Val1568fs)	CUL7		Three M syndrome 1	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001615	6	43006419 - 43006420	6	43038681 - 43038682	1615	16654	rs730880261	NC_000006.12:43038680:CACA:CA
NM_000193.4(SHH):c.383G>A (p.Trp128Ter)	SHH	W128*, W41*	Holoprosencephaly 3|Solitary median maxillary central incisor syndrome|not provided	Pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000008895	7	155599169	7	155806475	8895	23934	rs104894053	NC_000007.14:155806474:C:T
NM_000399.5(EGR2):c.1225C>T (p.Arg409Trp)	EGR2	R409W, R359W	Charcot-Marie-Tooth disease, demyelinating, type 1d|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000016750	10	64573173	10	62813413	16750	31789	rs104894159	NC_000010.11:62813412:G:A
NM_003156.3(STIM1):c.326A>G (p.His109Arg)	STIM1	H109R	Myopathy with tubular aggregates|Stormorken syndrome|Combined immunodeficiency due to STIM1 deficiency|Myopathy, tubular aggregate, 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000041483	11	4045158	11	4023928	41483	49922	rs397514677	NC_000011.10:4023927:A:G
NM_014780.4(CUL7):c.4333C>T (p.Arg1445Ter)	CUL7	R1445*, R1529*	Three M syndrome 1|not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000001613	6	43006687	6	43038949	1613	16652	rs121918228	NC_000006.12:43038948:G:A
NM_001172477.1(RRM2B):c.1166del (p.Ser388_Leu389insTer)	RRM2B	L317*	Mitochondrial diseases|RRM2B-related mitochondrial disease|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000030432	8	103220467	8	102208239	30432	39389	rs515726199	NC_000008.11:102208238:AAA:AA
NM_014251.3(SLC25A13):c.674C>A (p.Ser225Ter)	SLC25A13	S225*	Neonatal intrahepatic cholestasis caused by citrin deficiency|Citrullinemia type II	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000006004	7	95820501	7	96191189	6004	21043	rs80338719	NC_000007.14:96191188:G:T
NM_000195.5(HPS1):c.398+2T>C	HPS1		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000449037	10	100195027	10	98435270	449037	444694	rs1486224265	NC_000010.11:98435269:A:G
NM_000195.5(HPS1):c.988-44_1023delinsT	HPS1		not provided	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000280573	10	100185707 - 100185786	10	98425950 - 98426029	280573	264441	rs1554889184	
NM_000195.5(HPS1):c.1716dup (p.Pro573fs)	HPS1		not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000856246	10	100182152 - 100182153	10	98422395 - 98422396	856246	837573		NC_000010.11:98422395:CCCC:CCCCC
NM_000195.5(HPS1):c.238del (p.Leu80fs)	HPS1	L80fs, C5fs	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000853800	10	100195409	10	98435652	853800	837576		NC_000010.11:98435651:GG:G
NM_000195.5(HPS1):c.1437C>A (p.Cys479Ter)	HPS1	C359*, C155*, C446*, C323*, C356*, C392*, C479*	not provided	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000848274	10	100183605	10	98423848	848274	837574		NC_000010.11:98423847:G:T
NM_000195.5(HPS1):c.820dup (p.Trp274fs)	HPS1		not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000843353	10	100189594 - 100189595	10	98429837 - 98429838	843353	837575		NC_000010.11:98429837:A:AA
NM_000195.5(HPS1):c.551_552del (p.Ile184fs)	HPS1	I184fs, I61fs	not provided	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000658076	10	100191004 - 100191005	10	98431247 - 98431248	658076	639353		NC_000010.11:98431246:TAT:T
NM_000195.5(HPS1):c.974_975insC (p.Met325fs)	HPS1		Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021113	10	100186984 - 100186985	10	98427227 - 98427228	21113	33965	rs281865092	NC_000010.11:98427227::G
NM_000195.5(HPS1):c.962del (p.Gly321fs)	HPS1	G165fs, G198fs, G201fs, G234fs, G288fs, G321fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021110	10	100186997	10	98427240	21110	33962	rs281865081	NC_000010.11:98427239:CCCCCC:CCCCC
NM_000195.5(HPS1):c.932del (p.Ser311fs)	HPS1	S191fs, A239fs, A272fs, S155fs, S188fs, S224fs, S278fs, S311fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021109	10	100189335	10	98429578	21109	33961	rs281865091	NC_000010.11:98429577:C:
NM_000195.5(HPS1):c.716T>C (p.Leu239Pro)	HPS1	L239P, L152P, S200P, L116P	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021107	10	100190380	10	98430623	21107	33959	rs281865080	NC_000010.11:98430622:A:G
NM_000195.5(HPS1):c.532dup (p.Gln178fs)	HPS1		Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021106	10	100191023 - 100191024	10	98431266 - 98431267	21106	33958	rs281865079	NC_000010.11:98431266:GGGGG:GGGGGG
NM_000195.5(HPS1):c.418del (p.Ala140fs)	HPS1	G92fs, A140fs, A17fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021105	10	100193829	10	98434072	21105	33957	rs281865078	NC_000010.11:98434071:CC:C
NM_000195.5(HPS1):c.391C>T (p.Arg131Ter)	HPS1	R131*	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021104	10	100195036	10	98435279	21104	33956	rs281865076	NC_000010.11:98435278:G:A
NM_000195.5(HPS1):c.288del (p.Asp97fs)	HPS1	D97fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021102	10	100195139	10	98435382	21102	33954	rs281865074	NC_000010.11:98435381:A:
NM_000195.5(HPS1):c.2003T>C (p.Leu668Pro)	HPS1	L668P, L344P, L548P, L545P, L512P, L581P, L635P	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021101	10	100177421	10	98417664	21101	33953	rs281865090	NC_000010.11:98417663:A:G
NM_000195.5(HPS1):c.1749G>A (p.Trp583Ter)	HPS1	W583*, W496*, W550*, W259*, W427*, W460*, W463*	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021098	10	100179910	10	98420153	21098	33950	rs281865089	NC_000010.11:98420152:C:T
NM_000195.5(HPS1):c.1691del (p.Lys564fs)	HPS1	K240fs, K564fs, K441fs, K408fs, K444fs, K477fs, K531fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021096	10	100182178	10	98422421	21096	33948	rs281865087	NC_000010.11:98422420:TTTT:TTT
NM_000195.5(HPS1):c.163_165ATC[1] (p.Ile56del)	HPS1	I56del	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021095	10	100195479 - 100195481	10	98435722 - 98435724	21095	33947	rs281865073	NC_000010.11:98435721:GATGATGA:GATGA
NM_000195.5(HPS1):c.1375del (p.Ser459fs)	HPS1	S303fs, S339fs, S372fs, S426fs, S135fs, S336fs, S459fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021093	10	100184092	10	98424335	21093	33945	rs281865086	NC_000010.11:98424334:TTTT:TTT
NM_000195.5(HPS1):c.1323dup (p.Gln442fs)	HPS1		Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021092	10	100185309 - 100185310	10	98425552 - 98425553	21092	33944	rs281865085	NC_000010.11:98425552:T:TT
NM_000195.5(HPS1):c.1657C>T (p.Gln553Ter)	HPS1	Q229*, Q397*, Q430*, Q433*, Q466*, Q520*, Q553*	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000694730	10	100182212	10	98422455	694730	682849		NC_000010.11:98422454:G:A
NM_000195.5(HPS1):c.1807C>T (p.Gln603Ter)	HPS1	Q603*, Q447*, Q516*, Q480*, Q483*, Q279*, Q570*	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Mar 26, 2019)	no assertion criteria provided	VCV000627613	10	100179852	10	98420095	627613	615952		NC_000010.11:98420094:G:A
NM_000195.5(HPS1):c.187G>T (p.Glu63Ter)	HPS1	E63*	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Mar 26, 2019)	no assertion criteria provided	VCV000627612	10	100195460	10	98435703	627612	615953		NC_000010.11:98435702:C:A
NM_000195.5(HPS1):c.233_242del (p.Asn78fs)	HPS1	N78fs, T3fs	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000435451	10	100195405 - 100195414	10	98435648 - 98435657	435451	429155	rs773323079	NC_000010.11:98435647:TACAGGAAGTT:T
NM_080877.2(SLC34A3):c.304+2T>C	SLC34A3		not provided|Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000444092	9	140127157	9	137232705	444092	437700	rs201293634	NC_000009.12:137232704:T:C
NM_000195.5(HPS1):c.398+5G>A	HPS1		Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000005283	10	100195024	10	98435267	5283	20322	rs281865077	NC_000010.11:98435266:C:T
NM_000195.5(HPS1):c.397G>T (p.Glu133Ter)	HPS1	E133*	Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000005281	10	100195030	10	98435273	5281	20320	rs121908386	NC_000010.11:98435272:C:A
NM_000500.7:c.*28697405C>T	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000189134					189134	187081		
NM_207122.2(EXT2):c.442_455del (p.Asn148fs)	EXT2	N181fs, N148fs	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000817826	11	44129704 - 44129717	11	44108154 - 44108167	817826	805690		NC_000011.10:44108153:AACCGGGCCTGTCT:
NM_207122.2(EXT2):c.481_482dup (p.Asn161fs)	EXT2		not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000817343	11	44129742 - 44129743	11	44108192 - 44108193	817343	805691		NC_000011.10:44108192:AA:AAAA
NM_207122.2(EXT2):c.1260_1261AT[3] (p.Ala422fs)	EXT2		not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000817044	11	44193246 - 44193247	11	44171696 - 44171697	817044	805692		NC_000011.10:44171696:ATAT:ATATAT
NM_000401.3(EXT2):c.884dup (p.His295fs)	EXT2		not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000504053	11	44146379 - 44146380	11	44124829 - 44124830	504053	495476	rs1555005328	NC_000011.10:44124829:A:AA
NM_000401.3(EXT2):c.1281G>A (p.Trp427Ter)	EXT2	W394*, W427*	not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000449480	11	44193169	11	44171619	449480	444803	rs1555012835	NC_000011.10:44171618:G:A
NM_000401.3(EXT2):c.155del (p.Lys52fs)	EXT2	K52fs, K19fs	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000426966	11	44129317	11	44107767	426966	415268	rs1085307877	NC_000011.10:44107766:AA:A
NM_000401.3(EXT2):c.2028del (p.Ile677fs)	EXT2	I644fs, I654fs, I677fs	not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000423047	11	44255786	11	44234236	423047	408350	rs1064796192	NC_000011.10:44234235:TT:T
NM_000401.3(EXT2):c.726-2A>G	EXT2		not provided	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000419409	11	44135733	11	44114183	419409	408349	rs1064793854	NC_000011.10:44114182:A:G
NM_000401.3(EXT2):c.184_185CT[1] (p.Phe63fs)	EXT2		not provided	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000265701	11	44129347 - 44129348	11	44107797 - 44107798	265701	259982	rs886039744	NC_000011.10:44107796:CTCT:CT
NM_000401.3(EXT2):c.842+1G>A	EXT2		not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000265474	11	44135852	11	44114302	265474	259986	rs886039567	NC_000011.10:44114301:G:A
NM_000401.3(EXT2):c.679G>T (p.Gly227Ter)	EXT2	G194*, G227*	not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000265473	11	44130787	11	44109237	265473	259985	rs886039566	NC_000011.10:44109236:G:T
NM_000401.3(EXT2):c.638G>A (p.Trp213Ter)	EXT2	W180*, W213*	not provided	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000265472	11	44130746	11	44109196	265472	259983	rs886039565	NC_000011.10:44109195:G:A
NM_000401.3(EXT2):c.1922A>G (p.Tyr641Cys)	EXT2	Y608C, Y641C, Y618C	Seizures, scoliosis, and macrocephaly syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	no assertion criteria provided	VCV000638619	11	44255681	11	44234131	638619	626395		NC_000011.10:44234130:A:G
NM_207122.2(EXT2):c.211del (p.Leu71fs)	EXT2	L71fs, L104fs	Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000853306	11	44129473	11	44107923	853306	838422		NC_000011.10:44107922:C:
NM_207122.2(EXT2):c.600_601CA[1] (p.Thr201fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000853100	11	44130806 - 44130807	11	44109256 - 44109257	853100	838427		NC_000011.10:44109255:ACACA:ACA
NM_207122.2(EXT2):c.699T>G (p.Tyr233Ter)	EXT2	Y233*, Y266*	Multiple exostoses type 2	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000848100	11	44135807	11	44114257	848100	838428		NC_000011.10:44114256:T:G
NM_207122.2(EXT2):c.394G>T (p.Glu132Ter)	EXT2	E165*, E132*	Multiple exostoses type 2	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000838385	11	44129656	11	44108106	838385	838424		NC_000011.10:44108105:G:T
NM_207122.2(EXT2):c.426C>G (p.Tyr142Ter)	EXT2	Y142*, Y175*	Multiple exostoses type 2	Pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000834059	11	44129688	11	44108138	834059	822306		NC_000011.10:44108137:C:G
NC_000011.10:g.(?_44096233)_(44130158_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000832079	11	44117783 - 44151708			832079	820367		
NC_000011.10:g.(?_44107663)_(44109303_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000831261	11	44129213 - 44130853			831261	820370		
NM_207122.2(EXT2):c.1032del (p.Ile344fs)	EXT2	I344fs, I377fs	Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000666014	11	44148457	11	44126907	666014	640055		NC_000011.10:44126906:TT:T
NM_207122.1(EXT2):c.861_1173+5287del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000662037			11	44124906 - 44135425	662037	652126		
NM_207122.2(EXT2):c.1189dup (p.Glu397fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000661841	11	44193173 - 44193174	11	44171623 - 44171624	661841	640057		NC_000011.10:44171623:GGG:GGGG
NM_207122.2(EXT2):c.1627dup (p.Met543fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000660873	11	44228473 - 44228474	11	44206923 - 44206924	660873	640058		NC_000011.10:44206923:A:AA
NM_207122.2(EXT2):c.590del (p.Pro197fs)	EXT2	P197fs, P230fs	Multiple exostoses type 2	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000657872	11	44130793	11	44109243	657872	640051		NC_000011.10:44109242:CCCCC:CCCC
NM_000401.3(EXT2):c.1051_1052TG[2] (p.Val352fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000640236	11	44148378 - 44148379	11	44126828 - 44126829	640236	640054		NC_000011.10:44126827:TGTGTG:TGTG
NC_000011.9:g.(?_44228343)_(44228509_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000584248	11	44228343 - 44228509	11	44206793 - 44206959	584248	565025		
NC_000011.9:g.(?_44129213)_(44151708_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000583463	11	44129213 - 44151708	11	44107663 - 44130158	583463	564095		
NM_000401.3(EXT2):c.1839G>A (p.Trp613Ter)	EXT2	W580*, W613*, W590*	Multiple exostoses type 2	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000572306	11	44253980	11	44232430	572306	565774	rs1564986609	NC_000011.10:44232429:G:A
NM_000401.3(EXT2):c.769C>T (p.Gln257Ter)	EXT2	Q224*, Q257*	Multiple exostoses type 2	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000568961	11	44135778	11	44114228	568961	565765	rs1565199251	NC_000011.10:44114227:C:T
NC_000011.9:g.(?_44165777)_(44219588_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000534141	11	44165777 - 44219588	11	44144227 - 44198038	534141	525675		
NM_000401.3(EXT2):c.1027C>T (p.Gln343Ter)	EXT2	Q343*, Q310*	Multiple exostoses type 2	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000534137	11	44146523	11	44124973	534137	526396	rs1555005398	NC_000011.10:44124972:C:T
NM_000401.3(EXT2):c.528C>A (p.Tyr176Ter)	EXT2	Y143*, Y176*	Multiple exostoses type 2	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000465701	11	44129691	11	44108141	465701	461927	rs1555002543	NC_000011.10:44108140:C:A
NC_000011.9:g.(?_44228323)_(44228529_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000465696	11	44228323 - 44228529	11	44206773 - 44206979	465696	460433		
NM_000401.3(EXT2):c.871C>T (p.Gln291Ter)	EXT2	Q258*, Q291*	Multiple exostoses type 2	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000002476	11	44146367	11	44124817	2476	17515	rs267606786	NC_000011.10:44124816:C:T
NM_000401.3(EXT2):c.765C>G (p.Tyr255Ter)	EXT2	Y222*, Y255*	Multiple exostoses type 2	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000002475	11	44135774	11	44114224	2475	17514	rs121918281	NC_000011.10:44114223:C:G
NM_001168370.1(CUL7):c.2844T>G (p.Tyr948Ter)	CUL7	Y864*, Y948*	not provided|Three M syndrome 1	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000127244	6	43014042	6	43046304	127244	132701	rs201406974	NC_000006.12:43046303:A:C
NM_207122.2(EXT2):c.1205C>A (p.Ser402Ter)	EXT2	S402*, S435*	Multiple exostoses type 2	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000862385	11	44193192	11	44171642	862385	838434		NC_000011.10:44171641:C:A
NM_207122.2(EXT2):c.756C>A (p.Tyr252Ter)	EXT2	Y285*, Y252*	Multiple exostoses type 2	Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000839699	11	44146351	11	44124801	839699	838429		NC_000011.10:44124800:C:A
NM_207122.2(EXT2):c.1945C>T (p.Arg649Ter)	EXT2	R682*, R649*, R659*	Multiple exostoses type 2	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000838313	11	44257852	11	44236302	838313	838438		NC_000011.10:44236301:C:T
NC_000011.10:g.(?_44107663)_(44108268_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Feb 17, 2019)	criteria provided, single submitter	VCV000830793	11	44129213 - 44129818			830793	820369		
NM_000401.3(EXT2):c.1272+2T>A	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000578983	11	44151690	11	44130140	578983	564631	rs1565205890	NC_000011.10:44130139:T:A
NM_000401.3(EXT2):c.1231C>T (p.Gln411Ter)	EXT2	Q378*, Q411*	Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000534140	11	44151647	11	44130097	534140	526215	rs1555006433	NC_000011.10:44130096:C:T
NM_000401.3(EXT2):c.1404+1G>A	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Apr 29, 2019)	no assertion criteria provided	VCV000002473	11	44193293	11	44171743	2473	17512	rs864309637	NC_000011.10:44171742:G:A
NM_006766.5(KAT6A):c.3070C>T (p.Arg1024Ter)	KAT6A	R1024*	Mental retardation, autosomal dominant 32|KAT6A syndrome|not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000180230	8	41795056	8	41937538	180230	178418	rs786200961	NC_000008.11:41937537:G:A
NM_207122.2(EXT2):c.817C>T (p.Gln273Ter)	EXT2	Q273*, Q306*	Multiple exostoses type 2	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000835204	11	44146412	11	44124862	835204	838430		NC_000011.10:44124861:C:T
NC_000011.10:g.(?_44096233)_(44244388_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000833128	11	44117783 - 44265938			833128	820368		
NC_000011.10:g.(?_44124769)_(44126975_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000833010	11	44146319 - 44148525			833010	820371		
NM_000401.3(EXT2):c.1286G>A (p.Trp429Ter)	EXT2	W429*, W396*	Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000655909	11	44193174	11	44171624	655909	640056		NC_000011.10:44171623:G:A
NM_000401.3(EXT2):c.1173G>A (p.Trp391Ter)	EXT2	W391*, W358*	Multiple exostoses type 2	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000534139	11	44148500	11	44126950	534139	526206	rs1450980907	NC_000011.10:44126949:G:A
NM_000401.3(EXT2):c.343del (p.Asp115fs)	EXT2	D115fs, D82fs	Multiple exostoses type 2	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000465699	11	44129501	11	44107951	465699	461611	rs1555002457	NC_000011.10:44107950:GGGGGG:GGGGG
NC_000011.9:g.(?_44193141)_(44193312_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000465695			11	44171591 - 44171762	465695	461215		
NM_000401.3(EXT2):c.344dup (p.Asp115fs)	EXT2		not provided|Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449018	11	44129506 - 44129507	11	44107956 - 44107957	449018	444802	rs1555002460	NC_000011.10:44107956:A:AA
NM_000401.3(EXT2):c.497_500dup (p.Met168fs)	EXT2		not provided|Multiple exostoses type 2	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279944	11	44129659 - 44129660	11	44108109 - 44108110	279944	264541	rs886041272	NC_000011.10:44108109:TGCT:TGCTTGCT
NM_000401.3(EXT2):c.549_552CTGT[1] (p.Val187fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000002471	11	44129712 - 44129715	11	44108162 - 44108165	2471	17510	rs864309636	NC_000011.10:44108161:CTGTCTGT:CTGT
NM_000195.5(HPS1):c.355del (p.His119fs)	HPS1	H119fs	not provided|Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000021103	10	100195072	10	98435315	21103	33955	rs281865075	NC_000010.11:98435314:G:
NM_000195.5(HPS1):c.962dup (p.Thr322fs)	HPS1		not provided|Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000005282	10	100186996 - 100186997	10	98427239 - 98427240	5282	20321	rs281865081	NC_000010.11:98427239:CCCCCC:CCCCCCC
NM_012203.2(GRHPR):c.608_609del (p.Pro203fs)	GRHPR	P203fs	Primary hyperoxaluria, type II|not provided	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204252	9	37430517 - 37430518	9	37430520 - 37430521	204252	200638	rs180177316	NC_000009.12:37430519:CT:
NM_001122769.3(LCA5):c.1151del (p.Pro384fs)	LCA5	P384fs	not provided|Leber congenital amaurosis 5	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000000966	6	80198881	6	79489164	966	16005	rs386834252	NC_000006.12:79489163:GGG:GG
NM_018400.3(SCN3B):c.423C>G (p.Ile141Met)	SCN3B	I141M	Arrhythmia	Pathogenic(Last reviewed: Mar 27, 2015)	no assertion criteria provided	VCV000224720	11	123513176	11	123642468	224720	226503	rs879253730	NC_000011.10:123642467:G:C
NM_018400.3(SCN3B):c.17G>A (p.Arg6Lys)	SCN3B	R6K	Atrial fibrillation, familial, 16	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000140599	11	123524493	11	123653785	140599	150291	rs587777558	NC_000011.10:123653784:C:T
NM_018400.3(SCN3B):c.482T>C (p.Met161Thr)	SCN3B	M161T	Atrial fibrillation, familial, 16	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000140598	11	123508996	11	123638288	140598	150290	rs587777557	NC_000011.10:123638287:A:G
NM_207122.2(EXT2):c.455_458TGTT[1] (p.Val154fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000854619	11	44129717 - 44129720	11	44108167 - 44108170	854619	838425		NC_000011.10:44108166:TGTTTGTT:TGTT
NM_207122.2(EXT2):c.1079+1G>T	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000854123	11	44148506	11	44126956	854123	852350		NC_000011.10:44126955:G:T
NC_000011.10:g.(?_44171591)_(44206979_?)del	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000830413	11	44193141 - 44228529			830413	820372		
NM_000401.3(EXT2):c.459_460CT[1] (p.Ser154fs)	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000581984	11	44129621 - 44129622	11	44108071 - 44108072	581984	564626	rs1565196489	NC_000011.10:44108070:TCTCT:TCT
NM_000401.3(EXT2):c.166C>T (p.Arg56Ter)	EXT2	R23*, R56*	Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000534138	11	44129329	11	44107779	534138	526210	rs754533434	NC_000011.10:44107778:C:T
NM_000401.3(EXT2):c.843-2A>C	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000002477	11	44146337	11	44124787	2477	17516	rs864309638	NC_000011.10:44124786:A:C
NM_001540.5(HSPB1):c.404C>A (p.Ser135Tyr)	HSPB1	S135Y	|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000533813	7	75933158	7	76303841	533813	523269	rs28939680	NC_000007.14:76303840:C:A
NM_001017420.3(ESCO2):c.760del (p.Thr254fs)	ESCO2	T254fs	not provided|Roberts-SC phocomelia syndrome	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021247	8	27634577	8	27777060	21247	34099	rs80359852	NC_000008.11:27777059:AAAAAAAAA:AAAAAAAA
NM_001017420.3(ESCO2):c.1132-7A>G	ESCO2		not provided|Roberts-SC phocomelia syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021234	8	27646357	8	27788840	21234	34086	rs80359862	NC_000008.11:27788839:A:G
NM_080877.2(SLC34A3):c.586G>A (p.Gly196Arg)	SLC34A3	G196R	not provided|Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000001431	9	140127686	9	137233234	1431	16470	rs121918237	NC_000009.12:137233233:G:A
NM_014251.3(SLC25A13):c.1311+1G>A	SLC25A13		Citrin deficiency|Citrullinemia type II	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000006005	7	95799356	7	96170044	6005	21044	rs80338723	NC_000007.14:96170043:C:T
NM_004092.4(ECHS1):c.5C>T (p.Ala2Val)	ECHS1	A2V	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency|Leigh syndrome|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156434	10	135186833	10	133373329	156434	166207	rs587776498	NC_000010.11:133373328:G:A
SGCE, 6,872-BP DEL, EX6DEL	SGCE		Myoclonic dystonia	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000005778					5778	20817		
SGCE, 97-BP DEL	SGCE		Myoclonic dystonia	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000005771					5771	20810		
SGCE, 1-BP DEL, 565A	SGCE		Myoclonic dystonia	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000005770					5770	20809		
NM_000401.3(EXT2):c.767G>C (p.Arg256Pro)	EXT2	R223P, R256P	Multiple exostoses type 2	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000649849	11	44135776	11	44114226	649849	640053		NC_000011.10:44114225:G:C
NM_000401.3(EXT2):c.1178+1G>A	EXT2		Multiple exostoses type 2	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000569134	11	44148506	11	44126956	569134	565770	rs1369420640	NC_000011.10:44126955:G:A
NM_000401.3(EXT2):c.1036C>T (p.Gln346Ter)	EXT2	Q313*, Q346*	Multiple exostoses type 2|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265134	11	44146532	11	44124982	265134	259987	rs763718818	NC_000011.10:44124981:C:T
NM_000500.7:c.*28698317T>A	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000189132					189132	187079		
NM_139025.4(ADAMTS13):c.2863dup (p.Trp955fs)	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802531	9	136314904 - 136314905	9	133449783 - 133449784	802531	790858		NC_000009.12:133449783:T:TT
NM_139025.4(ADAMTS13):c.2209T>C (p.Cys737Arg)	ADAMTS13	C737R, C706R	Thrombotic thrombocytopenic purpura	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000559588	9	136307839	9	133442718	559588	550311	rs1554791280	NC_000009.12:133442717:T:C
NM_139025.4(ADAMTS13):c.581G>T (p.Gly194Val)	ADAMTS13	G194V	Thrombotic thrombocytopenic purpura	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000559578	9	136291360	9	133426240	559578	550301	rs1554785242	NC_000009.12:133426239:G:T
NM_139025.4(ADAMTS13):c.3044+1G>A	ADAMTS13		not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379656	9	136315087	9	133449966	379656	370801	rs1057520680	NC_000009.12:133449965:G:A
NM_139025.4(ADAMTS13):c.2931_2936del (p.Cys977_Arg979delinsTrp)	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000005821	9	136314972 - 136314977	9	133449851 - 133449856	5821	20860	rs387906346	NC_000009.12:133449850:GTGCCCG:G
NM_139025.4(ADAMTS13):c.331-1G>A	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000005819	9	136290648	9	133425528	5819	20858	rs786205078	NC_000009.12:133425527:G:A
NM_139025.4(ADAMTS13):c.749C>T (p.Ala250Val)	ADAMTS13	A250V	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000005818	9	136293816	9	133428696	5818	20857	rs121908478	NC_000009.12:133428695:C:T
NM_139025.4(ADAMTS13):c.803G>C (p.Arg268Pro)	ADAMTS13	R268P	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Sep 3, 2002)	no assertion criteria provided	VCV000005812	9	136293870	9	133428750	5812	20851	rs121908477	NC_000009.12:133428749:G:C
NM_139025.4(ADAMTS13):c.1345C>T (p.Gln449Ter)	ADAMTS13	Q449*, Q418*	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Sep 3, 2002)	no assertion criteria provided	VCV000005811	9	136301985	9	133436865	5811	20850	rs121908476	NC_000009.12:133436864:C:T
NM_139025.4(ADAMTS13):c.1584+5G>A	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005810	9	136303022	9	133437902	5810	20849	rs782235228	NC_000009.12:133437901:G:A
NM_139025.4(ADAMTS13):c.2074C>T (p.Arg692Cys)	ADAMTS13	R692C, R661C	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005809	9	136307625	9	133442504	5809	20848	rs121908475	NC_000009.12:133442503:C:T
NM_139025.4(ADAMTS13):c.3638G>A (p.Cys1213Tyr)	ADAMTS13	C1213Y, C1126Y, C1157Y	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005808	9	136321260	9	133456138	5808	20847	rs121908474	NC_000009.12:133456137:G:A
NM_139025.4(ADAMTS13):c.4143dup (p.Glu1382fs)	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000005807	9	136324160 - 136324161	9	133459038 - 133459039	5807	20846	rs387906343	NC_000009.12:133459038:A:AA
NM_139025.4(ADAMTS13):c.2376_2401del (p.Ala793fs)	ADAMTS13	A762fs, A793fs	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005806	9	136308636 - 136308661	9	133443515 - 133443540	5806	20845	rs387906342	NC_000009.12:133443514:CCAGCTGTGGCGCTGGAAACCTGCAACC:CC
NM_139025.4(ADAMTS13):c.3770dup (p.Leu1258fs)	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005805	9	136321718 - 136321719	9	133456596 - 133456597	5805	20844	rs387906341	NC_000009.12:133456596:T:TT
NM_139025.4(ADAMTS13):c.1582A>G (p.Arg528Gly)	ADAMTS13	R528G, R497G	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005804	9	136303015	9	133437895	5804	20843	rs121908473	NC_000009.12:133437894:A:G
NM_139025.4(ADAMTS13):c.3070T>G (p.Cys1024Gly)	ADAMTS13	C1024G, C993G	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005803	9	136319562	9	133454440	5803	20842	rs121908472	NC_000009.12:133454439:T:G
NM_139025.4(ADAMTS13):c.1193G>A (p.Arg398His)	ADAMTS13	R398H, R367H	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005802	9	136298598	9	133433478	5802	20841	rs121908471	NC_000009.12:133433477:G:A
NM_139025.4(ADAMTS13):c.304C>T (p.Arg102Cys)	ADAMTS13	R102C	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005800	9	136289572	9	133424452	5800	20839	rs121908469	NC_000009.12:133424451:C:T
NM_139025.4(ADAMTS13):c.2851T>G (p.Cys951Gly)	ADAMTS13	C951G, C920G	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005799	9	136313839	9	133448718	5799	20838	rs121908468	NC_000009.12:133448717:T:G
NM_139025.4(ADAMTS13):c.286C>G (p.His96Asp)	ADAMTS13	H96D	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000005798	9	136289554	9	133424434	5798	20837	rs121908467	NC_000009.12:133424433:C:G
NM_139025.4(ADAMTS13):c.291_319del (p.Glu98fs)	ADAMTS13	E98fs	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000005820	9	136289551 - 136289579	9	133424431 - 133424459	5820	20859	rs387906345	NC_000009.12:133424430:GCTCACCAGGAGGACACAGAGCGCTATGTGCTCACCA:GCTCACCA
NM_139025.4(ADAMTS13):c.1783_1784del (p.Leu595fs)	ADAMTS13	L564fs, L595fs	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000005815	9	136304564 - 136304565	9	133439443 - 133439444	5815	20854	rs387906344	NC_000009.12:133439442:TT:
NM_139025.4(ADAMTS13):c.587C>T (p.Thr196Ile)	ADAMTS13	T196I	Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Jan 15, 2004)	no assertion criteria provided	VCV000005801	9	136291366	9	133426246	5801	20840	rs121908470	NC_000009.12:133426245:C:T
NM_139025.4(ADAMTS13):c.414+1G>A	ADAMTS13		Upshaw-Schulman syndrome	Pathogenic(Last reviewed: Feb 15, 2004)	no assertion criteria provided	VCV000005817	9	136290733	9	133425613	5817	20856	rs786205077	NC_000009.12:133425612:G:A
NM_001613.4(ACTA2):c.1A>G (p.Met1Val)	ACTA2	M1V	not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000199663	10	90708687	10	88948930	199663	197405	rs794728019	NC_000010.11:88948929:T:C
NM_172218.2(SPAG1):c.2014C>T (p.Gln672Ter)	SPAG1	Q672*	Kartagener syndrome|Ciliary dyskinesia, primary, 28|Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000088683	8	101245664	8	100233436	88683	94263	rs201740530	NC_000008.11:100233435:C:T
NM_139025.4(ADAMTS13):c.1787C>T (p.Ala596Val)	ADAMTS13	A596V, A565V	not provided|Thrombotic thrombocytopenic purpura	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000068805	9	136305465	9	133440344	68805	79696	rs281875299	NC_000009.12:133440343:C:T
NM_000181.4(GUSB):c.526C>T (p.Leu176Phe)	GUSB	L176F	Mucopolysaccharidosis type 7|Mucopolysaccharidosis type 6|not provided	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000905	7	65444769	7	65979782	905	15944	rs121918181	NC_000007.14:65979781:G:A
NM_080877.2(SLC34A3):c.448+1G>A	SLC34A3		not provided|Autosomal recessive hypophosphatemic bone disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445687	9	140127380	9	137232928	445687	438959	rs150841256	NC_000009.12:137232927:G:A
NM_080877.2(SLC34A3):c.1402C>T (p.Arg468Trp)	SLC34A3	R468W	not provided|Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001432	9	140130470	9	137236018	1432	16471	rs121918238	NC_000009.12:137236017:C:T
NM_000401.3(EXT2):c.1005_1006dup (p.His336fs)	EXT2		not provided|Multiple exostoses type 2	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279805	11	44146500 - 44146501	11	44124950 - 44124951	279805	264544	rs886041199	NC_000011.10:44124950:GC:GCGC
NM_000494.4(COL17A1):c.3676C>T (p.Arg1226Ter)	COL17A1	R1226*	Epidermolysis bullosa, junctional, localisata variant|Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000017645	10	105794469	10	104034711	17645	32684	rs121912769	NC_000010.11:104034710:G:A
GRCh37/hg19 8q13.1-13.2(chr8:67987416-68078373)x1	CSPP1		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	no assertion criteria provided	VCV000689230	8	67987416 - 68078373			689230	676822		
GRCh37/hg19 8q13.2(chr8:68026827-68064392)x1	CSPP1		not provided	Pathogenic(Last reviewed: Dec 4, 2017)	no assertion criteria provided	VCV000685068	8	68026827 - 68064392			685068	672660		
NM_024790.6(CSPP1):c.1835_1845del (p.Arg612fs)	CSPP1	R579fs, R590fs, R576fs, R639fs, R318fs, R603fs, R612fs	not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000523960	8	68049703 - 68049713	8	67137468 - 67137478	523960	514577	rs1189289587	NC_000008.11:67137467:GAAGAAAGAAGGAAGAAAGAA:GAAGAAAGAA
NM_024790.6(CSPP1):c.457_458del (p.Arg153fs)	CSPP1	R117fs, R144fs, R153fs, R180fs	not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000450360	8	68005823 - 68005824	8	67093588 - 67093589	450360	444300	rs750696284	NC_000008.11:67093587:AG:
NM_001876.4(CPT1A):c.546_547TG[1] (p.Val183fs)	CPT1A		not provided	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	VCV000281872	11	68571474 - 68571475	11	68804006 - 68804007	281872	266109	rs886042250	NC_000011.10:68804005:CACA:CA
NM_001876.4(CPT1A):c.281+1G>A	CPT1A		not provided	Pathogenic(Last reviewed: Aug 13, 2012)	criteria provided, single submitter	VCV000093973	11	68579904	11	68812436	93973	99875	rs191107774	NC_000011.10:68812435:C:T
NM_001876.4(CPT1A):c.465del (p.Ile156fs)	CPT1A	I156fs	Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000844743	11	68571558	11	68804090	844743	838931		NC_000011.10:68804089:C:
NM_001876.4(CPT1A):c.122del (p.Lys41fs)	CPT1A	K41fs	Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000837468	11	68582821	11	68815353	837468	838932		NC_000011.10:68815352:TTTTT:TTTT
NM_001876.4(CPT1A):c.1792C>T (p.Arg598Ter)	CPT1A	R598*	Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000657820	11	68530178	11	68762710	657820	640392		NC_000011.10:68762709:G:A
NM_001876.4(CPT1A):c.1216C>T (p.Gln406Ter)	CPT1A	Q406*	Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000645430	11	68549375	11	68781907	645430	640395		NC_000011.10:68781906:G:A
NM_024790.6(CSPP1):c.1180G>T (p.Glu394Ter)	CSPP1	E394*, E100*, E421*, E385*, E358*, E361*	not provided	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000289003	8	68024266	8	67112031	289003	273240	rs886044058	NC_000008.11:67112030:G:T
NM_001876.3:c.986C>T	CPT1A		Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065662					65662	76570		
NM_001876.3:c.946C>G?	CPT1A		Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065658					65658	76566		
NM_001876.4(CPT1A):c.2156G>A (p.Gly719Asp)	CPT1A	G719D	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065652	11	68527116	11	68759648	65652	76560	rs397515544	NC_000011.10:68759647:C:T
NM_001876.4(CPT1A):c.1494T>G (p.Tyr498Ter)	CPT1A	Y498*	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065647	11	68542865	11	68775397	65647	76555	rs80356795	NC_000011.10:68775396:A:C
NM_001876.4(CPT1A):c.1425G>A (p.Trp475Ter)	CPT1A	W475*	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065643	11	68548141	11	68780673	65643	76551	rs80356794	NC_000011.10:68780672:C:T
NM_001876.4(CPT1A):c.1339C>T (p.Arg447Ter)	CPT1A	R447*	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065641	11	68549252	11	68781784	65641	76549	rs397515543	NC_000011.10:68781783:G:A
NM_024790.6(CSPP1):c.1534C>T (p.Arg512Ter)	CSPP1	R218*, R503*, R476*, R479*, R490*, R512*, R539*	Joubert syndrome 21	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000860634	8	68030535	8	67118300	860634	834997		NC_000008.11:67118299:C:T
NM_001291339.1(CSPP1):c.1325_1326GA[2] (p.Lys444fs)	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000850442	8	68070814 - 68070815	8	67158579 - 67158580	850442	835005		NC_000008.11:67158578:AGAGAGA:AGAGA
NM_024790.6(CSPP1):c.2089G>T (p.Glu697Ter)	CSPP1	E675*, E664*, E697*, E724*	Joubert syndrome 21	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000843899	8	68062146	8	67149911	843899	835003		NC_000008.11:67149910:G:T
NM_024790.6(CSPP1):c.2815A>T (p.Lys939Ter)	CSPP1	K939*, K906*, K917*, K966*, K594*, K852*, K879*	Joubert syndrome 21	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000581963	8	68084652	8	67172417	581963	562489	rs1380418532	NC_000008.11:67172416:A:T
NM_024790.6(CSPP1):c.167_168del (p.Lys56fs)	CSPP1	K20fs, K56fs	Joubert syndrome 21	Pathogenic(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000575640	8	67986545 - 67986546	8	67074310 - 67074311	575640	568053	rs766020802	NC_000008.11:67074309:AAA:A
NM_024790.6(CSPP1):c.2525del (p.His842fs)	CSPP1	H809fs, H820fs, H755fs, H782fs, H497fs, H842fs, H869fs	Joubert syndrome 21	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000573876	8	68074047	8	67161812	573876	568055	rs1563720581	NC_000008.11:67161811:A:
NM_024790.6(CSPP1):c.2512dup (p.Glu838fs)	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000541695	8	68071357 - 68071358	8	67159122 - 67159123	541695	523696	rs1554604482	NC_000008.11:67159122:GGGG:GGGGG
NM_024790.6(CSPP1):c.2814-9_2953+11del	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000434846	8	68084639 - 68084798	8	67172404 - 67172563	434846	428858	rs1554614893	
NM_001291339.1(CSPP1):c.1406_1412AGAAGAA[1] (p.Glu472fs)	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217651	8	68071285 - 68071291	8	67159050 - 67159056	217651	214266	rs863225191	NC_000008.11:67159049:AAGAAAGAAGAAAGAAGAA:AAGAAAGAAGAA
NM_001291339.1(CSPP1):c.1398_1401AGAA[2] (p.Lys469fs)	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217650	8	68071282 - 68071285	8	67159047 - 67159050	217650	214265	rs761382780	NC_000008.11:67159046:AGAAAGAAAGAA:AGAAAGAA
NM_024790.6(CSPP1):c.950+1G>C	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217649	8	68007968	8	67095733	217649	214261	rs863225194	NC_000008.11:67095732:G:C
NM_024790.6(CSPP1):c.2260C>T (p.Arg754Ter)	CSPP1	R754*, R694*, R781*, R409*, R667*, R721*, R732*	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217648	8	68070715	8	67158480	217648	214264	rs771203308	NC_000008.11:67158479:C:T
NM_024790.6(CSPP1):c.1682+1G>T	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217647	8	68031057	8	67118822	217647	214263	rs863225193	NC_000008.11:67118821:G:T
NM_024790.6(CSPP1):c.457del (p.Arg153fs)	CSPP1	R153fs, R144fs, R117fs, R180fs	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217644	8	68005823	8	67093588	217644	214260	rs863225192	NC_000008.11:67093587:A:
NM_001291339.1(CSPP1):c.1406_1412AGAAGAA[3] (p.Glu474fs)	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217643	8	68071284 - 68071285	8	67159049 - 67159050	217643	214267	rs863225191	NC_000008.11:67159049:AAGAAAGAAGAAAGAAGAA:AAGAAAGAAGAAAGAAGAAAGAAGAA
NM_024790.6(CSPP1):c.2773C>T (p.Arg925Ter)	CSPP1	R925*, R580*, R952*, R892*, R838*, R865*, R903*	Joubert syndrome 21	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000100676	8	68076703	8	67164468	100676	106548	rs537456518	NC_000008.11:67164467:C:T
NM_024790.6(CSPP1):c.652C>T (p.Gln218Ter)	CSPP1	Q218*, Q209*, Q182*, Q245*	Joubert syndrome 21	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000100675	8	68007669	8	67095434	100675	106547	rs587777146	NC_000008.11:67095433:C:T
NM_001876.4(CPT1A):c.96T>G (p.Tyr32Ter)	CPT1A	Y32*	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065661	11	68582847	11	68815379	65661	76569	rs80356786	NC_000011.10:68815378:A:C
NM_001876.4(CPT1A):c.941C>T (p.Thr314Ile)	CPT1A	T314I	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065657	11	68560809	11	68793341	65657	76565	rs80356776	NC_000011.10:68793340:G:A
NM_001876.4(CPT1A):c.912C>G (p.Cys304Trp)	CPT1A	C304W	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065656	11	68560838	11	68793370	65656	76564	rs80356789	NC_000011.10:68793369:G:C
NM_001876.4(CPT1A):c.2028+3_2028+6del	CPT1A		Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065651	11	68528997 - 68529000	11	68761529 - 68761532	65651	76559	rs80356799	NC_000011.10:68761528:ACTTACTT:ACTT
NM_001876.4(CPT1A):c.1737C>A (p.Tyr579Ter)	CPT1A	Y579*	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065649	11	68540736	11	68773268	65649	76557	rs80356785	NC_000011.10:68773267:G:T
NM_001876.4(CPT1A):c.1600del (p.Ser533_Leu534insTer)	CPT1A		Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065648	11	68540873	11	68773405	65648	76556	rs80356801	NC_000011.10:68773404:GGG:GG
NM_001876.4(CPT1A):c.1494T>A (p.Tyr498Ter)	CPT1A	Y498*	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065646	11	68542865	11	68775397	65646	76554	rs80356795	NC_000011.10:68775396:A:T
NM_001876.4(CPT1A):c.1451T>C (p.Leu484Pro)	CPT1A	L484P	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065645	11	68548115	11	68780647	65645	76553	rs80356793	NC_000011.10:68780646:A:G
NM_001876.4(CPT1A):c.1393G>T (p.Gly465Trp)	CPT1A	G465W	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065642	11	68548173	11	68780705	65642	76550	rs80356784	NC_000011.10:68780704:C:A
NM_001876.4(CPT1A):c.1069C>T (p.Arg357Trp)	CPT1A	R357W	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065640	11	68552377	11	68784909	65640	76548	rs80356777	NC_000011.10:68784908:G:A
NM_001876.4(CPT1A):c.1027T>G (p.Phe343Val)	CPT1A	F343V	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000065639	11	68552419	11	68784951	65639	76547	rs80356783	NC_000011.10:68784950:A:C
NM_024790.6(CSPP1):c.2953+1G>T	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000804338	8	68084791	8	67172556	804338	792679		NC_000008.11:67172555:G:T
NM_001031847.2(CPT1A):c.948delG (p.Ile317Serfs)	CPT1A	I317fs	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009070	11	68560802	11	68793334	9070	24109	rs80356800	NC_000011.10:68793333:CC:C
NM_001876.3(CPT1A):c.(?_1744)_2107del (p.(?))	CPT1A		Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009068	11	68527728 - 68536100	11	68760260 - 68768632	9068	24107		
NM_001876.4(CPT1A):c.1575+533_1575+534del	CPT1A		Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009064	11	68542250 - 68542251	11	68774782 - 68774783	9064	24103	rs1169875761	NC_000011.10:68774781:AAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAA
NM_001876.4(CPT1A):c.1079A>G (p.Glu360Gly)	CPT1A	E360G	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009062	11	68552367	11	68784899	9062	24101	rs80356787	NC_000011.10:68784898:T:C
NM_001876.4(CPT1A):c.1361A>G (p.Asp454Gly)	CPT1A	D454G	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009061	11	68548205	11	68780737	9061	24100	rs80356778	NC_000011.10:68780736:T:C
NM_004560.4(ROR2):c.566_569dup (p.Ile191fs)	ROR2		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000504160	9	94499725 - 94499726	9	91737443 - 91737444	504160	495438	rs1554754007	NC_000009.12:91737443:GTCCG:GTCCGTCCG
NM_004560.4(ROR2):c.2130_2151dup (p.Pro718delinsAlaAlaLeuProArgTer)	ROR2		not provided	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000282589	9	94486624 - 94486625	9	91724342 - 91724343	282589	266826	rs886042428	NC_000009.12:91724342:ACAGTCATCGGGGCAAGGCAGCAC:ACAGTCATCGGGGCAAGGCAGCACAGTCATCGGGGCAAGGCAGCAC
NM_004560.4(ROR2):c.2244del (p.Trp749fs)	ROR2	W749fs	Brachydactyly type B1	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000007317	9	94486532	9	91724250	7317	22356	rs863223292	NC_000009.12:91724249:GG:G
NM_004560.4(ROR2):c.1366dup (p.Leu456fs)	ROR2		Brachydactyly type B1	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000007316	9	94488842 - 94488843	9	91726560 - 91726561	7316	22355		NC_000009.12:91726560:GGGG:GGGGG
NM_024790.6(CSPP1):c.1961-2A>G	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000853035	8	68062016	8	67149781	853035	852152		NC_000008.11:67149780:A:G
NM_024790.6(CSPP1):c.1132C>T (p.Arg378Ter)	CSPP1	R378*, R342*, R84*, R405*, R345*, R369*	not provided|Joubert syndrome 21	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217646	8	68024218	8	67111983	217646	214262	rs374703898	NC_000008.11:67111982:C:T
NM_024790.6(CSPP1):c.658C>T (p.Arg220Ter)	CSPP1	R220*, R247*, R184*, R211*	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000100672	8	68007675	8	67095440	100672	106544	rs375113643	NC_000008.11:67095439:C:T
NM_024790.6(CSPP1):c.2527_2528del (p.Met843fs)	CSPP1	M810fs, M870fs, M783fs, M843fs, M498fs, M756fs, M821fs	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000100671	8	68074049 - 68074050	8	67161814 - 67161815	100671	106543	rs587777143	NC_000008.11:67161813:AT:
NM_024790.6(CSPP1):c.2953+1G>A	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000100670	8	68084791	8	67172556	100670	106542	rs587777142	NC_000008.11:67172555:G:A
NM_024790.6(CSPP1):c.2280del (p.Glu761fs)	CSPP1	E674fs, E761fs, E701fs, E739fs, E416fs, E728fs, E788fs	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000100668	8	68070735	8	67158500	100668	106540	rs587777140	NC_000008.11:67158499:A:
NM_024790.6(CSPP1):c.2244_2245del (p.Glu750fs)	CSPP1	E717fs, E728fs, E750fs, E777fs, E690fs, E405fs, E663fs	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000100667	8	68070698 - 68070699	8	67158463 - 67158464	100667	106539	rs587777139	NC_000008.11:67158462:AAA:A
NM_024790.6(CSPP1):c.2320C>T (p.Arg774Ter)	CSPP1	R774*, R801*, R429*, R714*, R752*, R687*, R741*	Joubert syndrome 21	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000100666	8	68070775	8	67158540	100666	106538	rs587777138	NC_000008.11:67158539:C:T
NM_001876.4(CPT1A):c.2126G>A (p.Gly709Glu)	CPT1A	G709E	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009069	11	68527709	11	68760241	9069	24108	rs28936374	NC_000011.10:68760240:C:T
NM_001876.4(CPT1A):c.1241C>T (p.Ala414Val)	CPT1A	A414V	Carnitine palmitoyltransferase I deficiency	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000009065	11	68549350	11	68781882	9065	24104	rs80356790	NC_000011.10:68781881:G:A
NG_008089.1:g.218534_227384del	ROR2		Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000007315	9	94490061 - 94498911	9	91727779 - 91736629	7315	22354		
NM_004560.4(ROR2):c.1937_1943del (p.Tyr646fs)	ROR2	Y646fs	Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	VCV000007313	9	94486833 - 94486839	9	91724551 - 91724557	7313	22352	rs863223291	NC_000009.12:91724550:AGCTTGTAG:AG
NM_004560.4(ROR2):c.613C>T (p.Arg205Ter)	ROR2	R205*	Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000007310	9	94499682	9	91737400	7310	22349	rs121909086	NC_000009.12:91737399:G:A
NM_004560.4(ROR2):c.2160G>A (p.Trp720Ter)	ROR2	W720*	Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000007309	9	94486616	9	91724334	7309	22348	rs121909085	NC_000009.12:91724333:C:T
NM_004560.4(ROR2):c.2249del (p.Gly750fs)	ROR2	G750fs	Brachydactyly type B1	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000007306	9	94486527	9	91724245	7306	22345	rs863223289	NC_000009.12:91724244:CCCC:CCC
NM_004560.4(ROR2):c.2246G>A (p.Trp749Ter)	ROR2	W749*	Brachydactyly type B1	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000007305	9	94486530	9	91724248	7305	22344	rs104894122	NC_000009.12:91724247:C:T
NM_004560.4(ROR2):c.2265C>A (p.Tyr755Ter)	ROR2	Y755*	Brachydactyly type B1	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000007304	9	94486511	9	91724229	7304	22343	rs121909082	NC_000009.12:91724228:G:T
NM_014251.3(SLC25A13):c.848+1G>T	SLC25A13		Citrullinemia type I|Citrin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802338	7	95818892	7	96189580	802338	790765		NC_000007.14:96189579:C:A
NM_004560.4(ROR2):c.2247G>A (p.Trp749Ter)	ROR2	W749*	Brachydactyly type B1	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000007312	9	94486529	9	91724247	7312	22351	rs104894121	NC_000009.12:91724246:C:T
NM_004560.4(ROR2):c.1321_1325del (p.Arg441fs)	ROR2	R441fs, S429fs	Robinow syndrome, autosomal recessive, with aplasia/hypoplasia of phalanges and metacarpals/metatarsals|Brachydactyly type B1	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000007311	9	94488884 - 94488888	9	91726602 - 91726606	7311	22350	rs863223290	NC_000009.12:91726601:CGCCGC:C
NM_004560.4(ROR2):c.1504C>T (p.Gln502Ter)	ROR2	Q502*	Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000007307	9	94487272	9	91724990	7307	22346	rs121909083	NC_000009.12:91724989:G:A
NM_002860.4(ALDH18A1):c.2246G>A (p.Arg749Gln)	ALDH18A1	R636Q, R747Q, R638Q, R714Q, R749Q, R537Q	Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000807367	10	97366661	10	95606904	807367	798629		NC_000010.11:95606903:C:T
NM_014491.4(FOXP2):c.1267-1G>A	FOXP2		not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000489181	7	114298120	7	114658065	489181	481777	rs1554440661	NC_000007.14:114658064:G:A
NM_014491.4(FOXP2):c.1723del (p.Val575fs)	FOXP2	V600fs, V592fs, V574fs, V575fs	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000419394	7	114302195	7	114662140	419394	406961	rs1064793842	NC_000007.14:114662139:G:
NM_002860.4(ALDH18A1):c.754C>T (p.Arg252Ter)	ALDH18A1	R252*, R217*, R139*, R250*, R40*, R141*	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000392664	10	97392770	10	95633013	392664	373631	rs758543218	NC_000010.11:95633012:G:A
NM_014491.4(FOXP2):c.678dup (p.Leu227fs)	FOXP2		not provided	Pathogenic(Last reviewed: Dec 26, 2013)	criteria provided, single submitter	VCV000167096	7	114271661 - 114271662	7	114631606 - 114631607	167096	177725	rs786200976	NC_000007.14:114631606:AA:AAA
NM_014491.4(FOXP2):c.553C>T (p.Gln185Ter)	FOXP2	Q210*, Q185*, Q202*	Speech-language disorder 1	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000807606	7	114270016	7	114629961	807606	798581		NC_000007.14:114629960:C:T
NM_002860.4(ALDH18A1):c.1499G>T (p.Gly500Val)	ALDH18A1	G500V, G288V, G387V, G389V, G465V, G498V	Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000638645	10	97376340	10	95616583	638645	626418		NC_000010.11:95616582:C:A
NM_014491.4(FOXP2):c.1426C>T (p.Arg476Ter)	FOXP2	R475*, R476*, R493*, R501*	Speech-language disorder 1	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617625	7	114298280	7	114658225	617625	609022	rs1178491246	NC_000007.14:114658224:C:T
NM_002860.4(ALDH18A1):c.741del (p.Asp247fs)	ALDH18A1	D134fs, D212fs, D35fs, D136fs, D245fs, D247fs	Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000459841	10	97392783	10	95633026	459841	460701	rs1555262375	NC_000010.11:95633025:A:
NM_002860.4(ALDH18A1):c.2345A>G (p.Tyr782Cys)	ALDH18A1	Y780C, Y782C, Y671C, Y747C, Y669C, Y570C	Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000217273	10	97366562	10	95606805	217273	213920	rs774047299	NC_000010.11:95606804:T:C
NM_002860.4(ALDH18A1):c.413G>A (p.Arg138Gln)	ALDH18A1	R138Q, R27Q	Cutis laxa, autosomal dominant 3	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000217260	10	97397084	10	95637327	217260	213904	rs863225045	NC_000010.11:95637326:C:T
NM_002860.4(ALDH18A1):c.1910T>C (p.Leu637Pro)	ALDH18A1	L637P, L524P, L602P, L635P, L425P, L526P	Spastic paraplegia 9b, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000217120	10	97373512	10	95613755	217120	213765	rs869320690	NC_000010.11:95613754:A:G
NM_002860.4(ALDH18A1):c.1802-2_1924-901del	ALDH18A1		Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000156547	10	97372100 - 97373622	10	95612343 - 95613865	156547	166330		
NM_002860.4(ALDH18A1):c.2131del (p.Leu711fs)	ALDH18A1	L676fs, L709fs, L711fs, L499fs, L600fs, L598fs	Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000156546	10	97370029	10	95610272	156546	166329	rs587777858	NC_000010.11:95610271:GG:G
NM_002860.4(ALDH18A1):c.1923+1G>A	ALDH18A1		Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000029727	10	97373498	10	95613741	29727	38682	rs863223315	NC_000010.11:95613740:C:T
NM_002860.4(ALDH18A1):c.2350C>T (p.His784Tyr)	ALDH18A1	H784Y, H671Y, H572Y, H673Y, H749Y, H782Y	Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000016086	10	97366557	10	95606800	16086	31125	rs121434583	NC_000010.11:95606799:G:A
NM_004560.4(ROR2):c.1324C>T (p.Arg442Ter)	ROR2	R441*, R442*	Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly|Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000007318	9	94488885	9	91726603	7318	22357	rs267607016	NC_000009.12:91726602:G:A
NM_004560.4(ROR2):c.355C>T (p.Arg119Ter)	ROR2	R119*	not provided|Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000007314	9	94519662	9	91757380	7314	22353	rs121909087	NC_000009.12:91757379:G:A
NM_004560.4(ROR2):c.550C>T (p.Arg184Cys)	ROR2	R184C	Robinow syndrome, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007308	9	94499745	9	91737463	7308	22347	rs121909084	NC_000009.12:91737462:G:A
NM_014491.4(FOXP2):c.1591T>C (p.Tyr531His)	FOXP2	Y531H, Y556H, Y530H, Y548H	Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242975	7	114299672	7	114659617	242975	244062	rs879253772	NC_000007.14:114659616:T:C
Uniparental disomy of chromosome 7	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242973					242973	244061		
7q22-q31.33, 22 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242971					242971	244059		
7q22-q31.3 deletion (15 Mb)	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242970					242970	244058		
7q31.2-q32, 26 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242969					242969	244057		
7q31.2-q32, 15 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242968					242968	244056		
7q31.2-q32, 14 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242967					242967	244055		
7q31.2-q32, 13 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242966					242966	244054		
NC_000007.12:g.112946520_114520576del	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242965					242965	244053		
7q31.1-q31.3, 15 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242964					242964	244052		
7q31.1-q31.3, 11 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242963					242963	244051		
7q31.1-q31.3, 16 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242962					242962	244050		
7q31.1-q31.2, 9.1 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242961					242961	244049		
7q31.1-q31.2, 1.57 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242960					242960	244048		
7q31.1-q31.3, 14.8 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242959					242959	244047		
7q31.1-q31.2, 6.5 Mb deletion	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242958					242958	244046		
NC_000007.12:g.111781517_120142536del	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242957					242957	244045		
t(3;7)(q23;q31.2)	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242953					242953	244041		
NM_014491.4(FOXP2):c.1168_1169del (p.Gln390fs)	FOXP2	Q390fs, Q407fs, Q389fs, Q415fs	Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242949	7	114292330 - 114292331	7	114652275 - 114652276	242949	244038	rs879253771	NC_000007.14:114652274:ACA:A
NM_002860.4(ALDH18A1):c.1994G>T (p.Arg665Leu)	ALDH18A1	R665L, R453L, R554L, R630L, R552L, R663L	Hereditary spastic paraplegia 9A	Pathogenic(Last reviewed: Aug 21, 2015)	no assertion criteria provided	VCV000217119	10	97371129	10	95611372	217119	213764	rs766264810	NC_000010.11:95611371:C:A
NM_002860.4(ALDH18A1):c.727G>C (p.Val243Leu)	ALDH18A1	V243L, V31L, V130L, V132L, V208L, V241L	Hereditary spastic paraplegia 9A	Pathogenic(Last reviewed: Aug 21, 2015)	no assertion criteria provided	VCV000217116	10	97392797	10	95633040	217116	213761	rs864321669	NC_000010.11:95633039:C:G
NM_002860.4(ALDH18A1):c.2143G>C (p.Asp715His)	ALDH18A1	D715H, D680H, D604H, D713H, D602H, D503H	Spastic paraplegia 9b, autosomal recessive	Pathogenic(Last reviewed: Aug 21, 2015)	no assertion criteria provided	VCV000217115	10	97370017	10	95610260	217115	213760	rs752669339	NC_000010.11:95610259:C:G
NM_024790.6(CSPP1):c.2708del (p.Asn903fs)	CSPP1	N843fs, N881fs, N903fs, N558fs, N816fs, N870fs, N930fs	Joubert syndrome 21	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217642	8	68076631	8	67164396	217642	214268	rs863225190	NC_000008.11:67164395:AAAAAAAA:AAAAAAA
NM_024790.6(CSPP1):c.363_364del (p.His121fs)	CSPP1	H85fs, H121fs	Joubert syndrome 21	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000100673	8	67998296 - 67998297	8	67086061 - 67086062	100673	106545	rs1554562278	NC_000008.11:67086060:ATA:A
NM_000500.7:c.*28699001G>T	CYP21A2		Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000189133					189133	187080		
t(5;7)(q22;q31.2)	FOXP2		Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242954					242954	244042		
NM_000370.3(TTPA):c.487del (p.Trp163fs)	TTPA	W163fs	Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188951	8	63978528	8	63065969	188951	186762	rs397515378	NC_000008.11:63065968:AA:A
NM_000195.5(HPS1):c.972del (p.Met325fs)	HPS1	M202fs, M238fs, M205fs, M292fs, M169fs, M325fs	not provided|Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000005280	10	100186987	10	98427230	5280	20319	rs281865082	NC_000010.11:98427229:GGGGGGGG:GGGGGGG
NM_002860.4(ALDH18A1):c.413G>T (p.Arg138Leu)	ALDH18A1	R138L, R27L	Cutis laxa, autosomal dominant 3|Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic	criteria provided, single submitter	VCV000217261	10	97397084	10	95637327	217261	213905	rs863225045	NC_000010.11:95637326:C:A
NM_002860.4(ALDH18A1):c.412C>T (p.Arg138Trp)	ALDH18A1	R138W, R27W	Cutis laxa, autosomal dominant 3|not provided	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	VCV000217259	10	97397085	10	95637328	217259	213903	rs863225044	NC_000010.11:95637327:G:A
NM_014491.4(FOXP2):c.982C>T (p.Arg328Ter)	FOXP2	R328*, R353*, R327*, R345*	Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000005068	7	114282671	7	114642616	5068	20107	rs121908378	NC_000007.14:114642615:C:T
NM_000190.4(HMBS):c.601C>T (p.Arg201Trp)	HMBS	R201W, R184W	not provided|Acute intermittent porphyria	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001462	11	118962225	11	119091515	1462	16501	rs118204109	NC_000011.10:119091514:C:T
NM_015570.4(AUTS2):c.2343dup (p.Ser782fs)	AUTS2		not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000817945	7	70252225 - 70252226	7	70787239 - 70787240	817945	805546		NC_000007.14:70787239:CCCC:CCCCC
GRCh37/hg19 7q11.22(chr7:69659882-69912722)x3	AUTS2		not provided	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000814986	7	69659882 - 69912722			814986	803195		
GRCh37/hg19 7q11.22(chr7:69532233-69644230)x1	AUTS2		not provided	Pathogenic(Last reviewed: Jan 4, 2019)	no assertion criteria provided	VCV000814984	7	69532233 - 69644230			814984	803193		
GRCh37/hg19 7q11.22(chr7:69489582-69603832)x1	AUTS2		not provided	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000814983	7	69489582 - 69603832			814983	803192		
GRCh37/hg19 7q11.22(chr7:67518091-70095739)x1	AUTS2		not provided	Pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	VCV000814980	7	67518091 - 70095739			814980	803189		
NM_015570.4(AUTS2):c.1547dup (p.Pro517fs)	AUTS2		Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000807381	7	70231175 - 70231176	7	70766189 - 70766190	807381	798589		NC_000007.14:70766189:CCC:CCCC
NM_015570.4(AUTS2):c.1882_1883del (p.Leu628fs)	AUTS2	L628fs	Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802324	7	70239064 - 70239065	7	70774078 - 70774079	802324	790751		NC_000007.14:70774077:TTT:T
GRCh37/hg19 7q11.22(chr7:69274353-69464494)x1	AUTS2		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000688585	7	69274353 - 69464494			688585	676177		
GRCh37/hg19 7q11.22(chr7:69220855-69449057)x1	AUTS2		not provided	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000687102	7	69220855 - 69449057			687102	674694		
NM_015570.4(AUTS2):c.376C>T (p.Arg126Ter)	AUTS2	R126*	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000620261	7	69364338	7	69899352	620261	611684	rs1562957809	NC_000007.14:69899351:C:T
NM_000235.4(LIPA):c.817_820del (p.Asn273fs)	LIPA	N157fs, N273fs	not provided	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000595492	10	90983443 - 90983446	10	89223686 - 89223689	595492	586554	rs1564752665	NC_000010.11:89223685:TATTTA:TA
NM_000235.4(LIPA):c.459dup (p.Ala154fs)	LIPA		not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000595466	10	90986730 - 90986731	10	89226973 - 89226974	595466	586528	rs1564754574	NC_000010.11:89226973:T:TT
NM_000235.4(LIPA):c.822+1G>C	LIPA		not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000595368	10	90983440	10	89223683	595368	586430	rs1204744283	NC_000010.11:89223682:C:G
GRCh37/hg19 7q11.22(chr7:69248785-69438070)x1	AUTS2		not provided	Pathogenic(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000563317	7	69248785 - 69438070			563317	554501		
GRCh37/hg19 7q11.22(chr7:69848278-70012732)x3	AUTS2		not provided	Pathogenic(Last reviewed: Feb 27, 2018)	no assertion criteria provided	VCV000563313	7	69848278 - 70012732			563313	554497		
GRCh37/hg19 7q11.22(chr7:70147871-70249445)x1	AUTS2		not provided	Pathogenic(Last reviewed: Feb 6, 2018)	no assertion criteria provided	VCV000563293	7	70147871 - 70249445			563293	554477		
NM_015570.4(AUTS2):c.742+1G>A	AUTS2		not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000546070	7	70163607	7	70698621	546070	536739	rs1554464807	NC_000007.14:70698620:G:A
NM_015570.4(AUTS2):c.1487del (p.Gln496fs)	AUTS2	Q496fs	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000451578	7	70231118	7	70766132	451578	444153	rs1554481713	NC_000007.14:70766131:A:
NM_015570.4(AUTS2):c.1582C>T (p.Gln528Ter)	AUTS2	Q528*	not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000450622	7	70231213	7	70766227	450622	444154	rs1554481763	NC_000007.14:70766226:C:T
GRCh37/hg19 7q11.22(chr7:69325515-69644230)x1	AUTS2		See cases	Pathogenic	no assertion criteria provided	VCV000397114	7	69325515 - 69644230			397114	384007		
GRCh37/hg19 7q11.22(chr7:69459746-70176827)x1	AUTS2		See cases	Pathogenic	no assertion criteria provided	VCV000397041	7	69459746 - 70176827			397041	383934		
NM_015570.4(AUTS2):c.1483C>T (p.Arg495Ter)	AUTS2	R495*	not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000372310	7	70231114	7	70766128	372310	359671	rs1057517708	NC_000007.14:70766127:C:T
NM_015570.4(AUTS2):c.1004dup (p.Pro336fs)	AUTS2		not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000280471	7	70228112 - 70228113	7	70763126 - 70763127	280471	264240	rs886041671	NC_000007.14:70763126:CCCCC:CCCCCC
NM_015570.4(AUTS2):c.1974G>A (p.Trp658Ter)	AUTS2	W658*, W634*	not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000280395	7	70242130	7	70777144	280395	264242	rs886041609	NC_000007.14:70777143:G:A
GRCh37/hg19 7q11.22(chr7:69892610-70037666)x1	AUTS2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253608	7	69892610 - 70037666			253608	248056		
GRCh37/hg19 7q11.22(chr7:69307298-69395898)x1	AUTS2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253373	7	69307298 - 69395898			253373	247821		
NM_031443.3(CCM2):c.30+5_30+6delinsTT	CCM2		not provided|Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193463	7	45039967 - 45039968	7	45000368 - 45000369	193463	190627	rs797044623	NC_000007.14:45000367:GC:TT
NM_015570.4(AUTS2):c.901C>T (p.Gln301Ter)	AUTS2	Q301*	Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000666574	7	70228014	7	70763028	666574	654130		NC_000007.14:70763027:C:T
NM_000235.4(LIPA):c.395_396TC[1] (p.Val134fs)	LIPA		not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000593493	10	90987987 - 90987988	10	89228230 - 89228231	593493	584557	rs1564755287	NC_000010.11:89228229:GAGAG:GAG
NM_015570.4(AUTS2):c.357_361dup (p.Leu121fs)	AUTS2		Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: Dec 14, 2017)	no assertion criteria provided	VCV000559629	7	69364317 - 69364318	7	69899331 - 69899332	559629	550361	rs1554401434	NC_000007.14:69899331:CGCCCC:CGCCCCGCCCC
GRCh37/hg19 7q11.22(chr7:69063905-69105486)x1	AUTS2		See cases	Pathogenic	no assertion criteria provided	VCV000395428	7	69063905 - 69105486			395428	382321		
GRCh37/hg19 7q11.22(chr7:69351193-70257735)x1	AUTS2		See cases	Pathogenic	no assertion criteria provided	VCV000394042	7	69351193 - 70257735			394042	380935		
NM_015570.4(AUTS2):c.857_858del (p.Lys286fs)	AUTS2	K286fs	Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000219193	7	70227969 - 70227970	7	70762983 - 70762984	219193	217219	rs864321694	NC_000007.14:70762982:AAA:A
Single allele	AUTS2		Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000183398	7	70105229 - 70203625	7	70640243 - 70738639	183398	181502		
GRCh38/hg38 7q11.22(chr7:70300438-70447453)x1	AUTS2		See cases	Pathogenic(Last reviewed: May 29, 2013)	no assertion criteria provided	VCV000155372	7	69765424 - 69912439	7	70300438 - 70447453	155372	165126		
GRCh38/hg38 7q11.22(chr7:70724914-70755760)x1	AUTS2		See cases	Pathogenic(Last reviewed: Feb 16, 2018)	no assertion criteria provided	VCV000149942	7	70189900 - 70220746	7	70724914 - 70755760	149942	159693		
NM_000235.4(LIPA):c.129C>G (p.Tyr43Ter)	LIPA	Y22*, Y43*	Wolman disease	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000000082	10	91005533	10	89245776	82	15121	rs121965087	NC_000010.11:89245775:G:C
NM_000235.4(LIPA):c.894+1G>A	LIPA		Wolman disease	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000000081	10	90982267	10	89222510	81	15120	rs1564751995	NC_000010.11:89222509:C:T
GRCh37/hg19 7q11.22(chr7:69867672-69957025)x1	AUTS2		See cases	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000446330	7	69867672 - 69957025			446330	439771		
NM_015570.4(AUTS2):c.1298del (p.Leu433fs)	AUTS2	L433fs	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373078	7	70229821	7	70764835	373078	359665	rs1057518198	NC_000007.14:70764834:T:
NM_002860.4(ALDH18A1):c.359T>C (p.Val120Ala)	ALDH18A1	V120A, V9A	Hereditary spastic paraplegia 9A|Cutis laxa, autosomal dominant 3|Hereditary spastic paraplegia 9A|Cutis laxa-corneal clouding-oligophrenia syndrome	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000217118	10	97397138	10	95637381	217118	213763	rs863224945	NC_000010.11:95637380:A:G
NM_000235.4(LIPA):c.804del (p.Asn268fs)	LIPA	N268fs, N152fs	Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000842105	10	90983459	10	89223702	842105	837473		NC_000010.11:89223701:A:
NM_000235.4(LIPA):c.419G>A (p.Trp140Ter)	LIPA	W140*, W24*	Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000554864	10	90987966	10	89228209	554864	545311	rs1457072724	NC_000010.11:89228208:C:T
NM_000235.4(LIPA):c.656T>G (p.Leu219Ter)	LIPA	L219*, L103*	Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000458507	10	90984868	10	89225111	458507	460671	rs1554865576	NC_000010.11:89225110:A:C
NM_000235.4(LIPA):c.253C>T (p.Gln85Ter)	LIPA	Q85*	Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	VCV000208594	10	90988132	10	89228375	208594	205164	rs797045094	NC_000010.11:89228374:G:A
NM_001540.5(HSPB1):c.523C>T (p.Gln175Ter)	HSPB1	Q175*	Charcot-Marie-Tooth disease|not provided|	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217231	7	75933395	7	76304078	217231	213814	rs863225023	NC_000007.14:76304077:C:T
NM_001876.4(CPT1A):c.222C>A (p.Tyr74Ter)	CPT1A	Y74*	Carnitine palmitoyltransferase I deficiency|Carnitine palmitoyl transferase 1A deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093972	11	68579964	11	68812496	93972	99874	rs398123654	NC_000011.10:68812495:G:T
NM_001876.4(CPT1A):c.478C>T (p.Arg160Ter)	CPT1A	R160*	Carnitine palmitoyltransferase I deficiency|Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000065654	11	68571545	11	68804077	65654	76562	rs80356782	NC_000011.10:68804076:G:A
NM_001876.4(CPT1A):c.298C>T (p.Gln100Ter)	CPT1A	Q100*	not provided|Carnitine palmitoyltransferase I deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009063	11	68575090	11	68807622	9063	24102	rs80356774	NC_000011.10:68807621:G:A
NM_016219.5(MAN1B1):c.172G>T (p.Glu58Ter)	MAN1B1	E58*	not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000816942	9	139981623	9	137087171	816942	805616		NC_000009.12:137087170:G:T
NM_016219.5(MAN1B1):c.179dup (p.Tyr60Ter)	MAN1B1		Mental retardation, autosomal recessive 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802546	9	139981629 - 139981630	9	137087177 - 137087178	802546	790873		NC_000009.12:137087177:A:AA
NM_016219.5(MAN1B1):c.1274_1275CA[1] (p.Gln426fs)	MAN1B1		Mental retardation, autosomal recessive 15	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000203378	9	140000595 - 140000596	9	137106143 - 137106144	203378	199791	rs794729645	NC_000009.12:137106142:ACACA:ACA
NM_016219.5(MAN1B1):c.1418G>A (p.Trp473Ter)	MAN1B1	W473*	Mental retardation, autosomal recessive 15	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030414	9	140000740	9	137106288	30414	39371	rs1564311909	NC_000009.12:137106287:G:A
NC_000010.11:g.(?_89228190)_(89228408_?)del	LIPA		Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000833070	10	90987947 - 90988165			833070	820279		
NC_000010.11:g.(?_89228180)_(89228418_?)del	LIPA		Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000830947	10	90987937 - 90988175			830947	820278		
NM_000235.4(LIPA):c.350_351insCC (p.Met117fs)	LIPA		Lysosomal acid lipase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556450	10	90988034 - 90988035	10	89228277 - 89228278	556450	545315	rs753796180	NC_000010.11:89228277::GG
NM_015570.4(AUTS2):c.946C>T (p.Arg316Ter)	AUTS2	R316*	Mental retardation, autosomal dominant 26|not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489014	7	70228059	7	70763073	489014	481792	rs1554480537	NC_000007.14:70763072:C:T
NM_001613.4(ACTA2):c.145A>G (p.Met49Val)	ACTA2	M49V	Aortic aneurysm, familial thoracic 6	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000065450	10	90707128	10	88947371	65450	76367	rs397515325	NC_000010.11:88947370:T:C
NM_001083116.3(PRF1):c.666C>A (p.His222Gln)	PRF1	H222Q	not provided|	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280112	10	72358811	10	70599055	280112	264466	rs751247865	NC_000010.11:70599054:G:T
NM_000019.4(ACAT1):c.1006-4_1006-1delinsAAA	ACAT1		not provided	Pathogenic(Last reviewed: Jan 12, 2015)	criteria provided, single submitter	VCV000193787	11	108016925 - 108016928	11	108146198 - 108146201	193787	190950	rs797044633	NC_000011.10:108146197:TAAG:AAA
NM_000019.4(ACAT1):c.905del (p.Lys302fs)	ACAT1	K302fs	not provided	Pathogenic(Last reviewed: Dec 26, 2012)	criteria provided, single submitter	VCV000092299	11	108013241	11	108142514	92299	98210	rs398123097	NC_000011.10:108142513:AA:A
NM_000019.4(ACAT1):c.730+2T>C	ACAT1		not provided	Pathogenic(Last reviewed: Dec 26, 2012)	criteria provided, single submitter	VCV000092298	11	108010944	11	108140217	92298	98209	rs398123096	NC_000011.10:108140216:T:C
NM_000019.4(ACAT1):c.642T>G (p.Tyr214Ter)	ACAT1	Y214*	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000864432	11	108010854	11	108140127	864432	837595		NC_000011.10:108140126:T:G
NM_000019.4(ACAT1):c.1049G>A (p.Trp350Ter)	ACAT1	W350*	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000858337	11	108016972	11	108146245	858337	837596		NC_000011.10:108146244:G:A
NC_000011.10:g.(?_108121597)_(108147400_?)del	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000832954	11	107992324 - 108018127			832954	820290		
NC_000011.9:g.(?_108009615)_(108010952_?)del	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000656823	11	108009615 - 108010952	11	108138888 - 108140225	656823	652057		
NM_007126.5(VCP):c.290G>A (p.Gly97Glu)	VCP	G97E, G52E	Charcot-Marie-Tooth disease, axonal, type 2y	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000218306	9	35067900	9	35067903	218306	215002	rs864309502	NC_000009.12:35067902:C:T
NM_001365276.2(TNXB):c.3991G>A (p.Gly1331Arg)	TNXB	G1331R	Vesicoureteral reflux 8	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000144114	6	32049196	6	32081419	144114	153866	rs587777684	NC_000006.12:32081418:C:T
NM_001365276.2(TNXB):c.9770C>T (p.Thr3257Ile)	TNXB	T3257I, T3255I	Vesicoureteral reflux 8	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000144113	6	32016415	6	32048638	144113	153865	rs587777683	NC_000006.12:32048637:G:A
NM_007126.5(VCP):c.1774G>A (p.Asp592Asn)	VCP	D592N, D547N	Amyotrophic lateral sclerosis 14 without frontotemporal dementia	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030153	9	35059720	9	35059723	30153	39109	rs387906790	NC_000009.12:35059722:C:T
NM_001365276.2(TNXB):c.2106_2107GT[7] (p.Val706_Glu707insTer)	TNXB		Ehlers-Danlos syndrome, classic-like, 1	Pathogenic(Last reviewed: Oct 18, 2001)	no assertion criteria provided	VCV000008551	6	32063512 - 32063513	6	32095735 - 32095736	8551	23590	rs144556766	NC_000006.12:32095735:ACACACACACAC:ACACACACACACAC
NM_000019.4(ACAT1):c.1181_1211dup (p.Gln404fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000853510	11	108018012 - 108018013	11	108147285 - 108147286	853510	837597		NC_000011.10:108147285:ATTGTTGGTCATTTGACTCATGCCTTGAAGCA:ATTGTTGGTCATTTGACTCATGCCTTGAAGCATTGTTGGTCATTTGACTCATGCCTTGAAGCA
NM_000019.3:c.(72+1_73-1)_(435+1_436-1)del	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666540					666540	654099		
NM_000019.3:c.(730+1_731-1)_(940+1_941-1)dup	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666539					666539	654098		
NM_000019.3:c.(120+1_121-1)_(344+1_345-1)del	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666537					666537	654096		
NG_009888.2:g.20624_29833delinsTAA	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666536					666536	654080		
NM_000019.4(ACAT1):c.1223_1226dup (p.Ala410fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666534	11	108018055 - 108018056	11	108147328 - 108147329	666534	654078		NC_000011.10:108147328:GTCT:GTCTGTCT
NM_000019.4(ACAT1):c.1163G>A (p.Gly388Glu)	ACAT1	G388E	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666529	11	108017086	11	108146359	666529	654074		NC_000011.10:108146358:G:A
NM_000019.4(ACAT1):c.1032dup (p.Glu345fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666523	11	108016949 - 108016950	11	108146222 - 108146223	666523	654068		NC_000011.10:108146222:AAAAAA:AAAAAAA
NM_000019.4(ACAT1):c.1013_1016dup (p.Asp339fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666521	11	108016934 - 108016935	11	108146207 - 108146208	666521	654066		NC_000011.10:108146207:AAAGA:AAAGAAAGA
NM_000019.4(ACAT1):c.1006-1G>A	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666520	11	108016928	11	108146201	666520	654091		NC_000011.10:108146200:G:A
NM_000019.4(ACAT1):c.940+1G>T	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666512	11	108013278	11	108142551	666512	654089		NC_000011.10:108142550:G:T
NM_000019.4(ACAT1):c.754_755insCT (p.Glu252fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666498	11	108012355 - 108012356	11	108141628 - 108141629	666498	654052		NC_000011.10:108141628::CT
NM_000019.4(ACAT1):c.730+1G>A	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666496	11	108010943	11	108140216	666496	654085		NC_000011.10:108140215:G:A
NM_000019.4(ACAT1):c.462_482delinsTCCTC (p.Glu154fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666486	11	108009651 - 108009671	11	108138924 - 108138944	666486	654041		NC_000011.10:108138923:GAGCATGTCCAATGTTCCATA:TCCTC
NM_000019.4(ACAT1):c.446del (p.Val149fs)	ACAT1	V149fs	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666484	11	108009635	11	108138908	666484	654039		NC_000011.10:108138907:T:
NM_000019.4(ACAT1):c.435+1G>A	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666483	11	108005970	11	108135243	666483	654084		NC_000011.10:108135242:G:A
NM_000019.4(ACAT1):c.414_415del (p.Leu140fs)	ACAT1	L140fs	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666481	11	108005947 - 108005948	11	108135220 - 108135221	666481	654037		NC_000011.10:108135219:AAA:A
NM_000019.4(ACAT1):c.354_355delinsG (p.Cys119fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666475	11	108005888 - 108005889	11	108135161 - 108135162	666475	654031		NC_000011.10:108135160:AT:G
NM_000019.4(ACAT1):c.334+1G>A	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666474	11	108005044	11	108134317	666474	654083		NC_000011.10:108134316:G:A
NM_000019.4(ACAT1):c.99T>A (p.Tyr33Ter)	ACAT1	Y33*	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666465	11	108002660	11	108131933	666465	654024		NC_000011.10:108131932:T:A
NM_000019.4(ACAT1):c.84_85TG[3] (p.Glu30fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666464	11	108002644 - 108002645	11	108131917 - 108131918	666464	654023		NC_000011.10:108131917:TGTG:TGTGTG
NM_000019.4(ACAT1):c.81_82AT[1] (p.Tyr28fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666463	11	108002642 - 108002643	11	108131915 - 108131916	666463	654022		NC_000011.10:108131914:ATAT:AT
NM_000019.4(ACAT1):c.79A>T (p.Arg27Ter)	ACAT1	R27*	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666462	11	108002640	11	108131913	666462	654021		NC_000011.10:108131912:A:T
NM_007126.5(VCP):c.475C>G (p.Arg159Gly)	VCP	R159G, R114G	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030152	9	35065349	9	35065352	30152	39108	rs387906789	NC_000009.12:35065351:G:C
NM_001365276.2(TNXB):c.3290_3291del (p.Lys1097fs)	TNXB	K1097fs	Ehlers-Danlos syndrome, classic-like, 1	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000008550	6	32052344 - 32052345	6	32084567 - 32084568	8550	23589	rs764070148	NC_000006.12:32084566:TTT:T
NM_007126.5(VCP):c.695C>A (p.Ala232Glu)	VCP	A232E, A187E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000008470	9	35064164	9	35064167	8470	23509	rs121909331	NC_000009.12:35064166:G:T
NM_000019.4(ACAT1):c.1124A>G (p.Asn375Ser)	ACAT1	N375S	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666528	11	108017047	11	108146320	666528	654073		NC_000011.10:108146319:A:G
NM_000019.4(ACAT1):c.951C>T (p.Asp317=)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666516	11	108014720	11	108143993	666516	654064		NC_000011.10:108143992:C:T
NM_000019.4(ACAT1):c.941-9T>A	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666513	11	108014701	11	108143974	666513	654090		NC_000011.10:108143973:T:A
NM_000019.4(ACAT1):c.731-46_752del	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666497	11	108012282 - 108012349	11	108141555 - 108141622	666497	654086		
NM_000019.4(ACAT1):c.380C>T (p.Ala127Val)	ACAT1	A127V	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666479	11	108005914	11	108135187	666479	654035		NC_000011.10:108135186:C:T
NM_000019.4(ACAT1):c.286C>T (p.Gln96Ter)	ACAT1	Q96*	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666471	11	108004995	11	108134268	666471	654028		NC_000011.10:108134267:C:T
NM_000019.4(ACAT1):c.121-13T>A	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666467	11	108004534	11	108133807	666467	654081		NC_000011.10:108133806:T:A
NM_000019.4(ACAT1):c.2T>C (p.Met1Thr)	ACAT1	M1T	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666461	11	107992335	11	108121608	666461	654020		NC_000011.10:108121607:T:C
NM_007126.5(VCP):c.464G>C (p.Arg155Pro)	VCP	R155P, R110P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000008472	9	35065360	9	35065363	8472	23511	rs121909329	NC_000009.12:35065362:C:G
NM_007126.5(VCP):c.283C>G (p.Arg95Gly)	VCP	R95G, R50G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000008471	9	35067907	9	35067910	8471	23510	rs121909332	NC_000009.12:35067909:G:C
NM_018344.6(SLC29A3):c.1309G>A (p.Gly437Arg)	SLC29A3	G437R, G359R	Histiocytosis-lymphadenopathy plus syndrome|not provided	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000565	10	73122246	10	71362489	565	15604	rs121912584	NC_000010.11:71362488:G:A
NM_014491.4(FOXP2):c.1658G>A (p.Arg553His)	FOXP2	R553H, R578H, R552H, R570H	Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000005067	7	114302130	7	114662075	5067	20106	rs121908377	NC_000007.14:114662074:G:A
NM_012470.3(TNPO3):c.2453G>C (p.Arg818Pro)	TNPO3	R818P, R754P	Limb-girdle muscular dystrophy, type 1F	Pathogenic(Last reviewed: May 7, 2013)	no assertion criteria provided	VCV000135661	7	128610347	7	128970293	135661	139379	rs587777431	NC_000007.14:128970292:C:G
NM_000019.4(ACAT1):c.1A>G (p.Met1Val)	ACAT1	M1V	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666460	11	107992334	11	108121607	666460	654019		NC_000011.10:108121606:A:G
NM_000019.4(ACAT1):c.1033_1034del (p.Glu345fs)	ACAT1	E345fs	not provided|Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000524080	11	108016955 - 108016956	11	108146228 - 108146229	524080	514616	rs781496140	NC_000011.10:108146227:AGA:A
NM_000019.4(ACAT1):c.149del (p.Thr50fs)	ACAT1	T50fs	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000208341	11	108004575	11	108133848	208341	204576	rs779565865	NC_000011.10:108133847:C:
TNXB, 30-KB DEL	TNXB		Ehlers-Danlos syndrome, classic-like, 1	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000008549					8549	23588		
NM_000019.4(ACAT1):c.1083dup (p.Ala362fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000002842	11	108017005 - 108017006	11	108146278 - 108146279	2842	17881	rs387906283	NC_000011.10:108146278:A:AA
NM_012470.3(TNPO3):c.2771del (p.Ter924CysextTer?)	TNPO3	*860fs, *924fs	Limb-girdle muscular dystrophy, type 1F	Pathogenic(Last reviewed: May 7, 2013)	no assertion criteria provided	VCV000135660	7	128597310	7	128957256	135660	139378	rs587777430	NC_000007.14:128957255:T:
GRCh37/hg19 7p14.3(chr7:33191099-33257303)x1	BBS9		not provided	Pathogenic(Last reviewed: Mar 5, 2018)	no assertion criteria provided	VCV000688955	7	33191099 - 33257303			688955	676547		
GRCh37/hg19 7p14.3(chr7:33431363-33552840)x1	BBS9		not provided	Pathogenic(Last reviewed: Jan 24, 2018)	no assertion criteria provided	VCV000688806	7	33431363 - 33552840			688806	676398		
NM_020745.4(AARS2):c.2356G>A (p.Ala786Thr)	AARS2	A786T	Combined oxidative phosphorylation deficiency 8	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488461	6	44270547	6	44302810	488461	481329	rs1554147776	NC_000006.12:44302809:C:T
NM_198428.3(BBS9):c.1167del (p.Ile391fs)	BBS9	I300fs, I391fs, I269fs, I346fs	not provided	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000281898	7	33376203	7	33336591	281898	266135	rs886042258	NC_000007.14:33336590:G:
NM_020745.4(AARS2):c.2598+1G>T	AARS2		not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000280559	6	44269796	6	44302059	280559	264265	rs768351915	NC_000006.12:44302058:C:A
NM_020745.4(AARS2):c.1008dup (p.Asp337Ter)	AARS2		not provided	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000213970	6	44275017 - 44275018	6	44307280 - 44307281	213970	211235	rs766771165	NC_000006.12:44307280:A:AA
NM_020745.4(AARS2):c.2681C>A (p.Ser894Ter)	AARS2	S894*	not provided	Pathogenic(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	VCV000213960	6	44269119	6	44301382	213960	211221	rs200781477	NC_000006.12:44301381:G:T
NM_020745.4(AARS2):c.2027A>C (p.Gln676Pro)	AARS2	Q676P	Combined oxidative phosphorylation deficiency 8	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623387	6	44271141	6	44303404	623387	612277	rs1561938413	NC_000006.12:44303403:T:G
NM_020376.4(PNPLA2):c.1043del (p.Phe348fs)	PNPLA2	F348fs	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000567557	11	824120	11	824120	567557	564926	rs1565089992	NC_000011.10:824119:TT:T
NM_020745.4(AARS2):c.1213G>A (p.Glu405Lys)	AARS2	E405K	Leukoencephalopathy, progressive, with ovarian failure	Pathogenic(Last reviewed: Jun 10, 2014)	no assertion criteria provided	VCV000143048	6	44274104	6	44306367	143048	152758	rs587777592	NC_000006.12:44306366:C:T
NM_020745.4(AARS2):c.2893G>A (p.Gly965Arg)	AARS2	G965R	Leukoencephalopathy, progressive, with ovarian failure	Pathogenic(Last reviewed: Jun 10, 2014)	no assertion criteria provided	VCV000143047	6	44268349	6	44300612	143047	152757	rs543267101	NC_000006.12:44300611:C:T
NM_020745.4(AARS2):c.149T>G (p.Phe50Cys)	AARS2	F50C	Leukoencephalopathy, progressive, with ovarian failure	Pathogenic(Last reviewed: Jun 10, 2014)	no assertion criteria provided	VCV000143045	6	44280912	6	44313175	143045	152755	rs587777590	NC_000006.12:44313174:A:C
NM_020376.4(PNPLA2):c.467_470CTCC[4] (p.Gln160fs)	PNPLA2		Neutral lipid storage myopathy	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000065421	11	822000 - 822001	11	822000 - 822001	65421	76351	rs796065310	NC_000011.10:822000:TCCCTCCCTCCCTCC:TCCCTCCCTCCCTCCCTCC
NM_020376.4(PNPLA2):c.543del (p.Ile182fs)	PNPLA2	I182fs	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000065420	11	822452	11	822452	65420	76350	rs796065309	NC_000011.10:822451:CC:C
NM_020376.4(PNPLA2):c.467del (p.Pro156fs)	PNPLA2	P156fs	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039868	11	822002	11	822002	39868	48467	rs796065307	NC_000011.10:822001:CCC:CC
NM_020376.4(PNPLA2):c.749A>C (p.Gln250Pro)	PNPLA2	Q250P	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039866	11	823579	11	823579	39866	48465	rs397514625	NC_000011.10:823578:A:C
NM_020376.4(PNPLA2):c.757+2T>C	PNPLA2		Neutral lipid storage myopathy	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039865	11	823589	11	823589	39865	48464	rs777539013	NC_000011.10:823588:T:C
NM_020376.4(PNPLA2):c.865C>T (p.Gln289Ter)	PNPLA2	Q289*	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001876	11	823801	11	823801	1876	16915	rs121918260	NC_000011.10:823800:C:T
NM_020376.4(PNPLA2):c.847del (p.Gln283fs)	PNPLA2	Q283fs	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001875	11	823781	11	823781	1875	16914	rs796065304	NC_000011.10:823780:CCC:CC
NM_198428.3(BBS9):c.727G>A (p.Glu243Lys)	BBS9	E243K, E152K, E198K, E121K	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585196	7	33312648	7	33273036	585196	576224	rs1562917450	NC_000007.14:33273035:G:A
NM_198428.3(BBS9):c.263+4A>G	BBS9		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585195	7	33192467	7	33152855	585195	576223	rs370916293	NC_000007.14:33152854:A:G
NM_198428.3(BBS9):c.113-2A>G	BBS9		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585194	7	33192311	7	33152699	585194	576222	rs1562686929	NC_000007.14:33152698:A:G
NC_000007.13:g.(?_33423258)_(33427776_?)dup	BBS9		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584143	7	33423258 - 33427776	7	33383646 - 33388164	584143	563855		
NM_198428.3(BBS9):c.445C>T (p.Arg149Ter)	BBS9	R149*, R27*, R58*, R104*	Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523079	7	33296850	7	33257238	523079	513580	rs781174906	NC_000007.14:33257237:C:T
NM_198428.3(BBS9):c.263+1G>A	BBS9		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000412264	7	33192464	7	33152852	412264	395637	rs137962929	NC_000007.14:33152851:G:A
NM_198428.3(BBS9):c.2115+1G>A	BBS9		Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266088	7	33427757	7	33388145	266088	260906	rs886039801	NC_000007.14:33388144:G:A
NM_198428.3(BBS9):c.956del (p.Thr319fs)	BBS9	T274fs, T319fs, T197fs, T228fs	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266086	7	33313508	7	33273896	266086	260905	rs886039799	NC_000007.14:33273895:C:
NM_198428.3(BBS9):c.1759C>T (p.Arg587Ter)	BBS9	R587*, R430*, R461*, R547*, R496*, R542*, R465*, R552*, R582*	Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000265771	7	33407444	7	33367832	265771	260446	rs746797123	NC_000007.14:33367831:C:T
NM_198428.3(BBS9):c.104_112+4del	BBS9		Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217437	7	33185966 - 33185978	7	33146354 - 33146366	217437	214072	rs869025208	NC_000007.14:33146353:AAATGGACAAGGTAA:AA
NM_198428.3(BBS9):c.1423G>T (p.Glu475Ter)	BBS9	E475*, E353*, E384*, E430*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	VCV000216145	7	33388773	7	33349161	216145	212581	rs863224534	NC_000007.14:33349160:G:T
NM_198428.3(BBS9):c.1370T>A (p.Leu457Ter)	BBS9	L457*, L366*, L412*, L335*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jan 10, 2015)	criteria provided, single submitter	VCV000216144	7	33388720	7	33349108	216144	212580	rs762511626	NC_000007.14:33349107:T:A
NM_198428.2(BBS9):c.(?_-1)_328+?del	BBS9		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000216143	7	33185864 - 33195314	7	33146252 - 33155702	216143	212527		
NM_014451.3(BBS9):c.(443-1675_443-1116)_(618-986_618-508)del	BBS9		Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000031623	7	33295173 - 33303394	7	33255561 - 33263782	31623	40301		
NM_020745.4(AARS2):c.464T>G (p.Leu155Arg)	AARS2	L155R	Combined oxidative phosphorylation deficiency 8	Pathogenic(Last reviewed: Jun 10, 2014)	no assertion criteria provided	VCV000030941	6	44279244	6	44311507	30941	39898	rs387907061	NC_000006.12:44311506:A:C
NM_198428.3(BBS9):c.442+1G>C	BBS9		Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002661	7	33217204	7	33177592	2661	17700	rs587777811	NC_000007.14:33177591:G:C
NM_198428.3(BBS9):c.421G>A (p.Gly141Arg)	BBS9	G141R, G50R, G19R, G96R	Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002659	7	33217182	7	33177570	2659	17698	rs137852857	NC_000007.14:33177569:G:A
NM_198428.3(BBS9):c.2045dup (p.Arg683fs)	BBS9		Bardet-Biedl syndrome 9	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002658	7	33427685 - 33427686	7	33388073 - 33388074	2658	17697	rs587777810	NC_000007.14:33388073:C:CC
NM_000019.4(ACAT1):c.52dup (p.Leu18fs)	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633029	11	107992380 - 107992381	11	108121653 - 108121654	633029	621324	rs1476273214	NC_000011.10:108121653:CCCCC:CCCCCC
NM_000019.4(ACAT1):c.890C>T (p.Thr297Met)	ACAT1	T297M	Deficiency of acetyl-CoA acetyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279672	11	108013227	11	108142500	279672	264388	rs886041122	NC_000011.10:108142499:C:T
NM_000019.4(ACAT1):c.1163+2T>C	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000002837	11	108017088	11	108146361	2837	17876	rs1280110907	NC_000011.10:108146360:T:C
NM_020376.4(PNPLA2):c.662G>C (p.Arg221Pro)	PNPLA2	R221P	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000663841	11	822572	11	822572	663841	640483		NC_000011.10:822571:G:C
NM_198428.3(BBS9):c.310del (p.Cys104fs)	BBS9	C104fs, C13fs, C59fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000462970	7	33195294	7	33155682	462970	457774	rs747388658	NC_000007.14:33155681:TTT:TT
NM_020745.4(AARS2):c.1561C>T (p.Arg521Ter)	AARS2	R521*	Combined oxidative phosphorylation deficiency 8|Leukoencephalopathy, progressive, with ovarian failure	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000143046	6	44272809	6	44305072	143046	152756	rs587777591	NC_000006.12:44305071:G:A
NM_006415.4(SPTLC1):c.992C>A (p.Ser331Tyr)	SPTLC1	S331Y, S176Y, S209Y	not provided|Neuropathy hereditary sensory and autonomic type 1|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372788	9	94809543	9	92047261	372788	359759	rs267607087	NC_000009.12:92047260:G:T
LIPA, 934G-A	LIPA		Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000000079					79	15118		
NM_004456.4(EZH2):c.2233G>A (p.Glu745Lys)	EZH2	E745K, E689K, E701K, E731K, E740K	Weaver syndrome	Pathogenic(Last reviewed: Jul 18, 2013)	no assertion criteria provided	VCV000065675	7	148504761	7	148807669	65675	76583	rs397515548	NC_000007.14:148807668:C:T
NM_004456.4(EZH2):c.2044G>A (p.Ala682Thr)	EZH2	A682T, A626T, A638T, A668T, A677T	Weaver syndrome	Pathogenic(Last reviewed: Jul 18, 2013)	no assertion criteria provided	VCV000065674	7	148506468	7	148809376	65674	76582	rs397515547	NC_000007.14:148809375:C:T
NM_198428.3(BBS9):c.1063C>T (p.Gln355Ter)	BBS9	Q355*, Q233*, Q264*, Q310*	Bardet-Biedl syndrome 9|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000002660	7	33376099	7	33336487	2660	17699	rs137852858	NC_000007.14:33336486:C:T
NM_004456.4(EZH2):c.2187dup (p.Asp730Ter)	EZH2		Weaver syndrome	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000210967	7	148506170 - 148506171	7	148809078 - 148809079	210967	207471	rs797045568	NC_000007.14:148809078:AAAAAA:AAAAAAA
NM_152998.3(EZH2):c.149T>C (p.Leu50Ser)	EZH2	L50S	Weaver syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208166	7	148543659	7	148846567	208166	204426	rs775407864	NC_000007.14:148846566:A:G
NM_004456.4(EZH2):c.458A>G (p.Tyr153Cys)	EZH2	Y153C, Y114C, Y144C	Weaver syndrome	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208085	7	148526846	7	148829754	208085	204364	rs797044844	NC_000007.14:148829753:T:C
NM_004456.4(EZH2):c.394C>T (p.Pro132Ser)	EZH2	P132S, P123S, P93S	Weaver syndrome	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030200	7	148526910	7	148829818	30200	39156	rs193921148	NC_000007.14:148829817:G:A
NM_004456.4(EZH2):c.2080C>T (p.His694Tyr)	EZH2	H694Y, H680Y, H638Y, H689Y, H650Y	Weaver syndrome	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030199	7	148506432	7	148809340	30199	39155	rs193921147	NC_000007.14:148809339:G:A
NM_004456.4(EZH2):c.1876G>A (p.Val626Met)	EZH2	V626M, V570M, V582M, V612M, V621M	Weaver syndrome	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	VCV000158579	7	148508788	7	148811696	158579	168576	rs587783625	NC_000007.14:148811695:C:T
EZH2, 3-BP DEL, NT457	EZH2		Weaver syndrome	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030198					30198	39154		
NM_198428.3(BBS9):c.832C>T (p.Arg278Ter)	BBS9	R187*, R156*, R233*, R278*	Retinal dystrophy|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000856112	7	33312753	7	33273141	856112	833581		NC_000007.14:33273140:C:T
NM_198428.3(BBS9):c.223C>T (p.Arg75Ter)	BBS9	R75*, R30*	Retinal vascular dystrophy|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000266106	7	33192423	7	33152811	266106	260904	rs775081992	NC_000007.14:33152810:C:T
NM_020745.4(AARS2):c.595C>T (p.Arg199Cys)	AARS2	R199C	not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213963	6	44278885	6	44311148	213963	211239	rs200105202	NC_000006.12:44311147:G:A
NM_198428.3(BBS9):c.263C>A (p.Ser88Ter)	BBS9	S88*, S43*	Bardet-Biedl syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000191219	7	33192463	7	33152851	191219	189022	rs749974697	NC_000007.14:33152850:C:A
NM_020376.4(PNPLA2):c.757+1G>T	PNPLA2		Neutral lipid storage myopathy	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000039867	11	823588	11	823588	39867	48466	rs869320738	NC_000011.10:823587:G:T
NM_198428.3(BBS9):c.1792C>T (p.Arg598Ter)	BBS9	R598*, R476*, R507*, R593*, R563*, R441*, R472*, R553*, R558*	Bardet-Biedl syndrome 9|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000002657	7	33423280	7	33383668	2657	17696	rs137852856	NC_000007.14:33383667:C:T
NM_198428.3(BBS9):c.1789+1G>A	BBS9		Bardet-Biedl syndrome 9|not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000002656	7	33407475	7	33367863	2656	17695	rs201938124	NC_000007.14:33367862:G:A
NM_020376.4(PNPLA2):c.808del (p.His270fs)	PNPLA2	H270fs	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000001873	11	823740	11	823740	1873	16912	rs796065303	NC_000011.10:823739:CCCCC:CCCC
NM_000318.3(PEX2):c.373C>T (p.Arg125Ter)	PEX2	R125*	Peroxisome biogenesis disorder 5a (zellweger)|Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder 5a (zellweger)|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549898	8	77896042	8	76983806	549898	544760	rs61752124	NC_000008.11:76983805:G:A
NM_012434.5(SLC17A5):c.918T>G (p.Tyr306Ter)	SLC17A5	Y306*	Salla disease|not specified|Salla disease|Sialic acid storage disease, severe infantile type	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000440272	6	74331587	6	73621864	440272	433918	rs201284672	NC_000006.12:73621863:A:C
NM_012434.5(SLC17A5):c.533del (p.Thr178fs)	SLC17A5	T178fs	not provided|Salla disease	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167693	6	74348215	6	73638492	167693	178074	rs727504156	NC_000006.12:73638491:G:
NM_000019.4(ACAT1):c.578T>G (p.Met193Arg)	ACAT1	M193R	Deficiency of acetyl-CoA acetyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666490	11	108009767	11	108139040	666490	654045		NC_000011.10:108139039:T:G
NM_000019.4(ACAT1):c.444_445del (p.Met148fs)	ACAT1	M148fs	Deficiency of acetyl-CoA acetyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000166649	11	108009633 - 108009634	11	108138906 - 108138907	166649	177468	rs727503795	NC_000011.10:108138905:GG:
NM_000401.3(EXT2):c.643C>T (p.Arg215Ter)	EXT2	R182*, R215*	Multiple exostoses type 2|not provided	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265133	11	44130751	11	44109201	265133	259984	rs886039358	NC_000011.10:44109200:C:T
NM_000319.4(PEX5):c.449-2A>G	PEX5		not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000500513	12	7351605	12	7199009	500513	491937	rs1555176945	NC_000012.12:7199008:A:G
NM_001131025.1(PEX5):c.552-1G>A	PEX5		not provided	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000418982	12	7354346	12	7201750	418982	408743	rs1064793563	NC_000012.12:7201749:G:A
NM_000319.4(PEX5):c.1779_1781delinsTC (p.Glu593fs)	PEX5		not provided	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000280450	12	7362702 - 7362704	12	7210106 - 7210108	280450	264536	rs886041656	NC_000012.12:7210105:GAA:TC
NM_000235.4(LIPA):c.796G>T (p.Gly266Ter)	LIPA	G245*, G266*, G150*	Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000000078	10	90983467	10	89223710	78	15117	rs267607218	NC_000010.11:89223709:C:A
NM_001131024.1(PEX5):c.643-337dup	PEX5		Rhizomelic chondrodysplasia punctata type 5|Rhizomelic chondrodysplasia punctata	Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	VCV000190410	12	7354870 - 7354871	12	7202274 - 7202275	190410	188236	rs796051881	NC_000012.12:7202274:A:AA
NM_001131025.1(PEX5):c.1279C>T (p.Arg427Ter)	PEX5	R390*, R419*, R427*, R442*, R448*, R382*, R405*, R411*, R424*, R426*	Peroxisome biogenesis disorder 2A (Zellweger)|not provided	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000009144	12	7361150	12	7208554	9144	24183	rs61752137	NC_000012.12:7208553:C:T
NM_001131025.1(PEX5):c.361G>T (p.Glu121Ter)	PEX5	E121*, E136*, E142*, E157*	not provided|Neonatal adrenoleucodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620217	12	7344209	12	7191613	620217	611777	rs1565673352	NC_000012.12:7191612:G:T
NM_001876.4(CPT1A):c.2129G>A (p.Gly710Glu)	CPT1A	G710E	not provided|Carnitine palmitoyltransferase I deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000009071	11	68527706	11	68760238	9071	24110	rs80356780	NC_000011.10:68760237:C:T
NM_004456.4(EZH2):c.2050C>T (p.Arg684Cys)	EZH2	R684C, R628C, R679C, R640C, R670C	Weaver syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158582	7	148506462	7	148809370	158582	168573	rs587783626	NC_000007.14:148809369:G:A
NM_000019.4(ACAT1):c.949G>A (p.Asp317Asn)	ACAT1	D317N	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666515	11	108014718	11	108143991	666515	654063		NC_000011.10:108143990:G:A
NM_000019.4(ACAT1):c.455G>C (p.Gly152Ala)	ACAT1	G152A	not provided|Deficiency of acetyl-CoA acetyltransferase	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198029	11	108009644	11	108138917	198029	195190	rs762991875	NC_000011.10:108138916:G:C
NM_000019.4(ACAT1):c.2T>A (p.Met1Lys)	ACAT1	M1K	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000002838	11	107992335	11	108121608	2838	17877	rs120074142	NC_000011.10:108121607:T:A
NM_000019.4(ACAT1):c.1006-2A>C	ACAT1		Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002835	11	108016927	11	108146200	2835	17874	rs145229472	NC_000011.10:108146199:A:C
NM_006734.4(HIVEP2):c.6964C>T (p.Gln2322Ter)	HIVEP2	Q2322*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000520986	6	143074621	6	142753484	520986	511628	rs1554274371	NC_000006.12:142753483:G:A
NM_080877.2(SLC34A3):c.575C>T (p.Ser192Leu)	SLC34A3	S192L	Autosomal recessive hypophosphatemic bone disease|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198610	9	140127675	9	137233223	198610	195771	rs199690076	NC_000009.12:137233222:C:T
NM_003172.4(SURF1):c.688C>T (p.Arg230Ter)	SURF1	R230*, R121*	not provided|Leigh syndrome	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280010	9	136219364	9	133352509	280010	264486	rs782623477	NC_000009.12:133352508:G:A
NM_020745.4(AARS2):c.647dup (p.Cys218fs)	AARS2		Pulmonary hypoplasia|not provided|Combined oxidative phosphorylation deficiency 8	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143044	6	44278832 - 44278833	6	44311095 - 44311096	143044	152754	rs587777589	NC_000006.12:44311095:CC:CCC
NM_020376.4(PNPLA2):c.584C>T (p.Pro195Leu)	PNPLA2	P195L	Neutral lipid storage myopathy	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000001874	11	822494	11	822494	1874	16913	rs121918259	NC_000011.10:822493:C:T
NM_001159287.1(TPI1):c.426G>C (p.Glu142Asp)	TPI1	E104D, E142D, E105D, E23D	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012468	12	6978338	12	6869174	12468	27507	rs121964845	NC_000012.12:6869173:G:C
NM_014846.4(WASHC5):c.1857G>T (p.Leu619Phe)	WASHC5	L619F, L471F		Pathogenic(Last reviewed: Aug 13, 2008)	no assertion criteria provided	VCV000039008	8	126069816	8	125057574	39008	47611	rs80338866	NC_000008.11:125057573:C:A
NM_014846.4(WASHC5):c.526C>T (p.Arg176Ter)	WASHC5	R176*, R28*	Ritscher-Schinzel syndrome 1|	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000647373	8	126091165	8	125078923	647373	636581		NC_000008.11:125078922:G:A
NM_014846.4(WASHC5):c.682C>T (p.Arg228Ter)	WASHC5	R228*, R80*	Ritscher-Schinzel syndrome 1|	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000583269	8	126091009	8	125078767	583269	564623	rs754463353	NC_000008.11:125078766:G:A
NM_014846.4(WASHC5):c.3020_3021AC[2] (p.Leu1009fs)	WASHC5		Ritscher-Schinzel syndrome 1|	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000573798	8	126051131 - 126051132	8	125038889 - 125038890	573798	564606	rs765926045	NC_000008.11:125038888:GTGTGT:GTGT
NM_014846.4(WASHC5):c.704dup (p.Tyr235Ter)	WASHC5		Ritscher-Schinzel syndrome 1|	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000570249	8	126090986 - 126090987	8	125078744 - 125078745	570249	564620	rs1563633906	NC_000008.11:125078744:T:TT
NM_014846.4(WASHC5):c.2087G>C (p.Gly696Ala)	WASHC5	G696A, G548A		Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000065713	8	126067843	8	125055601	65713	76621	rs397515564	NC_000008.11:125055600:C:G
NM_000235.4(LIPA):c.684del (p.Phe228fs)	LIPA	F112fs, F228fs	Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553192	10	90983579	10	89223822	553192	545953	rs770074196	NC_000010.11:89223821:AAA:AA
NM_001363118.2(SLC52A2):c.297G>C (p.Trp99Cys)	SLC52A2	W99C	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549671	8	145583449	8	144359789	549671	540452	rs782591841	NC_000008.11:144359788:G:C
NM_001363118.2(SLC52A2):c.865C>T (p.Leu289=)	SLC52A2		Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210040	8	145584017	8	144360357	210040	206606	rs797045201	NC_000008.11:144360356:C:T
NM_014846.4(WASHC5):c.511C>T (p.Arg171Ter)	WASHC5	R171*, R23*	Ritscher-Schinzel syndrome 1|	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000576266	8	126093910	8	125081668	576266	562351	rs1462319941	NC_000008.11:125081667:G:A
NM_014846.4(WASHC5):c.3335+2T>A	WASHC5		Ritscher-Schinzel syndrome 1	Pathogenic(Last reviewed: Jan 21, 2020)	no assertion criteria provided	VCV000092129	8	126044481	8	125032239	92129	97556	rs398123007	NC_000008.11:125032238:A:T
NM_014846.4(WASHC5):c.1411A>G (p.Asn471Asp)	WASHC5	N471D, N323D		Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001163	8	126073434	8	125061192	1163	16202	rs80338865	NC_000008.11:125061191:T:C
NM_014846.4(WASHC5):c.1857G>C (p.Leu619Phe)	WASHC5	L619F, L471F		Pathogenic(Last reviewed: Dec 15, 2014)	criteria provided, single submitter	VCV000001162	8	126069816	8	125057574	1162	16201	rs80338866	NC_000008.11:125057573:C:G
NC_000008.11:g.(?_144358571)_(144361296_?)del	SLC52A2		Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000830619	8	145582231 - 145584956			830619	819950		
NM_001363118.2(SLC52A2):c.751C>T (p.Gln251Ter)	SLC52A2	Q251*, Q87*	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000660959	8	145583903	8	144360243	660959	636796		NC_000008.11:144360242:C:T
NM_001363118.2(SLC52A2):c.116_130+83del	SLC52A2		Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000576124	8	145583037 - 145583134	8	144359377 - 144359474	576124	562069	rs1564653965	
NM_001363118.2(SLC52A2):c.551del (p.Pro184fs)	SLC52A2	P184fs	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000473205	8	145583698	8	144360038	473205	458053	rs1554854044	NC_000008.11:144360037:CCCCCC:CCCCC
NM_001363118.2(SLC52A2):c.700C>T (p.Gln234Ter)	SLC52A2	Q234*, Q70*	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210039	8	145583852	8	144360192	210039	206605	rs797045200	NC_000008.11:144360191:C:T
NM_001363118.2(SLC52A2):c.383C>T (p.Ser128Leu)	SLC52A2	S128L	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000210038	8	145583535	8	144359875	210038	206604	rs374071862	NC_000008.11:144359874:C:T
NM_001363118.2(SLC52A2):c.92G>C (p.Trp31Ser)	SLC52A2	W31S	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210037	8	145583045	8	144359385	210037	206603	rs797045199	NC_000008.11:144359384:G:C
NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)	HSPB1	P39L	|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000533814	7	75932145	7	76302828	533814	522820	rs557327165	NC_000007.14:76302827:C:T
NM_001540.5(HSPB1):c.418C>G (p.Arg140Gly)	HSPB1	R140G	|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007484	7	75933172	7	76303855	7484	22523	rs121909112	NC_000007.14:76303854:C:G
NM_001363118.2(SLC52A2):c.914A>G (p.Tyr305Cys)	SLC52A2	Y305C, Y141C	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000096703	8	145584066	8	144360406	96703	102594	rs398123068	NC_000008.11:144360405:A:G
NM_001363118.2(SLC52A2):c.851C>A (p.Ala284Asp)	SLC52A2	A284D, A120D	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000096702	8	145584003	8	144360343	96702	102593	rs398123067	NC_000008.11:144360342:C:A
NM_001363118.2(SLC52A2):c.368T>C (p.Leu123Pro)	SLC52A2	L123P	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000039576	8	145583520	8	144359860	39576	48175	rs397514538	NC_000008.11:144359859:T:C
NM_016219.5(MAN1B1):c.1000C>T (p.Arg334Cys)	MAN1B1	R334C	MAN1B1-Related Disorders|Mental retardation, autosomal recessive 15	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000030415	9	139995540	9	137101088	30415	39372	rs387906886	NC_000009.12:137101087:C:T
NM_001363118.2(SLC52A2):c.149dup (p.Tyr50Ter)	SLC52A2		Brown-Vialetto-Van Laere syndrome 2|not provided	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419108	8	145583300 - 145583301	8	144359640 - 144359641	419108	407346	rs782095095	NC_000008.11:144359640:A:AA
NM_001363118.2(SLC52A2):c.1255G>A (p.Gly419Ser)	SLC52A2	G419S, G255S	Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000040232	8	145584592	8	144360932	40232	48718	rs397514658	NC_000008.11:144360931:G:A
NM_032667.6:c.438+1G>A	BSCL2		Congenital generalized lipodystrophy type 2	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004538					4538	19577		
BSCL2, 258-BP DEL/12-BP INS	BSCL2		Congenital generalized lipodystrophy type 2	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004534					4534	19573		
NM_001083116.3(PRF1):c.673C>T (p.Arg225Trp)	PRF1	R225W		Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000013711	10	72358804	10	70599048	13711	28750	rs28933973	NC_000010.11:70599047:G:A
NM_213674.1(TPM2):c.412_414GAG[1] (p.Glu139del)	TPM2	E139del	Distal arthrogryposis type 1A|Nemaline myopathy 4|not provided|Cap myopathy 2	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012465	9	35685506 - 35685508	9	35685509 - 35685511	12465	27504	rs199476153	NC_000009.12:35685508:CTCCTC:CTC
NM_000019.4(ACAT1):c.622C>T (p.Arg208Ter)	ACAT1	R208*	not provided|Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376832	11	108010834	11	108140107	376832	363710	rs532190594	NC_000011.10:108140106:C:T
NM_002316.3(LMX1B):c.227G>A (p.Trp76Ter)	LMX1B	W76*	not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000265489	9	129377749	9	126615470	265489	259910	rs886039574	NC_000009.12:126615469:G:A
NM_000048.4(ASL):c.533_557dup (p.Leu187_Leu188insGlyThrAspProArgLeuTer)	ASL		not provided	Pathogenic(Last reviewed: May 21, 2014)	criteria provided, single submitter	VCV000203628	7	65551736 - 65551737	7	66086749 - 66086750	203628	200151	rs796051932	NC_000007.14:66086749:CGTGGCACTGACCCGAGACTCTGAGCG:CGTGGCACTGACCCGAGACTCTGAGCGTGGCACTGACCCGAGACTCTGAGCG
NM_001174147.2(LMX1B):c.746G>C (p.Arg249Pro)	LMX1B	R249P	Nail-patella syndrome	Pathogenic(Last reviewed: Aug 7, 2019)	no assertion criteria provided	VCV000830002	9	129455807	9	126693528	830002	818264		NC_000009.12:126693527:G:C
NM_001174147.2(LMX1B):c.932del (p.Pro311fs)	LMX1B	P311fs, P322fs	Nail-patella syndrome	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000807625	9	129458162	9	126695883	807625	798610		NC_000009.12:126695882:CC:C
NM_001174147.2(LMX1B):c.917_926del (p.Met306fs)	LMX1B	M317fs, M306fs	Nail-patella syndrome	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000807624	9	129458147 - 129458156	9	126695868 - 126695877	807624	798609		NC_000009.12:126695867:ATGGCTTCCTA:A
NM_001174147.2(LMX1B):c.709T>C (p.Ser237Pro)	LMX1B	S237P	Nail-patella syndrome	Pathogenic	no assertion criteria provided	VCV000694525	9	129455570	9	126693291	694525	682510		NC_000009.12:126693290:T:C
NM_002316.3(LMX1B):c.667del (p.Arg223fs)	LMX1B	R223fs	Nail-patella syndrome	Pathogenic	no assertion criteria provided	VCV000599397	9	129455525	9	126693246	599397	590733	rs1564169730	NC_000009.12:126693245:CCCC:CCC
NM_001174146.1(LMX1B):c.305A>G (p.Tyr102Cys)	LMX1B	Y102C	Nail-patella syndrome	Pathogenic	no assertion criteria provided	VCV000587694	9	129377827	9	126615548	587694	578652	rs1564143881	NC_000009.12:126615547:A:G
NM_002316.3(LMX1B):c.741+1G>T	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522461	9	129455603	9	126693324	522461	513077	rs1427331961	NC_000009.12:126693323:G:T
NM_002316.3(LMX1B):c.176G>T (p.Cys59Phe)	LMX1B	C59F	Nail-patella syndrome	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438683	9	129377698	9	126615419	438683	432300	rs1554721879	NC_000009.12:126615418:G:T
NM_002316.3(LMX1B):c.543del (p.Asp182fs)	LMX1B	D182fs	Nail-patella syndrome	Pathogenic	no assertion criteria provided	VCV000427737	9	129453328	9	126691049	427737	417439	rs1114167362	NC_000009.12:126691048:CCCC:CCC
NM_002316.3(LMX1B):c.285_289del (p.Tyr95_Arg97delinsTer)	LMX1B		not provided	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000377264	9	129377807 - 129377811	9	126615528 - 126615532	377264	364142	rs1057520178	NC_000009.12:126615527:CTTCC:
NM_001174147.2(LMX1B):c.783dup (p.Val262fs)	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	no assertion criteria provided	VCV000827647	9	129455843 - 129455844	9	126693564 - 126693565	827647	815851		NC_000009.12:126693564:C:CC
GRCh37/hg19 9q33.3(chr9:129414011-129460757)	LMX1B		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625639	9	129414011 - 129460757			625639	613943		
NM_001174146.1(LMX1B):c.306C>G (p.Tyr102Ter)	LMX1B	Y102*	Nail-patella syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208164	9	129377828	9	126615549	208164	204428	rs864621969	NC_000009.12:126615548:C:G
NM_000048.4(ASL):c.346C>T (p.Gln116Ter)	ASL	Q116*	Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Feb 3, 2011)	no assertion criteria provided	VCV000021254	7	65547921	7	66082934	21254	34106	rs367543006	NC_000007.14:66082933:C:T
LMX1B, DEL	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000007012					7012	22051		
LMX1B, 17-BP DEL	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000007011					7011	22050		
LMX1B, 672, G-T, +1	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000007009					7009	22048		
LMX1B, 672, G-A, +1	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000007008					7008	22047		
LMX1B, 2-BP DEL, 233TG	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000007004					7004	22043		
NM_002316.3(LMX1B):c.353G>T (p.Cys118Phe)	LMX1B	C95F, C118F	Nail-patella syndrome	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000007003	9	129453141	9	126690862	7003	22042	rs121909488	NC_000009.12:126690861:G:T
LMX1B, 1-BP INS, 713A	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000007002					7002	22041		
NM_002316.3(LMX1B):c.661C>T (p.Arg221Ter)	LMX1B	R198*, R221*	Nail-patella syndrome	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000007001	9	129455522	9	126693243	7001	22040	rs121909487	NC_000009.12:126693242:C:T
NM_002316.3(LMX1B):c.807C>A (p.Asn269Lys)	LMX1B	N246K, N269K	Nail-patella syndrome	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000007000	9	129455868	9	126693589	7000	22039	rs121909486	NC_000009.12:126693588:C:A
NM_000048.4(ASL):c.451_452dup (p.Asp152fs)	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000835209	7	65551575 - 65551576	7	66086588 - 66086589	835209	833801		NC_000007.14:66086588:CG:CGCG
NC_000007.14:g.(?_66076072)_(66092922_?)del	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000833451	7	65541059 - 65557909			833451	819909		
NM_001174147.2(LMX1B):c.819+1G>A	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827651	9	129455881	9	126693602	827651	815855		NC_000009.12:126693601:G:A
NM_001174147.2(LMX1B):c.793G>T (p.Val265Phe)	LMX1B	V265F	Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827649	9	129455854	9	126693575	827649	815853		NC_000009.12:126693574:G:T
NM_001174147.2(LMX1B):c.169G>T (p.Glu57Ter)	LMX1B	E57*	Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827646	9	129377691	9	126615412	827646	815850		NC_000009.12:126615411:G:T
NC_000007.13:g.(?_65541049)_(65557919_?)del	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000652397	7	65541049 - 65557919	7	66076062 - 66092932	652397	651642		
NM_000048.4(ASL):c.979del (p.Glu327Argfs)	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000649877	7	65554598	7	66089611	649877	651759		NC_000007.14:66089610:GG:G
NM_000048.4(ASL):c.765dup (p.Met256fs)	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000573845	7	65553838 - 65553839	7	66088851 - 66088852	573845	564395	rs1562742141	NC_000007.14:66088851:GG:GGG
NM_002316.3(LMX1B):c.737G>A (p.Arg246Gln)	LMX1B	R246Q	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000498798	9	129455598	9	126693319	498798	490222	rs1191455921	NC_000009.12:126693318:G:A
NM_000048.4(ASL):c.94_100del (p.Arg32fs)	ASL	R32fs	Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000459923	7	65546870 - 65546876	7	66081883 - 66081889	459923	457529	rs1554326263	NC_000007.14:66081882:CCGGCACC:C
NM_000048.4(ASL):c.1360C>T (p.Gln454Ter)	ASL	Q454*, Q434*, Q428*	Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224979	7	65557864	7	66092877	224979	226860	rs869312994	NC_000007.14:66092876:C:T
NM_000048.4(ASL):c.1122dup (p.Tyr375fs)	ASL		Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224978	7	65557050 - 65557051	7	66092063 - 66092064	224978	226859	rs869312993	NC_000007.14:66092063:CC:CCC
NM_000048.4(ASL):c.889C>T (p.Arg297Trp)	ASL	R297W, R271W	Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224977	7	65554133	7	66089146	224977	226858	rs869312992	NC_000007.14:66089145:C:T
NM_000048.4(ASL):c.762C>A (p.Ser254Arg)	ASL	S254R, S228R	Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224976	7	65553837	7	66088850	224976	226857	rs869312991	NC_000007.14:66088849:C:A
NM_000048.4(ASL):c.575_580dup (p.Lys192_Arg193dup)	ASL		Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224974	7	65551775 - 65551776	7	66086788 - 66086789	224974	226855	rs869312989	NC_000007.14:66086788:GCGGAAGCGGA:GCGGAAGCGGAAGCGGA
NM_000048.4(ASL):c.461T>C (p.Leu154Pro)	ASL	L154P	Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224973	7	65551586	7	66086599	224973	226854	rs869312988	NC_000007.14:66086598:T:C
NM_000048.3(ASL):c.292delG (p.Glu98Serfs)	ASL		Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224972	7	65547866	7	66082879	224972	226853	rs869312987	NC_000007.14:66082878:GG:G
NM_000048.4(ASL):c.257A>C (p.Glu86Ala)	ASL	E86A	Argininosuccinate lyase deficiency	Pathogenic	criteria provided, single submitter	VCV000224971	7	65547404	7	66082417	224971	226852	rs869312986	NC_000007.14:66082416:A:C
NM_002316.3(LMX1B):c.745C>T (p.Arg249Ter)	LMX1B	R226*, R249*	Nail-patella syndrome	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000007010	9	129455806	9	126693527	7010	22049	rs121909492	NC_000009.12:126693526:C:T
ASL, IVS5DS, G-A, +1	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000002400					2400	17439		
NM_000401.3(EXT2):c.725+1G>A	EXT2		Multiple exostoses type 2|not provided	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503618	11	44130834	11	44109284	503618	495713	rs1057521132	NC_000011.10:44109283:G:A
NM_001131025.1(PEX5):c.1578T>G (p.Asn526Lys)	PEX5	N489K, N518K, N526K, N541K, N547K, N523K, N481K, N504K, N510K, N525K	Peroxisome biogenesis disorder 2A (Zellweger)|not provided|Neonatal adrenoleucodystrophy	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000009143	12	7362296	12	7209700	9143	24182	rs61752138	NC_000012.12:7209699:T:G
NM_001876.4(CPT1A):c.1163+1G>A	CPT1A		Carnitine palmitoyltransferase I deficiency|Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371246	11	68552282	11	68784814	371246	358057	rs148059333	NC_000011.10:68784813:C:T
NM_001291339.1(CSPP1):c.1209_1212del (p.Glu405fs)	CSPP1	E405fs, E690fs, E717fs, E728fs, E750fs, E777fs, E663fs	Joubert syndrome 21|Meckel-Gruber syndrome|not provided	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100674	8	68070698 - 68070701	8	67158463 - 67158466	100674	106546	rs587777145	NC_000008.11:67158462:AAAGA:A
NC_000007.14:g.(?_66081783)_(66083194_?)del	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000830913	7	65546770 - 65548181			830913	819910		
NM_001174147.2(LMX1B):c.806_811del (p.Asn269_Gln270del)	LMX1B		Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827650	9	129455866 - 129455871	9	126693587 - 126693592	827650	815854		NC_000009.12:126693586:AACCAAA:A
NM_001174147.2(LMX1B):c.793G>C (p.Val265Leu)	LMX1B	V265L	Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827648	9	129455854	9	126693575	827648	815852		NC_000009.12:126693574:G:C
NM_002316.3(LMX1B):c.781C>T (p.Arg261Cys)	LMX1B	R261C	not provided|Nail-patella syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265491	9	129455842	9	126693563	265491	259911	rs886039576	NC_000009.12:126693562:C:T
NM_002316.3(LMX1B):c.668G>A (p.Arg223Gln)	LMX1B	R200Q, R223Q	Nail-patella syndrome	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000007007	9	129455529	9	126693250	7007	22046	rs121909491	NC_000009.12:126693249:G:A
NM_002316.3(LMX1B):c.691C>T (p.Arg231Ter)	LMX1B	R208*, R231*	Nail-patella syndrome|not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000007006	9	129455552	9	126693273	7006	22045	rs121909490	NC_000009.12:126693272:C:T
NM_002316.3(LMX1B):c.244C>T (p.Gln82Ter)	LMX1B	Q59*, Q82*	Nail-patella syndrome|not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000007005	9	129377766	9	126615487	7005	22044	rs121909489	NC_000009.12:126615486:C:T
NM_014846.4(WASHC5):c.1771T>C (p.Ser591Pro)	WASHC5	S591P, S443P	||	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000463137	8	126069902	8	125057660	463137	457808	rs1554593901	NC_000008.11:125057659:A:G
NM_003011.4(SET):c.126_129AGAC[1] (p.Arg44fs)	SET	R44fs, R35fs, R33fs, R57fs	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521454	9	131453501 - 131453504	9	128691222 - 128691225	521454	511804	rs1554776342	NC_000009.12:128691221:AGACAG:AG
NM_012144.4(DNAI1):c.1612G>A (p.Ala538Thr)	DNAI1	A538T, A542T	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000583106	9	34514434	9	34514436	583106	565872	rs368248592	NC_000009.12:34514435:G:A
NM_012144.4(DNAI1):c.1530del (p.Asp509_Tyr510insTer)	DNAI1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000570874	9	34513150	9	34513152	570874	563208	rs751920647	NC_000009.12:34513151:C:
NM_012144.4(DNAI1):c.625C>T (p.Arg209Ter)	DNAI1	R209*, R213*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000525320	9	34491496	9	34491498	525320	524518	rs769224534	NC_000009.12:34491497:C:T
NM_012144.4(DNAI1):c.1569+1G>T	DNAI1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000454829	9	34513190	9	34513192	454829	459147	rs1465404366	NC_000009.12:34513191:G:T
NM_012144.4(DNAI1):c.1188del (p.Tyr397fs)	DNAI1	Y397fs, Y401fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000411844	9	34506746	9	34506748	411844	397459	rs1060503515	NC_000009.12:34506747:CCCC:CCC
NM_012144.4(DNAI1):c.156del (p.Asp53fs)	DNAI1	D53fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000411805	9	34485214	9	34485216	411805	396872	rs1060503495	NC_000009.12:34485215:T:
NM_012144.4(DNAI1):c.912C>G (p.Tyr304Ter)	DNAI1	Y304*, Y308*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000240858	9	34500730	9	34500732	240858	240609	rs878854968	NC_000009.12:34500731:C:G
NM_012144.4(DNAI1):c.1307G>A (p.Trp436Ter)	DNAI1	W436*, W440*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000240853	9	34506868	9	34506870	240853	240611	rs769284314	NC_000009.12:34506869:G:A
NM_012144.4(DNAI1):c.1658_1669del (p.Thr553_Phe556del)	DNAI1		Kartagener syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000005607	9	34514478 - 34514489	9	34514480 - 34514491	5607	20646	rs606231165	NC_000009.12:34514479:CACCAAGGTCTTCA:CA
NM_012144.4(DNAI1):c.282_283insAATA (p.Gly95fs)	DNAI1		Kartagener syndrome	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000005605	9	34489341 - 34489342	9	34489343 - 34489344	5605	20644	rs606231164	NC_000009.12:34489343::AATA
NM_021957.4(GYS2):c.736C>T (p.Arg246Ter)	GYS2	R246*	Glycogen storage disease due to hepatic glycogen synthase deficiency|Glycogen storage disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016049	12	21721886	12	21568952	16049	31088	rs121918419	NC_000012.12:21568951:G:A
NM_000048.4(ASL):c.376C>T (p.Arg126Trp)	ASL	R126W	Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000643476	7	65548091	7	66083104	643476	636308		NC_000007.14:66083103:C:T
NM_000048.4(ASL):c.292G>T (p.Glu98Ter)	ASL	E98*	Argininosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553428	7	65547867	7	66082880	553428	544632	rs770375565	NC_000007.14:66082879:G:T
NM_000048.4(ASL):c.1045_1062+7del	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000529426	7	65554664 - 65554688	7	66089677 - 66089701	529426	523230	rs1329070853	NC_000007.14:66089676:CGTCATCTCTACGCTGCAGGCAAGAC:C
NM_002316.3(LMX1B):c.736C>T (p.Arg246Ter)	LMX1B	R246*	not provided|Nail-patella syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488835	9	129455597	9	126693318	488835	481835	rs1554728698	NC_000009.12:126693317:C:T
NM_000048.4(ASL):c.524+2T>G	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224981	7	65551651	7	66086664	224981	226862	rs869312976	NC_000007.14:66086663:T:G
NM_000048.4(ASL):c.602+1G>A	ASL		Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092365	7	65551809	7	66086822	92365	98276	rs398123127	NC_000007.14:66086821:G:A
NM_001363118.2(SLC52A2):c.808C>T (p.Gln270Ter)	SLC52A2	Q270*, Q106*	Brown-Vialetto-Van Laere syndrome 2|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188051	8	145583960	8	144360300	188051	185943	rs375088539	NC_000008.11:144360299:C:T
NM_003829.4(MPDZ):c.5302C>T (p.Gln1768Ter)	MPDZ	Q1768*, Q1735*	not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000286850	9	13119578	9	13119579	286850	271087	rs886043499	NC_000009.12:13119578:G:A
NM_003829.4(MPDZ):c.3211C>T (p.Arg1071Ter)	MPDZ	R1071*	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000548149	9	13168408	9	13168409	548149	538633	rs376078512	NC_000009.12:13168408:G:A
NM_003829.4(MPDZ):c.2230C>T (p.Arg744Ter)	MPDZ	R744*	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000548148	9	13188917	9	13188918	548148	538632	rs922703465	NC_000009.12:13188917:G:A
NM_003829.4(MPDZ):c.4469del (p.Gln1490fs)	MPDZ	Q1490fs, Q1457fs	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000548147	9	13126767	9	13126768	548147	538631	rs781251438	NC_000009.12:13126767:T:
NM_003829.4(MPDZ):c.755G>A (p.Trp252Ter)	MPDZ	W252*	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	VCV000211521	9	13221492	9	13221493	211521	207647	rs797045707	NC_000009.12:13221492:C:T
NM_138691.3(TMC1):c.236+1G>A	TMC1		Deafness, autosomal recessive 7|Rare genetic deafness|Deafness, autosomal dominant 36	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000504715	9	75309631	9	72694715	504715	497055	rs775428246	NC_000009.12:72694714:G:A
NM_138691.2(TMC1):c.1714G>A (p.Asp572Asn)	TMC1	D572N	Deafness, autosomal dominant 36|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004102	9	75431077	9	72816161	4102	19141	rs121908072	NC_000009.12:72816160:G:A
NM_003829.4(MPDZ):c.628C>T (p.Gln210Ter)	MPDZ	Q210*	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000050213	9	13222351	9	13222352	50213	59373	rs372127610	NC_000009.12:13222351:G:A
NM_005157.6(ABL1):c.1052T>C (p.Met351Thr)	ABL1	M351T, M370T	Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000012629	9	133748391	9	130873004	12629	27668	rs121913457	NC_000009.12:130873003:T:C
NM_005592.4(MUSK):c.40dup (p.Thr14fs)	MUSK		Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000190466	9	113431223 - 113431224	9	110668943 - 110668944	190466	188285	rs863223335	NC_000009.12:110668943:A:AA
NC_000009.11:g.(?_113431165)_(113563288_?)del	MUSK		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000583579	9	113431165 - 113563288	9	110668885 - 110801008	583579	565317		
Single allele	MUSK		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000476127			9	110734231 - 110734395	476127	458118		
NM_005592.4(MUSK):c.2180C>T (p.Ala727Val)	MUSK	A727V, A631V, A641V, A307V	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jun 15, 2010)	no assertion criteria provided	VCV000060522	9	113562838	9	110800558	60522	75105	rs397515450	NC_000009.12:110800557:C:T
NM_005592.4(MUSK):c.1815G>A (p.Met605Ile)	MUSK	M605I, M509I, M185I, M519I	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Jun 15, 2010)	no assertion criteria provided	VCV000060521	9	113550006	9	110787726	60521	75104	rs766640370	NC_000009.12:110787725:G:A
NM_005592.4(MUSK):c.1031C>G (p.Pro344Arg)	MUSK	P344R	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030175	9	113530210	9	110767930	30175	39131	rs387906803	NC_000009.12:110767929:C:G
NM_005592.4(MUSK):c.220dup (p.Arg74fs)	MUSK		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Dec 15, 2004)	no assertion criteria provided	VCV000008240	9	113449407 - 113449408	9	110687127 - 110687128	8240	23279	rs879255561	NC_000009.12:110687127:CCC:CCCC
NM_012144.4(DNAI1):c.336del (p.Asp114fs)	DNAI1	D114fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000228334	9	34489392	9	34489394	228334	229685	rs876657683	NC_000009.12:34489393:CCCC:CCC
NM_000048.4(ASL):c.337C>T (p.Arg113Trp)	ASL	R113W	Argininosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553111	7	65547912	7	66082925	553111	544239	rs767543051	NC_000007.14:66082924:C:T
NM_000429.3(MAT1A):c.791G>A (p.Arg264His)	MAT1A	R264H	Hepatic methionine adenosyltransferase deficiency|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001208	10	82034933	10	80275177	1208	16247	rs72558181	NC_000010.11:80275176:C:T
NM_000235.4(LIPA):c.398del (p.Leu132_Ser133insTer)	LIPA		not provided|Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289986	10	90987987	10	89228230	289986	274223	rs756016704	NC_000010.11:89228229:G:
NM_005592.4(MUSK):c.496C>T (p.Arg166Ter)	MUSK	R166*	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000849716	9	113459614	9	110697334	849716	835371		NC_000009.12:110697333:C:T
NM_022725.3(FANCF):c.484_485delCT	FANCF		Fanconi anemia, complementation group F|not specified|Fanconi anemia	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006343	11	22646872 - 22646873	11	22625326 - 22625327	6343	21382	rs587778340	NC_000011.10:22625325:AGAGAG:AGAG
NM_014846.4(WASHC5):c.1876G>T (p.Val626Phe)	WASHC5	V626F, V478F	||Ritscher-Schinzel syndrome 1	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000001161	8	126069059	8	125056817	1161	16200	rs80338867	NC_000008.11:125056816:C:A
NM_016156.5(MTMR2):c.1164G>A (p.Trp388Ter)	MTMR2	W388*, W316*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549685	11	95580893	11	95847729	549685	540457	rs1555060024	NC_000011.10:95847728:C:T
NM_016156.6(MTMR2):c.1090C>T (p.Arg364Ter)	MTMR2	R364*, R292*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000684410	11	95580967	11	95847803	684410	672005		NC_000011.10:95847802:G:A
NM_016156.5(MTMR2):c.1479+1G>A	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000684409	11	95574780	11	95841616	684409	672007		NC_000011.10:95841615:C:T
NM_016156.5(MTMR2):c.1768C>T (p.Gln590Ter)	MTMR2	Q590*, Q518*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623390	11	95569314	11	95836150	623390	612295	rs1565342506	NC_000011.10:95836149:G:A
MTMR2, 10-BP DEL/2-BP INS	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006235					6235	21274		
NM_016156.5(MTMR2):c.1444C>T (p.Gln482Ter)	MTMR2	Q482*, Q410*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006234	11	95574816	11	95841652	6234	21273	rs121434404	NC_000011.10:95841651:G:A
MTMR2, IVS13, G-A, +1	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006232					6232	21271		
NM_016156.6(MTMR2):c.874del (p.Ser292fs)	MTMR2	S292fs, S220fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000859440	11	95582957	11	95849793	859440	839194		NC_000011.10:95849792:T:
NM_016156.6(MTMR2):c.883C>T (p.Arg295Ter)	MTMR2	R295*, R223*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000684411	11	95582948	11	95849784	684411	672006		NC_000011.10:95849783:G:A
NM_016156.6(MTMR2):c.1490dup (p.Phe498fs)	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000684408	11	95571360 - 95571361	11	95838196 - 95838197	684408	672004		NC_000011.10:95838196:G:GG
NM_016156.5(MTMR2):c.1454_1457del (p.Asp485fs)	MTMR2	D485fs, D413fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000647003	11	95574803 - 95574806	11	95841639 - 95841642	647003	640536		NC_000011.10:95841638:CAGTCA:CA
NM_016156.5(MTMR2):c.454_458del (p.Glu152fs)	MTMR2	E152fs, E80fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000646293	11	95595166 - 95595170	11	95862002 - 95862006	646293	640547		NC_000011.10:95862001:GTTTC:
NM_201278.3(MTMR2):c.244_245GT[2] (p.Val82_Cys83insTer)	MTMR2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000543342	11	95595159 - 95595160	11	95861995 - 95861996	543342	526840	rs1358449243	NC_000011.10:95861994:ACACACA:ACACA
NM_201278.3(MTMR2):c.1319_1320TA[3] (p.Ser442fs)	MTMR2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000406679	11	95571312 - 95571313	11	95838148 - 95838149	406679	398790	rs1555057316	NC_000011.10:95838148:TATA:TATATA
NM_016156.5(MTMR2):c.832C>T (p.Gln278Ter)	MTMR2	Q278*, Q206*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000241077	11	95582999	11	95849835	241077	241219	rs757563721	NC_000011.10:95849834:G:A
NM_016156.5(MTMR2):c.1034del (p.Asn345fs)	MTMR2	N273fs, N345fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000216114	11	95581023	11	95847859	216114	212972	rs863224516	NC_000011.10:95847858:TTTT:TTT
NM_016156.5(MTMR2):c.826G>T (p.Glu276Ter)	MTMR2	E276*, E204*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000006233	11	95583005	11	95849841	6233	21272	rs121434403	NC_000011.10:95849840:C:A
NM_032888.4(COL27A1):c.3917del (p.Gly1306fs)	COL27A1	G1306fs	not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000843810	9	117046024	9	114283744	843810	835392		NC_000009.12:114283743:GGG:GG
NM_032888.4(COL27A1):c.3075del (p.Lys1026fs)	COL27A1	K1026fs	Steel syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807557	9	117014912	9	114252632	807557	798607		NC_000009.12:114252631:CCC:CC
NM_032888.4(COL27A1):c.93del (p.Phe32fs)	COL27A1	F32fs	Steel syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807556	9	116925025	9	114162745	807556	798606		NC_000009.12:114162744:G:
NM_032888.4(COL27A1):c.3556-2A>G	COL27A1		Steel syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	no assertion criteria provided	VCV000559511	9	117033006	9	114270726	559511	550234	rs1554821679	NC_000009.12:114270725:A:G
NM_032888.4(COL27A1):c.521_528del (p.Cys174fs)	COL27A1	C174fs	Steel syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	no assertion criteria provided	VCV000559388	9	116930356 - 116930363	9	114168076 - 114168083	559388	550116	rs1554787559	NC_000009.12:114168075:GCGGGCAG:
NM_032888.4(COL27A1):c.2119C>T (p.Arg707Ter)	COL27A1	R707*	Steel syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	no assertion criteria provided	VCV000559387	9	116958287	9	114196007	559387	550115	rs1401322428	NC_000009.12:114196006:C:T
NM_000019.4(ACAT1):c.997G>C (p.Ala333Pro)	ACAT1	A333P	Deficiency of acetyl-CoA acetyltransferase	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002845	11	108014766	11	108144039	2845	17884	rs120074147	NC_000011.10:108144038:G:C
NM_000048.4(ASL):c.1366C>T (p.Arg456Trp)	ASL	R436W, R430W, R456W	Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000660049	7	65557870	7	66092883	660049	636312		NC_000007.14:66092882:C:T
NM_000048.4(ASL):c.447-1G>A	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552765	7	65551571	7	66086584	552765	544572	rs778254333	NC_000007.14:66086583:G:A
NM_000048.4(ASL):c.175G>A (p.Glu59Lys)	ASL	E59K	Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224970	7	65546952	7	66081965	224970	226851	rs869312985	NC_000007.14:66081964:G:A
NM_017802.4(DNAAF5):c.948G>A (p.Trp316Ter)	DNAAF5	W316*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000663589	7	781026	7	741389	663589	636331		NC_000007.14:741388:G:A
NM_017802.4(DNAAF5):c.926G>A (p.Trp309Ter)	DNAAF5	W309*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000651485	7	781004	7	741367	651485	636330		NC_000007.14:741366:G:A
NM_017802.4(DNAAF5):c.2013_2028delinsATGGCC (p.Ala672fs)	DNAAF5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000649289	7	813766 - 813781	7	774129 - 774144	649289	636349		NC_000007.14:774128:GGCCATCCGCACGGCT:ATGGCC
NM_017802.4(DNAAF5):c.2346C>G (p.Tyr782Ter)	DNAAF5	Y782*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000454860	7	819696	7	780059	454860	457604	rs950490534	NC_000007.14:780058:C:G
NM_017802.4(DNAAF5):c.2108_2114delinsCCACCCTGGGT (p.Met703fs)	DNAAF5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000454858	7	814668 - 814674	7	775031 - 775037	454858	457930	rs1554255966	NC_000007.14:775030:TGCCCCA:CCACCCTGGGT
NM_017802.4(DNAAF5):c.2351_2352AG[1] (p.Ser785fs)	DNAAF5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000241202	7	819701 - 819702	7	780064 - 780065	241202	240179	rs878855036	NC_000007.14:780063:AGAG:AG
NM_007055.4(POLR3A):c.3291T>G (p.Tyr1097Ter)	POLR3A	Y1097*	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000816986	10	79744008	10	77984250	816986	805649		NC_000010.11:77984249:A:C
NM_007055.4(POLR3A):c.491-2A>G	POLR3A		not provided	Pathogenic(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	VCV000280427	10	79784463	10	78024705	280427	264482	rs886041636	NC_000010.11:78024704:T:C
NM_007055.4(POLR3A):c.1740dup (p.Val581fs)	POLR3A		not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000280111	10	79769651 - 79769652	10	78009893 - 78009894	280111	264563	rs781745727	NC_000010.11:78009893:TTT:TTTT
NM_007055.4(POLR3A):c.2325C>G (p.Asn775Lys)	POLR3A	N775K	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: May 23, 2019)	no assertion criteria provided	VCV000638561	10	79761989	10	78002231	638561	626348		NC_000010.11:78002230:G:C
NM_007055.4(POLR3A):c.3337-1G>A	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	no assertion criteria provided	VCV000617893	10	79743771	10	77984013	617893	609290	rs1041175828	NC_000010.11:77984012:C:T
NM_007055.4(POLR3A):c.4006C>T (p.Gln1336Ter)	POLR3A	Q1336*	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041249	10	79739917	10	77980159	41249	49673	rs267608675	NC_000010.11:77980158:G:A
NM_007055.4(POLR3A):c.3991G>A (p.Ala1331Thr)	POLR3A	A1331T	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041248	10	79739932	10	77980174	41248	49672	rs267608680	NC_000010.11:77980173:C:T
NM_007055.4(POLR3A):c.3742_3743insACC (p.Ser1248delinsTyrPro)	POLR3A		Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041247	10	79741928 - 79741929	10	77982170 - 77982171	41247	49671	rs267608669	NC_000010.11:77982170::GGT
NM_007055.4(POLR3A):c.3014G>A (p.Arg1005His)	POLR3A	R1005H	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041246	10	79745718	10	77985960	41246	49670	rs200118797	NC_000010.11:77985959:C:T
NM_007055.4(POLR3A):c.2830G>T (p.Glu944Ter)	POLR3A	E944*	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041245	10	79750883	10	77991125	41245	49669	rs267608674	NC_000010.11:77991124:C:A
NM_007055.4(POLR3A):c.2324A>T (p.Asn775Ile)	POLR3A	N775I	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041244	10	79761990	10	78002232	41244	49668	rs267608672	NC_000010.11:78002231:T:A
NM_007055.4(POLR3A):c.2171G>A (p.Cys724Tyr)	POLR3A	C724Y	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041243	10	79764550	10	78004792	41243	49667	rs267608679	NC_000010.11:78004791:C:T
NM_007055.4(POLR3A):c.1907C>A (p.Ser636Tyr)	POLR3A	S636Y	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000041242	10	79769297	10	78009539	41242	49666	rs267608676	NC_000010.11:78009538:G:T
NM_007055.4(POLR3A):c.3243-2A>G	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619038	10	79744058	10	77984300	619038	610434	rs1462460124	NC_000010.11:77984299:T:C
NM_007055.4(POLR3A):c.1572+1G>A	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619037	10	79773407	10	78013649	619037	610435	rs141484643	NC_000010.11:78013648:C:T
NM_007055.4(POLR3A):c.490+1G>A	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619036	10	79784728	10	78024970	619036	610436	rs1564623882	NC_000010.11:78024969:C:T
NM_007055.4(POLR3A):c.3243-1G>A	POLR3A		Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000436361	10	79744057	10	77984299	436361	429128	rs1554837782	NC_000010.11:77984298:C:T
NM_007055.4(POLR3A):c.1114G>A (p.Asp372Asn)	POLR3A	D372N	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000041240	10	79781375	10	78021617	41240	49664	rs267608673	NC_000010.11:78021616:C:T
NM_017802.4(DNAAF5):c.1784-1G>T	DNAAF5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000454854	7	810107	7	770470	454854	456926	rs765025514	NC_000007.14:770469:G:T
NM_007055.4(POLR3A):c.3583del (p.Asp1195fs)	POLR3A	D1195fs	Hypomyelinating leukodystrophy 7	Pathogenic	criteria provided, single submitter	VCV000684775	10	79742422	10	77982664	684775	672363		NC_000010.11:77982663:CC:C
NM_007055.4(POLR3A):c.1681C>T (p.Arg561Ter)	POLR3A	R561*	Hypomyelinating leukodystrophy 7	Pathogenic	criteria provided, single submitter	VCV000684772	10	79769711	10	78009953	684772	672364		NC_000010.11:78009952:G:A
NM_007055.4(POLR3A):c.3337-11T>C	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549559	10	79743781	10	77984023	549559	540042	rs1564613755	NC_000010.11:77984022:A:G
NM_007055.4(POLR3A):c.3013C>T (p.Arg1005Cys)	POLR3A	R1005C	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031149	10	79745719	10	77985961	31149	40106	rs267608682	NC_000010.11:77985960:G:A
NM_007055.4(POLR3A):c.2690T>A (p.Ile897Asn)	POLR3A	I897N	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031148	10	79753052	10	77993294	31148	40105	rs267608681	NC_000010.11:77993293:A:T
NM_007055.4(POLR3A):c.418C>T (p.Arg140Ter)	POLR3A	R140*	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031147	10	79784801	10	78025043	31147	40104	rs267608678	NC_000010.11:78025042:G:A
NM_012144.4(DNAI1):c.2001+1G>A	DNAI1		not provided|Primary ciliary dyskinesia|Kartagener syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065704	9	34517466	9	34517468	65704	76612	rs397515563	NC_000009.12:34517467:G:A
NM_012144.4(DNAI1):c.1543G>A (p.Gly515Ser)	DNAI1	G515S, G519S	Kartagener syndrome|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005606	9	34513163	9	34513165	5606	20645	rs79833450	NC_000009.12:34513164:G:A
GRCh37/hg19 10p12.1(chr10:26476682-26493359)x1	MYO3A		not provided	Pathogenic(Last reviewed: Apr 27, 2017)	no assertion criteria provided	VCV000686775	10	26476682 - 26493359			686775	674367		
NM_017433.5(MYO3A):c.2506-1G>A	MYO3A		not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000288758	10	26436358	10	26147429	288758	272995	rs201023600	NC_000010.11:26147428:G:A
NM_017433.5(MYO3A):c.3447_3448del (p.Arg1150fs)	MYO3A	R1150fs	not provided	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000284395	10	26462639 - 26462640	10	26173710 - 26173711	284395	268632	rs764507216	NC_000010.11:26173709:AAA:A
NM_017433.5(MYO3A):c.3819G>A (p.Trp1273Ter)	MYO3A	W1273*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000858273	10	26463012	10	26174083	858273	836778		NC_000010.11:26174082:G:A
NM_017433.5(MYO3A):c.3948dup (p.Cys1317fs)	MYO3A		Deafness, autosomal recessive 30	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802566	10	26463140 - 26463141	10	26174211 - 26174212	802566	790956		NC_000010.11:26174211:A:AA
NM_017433.5(MYO3A):c.1732G>T (p.Glu578Ter)	MYO3A	E578*	Deafness, autosomal recessive 30	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627463	10	26385567	10	26096638	627463	615809	rs1564544348	NC_000010.11:26096637:G:T
NM_017433.5(MYO3A):c.1684A>T (p.Arg562Ter)	MYO3A	R562*	Deafness, autosomal recessive 30	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627462	10	26385519	10	26096590	627462	615808	rs1564544199	NC_000010.11:26096589:A:T
NM_017433.5(MYO3A):c.2090T>G (p.Leu697Trp)	MYO3A	L697W	Nonsyndromic hearing loss and deafness	Pathogenic	criteria provided, single submitter	VCV000617675	10	26414513	10	26125584	617675	609078	rs1564573788	NC_000010.11:26125583:T:G
NM_016156.5(MTMR2):c.1276C>T (p.Gln426Ter)	MTMR2	Q426*, Q354*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000006231	11	95578227	11	95845063	6231	21270	rs121434402	NC_000011.10:95845062:G:A
NM_017433.5(MYO3A):c.4508_4511del (p.Asn1503fs)	MYO3A	N1503fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523983	10	26482200 - 26482203	10	26193271 - 26193274	523983	514608	rs757660866	NC_000010.11:26193270:TAAATAA:TAA
NM_017433.5(MYO3A):c.732-2A>G	MYO3A		Deafness, autosomal recessive 30	Pathogenic(Last reviewed: May 28, 2002)	no assertion criteria provided	VCV000004016	10	26312949	10	26024020	4016	19055	rs1023746725	NC_000010.11:26024019:A:G
NM_017433.5(MYO3A):c.1777-12G>A	MYO3A		Deafness, autosomal recessive 30	Pathogenic(Last reviewed: May 28, 2002)	no assertion criteria provided	VCV000004015	10	26409593	10	26120664	4015	19054	rs1564568849	NC_000010.11:26120663:G:A
NM_007055.4(POLR3A):c.1051C>T (p.Arg351Ter)	POLR3A	R351*	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000684773	10	79781438	10	78021680	684773	672365		NC_000010.11:78021679:G:A
NM_007055.4(POLR3A):c.2617C>T (p.Arg873Ter)	POLR3A	R873*	Neonatal pseudo-hydrocephalic progeroid syndrome|not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000235466	10	79753125	10	77993367	235466	237149	rs148932047	NC_000010.11:77993366:G:A
NM_007055.4(POLR3A):c.2015G>A (p.Gly672Glu)	POLR3A	G672E	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031143	10	79767519	10	78007761	31143	40100	rs267608670	NC_000010.11:78007760:C:T
NM_017433.5(MYO3A):c.3129T>G (p.Tyr1043Ter)	MYO3A	Y1043*	Deafness, autosomal recessive 30	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000004014	10	26457658	10	26168729	4014	19053	rs193919333	NC_000010.11:26168728:T:G
NM_004999.4(MYO6):c.790_795delinsAA (p.His264fs)	MYO6		not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000523990	6	76551069 - 76551074	6	75841352 - 75841357	523990	514540	rs1554207040	NC_000006.12:75841351:CATTTG:AA
NM_004999.4(MYO6):c.342_343AT[1] (p.Tyr115fs)	MYO6		not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000451624	6	76540213 - 76540214	6	75830496 - 75830497	451624	444015	rs1554204415	NC_000006.12:75830495:ATAT:AT
NM_004999.4(MYO6):c.897G>T (p.Glu299Asp)	MYO6	E299D, E294D	Deafness, autosomal dominant 22	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402263	6	76554694	6	75844977	402263	389225	rs1060499799	NC_000006.12:75844976:G:T
NM_004999.4(MYO6):c.1473_1473+2delinsC	MYO6		Deafness, autosomal dominant 22	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236034	6	76568710 - 76568712	6	75858993 - 75858995	236034	237602	rs878853225	NC_000006.12:75858992:GGT:C
NM_004999.4(MYO6):c.3765del (p.Cys1256fs)	MYO6	C1243fs, C1228fs, C1233fs, C1265fs, C1224fs, C1256fs	Deafness, autosomal dominant 22	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813826	6	76624636	6	75914919	813826	802074		NC_000006.12:75914918:C:
NM_004999.4(MYO6):c.2717C>A (p.Ser906Ter)	MYO6	S906*, S901*	Deafness, autosomal dominant 22	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000544693	6	76599832	6	75890115	544693	535237	rs1554218566	NC_000006.12:75890114:C:A
NM_004999.4(MYO6):c.2814_2815del (p.Arg939fs)	MYO6	R934fs, R939fs	Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2016)	criteria provided, single submitter	VCV000228375	6	76599926 - 76599927	6	75890209 - 75890210	228375	229525	rs876657709	NC_000006.12:75890208:AAAAA:AAA
NM_004629.1(FANCG):c.1183_1192del (p.Glu395fs)	FANCG	E395fs	Fanconi anemia, complementation group G	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000041224	9	35075703 - 35075712	9	35075706 - 35075715	41224	49648	rs397507559	NC_000009.12:35075705:AAAACACCTCA:A
NM_004999.4(MYO6):c.2417-1758T>G	MYO6		Deafness, autosomal dominant 22	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000008583	6	76593963	6	75884246	8583	23622	rs1562283089	NC_000006.12:75884245:T:G
NM_004999.4(MYO6):c.3496C>T (p.Arg1166Ter)	MYO6	R1166*, R1153*, R1134*, R1175*, R1138*, R1143*	Deafness, autosomal recessive 37	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000008579	6	76623836	6	75914119	8579	23618	rs121912558	NC_000006.12:75914118:C:T
NM_004999.4(MYO6):c.36dup (p.Thr13fs)	MYO6		Deafness, autosomal recessive 37	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000008578	6	76527299 - 76527300	6	75817582 - 75817583	8578	23617	rs1562201376	NC_000006.12:75817582:T:TT
NM_004999.4(MYO6):c.1325G>A (p.Cys442Tyr)	MYO6	C442Y, C437Y	Deafness, autosomal dominant 22	Pathogenic(Last reviewed: Jul 9, 2004)	no assertion criteria provided	VCV000008577	6	76566915	6	75857198	8577	23616	rs121912557	NC_000006.12:75857197:G:A
FANCG, IVS13, G-C, -1	FANCG		Fanconi anemia, complementation group G	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006713					6713	21752		
NM_007055.4(POLR3A):c.2005C>T (p.Arg669Ter)	POLR3A	R669*	Neonatal pseudo-hydrocephalic progeroid syndrome|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617891	10	79767529	10	78007771	617891	609288	rs774007232	NC_000010.11:78007770:G:A
NM_007055.4(POLR3A):c.2119C>T (p.Gln707Ter)	POLR3A	Q707*	not provided|Hypomyelinating leukodystrophy 7	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2015)	criteria provided, multiple submitters, no conflicts	VCV000430255	10	79764602	10	78004844	430255	421801	rs780839834	NC_000010.11:78004843:G:A
NM_005592.4(MUSK):c.79+2T>G	MUSK		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I|Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000211542	9	113431265	9	110668985	211542	207598	rs200783529	NC_000009.12:110668984:T:G
NM_004629.2(FANCG):c.822_823AG[1] (p.Glu275fs)	FANCG		Fanconi anemia	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000845992	9	35076820 - 35076821	9	35076823 - 35076824	845992	836095		NC_000009.12:35076822:CTCT:CT
NC_000009.12:g.(?_35076714)_(35077111_?)del	FANCG		Fanconi anemia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000833060	9	35076711 - 35077108			833060	820137		
NM_004629.2(FANCG):c.1573del (p.Trp524_Val525insTer)	FANCG		Fanconi anemia	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000657889	9	35074987	9	35074990	657889	638225		NC_000009.12:35074989:CCC:CC
NM_004629.2(FANCG):c.1216del (p.Gln406fs)	FANCG	Q406fs	Fanconi anemia	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000644909	9	35075679	9	35075682	644909	638227		NC_000009.12:35075681:GG:G
NM_004629.1(FANCG):c.1158del (p.Ser387fs)	FANCG	S387fs	Fanconi anemia, complementation group G	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000619961	9	35075737	9	35075740	619961	611355	rs757418016	NC_000009.12:35075739:GGGGGG:GGGGG
NM_004629.1(FANCG):c.925-2A>G	FANCG		Fanconi anemia, complementation group G	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000006716	9	35076582	9	35076585	6716	21755	rs397507561	NC_000009.12:35076584:T:C
NM_017433.5(MYO3A):c.1370_1371del (p.Arg457fs)	MYO3A	R457fs	not provided|Deafness, autosomal recessive 30	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000655296	10	26377141 - 26377142	10	26088212 - 26088213	655296	638842	rs760866131	NC_000010.11:26088211:AGA:A
NM_003977.4(AIP):c.643A>T (p.Lys215Ter)	AIP	K215*, K156*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000826401	11	67257683	11	67490212	826401	810907		NC_000011.10:67490211:A:T
NM_003977.4(AIP):c.218G>A (p.Trp73Ter)	AIP	W14*, W73*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000820837	11	67254595	11	67487124	820837	810873		NC_000011.10:67487123:G:A
NM_003977.4(AIP):c.811C>T (p.Arg271Trp)	AIP	R271W, A268V, R212W	Somatotroph adenoma	Pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000041210	11	67258282	11	67490811	41210	49632	rs267606579	NC_000011.10:67490810:C:T
NM_003977.4(AIP):c.721A>G (p.Lys241Glu)	AIP	K241E, K182E	Somatotroph adenoma	Pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000041200	11	67257862	11	67490391	41200	49622	rs267606573	NC_000011.10:67490390:A:G
NM_003977.4(AIP):c.241C>T (p.Arg81Ter)	AIP	R81*, R22*	Somatotroph adenoma	Pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000041167	11	67254618	11	67487147	41167	49589	rs267606541	NC_000011.10:67487146:C:T
NM_017802.4(DNAAF5):c.2384T>C (p.Leu795Pro)	DNAAF5	L795P	Ciliary dyskinesia, primary, 18|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000039684	7	819734	7	780097	39684	48283	rs397514561	NC_000007.14:780096:T:C
NP_002760.1(PRSS1):p.Cys139Ser	PRSS1		Hereditary pancreatitis	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000132152					132152	136374		
NM_005055.4(RAPSN):c.-210A>G	RAPSN		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Pena-Shokeir syndrome type I|Congenital myasthenic syndrome|Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008051	11	47470726	11	47449174	8051	23090	rs786200905	
PRSS1, 3-BP DEL	PRSS1		Hereditary pancreatitis	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000011879					11879	26918		
NM_003977.4(AIP):c.64C>T (p.Arg22Ter)	AIP	R22*	Somatotroph adenoma	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000004894	11	67250693	11	67483222	4894	19933	rs121908357	NC_000011.10:67483221:C:T
NM_003977.4(AIP):c.543del (p.Ile182fs)	AIP	I182fs, I123fs	Somatotroph adenoma	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000004891	11	67257582	11	67490111	4891	19930	rs267606559	NC_000011.10:67490110:TT:T
NM_003977.4(AIP):c.824dup (p.His275fs)	AIP		Somatotroph adenoma	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000004890	11	67258294 - 67258295	11	67490823 - 67490824	4890	19929	rs267606580	NC_000011.10:67490823:A:AA
NM_003977.4(AIP):c.66_71del (p.Gly23_Glu24del)	AIP		Somatotroph adenoma	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000004889	11	67250695 - 67250700	11	67483224 - 67483229	4889	19928	rs267606567	NC_000011.10:67483223:AGGAGA:
NM_003977.4(AIP):c.469-1G>A	AIP		Somatotroph adenoma	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000004887	11	67257508	11	67490037	4887	19926	rs267606555	NC_000011.10:67490036:G:A
NM_012203.2(GRHPR):c.404+3_404+6del	GRHPR		Primary hyperoxaluria, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204250	9	37426650 - 37426653	9	37426653 - 37426656	204250	200629	rs180177309	NC_000009.12:37426652:AAGTAAGT:AAGT
NM_012203.2(GRHPR):c.494G>A (p.Gly165Asp)	GRHPR	G165D	Primary hyperoxaluria|not provided|Primary hyperoxaluria, type II	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204235	9	37429729	9	37429732	204235	200634	rs180177314	NC_000009.12:37429731:G:A
NM_012203.2(GRHPR):c.862_863TG[2] (p.Val289fs)	GRHPR		Primary hyperoxaluria|Primary hyperoxaluria, type II|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162020	9	37432132 - 37432133	9	37432135 - 37432136	162020	171741	rs180177321	NC_000009.12:37432134:TGTG:TG
NM_004629.2(FANCG):c.85-2A>T	FANCG		Fanconi anemia	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000667395	9	35079240	9	35079243	667395	654539		NC_000009.12:35079242:T:A
NM_004629.1(FANCG):c.652C>T (p.Gln218Ter)	FANCG	Q218*	Fanconi anemia	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000576782	9	35077093	9	35077096	576782	563967	rs1209807088	NC_000009.12:35077095:G:A
NM_004629.1(FANCG):c.156dup (p.Leu53fs)	FANCG		Fanconi anemia	Pathogenic(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000216091	9	35079166 - 35079167	9	35079169 - 35079170	216091	212670	rs863224506	NC_000009.12:35079169:CCC:CCCC
NM_004999.4(MYO6):c.2545C>T (p.Arg849Ter)	MYO6	R849*, R844*	Deafness, autosomal dominant 22|Rare genetic deafness	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000008582	6	76596598	6	75886881	8582	23621	rs121912561	NC_000006.12:75886880:C:T
NM_024649.5(BBS1):c.76del (p.Ala26fs)	BBS1	A26fs	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817988	11	66278512	11	66511041	817988	805707		NC_000011.10:66511040:G:
NM_024649.5(BBS1):c.118del (p.Cys40fs)	BBS1	C40fs	Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802688	11	66278554	11	66511083	802688	791156		NC_000011.10:66511082:T:
NM_007055.4(POLR3A):c.601del (p.Ile201fs)	POLR3A	I201fs	not provided|Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000684774	10	79784351	10	78024593	684774	672366		NC_000010.11:78024592:T:
NM_007055.4(POLR3A):c.760C>T (p.Arg254Ter)	POLR3A	R254*	Neonatal pseudo-hydrocephalic progeroid syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617894	10	79782028	10	78022270	617894	609291	rs141659018	NC_000010.11:78022269:G:A
NM_007055.4(POLR3A):c.3G>T (p.Met1Ile)	POLR3A	M1I	Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549565	10	79789163	10	78029405	549565	540048	rs1168641193	NC_000010.11:78029404:C:A
NM_024649.5(BBS1):c.235G>T (p.Glu79Ter)	BBS1	E79*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000851968	11	66281952	11	66514481	851968	838811		NC_000011.10:66514480:G:T
NC_000011.10:g.(?_66519607)_(66521386_?)del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000833355	11	66287078 - 66288857			833355	820408		
NC_000011.10:g.(?_66523446)_(66524211_?)del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000833034	11	66290917 - 66291682			833034	820409		
NC_000011.10:g.(?_66510650)_(66511249_?)del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000831571	11	66278121 - 66278720			831571	820406		
NM_024649.4(BBS1):c.592-?_830+?del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585174					585174	576225		
NM_024649.4(BBS1):c.1111-?_1695+?del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585169					585169	576226		
NM_024649.5(BBS1):c.595_598del (p.Val199fs)	BBS1	V199fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000531836	11	66287089 - 66287092	11	66519618 - 66519621	531836	526422	rs1555047409	NC_000011.10:66519617:CAGTCA:CA
NM_024649.5(BBS1):c.48-3C>G	BBS1		Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217432	11	66278481	11	66511010	217432	214073	rs869025204	NC_000011.10:66511009:C:G
NM_024649.5(BBS1):c.-3_37del (p.Met1fs)	BBS1	M1fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 13, 2009)	no assertion criteria provided	VCV000021708	11	66278117 - 66278156	11	66510646 - 66510685	21708	34560	rs113994178	NC_000011.10:66510645:CGACGCCTGCGAAGATGGCCGCTGCGTCCTCATCGGATTCCGACGCCTGCG:CGACGCCTGCG
BBS1, 1-BP DEL, 1650C	BBS1		Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: Jul 15, 2003)	no assertion criteria provided	VCV000012149					12149	27188		
PRSS1, TRIPLICATION	PRSS1		Hereditary pancreatitis	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000011884					11884	26923		
NM_003977.4(AIP):c.804C>A (p.Tyr268Ter)	AIP	Y268*, L266I, Y209*	Somatotroph adenoma|Pituitary adenoma predisposition	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2012)	no assertion criteria provided	VCV000004892	11	67258275	11	67490804	4892	19931	rs121908356	NC_000011.10:67490803:C:A
NM_003172.4(SURF1):c.574C>T (p.Arg192Trp)	SURF1	R192W, R83W	Charcot-Marie-Tooth disease, type 4k|not provided|Leigh syndrome	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215235	9	136219563	9	133352708	215235	211361	rs782190413	NC_000009.12:133352707:G:A
NM_024649.5(BBS1):c.68G>A (p.Trp23Ter)	BBS1	W23*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000842654	11	66278504	11	66511033	842654	838808		NC_000011.10:66511032:G:A
NC_000011.10:g.(?_66510640)_(66523902_?)del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000833066	11	66278111 - 66291373			833066	820405		
NC_000011.10:g.(?_66510650)_(66524211_?)del	BBS1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000832534	11	66278121 - 66291682			832534	820407		
NM_024649.5(BBS1):c.124+1G>A	BBS1		Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000557428	11	66278561	11	66511090	557428	546143	rs1057516449	NC_000011.10:66511089:G:A
NM_001540.5(HSPB1):c.539C>T (p.Thr180Ile)	HSPB1	T180I	|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447531	7	75933411	7	76304094	447531	441146	rs1422978230	NC_000007.14:76304093:C:T
NM_001540.5(HSPB1):c.406C>T (p.Arg136Trp)	HSPB1	R136W		Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000007482	7	75933160	7	76303843	7482	22521	rs28939681	NC_000007.14:76303842:C:T
NM_001540.5(HSPB1):c.379C>T (p.Arg127Trp)	HSPB1	R127W	not provided||Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000007479	7	75933133	7	76303816	7479	22518	rs29001571	NC_000007.14:76303815:C:T
NM_003880.3(CCN6):c.1010G>A (p.Cys337Tyr)	CCN6	C337Y, C355Y	Progressive pseudorheumatoid dysplasia|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521955	6	112390768	6	112069565	521955	511619	rs781986930	NC_000006.12:112069564:G:A
NM_032888.4(COL27A1):c.2089G>C (p.Gly697Arg)	COL27A1	G697R	Steel syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143245	9	116958257	9	114195977	143245	152977	rs140950220	NC_000009.12:114195976:G:C
NM_000890.5(KCNJ5):c.736G>A (p.Glu246Lys)	KCNJ5	E246K	Familial hyperaldosteronism type 3	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000135681	11	128781904	11	128912009	135681	139393	rs587777439	NC_000011.10:128912008:G:A
NM_000890.5(KCNJ5):c.470T>G (p.Ile157Ser)	KCNJ5	I157S	Familial hyperaldosteronism type 3	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000135680	11	128781638	11	128911743	135680	139392	rs587777438	NC_000011.10:128911742:T:G
NM_000890.5(KCNJ5):c.452G>A (p.Gly151Glu)	KCNJ5	G151E	Familial hyperaldosteronism type 3	Pathogenic(Last reviewed: Feb 14, 2012)	no assertion criteria provided	VCV000135679	11	128781620	11	128911725	135679	139391	rs587777437	NC_000011.10:128911724:G:A
NM_012144.4(DNAI1):c.1644G>A (p.Trp548Ter)	DNAI1	W548*, W552*	Primary ciliary dyskinesia|Kartagener syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000240854	9	34514466	9	34514468	240854	240612	rs200669099	NC_000009.12:34514467:G:A
NM_001083116.3(PRF1):c.50del (p.Leu17fs)	PRF1	L17fs	not provided|	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468305	10	72360609	10	70600853	468305	460250	rs147035858	NC_000010.11:70600852:A:
NM_213674.1(TPM2):c.14_16AGA[2] (p.Lys7del)	TPM2	K7del	not provided|Distal arthrogryposis type 1A|Nemaline myopathy 4	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000140486	9	35689793 - 35689795	9	35689796 - 35689798	140486	150164	rs199476146	NC_000009.12:35689795:TCTTCTTCTT:TCTTCTT
NM_014251.3(SLC25A13):c.1799dup (p.Tyr600Ter)	SLC25A13		Citrin deficiency|Neonatal intrahepatic cholestasis caused by citrin deficiency|Citrullinemia type II	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006006	7	95751008 - 95751009	7	96121696 - 96121697	6006	21045	rs80338726	NC_000007.14:96121696:T:TT
NM_014251.3(SLC25A13):c.1638_1660dup (p.Ala554fs)	SLC25A13		Neonatal intrahepatic cholestasis caused by citrin deficiency|not provided|Citrin deficiency|Citrullinemia type II	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006003	7	95751240 - 95751241	7	96121928 - 96121929	6003	21042	rs80338725	NC_000007.14:96121928:CCCGGGCAGCCACCTGTAATCTC:CCCGGGCAGCCACCTGTAATCTCCCCGGGCAGCCACCTGTAATCTC
NM_005502.4(ABCA1):c.6402-1G>T	ABCA1		not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000504124	9	107547921	9	104785640	504124	495620	rs1554696687	NC_000009.12:104785639:C:A
NM_005502.4(ABCA1):c.5038C>T (p.Arg1680Trp)	ABCA1	R1680W	Tangier disease, variant	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000009500	9	107560785	9	104798504	9500	24539	rs137854498	NC_000009.12:104798503:G:A
NM_005502.4(ABCA1):c.1719C>A (p.Tyr573Ter)	ABCA1	Y573*	Tangier disease	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000009505	9	107593379	9	104831098	9505	24544	rs137854502	NC_000009.12:104831097:G:T
NM_005502.4(ABCA1):c.3849_3852del (p.Pro1284fs)	ABCA1	P1284fs	Familial hypoalphalipoproteinemia	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000009504	9	107576448 - 107576451	9	104814167 - 104814170	9504	24543	rs387906415	NC_000009.12:104814166:CGGGCG:CG
NM_005502.4(ABCA1):c.3865G>A (p.Asp1289Asn)	ABCA1	D1229N, D1289N	Tangier disease	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000009503	9	107576435	9	104814154	9503	24542	rs137854500	NC_000009.12:104814153:C:T
NM_005502.4(ABCA1):c.6026T>C (p.Phe2009Ser)	ABCA1	F2009S	Familial hypoalphalipoproteinemia	Pathogenic(Last reviewed: May 21, 2002)	no assertion criteria provided	VCV000009502	9	107550750	9	104788469	9502	24541	rs137854499	NC_000009.12:104788468:A:G
NM_005502.4(ABCA1):c.3295G>T (p.Asp1099Tyr)	ABCA1	D1099Y	Familial hypoalphalipoproteinemia	Pathogenic(Last reviewed: May 21, 2002)	no assertion criteria provided	VCV000009501	9	107581111	9	104818830	9501	24540	rs28933692	NC_000009.12:104818829:C:A
NM_005502.4(ABCA1):c.2803A>C (p.Asn935His)	ABCA1	N935H	Tangier disease	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000009498	9	107584802	9	104822521	9498	24537	rs28937314	NC_000009.12:104822520:T:G
NM_005502.4(ABCA1):c.4517C>T (p.Ser1506Leu)	ABCA1	S1446L, S1506L	Tangier disease	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000009496	9	107566949	9	104804668	9496	24535	rs137854497	NC_000009.12:104804667:G:A
NM_005502.4(ABCA1):c.2725del (p.Arg909fs)	ABCA1	R909fs	Tangier disease	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000009495	9	107584880	9	104822599	9495	24534	rs1554714092	NC_000009.12:104822598:GG:G
NM_005502.4(ABCA1):c.6241C>T (p.Arg2081Trp)	ABCA1	R2021W, R2081W	Tangier disease	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000009494	9	107549221	9	104786940	9494	24533	rs137854501	NC_000009.12:104786939:G:A
NM_005502.4(ABCA1):c.3343_3344del (p.Ser1115fs)	ABCA1	S1115fs	Tangier disease	Pathogenic(Last reviewed: Oct 26, 1999)	no assertion criteria provided	VCV000009493	9	107581062 - 107581063	9	104818781 - 104818782	9493	24532	rs387906414	NC_000009.12:104818780:GAG:G
NM_005502.4(ABCA1):c.1584_1597delinsCGGGCGTGGTGGCAGGAGCTGTAATCCCAGCTACTTGGGAGGCTGAGGCACGAGAATCACTTGAACTCAGGAGGCAGAGGTTGCAGTGAGCTGAGGTCACGCCACTGTAC (p.Glu529_Trp533delinsGlyArgGlyGlyArgSerCysAsnProSerTyrLeuGlyGlyTer)	ABCA1		Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009492	9	107594021 - 107594034	9	104831740 - 104831753	9492	24531	rs796051873	
NM_005502.4(ABCA1):c.2810C>T (p.Ala937Val)	ABCA1	A877V, A937V	Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009489	9	107584795	9	104822514	9489	24528	rs137854495	NC_000009.12:104822513:G:A
NM_005502.4(ABCA1):c.2804A>G (p.Asn935Ser)	ABCA1	N875S, N935S	Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009488	9	107584801	9	104822520	9488	24527	rs28937313	NC_000009.12:104822519:T:C
NM_005502.4(ABCA1):c.1824del (p.Thr609fs)	ABCA1	T609fs	Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009487	9	107593274	9	104830993	9487	24526	rs387906413	NC_000009.12:104830992:C:
NM_005502.4(ABCA1):c.1790A>G (p.Gln597Arg)	ABCA1	Q537R, Q597R	Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009485	9	107593308	9	104831027	9485	24524	rs2853578	NC_000009.12:104831026:T:C
NM_005502.4(ABCA1):c.3738+1G>C	ABCA1		Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009484	9	107578423	9	104816142	9484	24523	rs796051872	NC_000009.12:104816141:C:G
NM_005502.4(ABCA1):c.4429T>C (p.Cys1477Arg)	ABCA1	C1417R, C1477R	Tangier disease	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009483	9	107568557	9	104806276	9483	24522	rs137854494	NC_000009.12:104806275:A:G
NM_004629.1(FANCG):c.1642C>T (p.Arg548Ter)	FANCG	R548*	Fanconi anemia	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000574728	9	35074486	9	35074489	574728	569012	rs779834525	NC_000009.12:35074488:G:A
NM_000019.4(ACAT1):c.814C>T (p.Gln272Ter)	ACAT1	Q272*	Deficiency of acetyl-CoA acetyltransferase|not provided	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002840	11	108012415	11	108141688	2840	17879	rs120074144	NC_000011.10:108141687:C:T
NM_005502.4(ABCA1):c.2077_2079CTT[1] (p.Leu694del)	ABCA1	L694del	Familial hypoalphalipoproteinemia	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009486	9	107591230 - 107591232	9	104828949 - 104828951	9486	24525	rs387906412	NC_000009.12:104828948:AAGAAGA:AAGA
NM_024649.5(BBS1):c.345dup (p.Lys116Ter)	BBS1		Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555614	11	66282061 - 66282062	11	66514590 - 66514591	555614	546589	rs1555046611	NC_000011.10:66514590:T:TT
NM_024649.5(BBS1):c.223_224del (p.Leu75fs)	BBS1	L75fs	Retinal dystrophy|Bardet-Biedl syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370389	11	66281940 - 66281941	11	66514469 - 66514470	370389	358035	rs1057516451	NC_000011.10:66514468:CT:
NM_001258392.3(CLPB):c.1132A>G (p.Arg378Gly)	CLPB	R408G, R378G, R349G, R363G	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187785	11	72013383	11	72302339	187785	185683	rs144078282	NC_000011.10:72302338:T:C
NM_006019.4(TCIRG1):c.971dup (p.Cys324fs)	TCIRG1		not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000618414	11	67811761 - 67811762	11	68044294 - 68044295	618414	609807	rs1565156743	NC_000011.10:68044294:G:GG
NM_006019.4(TCIRG1):c.292C>T (p.Gln98Ter)	TCIRG1	Q98*	not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000499143	11	67810205	11	68042738	499143	490567	rs1554995115	NC_000011.10:68042737:C:T
NM_006019.4(TCIRG1):c.703dup (p.Ile235fs)	TCIRG1		not provided	Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000497723	11	67811109 - 67811110	11	68043642 - 68043643	497723	489147	rs1554995715	NC_000011.10:68043642:A:AA
NM_006019.4(TCIRG1):c.1249del (p.Ala417fs)	TCIRG1	A201fs, A119fs, A417fs	not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000862182	11	67814983	11	68047516	862182	838871		NC_000011.10:68047515:G:
NM_006019.4(TCIRG1):c.907dup (p.Tyr303fs)	TCIRG1		not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000852441	11	67811697 - 67811698	11	68044230 - 68044231	852441	838870		NC_000011.10:68044230:T:TT
NC_000011.10:g.(?_68039120)_(68041841_?)del	TCIRG1		not provided	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000833178	11	67806587 - 67809308			833178	820411		
NM_006019.4(TCIRG1):c.1114C>T (p.Gln372Ter)	TCIRG1	Q156*, Q372*, Q74*		Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830066	11	67812518	11	68045051	830066	818395		NC_000011.10:68045050:C:T
NM_006019.4(TCIRG1):c.2066G>A (p.Trp689Ter)	TCIRG1	W391*, W689*, W473*	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000658416	11	67817481	11	68050014	658416	640390		NC_000011.10:68050013:G:A
NM_006019.3(TCIRG1):c.649_674del (p.Met217Terfs)	TCIRG1			Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000005465	11	67811056 - 67811081	11	68043587 - 68043612	5465	20504		NC_000011.10:68043586:GGATGACCTTCCTCATCTCCTACTGGGG:GG
NM_006019.4(TCIRG1):c.1331G>T (p.Arg444Leu)	TCIRG1	R444L, R228L, R146L		Pathogenic(Last reviewed: Aug 15, 2001)	no assertion criteria provided	VCV000005464	11	67815139	11	68047672	5464	20503	rs137853151	NC_000011.10:68047671:G:T
NM_006019.4(TCIRG1):c.1674G>A (p.Val558=)	TCIRG1			Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005461	11	67816548	11	68049081	5461	20500	rs745971874	NC_000011.10:68049080:G:A
NM_006019.4(TCIRG1):c.1392C>A (p.Cys464Ter)	TCIRG1	C464*, C248*, C166*		Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005460	11	67815200	11	68047733	5460	20499	rs137853149	NC_000011.10:68047732:C:A
NM_006019.4(TCIRG1):c.922del (p.Gln308fs)	TCIRG1	Q308fs, Q92fs, Q10fs		Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005459	11	67811712	11	68044245	5459	20498	rs1554996130	NC_000011.10:68044244:CC:C
NM_007055.4(POLR3A):c.3337-5T>A	POLR3A		not provided|Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432594	10	79743775	10	77984017	432594	425890	rs368905417	NC_000010.11:77984016:A:T
NM_006019.4(TCIRG1):c.1276C>T (p.Arg426Ter)	TCIRG1	R426*, R128*, R210*		Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000557398	11	67815010	11	68047543	557398	546894	rs1489993984	NC_000011.10:68047542:C:T
NM_006019.4(TCIRG1):c.630+2T>C	TCIRG1			Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000551426	11	67810966	11	68043499	551426	546862	rs1392364437	NC_000011.10:68043498:T:C
NM_006019.4(TCIRG1):c.346C>T (p.Gln116Ter)	TCIRG1	Q116*	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552835	11	67810259	11	68042792	552835	546622	rs1338631330	NC_000011.10:68042791:C:T
NM_006019.4(TCIRG1):c.1213G>C (p.Gly405Arg)	TCIRG1	G405R, G107R, G189R		Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552227	11	67814947	11	68047480	552227	546514	rs137853150	NC_000011.10:68047479:G:C
NM_000288.4(PEX7):c.694C>T (p.Arg232Ter)	PEX7	R232*	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|not provided	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007783	6	137191088	6	136869950	7783	22822	rs121909153	NC_000006.12:136869949:C:T
NM_001033855.3(DCLRE1C):c.206T>A (p.Leu69Ter)	DCLRE1C	L69*	Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802564	10	14987144	10	14945145	802564	790954		NC_000010.11:14945144:A:T
NM_001033855.3(DCLRE1C):c.628del (p.Tyr210fs)	DCLRE1C	Y210fs, Y95fs, Y90fs	Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000861704	10	14976429	10	14934430	861704	836719		NC_000010.11:14934429:AA:A
NM_001033855.3(DCLRE1C):c.352G>T (p.Gly118Ter)	DCLRE1C	G118*	Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000852821	10	14978547	10	14936548	852821	836721		NC_000010.11:14936547:C:A
NM_001033855.3(DCLRE1C):c.481dup (p.Ser161fs)	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852427	10	14976757 - 14976758	10	14934758 - 14934759	852427	836720		NC_000010.11:14934758:TTT:TTTT
NM_001033855.3(DCLRE1C):c.754C>T (p.Gln252Ter)	DCLRE1C	Q132*, Q252*, Q137*	Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000666082	10	14974879	10	14932880	666082	638790		NC_000010.11:14932879:G:A
NM_001033855.3(DCLRE1C):c.449dup (p.His151fs)	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000664358	10	14977476 - 14977477	10	14935477 - 14935478	664358	638797		NC_000010.11:14935477:A:AA
NC_000010.10:g.(?_14981799)_(14987198_?)del	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000660671	10	14981799 - 14987198	10	14939800 - 14945199	660671	651954		
NM_001033855.3(DCLRE1C):c.522C>G (p.Tyr174Ter)	DCLRE1C	Y59*, Y174*, Y54*	Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000657472	10	14976717	10	14934718	657472	638794		NC_000010.11:14934717:G:C
NC_000010.10:g.(?_14977442)_(14978612_?)del	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000649069	10	14977442 - 14978612	10	14935443 - 14936613	649069	652095		
NM_001033855.3(DCLRE1C):c.194C>T (p.Thr65Ile)	DCLRE1C	T65I	Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000254217	10	14987156	10	14945157	254217	248738	rs886037925	NC_000010.11:14945156:G:A
NM_001033855.3(DCLRE1C):c.1669dup (p.Thr557fs)	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000254216	10	14950816 - 14950817	10	14908817 - 14908818	254216	248737	rs886037924	NC_000010.11:14908817:T:TT
NM_001033855.3(DCLRE1C):c.2T>C (p.Met1Thr)	DCLRE1C	M1T	Histiocytic medullary reticulosis	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000004677	10	14996008	10	14954009	4677	19716	rs121908158	NC_000010.11:14954008:A:G
DCLRE1C, 17-BP DEL	DCLRE1C		Severe combined immunodeficiency, partial	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000004676					4676	19715		
DCLRE1C, EX5-8DEL	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004672					4672	19711		
NM_001033855.3(DCLRE1C):c.780+1del	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004671	10	14974852	10	14932853	4671	19710	rs786205074	NC_000010.11:14932852:CC:C
NM_001033855.3(DCLRE1C):c.362+1G>T	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004670	10	14978536	10	14936537	4670	19709	rs1564446526	NC_000010.11:14936536:C:A
NM_001033855.3(DCLRE1C):c.917+1G>A	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004669	10	14970014	10	14928015	4669	19708	rs1564418254	NC_000010.11:14928014:C:T
NM_001033855.3(DCLRE1C):c.972+1G>C	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004668	10	14968841	10	14926842	4668	19707	rs1564414523	NC_000010.11:14926841:C:G
DCLRE1C, EX5-6DEL	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004667					4667	19706		
DCLRE1C, EX1-4DEL	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 20, 2001)	no assertion criteria provided	VCV000004666					4666	19705		
NC_000010.11:g.(?_14945095)_(14945199_?)del	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000831845	10	14987094 - 14987198			831845	820199		
NC_000010.10:g.(?_14987084)_(14987208_?)del	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000584297	10	14987084 - 14987208	10	14945085 - 14945209	584297	564410		
NC_000010.10:g.(?_14987084)_(14996029_?)del	DCLRE1C		Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000583822	10	14987084 - 14996029	10	14945085 - 14954030	583822	566107		
NM_006019.4(TCIRG1):c.1891del (p.Val631fs)	TCIRG1	V415fs, V631fs, V333fs	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555837	11	67817132	11	68049665	555837	546656	rs1300297240	NC_000011.10:68049664:GG:G
NM_006019.4(TCIRG1):c.2236C>T (p.Gln746Ter)	TCIRG1	Q746*, Q448*, Q530*		Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553240	11	67817721	11	68050254	553240	546525	rs748659068	NC_000011.10:68050253:C:T
NM_006019.4(TCIRG1):c.1118del (p.Gly373fs)	TCIRG1	G157fs, G75fs, G373fs	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552720	11	67812520	11	68045053	552720	546893	rs1269558164	NC_000011.10:68045052:GGG:GG
NM_006019.4(TCIRG1):c.979C>T (p.Arg327Ter)	TCIRG1	R327*, R29*, R111*	|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550832	11	67811770	11	68044303	550832	546884	rs749361897	NC_000011.10:68044302:C:T
NM_006019.4(TCIRG1):c.1213G>A (p.Gly405Arg)	TCIRG1	G405R, G107R, G189R		Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000005463	11	67814947	11	68047480	5463	20502	rs137853150	NC_000011.10:68047479:G:A
NM_024649.5(BBS1):c.17dup (p.Ser7fs)	BBS1		Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412283	11	66278146 - 66278147	11	66510675 - 66510676	412283	398446	rs1166022838	NC_000011.10:66510675:C:CC
NM_004999.4(MYO6):c.458C>G (p.Ser153Ter)	MYO6	S153*	Rare genetic deafness	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000228376	6	76542625	6	75832908	228376	229510	rs876657710	NC_000006.12:75832907:C:G
NM_000217.3(KCNA1):c.763A>G (p.Asn255Asp)	KCNA1	N255D	Myokymia 1 with hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000013494	12	5021307	12	4912141	13494	28533	rs121918067	NC_000012.12:4912140:A:G
NM_000217.3(KCNA1):c.677C>A (p.Thr226Lys)	KCNA1	T226K	Myokymia 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000013493	12	5021221	12	4912055	13493	28532	rs28933383	NC_000012.12:4912054:C:A
NM_000217.3(KCNA1):c.731C>A (p.Pro244His)	KCNA1	P244H	Myokymia 1	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000013490	12	5021275	12	4912109	13490	28529	rs28933382	NC_000012.12:4912108:C:A
NM_000217.3(KCNA1):c.1214C>T (p.Pro405Leu)	KCNA1	P405L	not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000447609	12	5021758	12	4912592	447609	441557	rs1555085798	NC_000012.12:4912591:C:T
NM_005502.4(ABCA1):c.1759C>T (p.Arg587Trp)	ABCA1	R587W	ABCA1-Related Disorders	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000632033	9	107593339	9	104831058	632033	620315	rs2853574	NC_000009.12:104831057:G:A
NM_005502.4(ABCA1):c.5192C>G (p.Ser1731Cys)	ABCA1	S1731C	Familial hypoalphalipoproteinemia	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000632032	9	107558635	9	104796354	632032	620314	rs760507032	NC_000009.12:104796353:G:C
NG_007981.1:g.[101177_102434delins36;107248_127198delins21]	ABCA1		Tangier disease	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000009499					9499	24538		
NM_000048.4(ASL):c.1255_1256del (p.Leu419fs)	ASL	L419fs, L393fs, L399fs	Argininosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555167	7	65557759 - 65557760	7	66092772 - 66092773	555167	544590	rs757109353	NC_000007.14:66092771:CT:
NM_000217.3(KCNA1):c.677C>T (p.Thr226Met)	KCNA1	T226M	Episodic ataxia type 1	Pathogenic(Last reviewed: Aug 16, 2012)	no assertion criteria provided	VCV000021127	12	5021221	12	4912055	21127	33979	rs28933383	NC_000012.12:4912054:C:T
NM_000217.3(KCNA1):c.530T>A (p.Ile177Asn)	KCNA1	I177N	Episodic ataxia type 1	Pathogenic(Last reviewed: Oct 29, 2018)	no assertion criteria provided	VCV000013488	12	5021074	12	4911908	13488	28527	rs267607195	NC_000012.12:4911907:T:A
NM_170606.3(KMT2C):c.1829_1830del (p.Thr610fs)	KMT2C	T610fs	not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000817245	7	151945689 - 151945690	7	152248604 - 152248605	817245	805534		NC_000007.14:152248603:TGT:T
NM_001040716.2(PC):c.229C>T (p.Arg77Trp)	PC	R77W	Congenital lactic acidosis	Pathogenic	no assertion criteria provided	VCV000812772	11	66639250	11	66871779	812772	801127		NC_000011.10:66871778:G:A
NM_001040716.2(PC):c.2306A>T (p.His769Leu)	PC	H769L	Congenital lactic acidosis	Pathogenic	no assertion criteria provided	VCV000812771	11	66618312	11	66850841	812771	801126		NC_000011.10:66850840:T:A
NM_033100.4(CDHR1):c.1485+2T>G	CDHR1		Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812262	10	85970923	10	84211167	812262	800693		NC_000010.11:84211166:T:G
NM_033100.4(CDHR1):c.1381C>T (p.Gln461Ter)	CDHR1	Q461*	Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812261	10	85970817	10	84211061	812261	800559		NC_000010.11:84211060:C:T
NM_170606.3(KMT2C):c.1951_1952del (p.Glu651fs)	KMT2C	E651fs	Kleefstra syndrome 2	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000807440	7	151945567 - 151945568	7	152248482 - 152248483	807440	798583		NC_000007.14:152248481:TCT:T
NM_033100.4(CDHR1):c.1782+1del	CDHR1		Cone-rod dystrophy 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802596	10	85972163	10	84212407	802596	790990		NC_000010.11:84212406:GG:G
NM_170606.3(KMT2C):c.10213C>T (p.Arg3405Ter)	KMT2C	R3405*	not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000620513	7	151860449	7	152163364	620513	611678	rs1485613651	NC_000007.14:152163363:G:A
NM_012330.4(KAT6B):c.457C>T (p.Arg153Ter)	KAT6B	R153*	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000620483	10	76603072	10	74843314	620483	611735	rs1564516087	NC_000010.11:74843313:C:T
NM_012330.4(KAT6B):c.282del (p.Ser95fs)	KAT6B	S95fs	not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000561960	10	76602894	10	74843136	561960	552621	rs1564515829	NC_000010.11:74843135:GGGG:GGG
NM_012330.4(KAT6B):c.3118C>T (p.Gln1040Ter)	KAT6B	Q1040*, Q748*, Q259*, Q857*, Q685*, Q694*, Q345*, Q477*	not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000561859	10	76781735	10	75021977	561859	552632	rs1564625942	NC_000010.11:75021976:C:T
NM_012330.4(KAT6B):c.3253del (p.Glu1085fs)	KAT6B	E1085fs, E304fs, E390fs, E730fs, E739fs, E902fs, E793fs, E522fs	not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000524091	10	76781869	10	75022111	524091	514613	rs1554843880	NC_000010.11:75022110:GG:G
NM_012330.4(KAT6B):c.3172C>T (p.Arg1058Ter)	KAT6B	R1058*, R277*, R495*, R712*, R363*, R703*, R766*, R875*	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000523902	10	76781789	10	75022031	523902	514612	rs1554843815	NC_000010.11:75022030:C:T
NM_170606.3(KMT2C):c.8390dup (p.Glu2798fs)	KMT2C		not provided	Pathogenic(Last reviewed: Aug 18, 2018)	criteria provided, single submitter	VCV000504224	7	151874147 - 151874148	7	152177062 - 152177063	504224	495317	rs747256476	NC_000007.14:152177062:TTTTTTTTT:TTTTTTTTTT
NM_012330.4(KAT6B):c.3349C>T (p.Gln1117Ter)	KAT6B	Q1117*, Q762*, Q771*, Q934*, Q336*, Q422*, Q554*, Q825*	not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000450178	10	76781966	10	75022208	450178	444652	rs1554843977	NC_000010.11:75022207:C:T
NM_012330.4(KAT6B):c.3286G>T (p.Glu1096Ter)	KAT6B	E1096*, E315*, E401*, E750*, E804*, E533*, E913*, E741*	not provided	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000424129	10	76781903	10	75022145	424129	407914	rs770674400	NC_000010.11:75022144:G:T
NM_012330.4(KAT6B):c.708_709del (p.Ala238fs)	KAT6B	A238fs, L57fs	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000422921	10	76719814 - 76719815	10	74960056 - 74960057	422921	407912	rs1064796095	NC_000010.11:74960055:TT:
NM_012330.4(KAT6B):c.3401del (p.Gly1134fs)	KAT6B	G439fs, G788fs, G571fs, G779fs, G842fs, G1134fs, G353fs, G951fs	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000422790	10	76784741	10	75024983	422790	407915	rs1064796000	NC_000010.11:75024982:GGGG:GGG
NM_170606.3(KMT2C):c.5101_5102AG[1] (p.Arg1701fs)	KMT2C		not provided	Pathogenic(Last reviewed: Jul 19, 2015)	criteria provided, single submitter	VCV000419269	7	151880220 - 151880221	7	152183135 - 152183136	419269	407077	rs1064793759	NC_000007.14:152183134:CTCT:CT
NM_012330.4(KAT6B):c.3021+1G>T	KAT6B		not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000391816	10	76781044	10	75021286	391816	370892	rs1057524241	NC_000010.11:75021285:G:T
NM_033100.4(CDHR1):c.863-1G>A	CDHR1		not provided	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000280752	10	85965582	10	84205826	280752	264374	rs886041900	NC_000010.11:84205825:G:A
NM_170606.3(KMT2C):c.5409_5413dup (p.Gly1805fs)	KMT2C		not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000280488	7	151879531 - 151879532	7	152182446 - 152182447	280488	264317	rs886041682	NC_000007.14:152182446:CACTAC:CACTACACTAC
NM_012330.4(KAT6B):c.3495_3496AG[2] (p.Arg1167fs)	KAT6B		not provided	Pathogenic(Last reviewed: Feb 27, 2016)	criteria provided, single submitter	VCV000280311	10	76784838 - 76784839	10	75025080 - 75025081	280311	264361	rs886041540	NC_000010.11:75025079:AGAGAG:AGAG
NM_012330.4(KAT6B):c.257del (p.Gly86fs)	KAT6B	G86fs	not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000265697	10	76602871	10	74843113	265697	259939	rs886039742	NC_000010.11:74843112:GG:G
NM_001040716.2(PC):c.797C>A (p.Ser266Tyr)	PC	S266Y	not provided	Pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	VCV000203922	11	66637879	11	66870408	203922	200207	rs796052030	NC_000011.10:66870407:G:T
NM_170606.3(KMT2C):c.6216T>G (p.Tyr2072Ter)	KMT2C	Y2072*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000852178	7	151878729	7	152181644	852178	833377		NC_000007.14:152181643:A:C
NM_033100.4(CDHR1):c.782del (p.Pro261fs)	CDHR1	P261fs	not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000838072	10	85962877	10	84203121	838072	837346		NC_000010.11:84203120:CC:C
NM_012330.4(KAT6B):c.3477_3480dup (p.Asp1161delinsLeuTer)	KAT6B		Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000807618	10	76784819 - 76784820	10	75025061 - 75025062	807618	798627		NC_000010.11:75025061:CTTT:CTTTCTTT
NM_012330.4(KAT6B):c.3041_3042del (p.Gln1014fs)	KAT6B	Q1014fs, Q319fs, Q659fs, Q451fs, Q668fs, Q722fs, Q233fs, Q831fs	Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807617	10	76781658 - 76781659	10	75021900 - 75021901	807617	798626		NC_000010.11:75021899:AA:
NM_170606.3(KMT2C):c.8026C>T (p.Gln2676Ter)	KMT2C	Q2676*	KMT2C-related condition	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000804252	7	151874512	7	152177427	804252	792603		NC_000007.14:152177426:G:A
NM_012330.4(KAT6B):c.1864C>T (p.Arg622Ter)	KAT6B	R622*	Autosomal dominant KAT6B-related disorders	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000692078	10	76735959	10	74976201	692078	679772		NC_000010.11:74976200:C:T
NM_170606.3(KMT2C):c.3462del (p.Leu1155_Val1156insTer)	KMT2C		Kleefstra syndrome due to a point mutation	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000667417	7	151919123	7	152222038	667417	654481		NC_000007.14:152222037:T:
NM_170606.3(KMT2C):c.1185-20_1185-7del	KMT2C		not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000633536	7	151960222 - 151960235	7	152263137 - 152263150	633536	622008	rs1563639759	NC_000007.14:152263136:AATAAGATAGCATTAAT:AAT
NM_198075.4(LRRC56):c.326+1G>A	LRRC56		CILIARY DYSKINESIA, PRIMARY, 39	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599213	11	544781	11	544781	599213	590435	rs1564800859	NC_000011.10:544780:G:A
NM_198075.4(LRRC56):c.760G>T (p.Glu254Ter)	LRRC56	E254*	CILIARY DYSKINESIA, PRIMARY, 39	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599212	11	551266	11	551266	599212	590434	rs372959912	NC_000011.10:551265:G:T
NM_198075.4(LRRC56):c.419T>C (p.Leu140Pro)	LRRC56	L140P	CILIARY DYSKINESIA, PRIMARY, 39	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599211	11	549994	11	549994	599211	590433	rs1564805039	NC_000011.10:549993:T:C
NM_198075.4(LRRC56):c.423+1G>A	LRRC56		CILIARY DYSKINESIA, PRIMARY, 39	Pathogenic(Last reviewed: Dec 21, 2018)	no assertion criteria provided	VCV000599210	11	549999	11	549999	599210	590432	rs1564805053	NC_000011.10:549998:G:A
NM_170606.3(KMT2C):c.10812_10815del (p.Lys3605fs)	KMT2C	K3605fs	Kleefstra syndrome 2	Pathogenic(Last reviewed: Nov 14, 2017)	no assertion criteria provided	VCV000446226	7	151859847 - 151859850	7	152162762 - 152162765	446226	439607	rs1554477105	NC_000007.14:152162761:TTTCTTT:TTT
NM_170606.3(KMT2C):c.5216del (p.Pro1739fs)	KMT2C	P1739fs	Kleefstra syndrome 2	Pathogenic(Last reviewed: Nov 14, 2017)	no assertion criteria provided	VCV000446223	7	151880108	7	152183023	446223	439604	rs1554505381	NC_000007.14:152183022:GG:G
NM_033100.4(CDHR1):c.838C>T (p.Arg280Ter)	CDHR1	R280*	not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000844427	10	85964337	10	84204581	844427	837348		NC_000010.11:84204580:C:T
NM_012330.4(KAT6B):c.2299C>T (p.His767Tyr)	KAT6B	H126Y, H412Y, H475Y, H584Y, H767Y	Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Dec 26, 2019)	no assertion criteria provided	VCV000828179	10	76741612	10	74981854	828179	816515		NC_000010.11:74981853:C:T
NM_012330.4(KAT6B):c.2408_2412del (p.Asn803fs)	KAT6B	N511fs, N448fs, N803fs, N620fs	KBG syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000620054	10	76744872 - 76744876	10	74985114 - 74985118	620054	611404	rs1564606246	NC_000010.11:74985113:ACCTT:
NM_001040716.2(PC):c.368_371AGCG[1] (p.Ala125fs)	PC		Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000575715	11	66638898 - 66638901	11	66871427 - 66871430	575715	570902	rs1565245427	NC_000011.10:66871426:CGCTCGCTC:CGCTC
NM_012330.4(KAT6B):c.3216del (p.Glu1073fs)	KAT6B	E378fs, E727fs, E718fs, E781fs, E292fs, E510fs, E890fs, E1073fs	Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000438296	10	76781832	10	75022074	438296	431920	rs1554843829	NC_000010.11:75022073:AA:A
NM_001040716.2(PC):c.1357C>T (p.Arg453Ter)	PC	R453*	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000436166	11	66631256	11	66863785	436166	429287	rs768514713	NC_000011.10:66863784:G:A
NM_001040716.2(PC):c.796T>A (p.Ser266Thr)	PC	S266T	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000021230	11	66637880	11	66870409	21230	34082	rs113994142	NC_000011.10:66870408:A:T
NM_001040716.2(PC):c.3409_3410del (p.Leu1137fs)	PC	L1137fs	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000021229	11	66616497 - 66616498	11	66849026 - 66849027	21229	34081	rs113994148	NC_000011.10:66849025:AG:
NM_001040716.2(PC):c.2540C>T (p.Ala847Val)	PC	A847V	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000021226	11	66617869	11	66850398	21226	34078	rs113994147	NC_000011.10:66850397:G:A
NM_001040716.2(PC):c.2114C>A (p.Ser705Ter)	PC	S705*	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000021223	11	66618620	11	66851149	21223	34075	rs113994146	NC_000011.10:66851148:G:T
NM_001040716.2(PC):c.184C>T (p.Arg62Cys)	PC	R62C	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000021221	11	66639295	11	66871824	21221	34073	rs113994141	NC_000011.10:66871823:G:A
NM_001040716.2(PC):c.1705A>G (p.Thr569Ala)	PC	T569A	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000021220	11	66620030	11	66852559	21220	34072	rs113994144	NC_000011.10:66852558:T:C
NM_001040716.2(PC):c.2876dup (p.Glu961fs)	PC		Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000002102	11	66617429 - 66617430	11	66849958 - 66849959	2102	17141	rs1565209327	NC_000011.10:66849958:AA:AAA
NM_001040716.2(PC):c.1748G>T (p.Arg583Leu)	PC	R583L	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000002101	11	66619987	11	66852516	2101	17140	rs119103242	NC_000011.10:66852515:C:A
PC, 2-BP DEL, 2491GT	PC		Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000002099					2099	17138		
PC, IVS15, 4-BP DEL, TAGG, +2-5	PC		Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000002098					2098	17137		
NM_000217.3(KCNA1):c.724G>C (p.Ala242Pro)	KCNA1	A242P	not provided|Myokymia 1	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000013489	12	5021268	12	4912102	13489	28528	rs28933381	NC_000012.12:4912101:G:C
NM_000217.3(KCNA1):c.1210G>A (p.Val404Ile)	KCNA1	V404I	Episodic ataxia type 1	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000013487	12	5021754	12	4912588	13487	28526	rs104894355	NC_000012.12:4912587:G:A
NM_000217.3(KCNA1):c.676A>G (p.Thr226Ala)	KCNA1	T226A	Episodic ataxia type 1	Pathogenic(Last reviewed: Oct 29, 2018)	no assertion criteria provided	VCV000013486	12	5021220	12	4912054	13486	28525	rs104894354	NC_000012.12:4912053:A:G
NM_003977.4(AIP):c.40C>T (p.Gln14Ter)	AIP	Q14*	Pituitary adenoma predisposition|Somatotroph adenoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000004886	11	67250669	11	67483198	4886	19925	rs104894194	NC_000011.10:67483197:C:T
NM_001171971.3(CDHR1):c.2087_2090del (p.Thr696fs)	CDHR1	T696fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812263	10	85978879 - 85978882	10	84219123 - 84219126	812263	800560		NC_000010.11:84219122:AACAAA:AA
NM_033100.4(CDHR1):c.1A>T (p.Met1Leu)	CDHR1	M1L	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812258	10	85954517	10	84194761	812258	800556		NC_000010.11:84194760:A:T
NM_170606.3(KMT2C):c.560C>G (p.Ser187Ter)	KMT2C	S187*	Intellectual disability	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561045	7	152012253	7	152315168	561045	552115	rs1563831738	NC_000007.14:152315167:G:C
NM_012330.4(KAT6B):c.3581del (p.Gln1194fs)	KAT6B	Q1011fs, Q1194fs, Q499fs, Q848fs, Q902fs, Q413fs, Q631fs, Q839fs	Genitopatellar syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561036	10	76784924	10	75025166	561036	552145	rs1564628365	NC_000010.11:75025165:A:
NM_001040716.2(PC):c.2491_2492GT[1] (p.Val831_Phe832insTer)	PC		Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000556347	11	66617915 - 66617916	11	66850444 - 66850445	556347	546484	rs756355930	NC_000011.10:66850443:ACAC:AC
NM_001040716.2(PC):c.2668G>T (p.Val890Phe)	PC	V890F	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000487339	11	66617741	11	66850270	487339	480411	rs1555014957	NC_000011.10:66850269:C:A
NM_012330.4(KAT6B):c.3664+1G>A	KAT6B		Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000369663	10	76785008	10	75025250	369663	353900	rs1057516033	NC_000010.11:75025249:G:A
NM_033100.4(CDHR1):c.338del (p.Gly113fs)	CDHR1	G113fs	Retinitis pigmentosa 65|Retinal dystrophy	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000037292	10	85957581	10	84197825	37292	45865	rs747425652	NC_000010.11:84197824:GG:G
NM_000322.5(PRPH2):c.774_775del (p.Tyr258_Ser259delinsTer)	PRPH2		Retinal dystrophy	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000866423	6	42672156 - 42672157	6	42704418 - 42704419	866423	856449		NC_000006.12:42704417:TGT:T
NM_000322.5(PRPH2):c.934del (p.Val312fs)	PRPH2	V312fs	Retinal dystrophy	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000865787	6	42666140	6	42698402	865787	856445		NC_000006.12:42698401:C:
NM_000322.5(PRPH2):c.707dup (p.Tyr236Ter)	PRPH2		not provided	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000816994	6	42672223 - 42672224	6	42704485 - 42704486	816994	805502		NC_000006.12:42704485:T:TT
NM_000322.5(PRPH2):c.227C>A (p.Ser76Ter)	PRPH2	S76*	Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802215	6	42689846	6	42722108	802215	790630		NC_000006.12:42722107:G:T
NM_000322.5(PRPH2):c.737G>A (p.Trp246Ter)	PRPH2	W246*	Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802214	6	42672194	6	42704456	802214	790629		NC_000006.12:42704455:C:T
NM_000322.5(PRPH2):c.303C>G (p.Tyr101Ter)	PRPH2	Y101*	not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419667	6	42689770	6	42722032	419667	406871	rs61755776	NC_000006.12:42722031:G:C
NM_000322.5(PRPH2):c.748T>A (p.Cys250Ser)	PRPH2	C250S	not provided	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000419521	6	42672183	6	42704445	419521	406868	rs1064793931	NC_000006.12:42704444:A:T
NM_000322.5(PRPH2):c.290G>A (p.Trp97Ter)	PRPH2	W97*	PRPH2-Related Disorders	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000861236	6	42689783	6	42722045	861236	831964		NC_000006.12:42722044:C:T
NM_000322.5(PRPH2):c.237dup (p.Lys80fs)	PRPH2		PRPH2-Related Disorders	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000860621	6	42689835 - 42689836	6	42722097 - 42722098	860621	831965		NC_000006.12:42722097:CCC:CCCC
NM_000322.5(PRPH2):c.148del (p.Asp50fs)	PRPH2	D50fs	PRPH2-Related Disorders	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000856260	6	42689925	6	42722187	856260	831966		NC_000006.12:42722186:C:
NM_000322.5(PRPH2):c.314_315GT[1] (p.Val106fs)	PRPH2		Macular dystrophy, vitelliform, adult-onset	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000599068	6	42689756 - 42689757	6	42722018 - 42722019	599068	590281	rs1562434117	NC_000006.12:42722017:ACACA:ACA
NM_000322.5(PRPH2):c.418_421dup (p.Tyr141fs)	PRPH2		Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000013174	6	42689651 - 42689652	6	42721913 - 42721914	13174	28213	rs672601326	NC_000006.12:42721913:AGTA:AGTAAGTA
PRPH2, 2-BP DEL	PRPH2		Retinitis punctata albescens, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000013166					13166	28205		
NM_000322.5(PRPH2):c.259_266del (p.Asp87fs)	PRPH2	D87fs	Retinal dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000437964	6	42689807 - 42689814	6	42722069 - 42722076	437964	431695	rs1554270834	NC_000006.12:42722068:GCTGGGTC:
NM_000322.5(PRPH2):c.441del (p.Gly148fs)	PRPH2	G148fs	not provided|maculopathy	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000098668	6	42689632	6	42721894	98668	104558	rs61755784	NC_000006.12:42721893:A:
NM_000322.5(PRPH2):c.774C>A (p.Tyr258Ter)	PRPH2	Y258*	Macular dystrophy, vitelliform, adult-onset	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000013168	6	42672157	6	42704419	13168	28207	rs121918564	NC_000006.12:42704418:G:T
NM_012330.4(KAT6B):c.3606_3609del (p.Thr1203fs)	KAT6B	T848fs, T857fs, T1020fs, T1203fs, T422fs, T508fs, T640fs, T911fs	Genitopatellar syndrome|Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689768	10	76784946 - 76784949	10	75025188 - 75025191	689768	677431		NC_000010.11:75025187:ACAAACA:ACA
NM_033100.4(CDHR1):c.1463del (p.Gly488fs)	CDHR1	G488fs	Retinal dystrophy|Retinitis pigmentosa 65	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438116	10	85970895	10	84211139	438116	431741	rs756678484	NC_000010.11:84211138:GGGGG:GGGG
NM_012330.4(KAT6B):c.3018del (p.Glu1007fs)	KAT6B	E312fs, E715fs, E652fs, E824fs, E1007fs, E226fs, E444fs, E661fs	not provided|Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Nov 11, 2011)	no assertion criteria provided	VCV000030527	10	76781038	10	75021280	30527	39484	rs199470468	NC_000010.11:75021279:AAA:AA
NM_001040716.2(PC):c.1351C>T (p.Arg451Cys)	PC	R451C	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000002097	11	66631262	11	66863791	2097	17136	rs113994143	NC_000011.10:66863790:G:A
NM_001040716.2(PC):c.434T>C (p.Val145Ala)	PC	V145A	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000002096	11	66638839	11	66871368	2096	17135	rs28940591	NC_000011.10:66871367:A:G
NM_001040716.2(PC):c.2229G>T (p.Met743Ile)	PC	M743I	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000002095	11	66618389	11	66850918	2095	17134	rs28940590	NC_000011.10:66850917:C:A
NM_001040716.2(PC):c.1828G>A (p.Ala610Thr)	PC	A610T	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Jul 21, 2011)	no assertion criteria provided	VCV000002094	11	66619415	11	66851944	2094	17133	rs28940589	NC_000011.10:66851943:C:T
NM_000322.5(PRPH2):c.497G>A (p.Cys166Tyr)	PRPH2	C166Y	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000191208	6	42689576	6	42721838	191208	189011	rs786205579	NC_000006.12:42721837:C:T
NM_000322.5(PRPH2):c.584G>T (p.Arg195Leu)	PRPH2	R195L	not provided|Choroidal dystrophy, central areolar 2	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000013182	6	42672347	6	42704609	13182	28221	rs121918567	NC_000006.12:42704608:C:A
PRPH2, 1-BP DEL, 1160T	PRPH2		Retinitis pigmentosa 7	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000013180					13180	28219		
NM_000322.5(PRPH2):c.897_898del (p.Ser301fs)	PRPH2	S301fs	not provided|Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000013171	6	42666176 - 42666177	6	42698438 - 42698439	13171	28210	rs61748429	NC_000006.12:42698437:CA:
NM_000322.5(PRPH2):c.500G>A (p.Gly167Asp)	PRPH2	G167D	not provided|Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000013169	6	42689573	6	42721835	13169	28208	rs61755789	NC_000006.12:42721834:C:T
NM_000217.3(KCNA1):c.677C>G (p.Thr226Arg)	KCNA1	T226R	Episodic ataxia type 1	Pathogenic(Last reviewed: Aug 16, 2012)	no assertion criteria provided	VCV000013492	12	5021221	12	4912055	13492	28531	rs28933383	NC_000012.12:4912054:C:G
NM_000217.3(KCNA1):c.975G>C (p.Glu325Asp)	KCNA1	E325D	Episodic ataxia type 1	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013485	12	5021519	12	4912353	13485	28524	rs104894353	NC_000012.12:4912352:G:C
NM_000217.3(KCNA1):c.551T>G (p.Phe184Cys)	KCNA1	F184C	Episodic ataxia type 1	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013484	12	5021095	12	4911929	13484	28523	rs104894357	NC_000012.12:4911928:T:G
NM_000217.3(KCNA1):c.745T>A (p.Phe249Ile)	KCNA1	F249I	Episodic ataxia type 1	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013483	12	5021289	12	4912123	13483	28522	rs104894356	NC_000012.12:4912122:T:A
NM_000217.3(KCNA1):c.520G>T (p.Val174Phe)	KCNA1	V174F	Episodic ataxia type 1	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013482	12	5021064	12	4911898	13482	28521	rs104894349	NC_000012.12:4911897:G:T
NM_000217.3(KCNA1):c.715C>A (p.Arg239Ser)	KCNA1	R239S	Episodic ataxia type 1	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013481	12	5021259	12	4912093	13481	28520	rs104894348	NC_000012.12:4912092:C:A
NM_006059.4(LAMC3):c.2430C>A (p.Cys810Ter)	LAMC3	C810*	not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000497752	9	133942429	9	131067042	497752	489176	rs769118642	NC_000009.12:131067041:C:A
NM_006059.4(LAMC3):c.1048G>A (p.Gly350Arg)	LAMC3	G350R	Cortical malformations, occipital	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030419	9	133914322	9	131038935	30419	39376	rs571785750	NC_000009.12:131038934:G:A
NM_006059.4(LAMC3):c.1156C>T (p.Gln386Ter)	LAMC3	Q386*	Cortical malformations, occipital	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030418	9	133914430	9	131039043	30418	39375	rs387906887	NC_000009.12:131039042:C:T
NM_006059.4(LAMC3):c.470G>A (p.Trp157Ter)	LAMC3	W157*	Cortical malformations, occipital	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030417	9	133901768	9	131026381	30417	39374	rs1564365706	NC_000009.12:131026380:G:A
NM_006059.4(LAMC3):c.901_902TG[1] (p.Cys301_Glu302delinsTer)	LAMC3		Cortical malformations, occipital	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030416	9	133911644 - 133911645	9	131036257 - 131036258	30416	39373	rs761516738	NC_000009.12:131036256:TGTG:TG
NM_000399.5(EGR2):c.1142G>A (p.Arg381His)	EGR2	R381H, R331H	Charcot-Marie-Tooth disease, demyelinating, type 1d|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000041008	10	64573256	10	62813496	41008	49430	rs281865137	NC_000010.11:62813495:C:T
NM_000322.5(PRPH2):c.809_810del (p.Leu270fs)	PRPH2	L270fs	PRPH2-Related Disorders	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000856902	6	42672121 - 42672122	6	42704383 - 42704384	856902	831958		NC_000006.12:42704382:GAG:G
NC_000006.12:g.(?_42704365)_(42704611_?)del	PRPH2		PRPH2-Related Disorders	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000831812	6	42672103 - 42672349			831812	819689		
NM_000322.5(PRPH2):c.829-4C>G	PRPH2		PRPH2-Related Disorders|Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802213	6	42666249	6	42698511	802213	790628		NC_000006.12:42698510:G:C
NM_000322.5(PRPH2):c.715C>T (p.Gln239Ter)	PRPH2	Q239*	Macular dystrophy|not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000098703	6	42672216	6	42704478	98703	104593	rs61755814	NC_000006.12:42704477:G:A
NM_000322.5(PRPH2):c.656_658del (p.Pro219del)	PRPH2	P219del	Retinitis pigmentosa 7|not provided	Pathogenic(Last reviewed: Dec 12, 1991)	no assertion criteria provided	VCV000098697	6	42672273 - 42672275	6	42704535 - 42704537	98697	104587	rs61755807	NC_000006.12:42704534:GTGG:G
NM_000322.5(PRPH2):c.518A>T (p.Asp173Val)	PRPH2	D173V	not provided|Retinitis pigmentosa 7	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000013181	6	42689555	6	42721817	13181	28220	rs61755794	NC_000006.12:42721816:T:A
NM_000322.5(PRPH2):c.947G>A (p.Trp316Ter)	PRPH2	W316*	Macular dystrophy, vitelliform, adult-onset|not provided	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000013176	6	42666127	6	42698389	13176	28215	rs121918566	NC_000006.12:42698388:C:T
NM_000322.5(PRPH2):c.2T>C (p.Met1Thr)	PRPH2	M1T	not provided|Macular dystrophy, vitelliform, adult-onset	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000013175	6	42690071	6	42722333	13175	28214	rs121918565	NC_000006.12:42722332:A:G
NM_000322.5(PRPH2):c.732C>A (p.Asn244Lys)	PRPH2	N244K	not provided|Retinitis pigmentosa 7	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000013172	6	42672199	6	42704461	13172	28211	rs61755816	NC_000006.12:42704460:G:T
NM_000890.5(KCNJ5):c.451G>A (p.Gly151Arg)	KCNJ5	G151R	Familial hyperaldosteronism type 3|Aldosterone-producing adrenal adenoma, somatic|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2012)	no assertion criteria provided	VCV000091915	11	128781619	11	128911724	91915	97393	rs386352319	NC_000011.10:128911723:G:A
NM_006214.4(PHYH):c.823C>T (p.Arg275Trp)	PHYH	R275W, R175W, R177W, R277W, R187W	Refsum disease, adult, 1|Phytanic acid storage disease|Retinitis pigmentosa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007580	10	13325695	10	13283695	7580	22619	rs104894178	NC_000010.11:13283694:G:A
NM_012330.4(KAT6B):c.3147G>A (p.Pro1049=)	KAT6B		not provided|Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000279815	10	76781764	10	75022006	279815	264349	rs886041207	NC_000010.11:75022005:G:A
NM_033100.4(CDHR1):c.524dup (p.Asn176fs)	CDHR1		Cone-rod dystrophy 15|Leber congenital amaurosis	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000018416	10	85960441 - 85960442	10	84200685 - 84200686	18416	33455	rs781781440	NC_000010.11:84200685:A:AA
NM_016628.5(WAC):c.374C>A (p.Ser125Ter)	WAC	S125*, S80*	Inborn genetic diseases|Desanto-shinawi syndrome	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000219142	10	28872427	10	28583498	219142	216948	rs864321692	NC_000010.11:28583497:C:A
NM_004820.5(CYP7B1):c.1250G>A (p.Arg417His)	CYP7B1	R417H	Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006103	8	65509470	8	64596913	6103	21142	rs121908611	NC_000008.11:64596912:C:T
NM_000322.5(PRPH2):c.736T>C (p.Trp246Arg)	PRPH2	W246R	not provided|Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000098706	6	42672195	6	42704457	98706	104596	rs61755817	NC_000006.12:42704456:A:G
NM_000322.4(PRPH2):c.356_358delGCT (p.Cys119del)	PRPH2	C118del, C119del	not provided|Retinitis pigmentosa 7	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000013162	6	42689715 - 42689717	6	42721977 - 42721979	13162	28201	rs61755777	NC_000006.12:42721976:AGCAGCAG:AGCAG
NM_033360.4(KRAS):c.*11G>A	KRAS	D153N	not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000561755	12	25362839	12	25209905	561755	552688	rs1565878932	NC_000012.12:25209904:C:T
NM_033360.4(KRAS):c.31_32insGGC (p.Ala11delinsGlyPro)	KRAS		not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000424018	12	25398287 - 25398288	12	25245353 - 25245354	424018	408621	rs1064796748	NC_000012.12:25245353::GCC
NM_033360.4(KRAS):c.15A>C (p.Lys5Asn)	KRAS	K5N	not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	VCV000372705	12	25398304	12	25245370	372705	360085	rs104894361	NC_000012.12:25245369:T:G
NM_033360.4(KRAS):c.65A>T (p.Gln22Leu)	KRAS	Q22L	not provided	Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	VCV000040453	12	25398254	12	25245320	40453	48923	rs727503110	NC_000012.12:25245319:T:A
NM_004999.4(MYO6):c.826C>T (p.Arg276Ter)	MYO6	R276*, R271*	not provided|Deafness, autosomal recessive 37|Deafness, autosomal dominant 22|Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164634	6	76554623	6	75844906	164634	174141	rs727503326	NC_000006.12:75844905:C:T
NM_000217.3(KCNA1):c.1223T>C (p.Val408Ala)	KCNA1	V408A	Episodic ataxia type 1	Pathogenic(Last reviewed: Jun 25, 2015)	no assertion criteria provided	VCV000013480	12	5021767	12	4912601	13480	28519	rs104894352	NC_000012.12:4912600:T:C
NM_033360.4(KRAS):c.440A>G (p.Lys147Arg)	KRAS	K147R	Noonan syndrome 3	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431103	12	25378558	12	25225624	431103	424626	rs1135401776	NC_000012.12:25225623:T:C
NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	KRAS	Y71H	Cardiofaciocutaneous syndrome 2	Pathogenic(Last reviewed: Jan 15, 2013)	no assertion criteria provided	VCV000031940	12	25380247	12	25227313	31940	40605	rs387907205	NC_000012.12:25227312:A:G
NM_033360.4(KRAS):c.*9T>G	KRAS	V152G	Noonan syndrome 3	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000012591	12	25362841	12	25209907	12591	27630	rs104894367	NC_000012.12:25209906:A:C
NM_000235.4(LIPA):c.193C>T (p.Arg65Ter)	LIPA	R65*	Wolman disease|Lysosomal acid lipase deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558291	10	91005469	10	89245712	558291	545648	rs779712562	NC_000010.11:89245711:G:A
NM_019892.6(INPP5E):c.44del (p.Pro15fs)	INPP5E	P15fs	not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000817662	9	139333828	9	136439376	817662	805614		NC_000009.12:136439375:GGGG:GGG
NM_019892.6(INPP5E):c.490dup (p.Val164fs)	INPP5E		not provided	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000279812	9	139333381 - 139333382	9	136438929 - 136438930	279812	264440	rs886041204	NC_000009.12:136438929:CCCC:CCCCC
NM_019892.6(INPP5E):c.1879C>T (p.Gln627Ter)	INPP5E	Q627*, Q626*	MORM syndrome	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000396	9	139324183	9	136429731	396	15435	rs121918127	NC_000009.12:136429730:G:A
NM_058246.4(DNAJB6):c.346+5G>A	DNAJB6		Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000225177	7	157160182	7	157367488	225177	227092	rs869320702	NC_000007.14:157367487:G:A
NM_019892.6(INPP5E):c.1688G>A (p.Arg563His)	INPP5E	R563H, R562H	Joubert syndrome 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000398	9	139324843	9	136430391	398	15437	rs121918128	NC_000009.12:136430390:C:T
NM_019892.6(INPP5E):c.1543C>T (p.Arg515Trp)	INPP5E	R515W, R514W	Joubert syndrome 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000397	9	139326282	9	136431830	397	15436	rs13297509	NC_000009.12:136431829:G:A
NM_033360.4(KRAS):c.27_29dup (p.Gly10dup)	KRAS		Acute myeloid leukemia	Pathogenic(Last reviewed: Dec 20, 1996)	no assertion criteria provided	VCV000012585	12	25398289 - 25398290	12	25245355 - 25245356	12585	27624	rs606231202	NC_000012.12:25245355:CCA:CCACCA
NM_058246.4(DNAJB6):c.271T>A (p.Phe91Ile)	DNAJB6	F91I	Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000225175	7	157160102	7	157367408	225175	227090	rs869320701	NC_000007.14:157367407:T:A
NM_058246.4(DNAJB6):c.298T>G (p.Phe100Val)	DNAJB6	F100V	Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Sep 26, 2018)	no assertion criteria provided	VCV000225174	7	157160129	7	157367435	225174	227089	rs869320700	NC_000007.14:157367434:T:G
NM_019892.6(INPP5E):c.1468G>T (p.Asp490Tyr)	INPP5E	D490Y, D489Y	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217665	9	139326357	9	136431905	217665	214300	rs757222534	NC_000009.12:136431904:C:A
NM_019892.6(INPP5E):c.1249T>C (p.Ser417Pro)	INPP5E	S417P	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217664	9	139327438	9	136432986	217664	214301	rs863225202	NC_000009.12:136432985:A:G
NM_019892.6(INPP5E):c.1162G>T (p.Val388Leu)	INPP5E	V388L	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217663	9	139327525	9	136433073	217663	214302	rs863225201	NC_000009.12:136433072:C:A
NM_019892.6(INPP5E):c.1021G>A (p.Gly341Ser)	INPP5E	G341S	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217661	9	139328502	9	136434050	217661	214305	rs780882740	NC_000009.12:136434049:C:T
NM_019892.6(INPP5E):c.1577C>T (p.Pro526Leu)	INPP5E	P526L, P525L	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217660	9	139325542	9	136431090	217660	214299	rs746867724	NC_000009.12:136431089:G:A
NM_019892.6(INPP5E):c.1154G>A (p.Cys385Tyr)	INPP5E	C385Y	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217659	9	139327612	9	136433160	217659	214303	rs863225200	NC_000009.12:136433159:C:T
NM_019892.6(INPP5E):c.1897_1898del (p.Gln633fs)	INPP5E	Q632fs, Q633fs	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217658	9	139324164 - 139324165	9	136429712 - 136429713	217658	214295	rs863225199	NC_000009.12:136429711:TGT:T
NM_019892.6(INPP5E):c.1754G>A (p.Arg585His)	INPP5E	R585H, R584H	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217657	9	139324777	9	136430325	217657	214297	rs752300607	NC_000009.12:136430324:C:T
NM_019892.6(INPP5E):c.1760del (p.Val587fs)	INPP5E	V586fs, V587fs	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217656	9	139324771	9	136430319	217656	214296	rs775518991	NC_000009.12:136430318:A:
NM_019892.6(INPP5E):c.1064C>T (p.Thr355Met)	INPP5E	T355M	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217655	9	139327702	9	136433250	217655	214304	rs863225198	NC_000009.12:136433249:G:A
NM_019892.6(INPP5E):c.1684A>G (p.Ser562Gly)	INPP5E	S562G, S561G	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217654	9	139324847	9	136430395	217654	214298	rs863225197	NC_000009.12:136430394:T:C
NM_019892.6(INPP5E):c.907G>A (p.Val303Met)	INPP5E	V303M	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217653	9	139329221	9	136434769	217653	214307	rs746212325	NC_000009.12:136434768:C:T
NM_058246.4(DNAJB6):c.277T>C (p.Phe93Leu)	DNAJB6	F93L	Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030904	7	157160108	7	157367414	30904	39861	rs387907046	NC_000007.14:157367413:T:C
NM_177924.5(ASAH1):c.147G>A (p.Trp49Ter)	ASAH1	W49*, W65*, W72*	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000620456	8	17928878	8	18071369	620456	611695	rs369707059	NC_000008.11:18071368:C:T
NC_000008.10:g.(?_17933030)_(17942330_?)del	ASAH1		not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000646400	8	17933030 - 17942330	8	18075521 - 18084821	646400	651845		
NM_177924.5(ASAH1):c.703G>C (p.Gly235Arg)	ASAH1	G235R, G251R, G170R, G229R	Farber disease	Pathogenic(Last reviewed: Jan 31, 2018)	no assertion criteria provided	VCV000545563	8	17919195	8	18061686	545563	536065	rs1554808625	NC_000008.11:18061685:C:G
NM_177924.5(ASAH1):c.886C>T (p.Arg296Ter)	ASAH1	R231*, R290*, R296*, R312*	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000812508	8	17917112	8	18059603	812508	800721		NC_000008.11:18059602:G:A
NM_177924.5(ASAH1):c.256dup (p.Thr86fs)	ASAH1		Farber disease	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000812502	8	17927347 - 17927348	8	18069838 - 18069839	812502	800739		NC_000008.11:18069838:T:TT
NM_177924.5(ASAH1):c.223_224insC (p.Val75fs)	ASAH1		Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812500	8	17927380 - 17927381	8	18069871 - 18069872	812500	800740		NC_000008.11:18069871::G
NC_000008.11:g.18069805_18069807ACC[1]	ASAH1		Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812499	8	17927312 - 17927314	8	18069803 - 18069805	812499	800736		NC_000008.11:18069802:CCACCACC:CCACC
NM_177924.5(ASAH1):c.1085C>G (p.Pro362Arg)	ASAH1	P362R, P378R, P297R, P356R	Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812498	8	17916357	8	18058848	812498	800715		NC_000008.11:18058847:G:C
NM_177924.5(ASAH1):c.174dup (p.Tyr59fs)	ASAH1		Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812486	8	17928850 - 17928851	8	18071341 - 18071342	812486	800742		NC_000008.11:18071341:GGG:GGGG
NM_177924.5(ASAH1):c.383-10_383-6del	ASAH1		Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812484	8	17922046 - 17922050	8	18064537 - 18064541	812484	800751		NC_000008.11:18064536:AGAAAAGAAAA:AGAAAA
NM_177924.5(ASAH1):c.77C>G (p.Pro26Arg)	ASAH1	P26R	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812482	8	17941491	8	18083982	812482	800744		NC_000008.11:18083981:G:C
NM_177924.5(ASAH1):c.594_599dup (p.Lys200_Ala201insAsnPhe)	ASAH1		Farber disease|Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812481	8	17919836 - 17919837	8	18062327 - 18062328	812481	800727		NC_000008.11:18062327:TTGAAG:TTGAAGTTGAAG
NM_177924.5(ASAH1):c.518A>T (p.Asn173Ile)	ASAH1	N173I, N189I, N108I, N167I	Farber disease|Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812480	8	17919918	8	18062409	812480	800730		NC_000008.11:18062408:T:A
NM_177924.5(ASAH1):c.760A>G (p.Arg254Gly)	ASAH1	R254G, R270G, R189G, R248G	Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812478	8	17918911	8	18061402	812478	800724		NC_000008.11:18061401:T:C
NM_177924.5(ASAH1):c.502G>T (p.Gly168Trp)	ASAH1	G162W, G184W, G103W, G168W	Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812477	8	17920695	8	18063186	812477	800731		NC_000008.11:18063185:C:A
NM_177924.5(ASAH1):c.290T>A (p.Val97Glu)	ASAH1	V113E, V32E, V97E	Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812473	8	17927314	8	18069805	812473	800738		NC_000008.11:18069804:A:T
NM_177924.5(ASAH1):c.410_411del (p.Phe136_Tyr137insTer)	ASAH1		Farber disease	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812471	8	17922012 - 17922013	8	18064503 - 18064504	812471	800733		NC_000008.11:18064502:ATA:A
NM_177924.5(ASAH1):c.850G>T (p.Gly284Ter)	ASAH1	G284*, G300*, G219*, G278*	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000180642	8	17917148	8	18059639	180642	178804	rs794729663	NC_000008.11:18059638:C:A
NM_177924.5(ASAH1):c.544C>G (p.Leu182Val)	ASAH1	L182V, L198V, L176V, L117V	Farber disease	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000000095	8	17919892	8	18062383	95	15134	rs137853597	NC_000008.11:18062382:G:C
NM_177924.5(ASAH1):c.958A>G (p.Asn320Asp)	ASAH1	N320D, N336D, N314D, N255D	Farber disease	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000000094	8	17916933	8	18059424	94	15133	rs137853596	NC_000008.11:18059423:T:C
NM_177924.5(ASAH1):c.665C>A (p.Thr222Lys)	ASAH1	T222K, T238K, T216K, T157K	Farber disease	Pathogenic(Last reviewed: Dec 20, 1996)	no assertion criteria provided	VCV000000091	8	17919233	8	18061724	91	15130	rs137853593	NC_000008.11:18061723:G:T
NM_003977.4(AIP):c.490C>T (p.Gln164Ter)	AIP	Q164*, Q105*	Somatotroph adenoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000041185	11	67257530	11	67490059	41185	49607	rs104895073	NC_000011.10:67490058:C:T
NM_019892.6(INPP5E):c.1844T>G (p.Leu615Ter)	INPP5E	L615*, L614*	Joubert syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000568818	9	139324218	9	136429766	568818	563035	rs1564430716	NC_000009.12:136429765:A:C
NM_058246.4(DNAJB6):c.273C>G (p.Phe91Leu)	DNAJB6	F91L	not provided|Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000225176	7	157160104	7	157367410	225176	227091	rs759982570	NC_000007.14:157367409:C:G
NM_000322.5(PRPH2):c.80C>T (p.Ser27Phe)	PRPH2	S27F	Retinal dystrophy|not provided|PRPH2-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098711	6	42689993	6	42722255	98711	104601	rs61755766	NC_000006.12:42722254:G:A
NM_000322.5(PRPH2):c.637T>C (p.Cys213Arg)	PRPH2	C213R	not provided|Leber congenital amaurosis 18|Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000098691	6	42672294	6	42704556	98691	104581	rs61755802	NC_000006.12:42704555:A:G
NM_000322.5(PRPH2):c.635G>C (p.Ser212Thr)	PRPH2	S212T	not provided|Patterned dystrophy of retinal pigment epithelium|Adult onset vitelliform dystrophy|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098690	6	42672296	6	42704558	98690	104580	rs61755801	NC_000006.12:42704557:C:G
NM_000322.5(PRPH2):c.578_579del (p.Lys193fs)	PRPH2	K193fs	Retinal dystrophy|PRPH2-Related Disorders|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098680	6	42689494 - 42689495	6	42721756 - 42721757	98680	104570	rs62645929	NC_000006.12:42721755:TTT:T
NM_000322.5(PRPH2):c.458_460AGA[1] (p.Lys154del)	PRPH2	K154del	Patterned dystrophy of retinal pigment epithelium|not provided|Retinitis pigmentosa 7	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000013178	6	42689610 - 42689612	6	42721872 - 42721874	13178	28217	rs61755786	NC_000006.12:42721871:TCTTCTTC:TCTTC
NM_001033855.3(DCLRE1C):c.1350_1356del (p.Asp451fs)	DCLRE1C	D451fs, D331fs, D336fs	Severe combined immunodeficiency, partial|Severe combined immunodeficiency due to DCLRE1C deficiency	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000004675	10	14951130 - 14951136	10	14909131 - 14909137	4675	19714	rs786200884	NC_000010.11:14909130:ACAATCTACAA:ACAA
NM_001033855.3(DCLRE1C):c.597C>A (p.Tyr199Ter)	DCLRE1C	Y192*, Y199*, Y79*, Y84*	Severe combined immunodeficiency due to DCLRE1C deficiency|Severe combined immunodeficiency, athabascan-type|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004673	10	14976460	10	14934461	4673	19712	rs121908157	NC_000010.11:14934460:G:T
NM_177924.4(ASAH1):c.126-3941_382+1358del	ASAH1		Farber disease	Pathogenic(Last reviewed: Jan 31, 2018)	no assertion criteria provided	VCV000545564	8	17923371 - 17932840	8	18065862 - 18075331	545564	536066		
NM_177924.5(ASAH1):c.1154T>C (p.Leu385Pro)	ASAH1	L401P, L379P, L385P, L320P	Keloid formation	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2017)	no assertion criteria provided	VCV000417797	8	17915077	8	18057568	417797	404698	rs368345612	NC_000008.11:18057567:A:G
NM_177924.5(ASAH1):c.410A>G (p.Tyr137Cys)	ASAH1	Y153C, Y131C, Y137C, Y72C	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000375548	8	17922013	8	18064504	375548	362358	rs371666412	NC_000008.11:18064503:T:C
NM_033360.4(KRAS):c.214A>T (p.Met72Leu)	KRAS	M72L	Noonan syndrome	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	VCV000179141	12	25380244	12	25227310	179141	175714	rs727504662	NC_000012.12:25227309:T:A
NM_033360.4(KRAS):c.64C>G (p.Gln22Glu)	KRAS	Q22E	Rasopathy	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000040451	12	25398255	12	25245321	40451	48921	rs121913236	NC_000012.12:25245320:G:C
NM_033360.4(KRAS):c.*22C>G	KRAS	F156L	Cardiofaciocutaneous syndrome 2|not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000012595	12	25362828	12	25209894	12595	27634	rs104894362	NC_000012.12:25209893:G:C
NM_177924.5(ASAH1):c.917+4A>G	ASAH1		Farber disease	Pathogenic(Last reviewed: Jan 31, 2018)	no assertion criteria provided	VCV000055908	8	17917077	8	18059568	55908	70551	rs397509415	NC_000008.11:18059567:T:C
NM_000019.4(ACAT1):c.1006-1G>C	ACAT1		not provided|Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429749	11	108016928	11	108146201	429749	421815	rs1131691567	NC_000011.10:108146200:G:C
NM_000019.4(ACAT1):c.473A>G (p.Asn158Ser)	ACAT1	N158S	Deficiency of acetyl-CoA acetyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198030	11	108009662	11	108138935	198030	195191	rs199524907	NC_000011.10:108138934:A:G
NC_000009.12:g.(?_136429675)_(136438954_?)del	INPP5E		Joubert syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000832414	9	139324127 - 139333406			832414	820098		
NM_058246.4(DNAJB6):c.279C>A (p.Phe93Leu)	DNAJB6	F93L	not provided|Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031530	7	157160110	7	157367416	31530	40203	rs149278319	NC_000007.14:157367415:C:A
NM_000448.3(RAG1):c.1048_1075delinsAAAAGAGTG (p.Val350fs)	RAG1		not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000817816	11	36595902 - 36595929	11	36574352 - 36574379	817816	805689		NC_000011.10:36574351:GTCTTGAATTCCCTGATGGTGAAATGTC:AAAAGAGTG
NM_000448.3(RAG1):c.967del (p.Val323fs)	RAG1	V323fs	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000817813	11	36595821	11	36574271	817813	805688		NC_000011.10:36574270:G:
NC_000011.10:g.36575636C>T	RAG1	R778W	Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802672	11	36597186	11	36575636	802672	791134		NC_000011.10:36575635:C:T
NC_000011.10:g.36573664_36573671del	RAG1	D121fs	Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802671	11	36595210 - 36595217	11	36573660 - 36573667	802671	791133		NC_000011.10:36573659:GAGCTGATGAGC:GAGC
NM_000448.2(RAG1):c.999T>A (p.Tyr333Ter)	RAG1	Y333*	not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000449383	11	36595853	11	36574303	449383	444799	rs902350422	NC_000011.10:36574302:T:A
NM_000448.3(RAG1):c.746dup (p.His249fs)	RAG1		not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000280562	11	36595600	11	36574049 - 36574050	280562	264424	rs886041745	NC_000011.10:36574049:A:AA
NM_000448.2(RAG1):c.1621del (p.Leu541fs)	RAG1	L541fs	Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Aug 26, 2010)	no assertion criteria provided	VCV000029867	11	36596475	11	36574925	29867	38822		NC_000011.10:36574924:C:
NM_000448.2(RAG1):c.940C>T (p.Arg314Trp)	RAG1	R314W	Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: May 8, 2008)	no assertion criteria provided	VCV000013156	11	36595794	11	36574244	13156	28195	rs121918568	NC_000011.10:36574243:C:T
NM_000448.2(RAG1):c.2942A>C (p.Gln981Pro)	RAG1	Q981P	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000013155	11	36597796	11	36576246	13155	28194	rs104894288	NC_000011.10:36576245:A:C
RAG1, 1-BP DEL, 887A	RAG1		Histiocytic medullary reticulosis	Pathogenic(Last reviewed: Dec 19, 2000)	no assertion criteria provided	VCV000013152					13152	28191		
RAG1, 13-BP DEL, NT1723	RAG1		Histiocytic medullary reticulosis	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000013150					13150	28189		
NM_000448.2(RAG1):c.1286A>G (p.Asp429Gly)	RAG1	D429G	Histiocytic medullary reticulosis	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000013147	11	36596140	11	36574590	13147	28186	rs104894292	NC_000011.10:36574589:A:G
NM_000448.2(RAG1):c.2735A>G (p.Tyr912Cys)	RAG1	Y912C	Histiocytic medullary reticulosis	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000013145	11	36597589	11	36576039	13145	28184	rs104894290	NC_000011.10:36576038:A:G
NM_000448.2(RAG1):c.1682G>A (p.Arg561His)	RAG1	R561H	Histiocytic medullary reticulosis	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000013143	11	36596536	11	36574986	13143	28182	rs104894284	NC_000011.10:36574985:G:A
NM_000448.2(RAG1):c.2814T>G (p.Tyr938Ter)	RAG1	Y938*	Severe combined immunodeficiency, B cell-negative	Pathogenic(Last reviewed: Oct 4, 1996)	no assertion criteria provided	VCV000013141	11	36597668	11	36576118	13141	28180	rs104894283	NC_000011.10:36576117:T:G
NM_000448.2(RAG1):c.2320G>T (p.Glu774Ter)	RAG1	E774*	Severe combined immunodeficiency, B cell-negative	Pathogenic(Last reviewed: Oct 4, 1996)	no assertion criteria provided	VCV000013140	11	36597174	11	36575624	13140	28179	rs104894282	NC_000011.10:36575623:G:T
NM_000448.2(RAG1):c.2164G>A (p.Glu722Lys)	RAG1	E722K	Severe combined immunodeficiency, B cell-negative	Pathogenic(Last reviewed: Oct 4, 1996)	no assertion criteria provided	VCV000013139	11	36597018	11	36575468	13139	28178	rs28933392	NC_000011.10:36575467:G:A
NM_000448.2(RAG1):c.775del (p.Ser259fs)	RAG1	S259fs	not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235411	11	36595629	11	36574079	235411	237096	rs878853031	NC_000011.10:36574078:A:
NM_000448.2(RAG1):c.2521C>T (p.Arg841Trp)	RAG1	R841W	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000013154	11	36597375	11	36575825	13154	28193	rs104894287	NC_000011.10:36575824:C:T
NM_000448.2(RAG1):c.424C>T (p.Arg142Ter)	RAG1	R142*	Combined cellular and humoral immune defects with granulomas|Combined cellular and humoral immune defects with granulomas|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity|Histiocytic medullary reticulosis|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000626157	11	36595278	11	36573728	626157	614356	rs773929270	NC_000011.10:36573727:C:T
NM_000448.2(RAG1):c.2333G>A (p.Arg778Gln)	RAG1	R778Q	not provided|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000013158	11	36597187	11	36575637	13158	28197	rs121918569	NC_000011.10:36575636:G:A
NM_000217.3(KCNA1):c.1249C>T (p.Arg417Ter)	KCNA1	R417*	Episodic ataxia type 1	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000013491	12	5021793	12	4912627	13491	28530	rs104894358	NC_000012.12:4912626:C:T
NM_000448.2(RAG1):c.1331C>T (p.Ala444Val)	RAG1	A444V	not provided|	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000068681	11	36596185	11	36574635	68681	79573	rs199474685	NC_000011.10:36574634:C:T
NM_033360.4(KRAS):c.57G>C (p.Leu19Phe)	KRAS	L19F	OCULOECTODERMAL SYNDROME, SOMATIC|Angiosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000217822	12	25398262	12	25245328	217822	214479	rs121913538	NC_000012.12:25245327:C:G
NM_033360.4(KRAS):c.439A>G (p.Lys147Glu)	KRAS	K147E	Cardiofaciocutaneous syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031941	12	25378559	12	25225625	31941	40606	rs387907206	NC_000012.12:25225624:T:C
NM_033360.4(KRAS):c.175G>A (p.Ala59Thr)	KRAS	A59T	Neoplasm of the large intestine|Bladder cancer, transitional cell, somatic	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000012581	12	25380283	12	25227349	12581	27620	rs121913528	NC_000012.12:25227348:C:T
NM_198428.3(BBS9):c.1877_1880del (p.Lys626fs)	BBS9	K504fs, K581fs, K500fs, K535fs, K621fs, K626fs, K586fs, K591fs, K469fs	not provided|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002662	7	33423364 - 33423367	7	33383752 - 33383755	2662	17701	rs606231137	NC_000007.14:33383751:AAACA:A
NM_012203.2(GRHPR):c.295C>T (p.Arg99Ter)	GRHPR	R99*	Primary hyperoxaluria|not provided|Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005637	9	37426542	9	37426545	5637	20676	rs119490108	NC_000009.12:37426544:C:T
NM_000048.4(ASL):c.637C>T (p.Arg213Ter)	ASL	R213*, R187*	not provided|Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426366	7	65552355	7	66087368	426366	415107	rs761651320	NC_000007.14:66087367:C:T
NM_000048.4(ASL):c.649C>T (p.Arg217Ter)	ASL	R217*, R191*	not provided|Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203615	7	65552367	7	66087380	203615	200154	rs369879957	NC_000007.14:66087379:C:T
NM_000048.4(ASL):c.283C>T (p.Arg95Cys)	ASL	R95C	Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002398	7	65547430	7	66082443	2398	17437	rs28940585	NC_000007.14:66082442:C:T
NM_007055.4(POLR3A):c.1909+18G>A	POLR3A		Hypomyelinating leukodystrophy 7|not provided|Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031144	10	79769277	10	78009519	31144	40101	rs267608677	NC_000010.11:78009518:C:T
NM_000322.5(PRPH2):c.394del (p.Gln132fs)	PRPH2	Q132fs	Retinitis pigmentosa 7|Autosomal dominant retinitis pigmentosa|PRPH2-Related Disorders	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000684461	6	42689679	6	42721941	684461	672067		NC_000006.12:42721940:GG:G
NM_000322.5(PRPH2):c.612C>G (p.Tyr204Ter)	PRPH2	Y204*	not provided|Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523772	6	42672319	6	42704581	523772	514535	rs1554269081	NC_000006.12:42704580:G:C
NM_000322.5(PRPH2):c.638G>A (p.Cys213Tyr)	PRPH2	C213Y	Retinal dystrophy|PRPH2-Related Disorders|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098692	6	42672293	6	42704555	98692	104582	rs61755803	NC_000006.12:42704554:C:T
NM_000322.5(PRPH2):c.113del (p.Gly38fs)	PRPH2	G38fs	Macular dystrophy, vitelliform, adult-onset|not provided|Retinal dystrophy	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013177	6	42689960	6	42722222	13177	28216	rs61755769	NC_000006.12:42722221:CC:C
NM_000448.2(RAG1):c.1180C>T (p.Arg394Trp)	RAG1	R394W	|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000660211	11	36596034	11	36574484	660211	640014		NC_000011.10:36574483:C:T
NM_000448.2(RAG1):c.994C>T (p.Arg332Ter)	RAG1	R332*	|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000649706	11	36595848	11	36574298	649706	640010		NC_000011.10:36574297:C:T
RAG1, 2-BP DEL, 368AA	RAG1		Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity|Histiocytic medullary reticulosis	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000013151					13151	28190		
NM_139025.4(ADAMTS13):c.3178C>T (p.Arg1060Trp)	ADAMTS13	R1060W, R1029W	Upshaw-Schulman syndrome|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000068815	9	136319670	9	133454548	68815	79706	rs142572218	NC_000009.12:133454547:C:T
NM_000497.3(CYP11B1):c.372del (p.His125fs)	CYP11B1	H125fs	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000551998	8	143960471	8	142879055	551998	544677	rs1554653520	NC_000008.11:142879054:CCC:CC
CYP11B1, CYP11B1/CYP11B2 CHIMERA	CYP11B1		Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000001184					1184	16223		
CYP11B1, CYP11B1/CYP11B2 CHIMERA	CYP11B1		Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000001182					1182	16221		
CYP11B1, 954G-A	CYP11B1		Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000001180					1180	16219		
NM_000497.3(CYP11B1):c.347G>A (p.Trp116Ter)	CYP11B1	W116*	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001176	8	143960496	8	142879080	1176	16215	rs104894066	NC_000008.11:142879079:C:T
CYP11B1, 2-BP INS	CYP11B1		Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000001175					1175	16214		
CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA	CYP11B1		Hyperaldosteronism, familial, type I	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000001172					1172	16211		
NM_004629.1(FANCG):c.1795_1804del (p.Trp599Profs)	FANCG	W599fs	Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000006718	9	35074170 - 35074179	9	35074173 - 35074182	6718	21757	rs397507560	NC_000009.12:35074172:GACGGATCCAG:G
NM_000497.3(CYP11B1):c.124C>T (p.Pro42Ser)	CYP11B1	P42S	Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000001179	8	143961106	8	142879690	1179	16218	rs104894069	NC_000008.11:142879689:G:A
NM_015404.4(WHRN):c.2388_2389del (p.Asn796fs)	WHRN	N796fs, N795fs, N445fs, N413fs	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560920	9	117166205 - 117166206	9	114403925 - 114403926	560920	552007	rs1564113368	NC_000009.12:114403924:CG:
NM_032415.6(CARD11):c.220+1G>A	CARD11		not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000489270	7	2987208	7	2947574	489270	481786	rs1554276623	NC_000007.14:2947573:C:T
NM_015404.4(WHRN):c.1417-1G>A	WHRN		not provided	Pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	VCV000198565	9	117185804	9	114423524	198565	195726	rs779760634	NC_000009.12:114423523:C:T
NC_000007.14:g.(?_2944192)_(2947807_?)del	CARD11		B-cell expansion with NFKB and T-cell anergy|Immunodeficiency 11	Pathogenic(Last reviewed: Feb 16, 2019)	criteria provided, single submitter	VCV000830915	7	2983826 - 2987441			830915	819869		
NM_032415.6(CARD11):c.2509C>T (p.Arg837Ter)	CARD11	R837*	B-cell expansion with NFKB and T-cell anergy|Immunodeficiency 11	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000540976	7	2959007	7	2919373	540976	523280	rs1554271741	NC_000007.14:2919372:G:A
CARD11, 42-BP DUP	CARD11		IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS	Pathogenic(Last reviewed: Aug 22, 2017)	no assertion criteria provided	VCV000433536					433536	427110		
CARD11, GLU57ASP	CARD11	E57D	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS	Pathogenic(Last reviewed: Aug 22, 2017)	no assertion criteria provided	VCV000433534					433534	427108		
CARD11, LEU194PRO	CARD11	L194P	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS	Pathogenic(Last reviewed: Aug 22, 2017)	no assertion criteria provided	VCV000433533					433533	427107		
NM_032415.6(CARD11):c.146G>A (p.Cys49Tyr)	CARD11	C49Y	B-cell expansion with NFKB and T-cell anergy	Pathogenic(Last reviewed: Apr 27, 2015)	no assertion criteria provided	VCV000203461	7	2987283	7	2947649	203461	199872	rs794729673	NC_000007.14:2947648:C:T
NM_032415.5(CARD11):c.2704-890_2839+352del	CARD11		Immunodeficiency 11	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000048650			7	2914850 - 2916262	48650	57812		
NM_032415.6(CARD11):c.2833C>T (p.Gln945Ter)	CARD11	Q945*	Immunodeficiency 11	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000048649	7	2954877	7	2915243	48649	57811	rs397514686	NC_000007.14:2915242:G:A
NM_032415.6(CARD11):c.401A>G (p.Glu134Gly)	CARD11	E127G, E134G	B-cell expansion with NFKB and T-cell anergy	Pathogenic(Last reviewed: Nov 19, 2012)	no assertion criteria provided	VCV000048647	7	2984129	7	2944495	48647	57809	rs387907351	NC_000007.14:2944494:T:C
NM_015404.4(WHRN):c.643del (p.Val215fs)	WHRN	V215fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 5, 2012)	criteria provided, single submitter	VCV000045679	9	117241027	9	114478747	45679	54844	rs397517258	NC_000009.12:114478746:CC:C
NM_015404.4(WHRN):c.1267C>T (p.Arg423Ter)	WHRN	R423*, R40*, R72*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 4, 2010)	criteria provided, single submitter	VCV000045645	9	117186763	9	114424483	45645	54810	rs397517255	NC_000009.12:114424482:G:A
NM_015404.4(WHRN):c.26C>A (p.Ser9Ter)	WHRN	S9*	Deafness, autosomal recessive 31	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627492	9	117267056	9	114504776	627492	615804	rs776268964	NC_000009.12:114504775:G:T
NM_015404.4(WHRN):c.2423del (p.Gly808fs)	WHRN	G808fs, G807fs, G425fs, G457fs	Deafness, autosomal recessive 31	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000208207	9	117165615	9	114403335	208207	204465	rs869320674	NC_000009.12:114403334:CC:C
NM_032415.6(CARD11):c.368G>A (p.Gly123Asp)	CARD11	G123D	B-cell expansion with NFKB and T-cell anergy	Pathogenic(Last reviewed: Oct 29, 2014)	no assertion criteria provided	VCV000183144	7	2984162	7	2944528	183144	181280	rs571517554	NC_000007.14:2944527:C:T
NM_015404.4(WHRN):c.680dup (p.Tyr228fs)	WHRN		Usher syndrome, type 2D	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031705	9	117240989 - 117240990	9	114478709 - 114478710	31705	40365		NC_000009.12:114478709:CCCCC:CCCCCC
NM_015404.4(WHRN):c.737del (p.Pro246fs)	WHRN	P246fs	Usher syndrome, type 2D	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031704	9	117240933	9	114478653	31704	40364		NC_000009.12:114478652:GGGG:GGG
DFNB31, IVS2DS, G-A, +1	WHRN		Usher syndrome, type 2D	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002691					2691	17730		
NM_015404.4(WHRN):c.307C>T (p.Gln103Ter)	WHRN	Q103*	Usher syndrome, type 2D	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002690	9	117266775	9	114504495	2690	17729	rs137852840	NC_000009.12:114504494:G:A
NM_015404.4(WHRN):c.2332C>T (p.Arg778Ter)	WHRN	R778*, R395*, R427*, R777*	Deafness, autosomal recessive 31	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000002689	9	117166262	9	114403982	2689	17728	rs137852839	NC_000009.12:114403981:G:A
NM_000448.2(RAG1):c.2348C>G (p.Ser783Ter)	RAG1	S783*	Combined cellular and humoral immune defects with granulomas||Histiocytic medullary reticulosis|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity|Combined cellular and humoral immune defects with granulomas|	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000573434	11	36597202	11	36575652	573434	567241	rs754502950	NC_000011.10:36575651:C:G
NM_000448.2(RAG1):c.2974A>G (p.Lys992Glu)	RAG1	K992E	Combined cellular and humoral immune defects with granulomas||not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372488	11	36597828	11	36576278	372488	359938	rs539590514	NC_000011.10:36576277:A:G
RAG1, 1-BP DEL, 631T	RAG1		Histiocytic medullary reticulosis|Severe combined immunodeficiency, B cell-negative|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000013153					13153	28192		
NM_001540.5(HSPB1):c.380G>T (p.Arg127Leu)	HSPB1	R127L	Charcot-Marie-Tooth disease|	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000157529	7	75933134	7	76303817	157529	167391	rs587781250	NC_000007.14:76303816:G:T
GRCh37/hg19 9q31.1(chr9:102965586-103023946)x1	INVS		not provided	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000688978	9	102965586 - 103023946			688978	676570		
NM_014425.5(INVS):c.2097_2098del (p.Gln699fs)	INVS	Q699fs, Q373fs, Q603fs	not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000596625	9	103054636 - 103054637	9	100292354 - 100292355	596625	587686	rs1564193130	NC_000009.12:100292353:AT:
NM_014425.5(INVS):c.1464+1G>T	INVS		not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000594813	9	103015419	9	100253137	594813	585875	rs375753623	NC_000009.12:100253136:G:T
NM_014425.5(INVS):c.662dup (p.Arg222fs)	INVS		not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	VCV000284310	9	103002385 - 103002386	9	100240103 - 100240104	284310	268547	rs769739938	NC_000009.12:100240103:GGG:GGGG
NM_014425.5(INVS):c.2509C>T (p.Gln837Ter)	INVS	Q837*, Q741*, Q511*	not provided	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000194404	9	103055048	9	100292766	194404	191567	rs755549444	NC_000009.12:100292765:C:T
NM_014425.5(INVS):c.671_672CT[1] (p.Leu225fs)	INVS		Nephronophthisis	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000859885	9	103002397 - 103002398	9	100240115 - 100240116	859885	835285		NC_000009.12:100240114:CTCT:CT
NM_014425.5(INVS):c.2972C>G (p.Ser991Ter)	INVS	S665*, S895*, S991*	Nephronophthisis	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000834292	9	103059384	9	100297102	834292	835300		NC_000009.12:100297101:C:G
NC_000009.11:g.(?_102888645)_(102888851_?)del	INVS		Nephronophthisis	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000583808	9	102888645 - 102888851	9	100126363 - 100126569	583808	562568		
NM_014425.5(INVS):c.177_180dup (p.Leu61fs)	INVS		Nephronophthisis	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000568738	9	102888732 - 102888733	9	100126450 - 100126451	568738	562618	rs1564123602	NC_000009.12:100126450:GACAGA:GACAGACAGA
NM_014425.5(INVS):c.2887C>T (p.Gln963Ter)	INVS	Q963*, Q637*, Q867*	Nephronophthisis	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000567470	9	103059299	9	100297017	567470	563264	rs1425211517	NC_000009.12:100297016:C:T
NM_014425.5(INVS):c.2056A>T (p.Arg686Ter)	INVS	R686*, R360*, R590*	Nephronophthisis	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000531629	9	103046873	9	100284591	531629	524121	rs150001738	NC_000009.12:100284590:A:T
NC_000009.11:g.(?_102866780)_(102866909_?)del	INVS		Nephronophthisis	Pathogenic(Last reviewed: Aug 14, 2016)	criteria provided, single submitter	VCV000417554	9	102866780 - 102866909	9	100104498 - 100104627	417554	396652		
NM_014425.5(INVS):c.3125del (p.Asn1042fs)	INVS	N1042fs, N716fs, N946fs	Nephronophthisis	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000242359	9	103062882	9	100300600	242359	243909	rs878855333	NC_000009.12:100300599:AA:A
NM_014425.5(INVS):c.1417del (p.Ala473fs)	INVS	A473fs, A377fs, A147fs	Nephronophthisis	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000242358	9	103015370	9	100253088	242358	243907	rs878855332	NC_000009.12:100253087:GG:G
NM_000370.3(TTPA):c.400C>T (p.Arg134Ter)	TTPA	R134*	Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009141	8	63978615	8	63066056	9141	24180	rs121917851	NC_000008.11:63066055:G:A
NM_014425.5(INVS):c.2719C>T (p.Arg907Ter)	INVS	R907*, R581*, R811*	Infantile nephronophthisis	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000011961	9	103055258	9	100292976	11961	27000	rs267607185	NC_000009.12:100292975:C:T
NM_014425.5(INVS):c.1478T>C (p.Leu493Ser)	INVS	L493S, L397S, L167S	Infantile nephronophthisis	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011960	9	103027117	9	100264835	11960	26999	rs121964995	NC_000009.12:100264834:T:C
NM_003977.4(AIP):c.805_825dup (p.Phe269_His275dup)	AIP		Somatotroph adenoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000041208	11	67258273 - 67258274	11	67490802 - 67490803	41208	49630	rs267606578	NC_000011.10:67490802:ACTTCAAGCGGGGCAAGGCCCAC:ACTTCAAGCGGGGCAAGGCCCACTTCAAGCGGGGCAAGGCCCAC
NM_001026213.1(CYP11B1):c.317_344del (p.Leu106fs)	CYP11B1	L106fs	Deficiency of steroid 11-beta-monooxygenase|not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551876	8	143960499 - 143960526	8	142879083 - 142879110	551876	544396	rs764418169	NC_000008.11:142879082:GGCTCCAGGCTCATCCTGTGGGGATGCAGGCT:GGCT
NM_006096.3(NDRG1):c.681dup (p.Ile228fs)	NDRG1		not provided	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000246500	8	134262699 - 134262700	8	133250456 - 133250457	246500	244510	rs879254290	NC_000008.11:133250456:G:GG
NG_007943.1:g.(43089_43830)_(47717_51712)dup	NDRG1		Charcot-Marie-Tooth disease, type 4D	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000132796	8	134262787 - 134271410	8	133250544 - 133259167	132796	136545		
NM_006096.4(NDRG1):c.604C>T (p.Gln202Ter)	NDRG1	Q136*, Q121*, Q202*, Q219*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000845545	8	134262777	8	133250534	845545	834151		NC_000008.11:133250533:G:A
NM_001040716.2(PC):c.1892G>A (p.Arg631Gln)	PC	R631Q	not provided|Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000021222	11	66619351	11	66851880	21222	34074	rs113994145	NC_000011.10:66851879:C:T
NM_177924.5(ASAH1):c.125+1G>A	ASAH1		not provided|Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000662497	8	17933049	8	18075540	662497	651777		NC_000008.11:18075539:C:T
NM_177924.5(ASAH1):c.125C>T (p.Thr42Met)	ASAH1	T42M, T58M, T58I	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000035544	8	17933050	8	18075541	35544	44215	rs145873635	NC_000008.11:18075540:G:A
NM_152419.3(HGSNAT):c.398G>C (p.Gly133Ala)	HGSNAT	G133A	Retinitis pigmentosa 73	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208814	8	43014092	8	43158949	208814	205375	rs797045120	NC_000008.11:43158948:G:C
NM_152419.3(HGSNAT):c.1437dup (p.Ile480fs)	HGSNAT		Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000840032	8	43048957 - 43048958	8	43193814 - 43193815	840032	834791		NC_000008.11:43193814:CC:CCC
NM_152419.3(HGSNAT):c.1174C>T (p.Gln392Ter)	HGSNAT	Q104*, Q328*, Q392*	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000837469	8	43046662	8	43191519	837469	834788		NC_000008.11:43191518:C:T
NC_000008.11:g.(?_43169153)_(43178254_?)del	HGSNAT		Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832880	8	43024296 - 43033397			832880	819966		
NC_000008.11:g.(?_43140497)_(43161507_?)del	HGSNAT		Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000832581	8	42995640 - 43016650			832581	819965		
NM_152419.3(HGSNAT):c.1616C>G (p.Ser539Cys)	HGSNAT	S251C, S475C, S539C, S568C	Mucopolysaccharidosis	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000830366	8	43052985	8	43197842	830366	818747		NC_000008.11:43197841:C:G
NM_152419.3(HGSNAT):c.784G>A (p.Gly262Arg)	HGSNAT	G262R	Mucopolysaccharidosis	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000830365	8	43027493	8	43172350	830365	818746		NC_000008.11:43172349:G:A
NM_152419.3(HGSNAT):c.164T>A (p.Leu55Ter)	HGSNAT	L55*	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000651853	8	43002136	8	43146993	651853	637223		NC_000008.11:43146992:T:A
NM_152419.3(HGSNAT):c.1048C>T (p.Gln350Ter)	HGSNAT	Q350*, Q286*, Q62*	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638471	8	43037323	8	43182180	638471	626178		NC_000008.11:43182179:C:T
NM_152419.3(HGSNAT):c.887C>A (p.Ser296Ter)	HGSNAT	S296*, S8*	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000542424	8	43033252	8	43178109	542424	523582	rs372933126	NC_000008.11:43178108:C:A
NM_152419.3(HGSNAT):c.525dup (p.Val176fs)	HGSNAT		Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000001235	8	43016611 - 43016612	8	43161468 - 43161469	1235	16274	rs483352895	NC_000008.11:43161468:T:TT
NM_152419.3(HGSNAT):c.1445T>A (p.Met482Lys)	HGSNAT	M510K, M482K, M418K, M194K	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001234	8	43048967	8	43193824	1234	16273	rs121908284	NC_000008.11:43193823:T:A
NM_152419.3(HGSNAT):c.962T>G (p.Leu321Ter)	HGSNAT	L349*, L321*, L33*	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001233	8	43033327	8	43178184	1233	16272	rs121908283	NC_000008.11:43178183:T:G
Single allele	NDRG1		Charcot-Marie-Tooth disease, type 4D	Pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	VCV000218919	8	134265065 - 134271319			218919	215728		
NM_152419.3(HGSNAT):c.1464+1G>A	HGSNAT		not provided|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096502	8	43048987	8	43193844	96502	102396	rs398124545	NC_000008.11:43193843:G:A
NM_152419.3(HGSNAT):c.1553C>T (p.Ser518Phe)	HGSNAT	S518F, S230F, S454F, S547F	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000001238	8	43052825	8	43197682	1238	16277	rs121908286	NC_000008.11:43197681:C:T
NM_000448.3(RAG1):c.1181G>A (p.Arg394Gln)	RAG1	R394Q	|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000863577	11	36596035	11	36574485	863577	838367		NC_000011.10:36574484:G:A
NM_000448.3(RAG1):c.1228C>T (p.Arg410Trp)	RAG1	R410W	Combined cellular and humoral immune defects with granulomas|	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000859249	11	36596082	11	36574532	859249	838369		NC_000011.10:36574531:C:T
NM_000448.2(RAG1):c.1421G>A (p.Arg474His)	RAG1	R474H	|Combined cellular and humoral immune defects with granulomas|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000068684	11	36596275	11	36574725	68684	79576	rs199474686	NC_000011.10:36574724:G:A
NM_000448.2(RAG1):c.983G>A (p.Cys328Tyr)	RAG1	C328Y	Histiocytic medullary reticulosis|Combined cellular and humoral immune defects with granulomas|	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000013160	11	36595837	11	36574287	13160	28199	rs121918571	NC_000011.10:36574286:G:A
NM_000448.2(RAG1):c.1681C>T (p.Arg561Cys)	RAG1	R561C	Severe combined immunodeficiency, B cell-negative||Histiocytic medullary reticulosis	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000013148	11	36596535	11	36574985	13148	28187	rs104894285	NC_000011.10:36574984:C:T
NM_006096.3(NDRG1):c.205+1G>A	NDRG1		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000410952	8	134276789	8	133264546	410952	396584	rs1060503092	NC_000008.11:133264545:C:T
NM_152419.3(HGSNAT):c.852-1G>A	HGSNAT		Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556501	8	43033216	8	43178073	556501	544779	rs1447092074	NC_000008.11:43178072:G:A
NM_152419.3(HGSNAT):c.518G>A (p.Gly173Asp)	HGSNAT	G173D	Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000252961	8	43016605	8	43161462	252961	247363	rs370717845	NC_000008.11:43161461:G:A
NM_003156.3(STIM1):c.343A>T (p.Ile115Phe)	STIM1	I115F	not provided|Combined immunodeficiency due to STIM1 deficiency|Stormorken syndrome|Myopathy, tubular aggregate, 1|Myopathy, tubular aggregate, 1|Stormorken syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000143191	11	4045175	11	4023945	143191	152909	rs527236030	NC_000011.10:4023944:A:T
NM_021930.6(RINT1):c.1102G>A (p.Ala368Thr)	RINT1	A368T, A290T, A27T, A60T	INFANTILE LIVER FAILURE SYNDROME 3	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692228	7	105190607	7	105550160	692228	680032		NC_000007.14:105550159:G:A
NM_021930.6(RINT1):c.1333+1G>T	RINT1		INFANTILE LIVER FAILURE SYNDROME 3	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692227	7	105190934	7	105550487	692227	680031		NC_000007.14:105550486:G:T
NM_021930.6(RINT1):c.1109T>C (p.Leu370Pro)	RINT1	L370P, L62P, L292P, L29P	INFANTILE LIVER FAILURE SYNDROME 3|Fulminant hepatic failure	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000599396	7	105190709	7	105550262	599396	590732	rs1562849964	NC_000007.14:105550261:T:C
NM_033360.4(KRAS):c.182A>C (p.Gln61Pro)	KRAS	Q61P	Neoplasm of the large intestine|Neoplasm of the thyroid gland	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375966	12	25380276	12	25227342	375966	362845	rs121913240	NC_000012.12:25227341:T:G
NM_033360.4(KRAS):c.*20T>A	KRAS	F156I	Cardio-facio-cutaneous syndrome|Noonan syndrome|not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163758	12	25362830	12	25209896	163758	175711	rs397517042	NC_000012.12:25209895:A:T
NM_033360.4(KRAS):c.*20T>G	KRAS	F156V	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045127	12	25362830	12	25209896	45127	54294	rs397517042	NC_000012.12:25209895:A:C
NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	KRAS	G60S	Noonan syndrome 3|Rasopathy|not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012597	12	25380280	12	25227346	12597	27636	rs104894359	NC_000012.12:25227345:C:T
GRCh37/hg19 6q14.1(chr6:80964546-80983538)x1	BCKDHB		not provided	Pathogenic(Last reviewed: Jan 19, 2018)	no assertion criteria provided	VCV000688802	6	80964546 - 80983538			688802	676394		
NM_183050.4(BCKDHB):c.776del (p.Pro259fs)	BCKDHB	P189fs, P259fs	not provided	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000424275	6	80910682	6	80200965	424275	406935	rs1064796892	NC_000006.12:80200964:CCC:CC
NM_183050.4(BCKDHB):c.952-1G>A	BCKDHB		not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000096620	6	80982851	6	80273134	96620	102513	rs398124602	NC_000006.12:80273133:G:A
NM_183050.4(BCKDHB):c.592_593del (p.Gln198fs)	BCKDHB	Q128fs, Q198fs	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000096598	6	80878706 - 80878707	6	80168989 - 80168990	96598	102491	rs398124586	NC_000006.12:80168988:CA:
NM_183050.4(BCKDHB):c.526A>T (p.Asn176Tyr)	BCKDHB	N176Y, N106Y	not provided	Pathogenic(Last reviewed: Sep 4, 2013)	criteria provided, single submitter	VCV000096593	6	80878640	6	80168923	96593	102486	rs398124582	NC_000006.12:80168922:A:T
NM_183050.4(BCKDHB):c.488A>T (p.Glu163Val)	BCKDHB	E163V, E93V	not provided	Pathogenic(Last reviewed: Sep 4, 2013)	criteria provided, single submitter	VCV000096584	6	80878602	6	80168885	96584	102477	rs398124577	NC_000006.12:80168884:A:T
NM_183050.4(BCKDHB):c.344-1G>A	BCKDHB		not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000096580	6	80877394	6	80167677	96580	102473	rs398124574	NC_000006.12:80167676:G:A
BCKDHB, 8-BP INS, NT1109	BCKDHB		MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011941					11941	26980		
NM_183050.2(BCKDHB):c.1039-7_1039-4delTCTG	BCKDHB		MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011940					11940	26979		
NM_183050.4(BCKDHB):c.356T>G (p.Val119Gly)	BCKDHB	V69G, V119G, V49G	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011939	6	80877407	6	80167690	11939	26978	rs121965005	NC_000006.12:80167689:T:G
NM_183050.4(BCKDHB):c.616C>T (p.His206Tyr)	BCKDHB	H156Y, H206Y, H136Y	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011938	6	80878730	6	80169013	11938	26977	rs121965004	NC_000006.12:80169012:C:T
NM_183050.4(BCKDHB):c.908dup (p.Asp303fs)	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000849015	6	80912885 - 80912886	6	80203168 - 80203169	849015	832588		NC_000006.12:80203168:A:AA
NM_183050.4(BCKDHB):c.583dup (p.Tyr195fs)	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000838288	6	80878696 - 80878697	6	80168979 - 80168980	838288	832586		NC_000006.12:80168979:T:TT
NC_000006.12:g.(?_80200924)_(80201041_?)del	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000831655	6	80910641 - 80910758			831655	819758		
NM_183050.4(BCKDHB):c.70_71insTTCCTGGCAGGGGCTGAGGA (p.Arg24delinsLeuProGlyArgGlyTer)	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000653956	6	80816480 - 80816481	6	80106763 - 80106764	653956	635310		NC_000006.12:80106763::TTCCTGGCAGGGGCTGAGGA
NM_183050.4(BCKDHB):c.57_64dup (p.His22fs)	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000568561	6	80816460 - 80816461	6	80106743 - 80106744	568561	561122	rs1410520713	NC_000006.12:80106743:AGGGGCTGAGGGGC:AGGGGCTGAGGGGCTGAGGGGC
NM_183050.4(BCKDHB):c.714dup (p.Glu239Ter)	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000527130	6	80881073 - 80881074	6	80171356 - 80171357	527130	522231	rs1167005638	NC_000006.12:80171356:TTTTTT:TTTTTTT
NM_183050.4(BCKDHB):c.152del (p.Val51fs)	BCKDHB	V51fs	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000527129	6	80816562	6	80106845	527129	522220	rs867612284	NC_000006.12:80106844:T:
NM_183050.4(BCKDHB):c.348del (p.Asp117fs)	BCKDHB	D117fs, D47fs	Maple syrup urine disease	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000457148	6	80877396	6	80167679	457148	456100	rs1400121541	NC_000006.12:80167678:AAAA:AAA
NM_000056.4(BCKDHB):c.-66_196+1del	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000224058	6	80816344 - 80816606	6	80106627 - 80106889	224058	225782	rs1554180622	
NM_183050.4(BCKDHB):c.3G>A (p.Met1Ile)	BCKDHB	M1I	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000224057	6	80816413	6	80106696	224057	225783	rs869312128	NC_000006.12:80106695:G:A
NM_183050.4(BCKDHB):c.197-2A>G	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	VCV000224056	6	80837262	6	80127545	224056	225784	rs869312127	NC_000006.12:80127544:A:G
NM_183050.4(BCKDHB):c.554C>T (p.Pro185Leu)	BCKDHB	P185L, P115L	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2010)	criteria provided, single submitter	VCV000224055	6	80878668	6	80168951	224055	225787	rs148905512	NC_000006.12:80168950:C:T
NM_000941.3(POR):c.1370G>A (p.Arg457His)	POR	R457H	Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016907	7	75614497	7	75985179	16907	31946	rs28931608	NC_000007.14:75985178:G:A
NM_007055.4(POLR3A):c.2617-1G>A	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome|Hypomyelinating leukodystrophy 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031146	10	79753126	10	77993368	31146	40103	rs181087667	NC_000010.11:77993367:C:T
NC_000006.12:g.(?_80106674)_(80106909_?)del	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000832004	6	80816391 - 80816626			832004	819756		
NM_183050.4(BCKDHB):c.564T>A (p.Cys188Ter)	BCKDHB	C188*, C118*	Maple syrup urine disease	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000580585	6	80878678	6	80168961	580585	563824	rs774306610	NC_000006.12:80168960:T:A
NM_183050.4(BCKDHB):c.275-2A>G	BCKDHB		Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449661	6	80838876	6	80129159	449661	444020	rs1554184224	NC_000006.12:80129158:A:G
NM_183050.4(BCKDHB):c.79_89del (p.Pro27fs)	BCKDHB	P27fs	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370823	6	80816489 - 80816499	6	80106772 - 80106782	370823	357517	rs1057516795	NC_000006.12:80106771:CCTGGCGCGGG:
NM_183050.4(BCKDHB):c.840+1G>T	BCKDHB		Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000370274	6	80910749	6	80201032	370274	357524	rs760538465	NC_000006.12:80201031:G:T
NM_183050.4(BCKDHB):c.964A>G (p.Thr322Ala)	BCKDHB	T322A, T252A	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000224061	6	80982864	6	80273147	224061	225788	rs869312131	NC_000006.12:80273146:A:G
NM_183050.4(BCKDHB):c.401T>A (p.Ile134Asn)	BCKDHB	I134N, I64N	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2011)	criteria provided, single submitter	VCV000224060	6	80877452	6	80167735	224060	225786	rs869312130	NC_000006.12:80167734:T:A
NM_183050.4(BCKDHB):c.840+2T>G	BCKDHB		not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000096611	6	80910750	6	80201033	96611	102504	rs398124596	NC_000006.12:80201032:T:G
NM_183050.4(BCKDHB):c.342T>G (p.Tyr114Ter)	BCKDHB	Y114*, Y44*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000096579	6	80838945	6	80129228	96579	102472	rs398124573	NC_000006.12:80129227:T:G
NC_000008.11:g.(?_43196928)_(43197972_?)del	HGSNAT		Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000830681	8	43052071 - 43053115			830681	819967		
NM_152419.3(HGSNAT):c.607C>T (p.Arg203Ter)	HGSNAT	R203*	Sanfilippo syndrome|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569138	8	43024359	8	43169216	569138	562427	rs1563366896	NC_000008.11:43169215:C:T
NM_031466.8(TRAPPC9):c.-125_-124insTACCGTGAGGGTCACGGGGG	TRAPPC9		not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000817852	8	141468493 - 141468494	8	140458394 - 140458395	817852	806282		NC_000008.11:140458394:CCCCCGTGAC:CCCCCGTGACCCTCACGGTACCCCCGTGAC
GRCh37/hg19 8q24.3(chr8:141270416-141289943)x1	TRAPPC9		not provided	Pathogenic(Last reviewed: Sep 19, 2018)	no assertion criteria provided	VCV000688310	8	141270416 - 141289943			688310	675902		
NM_001160372.4(TRAPPC9):c.370_373dup (p.Val125fs)	TRAPPC9		Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000437052	8	141461099 - 141461100	8	140451000 - 140451001	437052	428796	rs1174482090	NC_000008.11:140451000:CGATC:CGATCGATC
NM_001160372.4(TRAPPC9):c.531dup (p.Leu178fs)	TRAPPC9		Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000437051	8	141460941 - 141460942	8	140450842 - 140450843	437051	428794	rs1554689877	NC_000008.11:140450842:AA:AAA
NM_001160372.4(TRAPPC9):c.2557-2A>C	TRAPPC9		Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041419	8	141034178	8	140024081	41419	49854		NC_000008.11:140024080:T:G
NM_001160372.4(TRAPPC9):c.2491C>T (p.Arg831Ter)	TRAPPC9	R822*, R831*, R929*	Intellectual disability	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000694658	8	141231623	8	140221524	694658	682754		NC_000008.11:140221523:G:A
TRAPPC9, 4-BP DEL, 2311TGTT	TRAPPC9		Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000000760					760	15799		
NM_001160372.4(TRAPPC9):c.367G>T (p.Glu123Ter)	TRAPPC9	E221*, E123*	Mental retardation, autosomal recessive 13|not provided	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, multiple submitters, no conflicts	VCV000130637	8	141461106	8	140451007	130637	136083	rs587780486	NC_000008.11:140451006:C:A
NM_001160372.4(TRAPPC9):c.1129C>T (p.Arg377Ter)	TRAPPC9	R475*, R377*, R368*	Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000000758	8	141407724	8	140397625	758	15797	rs267607136	NC_000008.11:140397624:G:A
NM_183050.4(BCKDHB):c.403G>A (p.Gly135Arg)	BCKDHB	G135R, G65R	Maple syrup urine disease type 1B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496569	6	80877454	6	80167737	496569	487098	rs751953459	NC_000006.12:80167736:G:A
NM_183050.4(BCKDHB):c.1022T>A (p.Ile341Asn)	BCKDHB	I341N, I271N	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203639	6	80982922	6	80273205	203639	200129	rs796051939	NC_000006.12:80273204:T:A
NM_183050.4(BCKDHB):c.748G>T (p.Glu250Ter)	BCKDHB	E250*, E180*	Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096607	6	80910656	6	80200939	96607	102500	rs398124592	NC_000006.12:80200938:G:T
NM_004629.2(FANCG):c.1158dup (p.Ser387fs)	FANCG		Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623182	9	35075736 - 35075737	9	35075739 - 35075740	623182	612190	rs757418016	NC_000009.12:35075739:GGGGGG:GGGGGGG
NM_004629.1(FANCG):c.1066C>T (p.Gln356Ter)	FANCG	Q356*	Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000006715	9	35076439	9	35076442	6715	21754	rs121434426	NC_000009.12:35076441:G:A
NM_007126.5(VCP):c.277C>T (p.Arg93Cys)	VCP	R93C, R48C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000593071	9	35067913	9	35067916	593071	584135	rs1554669087	NC_000009.12:35067915:G:A
NM_000019.4(ACAT1):c.757G>A (p.Asp253Asn)	ACAT1	D253N	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 4, 2012)	criteria provided, single submitter	VCV000225062	11	108012358	11	108141631	225062	226924	rs869312946	NC_000011.10:108141630:G:A
NM_000048.4(ASL):c.299T>C (p.Ile100Thr)	ASL	I100T	Argininosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495379	7	65547874	7	66082887	495379	487358	rs202142867	NC_000007.14:66082886:T:C
NM_000048.4(ASL):c.545G>A (p.Arg182Gln)	ASL	R182Q	Argininosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203613	7	65551751	7	66086764	203613	200152	rs751590073	NC_000007.14:66086763:G:A
NM_000048.4(ASL):c.544C>T (p.Arg182Ter)	ASL	R182*	not provided|Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092362	7	65551750	7	66086763	92362	98273	rs398123126	NC_000007.14:66086762:C:T
NM_014425.5(INVS):c.1453del (p.Gln485fs)	INVS	Q159fs, Q485fs, Q389fs	Infantile nephronophthisis|not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011963	9	103015407	9	100253125	11963	27002	rs753348470	NC_000009.12:100253124:C:
NM_001191061.2(SLC25A22):c.146+2_146+3del	SLC25A22		not provided	Pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000207163	11	794773 - 794774	11	794773 - 794774	207163	202640	rs796053238	NC_000011.10:794772:CACA:CA
NC_000011.10:g.(?_791895)_(795026_?)del	SLC25A22		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000833412	11	791895 - 795026			833412	820418		
NM_001191061.2(SLC25A22):c.818G>A (p.Arg273Lys)	SLC25A22	R273K	Early myoclonic encephalopathy	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000626258	11	792142	11	792142	626258	614552	rs1195505218	NC_000011.10:792141:C:T
NM_001191061.2(SLC25A22):c.271C>T (p.Arg91Ter)	SLC25A22	R91*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000530429	11	793551	11	793551	530429	527067	rs936639741	NC_000011.10:793550:G:A
NM_001191061.2(SLC25A22):c.328G>C (p.Gly110Arg)	SLC25A22	G110R	Early myoclonic encephalopathy	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000120308	11	792954	11	792954	120308	125902	rs587777243	NC_000011.10:792953:C:G
NM_001191061.2(SLC25A22):c.706G>T (p.Gly236Trp)	SLC25A22	G236W	Early myoclonic encephalopathy	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001776	11	792340	11	792340	1776	16815	rs121918335	NC_000011.10:792339:C:A
NM_000448.2(RAG1):c.1187G>A (p.Arg396His)	RAG1	R396H	|Combined cellular and humoral immune defects with granulomas|Histiocytic medullary reticulosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000013146	11	36596041	11	36574491	13146	28185	rs104894291	NC_000011.10:36574490:G:A
NM_001191061.2(SLC25A22):c.811_812TG[1] (p.Ala272fs)	SLC25A22		Early myoclonic encephalopathy	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000618891	11	792146 - 792147	11	792146 - 792147	618891	610292	rs1565035177	NC_000011.10:792145:CACA:CA
NM_000401.3(EXT2):c.778G>A (p.Asp260Asn)	EXT2	D227N, D260N	Seizures, scoliosis, and macrocephaly syndrome|Multiple exostoses type 2	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000002474	11	44135787	11	44114237	2474	17513	rs121918280	NC_000011.10:44114236:G:A
NM_033100.4(CDHR1):c.1485+2T>C	CDHR1		Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000847679	10	85970923	10	84211167	847679	852268		NC_000010.11:84211166:T:C
NM_001191061.2(SLC25A22):c.418C>T (p.Gln140Ter)	SLC25A22	Q140*	not provided|Early myoclonic encephalopathy	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212198	11	792722	11	792722	212198	207916	rs797045969	NC_000011.10:792721:G:A
NM_001160372.4(TRAPPC9):c.1414C>T (p.Arg472Ter)	TRAPPC9	R570*, R472*, R463*	Mental retardation, autosomal recessive 13|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000759	8	141370230	8	140360131	759	15798	rs267607137	NC_000008.11:140360130:G:A
NM_001191061.2(SLC25A22):c.394C>T (p.Gln132Ter)	SLC25A22	Q132*	Early infantile epileptic encephalopathy|Early myoclonic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000436749	11	792888	11	792888	436749	429321	rs1554965669	NC_000011.10:792887:G:A
NM_001191061.2(SLC25A22):c.735_736del (p.Pro245_Cys246insTer)	SLC25A22		Early infantile epileptic encephalopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207174	11	792310 - 792311	11	792310 - 792311	207174	202623	rs796053242	NC_000011.10:792309:AG:
NM_183050.4(BCKDHB):c.1114G>T (p.Glu372Ter)	BCKDHB	E372*, E302*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000065770	6	81053456	6	80343739	65770	76678	rs386834234	NC_000006.12:80343738:G:T
NM_013266.4(CTNNA3):c.281T>A (p.Val94Asp)	CTNNA3	V94D, V106D	Arrhythmogenic right ventricular dysplasia, familial, 13	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000100656	10	69366626	10	67606868	100656	106528	rs587777134	NC_000010.11:67606867:A:T
NM_152419.3(HGSNAT):c.1516C>T (p.Arg506Ter)	HGSNAT	R506*, R218*, R535*, R442*	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552134	8	43052142	8	43196999	552134	544843	rs747240928	NC_000008.11:43196998:C:T
NM_006415.4(SPTLC1):c.398G>A (p.Cys133Tyr)	SPTLC1	C133Y	Neuropathy hereditary sensory and autonomic type 1|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000004800	9	94842327	9	92080045	4800	19839	rs119482081	NC_000009.12:92080044:C:T
NM_000890.5(KCNJ5):c.472A>G (p.Thr158Ala)	KCNJ5	T158A	Aldosterone-producing adrenal adenoma, somatic|Andersen Tawil syndrome|Familial hyperaldosteronism type 3	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000030125	11	128781640	11	128911745	30125	39081	rs387906778	NC_000011.10:128911744:A:G
NM_000035.4(ALDOB):c.1013C>T (p.Ala338Val)	ALDOB	A338V	Hereditary fructosuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188739	9	104184173	9	101421891	188739	186775	rs77718928	NC_000009.12:101421890:G:A
NM_033360.4(KRAS):c.351A>T (p.Lys117Asn)	KRAS	K117N	Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375964	12	25378647	12	25225713	375964	362843	rs770248150	NC_000012.12:25225712:T:A
NM_005502.4(ABCA1):c.5398A>C (p.Asn1800His)	ABCA1	N1800H	ABCA1-Related Disorders	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000364389	9	107556776	9	104794495	364389	310464	rs146292819	NC_000009.12:104794494:T:G
NM_006624.5(ZMYND11):c.1072C>T (p.Arg358Ter)	ZMYND11	R358*, R201*, R239*, R256*, R318*, R327*, R336*, R282*, R304*, R264*, R332*, R341*, R273*, R303*, R357*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	VCV000520843	10	292827	10	246887	520843	511866	rs1554792556	NC_000010.11:246886:C:T
NM_019892.6(INPP5E):c.1132C>T (p.Arg378Cys)	INPP5E	R378C	Joubert syndrome|Patent ductus arteriosus|Short femur|Skeletal dysplasia|Clubfoot|Micrognathia|Vertebral hypoplasia|Chronic lung disease|Hemivertebrae|Pseudoarthrosis|Interstitial pulmonary abnormality|Respiratory failure|Coat hanger sign of ribs|Preaxial foot polydactyly|Vertebral segmentation defect|Cleft palate|Absent epiphyses|Joubert syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000400	9	139327634	9	136433182	400	15439	rs121918130	NC_000009.12:136433181:G:A
NM_019892.6(INPP5E):c.1304G>A (p.Arg435Gln)	INPP5E	R435Q, R434Q	Joubert syndrome|Retinal dystrophy|Joubert syndrome 1	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000399	9	139327014	9	136432562	399	15438	rs121918129	NC_000009.12:136432561:C:T
NM_018249.6(CDK5RAP2):c.250C>T (p.Leu84Phe)	CDK5RAP2	L84F	Microcephaly	Pathogenic	no assertion criteria provided	VCV000812994	9	123313126	9	120550848	812994	801105		NC_000009.12:120550847:G:A
GRCh37/hg19 9q33.2(chr9:123292273-123310996)x1	CDK5RAP2		not provided	Pathogenic(Last reviewed: May 22, 2018)	no assertion criteria provided	VCV000688332	9	123292273 - 123310996			688332	675924		
GRCh37/hg19 9q33.2(chr9:123292273-123310737)x1	CDK5RAP2		not provided	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000687236	9	123292273 - 123310737			687236	674828		
NM_018249.6(CDK5RAP2):c.1376del (p.Asn459fs)	CDK5RAP2	N459fs	Primary autosomal recessive microcephaly 3	Pathogenic	no assertion criteria provided	VCV000694012	9	123253691	9	120491413	694012	681827		NC_000009.12:120491412:TTTT:TTT
NM_018249.6(CDK5RAP2):c.4666_4667TC[2] (p.Leu1557fs)	CDK5RAP2		Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000446421	9	123170680 - 123170681	9	120408402 - 120408403	446421	439881	rs1554730137	NC_000009.12:120408401:GAGAGA:GAGA
NM_018249.6(CDK5RAP2):c.5121_5122GT[5] (p.Ser1710fs)	CDK5RAP2		Primary autosomal recessive microcephaly 3	Pathogenic	no assertion criteria provided	VCV000430628	9	123165262 - 123165263	9	120402984 - 120402985	430628	423859	rs1554728351	NC_000009.12:120402984:ACACACAC:ACACACACAC
NM_018249.6(CDK5RAP2):c.4207C>T (p.Arg1403Ter)	CDK5RAP2	R1403*, R1173*	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	VCV000210637	9	123177408	9	120415130	210637	207602	rs754282058	NC_000009.12:120415129:G:A
NM_018249.6(CDK5RAP2):c.1018del (p.Glu340fs)	CDK5RAP2	E340fs	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	VCV000210631	9	123287338	9	120525060	210631	207608	rs797045441	NC_000009.12:120525059:C:
NM_018249.6(CDK5RAP2):c.5227C>T (p.Gln1743Ter)	CDK5RAP2	Q1743*, Q1513*, Q1664*	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	VCV000158157	9	123165164	9	120402886	158157	168715	rs587783392	NC_000009.12:120402885:G:A
NM_018249.6(CDK5RAP2):c.4672C>T (p.Arg1558Ter)	CDK5RAP2	R1558*, R1328*	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Sep 19, 2013)	no assertion criteria provided	VCV000091407	9	123170679	9	120408401	91407	96884	rs373278668	NC_000009.12:120408400:G:A
NM_018249.6(CDK5RAP2):c.4546G>T (p.Glu1516Ter)	CDK5RAP2	E1516*, E1286*	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Sep 19, 2013)	no assertion criteria provided	VCV000091406	9	123171463	9	120409185	91406	96883	rs374351172	NC_000009.12:120409184:C:A
NM_018249.6(CDK5RAP2):c.700G>T (p.Glu234Ter)	CDK5RAP2	E234*	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000091405	9	123292381	9	120530103	91405	96882	rs398122971	NC_000009.12:120530102:C:A
NM_183050.4(BCKDHB):c.503G>A (p.Arg168His)	BCKDHB	R168H, R98H	Maple syrup urine disease	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000457149	6	80878617	6	80168900	457149	456437	rs749033513	NC_000006.12:80168899:G:A
NM_183050.4(BCKDHB):c.487G>T (p.Glu163Ter)	BCKDHB	E163*, E93*	Maple syrup urine disease type 1B|Maple syrup urine disease	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370827	6	80878601	6	80168884	370827	357521	rs1057516799	NC_000006.12:80168883:G:T
NM_183050.4(BCKDHB):c.1065del (p.Pro356fs)	BCKDHB	P356fs, P286fs	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224059	6	81053407	6	80343690	224059	225789	rs869312129	NC_000006.12:80343689:T:
NM_183050.4(BCKDHB):c.633+1G>A	BCKDHB		not provided|Maple syrup urine disease	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096602	6	80878748	6	80169031	96602	102495	rs398124589	NC_000006.12:80169030:G:A
NM_014425.5(INVS):c.1807C>T (p.Arg603Ter)	INVS	R603*, R507*, R277*	Nephronophthisis|Infantile nephronophthisis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011959	9	103046624	9	100284342	11959	26998	rs121964994	NC_000009.12:100284341:C:T
NM_018249.6(CDK5RAP2):c.4005-15A>G	CDK5RAP2		Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000002489	9	123182253	9	120419975	2489	17528	rs387906274	NC_000009.12:120419974:T:C
NM_054012.4(ASS1):c.566+1G>T	ASS1		not provided	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000379598	9	133346292	9	130470905	379598	370421	rs1057520659	NC_000009.12:130470904:G:T
NM_054012.4(ASS1):c.1064del (p.Lys355fs)	ASS1	K355fs	not provided	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000285378	9	133370346	9	130494959	285378	269615	rs886043088	NC_000009.12:130494958:AA:A
NM_054012.4(ASS1):c.793C>T (p.Arg265Cys)	ASS1	R265C	not provided	Pathogenic(Last reviewed: Jan 18, 2013)	criteria provided, single submitter	VCV000092373	9	133355791	9	130480404	92373	98284	rs148918985	NC_000009.12:130480403:C:T
NM_018972.4(GDAP1):c.862dup (p.Thr288fs)	GDAP1		Neuropathy, axonal, with vocal cord paresis, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004194	8	75276382 - 75276383	8	74364147 - 74364148	4194	19233		NC_000008.11:74364147:AAAAA:AAAAAA
NM_018972.4(GDAP1):c.928del (p.Arg310fs)	GDAP1	R201fs, R252fs, R242fs, R310fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637555	8	75276452	8	74364217	637555	625191		NC_000008.11:74364216:CC:C
NM_018972.4(GDAP1):c.1A>T (p.Met1Leu)	GDAP1	M1L	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637503	8	75262697	8	74350462	637503	625156		NC_000008.11:74350461:A:T
NM_001362931.2(GDAP1):c.694+932_694+1314del	GDAP1		Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549689	8	75276217 - 75276599	8	74363982 - 74364364	549689	540453	rs1554548327	
NM_006019.4(TCIRG1):c.2236+1G>A	TCIRG1		not provided|	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558226	11	67817722	11	68050255	558226	546282	rs1475338876	NC_000011.10:68050254:G:A
NM_006019.4(TCIRG1):c.2008C>T (p.Arg670Ter)	TCIRG1	R670*, R372*, R454*	|not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551284	11	67817250	11	68049783	551284	546277	rs371263807	NC_000011.10:68049782:C:T
NM_006019.4(TCIRG1):c.117+4A>T	TCIRG1		|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005462	11	67808859	11	68041392	5462	20501	rs751881962	NC_000011.10:68041391:A:T
NM_018249.6(CDK5RAP2):c.4005-1G>A	CDK5RAP2		Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	VCV000158146	9	123182239	9	120419961	158146	168726	rs587783387	NC_000009.12:120419960:C:T
NM_054012.4(ASS1):c.832del (p.Ser278fs)	ASS1	S278fs	Citrullinemia type I	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000845376	9	133355830	9	130480443	845376	835574		NC_000009.12:130480442:T:
NM_054012.4(ASS1):c.846C>A (p.Tyr282Ter)	ASS1	Y282*	Citrullinemia type I	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000840768	9	133364727	9	130489340	840768	835575		NC_000009.12:130489339:C:A
NM_054012.4(ASS1):c.774-2A>G	ASS1		Citrullinemia type I	Pathogenic	criteria provided, single submitter	VCV000813462	9	133355770	9	130480383	813462	801672		NC_000009.12:130480382:A:G
NM_054012.4(ASS1):c.689-2A>C	ASS1		Citrullinemia type I	Pathogenic	criteria provided, single submitter	VCV000813460	9	133355101	9	130479714	813460	801670		NC_000009.12:130479713:A:C
NM_054012.4(ASS1):c.484dup (p.Glu162fs)	ASS1		Citrullinemia type I	Pathogenic	criteria provided, single submitter	VCV000813409	9	133342173 - 133342174	9	130466786 - 130466787	813409	801668		NC_000009.12:130466786:GG:GGG
NM_054012.4(ASS1):c.469C>T (p.Arg157Cys)	ASS1	R157C	Citrullinemia type I	Pathogenic	criteria provided, single submitter	VCV000813408	9	133342160	9	130466773	813408	801667		NC_000009.12:130466772:C:T
NM_054012.4(ASS1):c.421-2A>C	ASS1		Citrullinemia type I	Pathogenic	criteria provided, single submitter	VCV000813407	9	133342110	9	130466723	813407	801666		NC_000009.12:130466722:A:C
NM_054012.4(ASS1):c.352G>A (p.Ala118Thr)	ASS1	A118T	Citrullinemia type I	Pathogenic	criteria provided, single submitter	VCV000813406	9	133333965	9	130458578	813406	801665		NC_000009.12:130458577:G:A
NC_000009.11:g.(?_133327601)_(133329770_?)del	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000649068	9	133327601 - 133329770	9	130452214 - 130454383	649068	651832		
NC_000008.9:g.(75248716_75262617)_(75559358_75586021)del	GDAP1		Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000598944					598944	590031		
NM_054012.4(ASS1):c.319del (p.Gln107fs)	ASS1	Q107fs	Citrullinemia type I	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000573823	9	133333930	9	130458543	573823	565573	rs1564903969	NC_000009.12:130458542:CCC:CC
NM_054012.4(ASS1):c.120del (p.Lys41fs)	ASS1	K41fs	Citrullinemia type I	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000528374	9	133329706	9	130454319	528374	524366	rs1554982237	NC_000009.12:130454318:G:
Single allele	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000458669			9	130458401 - 130458589	458669	458127		
NM_054012.4(ASS1):c.851C>T (p.Thr284Ile)	ASS1	T284I	Citrullinemia type I	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000265961	9	133364732	9	130489345	265961	260672	rs886039853	NC_000009.12:130489344:C:T
NM_054012.4(ASS1):c.257G>A (p.Arg86His)	ASS1	R86H	Citrullinemia type I	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000265960	9	133333870	9	130458483	265960	260670	rs575001023	NC_000009.12:130458482:G:A
NM_018972.4(GDAP1):c.821C>T (p.Pro274Leu)	GDAP1	P274L, P216L, P165L, P206L	Charcot-Marie-Tooth disease type 2K	Pathogenic(Last reviewed: Aug 9, 2011)	no assertion criteria provided	VCV000050559	8	75276346	8	74364111	50559	59597	rs397515443	NC_000008.11:74364110:C:T
NM_018972.4(GDAP1):c.467C>G (p.Ala156Gly)	GDAP1	A156G, A47G, A88G	Charcot-Marie-Tooth disease type 2K	Pathogenic(Last reviewed: Aug 9, 2011)	no assertion criteria provided	VCV000050557	8	75272528	8	74360293	50557	59595	rs397515441	NC_000008.11:74360292:C:G
ASS1, IVS6, G-A, +5	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000006337					6337	21376		
ASS1, IVS6AS, A-G, -2	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000006323					6323	21362		
ASS1, EX6DEL	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000006322					6322	21361		
ASS1, EX5DEL	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000006321					6321	21360		
NM_018972.4(GDAP1):c.678A>T (p.Arg226Ser)	GDAP1	R226S, R117S, R168S, R158S	Charcot-Marie-Tooth disease type 2K	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000004204	8	75275272	8	74363037	4204	19243	rs267606842	NC_000008.11:74363036:A:T
NM_018972.4(GDAP1):c.719G>A (p.Cys240Tyr)	GDAP1	C240Y, C131Y, C182Y, C172Y	Charcot-Marie-Tooth disease type 2K	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000004203	8	75276244	8	74364009	4203	19242	rs121908115	NC_000008.11:74364008:G:A
NM_018972.4(GDAP1):c.652C>G (p.Gln218Glu)	GDAP1	Q218E, Q160E, Q109E, Q150E	Charcot-Marie-Tooth disease type 2K	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000004201	8	75275246	8	74363011	4201	19240	rs121908113	NC_000008.11:74363010:C:G
GDAP1, IVS4DS, G-A, +1	GDAP1		Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000004197					4197	19236		
NM_013266.4(CTNNA3):c.2293_2295TTG[1] (p.Leu766del)	CTNNA3	L766del	Arrhythmogenic right ventricular dysplasia, familial, 13|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	VCV000100657	10	67726472 - 67726474	10	65966714 - 65966716	100657	106529	rs587777135	NC_000010.11:65966713:CAACAA:CAA
NC_000012.12:g.1839550_1875411del	CACNA2D4		Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812253					812253	800696		
GRCh37/hg19 12p13.33(chr12:1950037-1985170)x1	CACNA2D4		not provided	Pathogenic(Last reviewed: May 24, 2017)	no assertion criteria provided	VCV000687142	12	1950037 - 1985170			687142	674734		
GRCh37/hg19 12p13.33(chr12:1949889-1986237)x1	CACNA2D4		not provided	Pathogenic(Last reviewed: Dec 20, 2017)	no assertion criteria provided	VCV000686567	12	1949889 - 1986237			686567	674159		
GRCh37/hg19 12p13.33(chr12:1949889-1986237)x1	CACNA2D4		not provided	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	VCV000686267	12	1949889 - 1986237			686267	673859		
GRCh37/hg19 12p13.33(chr12:1949889-1986237)x1	CACNA2D4		not provided	Pathogenic(Last reviewed: Mar 23, 2018)	no assertion criteria provided	VCV000685775	12	1949889 - 1986237			685775	673367		
GRCh37/hg19 12p13.33(chr12:1950037-1986237)x1	CACNA2D4		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000685389	12	1950037 - 1986237			685389	672981		
NM_172364.4(CACNA2D4):c.1720-74_2551+1189delinsTG	CACNA2D4		Retinal cone dystrophy 4	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000375308	12	1948716 - 1984577	12	1839550 - 1875410	375308	362084		
NC_000009.11:g.(?_133339478)_(133339574_?)del	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000583445	9	133339478 - 133339574	9	130464091 - 130464187	583445	565354		
NM_054012.4(ASS1):c.1128-6_1188dup	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000495381	9	133374882 - 133374883	9	130499495 - 130499496	495381	487354	rs1554725677	
NM_018972.4(GDAP1):c.929G>A (p.Arg310Gln)	GDAP1	R310Q, R201Q, R252Q, R242Q	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000449535	8	75276454	8	74364219	449535	444306	rs1323153568	NC_000008.11:74364218:G:A
NM_018972.4(GDAP1):c.501del (p.Glu168fs)	GDAP1	E59fs, E100fs, E110fs, E168fs	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000280104	8	75274135	8	74361900	280104	264285	rs886041386	NC_000008.11:74361899:A:
NM_018972.4(GDAP1):c.482G>A (p.Arg161His)	GDAP1	R161H, R52H, R93H	Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004192	8	75272543	8	74360308	4192	19231	rs104894076	NC_000008.11:74360307:G:A
NM_018972.4(GDAP1):c.92G>A (p.Trp31Ter)	GDAP1	W31*	Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004190	8	75262788	8	74350553	4190	19229	rs121908112	NC_000008.11:74350552:G:A
NM_001033855.3(DCLRE1C):c.241C>T (p.Arg81Ter)	DCLRE1C	R74*, R81*	Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004665	10	14987109	10	14945110	4665	19704	rs121908156	NC_000010.11:14945109:G:A
NM_152419.3(HGSNAT):c.1622C>T (p.Ser541Leu)	HGSNAT	S541L, S477L, S253L, S570L	Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569073	8	43052991	8	43197848	569073	567933	rs756310864	NC_000008.11:43197847:C:T
NM_152419.3(HGSNAT):c.739del (p.Arg247fs)	HGSNAT	R247fs	Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426971	8	43025833	8	43170690	426971	415132	rs1085307880	NC_000008.11:43170689:A:
NM_000448.2(RAG1):c.1210C>T (p.Arg404Trp)	RAG1	R404W	Combined cellular and humoral immune defects with granulomas||not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636824	11	36596064	11	36574514	636824	624428		NC_000011.10:36574513:C:T
NM_018249.6(CDK5RAP2):c.4604+1G>C	CDK5RAP2		Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000209967	9	123171404	9	120409126	209967	206557	rs869025200	NC_000009.12:120409125:C:G
NM_018249.6(CDK5RAP2):c.3097del (p.Val1033fs)	CDK5RAP2	V1033fs, V803fs	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000209966	9	123205949	9	120443671	209966	206558	rs747831095	NC_000009.12:120443670:C:
NM_018249.6(CDK5RAP2):c.246T>A (p.Tyr82Ter)	CDK5RAP2	Y82*	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000002488	9	123313130	9	120550852	2488	17527	rs199422126	NC_000009.12:120550851:A:T
NM_018972.4(GDAP1):c.817C>T (p.Arg273Ter)	GDAP1	R215*, R205*, R273*, R164*	Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000849494	8	75276342	8	74364107	849494	835045		NC_000008.11:74364106:C:T
NM_054012.4(ASS1):c.174+1G>T	ASS1		Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000623124	9	133329761	9	130454374	623124	612131	rs748264993	NC_000009.12:130454373:G:T
NM_054012.4(ASS1):c.931C>T (p.Gln311Ter)	ASS1	Q311*	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000552773	9	133364812	9	130489425	552773	545228	rs1301613270	NC_000009.12:130489424:C:T
NM_054012.4(ASS1):c.370G>A (p.Asp124Asn)	ASS1	D124N	Citrullinemia type I	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000458673	9	133339504	9	130464117	458673	458934	rs936192871	NC_000009.12:130464116:G:A
NM_054012.4(ASS1):c.773+1G>A	ASS1		Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371254	9	133355188	9	130479801	371254	357780	rs982830431	NC_000009.12:130479800:G:A
NM_054012.4(ASS1):c.496-2A>G	ASS1		Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092368	9	133346219	9	130470832	92368	98279	rs398123130	NC_000009.12:130470831:A:G
ASS1, IVS15, G-C, -1	ASS1		Citrullinemia type I	Pathogenic(Last reviewed: Aug 15, 2004)	no assertion criteria provided	VCV000006338					6338	21377		
GRCh37/hg19 7q21.2(chr7:91809746-91836087)x1	KRIT1		not provided	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000815009	7	91809746 - 91836087			815009	803218		
NM_194456.1(KRIT1):c.1315G>T (p.Gly439Ter)	KRIT1	G201*, G391*, G439*	not specified	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000811393	7	91852232	7	92222918	811393	799521		NC_000007.14:92222917:C:A
NM_194456.1(KRIT1):c.1775del (p.Ser592fs)	KRIT1	S354fs, S592fs, S544fs	not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000618697	7	91843249	7	92213935	618697	609676	rs1563242833	NC_000007.14:92213934:C:
NM_194456.1(KRIT1):c.999del (p.Val334fs)	KRIT1	V96fs, V334fs, V286fs	not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000524040	7	91855987	7	92226673	524040	514562	rs1554518750	NC_000007.14:92226672:TTTT:TTT
NM_194456.1(KRIT1):c.1970dup (p.Val658fs)	KRIT1		not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000503997	7	91842563 - 91842564	7	92213249 - 92213250	503997	495343	rs1554502838	NC_000007.14:92213249:GGG:GGGG
NM_194456.1(KRIT1):c.690C>G (p.Tyr230Ter)	KRIT1	Y230*	not provided	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000488784	7	91864756	7	92235442	488784	481794	rs1554528662	NC_000007.14:92235441:G:C
NM_194456.1(KRIT1):c.397dup (p.Tyr133fs)	KRIT1		not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000451998	7	91865814 - 91865815	7	92236500 - 92236501	451998	444175	rs757560062	NC_000007.14:92236500:AAAAAA:AAAAAAA
NM_194456.1(KRIT1):c.1765A>T (p.Lys589Ter)	KRIT1	K589*, K351*, K541*	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000450666	7	91843259	7	92213945	450666	444170	rs1554503702	NC_000007.14:92213944:T:A
NM_004912.4(KRIT1):c.1821_1822TC[1] (p.Leu608fs)	KRIT1		not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000449940	7	91842710 - 91842711	7	92213396 - 92213397	449940	444169	rs1554503202	NC_000007.14:92213395:GAGA:GA
NM_194456.1(KRIT1):c.730G>T (p.Val244Leu)	KRIT1	V244L, V6L	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000449498	7	91864237	7	92234923	449498	444173	rs1554527919	NC_000007.14:92234922:C:A
NM_004912.4(KRIT1):c.1356_1357TC[2] (p.Ser454fs)	KRIT1		not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000449497	7	91852184 - 91852187	7	92222870 - 92222873	449497	444172	rs1180476377	NC_000007.14:92222869:GAGAGAGA:GAGA
NM_194456.1(KRIT1):c.1932dup (p.Phe645fs)	KRIT1		not specified	Pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000439853	7	91842602	7	92213287 - 92213288	439853	433657	rs1554502927	NC_000007.14:92213287:T:TT
NM_194456.1(KRIT1):c.1762dup (p.Thr588fs)	KRIT1		not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000418704	7	91843261 - 91843262	7	92213947 - 92213948	418704	407272	rs1554503705	NC_000007.14:92213947:T:TT
NM_194456.1(KRIT1):c.1959_1960del (p.His653fs)	KRIT1	H415fs, H605fs, H653fs	not provided	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000418657	7	91842574 - 91842575	7	92213260 - 92213261	418657	407271	rs1064793348	NC_000007.14:92213259:TAT:T
NM_194456.1(KRIT1):c.486-2A>G	KRIT1		not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000379227	7	91864962	7	92235648	379227	369300	rs965713946	NC_000007.14:92235647:T:C
NM_194456.1(KRIT1):c.907_913del (p.Leu303fs)	KRIT1	L303fs, L65fs	not provided	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000372397	7	91863839 - 91863845	7	92234525 - 92234531	372397	359862	rs1057517752	NC_000007.14:92234524:TTAGTAATT:TT
NM_194456.1(KRIT1):c.1685dup (p.Tyr563fs)	KRIT1		not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000280351	7	91843969 - 91843970	7	92214655 - 92214656	280351	264350	rs886041572	NC_000007.14:92214655:A:AA
NM_194456.1(KRIT1):c.1192_1204del (p.Glu398fs)	KRIT1	E398fs, E160fs, E350fs	not provided	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000280331	7	91855084 - 91855096	7	92225770 - 92225782	280331	264345	rs886041557	NC_000007.14:92225769:TTTGTTTGTTTTCTT:TT
NM_194456.1(KRIT1):c.1355_1356del (p.Arg452fs)	KRIT1	R214fs, R404fs, R452fs	not provided	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	VCV000280152	7	91852191 - 91852192	7	92222877 - 92222878	280152	264381	rs886041415	NC_000007.14:92222876:AC:
NM_194456.1(KRIT1):c.802C>T (p.Gln268Ter)	KRIT1	Q268*, Q30*	not provided	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000265602	7	91864165	7	92234851	265602	259879	rs886039659	NC_000007.14:92234850:G:A
NM_194456.1(KRIT1):c.1731-2A>G	KRIT1		not provided	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000265482	7	91843295	7	92213981	265482	259876	rs886039571	NC_000007.14:92213980:T:C
NM_194456.1(KRIT1):c.880C>T (p.Arg294Ter)	KRIT1	R294*, R56*	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000590759	7	91863872	7	92234558	590759	581389	rs764960797	NC_000007.14:92234557:G:A
NM_194456.1(KRIT1):c.845+1G>A	KRIT1		not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000590756	7	91864121	7	92234807	590756	581392	rs1563302941	NC_000007.14:92234806:C:T
NM_194456.1(KRIT1):c.842del (p.Asp281fs)	KRIT1	D43fs, D281fs	not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000590755	7	91864125	7	92234811	590755	581393	rs1563302951	NC_000007.14:92234810:T:
NM_194456.1(KRIT1):c.730-1G>A	KRIT1		not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000590753	7	91864238	7	92234924	590753	581395	rs1554527922	NC_000007.14:92234923:C:T
NM_194456.1(KRIT1):c.679dup (p.Thr227fs)	KRIT1		not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000590749	7	91864766 - 91864767	7	92235452 - 92235453	590749	581399	rs1563305588	NC_000007.14:92235452:T:TT
NM_194456.1(KRIT1):c.418C>T (p.Arg140Ter)	KRIT1	R140*	not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000590743	7	91865794	7	92236480	590743	581405	rs866982998	NC_000007.14:92236479:G:A
NM_194456.1(KRIT1):c.2092C>T (p.Gln698Ter)	KRIT1	Q698*, Q650*, Q460*	not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000590734	7	91830671	7	92201357	590734	581340	rs1563211627	NC_000007.14:92201356:G:A
NM_194456.1(KRIT1):c.2026-12A>G	KRIT1		not provided	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000590731	7	91830749	7	92201435	590731	581343	rs1041438637	NC_000007.14:92201434:T:C
NM_194456.1(KRIT1):c.1815C>G (p.Tyr605Ter)	KRIT1	Y605*, Y367*, Y557*	not provided	Pathogenic(Last reviewed: Apr 22, 2018)	criteria provided, single submitter	VCV000590723	7	91843209	7	92213895	590723	581351	rs1563242500	NC_000007.14:92213894:G:C
NM_194456.1(KRIT1):c.1730+5G>A	KRIT1		not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000590718	7	91843920	7	92214606	590718	581357	rs1563244618	NC_000007.14:92214605:C:T
NM_194456.1(KRIT1):c.1710del (p.Lys570fs)	KRIT1	K332fs, K522fs, K570fs	not provided	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000590716	7	91843945	7	92214631	590716	581358	rs1563244807	NC_000007.14:92214630:TTTTTT:TTTTT
NM_194456.1(KRIT1):c.1657dup (p.Thr553fs)	KRIT1		not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000590714	7	91843997 - 91843998	7	92214683 - 92214684	590714	581360	rs1563245290	NC_000007.14:92214683:TT:TTT
NM_194456.1(KRIT1):c.1563+1G>A	KRIT1		not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000590711	7	91851215	7	92221901	590711	581362	rs549591728	NC_000007.14:92221900:C:T
NM_194456.1(KRIT1):c.1513C>T (p.Gln505Ter)	KRIT1	Q505*, Q457*, Q267*	not provided	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000590709	7	91851266	7	92221952	590709	581365	rs1563263366	NC_000007.14:92221951:G:A
NM_194456.1(KRIT1):c.1391G>A (p.Trp464Ter)	KRIT1	W464*, W226*, W416*	not provided	Pathogenic(Last reviewed: Dec 26, 2013)	criteria provided, single submitter	VCV000590701	7	91852156	7	92222842	590701	581372	rs1563265959	NC_000007.14:92222841:C:T
NM_194456.1(KRIT1):c.1255-1G>A	KRIT1		not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000590694	7	91852293	7	92222979	590694	581379	rs1563267100	NC_000007.14:92222978:C:T
NM_004912.4(KRIT1):c.1233_1236GAAG[1] (p.Glu413fs)	KRIT1		not provided	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000590692	7	91855048 - 91855051	7	92225734 - 92225737	590692	581380	rs1563275256	NC_000007.14:92225733:CTTCCTTC:CTTC
NM_194456.1(KRIT1):c.486-1G>A	KRIT1		not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000447675	7	91864961	7	92235647	447675	441151	rs1554529341	NC_000007.14:92235646:C:T
KRIT1, 1-BP INS, 1374C	KRIT1		Cavernous malformations of CNS and retina	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000005727					5727	20766		
KRIT1, 1-BP DEL, 103G	KRIT1		Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000005722					5722	20761		
NM_194456.1(KRIT1):c.1524_1528del (p.Arg510fs)	KRIT1	R510fs, R462fs, R272fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372399	7	91851251 - 91851255	7	92221937 - 92221941	372399	359855	rs1057517754	NC_000007.14:92221936:TTCTT:
NM_001350671.1(KRIT1):c.-437_-434AAAG[1]	KRIT1		not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279827	7	91870415 - 91870418	7	92241101 - 92241104	279827	264247	rs886041209	NC_000007.14:92241100:CTTTCTTTCT:CTTTCT
NM_194456.1(KRIT1):c.1146+1G>A	KRIT1		not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265215	7	91855839	7	92226525	265215	259878	rs886039401	NC_000007.14:92226524:C:T
NM_001003800.2(BICD2):c.1604C>T (p.Ala535Val)	BICD2	A535V	Autosomal dominant distal hereditary motor neuropathy	Pathogenic	no assertion criteria provided	VCV000637066	9	95481323	9	92719041	637066	625199		NC_000009.12:92719040:G:A
NM_001003800.2(BICD2):c.565A>T (p.Ile189Phe)	BICD2	I189F	Autosomal dominant distal hereditary motor neuropathy	Pathogenic	no assertion criteria provided	VCV000637065	9	95484979	9	92722697	637065	625200		NC_000009.12:92722696:T:A
NM_001003800.2(BICD2):c.581A>G (p.Gln194Arg)	BICD2	Q194R	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Jan 30, 2019)	no assertion criteria provided	VCV000617527	9	95484963	9	92722681	617527	608895	rs1564061982	NC_000009.12:92722680:T:C
NM_001003800.2(BICD2):c.1502G>C (p.Arg501Pro)	BICD2	R501P	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055862	9	95481425	9	92719143	55862	70516	rs398123032	NC_000009.12:92719142:C:G
NM_001003800.2(BICD2):c.1523A>C (p.Lys508Thr)	BICD2	K508T	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055861	9	95481404	9	92719122	55861	70515	rs398123031	NC_000009.12:92719121:T:G
NM_001003800.2(BICD2):c.563A>C (p.Asn188Thr)	BICD2	N188T	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055859	9	95484981	9	92722699	55859	70513	rs398123029	NC_000009.12:92722698:T:G
NM_194456.1(KRIT1):c.787dup (p.Ile263fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000859455	7	91864179 - 91864180	7	92234865 - 92234866	859455	833920		NC_000007.14:92234865:TTTTT:TTTTTT
NM_194456.1(KRIT1):c.695del (p.Pro232fs)	KRIT1	P232fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000857412	7	91864751	7	92235437	857412	833921		NC_000007.14:92235436:GGG:GG
NM_194456.1(KRIT1):c.1739dup (p.Asn580fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000847968	7	91843284 - 91843285	7	92213970 - 92213971	847968	833917		NC_000007.14:92213970:TTTT:TTTTT
NM_194456.1(KRIT1):c.2065C>T (p.Gln689Ter)	KRIT1	Q451*, Q689*, Q641*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000846115	7	91830698	7	92201384	846115	833916		NC_000007.14:92201383:G:A
NM_194456.1(KRIT1):c.649_661del (p.Ser217fs)	KRIT1	S217fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000842646	7	91864785 - 91864797	7	92235471 - 92235483	842646	833922		NC_000007.14:92235470:CTAACATTTTACTCT:CT
NM_194456.1(KRIT1):c.1263del (p.Val422fs)	KRIT1	V422fs, V374fs, V184fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000839732	7	91852284	7	92222970	839732	833919		NC_000007.14:92222969:TTTTT:TTTT
NC_000007.14:g.(?_92234429)_(92234943_?)del	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832611	7	91863743 - 91864257			832611	819922		
NM_194456.1(KRIT1):c.659dup (p.Leu220fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000660376	7	91864786 - 91864787	7	92235472 - 92235473	660376	636442		NC_000007.14:92235472:AA:AAA
NM_194456.1(KRIT1):c.810dup (p.Trp271fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000654640	7	91864156 - 91864157	7	92234842 - 92234843	654640	636440		NC_000007.14:92234842:TTTTT:TTTTTT
NM_194456.1(KRIT1):c.1558A>T (p.Lys520Ter)	KRIT1	K472*, K520*, K282*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000653656	7	91851221	7	92221907	653656	636438		NC_000007.14:92221906:T:A
NM_194456.1(KRIT1):c.747_750del (p.Asn250fs)	KRIT1	N12fs, N250fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000653169	7	91864217 - 91864220	7	92234903 - 92234906	653169	636441		NC_000007.14:92234902:ATTTATT:ATT
NM_194456.1(KRIT1):c.1342del (p.Met448fs)	KRIT1	M400fs, M448fs, M210fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000649953	7	91852205	7	92222891	649953	636439		NC_000007.14:92222890:TT:T
NM_194456.1(KRIT1):c.1373del (p.Gln458fs)	KRIT1	Q220fs, Q410fs, Q458fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000580059	7	91852174	7	92222860	580059	562247	rs1563266147	NC_000007.14:92222859:T:
NM_194456.1(KRIT1):c.1437_1438del (p.Lys479fs)	KRIT1	K431fs, K479fs, K241fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000576708	7	91851341 - 91851342	7	92222027 - 92222028	576708	561802	rs1563263905	NC_000007.14:92222026:GT:
NC_000007.13:g.(?_91855014)_(91856016_?)del	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000536123	7	91855014 - 91856016	7	92225700 - 92226702	536123	522652		
NM_194456.1(KRIT1):c.972_975CATT[3] (p.Tyr327fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000536121	7	91863772 - 91863773	7	92234458 - 92234459	536121	523471	rs1326827713	NC_000007.14:92234458:AATGAATG:AATGAATGAATG
NM_194456.1(KRIT1):c.196C>T (p.Gln66Ter)	KRIT1	Q66*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522191	7	91870373	7	92241059	522191	512829	rs771656368	NC_000007.14:92241058:G:A
NM_194456.1(KRIT1):c.2119_2120del (p.Ser707fs)	KRIT1	S469fs, S659fs, S707fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000522190	7	91830643 - 91830644	7	92201329 - 92201330	522190	512828	rs1554490317	NC_000007.14:92201328:CTC:C
NM_194456.1(KRIT1):c.990G>A (p.Trp330Ter)	KRIT1	W330*, W92*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000468221	7	91855996	7	92226682	468221	457571	rs1554518783	NC_000007.14:92226681:C:T
NM_194456.1(KRIT1):c.812G>A (p.Trp271Ter)	KRIT1	W271*, W33*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000468220	7	91864155	7	92234841	468220	457572	rs1554527779	NC_000007.14:92234840:C:T
NM_194456.1(KRIT1):c.782C>G (p.Ser261Ter)	KRIT1	S261*, S23*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000468219	7	91864185	7	92234871	468219	457673	rs1554527817	NC_000007.14:92234870:G:C
NM_194456.1(KRIT1):c.1545del (p.Leu516fs)	KRIT1	L468fs, L516fs, L278fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000468210	7	91851234	7	92221920	468210	458021	rs1554512658	NC_000007.14:92221919:GGG:GG
NM_194456.1(KRIT1):c.1417C>T (p.Gln473Ter)	KRIT1	Q473*, Q425*, Q235*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000468209	7	91851362	7	92222048	468209	457065	rs1554513061	NC_000007.14:92222047:G:A
NC_000007.13:g.(?_91870287)_(91871469_?)del	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000468203	7	91870287 - 91871469	7	92240973 - 92242155	468203	456856		
NC_000007.13:g.(?_91863763)_(91871451_?)del	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000468201	7	91863763 - 91871451			468201	456854		
Single allele	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000468200			7	92213175 - 92242155	468200	456163		
NM_194456.1(KRIT1):c.1849G>T (p.Glu617Ter)	KRIT1	E617*, E379*, E569*	not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000447674	7	91842685	7	92213371	447674	441148	rs1554503116	NC_000007.14:92213370:C:A
KRIT1, 2-BP DEL, 741TC	KRIT1		Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000005724					5724	20763		
KRIT1, IVS2DS, T-C, +2	KRIT1		Cerebral cavernous malformations 1	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000005723					5723	20762		
KRIT1, 1-BP INS, 1271C	KRIT1		Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000005720					5720	20759		
KRIT1, 1-BP DEL, 1342A	KRIT1		Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000005719					5719	20758		
KRIT1, 1283C-T	KRIT1		Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000005718					5718	20757		
NM_001003800.2(BICD2):c.2321A>G (p.Glu774Gly)	BICD2	E774G	not provided|Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000055860	9	95477683	9	92715401	55860	70514	rs398123030	NC_000009.12:92715400:T:C
NM_018249.6(CDK5RAP2):c.4441C>T (p.Arg1481Ter)	CDK5RAP2	R1481*, R1251*	Primary autosomal recessive microcephaly 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158152	9	123171568	9	120409290	158152	168720	rs587783390	NC_000009.12:120409289:G:A
NM_022970.3(FGFR2):c.1087+1298A>G	FGFR2	Y340C, Y112C, Y225C, Y251C	not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000449398	10	123276898	10	121517384	449398	444565	rs1554928884	NC_000010.11:121517383:T:C
NM_022970.3(FGFR2):c.1980G>C (p.Lys660Asn)	FGFR2	K542N, K543N, K544N, K570N, K571N, K547N, K657N, K660N, K431N, K659N	FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000661397	10	123247514	10	121488000	661397	638761		NC_000010.11:121487999:C:G
NM_022970.3(FGFR2):c.1087+1303T>G	FGFR2	C342G, C114G, C253G, C227G	Pfeiffer syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000374818	10	123276893	10	121517379	374818	361712	rs121918488	NC_000010.11:121517378:A:C
NM_022970.3(FGFR2):c.1087+1291G>C	FGFR2	G338R, G110R, G249R, G223R	Crouzon syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000374816	10	123276905	10	121517391	374816	361714	rs1057519043	NC_000010.11:121517390:C:G
NM_022970.3(FGFR2):c.923A>G (p.Tyr308Cys)	FGFR2	Y308C, Y193C, Y219C, Y80C	Crouzon syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000374813	10	123279509	10	121519995	374813	361717	rs1057519040	NC_000010.11:121519994:T:C
NM_022970.3(FGFR2):c.869G>C (p.Trp290Ser)	FGFR2	W290S, W62S, W201S, W175S	Crouzon syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000374812	10	123279563	10	121520049	374812	361718	rs1057519039	NC_000010.11:121520048:C:G
NM_022970.3(FGFR2):c.1950_1952del (p.Arg650_Asp651delinsSer)	FGFR2		Levy-Hollister syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000013297	10	123247542 - 123247544	10	121488028 - 121488030	13297	28336	rs879253720	NC_000010.11:121488027:TCT:
NM_022970.3(FGFR2):c.755_757delinsTCT (p.Ser252_Pro253delinsPheSer)	FGFR2		Pfeiffer syndrome variant	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000013280	10	123279675 - 123279677	10	121520161 - 121520163	13280	28319	rs281865420	NC_000010.11:121520160:GCG:AGA
NM_022970.3(FGFR2):c.1087+1286A>G	FGFR2	D336G, D221G, D108G, D247G	Crouzon syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374815	10	123276910	10	121517396	374815	361715	rs1057519042	NC_000010.11:121517395:T:C
NM_022970.3(FGFR2):c.864_881del (p.Ile288_Val294delinsMet)	FGFR2		Pfeiffer syndrome	Pathogenic	no assertion criteria provided	VCV000254237	10	123279551 - 123279568	10	121520037 - 121520054	254237	248739	rs886037837	NC_000010.11:121520036:ACGTGCTTGATCCACTGGA:A
NM_022970.3(FGFR2):c.1087+1288G>C	FGFR2	A337P, A222P, A248P, A109P	Crouzon syndrome	Pathogenic(Last reviewed: Jul 7, 1998)	no assertion criteria provided	VCV000029853	10	123276908	10	121517394	29853	38808	rs387906676	NC_000010.11:121517393:C:G
NM_022970.3(FGFR2):c.859_921del (p.His287_Pro307del)	FGFR2			Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000029852	10	123279511 - 123279573	10	121519997 - 121520059	29852	38807	rs1554930637	
NM_022970.3(FGFR2):c.818_820del (p.Asp273del)	FGFR2	D273del, D158del, D45del, D184del	Pfeiffer syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000013288	10	123279612 - 123279614	10	121520098 - 121520100	13288	28327	rs121918503	NC_000010.11:121520097:CGTC:C
NM_022970.3(FGFR2):c.804_809del (p.Val269_Val270del)	FGFR2		Saethre-Chotzen syndrome	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000013285	10	123279623 - 123279628	10	121520109 - 121520114	13285	28324	rs879253718	NC_000010.11:121520108:ACCACT:
NM_022970.3(FGFR2):c.874A>G (p.Lys292Glu)	FGFR2	K292E, K177E, K203E, K64E	Crouzon syndrome	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000013282	10	123279558	10	121520044	13282	28321	rs121918500	NC_000010.11:121520043:T:C
NM_022970.3(FGFR2):c.1087+1219G>T	FGFR2	A314S, A199S, A225S, A86S	FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000478049	10	123276977	10	121517463	478049	460158	rs1358919643	NC_000010.11:121517462:C:A
NM_022970.3(FGFR2):c.756_758delinsCTT (p.Pro253Phe)	FGFR2		Acrocephalosyndactyly type I	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000055867	10	123279674 - 123279676	10	121520160 - 121520162	55867	70518	rs387907372	NC_000010.11:121520159:GGC:AAG
NM_022970.3(FGFR2):c.1945G>A (p.Ala649Thr)	FGFR2	A648T, A649T, A531T, A533T, A532T, A559T, A420T, A536T, A560T, A646T	Levy-Hollister syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000013296	10	123247549	10	121488035	13296	28335	rs121918508	NC_000010.11:121488034:C:T
FGFR2, ALU INS	FGFR2		Acrocephalosyndactyly type I	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000013287					13287	28326		
NM_022970.3(FGFR2):c.868T>G (p.Trp290Gly)	FGFR2	W290G, W201G, W175G, W62G	Crouzon syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000013284	10	123279564	10	121520050	13284	28323	rs121918501	NC_000010.11:121520049:A:C
NM_022970.3(FGFR2):c.1087+1297T>C	FGFR2	Y340H, Y251H, Y112H, Y225H	Crouzon syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000013264	10	123276899	10	121517385	13264	28303	rs121918489	NC_000010.11:121517384:A:G
NM_183050.4(BCKDHB):c.82_92GGCGCGGGGCT[3] (p.Phe35fs)	BCKDHB		Maple syrup urine disease|Maple syrup urine disease type 1B	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189101	6	80816489 - 80816490	6	80106772 - 80106773	189101	186721	rs398124601	NC_000006.12:80106772:CTGGCGCGGGGCTGGCGCGGGGCT:CTGGCGCGGGGCTGGCGCGGGGCTGGCGCGGGGCT
NM_183050.4(BCKDHB):c.82_92GGCGCGGGGCT[1] (p.Ala32fs)	BCKDHB		not provided|Maple syrup urine disease type 1B|MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096618	6	80816490 - 80816500	6	80106773 - 80106783	96618	102511	rs398124601	NC_000006.12:80106772:CTGGCGCGGGGCTGGCGCGGGGCT:CTGGCGCGGGGCT
NM_183050.4(BCKDHB):c.1016C>T (p.Ser339Leu)	BCKDHB	S339L, S269L	Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096563	6	80982916	6	80273199	96563	102456	rs398124561	NC_000006.12:80273198:C:T
NM_000322.5(PRPH2):c.828+3A>T	PRPH2		Retinal dystrophy|PRPH2-Related Disorders|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098713	6	42672100	6	42704362	98713	104603	rs281865373	NC_000006.12:42704361:T:A
NM_018972.4(GDAP1):c.349dup (p.Tyr117fs)	GDAP1		Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000637122	8	75272409 - 75272410	8	74360174 - 74360175	637122	625167		NC_000008.11:74360174:T:TT
NM_018972.4(GDAP1):c.112C>T (p.Gln38Ter)	GDAP1	Q38*	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000569560	8	75262808	8	74350573	569560	565215	rs761035569	NC_000008.11:74350572:C:T
NM_018972.4(GDAP1):c.703C>T (p.Gln235Ter)	GDAP1	Q235*, Q177*, Q126*, Q167*	Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000467768	8	75276228	8	74363993	467768	458625	rs1554548334	NC_000008.11:74363992:C:T
NM_018972.4(GDAP1):c.501_502AG[1] (p.Glu168fs)	GDAP1		Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000467764	8	75274135 - 75274136	8	74361900 - 74361901	467764	459027	rs1221804567	NC_000008.11:74361899:AGAG:AG
NM_054012.4(ASS1):c.794G>A (p.Arg265His)	ASS1	R265H	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000092374	9	133355792	9	130480405	92374	98285	rs398123131	NC_000009.12:130480404:G:A
NM_001909.5(CTSD):c.268dup (p.Gln90fs)	CTSD		not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000430138	11	1780829 - 1780830	11	1759599 - 1759600	430138	421842	rs752612332	NC_000011.10:1759599:GGGGGGG:GGGGGGGG
NM_194456.1(KRIT1):c.1392G>A (p.Trp464Ter)	KRIT1	W416*, W464*, W226*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000846184	7	91852155	7	92222841	846184	833918		NC_000007.14:92222840:C:T
NM_004912.4(KRIT1):c.1199_1203AACAA[1] (p.Asn402fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000566352	7	91855080 - 91855084	7	92225766 - 92225770	566352	564478	rs1563275562	NC_000007.14:92225765:TTGTTTTGTTT:TTGTTT
NM_194456.1(KRIT1):c.1683_1695del (p.Val562fs)	KRIT1	V324fs, V514fs, V562fs	Cerebral cavernous malformation	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000468211	7	91843960 - 91843972	7	92214646 - 92214658	468211	458018	rs1554504519	NC_000007.14:92214645:ATTTCCATAGACTATTT:ATTT
NM_194456.1(KRIT1):c.1201C>T (p.Gln401Ter)	KRIT1	Q401*, Q163*, Q353*	Cerebral cavernous malformation	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000468205	7	91855087	7	92225773	468205	457669	rs1331502949	NC_000007.14:92225772:G:A
NM_194456.1(KRIT1):c.1144dup (p.Arg382fs)	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000427907	7	91855841 - 91855842	7	92226527 - 92226528	427907	418981	rs1554518386	NC_000007.14:92226527:T:TT
NM_194456.1(KRIT1):c.729+2T>C	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000427906	7	91864715	7	92235401	427906	418980	rs1554528541	NC_000007.14:92235400:A:G
NM_001909.4:c.486-12G>A	CTSD			Pathogenic	no assertion criteria provided	VCV000100733					100733	106598		
NM_001909.5(CTSD):c.1196G>A (p.Arg399His)	CTSD	R399H		Pathogenic(Last reviewed: Nov 11, 2014)	no assertion criteria provided	VCV000208849	11	1774776	11	1753546	208849	205410	rs797045138	NC_000011.10:1753545:C:T
NM_001909.5(CTSD):c.446G>T (p.Gly149Val)	CTSD	G149V		Pathogenic(Last reviewed: Nov 11, 2014)	no assertion criteria provided	VCV000208848	11	1780224	11	1758994	208848	205409	rs797045137	NC_000011.10:1758993:C:A
NM_001909.5(CTSD):c.764dup (p.Tyr255Ter)	CTSD			Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000017575	11	1776198 - 1776199	11	1754968 - 1754969	17575	32614	rs786205105	NC_000011.10:1754968:T:TT
NM_001909.5(CTSD):c.1149G>C (p.Trp383Cys)	CTSD	W383C		Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000017574	11	1774823	11	1753593	17574	32613	rs121912790	NC_000011.10:1753592:C:G
NM_001909.5(CTSD):c.685T>A (p.Phe229Ile)	CTSD	F229I		Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000017573	11	1778573	11	1757343	17573	32612	rs121912789	NC_000011.10:1757342:A:T
NM_012434.5(SLC17A5):c.802_816del (p.Ser268_Asn272del)	SLC17A5		not provided|Salla disease	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056558	6	74345108 - 74345122	6	73635385 - 73635399	56558	71197	rs386833994	NC_000006.12:73635384:ATTTCTTAATGATGAA:A
NM_000190.4(HMBS):c.76C>T (p.Arg26Cys)	HMBS	R26C, R9C	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000645443	11	118959007	11	119088297	645443	639774		NC_000011.10:119088296:C:T
NM_000190.4(HMBS):c.499C>T (p.Arg167Trp)	HMBS	R167W, R150W	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001456	11	118962123	11	119091413	1456	16495	rs118204101	NC_000011.10:119091412:C:T
NM_000141.5(FGFR2):c.863T>A (p.Ile288Asn)	FGFR2	I173N, I288N, I60N, I199N	FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000846218	10	123279569	10	121520055	846218	836685		NC_000010.11:121520054:A:T
NM_022970.3(FGFR2):c.1175T>G (p.Met392Arg)	FGFR2	M391R, M392R, M163R, M303R, M276R, M279R, M302R	Bent bone dysplasia syndrome|not provided	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000029855	10	123274746	10	121515232	29855	38810	rs387906677	NC_000010.11:121515231:A:C
NM_022970.3(FGFR2):c.1885G>A (p.Ala629Thr)	FGFR2	A628T, A629T, A400T, A511T, A516T, A540T, A513T, A512T, A539T, A626T	not provided|Levy-Hollister syndrome	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000013298	10	123247609	10	121488095	13298	28337	rs121918509	NC_000010.11:121488094:C:T
NM_004629.1(FANCG):c.307+1G>C	FANCG		Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000006714	9	35078601	9	35078604	6714	21753	rs200479612	NC_000009.12:35078603:C:G
NM_022970.3(FGFR2):c.833_834delinsTT (p.Cys278Phe)	FGFR2		FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000578389	10	123279598 - 123279599	10	121520084 - 121520085	578389	566194	rs1057519037	NC_000010.11:121520083:GC:AA
NM_022970.3(FGFR2):c.1925A>G (p.Lys642Arg)	FGFR2	K641R, K642R, K413R, K526R, K553R, K552R, K524R, K639R, K525R, K529R	not provided|Pfeiffer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374824	10	123247569	10	121488055	374824	361706	rs1057519047	NC_000010.11:121488054:T:C
NM_022970.3(FGFR2):c.1087+1241A>C	FGFR2	D321A, D232A, D206A, D93A	Pfeiffer syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000013300	10	123276955	10	121517441	13300	28339	rs121918510	NC_000010.11:121517440:T:G
NM_022970.3(FGFR2):c.1579A>G (p.Lys527Glu)	FGFR2	K526E, K527E, K437E, K298E, K409E, K414E, K438E, K410E, K411E, K524E	Crouzon syndrome|Scaphocephaly, maxillary retrusion, and mental retardation	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000013295	10	123258105	10	121498591	13295	28334	rs121918507	NC_000010.11:121498590:T:C
NM_022970.3(FGFR2):c.1087+1222G>T	FGFR2	A315S, A226S, A87S, A200S	Crouzon syndrome|Craniosynostosis, nonsyndromic unicoronal	Pathogenic	criteria provided, single submitter	VCV000013289	10	123276974	10	121517460	13289	28328	rs121918504	NC_000010.11:121517459:C:A
NM_194456.1(KRIT1):c.535C>T (p.Arg179Ter)	KRIT1	R179*	Cerebral cavernous malformation	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000856854	7	91864911	7	92235597	856854	833923		NC_000007.14:92235596:G:A
NM_194456.1(KRIT1):c.1742_1748dup (p.Ile584fs)	KRIT1		Cerebral cavernous malformation|not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000663252	7	91843275 - 91843276	7	92213961 - 92213962	663252	636437		NC_000007.14:92213961:GATTTTAGATTTT:GATTTTAGATTTTAGATTTT
NM_194456.1(KRIT1):c.1400C>A (p.Ser467Ter)	KRIT1	S467*, S229*, S419*	not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489287	7	91852147	7	92222833	489287	481793	rs1554513911	NC_000007.14:92222832:G:T
NM_194456.1(KRIT1):c.410A>G (p.Asp137Gly)	KRIT1	D137G	Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000005725	7	91865802	7	92236488	5725	20764	rs137853139	NC_000007.14:92236487:T:C
NM_001083116.3(PRF1):c.1349C>T (p.Thr450Met)	PRF1	T450M		Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468301	10	72358128	10	70598372	468301	460482	rs189650890	NC_000010.11:70598371:G:A
NC_000007.13:g.(?_65556973)_(65557919_?)del	ASL		Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000656807	7	65556973 - 65557919	7	66091986 - 66092932	656807	651728		
NM_000048.4(ASL):c.446+1G>A	ASL		Argininosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092361	7	65548162	7	66083175	92361	98272	rs142637046	NC_000007.14:66083174:G:A
NM_000048.4(ASL):c.1060C>T (p.Gln354Ter)	ASL	Q354*, Q328*, Q334*	not provided|Argininosuccinate lyase deficiency	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021253	7	65554680	7	66089693	21253	34105	rs367543005	NC_000007.14:66089692:C:T
NM_000048.4(ASL):c.1135C>T (p.Arg379Cys)	ASL	R379C, R353C, R359C	Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002403	7	65557065	7	66092078	2403	17442	rs28940287	NC_000007.14:66092077:C:T
NM_001003800.2(BICD2):c.2239C>T (p.Arg747Cys)	BICD2	R747C	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant|Muscular Diseases|Pelvic girdle muscle weakness|Autosomal dominant distal hereditary motor neuropathy	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000637067	9	95480098	9	92717816	637067	625198		NC_000009.12:92717815:G:A
NM_058246.4(DNAJB6):c.265T>A (p.Phe89Ile)	DNAJB6	F89I	not provided|Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031531	7	157160096	7	157367402	31531	40204	rs387907150	NC_000007.14:157367401:T:A
NM_058246.4(DNAJB6):c.279C>G (p.Phe93Leu)	DNAJB6	F93L	not provided|Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000031529	7	157160110	7	157367416	31529	40202	rs149278319	NC_000007.14:157367415:C:G
NM_058246.4(DNAJB6):c.287C>G (p.Pro96Arg)	DNAJB6	P96R	not provided|Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030905	7	157160118	7	157367424	30905	39862	rs387907047	NC_000007.14:157367423:C:G
NM_018972.4(GDAP1):c.116del (p.Lys39fs)	GDAP1	K39fs	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000637504	8	75262809	8	74350574	637504	625159		NC_000008.11:74350573:AAAA:AAA
NM_054012.4(ASS1):c.838+1G>T	ASS1		Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555072	9	133355837	9	130480450	555072	545125	rs750214431	NC_000009.12:130480449:G:T
NM_018972.4(GDAP1):c.579del (p.Lys193fs)	GDAP1	K193fs, K84fs, K125fs, K135fs	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000406137	8	75274211	8	74361976	406137	396279	rs1060500979	NC_000008.11:74361975:AAA:AA
NM_018972.4(GDAP1):c.769C>T (p.Arg257Ter)	GDAP1	R257*, R199*, R148*, R189*	not provided|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000245608	8	75276294	8	74364059	245608	244526	rs770501034	NC_000008.11:74364058:C:T
NM_054012.4(ASS1):c.421-2A>G	ASS1		Citrullinemia type I|not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198386	9	133342110	9	130466723	198386	195547	rs751930594	NC_000009.12:130466722:A:G
NM_054012.4(ASS1):c.1030C>T (p.Arg344Ter)	ASS1	R344*	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188885	9	133370313	9	130494926	188885	186783	rs786204537	NC_000009.12:130494925:C:T
NM_152419.3(HGSNAT):c.852-2A>C	HGSNAT		not provided|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504466	8	43033215	8	43178072	504466	495386	rs755710040	NC_000008.11:43178071:A:C
NM_014780.4(CUL7):c.4717C>T (p.Arg1573Ter)	CUL7	R1573*, R1657*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, multiple submitters, no conflicts	VCV000195894	6	43006061	6	43038323	195894	193055	rs749509661	NC_000006.12:43038322:G:A
NM_022970.3(FGFR2):c.812G>T (p.Gly271Val)	FGFR2	G271V, G156V, G43V, G182V	Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000573667	10	123279620	10	121520106	573667	563601	rs1564919048	NC_000010.11:121520105:C:A
NM_022970.3(FGFR2):c.1087+1216_1087+1225delinsACC	FGFR2		Pfeiffer syndrome	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000013292	10	123276971 - 123276980	10	121517457 - 121517466	13292	28331		NC_000010.11:121517456:CGGCGGCCTA:GGT
NM_022970.3(FGFR2):c.870G>C (p.Trp290Cys)	FGFR2	W290C, W201C, W62C, W175C	Pfeiffer syndrome|Squamous cell lung carcinoma	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000013281	10	123279562	10	121520048	13281	28320	rs121918499	NC_000010.11:121520047:C:G
GRCh37/hg19 8q23.3(chr8:116415097-116502268)x1	TRPS1		not provided	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000685080	8	116415097 - 116502268			685080	672672		
NM_014112.5(TRPS1):c.1173_1174CT[1] (p.Asn391_Ser392insTer)	TRPS1		not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000593589	8	116617020 - 116617021	8	115604793 - 115604794	593589	584653	rs1563638218	NC_000008.11:115604792:AGAG:AG
NM_014112.5(TRPS1):c.478_502dup (p.Lys168fs)	TRPS1		not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000503818	8	116631822 - 116631823	8	115619595 - 115619596	503818	495225	rs1554598994	NC_000008.11:115619595:TCTGATCTTCCTTTGTCTCCAGTGA:TCTGATCTTCCTTTGTCTCCAGTGATCTGATCTTCCTTTGTCTCCAGTGA
NM_014112.4(TRPS1):c.1766dup (p.His590Alafs)	TRPS1		not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000502637	8	116616429 - 116616430	8	115604202 - 115604203	502637	494060	rs1554596004	NC_000008.11:115604202:TTTT:TTTTT
NM_014112.5(TRPS1):c.2421G>A (p.Trp807Ter)	TRPS1	W807*, W794*, W800*, W798*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419458	8	116599507	8	115587280	419458	407293	rs1064793885	NC_000008.11:115587279:C:T
NM_014112.5(TRPS1):c.3319del (p.Leu1107fs)	TRPS1	L1100fs, L1107fs, L1094fs, L1098fs	not provided	Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	VCV000282869	8	116426817	8	115414589	282869	267106	rs886042507	NC_000008.11:115414588:G:
NM_014112.5(TRPS1):c.2822C>A (p.Ser941Ter)	TRPS1	S941*, S932*, S928*, S934*	not provided	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000280747	8	116430559	8	115418331	280747	264385	rs748664291	NC_000008.11:115418330:G:T
NM_014112.5(TRPS1):c.3698G>A (p.Cys1233Tyr)	TRPS1	C1233Y, C1220Y, C1226Y, C1224Y	Trichorhinophalangeal dysplasia type I	Pathogenic	no assertion criteria provided	VCV000635360	8	116426438	8	115414210	635360	623186		NC_000008.11:115414209:C:T
GRCh37/hg19 8q23.3(chr8:115656140-116918407)x1	TRPS1		See cases	Pathogenic	no assertion criteria provided	VCV000395350	8	115656140 - 116918407			395350	382243		
NM_014112.5(TRPS1):c.2740A>C (p.Thr914Pro)	TRPS1	T914P, T905P, T907P		Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000005575	8	116430641	8	115418413	5575	20614	rs121908433	NC_000008.11:115418412:T:G
NM_014112.5(TRPS1):c.1176_1179del (p.Asn393fs)	TRPS1	N386fs, N393fs, N380fs, N384fs	Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000839906	8	116617017 - 116617020	8	115604790 - 115604793	839906	834040		NC_000008.11:115604789:GTTAG:G
NM_014112.5(TRPS1):c.2110del (p.Cys704fs)	TRPS1	C691fs, C695fs, C697fs, C704fs	Trichorhinophalangeal dysplasia type I	Pathogenic	criteria provided, single submitter	VCV000694692	8	116599818	8	115587591	694692	682809		NC_000008.11:115587590:A:
NM_014112.5(TRPS1):c.2666del (p.Asn889fs)	TRPS1	N876fs, N880fs, N882fs, N889fs	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000692064	8	116599262	8	115587035	692064	679759		NC_000008.11:115587034:TTTT:TTT
NM_014112.5(TRPS1):c.2641C>T (p.Gln881Ter)	TRPS1	Q868*, Q881*, Q874*, Q872*	Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000655892	8	116599287	8	115587060	655892	636541		NC_000008.11:115587059:G:A
NM_014112.5(TRPS1):c.489_492del (p.Glu165fs)	TRPS1	E156fs, E165fs, E152fs, E158fs	|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000652109	8	116631833 - 116631836	8	115619606 - 115619609	652109	636543		NC_000008.11:115619605:CTTT:
NM_014112.5(TRPS1):c.2892_2899dup (p.Asn967fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Feb 18, 2017)	criteria provided, single submitter	VCV000620586	8	116427236 - 116427237	8	115415008 - 115415009	620586	611976	rs1563714392	NC_000008.11:115415008:TAAGGCGCT:TAAGGCGCTAAGGCGCT
NC_000008.10:g.(?_116616080)_(116635884_?)dup	TRPS1		|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000584199	8	116616080 - 116635884	8	115603853 - 115623657	584199	567295		
NM_014112.5(TRPS1):c.1014_1017dup (p.Gln340fs)	TRPS1		|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000579060	8	116617178 - 116617179	8	115604951 - 115604952	579060	564578	rs1563638577	NC_000008.11:115604951:GCAA:GCAAGCAA
NM_014112.5(TRPS1):c.1695_1705del (p.Gln565fs)	TRPS1	Q556fs, Q552fs, Q565fs, Q558fs	|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000574745	8	116616491 - 116616501	8	115604264 - 115604274	574745	561898	rs1563637033	NC_000008.11:115604263:TGTTATGGAGCTGTT:TGTT
NM_014112.5(TRPS1):c.2086C>T (p.Arg696Ter)	TRPS1	R696*, R687*, R683*, R689*	|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000574440	8	116616110	8	115603883	574440	561897	rs368166434	NC_000008.11:115603882:G:A
NM_014112.5(TRPS1):c.2568T>G (p.Tyr856Ter)	TRPS1	Y856*, Y843*, Y849*, Y847*	Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000568409	8	116599360	8	115587133	568409	562337	rs1563623987	NC_000008.11:115587132:A:C
NM_014112.5(TRPS1):c.2195_2204del (p.Gln732fs)	TRPS1	Q732fs, Q719fs, Q725fs, Q723fs	Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000536120	8	116599724 - 116599733	8	115587497 - 115587506	536120	523431	rs1554593085	NC_000008.11:115587496:GTGATGTCCTGT:GT
NM_014112.5(TRPS1):c.1649_1650del (p.Gly550fs)	TRPS1	G543fs, G537fs, G541fs, G550fs	|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	VCV000468199	8	116616546 - 116616547	8	115604319 - 115604320	468199	457129	rs1554596063	NC_000008.11:115604318:GC:
inv(8)(q21.1q24.1)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438476					438476	432087		
inv(8)(q13q24.1)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438475					438475	432086		
NM_014112.5(TRPS1):c.3424del (p.Ser1142fs)	TRPS1	S1135fs, S1142fs, S1133fs, S1129fs	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438474	8	116426712	8	115414484	438474	432061	rs1554616802	NC_000008.11:115414483:T:
NM_014112.5(TRPS1):c.3140del (p.Pro1047fs)	TRPS1	P1038fs, P1040fs, P1047fs, P1034fs	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438473	8	116426996	8	115414768	438473	432062	rs1554616950	NC_000008.11:115414767:GG:G
NM_014112.5(TRPS1):c.3077del (p.Ser1026fs)	TRPS1	S1017fs, S1019fs, S1013fs, S1026fs	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438472	8	116427059	8	115414831	438472	432063	rs1554616971	NC_000008.11:115414830:C:
NM_014112.5(TRPS1):c.2979_2980AG[1] (p.Glu994fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438471	8	116427152 - 116427155	8	115414924 - 115414927	438471	432064	rs1554617011	NC_000008.11:115414923:CTCTCT:CT
NM_014112.5(TRPS1):c.2852_2859dup (p.Gly954fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438470	8	116427276 - 116427277	8	115415048 - 115415049	438470	432065	rs1554617078	NC_000008.11:115415048:GTTGTTTTGTT:GTTGTTTTGTTGTTTTGTT
NM_014112.4(TRPS1):c.(2823+1_2824-1)_(*1_?)del	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438469	8	116426250 - 116430557	8	115414022 - 115418329	438469	432059		
NM_014112.5(TRPS1):c.2824-23T>G	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438468	8	116427335	8	115415107	438468	432066	rs752405769	NC_000008.11:115415106:A:C
NM_014112.5(TRPS1):c.2823+1G>T	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438467	8	116430557	8	115418329	438467	432067	rs1554617549	NC_000008.11:115418328:C:A
NM_014112.5(TRPS1):c.2801G>T (p.Gly934Val)	TRPS1	G934V, G925V, G921V, G927V	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438466	8	116430580	8	115418352	438466	432068	rs1554617561	NC_000008.11:115418351:C:A
NM_014112.5(TRPS1):c.2783_2784insC (p.Val929fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438465	8	116430597 - 116430598	8	115418369 - 115418370	438465	432069	rs1554617567	NC_000008.11:115418369::G
NM_014112.5(TRPS1):c.2762G>C (p.Arg921Pro)	TRPS1	R921P, R914P, R912P, R908P	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438464	8	116430619	8	115418391	438464	432070	rs121908435	NC_000008.11:115418390:C:G
NM_014112.5(TRPS1):c.2756T>C (p.Leu919Pro)	TRPS1	L919P, L910P, L906P, L912P	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438462	8	116430625	8	115418397	438462	432072	rs1554617573	NC_000008.11:115418396:A:G
NM_014112.5(TRPS1):c.2732A>G (p.Asn911Ser)	TRPS1	N911S, N902S, N904S, N898S	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438461	8	116430649	8	115418421	438461	432073	rs1554617580	NC_000008.11:115418420:T:C
NM_014112.5(TRPS1):c.2731A>T (p.Asn911Tyr)	TRPS1	N911Y, N902Y, N898Y, N904Y	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438460	8	116430650	8	115418422	438460	432074	rs1554617581	NC_000008.11:115418421:T:A
NM_014112.5(TRPS1):c.2394dup (p.Ser799fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438458	8	116599533 - 116599534	8	115587306 - 115587307	438458	432075	rs1554592981	NC_000008.11:115587306:GG:GGG
NM_014112.5(TRPS1):c.2353_2354GA[1] (p.Lys786fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438457	8	116599572 - 116599573	8	115587345 - 115587346	438457	432076	rs1554592995	NC_000008.11:115587344:TCTCT:TCT
NM_014112.5(TRPS1):c.2179_2180del (p.Val727fs)	TRPS1	V718fs, V727fs, V714fs, V720fs	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438456	8	116599748 - 116599749	8	115587521 - 115587522	438456	432077	rs1554593099	NC_000008.11:115587520:ACA:A
NM_014112.5(TRPS1):c.2094C>A (p.Tyr698Ter)	TRPS1	Y698*, Y689*, Y691*, Y685*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438453	8	116616102	8	115603875	438453	432078	rs1554595857	NC_000008.11:115603874:G:T
NM_014112.5(TRPS1):c.1882C>T (p.Gln628Ter)	TRPS1	Q628*, Q615*, Q621*, Q619*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438452	8	116616314	8	115604087	438452	432079	rs1554595930	NC_000008.11:115604086:G:A
NM_014112.5(TRPS1):c.1460del (p.Lys487fs)	TRPS1	K478fs, K487fs, K474fs, K480fs	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438451	8	116616736	8	115604509	438451	432080	rs1554596193	NC_000008.11:115604508:TT:T
NM_014112.5(TRPS1):c.1231dup (p.Gln411fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438450	8	116616964 - 116616965	8	115604737 - 115604738	438450	432081	rs1554596300	NC_000008.11:115604737:G:GG
NM_014112.5(TRPS1):c.1105C>T (p.Gln369Ter)	TRPS1	Q369*, Q356*, Q360*, Q362*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438448	8	116617091	8	115604864	438448	432083	rs1554596391	NC_000008.11:115604863:G:A
NM_014112.5(TRPS1):c.1093C>T (p.Gln365Ter)	TRPS1	Q365*, Q356*, Q358*, Q352*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438447	8	116617103	8	115604876	438447	432084	rs1554596393	NC_000008.11:115604875:G:A
NM_014112.5(TRPS1):c.1010_1014dup (p.Cys339fs)	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000438446	8	116617181 - 116617182	8	115604954 - 115604955	438446	432085	rs1554596430	NC_000008.11:115604954:ATCTG:ATCTGATCTG
NM_014112.5(TRPS1):c.1693C>T (p.Gln565Ter)	TRPS1	Q565*, Q552*, Q558*, Q556*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208170	8	116616503	8	115604276	208170	204427	rs864621974	NC_000008.11:115604275:G:A
NM_014112.5(TRPS1):c.3315C>G (p.Tyr1105Ter)	TRPS1	Y1105*, Y1096*, Y1098*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000005576	8	116426821	8	115414593	5576	20615	rs121908434	NC_000008.11:115414592:G:C
TRPS1, 4-BP INS, 3360GGAG	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005574					5574	20613		
TRPS1, 1-BP INS, 2441T	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005572					5572	20611		
TRPS1, 1-BP INS, 2406G	TRPS1		Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005571					5571	20610		
NM_014112.5(TRPS1):c.1053C>A (p.Cys351Ter)	TRPS1	C351*, C342*, C344*	Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005569	8	116617143	8	115604916	5569	20608	rs121908430	NC_000008.11:115604915:G:T
NM_014112.5(TRPS1):c.2956_2960dup (p.Val988fs)	TRPS1		|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000846686	8	116427175 - 116427176	8	115414947 - 115414948	846686	834035		NC_000008.11:115414947:TGCTC:TGCTCTGCTC
NM_014112.5(TRPS1):c.2880del (p.Arg961fs)	TRPS1	R954fs, R948fs, R952fs, R961fs	Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000660864	8	116427256	8	115415028	660864	636540		NC_000008.11:115415027:CC:C
NM_014112.5(TRPS1):c.2337_2338GA[3] (p.Lys782fs)	TRPS1		Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000659289	8	116599584 - 116599585	8	115587357 - 115587358	659289	636542		NC_000008.11:115587356:TCTCTCTCT:TCTCTCT
NM_014112.5(TRPS1):c.2700+1G>A	TRPS1		|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000649585	8	116599227	8	115587000	649585	651910		NC_000008.11:115586999:C:T
NC_000008.10:g.(?_116426231)_(116635884_?)del	TRPS1		|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000583713	8	116426231 - 116635884			583713	564540		
NM_000443.4(ABCB4):c.1015dup (p.Ser339fs)	ABCB4		Cholestasis, intrahepatic, of pregnancy 3	Pathogenic	no assertion criteria provided	VCV000812984	7	87074281 - 87074282	7	87444965 - 87444966	812984	801097		NC_000007.14:87444965:AAAAAAAAA:AAAAAAAAAA
NM_000443.4(ABCB4):c.2683-883_2783+345del	ABCB4		Cholestasis, intrahepatic, of pregnancy 3	Pathogenic	no assertion criteria provided	VCV000812921	7	87042588 - 87043916	7	87413272 - 87414600	812921	801093		
NM_000037.4(ANK1):c.4153C>T (p.Arg1385Ter)	ANK1	R1385*, R1426*	Spherocytosis type 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000811958	8	41546059	8	41688541	811958	799541		NC_000008.11:41688540:G:A
NM_000037.4(ANK1):c.4306C>T (p.Arg1436Ter)	ANK1	R1436*, R1477*	Spherocytosis type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000811943	8	41543754	8	41686236	811943	799540		NC_000008.11:41686235:G:A
NM_000037.4(ANK1):c.3555G>A (p.Trp1185Ter)	ANK1	W1185*, W1226*	Spherocytosis type 1	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000811917	8	41550697	8	41693179	811917	799543		NC_000008.11:41693178:C:T
NM_000037.4(ANK1):c.2029C>T (p.Gln677Ter)	ANK1	Q677*, Q710*	Spherocytosis type 1	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000617979	8	41563729	8	41706211	617979	609696	rs1563502820	NC_000008.11:41706210:G:A
NM_018849.3(ABCB4):c.94A>T (p.Lys32Ter)	ABCB4	K32*	not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000598259	7	87101978	7	87472662	598259	589320	rs1563009379	NC_000007.14:87472661:T:A
NM_018849.3(ABCB4):c.2316+1G>A	ABCB4		not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000598123	7	87051436	7	87422120	598123	589184	rs1562961442	NC_000007.14:87422119:C:T
NM_018849.3(ABCB4):c.879del (p.Ala294fs)	ABCB4	A294fs	not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000597760	7	87076476	7	87447160	597760	588821	rs1326932143	NC_000007.14:87447159:TTTTTT:TTTTT
NM_018849.3(ABCB4):c.1635_1648delinsCCATTCAGG (p.Ala546fs)	ABCB4		not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000597519	7	87069066 - 87069079	7	87439750 - 87439763	597519	588580	rs1562975541	NC_000007.14:87439749:TGCGAACCAGGGCA:CCTGAATGG
NM_018849.3(ABCB4):c.1943del (p.Lys648fs)	ABCB4	K648fs	not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000597269	7	87056187	7	87426871	597269	588330	rs1562965250	NC_000007.14:87426870:TTTT:TTT
NM_018849.3(ABCB4):c.609dup (p.Ala204fs)	ABCB4		not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000596911	7	87081037 - 87081038	7	87451721 - 87451722	596911	587972	rs1562988165	NC_000007.14:87451721:AAAAAA:AAAAAAA
NM_018849.3(ABCB4):c.927T>G (p.Tyr309Ter)	ABCB4	Y309*	not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000595982	7	87076428	7	87447112	595982	587043	rs199504845	NC_000007.14:87447111:A:C
NM_018849.3(ABCB4):c.932C>A (p.Ser311Ter)	ABCB4	S311*	not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000595571	7	87076423	7	87447107	595571	586633	rs1562983272	NC_000007.14:87447106:G:T
NM_018849.3(ABCB4):c.345-2A>G	ABCB4		not provided	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000594959	7	87082453	7	87453137	594959	586021	rs1562989885	NC_000007.14:87453136:T:C
NM_018849.3(ABCB4):c.1501G>T (p.Glu501Ter)	ABCB4	E501*	not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000594825	7	87069574	7	87440258	594825	585887	rs1562976167	NC_000007.14:87440257:C:A
NM_018849.3(ABCB4):c.2082_2088del (p.Val695fs)	ABCB4	V695fs	not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000594748	7	87053345 - 87053351	7	87424029 - 87424035	594748	585810	rs1562963055	NC_000007.14:87424028:GGACACTGG:GG
NM_018849.3(ABCB4):c.2002C>T (p.Gln668Ter)	ABCB4	Q668*	not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000594559	7	87056128	7	87426812	594559	585622	rs1562965098	NC_000007.14:87426811:G:A
NM_018849.3(ABCB4):c.3300G>C (p.Gln1100His)	ABCB4	Q1100H	not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000594502	7	87035811	7	87406495	594502	585565	rs1562949296	NC_000007.14:87406494:C:G
NM_018849.3(ABCB4):c.834-2A>G	ABCB4		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000594342	7	87076523	7	87447207	594342	585405	rs1562983531	NC_000007.14:87447206:T:C
NM_018849.3(ABCB4):c.139C>T (p.Arg47Ter)	ABCB4	R47*	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000502776	7	87092221	7	87462905	502776	494199	rs376926391	NC_000007.14:87462904:G:A
NM_018849.3(ABCB4):c.1006-2A>C	ABCB4		not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000502052	7	87074293	7	87444977	502052	493476	rs1348606984	NC_000007.14:87444976:T:G
NM_018849.3(ABCB4):c.3654+1G>T	ABCB4		not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000501851	7	87032450	7	87403134	501851	493275	rs1245472904	NC_000007.14:87403133:C:A
NM_018849.3(ABCB4):c.2473C>T (p.Gln825Ter)	ABCB4	Q825*	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000501419	7	87047858	7	87418542	501419	492843	rs1554401324	NC_000007.14:87418541:G:A
NM_018849.3(ABCB4):c.100dup (p.Thr34fs)	ABCB4		not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000499326	7	87101971 - 87101972	7	87472655 - 87472656	499326	490750	rs1554417376	NC_000007.14:87472655:TTTTTTT:TTTTTTTT
NM_018849.3(ABCB4):c.2446del (p.Arg816fs)	ABCB4	R816fs	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000499077	7	87047885	7	87418569	499077	490501	rs1554401344	NC_000007.14:87418568:TT:T
NM_018849.3(ABCB4):c.1006-1G>T	ABCB4		not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000498111	7	87074292	7	87444976	498111	489535	rs772823352	NC_000007.14:87444975:C:A
NM_018849.3(ABCB4):c.1144G>T (p.Glu382Ter)	ABCB4	E382*	not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000498031	7	87073065	7	87443749	498031	489455	rs1554407511	NC_000007.14:87443748:C:A
NM_018849.3(ABCB4):c.3081+1G>C	ABCB4		not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000497633	7	87038551	7	87409235	497633	489057	rs750829010	NC_000007.14:87409234:C:G
NM_018849.3(ABCB4):c.2625_2626delinsAT (p.Met875_Lys876delinsIleTer)	ABCB4		not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000287799	7	87046684 - 87046685	7	87417368 - 87417369	287799	272036	rs886043734	NC_000007.14:87417367:TC:AT
NM_018849.3(ABCB4):c.2626A>T (p.Lys876Ter)	ABCB4	K876*	not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000287778	7	87046684	7	87417368	287778	272015	rs886043725	NC_000007.14:87417367:T:A
NM_018849.3(ABCB4):c.2833C>T (p.Gln945Ter)	ABCB4	Q945*	not provided	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000283134	7	87041300	7	87411984	283134	267371	rs886042562	NC_000007.14:87411983:G:A
NM_001142446.2(ANK1):c.2859-1G>A	ANK1		not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000280903	8	41554106	8	41696588	280903	264367	rs886042022	NC_000008.11:41696587:C:T
NM_018849.3(ABCB4):c.2211+1G>A	ABCB4		not provided	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000194708	7	87053221	7	87423905	194708	191871	rs794727183	NC_000007.14:87423904:C:T
NM_000443.4(ABCB4):c.1714C>T (p.Gln572Ter)	ABCB4	Q572*	Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802328	7	87069000	7	87439684	802328	790755		NC_000007.14:87439683:G:A
NM_000443.4(ABCB4):c.1745G>A (p.Arg582Gln)	ABCB4	R582Q	Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802327	7	87060868	7	87431552	802327	790754		NC_000007.14:87431551:C:T
NM_000443.4(ABCB4):c.2784-12T>C	ABCB4		Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802326	7	87041361	7	87412045	802326	790753		NC_000007.14:87412044:A:G
NM_000443.4(ABCB4):c.2044del (p.Asp682fs)	ABCB4	D682fs	Cholestasis, intrahepatic, of pregnancy 3	Pathogenic	criteria provided, single submitter	VCV000617459	7	87056086	7	87426770	617459	608808	rs1562965036	NC_000007.14:87426769:C:
NM_001142446.2(ANK1):c.3531_3550del (p.Arg1178fs)	ANK1	R1178fs, R1137fs	not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000559408	8	41551521 - 41551540	8	41694003 - 41694022	559408	550140	rs1554544862	NC_000008.11:41694002:GGTGGAACTTCCGGCGCCGGGG:GG
NM_000037.4(ANK1):c.534del (p.His178fs)	ANK1	H178fs, H211fs	Spherocytosis type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544804	8	41583357	8	41725839	544804	535250	rs1554578304	NC_000008.11:41725838:G:
NM_000037.4(ANK1):c.1702-2A>C	ANK1		Spherocytosis type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544801	8	41571774	8	41714256	544801	535249	rs1554567249	NC_000008.11:41714255:T:G
NM_000037.4(ANK1):c.5152C>T (p.Gln1718Ter)	ANK1	Q1718*, Q1759*, Q1556*	Spherocytosis type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544800	8	41526027	8	41668509	544800	535247	rs1554522035	NC_000008.11:41668508:G:A
NM_018849.3(ABCB4):c.3629C>G (p.Ser1210Ter)	ABCB4	S1210*, S1203*, S1156*	not provided	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000287358	7	87032476	7	87403160	287358	271595	rs748842753	NC_000007.14:87403159:G:C
NM_018849.3(ABCB4):c.1633C>G (p.Arg545Gly)	ABCB4	R545G	Gallbladder disease 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000039841	7	87069081	7	87439765	39841	48440	rs397514620	NC_000007.14:87439764:G:C
NM_000443.4(ABCB4):c.430C>T (p.Arg144Ter)	ABCB4	R144*	Cholestasis, intrahepatic, of pregnancy 3	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000013696	7	87082366	7	87453050	13696	28735	rs72552780	NC_000007.14:87453049:G:A
NM_000443.4(ABCB4):c.1207T>C (p.Tyr403His)	ABCB4	Y403H	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013695	7	87073002	7	87443686	13695	28734	rs121918443	NC_000007.14:87443685:A:G
NM_000443.4(ABCB4):c.2169dup (p.Leu724fs)	ABCB4		Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013694	7	87053263 - 87053264	7	87423947 - 87423948	13694	28733	rs387906529	NC_000007.14:87423947:CCCCCC:CCCCCCC
NM_000443.4(ABCB4):c.394_400del (p.Tyr132fs)	ABCB4	Y132fs	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000013686	7	87082396 - 87082402	7	87453080 - 87453086	13686	28725	rs387906526	NC_000007.14:87453079:GTATATAG:G
NM_000037.4(ANK1):c.1519dup (p.Leu507fs)	ANK1		Spherocytosis type 1	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000000511	8	41573252 - 41573253	8	41715734 - 41715735	511	15550	rs397514029	NC_000008.11:41715734:GGGGGG:GGGGGGG
NM_000037.4(ANK1):c.5163G>A (p.Trp1721Ter)	ANK1	W1721*, W1762*, W1559*	Spherocytosis type 1	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000000509	8	41526016	8	41668498	509	15548	rs137852830	NC_000008.11:41668497:C:T
NM_001142446.2(ANK1):c.127-39474_127-39473del	ANK1		Spherocytosis, type 1, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000000508	8	41655128 - 41655129	8	41797610 - 41797611	508	15547	rs786205242	NC_000008.11:41797609:CAC:C
NM_000037.4(ANK1):c.5005G>T (p.Glu1669Ter)	ANK1	E1669*, E1710*	Spherocytosis type 1	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000000506	8	41529963	8	41672445	506	15545	rs137852829	NC_000008.11:41672444:C:A
NM_000443.4(ABCB4):c.3077del (p.Lys1026fs)	ABCB4	K979fs, K1026fs	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635317	7	87038556	7	87409240	635317	623143		NC_000007.14:87409239:TT:T
NM_000037.4(ANK1):c.4462C>T (p.Arg1488Ter)	ANK1	R1488*, R1529*	Spherocytosis type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544802	8	41542137	8	41684619	544802	535248	rs777701149	NC_000008.11:41684618:G:A
NM_000443.4(ABCB4):c.3486+1G>A	ABCB4		Cholestasis, intrahepatic, of pregnancy 3|not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000501724	7	87035603	7	87406287	501724	493148	rs764513998	NC_000007.14:87406286:C:T
NM_018849.3(ABCB4):c.1015del (p.Ser339fs)	ABCB4	S339fs	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000500242	7	87074282	7	87444966	500242	491666	rs753104429	NC_000007.14:87444965:AAAAAAAAA:AAAAAAAA
NM_001142446.2(ANK1):c.619_638del (p.Leu207fs)	ANK1	L207fs, L174fs	Spherocytosis, type 1, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000000514	8	41583352 - 41583371	8	41725834 - 41725853	514	15553	rs786205244	NC_000008.11:41725833:GCGATGTGCAGGGCCGGGAGGCG:GCG
NC_000008.11:g.(?_115586981)_(115587624_?)del	TRPS1		Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000831201	8	116599208 - 116599851			831201	819934		
NM_001282902.3(TRPS1):c.1149dup (p.Asn384Ter)	TRPS1		Trichorhinophalangeal dysplasia type I|not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000438449	8	116617019 - 116617020	8	115604792 - 115604793	438449	432082	rs1554596328	NC_000008.11:115604792:A:AA
NM_014112.5(TRPS1):c.2725dup (p.Cys909fs)	TRPS1		Langer-Giedion syndrome|not provided	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000419064	8	116430655 - 116430656	8	115418427 - 115418428	419064	407292	rs1554617582	NC_000008.11:115418427:AAAAAA:AAAAAAA
NM_000443.4(ABCB4):c.1553del (p.Leu518fs)	ABCB4	L518fs	not provided|Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595241	7	87069522	7	87440206	595241	586303	rs1562976061	NC_000007.14:87440205:AA:A
NM_000443.4(ABCB4):c.3724dup (p.Ile1242fs)	ABCB4		Cholestasis, progressive familial intrahepatic 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000594504	7	87031527 - 87031528	7	87402211 - 87402212	594504	585567	rs1562945221	NC_000007.14:87402211:TT:TTT
NM_000443.4(ABCB4):c.1328_1329delinsCAA (p.Gln443fs)	ABCB4		Gallbladder disease 1|Cholestasis, intrahepatic, of pregnancy 3	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000013693	7	87072662 - 87072663	7	87443346 - 87443347	13693	28732	rs387906528	NC_000007.14:87443345:CT:TTG
NM_000443.4(ABCB4):c.1712del (p.Val571fs)	ABCB4	V571fs	Progressive familial intrahepatic cholestasis 3|Cholestasis, intrahepatic, of pregnancy 3	Pathogenic(Last reviewed: Jan 16, 1999)	no assertion criteria provided	VCV000013688	7	87069002	7	87439686	13688	28727	rs387906527	NC_000007.14:87439685:A:
NM_000037.4(ANK1):c.5497C>T (p.Arg1833Ter)	ANK1	R1833*, R1874*, R108*, R1671*	Spherocytosis type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000000510	8	41519441	8	41661923	510	15549	rs137852831	NC_000008.11:41661922:G:A
NM_000019.4(ACAT1):c.472A>G (p.Asn158Asp)	ACAT1	N158D	Deficiency of acetyl-CoA acetyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092297	11	108009661	11	108138934	92297	98208	rs148639841	NC_000011.10:108138933:A:G
NM_004408.4(DNM1):c.1036G>A (p.Gly346Ser)	DNM1	G346S	Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000520433	9	130984783	9	128222504	520433	511029	rs1554774575	NC_000009.12:128222503:G:A
NM_004408.4(DNM1):c.865A>T (p.Ile289Phe)	DNM1	I289F	Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190311	9	130984491	9	128222212	190311	188140	rs1554774401	NC_000009.12:128222211:A:T
NM_004408.4(DNM1):c.1090_1091insTTCCAC (p.Arg364_Ile365insLeuPro)	DNM1		Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000587399	9	130984836 - 130984837	9	128222557 - 128222558	587399	578355	rs1564332930	NC_000009.12:128222557:C:CTTCCAC
NM_004408.4(DNM1):c.1076G>C (p.Gly359Ala)	DNM1	G359A	Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000156559	9	130984823	9	128222544	156559	166363	rs587777862	NC_000009.12:128222543:G:C
NM_004408.4(DNM1):c.618G>C (p.Lys206Asn)	DNM1	K206N	Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000156558	9	130982295	9	128220016	156558	166362	rs587777861	NC_000009.12:128220015:G:C
NM_004408.4(DNM1):c.529G>C (p.Ala177Pro)	DNM1	A177P	Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000156557	9	130981471	9	128219192	156557	166361	rs587777860	NC_000009.12:128219191:G:C
NM_194456.1(KRIT1):c.937dup (p.Ser313fs)	KRIT1		not provided|Cerebral cavernous malformation	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503945	7	91863814 - 91863815	7	92234500 - 92234501	503945	495222	rs1554527032	NC_000007.14:92234500:AAAA:AAAAA
NM_004912.4(KRIT1):c.1700_1701AG[1] (p.Glu567_Ser568insTer)	KRIT1		not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000468212	7	91843952 - 91843953	7	92214638 - 92214639	468212	457061	rs1554504484	NC_000007.14:92214637:CTCTC:CTC
NM_194456.1(KRIT1):c.1412-1G>T	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000468208	7	91851368	7	92222054	468208	458024	rs1554513070	NC_000007.14:92222053:C:A
NM_194456.1(KRIT1):c.1084del (p.Ala362fs)	KRIT1	A314fs, A362fs, A124fs	Cerebral cavernous malformation|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447673	7	91855902	7	92226588	447673	441149	rs1554518541	NC_000007.14:92226587:C:
NM_194456.1(KRIT1):c.1890G>A (p.Trp630Ter)	KRIT1	W630*, W392*, W582*	not specified|Cerebral cavernous malformation	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439854	7	91842644	7	92213330	439854	433658	rs1554503009	NC_000007.14:92213329:C:T
NM_194456.1(KRIT1):c.601C>G (p.Gln201Glu)	KRIT1	Q201E	not provided|Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000005726	7	91864845	7	92235531	5726	20765	rs137853140	NC_000007.14:92235530:G:C
NM_000448.2(RAG1):c.2689C>T (p.Arg897Ter)	RAG1	R897*	Combined cellular and humoral immune defects with granulomas||not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488725	11	36597543	11	36575993	488725	481990	rs757797994	NC_000011.10:36575992:C:T
NM_014112.5(TRPS1):c.2795C>T (p.Ala932Val)	TRPS1	A932V, A925V, A923V	Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Jan 24, 2017)	no assertion criteria provided	VCV000005578	8	116430586	8	115418358	5578	20617	rs121908436	NC_000008.11:115418357:G:A
NM_000787.4(DBH):c.339+2T>C	DBH		not provided|Orthostatic hypotension 1	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001750	9	136501834	9	133636712	1750	16789	rs74853476	NC_000009.12:133636711:T:C
NM_000443.4(ABCB4):c.475C>T (p.Arg159Ter)	ABCB4	R159*	Cholestasis, intrahepatic, of pregnancy 3|Cholestasis, progressive familial intrahepatic 1|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000596680	7	87082321	7	87453005	596680	587741	rs377160065	NC_000007.14:87453004:G:A
NM_000037.4(ANK1):c.1801-17G>A	ANK1		Spherocytosis, type 1, autosomal recessive|Spherocytosis type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000000513	8	41566510	8	41708992	513	15552	rs786205243	NC_000008.11:41708991:C:T
NM_022970.3(FGFR2):c.1087+1366A>G	FGFR2		Crouzon syndrome|Pfeiffer syndrome	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000013299	10	123276830	10	121517316	13299	28338	rs879253721	NC_000010.11:121517315:T:C
NM_022970.3(FGFR2):c.1118C>G (p.Ser373Cys)	FGFR2	S372C, S373C, S257C, S260C, S283C, S284C, S144C	|Endometrial neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000013278	10	123274803	10	121515289	13278	28317	rs121913477	NC_000010.11:121515288:G:C
NM_022970.3(FGFR2):c.866A>C (p.Gln289Pro)	FGFR2	Q289P, Q174P, Q200P, Q61P	Jackson-Weiss syndrome|Pfeiffer syndrome|Crouzon syndrome	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000013276	10	123279566	10	121520052	13276	28315	rs121918497	NC_000010.11:121520051:T:G
NM_022970.3(FGFR2):c.1087+1310C>G	FGFR2	A344G, A229G, A255G, A116G	Jackson-Weiss syndrome|Crouzon syndrome	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000013269	10	123276886	10	121517372	13269	28308	rs121918492	NC_000010.11:121517371:G:C
NM_004183.4(BEST1):c.334_340del (p.Gly112fs)	BEST1	G112fs, G6fs, G52fs	not provided	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000817977	11	61723273 - 61723279	11	61955801 - 61955807	817977	805701		NC_000011.10:61955800:TCGGGCTTCG:TCG
NM_004183.4(BEST1):c.777_778insAA (p.Pro260fs)	BEST1		not provided	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000817976	11	61725680 - 61725681	11	61958208 - 61958209	817976	805703		NC_000011.10:61958208::AA
NM_004183.4(BEST1):c.1120dup (p.Glu374fs)	BEST1		not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000817619	11	61729744 - 61729745	11	61962272 - 61962273	817619	805704		NC_000011.10:61962272:GG:GGG
NM_004183.4(BEST1):c.779del (p.Pro260fs)	BEST1	P260fs, P154fs, P200fs	not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000817618	11	61725680	11	61958208	817618	805702		NC_000011.10:61958207:CCC:CC
NM_004183.4(BEST1):c.44G>A (p.Gly15Asp)	BEST1	G15D	not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000429731	11	61719322	11	61951850	429731	421864	rs766379510	NC_000011.10:61951849:G:A
NM_004183.4(BEST1):c.636+1G>A	BEST1		not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000265463	11	61724471	11	61956999	265463	259989	rs62637337	NC_000011.10:61956998:G:A
NM_004183.4(BEST1):c.604C>T (p.Arg202Trp)	BEST1	R202W, R142W, R96W	not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000265462	11	61724438	11	61956966	265462	259988	rs765998048	NC_000011.10:61956965:C:T
NM_004183.4(BEST1):c.1175del (p.Arg392fs)	BEST1	R68fs, R286fs, R392fs, R305fs, R332fs	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000851696	11	61729801	11	61962329	851696	838614		NC_000011.10:61962328:G:
NM_004183.4(BEST1):c.956T>C (p.Leu319Pro)	BEST1	L319P, C387R, L213P, L232P, L259P	Bestrophinopathy, autosomal recessive	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000522530	11	61727371	11	61959899	522530	513094	rs1554963305	NC_000011.10:61959898:T:C
NM_004183.4(BEST1):c.1370C>G (p.Pro457Arg)	BEST1	P457R, P133R, P370R, P351R, P397R	Bestrophinopathy, autosomal recessive	Pathogenic(Last reviewed: Oct 10, 2017)	no assertion criteria provided	VCV000522511	11	61729996	11	61962524	522511	513095	rs1554964287	NC_000011.10:61962523:C:G
NM_004183.4(BEST1):c.272C>T (p.Thr91Ile)	BEST1	T91I, T31I	not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000099701	11	61723214	11	61955742	99701	105590	rs281865223	NC_000011.10:61955741:C:T
NM_014112.5(TRPS1):c.2761C>T (p.Arg921Ter)	TRPS1	R921*, R908*, R912*, R914*	Trichorhinophalangeal dysplasia type I||Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000438463	8	116430620	8	115418392	438463	432071	rs751565386	NC_000008.11:115418391:G:A
NM_014112.5(TRPS1):c.2557C>T (p.Arg853Ter)	TRPS1	R853*, R846*, R844*	Trichorhinophalangeal dysplasia type I|not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000005573	8	116599371	8	115587144	5573	20612	rs121908432	NC_000008.11:115587143:G:A
NM_014112.5(TRPS1):c.1870C>T (p.Arg624Ter)	TRPS1	R624*, R615*, R617*	Trichorhinophalangeal dysplasia type I|not provided	Pathogenic(Last reviewed: Dec 18, 2016)	criteria provided, single submitter	VCV000005570	8	116616326	8	115604099	5570	20609	rs121908431	NC_000008.11:115604098:G:A
NM_004183.4(BEST1):c.908A>T (p.Asp303Val)	BEST1	D243V, D197V, D303V, M371L	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812233	11	61727010	11	61959538	812233	800569		NC_000011.10:61959537:A:T
NM_004183.4(BEST1):c.404G>A (p.Gly135Asp)	BEST1	G135D, G29D, G75D	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812231	11	61723346	11	61955874	812231	800567		NC_000011.10:61955873:G:A
NM_004183.4(BEST1):c.294G>C (p.Glu98Asp)	BEST1	E38D, E98D	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812230	11	61723236	11	61955764	812230	800566		NC_000011.10:61955763:G:C
NM_004183.4(BEST1):c.910G>A (p.Asp304Asn)	BEST1	D304N, D244N, M371I, D198N	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Jan 21, 2015)	no assertion criteria provided	VCV000496689	11	61727012	11	61959540	496689	488171	rs1554963095	NC_000011.10:61959539:G:A
NM_004183.4(BEST1):c.-37+1G>T	BEST1		Retinal dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438184	11	61717900	11	61950428	438184	431754	rs1555096248	NC_000011.10:61950427:G:T
NM_004183.4(BEST1):c.172_173dup (p.Gln58fs)	BEST1		Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Feb 18, 2010)	no assertion criteria provided	VCV000162042	11	61722596 - 61722597	11	61955124 - 61955125	162042	171760	rs672601356	NC_000011.10:61955124:ACA:ACACA
NM_004183.4(BEST1):c.900G>C (p.Glu300Asp)	BEST1	E300D, E194D, E240D, R368T	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000099770	11	61727002	11	61959530	99770	105659	rs1805144	NC_000011.10:61959529:G:C
NM_004183.4(BEST1):c.898G>A (p.Glu300Lys)	BEST1	E300K, E240K, E194K	Retinal dystrophy|not provided	Pathogenic(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000099768	11	61727000	11	61959528	99768	105657	rs281865258	NC_000011.10:61959527:G:A
NM_004183.4(BEST1):c.28G>A (p.Ala10Thr)	BEST1	A10T	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000099706	11	61719306	11	61951834	99706	105595	rs281865206	NC_000011.10:61951833:G:A
NM_004183.4(BEST1):c.704T>C (p.Val235Ala)	BEST1	V235A, V129A, V175A	Vitreoretinochoroidopathy	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000002751	11	61724926	11	61957454	2751	17790	rs267606679	NC_000011.10:61957453:T:C
NM_004183.4(BEST1):c.715G>A (p.Val239Met)	BEST1	V239M, V133M, V179M	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002745	11	61725618	11	61958146	2745	17784	rs121918290	NC_000011.10:61958145:G:A
NM_004183.4(BEST1):c.949G>A (p.Val317Met)	BEST1	V317M, V257M, V211M, V230M	Bestrophinopathy, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002742	11	61727364	11	61959892	2742	17781	rs121918287	NC_000011.10:61959891:G:A
NM_004183.4(BEST1):c.598C>T (p.Arg200Ter)	BEST1	R200*, R94*, R140*	Bestrophinopathy, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002741	11	61724432	11	61956960	2741	17780	rs121918286	NC_000011.10:61956959:C:T
NM_054012.4(ASS1):c.919C>T (p.Arg307Cys)	ASS1	R307C	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265044	9	133364800	9	130489413	265044	259915	rs183276875	NC_000009.12:130489412:C:T
NM_054012.4(ASS1):c.450_451del (p.Phe150fs)	ASS1	F150fs	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189044	9	133342140 - 133342141	9	130466753 - 130466754	189044	186781	rs786204648	NC_000009.12:130466752:TCT:T
NM_004183.4(BEST1):c.905A>C (p.Asp302Ala)	BEST1	D302A, D196A, D242A, M370L	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636002	11	61727007	11	61959535	636002	623874		NC_000011.10:61959534:A:C
NM_004183.4(BEST1):c.904G>A (p.Asp302Asn)	BEST1	D302N, D196N, M369I, D242N	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636001	11	61727006	11	61959534	636001	623873		NC_000011.10:61959533:G:A
NM_004183.4(BEST1):c.58C>G (p.Leu20Val)	BEST1	L20V	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636000	11	61719336	11	61951864	636000	623870		NC_000011.10:61951863:C:G
NM_004183.4(BEST1):c.763C>T (p.Arg255Trp)	BEST1	R255W, R149W, R195W	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143127	11	61725666	11	61958194	143127	152845	rs372989281	NC_000011.10:61958193:C:T
NM_004183.4(BEST1):c.614T>C (p.Ile205Thr)	BEST1	I205T, I145T, I99T	Retinitis pigmentosa 50	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000002747	11	61724448	11	61956976	2747	17786	rs267606680	NC_000011.10:61956975:T:C
NM_004183.4(BEST1):c.707A>G (p.Tyr236Cys)	BEST1	Y236C, Y176C, Y130C	Vitreoretinochoroidopathy	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000002746	11	61724929	11	61957457	2746	17785	rs121918291	NC_000011.10:61957456:A:G
NM_004183.4(BEST1):c.87C>G (p.Tyr29Ter)	BEST1	Y29*	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000002730	11	61719365	11	61951893	2730	17769	rs121918285	NC_000011.10:61951892:C:G
NM_000288.4(PEX7):c.120C>G (p.Tyr40Ter)	PEX7	Y40*	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Phytanic acid storage disease|PEX7-Related Disorders|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007788	6	137143923	6	136822785	7788	22827	rs61753238	NC_000006.12:136822784:C:G
NM_000497.3(CYP11B1):c.281C>T (p.Pro94Leu)	CYP11B1	P94L	Congenital adrenal hyperplasia|not provided|Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000001186	8	143960562	8	142879146	1186	16225	rs104894070	NC_000008.11:142879145:G:A
NM_004183.4(BEST1):c.821C>G (p.Pro274Arg)	BEST1	P168R, P274R, P214R	not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000851138	11	61725724	11	61958252	851138	838608		NC_000011.10:61958251:C:G
NM_004183.4(BEST1):c.888C>G (p.Asn296Lys)	BEST1	N296K, N190K, N236K, T364S	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000559498	11	61726990	11	61959518	559498	550222	rs1554963058	NC_000011.10:61959517:C:G
NM_004183.4(BEST1):c.74G>A (p.Arg25Gln)	BEST1	R25Q	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000099752	11	61719352	11	61951880	99752	105641	rs281865215	NC_000011.10:61951879:G:A
NM_004183.4(BEST1):c.727G>A (p.Ala243Thr)	BEST1	A243T, A137T, A183T	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099749	11	61725630	11	61958158	99749	105638	rs137853905	NC_000011.10:61958157:G:A
NM_004183.4(BEST1):c.665G>T (p.Gly222Val)	BEST1	G222V, G162V, G116V	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000099739	11	61724887	11	61957415	99739	105628	rs281865241	NC_000011.10:61957414:G:T
NM_004183.4(BEST1):c.29C>T (p.Ala10Val)	BEST1	A10V	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000099709	11	61719307	11	61951835	99709	105598	rs281865207	NC_000011.10:61951834:C:T
NM_004183.4(BEST1):c.122T>C (p.Leu41Pro)	BEST1	L41P	not provided|Bestrophinopathy, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002743	11	61719400	11	61951928	2743	17782	rs121918288	NC_000011.10:61951927:T:C
NM_023110.2(FGFR1):c.2052G>A (p.Trp684Ter)	FGFR1	W684*, W680*, W591*, W593*, W595*, W674*, W682*, W715*	not provided	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000546028	8	38271804	8	38414286	546028	536337	rs1554547400	NC_000008.11:38414285:C:T
NM_023110.2(FGFR1):c.1589C>A (p.Ser530Ter)	FGFR1	S530*, S437*, S520*, S561*, S439*, S526*, S441*, S528*	not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000523869	8	38274898	8	38417380	523869	514568	rs1554551706	NC_000008.11:38417379:G:T
NM_023110.2(FGFR1):c.1839T>G (p.Tyr613Ter)	FGFR1	Y613*, Y520*, Y603*, Y611*, Y644*, Y522*, Y524*, Y609*	not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000452148	8	38273403	8	38415885	452148	444274	rs1554549628	NC_000008.11:38415884:A:C
NM_023110.2(FGFR1):c.2152C>G (p.Arg718Gly)	FGFR1	R718G, R716G, R625G, R629G, R708G, R714G, R749G, R627G	not provided	Pathogenic(Last reviewed: Mar 21, 2015)	criteria provided, single submitter	VCV000379237	8	38271704	8	38414186	379237	371858	rs1057520536	NC_000008.11:38414185:G:C
NM_015850.4(FGFR1):c.1758_1768del (p.Ser586fs)	FGFR1	S499fs, S588fs, S619fs, S584fs, S586fs, S495fs, S497fs, S578fs	not provided	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000373103	8	38273468 - 38273478	8	38415950 - 38415960	373103	359850	rs1057518218	NC_000008.11:38415949:CTGGGTTGTGGCTGGG:CTGGG
NM_023110.2(FGFR1):c.1431-1G>A	FGFR1		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000280606	8	38275510	8	38417992	280606	264353	rs886041780	NC_000008.11:38417991:C:T
NM_023110.2(FGFR1):c.1864C>G (p.Arg622Gly)	FGFR1	R622G, R531G, R533G, R653G, R612G, R618G, R529G, R620G	not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000265428	8	38272410	8	38414892	265428	259898	rs121909628	NC_000008.11:38414891:G:C
NM_023110.2(FGFR1):c.91+1G>A	FGFR1		not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634622	8	38314873	8	38457355	634622	622508	rs1563626890	NC_000008.11:38457354:C:T
NM_023110.2(FGFR1):c.36_42dup (p.Thr15fs)	FGFR1		not provided	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000585867	8	38314922 - 38314923	8	38457404 - 38457405	585867	577062	rs1563627742	NC_000008.11:38457404:GACCAGC:GACCAGCGACCAGC
NM_023110.2(FGFR1):c.821del (p.Glu274fs)	FGFR1	E183fs, E274fs, E266fs, E272fs, E305fs, E185fs	not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000447330	8	38282142	8	38424624	447330	441234	rs1554562081	NC_000008.11:38424623:T:
NM_015850.4(FGFR1):c.1462G>A (p.Gly488Arg)	FGFR1	G490R, G397R, G480R, G486R, G488R, G399R, G401R, G521R	not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000377227	8	38275472	8	38417954	377227	364105	rs869025670	NC_000008.11:38417953:C:T
NM_023110.2(FGFR1):c.565C>T (p.Arg189Cys)	FGFR1	R189C, R100C, R181C, R187C, R220C, R98C		Pathogenic	criteria provided, single submitter	VCV000183685	8	38285495	8	38427977	183685	181583	rs863223331	NC_000008.11:38427976:G:A
NM_015850.4(FGFR1):c.2158C>T (p.Pro720Ser)	FGFR1	P722S, P629S, P633S, P718S, P631S, P712S, P753S, P720S	Hypogonadotropic hypogonadism 2 with anosmia	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016300	8	38271692	8	38414174	16300	31339	rs121909642	NC_000008.11:38414173:G:A
FGFR1, CYS379ARG	FGFR1	C379R	Osteoglophonic dysplasia	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000016288					16288	31327		
NM_015850.4(FGFR1):c.1115A>G (p.Tyr372Cys)	FGFR1	Y372C, Y374C, Y366C, Y405C, Y285C, Y283C	Osteoglophonic dysplasia	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000016287	8	38277214	8	38419696	16287	31326	rs121909631	NC_000008.11:38419695:T:C
NM_015850.4(FGFR1):c.493G>T (p.Ala165Ser)	FGFR1	A167S, A159S, A76S, A165S, A78S, A198S	Hypogonadotropic hypogonadism 2 with anosmia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000016285	8	38285561	8	38428043	16285	31324	rs121909630	NC_000008.11:38428042:C:A
Single allele	FGFR1		Hypogonadism with anosmia	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635961	8	38320755 - 38328265			635961	623774		
NM_023105.3(FGFR1):c.1614G>C (p.Arg538Ser)	FGFR1	R538S, R627S, R534S, R623S, R658S, R625S, R536S, R617S	Hartsfield syndrome|Cerebellar vermis hypoplasia	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632588	8	38272393	8	38414875	632588	621027	rs1563436265	NC_000008.11:38414874:C:G
NM_023110.2(FGFR1):c.880G>A (p.Glu294Lys)	FGFR1	E294K, E203K, E205K, E286K, E325K, E292K	Holoprosencephaly sequence	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000517665	8	38282083	8	38424565	517665	508756	rs528376963	NC_000008.11:38424564:C:T
NM_015850.4(FGFR1):c.1705del (p.Glu569fs)	FGFR1	E478fs, E482fs, E561fs, E602fs, E569fs, E571fs, E480fs, E567fs		Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000397530	8	38273531	8	38416013	397530	384419	rs1060499663	NC_000008.11:38416012:CCC:CC
NM_015850.4(FGFR1):c.2078C>T (p.Thr693Ile)	FGFR1	T695I, T602I, T685I, T606I, T691I, T693I, T726I, T604I		Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	VCV000132648	8	38271772	8	38414254	132648	136396	rs515726225	NC_000008.11:38414253:G:A
NM_015850.4(FGFR1):c.784A>C (p.Asn262His)	FGFR1	N264H, N295H, N256H, N173H, N175H, N262H		Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	VCV000132646	8	38282173	8	38424655	132646	136394	rs515726223	NC_000008.11:38424654:T:G
NM_015850.4(FGFR1):c.2286G>T (p.Gln762His)	FGFR1	Q764H, Q673H, Q795H, Q671H, Q760H, Q762H, Q675H, Q754H		Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000016301	8	38271436	8	38413918	16301	31340	rs121909643	NC_000008.11:38413917:C:A
NM_023105.3(FGFR1):c.92-1463G>A	FGFR1	G48S, G40S, G81S		Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016298	8	38287416	8	38429898	16298	31337	rs121909640	NC_000008.11:38429897:C:T
NM_015850.4(FGFR1):c.1135T>C (p.Cys379Arg)	FGFR1	C381R, C379R, C412R, C290R, C292R, C373R	Osteoglophonic dysplasia	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000016290	8	38277194	8	38419676	16290	31329	rs121909634	NC_000008.11:38419675:A:G
NM_032415.6(CARD11):c.367G>A (p.Gly123Ser)	CARD11	G116S, G123S	B-cell expansion with NFKB and T-cell anergy|Immunodeficiency 11|B-cell expansion with NFKB and T-cell anergy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000048648	7	2984163	7	2944529	48648	57810	rs387907352	NC_000007.14:2944528:C:T
NM_023110.3(FGFR1):c.1512del (p.Lys504fs)	FGFR1	K535fs, K494fs, K502fs, K411fs, K413fs, K500fs, K415fs, K504fs	Pfeiffer syndrome|	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000862263	8	38275428	8	38417910	862263	834739		NC_000008.11:38417909:TTT:TT
NC_000008.11:g.(?_38424489)_(38461126_?)del	FGFR1		|Pfeiffer syndrome	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000832441	8	38282007 - 38318644			832441	819961		
NM_001174066.2(FGFR1):c.1729T>C (p.Trp577Arg)	FGFR1	W577R, W666R, W656R, W664R, W575R, W662R, W697R, W573R	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000585294	8	38272129	8	38414611	585294	576331	rs1563433902	NC_000008.11:38414610:A:G
NM_023110.2(FGFR1):c.1869C>G (p.Asp623Glu)	FGFR1	D623E, D613E, D534E, D621E, D619E, D530E, D532E, D654E	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000522553	8	38272405	8	38414887	522553	513166	rs780009859	NC_000008.11:38414886:G:C
NM_023110.2(FGFR1):c.1921G>A (p.Asp641Asn)	FGFR1	D641N, D548N, D637N, D672N, D631N, D639N, D550N, D552N	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000517666	8	38272353	8	38414835	517666	508757	rs1554548253	NC_000008.11:38414834:C:T
NM_023110.2(FGFR1):c.1604T>A (p.Met535Lys)	FGFR1	M535K, M525K, M531K, M533K, M566K, M442K, M444K, M446K	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000496784	8	38274883	8	38417365	496784	488207	rs1554551667	NC_000008.11:38417364:A:T
NM_023110.2(FGFR1):c.1977+1G>A	FGFR1		|Semilobar holoprosencephaly	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000235087	8	38272296	8	38414778	235087	236849	rs876661334	NC_000008.11:38414777:C:T
NM_023110.2(FGFR1):c.1884T>G (p.Asn628Lys)	FGFR1	N628K, N539K, N624K, N537K, N618K, N626K, N535K, N659K	Hartsfield syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000223246	8	38272390	8	38414872	223246	224975	rs869025672	NC_000008.11:38414871:A:C
NM_023110.2(FGFR1):c.572T>C (p.Leu191Ser)	FGFR1	L191S, L183S, L100S, L189S, L222S, L102S	Hartsfield syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000223243	8	38285488	8	38427970	223243	224978	rs869025669	NC_000008.11:38427969:A:G
NM_015850.4(FGFR1):c.983A>T (p.Asn328Ile)	FGFR1	N330I, N239I, N322I, N241I, N361I, N328I	Osteoglophonic dysplasia	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000016286	8	38279407	8	38421889	16286	31325	rs121909632	NC_000008.11:38421888:T:A
NM_004183.4(BEST1):c.355G>C (p.Glu119Gln)	BEST1	E119Q, E13Q, E59Q	not provided|Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000002735	11	61723297	11	61955825	2735	17774	rs1805142	NC_000011.10:61955824:G:C
NM_004183.4(BEST1):c.25G>A (p.Val9Met)	BEST1	V9M	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000002734	11	61719303	11	61951831	2734	17773	rs28940276	NC_000011.10:61951830:G:A
NM_004183.3(BEST1):c.884_886delTCA (p.Ile295del)	BEST1	I295del	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000002733	11	61726983 - 61726985	11	61959511 - 61959513	2733	17772	rs121918283	NC_000011.10:61959510:TCATCA:TCA
NM_004183.4(BEST1):c.896G>A (p.Gly299Glu)	BEST1	G299E, E367K, G193E, G239E	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000002729	11	61726998	11	61959526	2729	17768	rs28941468	NC_000011.10:61959525:G:A
NM_000360.4(TH):c.991G>T (p.Glu331Ter)	TH	E331*, E362*, E358*	Dystonia	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000840013	11	2187766	11	2166536	840013	838191		NC_000011.10:2166535:C:A
NM_000360.4(TH):c.448C>T (p.Gln150Ter)	TH	Q150*, Q177*, Q181*	Dystonia	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000691995	11	2189760	11	2168530	691995	679778		NC_000011.10:2168529:G:A
NM_000360.4(TH):c.283del (p.Ala95fs)	TH	A95fs, A122fs, A126fs	Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	VCV000208620	11	2190909	11	2169679	208620	205167	rs797045111	NC_000011.10:2169678:CC:C
NM_000360.4(TH):c.983G>T (p.Cys328Phe)	TH	C359F, C328F, C355F	Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000012334	11	2187774	11	2166544	12334	27373	rs121917765	NC_000011.10:2166543:C:A
NM_000360.4(TH):c.1105-24T>A	TH		Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000012331	11	2187017	11	2165787	12331	27370	rs587776767	NC_000011.10:2165786:A:T
NM_000360.4(TH):c.733A>C (p.Thr245Pro)	TH	T276P, T245P, T272P	Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000012329	11	2188225	11	2166995	12329	27368	rs28934581	NC_000011.10:2166994:T:G
NM_023110.2(FGFR1):c.1430+1G>A	FGFR1		Pfeiffer syndrome|	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000463529	8	38275745	8	38418227	463529	458465	rs1554552774	NC_000008.11:38418226:C:T
NM_023110.2(FGFR1):c.1468G>C (p.Gly490Arg)	FGFR1	G490R, G397R, G399R, G401R, G521R, G480R, G486R, G488R	Hartsfield syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000223244	8	38275472	8	38417954	223244	224977	rs869025670	NC_000008.11:38417953:C:G
NM_023110.2(FGFR1):c.1867G>T (p.Asp623Tyr)	FGFR1	D623Y, D530Y, D534Y, D613Y, D621Y, D532Y, D619Y, D654Y	Hartsfield syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000066080	8	38272407	8	38414889	66080	76982	rs398122946	NC_000008.11:38414888:C:A
NM_023110.2(FGFR1):c.1042G>A (p.Gly348Arg)	FGFR1	G348R, G257R, G259R, G340R, G346R, G379R	not provided|Hypogonadotropic hypogonadism 2 with anosmia	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000050849	8	38279354	8	38421836	50849	59835	rs886037634	NC_000008.11:38421835:C:T
NM_194456.1(KRIT1):c.1255-2A>G	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000859572	7	91852294	7	92222980	859572	852382		NC_000007.14:92222979:T:C
NM_194456.1(KRIT1):c.1730+4_1730+7del	KRIT1		Cerebral cavernous malformation|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590717	7	91843918 - 91843921	7	92214604 - 92214607	590717	581356	rs1563244596	NC_000007.14:92214603:TACTTACTT:TACTT
NM_194456.1(KRIT1):c.1147-13C>G	KRIT1		Cerebral cavernous malformation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590691	7	91855154	7	92225840	590691	581382	rs779465895	NC_000007.14:92225839:G:C
NM_194456.1(KRIT1):c.1A>G (p.Met1Val)	KRIT1	M1V	not provided|Cerebral cavernous malformation	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000468215	7	91871449	7	92242135	468215	457577	rs1554539120	NC_000007.14:92242134:T:C
NM_194456.1(KRIT1):c.987C>A (p.Cys329Ter)	KRIT1	C329*, C91*	Cerebral cavernous malformation|Cerebral cavernous malformations 1	Pathogenic(Last reviewed: Aug 4, 2016)	no assertion criteria provided	VCV000005728	7	91863765	7	92234451	5728	20767	rs267607204	NC_000007.14:92234450:G:T
NM_000360.4(TH):c.601C>T (p.Gln201Ter)	TH	Q201*, Q232*, Q228*	Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000371630	11	2189139	11	2167909	371630	357968	rs1057517423	NC_000011.10:2167908:G:A
TH, -70G-A	TH		Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000012333					12333	27372		
TH, 1-BP DEL, 291C	TH		Segawa syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000012332					12332	27371		
NM_000322.5(PRPH2):c.584G>A (p.Arg195Gln)	PRPH2	R195Q	PRPH2-Related Disorders|Patterned dystrophy of retinal pigment epithelium|Cone Rod Dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623212	6	42672347	6	42704609	623212	612147	rs121918567	NC_000006.12:42704608:C:T
NM_199292.2(TH):c.-70G>A	TH		Dystonia	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000526213	11	2193086	11	2171856	526213	526534	rs1372180906	NC_000011.10:2171855:C:T
NM_014112.5(TRPS1):c.2893C>T (p.Arg965Cys)	TRPS1	R965C, R956C, R958C	Trichorhinophalangeal dysplasia type I||Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000005579	8	116427243	8	115415015	5579	20618	rs28939069	NC_000008.11:115415014:G:A
NM_000127.3(EXT1):c.1461_1465del (p.Thr488fs)	EXT1	T488fs	not provided	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000818006	8	118831986 - 118831990	8	117819747 - 117819751	818006	805559		NC_000008.11:117819746:GGGTC:
NM_000127.3(EXT1):c.1323_1324del (p.Asn441fs)	EXT1	N441fs	not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000817636	8	118834797 - 118834798	8	117822558 - 117822559	817636	805560		NC_000008.11:117822557:TGT:T
NM_000127.3(EXT1):c.1215_1218del (p.Arg405fs)	EXT1	R405fs	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817594	8	118842535 - 118842538	8	117830296 - 117830299	817594	805561		NC_000008.11:117830295:CTGTCT:CT
NM_000127.3(EXT1):c.1746G>A (p.Trp582Ter)	EXT1	W582*	not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000817515	8	118819593	8	117807354	817515	805558		NC_000008.11:117807353:C:T
NM_000127.3(EXT1):c.115del (p.Glu39fs)	EXT1	E39fs	not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000817043	8	119123171	8	118110932	817043	805562		NC_000008.11:118110931:C:
GRCh37/hg19 8q24.11(chr8:119102236-119147280)x1	EXT1		not provided	Pathogenic(Last reviewed: Oct 16, 2018)	no assertion criteria provided	VCV000815159	8	119102236 - 119147280			815159	803368		
NM_000127.2(EXT1):c.1235G>A (p.Trp412Ter)	EXT1	W412*	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000620134	8	118842518	8	117830279	620134	611690	rs1563573730	NC_000008.11:117830278:C:T
NM_000127.2(EXT1):c.313del (p.Asp105fs)	EXT1	D105fs	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000524133	8	119122973	8	118110734	524133	514563	rs1554601550	NC_000008.11:118110733:C:
NM_000127.2(EXT1):c.1685_1701dup (p.Thr568fs)	EXT1		not provided	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000503990	8	118825131 - 118825132	8	117812892 - 117812893	503990	495365	rs1554657927	NC_000008.11:117812892:GTCCTCGTCAAGGCTGAG:GTCCTCGTCAAGGCTGAGTCCTCGTCAAGGCTGAG
NM_000127.2(EXT1):c.247dup (p.Arg83fs)	EXT1		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000503617	8	119123038 - 119123039	8	118110799 - 118110800	503617	495227	rs1554601559	NC_000008.11:118110799:GGGGGG:GGGGGGG
NM_000127.2(EXT1):c.456C>A (p.Cys152Ter)	EXT1	C152*	not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000489051	8	119122830	8	118110591	489051	481804	rs1554601534	NC_000008.11:118110590:G:T
NM_000127.2(EXT1):c.1092G>A (p.Trp364Ter)	EXT1	W364*	not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000488828	8	118847755	8	117835516	488828	481802	rs1554580035	NC_000008.11:117835515:C:T
NM_000127.2(EXT1):c.2034T>G (p.Tyr678Ter)	EXT1	Y678*	not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488826	8	118816982	8	117804743	488826	481800	rs1554657213	NC_000008.11:117804742:A:C
NM_000127.2(EXT1):c.972T>A (p.Tyr324Ter)	EXT1	Y324*	not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000449479	8	118849431	8	117837192	449479	444206	rs1554580158	NC_000008.11:117837191:A:T
NM_000127.2(EXT1):c.1557T>A (p.Cys519Ter)	EXT1	C519*	not provided	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000449477	8	118830749	8	117818510	449477	444202	rs1554578706	NC_000008.11:117818509:A:T
NM_000127.2(EXT1):c.963-1G>C	EXT1		not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000432274	8	118849441	8	117837202	432274	425774	rs1554580160	NC_000008.11:117837201:C:G
NM_000127.2(EXT1):c.2000T>A (p.Leu667Ter)	EXT1	L667*	not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000430552	8	118817016	8	117804777	430552	421652	rs1131692020	NC_000008.11:117804776:A:T
NM_000127.2(EXT1):c.1884-1G>C	EXT1		not provided	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000429834	8	118817133	8	117804894	429834	421653	rs1131691623	NC_000008.11:117804893:C:G
NM_000127.2(EXT1):c.917dup (p.His307fs)	EXT1		not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000423122	8	119122368 - 119122369	8	118110129 - 118110130	423122	407297	rs1554601473	NC_000008.11:118110129:TTTT:TTTTT
NM_000127.2(EXT1):c.61_62insAA (p.Phe21Ter)	EXT1		not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000422434	8	119123224 - 119123225	8	118110985 - 118110986	422434	407302	rs1064795778	NC_000008.11:118110985::TT
NM_000127.2(EXT1):c.1726_1727insT (p.Asp576fs)	EXT1		not provided	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000419832	8	118819612 - 118819613	8	117807373 - 117807374	419832	407296	rs1064794137	NC_000008.11:117807373::A
NM_000127.2(EXT1):c.812A>G (p.Tyr271Cys)	EXT1	Y271C	not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419313	8	119122474	8	118110235	419313	407299	rs1064793786	NC_000008.11:118110234:T:C
NM_000127.2(EXT1):c.250C>T (p.Gln84Ter)	EXT1	Q84*	not provided	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000419258	8	119123036	8	118110797	419258	407301	rs1064793753	NC_000008.11:118110796:G:A
NM_000127.2(EXT1):c.362del (p.Gln121fs)	EXT1	Q121fs	not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000418834	8	119122924	8	118110685	418834	407300	rs1064793465	NC_000008.11:118110684:T:
NM_000127.2(EXT1):c.1147G>T (p.Glu383Ter)	EXT1	E383*	not provided	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000379236	8	118847700	8	117835461	379236	371473	rs1057520535	NC_000008.11:117835460:C:A
NM_000127.2(EXT1):c.819_820del (p.Gly274fs)	EXT1	G274fs	not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000280507	8	119122466 - 119122467	8	118110227 - 118110228	280507	264249	rs886041699	NC_000008.11:118110226:CT:
NM_000127.2(EXT1):c.535C>T (p.Gln179Ter)	EXT1	Q179*	not provided	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000265468	8	119122751	8	118110512	265468	259896	rs886039561	NC_000008.11:118110511:G:A
NM_000127.2(EXT1):c.1878C>G (p.Tyr626Ter)	EXT1	Y626*	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000265132	8	118819461	8	117807222	265132	259888	rs886039357	NC_000008.11:117807221:G:C
NM_000127.2(EXT1):c.1056+1G>T	EXT1		not provided	Pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, single submitter	VCV000265128	8	118849346	8	117837107	265128	259891	rs886039354	NC_000008.11:117837106:C:A
NM_000127.2(EXT1):c.962+1G>T	EXT1		not provided	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000265127	8	119122323	8	118110084	265127	259893	rs886039353	NC_000008.11:118110083:C:A
NM_000127.2(EXT1):c.165G>A (p.Trp55Ter)	EXT1	W55*	Multiple exostoses type 1	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000638562	8	119123121	8	118110882	638562	626349		NC_000008.11:118110881:C:T
NM_000127.2(EXT1):c.521del (p.Asn173_Leu174insTer)	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000495063	8	119122765	8	118110526	495063	486610	rs1554601526	NC_000008.11:118110525:AAA:AA
GRCh37/hg19 8q24.11(chr8:118796828-118890987)	EXT1		See cases	Pathogenic	no assertion criteria provided	VCV000395047	8	118796828 - 118890987			395047	381940		
GRCh37/hg19 8q24.11(chr8:118825108-119054752)x3	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000225137	8	118825108 - 119054752			225137	227031		
NM_000127.2(EXT1):c.962+3_962+6del	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000002503	8	119122318 - 119122321	8	118110079 - 118110082	2503	17542		NC_000008.11:118110078:ACTTACTT:ACTT
NM_000127.2(EXT1):c.1664dup (p.Asn555fs)	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000002502	8	118825168 - 118825169	8	117812929 - 117812930	2502	17541		NC_000008.11:117812929:TT:TTT
NM_000127.2(EXT1):c.962+1G>C	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000002501	8	119122323	8	118110084	2501	17540		NC_000008.11:118110083:C:G
NM_000127.2(EXT1):c.357C>A (p.Tyr119Ter)	EXT1	Y119*	Multiple exostoses type 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000002499	8	119122929	8	118110690	2499	17538	rs119103289	NC_000008.11:118110689:G:T
NM_000127.2(EXT1):c.528_535del (p.Lys177fs)	EXT1	K177fs	Chondrosarcoma	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000002497	8	119122751 - 119122758	8	118110512 - 118110519	2497	17536	rs587776540	NC_000008.11:118110511:GCACTTTGG:G
EXT1, 1-BP INS, 2077C	EXT1		Chondrosarcoma, sporadic	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000002496					2496	17535		
EXT1, 4-BP INS, NT1035	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000002494					2494	17533		
EXT1, 1-BP DEL, 1364C	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000002493					2493	17532		
EXT1, 1-BP DEL, 2120T	EXT1		Multiple exostoses type 1	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000002492					2492	17531		
NM_000127.3(EXT1):c.1656del (p.Tyr553fs)	EXT1	Y553fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000863015	8	118825177	8	117812938	863015	834078		NC_000008.11:117812937:GGG:GG
NC_000008.11:g.117819794del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000859584					859584	851173		
NM_000127.3(EXT1):c.46del (p.Cys16fs)	EXT1	C16fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000857317	8	119123240	8	118111001	857317	834105		NC_000008.11:118111000:AA:A
NM_000127.3(EXT1):c.516_517insTA (p.Asn173Ter)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000856715	8	119122769 - 119122770	8	118110530 - 118110531	856715	834096		NC_000008.11:118110530::TA
NM_000127.3(EXT1):c.1405del (p.Tyr469fs)	EXT1	Y469fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000852382	8	118834716	8	117822477	852382	834081		NC_000008.11:117822476:A:
NM_000127.3(EXT1):c.266dup (p.Asn89fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000848257	8	119123019 - 119123020	8	118110780 - 118110781	848257	834101		NC_000008.11:118110780:TT:TTT
NM_000127.3(EXT1):c.747dup (p.Phe250fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000846554	8	119122538 - 119122539	8	118110299 - 118110300	846554	834094		NC_000008.11:118110299:CCCCC:CCCCCC
NM_000127.3(EXT1):c.1677_1678insTGTCATCACAGAC (p.Ala560fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000840333	8	118825155 - 118825156	8	117812916 - 117812917	840333	834077		NC_000008.11:117812916:GTCTGTGATGA:GTCTGTGATGACAGTCTGTGATGA
NM_000127.3(EXT1):c.287del (p.Lys96fs)	EXT1	K96fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000837584	8	119122999	8	118110760	837584	834100		NC_000008.11:118110759:TT:T
NC_000008.11:g.(?_117807197)_(117807397_?)del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000832787	8	118819436 - 118819636			832787	819941		
NC_000008.11:g.(?_117812852)_(117837221_?)dup	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000831112	8	118825091 - 118849460			831112	819942		
NM_000127.3(EXT1):c.1952_1959del (p.Asn651fs)	EXT1	N651fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV000830046	8	118817057 - 118817064	8	117804818 - 117804825	830046	818382		NC_000008.11:117804817:CTCACAAT:
NM_000127.3(EXT1):c.1773del (p.Tyr592fs)	EXT1	Y592fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000804166	8	118819566	8	117807327	804166	792536		NC_000008.11:117807326:CCCC:CCC
NM_000127.3(EXT1):c.111del (p.Glu38fs)	EXT1	E38fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000663481	8	119123175	8	118110936	663481	636576		NC_000008.11:118110935:T:
NM_000127.2(EXT1):c.642_675del (p.Met215fs)	EXT1	M215fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000659760	8	119122611 - 119122644	8	118110372 - 118110405	659760	636571		NC_000008.11:118110371:GTTTTCAGTACTGATGCTGGCTTTGGCCAGCATCG:G
NM_000127.3(EXT1):c.1944del (p.Gln648fs)	EXT1	Q648fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000659671	8	118817072	8	117804833	659671	636560		NC_000008.11:117804832:TT:T
NM_000127.2(EXT1):c.276_277dup (p.Tyr93fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000653826	8	119123008 - 119123009	8	118110769 - 118110770	653826	636575		NC_000008.11:118110769:AGA:AGAGA
NM_000127.2(EXT1):c.364C>T (p.Gln122Ter)	EXT1	Q122*	Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000646183	8	119122922	8	118110683	646183	636574		NC_000008.11:118110682:G:A
NM_000127.2(EXT1):c.584T>G (p.Leu195Ter)	EXT1	L195*	Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000644357	8	119122702	8	118110463	644357	636573		NC_000008.11:118110462:A:C
NM_000127.2(EXT1):c.642_663del (p.Met215fs)	EXT1	M215fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000642724	8	119122623 - 119122644	8	118110384 - 118110405	642724	636572		NC_000008.11:118110383:GATGCTGGCTTTGGCCAGCATCG:G
NM_000127.2(EXT1):c.957T>A (p.Tyr319Ter)	EXT1	Y319*	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000638993	8	119122329	8	118110090	638993	636568		NC_000008.11:118110089:A:T
NC_000008.10:g.(?_118842449)_(118849460_?)del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000583827	8	118842449 - 118849460	8	117830210 - 117837221	583827	567304		
NM_000127.2(EXT1):c.103del (p.Ser35fs)	EXT1	S35fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000580698	8	119123183	8	118110944	580698	567348	rs1563659821	NC_000008.11:118110943:T:
NM_000127.2(EXT1):c.988_989insTC (p.Asn330fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000572097	8	118849414 - 118849415	8	117837175 - 117837176	572097	561912	rs1563575697	NC_000008.11:117837175::GA
NM_000127.2(EXT1):c.1065C>A (p.Cys355Ter)	EXT1	C355*	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000570990	8	118847782	8	117835543	570990	564600	rs11546829	NC_000008.11:117835542:G:T
NM_000127.2(EXT1):c.798del (p.Phe266fs)	EXT1	F266fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000569738	8	119122488	8	118110249	569738	561920	rs1563659352	NC_000008.11:118110248:G:
NM_000127.2(EXT1):c.282dup (p.Gly95fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000568204	8	119123003 - 119123004	8	118110764 - 118110765	568204	561939	rs1563659649	NC_000008.11:118110764:TTT:TTTT
NM_000127.2(EXT1):c.1316C>G (p.Ser439Ter)	EXT1	S439*	Multiple congenital exostosis	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000568116	8	118834805	8	117822566	568116	567333	rs1563571318	NC_000008.11:117822565:G:C
NM_000127.2(EXT1):c.1576A>T (p.Lys526Ter)	EXT1	K526*	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000566580	8	118830730	8	117818491	566580	564596	rs1563569983	NC_000008.11:117818490:T:A
NM_000127.2(EXT1):c.369_370delinsT (p.Lys123fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000566150	8	119122916 - 119122917	8	118110677 - 118110678	566150	561934	rs1563659571	NC_000008.11:118110676:CT:A
NM_000127.2(EXT1):c.279C>G (p.Tyr93Ter)	EXT1	Y93*	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000526308	8	119123007	8	118110768	526308	523612	rs1227875610	NC_000008.11:118110767:G:C
NM_000127.2(EXT1):c.846del (p.Leu283fs)	EXT1	L283fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000526306	8	119122440	8	118110201	526306	523599	rs1554601481	NC_000008.11:118110200:GG:G
NM_000127.2(EXT1):c.533_534dup (p.Gln179fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000526299	8	119122751 - 119122752	8	118110512 - 118110513	526299	523472	rs1554601525	NC_000008.11:118110512:CAC:CACAC
NM_000127.2(EXT1):c.598_669del (p.Trp200_Thr223del)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000456064	8	119122617 - 119122688	8	118110378 - 118110449	456064	457181	rs1554601502	
NM_000127.2(EXT1):c.1633-34_1670del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000456063	8	118825163 - 118825234	8	117812924 - 117812995	456063	457804	rs1554657940	
NM_000127.2(EXT1):c.1401del (p.Tyr468fs)	EXT1	Y468fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000456061	8	118834720	8	117822481	456061	458176	rs1554579004	NC_000008.11:117822480:G:
NM_000127.2(EXT1):c.1056+3A>C	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000456060	8	118849344	8	117837105	456060	458178	rs1554580140	NC_000008.11:117837104:T:G
NM_000127.2(EXT1):c.1056+2T>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jun 4, 2017)	criteria provided, single submitter	VCV000456059	8	118849345	8	117837106	456059	457175	rs1554580142	NC_000008.11:117837105:A:T
NM_015850.4(FGFR1):c.1595_1597TGA[1] (p.Met533del)	FGFR1	M535del	Hartsfield syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449023	8	38274881 - 38274883	8	38417363 - 38417365	449023	444275	rs1554551657	NC_000008.11:38417362:TCATCATC:TCATC
NM_023110.2(FGFR1):c.494T>C (p.Leu165Ser)	FGFR1	L165S, L157S, L196S, L76S, L163S, L74S	Hartsfield syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000066079	8	38285566	8	38428048	66079	76981	rs397515481	NC_000008.11:38428047:A:G
NM_023110.2(FGFR1):c.2174G>A (p.Cys725Tyr)	FGFR1	C725Y, C636Y, C715Y, C632Y, C634Y, C723Y, C756Y, C721Y	Hartsfield syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000066078	8	38271682	8	38414164	66078	76980	rs398122945	NC_000008.11:38414163:C:T
NM_000127.3(EXT1):c.1421T>A (p.Leu474Ter)	EXT1	L474*	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000863316	8	118832030	8	117819791	863316	834080		NC_000008.11:117819790:A:T
NM_000127.3(EXT1):c.1796G>A (p.Trp599Ter)	EXT1	W599*	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000862384	8	118819543	8	117807304	862384	834072		NC_000008.11:117807303:C:T
NM_000127.3(EXT1):c.802G>A (p.Gly268Arg)	EXT1	G268R	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000859847	8	119122484	8	118110245	859847	834093		NC_000008.11:118110244:C:T
NM_000127.3(EXT1):c.1718_1719del (p.Thr573fs)	EXT1	T573fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000856277	8	118825114 - 118825115	8	117812875 - 117812876	856277	834076		NC_000008.11:117812874:TGT:T
NM_000127.3(EXT1):c.1010C>G (p.Pro337Arg)	EXT1	P337R	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000855456	8	118849393	8	117837154	855456	834089		NC_000008.11:117837153:G:C
NM_000127.3(EXT1):c.176del (p.Pro59fs)	EXT1	P59fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000853599	8	119123110	8	118110871	853599	834103		NC_000008.11:118110870:GGG:GG
NM_000127.3(EXT1):c.208C>T (p.Gln70Ter)	EXT1	Q70*	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000851212	8	119123078	8	118110839	851212	834102		NC_000008.11:118110838:G:A
NM_000127.3(EXT1):c.488_489GA[1] (p.Asp164fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000850636	8	119122795 - 119122796	8	118110556 - 118110557	850636	834097		NC_000008.11:118110555:TCTCT:TCT
NM_000127.3(EXT1):c.1126C>T (p.Gln376Ter)	EXT1	Q376*	Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000847967	8	118847721	8	117835482	847967	834086		NC_000008.11:117835481:G:A
NM_000127.3(EXT1):c.1192C>T (p.Gln398Ter)	EXT1	Q398*	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000846943	8	118842561	8	117830322	846943	834084		NC_000008.11:117830321:G:A
NM_000127.3(EXT1):c.1770_1774del (p.Gly591fs)	EXT1	G591fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000846736	8	118819565 - 118819569	8	117807326 - 117807330	846736	834074		NC_000008.11:117807325:ACCCCAC:AC
NM_000127.3(EXT1):c.1797G>A (p.Trp599Ter)	EXT1	W599*	Multiple congenital exostosis	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000845784	8	118819542	8	117807303	845784	834071		NC_000008.11:117807302:C:T
NM_000127.3(EXT1):c.1818G>A (p.Trp606Ter)	EXT1	W606*	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000842925	8	118819521	8	117807282	842925	834070		NC_000008.11:117807281:C:T
NM_000127.3(EXT1):c.1167del (p.Pro390fs)	EXT1	P390fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000837714	8	118842586	8	117830347	837714	834085		NC_000008.11:117830346:AA:A
NM_000127.3(EXT1):c.4C>T (p.Gln2Ter)	EXT1	Q2*	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000837149	8	119123282	8	118111043	837149	834107		NC_000008.11:118111042:G:A
NM_000127.3(EXT1):c.2044_2047del (p.Met682fs)	EXT1	M682fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000834281	8	118816969 - 118816972	8	117804730 - 117804733	834281	834067		NC_000008.11:117804729:TCATT:T
NC_000008.11:g.(?_117799692)_(118111066_?)del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000833433	8	118811931 - 119123305			833433	819940		
NC_000008.11:g.(?_117799692)_(117799917_?)del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000833208	8	118811931 - 118812156			833208	819939		
NM_000127.2(EXT1):c.1817G>A (p.Trp606Ter)	EXT1	W606*	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000662503	8	118819522	8	117807283	662503	636562		NC_000008.11:117807282:C:T
NM_000127.2(EXT1):c.1911C>A (p.Tyr637Ter)	EXT1	Y637*	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000648749	8	118817105	8	117804866	648749	636561		NC_000008.11:117804865:G:T
NM_000127.2(EXT1):c.840G>C (p.Arg280Ser)	EXT1	R280S	Multiple congenital exostosis	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000576662	8	119122446	8	118110207	576662	561914	rs1563659325	NC_000008.11:118110206:C:G
NM_000127.2(EXT1):c.540_541TC[1] (p.Leu181fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000566357	8	119122743 - 119122744	8	118110504 - 118110505	566357	561927	rs1563659474	NC_000008.11:118110503:GAGA:GA
NM_000127.2(EXT1):c.644_647dup (p.Lys218fs)	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000526297	8	119122638 - 119122639	8	118110399 - 118110400	526297	523611	rs1554601507	NC_000008.11:118110399:AGCA:AGCAAGCA
NM_022970.3(FGFR2):c.1087+1292G>A	FGFR2	G338E, G249E, G110E, G223E	Bent bone dysplasia syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Jackson-Weiss syndrome|Acrocephalosyndactyly type I||Scaphocephaly, maxillary retrusion, and mental retardation|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Neoplasm of stomach|Crouzon syndrome|Crouzon syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374817	10	123276904	10	121517390	374817	361713	rs1057519044	NC_000010.11:121517389:C:T
NM_022970.3(FGFR2):c.1087+1262A>G	FGFR2	Y328C, Y100C, Y213C, Y239C	Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013270	10	123276934	10	121517420	13270	28309	rs121918493	NC_000010.11:121517419:T:C
NM_152419.3(HGSNAT):c.1150C>T (p.Arg384Ter)	HGSNAT	R384*, R96*, R320*	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549921	8	43046638	8	43191495	549921	544423	rs775078211	NC_000008.11:43191494:C:T
NM_004183.4(BEST1):c.16A>G (p.Thr6Ala)	BEST1	T6A	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000858577	11	61719294	11	61951822	858577	838601		NC_000011.10:61951821:A:G
NM_004183.4(BEST1):c.874G>A (p.Glu292Lys)	BEST1	E292K, E186K, E232K	Retinal dystrophy|not provided|Vitelliform macular dystrophy type 2	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265047	11	61726976	11	61959504	265047	259990	rs886039311	NC_000011.10:61959503:G:A
NM_004183.4(BEST1):c.256G>A (p.Val86Met)	BEST1	V86M, V26M	Vitreoretinochoroidopathy|Retinal dystrophy	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000002744	11	61723198	11	61955726	2744	17783	rs121918289	NC_000011.10:61955725:G:A
NM_004183.4(BEST1):c.436_437delinsAA (p.Ala146Lys)	BEST1	A146K	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000002736	11	61723378 - 61723379	11	61955906 - 61955907	2736	17775	rs1800995	NC_000011.10:61955905:GC:AA
NM_004183.4(BEST1):c.279G>C (p.Trp93Cys)	BEST1	W93C, W33C	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000002727	11	61723221	11	61955749	2727	17766	rs28940273	NC_000011.10:61955748:G:C
NM_000127.3(EXT1):c.1219C>T (p.Gln407Ter)	EXT1	Q407*	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000864152	8	118842534	8	117830295	864152	834083		NC_000008.11:117830294:G:A
NM_000127.3(EXT1):c.1776C>A (p.Tyr592Ter)	EXT1	Y592*	Multiple congenital exostosis	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000854386	8	118819563	8	117807324	854386	834073		NC_000008.11:117807323:G:T
NM_000127.3(EXT1):c.1567del (p.Leu523fs)	EXT1	L523fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000852696	8	118830739	8	117818500	852696	834079		NC_000008.11:117818499:GGGG:GGG
NM_000127.3(EXT1):c.351C>G (p.Tyr117Ter)	EXT1	Y117*	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000852597	8	119122935	8	118110696	852597	834099		NC_000008.11:118110695:G:C
NM_000127.3(EXT1):c.124_962+1815del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000851459	8	119120509 - 119123162	8	118108270 - 118110923	851459	851177		
NM_000127.3(EXT1):c.2026A>T (p.Lys676Ter)	EXT1	K676*	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000850437	8	118816990	8	117804751	850437	834068		NC_000008.11:117804750:T:A
NC_000008.10:g.(?_119122304)_(119123305_?)del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000664442	8	119122304 - 119123305	8	118110065 - 118111066	664442	651757		
NM_000127.2(EXT1):c.1236G>A (p.Trp412Ter)	EXT1	W412*	Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000650518	8	118842517	8	117830278	650518	636565		NC_000008.11:117830277:C:T
NM_000127.2(EXT1):c.2104C>T (p.Gln702Ter)	EXT1	Q702*	Multiple congenital exostosis	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000526307	8	118812088	8	117799849	526307	523454	rs1554656266	NC_000008.11:117799848:G:A
NM_000127.2(EXT1):c.651_663del (p.Lys218fs)	EXT1	K218fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000526303	8	119122623 - 119122635	8	118110384 - 118110396	526303	523605	rs1554601504	NC_000008.11:118110383:GATGCTGGCTTTGG:G
NM_000127.2(EXT1):c.854dup (p.His285fs)	EXT1		not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423050	8	119122431 - 119122432	8	118110192 - 118110193	423050	407298	rs1554601476	NC_000008.11:118110192:T:TT
NM_000127.2(EXT1):c.852T>A (p.Tyr284Ter)	EXT1	Y284*	not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379472	8	119122434	8	118110195	379472	371474	rs1057520608	NC_000008.11:118110194:A:T
NM_006158.5(NEFL):c.32C>A (p.Ser11Ter)	NEFL	S11*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000852797	8	24813998	8	24956484	852797	834566		NC_000008.11:24956483:G:T
NM_006158.4(NEFL):c.1117C>T (p.Gln373Ter)	NEFL	Q373*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000533513	8	24811747	8	24954233	533513	523411	rs757417962	NC_000008.11:24954232:G:A
NM_006158.4(NEFL):c.487G>T (p.Glu163Ter)	NEFL	E163*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000369981	8	24813543	8	24956029	369981	354198	rs876661155	NC_000008.11:24956028:C:A
NM_006158.4(NEFL):c.1261C>T (p.Arg421Ter)	NEFL	R421*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000192322	8	24811218	8	24953704	192322	190114	rs191346286	NC_000008.11:24953703:G:A
NM_006158.4(NEFL):c.1001A>C (p.Gln334Pro)	NEFL	Q334P	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000041235	8	24813029	8	24955515	41235	49659	rs281865140	NC_000008.11:24955514:T:G
NM_006158.4(NEFL):c.628G>T (p.Glu210Ter)	NEFL	E210*	Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000029803	8	24813402	8	24955888	29803	38758	rs199422214	NC_000008.11:24955887:C:A
NM_033360.4(KRAS):c.436G>C (p.Ala146Pro)	KRAS	A146P	Neoplasm of the large intestine|Multiple myeloma	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2019)	no assertion criteria provided	VCV000375963	12	25378562	12	25225628	375963	362842	rs121913527	NC_000012.12:25225627:C:G
NM_006158.4(NEFL):c.65C>G (p.Pro22Arg)	NEFL	P22R	Charcot-Marie-Tooth disease, demyelinating, type 1f|not provided	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000041239	8	24813965	8	24956451	41239	49663	rs267607538	NC_000008.11:24956450:G:C
NM_006158.4(NEFL):c.64C>A (p.Pro22Thr)	NEFL	P22T	Charcot-Marie-Tooth disease, demyelinating, type 1f|not provided	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000041238	8	24813966	8	24956452	41238	49662	rs28928910	NC_000008.11:24956451:G:T
NM_006158.4(NEFL):c.446C>T (p.Ala149Val)	NEFL	A149V	Charcot-Marie-Tooth disease, demyelinating, type 1f|not provided	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000041237	8	24813584	8	24956070	41237	49661	rs59101996	NC_000008.11:24956069:G:A
NM_004629.1(FANCG):c.637_643del (p.Tyr213fs)	FANCG	Y213fs	Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000006719	9	35077264 - 35077270	9	35077267 - 35077273	6719	21758	rs587776640	NC_000009.12:35077266:GGCGGTAGGC:GGC
NM_133497.4(KCNV2):c.339C>A (p.Cys113Ter)	KCNV2	C113*	Retinal dystrophy	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000867070	9	2718078	9	2718078	867070	856636		NC_000009.12:2718077:C:A
NM_133497.4(KCNV2):c.529T>C (p.Cys177Arg)	KCNV2	C177R	Retinal dystrophy	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000866393	9	2718268	9	2718268	866393	856640		NC_000009.12:2718267:T:C
NM_133497.4(KCNV2):c.991_992GC[4] (p.Ser333fs)	KCNV2		cone dystrophy with supernormal rod electroretinogram	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812344	9	2718728 - 2718729	9	2718728 - 2718729	812344	800551		NC_000009.12:2718728:CGCGCGC:CGCGCGCGC
NM_133497.4(KCNV2):c.958C>T (p.Arg320Cys)	KCNV2	R320C	cone dystrophy with supernormal rod electroretinogram	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812343	9	2718697	9	2718697	812343	800550		NC_000009.12:2718696:C:T
NM_133497.4(KCNV2):c.782C>A (p.Ala261Asp)	KCNV2	A261D	cone dystrophy with supernormal rod electroretinogram	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812342	9	2718521	9	2718521	812342	800549		NC_000009.12:2718520:C:A
NM_133497.4(KCNV2):c.725_730del (p.Gln242_Arg243del)	KCNV2		cone dystrophy with supernormal rod electroretinogram	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812340	9	2718462 - 2718467	9	2718462 - 2718467	812340	800547		NC_000009.12:2718461:GCAGCGGC:GC
NM_133497.4(KCNV2):c.411_414del (p.Leu138fs)	KCNV2	L138fs	cone dystrophy with supernormal rod electroretinogram	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812338	9	2718149 - 2718152	9	2718149 - 2718152	812338	800545		NC_000009.12:2718148:GCCTG:G
NM_133497.4(KCNV2):c.866del (p.Ser289fs)	KCNV2	S289fs	not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000861936	9	2718605	9	2718605	861936	836020		NC_000009.12:2718604:C:
NM_133497.4(KCNV2):c.417C>A (p.Cys139Ter)	KCNV2	C139*	not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000849612	9	2718156	9	2718156	849612	836010		NC_000009.12:2718155:C:A
NG_012181.1:g.5233_16321delinsCATTTG	KCNV2		Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000039813					39813	48412		
NM_133497.4(KCNV2):c.491T>C (p.Phe164Ser)	KCNV2	F164S	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000039812	9	2718230	9	2718230	39812	48411	rs397514604	NC_000009.12:2718229:T:C
NM_133497.4(KCNV2):c.226C>T (p.Gln76Ter)	KCNV2	Q76*	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000037249	9	2717965	9	2717965	37249	45842	rs387907302	NC_000009.12:2717964:C:T
NM_016952.4(CDON):c.2818A>C (p.Ser940Arg)	CDON	S940R	Holoprosencephaly 11	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030750	11	125853944	11	125984049	30750	39707	rs369673018	NC_000011.10:125984048:T:G
NM_016952.4(CDON):c.2368A>G (p.Thr790Ala)	CDON	T790A	Holoprosencephaly 11	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030749	11	125864942	11	125995047	30749	39706	rs387906997	NC_000011.10:125995046:T:C
NM_016952.4(CDON):c.2339T>A (p.Val780Glu)	CDON	V780E	Holoprosencephaly 11	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030748	11	125867125	11	125997230	30748	39705	rs387906996	NC_000011.10:125997229:A:T
NM_133497.4(KCNV2):c.767C>G (p.Ser256Trp)	KCNV2	S256W	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000003014	9	2718506	9	2718506	3014	18053	rs104894116	NC_000009.12:2718505:C:G
NM_133497.4(KCNV2):c.1376G>A (p.Gly459Asp)	KCNV2	G459D	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000003012	9	2729465	9	2729465	3012	18051	rs104894115	NC_000009.12:2729464:G:A
NM_133497.4(KCNV2):c.916G>T (p.Glu306Ter)	KCNV2	E306*	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000003011	9	2718655	9	2718655	3011	18050	rs104894114	NC_000009.12:2718654:G:T
NM_133497.4(KCNV2):c.427G>T (p.Glu143Ter)	KCNV2	E143*	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000003010	9	2718166	9	2718166	3010	18049	rs104894113	NC_000009.12:2718165:G:T
NM_133497.4(KCNV2):c.1293_1294TG[1] (p.Val432fs)	KCNV2		not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000861935	9	2719032 - 2719033	9	2719032 - 2719033	861935	836030		NC_000009.12:2719031:TGTG:TG
NM_133497.4(KCNV2):c.531T>A (p.Cys177Ter)	KCNV2	C177*	not provided	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000835076	9	2718270	9	2718270	835076	836014		NC_000009.12:2718269:T:A
NM_133497.4(KCNV2):c.442G>T (p.Glu148Ter)	KCNV2	E148*	Cone dystrophy with supernormal rod response	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000039811	9	2718181	9	2718181	39811	48410	rs140256288	NC_000009.12:2718180:G:T
NM_000127.3(EXT1):c.1417+1G>T	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000845456	8	118834703	8	117822464	845456	851175		NC_000008.11:117822463:C:A
NM_000127.3(EXT1):c.1108G>T (p.Glu370Ter)	EXT1	E370*	Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000843973	8	118847739	8	117835500	843973	834087		NC_000008.11:117835499:C:A
NM_000127.2(EXT1):c.1745G>A (p.Trp582Ter)	EXT1	W582*	Multiple congenital exostosis	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000659880	8	118819594	8	117807355	659880	636563		NC_000008.11:117807354:C:T
NM_000127.2(EXT1):c.1057-1G>C	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000653328	8	118847791	8	117835552	653328	651769		NC_000008.11:117835551:C:G
NM_000127.2(EXT1):c.1633-2A>G	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000645969	8	118825202	8	117812963	645969	651738		NC_000008.11:117812962:T:C
NM_000127.2(EXT1):c.2004del (p.Pro669fs)	EXT1	P669fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000581676	8	118817012	8	117804773	581676	562339	rs1563872934	NC_000008.11:117804772:A:
NM_000127.2(EXT1):c.1884-1G>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000569935	8	118817133	8	117804894	569935	564592	rs1131691623	NC_000008.11:117804893:C:T
NM_000127.2(EXT1):c.1053_1056+1del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000569431	8	118849346 - 118849350	8	117837107 - 117837111	569431	562347	rs1563575654	NC_000008.11:117837106:CCTGC:
NM_000127.2(EXT1):c.2059del (p.Ser687fs)	EXT1	S687fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000526309	8	118812133	8	117799894	526309	523252	rs1554656288	NC_000008.11:117799893:AA:A
NM_000127.2(EXT1):c.838A>G (p.Arg280Gly)	EXT1	R280G	Multiple congenital exostosis	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000526305	8	119122448	8	118110209	526305	523468	rs1554601483	NC_000008.11:118110208:T:C
NM_000127.2(EXT1):c.218del (p.Asn73fs)	EXT1	N73fs	Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000526304	8	119123068	8	118110829	526304	522976	rs1554601568	NC_000008.11:118110828:TTTT:TTT
NM_000127.2(EXT1):c.1036A>G (p.Arg346Gly)	EXT1	R346G	Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000526301	8	118849367	8	117837128	526301	522969	rs1554580147	NC_000008.11:117837127:T:C
NM_000127.2(EXT1):c.1810G>T (p.Glu604Ter)	EXT1	E604*	not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488827	8	118819529	8	117807290	488827	481801	rs1554657437	NC_000008.11:117807289:C:A
NM_000127.2(EXT1):c.913C>T (p.Gln305Ter)	EXT1	Q305*	not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488690	8	119122373	8	118110134	488690	481803	rs1554601474	NC_000008.11:118110133:G:A
NM_000127.2(EXT1):c.1468del (p.Leu490fs)	EXT1	L490fs	not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265130	8	118831983	8	117819744	265130	259890	rs886039355	NC_000008.11:117819743:GGGGGG:GGGGG
NM_023110.2(FGFR1):c.214C>T (p.Gln72Ter)	FGFR1	Q72*, Q105*, Q64*	|Pfeiffer syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000502125	8	38287344	8	38429826	502125	493549	rs1554570813	NC_000008.11:38429825:G:A
NC_000009.12:g.(?_2717740)_(2729727_?)del	KCNV2		not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000832981	9	2717740 - 2729727			832981	820127		
NM_006269.2(RP1):c.2105_2108del (p.Ile702fs)	RP1	I702fs	Retinal dystrophy	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000866555	8	55538545 - 55538548	8	54625985 - 54625988	866555	856602		NC_000008.11:54625984:AATAAA:AA
NM_006269.2(RP1):c.2200del (p.Ser734fs)	RP1	S734fs	Retinal dystrophy	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000866005	8	55538639	8	54626079	866005	856603		NC_000008.11:54626078:AAAA:AAA
NM_006269.2(RP1):c.3734del (p.Cys1245fs)	RP1	C1245fs	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000595277	8	55540176	8	54627616	595277	586339	rs1563331742	NC_000008.11:54627615:G:
NM_006269.2(RP1):c.2745delinsAA (p.Tyr915Ter)	RP1		not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000498851	8	55539187	8	54626627	498851	490275	rs1554519662	NC_000008.11:54626626:T:AA
NM_006269.2(RP1):c.2570C>G (p.Ser857Ter)	RP1	S857*	not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000391250	8	55539012	8	54626452	391250	371927	rs1057524016	NC_000008.11:54626451:C:G
NM_006269.2(RP1):c.4555del (p.Arg1519fs)	RP1	R1519fs	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000197271	8	55540992	8	54628432	197271	194432	rs794727640	NC_000008.11:54628431:AAAAAA:AAAAA
NM_006269.2(RP1):c.5019T>G (p.Tyr1673Ter)	RP1	Y1673*	not provided	Pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	VCV000095353	8	55541461	8	54628901	95353	101252	rs398124220	NC_000008.11:54628900:T:G
NM_006269.2(RP1):c.3396G>A (p.Trp1132Ter)	RP1	W1132*	Retinitis pigmentosa 1	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800956	8	55539838	8	54627278	800956	788828		NC_000008.11:54627277:G:A
NM_006269.2(RP1):c.366_367GC[3] (p.Pro124fs)	RP1		Retinitis pigmentosa 1	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560493	8	55533891 - 55533892	8	54621331 - 54621332	560493	551554	rs1246397238	NC_000008.11:54621331:GCGC:GCGCGC
NM_006269.2(RP1):c.2335del (p.Ser779fs)	RP1	S779fs	Retinitis pigmentosa 1	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560492	8	55538777	8	54626217	560492	551556	rs1563330595	NC_000008.11:54626216:T:
NM_006269.2(RP1):c.5105_5109del (p.Asp1702fs)	RP1	D1702fs	Retinitis pigmentosa 1	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522458	8	55541544 - 55541548	8	54628984 - 54628988	522458	513070	rs1278053918	NC_000008.11:54628983:AAGATAAG:AAG
NM_006269.2(RP1):c.4743dup (p.Cys1582fs)	RP1		Retinitis pigmentosa 1	Pathogenic	no assertion criteria provided	VCV000268180	8	55541178 - 55541179	8	54628618 - 54628619	268180	263798	rs886041040	NC_000008.11:54628618:AAAAAAA:AAAAAAAA
NM_006269.2(RP1):c.2700dup (p.Pro901fs)	RP1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197272	8	55539136 - 55539137	8	54626576 - 54626577	197272	194433	rs797044735	NC_000008.11:54626576:AAAAAA:AAAAAAA
NM_006269.2(RP1):c.797_798AT[1] (p.Met267fs)	RP1		not provided	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000856684	8	55537239 - 55537240	8	54624679 - 54624680	856684	834876		NC_000008.11:54624678:ATAT:AT
NM_006269.2(RP1):c.5962dup (p.Ile1988fs)	RP1		not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523946	8	55542403 - 55542404	8	54629843 - 54629844	523946	514574	rs769512989	NC_000008.11:54629843:A:AA
NM_006269.2(RP1):c.5017del (p.Tyr1673fs)	RP1	Y1673fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000498306	8	55541457	8	54628897	498306	489730	rs753090404	NC_000008.11:54628896:TTT:TT
NM_006269.2(RP1):c.1458_1461dup (p.Glu488Ter)	RP1		Retinitis pigmentosa 1	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000005971	8	55537899 - 55537900	8	54625339 - 54625340	5971	21010	rs869320728	NC_000008.11:54625339:TGAA:TGAATGAA
NM_006269.2(RP1):c.2287_2290del (p.Asn763fs)	RP1	N763fs	Retinitis pigmentosa 1	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005967	8	55538727 - 55538730	8	54626167 - 54626170	5967	21006	rs869320727	NC_000008.11:54626166:TAAATA:TA
NM_006158.4(NEFL):c.803T>C (p.Leu268Pro)	NEFL	L268P	Charcot-Marie-Tooth disease type 2E|not provided	Pathogenic	criteria provided, single submitter	VCV000066698	8	24813227	8	24955713	66698	77595	rs62636502	NC_000008.11:24955712:A:G
NM_006158.4(NEFL):c.418G>T (p.Glu140Ter)	NEFL	E140*	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000014034	8	24813612	8	24956098	14034	29073	rs121913663	NC_000008.11:24956097:C:A
NM_006158.4(NEFL):c.281T>C (p.Leu94Pro)	NEFL	L94P	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000014033	8	24813749	8	24956235	14033	29072	rs62636505	NC_000008.11:24956234:A:G
NM_000360.4(TH):c.1035_1045del (p.Gln346fs)	TH	Q346fs, Q377fs, Q373fs	Segawa syndrome, autosomal recessive|Dystonia	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000639906	11	2187712 - 2187722	11	2166482 - 2166492	639906	639864		NC_000011.10:2166481:GCGAGAACTGCGCGA:GCGA
NM_133497.4(KCNV2):c.778A>T (p.Lys260Ter)	KCNV2	K260*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265419	9	2718517	9	2718517	265419	259927	rs139027297	NC_000009.12:2718516:A:T
NM_177924.5(ASAH1):c.456A>C (p.Lys152Asn)	ASAH1	K152N, K168N, K146N, K87N	not provided|Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180643	8	17921967	8	18064458	180643	178805	rs200455852	NC_000008.11:18064457:T:G
NM_006269.2(RP1):c.6125del (p.Leu2041_Leu2042insTer)	RP1		not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000849072	8	55542566	8	54630006	849072	834914		NC_000008.11:54630005:TT:T
NM_006269.2(RP1):c.1468G>T (p.Glu490Ter)	RP1	E490*	not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000849071	8	55537910	8	54625350	849071	834881		NC_000008.11:54625349:G:T
NM_006269.2(RP1):c.6091_6092delinsTA (p.Arg2031Ter)	RP1		not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000843617	8	55542533 - 55542534	8	54629973 - 54629974	843617	834911		NC_000008.11:54629972:AG:TA
NM_006269.2(RP1):c.688G>T (p.Gly230Ter)	RP1	G230*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812399	8	55534749	8	54622189	812399	800536		NC_000008.11:54622188:G:T
NM_006269.2(RP1):c.2778T>A (p.Tyr926Ter)	RP1	Y926*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802406	8	55539220	8	54626660	802406	790806		NC_000008.11:54626659:T:A
NM_006269.2(RP1):c.1265dup (p.Ala423fs)	RP1		Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802405	8	55537706 - 55537707	8	54625146 - 54625147	802405	790805		NC_000008.11:54625146:C:CC
NM_006269.2(RP1):c.1234dup (p.Met412fs)	RP1		Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802404	8	55537673 - 55537674	8	54625113 - 54625114	802404	790804		NC_000008.11:54625113:AAA:AAAA
NM_006269.2(RP1):c.2035C>T (p.Gln679Ter)	RP1	Q679*	Retinitis pigmentosa 1	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000005968	8	55538477	8	54625917	5968	21007	rs104894083	NC_000008.11:54625916:C:T
NM_001173990.3(TMEM216):c.253C>T (p.Arg85Ter)	TMEM216	R24*, R85*	not provided||TMEM216-Related Disorders|Joubert syndrome 2||Joubert syndrome 2|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056384	11	61165269	11	61397797	56384	71023	rs11230683	NC_000011.10:61397796:C:T
NM_018972.4(GDAP1):c.571C>T (p.Arg191Ter)	GDAP1	R191*, R123*, R133*, R82*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000535790	8	75274205	8	74361970	535790	524304	rs1554547986	NC_000008.11:74361969:C:T
NM_018972.4(GDAP1):c.579+1G>A	GDAP1		Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000220379	8	75274214	8	74361979	220379	221768	rs864622501	NC_000008.11:74361978:G:A
NM_054012.4(ASS1):c.1085G>T (p.Gly362Val)	ASS1	G362V	Citrullinemia type I|Citrullinemia, mild|not provided	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000006336	9	133370368	9	130494981	6336	21375	rs121908647	NC_000009.12:130494980:G:T
NM_183050.4(BCKDHB):c.799C>T (p.Gln267Ter)	BCKDHB	Q267*, Q197*	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096609	6	80910707	6	80200990	96609	102502	rs398124594	NC_000006.12:80200989:C:T
NM_006269.2(RP1):c.2690_2695del (p.Ser897_Lys899delinsTer)	RP1		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636092	8	55539132 - 55539137	8	54626572 - 54626577	636092	623867		NC_000008.11:54626571:CTTTGA:
NM_006269.2(RP1):c.2585C>G (p.Ser862Ter)	RP1	S862*	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636091	8	55539027	8	54626467	636091	623866		NC_000008.11:54626466:C:G
NM_006269.2(RP1):c.1451C>A (p.Ser484Ter)	RP1	S484*	Retinitis pigmentosa 1|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000560491	8	55537893	8	54625333	560491	551555	rs1563329888	NC_000008.11:54625332:C:A
NM_006269.2(RP1):c.679T>G (p.Phe227Val)	RP1	F227V	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191355	8	55534740	8	54622180	191355	189160	rs863223340	NC_000008.11:54622179:T:G
NM_004183.4(BEST1):c.887A>G (p.Asn296Ser)	BEST1	N296S, N190S, N236S, T364A	Vitelliform macular dystrophy type 2|Macular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000099764	11	61726989	11	61959517	99764	105653	rs281865255	NC_000011.10:61959516:A:G
NM_004183.4(BEST1):c.140G>A (p.Arg47His)	BEST1	R47H	Vitelliform macular dystrophy type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000002738	11	61719418	11	61951946	2738	17777	rs28940278	NC_000011.10:61951945:G:A
NM_004183.4(BEST1):c.16A>C (p.Thr6Pro)	BEST1	T6P	Vitelliform macular dystrophy type 2|not provided	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000002732	11	61719294	11	61951822	2732	17771	rs28940275	NC_000011.10:61951821:A:C
NM_000127.3(EXT1):c.1722+1G>T	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000863192	8	118825110	8	117812871	863192	851171		NC_000008.11:117812870:C:A
NM_000127.2(EXT1):c.1537-2A>G	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000657320	8	118830771	8	117818532	657320	651841		NC_000008.11:117818531:T:C
NC_000008.10:g.(?_118811931)_(118849460_?)del	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000526310	8	118811931 - 118849460	8	117799692 - 117837221	526310	523515		
NM_000127.2(EXT1):c.963-2A>G	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000526302	8	118849442	8	117837203	526302	523597	rs1554580162	NC_000008.11:117837202:T:C
NM_000127.2(EXT1):c.1417+2T>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000526300	8	118834702	8	117822463	526300	523255	rs1554578992	NC_000008.11:117822462:A:T
NM_000127.2(EXT1):c.2101C>T (p.Arg701Ter)	EXT1	R701*	not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488691	8	118812091	8	117799852	488691	481799	rs1363815113	NC_000008.11:117799851:G:A
NM_000127.2(EXT1):c.2132G>A (p.Trp711Ter)	EXT1	W711*	Multiple congenital exostosis|not provided	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000191230	8	118812060	8	117799821	191230	189033	rs786205593	NC_000008.11:117799820:C:T
NM_000380.3(XPA):c.682C>T (p.Arg228Ter)	XPA	R228*, R186*	Xeroderma pigmentosum|not provided|	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000995	9	100437861	9	97675579	995	16034	rs104894132	NC_000009.12:97675578:G:A
NM_000448.2(RAG1):c.1566G>T (p.Trp522Cys)	RAG1	W522C	|Combined cellular and humoral immune defects with granulomas|not provided|Combined cellular and humoral immune defects with granulomas	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036710	11	36596420	11	36574870	36710	45371	rs193922461	NC_000011.10:36574869:G:T
NM_006269.2(RP1):c.2953_2956del (p.Asn985fs)	RP1	N985fs	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000841165	8	55539395 - 55539398	8	54626835 - 54626838	841165	834892		NC_000008.11:54626834:AATC:
NM_006269.2(RP1):c.2167G>T (p.Gly723Ter)	RP1	G723*	Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000812400	8	55538609	8	54626049	812400	800537		NC_000008.11:54626048:G:T
NM_006269.2(RP1):c.2172_2185del (p.Ile725fs)	RP1	I725fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000437950	8	55538610 - 55538623	8	54626050 - 54626063	437950	431726	rs1554519546	NC_000008.11:54626049:GAGGGATACTTTGTGAGG:GAGG
NM_006269.2(RP1):c.2056C>T (p.Gln686Ter)	RP1	Q686*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000437948	8	55538498	8	54625938	437948	431724	rs1554519533	NC_000008.11:54625937:C:T
NM_000443.4(ABCB4):c.3136C>T (p.Arg1046Ter)	ABCB4	R1046*, R999*	Cholestasis, intrahepatic, of pregnancy 3|not provided|Progressive familial intrahepatic cholestasis 3|Gallbladder disease 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000587488	7	87037496	7	87408180	587488	578462	rs759202962	NC_000007.14:87408179:G:A
NM_004912.4(KRIT1):c.1301_1305TTGAA[1] (p.Leu436fs)	KRIT1		not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000590697	7	91852237 - 91852241	7	92222923 - 92222927	590697	581376	rs1563266658	NC_000007.14:92222922:TTCAATTCAA:TTCAA
NM_194456.1(KRIT1):c.730-2A>G	KRIT1		Cerebral cavernous malformation	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000468218	7	91864239	7	92234925	468218	457675	rs1554527925	NC_000007.14:92234924:T:C
NM_194456.1(KRIT1):c.152_155del (p.Lys51fs)	KRIT1	K51fs	not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265214	7	91870414 - 91870417	7	92241100 - 92241103	265214	259880	rs886039400	NC_000007.14:92241099:ACTT:
NM_000287.4(PEX6):c.510_511del (p.Asp172fs)	PEX6	D172fs	Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802216	6	42946378 - 42946379	6	42978640 - 42978641	802216	790631		NC_000006.12:42978639:CA:
NM_000287.4(PEX6):c.2398_2417delinsT (p.Ile800fs)	PEX6		not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000598162	6	42933473 - 42933492	6	42965735 - 42965754	598162	589223	rs62653602	NC_000006.12:42965734:TCCAGTTCATCAAAGAAGAT:A
NM_000287.4(PEX6):c.2406del (p.Phe802fs)	PEX6	F714fs, F802fs	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	no assertion criteria provided	VCV000545100	6	42933484	6	42965746	545100	535309	rs1554126965	NC_000006.12:42965745:AAA:AA
NM_000287.4(PEX6):c.1202T>A (p.Leu401Ter)	PEX6	L401*, L313*	not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000290377	6	42937654	6	42969916	290377	274614	rs886044436	NC_000006.12:42969915:A:T
NM_000287.4(PEX6):c.684dup (p.Arg229fs)	PEX6		not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000288468	6	42946204 - 42946205	6	42978466 - 42978467	288468	272705	rs886043908	NC_000006.12:42978466:GG:GGG
NM_000287.4(PEX6):c.1336_1337TG[1] (p.Ala447fs)	PEX6		not provided	Pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000092779	6	42937434 - 42937435	6	42969696 - 42969697	92779	98686	rs398123303	NC_000006.12:42969695:CACA:CA
NM_000287.4(PEX6):c.802_815del (p.Asp268fs)	PEX6	D268fs	Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000555443	6	42946074 - 42946087	6	42978336 - 42978349	555443	544100	rs63749004	NC_000006.12:42978335:AGCGCCAGTCCGTCAGCG:AGCG
NM_002047.4(GARS1):c.929G>A (p.Arg310Gln)	GARS1	R310Q, R256Q	GARS-associated growth retardation and developmental delay	Pathogenic	no assertion criteria provided	VCV000431181	7	30651759	7	30612143	431181	424704	rs1135401748	NC_000007.14:30612142:G:A
NM_002047.4(GARS1):c.246_249del (p.Glu83fs)	GARS1	E29fs, E83fs	GARS-associated growth retardation and developmental delay	Pathogenic	no assertion criteria provided	VCV000431180	7	30638433 - 30638436	7	30598817 - 30598820	431180	424703	rs1135401747	NC_000007.14:30598816:AAAGAA:AA
NM_000287.4(PEX6):c.2714G>T (p.Cys905Phe)	PEX6	C905F, C817F	Heimler syndrome 2	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000224322	6	42932620	6	42964882	224322	226046	rs886037782	NC_000006.12:42964881:C:A
NM_000287.4(PEX6):c.296G>T (p.Arg99Leu)	PEX6	R99L	Heimler syndrome 2	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000224320	6	42946593	6	42978855	224320	226050	rs886037781	NC_000006.12:42978854:C:A
NM_000287.4(PEX6):c.275T>G (p.Val92Gly)	PEX6	V92G	Heimler syndrome 2	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000224319	6	42946614	6	42978876	224319	226051	rs886037780	NC_000006.12:42978875:A:C
NM_000287.4(PEX6):c.1930C>T (p.Arg644Trp)	PEX6	R644W, R556W	Heimler syndrome 2	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000217425	6	42934551	6	42966813	217425	214064	rs769896492	NC_000006.12:42966812:G:A
NM_000287.4(PEX6):c.685_686AG[4] (p.Ser232fs)	PEX6		not provided	Pathogenic(Last reviewed: Mar 26, 2013)	criteria provided, single submitter	VCV000092790	6	42946198 - 42946199	6	42978460 - 42978461	92790	98697	rs398123305	NC_000006.12:42978460:CTCTCT:CTCTCTCT
NM_000287.4(PEX6):c.1601T>C (p.Leu534Pro)	PEX6	L534P, L446P	Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000030195	6	42936115	6	42968377	30195	39151	rs387906809	NC_000006.12:42968376:A:G
PEX6, 269-BP DEL/21-BP INS	PEX6		Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008126					8126	23165		
NM_000287.4(PEX6):c.1301del (p.Ser434fs)	PEX6	S346fs, S434fs	Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000008124	6	42937472	6	42969734	8124	23163		NC_000006.12:42969733:G:
NM_000287.4(PEX6):c.1688+1G>A	PEX6		Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000008123	6	42936027	6	42968289	8123	23162		NC_000006.12:42968288:C:T
NM_000287.4(PEX6):c.1130+1G>A	PEX6		Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008122	6	42941740	6	42974002	8122	23161		NC_000006.12:42974001:C:T
PEX6, 1-BP INS, NT511	PEX6		Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008121					8121	23160		
PEX6, 20-BP DEL/1-BP INS	PEX6		Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Jun 17, 1996)	no assertion criteria provided	VCV000008120					8120	23159		
PEX6, IVSAS, G-A, -1, 8-BP DEL	PEX6		Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Jun 17, 1996)	no assertion criteria provided	VCV000008119					8119	23158		
NM_023110.2(FGFR1):c.1460G>A (p.Gly487Asp)	FGFR1	G487D, G394D, G477D, G483D, G396D, G398D, G485D, G518D	Hartsfield syndrome|	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000132647	8	38275480	8	38417962	132647	136395	rs515726224	NC_000008.11:38417961:C:T
NM_023110.2(FGFR1):c.1825C>T (p.Arg609Ter)	FGFR1	R609*, R518*, R516*, R520*, R607*, R640*, R599*, R605*	not provided|Hypogonadotropic hypogonadism 2 with anosmia|	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000016296	8	38273417	8	38415899	16296	31335	rs121909639	NC_000008.11:38415898:G:A
NM_000287.4(PEX6):c.233_234GC[2] (p.Leu80fs)	PEX6		Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000837284	6	42946651 - 42946652	6	42978913 - 42978914	837284	831982		NC_000006.12:42978912:GCGCGCG:GCGCG
NC_000006.12:g.(?_42968280)_(42979253_?)del	PEX6		Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000833404	6	42936018 - 42946991			833404	819691		
NC_000006.12:g.(?_42974865)_(42975048_?)del	PEX6		Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000830981	6	42942603 - 42942786			830981	819692		
NM_000287.4(PEX6):c.2439del (p.Arg814fs)	PEX6	R726fs, R814fs	Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000653703	6	42933451	6	42965713	653703	634932		NC_000006.12:42965712:CCCCC:CCCC
NM_000287.4(PEX6):c.2074C>T (p.Gln692Ter)	PEX6	Q692*, Q604*	Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000643229	6	42934283	6	42966545	643229	634933		NC_000006.12:42966544:G:A
NM_002047.4(GARS1):c.1031+1G>A	GARS1		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637502	7	30651862	7	30612246	637502	625744		NC_000007.14:30612245:G:A
NM_002047.4(GARS1):c.1809+1G>A	GARS1		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637501	7	30668286	7	30628670	637501	625745		NC_000007.14:30628669:G:A
NM_000287.4(PEX6):c.1941C>A (p.Cys647Ter)	PEX6	C647*, C559*	Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000576022	6	42934540	6	42966802	576022	560857	rs781475201	NC_000006.12:42966801:G:T
NM_000287.4(PEX6):c.517del (p.Ser173fs)	PEX6	S173fs	Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000557701	6	42946372	6	42978634	557701	544108	rs61753212	NC_000006.12:42978633:T:
NM_000287.4(PEX6):c.621_882+2del	PEX6		Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008125	6	42946005 - 42946268	6	42978267 - 42978530	8125	23164	rs1554128347	
NM_000287.4(PEX6):c.2364_2365del (p.Phe789Cysfs)	PEX6		Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632941	6	42933525 - 42933526	6	42965787 - 42965788	632941	621749	rs755716911	NC_000006.12:42965786:ACAC:AC
NM_000287.4(PEX6):c.311del (p.Gly104fs)	PEX6	G104fs	Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorder 4a (zellweger)|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000499109	6	42946578	6	42978840	499109	490533	rs61753209	NC_000006.12:42978839:CC:C
NM_000287.4(PEX6):c.1360C>T (p.Gln454Ter)	PEX6	Q454*, Q366*	Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495795	6	42937413	6	42969675	495795	487075	rs1554127491	NC_000006.12:42969674:G:A
NM_001003800.2(BICD2):c.2108C>T (p.Thr703Met)	BICD2	T703M	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000055858	9	95480229	9	92717947	55858	70512	rs371707778	NC_000009.12:92717946:G:A
NM_000048.4(ASL):c.1045_1057del (p.Val349fs)	ASL	V329fs, V349fs, V323fs	Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203629	7	65554663 - 65554675	7	66089676 - 66089688	203629	200158	rs796051933	NC_000007.14:66089675:GCGTCATCTCTACGC:GC
NM_133497.4(KCNV2):c.8_11del (p.Lys3fs)	KCNV2	K3fs	not provided|Cone dystrophy with supernormal rod response|Retinal dystrophy	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000039810	9	2717745 - 2717748	9	2717745 - 2717748	39810	48409	rs786205121	NC_000009.12:2717744:CAAACA:CA
NM_000287.4(PEX6):c.383_384GA[1] (p.Glu129fs)	PEX6		Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555544	6	42946501 - 42946504	6	42978763 - 42978766	555544	543959	rs1554128501	NC_000006.12:42978762:TCTCTC:TC
NM_000287.4(PEX6):c.2082del (p.Gly695fs)	PEX6	G607fs, G695fs	Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553235	6	42934275	6	42966537	553235	544091	rs766483138	NC_000006.12:42966536:AA:A
NM_000287.4(PEX6):c.1962-1G>A	PEX6		Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorder 4a (zellweger)	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000550358	6	42934396	6	42966658	550358	543958	rs267608229	NC_000006.12:42966657:C:T
NM_002047.4(GARS1):c.875T>G (p.Met292Arg)	GARS1	M292R, M238R	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000476764	7	30649340	7	30609724	476764	457156	rs1064795123	NC_000007.14:30609723:T:G
NM_002047.4(GARS1):c.893C>T (p.Pro298Leu)	GARS1	P244L, P298L	Charcot-Marie-Tooth disease type 2D	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009209	7	30651723	7	30612107	9209	24248	rs137852648	NC_000007.14:30612106:C:T
NM_022970.3(FGFR2):c.1153G>A (p.Gly385Arg)	FGFR2	G384R, G385R, G156R, G295R, G269R, G296R, G272R	|Bent bone dysplasia syndrome|Pfeiffer syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Neoplasm of stomach|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Levy-Hollister syndrome|Jackson-Weiss syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000478046	10	123274768	10	121515254	478046	459906	rs1554927408	NC_000010.11:121515253:C:T
NM_022970.3(FGFR2):c.1087+1217A>G	FGFR2		Pfeiffer syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374814	10	123276979	10	121517465	374814	361716	rs1057519041	NC_000010.11:121517464:T:C
NM_022970.3(FGFR2):c.1087+1218G>A	FGFR2		FGFR2 related craniosynostosis|Pfeiffer syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000013291	10	123276978	10	121517464	13291	28330	rs879253719	NC_000010.11:121517463:C:T
NM_022970.3(FGFR2):c.1087+1300A>C	FGFR2	T341P, T113P, T226P, T252P	Pfeiffer syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013274	10	123276896	10	121517382	13274	28313	rs121918495	NC_000010.11:121517381:T:G
NM_006269.2(RP1):c.2332A>T (p.Lys778Ter)	RP1	K778*	not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000845845	8	55538774	8	54626214	845845	834887		NC_000008.11:54626213:A:T
NM_006269.2(RP1):c.3419del (p.Gly1140fs)	RP1	G1140fs	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000844052	8	55539859	8	54627299	844052	834897		NC_000008.11:54627298:GGG:GG
NM_000127.3(EXT1):c.1883+2T>C	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000852699	8	118819454	8	117807215	852699	851668		NC_000008.11:117807214:A:G
NM_000127.3(EXT1):c.1722+2T>G	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000838369	8	118825109	8	117812870	838369	852412		NC_000008.11:117812869:A:C
NM_000127.2(EXT1):c.962+1G>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000642916	8	119122323	8	118110084	642916	651749		NC_000008.11:118110083:C:T
NM_000127.2(EXT1):c.1417+1G>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000642160	8	118834703	8	117822464	642160	651739		NC_000008.11:117822463:C:T
NM_000127.2(EXT1):c.1057-2A>G	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Oct 7, 2018)	criteria provided, single submitter	VCV000640558	8	118847792	8	117835553	640558	651844		NC_000008.11:117835552:T:C
NM_000127.2(EXT1):c.536_537AG[1] (p.Leu181fs)	EXT1		Multiple congenital exostosis|not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265339	8	119122747 - 119122748	8	118110508 - 118110509	265339	259895	rs886039486	NC_000008.11:118110507:CTCT:CT
NM_000287.4(PEX6):c.2667-2A>C	PEX6		Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000575426	6	42932669	6	42964931	575426	563613	rs267608249	NC_000006.12:42964930:T:G
NM_000287.4(PEX6):c.273G>A (p.Trp91Ter)	PEX6	W91*	not provided|Peroxisome biogenesis disorder 4B	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498713	6	42946616	6	42978878	498713	490137	rs1010184002	NC_000006.12:42978877:C:T
NM_000287.4(PEX6):c.1715C>T (p.Thr572Ile)	PEX6	T572I, T484I	Peroxisome biogenesis disorder|Heimler syndrome 2	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000224323	6	42935275	6	42967537	224323	226047	rs61753224	NC_000006.12:42967536:G:A
NM_000287.4(PEX6):c.1841del (p.Leu614fs)	PEX6	L526fs, L614fs	not provided|Heimler syndrome 2|Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217426	6	42935149	6	42967411	217426	214065	rs863225083	NC_000006.12:42967410:A:
GRCh37/hg19 8p23.3(chr8:1718834-1729007)x1	CLN8		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253419	8	1718834 - 1729007			253419	247867		
NM_018941.3(CLN8):c.1A>G (p.Met1Val)	CLN8	M1V		Pathogenic	criteria provided, single submitter	VCV000487522	8	1719221	8	1771055	487522	480573	rs143730802	NC_000008.11:1771054:A:G
NM_018941.3(CLN8):c.88G>C (p.Ala30Pro)	CLN8	A30P		Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000002806	8	1719308	8	1771142	2806	17845	rs137852883	NC_000008.11:1771141:G:C
NM_018941.4(CLN8):c.311G>A (p.Trp104Ter)	CLN8	W104*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000852440	8	1719531	8	1771365	852440	834531		NC_000008.11:1771364:G:A
NM_018941.3(CLN8):c.295C>T (p.Gln99Ter)	CLN8	Q99*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000654163	8	1719515	8	1771349	654163	637015		NC_000008.11:1771348:C:T
NM_018941.3(CLN8):c.789G>C (p.Trp263Cys)	CLN8	W263C		Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000002803	8	1728661	8	1780495	2803	17842	rs28940569	NC_000008.11:1780494:G:C
NM_000235.4(LIPA):c.260G>T (p.Gly87Val)	LIPA	G87V	Lysosomal acid lipase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088770	10	90988125	10	89228368	88770	94353	rs587778878	NC_000010.11:89228367:C:A
NM_000235.4(LIPA):c.599T>C (p.Leu200Pro)	LIPA	L179P, L200P, L84P	Lysosomal acid lipase deficiency|Wolman disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000077	10	90984925	10	89225168	77	15116	rs121965086	NC_000010.11:89225167:A:G
NM_004183.4(BEST1):c.73C>T (p.Arg25Trp)	BEST1	R25W	not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000099751	11	61719351	11	61951879	99751	105640	rs281865214	NC_000011.10:61951878:C:T
NM_004183.4(BEST1):c.274C>T (p.Arg92Cys)	BEST1	R92C, R32C	not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099703	11	61723216	11	61955744	99703	105592	rs281865224	NC_000011.10:61955743:C:T
NM_004183.4(BEST1):c.1468_1469CA[1] (p.His490fs)	BEST1		Vitelliform macular dystrophy type 2|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002739	11	61730094 - 61730095	11	61962622 - 61962623	2739	17778	rs281865528	NC_000011.10:61962621:CACA:CA
NC_000008.10:g.(?_1719211)_(1728743_?)del	CLN8		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000647473	8	1719211 - 1728743	8	1771045 - 1780577	647473	651761		
NC_000008.10:g.(?_1719201)_(1728753_?)del	CLN8		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000457933	8	1719201 - 1728753	8	1771035 - 1780587	457933	457688		
NM_018941.3(CLN8):c.66del (p.Ile23fs)	CLN8	I23fs		Pathogenic/Likely pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000056718	8	1719282	8	1771116	56718	71357	rs34238807	NC_000008.11:1771115:GGGGG:GGGG
NM_018941.3(CLN8):c.181_183del (p.Lys61del)	CLN8	K61del		Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000056703	8	1719399 - 1719401	8	1771233 - 1771235	56703	71342	rs386834123	NC_000008.11:1771232:AGAAG:AG
NM_133497.4(KCNV2):c.357dup (p.Lys120fs)	KCNV2		Progressive cone dystrophy (without rod involvement)|Cone dystrophy with supernormal rod response|Stargardt disease	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636178	9	2718092 - 2718093	9	2718092 - 2718093	636178	623984	rs1402837406	NC_000009.12:2718092:CCCC:CCCCC
NM_002047.4(GARS1):c.1001T>G (p.Ile334Ser)	GARS1	I280S, I334S	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000834274	7	30651831	7	30612215	834274	833567		NC_000007.14:30612214:T:G
NM_002047.4(GARS1):c.1001T>A (p.Ile334Asn)	GARS1	I334N, I280N	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000543227	7	30651831	7	30612215	543227	522909	rs1554338262	NC_000007.14:30612214:T:A
NM_000287.4(PEX6):c.2578C>T (p.Arg860Trp)	PEX6	R860W, R772W	Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000492968	6	42933000	6	42965262	492968	485898	rs61753230	NC_000006.12:42965261:G:A
NM_000217.3(KCNA1):c.1202C>T (p.Ala401Val)	KCNA1	A401V	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	VCV000208748	12	5021746	12	4912580	208748	205276	rs797044929	NC_000012.12:4912579:C:T
NM_003002.4(SDHD):c.52+1G>A	SDHD		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000825543	11	111957684	11	112086960	825543	815502		NC_000011.10:112086959:G:A
NM_003002.4(SDHD):c.135_160del (p.Val46fs)	SDHD	V46fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000818930	11	111958663 - 111958688	11	112087939 - 112087964	818930	810759		NC_000011.10:112087938:AGTGCAGCACATACACTTGTCACCGA:
NM_003002.4(SDHD):c.352del (p.Asp118fs)	SDHD	M70fs, D118fs, D79fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000428938	11	111965563	11	112094839	428938	420757	rs1131691064	NC_000011.10:112094838:GGGG:GGG
NM_018941.3(CLN8):c.88del (p.Ala30fs)	CLN8	A30fs		Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000056720	8	1719308	8	1771142	56720	71359	rs386834139	NC_000008.11:1771141:G:
NM_006269.2(RP1):c.668del (p.Gly223fs)	RP1	G223fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000862472	8	55534728	8	54622168	862472	834874		NC_000008.11:54622167:GG:G
NM_006269.2(RP1):c.2374A>T (p.Lys792Ter)	RP1	K792*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000853663	8	55538816	8	54626256	853663	834889		NC_000008.11:54626255:A:T
NM_006269.2(RP1):c.3843del (p.Pro1282fs)	RP1	P1282fs	Retinitis pigmentosa|Retinitis pigmentosa 1	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000437957	8	55540279	8	54627719	437957	431733	rs769601671	NC_000008.11:54627718:TTTTTTT:TTTTTT
NM_001365276.2(TNXB):c.1878del (p.His626fs)	TNXB	H626fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000521427	6	32063752	6	32095975	521427	511659	rs1554334255	NC_000006.12:32095974:G:
NM_000019.4(ACAT1):c.826+1G>T	ACAT1		Deficiency of acetyl-CoA acetyltransferase|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000166650	11	108012428	11	108141701	166650	177469	rs727503796	NC_000011.10:108141700:G:T
NM_003002.4(SDHD):c.388dup (p.Ala130fs)	SDHD		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000428937	11	111965600 - 111965601	11	112094876 - 112094877	428937	420758	rs1131691063	NC_000011.10:112094876:GG:GGG
NM_003002.4(SDHD):c.275A>G (p.Asp92Gly)	SDHD	D92G, D53G	Fatal infantile mitochondrial cardiomyopathy|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: May 26, 2015)	no assertion criteria provided	VCV000180590	11	111959696	11	112088972	180590	178768	rs786205436	NC_000011.10:112088971:A:G
NM_012330.4(KAT6B):c.3264dup (p.Glu1089fs)	KAT6B		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	VCV000225094	10	76781879 - 76781880	10	75022121 - 75022122	225094	226921	rs869312962	NC_000010.11:75022121:AA:AAA
NM_003156.3(STIM1):c.910C>T (p.Arg304Trp)	STIM1	R304W	Combined immunodeficiency due to STIM1 deficiency|Stormorken syndrome|Combined immunodeficiency due to STIM1 deficiency|Myopathy, tubular aggregate, 1|Stormorken syndrome|Stormorken syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132887	11	4095850	11	4074620	132887	136636	rs483352867	NC_000011.10:4074619:C:T
NM_003002.4(SDHD):c.315_480del (p.Trp105fs)	SDHD	W105fs, W66fs, W57fs	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438442	11	111965529 - 111965694	11	112094805 - 112094970	438442	432048	rs1555187570	
NM_003002.3:c.1_169del	SDHD		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438441					438441	432056		
NM_003002.4(SDHD):c.381del (p.Leu128fs)	SDHD	G79fs, L128fs, L89fs	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438439	11	111965593	11	112094869	438439	432051	rs1555187601	NC_000011.10:112094868:GGG:GG
NM_014112.5(TRPS1):c.2762G>A (p.Arg921Gln)	TRPS1	R921Q, R914Q, R912Q	Trichorhinophalangeal dysplasia type I|||Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000005577	8	116430619	8	115418391	5577	20616	rs121908435	NC_000008.11:115418390:C:T
NM_012434.5(SLC17A5):c.406A>G (p.Lys136Glu)	SLC17A5	K136E	Salla disease|not provided|Sialic acid storage disease, severe infantile type|Salla disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021493	6	74351533	6	73641810	21493	34345	rs80338795	NC_000006.12:73641809:T:C
NM_054012.4(ASS1):c.1069C>T (p.Gln357Ter)	ASS1	Q357*	not provided|Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000528373	9	133370352	9	130494965	528373	524588	rs756859126	NC_000009.12:130494964:C:T
NM_018972.4(GDAP1):c.786del (p.Phe263fs)	GDAP1	F195fs, F263fs, F154fs, F205fs	Charcot-Marie-Tooth disease, type 4A|not provided|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000406136	8	75276308	8	74364073	406136	396551	rs1060500978	NC_000008.11:74364072:GGGG:GGG
NM_054012.4(ASS1):c.836G>A (p.Arg279Gln)	ASS1	R279Q	not provided|Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092375	9	133355834	9	130480447	92375	98286	rs371265106	NC_000009.12:130480446:G:A
NM_018972.4(GDAP1):c.347T>G (p.Met116Arg)	GDAP1	M116R, M48R, M7R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000038411	8	75272408	8	74360173	38411	46970	rs281865060	NC_000008.11:74360172:T:G
NM_003002.4(SDHD):c.14G>A (p.Trp5Ter)	SDHD	W5*	Pheochromocytoma	Pathogenic(Last reviewed: May 9, 2002)	no assertion criteria provided	VCV000006916	11	111957645	11	112086921	6916	21955	rs104894310	NC_000011.10:112086920:G:A
NM_000127.3(EXT1):c.1883+1G>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000864699	8	118819455	8	117807216	864699	851670		NC_000008.11:117807215:C:T
NM_000127.2(EXT1):c.1468dup (p.Leu490fs)	EXT1		not provided|Multiple congenital exostosis	Pathogenic(Last reviewed: May 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279804	8	118831982 - 118831983	8	117819743 - 117819744	279804	264357	rs886039355	NC_000008.11:117819743:GGGGGG:GGGGGGG
NM_000127.2(EXT1):c.1016G>A (p.Gly339Asp)	EXT1	G339D	Multiple congenital exostosis|Multiple exostoses type 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000002498	8	118849387	8	117837148	2498	17537	rs119103288	NC_000008.11:117837147:C:T
NM_018941.4(CLN8):c.792C>G (p.Asn264Lys)	CLN8	N264K	Neuronal ceroid lipofuscinosis|	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100736	8	1728664	8	1780498	100736	106601	rs587779411	NC_000008.11:1780497:C:G
NM_001029835.2(CCM2):c.118C>T (p.Arg40Ter)	CCM2	R19*, R40*	not provided|Cerebral cavernous malformations 2	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447028	7	45077876	7	45038277	447028	441131	rs755800734	NC_000007.14:45038276:C:T
NM_003383.5(VLDLR):c.1041_1045del (p.Trp347_Asp349delinsTer)	VLDLR		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000450521	9	2643932 - 2643936	9	2643932 - 2643936	450521	444467	rs1554621211	NC_000009.12:2643931:TGGAGTG:TG
NM_003383.5(VLDLR):c.1586G>A (p.Trp529Ter)	VLDLR	W529*, W488*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000265344	9	2646435	9	2646435	265344	259925	rs745973997	NC_000009.12:2646434:G:A
NM_003383.5(VLDLR):c.83-1G>A	VLDLR		Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000212565	9	2635452	9	2635452	212565	207707	rs770269674	NC_000009.12:2635451:G:A
NM_003383.5(VLDLR):c.2117G>T (p.Cys706Phe)	VLDLR	C706F, C665F	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	VCV000064373	9	2650382	9	2650382	64373	75338	rs397514750	NC_000009.12:2650381:G:T
NM_000287.4(PEX6):c.2435G>A (p.Arg812Gln)	PEX6	R812Q, R724Q	Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555170	6	42933455	6	42965717	555170	544081	rs61753229	NC_000006.12:42965716:C:T
NM_006158.4(NEFL):c.995A>C (p.Gln332Pro)	NEFL	Q333P, Q332P	Charcot-Marie-Tooth disease type 2E|not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000014028	8	24813035	8	24955521	14028	29067	rs59443585	NC_000008.11:24955520:T:G
NM_003383.5(VLDLR):c.1249_1255del (p.Tyr417fs)	VLDLR	Y376fs, Y417fs	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Jun 13, 2012)	no assertion criteria provided	VCV000055852	9	2645017 - 2645023	9	2645017 - 2645023	55852	70506	rs398122380	NC_000009.12:2645016:GTTACAAGT:GT
NM_003383.5(VLDLR):c.1342C>T (p.Arg448Ter)	VLDLR	R448*, R407*	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000021381	9	2645603	9	2645603	21381	34233	rs80338905	NC_000009.12:2645602:C:T
NM_003383.5(VLDLR):c.769C>T (p.Arg257Ter)	VLDLR	R257*, R216*	Cerebellar ataxia and mental retardation with quadrupedal locomotion 1|Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000012201	9	2643480	9	2643480	12201	27240	rs80338907	NC_000009.12:2643479:C:T
NM_194456.1(KRIT1):c.268C>T (p.Arg90Ter)	KRIT1	R90*	not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000590740	7	91867068	7	92237754	590740	581408	rs1563313372	NC_000007.14:92237753:G:A
NM_004912.4(KRIT1):c.1356_1357TC[3] (p.Gln455fs)	KRIT1		not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468207	7	91852184 - 91852185	7	92222870 - 92222871	468207	457668	rs1180476377	NC_000007.14:92222869:GAGAGAGA:GAGAGA
NM_004912.4(KRIT1):c.1197_1200CAAA[1] (p.Gln401fs)	KRIT1		not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372398	7	91855084 - 91855087	7	92225770 - 92225773	372398	359673	rs1057517753	NC_000007.14:92225769:TTTGTTTGTTT:TTTGTTT
NM_194456.1(KRIT1):c.715C>T (p.Gln239Ter)	KRIT1	Q239*	not provided|Cerebral cavernous malformation	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286066	7	91864731	7	92235417	286066	270303	rs886043300	NC_000007.14:92235416:G:A
NM_183050.4(BCKDHB):c.410C>T (p.Ala137Val)	BCKDHB	A137V, A67V	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370949	6	80877461	6	80167744	370949	357520	rs776631396	NC_000006.12:80167743:C:T
NM_005445.3(SMC3):c.2750A>C (p.His917Pro)	SMC3	H917P	Cornelia de Lange syndrome 3|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	VCV000208656	10	112361500	10	110601742	208656	205262	rs797044861	NC_000010.11:110601741:A:C
NM_005670.4(EPM2A):c.721C>T (p.Arg241Ter)	EPM2A	R241*, R160*, R87*, P160L, R103*	not provided|Lafora disease|Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003098	6	145948827	6	145627691	3098	18137	rs104893950	NC_000006.12:145627690:G:A
NM_000392.5(ABCC2):c.4239_4240dup (p.His1414fs)	ABCC2		not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000818031	10	101606808 - 101606809	10	99847051 - 99847052	818031	805659		NC_000010.11:99847051:CTC:CTCTC
NM_000392.5(ABCC2):c.2443C>T (p.Arg815Ter)	ABCC2	R815*	not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000598367	10	101578849	10	99819092	598367	589428	rs773850184	NC_000010.11:99819091:C:T
NM_000392.5(ABCC2):c.1968-1G>C	ABCC2		not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000596854	10	101572774	10	99813017	596854	587915	rs756707816	NC_000010.11:99813016:G:C
NM_000392.5(ABCC2):c.3422_3423del (p.Tyr1141fs)	ABCC2	Y1141fs	not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000596272	10	101595854 - 101595855	10	99836097 - 99836098	596272	587333	rs774778158	NC_000010.11:99836096:TAT:T
NM_000392.5(ABCC2):c.3580C>T (p.Gln1194Ter)	ABCC2	Q1194*	not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000595943	10	101596013	10	99836256	595943	587004	rs559137047	NC_000010.11:99836255:C:T
NM_000392.5(ABCC2):c.3216dup (p.Asp1073Ter)	ABCC2		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000595904	10	101591840 - 101591841	10	99832083 - 99832084	595904	586965	rs771652807	NC_000010.11:99832083:TTTTTT:TTTTTTT
NM_000392.5(ABCC2):c.821_822del (p.Pro274fs)	ABCC2	P274fs	not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000595795	10	101557042 - 101557043	10	99797285 - 99797286	595795	586857	rs1158274146	NC_000010.11:99797284:CT:
NM_000392.5(ABCC2):c.207+1G>A	ABCC2		not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000595381	10	101544539	10	99784782	595381	586443	rs1161530285	NC_000010.11:99784781:G:A
NM_000392.5(ABCC2):c.3811C>T (p.Arg1271Ter)	ABCC2	R1271*	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000595292	10	101603625	10	99843868	595292	586354	rs761406918	NC_000010.11:99843867:C:T
NM_000392.5(ABCC2):c.3741+1G>T	ABCC2		not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000595090	10	101601851	10	99842094	595090	586152	rs34937870	NC_000010.11:99842093:G:T
NM_000392.5(ABCC2):c.1291del (p.Leu431fs)	ABCC2	L431fs	not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000594930	10	101563857	10	99804100	594930	585992	rs1208873596	NC_000010.11:99804099:C:
NM_000392.5(ABCC2):c.697dup (p.Met233fs)	ABCC2		not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000594817	10	101556917 - 101556918	10	99797160 - 99797161	594817	585879	rs1314486961	NC_000010.11:99797160:A:AA
NM_000392.5(ABCC2):c.1893C>A (p.Cys631Ter)	ABCC2	C631*	not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000594398	10	101569968	10	99810211	594398	585461	rs1257076487	NC_000010.11:99810210:C:A
NM_000392.5(ABCC2):c.4246A>T (p.Lys1416Ter)	ABCC2	K1416*	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000593795	10	101606817	10	99847060	593795	584858	rs1564702358	NC_000010.11:99847059:A:T
NM_000392.5(ABCC2):c.2325del (p.Tyr776fs)	ABCC2	Y776fs	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000593794	10	101578599	10	99818842	593794	584857	rs1564688595	NC_000010.11:99818841:CC:C
NM_000392.5(ABCC2):c.3538C>T (p.Gln1180Ter)	ABCC2	Q1180*	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000593738	10	101595971	10	99836214	593738	584801	rs183923599	NC_000010.11:99836213:C:T
NM_000392.5(ABCC2):c.1014_1017del (p.Ser339fs)	ABCC2	S339fs	not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000593616	10	101559108 - 101559111	10	99799351 - 99799354	593616	584680	rs1564674618	NC_000010.11:99799350:GTGAGT:GT
NM_000392.5(ABCC2):c.3472_3473del (p.Pro1158fs)	ABCC2	P1158fs	not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000593494	10	101595903 - 101595904	10	99836146 - 99836147	593494	584558	rs762291612	NC_000010.11:99836145:CCCC:CC
NM_000392.5(ABCC2):c.2260del (p.Ile754fs)	ABCC2	I754fs	not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000593171	10	101577230	10	99817473	593171	584235	rs1564687941	NC_000010.11:99817472:A:
NM_000392.4(ABCC2):c.2322dup (p.Thr775Tyrfs)	ABCC2		not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000502572	10	101578596 - 101578597	10	99818839 - 99818840	502572	493995	rs1554851699	NC_000010.11:99818839:T:TT
NM_000392.5(ABCC2):c.156T>A (p.Tyr52Ter)	ABCC2	Y52*	not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000502331	10	101544487	10	99784730	502331	493755	rs1554845888	NC_000010.11:99784729:T:A
NM_000392.5(ABCC2):c.1651C>T (p.Gln551Ter)	ABCC2	Q551*	not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000502129	10	101567261	10	99807504	502129	493553	rs1554849397	NC_000010.11:99807503:C:T
NM_000392.5(ABCC2):c.476del (p.Asn159fs)	ABCC2	N159fs	not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000501700	10	101553655	10	99793898	501700	493124	rs769798659	NC_000010.11:99793897:AA:A
NM_000392.5(ABCC2):c.2426del (p.Leu809fs)	ABCC2	L809fs	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000501522	10	101578701	10	99818944	501522	492946	rs765580991	NC_000010.11:99818943:T:
NM_000392.5(ABCC2):c.4239_4240insTC (p.His1414fs)	ABCC2		not provided	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000500957	10	101606810 - 101606811	10	99847053 - 99847054	500957	492381	rs1554854612	NC_000010.11:99847053::TC
NM_000392.5(ABCC2):c.3500dup (p.Ser1168fs)	ABCC2		not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000498805	10	101595932 - 101595933	10	99836175 - 99836176	498805	490229	rs1333544687	NC_000010.11:99836175:T:TT
NM_000392.5(ABCC2):c.3599G>A (p.Trp1200Ter)	ABCC2	W1200*	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000498804	10	101596032	10	99836275	498804	490228	rs577353173	NC_000010.11:99836274:G:A
NM_000392.5(ABCC2):c.3258+1G>A	ABCC2		not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000498429	10	101591889	10	99832132	498429	489853	rs762243203	NC_000010.11:99832131:G:A
NM_000392.5(ABCC2):c.3463del (p.Thr1155fs)	ABCC2	T1155fs	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000498041	10	101595896	10	99836139	498041	489465	rs919078015	NC_000010.11:99836138:A:
NM_000392.5(ABCC2):c.3220_3226del (p.Thr1074fs)	ABCC2	T1074fs	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000498026	10	101591848 - 101591854	10	99832091 - 99832097	498026	489450	rs777325157	NC_000010.11:99832090:ACACAACAC:AC
NM_000392.5(ABCC2):c.2855_2858del (p.Ile952fs)	ABCC2	I952fs	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000498025	10	101590577 - 101590580	10	99830820 - 99830823	498025	489449	rs1554853026	NC_000010.11:99830819:TAATTAA:TAA
NM_000392.5(ABCC2):c.3337del (p.Val1114fs)	ABCC2	V1114fs	not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000426249	10	101594213	10	99834456	426249	415245	rs775771081	NC_000010.11:99834455:CCC:CC
NM_000392.5(ABCC2):c.974C>G (p.Ser325Ter)	ABCC2	S325*	not provided	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000290905	10	101559070	10	99799313	290905	275142	rs371866713	NC_000010.11:99799312:C:G
NM_000392.5(ABCC2):c.2125T>C (p.Trp709Arg)	ABCC2	W709R	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000289529	10	101577095	10	99817338	289529	273766	rs764958537	NC_000010.11:99817337:T:C
NM_000392.5(ABCC2):c.2901C>A (p.Tyr967Ter)	ABCC2	Y967*	not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000195649	10	101591385	10	99831628	195649	192810	rs17222547	NC_000010.11:99831627:C:A
NM_000392.5(ABCC2):c.3851G>A (p.Trp1284Ter)	ABCC2	W1284*	Dubin-Johnson syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000692030	10	101604086	10	99844329	692030	679774		NC_000010.11:99844328:G:A
NM_000392.5(ABCC2):c.1011_1012TG[1] (p.Val338fs)	ABCC2		Dubin-Johnson syndrome	Pathogenic	no assertion criteria provided	VCV000218946	10	101559107 - 101559108	10	99799350 - 99799351	218946	215780	rs864309675	NC_000010.11:99799349:TGTG:TG
ABCC2, 168-BP DEL, NT2272	ABCC2		Dubin-Johnson syndrome	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000039800					39800	48399		
NM_000392.5(ABCC2):c.3449G>A (p.Arg1150His)	ABCC2	R1150H	Dubin-Johnson syndrome	Pathogenic(Last reviewed: Oct 5, 2001)	no assertion criteria provided	VCV000008419	10	101595882	10	99836125	8419	23458	rs72558200	NC_000010.11:99836124:G:A
NM_000392.5(ABCC2):c.1967+2T>C	ABCC2		Dubin-Johnson syndrome	Pathogenic(Last reviewed: Dec 18, 1998)	no assertion criteria provided	VCV000008417	10	101571361	10	99811604	8417	23456	rs387906396	NC_000010.11:99811603:T:C
NM_000392.5(ABCC2):c.4145A>G (p.Gln1382Arg)	ABCC2	Q1382R	Dubin-Johnson syndrome	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000008416	10	101605538	10	99845781	8416	23455	rs72558202	NC_000010.11:99845780:A:G
ABCC2, IVS18DS, T-C, +2	ABCC2		Dubin-Johnson syndrome	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000008415					8415	23454		
NM_000392.5(ABCC2):c.1815+2T>A	ABCC2		Dubin-Johnson syndrome	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000008414	10	101567988	10	99808231	8414	23453	rs387906395	NC_000010.11:99808230:T:A
NM_003002.4(SDHD):c.284T>C (p.Leu95Pro)	SDHD	L95P, L56P	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000021351	11	111959705	11	112088981	21351	34203	rs80338846	NC_000011.10:112088980:T:C
NM_000392.5(ABCC2):c.3399_3400del (p.Tyr1134fs)	ABCC2	Y1134fs	Dubin-Johnson syndrome|not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290862	10	101594276 - 101594277	10	99834519 - 99834520	290862	275099	rs762914474	NC_000010.11:99834518:TTT:T
NM_000392.5(ABCC2):c.3741+1G>A	ABCC2		Dubin-Johnson syndrome|not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208557	10	101601851	10	99842094	208557	205166	rs34937870	NC_000010.11:99842093:G:A
NM_133497.4(KCNV2):c.1381G>A (p.Gly461Arg)	KCNV2	G461R	Cone dystrophy with supernormal rod response|Retinal dystrophy	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037247	9	2729470	9	2729470	37247	45840	rs149648640	NC_000009.12:2729469:G:A
NM_020549.4(CHAT):c.85A>T (p.Arg29Ter)	CHAT	R29*	not provided	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000286608	10	50822320	10	49614274	286608	270845	rs772025588	NC_000010.11:49614273:A:T
NR_003051.3(RMRP):n.215A>C	RMRP		not provided	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000279884	9	35657801	9	35657804	279884	264444	rs886041234	NC_000009.12:35657803:T:G
NM_020549.4(CHAT):c.418C>T (p.Gln140Ter)	CHAT	Q140*, Q22*, Q58*	not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000196498	10	50827801	10	49619755	196498	193659	rs794727516	NC_000010.11:49619754:C:T
NC_000009.12:g.(?_35657741)_(35658028_?)del	RMRP		Anauxetic dysplasia	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000830436	9	35657738 - 35658025			830436	820138		
NM_020549.4(CHAT):c.2081C>G (p.Ser694Cys)	CHAT	S576C, S694C, S612C	Febrile seizures|Lactic acidosis|Progressive muscle weakness|Progressive ptosis|Central sleep apnea syndrome|Pes planus|Aspiration pneumonia|Respiratory insufficiency|Gastroesophageal reflux|Decreased activity of the pyruvate dehydrogenase complex|External ophthalmoplegia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523529	10	50872926	10	49664880	523529	513999	rs201439531	NC_000010.11:49664879:C:G
NM_020549.4(CHAT):c.476_477delinsAG (p.Phe159Ter)	CHAT		Familial infantile myasthenia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000858247	10	50827859 - 50827860	10	49619813 - 49619814	858247	836923		NC_000010.11:49619812:TC:AG
NC_000010.10:g.(?_50822216)_(50873112_?)del	CHAT		Familial infantile myasthenia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000657906	10	50822216 - 50873112	10	49614170 - 49665066	657906	651966		
NR_003051.3(RMRP):n.-13_1dup14	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000633396	9	35658014 - 35658015	9	35658017 - 35658018	633396	621789	rs1554651373	NC_000009.12:35658017:CACGTCCTCAGCTTCAC:CACGTCCTCAGCTTCACGTCCTCAGCTTCAC
NM_020549.4(CHAT):c.669del (p.Gln223fs)	CHAT	Q223fs, Q105fs, Q141fs	Familial infantile myasthenia	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000461462	10	50828630	10	49620584	461462	460765	rs1554802808	NC_000010.11:49620583:G:
NM_020549.4(CHAT):c.1642C>T (p.Arg548Ter)	CHAT	R548*, R430*, R466*	Familial infantile myasthenia	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000461449	10	50863148	10	49655102	461449	460080	rs369251527	NC_000010.11:49655101:C:T
NM_020549.4(CHAT):c.1007T>C (p.Ile336Thr)	CHAT	I218T, I254T, I336T	Familial infantile myasthenia	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000017515	10	50835727	10	49627681	17515	32554	rs121912823	NC_000010.11:49627680:T:C
NM_020549.4(CHAT):c.1258C>T (p.Arg420Cys)	CHAT	R420C, R302C, R338C	Familial infantile myasthenia	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000017514	10	50854697	10	49646651	17514	32553	rs121912822	NC_000010.11:49646650:C:T
NM_020549.4(CHAT):c.1493C>T (p.Ser498Leu)	CHAT	S498L, S380L, S416L	Familial infantile myasthenia	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000017512	10	50857664	10	49649618	17512	32551	rs121912821	NC_000010.11:49649617:C:T
NM_020549.4(CHAT):c.629T>C (p.Leu210Pro)	CHAT	L210P, L92P, L128P	Familial infantile myasthenia	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000017511	10	50828590	10	49620544	17511	32550	rs121912820	NC_000010.11:49620543:T:C
NM_020549.4(CHAT):c.1516G>T (p.Val506Leu)	CHAT	V506L, V388L, V424L	Familial infantile myasthenia	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000017508	10	50859934	10	49651888	17508	32547	rs121912817	NC_000010.11:49651887:G:T
NM_020549.4(CHAT):c.631C>G (p.Pro211Ala)	CHAT	P211A, P93A, P129A	Familial infantile myasthenia	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000017506	10	50828592	10	49620546	17506	32545	rs121912815	NC_000010.11:49620545:C:G
CHAT, 2-BP INS, 523CC	CHAT		Familial infantile myasthenia	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000017505					17505	32544		
RMRP, 10-BP DEL, NT254	RMRP		Anauxetic dysplasia 1	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000014229					14229	29268		
RMRP, 254C-G	RMRP		Anauxetic dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000014228					14228	29267		
RMRP, 182G-A	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Dec 15, 2003)	no assertion criteria provided	VCV000014222					14222	29261		
NR_003051.3(RMRP):n.-14_3dup	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Dec 15, 2003)	no assertion criteria provided	VCV000014221	9	35658012 - 35658013	9	35658015 - 35658016	14221	29260	rs878853178	NC_000009.12:35658015:ACCACGTCCTCAGCTTCAC:ACCACGTCCTCAGCTTCACCACGTCCTCAGCTTCAC
RMRP, 218A-G	RMRP		Metaphyseal dysplasia without hypotrichosis	Pathogenic(Last reviewed: Dec 15, 2003)	no assertion criteria provided	VCV000014220					14220	29259		
RMRP, 12-BP DUP, NT-2	RMRP		Metaphyseal dysplasia without hypotrichosis	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000014218					14218	29257		
RMRP, 195C-T	RMRP		Metaphyseal dysplasia without hypotrichosis	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000014217					14217	29256		
RMRP, 238C-T	RMRP		Metaphyseal dysplasia without hypotrichosis	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000014216					14216	29255		
RMRP, 193G-A	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Jan 26, 2001)	no assertion criteria provided	VCV000014215					14215	29254		
NR_003051.3(RMRP):n.-6_-5insCCTGAG	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Jan 26, 2001)	no assertion criteria provided	VCV000014213	9	35658020 - 35658021	9	35658023 - 35658024	14213	29252	rs1554651446	NC_000009.12:35658023:CTCAG:CTCAGGCTCAG
RMRP, 2-BP DUP, 98TG	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Jan 26, 2001)	no assertion criteria provided	VCV000014212					14212	29251		
NM_003383.5(VLDLR):c.2339del (p.Ile780fs)	VLDLR	I711fs, I752fs, I739fs, I780fs	Cerebellar ataxia and mental retardation with quadrupedal locomotion 1|Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000012202	9	2651877	9	2651877	12202	27241	rs80338906	NC_000009.12:2651876:T:
NR_003051.3(RMRP):n.91_92delinsGC	RMRP		Anauxetic dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000014227	9	35657924 - 35657925	9	35657927 - 35657928	14227	29266	rs387906533	NC_000009.12:35657926:CT:GC
RMRP, 14G-A	RMRP		Anauxetic dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000014226					14226	29265		
RMRP, 14-BP INS, NT111	RMRP		Anauxetic dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000014225					14225	29264		
NM_022970.3(FGFR2):c.826T>G (p.Phe276Val)	FGFR2	F276V, F161V, F187V, F48V	Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374809	10	123279606	10	121520092	374809	361721	rs1057519036	NC_000010.11:121520091:A:C
NM_004183.4(BEST1):c.934G>A (p.Asp312Asn)	BEST1	D312N, D206N, D252N	not provided	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099786	11	61727036	11	61959564	99786	105675	rs281865277	NC_000011.10:61959563:G:A
NM_004183.4(BEST1):c.903T>G (p.Asp301Glu)	BEST1	D301E, D195E, D241E, M369R	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099773	11	61727005	11	61959533	99773	105662	rs281865261	NC_000011.10:61959532:T:G
NM_004183.4(BEST1):c.679T>A (p.Tyr227Asn)	BEST1	Y227N, Y167N, Y121N	Vitelliform macular dystrophy type 2|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000002731	11	61724901	11	61957429	2731	17770	rs28941469	NC_000011.10:61957428:T:A
NM_004183.4(BEST1):c.253T>C (p.Tyr85His)	BEST1	Y85H, Y25H	Vitelliform macular dystrophy type 2|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000002728	11	61723195	11	61955723	2728	17767	rs28940274	NC_000011.10:61955722:T:C
NM_020549.4(CHAT):c.914T>C (p.Ile305Thr)	CHAT	I305T, I187T, I223T	Familial infantile myasthenia|Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000017513	10	50833680	10	49625634	17513	32552	rs75466054	NC_000010.11:49625633:T:C
NR_003051.3(RMRP):n.-19_-3dup17	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000014214	9	35658017 - 35658018	9	35658020 - 35658021	14214	29253	rs727502778	NC_000009.12:35658020:GTCCTCAGCTTCACAGAGT:GTCCTCAGCTTCACAGAGTCCTCAGCTTCACAGAGT
NR_003051.3(RMRP):n.263G>T	RMRP		Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000014209	9	35657753	9	35657756	14209	29248	rs727502774	NC_000009.12:35657755:C:A
NM_004629.1(FANCG):c.1077-2A>G	FANCG		Fanconi anemia|not provided|Fanconi anemia, complementation group G	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445394	9	35076027	9	35076030	445394	438666	rs769547477	NC_000009.12:35076029:T:C
NM_004629.1(FANCG):c.1480+1G>C	FANCG		Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006717	9	35075275	9	35075278	6717	21756	rs149616199	NC_000009.12:35075277:C:G
NM_004629.1(FANCG):c.313G>T (p.Glu105Ter)	FANCG	E105*	Fanconi anemia, complementation group G|Fanconi anemia	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006712	9	35078335	9	35078338	6712	21751	rs121434425	NC_000009.12:35078337:C:A
NM_000448.2(RAG1):c.2924G>A (p.Arg975Gln)	RAG1	R975Q	Severe combined immunodeficiency disease|not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068693	11	36597778	11	36576228	68693	79585	rs150739647	NC_000011.10:36576227:G:A
NM_000448.2(RAG1):c.1303A>G (p.Met435Val)	RAG1	M435V	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity||Combined cellular and humoral immune defects with granulomas|Histiocytic medullary reticulosis|not provided||Combined cellular and humoral immune defects with granulomas	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068680	11	36596157	11	36574607	68680	79572	rs141524540	NC_000011.10:36574606:A:G
NM_000448.2(RAG1):c.1186C>T (p.Arg396Cys)	RAG1	R396C	Histiocytic medullary reticulosis|not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013144	11	36596040	11	36574490	13144	28183	rs104894289	NC_000011.10:36574489:C:T
NM_003002.4(SDHD):c.298_301del (p.Thr100fs)	SDHD	T100fs, T61fs	Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Oct 15, 2014)	criteria provided, single submitter	VCV000186590	11	111959716 - 111959719	11	112088992 - 112088995	186590	183478	rs786203067	NC_000011.10:112088991:CTCACTC:CTC
NM_000287.4(PEX6):c.2362G>A (p.Val788Met)	PEX6	V788M, V700M	Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556244	6	42933782	6	42966044	556244	543636	rs267608240	NC_000006.12:42966043:C:T
NM_001257180.2(SLC20A2):c.51_54dup (p.Ile19fs)	SLC20A2		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000521021	8	42329854 - 42329855	8	42472336 - 42472337	521021	511755	rs1554561128	NC_000008.11:42472336:GAAAG:GAAAGAAAG
NM_000392.5(ABCC2):c.3196C>T (p.Arg1066Ter)	ABCC2	R1066*	Dubin-Johnson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031603	10	101591826	10	99832069	31603	40287	rs72558199	NC_000010.11:99832068:C:T
NM_000392.5(ABCC2):c.3517A>T (p.Ile1173Phe)	ABCC2	I1173F	Dubin-Johnson syndrome|not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008418	10	101595950	10	99836193	8418	23457	rs72558201	NC_000010.11:99836192:A:T
NM_000392.5(ABCC2):c.2302C>T (p.Arg768Trp)	ABCC2	R768W	Dubin-Johnson syndrome|not provided	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000008412	10	101578577	10	99818820	8412	23451	rs56199535	NC_000010.11:99818819:C:T
NM_000127.2(EXT1):c.1431dup (p.Ser478fs)	EXT1		Multiple congenital exostosis|not provided	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000456062	8	118832019 - 118832020	8	117819780 - 117819781	456062	458170	rs1554578798	NC_000008.11:117819780:GGGGGG:GGGGGGG
NM_000127.2(EXT1):c.1469del (p.Leu490fs)	EXT1	L490fs	Multiple exostoses type 1|Multiple congenital exostosis|not provided	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265131	8	118831982	8	117819743	265131	259889	rs886039356	NC_000008.11:117819742:A:
NM_020638.3(FGF23):c.536G>A (p.Arg179Gln)	FGF23	R179Q	Autosomal dominant hypophosphatemic rickets	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, multiple submitters, no conflicts	VCV000036135	12	4479729	12	4370563	36135	44799	rs193922702	NC_000012.12:4370562:C:T
NM_019098.4(CNGB3):c.298del (p.Glu100fs)	CNGB3	E100fs	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000817918	8	87738799	8	86726571	817918	805589		NC_000008.11:86726570:C:
NM_001197104.2(KMT2A):c.9921del (p.Ser3308fs)	KMT2A	S3305fs, S3308fs	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000817913	11	118376528	11	118505813	817913	805674		NC_000011.10:118505812:G:
NM_001197104.2(KMT2A):c.7071del (p.Ser2358fs)	KMT2A	S2355fs, S2358fs	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817905	11	118373676	11	118502961	817905	805667		NC_000011.10:118502960:CCC:CC
NM_001197104.2(KMT2A):c.1468_1469TC[1] (p.Gln491fs)	KMT2A		not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000817896	11	118343341 - 118343342	11	118472626 - 118472627	817896	805662		NC_000011.10:118472625:CTCTC:CTC
NM_001197104.2(KMT2A):c.2619_2620del (p.Ser873fs)	KMT2A	S873fs	not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000817860	11	118344493 - 118344494	11	118473778 - 118473779	817860	805663		NC_000011.10:118473777:TA:
NM_001197104.2(KMT2A):c.3178_3184delinsCTAGGCTGCAGTGAGCTGTGACTGTGCCACTGTATTGCAGCCTAGGCAACAAAGCAATC (p.Glu1060_Ser1062delinsLeuGlyCysSerGluLeuTer)	KMT2A		not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000817840	11	118347541 - 118347547	11	118476826 - 118476832	817840	805664		
NM_001197104.2(KMT2A):c.5804_5817dup (p.Gln1940fs)	KMT2A		not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000817828	11	118369085 - 118369086	11	118498370 - 118498371	817828	805666		NC_000011.10:118498370:GATGTGAATTCTGC:GATGTGAATTCTGCGATGTGAATTCTGC
NM_001197104.2(KMT2A):c.8454del (p.Ser2819fs)	KMT2A	S2816fs, S2819fs	not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000817795	11	118375057	11	118504342	817795	805671		NC_000011.10:118504341:CCCCC:CCCC
NM_001197104.2(KMT2A):c.9768_9769del (p.Leu3257fs)	KMT2A	L3254fs, L3257fs	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000817751	11	118376375 - 118376376	11	118505660 - 118505661	817751	805673		NC_000011.10:118505659:AT:
NM_001197104.2(KMT2A):c.7226_7237delinsTTATG (p.Gly2409fs)	KMT2A		not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000817715	11	118373833 - 118373844	11	118503118 - 118503129	817715	805669		NC_000011.10:118503117:GAATGAGCAACA:TTATG
NM_001197104.2(KMT2A):c.7349del (p.Leu2450fs)	KMT2A	L2450fs, L2447fs	not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000817708	11	118373951	11	118503236	817708	805670		NC_000011.10:118503235:TTTTTT:TTTTT
NM_001197104.2(KMT2A):c.11001dup (p.Pro3668fs)	KMT2A		not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000817699	11	118380757 - 118380758	11	118510042 - 118510043	817699	805676		NC_000011.10:118510042:AAAAAA:AAAAAAA
NM_001197104.2(KMT2A):c.7124del (p.His2374_Leu2375insTer)	KMT2A		not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000817564	11	118373729	11	118503014	817564	805668		NC_000011.10:118503013:TTT:TT
NM_019098.4(CNGB3):c.1245_1246del (p.Gln415fs)	CNGB3	Q415fs	not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000817443	8	87645054 - 87645055	8	86632826 - 86632827	817443	805588		NC_000008.11:86632825:TTT:T
NM_001197104.2(KMT2A):c.10550dup (p.Ser3518fs)	KMT2A		not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000817426	11	118377152 - 118377153	11	118506437 - 118506438	817426	805675		NC_000011.10:118506437:GGGGG:GGGGGG
NM_001197104.2(KMT2A):c.5196dup (p.Ile1733fs)	KMT2A		not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000817412	11	118365019 - 118365020	11	118494304 - 118494305	817412	805665		NC_000011.10:118494304:T:TT
NM_001197104.2(KMT2A):c.9565delinsGAAGGC (p.Ile3189fs)	KMT2A		not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000817149	11	118376172	11	118505457	817149	805672		NC_000011.10:118505456:A:GAAGGC
NM_001197104.2(KMT2A):c.1844del (p.Pro615fs)	KMT2A	P615fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000807622	11	118343717	11	118473002	807622	798636		NC_000011.10:118473001:CC:C
NM_001197104.2(KMT2A):c.3157-7_3161del	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000807434	11	118347510 - 118347521	11	118476795 - 118476806	807434	798637		NC_000011.10:118476794:TCATATTCAGGGTCA:TCA
NM_001197104.2(KMT2A):c.7899del (p.Thr2635fs)	KMT2A	T2635fs, T2632fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802803	11	118374504	11	118503789	802803	791111		NC_000011.10:118503788:GGG:GG
NM_001197104.2(KMT2A):c.7643del (p.Ala2548fs)	KMT2A	A2545fs, A2548fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802802	11	118374250	11	118503535	802802	791110		NC_000011.10:118503534:C:
NM_001197104.2(KMT2A):c.3680_3683del (p.Asp1227fs)	KMT2A	D1227fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802799	11	118352473 - 118352476	11	118481758 - 118481761	802799	791107		NC_000011.10:118481757:AGACAG:AG
NM_001197104.2(KMT2A):c.3592C>T (p.Gln1198Ter)	KMT2A	Q1198*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802798	11	118350911	11	118480196	802798	791106		NC_000011.10:118480195:C:T
NM_001197104.2(KMT2A):c.3455C>A (p.Ser1152Ter)	KMT2A	S1152*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802797	11	118348802	11	118478087	802797	791105		NC_000011.10:118478086:C:A
NM_001197104.2(KMT2A):c.502+1G>A	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802796	11	118339560	11	118468845	802796	791104		NC_000011.10:118468844:G:A
NM_001197104.2(KMT2A):c.173dup (p.Ala59fs)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802795	11	118307393 - 118307394	11	118436678 - 118436679	802795	791103		NC_000011.10:118436678:CCCCCCC:CCCCCCCC
NM_001197104.1(KMT2A):c.3034C>T (p.Gln1012Ter)	KMT2A	Q1012*	not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000620556	11	118344908	11	118474193	620556	611742	rs1565280934	NC_000011.10:118474192:C:T
NM_001197104.1(KMT2A):c.517C>T (p.Arg173Ter)	KMT2A	R173*	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000620258	11	118342391	11	118471676	620258	611741	rs1555035511	NC_000011.10:118471675:C:T
NM_001197104.1(KMT2A):c.4988T>A (p.Leu1663Ter)	KMT2A	L1663*, L1660*	not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000620186	11	118362627	11	118491912	620186	611744	rs1565294188	NC_000011.10:118491911:T:A
NM_001197104.1(KMT2A):c.3247C>T (p.Arg1083Ter)	KMT2A	R1083*	not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000620155	11	118347610	11	118476895	620155	611743	rs782451966	NC_000011.10:118476894:C:T
NM_001197104.1(KMT2A):c.9139C>T (p.Gln3047Ter)	KMT2A	Q3047*, Q3044*	not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000546223	11	118375746	11	118505031	546223	536806	rs1555047532	NC_000011.10:118505030:C:T
NM_005933.4(KMT2A):c.2319dup (p.Ser774fs)	KMT2A		not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000545915	11	118344192 - 118344193	11	118473477 - 118473478	545915	536396	rs1555036475	NC_000011.10:118473477:G:GG
NM_001197104.1(KMT2A):c.5005-2A>G	KMT2A		not provided	Pathogenic(Last reviewed: Nov 3, 2016)	no assertion criteria provided	VCV000545047	11	118363770	11	118493055	545047	535318	rs1555042987	NC_000011.10:118493054:A:G
NM_005933.4(KMT2A):c.6296del (p.Pro2099fs)	KMT2A	P2102fs, P2099fs	not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000524116	11	118371847	11	118501132	524116	514619	rs1555045506	NC_000011.10:118501131:CC:C
NM_001197104.1(KMT2A):c.6571C>T (p.Arg2191Ter)	KMT2A	R2191*, R2188*	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000523900	11	118373178	11	118502463	523900	514620	rs200497972	NC_000011.10:118502462:C:T
NM_001197104.1(KMT2A):c.9694C>T (p.Arg3232Ter)	KMT2A	R3232*, R3229*	not provided	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000523803	11	118376301	11	118505586	523803	514621	rs782690725	NC_000011.10:118505585:C:T
NM_005933.4(KMT2A):c.7713_7716CCAA[1] (p.Pro2573fs)	KMT2A		not provided	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000504342	11	118374329 - 118374332	11	118503614 - 118503617	504342	495466	rs1555046764	NC_000011.10:118503613:CCAACCAA:CCAA
NM_001197104.1(KMT2A):c.4012+1G>C	KMT2A		not provided	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000504299	11	118352808	11	118482093	504299	495463	rs1555039476	NC_000011.10:118482092:G:C
NM_001197104.1(KMT2A):c.4576-1G>C	KMT2A		not provided	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000504298	11	118360843	11	118490128	504298	495702	rs563239	NC_000011.10:118490127:G:C
NM_001197104.1(KMT2A):c.3634+2T>C	KMT2A		not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000489138	11	118350955	11	118480240	489138	481976	rs1555038844	NC_000011.10:118480239:T:C
NM_001197104.1(KMT2A):c.2635G>T (p.Glu879Ter)	KMT2A	E879*	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000453144	11	118344509	11	118473794	453144	444729	rs1555036663	NC_000011.10:118473793:G:T
NM_005933.4(KMT2A):c.2068dup (p.Met690fs)	KMT2A		not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000452669	11	118343941 - 118343942	11	118473226 - 118473227	452669	444727	rs1555036328	NC_000011.10:118473226:A:AA
NM_005933.4(KMT2A):c.9374del (p.Met3125fs)	KMT2A	M3125fs, M3128fs	not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000452382	11	118375990	11	118505275	452382	444734	rs1555047647	NC_000011.10:118505274:T:
NM_001197104.1(KMT2A):c.10171C>T (p.Gln3391Ter)	KMT2A	Q3391*, Q3388*	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000450707	11	118376778	11	118506063	450707	444735	rs1555048203	NC_000011.10:118506062:C:T
NM_001197104.1(KMT2A):c.6487C>T (p.Arg2163Ter)	KMT2A	R2163*, R2160*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000450062	11	118372554	11	118501839	450062	444732	rs1555045816	NC_000011.10:118501838:C:T
NM_005933.4(KMT2A):c.2514del (p.Trp838fs)	KMT2A	W838fs	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000450037	11	118344387	11	118473672	450037	444728	rs1555036599	NC_000011.10:118473671:GG:G
NM_001197104.1(KMT2A):c.3190C>T (p.Arg1064Ter)	KMT2A	R1064*	not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000432486	11	118347553	11	118476838	432486	425905	rs1555037629	NC_000011.10:118476837:C:T
NM_001197104.1(KMT2A):c.3557A>C (p.Lys1186Thr)	KMT2A	K1186T	not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000432267	11	118348904	11	118478189	432267	425907	rs1555038122	NC_000011.10:118478188:A:C
NM_005933.4(KMT2A):c.8140del (p.Ile2714fs)	KMT2A	I2714fs, I2717fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000430946	11	118374752	11	118504037	430946	424489	rs1131692268	NC_000011.10:118504036:AAAAA:AAAA
NM_005933.4(KMT2A):c.3558_3559delinsTT (p.Lys1186_Gln1187delinsAsnTer)	KMT2A		not provided	Pathogenic(Last reviewed: Sep 12, 2015)	criteria provided, single submitter	VCV000429821	11	118348905 - 118348906	11	118478190 - 118478191	429821	421826	rs1131691614	NC_000011.10:118478189:GC:TT
NM_001197104.1(KMT2A):c.3473G>C (p.Cys1158Ser)	KMT2A	C1158S	not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000429638	11	118348820	11	118478105	429638	421825	rs1131691503	NC_000011.10:118478104:G:C
NM_001197104.1(KMT2A):c.4343G>A (p.Cys1448Tyr)	KMT2A	C1448Y	not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000426928	11	118359339	11	118488624	426928	415250	rs1085307857	NC_000011.10:118488623:G:A
NM_001197104.1(KMT2A):c.9133C>T (p.Gln3045Ter)	KMT2A	Q3045*, Q3042*	not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000426740	11	118375740	11	118505025	426740	415251	rs1085307772	NC_000011.10:118505024:C:T
NM_001197104.1(KMT2A):c.10139C>G (p.Ser3380Ter)	KMT2A	S3380*, S3377*	not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000424534	11	118376746	11	118506031	424534	408287	rs1064797024	NC_000011.10:118506030:C:G
NM_001197104.1(KMT2A):c.6764C>A (p.Ser2255Ter)	KMT2A	S2255*, S2252*	not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000424207	11	118373371	11	118502656	424207	408286	rs1064796862	NC_000011.10:118502655:C:A
NM_005933.4(KMT2A):c.4433del (p.Arg1478fs)	KMT2A	R1478fs	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000423946	11	118359429	11	118488714	423946	408281	rs1064796711	NC_000011.10:118488713:G:
NM_005933.4(KMT2A):c.5107del (p.Gln1703fs)	KMT2A	Q1703fs, Q1706fs	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000423869	11	118363883	11	118493168	423869	408283	rs1064796672	NC_000011.10:118493167:C:
NM_001197104.1(KMT2A):c.4706_4707insAAACTCTCTG (p.Cys1569Ter)	KMT2A		not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000421746	11	118361916 - 118361917	11	118491201 - 118491202	421746	408282	rs1064795340	NC_000011.10:118491201:TCTG:TCTGAAACTCTCTG
NM_005933.4(KMT2A):c.2348_2349del (p.Ser783fs)	KMT2A	S783fs	not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000418816	11	118344221 - 118344222	11	118473506 - 118473507	418816	408278	rs1064793451	NC_000011.10:118473505:TCT:T
NM_001197104.1(KMT2A):c.8570T>A (p.Leu2857Gln)	KMT2A	L2857Q, L2854Q	not provided	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000379700	11	118375177	11	118504462	379700	371262	rs1057520696	NC_000011.10:118504461:T:A
NM_001197104.1(KMT2A):c.6002_6005del (p.Phe2001fs)	KMT2A	F2001fs, F1998fs	Wiedemann-Steiner syndrome	Pathogenic	no assertion criteria provided	VCV000375624	11	118370055 - 118370058	11	118499340 - 118499343	375624	362438	rs1057519408	NC_000011.10:118499339:TGTTTGT:TGT
NM_001197104.1(KMT2A):c.4696+1G>A	KMT2A		Wiedemann-Steiner syndrome	Pathogenic	no assertion criteria provided	VCV000375623	11	118360965	11	118490250	375623	362437	rs1057519407	NC_000011.10:118490249:G:A
NM_005933.4(KMT2A):c.8855_8859del (p.Ile2952fs)	KMT2A	I2952fs, I2955fs	not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000280807	11	118375470 - 118375474	11	118504755 - 118504759	280807	264412	rs886041947	NC_000011.10:118504754:ATCTCA:A
NM_001197104.1(KMT2A):c.3560A>T (p.Gln1187Leu)	KMT2A	Q1187L	not provided	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000280730	11	118348907	11	118478192	280730	264591	rs886041881	NC_000011.10:118478191:A:T
NM_001197104.1(KMT2A):c.3565T>C (p.Cys1189Arg)	KMT2A	C1189R	not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000280722	11	118348912	11	118478197	280722	264447	rs886041875	NC_000011.10:118478196:T:C
NM_005933.4(KMT2A):c.9901_9902del (p.Leu3301fs)	KMT2A	L3301fs, L3304fs	not provided	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000280667	11	118376517 - 118376518	11	118505802 - 118505803	280667	264599	rs886041834	NC_000011.10:118505801:CT:
NM_001197104.1(KMT2A):c.3991C>T (p.Gln1331Ter)	KMT2A	Q1331*	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000280349	11	118352786	11	118482071	280349	264597	rs886041571	NC_000011.10:118482070:C:T
NM_001197104.1(KMT2A):c.10217C>A (p.Ser3406Ter)	KMT2A	S3406*, S3403*	not provided	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000265601	11	118376824	11	118506109	265601	259977	rs886039658	NC_000011.10:118506108:C:A
NM_001197104.1(KMT2A):c.6329C>G (p.Ser2110Ter)	KMT2A	S2110*, S2107*	not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000218541	11	118372396	11	118501681	218541	215425	rs864309569	NC_000011.10:118501680:C:G
NM_019098.4(CNGB3):c.2011G>T (p.Glu671Ter)	CNGB3	E671*	not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000864643	8	87591009	8	86578781	864643	835063		NC_000008.11:86578780:C:A
NM_001197104.2(KMT2A):c.1822C>T (p.Arg608Ter)	KMT2A	R608*	not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000857752	11	118343696	11	118472981	857752	838040		NC_000011.10:118472980:C:T
NM_019098.4(CNGB3):c.192_195dup (p.His66fs)	CNGB3		not provided	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000852227	8	87751898 - 87751899	8	86739670 - 86739671	852227	835087		NC_000008.11:86739670:TGGCT:TGGCTGGCT
NC_000008.11:g.86666999_86667000AT[1]	CNGB3		not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000845860	8	87679227 - 87679228	8	86666999 - 86667000	845860	835079		NC_000008.11:86666998:ATAT:AT
NM_001197104.2(KMT2A):c.2522del (p.Pro841fs)	KMT2A	P841fs	not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000843507	11	118344393	11	118473678	843507	838041		NC_000011.10:118473677:CCCC:CCC
NM_019098.4(CNGB3):c.1706_1707del (p.Val569fs)	CNGB3	V569fs	not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000838456	8	87616395 - 87616396	8	86604167 - 86604168	838456	835069		NC_000008.11:86604166:GA:
NM_019098.4(CNGB3):c.567G>A (p.Trp189Ter)	CNGB3	W189*	not provided	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000835093	8	87680323	8	86668095	835093	835082		NC_000008.11:86668094:C:T
NC_000008.11:g.(?_86739645)_(86743637_?)del	CNGB3		not provided	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000832600	8	87751873 - 87755865			832600	819989		
NC_000011.10:g.118504296_118504300GCTCA[2]	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000816901					816901	805094		
NC_000011.10:g.118472093_118472094insC	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000816900					816900	805093		
NC_000011.10:g.118471731C>A	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000816873					816873	805092		
NM_019098.4(CNGB3):c.105_114del (p.Gln36fs)	CNGB3	Q36fs	Achromatopsia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812290	8	87755742 - 87755751	8	86743514 - 86743523	812290	800542		NC_000008.11:86743513:CTGAGACTGA:
NM_019098.4(CNGB3):c.819del (p.Arg274fs)	CNGB3	R274fs	Achromatopsia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812288	8	87679186	8	86666958	812288	800540		NC_000008.11:86666957:GGG:GG
NM_019098.4(CNGB3):c.1207C>T (p.Arg403Ter)	CNGB3	R403*	Achromatopsia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812287	8	87645093	8	86632865	812287	800539		NC_000008.11:86632864:G:A
NM_005933.4(KMT2A):c.10367del (p.Asn3456fs)	KMT2A	N3456fs, N3459fs	Wiedemann-Steiner syndrome	Pathogenic	criteria provided, single submitter	VCV000694676	11	118376982	11	118506267	694676	682816		NC_000011.10:118506266:AA:A
NM_005933.4(KMT2A):c.4032del (p.Val1347fs)	KMT2A	V1347fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000691252	11	118353156	11	118482441	691252	678941		NC_000011.10:118482440:G:
NM_005933.4(KMT2A):c.4012+2T>A	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689770	11	118352809	11	118482094	689770	677432		NC_000011.10:118482093:T:A
NM_019098.4(CNGB3):c.1216_1219del (p.Ile406fs)	CNGB3	I406fs	not provided	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000663926	8	87645081 - 87645084	8	86632853 - 86632856	663926	637408		NC_000008.11:86632852:TAATTAA:TAA
NM_005933.4(KMT2A):c.11022del (p.Ser3675fs)	KMT2A	S3675fs, S3678fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000562045	11	118380792	11	118510077	562045	553179	rs1565310297	NC_000011.10:118510076:CC:C
NM_005933.4(KMT2A):c.8261dup (p.Ile2755fs)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000562035	11	118374874 - 118374875	11	118504159 - 118504160	562035	553178	rs1565304395	NC_000011.10:118504159:AAA:AAAA
NM_005933.4(KMT2A):c.766dup (p.Ile256fs)	KMT2A		Intellectual disability	Pathogenic	no assertion criteria provided	VCV000560380	11	118342633 - 118342634	11	118471918 - 118471919	560380	551430	rs1565278132	NC_000011.10:118471918:AAAAAAA:AAAAAAAA
NM_005933.4(KMT2A):c.1038del (p.Val347fs)	KMT2A	V347fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000523096	11	118342912	11	118472197	523096	513720	rs1555035779	NC_000011.10:118472196:A:
NM_005933.4(KMT2A):c.3566G>A (p.Cys1189Tyr)	KMT2A	C1189Y	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000523095	11	118348913	11	118478198	523095	513719	rs1555038125	NC_000011.10:118478197:G:A
NM_001197104.1(KMT2A):c.3521T>G (p.Leu1174Ter)	KMT2A	L1174*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000522805	11	118348868	11	118478153	522805	513437	rs1555038111	NC_000011.10:118478152:T:G
NM_001197104.1(KMT2A):c.2896A>T (p.Arg966Ter)	KMT2A	R966*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522659	11	118344770	11	118474055	522659	513312	rs1555036801	NC_000011.10:118474054:A:T
NM_001197104.1(KMT2A):c.478C>T (p.Arg160Ter)	KMT2A	R160*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504304	11	118339535	11	118468820	504304	495699	rs1555034779	NC_000011.10:118468819:C:T
NM_001197104.1(KMT2A):c.3341C>A (p.Ser1114Ter)	KMT2A	S1114*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000488383	11	118348688	11	118477973	488383	481237	rs1555038029	NC_000011.10:118477972:C:A
NM_001197104.1(KMT2A):c.11071+1G>A	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000446424	11	118380834	11	118510119	446424	439883	rs1555049702	NC_000011.10:118510118:G:A
NM_001197104.2(KMT2A):c.602_603insT (p.Lys201fs)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000440482	11	118342476 - 118342477	11	118471761 - 118471762	440482	434105	rs1555035550	NC_000011.10:118471761::T
NM_001197104.1(KMT2A):c.3334+1G>A	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431178	11	118347698	11	118476983	431178	424701	rs1135401764	NC_000011.10:118476982:G:A
NM_005933.4(KMT2A):c.10325dup (p.Ser3443fs)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 6, 2014)	criteria provided, single submitter	VCV000216952	11	118376939 - 118376940	11	118506224 - 118506225	216952	213608	rs863224888	NC_000011.10:118506224:CC:CCC
NM_005933.4(KMT2A):c.3651dup (p.Lys1218fs)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	VCV000216951	11	118352445 - 118352446	11	118481730 - 118481731	216951	213605	rs863224887	NC_000011.10:118481730:G:GG
NM_001197104.1(KMT2A):c.6811del (p.Arg2271fs)	KMT2A	R2271fs, R2268fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000211315	11	118373416	11	118502701	211315	207816	rs797045656	NC_000011.10:118502700:AAA:AA
NM_001197104.1(KMT2A):c.7831G>T (p.Glu2611Ter)	KMT2A	E2611*, E2608*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	VCV000158708	11	118374438	11	118503723	158708	168858	rs587783679	NC_000011.10:118503722:G:T
NM_001197104.1(KMT2A):c.458C>G (p.Ser153Ter)	KMT2A	S153*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	VCV000158704	11	118339515	11	118468800	158704	168851	rs587783678	NC_000011.10:118468799:C:G
NM_005933.4(KMT2A):c.2671_2672GA[1] (p.Arg893fs)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	VCV000158701	11	118344544 - 118344545	11	118473829 - 118473830	158701	168852	rs587783676	NC_000011.10:118473828:AGAGA:AGA
NM_005933.4(KMT2A):c.4599dup (p.Lys1534Ter)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037075	11	118360866 - 118360867	11	118490151 - 118490152	37075	45751	rs398122881	NC_000011.10:118490151:T:TT
NM_005933.4(KMT2A):c.7135C>T (p.Arg2379Ter)	KMT2A	R2382*, R2379*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037074	11	118373751	11	118503036	37074	45750	rs387907275	NC_000011.10:118503035:C:T
NM_005933.4(KMT2A):c.6904del (p.Ser2302fs)	KMT2A	S2302fs, S2305fs	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037073	11	118373520	11	118502805	37073	45749	rs398122880	NC_000011.10:118502804:T:
NM_005933.4(KMT2A):c.8258del (p.Asn2752_Leu2753insTer)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037072	11	118374873	11	118504158	37072	45748	rs398122879	NC_000011.10:118504157:TT:T
NM_005933.4(KMT2A):c.8793_8796GTCT[1] (p.Ser2932_Val2933insTer)	KMT2A		Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037071	11	118375406 - 118375409	11	118504691 - 118504694	37071	45747	rs398122878	NC_000011.10:118504690:TCTGTCTGTCT:TCTGTCT
NC_000008.11:g.(?_86654002)_(86654072_?)dup	CNGB3		not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000831482	8	87666230 - 87666300			831482	819988		
NC_000008.11:g.(?_86604083)_(86604221_?)del	CNGB3		not provided	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000830584	8	87616311 - 87616449			830584	819987		
NM_019098.4(CNGB3):c.1781+1G>T	CNGB3		Achromatopsia 3|Stargardt disease 1	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000810781	8	87616320	8	86604092	810781	799030		NC_000008.11:86604091:C:A
NM_019098.4(CNGB3):c.1663-1205G>A	CNGB3		Achromatopsia	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000635822	8	87617644	8	86605416	635822	623639		NC_000008.11:86605415:C:T
NC_000008.11:g.86711345_86711346insMF045864.2g.1_98770	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000430673			8	86711345 - 86711346	430673	424201		
NC_000008.11:g.86688947_86688948insMF045863.1g.1_36978	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000430672			8	86688947 - 86688948	430672	424200		
NM_019098.4(CNGB3):c.1782-3723_2103+739del	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427721	8	87590194 - 87595219	8	86577950 - 86582975	427721	417081		
NM_019098.4(CNGB3):c.1663-2660_1781+5516del	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427720	8	87610805 - 87619099	8	86598577 - 86606871	427720	417087		
NM_019098.4(CNGB3):c.(1578+1_1579-1)_(*1_?)del	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427719					427719	417157		
NM_019098.4(CNGB3):c.904-2824_1782-8208delinsKY923049.1g1_466	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427718			8	86587460 - 86650711	427718	417156		
NM_019098.4(CNGB3):c.852+4013_903+1698dup	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427717			8	86652314 - 86662912	427717	417121		
NM_019098.4(CNGB3):c.(338+1_339-1)_(*1_?)del	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427716					427716	417155		
NM_019098.4(CNGB3):c.212-2527_338+2854del	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427713	8	87735905 - 87741412	8	86723677 - 86729184	427713	417138		
NM_019098.4(CNGB3):c.(?_-1)_(129+1_130-1)del	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427712					427712	417152		
NM_019098.4(CNGB3):c.1782-2A>C	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427710	8	87591482	8	86579254	427710	417086	rs1554604851	NC_000008.11:86579253:T:G
NM_019098.4(CNGB3):c.1781+1G>A	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427708	8	87616320	8	86604092	427708	417089	rs1375507464	NC_000008.11:86604091:C:T
NM_019098.4(CNGB3):c.1578+1G>T	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427704	8	87638210	8	86625982	427704	417096	rs372006750	NC_000008.11:86625981:C:A
NM_019098.4(CNGB3):c.1056-2A>G	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427702	8	87656103	8	86643875	427702	417116	rs1385347376	NC_000008.11:86643874:T:C
NM_019098.4(CNGB3):c.904-2A>T	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427700	8	87660117	8	86647889	427700	417120	rs1554612159	NC_000008.11:86647888:T:A
NM_019098.4(CNGB3):c.852+1G>C	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427699	8	87679152	8	86666924	427699	417124	rs1201521544	NC_000008.11:86666923:C:G
NM_019098.4(CNGB3):c.643+2T>C	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427698	8	87680245	8	86668017	427698	417132	rs1391492794	NC_000008.11:86668016:A:G
NM_019098.4(CNGB3):c.494-2A>T	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427697	8	87680398	8	86668170	427697	417135	rs1554614157	NC_000008.11:86668169:T:A
NM_019098.4(CNGB3):c.130-1G>T	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427696	8	87751965	8	86739737	427696	417145	rs1554619303	NC_000008.11:86739736:C:A
NM_019098.4(CNGB3):c.129+2T>C	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427695	8	87755725	8	86743497	427695	417146	rs1554619498	NC_000008.11:86743496:A:G
NM_019098.4(CNGB3):c.1635T>A (p.Tyr545Ter)	CNGB3	Y545*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427694	8	87623843	8	86611615	427694	417094	rs1554608319	NC_000008.11:86611614:A:T
NM_019098.4(CNGB3):c.1460G>A (p.Trp487Ter)	CNGB3	W487*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427693	8	87641167	8	86628939	427693	417101	rs999921351	NC_000008.11:86628938:C:T
NM_019098.4(CNGB3):c.1426C>T (p.Gln476Ter)	CNGB3	Q476*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427691	8	87641201	8	86628973	427691	417105	rs1554610284	NC_000008.11:86628972:G:A
NM_019098.4(CNGB3):c.1243C>T (p.Gln415Ter)	CNGB3	Q415*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427689	8	87645057	8	86632829	427689	417112	rs1554610668	NC_000008.11:86632828:G:A
NM_019098.4(CNGB3):c.1194T>G (p.Tyr398Ter)	CNGB3	Y398*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427688	8	87645106	8	86632878	427688	417113	rs775038513	NC_000008.11:86632877:A:C
NM_019098.4(CNGB3):c.882C>G (p.Tyr294Ter)	CNGB3	Y294*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427686	8	87666261	8	86654033	427686	417122	rs1554612805	NC_000008.11:86654032:G:C
NM_019098.4(CNGB3):c.756C>G (p.Tyr252Ter)	CNGB3	Y252*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427685	8	87679249	8	86667021	427685	417127	rs371318766	NC_000008.11:86667020:G:C
NM_019098.4(CNGB3):c.702T>A (p.Cys234Ter)	CNGB3	C234*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427684	8	87679303	8	86667075	427684	417130	rs6471482	NC_000008.11:86667074:A:T
NM_019098.4(CNGB3):c.301C>T (p.Gln101Ter)	CNGB3	Q101*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427683	8	87738796	8	86726568	427683	417139	rs1554618404	NC_000008.11:86726567:G:A
NM_019098.4(CNGB3):c.265C>T (p.Gln89Ter)	CNGB3	Q89*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427682	8	87738832	8	86726604	427682	417141	rs1554618417	NC_000008.11:86726603:G:A
NM_019098.4(CNGB3):c.208C>T (p.Gln70Ter)	CNGB3	Q70*	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427681	8	87751886	8	86739658	427681	417143	rs1052078370	NC_000008.11:86739657:G:A
NM_019098.4(CNGB3):c.926C>T (p.Pro309Leu)	CNGB3	P309L	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427674	8	87660093	8	86647865	427674	417119	rs1554612145	NC_000008.11:86647864:G:A
NM_019098.4(CNGB3):c.3G>A (p.Met1Ile)	CNGB3	M1I	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427670	8	87755853	8	86743625	427670	417150	rs1554619513	NC_000008.11:86743624:C:T
NM_019098.4(CNGB3):c.2359del (p.Ser787fs)	CNGB3	S787fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427668	8	87588103	8	86575875	427668	417079	rs1554604525	NC_000008.11:86575874:T:
NM_019098.4(CNGB3):c.2221del (p.Asp741fs)	CNGB3	D741fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427667	8	87588241	8	86576013	427667	417080	rs1554604552	NC_000008.11:86576012:C:
NM_019098.4(CNGB3):c.1815del (p.Ala606fs)	CNGB3	A606fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427666	8	87591447	8	86579219	427666	417085	rs1362472371	NC_000008.11:86579218:A:
NM_019098.4(CNGB3):c.1566_1569dup (p.Leu524fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427665	8	87638219 - 87638220	8	86625991 - 86625992	427665	417097	rs1554609946	NC_000008.11:86625991:GTCG:GTCGGTCG
NM_019098.4(CNGB3):c.1534delinsGT (p.Ile512fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427664	8	87638255	8	86626027	427664	417098	rs1554609956	NC_000008.11:86626026:T:AC
NM_019098.4(CNGB3):c.1516del (p.Val506fs)	CNGB3	V506fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427663	8	87638273	8	86626045	427663	417099	rs768735888	NC_000008.11:86626044:CC:C
NM_019098.4(CNGB3):c.1493del (p.Leu498fs)	CNGB3	L498fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427662	8	87638296	8	86626068	427662	417100	rs773381712	NC_000008.11:86626067:AAA:AA
NM_019098.4(CNGB3):c.1430_1431delinsC (p.Lys477fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427661	8	87641196 - 87641197	8	86628968 - 86628969	427661	417104	rs1554610279	NC_000008.11:86628967:CT:G
NM_019098.4(CNGB3):c.1297_1298GT[1] (p.Phe434fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427660	8	87645000 - 87645001	8	86632772 - 86632773	427660	417108	rs1554610655	NC_000008.11:86632771:ACACA:ACA
NM_019098.4(CNGB3):c.1285dup (p.Ser429fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427659	8	87645014 - 87645015	8	86632786 - 86632787	427659	417110	rs776896038	NC_000008.11:86632786:AAAAAAAA:AAAAAAAAA
NM_019098.4(CNGB3):c.1005dup (p.Glu336Ter)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427656	8	87656899 - 87656900	8	86644671 - 86644672	427656	417118	rs1554611860	NC_000008.11:86644671:AAAAAA:AAAAAAA
NM_019098.4(CNGB3):c.873delinsCAAAC (p.Arg291fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427655	8	87666270	8	86654042	427655	417123	rs1554612806	NC_000008.11:86654041:C:GTTTG
NM_019098.4(CNGB3):c.791_794del (p.Tyr264fs)	CNGB3	Y264fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427654	8	87679211 - 87679214	8	86666983 - 86666986	427654	417126	rs1554613998	NC_000008.11:86666982:AGGTAG:AG
NM_019098.4(CNGB3):c.706delinsTT (p.Ile236fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427653	8	87679299	8	86667071	427653	417129	rs1554614022	NC_000008.11:86667070:T:AA
NM_019098.4(CNGB3):c.702_706delinsGTTTTT (p.Cys234fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427652	8	87679299 - 87679303	8	86667071 - 86667075	427652	417128	rs1554614024	NC_000008.11:86667070:TAAAA:AAAAAC
NM_019098.4(CNGB3):c.682dup (p.Ala228fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427651	8	87679322 - 87679323	8	86667094 - 86667095	427651	417131	rs1554614038	NC_000008.11:86667094:C:CC
NM_019098.4(CNGB3):c.589_590del (p.Leu197fs)	CNGB3	L197fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427650	8	87680300 - 87680301	8	86668072 - 86668073	427650	417134	rs1554614131	NC_000008.11:86668071:AAA:A
NM_019098.4(CNGB3):c.393_394delinsTCCTGGTGA (p.Gln131fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427649	8	87683271 - 87683272	8	86671043 - 86671044	427649	417137	rs1554614423	NC_000008.11:86671042:GC:TCACCAGGA
NM_019098.4(CNGB3):c.281_284del (p.Pro94fs)	CNGB3	P94fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427648	8	87738813 - 87738816	8	86726585 - 86726588	427648	417140	rs1554618413	NC_000008.11:86726584:GTTGGTT:GTT
NM_019098.4(CNGB3):c.257del (p.Pro86fs)	CNGB3	P86fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427647	8	87738840	8	86726612	427647	417142	rs1554618420	NC_000008.11:86726611:GGG:GG
NM_019098.4(CNGB3):c.190del (p.Glu64fs)	CNGB3	E64fs	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427646	8	87751904	8	86739676	427646	417144	rs1554619292	NC_000008.11:86739675:C:
NM_019098.4(CNGB3):c.95dup (p.His32fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427645	8	87755760 - 87755761	8	86743532 - 86743533	427645	417147	rs1554619500	NC_000008.11:86743532:T:TT
NM_019098.4(CNGB3):c.31dup (p.Val11fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427644	8	87755824 - 87755825	8	86743596 - 86743597	427644	417148	rs1554619509	NC_000008.11:86743596:CC:CCC
NM_019098.4(CNGB3):c.29dup (p.Val11fs)	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427643	8	87755826 - 87755827	8	86743598 - 86743599	427643	417149	rs1442286151	NC_000008.11:86743598:TT:TTT
NM_019098.4(CNGB3):c.1098_1101dup (p.Ala368Ter)	CNGB3		not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372954	8	87656055 - 87656056	8	86643827 - 86643828	372954	359897	rs1057518098	NC_000008.11:86643827:ATTAAT:ATTAATTAAT
NM_001197104.1(KMT2A):c.3301C>T (p.Arg1101Ter)	KMT2A	R1101*	not provided|intellectual deficiency	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000280699	11	118347664	11	118476949	280699	264585	rs886041856	NC_000011.10:118476948:C:T
CNGB3, 1-BP INS, 492T	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000005224					5224	20263		
NM_019098.4(CNGB3):c.595del (p.Glu199fs)	CNGB3	E199fs	not provided	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000847858	8	87680295	8	86668067	847858	835081		NC_000008.11:86668066:C:
NM_001197104.1(KMT2A):c.7438C>T (p.Arg2480Ter)	KMT2A	R2480*, R2477*	Wiedemann-Steiner syndrome|not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000449960	11	118374045	11	118503330	449960	444733	rs1555046568	NC_000011.10:118503329:C:T
NM_005933.4(KMT2A):c.3460C>T (p.Arg1154Trp)	KMT2A	R1154W	not provided|Wiedemann-Steiner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431895	11	118348807	11	118478092	431895	425906	rs1555038090	NC_000011.10:118478091:C:T
NM_005933.4(KMT2A):c.5794-1G>A	KMT2A		Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000430819	11	118369084	11	118498369	430819	424354	rs1555044700	NC_000011.10:118498368:G:A
NM_019098.4(CNGB3):c.2T>C (p.Met1Thr)	CNGB3	M1T	Achromatopsia 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000427669	8	87755854	8	86743626	427669	417151	rs1554619514	NC_000008.11:86743625:A:G
NM_005933.4(KMT2A):c.5612dup (p.Gln1872fs)	KMT2A		not provided|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jul 15, 2015)	criteria provided, multiple submitters, no conflicts	VCV000419205	11	118367038 - 118367039	11	118496323 - 118496324	419205	408285	rs1555043939	NC_000011.10:118496323:G:GG
NM_005933.4(KMT2A):c.2318dup (p.Ser774fs)	KMT2A		not provided|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374257	11	118344185 - 118344186	11	118473470 - 118473471	374257	361201	rs782297546	NC_000011.10:118473470:CCCCCCC:CCCCCCCC
NM_001197104.1(KMT2A):c.7567_7570del (p.Val2523fs)	KMT2A	V2520fs, V2523fs	Wiedemann-Steiner syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000191274	11	118374172 - 118374175	11	118503457 - 118503460	191274	189077	rs797044565	NC_000011.10:118503456:CAGTCA:CA
NM_001197104.1(KMT2A):c.8095C>T (p.Arg2699Ter)	KMT2A	R2699*, R2696*	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158709	11	118374702	11	118503987	158709	168859	rs587783680	NC_000011.10:118503986:C:T
CNGB3, 8-BP DEL, NT819	CNGB3		Achromatopsia 3	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005226					5226	20265		
NM_019098.4(CNGB3):c.1663-2137C>T	CNGB3		Achromatopsia|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635823	8	87618576	8	86606348	635823	623640		NC_000008.11:86606347:G:A
NM_019098.4(CNGB3):c.1810C>T (p.Arg604Ter)	CNGB3	R604*	Abnormality of the eye|Achromatopsia 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000438042	8	87591452	8	86579224	438042	431735	rs200805087	NC_000008.11:86579223:G:A
NM_019098.4(CNGB3):c.1781+1G>C	CNGB3		Retinal dystrophy|Achromatopsia 3	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000427709	8	87616320	8	86604092	427709	417088	rs1375507464	NC_000008.11:86604091:C:G
NM_019098.4(CNGB3):c.1579-2A>G	CNGB3		Retinal dystrophy|Achromatopsia 3	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000427705	8	87623901	8	86611673	427705	417095	rs772725807	NC_000008.11:86611672:T:C
NM_005933.4(KMT2A):c.2233C>T (p.Arg745Ter)	KMT2A	R745*	not provided|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000180201	11	118344107	11	118473392	180201	178383	rs727503777	NC_000011.10:118473391:C:T
NM_006946.3(SPTBN2):c.5515C>T (p.Gln1839Ter)	SPTBN2	Q1839*	not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000620423	11	66458805	11	66691334	620423	611752	rs1166383301	NC_000011.10:66691333:G:A
NM_006946.3(SPTBN2):c.1261_1263del (p.Glu421del)	SPTBN2	E421del	not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000279901	11	66475699 - 66475701	11	66708228 - 66708230	279901	264633	rs886041245	NC_000011.10:66708227:CTCCT:CT
NM_006946.3(SPTBN2):c.2864_2868del (p.Thr955fs)	SPTBN2	T955fs	Spinocerebellar ataxia, autosomal recessive 14	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000064369	11	66468702 - 66468706	11	66701231 - 66701235	64369	75334	rs373728971	NC_000011.10:66701230:TGAGGTGAG:TGAG
NM_006946.3(SPTBN2):c.1881C>A (p.Cys627Ter)	SPTBN2	C627*	Spinocerebellar ataxia, autosomal recessive 14	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000064367	11	66472866	11	66705395	64367	75332	rs146859515	NC_000011.10:66705394:G:T
SPTBN2, 15-BP DEL, NT1886	SPTBN2			Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000005274					5274	20313		
SPTBN2, 39-BP DEL	SPTBN2			Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000005273					5273	20312		
NM_001042413.2(GLIS3):c.932del (p.Gly311fs)	GLIS3	G156fs, G311fs	Diabetes mellitus, neonatal, with congenital hypothyroidism	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253045	9	4118546	9	4118546	253045	247456	rs879255609	NC_000009.12:4118545:CC:C
NM_001042413.2(GLIS3):c.1681C>T (p.His561Tyr)	GLIS3	H561Y, H406Y	Diabetes mellitus, neonatal, with congenital hypothyroidism	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253044	9	4117797	9	4117797	253044	247455	rs868197660	NC_000009.12:4117796:G:A
NM_001042413.2(GLIS3):c.1608C>G (p.Cys536Trp)	GLIS3	C536W, C381W	Diabetes mellitus, neonatal, with congenital hypothyroidism	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253043	9	4117870	9	4117870	253043	247454	rs879255608	NC_000009.12:4117869:G:C
NM_001042413.2(GLIS3):c.2338dup (p.Arg780fs)	GLIS3		Diabetes mellitus, neonatal, with congenital hypothyroidism	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000001325	9	3856143 - 3856144	9	3856143 - 3856144	1325	16364	rs869320723	NC_000009.12:3856143:GGGGG:GGGGGG
NM_001220.5(CAMK2B):c.416C>T (p.Pro139Leu)	CAMK2B	P139L	Intellectual disability|Global developmental delay|Dystonia|Agitation|Hyperventilation|Microcephaly|Apnea|Inborn genetic diseases|Intellectual disability, autosomal dominant 54	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430922	7	44283125	7	44243526	430922	424467	rs1554389088	NC_000007.14:44243525:G:A
NM_019098.4(CNGB3):c.2103+1G>A	CNGB3		Achromatopsia 3|Macular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427711	8	87590916	8	86578688	427711	417082	rs1554604767	NC_000008.11:86578687:C:T
NM_019098.4(CNGB3):c.1285del (p.Ser429fs)	CNGB3	S429fs	Achromatopsia 3|Abnormality of the eye	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000427658	8	87645015	8	86632787	427658	417109	rs776896038	NC_000008.11:86632786:AAAAAAAA:AAAAAAA
NM_019098.4(CNGB3):c.446_447insT (p.Lys149fs)	CNGB3		Achromatopsia 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370100	8	87683218 - 87683219	8	86670990 - 86670991	370100	357651	rs748993388	NC_000008.11:86670990::A
NM_006946.3(SPTBN2):c.1596_1634del (p.Glu532_Met544del)	SPTBN2		not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000448482	11	66475006 - 66475044	11	66707535 - 66707573	448482	441474	rs1554985851	NC_000011.10:66707534:TCCATGAGGTAGAGCAGGTCCTGGAACACCTTCTGCAGCTCCA:TCCA
NM_006946.3(SPTBN2):c.758T>C (p.Leu253Pro)	SPTBN2	L253P		Pathogenic(Last reviewed: Sep 15, 2010)	no assertion criteria provided	VCV000005275	11	66481116	11	66713645	5275	20314	rs121918306	NC_000011.10:66713644:A:G
NM_006269.2(RP1):c.2280_2284TAAAT[1] (p.Leu762fs)	RP1		Retinitis pigmentosa 1|Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000005966	8	55538722 - 55538726	8	54626162 - 54626166	5966	21005	rs869320726	NC_000008.11:54626161:TAAATTAAAT:TAAAT
GRCh37/hg19 11q13.4(chr11:71154800-71157788)x1	DHCR7		See cases	Pathogenic	no assertion criteria provided	VCV000394257	11	71154800 - 71157788			394257	381150		
NM_014425.5(INVS):c.2695C>T (p.Arg899Ter)	INVS	R899*, R573*, R803*	Infantile nephronophthisis|Nephronophthisis	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011962	9	103055234	9	100292952	11962	27001	rs200844390	NC_000009.12:100292951:C:T
NC_000011.10:g.(?_71441217)_(71441450_?)del	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000831165	11	71152263 - 71152496			831165	820413		
NC_000011.10:g.(?_71441217)_(71444962_?)del	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000830646	11	71152263 - 71156008			830646	820414		
NM_001360.3(DHCR7):c.1076_1077dup (p.Leu360fs)	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000813485	11	71146771 - 71146772	11	71435725 - 71435726	813485	801706		NC_000011.10:71435725:GT:GTGT
NM_001360.3(DHCR7):c.355del (p.His119fs)	DHCR7	H119fs	Smith-Lemli-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000813425	11	71153366	11	71442320	813425	801709		NC_000011.10:71442319:GG:G
NM_001360.3(DHCR7):c.626+2dup	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000813424	11	71152270 - 71152271	11	71441224 - 71441225	813424	801708		NC_000011.10:71441224:A:AA
NM_001360.3(DHCR7):c.696G>A (p.Trp232Ter)	DHCR7	W232*	Smith-Lemli-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000813423	11	71150060	11	71439014	813423	801707		NC_000011.10:71439013:C:T
NM_001360.2(DHCR7):c.1A>C (p.Met1Leu)	DHCR7	M1L	Smith-Lemli-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000694691	11	71155998	11	71444952	694691	682818		NC_000011.10:71444951:T:G
NM_001360.2(DHCR7):c.412+3A>T	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000030278	11	71153306	11	71442260	30278	39234	rs786200926	NC_000011.10:71442259:T:A
DHCR7, TRP37TER	DHCR7	W37*	Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000006786					6786	21825		
DHCR7, 1-BP INS, 586T	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000006779					6779	21818		
DHCR7, 1-BP INS, 505C	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000006778					6778	21817		
DHCR7, 96-BP DEL	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000006777					6777	21816		
NM_054012.4(ASS1):c.349G>A (p.Gly117Ser)	ASS1	G117S	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556029	9	133333962	9	130458575	556029	545115	rs770944877	NC_000009.12:130458574:G:A
NM_054012.4(ASS1):c.814C>T (p.Arg272Cys)	ASS1	R272C	Citrullinemia type I	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371132	9	133355812	9	130480425	371132	357781	rs762387914	NC_000009.12:130480424:C:T
NM_054012.4(ASS1):c.571G>A (p.Glu191Lys)	ASS1	E191K	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208153	9	133346876	9	130471489	208153	204411	rs777828000	NC_000009.12:130471488:G:A
NM_054012.4(ASS1):c.256C>T (p.Arg86Cys)	ASS1	R86C	Citrullinemia type I	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006332	9	133333869	9	130458482	6332	21371	rs121908644	NC_000009.12:130458481:C:T
NM_006019.4(TCIRG1):c.1674-1G>A	TCIRG1		|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189246	11	67816547	11	68049080	189246	187118	rs139617644	NC_000011.10:68049079:G:A
GRCh37/hg19 6q23.3(chr6:135711485-135735779)x1	AHI1		not provided	Pathogenic(Last reviewed: Jun 29, 2017)	no assertion criteria provided	VCV000689022	6	135711485 - 135735779			689022	676614		
GRCh37/hg19 6q23.3(chr6:135710693-135735779)x1	AHI1		not provided	Pathogenic(Last reviewed: Sep 24, 2018)	no assertion criteria provided	VCV000687865	6	135710693 - 135735779			687865	675457		
GRCh37/hg19 6q23.3(chr6:135721284-135730984)x1	AHI1		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000687855	6	135721284 - 135730984			687855	675447		
GRCh37/hg19 6q23.3(chr6:135721284-135730984)x1	AHI1		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000687854	6	135721284 - 135730984			687854	675446		
GRCh37/hg19 6q23.3(chr6:135711485-135735779)x1	AHI1		not provided	Pathogenic(Last reviewed: Mar 8, 2018)	no assertion criteria provided	VCV000685821	6	135711485 - 135735779			685821	673413		
NM_001134831.2(AHI1):c.1070C>G (p.Ser357Ter)	AHI1	S357*	not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000620264	6	135778713	6	135457575	620264	611645	rs1562219266	NC_000006.12:135457574:G:C
NM_001134831.2(AHI1):c.1235dup (p.Leu413fs)	AHI1		not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000592999	6	135776980 - 135776981	6	135455842 - 135455843	592999	584063	rs772289223	NC_000006.12:135455842:T:TT
NM_001134831.2(AHI1):c.2609G>A (p.Trp870Ter)	AHI1	W870*	not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000393224	6	135749781	6	135428643	393224	368349	rs1057524843	NC_000006.12:135428642:C:T
NM_001134831.2(AHI1):c.2493-2A>G	AHI1		not provided	Pathogenic(Last reviewed: Mar 14, 2015)	criteria provided, single submitter	VCV000265309	6	135749899	6	135428761	265309	259835	rs886039465	NC_000006.12:135428760:T:C
NM_001134831.2(AHI1):c.2742del (p.Leu915fs)	AHI1	L915fs	Joubert syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802271	6	135748327	6	135427189	802271	790589		NC_000006.12:135427188:AA:A
NM_001134831.2(AHI1):c.1912+5G>T	AHI1		Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427859	6	135763715	6	135442577	427859	418821	rs1554347012	NC_000006.12:135442576:C:A
NM_001134831.2(AHI1):c.2598_2604del (p.Ile866fs)	AHI1	I866fs	Joubert syndrome 3	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156383	6	135749786 - 135749792	6	135428648 - 135428654	156383	166164	rs587783014	NC_000006.12:135428647:ATACACTATAC:ATAC
NM_001134831.2(AHI1):c.1626+4_1626+5insTTAC	AHI1		Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217550	6	135769423 - 135769424	6	135448285 - 135448286	217550	214248	rs863225148	NC_000006.12:135448285::GTAA
NM_001134831.2(AHI1):c.2705T>A (p.Val902Asp)	AHI1	V902D	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217549	6	135748364	6	135427226	217549	214230	rs368788993	NC_000006.12:135427225:A:T
NM_001134831.2(AHI1):c.2361G>T (p.Trp787Cys)	AHI1	W787C	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217547	6	135752358	6	135431220	217547	214233	rs863225146	NC_000006.12:135431219:C:A
NM_001134831.2(AHI1):c.2023G>A (p.Asp675Asn)	AHI1	D675N	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217546	6	135759526	6	135438388	217546	214242	rs863225145	NC_000006.12:135438387:C:T
NM_001134831.2(AHI1):c.1976A>T (p.Asp659Val)	AHI1	D659V	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217544	6	135759573	6	135438435	217544	214245	rs541041911	NC_000006.12:135438434:T:A
NM_001134831.2(AHI1):c.736A>T (p.Lys246Ter)	AHI1	K246*	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217542	6	135786965	6	135465827	217542	214257	rs863225142	NC_000006.12:135465826:T:A
NM_001134831.2(AHI1):c.1614del (p.Val539fs)	AHI1	V539fs	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217541	6	135769440	6	135448302	217541	214250	rs863225141	NC_000006.12:135448301:TTT:TT
NM_001134831.2(AHI1):c.2187_2196del (p.Met729fs)	AHI1	M729fs	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217540	6	135754235 - 135754244	6	135433097 - 135433106	217540	214236	rs863225140	NC_000006.12:135433096:ATCTTCTCTCATCT:ATCT
NM_001134831.2(AHI1):c.2297G>A (p.Gly766Glu)	AHI1	G766E	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217539	6	135752422	6	135431284	217539	214234	rs863225139	NC_000006.12:135431283:C:T
NM_001134831.2(AHI1):c.662C>G (p.Ser221Ter)	AHI1	S221*	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217538	6	135787039	6	135465901	217538	214258	rs863225138	NC_000006.12:135465900:G:C
NM_001134831.2(AHI1):c.2172del (p.Trp725fs)	AHI1	W725fs	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217537	6	135754259	6	135433121	217537	214238	rs755407014	NC_000006.12:135433120:T:
NM_001134831.2(AHI1):c.910dup (p.Thr304fs)	AHI1		Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217536	6	135784283 - 135784284	6	135463145 - 135463146	217536	214256	rs753874898	NC_000006.12:135463145:TTTTTTTT:TTTTTTTTT
NM_001134831.2(AHI1):c.2687A>G (p.His896Arg)	AHI1	H896R	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217532	6	135748382	6	135427244	217532	214231	rs863225135	NC_000006.12:135427243:T:C
NM_001134831.2(AHI1):c.1917T>A (p.Tyr639Ter)	AHI1	Y639*	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217531	6	135759632	6	135438494	217531	214246	rs764412921	NC_000006.12:135438493:A:T
NM_001134831.2(AHI1):c.1115A>G (p.Asp372Gly)	AHI1	D372G	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217529	6	135778668	6	135457530	217529	214255	rs863225133	NC_000006.12:135457529:T:C
NM_001134831.2(AHI1):c.2012C>T (p.Thr671Ile)	AHI1	T671I	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217528	6	135759537	6	135438399	217528	214243	rs772989270	NC_000006.12:135438398:G:A
NM_001134831.2(AHI1):c.1152-2A>G	AHI1		Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217527	6	135777066	6	135455928	217527	214254	rs753085250	NC_000006.12:135455927:T:C
NM_001134831.2(AHI1):c.1897_1898dup (p.Tyr634fs)	AHI1		Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217526	6	135763733 - 135763734	6	135442595 - 135442596	217526	214247	rs863225132	NC_000006.12:135442595:CC:CCCC
NM_001134831.2(AHI1):c.2495T>G (p.Leu832Ter)	AHI1	L832*	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217524	6	135749895	6	135428757	217524	214232	rs863225131	NC_000006.12:135428756:A:C
NM_001134831.2(AHI1):c.2036+1G>T	AHI1		Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217522	6	135759512	6	135438374	217522	214241	rs776093293	NC_000006.12:135438373:C:A
NM_001134831.2(AHI1):c.1484G>A (p.Arg495His)	AHI1	R495H	Joubert syndrome 3	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000030761	6	135769570	6	135448432	30761	39718	rs387907003	NC_000006.12:135448431:C:T
NM_001134831.2(AHI1):c.2368_2369insT (p.Asn790fs)	AHI1		Joubert syndrome 3	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000002016	6	135752350 - 135752351	6	135431212 - 135431213	2016	17055	rs387906270	NC_000006.12:135431212::A
NM_001134831.2(AHI1):c.1303C>T (p.Arg435Ter)	AHI1	R435*	Joubert syndrome 3	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002011	6	135776913	6	135455775	2011	17050	rs121434349	NC_000006.12:135455774:G:A
NM_006946.3(SPTBN2):c.1438C>T (p.Arg480Trp)	SPTBN2	R480W		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000064368	11	66475202	11	66707731	64368	75333	rs397514749	NC_000011.10:66707730:G:A
NM_001360.3(DHCR7):c.1325A>G (p.His442Arg)	DHCR7	H442R	Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000854086	11	71146524	11	71435478	854086	838975		NC_000011.10:71435477:T:C
NC_000011.10:g.(?_71443983)_(71444962_?)del	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000832024	11	71155029 - 71156008			832024	820415		
NM_001360.2(DHCR7):c.546G>A (p.Trp182Ter)	DHCR7	W182*	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000623647	11	71152353	11	71441307	623647	612484	rs1032242817	NC_000011.10:71441306:C:T
NM_001163817.2(DHCR7):c.1328G>A (p.Arg443His)	DHCR7	R443H	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000397519	11	71146521	11	71435475	397519	384408	rs781687341	NC_000011.10:71435474:C:T
NM_001360.2(DHCR7):c.1066del (p.His356fs)	DHCR7	H356fs	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370598	11	71146783	11	71435737	370598	358067	rs774291653	NC_000011.10:71435736:GG:G
NM_001360.2(DHCR7):c.744G>T (p.Trp248Cys)	DHCR7	W248C	Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Feb 14, 2000)	no assertion criteria provided	VCV000006782	11	71150012	11	71438966	6782	21821	rs104894212	NC_000011.10:71438965:C:A
NM_001134831.2(AHI1):c.1312dup (p.Asp438fs)	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000862509	6	135776903 - 135776904	6	135455765 - 135455766	862509	831593		NC_000006.12:135455765:C:CC
NM_001134831.2(AHI1):c.1840dup (p.Cys614fs)	AHI1		Joubert syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000861243	6	135763791 - 135763792	6	135442653 - 135442654	861243	831590		NC_000006.12:135442653:AAAAA:AAAAAA
NM_001134831.2(AHI1):c.910del (p.Thr304fs)	AHI1	T304fs	Joubert syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000851129	6	135784284	6	135463146	851129	831596		NC_000006.12:135463145:TTTTTTTT:TTTTTTT
NM_001134831.2(AHI1):c.3229_3235dup (p.Arg1079fs)	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000839079	6	135644392 - 135644393	6	135323254 - 135323255	839079	831580		NC_000006.12:135323254:GGATAATG:GGATAATGGATAATG
NM_001134831.2(AHI1):c.1889del (p.Ser630fs)	AHI1	S630fs	Joubert syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000837650	6	135763743	6	135442605	837650	831589		NC_000006.12:135442604:C:
NC_000006.12:g.(?_135358112)_(135358207_?)del	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000830948	6	135679250 - 135679345			830948	819664		
NM_001134831.2(AHI1):c.836del (p.Asp279fs)	AHI1	D279fs	Joubert syndrome	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000530888	6	135784358	6	135463220	530888	522028	rs1554214237	NC_000006.12:135463219:T:
NM_001134831.2(AHI1):c.1497_1498del (p.Tyr499_Tyr500delinsTer)	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000530887	6	135769556 - 135769557	6	135448418 - 135448419	530887	521727	rs905262279	NC_000006.12:135448417:AA:
NM_001134831.2(AHI1):c.1677dup (p.Pro560fs)	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000461742	6	135768247 - 135768248	6	135447109 - 135447110	461742	455964	rs1554350503	NC_000006.12:135447109:TTT:TTTT
NM_001134831.2(AHI1):c.1355del (p.Phe452fs)	AHI1	F452fs	Joubert syndrome	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000461740	6	135774564	6	135453426	461740	455966	rs1554208431	NC_000006.12:135453425:AAA:AA
Single allele	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000461739			6	135457583 - 135465286	461739	455758		
NC_000006.11:g.(?_135751020)_(135754394_?)del	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Sep 25, 2016)	criteria provided, single submitter	VCV000417415	6	135751020 - 135754394	6	135429882 - 135433256	417415	395169		
NM_000048.4(ASL):c.578G>A (p.Arg193Gln)	ASL	R193Q	Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372306	7	65551784	7	66086797	372306	359828	rs373697663	NC_000007.14:66086796:G:A
NM_001134831.2(AHI1):c.2623+1G>T	AHI1		Joubert syndrome 3|Joubert syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638504	6	135749766	6	135428628	638504	626308		NC_000006.12:135428627:C:A
NM_001134831.2(AHI1):c.1260G>A (p.Trp420Ter)	AHI1	W420*	Joubert syndrome 3	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217543	6	135776956	6	135455818	217543	214253	rs863225143	NC_000006.12:135455817:C:T
NM_001134831.2(AHI1):c.2156A>G (p.Asp719Gly)	AHI1	D719G	not provided|Joubert syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217530	6	135754275	6	135433137	217530	214239	rs863225134	NC_000006.12:135433136:T:C
NM_001134831.2(AHI1):c.1052G>T (p.Arg351Leu)	AHI1	R351L	Joubert syndrome 3	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000060535	6	135778731	6	135457593	60535	75116	rs397514726	NC_000006.12:135457592:C:A
NM_001134831.2(AHI1):c.1765C>T (p.Arg589Ter)	AHI1	R589*	not provided|Joubert syndrome 3	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000002014	6	135768160	6	135447022	2014	17053	rs267606641	NC_000006.12:135447021:G:A
NM_019098.4(CNGB3):c.1781+1del	CNGB3		not provided|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427707	8	87616320	8	86604092	427707	417090	rs1554607546	NC_000008.11:86604091:CC:C
NM_019098.4(CNGB3):c.1304C>T (p.Ser435Phe)	CNGB3	S435F	Achromatopsia 3	Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000005222	8	87644996	8	86632768	5222	20261	rs121918344	NC_000008.11:86632767:G:A
NM_152419.3(HGSNAT):c.493+1G>A	HGSNAT		Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001230	8	43014188	8	43159045	1230	16269	rs193066451	NC_000008.11:43159044:G:A
NM_000370.3(TTPA):c.744del (p.Glu249fs)	TTPA	E249fs	Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009136	8	63973904	8	63061345	9136	24175	rs397515377	NC_000008.11:63061344:TT:T
NM_001360.2(DHCR7):c.356A>T (p.His119Leu)	DHCR7	H119L	not provided|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000006780	11	71153365	11	71442319	6780	21819	rs28938174	NC_000011.10:71442318:T:A
NM_006415.4(SPTLC1):c.399T>G (p.Cys133Trp)	SPTLC1	C133W	Neuropathy hereditary sensory and autonomic type 1|Sensorimotor neuropathy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000004803	9	94842326	9	92080044	4803	19842	rs119482082	NC_000009.12:92080043:A:C
NM_194456.1(KRIT1):c.1807del (p.His603fs)	KRIT1	H365fs, H603fs, H555fs	not specified|Cerebral cavernous malformation|not provided	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265485	7	91843217	7	92213903	265485	259875	rs886039572	NC_000007.14:92213902:G:
NM_194456.1(KRIT1):c.1267C>T (p.Arg423Ter)	KRIT1	R423*, R375*, R185*	not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265216	7	91852280	7	92222966	265216	259877	rs886039402	NC_000007.14:92222965:G:A
NM_001134831.2(AHI1):c.2247dup (p.Leu750fs)	AHI1		Joubert syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000852023	6	135754183 - 135754184	6	135433045 - 135433046	852023	831587		NC_000006.12:135433045:T:TT
NM_001134831.2(AHI1):c.703dup (p.Arg235fs)	AHI1		Retinal dystrophy|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000847622	6	135786997 - 135786998	6	135465859 - 135465860	847622	831599		NC_000006.12:135465859:TTTTTT:TTTTTTT
NM_023110.2(FGFR1):c.1864C>T (p.Arg622Ter)	FGFR1	R622*, R529*, R533*, R612*, R618*, R620*, R653*, R531*	not provided|Hypogonadotropic hypogonadism 7 with or without anosmia|Delayed puberty|	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016282	8	38272410	8	38414892	16282	31321	rs121909628	NC_000008.11:38414891:G:A
NM_000035.4(ALDOB):c.178C>T (p.Arg60Ter)	ALDOB	R59*, R60*	Hereditary fructosuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000472	9	104192183	9	101429901	472	15511	rs118204429	NC_000009.12:101429900:G:A
NM_018238.4(AGK):c.390+1G>T	AGK		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000521660	7	141311088	7	141611288	521660	511702	rs777096695	NC_000007.14:141611287:G:T
NM_022970.3(FGFR2):c.868T>C (p.Trp290Arg)	FGFR2	W290R, W201R, W175R, W62R	Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013283	10	123279564	10	121520050	13283	28322	rs121918501	NC_000010.11:121520049:A:G
NM_000322.5(PRPH2):c.554T>C (p.Leu185Pro)	PRPH2	L185P	not provided|Leber congenital amaurosis 18|Retinal dystrophy|Retinitis pigmentosa 7, digenic|Patterned dystrophy of retinal pigment epithelium	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013165	6	42689519	6	42721781	13165	28204	rs121918563	NC_000006.12:42721780:A:G
NM_183050.4(BCKDHB):c.1006G>A (p.Gly336Ser)	BCKDHB	G336S, G266S	not provided|Maple syrup urine disease type 1B|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096562	6	80982906	6	80273189	96562	102455	rs398124560	NC_000006.12:80273188:G:A
NM_001134831.2(AHI1):c.2671C>T (p.Arg891Ter)	AHI1	R891*	Retinal dystrophy|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000858292	6	135748398	6	135427260	858292	831586		NC_000006.12:135427259:G:A
NM_001134831.2(AHI1):c.1516C>T (p.Arg506Ter)	AHI1	R506*	Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217534	6	135769538	6	135448400	217534	214251	rs371637724	NC_000006.12:135448399:G:A
NM_001134831.2(AHI1):c.985C>T (p.Arg329Ter)	AHI1	R329*	not provided|Retinal dystrophy|Joubert syndrome 3	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030760	6	135778798	6	135457660	30760	39717	rs201391050	NC_000006.12:135457659:G:A
NM_001134831.2(AHI1):c.1051C>T (p.Arg351Ter)	AHI1	R351*	Joubert syndrome|Joubert syndrome 3	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000002010	6	135778732	6	135457594	2010	17049	rs121434348	NC_000006.12:135457593:G:A
NM_019098.4(CNGB3):c.1432C>T (p.Arg478Ter)	CNGB3	R478*	Retinal dystrophy|Achromatopsia 3|Achromatopsia	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000427692	8	87641195	8	86628967	427692	417103	rs201320564	NC_000008.11:86628966:G:A
NM_005933.4(KMT2A):c.3464G>A (p.Cys1155Tyr)	KMT2A	C1155Y	not provided|Wiedemann-Steiner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372920	11	118348811	11	118478096	372920	359911	rs1057518074	NC_000011.10:118478095:G:A
NR_003051.3(RMRP):n.219A>G	RMRP		Metaphyseal chondrodysplasia, McKusick type|Anauxetic dysplasia	Pathogenic(Last reviewed: Dec 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580378	9	35657797	9	35657800	580378	563255	rs936059863	NC_000009.12:35657799:T:C
NM_000127.2(EXT1):c.1056+1G>A	EXT1		Multiple congenital exostosis	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000583370	8	118849346	8	117837107	583370	564605	rs886039354	NC_000008.11:117837106:C:T
NM_000127.2(EXT1):c.1418-2A>G	EXT1		Multiple congenital exostosis|Multiple exostoses type 1	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448898	8	118832035	8	117819796	448898	442479	rs1554578802	NC_000008.11:117819795:T:C
NM_000127.2(EXT1):c.1019G>T (p.Arg340Leu)	EXT1	R340L	Multiple congenital exostosis|Multiple exostoses type 1	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000002495	8	118849384	8	117837145	2495	17534	rs119103287	NC_000008.11:117837144:C:A
NM_138691.3(TMC1):c.100C>T (p.Arg34Ter)	TMC1	R34*	Deafness, autosomal recessive 7|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004103	9	75309494	9	72694578	4103	19142	rs121908073	NC_000009.12:72694577:C:T
NM_024596.5(MCPH1):c.321dup (p.Arg108fs)	MCPH1		not provided	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000523934	8	6289098 - 6289099	8	6431577 - 6431578	523934	514576	rs759663956	NC_000008.11:6431577:AAAAAAAAA:AAAAAAAAAA
NM_024596.5(MCPH1):c.313A>T (p.Lys105Ter)	MCPH1	K105*, K103*, K71*	not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000489240	8	6289099	8	6431578	489240	481824	rs1424203921	NC_000008.11:6431577:A:T
NM_024596.5(MCPH1):c.80C>G (p.Thr27Arg)	MCPH1	T27R, T25R	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021704	8	6266857	8	6409336	21704	34556	rs199422124	NC_000008.11:6409335:C:G
NM_024596.5(MCPH1):c.22+2_22+4del	MCPH1		Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000435838	8	6264212 - 6264214	8	6406691 - 6406693	435838	428850	rs1554471681	NC_000008.11:6406690:TGA:
NM_024596.5(MCPH1):c.1924_1925insCA (p.Arg642fs)	MCPH1		Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000435835	8	6312761 - 6312762	8	6455240 - 6455241	435835	428854	rs1554496609	NC_000008.11:6455240:A:ACA
NM_024596.5(MCPH1):c.1869_1870del (p.Ser623_Cys624insTer)	MCPH1		Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	VCV000158830	8	6312707 - 6312708	8	6455186 - 6455187	158830	168672	rs587783735	NC_000008.11:6455185:AT:
NM_024596.5(MCPH1):c.215C>T (p.Ser72Leu)	MCPH1	S72L, S38L, S70L	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030641	8	6272386	8	6414865	30641	39598	rs387906961	NC_000008.11:6414864:C:T
NM_024596.5(MCPH1):c.147C>G (p.His49Gln)	MCPH1	H49Q, H15Q, H47Q	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030640	8	6272318	8	6414797	30640	39597	rs1488084787	NC_000008.11:6414796:C:G
NM_024596.5(MCPH1):c.566dup (p.Asn189fs)	MCPH1		Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030639	8	6296599 - 6296600	8	6439078 - 6439079	30639	39596	rs753597039	NC_000008.11:6439078:AAAA:AAAAA
NM_024596.5(MCPH1):c.302C>G (p.Ser101Ter)	MCPH1	S101*, S67*, S99*	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000030642	8	6289088	8	6431567	30642	39599	rs755862917	NC_000008.11:6431566:C:G
NC_000008.10:g.(?_6264113)_(6296618_6299587)del	MCPH1		Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003456	8	6264113 - 6299587	8	6406592 - 6442066	3456	18495		
NM_033360.4(KRAS):c.*12A>G	KRAS	D153G	not provided|Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040465	12	25362838	12	25209904	40465	48935	rs104894360	NC_000012.12:25209903:T:C
NM_024596.5(MCPH1):c.74C>G (p.Ser25Ter)	MCPH1	S25*, S23*	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003454	8	6266851	8	6409330	3454	18493	rs121434305	NC_000008.11:6409329:C:G
NM_005609.4(PYGM):c.501dup (p.Asn168Ter)	PYGM		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496892	11	64525744 - 64525745	11	64758272 - 64758273	496892	488316	rs1555136390	NC_000011.10:64758272:AAAAA:AAAAAA
NM_005609.4(PYGM):c.2178-1G>A	PYGM		not provided	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000449668	11	64514831	11	64747359	449668	444843	rs143670942	NC_000011.10:64747358:C:T
NM_005609.4(PYGM):c.1466dup (p.Arg490fs)	PYGM		not provided	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000280234	11	64520596 - 64520597	11	64753124 - 64753125	280234	264625	rs886041476	NC_000011.10:64753124:GGGG:GGGGG
NM_005609.4(PYGM):c.2075_2076del (p.Thr692fs)	PYGM	T692fs, T604fs	Glycogen storage disease, type V	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802681	11	64517949 - 64517950	11	64750477 - 64750478	802681	791148		NC_000011.10:64750476:GG:
NM_005609.4(PYGM):c.661-601G>A	PYGM		McArdle disease, mild	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000002315	11	64523631	11	64756159	2315	17354		NC_000011.10:64756158:C:T
NM_005609.4(PYGM):c.682del (p.Asp228fs)	PYGM	D140fs, D228fs	Glycogen storage disease, type V	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000861525	11	64523009	11	64755537	861525	838701		NC_000011.10:64755536:C:
NM_005609.4(PYGM):c.1657G>T (p.Glu553Ter)	PYGM	E465*, E553*	Glycogen storage disease, type V	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000857820	11	64519507	11	64752035	857820	838697		NC_000011.10:64752034:C:A
NM_005609.4(PYGM):c.129_150del (p.Asp43fs)	PYGM	D43fs	Glycogen storage disease, type V	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000848029	11	64527221 - 64527242	11	64759749 - 64759770	848029	838704		NC_000011.10:64759748:TCGTGGGGTGGCCACATTGCGGTC:TC
NM_005609.4(PYGM):c.521dup (p.Trp175fs)	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000844539	11	64525724 - 64525725	11	64758252 - 64758253	844539	838702		NC_000011.10:64758252:CCCCC:CCCCCC
NM_005609.4(PYGM):c.1561A>T (p.Lys521Ter)	PYGM	K433*, K521*	Glycogen storage disease, type V	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000650465	11	64519934	11	64752462	650465	640252		NC_000011.10:64752461:T:A
NM_005609.4(PYGM):c.21_28dup (p.Lys10fs)	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000582100	11	64527342 - 64527343	11	64759870 - 64759871	582100	567410	rs770037766	NC_000011.10:64759870:TCTCTTGGTCT:TCTCTTGGTCTCTTGGTCT
NM_005609.4(PYGM):c.280C>T (p.Arg94Trp)	PYGM	R94W	Glycogen storage disease, type V	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000456518	11	64526140	11	64758668	456518	462106	rs370247862	NC_000011.10:64758667:G:A
NM_005609.4(PYGM):c.152_154ACT[2] (p.Tyr53del)	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000040043	11	64527211 - 64527213	11	64759739 - 64759741	40043	48555		NC_000011.10:64759738:AGTAGTAGT:AGTAGT
NM_005609.4(PYGM):c.152A>G (p.Asp51Gly)	PYGM	D51G	Glycogen storage disease, type V	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000040042	11	64527219	11	64759747	40042	48554	rs397514631	NC_000011.10:64759746:T:C
PYGM, 1-BP INS, A/8-BP DEL, CODON 387	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000002311					2311	17350		
NM_005609.4(PYGM):c.1621G>T (p.Glu541Ter)	PYGM	E540*, E541*, E453*	Glycogen storage disease, type V	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000002310	11	64519543	11	64752071	2310	17349	rs119103257	NC_000011.10:64752070:C:A
NM_005609.4(PYGM):c.1725del (p.Lys575fs)	PYGM	K487fs, K575fs	Glycogen storage disease, type V	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000002308	11	64519439	11	64751967	2308	17347	rs786200874	NC_000011.10:64751966:TTT:TT
NM_005609.4(PYGM):c.1187T>C (p.Leu396Pro)	PYGM	L396P, L308P	Glycogen storage disease, type V	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000002304	11	64521403	11	64753931	2304	17343	rs119103254	NC_000011.10:64753930:A:G
NM_005609.4(PYGM):c.1996C>G (p.Gln666Glu)	PYGM	Q665E, Q666E, Q578E	Glycogen storage disease, type V	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000002303	11	64518029	11	64750557	2303	17342	rs119103256	NC_000011.10:64750556:G:C
NM_005609.4(PYGM):c.1963G>A (p.Glu655Lys)	PYGM	E654K, E655K, E567K	Glycogen storage disease, type V	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000002302	11	64518803	11	64751331	2302	17341	rs119103253	NC_000011.10:64751330:C:T
NM_001360.2(DHCR7):c.453G>A (p.Trp151Ter)	DHCR7	W151*	Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000006784	11	71152446	11	71441400	6784	21823	rs104894213	NC_000011.10:71441399:C:T
NM_001360.2(DHCR7):c.730G>A (p.Gly244Arg)	DHCR7	G244R	Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006781	11	71150026	11	71438980	6781	21820	rs121909764	NC_000011.10:71438979:C:T
NM_005609.4(PYGM):c.1545_1546del (p.Leu516fs)	PYGM	L428fs, L516fs	Glycogen storage disease, type V	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000857352	11	64519949 - 64519950	11	64752477 - 64752478	857352	838698		NC_000011.10:64752476:GG:
NM_005609.4(PYGM):c.2380-1G>A	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000553507	11	64514281	11	64746809	553507	546093	rs1555133248	NC_000011.10:64746808:C:T
NM_005609.4(PYGM):c.1A>T (p.Met1Leu)	PYGM	M1L	Glycogen storage disease, type V	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000553271	11	64527370	11	64759898	553271	546123	rs267606993	NC_000011.10:64759897:T:A
NM_005609.4(PYGM):c.1A>C (p.Met1Leu)	PYGM	M1L	Glycogen storage disease, type V	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000156341	11	64527370	11	64759898	156341	166121	rs267606993	NC_000011.10:64759897:T:G
GRCh37/hg19 9p22.3(chr9:14757743-14830372)x1	FREM1		not provided	Pathogenic(Last reviewed: Jul 20, 2018)	no assertion criteria provided	VCV000686211	9	14757743 - 14830372			686211	673803		
NM_144966.5(FREM1):c.4941C>A (p.Tyr1647Ter)	FREM1	Y1647*, Y183*	not provided	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000597418	9	14770721	9	14770723	597418	588479	rs373880888	NC_000009.12:14770722:G:T
NM_144966.5(FREM1):c.3925del (p.Glu1309fs)	FREM1	E1309fs	not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000504423	9	14792797	9	14792799	504423	495417	rs773469926	NC_000009.12:14792798:CCC:CC
NM_144966.5(FREM1):c.3910G>T (p.Glu1304Ter)	FREM1	E1304*	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000430003	9	14792812	9	14792814	430003	421743	rs1131691724	NC_000009.12:14792813:C:A
FREM1, VAL209ILE	FREM1	V209I	Oculotrichoanal syndrome	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030765					30765	39722		
NM_001134831.2(AHI1):c.2492+1G>A	AHI1		not provided|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000661866	6	135751019	6	135429881	661866	651634		NC_000006.12:135429880:C:T
NM_001134831.2(AHI1):c.1328T>A (p.Val443Asp)	AHI1	V443D	Joubert syndrome 3|Typical Joubert syndrome MRI findings|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000002012	6	135776888	6	135455750	2012	17051	rs121434350	NC_000006.12:135455749:A:T
NM_014112.5(TRPS1):c.2794G>A (p.Ala932Thr)	TRPS1	A932T, A923T, A919T, A925T	Brachydactyly|Alopecia areata|Proportionate short stature|Pear-shaped nose|Trichorhinophalangeal dysplasia type I||Trichorhinophalangeal dysplasia type I	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374202	8	116430587	8	115418359	374202	360897	rs1057518972	NC_000008.11:115418358:C:T
NM_024596.5(MCPH1):c.1625T>G (p.Leu542Ter)	MCPH1	L542*, L540*, L494*, L508*	not provided|Primary autosomal recessive microcephaly 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586140	8	6302868	8	6445347	586140	577066	rs748011724	NC_000008.11:6445346:T:G
NC_000011.10:g.(?_64750356)_(64750603_?)del	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000831897	11	64517828 - 64518075			831897	820396		
NC_000011.10:g.(?_64750366)_(64750593_?)del	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000830781	11	64517838 - 64518065			830781	820397		
NM_005609.4(PYGM):c.13_14del (p.Leu5fs)	PYGM	L5fs	Glycogen storage disease, type V	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000371064	11	64527357 - 64527358	11	64759885 - 64759886	371064	358019	rs772194378	NC_000011.10:64759884:AG:
NM_144966.5(FREM1):c.4499A>T (p.Glu1500Val)	FREM1	E1500V, E36V	Trigonocephaly 2|not provided	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000030766	9	14776145	9	14776147	30766	39723	rs281875280	NC_000009.12:14776146:T:A
NM_144966.5(FREM1):c.2097_2100del (p.Lys699fs)	FREM1	K699fs	Oculotrichoanal syndrome	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030763	9	14824092 - 14824095	9	14824094 - 14824097	30763	39720		NC_000009.12:14824093:TAATT:T
NG_017005.2:g.64585_124811del	FREM1		Oculotrichoanal syndrome	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030762	9	14790424 - 14850650	9	14790426 - 14850652	30762	39719		
NM_144966.5(FREM1):c.2722del (p.Val908fs)	FREM1	V908fs	BNAR syndrome	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000001988	9	14812981	9	14812983	1988	17027		NC_000009.12:14812982:CC:C
NM_007327.4(GRIN1):c.1930G>A (p.Val644Met)	GRIN1	V644M, V665M	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000451906	9	140057108	9	137162656	451906	444452	rs1554770248	NC_000009.12:137162655:G:A
NM_007327.4(GRIN1):c.1955C>T (p.Ala652Val)	GRIN1	A652V, A673V	not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000424537	9	140057133	9	137162681	424537	407633	rs1064797027	NC_000009.12:137162680:C:T
NM_007327.4(GRIN1):c.1342del (p.Arg448fs)	GRIN1	R448fs, R469fs	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000807609	9	140055648	9	137161196	807609	798618		NC_000009.12:137161195:CC:C
NM_007327.4(GRIN1):c.649C>T (p.Arg217Trp)	GRIN1	R217W, R238W	NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS WITHOUT SEIZURES, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487505	9	140043539	9	137149087	487505	480556	rs200777850	NC_000009.12:137149086:C:T
NM_007327.4(GRIN1):c.2504T>C (p.Ile835Thr)	GRIN1	I835T, I856T	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433116	9	140058271	9	137163819	433116	426679	rs1554770659	NC_000009.12:137163818:T:C
NM_007327.4(GRIN1):c.1961T>G (p.Phe654Cys)	GRIN1	F654C, F675C	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000559643	9	140057139	9	137162687	559643	550363	rs1554770262	NC_000009.12:137162686:T:G
NM_007327.4(GRIN1):c.1858G>A (p.Gly620Arg)	GRIN1	G620R, G641R	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000487508	9	140056962	9	137162510	487508	480559	rs797045047	NC_000009.12:137162509:G:A
NM_007327.4(GRIN1):c.1666C>T (p.Gln556Ter)	GRIN1	Q556*, Q577*	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487506	9	140056657	9	137162205	487506	480557	rs1554770057	NC_000009.12:137162204:C:T
NM_007327.4(GRIN1):c.2449T>C (p.Phe817Leu)	GRIN1	F817L, F838L	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487504	9	140058216	9	137163764	487504	480555	rs1554770624	NC_000009.12:137163763:T:C
NM_007327.4(GRIN1):c.1950C>G (p.Asn650Lys)	GRIN1	N650K, N671K	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000487502	9	140057128	9	137162676	487502	480553	rs771610568	NC_000009.12:137162675:C:G
NM_007327.4(GRIN1):c.1854_1859dup (p.Ile619_Gly620dup)	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000397504	9	140056954 - 140056955	9	137162502 - 137162503	397504	384406	rs1554770185	NC_000009.12:137162502:CGGCATCGG:CGGCATCGGCATCGG
NM_007327.4(GRIN1):c.1670C>G (p.Pro557Arg)	GRIN1	P557R, P578R	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235846	9	140056661	9	137162209	235846	237500	rs878853143	NC_000009.12:137162208:C:G
NM_007327.4(GRIN1):c.1679_1681dup (p.Ser560dup)	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000029726	9	140056668 - 140056669	9	137162216 - 137162217	29726	38681	rs1554770064	NC_000009.12:137162216:AGCA:AGCAGCA
NM_007327.4(GRIN1):c.1656C>A (p.Asp552Glu)	GRIN1	D552E, D573E	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487501	9	140056647	9	137162195	487501	480552	rs1554770054	NC_000009.12:137162194:C:A
NM_007327.4(GRIN1):c.1656C>G (p.Asp552Glu)	GRIN1	D552E, D573E	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487500	9	140056647	9	137162195	487500	480551	rs1554770054	NC_000009.12:137162194:C:G
NM_007327.4(GRIN1):c.1984G>A (p.Glu662Lys)	GRIN1	E662K, E683K	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000029725	9	140057162	9	137162710	29725	38680	rs387906635	NC_000009.12:137162709:G:A
NM_144966.5(FREM1):c.4318G>A (p.Gly1440Ser)	FREM1	G1440S	not provided|BNAR syndrome	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000001990	9	14784492	9	14784494	1990	17029	rs121912610	NC_000009.12:14784493:C:T
NM_144966.5(FREM1):c.1945C>T (p.Arg649Trp)	FREM1	R649W	not provided|BNAR syndrome	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000001989	9	14824927	9	14824929	1989	17028	rs121912609	NC_000009.12:14824928:G:A
NM_006502.2(POLH):c.512del (p.Leu171fs)	POLH	L171fs, L47fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000520989	6	43565453	6	43597716	520989	511681	rs1554140189	NC_000006.12:43597715:TT:T
NM_005609.4(PYGM):c.395_408del (p.Leu132fs)	PYGM	L132fs	not provided|Glycogen storage disease, type V	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000591687	11	64525925 - 64525938	11	64758453 - 64758466	591687	582676	rs1565538121	NC_000011.10:64758452:GCCCCCGTTGCCCAGCCCC:GCCCC
NM_005609.4(PYGM):c.1239+1G>A	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000569514	11	64521350	11	64753878	569514	565956	rs759657964	NC_000011.10:64753877:C:T
NM_005609.4(PYGM):c.2392T>A (p.Trp798Arg)	PYGM	W798R, W710R	Glycogen storage disease, type V	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000526617	11	64514268	11	64746796	526617	526859	rs119103258	NC_000011.10:64746795:A:T
NM_005609.4(PYGM):c.1948C>T (p.Arg650Ter)	PYGM	R650*, R562*	Glycogen storage disease, type V	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000433147	11	64518818	11	64751346	433147	426717	rs114073621	NC_000011.10:64751345:G:A
PYGM, IVS14, G-A, +1	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000002305					2305	17344		
NM_005609.4(PYGM):c.1628A>C (p.Lys543Thr)	PYGM	K543T, K455T	not provided|Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002300	11	64519536	11	64752064	2300	17339	rs119103252	NC_000011.10:64752063:T:G
NM_007327.4(GRIN1):c.1923G>A (p.Met641Ile)	GRIN1	M641I, M662I	GRIN1-Related Disorder|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000403957	9	140057101	9	137162649	403957	397398	rs1060500046	NC_000009.12:137162648:G:A
NM_004408.4(DNM1):c.709C>T (p.Arg237Trp)	DNM1	R237W	not provided|Epileptic encephalopathy, early infantile, 31	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280148	9	130982480	9	128220201	280148	264472	rs760270633	NC_000009.12:128220200:C:T
NM_019098.4(CNGB3):c.1255G>T (p.Glu419Ter)	CNGB3	E419*	not provided|Achromatopsia 3	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427690	8	87645045	8	86632817	427690	417111	rs372302139	NC_000008.11:86632816:C:A
NM_019098.4(CNGB3):c.1119G>A (p.Trp373Ter)	CNGB3	W373*	Retinal dystrophy|not provided|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189190	8	87656038	8	86643810	189190	186765	rs786204762	NC_000008.11:86643809:C:T
NM_000190.4(HMBS):c.77G>A (p.Arg26His)	HMBS	R26H, R9H	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000001443	11	118959008	11	119088298	1443	16482	rs118204103	NC_000011.10:119088297:G:A
NM_004817.4(TJP2):c.1000C>T (p.Arg334Ter)	TJP2	R334*, R311*, R338*, R365*	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Sep 24, 2019)	no assertion criteria provided	VCV000694274	9	71840267	9	69225351	694274	682120		NC_000009.12:69225350:C:T
NM_004817.4(TJP2):c.2509C>T (p.Arg837Ter)	TJP2	R837*, R868*, R841*, R812*, R814*	not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000598358	9	71855006	9	69240090	598358	589419	rs746830415	NC_000009.12:69240089:C:T
NM_004817.4(TJP2):c.2353C>T (p.Gln785Ter)	TJP2	Q785*, Q760*, Q816*, Q762*, Q789*	not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000595122	9	71853703	9	69238787	595122	586184	rs1563948951	NC_000009.12:69238786:C:T
NM_004817.4(TJP2):c.1771C>T (p.Arg591Ter)	TJP2	R591*, R566*, R568*, R595*, R622*	not provided	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000595031	9	71849454	9	69234538	595031	586093	rs764379398	NC_000009.12:69234537:C:T
NM_004817.4(TJP2):c.84dup (p.Trp29fs)	TJP2		not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000593570	9	71827486 - 71827487	9	69212570 - 69212571	593570	584634	rs1563915664	NC_000009.12:69212570:A:AA
NM_004817.4(TJP2):c.1780+1G>T	TJP2		not provided	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000502536	9	71849464	9	69234548	502536	493960	rs1554664852	NC_000009.12:69234547:G:T
NM_004817.4(TJP2):c.1451del (p.Pro484fs)	TJP2	P484fs, P488fs, P515fs, P459fs, P461fs	not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000501704	9	71843023	9	69228107	501704	493128	rs1554662952	NC_000009.12:69228106:CCCCCC:CCCCC
NM_004817.4(TJP2):c.782del (p.Tyr261fs)	TJP2	Y238fs, Y261fs, Y265fs, Y292fs	not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000499233	9	71836242	9	69221326	499233	490657	rs771690686	NC_000009.12:69221325:A:
NM_004817.4(TJP2):c.1243del (p.Ser415fs)	TJP2	S392fs, S446fs, S419fs, S415fs	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000374295	9	71842710	9	69227794	374295	361198	rs1057518679	NC_000009.12:69227793:TTTT:TTT
NM_004817.4(TJP2):c.498dup (p.Arg167fs)	TJP2		not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000289946	9	71835952 - 71835953	9	69221036 - 69221037	289946	274183	rs781334233	NC_000009.12:69221036:GGGGGG:GGGGGGG
NM_004817.4(TJP2):c.1697T>A (p.Leu566Ter)	TJP2	L566*, L541*, L570*, L597*, L543*	not provided	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	VCV000282349	9	71849380	9	69234464	282349	266586	rs886042381	NC_000009.12:69234463:T:A
NC_000009.11:g.71705804_71974823invdup	TJP2		Deafness, autosomal dominant 51	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236063					236063	237628		
NC_000009.11:g.71704982_71840362dup	TJP2		Deafness, autosomal dominant 51	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236035	9	71704982 - 71840362	9	69090066 - 69225446	236035	237603		
NM_004817.4(TJP2):c.1885dup (p.Glu629fs)	TJP2		not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000844723	9	71851044 - 71851045	9	69236128 - 69236129	844723	836235		NC_000009.12:69236128:GGGG:GGGGG
NC_000009.12:g.69228098_69228114del	TJP2		not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000840186					840186	852208		
9q21.11 duplication	TJP2		Deafness, autosomal dominant 51	Pathogenic(Last reviewed: Nov 24, 2019)	no assertion criteria provided	VCV000813832					813832	802084		
NM_004817.4(TJP2):c.115-2A>C	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805845	9	71831253	9	69216337	805845	794162		NC_000009.12:69216336:A:C
NM_004817.4(TJP2):c.1234C>T (p.Arg412Ter)	TJP2	R389*, R412*, R416*, R443*	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805844	9	71842704	9	69227788	805844	794156		NC_000009.12:69227787:C:T
NM_004817.4(TJP2):c.2173C>T (p.Arg725Ter)	TJP2	R700*, R702*, R725*, R729*, R756*	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805843	9	71852046	9	69237130	805843	794159		NC_000009.12:69237129:C:T
NM_004817.4(TJP2):c.115-1G>A	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805842	9	71831254	9	69216338	805842	794163		NC_000009.12:69216337:G:A
NM_004817.4(TJP2):c.1292C>G (p.Ser431Ter)	TJP2	S408*, S431*, S435*, S462*	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805840	9	71842762	9	69227846	805840	794157		NC_000009.12:69227845:C:G
NM_004817.4(TJP2):c.2908C>T (p.Arg970Ter)	TJP2	R1001*, R945*, R947*, R970*, R974*	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805839	9	71864318	9	69249402	805839	794161		NC_000009.12:69249401:C:T
NM_004817.4(TJP2):c.2209G>A (p.Gly737Ser)	TJP2	G712S, G714S, G737S, G741S, G768S	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805838	9	71852823	9	69237907	805838	794160		NC_000009.12:69237906:G:A
NM_004817.4(TJP2):c.1672-1G>A	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000805837	9	71849354	9	69234438	805837	794164		NC_000009.12:69234437:G:A
NM_004817.4(TJP2):c.811_812CG[1] (p.Ala273fs)	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Nov 6, 2013)	no assertion criteria provided	VCV000438788	9	71836270 - 71836271	9	69221354 - 69221355	438788	432381	rs1554660803	NC_000009.12:69221353:GCGCG:GCG
NC_000009.11:g.(71833276_71835802)_(71855064_71861605)dup	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000397506	9	71833276 - 71861605	9	69218360 - 69246689	397506	384405		
NM_004817.4(TJP2):c.2438dup (p.Asn814fs)	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000219196	9	71854928 - 71854929	9	69240012 - 69240013	219196	217222	rs776869985	NC_000009.12:69240012:TTTTTTT:TTTTTTTT
NM_004817.4(TJP2):c.2668-1G>T	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000219195	9	71862927	9	69248011	219195	217221	rs864321695	NC_000009.12:69248010:G:T
NM_004817.3(TJP2):c.3408_3573del166 (p.Ser1136Argfs)	TJP2		Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000217498	9	71869122 - 71869287	9	69254206 - 69254371	217498	214139	rs1554669525	
NM_004817.4(TJP2):c.1361del (p.Ala454fs)	TJP2	A454fs, A458fs, A485fs, A431fs, A429fs	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139629	9	71842938	9	69228022	139629	143252	rs587777520	NC_000009.12:69228021:C:
NM_004817.4(TJP2):c.885del (p.Ser296fs)	TJP2	S273fs, S296fs, S300fs, S327fs	Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139628	9	71836342	9	69221426	139628	143251	rs587777519	NC_000009.12:69221425:CCCC:CCC
NM_004817.4(TJP2):c.143T>C (p.Val48Ala)	TJP2	V48A, V52A, V79A, V25A	Hypercholanemia, familial	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000002907	9	71831283	9	69216367	2907	17946	rs121918299	NC_000009.12:69216366:T:C
NM_004817.4(TJP2):c.570_574dup (p.Ser192fs)	TJP2		Progressive familial intrahepatic cholestasis 4|not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000280808	9	71836028 - 71836029	9	69221112 - 69221113	280808	264337	rs886041948	NC_000009.12:69221112:ACCTCA:ACCTCACCTCA
NM_004817.4(TJP2):c.817del (p.Ala273fs)	TJP2	A250fs, A277fs, A304fs, A273fs	not provided|Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000219197	9	71836274	9	69221358	219197	217223	rs864321697	NC_000009.12:69221357:GGGG:GGG
NM_004817.4(TJP2):c.1992-2A>G	TJP2		not provided|Progressive familial intrahepatic cholestasis 4	Pathogenic(Last reviewed: Oct 22, 2014)	criteria provided, single submitter	VCV000139630	9	71851863	9	69236947	139630	143253	rs587777521	NC_000009.12:69236946:A:G
NM_004817.4(TJP2):c.766_769del (p.Ala256fs)	TJP2	A260fs, A287fs, A233fs, A256fs	Progressive familial intrahepatic cholestasis 4|not provided	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000139627	9	71836226 - 71836229	9	69221310 - 69221313	139627	143250	rs587777518	NC_000009.12:69221309:GCCT:
NM_000287.4(PEX6):c.1947del (p.Ile650fs)	PEX6	I562fs, I650fs	not provided|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 4B	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495796	6	42934534	6	42966796	495796	487200	rs267608227	NC_000006.12:42966795:CC:C
NM_004064.5(CDKN1B):c.269dup (p.Pro91fs)	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000857540	12	12871041 - 12871042	12	12718107 - 12718108	857540	839393		NC_000012.12:12718107:G:GG
NM_004064.5(CDKN1B):c.229_238dup (p.Glu80fs)	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000854005	12	12870997 - 12870998	12	12718063 - 12718064	854005	839390		NC_000012.12:12718063:GTGGCAAGAGGTGG:GTGGCAAGAGGTGGCAAGAGGTGG
NM_004064.5(CDKN1B):c.58C>T (p.Gln20Ter)	CDKN1B	Q20*	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000843386	12	12870831	12	12717897	843386	839385		NC_000012.12:12717896:C:T
NC_000012.12:g.(?_12717830)_(12718956_?)del	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000832716	12	12870764 - 12871890			832716	820455		
NC_000012.12:g.(?_12717384)_(12718946_?)del	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000831994	12	12870318 - 12871880			831994	820454		
NM_004064.5(CDKN1B):c.320del (p.Gln107fs)	CDKN1B	Q107fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000823199	12	12871093	12	12718159	823199	811139		NC_000012.12:12718158:A:
NM_004064.5(CDKN1B):c.310C>T (p.Gln104Ter)	CDKN1B	Q104*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000822910	12	12871083	12	12718149	822910	811138		NC_000012.12:12718148:C:T
NM_004064.5(CDKN1B):c.178dup (p.Trp60fs)	CDKN1B		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000820078	12	12870950 - 12870951	12	12718016 - 12718017	820078	811128		NC_000012.12:12718016:T:TT
NM_004064.4(CDKN1B):c.215del (p.Gly72fs)	CDKN1B	G72fs	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000661423	12	12870986	12	12718052	661423	640681		NC_000012.12:12718051:GGG:GG
NM_004064.4(CDKN1B):c.251T>A (p.Leu84Ter)	CDKN1B	L84*	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000657339	12	12871024	12	12718090	657339	640684		NC_000012.12:12718089:T:A
NM_004064.4(CDKN1B):c.217A>T (p.Lys73Ter)	CDKN1B	K73*	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000639545	12	12870990	12	12718056	639545	640683		NC_000012.12:12718055:A:T
NM_004064.4(CDKN1B):c.285dup (p.Lys96fs)	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000536843	12	12871052 - 12871053	12	12718118 - 12718119	536843	526718	rs1555085575	NC_000012.12:12718118:CCCCCC:CCCCCCC
NM_004064.4(CDKN1B):c.267C>G (p.Tyr89Ter)	CDKN1B	Y89*	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000469010	12	12871040	12	12718106	469010	462255	rs532903617	NC_000012.12:12718105:C:G
NM_004064.4(CDKN1B):c.49_52del (p.Asp17fs)	CDKN1B	D17fs	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000404266	12	12870821 - 12870824	12	12717887 - 12717890	404266	398866	rs1060500186	NC_000012.12:12717886:GGACG:G
NM_004064.4(CDKN1B):c.372_373CT[1] (p.Asn124_Ser125insTer)	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000183395	12	12871145 - 12871146	12	12718211 - 12718212	183395	181499	rs786201011	NC_000012.12:12718210:CTCT:CT
NM_004064.4(CDKN1B):c.206C>T (p.Pro69Leu)	CDKN1B	P69L	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000183393	12	12870979	12	12718045	183393	181497	rs777354267	NC_000012.12:12718044:C:T
NM_004064.4(CDKN1B):c.59_77dup (p.Ser27fs)	CDKN1B		Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000183391	12	12870830 - 12870831	12	12717896 - 12717897	183391	181495	rs786201007	NC_000012.12:12717896:CAGGCGGAGCACCCCAAGCC:CAGGCGGAGCACCCCAAGCCAGGCGGAGCACCCCAAGCC
NM_004064.4(CDKN1B):c.227G>A (p.Trp76Ter)	CDKN1B	W76*	Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000008823	12	12871000	12	12718066	8823	23862	rs121917832	NC_000012.12:12718065:G:A
NM_017547.4(FOXRED1):c.1054C>T (p.Arg352Trp)	FOXRED1	R352W	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19|Inborn genetic diseases	Pathogenic(Last reviewed: May 13, 2017)	criteria provided, single submitter	VCV000031048	11	126146371	11	126276476	31048	40005	rs387907087	NC_000011.10:126276475:C:T
NM_001540.5(HSPB1):c.250G>C (p.Gly84Arg)	HSPB1	G84R	|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220419	7	75932279	7	76302962	220419	221739	rs770272088	NC_000007.14:76302961:G:C
NM_000543.5(SMPD1):c.1533del (p.His511fs)	SMPD1	H204fs, H510fs, H467fs, H511fs	not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000594223	11	6415474	11	6394244	594223	585286	rs1564927308	NC_000011.10:6394243:C:
NM_000543.5(SMPD1):c.1630del (p.Thr544fs)	SMPD1	T544fs, T543fs, T237fs, T500fs	not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000592260	11	6415569	11	6394339	592260	583298	rs770962157	NC_000011.10:6394338:AAA:AA
NM_000543.5(SMPD1):c.564del (p.Lys189fs)	SMPD1	K188fs, K189fs	not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000496857	11	6412854	11	6391624	496857	488281	rs756366019	NC_000011.10:6391623:CCCCCC:CCCCC
NM_000543.5(SMPD1):c.1117C>T (p.Pro373Ser)	SMPD1	P373S, P66S, P372S	not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000496822	11	6414471	11	6393241	496822	488246	rs1342372980	NC_000011.10:6393240:C:T
NM_000543.5(SMPD1):c.1264-1G>A	SMPD1		not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000379505	11	6414846	11	6393616	379505	371519	rs1057516454	NC_000011.10:6393615:G:A
NM_000543.5(SMPD1):c.558_559insT (p.Pro187fs)	SMPD1		not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000195089	11	6412853 - 6412854	11	6391623 - 6391624	195089	192250	rs1554934241	NC_000011.10:6391623::T
NM_000543.5(SMPD1):c.416T>C (p.Leu139Pro)	SMPD1	L139P, L138P	Sphingomyelin/cholesterol lipidosis	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000203424	11	6412711	11	6391481	203424	199815	rs797044797	NC_000011.10:6391480:T:C
NM_000543.5(SMPD1):c.1675_1676del (p.Val559fs)	SMPD1	V558fs, V559fs, V252fs, V515fs	not specified	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000633426	11	6415616 - 6415617	11	6394386 - 6394387	633426	621365	rs759389193	NC_000011.10:6394385:GT:
NM_000543.5(SMPD1):c.1734G>C (p.Lys578Asn)	SMPD1	K578N, K271N, K577N, K534N	Sphingomyelin/cholesterol lipidosis	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000203428	11	6415675	11	6394445	203428	199820	rs747342458	NC_000011.10:6394444:G:C
NM_000543.5(SMPD1):c.1076C>A (p.Ala359Asp)	SMPD1	A359D, A358D, P39T	Sphingomyelin/cholesterol lipidosis	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000203427	11	6413371	11	6392141	203427	199818	rs797044800	NC_000011.10:6392140:C:A
NM_000543.5(SMPD1):c.1154A>G (p.Asn385Ser)	SMPD1	N383S, N385S, N384S, N78S	Niemann-Pick disease, type B	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000002988	11	6414508	11	6393278	2988	18027	rs120074123	NC_000011.10:6393277:A:G
NM_000543.5(SMPD1):c.1314C>A (p.Ser438Arg)	SMPD1	S436R, S438R, S131R, S437R, S394R	Niemann-Pick disease, type B	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000002983	11	6414897	11	6393667	2983	18022	rs267607073	NC_000011.10:6393666:C:A
NM_004183.4(BEST1):c.920C>T (p.Thr307Ile)	BEST1	T307I, P375S, T247I, T201I	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099782	11	61727022	11	61959550	99782	105671	rs281865269	NC_000011.10:61959549:C:T
NM_000543.5(SMPD1):c.564dup (p.Lys189fs)	SMPD1		not specified	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000632992	11	6412853 - 6412854	11	6391623 - 6391624	632992	621363	rs756366019	NC_000011.10:6391623:CCCCCC:CCCCCCC
NM_000195.5(HPS1):c.1189del (p.Gln397fs)	HPS1	Q241fs, Q310fs, Q364fs, Q274fs, Q277fs, Q397fs, Q73fs	not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021091	10	100185444	10	98425687	21091	33943	rs281865084	NC_000010.11:98425686:GGG:GG
NM_000195.5(HPS1):c.1472_1487dup (p.His497fs)	HPS1		not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005277	10	100183554 - 100183555	10	98423797 - 98423798	5277	20316	rs281865163	NC_000010.11:98423797:GGGCCTCCCCTGCTGGGGGC:GGGCCTCCCCTGCTGGGGGCCTCCCCTGCTGGGGGC
NM_138361.5(LRSAM1):c.2104_2133dup (p.Pro702_Gln711dup)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Jun 29, 2018)	no assertion criteria provided	VCV000585203	9	130265104 - 130265105	9	127502825 - 127502826	585203	576252	rs1564287871	NC_000009.12:127502825:GCCAGCCACTGCGCACCTGCCCGCTGTGCCGCCAG:GCCAGCCACTGCGCACCTGCCCGCTGTGCCGCCAGCCACTGCGCACCTGCCCGCTGTGCCGCCAG
NM_001134831.2(AHI1):c.1626+1G>A	AHI1		Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217535	6	135769427	6	135448289	217535	214249	rs863225137	NC_000006.12:135448288:C:T
NM_001134831.2(AHI1):c.2098_2099dup (p.Tyr701fs)	AHI1		Joubert syndrome 3|not provided|Joubert syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217533	6	135754331 - 135754332	6	135433193 - 135433194	217533	214240	rs863225136	NC_000006.12:135433193:ACA:ACACA
NM_001134831.2(AHI1):c.1861G>T (p.Gly621Ter)	AHI1	G621*	not provided|Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210113	6	135763771	6	135442633	210113	207326	rs797045223	NC_000006.12:135442632:C:A
NM_018972.4(GDAP1):c.458C>T (p.Pro153Leu)	GDAP1	P153L, P44L, P85L	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406135	8	75272519	8	74360284	406135	396265	rs538412810	NC_000008.11:74360283:C:T
NM_054012.4(ASS1):c.40G>A (p.Gly14Ser)	ASS1	G14S	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006324	9	133327655	9	130452268	6324	21363	rs121908636	NC_000009.12:130452267:G:A
NM_138361.5(LRSAM1):c.1815del (p.Asp607fs)	LRSAM1	D607fs, D580fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000859441	9	130258359	9	127496080	859441	835449		NC_000009.12:127496079:A:
NM_001190723.3(LRSAM1):c.1423-1517_1423-1516del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000645695	9	130253562 - 130253563	9	127491283 - 127491284	645695	637661		NC_000009.12:127491282:AGAG:AG
NM_138361.5(LRSAM1):c.1957dup (p.Gln653fs)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000639489	9	130263327 - 130263328	9	127501048 - 127501049	639489	637668		NC_000009.12:127501048:CCCCCC:CCCCCCC
NM_138361.5(LRSAM1):c.1694del (p.Leu565fs)	LRSAM1	L538fs, L565fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000577820	9	130257693	9	127495414	577820	568465	rs749012928	NC_000009.12:127495413:T:
NM_138361.5(LRSAM1):c.1914G>A (p.Glu638=)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 26, 2010)	no assertion criteria provided	VCV000030859	9	130263290	9	127501011	30859	39816	rs387907032	NC_000009.12:127501010:G:A
NM_138425.4(C12orf57):c.1A>G (p.Met1Val)	C12orf57	M1V	Temtamy syndrome|not provided|Global developmental delay|Corpus callosum abnormalities|Seizures|Colobomatous microphthalmia	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041942	12	7053285	12	6944122	41942	51108	rs587776954	NC_000012.12:6944121:A:G
NM_138361.5(LRSAM1):c.636C>G (p.Tyr212Ter)	LRSAM1	Y212*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000540003	9	130236096	9	127473817	540003	524474	rs1345228128	NC_000009.12:127473816:C:G
NM_138361.5(LRSAM1):c.1279C>T (p.Arg427Ter)	LRSAM1	R427*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000241836	9	130249974	9	127487695	241836	240444	rs138226428	NC_000009.12:127487694:C:T
NM_000543.5(SMPD1):c.1122C>G (p.Tyr374Ter)	SMPD1	Y373*, Y374*, Y67*	Niemann-Pick disease, type A|Niemann-Pick disease, type B	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000857473	11	6414476	11	6393246	857473	838670		NC_000011.10:6393245:C:G
NM_000543.5(SMPD1):c.1311G>A (p.Trp437Ter)	SMPD1	W130*, W437*, W393*, W436*	Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000837822	11	6414894	11	6393664	837822	838671		NC_000011.10:6393663:G:A
NM_000543.5(SMPD1):c.1252C>T (p.Arg418Ter)	SMPD1	R417*, R418*, R111*	Niemann-Pick disease, type A	Pathogenic	criteria provided, single submitter	VCV000813480	11	6414606	11	6393376	813480	801699		NC_000011.10:6393375:C:T
NM_000543.5(SMPD1):c.766dup (p.Leu256fs)	SMPD1		Niemann-Pick disease, type A	Pathogenic	criteria provided, single submitter	VCV000813477	11	6413057 - 6413058	11	6391827 - 6391828	813477	801696		NC_000011.10:6391827:CCCC:CCCCC
NM_000543.5(SMPD1):c.107_116delinsCGC (p.Val36fs)	SMPD1		Niemann-Pick disease, type A	Pathogenic	criteria provided, single submitter	VCV000813474	11	6411935 - 6411944	11	6390705 - 6390714	813474	801693		NC_000011.10:6390704:TGCTGGCGCT:CGC
NM_000543.5(SMPD1):c.106dup (p.Val36fs)	SMPD1		Niemann-Pick disease, type A	Pathogenic	criteria provided, single submitter	VCV000813473	11	6411932 - 6411933	11	6390702 - 6390703	813473	801692		NC_000011.10:6390702:GG:GGG
NM_000543.5(SMPD1):c.1382_1383del (p.His461fs)	SMPD1	H154fs, H461fs, H460fs, H417fs	Niemann-Pick disease, type A	Pathogenic	criteria provided, single submitter	VCV000813421	11	6415167 - 6415168	11	6393937 - 6393938	813421	801701		NC_000011.10:6393936:AT:
NM_000543.5(SMPD1):c.1108dup (p.Ala370fs)	SMPD1		Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000640937	11	6414461 - 6414462	11	6393231 - 6393232	640937	640228		NC_000011.10:6393231:G:GG
NM_000543.5(SMPD1):c.7del (p.Arg3fs)	SMPD1	R3fs	Niemann-Pick disease, type A	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000553962	11	6411832	11	6390602	553962	546332	rs281860663	NC_000011.10:6390601:CCCC:CCC
NM_000543.5(SMPD1):c.1498T>A (p.Tyr500Asn)	SMPD1	C506*, Y499N, Y500N, Y193N, Y456N	Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225626	11	6415439	11	6394209	225626	227459	rs771336819	NC_000011.10:6394208:T:A
NM_000543.5(SMPD1):c.1673T>C (p.Leu558Pro)	SMPD1	L557P, L558P, L251P, L514P	Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225624	11	6415614	11	6394384	225624	227460	rs875989836	NC_000011.10:6394383:T:C
NM_000543.5(SMPD1):c.565_566insC (p.Lys189fs)	SMPD1		Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225623	11	6412860 - 6412861	11	6391630 - 6391631	225623	227455	rs875989835	NC_000011.10:6391630::C
NM_000543.5(SMPD1):c.1491_1503del (p.Gly496_Tyr497insTer)	SMPD1	T504fs	Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225622	11	6415431 - 6415443	11	6394201 - 6394213	225622	227458	rs875989834	NC_000011.10:6394200:ACCGTGTGTACCAA:A
NM_000543.5(SMPD1):c.521_522insT (p.Ser175fs)	SMPD1		Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225621	11	6412816 - 6412817	11	6391586 - 6391587	225621	227454	rs875989833	NC_000011.10:6391586::T
NM_000543.5(SMPD1):c.795del (p.Leu266fs)	SMPD1	L265fs, L266fs	Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225620	11	6413088	11	6391858	225620	227456	rs875989832	NC_000011.10:6391857:GGG:GG
NM_000543.5(SMPD1):c.874C>A (p.Gln292Lys)	SMPD1	Q292K, Q291K	Sphingomyelin/cholesterol lipidosis	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000203426	11	6413169	11	6391939	203426	199841	rs797044799	NC_000011.10:6391938:C:A
NM_000543.5(SMPD1):c.1406A>C (p.Tyr469Ser)	SMPD1	Y467S, Y468S, Y469S, Y162S, Y425S	Niemann-Pick disease, type A	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000002996	11	6415191	11	6393961	2996	18035	rs267607074	NC_000011.10:6393960:A:C
NM_000543.5(SMPD1):c.730G>A (p.Gly244Arg)	SMPD1	G242R, G244R, G243R	not provided|Niemann-Pick disease, type B	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000002987	11	6413025	11	6391795	2987	18026	rs120074122	NC_000011.10:6391794:G:A
SMPD1, 2-BP DEL, LEU178FS	SMPD1		Niemann-Pick disease, type A	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000002985					2985	18024		
NM_000543.5(SMPD1):c.788T>A (p.Leu263Ter)	SMPD1	L261*, L263*, L262*	Niemann-Pick disease, type A	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000002984	11	6413083	11	6391853	2984	18023	rs120074120	NC_000011.10:6391852:T:A
NM_138361.5(LRSAM1):c.2081G>A (p.Cys694Tyr)	LRSAM1	C694Y, C667Y	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 8, 2016)	no assertion criteria provided	VCV000268046	9	130265087	9	127502808	268046	263456	rs886041051	NC_000009.12:127502807:G:A
NM_024649.5(BBS1):c.436C>T (p.Arg146Ter)	BBS1	R146*	Bardet-Biedl syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188752	11	66283014	11	66515543	188752	186836	rs786204444	NC_000011.10:66515542:C:T
NM_032634.4(PIGO):c.1355_1356del (p.Ala452fs)	PIGO	A452fs	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000498812	9	35092528 - 35092529	9	35092531 - 35092532	498812	490236	rs1554672911	NC_000009.12:35092530:CGC:C
NM_000255.4(MMUT):c.1898T>G (p.Val633Gly)	MMUT	V633G	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000449393	6	49407977	6	49440264	449393	443970	rs200055428	NC_000006.12:49440263:A:C
NM_000255.4(MMUT):c.1599T>A (p.Cys533Ter)	MMUT	C533*	not provided	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000281332	6	49412429	6	49444716	281332	265569	rs886042128	NC_000006.12:49444715:A:T
NM_000255.4(MMUT):c.1065_1068dup (p.Ser357fs)	MMUT		not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000280817	6	49421312 - 49421313	6	49453599 - 49453600	280817	264269	rs886041957	NC_000006.12:49453599:CCATCCA:CCATCCATCCA
NM_000255.4(MMUT):c.842T>C (p.Leu281Ser)	MMUT	L281S	not provided	Pathogenic(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	VCV000203858	6	49423862	6	49456149	203858	200118	rs796052007	NC_000006.12:49456148:A:G
NM_000255.4(MMUT):c.1885A>G (p.Arg629Gly)	MMUT	R629G	not provided	Pathogenic(Last reviewed: Mar 12, 2014)	criteria provided, single submitter	VCV000203851	6	49407990	6	49440277	203851	200108	rs796052004	NC_000006.12:49440276:T:C
NM_000255.4(MMUT):c.280G>A (p.Gly94Arg)	MMUT	G94R	not provided	Pathogenic(Last reviewed: Dec 4, 2013)	criteria provided, single submitter	VCV000167312	6	49426900	6	49459187	167312	177846	rs727504022	NC_000006.12:49459186:C:T
NM_000255.4(MMUT):c.1445-2A>G	MMUT		not provided	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	VCV000092679	6	49415500	6	49447787	92679	98586	rs398123276	NC_000006.12:49447786:T:C
NM_032634.4(PIGO):c.590del (p.Pro197fs)	PIGO	P197fs	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000851969	9	35094278	9	35094281	851969	836127		NC_000009.12:35094280:GGG:GG
NM_032634.4(PIGO):c.1187del (p.Leu396fs)	PIGO	L396fs	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000836206	9	35092697	9	35092700	836206	836122		NC_000009.12:35092699:A:
NM_000255.4(MMUT):c.1040T>G (p.Leu347Arg)	MMUT	L347R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807633	6	49421341	6	49453628	807633	798576		NC_000006.12:49453627:A:C
NM_032634.4(PIGO):c.2397A>C (p.Gln799His)	PIGO	Q799H	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694694	9	35091487	9	35091490	694694	682814		NC_000009.12:35091489:T:G
NM_032634.4(PIGO):c.438del (p.Phe146fs)	PIGO	F146fs	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Oct 14, 2018)	criteria provided, single submitter	VCV000656785	9	35095125	9	35095128	656785	638272		NC_000009.12:35095127:AAA:AA
NM_032634.4(PIGO):c.1549del (p.Ala517fs)	PIGO	A517fs	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000655474	9	35092335	9	35092338	655474	638255		NC_000009.12:35092337:CC:C
NM_032634.4(PIGO):c.196C>T (p.Arg66Ter)	PIGO	R66*	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000651005	9	35095367	9	35095370	651005	638276		NC_000009.12:35095369:G:A
NM_032634.4(PIGO):c.511G>T (p.Gly171Ter)	PIGO	G171*	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000647724	9	35095052	9	35095055	647724	638271		NC_000009.12:35095054:C:A
NM_032634.4(PIGO):c.91dup (p.Thr31fs)	PIGO		Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645706	9	35095471 - 35095472	9	35095474 - 35095475	645706	638277		NC_000009.12:35095474:T:TT
NM_032634.4(PIGO):c.2007G>A (p.Trp669Ter)	PIGO	W669*	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000581964	9	35091877	9	35091880	581964	563243	rs1563996824	NC_000009.12:35091879:C:T
NM_032634.4(PIGO):c.1269_1270TG[1] (p.Val424fs)	PIGO		Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000577203	9	35092612 - 35092613	9	35092615 - 35092616	577203	564005	rs1563998317	NC_000009.12:35092614:CACA:CA
NM_032634.4(PIGO):c.2191dup (p.Arg731fs)	PIGO		Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000574404	9	35091692 - 35091693	9	35091695 - 35091696	574404	569042	rs760848629	NC_000009.12:35091695:GGGGGGG:GGGGGGGG
NM_032634.4(PIGO):c.204dup (p.Arg69fs)	PIGO		Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000574401	9	35095358 - 35095359	9	35095361 - 35095362	574401	565902	rs751086453	NC_000009.12:35095361:C:CC
NM_032634.4(PIGO):c.1959G>A (p.Trp653Ter)	PIGO	W653*	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000565791	9	35091925	9	35091928	565791	569050	rs1391418639	NC_000009.12:35091927:C:T
NM_000255.4(MMUT):c.653A>G (p.Gln218Arg)	MMUT	Q218R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jul 28, 2014)	no assertion criteria provided	VCV000225185	6	49425504	6	49457791	225185	227102	rs869320653	NC_000006.12:49457790:T:C
NM_000255.4(MMUT):c.1097A>G (p.Asn366Ser)	MMUT	N366S	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218993	6	49419414	6	49451701	218993	216046	rs864309737	NC_000006.12:49451700:T:C
NM_000255.4(MMUT):c.691T>A (p.Tyr231Asn)	MMUT	Y231N	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218992	6	49425466	6	49457753	218992	216048	rs864309736	NC_000006.12:49457752:A:T
NM_000255.4(MMUT):c.299A>G (p.Tyr100Cys)	MMUT	Y100C	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218991	6	49426881	6	49459168	218991	216052	rs864309735	NC_000006.12:49459167:T:C
NM_000255.4(MMUT):c.935G>T (p.Gly312Val)	MMUT	G312V	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218988	6	49421446	6	49453733	218988	216047	rs864309734	NC_000006.12:49453732:C:A
NM_000255.4(MMUT):c.521T>C (p.Phe174Ser)	MMUT	F174S	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218986	6	49425636	6	49457923	218986	216051	rs864309733	NC_000006.12:49457922:A:G
NM_000255.4(MMUT):c.284C>G (p.Pro95Arg)	MMUT	P95R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218985	6	49426896	6	49459183	218985	216053	rs190834116	NC_000006.12:49459182:G:C
GRCh38/hg38 6p12.3(chr6:49345635-49462709)x0	MMUT		See cases	Pathogenic(Last reviewed: Dec 10, 2012)	no assertion criteria provided	VCV000149548	6	49313295 - 49430422	6	49345635 - 49462709	149548	159299		
NM_032634.3(PIGO):c.3069+5G>A	PIGO		Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035601	9	35090058	9	35090061	35601	44266	rs368953604	NC_000009.12:35090060:C:T
NM_032634.4(PIGO):c.2869C>T (p.Leu957Phe)	PIGO	L957F, L540F	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035599	9	35090263	9	35090266	35599	44264	rs142164373	NC_000009.12:35090265:G:A
MUT, 1808G-A	MMUT		METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000001890					1890	16929		
NM_000255.4(MMUT):c.2107G>C (p.Gly703Arg)	MMUT	G703R	METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000001885	6	49403186	6	49435473	1885	16924	rs121918255	NC_000006.12:49435472:C:G
MUT, 2-BP DEL, 769CA	MMUT		METHYLMALONIC ACIDURIA, mut(-) TYPE	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000001883					1883	16922		
NM_000255.4(MMUT):c.1130C>A (p.Ala377Glu)	MMUT	A378E, A377E	METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Nov 1, 1990)	no assertion criteria provided	VCV000001879	6	49419381	6	49451668	1879	16918	rs121918250	NC_000006.12:49451667:G:T
NM_000255.4(MMUT):c.514del (p.Ile172fs)	MMUT	I172fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000863700	6	49425643	6	49457930	863700	831995		NC_000006.12:49457929:TTTT:TTT
NM_000255.4(MMUT):c.1441del (p.Ser481fs)	MMUT	S481fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000863204	6	49416532	6	49448819	863204	831993		NC_000006.12:49448818:AA:A
NM_032634.4(PIGO):c.2191del (p.Arg731fs)	PIGO	R731fs	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000852858	9	35091693	9	35091696	852858	836111		NC_000009.12:35091695:GGGGGGG:GGGGGG
NM_000255.4(MMUT):c.322del (p.Arg108fs)	MMUT	R108fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000836528	6	49426858	6	49459145	836528	831997		NC_000006.12:49459144:GG:G
NC_000006.12:g.(?_49447660)_(49459506_?)del	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000833159	6	49415373 - 49427219			833159	819693		
NM_000255.4(MMUT):c.281G>T (p.Gly94Val)	MMUT	G94V	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000657887	6	49426899	6	49459186	657887	634947		NC_000006.12:49459185:C:A
NC_000006.11:g.(?_49423783)_(49423960_?)del	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000641563	6	49423783 - 49423960	6	49456070 - 49456247	641563	651553		
NM_000255.4(MMUT):c.2026G>A (p.Ala676Thr)	MMUT	A676T	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000574601	6	49403267	6	49435554	574601	563617	rs147715336	NC_000006.12:49435553:C:T
NM_000255.4(MMUT):c.1885dup (p.Arg629fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000568904	6	49407989 - 49407990	6	49440276 - 49440277	568904	565693	rs1561952122	NC_000006.12:49440276:T:TT
NM_000255.4(MMUT):c.1741C>T (p.Arg581Ter)	MMUT	R581*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000554675	6	49409620	6	49441907	554675	544026	rs1238694184	NC_000006.12:49441906:G:A
NM_000255.4(MMUT):c.1332+1del	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000554656	6	49419178	6	49451465	554656	543694	rs771542321	NC_000006.12:49451464:CC:C
NM_000255.4(MMUT):c.1962_1963del (p.Pro654_Arg655insTer)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000552144	6	49403330 - 49403331	6	49435617 - 49435618	552144	544125	rs1554158377	NC_000006.12:49435616:GAG:G
NM_000255.4(MMUT):c.1207C>G (p.Arg403Gly)	MMUT	R403G	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522690	6	49419304	6	49451591	522690	513283	rs727504020	NC_000006.12:49451590:G:C
NM_000255.4(MMUT):c.806C>T (p.Ala269Val)	MMUT	A269V	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522652	6	49423898	6	49456185	522652	513284	rs767593892	NC_000006.12:49456184:G:A
NM_000255.4(MMUT):c.1083+2T>A	MMUT		Methylmalonic acidemia	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000495775	6	49421296	6	49453583	495775	487190	rs746085723	NC_000006.12:49453582:A:T
NM_000255.4(MMUT):c.2054T>G (p.Leu685Arg)	MMUT	L685R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000218995	6	49403239	6	49435526	218995	216040	rs864309739	NC_000006.12:49435525:A:C
NM_000255.4(MMUT):c.1553T>C (p.Leu518Pro)	MMUT	L518P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000218994	6	49415390	6	49447677	218994	216043	rs864309738	NC_000006.12:49447676:A:G
NM_000255.4(MMUT):c.19C>T (p.Gln7Ter)	MMUT	Q7*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000218984	6	49427161	6	49459448	218984	216054	rs761773115	NC_000006.12:49459447:G:A
MUT, IVS11, C-A, -891	MMUT		METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000001889					1889	16928		
NM_000255.4(MMUT):c.1765C>T (p.Gln589Ter)	MMUT	Q589*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000845401	6	49409596	6	49441883	845401	831992		NC_000006.12:49441882:G:A
NM_000255.4(MMUT):c.1877_1889del (p.Gly626fs)	MMUT	G626fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000841103	6	49407986 - 49407998	6	49440273 - 49440285	841103	831991		NC_000006.12:49440272:CCTCTGTCATGGCC:C
NM_000255.4(MMUT):c.622del (p.Val208fs)	MMUT	V208fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000640726	6	49425535	6	49457822	640726	634944		NC_000006.12:49457821:C:
NM_032634.4(PIGO):c.2404C>T (p.Arg802Ter)	PIGO	R802*	Hyperphosphatasia with mental retardation syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620478	9	35091480	9	35091483	620478	611719	rs1199247059	NC_000009.12:35091482:G:A
NM_000255.4(MMUT):c.360dup (p.Lys121Ter)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000557861	6	49426819 - 49426820	6	49459106 - 49459107	557861	544065	rs1554160919	NC_000006.12:49459106:A:AA
NM_000255.4(MMUT):c.1677-1G>C	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000556968	6	49409685	6	49441972	556968	544137	rs754369323	NC_000006.12:49441971:C:G
NM_000255.4(MMUT):c.1957-2A>G	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000555787	6	49403338	6	49435625	555787	543675	rs1554158379	NC_000006.12:49435624:T:C
NM_000255.4(MMUT):c.29dup (p.Leu10fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000553287	6	49427150 - 49427151	6	49459437 - 49459438	553287	544025	rs1437477079	NC_000006.12:49459437:AAAAAAA:AAAAAAAA
NM_000255.4(MMUT):c.394C>T (p.Gln132Ter)	MMUT	Q132*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000534566	6	49425763	6	49458050	534566	521676	rs1554160743	NC_000006.12:49458049:G:A
NM_000255.4(MMUT):c.1126_1127del (p.Ala376fs)	MMUT	A376fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488555	6	49419384 - 49419385	6	49451671 - 49451672	488555	481423	rs1554159950	NC_000006.12:49451670:GC:
NM_000255.4(MMUT):c.1007del (p.Met336fs)	MMUT	M336fs	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000423257	6	49421374	6	49453661	423257	406880	rs1064796328	NC_000006.12:49453660:A:
NM_000255.4(MMUT):c.312del (p.Trp105fs)	MMUT	W105fs	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419283	6	49426868	6	49459155	419283	406883	rs1064793768	NC_000006.12:49459154:GGG:GG
NM_000255.4(MMUT):c.2193_2196dup (p.Val733fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222941	6	49399497 - 49399498	6	49431784 - 49431785	222941	224620	rs879253850	NC_000006.12:49431784:GGCAG:GGCAGGCAG
NM_000255.4(MMUT):c.2078del (p.Gly693fs)	MMUT	G693fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222940	6	49403215	6	49435502	222940	224621	rs879253849	NC_000006.12:49435501:CC:C
NM_000255.4(MMUT):c.1975C>T (p.Gln659Ter)	MMUT	Q659*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222939	6	49403318	6	49435605	222939	224622	rs879253848	NC_000006.12:49435604:G:A
NM_000255.4(MMUT):c.1874A>G (p.Asp625Gly)	MMUT	D625G	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222938	6	49408001	6	49440288	222938	224623	rs879253847	NC_000006.12:49440287:T:C
NM_000255.4(MMUT):c.1853T>C (p.Leu618Pro)	MMUT	L618P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222937	6	49408022	6	49440309	222937	224624	rs879253846	NC_000006.12:49440308:A:G
NM_000255.4(MMUT):c.1677_1747dup (p.Val583Aspfs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222936	6	49409614 - 49409684	6	49441901 - 49441971	222936	224625	rs1554158970	
NM_000255.4(MMUT):c.1655C>T (p.Ala552Val)	MMUT	A552V	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222935	6	49412373	6	49444660	222935	224626	rs879253845	NC_000006.12:49444659:G:A
NM_000255.4(MMUT):c.1333-20_1333-9del	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222933	6	49416649 - 49416660	6	49448936 - 49448947	222933	224628	rs879253843	NC_000006.12:49448935:AAAAACATTAACAAAA:AAAA
NM_000255.4(MMUT):c.1277G>A (p.Gly426Glu)	MMUT	G426E	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222932	6	49419234	6	49451521	222932	224629	rs533755473	NC_000006.12:49451520:C:T
NM_000255.4(MMUT):c.1271C>T (p.Pro424Leu)	MMUT	P424L	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222931	6	49419240	6	49451527	222931	224630	rs879253842	NC_000006.12:49451526:G:A
NM_000255.4(MMUT):c.1181dup (p.Leu394fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222930	6	49419329 - 49419330	6	49451616 - 49451617	222930	224631	rs879253841	NC_000006.12:49451616:AAA:AAAA
NM_000255.4(MMUT):c.1164T>A (p.Asn388Lys)	MMUT	N388K	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222929	6	49419347	6	49451634	222929	224632	rs879253840	NC_000006.12:49451633:A:T
NM_000255.4(MMUT):c.1084-1G>A	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222927	6	49419428	6	49451715	222927	224633	rs879253838	NC_000006.12:49451714:C:T
NM_000255.4(MMUT):c.977G>A (p.Arg326Lys)	MMUT	R326K	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222926	6	49421404	6	49453691	222926	224635	rs758577372	NC_000006.12:49453690:C:T
NM_000255.4(MMUT):c.974G>A (p.Gly325Asp)	MMUT	G325D	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222925	6	49421407	6	49453694	222925	224636	rs879253837	NC_000006.12:49453693:C:T
NM_000255.4(MMUT):c.927G>A (p.Trp309Ter)	MMUT	W309*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222924	6	49421454	6	49453741	222924	224637	rs879253836	NC_000006.12:49453740:C:T
NM_000255.4(MMUT):c.851G>A (p.Gly284Glu)	MMUT	G284E	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222923	6	49423853	6	49456140	222923	224638	rs879253835	NC_000006.12:49456139:C:T
NM_000255.4(MMUT):c.850G>A (p.Gly284Arg)	MMUT	G284R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222922	6	49423854	6	49456141	222922	224639	rs761477436	NC_000006.12:49456140:C:T
NM_000255.4(MMUT):c.828G>C (p.Glu276Asp)	MMUT	E276D	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222921	6	49423876	6	49456163	222921	224640	rs12175488	NC_000006.12:49456162:C:G
NM_000255.4(MMUT):c.692dup (p.Tyr231Ter)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222919	6	49425464 - 49425465	6	49457751 - 49457752	222919	224642	rs747777227	NC_000006.12:49457751:T:TT
NM_000255.4(MMUT):c.689C>G (p.Thr230Arg)	MMUT	T230R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222918	6	49425468	6	49457755	222918	224643	rs879253833	NC_000006.12:49457754:G:C
NM_000255.4(MMUT):c.630del (p.Glu211fs)	MMUT	E211fs	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222917	6	49425527	6	49457814	222917	224644	rs879253832	NC_000006.12:49457813:TTT:TT
NM_000255.4(MMUT):c.610_612GAA[1] (p.Glu205del)	MMUT	E205del	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222916	6	49425542 - 49425544	6	49457829 - 49457831	222916	224645	rs879253831	NC_000006.12:49457828:TTCTTCT:TTCT
NM_000255.4(MMUT):c.566A>T (p.Asn189Ile)	MMUT	N189I	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222915	6	49425591	6	49457878	222915	224646	rs200908035	NC_000006.12:49457877:T:A
NM_000255.4(MMUT):c.560C>G (p.Thr187Ser)	MMUT	T187S	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222914	6	49425597	6	49457884	222914	224647	rs879253830	NC_000006.12:49457883:G:C
NM_000255.4(MMUT):c.467A>T (p.Asp156Val)	MMUT	D156V	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222913	6	49425690	6	49457977	222913	224648	rs757000253	NC_000006.12:49457976:T:A
NM_000255.4(MMUT):c.415G>A (p.Asp139Asn)	MMUT	D139N	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222912	6	49425742	6	49458029	222912	224649	rs879253829	NC_000006.12:49458028:C:T
NM_000255.4(MMUT):c.397G>A (p.Gly133Arg)	MMUT	G133R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222911	6	49425760	6	49458047	222911	224650	rs879253828	NC_000006.12:49458046:C:T
NM_000255.4(MMUT):c.378C>A (p.Asn126Lys)	MMUT	N126K	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222910	6	49426802	6	49459089	222910	224651	rs879253827	NC_000006.12:49459088:G:T
NM_000255.4(MMUT):c.88C>T (p.Gln30Ter)	MMUT	Q30*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222907	6	49427092	6	49459379	222907	224654	rs879253824	NC_000006.12:49459378:G:A
NM_000255.4(MMUT):c.30dup (p.Leu11fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	VCV000222904	6	49427149 - 49427150	6	49459436 - 49459437	222904	224656	rs879253821	NC_000006.12:49459436:T:TT
NM_000255.4(MMUT):c.329A>G (p.Tyr110Cys)	MMUT	Y110C	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000203853	6	49426851	6	49459138	203853	200126	rs796052005	NC_000006.12:49459137:T:C
NM_000543.5(SMPD1):c.1264-1G>T	SMPD1		Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370394	11	6414846	11	6393616	370394	357991	rs1057516454	NC_000011.10:6393615:G:T
NM_000543.5(SMPD1):c.1139_1140TC[3] (p.Leu382fs)	SMPD1		Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370363	11	6414493 - 6414494	11	6393263 - 6393264	370363	357990	rs1057516432	NC_000011.10:6393262:TCTCTCTC:TCTCTC
NM_000543.5(SMPD1):c.114del (p.Leu39fs)	SMPD1	L39fs	Niemann-Pick disease, type A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000285415	11	6411942	11	6390712	285415	269652	rs886043098	NC_000011.10:6390711:G:
NM_000543.5(SMPD1):c.354del (p.Ile119fs)	SMPD1	I118fs, I119fs	not provided|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, multiple submitters, no conflicts	VCV000167708	11	6412648	11	6391418	167708	178085	rs727504165	NC_000011.10:6391417:CC:C
NM_000543.5(SMPD1):c.1152G>A (p.Met384Ile)	SMPD1	M382I, M384I, M383I, M77I	not provided|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000002986	11	6414506	11	6393276	2986	18025	rs120074121	NC_000011.10:6393275:G:A
NM_000360.4(TH):c.364C>T (p.Arg122Ter)	TH	R153*, R122*, R149*	Dystonia|Segawa syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449110	11	2189844	11	2168614	449110	444773	rs771610752	NC_000011.10:2168613:G:A
NM_201596.3(CACNB2):c.214-60966C>T	CACNB2	T11I	Brugada syndrome 4	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000156228	10	18629887	10	18340958	156228	166021	rs587777742	NC_000010.11:18340957:C:T
NM_021830.5(TWNK):c.1121G>A (p.Arg374Gln)	TWNK	R374Q	Mitochondrial diseases|Dysphonia|EMG: myopathic abnormalities|Abnormal mitochondria in muscle tissue|Bilateral sensorineural hearing impairment|Bilateral ptosis|Progressive external ophthalmoplegia|Depressivity|Neuromuscular dysphagia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426106	10	102749088	10	100989331	426106	414704	rs1554887097	NC_000010.11:100989330:G:A
NM_005609.4(PYGM):c.2125_2127TTC[1] (p.Phe710del)	PYGM	F710del	Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000139609	11	64517895 - 64517897	11	64750423 - 64750425	139609	143234	rs527236147	NC_000011.10:64750422:GAAGAAG:GAAG
NM_005609.4(PYGM):c.1466C>G (p.Pro489Arg)	PYGM	P489R, P401R	not provided|Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095291	11	64520597	11	64753125	95291	101190	rs398124209	NC_000011.10:64753124:G:C
NM_000255.4(MMUT):c.947A>G (p.Tyr316Cys)	MMUT	Y316C	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000640484	6	49421434	6	49453721	640484	634942		NC_000006.12:49453720:T:C
NM_000255.4(MMUT):c.1194_1195TG[1] (p.Val399fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000578141	6	49419314 - 49419315	6	49451601 - 49451602	578141	565694	rs1227030642	NC_000006.12:49451600:CACA:CA
NM_000255.4(MMUT):c.1489G>T (p.Glu497Ter)	MMUT	E497*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222934	6	49415454	6	49447741	222934	224627	rs879253844	NC_000006.12:49447740:C:A
NM_000255.4(MMUT):c.1084-2A>G	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000222928	6	49419429	6	49451716	222928	224634	rs879253839	NC_000006.12:49451715:T:C
NM_000255.4(MMUT):c.129G>A (p.Trp43Ter)	MMUT	W43*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222908	6	49427051	6	49459338	222908	224653	rs879253825	NC_000006.12:49459337:C:T
NM_000255.4(MMUT):c.643G>A (p.Gly215Ser)	MMUT	G215S	METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000001888	6	49425514	6	49457801	1888	16927	rs121918258	NC_000006.12:49457800:C:T
NM_138361.5(LRSAM1):c.2019dup (p.Glu674fs)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000651567	9	130263394 - 130263395	9	127501115 - 127501116	651567	637669		NC_000009.12:127501115:A:AA
NC_000009.11:g.(?_130263279)_(130263432_?)del	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000644828	9	130263279 - 130263432	9	127501000 - 127501153	644828	651817		
NM_138361.5(LRSAM1):c.2080T>C (p.Cys694Arg)	LRSAM1	C694R, C667R	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000408267	9	130265086	9	127502807	408267	396678	rs759312530	NC_000009.12:127502806:T:C
NM_138361.5(LRSAM1):c.2121_2122dup (p.Leu708fs)	LRSAM1		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	VCV000030860	9	130265125 - 130265126	9	127502846 - 127502847	30860	39817	rs786200930	NC_000009.12:127502846:CGC:CGCGC
NM_194456.1(KRIT1):c.1412-2A>C	KRIT1		Cerebral cavernous malformation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590705	7	91851369	7	92222055	590705	581369	rs1563264113	NC_000007.14:92222054:T:G
NM_194456.1(KRIT1):c.730-1G>C	KRIT1		not provided|Cerebral cavernous malformation	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000536122	7	91864238	7	92234924	536122	523473	rs1554527922	NC_000007.14:92234923:C:G
NM_194456.1(KRIT1):c.1255-1_1256del	KRIT1		Cerebral cavernous malformation|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468206	7	91852291 - 91852293	7	92222977 - 92222979	468206	458026	rs1554514380	NC_000007.14:92222976:TACTAC:TAC
NM_004064.4(CDKN1B):c.149_150GA[1] (p.Asp51fs)	CDKN1B		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 4	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000689357	12	12870921 - 12870922	12	12717987 - 12717988	689357	676949		NC_000012.12:12717986:AGAGA:AGA
NM_003002.4(SDHD):c.315-1112_0del	SDHD		Paragangliomas 1	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000598762	11	111964415 - 111966592	11	112093691 - 112095868	598762	589823		
NM_003002.4(SDHD):c.336dup (p.Asp113Ter)	SDHD		Paragangliomas 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547770	11	111965549 - 111965550	11	112094825 - 112094826	547770	537876	rs1555187583	NC_000011.10:112094825:T:TT
NM_003002.4(SDHD):c.53dup (p.Leu19fs)	SDHD		not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279889	11	111958580 - 111958581	11	112087856 - 112087857	279889	264583	rs886041237	NC_000011.10:112087856:C:CC
NM_003002.4(SDHD):c.361C>T (p.Gln121Ter)	SDHD	Q121*, Q82*	Paragangliomas 1	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000239470	11	111965575	11	112094851	239470	241050	rs878854594	NC_000011.10:112094850:C:T
SDHD, 96-KB DEL	SDHD		Paragangliomas 1	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000006914					6914	21953		
NM_003002.4(SDHD):c.463del (p.Met155fs)	SDHD	M116fs, M155fs	Paragangliomas 1	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000006910	11	111965677	11	112094953	6910	21949	rs587776647	NC_000011.10:112094952:A:
NM_003002.4(SDHD):c.278_280del (p.Tyr93del)	SDHD	Y93del, Y54del	Paragangliomas 1	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000006905	11	111959698 - 111959700	11	112088974 - 112088976	6905	21944	rs121908983	NC_000011.10:112088973:TATT:T
NM_003002.4(SDHD):c.443del (p.Gly148fs)	SDHD	G148fs, G109fs	Paragangliomas 1	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	VCV000006902	11	111965655	11	112094931	6902	21941	rs587776646	NC_000011.10:112094930:GGG:GG
NM_003002.4(SDHD):c.337_338insT (p.Asp113fs)	SDHD		Paragangliomas 1	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	VCV000006899	11	111965551 - 111965552	11	112094827 - 112094828	6899	21938	rs587776645	NC_000011.10:112094827::T
NM_003002.4(SDHD):c.52+2T>G	SDHD		Paragangliomas 1	Pathogenic(Last reviewed: Dec 15, 2000)	no assertion criteria provided	VCV000006894	11	111957685	11	112086961	6894	21933	rs587776644	NC_000011.10:112086960:T:G
NM_001135242.2(NDRG1):c.442C>T (p.Arg148Ter)	NDRG1	R148*, R67*, R82*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4D	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000005120	8	134270617	8	133258374	5120	20159	rs119483085	NC_000008.11:133258373:G:A
NM_000255.4(MMUT):c.1351G>T (p.Glu451Ter)	MMUT	E451*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557114	6	49416622	6	49448909	557114	544007	rs768608311	NC_000006.12:49448908:C:A
NM_000255.4(MMUT):c.1420C>T (p.Arg474Ter)	MMUT	R474*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554873	6	49416553	6	49448840	554873	544043	rs887126161	NC_000006.12:49448839:G:A
NM_000255.4(MMUT):c.671_678dup (p.Val227fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554641	6	49425478 - 49425479	6	49457765 - 49457766	554641	544021	rs758008398	NC_000006.12:49457765:CATAAATTC:CATAAATTCATAAATTC
NM_000255.4(MMUT):c.1287C>G (p.Tyr429Ter)	MMUT	Y429*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554278	6	49419224	6	49451511	554278	544141	rs1346775255	NC_000006.12:49451510:G:C
NM_000255.4(MMUT):c.1481T>A (p.Leu494Ter)	MMUT	L494*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000551275	6	49415462	6	49447749	551275	544041	rs764173488	NC_000006.12:49447748:A:T
NM_000255.4(MMUT):c.160A>T (p.Lys54Ter)	MMUT	K54*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000466219	6	49427020	6	49459307	466219	455819	rs1554161054	NC_000006.12:49459306:T:A
NM_000255.4(MMUT):c.2200C>T (p.Gln734Ter)	MMUT	Q734*	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000222943	6	49399494	6	49431781	222943	224618	rs879253852	NC_000006.12:49431780:G:A
NM_000255.4(MMUT):c.330T>G (p.Tyr110Ter)	MMUT	Y110*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222909	6	49426850	6	49459137	222909	224652	rs879253826	NC_000006.12:49459136:A:C
NM_000255.4(MMUT):c.55dup (p.Val19fs)	MMUT		not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000222906	6	49427124 - 49427125	6	49459411 - 49459412	222906	224655	rs879253823	NC_000006.12:49459411:CC:CCC
NM_000255.4(MMUT):c.753+2T>A	MMUT		Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Mar 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203856	6	49425402	6	49457689	203856	200121	rs796052006	NC_000006.12:49457688:A:T
NM_019098.4(CNGB3):c.886_896delinsT (p.Thr296fs)	CNGB3		Achromatopsia 3|not provided|CNGB3-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000363876	8	87666247 - 87666257	8	86654019 - 86654029	363876	315327	rs886063161	NC_000008.11:86654018:TTTGTAGAAGT:A
NM_019098.4(CNGB3):c.112C>T (p.Gln38Ter)	CNGB3	Q38*	Achromatopsia|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188828	8	87755744	8	86743516	188828	186771	rs786204498	NC_000008.11:86743515:G:A
NM_152419.3(HGSNAT):c.1250+1G>A	HGSNAT		not provided|Retinal dystrophy|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096500	8	43046739	8	43191596	96500	102394	rs398124544	NC_000008.11:43191595:G:A
NM_152419.3(HGSNAT):c.1030C>T (p.Arg344Cys)	HGSNAT	R344C, R280C, R56C	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001237	8	43037305	8	43182162	1237	16276	rs121908285	NC_000008.11:43182161:C:T
NM_152419.3(HGSNAT):c.372-2A>G	HGSNAT		Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001236	8	43014064	8	43158921	1236	16275	rs483352896	NC_000008.11:43158920:A:G
NM_000543.5(SMPD1):c.742G>A (p.Glu248Lys)	SMPD1	E248K, E247K	not provided|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000496823	11	6413037	11	6391807	496823	488247	rs200763423	NC_000011.10:6391806:G:A
NM_000543.5(SMPD1):c.952G>A (p.Val318Met)	SMPD1	V317M, V318M	Niemann-Pick disease, type A|not provided	Pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	VCV000225625	11	6413247	11	6392017	225625	227457	rs875989837	NC_000011.10:6392016:G:A
NM_000543.5(SMPD1):c.592G>C (p.Ala198Pro)	SMPD1	A198P, A197P	Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A	Pathogenic	criteria provided, single submitter	VCV000203425	11	6412887	11	6391657	203425	199816	rs797044798	NC_000011.10:6391656:G:C
NM_006158.4(NEFL):c.1319C>T (p.Pro440Leu)	NEFL	P440L	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000155738	8	24811160	8	24953646	155738	165492	rs587777882	NC_000008.11:24953645:G:A
NM_001277269.2(OTOG):c.468del (p.Gln157fs)	OTOG	Q145fs, Q157fs	not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000817689	11	17574954	11	17553407	817689	805679		NC_000011.10:17553406:GGGGG:GGGG
NM_001277269.1(OTOG):c.7235del (p.Cys2412fs)	OTOG	C2400fs, C2412fs	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560902	11	17655353	11	17633806	560902	552015	rs1565127413	NC_000011.10:17633805:G:
NM_001277269.1(OTOG):c.7453C>T (p.Arg2485Ter)	OTOG	R2485*, R2473*	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000520437	11	17655765	11	17634218	520437	511040	rs866476223	NC_000011.10:17634217:C:T
NM_001277269.1(OTOG):c.330C>G (p.Tyr110Ter)	OTOG	Y110*, Y98*	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Jun 9, 2017)	no assertion criteria provided	VCV000496812	11	17574667	11	17553120	496812	488236	rs574007567	NC_000011.10:17553119:C:G
NM_001277269.1(OTOG):c.3700C>T (p.Arg1234Ter)	OTOG	R1234*, R1222*	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000489360	11	17618536	11	17596989	489360	481982	rs560339163	NC_000011.10:17596988:C:T
NM_001277269.1(OTOG):c.5092C>T (p.Gln1698Ter)	OTOG	Q1698*, Q1686*	not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000489359	11	17631903	11	17610356	489359	481983	rs930688767	NC_000011.10:17610355:C:T
NM_003070.5(SMARCA2):c.3464A>C (p.Gln1155Pro)	SMARCA2	Q1155P, Q1097P	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000419659	9	2115829	9	2115829	419659	407648	rs1064794024	NC_000009.12:2115828:A:C
NM_003070.5(SMARCA2):c.3446A>G (p.Asn1149Ser)	SMARCA2	N1149S, N1091S	not provided	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000379917	9	2110407	9	2110407	379917	372914	rs1057520784	NC_000009.12:2110406:A:G
NM_003070.5(SMARCA2):c.3484C>T (p.Arg1162Cys)	SMARCA2	R1162C, R1104C	not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000373431	9	2115849	9	2115849	373431	359925	rs1057518414	NC_000009.12:2115848:C:T
NM_003070.5(SMARCA2):c.3650T>C (p.Leu1217Pro)	SMARCA2	L1217P, L1159P	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000280814	9	2116015	9	2116015	280814	264326	rs886041954	NC_000009.12:2116014:T:C
NM_003070.5(SMARCA2):c.3313C>G (p.Arg1105Gly)	SMARCA2	R1105G, R1047G	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000280726	9	2110274	9	2110274	280726	264523	rs281875192	NC_000009.12:2110273:C:G
NM_003070.5(SMARCA2):c.3439G>A (p.Asp1147Asn)	SMARCA2	D1147N, D1089N	not provided	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000279980	9	2110400	9	2110400	279980	264525	rs886041299	NC_000009.12:2110399:G:A
NM_001277269.1(OTOG):c.6347C>T (p.Pro2116Leu)	OTOG	P2116L, P2104L	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039818	11	17634185	11	17612638	39818	48417	rs397514607	NC_000011.10:17612637:C:T
NM_001277269.1(OTOG):c.5508del (p.Ala1838fs)	OTOG	A1826fs, A1838fs	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039817	11	17632316	11	17610769	39817	48416	rs1029389440	NC_000011.10:17610768:CCCC:CCC
NM_003070.5(SMARCA2):c.2361C>A (p.Asn787Lys)	SMARCA2	N787K	Nicolaides-Baraitser syndrome	Pathogenic	criteria provided, single submitter	VCV000694693	9	2083359	9	2083359	694693	682813		NC_000009.12:2083358:C:A
NM_003070.5(SMARCA2):c.2853G>C (p.Lys951Asn)	SMARCA2	K951N, K893N	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000436805	9	2088583	9	2088583	436805	428992	rs1554624100	NC_000009.12:2088582:G:C
NM_003070.5(SMARCA2):c.2554G>A (p.Glu852Lys)	SMARCA2	E852K	not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000068762	9	2086856	9	2086856	68762	79654	rs281875199	NC_000009.12:2086855:G:A
NM_003070.5(SMARCA2):c.3395G>A (p.Gly1132Asp)	SMARCA2	G1132D, G1074D	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000031687	9	2110356	9	2110356	31687	40347	rs387907194	NC_000009.12:2110355:G:A
SMARCA2, 55-KB DEL	SMARCA2		Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000030020					30020	38975		
NM_003070.5(SMARCA2):c.2815C>T (p.His939Tyr)	SMARCA2	H939Y, H881Y	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030018	9	2088545	9	2088545	30018	38973	rs281875190	NC_000009.12:2088544:C:T
NM_003070.5(SMARCA2):c.2648C>T (p.Pro883Leu)	SMARCA2	P883L	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030016	9	2086950	9	2086950	30016	38971	rs281875188	NC_000009.12:2086949:C:T
NM_003070.5(SMARCA2):c.3476G>T (p.Arg1159Leu)	SMARCA2	R1159L, R1101L	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030015	9	2115841	9	2115841	30015	38970	rs281875187	NC_000009.12:2115840:G:T
NM_003070.5(SMARCA2):c.2642G>T (p.Gly881Val)	SMARCA2	G881V	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030013	9	2086944	9	2086944	30013	38968	rs281875185	NC_000009.12:2086943:G:T
NM_003070.5(SMARCA2):c.3475C>G (p.Arg1159Gly)	SMARCA2	R1159G, R1101G	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030012	9	2115840	9	2115840	30012	38967	rs281875184	NC_000009.12:2115839:C:G
NM_003070.5(SMARCA2):c.3473A>T (p.Asp1158Val)	SMARCA2	D1158V, D1100V	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030011	9	2115838	9	2115838	30011	38966	rs281875240	NC_000009.12:2115837:A:T
NM_003070.5(SMARCA2):c.3476G>A (p.Arg1159Gln)	SMARCA2	R1159Q, R1101Q	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030010	9	2115841	9	2115841	30010	38965	rs281875187	NC_000009.12:2115840:G:A
NM_003070.5(SMARCA2):c.3604G>T (p.Gly1202Cys)	SMARCA2	G1202C, G1144C	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030009	9	2115969	9	2115969	30009	38964	rs281875239	NC_000009.12:2115968:G:T
NM_003070.5(SMARCA2):c.3637C>T (p.Arg1213Trp)	SMARCA2	R1213W, R1155W	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030008	9	2116002	9	2116002	30008	38963	rs281875238	NC_000009.12:2116001:C:T
NM_001363118.2(SLC52A2):c.916G>A (p.Gly306Arg)	SLC52A2	G306R, G142R	Brown-Vialetto-Van Laere syndrome 2|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035470	8	145584068	8	144360408	35470	44139	rs398124641	NC_000008.11:144360407:G:A
NM_000255.4(MMUT):c.454C>T (p.Arg152Ter)	MMUT	R152*	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426467	6	49425703	6	49457990	426467	415056	rs780068818	NC_000006.12:49457989:G:A
NM_000255.4(MMUT):c.-39-1G>A	MMUT		not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000222905	6	49427219	6	49459506	222905	224658	rs879253822	NC_000006.12:49459505:C:T
NM_000255.4(MMUT):c.2T>C (p.Met1Thr)	MMUT	M1T	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222903	6	49427178	6	49459465	222903	224657	rs879253820	NC_000006.12:49459464:A:G
NM_000255.4(MMUT):c.1630_1631delinsTA (p.Gly544Ter)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203860	6	49412397 - 49412398	6	49444684 - 49444685	203860	200110	rs796052008	NC_000006.12:49444683:CC:TA
NM_000255.4(MMUT):c.349G>T (p.Glu117Ter)	MMUT	E117*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|METHYLMALONIC ACIDURIA, mut(-) TYPE	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000001882	6	49426831	6	49459118	1882	16921	rs121918253	NC_000006.12:49459117:C:A
NM_003172.4(SURF1):c.790_791AG[1] (p.Arg264fs)	SURF1		Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial complex IV deficiency|not provided|Leigh syndrome	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215238	9	136218956 - 136218957	9	133352101 - 133352102	215238	211358	rs782490558	NC_000009.12:133352100:CTCT:CT
NM_006269.2(RP1):c.2180_2181delinsAA (p.Cys727Ter)	RP1		not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000812401	8	55538622 - 55538623	8	54626062 - 54626063	812401	800538		NC_000008.11:54626061:GT:AA
NM_001360.2(DHCR7):c.902A>G (p.His301Arg)	DHCR7	H301R	not provided|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595087	11	71148919	11	71437873	595087	586149	rs1565586067	NC_000011.10:71437872:T:C
NM_001360.2(DHCR7):c.1190C>T (p.Ser397Leu)	DHCR7	S397L	History of neurodevelopmental disorder|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000587952	11	71146659	11	71435613	587952	579746	rs773134475	NC_000011.10:71435612:G:A
NM_001163817.2(DHCR7):c.296T>C (p.Leu99Pro)	DHCR7	L99P	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553296	11	71155064	11	71444018	553296	546593	rs104886041	NC_000011.10:71444017:A:G
NM_001360.2(DHCR7):c.385_412+5del	DHCR7		not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370449	11	71153304 - 71153336	11	71442258 - 71442290	370449	358077	rs746482788	NC_000011.10:71442257:GCTACCTGCAGGAGTCACGGCCCCCTCCTGGATGC:GC
NM_001292063.1(OTOG):c.499del (p.Val167fs)	OTOG	V167fs, V179fs	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228284	11	17575024	11	17553477	228284	230048	rs876657657	NC_000011.10:17553476:GG:G
NM_003070.5(SMARCA2):c.2255G>C (p.Gly752Ala)	SMARCA2	G752A	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030019	9	2081902	9	2081902	30019	38974	rs281875198	NC_000009.12:2081901:G:C
NM_003070.5(SMARCA2):c.3602C>T (p.Ala1201Val)	SMARCA2	A1201V, A1143V	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000030017	9	2115967	9	2115967	30017	38972	rs281875189	NC_000009.12:2115966:C:T
NM_003070.5(SMARCA2):c.3485G>A (p.Arg1162His)	SMARCA2	R1162H, R1104H	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000030014	9	2115850	9	2115850	30014	38969	rs281875186	NC_000009.12:2115849:G:A
NM_005422.2(TECTA):c.1774+1G>T	TECTA		not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000595210	11	120996582	11	121125873	595210	586272	rs372925383	NC_000011.10:121125872:G:T
NM_005422.2(TECTA):c.730_737del (p.Arg244fs)	TECTA	R244fs	not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000594351	11	120984364 - 120984371	11	121113655 - 121113662	594351	585414	rs1565518246	NC_000011.10:121113654:GGCCGCTGGGC:GGC
NM_005422.2(TECTA):c.1774G>A (p.Val592Met)	TECTA	V592M	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560912	11	120996581	11	121125872	560912	552014	rs1565522273	NC_000011.10:121125871:G:A
NM_005422.2(TECTA):c.1131_1134del (p.Ser376_Trp377insTer)	TECTA		not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000503983	11	120989353 - 120989356	11	121118644 - 121118647	503983	495517	rs1330220728	NC_000011.10:121118643:TGGGTG:TG
NM_005422.2(TECTA):c.5826C>A (p.Tyr1942Ter)	TECTA	Y1942*	not provided	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000498535	11	121039461	11	121168752	498535	489959	rs955468054	NC_000011.10:121168751:C:A
NM_005422.2(TECTA):c.1893C>A (p.Cys631Ter)	TECTA	C631*	not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000498103	11	120998579	11	121127870	498103	489527	rs1555123909	NC_000011.10:121127869:C:A
NM_005422.2(TECTA):c.5941T>A (p.Tyr1981Asn)	TECTA	Y1981N	not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000379299	11	121039576	11	121168867	379299	371292	rs1057520561	NC_000011.10:121168866:T:A
NM_005422.2(TECTA):c.5866C>T (p.Arg1956Ter)	TECTA	R1956*	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627480	11	121039501	11	121168792	627480	615812	rs1565536400	NC_000011.10:121168791:C:T
NM_005422.2(TECTA):c.1247_1248del (p.Gly416fs)	TECTA	G416fs	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619173	11	120996052 - 120996053	11	121125343 - 121125344	619173	610568	rs773573968	NC_000011.10:121125342:GGGG:GG
NM_005422.2(TECTA):c.2736C>A (p.Cys912Ter)	TECTA	C912*	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562089	11	121000715	11	121130006	562089	553263	rs368050948	NC_000011.10:121130005:C:A
NM_005422.2(TECTA):c.6162+5G>A	TECTA		Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562088	11	121058708	11	121187999	562088	553264	rs1565541888	NC_000011.10:121187998:G:A
NM_005422.2(TECTA):c.840_841insT (p.Val281fs)	TECTA		Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562087	11	120989064 - 120989065	11	121118355 - 121118356	562087	553262	rs1565519673	NC_000011.10:121118355::T
NM_005422.2(TECTA):c.5754_5755del (p.Val1918_Ile1919insTer)	TECTA		Rare genetic deafness	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000505042	11	121039389 - 121039390	11	121168680 - 121168681	505042	497174	rs1555129231	NC_000011.10:121168679:AA:
NM_005422.2(TECTA):c.4857C>A (p.Cys1619Ter)	TECTA	C1619*	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402279	11	121031011	11	121160302	402279	389239	rs764153521	NC_000011.10:121160301:C:A
NM_005422.2(TECTA):c.2887G>A (p.Ala963Thr)	TECTA	A963T	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236059	11	121000866	11	121130157	236059	237609	rs753896285	NC_000011.10:121130156:G:A
NM_005422.2(TECTA):c.6017A>G (p.Asp2006Gly)	TECTA	D2006G	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236033	11	121058558	11	121187849	236033	237611	rs878853224	NC_000011.10:121187848:A:G
NM_005422.2(TECTA):c.6037del (p.Glu2013fs)	TECTA	E2013fs	Deafness, neurosensory autosomal recessive 21	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000007019	11	121058577	11	121187868	7019	22058		NC_000011.10:121187867:GG:G
NM_005422.2(TECTA):c.651dup (p.Asn218fs)	TECTA		Deafness, neurosensory autosomal recessive 21	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000007018	11	120984286 - 120984287	11	121113577 - 121113578	7018	22057		NC_000011.10:121113577:CC:CCC
NM_005422.2(TECTA):c.2941+1G>A	TECTA		Deafness, neurosensory autosomal recessive 21	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000007015	11	121000921	11	121130212	7015	22054		NC_000011.10:121130211:G:A
NM_001134831.2(AHI1):c.2212C>T (p.Arg738Ter)	AHI1	R738*	not provided|Joubert syndrome 3|Retinitis pigmentosa	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217525	6	135754219	6	135433081	217525	214235	rs372659908	NC_000006.12:135433080:G:A
NC_000011.10:g.121109260C>T	TECTA	T83M	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813831	11	120979969	11	121109260	813831	802076		NC_000011.10:121109259:C:T
NM_183050.4(BCKDHB):c.853C>T (p.Arg285Ter)	BCKDHB	R285*, R215*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096615	6	80912831	6	80203114	96615	102508	rs398124598	NC_000006.12:80203113:C:T
NM_183050.4(BCKDHB):c.752T>C (p.Val251Ala)	BCKDHB	V251A, V181A	Maple syrup urine disease|not provided|Maple syrup urine disease type 1B	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096608	6	80910660	6	80200943	96608	102501	rs398124593	NC_000006.12:80200942:T:C
NM_005422.2(TECTA):c.5331G>A (p.Leu1777=)	TECTA		Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000007024	11	121036040	11	121165331	7024	22063		NC_000011.10:121165330:G:A
NM_005422.2(TECTA):c.5509T>C (p.Cys1837Arg)	TECTA	C1837R	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000007023	11	121037412	11	121166703	7023	22062	rs121909061	NC_000011.10:121166702:T:C
NM_005422.2(TECTA):c.5509T>G (p.Cys1837Gly)	TECTA	C1837G	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000007020	11	121037412	11	121166703	7020	22059	rs121909061	NC_000011.10:121166702:T:G
NM_005422.2(TECTA):c.4856G>C (p.Cys1619Ser)	TECTA	C1619S	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000007017	11	121031010	11	121160301	7017	22056	rs121909060	NC_000011.10:121160300:G:C
NM_005422.2(TECTA):c.3169T>A (p.Cys1057Ser)	TECTA	C1057S	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000007016	11	121008357	11	121137648	7016	22055	rs121909059	NC_000011.10:121137647:T:A
NM_005422.2(TECTA):c.5609A>G (p.Tyr1870Cys)	TECTA	Y1870C	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000007014	11	121038785	11	121168076	7014	22053	rs121909058	NC_000011.10:121168075:A:G
NM_001613.4(ACTA2):c.535C>T (p.Arg179Cys)	ACTA2	R179C	Aortic aneurysm, familial thoracic 6|not provided|Familial aortopathy	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265026	10	90701067	10	88941310	265026	259943	rs886039303	NC_000010.11:88941309:G:A
NM_005422.2(TECTA):c.2139C>A (p.Cys713Ter)	TECTA	C713*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000505476	11	120998825	11	121128116	505476	496965	rs768295360	NC_000011.10:121128115:C:A
NM_005422.2(TECTA):c.5977C>T (p.Arg1993Ter)	TECTA	R1993*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2016)	criteria provided, single submitter	VCV000228404	11	121039612	11	121168903	228404	230005	rs760574657	NC_000011.10:121168902:C:T
NC_000011.10:g.(?_64758226)_(64758724_?)del	PYGM		Glycogen storage disease, type V	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000833280	11	64525698 - 64526196			833280	820398		
NM_005609.4(PYGM):c.78_79del (p.Glu27fs)	PYGM	E27fs	Glycogen storage disease, type V|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188778	11	64527292 - 64527293	11	64759820 - 64759821	188778	186832	rs755117847	NC_000011.10:64759819:CA:
NM_005609.4(PYGM):c.1366G>A (p.Val456Met)	PYGM	V456M, V368M	not provided|Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, multiple submitters, no conflicts	VCV000095290	11	64521028	11	64753556	95290	101189	rs398124208	NC_000011.10:64753555:C:T
NM_000543.5(SMPD1):c.1054G>T (p.Glu352Ter)	SMPD1	E351*, E352*	Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000650777	11	6413349	11	6392119	650777	640227		NC_000011.10:6392118:G:T
NM_000543.5(SMPD1):c.151_154del (p.Asp51fs)	SMPD1	D51fs	Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371029	11	6411977 - 6411980	11	6390747 - 6390750	371029	357977	rs1057516949	NC_000011.10:6390746:CTGACT:CT
NM_000543.5(SMPD1):c.1341-1G>A	SMPD1		not provided|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370902	11	6415125	11	6393895	370902	357993	rs1057516854	NC_000011.10:6393894:G:A
NM_000543.5(SMPD1):c.241C>T (p.Arg81Ter)	SMPD1	R81*	Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370753	11	6412069	11	6390839	370753	357981	rs868423827	NC_000011.10:6390838:C:T
NM_000543.5(SMPD1):c.842_849dup (p.His284fs)	SMPD1		Niemann-Pick disease, type A|not provided	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000093321	11	6413134 - 6413135	11	6391904 - 6391905	93321	99228	rs281860677	NC_000011.10:6391904:CATCCCCGCA:CATCCCCGCATCCCCGCA
NM_000543.5(SMPD1):c.1451C>A (p.Ala484Glu)	SMPD1	A482E, A483E, A484E, A177E, A440E	Niemann-Pick disease, type A|not specified	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000002995	11	6415236	11	6394006	2995	18034	rs267607075	NC_000011.10:6394005:C:A
GRCh37/hg19 7p21.2(chr7:16369989-16486969)x1	CRPPA		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000688561	7	16369989 - 16486969			688561	676153		
NM_001101426.4(CRPPA):c.1A>T (p.Met1Leu)	CRPPA	M1L	not provided	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000287129	7	16460947	7	16421322	287129	271366	rs886043573	NC_000007.14:16421321:T:A
NM_001101426.4(CRPPA):c.165dup (p.Cys56fs)	CRPPA		Muscular dystrophy-dystroglycanopathy	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000435529	7	16460782 - 16460783	7	16421157 - 16421158	435529	428699	rs1554371369	NC_000007.14:16421157:CCCCCC:CCCCCCC
NM_001101426.4(CRPPA):c.161G>C (p.Gly54Ala)	CRPPA	G54A	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000156454	7	16460787	7	16421162	156454	166226	rs587777797	NC_000007.14:16421161:C:G
NC_000007.13:g.(?_16341036)_(16348262_?)del	CRPPA		Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000656841	7	16341036 - 16348262	7	16301411 - 16308637	656841	651666		
NM_001101426.4(CRPPA):c.773C>A (p.Ser258Ter)	CRPPA	S258*, S208*	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000656769	7	16348164	7	16308539	656769	635967		NC_000007.14:16308538:G:T
NM_001101426.4(CRPPA):c.874_886del (p.Glu292fs)	CRPPA	E242fs, E257fs, E292fs	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000473159	7	16317801 - 16317813	7	16278176 - 16278188	473159	456530	rs1554305719	NC_000007.14:16278175:TGTTATCTTCTTCTGT:TGT
Single allele	CRPPA		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000473152			7	16406061 - 16406337	473152	456460		
NC_000007.13:g.(?_16341026)_(16348272_?)del	CRPPA		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000473151	7	16341026 - 16348272			473151	455864		
NM_001101426.4(CRPPA):c.184del (p.Val62fs)	CRPPA	V62fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423167	7	16460764	7	16421139	423167	407116	rs1048457038	NC_000007.14:16421138:CCCCC:CCCC
NM_001101426.4(CRPPA):c.256A>T (p.Arg86Ter)	CRPPA	R86*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039613	7	16460692	7	16421067	39613	48212	rs397514548	NC_000007.14:16421066:T:A
NM_001101426.4(CRPPA):c.466G>A (p.Asp156Asn)	CRPPA	D156N	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039611	7	16445754	7	16406129	39611	48210	rs397514547	NC_000007.14:16406128:C:T
NM_001101426.3(CRPPA):c.535-?_933+?del	CRPPA		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039610	7	16317753 - 16415867	7	16278129 - 16376241	39610	48209		
NM_001101426.4(CRPPA):c.638T>G (p.Met213Arg)	CRPPA	M213R	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039609	7	16415763	7	16376138	39609	48208	rs397515408	NC_000007.14:16376137:A:C
NM_001101426.4(CRPPA):c.364G>C (p.Ala122Pro)	CRPPA	A122P	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031567	7	16445856	7	16406231	31567	40247	rs387907162	NC_000007.14:16406230:C:G
NM_001101426.4(CRPPA):c.832A>T (p.Lys278Ter)	CRPPA	K278*, K243*, K228*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031566	7	16341049	7	16301424	31566	40246	rs387907161	NC_000007.14:16301423:T:A
NM_001101426.4(CRPPA):c.647C>A (p.Ala216Asp)	CRPPA	A216D	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031565	7	16415754	7	16376129	31565	40245	rs387907160	NC_000007.14:16376128:G:T
NM_001101426.4(CRPPA):c.789+2T>G	CRPPA		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031563	7	16348146	7	16308521	31563	40243	rs397515397	NC_000007.14:16308520:A:C
NR_003051.3(RMRP):n.196C>T	RMRP		Metaphyseal chondrodysplasia, McKusick type|Anauxetic dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633393	9	35657820	9	35657823	633393	621308	rs948931144	NC_000009.12:35657822:G:A
NR_003051.3(RMRP):n.-24_-18dup	RMRP		Anauxetic dysplasia|Metaphyseal chondrodysplasia, McKusick type	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553917	9	35658032 - 35658033	9	35658035 - 35658036	553917	545409	rs1554651543	NC_000009.12:35658035:GAGTAGT:GAGTAGTGAGTAGT
NC_000007.13:g.(?_16348138)_(16415876_?)del	CRPPA		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000663410	7	16348138 - 16415876	7	16308513 - 16376251	663410	651612		
NM_001101426.4(CRPPA):c.1315G>T (p.Glu439Ter)	CRPPA	E439*, E389*, E404*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561033	7	16131361	7	16091736	561033	552117	rs1202301143	NC_000007.14:16091735:C:A
NM_001101426.4(CRPPA):c.643C>T (p.Gln215Ter)	CRPPA	Q215*	ISPD-Related Disorder|not provided	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282846	7	16415758	7	16376133	282846	267083	rs370627877	NC_000007.14:16376132:G:A
NM_138361.5(LRSAM1):c.1913-1G>A	LRSAM1		Charcot-Marie-Tooth disease type 2P|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000204301	9	130263288	9	127501009	204301	200697	rs756880678	NC_000009.12:127501008:G:A
NM_001101426.4(CRPPA):c.1354T>A (p.Ter452Arg)	CRPPA	*452R, *417R, *402R	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561034	7	16131322	7	16091697	561034	552116	rs186882839	NC_000007.14:16091696:A:T
NM_001101426.3(CRPPA):c.(535_684)+6399_(535_684)+14526del	CRPPA		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031562	7	16401191 - 16431594	7	16361566 - 16391969	31562	40242		
NM_000322.5(PRPH2):c.499G>A (p.Gly167Ser)	PRPH2	G167S	PRPH2-Related Disorders|Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143070	6	42689574	6	42721836	143070	152788	rs527236098	NC_000006.12:42721835:C:T
NM_000287.4(PEX6):c.2440C>T (p.Arg814Ter)	PEX6	R814*, R726*	Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|not provided|Peroxisome biogenesis disorder 4a (zellweger)|Heimler syndrome 2|Peroxisome biogenesis disorder 4B	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194165	6	42933450	6	42965712	194165	191328	rs267608241	NC_000006.12:42965711:G:A
NM_000255.4(MMUT):c.2125-3C>G	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000657043	6	49399572	6	49431859	657043	651561		NC_000006.12:49431858:G:C
NM_000255.4(MMUT):c.257C>T (p.Pro86Leu)	MMUT	P86L	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553773	6	49426923	6	49459210	553773	544068	rs769348060	NC_000006.12:49459209:G:A
NM_000255.4(MMUT):c.693C>G (p.Tyr231Ter)	MMUT	Y231*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222920	6	49425464	6	49457751	222920	224641	rs879253834	NC_000006.12:49457750:G:C
NM_000255.4(MMUT):c.1663G>A (p.Ala555Thr)	MMUT	A555T	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203850	6	49412365	6	49444652	203850	200109	rs753564352	NC_000006.12:49444651:C:T
NM_000255.4(MMUT):c.1560+1G>T	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203849	6	49415382	6	49447669	203849	200111	rs200019422	NC_000006.12:49447668:C:A
GRCh38/hg38 9p24.3(chr9:556625-703693)x1	KANK1		See cases	Pathogenic(Last reviewed: Oct 19, 2010)	no assertion criteria provided	VCV000146577	9	556625 - 703693	9	556625 - 703693	146577	156328		
KANK1, DEL, PATERNAL ALLELE	KANK1		Cerebral palsy, spastic quadriplegic, 2	Pathogenic(Last reviewed: Dec 15, 2005)	no assertion criteria provided	VCV000002908					2908	17947		
NM_000288.4(PEX7):c.649G>A (p.Gly217Arg)	PEX7	G217R	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007782	6	137191043	6	136869905	7782	22821	rs121909152	NC_000006.12:136869904:G:A
NM_006940.6(SOX5):c.747_748del (p.Arg250fs)	SOX5	R215fs, R240fs, R250fs, R237fs	Lamb-shaffer syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000522101	12	23887680 - 23887681	12	23734746 - 23734747	522101	511984	rs1555301854	NC_000012.12:23734745:TT:
NM_001101426.4(CRPPA):c.258-1G>C	CRPPA		Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000287941	7	16445963	7	16406338	287941	272178	rs767978961	NC_000007.14:16406337:C:G
NM_001101426.4(CRPPA):c.802C>T (p.Arg268Ter)	CRPPA	R268*, R218*, R233*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031568	7	16341079	7	16301454	31568	40248	rs368593151	NC_000007.14:16301453:G:A
NM_006059.4(LAMC3):c.1033_1039del (p.Ser345fs)	LAMC3	S345fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000521645	9	133914307 - 133914313	9	131038920 - 131038926	521645	511805	rs1426926688	NC_000009.12:131038919:AGCACAG:
NM_006258.4(PRKG1):c.575G>A (p.Arg192Gln)	PRKG1	R177Q, R192Q	not provided|Aortic aneurysm, familial thoracic 8|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065477	10	53227579	10	51467819	65477	76388	rs397515330	NC_000010.11:51467818:G:A
NM_006731.2(FKTN):c.369+1G>C	FKTN		not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000596647	9	108363630	9	105601349	596647	587708	rs764125009	NC_000009.12:105601348:G:C
NM_006731.2(FKTN):c.911-1G>A	FKTN		not provided	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000595560	9	108380239	9	105617958	595560	586622	rs958678700	NC_000009.12:105617957:G:A
NM_001079802.1(FKTN):c.657dup (p.Gln220Thrfs)	FKTN		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000501684	9	108370108 - 108370109	9	105607827 - 105607828	501684	493108	rs1554754678	NC_000009.12:105607827:A:AA
NM_001079802.1(FKTN):c.*4375_*4376ins3062	FKTN		not provided	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	VCV000193830	9	108401920 - 108401921	9	105639639 - 105639640	193830	190993		
NM_006731.2(FKTN):c.1167_1168dup (p.Phe390fs)	FKTN		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000804217	9	108382336 - 108382337	9	105620055 - 105620056	804217	792576		NC_000009.12:105620055:AT:ATAT
NM_006731.2(FKTN):c.456_457del (p.Ser154fs)	FKTN	S131fs, S22fs, S154fs	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000283622	9	108366581 - 108366582	9	105604300 - 105604301	283622	267859	rs760731888	NC_000009.12:105604299:CAC:C
NM_006731.2(FKTN):c.369+1G>T	FKTN		not provided	Pathogenic(Last reviewed: Jan 30, 2015)	criteria provided, single submitter	VCV000235328	9	108363630	9	105601349	235328	237015	rs764125009	NC_000009.12:105601348:G:T
FKTN, 473-BP DEL, NT5370	FKTN		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000003212					3212	18251		
NM_006731.2(FKTN):c.1363del (p.Asp455fs)	FKTN	D323fs, D432fs, D455fs	Limb-girdle muscular dystrophy-dystroglycanopathy, type C4	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000003207	9	108397520	9	105635239	3207	18246	rs587777814	NC_000009.12:105635238:GGG:GG
NM_006731.2(FKTN):c.454dup (p.Ser152fs)	FKTN		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003205	9	108366579 - 108366580	9	105604298 - 105604299	3205	18244	rs587777748	NC_000009.12:105604298:T:TT
FKTN, L1 INS	FKTN		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000003202					3202	18241		
NM_006731.2(FKTN):c.187_188del (p.Met63fs)	FKTN	M63fs, M40fs	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Jul 23, 1998)	no assertion criteria provided	VCV000003201	9	108363446 - 108363447	9	105601165 - 105601166	3201	18240	rs587777813	NC_000009.12:105601164:TAT:T
NM_000543.5(SMPD1):c.84del (p.Gly29fs)	SMPD1	G29fs	Niemann-Pick disease, type A	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000551367	11	6411908	11	6390678	551367	546338	rs750157176	NC_000011.10:6390677:CCCCC:CCCC
NM_000543.5(SMPD1):c.509G>A (p.Trp170Ter)	SMPD1	W170*, W169*	Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000529233	11	6412804	11	6391574	529233	526300	rs1554934193	NC_000011.10:6391573:G:A
NM_006731.2(FKTN):c.329_330del (p.Phe110fs)	FKTN	F87fs, F110fs	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000844703	9	108363588 - 108363589	9	105601307 - 105601308	844703	835302		NC_000009.12:105601306:TTT:T
NC_000009.12:g.(?_105575023)_(105575147_?)del	FKTN		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000831068	9	108337304 - 108337428			831068	820036		
NM_006731.2(FKTN):c.868A>T (p.Lys290Ter)	FKTN	K290*, K267*, K158*	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000657849	9	108377646	9	105615365	657849	637566		NC_000009.12:105615364:A:T
NM_006731.2(FKTN):c.1153A>T (p.Lys385Ter)	FKTN	K362*, K385*, K253*	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000649651	9	108382323	9	105620042	649651	637570		NC_000009.12:105620041:A:T
NM_006731.2(FKTN):c.432del (p.Arg146fs)	FKTN	R123fs, R14fs, R146fs	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000648485	9	108366558	9	105604277	648485	637559		NC_000009.12:105604276:T:
NM_006731.2(FKTN):c.403_404insGCCTAAATCT (p.Phe135fs)	FKTN		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000566601	9	108366528 - 108366529	9	105604247 - 105604248	566601	568328	rs1564290459	NC_000009.12:105604247:T:TGCCTAAATCT
FKTN, 1-BP DEL, 42G	FKTN		Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003217					3217	18256		
NM_006731.2(FKTN):c.509C>A (p.Ala170Glu)	FKTN	A170E, A38E, A147E	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000003214	9	108366635	9	105604354	3214	18253	rs119464997	NC_000009.12:105604353:C:A
NM_006731.2(FKTN):c.1073A>C (p.Gln358Pro)	FKTN	Q358P, Q335P, Q226P	Dilated cardiomyopathy 1X	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000003209	9	108382243	9	105619962	3209	18248	rs119463993	NC_000009.12:105619961:A:C
NM_019098.4(CNGB3):c.644-1G>C	CNGB3		Achromatopsia|Achromatopsia 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188780	8	87679362	8	86667134	188780	186769	rs201794629	NC_000008.11:86667133:C:G
NM_006731.2(FKTN):c.658C>T (p.Gln220Ter)	FKTN	Q220*, Q88*, Q197*	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000842546	9	108370110	9	105607829	842546	835305		NC_000009.12:105607828:C:T
NM_006731.2(FKTN):c.766C>T (p.Arg256Ter)	FKTN	R233*, R124*, R256*	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000842124	9	108370218	9	105607937	842124	835308		NC_000009.12:105607936:C:T
NM_006731.2(FKTN):c.330dup (p.Thr111fs)	FKTN		not provided|Fukuyama congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	VCV000281839	9	108363587 - 108363588	9	105601306 - 105601307	281839	266076	rs767865405	NC_000009.12:105601306:TTT:TTTT
NM_003002.4(SDHD):c.315G>A (p.Trp105Ter)	SDHD	W105*, W66*, W57*	Pheochromocytoma|Paragangliomas 1	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000412497	11	111965529	11	112094805	412497	398031	rs1060503769	NC_000011.10:112094804:G:A
NM_003002.4(SDHD):c.242del (p.Pro81fs)	SDHD	P81fs, P42fs	Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000239464	11	111959662	11	112088938	239464	241045	rs878854591	NC_000011.10:112088937:CC:C
NM_003002.4(SDHD):c.173del (p.Gly58fs)	SDHD	G58fs, G19fs	Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000239461	11	111959593	11	112088869	239461	241043	rs878854590	NC_000011.10:112088868:GG:G
NM_003002.4(SDHD):c.10dup (p.Leu4fs)	SDHD		Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000239460	11	111957640 - 111957641	11	112086916 - 112086917	239460	241038	rs878854589	NC_000011.10:112086916:C:CC
NM_003002.3(SDHD):c.-84_*831del	SDHD		Paragangliomas 1|Pheochromocytoma	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000239459	11	111957548 - 111966525	11	112086824 - 112095801	239459	240898		
NM_000255.4(MMUT):c.1531C>T (p.Arg511Ter)	MMUT	R511*	Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556124	6	49415412	6	49447699	556124	544140	rs761525156	NC_000006.12:49447698:G:A
NM_000255.4(MMUT):c.850G>T (p.Gly284Ter)	MMUT	G284*	Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553762	6	49423854	6	49456141	553762	544057	rs761477436	NC_000006.12:49456140:C:A
NM_000255.4(MMUT):c.1880A>G (p.His627Arg)	MMUT	H627R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551830	6	49407995	6	49440282	551830	543994	rs372486357	NC_000006.12:49440281:T:C
NM_000255.4(MMUT):c.970G>A (p.Ala324Thr)	MMUT	A324T	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550893	6	49421411	6	49453698	550893	544049	rs780387525	NC_000006.12:49453697:C:T
NM_032634.4(PIGO):c.1810dup (p.Arg604fs)	PIGO		not provided|Hyperphosphatasia-intellectual disability syndrome|Hyperphosphatasia with mental retardation syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286126	9	35092073 - 35092074	9	35092076 - 35092077	286126	270363	rs774508288	NC_000009.12:35092076:GGGG:GGGGG
NM_000255.4(MMUT):c.2194_2197delinsTGGAA (p.Ala732fs)	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222942	6	49399497 - 49399500	6	49431784 - 49431787	222942	224619	rs879253851	NC_000006.12:49431783:CGGC:TTCCA
NM_000255.4(MMUT):c.607G>A (p.Gly203Arg)	MMUT	G203R	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000218987	6	49425550	6	49457837	218987	216050	rs778702777	NC_000006.12:49457836:C:T
NC_000009.12:g.(?_105606576)_(105641128_?)del	FKTN		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000830968	9	108368857 - 108403409			830968	820038		
NM_000448.2(RAG1):c.322C>T (p.Arg108Ter)	RAG1	R108*	RAG1-Related Disorders||Combined cellular and humoral immune defects with granulomas|not provided|Severe combined immunodeficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036714	11	36595176	11	36573626	36714	45375	rs193922464	NC_000011.10:36573625:C:T
NM_001360.2(DHCR7):c.1349_1350delinsTG (p.Arg450Leu)	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000652894	11	71146499 - 71146500	11	71435453 - 71435454	652894	640438		NC_000011.10:71435452:GC:CA
NM_000050.4(ASS1):c.970+5G>A	ASS1		Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265962	9	133364856	9	130489469	265962	260673	rs372128852	NC_000009.12:130489468:G:A
NM_018972.4(GDAP1):c.469A>C (p.Thr157Pro)	GDAP1	T157P, T48P, T89P	Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000004199	8	75272530	8	74360295	4199	19238	rs104894079	NC_000008.11:74360294:A:C
NM_018972.4(GDAP1):c.844C>T (p.Arg282Cys)	GDAP1	R282C, R214C, R224C, R173C	Charcot-Marie-Tooth disease, recessive intermediate A|not provided	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004195	8	75276369	8	74364134	4195	19234	rs28937906	NC_000008.11:74364133:C:T
NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	NC_000009.12:35065351:G:A
NM_006731.2(FKTN):c.346C>T (p.Gln116Ter)	FKTN	Q116*, Q93*	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000003206	9	108363606	9	105601325	3206	18245	rs119463991	NC_000009.12:105601324:C:T
NM_006731.2(FKTN):c.527T>C (p.Phe176Ser)	FKTN	F176S, F153S, F44S	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000003204	9	108366653	9	105604372	3204	18243	rs119463996	NC_000009.12:105604371:T:C
NM_194456.1(KRIT1):c.902C>G (p.Ser301Ter)	KRIT1	S301*, S63*	Cavernous hemangioma|not provided|Cerebral cavernous malformation	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523476	7	91863850	7	92234536	523476	513975	rs1554527169	NC_000007.14:92234535:G:C
NM_020745.4(AARS2):c.2146-2A>G	AARS2		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000520861	6	44270914	6	44303177	520861	511682	rs368934219	NC_000006.12:44303176:T:C
NM_000742.4(CHRNA2):c.1126C>T (p.Arg376Trp)	CHRNA2	R376W, R361W, R217W, R178W	Seizures, benign familial infantile, 6	Pathogenic(Last reviewed: Apr 19, 2018)	no assertion criteria provided	VCV000522581	8	27320834	8	27463317	522581	513195	rs1018084204	NC_000008.11:27463316:G:A
NM_000742.4(CHRNA2):c.889A>T (p.Ile297Phe)	CHRNA2	I297F, I282F, I99F, I138F	Epilepsy, nocturnal frontal lobe, type 4	Pathogenic(Last reviewed: Apr 19, 2018)	no assertion criteria provided	VCV000522582	8	27321071	8	27463554	522582	513196	rs1554514507	NC_000008.11:27463553:T:A
NM_000742.4(CHRNA2):c.836T>A (p.Ile279Asn)	CHRNA2	I279N, I81N, I120N, I264N	Epilepsy, nocturnal frontal lobe, type 4	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000017504	8	27321124	8	27463607	17504	32543	rs104894063	NC_000008.11:27463606:A:T
NR_003051.3(RMRP):n.147G>A	RMRP		Metaphyseal chondrodysplasia, McKusick type|not provided|Anauxetic dysplasia	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379208	9	35657869	9	35657872	379208	373048	rs753874439	NC_000009.12:35657871:C:T
NR_003051.3(RMRP):n.-19_-13dupTCTGTGA	RMRP		Metaphyseal chondrodysplasia, McKusick type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279883	9	35658027 - 35658028	9	35658030 - 35658031	279883	264540	rs1554651506	NC_000009.12:35658030:TCACAGA:TCACAGATCACAGA
NM_004281.3(BAG3):c.252_258dup (p.Pro87fs)	BAG3		Dilated cardiomyopathy	Pathogenic(Last reviewed: Mar 31, 2017)	no assertion criteria provided	VCV000560609	10	121429432 - 121429433	10	119669920 - 119669921	560609	551708	rs1564773559	NC_000010.11:119669920:CTGTGTAC:CTGTGTACTGTGTAC
NM_004281.3(BAG3):c.206dup (p.Ser70fs)	BAG3		not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000418720	10	121429385 - 121429386	10	119669873 - 119669874	418720	407818	rs1554876984	NC_000010.11:119669873:CCC:CCCC
NM_004281.3(BAG3):c.1292dup (p.Val432fs)	BAG3		Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000264518	10	121436356 - 121436357	10	119676844 - 119676845	264518	258633	rs886039182	NC_000010.11:119676844:AA:AAA
NM_004281.3(BAG3):c.626C>A (p.Pro209Gln)	BAG3	P209Q	Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000156530	10	121431885	10	119672373	156530	166295	rs121918312	NC_000010.11:119672372:C:A
NM_004281.4(BAG3):c.765G>A (p.Trp255Ter)	BAG3	W255*	Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000862211	10	121432024	10	119672512	862211	836663		NC_000010.11:119672511:G:A
NM_004281.4(BAG3):c.403C>T (p.Gln135Ter)	BAG3	Q135*	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000842686	10	121429585	10	119670073	842686	836656		NC_000010.11:119670072:C:T
NM_004281.3(BAG3):c.514C>T (p.Gln172Ter)	BAG3	Q172*	Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000648595	10	121431773	10	119672261	648595	638746		NC_000010.11:119672260:C:T
NM_004281.3(BAG3):c.537C>A (p.Cys179Ter)	BAG3	C179*	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000570844	10	121431796	10	119672284	570844	566179	rs1564774433	NC_000010.11:119672283:C:A
NM_004281.3(BAG3):c.146G>A (p.Trp49Ter)	BAG3	W49*	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000566338	10	121411333	10	119651821	566338	566176	rs1564767043	NC_000010.11:119651820:G:A
NM_004281.3(BAG3):c.277dup (p.Tyr93fs)	BAG3		Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000566318	10	121429458 - 121429459	10	119669946 - 119669947	566318	566178	rs1564773589	NC_000010.11:119669946:T:TT
NM_004281.3(BAG3):c.607dup (p.Arg203fs)	BAG3		Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000410229	10	121431865 - 121431866	10	119672353 - 119672354	410229	397567	rs1554877224	NC_000010.11:119672353:C:CC
NM_004281.3(BAG3):c.652del (p.Arg218fs)	BAG3	R218fs	Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000030398	10	121431909	10	119672397	30398	39355		NC_000010.11:119672396:CCC:CC
BAG3, EX4DEL	BAG3		Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000030395					30395	39352		
NM_000278.5(PAX2):c.76dup (p.Val26fs)	PAX2		Renal coloboma syndrome|Focal segmental glomerulosclerosis 7|Renal coloboma syndrome|Focal segmental glomerulosclerosis 7|not provided	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156297	10	102509528 - 102509529	10	100749771 - 100749772	156297	166077	rs75462234	NC_000010.11:100749771:GGGGGGG:GGGGGGGG
NM_004281.4(BAG3):c.974del (p.Pro325fs)	BAG3	P325fs	Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000854159	10	121436039	10	119676527	854159	836669		NC_000010.11:119676526:CC:C
NM_006269.2(RP1):c.1719_1723del (p.Ser574fs)	RP1	S574fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000191341	8	55538159 - 55538163	8	54625599 - 54625603	191341	189144	rs750542962	NC_000008.11:54625598:AACTCAA:AA
NM_014855.3(AP5Z1):c.1343_1346dup (p.Glu449fs)	AP5Z1		Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000590776	7	4827295 - 4827296	7	4787664 - 4787665	590776	581712	rs1562410566	NC_000007.14:4787664:CCGA:CCGACCGA
NM_014855.3(AP5Z1):c.706C>T (p.Gln236Ter)	AP5Z1	Q236*, Q80*	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000578441	7	4823918	7	4784287	578441	561630	rs988434253	NC_000007.14:4784286:C:T
NM_014855.3(AP5Z1):c.210_231del (p.Gln70fs)	AP5Z1	Q70fs	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000567257	7	4821224 - 4821245	7	4781593 - 4781614	567257	561959	rs1562404571	NC_000007.14:4781592:CTGCAGGCCACCCTCGGCCTGCCTGCA:CTGCA
NM_014855.3(AP5Z1):c.868del (p.Arg290fs)	AP5Z1	R134fs, R290fs	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000566755	7	4824613	7	4784982	566755	561635	rs756556933	NC_000007.14:4784981:CCCC:CCC
NM_014855.3(AP5Z1):c.1732C>T (p.Gln578Ter)	AP5Z1	Q578*, Q422*	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000375316	7	4829487	7	4789856	375316	362092	rs1057519342	NC_000007.14:4789855:C:T
NM_014855.3(AP5Z1):c.616C>T (p.Arg206Trp)	AP5Z1	R206W, R50W	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000375315	7	4823424	7	4783793	375315	362091	rs761451474	NC_000007.14:4783792:C:T
NM_014855.3(AP5Z1):c.1413_1426del (p.Leu473fs)	AP5Z1	L317fs, L473fs	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Jun 29, 2010)	no assertion criteria provided	VCV000000003	7	4827361 - 4827374	7	4787730 - 4787743	3	15042	rs397704709	NC_000007.14:4787729:CTGCTGGACCTGCCCTGCT:CTGCT
NM_014855.3(AP5Z1):c.80_83delinsTGCTGTAAACTGTAACTGTAAA (p.Arg27_Ile28delinsLeuLeuTer)	AP5Z1		Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Jun 29, 2010)	no assertion criteria provided	VCV000000002	7	4820844 - 4820847	7	4781213 - 4781216	2	15041	rs397704705	NC_000007.14:4781212:GGAT:TGCTGTAAACTGTAACTGTAAA
NM_006731.2(FKTN):c.42del (p.Thr14_Leu15insTer)	FKTN		Walker-Warburg congenital muscular dystrophy|Fukuyama congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555661	9	108337355	9	105575074	555661	545153	rs1309132512	NC_000009.12:105575073:G:
NM_014855.3(AP5Z1):c.1322G>A (p.Trp441Ter)	AP5Z1	W441*, W285*	Spastic paraplegia 48, autosomal recessive	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000375313	7	4827275	7	4787644	375313	362089	rs373919408	NC_000007.14:4787643:G:A
NM_001101426.4(CRPPA):c.53dup (p.Ser19Glufs)	CRPPA		Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|not provided	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279985	7	16460894 - 16460895	7	16421269 - 16421270	279985	264316	rs886041302	NC_000007.14:16421269:A:AA
NM_000255.4(MMUT):c.1022dup (p.Asn341fs)	MMUT		Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553958	6	49421358 - 49421359	6	49453645 - 49453646	553958	544144	rs752898811	NC_000006.12:49453645:TTTTT:TTTTTT
NM_000255.4(MMUT):c.670G>T (p.Glu224Ter)	MMUT	E224*	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552718	6	49425487	6	49457774	552718	543729	rs1554160638	NC_000006.12:49457773:C:A
NM_000255.4(MMUT):c.1677-1G>A	MMUT		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550012	6	49409685	6	49441972	550012	543691	rs754369323	NC_000006.12:49441971:C:T
NM_000255.4(MMUT):c.1025C>A (p.Ser342Ter)	MMUT	S342*	Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495777	6	49421356	6	49453643	495777	487143	rs770466993	NC_000006.12:49453642:G:T
NM_000255.4(MMUT):c.643G>T (p.Gly215Cys)	MMUT	G215C	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418341	6	49425514	6	49457801	418341	406882	rs121918258	NC_000006.12:49457800:C:A
NM_000255.4(MMUT):c.313T>C (p.Trp105Arg)	MMUT	W105R	not provided|METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001878	6	49426867	6	49459154	1878	16917	rs121918249	NC_000006.12:49459153:A:G
NM_004281.4(BAG3):c.946C>T (p.Gln316Ter)	BAG3	Q316*	Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000840339	10	121436012	10	119676500	840339	836667		NC_000010.11:119676499:C:T
NC_000010.10:g.(?_121435966)_(121437012_?)del	BAG3		Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000645351	10	121435966 - 121437012	10	119676454 - 119677500	645351	652253		
NM_004281.3(BAG3):c.855_859dup (p.Leu287fs)	BAG3		Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373624	10	121432110 - 121432111	10	119672598 - 119672599	373624	359800	rs1057518511	NC_000010.11:119672598:CACGCCAC:CACGCCACGCCAC
NM_004281.3(BAG3):c.268C>T (p.Arg90Ter)	BAG3	R90*	Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related|not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372723	10	121429450	10	119669938	372723	359836	rs1057517945	NC_000010.11:119669937:C:T
NM_004281.3(BAG3):c.699C>A (p.Tyr233Ter)	BAG3	Y233*	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234982	10	121431958	10	119672446	234982	236775	rs876661342	NC_000010.11:119672445:C:A
NM_024596.5(MCPH1):c.427dup (p.Thr143fs)	MCPH1		Abnormality of brain morphology|Primary autosomal recessive microcephaly 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003455	8	6293668 - 6293669	8	6436147 - 6436148	3455	18494	rs199422125	NC_000008.11:6436147:AAAAAA:AAAAAAA
NM_002047.4(GARS1):c.373G>A (p.Glu125Lys)	GARS1	E125K, E71K	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 22, 2013)	criteria provided, single submitter	VCV000208650	7	30639611	7	30599995	208650	205253	rs797044855	NC_000007.14:30599994:G:A
NM_004562.3(PRKN):c.220_221dup (p.Trp74fs)	PRKN		not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000817926	6	162683747 - 162683748	6	162262715 - 162262716	817926	805490		NC_000006.12:162262715:CAC:CACAC
GRCh37/hg19 6q26(chr6:162614287-162660066)x1	PRKN		not provided	Pathogenic(Last reviewed: Nov 30, 2017)	no assertion criteria provided	VCV000688838	6	162614287 - 162660066			688838	676430		
NM_033305.3(VPS13A):c.6358A>T (p.Lys2120Ter)	VPS13A	K2120*, K2081*	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000620232	9	79952433	9	77337517	620232	611722	rs1409849850	NC_000009.12:77337516:A:T
NM_033305.3(VPS13A):c.4956+1G>A	VPS13A		not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000426835	9	79932615	9	77317699	426835	415201	rs1085307823	NC_000009.12:77317698:G:A
NM_033305.3(VPS13A):c.9427_9428AG[2] (p.Glu3144fs)	VPS13A		not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426695	9	80022476 - 80022477	9	77407560 - 77407561	426695	415202	rs1085307750	NC_000009.12:77407559:AGAGAG:AGAG
NM_033305.3(VPS13A):c.799C>T (p.Arg267Ter)	VPS13A	R267*	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000373362	9	79834914	9	77219998	373362	359751	rs771004767	NC_000009.12:77219997:C:T
NM_033305.3(VPS13A):c.3889C>T (p.Arg1297Ter)	VPS13A	R1297*, R1258*	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000372726	9	79917907	9	77302991	372726	359940	rs200280742	NC_000009.12:77302990:C:T
NM_033305.3(VPS13A):c.849_853ACATA[1] (p.Asn285fs)	VPS13A		not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000862157	9	79834964 - 79834968	9	77220048 - 77220052	862157	836237		NC_000009.12:77220047:ACATAACATA:ACATA
NM_033305.3(VPS13A):c.952A>T (p.Lys318Ter)	VPS13A	K318*	not provided	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000861864	9	79835262	9	77220346	861864	836238		NC_000009.12:77220345:A:T
NM_033305.3(VPS13A):c.2953C>T (p.Gln985Ter)	VPS13A	Q985*	not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000857353	9	79896831	9	77281915	857353	836242		NC_000009.12:77281914:C:T
NM_033305.3(VPS13A):c.9068del (p.Gly3023fs)	VPS13A	G2984fs, G3023fs	not provided	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000856594	9	79986054	9	77371138	856594	836248		NC_000009.12:77371137:GGG:GG
NM_033305.3(VPS13A):c.2149C>T (p.Gln717Ter)	VPS13A	Q717*	not provided	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000852695	9	79865124	9	77250208	852695	836240		NC_000009.12:77250207:C:T
NM_033305.3(VPS13A):c.6581T>G (p.Leu2194Ter)	VPS13A	L2155*, L2194*	not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000851400	9	79954634	9	77339718	851400	836247		NC_000009.12:77339717:T:G
NM_033305.3(VPS13A):c.3184C>T (p.Gln1062Ter)	VPS13A	Q1062*	not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000850391	9	79898336	9	77283420	850391	836244		NC_000009.12:77283419:C:T
NM_033305.3(VPS13A):c.2765dup (p.Tyr922Ter)	VPS13A		not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000846229	9	79891077 - 79891078	9	77276161 - 77276162	846229	836241		NC_000009.12:77276161:A:AA
NM_033305.3(VPS13A):c.218del (p.Asn73fs)	VPS13A	N73fs	not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000840760	9	79820255	9	77205339	840760	836236		NC_000009.12:77205338:AAAAA:AAAA
NC_000009.12:g.(?_77250087)_(77252362_?)del	VPS13A		not provided	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000831921	9	79865003 - 79867278			831921	820166		
NC_000009.12:g.(?_77280149)_(77295856_?)del	VPS13A		not provided	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000831900	9	79895065 - 79910772			831900	820167		
NM_033305.3(VPS13A):c.257_260TTTA[1] (p.Leu88_Leu89insTer)	VPS13A		not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000664894	9	79820297 - 79820300	9	77205381 - 77205384	664894	638386		NC_000009.12:77205380:ATTTATTTA:ATTTA
NM_033305.3(VPS13A):c.1108A>T (p.Lys370Ter)	VPS13A	K370*	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000648063	9	79836219	9	77221303	648063	638387		NC_000009.12:77221302:A:T
NM_033305.3(VPS13A):c.4498dup (p.Ala1500fs)	VPS13A		not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000647689	9	79930253 - 79930254	9	77315337 - 77315338	647689	638389		NC_000009.12:77315337:G:GG
NM_033305.3(VPS13A):c.6094C>T (p.Arg2032Ter)	VPS13A	R2032*, R1993*	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000645922	9	79947028	9	77332112	645922	638390		NC_000009.12:77332111:C:T
NM_033305.3(VPS13A):c.9078-4708_9078-4707del	VPS13A		primray hypomagnesemia with secondary hypocalcemia	Pathogenic	criteria provided, single submitter	VCV000585205	9	79992184 - 79992185	9	77377268 - 77377269	585205	576254	rs1563974797	NC_000009.12:77377267:GG:
GRCh37/hg19 6q26(chr6:162638345-162754162)x0	PRKN		See cases	Pathogenic(Last reviewed: Sep 1, 2015)	no assertion criteria provided	VCV000443700	6	162638345 - 162754162			443700	437362		
VPS13A, 2-BP DUP, 3556AC	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Dec 18, 2019)	no assertion criteria provided	VCV000004690					4690	19729		
NM_033305.3(VPS13A):c.5905_5906AG[2] (p.Glu1970fs)	VPS13A		not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000857694	9	79938057 - 79938058	9	77323141 - 77323142	857694	836245		NC_000009.12:77323140:AGAGAG:AGAG
NM_004562.3(PRKN):c.97C>T (p.Arg33Ter)	PRKN	R33*	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000853293	6	162864416	6	162443384	853293	831749		NC_000006.12:162443383:G:A
NM_033305.3(VPS13A):c.3157C>T (p.Gln1053Ter)	VPS13A	Q1053*	not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000849426	9	79898309	9	77283393	849426	836243		NC_000009.12:77283392:C:T
NM_004562.3(PRKN):c.337_376del (p.Pro113fs)	PRKN	P113fs	not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000846957	6	162683593 - 162683632	6	162262561 - 162262600	846957	831746		NC_000006.12:162262560:CAGTGTGCAGAATGACAGCCAGCCCCACAGAGTCTCCTGG:
NC_000006.12:g.(?_161973292)_(161973427_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000832477	6	162394324 - 162394459			832477	819674		
NC_000006.12:g.(?_161973292)_(161973427_?)del	PRKN		not provided	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000831905	6	162394324 - 162394459			831905	819673		
NC_000009.12:g.(?_77212959)_(77213324_?)del	VPS13A		not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000831596	9	79827875 - 79828240			831596	820165		
NC_000009.12:g.(?_77209413)_(77276231_?)del	VPS13A		not provided	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000830870	9	79824329 - 79891147			830870	820164		
NM_033305.3(VPS13A):c.4918C>T (p.Gln1640Ter)	VPS13A	Q1601*, Q1640*	Choreoacanthocytosis	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000830219	9	79932576	9	77317660	830219	818580		NC_000009.12:77317659:C:T
NM_033305.3(VPS13A):c.555+1G>A	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000818223	9	79825592	9	77210676	818223	806436		NC_000009.12:77210675:G:A
NM_033305.3(VPS13A):c.337C>T (p.Gln113Ter)	VPS13A	Q113*	Choreoacanthocytosis	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000812513	9	79820947	9	77206031	812513	800756		NC_000009.12:77206030:C:T
NC_000006.11:g.(?_162683547)_(162683807_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000643720	6	162683547 - 162683807	6	162262515 - 162262775	643720	651546		
NM_033305.3(VPS13A):c.1305G>A (p.Trp435Ter)	VPS13A	W435*	Choreoacanthocytosis	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000037235	9	79841462	9	77226546	37235	45830		NC_000009.12:77226545:G:A
VPS13A, 37-KB DEL	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000004689					4689	19728		
VPS13A, 7-KB DEL	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000004688					4688	19727		
VPS13A, 1-BP DEL, 6059C	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000004687					4687	19726		
VPS13A, 260-BP DEL	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000004684					4684	19723		
NM_033305.3(VPS13A):c.6404dup (p.Ser2136fs)	VPS13A		Choreoacanthocytosis	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000004683	9	79954456 - 79954457	9	77339540 - 77339541	4683	19722		NC_000009.12:77339540:T:TT
NM_033305.3(VPS13A):c.269T>A (p.Ile90Lys)	VPS13A	I90K	Choreoacanthocytosis	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000004682	9	79820310	9	77205394	4682	19721	rs119477052	NC_000009.12:77205393:T:A
NM_033305.3(VPS13A):c.9403C>T (p.Arg3135Ter)	VPS13A	R3096*, R3135*	not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000860008	9	80022452	9	77407536	860008	836250		NC_000009.12:77407535:C:T
NM_033305.3(VPS13A):c.1400_1401del (p.Leu466_Tyr467insTer)	VPS13A		not provided	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000851289	9	79842348 - 79842349	9	77227432 - 77227433	851289	836239		NC_000009.12:77227431:TAT:T
NM_004562.3(PRKN):c.804T>A (p.Cys268Ter)	PRKN	C240*, C268*, C119*	not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000805244	6	162206871	6	161785839	805244	793178		NC_000006.12:161785838:A:T
NM_033305.3(VPS13A):c.6283del (p.Ser2095fs)	VPS13A	S2095fs, S2056fs	Choreoacanthocytosis	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000667398	9	79952357	9	77337441	667398	654549		NC_000009.12:77337440:TT:T
NC_000006.11:g.(?_162864332)_(162864519_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000658968	6	162864332 - 162864519	6	162443300 - 162443487	658968	651499		
NC_000006.11:g.(?_162206794)_(162206950_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000657369	6	162206794 - 162206950	6	161785762 - 161785918	657369	651489		
NM_033305.3(VPS13A):c.3556_3557dup (p.Val1187fs)	VPS13A		not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000654006	9	79910505 - 79910506	9	77295589 - 77295590	654006	638388		NC_000009.12:77295589:AC:ACAC
NC_000006.11:g.(?_161969876)_(161990458_?)del	PRKN		not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000640466	6	161969876 - 161990458	6	161548844 - 161569426	640466	651579		
NM_033305.3(VPS13A):c.4411C>T (p.Arg1471Ter)	VPS13A	R1471*, R1432*	not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000448862	9	79929579	9	77314663	448862	441347	rs1193250444	NC_000009.12:77314662:C:T
NM_033305.3(VPS13A):c.8035G>A (p.Ala2679Thr)	VPS13A	A2640T, A2679T	Choreoacanthocytosis	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000004686	9	79973354	9	77358438	4686	19725		NC_000009.12:77358437:G:A
NM_033305.3(VPS13A):c.622C>T (p.Arg208Ter)	VPS13A	R208*	Choreoacanthocytosis	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000004685	9	79828156	9	77213240	4685	19724	rs119477053	NC_000009.12:77213239:C:T
NM_005609.4(PYGM):c.1827G>A (p.Lys609=)	PYGM	K608K	Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002313	11	64519069	11	64751597	2313	17352	rs119103259	NC_000011.10:64751596:C:T
NM_005609.4(PYGM):c.1726C>T (p.Arg576Ter)	PYGM	R575*, R576*, R488*	Glycogen storage disease, type V|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002307	11	64519438	11	64751966	2307	17346	rs119103255	NC_000011.10:64751965:G:A
NM_004281.3(BAG3):c.1034_1038del (p.Glu345fs)	BAG3	E345fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000519116	10	121436099 - 121436103	10	119676587 - 119676591	519116	510153	rs1554877731	NC_000010.11:119676586:GAGGTG:G
NM_004281.3(BAG3):c.481C>T (p.Gln161Ter)	BAG3	Q161*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	VCV000264102	10	121429663	10	119670151	264102	258630	rs886039044	NC_000010.11:119670150:C:T
NM_033305.3(VPS13A):c.6059del (p.Pro2020fs)	VPS13A	P1981fs, P2020fs	not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000838917	9	79946992	9	77332076	838917	836246		NC_000009.12:77332075:CC:C
NM_033305.3(VPS13A):c.9109C>T (p.Arg3037Ter)	VPS13A	R2998*, R3037*	not provided	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000834822	9	79996923	9	77382007	834822	836249		NC_000009.12:77382006:C:T
NC_000006.11:g.(?_162206784)_(162206960_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000639364	6	162206784 - 162206960	6	161785752 - 161785928	639364	651540		
NC_000006.11:g.(?_162394314)_(162475226_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000583917	6	162394314 - 162475226	6	161973282 - 162054194	583917	560506		
NM_004562.3(PRKN):c.560T>G (p.Leu187Ter)	PRKN	L187*	Parkinson disease 2	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000582111	6	162475181	6	162054149	582111	560503	rs1562485799	NC_000006.12:162054148:A:C
NC_000006.11:g.(?_162622143)_(162622304_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000468578			6	162201111 - 162201272	468578	455265		
NC_000006.11:g.(?_162475123)_(162475206_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000417464	6	162475123 - 162475206	6	162054091 - 162054174	417464	395171		
NC_000006.11:g.(?_162622163)_(162864505_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000417459	6	162622163 - 162864505	6	162201131 - 162443473	417459	395641		
PARK2, EX5-6DEL	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000007055					7055	22094		
NM_004562.3(PRKN):c.633A>T (p.Lys211Asn)	PRKN	K211N, K62N, K183N	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007051	6	162394435	6	161973403	7051	22090	rs137853060	NC_000006.12:161973402:T:A
NM_004562.2(PRKN):c.872-?_1083+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Oct 24, 1998)	no assertion criteria provided	VCV000007041	6	161969886 - 161990448	6	161548854 - 161569416	7041	22080		
PARK2, DEL	PRKN		Neoplasm of ovary	Pathogenic(Last reviewed: May 13, 2003)	no assertion criteria provided	VCV000007039					7039	22078		
NM_004562.2(PRKN):c.172-?_871+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 9, 1998)	no assertion criteria provided	VCV000007034	6	162206804 - 162683797	6	161785772 - 162262765	7034	22073		
NM_019098.4(CNGB3):c.1578+1G>A	CNGB3		Achromatopsia|not provided|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189031	8	87638210	8	86625982	189031	186764	rs372006750	NC_000008.11:86625981:C:T
NC_000006.12:g.(?_162201121)_(162443487_?)del	PRKN		not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000833036	6	162622153 - 162864519			833036	819678		
NC_000006.12:g.(?_161973292)_(162054184_?)del	PRKN		not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000830475	6	162394324 - 162475216			830475	819675		
NM_004562.3(PRKN):c.101del (p.Gln34fs)	PRKN	Q34fs	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810636	6	162864412	6	162443380	810636	798915		NC_000006.12:162443379:T:
NC_000006.11:g.(?_162683547)_(162864519_?)del	PRKN		not provided	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000656296	6	162683547 - 162864519	6	162262515 - 162443487	656296	651495		
NC_000006.11:g.(?_162622153)_(162683807_?)del	PRKN		not provided	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000650192	6	162622153 - 162683807	6	162201121 - 162262775	650192	651468		
NC_000006.11:g.(?_161990367)_(161990468_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000583674	6	161990367 - 161990468	6	161569335 - 161569436	583674	560399		
NM_004562.3(PRKN):c.1292G>T (p.Cys431Phe)	PRKN	C431F, C403F, C282F	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000050354	6	161771237	6	161350205	50354	59479	rs397514694	NC_000006.12:161350204:C:A
PARK2, 1-BP DEL, 1072T	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007052					7052	22091		
PARK2, 1-BP DEL, 255A	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007048					7048	22087		
PARK2, 1-BP DEL, 202A	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 22, 2003)	no assertion criteria provided	VCV000007044					7044	22083		
NM_004562.3(PRKN):c.483A>T (p.Lys161Asn)	PRKN	K161N	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007043	6	162622214	6	162201182	7043	22082	rs137853057	NC_000006.12:162201181:T:A
NM_004562.3(PRKN):c.931C>T (p.Gln311Ter)	PRKN	Q311*, Q162*, Q283*	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007037	6	161990389	6	161569357	7037	22076	rs137853055	NC_000006.12:161569356:G:A
NM_004562.3(PRKN):c.719C>G (p.Thr240Arg)	PRKN	T240R, T212R, T91R	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007036	6	162394349	6	161973317	7036	22075	rs137853054	NC_000006.12:161973316:G:C
NM_213674.1(TPM2):c.349G>A (p.Glu117Lys)	TPM2	E117K	Distal arthrogryposis type 1A|Nemaline myopathy 4|not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012462	9	35685669	9	35685672	12462	27501	rs104894129	NC_000009.12:35685671:C:T
NM_018941.3(CLN8):c.499G>T (p.Glu167Ter)	CLN8	E167*	|Neuronal ceroid lipofuscinosis|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205194	8	1719719	8	1771553	205194	202209	rs144495588	NC_000008.11:1771552:G:T
NM_018941.3(CLN8):c.70C>G (p.Arg24Gly)	CLN8	R24G	Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant||Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002802	8	1719290	8	1771124	2802	17841	rs104894064	NC_000008.11:1771123:C:G
GRCh37/hg19 6q22.31(chr6:123551934-123597121)x1	TRDN		not provided	Pathogenic(Last reviewed: Mar 30, 2018)	no assertion criteria provided	VCV000685818	6	123551934 - 123597121			685818	673410		
GRCh37/hg19 6q22.31(chr6:123815422-123951153)x1	TRDN		not provided	Pathogenic(Last reviewed: Dec 11, 2017)	no assertion criteria provided	VCV000685063	6	123815422 - 123951153			685063	672655		
NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer)	TRDN		not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000449691	6	123851693 - 123851697	6	123530548 - 123530552	449691	443865	rs752256846	NC_000006.12:123530547:TCTTATCTT:TCTT
NM_006073.4(TRDN):c.529A>T (p.Lys177Ter)	TRDN	K177*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000583099	6	123837307	6	123516162	583099	560566	rs1468290898	NC_000006.12:123516161:T:A
NM_006073.4(TRDN):c.1375A>T (p.Arg459Ter)	TRDN	R459*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000573657	6	123658809	6	123337664	573657	560431	rs1562267979	NC_000006.12:123337663:T:A
NM_006073.4(TRDN):c.1923_1924del (p.Leu643fs)	TRDN	L643fs	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000532364	6	123576253 - 123576254	6	123255108 - 123255109	532364	521715	rs781420323	NC_000006.12:123255107:TTT:T
NM_006073.4(TRDN):c.1806del (p.Gly603fs)	TRDN	G603fs	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000532317	6	123586463	6	123265318	532317	521723	rs1381728472	NC_000006.12:123265317:TT:T
NM_006073.4(TRDN):c.573dup (p.Lys192fs)	TRDN		Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000532312	6	123833484 - 123833485	6	123512339 - 123512340	532312	521735	rs1554251609	NC_000006.12:123512339:C:CC
NM_006073.4(TRDN):c.1934T>G (p.Leu645Ter)	TRDN	L645*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000532311	6	123576243	6	123255098	532311	521633	rs747836980	NC_000006.12:123255097:A:C
NM_006073.4(TRDN):c.618del (p.Ala208fs)	TRDN	A208fs	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000408737	6	123825039	6	123503894	408737	395202	rs1060502114	NC_000006.12:123503893:C:
NM_006073.4(TRDN):c.176C>G (p.Thr59Arg)	TRDN	T59R	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	VCV000066017	6	123892124	6	123570979	66017	76927	rs397515459	NC_000006.12:123570978:G:C
NM_006073.4(TRDN):c.502G>T (p.Glu168Ter)	TRDN	E168*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000838068	6	123837334	6	123516189	838068	831486		NC_000006.12:123516188:C:A
NM_006073.4(TRDN):c.1187-2A>G	TRDN		Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561136	6	123699045	6	123377900	561136	552091	rs578024729	NC_000006.12:123377899:T:C
NM_001134831.2(AHI1):c.2168G>A (p.Arg723Gln)	AHI1	R723Q	Joubert syndrome|Joubert syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002015	6	135754263	6	135433125	2015	17054	rs121434351	NC_000006.12:135433124:C:T
NM_004281.3(BAG3):c.625C>T (p.Pro209Ser)	BAG3	P209S	Peripheral axonal neuropathy|Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000657299	10	121431884	10	119672372	657299	638747		NC_000010.11:119672371:C:T
NM_004281.4(BAG3):c.77G>A (p.Trp26Ter)	BAG3	W26*	not provided|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505229	10	121411264	10	119651752	505229	497125	rs1554875409	NC_000010.11:119651751:G:A
NM_004281.4(BAG3):c.730C>T (p.Gln244Ter)	BAG3	Q244*	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228246	10	121431989	10	119672477	228246	229742	rs876657634	NC_000010.11:119672476:C:T
NC_000006.11:g.(?_162475113)_(162475216_?)del	PRKN		not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000663416	6	162475113 - 162475216	6	162054081 - 162054184	663416	651544		
NC_000006.11:g.(?_162864322)_(162864525_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000468582	6	162864322 - 162864525	6	162443290 - 162443493	468582	455272		
NM_004562.2(PRKN):c.735-?_871+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007045	6	162206804 - 162206940	6	161785772 - 161785908	7045	22084		
NC_000011.10:g.(?_112086902)_(112094975_?)del	SDHD		Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 1|Cowden syndrome 3	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832458	11	111957626 - 111965699			832458	820333		
NC_000011.9:g.(?_111957622)_(111965704_?)del	SDHD		Paragangliomas 1|Pheochromocytoma|Cowden syndrome 3|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000584168	11	111957622 - 111965704	11	112086898 - 112094980	584168	569941		
NM_006073.4(TRDN):c.1282C>T (p.Arg428Ter)	TRDN	R428*, R429*	Catecholaminergic polymorphic ventricular tachycardia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000532333	6	123687319	6	123366174	532333	521985	rs202219343	NC_000006.12:123366173:G:A
NM_006073.4(TRDN):c.1900_1903del (p.Glu634fs)	TRDN	E634fs	not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423985	6	123577015 - 123577018	6	123255870 - 123255873	423985	406797	rs750469686	NC_000006.12:123255869:TTTCTT:TT
NM_000543.5(SMPD1):c.1785_1786del (p.Ala597fs)	SMPD1	A290fs, A597fs, A553fs, A596fs	Niemann-Pick disease, type A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370328	11	6415725 - 6415726	11	6394495 - 6394496	370328	357998	rs1057516403	NC_000011.10:6394494:TTT:T
NM_000543.5(SMPD1):c.1418_1419CT[1] (p.Leu474fs)	SMPD1		Niemann-Pick disease, type A|not specified|not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093314	11	6415203 - 6415204	11	6393973 - 6393974	93314	99221	rs398123476	NC_000011.10:6393972:CTCT:CT
NM_152743.4(BRAT1):c.1201_1202TG[1] (p.Cys401_Asp402delinsTer)	BRAT1		not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000426933	7	2581049 - 2581050	7	2541415 - 2541416	426933	415095	rs773772842	NC_000007.14:2541414:CACA:CA
NM_152743.4(BRAT1):c.1771-1G>A	BRAT1		not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424247	7	2578399	7	2538765	424247	407118	rs1064796877	NC_000007.14:2538764:C:T
NM_152743.4(BRAT1):c.1492del (p.Leu498fs)	BRAT1	L498fs, L323fs	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000848367	7	2579426	7	2539792	848367	833518		NC_000007.14:2539791:GG:G
NM_152743.4(BRAT1):c.398_405del (p.His133fs)	BRAT1	H133fs	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000842737	7	2584568 - 2584575	7	2544934 - 2544941	842737	833536		NC_000007.14:2544933:GCTGGGGTGCTG:GCTG
NM_152743.4(BRAT1):c.1684C>T (p.Arg562Ter)	BRAT1	R387*, R562*	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000661637	7	2578899	7	2539265	661637	636062		NC_000007.14:2539264:G:A
NC_000007.13:g.(?_2593939)_(2594065_?)del	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000651803	7	2593939 - 2594065	7	2554305 - 2554431	651803	651613		
NC_000007.13:g.(?_2593919)_(2594085_?)del	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000647953	7	2593919 - 2594085	7	2554285 - 2554451	647953	651717		
NM_152743.4(BRAT1):c.1013dup (p.Gly339fs)	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000647546	7	2581755 - 2581756	7	2542121 - 2542122	647546	636077		NC_000007.14:2542121:GGGGG:GGGGGG
NM_152743.4(BRAT1):c.105G>A (p.Trp35Ter)	BRAT1	W35*	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000573854	7	2593961	7	2554327	573854	561891	rs1562596651	NC_000007.14:2554326:C:T
NM_152743.4(BRAT1):c.171del (p.Glu57fs)	BRAT1	E57fs	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Aug 2, 2018)	no assertion criteria provided	VCV000559429	7	2587069	7	2547435	559429	550154	rs1554297097	NC_000007.14:2547434:C:
NM_152743.4(BRAT1):c.1543_1564delinsTC (p.Glu515fs)	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000540176	7	2579211 - 2579232	7	2539577 - 2539598	540176	522975	rs1554293869	NC_000007.14:2539576:CGAGGGCGGAGTCCCTCACCTC:GA
NC_000007.13:g.(?_2584523)_(2594085_?)del	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000472924			7	2544889 - 2554451	472924	456461		
NM_152743.4(BRAT1):c.964C>T (p.Gln322Ter)	BRAT1	Q322*, Q147*	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000434520	7	2581805	7	2542171	434520	428701	rs1554295159	NC_000007.14:2542170:G:A
NM_152743.4(BRAT1):c.1177del (p.Ala393fs)	BRAT1	A393fs, A218fs	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Nov 29, 2014)	no assertion criteria provided	VCV000180139	7	2581076	7	2541442	180139	178320	rs727505365	NC_000007.14:2541441:CCCCC:CCCC
NM_152743.4(BRAT1):c.960_961TC[1] (p.Leu321fs)	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000180138	7	2581806 - 2581807	7	2542172 - 2542173	180138	178319	rs727505364	NC_000007.14:2542171:GAGA:GA
NM_152743.4(BRAT1):c.176T>C (p.Leu59Pro)	BRAT1	L59P	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000180137	7	2587064	7	2547430	180137	178318	rs727505363	NC_000007.14:2547429:A:G
NM_152743.4(BRAT1):c.453_454insGAGAAGAT (p.Leu152fs)	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Oct 3, 2012)	no assertion criteria provided	VCV000180136	7	2583573 - 2583574	7	2543939 - 2543940	180136	178317	rs1554296088	NC_000007.14:2543939::ATCTTCTC
NM_000322.5(PRPH2):c.623G>A (p.Gly208Asp)	PRPH2	G208D	Patterned dystrophy of retinal pigment epithelium|PRPH2-Related Disorders|Retinal dystrophy|Macular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437965	6	42672308	6	42704570	437965	431694	rs139185976	NC_000006.12:42704569:C:T
NM_000322.5(PRPH2):c.646C>T (p.Pro216Ser)	PRPH2	P216S	not provided|PRPH2-Related Disorders|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000098695	6	42672285	6	42704547	98695	104585	rs61755805	NC_000006.12:42704546:G:A
NM_000322.5(PRPH2):c.136C>T (p.Arg46Ter)	PRPH2	R46*	PRPH2-Related Disorders|not provided|Retinal dystrophy|Retinitis pigmentosa 7|Patterned dystrophy of retinal pigment epithelium	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013179	6	42689937	6	42722199	13179	28218	rs61755771	NC_000006.12:42722198:G:A
NM_000322.5(PRPH2):c.514C>T (p.Arg172Trp)	PRPH2	R172W	PRPH2-Related Disorders|not provided|Choroidal dystrophy, central areolar 2|maculopathy	Pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000013170	6	42689559	6	42721821	13170	28209	rs61755792	NC_000006.12:42721820:G:A
NC_000007.14:g.(?_2538049)_(2539371_?)del	BRAT1		Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000833357	7	2577683 - 2579005			833357	819863		
NM_152743.4(BRAT1):c.1857G>A (p.Trp619Ter)	BRAT1	W619*, W679*, W444*	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Dec 2, 2013)	no assertion criteria provided	VCV000202197	7	2578312	7	2538678	202197	198630	rs794729222	NC_000007.14:2538677:C:T
NM_152743.4(BRAT1):c.803G>A (p.Arg268His)	BRAT1	R268H, R93H	not provided|Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429928	7	2583224	7	2543590	429928	421631	rs1131691679	NC_000007.14:2543589:C:T
NM_000391.4(TPP1):c.787C>T (p.Gln263Ter)	TPP1	Q263*	not provided	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000429701	11	6637991	11	6616760	429701	421875	rs1131691539	NC_000011.10:6616759:G:A
NM_000391.4(TPP1):c.500_503dup (p.Phe169fs)	TPP1		not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000423868	11	6638536 - 6638537	11	6617305 - 6617306	423868	408427	rs1554902020	NC_000011.10:6617305:TCCA:TCCATCCA
NM_000391.4(TPP1):c.274del (p.Ser92fs)	TPP1	S92fs	not provided	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000419346	11	6638963	11	6617732	419346	408428	rs1064793806	NC_000011.10:6617731:A:
GRCh37/hg19 11p15.4(chr11:6639647-6641899)x1	TPP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253548	11	6639647 - 6641899			253548	247996		
NM_000391.4(TPP1):c.1029G>C (p.Glu343Asp)	TPP1	E343D	Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia	Pathogenic(Last reviewed: May 4, 2016)	no assertion criteria provided	VCV000225692	11	6637592	11	6616361	225692	227507	rs886037833	NC_000011.10:6616360:C:G
NM_000391.4(TPP1):c.687+1G>C	TPP1		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802655	11	6638205	11	6616974	802655	791155		NC_000011.10:6616973:C:G
NM_000391.4(TPP1):c.237C>G (p.Tyr79Ter)	TPP1	Y79*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 3, 2012)	no assertion criteria provided	VCV000560628	11	6639000	11	6617769	560628	551717	rs1564855860	NC_000011.10:6617768:G:C
NM_000255.4(MMUT):c.729_730insTT (p.Asp244fs)	MMUT		Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552079	6	49425427 - 49425428	6	49457714 - 49457715	552079	544019	rs780283588	NC_000006.12:49457714:A:AAA
NM_000255.4(MMUT):c.52C>T (p.Gln18Ter)	MMUT	Q17*, Q18*	METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001877	6	49427128	6	49459415	1877	16916	rs121918248	NC_000006.12:49459414:G:A
NM_000391.4(TPP1):c.941_942del (p.Glu314fs)	TPP1	E314fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000861410	11	6637679 - 6637680	11	6616448 - 6616449	861410	838790		NC_000011.10:6616447:CTC:C
NM_000391.4(TPP1):c.325C>T (p.Gln109Ter)	TPP1	Q109*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000645209	11	6638912	11	6617681	645209	640351		NC_000011.10:6617680:G:A
NM_000391.4(TPP1):c.1098G>A (p.Trp366Ter)	TPP1	W366*	Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561135	11	6637283	11	6616052	561135	552152	rs1564854729	NC_000011.10:6616051:C:T
NM_000391.4(TPP1):c.640C>T (p.Gln214Ter)	TPP1	Q214*	Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000371293	11	6638253	11	6617022	371293	358028	rs752164603	NC_000011.10:6617021:G:A
NM_000391.4(TPP1):c.509-1G>T	TPP1		not provided|Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280202	11	6638385	11	6617154	280202	264631	rs56144125	NC_000011.10:6617153:C:A
NC_000006.12:g.(?_162262525)_(162275409_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830820	6	162683557 - 162696441			830820	819680		
NC_000006.11:g.(?_162683547)_(162683807_?)del	PRKN		not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000654668	6	162683547 - 162683807	6	162262515 - 162262775	654668	651473		
Single allele	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000468580			6	162262505 - 162262785	468580	455271		
NM_004562.3(PRKN):c.101_102del (p.Gln34fs)	PRKN	Q34fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000425403	6	162864411 - 162864412	6	162443379 - 162443380	425403	413737	rs55777503	NC_000006.12:162443378:CT:
NM_000076.2(CDKN1C):c.689del (p.Gln230fs)	CDKN1C	Q230fs, Q219fs	not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000502675	11	2906031	11	2884801	502675	494098	rs1554937790	NC_000011.10:2884800:T:
NM_000076.2(CDKN1C):c.431del (p.Pro144fs)	CDKN1C	P133fs, P144fs	not provided	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000502216	11	2906289	11	2885059	502216	493640	rs1554938069	NC_000011.10:2885058:GGGG:GGG
NM_000076.2(CDKN1C):c.842G>T (p.Arg281Ile)	CDKN1C	R281I, D93Y, R270I	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000254171	11	2905343	11	2884113	254171	248650	rs886037912	NC_000011.10:2884112:C:A
NM_000076.2(CDKN1C):c.815T>G (p.Ile272Ser)	CDKN1C	I272S, I261S	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000132130	11	2905905	11	2884675	132130	136352	rs515726203	NC_000011.10:2884674:A:C
NM_000076.2(CDKN1C):c.820G>A (p.Asp274Asn)	CDKN1C	D274N, D263N	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035531	11	2905900	11	2884670	35531	44202	rs387907225	NC_000011.10:2884669:C:T
NM_001362475.2(CDKN1C):c.255+353_255+356delinsGGG	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000192357	11	2906076 - 2906079	11	2884846 - 2884849	192357	190141	rs786205240	NC_000011.10:2884845:GCCG:CCC
NM_000076.2(CDKN1C):c.635del (p.Pro212fs)	CDKN1C	P201fs, P212fs	Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000192356	11	2906085	11	2884855	192356	190143	rs786205237	NC_000011.10:2884854:GGGG:GGG
NM_000076.2(CDKN1C):c.631delinsAA (p.Ala211fs)	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000192355	11	2906089	11	2884859	192355	190144	rs786205239	NC_000011.10:2884858:C:TT
NM_000076.2(CDKN1C):c.629_630insGCTCCGGCCCC (p.Ala211fs)	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000192354	11	2906090 - 2906091	11	2884860 - 2884861	192354	190145	rs786205241	NC_000011.10:2884860:GGGGCCGG:GGGGCCGGAGCGGGGCCGG
NM_001362475.2(CDKN1C):c.255+161del	CDKN1C	P150fs, P139fs	Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000192352	11	2906271	11	2885041	192352	190146	rs786205234	NC_000011.10:2885040:GGGGG:GGGG
NM_000076.2(CDKN1C):c.*5+2T>C	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000143246	11	2905227	11	2883997	143246	152978	rs587777866	NC_000011.10:2883996:A:G
NM_001362475.2(CDKN1C):c.255+111dup	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000132850	11	2906319 - 2906320	11	2885089 - 2885090	132850	136599	rs786205236	NC_000011.10:2885089:CC:CCC
NM_001362475.2(CDKN1C):c.255+45dup	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000132848	11	2906386 - 2906387	11	2885156 - 2885157	132848	136597	rs786205235	NC_000011.10:2885156:G:GG
NM_000076.2(CDKN1C):c.836G>C (p.Arg279Pro)	CDKN1C	R279P, R268P, A91P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000035530	11	2905349	11	2884119	35530	44201	rs318240750	NC_000011.10:2884118:C:G
NM_000076.2(CDKN1C):c.827T>C (p.Phe276Ser)	CDKN1C	F276S, F265S, S88P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000035529	11	2905358	11	2884128	35529	44200	rs387907224	NC_000011.10:2884127:A:G
NM_000391.4(TPP1):c.481C>T (p.Gln161Ter)	TPP1	Q161*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000859613	11	6638559	11	6617328	859613	838797		NC_000011.10:6617327:G:A
NM_000391.4(TPP1):c.1676_1677CT[1] (p.Leu560fs)	TPP1		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000661918	11	6635790 - 6635791	11	6614559 - 6614560	661918	640340		NC_000011.10:6614558:AGAG:AG
NM_000391.4(TPP1):c.380+5G>A	TPP1		Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000599035	11	6638852	11	6617621	599035	590164	rs1564855725	NC_000011.10:6617620:C:T
NM_000391.4(TPP1):c.1525C>T (p.Gln509Ter)	TPP1	Q509*	Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000551316	11	6636123	11	6614892	551316	546128	rs1184563885	NC_000011.10:6614891:G:A
NM_000391.4(TPP1):c.687+2T>G	TPP1		Ceroid lipofuscinosis neuronal 2|Developmental regression	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371022	11	6638204	11	6616973	371022	358027	rs1057516945	NC_000011.10:6616972:A:C
NM_000391.4(TPP1):c.616C>T (p.Arg206Cys)	TPP1	R206C	Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000002646	11	6638277	11	6617046	2646	17685	rs28940573	NC_000011.10:6617045:G:A
NM_000391.4(TPP1):c.1093T>C (p.Cys365Arg)	TPP1	C365R	Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Sep 19, 1997)	no assertion criteria provided	VCV000002641	11	6637288	11	6616057	2641	17680	rs119455953	NC_000011.10:6616056:A:G
NM_006073.4(TRDN):c.53_56del (p.Asp18fs)	TRDN	D18fs	Catecholaminergic polymorphic ventricular tachycardia|Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000066015	6	123892244 - 123892247	6	123571099 - 123571102	66015	76925	rs768049331	NC_000006.12:123571098:CTGTCT:CT
NM_152743.4(BRAT1):c.1313_1314del (p.Gln438fs)	BRAT1	Q438fs, Q263fs	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000472936	7	2580939 - 2580940	7	2541305 - 2541306	472936	456665	rs749240175	NC_000007.14:2541304:CT:
NM_012144.4(DNAI1):c.48+2dup	DNAI1		not provided|Kartagener syndrome|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005604	9	34459052 - 34459053	9	34459054 - 34459055	5604	20643	rs397515363	NC_000009.12:34459054:T:TT
NM_033360.4(KRAS):c.101C>T (p.Pro34Leu)	KRAS	P34L	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040454	12	25398218	12	25245284	40454	48924	rs104894366	NC_000012.12:25245283:G:A
NM_000076.2(CDKN1C):c.311_312insAGCA (p.Pro106fs)	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000861381	11	2906408 - 2906409	11	2885178 - 2885179	861381	838280		NC_000011.10:2885178::TGCT
NM_000076.2(CDKN1C):c.388G>T (p.Glu130Ter)	CDKN1C	E119*, E130*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000850254	11	2906332	11	2885102	850254	838278		NC_000011.10:2885101:C:A
NM_000076.2(CDKN1C):c.632_642del (p.Ala211fs)	CDKN1C	A200fs, A211fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000848031	11	2906078 - 2906088	11	2884848 - 2884858	848031	838263		NC_000011.10:2884847:CGGGGCCGGGGCGGGG:CGGGG
NM_000076.2(CDKN1C):c.387del (p.Glu130fs)	CDKN1C	E130fs, E119fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000646542	11	2906333	11	2885103	646542	639940		NC_000011.10:2885102:G:
NM_000076.2(CDKN1C):c.706G>T (p.Glu236Ter)	CDKN1C	E236*, E225*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000574120	11	2906014	11	2884784	574120	565664	rs1564929426	NC_000011.10:2884783:C:A
NM_000076.2(CDKN1C):c.673G>T (p.Glu225Ter)	CDKN1C	E225*, E214*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000571827	11	2906047	11	2884817	571827	565673	rs1564929520	NC_000011.10:2884816:C:A
NM_000076.2(CDKN1C):c.647del (p.Pro216fs)	CDKN1C	P205fs, P216fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 25, 2018)	criteria provided, single submitter	VCV000565906	11	2906073	11	2884843	565906	570518	rs1564929584	NC_000011.10:2884842:GGGG:GGG
NM_000076.2(CDKN1C):c.189_190insTTCCAGCTGG (p.Asp64fs)	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000524696	11	2906530 - 2906531	11	2885300 - 2885301	524696	526615	rs1554938197	NC_000011.10:2885300::CCAGCTGGAA
NM_000076.2(CDKN1C):c.384_391del (p.Leu129fs)	CDKN1C	L118fs, L129fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 19, 2017)	criteria provided, single submitter	VCV000524690	11	2906329 - 2906336	11	2885099 - 2885106	524690	526279	rs1554938087	NC_000011.10:2885098:CCTCGAGGCC:CC
NM_000076.2(CDKN1C):c.196del (p.Gln66fs)	CDKN1C	Q55fs, Q66fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	VCV000453991	11	2906524	11	2885294	453991	461214	rs1554938194	NC_000011.10:2885293:GG:G
NM_000076.2(CDKN1C):c.694C>T (p.Gln232Ter)	CDKN1C	Q232*, Q221*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000210647	11	2906026	11	2884796	210647	207864	rs797045445	NC_000011.10:2884795:G:A
NM_000076.2(CDKN1C):c.845C>A (p.Ser282Ter)	CDKN1C	S282*, Q94K, S271*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000018446	11	2905340	11	2884110	18446	33485	rs267606716	NC_000011.10:2884109:G:T
NM_000076.2(CDKN1C):c.310_311delinsG (p.Leu104fs)	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000008748	11	2906409 - 2906410	11	2885179 - 2885180	8748	23787	rs387906399	NC_000011.10:2885178:AG:C
NM_000127.2(EXT1):c.1019G>A (p.Arg340His)	EXT1	R340H	Multiple congenital exostosis|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265129	8	118849384	8	117837145	265129	259892	rs119103287	NC_000008.11:117837144:C:T
NM_000391.4(TPP1):c.182_183TC[1] (p.Ser62fs)	TPP1		Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552025	11	6640050 - 6640052	11	6618820 - 6618821	552025	546576	rs1554902216	NC_000011.10:6618819:GAGAG:GAG
NM_000391.4(TPP1):c.1551+1G>A	TPP1		not provided|Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	VCV000188909	11	6636096	11	6614865	188909	186833	rs786204553	NC_000011.10:6614864:C:T
NM_006731.2(FKTN):c.*4392_*4393insAB185332.1	FKTN		Dilated cardiomyopathy 1X|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000003199					3199	18238		
NM_003172.4(SURF1):c.870dup (p.Lys291Ter)	SURF1		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000520829	9	136218800 - 136218801	9	133351945 - 133351946	520829	511813	rs782061187	NC_000009.12:133351945:AAA:AAAA
NM_005476.7(GNE):c.1790_1791AG[3] (p.Glu599fs)	GNE		not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000597827	9	36219857 - 36219858	9	36219860 - 36219861	597827	588888	rs1563928043	NC_000009.12:36219860:CTCT:CTCTCT
NM_000466.3(PEX1):c.2468del (p.Pro823fs)	PEX1	P615fs, P823fs, P766fs	not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000596283	7	92130936	7	92501622	596283	587344	rs766947924	NC_000007.14:92501621:GG:G
NM_000466.3(PEX1):c.1803+1G>T	PEX1		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000596059	7	92136307	7	92506993	596059	587120	rs1562857871	NC_000007.14:92506992:C:A
NM_000466.3(PEX1):c.2396dup (p.Ser800fs)	PEX1		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000593271	7	92131223 - 92131224	7	92501909 - 92501910	593271	584335	rs778871894	NC_000007.14:92501909:T:TT
NM_005476.7(GNE):c.164+1G>A	GNE		not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000500485	9	36249188	9	36249191	500485	491909	rs1554664043	NC_000009.12:36249190:C:T
NM_005476.7(GNE):c.617-2A>G	GNE		not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000499107	9	36236983	9	36236986	499107	490531	rs1554661582	NC_000009.12:36236985:T:C
NM_001128227.2(GNE):c.1726_1726+3delGGTA	GNE		not provided	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000498631	9	36222771 - 36222774	9	36222774 - 36222777	498631	490055	rs1554658877	
NM_005476.7(GNE):c.470_471del (p.His157fs)	GNE	H157fs, H98fs, H188fs, H152fs	not provided	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000498582	9	36246173 - 36246174	9	36246176 - 36246177	498582	490006	rs1554663368	NC_000009.12:36246175:AT:
NM_005476.7(GNE):c.601_604dup (p.Arg202fs)	GNE		not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000496957	9	36246039 - 36246040	9	36246042 - 36246043	496957	488381	rs1554663306	NC_000009.12:36246042:GAATGA:GAATGAATGA
NM_005476.7(GNE):c.1770C>A (p.Tyr590Ter)	GNE	Y621*, Y590*, Y516*, Y480*, Y585*	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000489077	9	36219881	9	36219884	489077	481857	rs111302956	NC_000009.12:36219883:G:T
NM_005476.7(GNE):c.1915C>T (p.Gln639Ter)	GNE	Q670*, Q639*, Q529*, Q565*, Q634*	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000281593	9	36218198	9	36218201	281593	265830	rs886042195	NC_000009.12:36218200:G:A
NM_000466.3(PEX1):c.1792del (p.Thr598fs)	PEX1	T598fs, T390fs	Deafness enamel hypoplasia nail defects	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000224324	7	92136319	7	92507005	224324	226053	rs886037783	NC_000007.14:92507004:T:
NM_000076.2(CDKN1C):c.579del (p.Pro194fs)	CDKN1C	P183fs, P194fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000857422	11	2906141	11	2884911	857422	838265		NC_000011.10:2884910:A:
NC_000011.9:g.(?_2905209)_(2906985_?)del	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Apr 8, 2018)	criteria provided, single submitter	VCV000584251	11	2905209 - 2906985	11	2883979 - 2885755	584251	565024		
NM_000076.2(CDKN1C):c.836G>T (p.Arg279Leu)	CDKN1C	R279L, A91S, R268L	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies|Russell-Silver syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000192361	11	2905349	11	2884119	192361	190151	rs318240750	NC_000011.10:2884118:C:A
NM_001362475.2(CDKN1C):c.255+323_255+347dup	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, single submitter	VCV000192353	11	2906084 - 2906085	11	2884854 - 2884855	192353	190142	rs1554937847	NC_000011.10:2884854:GGGGCGGGGGCCGGGGCCGGGGCCGGGG:GGGGCGGGGGCCGGGGCCGGGGCCGGGGGCGGGGGCCGGGGCCGGGGCCGGGG
NM_000076.2(CDKN1C):c.832A>G (p.Lys278Glu)	CDKN1C	K278E, K267E	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic	criteria provided, single submitter	VCV000035532	11	2905353	11	2884123	35532	44203	rs387907226	NC_000011.10:2884122:T:C
NM_000076.2(CDKN1C):c.826T>G (p.Phe276Val)	CDKN1C	F276V, F265V	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000035528	11	2905359	11	2884129	35528	44199	rs387907223	NC_000011.10:2884128:A:C
CDKN1C, 1-BP DEL/2-BP INS, 1086T-AG	CDKN1C		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000008747					8747	23786		
NM_000076.2(CDKN1C):c.139C>T (p.Gln47Ter)	CDKN1C	E47*, Q36*, Q47*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000008746	11	2906581	11	2885351	8746	23785	rs137852766	NC_000011.10:2885350:G:A
NM_000466.3(PEX1):c.1817C>G (p.Ser606Ter)	PEX1	S398*, S606*	Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000844762	7	92135645	7	92506331	844762	833938		NC_000007.14:92506330:G:C
NM_000466.3(PEX1):c.1727dup (p.Arg577fs)	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830063	7	92136383 - 92136384	7	92507069 - 92507070	830063	818389		NC_000007.14:92507069:CCC:CCCC
NM_000466.3(PEX1):c.1483+1G>A	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830062	7	92140893	7	92511579	830062	818403		NC_000007.14:92511578:C:T
NM_000466.3(PEX1):c.130-1G>T	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B	Pathogenic	criteria provided, single submitter	VCV000813453	7	92151560	7	92522246	813453	801656		NC_000007.14:92522245:C:A
NM_000466.3(PEX1):c.1126del (p.Glu376fs)	PEX1	E168fs, E376fs	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B	Pathogenic	criteria provided, single submitter	VCV000813450	7	92146703	7	92517389	813450	801653		NC_000007.14:92517388:C:
NM_000466.3(PEX1):c.2085_2089del (p.Met695fs)	PEX1	M487fs, M638fs, M695fs	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B	Pathogenic	criteria provided, single submitter	VCV000813403	7	92132492 - 92132496	7	92503178 - 92503182	813403	801651		NC_000007.14:92503177:TTATC:
NM_000466.3(PEX1):c.2471del (p.Ala824fs)	PEX1	A824fs, A616fs, A767fs	Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000665163	7	92130933	7	92501619	665163	636447		NC_000007.14:92501618:G:
NM_000466.3(PEX1):c.1163G>A (p.Trp388Ter)	PEX1	W180*, W388*	Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000639480	7	92146666	7	92517352	639480	636451		NC_000007.14:92517351:C:T
NM_000466.3(PEX1):c.130-2A>G	PEX1		Peroxisome biogenesis disorder	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635303	7	92151561	7	92522247	635303	623176		NC_000007.14:92522246:T:C
NM_000466.3(PEX1):c.1927del (p.Thr643fs)	PEX1	T435fs, T643fs	Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000576112	7	92134190	7	92504876	576112	564500	rs1554372180	NC_000007.14:92504875:TTTTTT:TTTTT
Single allele	GNE		Inclusion body myositis|GNE myopathy	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000438624	9	36259402 - 36266483	9	36259405 - 36266486	438624	432248		
NM_000466.3(PEX1):c.1906_2064del (p.Arg636_Leu688del)	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Apr 14, 1998)	no assertion criteria provided	VCV000007518					7518	22557	rs1554372074	
NM_005476.7(GNE):c.511A>G (p.Met171Val)	GNE	M171V, M112V, M166V, M202V	GNE myopathy	Pathogenic(Last reviewed: Dec 10, 2002)	no assertion criteria provided	VCV000006036	9	36246133	9	36246136	6036	21075	rs121908634	NC_000009.12:36246135:T:C
NM_005476.7(GNE):c.907_908delinsGT (p.Cys303Val)	GNE	C303V	GNE myopathy	Pathogenic(Last reviewed: Aug 13, 2002)	no assertion criteria provided	VCV000006034	9	36233991 - 36233992	9	36233994 - 36233995	6034	21073	rs121908633	NC_000009.12:36233993:CA:AC
NM_005476.7(GNE):c.909T>A (p.Cys303Ter)	GNE	C303*, C193*, C298*, C334*	GNE myopathy	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006029	9	36233990	9	36233993	6029	21068	rs121908628	NC_000009.12:36233992:A:T
NM_005476.7(GNE):c.1891G>A (p.Ala631Thr)	GNE	A631T, A521T, A557T, A626T, A662T	GNE myopathy	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006027	9	36218222	9	36218225	6027	21066	rs121908626	NC_000009.12:36218224:C:T
NM_005476.7(GNE):c.1727G>A (p.Gly576Glu)	GNE	G576E, G607E, G571E, G502E, G466E	GNE myopathy	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006026	9	36219924	9	36219927	6026	21065	rs121908625	NC_000009.12:36219926:C:T
NM_006158.4(NEFL):c.22_23delCCinsAG (p.Pro8Arg)	NEFL	P8R	Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|not provided	Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000014030	8	24814007 - 24814008	8	24956493 - 24956494	14030	29069	rs60261494	NC_000008.11:24956492:GG:CT
NM_138413.4(HOGA1):c.938_940AGG[2] (p.Glu315del)	HOGA1	E315del	Primary hyperoxaluria, type III|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000029	10	99371369 - 99371371	10	97611612 - 97611614	29	15068	rs397509360	NC_000010.11:97611611:GAGGAGGAGG:GAGGAGG
NM_005476.7(GNE):c.1546_1547del (p.Asp515_Asn516insTer)	GNE		Sialuria|GNE myopathy	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000847245	9	36222860 - 36222861	9	36222863 - 36222864	847245	836160		NC_000009.12:36222862:TT:
NC_000009.12:g.(?_36276884)_(36277052_?)del	GNE		Sialuria|GNE myopathy	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000832598	9	36276881 - 36277049			832598	820141		
NC_000007.14:g.(?_92509319)_(92509421_?)del	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000830618	7	92138633 - 92138735			830618	819924		
NM_005476.7(GNE):c.1258C>T (p.Arg420Ter)	GNE	R451*, R420*, R310*, R415*	GNE myopathy	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000552288	9	36227268	9	36227271	552288	545150	rs747199032	NC_000009.12:36227270:G:A
NM_005476.7(GNE):c.1686del (p.Cys563fs)	GNE	C453fs, C558fs, C563fs, C594fs, C489fs	GNE myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000290423	9	36219965	9	36219968	290423	274660	rs886044449	NC_000009.12:36219967:G:
NM_000466.3(PEX1):c.1131del (p.Asp378fs)	PEX1	D378fs, D170fs	Peroxisome biogenesis disorder 1B|not provided	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000286796	7	92146698	7	92517384	286796	271033	rs886043479	NC_000007.14:92517383:TT:T
NM_000466.3(PEX1):c.1742G>C (p.Arg581Pro)	PEX1	R581P, R373P	Deafness enamel hypoplasia nail defects|Retinal dystrophy	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000217429	7	92136369	7	92507055	217429	214068	rs370483961	NC_000007.14:92507054:C:G
NM_000466.3(PEX1):c.2230C>T (p.Gln744Ter)	PEX1	Q744*, Q687*, Q536*	not provided|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093104	7	92131390	7	92502076	93104	99011	rs398123409	NC_000007.14:92502075:G:A
NM_000162.5(GCK):c.770G>A (p.Trp257Ter)	GCK	W258*, W257*, W256*	not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000598320	7	44187342	7	44147743	598320	589381	rs1562715426	NC_000007.14:44147742:C:T
NM_000162.5(GCK):c.675C>G (p.Ile225Met)	GCK	I225M, I226M, I224M	not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000546098	7	44189363	7	44149764	546098	536735	rs772754004	NC_000007.14:44149763:G:C
NM_000162.5(GCK):c.208+1G>A	GCK		not provided	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000488813	7	44192899	7	44153300	488813	481791	rs1554335913	NC_000007.14:44153299:C:T
NM_000162.5(GCK):c.483+2T>C	GCK		not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000488812	7	44190553	7	44150954	488812	481790	rs1554335564	NC_000007.14:44150953:A:G
NM_000162.5(GCK):c.580-1G>A	GCK		not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000449414	7	44189459	7	44149860	449414	444136	rs1554335421	NC_000007.14:44149859:C:T
NM_000162.5(GCK):c.431del (p.Leu144fs)	GCK	L145fs, L143fs, L144fs	not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000423412	7	44190607	7	44151008	423412	407145	rs1064796410	NC_000007.14:44151007:A:
NM_000162.5(GCK):c.435_436dup (p.Leu146fs)	GCK		not provided	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000418780	7	44190601 - 44190602	7	44151002 - 44151003	418780	407144	rs1064793428	NC_000007.14:44151002:GGGG:GGGGGG
NM_000162.5(GCK):c.1163dup (p.Val389fs)	GCK		not provided	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000280892	7	44185185 - 44185186	7	44145586 - 44145587	280892	264329	rs886042015	NC_000007.14:44145586:CCC:CCCC
NM_000162.5(GCK):c.148dup (p.His50fs)	GCK		not provided	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000280498	7	44192959 - 44192960	7	44153360 - 44153361	280498	264352	rs886041690	NC_000007.14:44153360:GGG:GGGG
NM_000162.5(GCK):c.533G>A (p.Gly178Glu)	GCK	G178E, G179E, G177E	not provided	Pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	VCV000265174	7	44189614	7	44150015	265174	259866	rs886039380	NC_000007.14:44150014:C:T
NM_000162.5(GCK):c.854del (p.Gly285fs)	GCK	G286fs, G284fs, G285fs	not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000804860	7	44187258	7	44147659	804860	793227		NC_000007.14:44147658:CC:C
NM_000162.5(GCK):c.183C>A (p.Tyr61Ter)	GCK	Y60*, Y61*, Y62*	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802309	7	44192925	7	44153326	802309	790725		NC_000007.14:44153325:G:T
NM_000162.5(GCK):c.1031_1034dup (p.Lys346fs)	GCK		Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802307	7	44185314 - 44185315	7	44145715 - 44145716	802307	790723		NC_000007.14:44145715:CGGTCG:CGGTCGGTCG
NM_000162.5(GCK):c.291del (p.Gln98fs)	GCK	Q99fs, Q98fs, Q97fs	not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000590262	7	44191942	7	44152343	590262	581204	rs1562719029	NC_000007.14:44152342:CCCC:CCC
NM_000162.5(GCK):c.863+1G>A	GCK		not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000585928	7	44187248	7	44147649	585928	576984	rs1376796469	NC_000007.14:44147648:C:T
NM_000162.5(GCK):c.1327G>T (p.Glu443Ter)	GCK	E443*, E444*, E63*, E106*, E121*, E442*	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000585915	7	44184806	7	44145207	585915	576977	rs1562711915	NC_000007.14:44145206:C:A
NM_000162.5(GCK):c.1054del (p.Ile351_Leu352insTer)	GCK		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000585907	7	44185295	7	44145696	585907	576982	rs1562713041	NC_000007.14:44145695:GG:G
NM_000162.5(GCK):c.763_779dup (p.Phe260fs)	GCK		not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000447415	7	44187332 - 44187333	7	44147733 - 44147734	447415	441103	rs1554335128	NC_000007.14:44147733:AAGGCGCCCCACTCGGTA:AAGGCGCCCCACTCGGTAAGGCGCCCCACTCGGTA
NM_000162.5(GCK):c.686del (p.Gly229fs)	GCK	G230fs, G229fs, G228fs	not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000447414	7	44187426	7	44147827	447414	441106	rs1554335164	NC_000007.14:44147826:CCC:CC
NM_000162.5(GCK):c.440del (p.Gly147fs)	GCK	G146fs, G147fs, G148fs	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000447398	7	44190598	7	44150999	447398	441121	rs1554335585	NC_000007.14:44150998:CCC:CC
NM_000162.5(GCK):c.1155dup (p.Leu386fs)	GCK		not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000447385	7	44185193 - 44185194	7	44145594 - 44145595	447385	441086	rs1400535021	NC_000007.14:44145594:CCCC:CCCCC
NM_000162.5(GCK):c.1133_1149del (p.Ala378fs)	GCK	A377fs, A379fs, M1fs, A378fs, A41fs, A56fs	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000447381	7	44185200 - 44185216	7	44145601 - 44145617	447381	441087	rs1554334610	NC_000007.14:44145600:CGAGCACATGTGCGCAGCG:CG
NM_000162.5(GCK):c.1020-1G>A	GCK		not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000447378	7	44185330	7	44145731	447378	441093	rs193922258	NC_000007.14:44145730:C:T
NM_000162.5(GCK):c.171G>T (p.Met57Ile)	GCK	M57I, M58I, M56I	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000377026	7	44192937	7	44153338	377026	363904	rs1057520109	NC_000007.14:44153337:C:A
NM_000162.5(GCK):c.112C>T (p.Gln38Ter)	GCK	Q38*, Q39*, Q37*	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000236192	7	44192996	7	44153397	236192	237750	rs878853246	NC_000007.14:44153396:G:A
NM_000162.5(GCK):c.706G>A (p.Glu236Lys)	GCK	E236K, E237K, E235K		Pathogenic(Last reviewed: Jul 23, 2013)	criteria provided, single submitter	VCV000129146	7	44187406	7	44147807	129146	134592	rs587780347	NC_000007.14:44147806:C:T
NM_018972.4(GDAP1):c.767A>G (p.His256Arg)	GDAP1	H256R, H188R, H198R, H147R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618662	8	75276292	8	74364057	618662	609702	rs1476856429	NC_000008.11:74364056:A:G
NM_054012.4(ASS1):c.892del (p.Glu298fs)	ASS1	E298fs	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188832	9	133364773	9	130489386	188832	186782	rs770362721	NC_000009.12:130489385:G:
NM_054012.4(ASS1):c.1194-1G>C	ASS1		Citrullinemia type I|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000166704	9	133376362	9	130500975	166704	177496	rs727503814	NC_000009.12:130500974:G:C
NM_000162.5(GCK):c.70C>T (p.Gln24Ter)	GCK	Q25*, Q24*, Q23*	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000804854	7	44193038	7	44153439	804854	793242		NC_000007.14:44153438:G:A
NM_000162.5(GCK):c.387C>A (p.Cys129Ter)	GCK	C128*, C130*, C129*	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000804846	7	44190651	7	44151052	804846	793239		NC_000007.14:44151051:G:T
NM_000162.5(GCK):c.148C>T (p.His50Tyr)	GCK	H50Y, H49Y, H51Y	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	VCV000631495	7	44192960	7	44153361	631495	619858	rs1562719705	NC_000007.14:44153360:G:A
NM_000162.5(GCK):c.680-2A>G	GCK		not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000585924	7	44187434	7	44147835	585924	576988	rs1562715657	NC_000007.14:44147834:T:C
NM_033507.2(GCK):c.488del (p.Gly163Alafs)	GCK		not provided	Pathogenic(Last reviewed: Dec 19, 2014)	criteria provided, single submitter	VCV000447407	7	44189662	7	44150063	447407	441113	rs1246464603	NC_000007.14:44150062:CCC:CC
NM_000162.5(GCK):c.678_679+2del	GCK		Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000435308	7	44189357 - 44189360	7	44149758 - 44149761	435308	428729	rs1554335391	NC_000007.14:44149757:ACCCAC:AC
NM_000162.5(GCK):c.941T>C (p.Leu314Pro)	GCK	L314P, L315P, L313P	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000435305	7	44186140	7	44146541	435305	428724	rs1554334886	NC_000007.14:44146540:A:G
NM_000162.5(GCK):c.295del (p.Trp99fs)	GCK	W98fs, W99fs, W100fs	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000435304	7	44191938	7	44152339	435304	428733	rs1554335752	NC_000007.14:44152338:A:
NM_000162.5(GCK):c.775G>A (p.Ala259Thr)	GCK	A259T, A260T, A258T	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000435302	7	44187337	7	44147738	435302	428727	rs1375656631	NC_000007.14:44147737:C:T
NM_000162.5(GCK):c.1165G>C (p.Val389Leu)	GCK	V389L, V390L, V9L, V388L, V52L, V67L	Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000435300	7	44185184	7	44145585	435300	428723	rs1350717554	NC_000007.14:44145584:C:G
NM_000162.5(GCK):c.1358_1360CGG[3] (p.Ala454dup)	GCK		Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000435297	7	44184769 - 44184770	7	44145170 - 44145171	435297	428720	rs1554334433	NC_000007.14:44145170:CCGCCG:CCGCCGCCG
NM_000162.5(GCK):c.317_333del (p.Gln106fs)	GCK	Q105fs, Q107fs, Q106fs	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000211071	7	44191900 - 44191916	7	44152301 - 44152317	211071	207486	rs797045595	NC_000007.14:44152300:GGGGATGGAGTACATCTGG:GG
NM_000162.5(GCK):c.118G>A (p.Glu40Lys)	GCK	E40K, E41K, E39K	not provided	Pathogenic(Last reviewed: Nov 22, 2014)	criteria provided, single submitter	VCV000195024	7	44192990	7	44153391	195024	192186	rs794727236	NC_000007.14:44153390:C:T
NM_000162.5(GCK):c.1015G>A (p.Glu339Lys)	GCK	E339K, E340K, E338K	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000039759	7	44186066	7	44146467	39759	48358	rs397514580	NC_000007.14:44146466:C:T
NM_000162.5(GCK):c.790G>A (p.Gly264Ser)	GCK	G264S, G265S, G263S	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021078	7	44187322	7	44147723	21078	33930	rs193929373	NC_000007.14:44147722:C:T
NM_000162.5(GCK):c.1133C>T (p.Ala378Val)	GCK	A378V, A379V, A41V, A56V, A377V	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021076	7	44185216	7	44145617	21076	33928	rs193929374	NC_000007.14:44145616:G:A
GCK, VAL91LEU	GCK	V91L	Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Apr 8, 2010)	no assertion criteria provided	VCV000016146					16146	31185		
NM_000162.5(GCK):c.1132G>A (p.Ala378Thr)	GCK	A378T, A379T, A377T, A41T, A56T	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016145	7	44185217	7	44145618	16145	31184	rs104894016	NC_000007.14:44145617:C:T
NM_000162.5(GCK):c.641A>G (p.Tyr214Cys)	GCK	Y214C, Y215C, Y213C	Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000016144	7	44189397	7	44149798	16144	31183	rs104894015	NC_000007.14:44149797:T:C
NM_000162.5(GCK):c.1367C>T (p.Ala456Val)	GCK	A456V, A457V, A455V, A76V, A119V, A134V	Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000016143	7	44184766	7	44145167	16143	31182	rs104894014	NC_000007.14:44145166:G:A
NM_000162.5(GCK):c.391T>C (p.Ser131Pro)	GCK	S131P, S132P, S130P	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000016138	7	44190647	7	44151048	16138	31177	rs104894010	NC_000007.14:44151047:A:G
GCK, IVS4DS, 15-BP DEL	GCK		Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000016137					16137	31176		
NM_000162.5(GCK):c.895G>C (p.Gly299Arg)	GCK	G299R, G300R, G298R	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000016136	7	44186186	7	44146587	16136	31175	rs104894009	NC_000007.14:44146586:C:G
NM_000162.5(GCK):c.483+2_483+16del	GCK		not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000804847	7	44190539 - 44190553	7	44150940 - 44150954	804847	794029		NC_000007.14:44150939:CCTCCACCCGGCCCACCT:CCT
NM_000162.5(GCK):c.1113C>A (p.Cys371Ter)	GCK	C371*, C372*, C49*, C370*, C34*	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000617645	7	44185236	7	44145637	617645	609049	rs556581174	NC_000007.14:44145636:G:T
NM_000162.5(GCK):c.781G>C (p.Gly261Arg)	GCK	G261R, G262R, G260R	not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000447418	7	44187331	7	44147732	447418	441102	rs104894008	NC_000007.14:44147731:C:G
NM_000162.5(GCK):c.364-1G>A	GCK		not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000381600	7	44190675	7	44151076	381600	369463	rs1057521094	NC_000007.14:44151075:C:T
NM_000162.5(GCK):c.871A>T (p.Lys291Ter)	GCK	K291*, K292*, K290*	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036263	7	44186210	7	44146611	36263	44927	rs193922335	NC_000007.14:44146610:T:A
NM_000162.5(GCK):c.1003del (p.Val335fs)	GCK	V334fs, V336fs, V335fs	not provided|Maturity-onset diabetes of the young, type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036166	7	44186078	7	44146479	36166	44830	rs193922254	NC_000007.14:44146478:C:
NM_000162.5(GCK):c.1363G>A (p.Val455Met)	GCK	V455M, V456M, V118M, V133M, V454M, V75M	Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Jan 22, 1998)	no assertion criteria provided	VCV000016140	7	44184770	7	44145171	16140	31179	rs104894012	NC_000007.14:44145170:C:T
NM_000466.3(PEX1):c.5G>A (p.Trp2Ter)	PEX1	W2*	Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558040	7	92157745	7	92528431	558040	544355	rs762679408	NC_000007.14:92528430:C:T
NM_005476.7(GNE):c.616+1del	GNE		GNE myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553323	9	36246027	9	36246030	553323	545162	rs1554663295	NC_000009.12:36246029:CC:C
NM_005476.7(GNE):c.22C>T (p.Arg8Ter)	GNE	R8*, R39*	GNE myopathy	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000552994	9	36249331	9	36249334	552994	545456	rs766420673	NC_000009.12:36249333:G:A
NM_000466.3(PEX1):c.2T>C (p.Met1Thr)	PEX1	M1T	Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000371746	7	92157748	7	92528434	371746	357627	rs766020928	NC_000007.14:92528433:A:G
NM_005476.7(GNE):c.4G>T (p.Glu2Ter)	GNE	E33*, E2*	GNE myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000290631	9	36249349	9	36249352	290631	274868	rs886044514	NC_000009.12:36249351:C:A
NM_000466.3(PEX1):c.2387_2388TC[2] (p.Arg798fs)	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188851	7	92131228 - 92131229	7	92501914 - 92501915	188851	186753	rs61750414	NC_000007.14:92501913:GAGAGAG:GAGAG
PEX1, 1-BP DEL, 2916A	PEX1		Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000007520					7520	22559		
NM_005476.7(GNE):c.788G>T (p.Arg263Leu)	GNE	R263L, R294L, R153L, R258L	Sialuria	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000006023	9	36234111	9	36234114	6023	21062	rs121908623	NC_000009.12:36234113:C:A
NM_005476.7(GNE):c.796C>T (p.Arg266Trp)	GNE	R266W, R297W, R156W, R261W	Sialuria	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000006021	9	36234103	9	36234106	6021	21060	rs121908621	NC_000009.12:36234105:G:A
NM_000162.5(GCK):c.46-2A>G	GCK		not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000447400	7	44193064	7	44153465	447400	441129	rs1554335966	NC_000007.14:44153464:T:C
NM_000162.5(GCK):c.1016A>G (p.Glu339Gly)	GCK	E339G, E340G, E338G	Monogenic diabetes	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000393450	7	44186065	7	44146466	393450	380269	rs1057524903	NC_000007.14:44146465:T:C
NM_000162.5(GCK):c.944T>A (p.Leu315His)	GCK	L315H, L316H, L314H	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036266	7	44186137	7	44146538	36266	44930	rs193922338	NC_000007.14:44146537:A:T
NM_000162.5(GCK):c.1019+2T>G	GCK		not provided|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000021075	7	44186060	7	44146461	21075	33927	rs193929376	NC_000007.14:44146460:A:C
NM_000162.5(GCK):c.835G>T (p.Glu279Ter)	GCK	E279*, E280*, E278*	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: May 30, 1992)	no assertion criteria provided	VCV000016132	7	44187277	7	44147678	16132	31171	rs104894005	NC_000007.14:44147677:C:A
NM_000391.4(TPP1):c.89+5G>C	TPP1		not provided|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207599	11	6640422	11	6619191	207599	202604	rs746085696	NC_000011.10:6619190:C:G
NM_000391.4(TPP1):c.833A>G (p.Gln278Arg)	TPP1	Q278R	not provided|Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207582	11	6637945	11	6616714	207582	202575	rs796053439	NC_000011.10:6616713:T:C
NM_000391.4(TPP1):c.1166G>A (p.Gly389Glu)	TPP1	G389E	Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000068737	11	6636773	11	6615542	68737	79629	rs121908199	NC_000011.10:6615541:C:T
NM_000076.2(CDKN1C):c.740C>A (p.Ser247Ter)	CDKN1C	S247*, S236*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000008749	11	2905980	11	2884750	8749	23788	rs104894200	NC_000011.10:2884749:G:T
NM_006269.2(RP1):c.1625C>G (p.Ser542Ter)	RP1	S542*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620129	8	55538067	8	54625507	620129	611700	rs779334655	NC_000008.11:54625506:C:G
NM_000466.3(PEX1):c.403C>T (p.Arg135Ter)	PEX1	R135*	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic	criteria provided, single submitter	VCV000810635	7	92147524	7	92518210	810635	798917		NC_000007.14:92518209:G:A
NM_000466.3(PEX1):c.1108dup (p.Ile370fs)	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Apr 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000644707	7	92146720 - 92146721	7	92517406 - 92517407	644707	636452	rs61750406	NC_000007.14:92517406:TTTTTTTTT:TTTTTTTTTT
NM_000466.3(PEX1):c.721del (p.Ser241fs)	PEX1	S33fs, S241fs	Peroxisome biogenesis disorder 1A (Zellweger)|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000591770	7	92147108	7	92517794	591770	582759	rs894289737	NC_000007.14:92517793:A:
NM_000466.3(PEX1):c.1A>T (p.Met1Leu)	PEX1	M1L	Peroxisome biogenesis disorder 1B|not provided|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000371744	7	92157749	7	92528435	371744	357628	rs1057517501	NC_000007.14:92528434:T:A
NM_000466.3(PEX1):c.1908del (p.Arg636fs)	PEX1	R636fs, R428fs	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371713	7	92134209	7	92504895	371713	357605	rs1057517478	NC_000007.14:92504894:CC:C
NM_000466.3(PEX1):c.2T>G (p.Met1Arg)	PEX1	M1R	Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371688	7	92157748	7	92528434	371688	357626	rs766020928	NC_000007.14:92528433:A:C
NM_000466.3(PEX1):c.2730del (p.Leu910fs)	PEX1	L702fs, L853fs, L910fs	Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188971	7	92126080	7	92496766	188971	186752	rs61750423	NC_000007.14:92496765:T:
NM_005476.7(GNE):c.797G>A (p.Arg266Gln)	GNE	R266Q, R297Q, R156Q, R261Q	Sialuria	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000006022	9	36234102	9	36234105	6022	21061	rs121908622	NC_000009.12:36234104:C:T
NM_004562.3(PRKN):c.125G>C (p.Arg42Pro)	PRKN	R42P	not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000644125	6	162864388	6	162443356	644125	634774		NC_000006.12:162443355:C:G
NC_000006.11:g.(?_162206784)_(162394469_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000536459	6	162206784 - 162394469	6	161785752 - 161973437	536459	521887		
Single allele	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000468581			6	162262505 - 162443493	468581	455116		
NC_000006.11:g.(?_162622143)_(162683817_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000468579	6	162622143 - 162683817	6	162201111 - 162262785	468579	455998		
NM_004562.2(PRKN):c.413-?_534+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000007035	6	162622163 - 162622284	6	162201131 - 162201252	7035	22074		
NM_000162.5(GCK):c.864-1G>A	GCK	S3N	not provided	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000804861	7	44186218	7	44146619	804861	794028		NC_000007.14:44146618:C:T
NM_000162.5(GCK):c.793G>T (p.Glu265Ter)	GCK	E265*, E266*, E264*	not provided|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000016139	7	44187319	7	44147720	16139	31178	rs104894011	NC_000007.14:44147719:C:A
NM_153676.4(USH1C):c.191del (p.Pro64fs)	USH1C	P64fs	not provided	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000850205	11	17553003	11	17531456	850205	838145		NC_000011.10:17531455:GG:G
NM_153676.4(USH1C):c.1211-1125G>T	USH1C	E424*, E405*	not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000661853	11	17538962	11	17517415	661853	639832		NC_000011.10:17517414:C:A
NM_153676.4(USH1C):c.1134G>A (p.Trp378Ter)	USH1C	W359*, W378*	not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000640495	11	17542493	11	17520946	640495	639833		NC_000011.10:17520945:C:T
NM_153676.4(USH1C):c.2491-1G>T	USH1C		Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627489	11	17518361	11	17496814	627489	615840	rs1565017125	NC_000011.10:17496813:C:A
NM_153676.4(USH1C):c.1019+5G>C	USH1C		Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000005147	11	17544326	11	17522779	5147	20186		NC_000011.10:17522778:C:G
NM_000288.4(PEX7):c.653C>T (p.Ala218Val)	PEX7	A218V	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007781	6	137191047	6	136869909	7781	22820	rs121909151	NC_000006.12:136869908:C:T
NM_153676.4(USH1C):c.7C>T (p.Arg3Ter)	USH1C	R3*	Usher syndrome, type 1C	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000218193	11	17565848	11	17544301	218193	214845	rs876657624	NC_000011.10:17544300:G:A
USH1C, 1-BP DEL, 1220G	USH1C		Usher syndrome, type 1C	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000039429					39429	48028		
NM_153676.4(USH1C):c.2227-1G>A	USH1C		Usher syndrome, type 1C	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000039428	11	17523083	11	17501536	39428	48027		NC_000011.10:17501535:C:T
NM_153676.4(USH1C):c.36+1G>T	USH1C		Usher syndrome, type 1C	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000005144	11	17565818	11	17544271	5144	20183		NC_000011.10:17544270:C:A
NM_080680.3(COL11A2):c.2083_2086AAGG[1] (p.Glu696fs)	COL11A2		Fibrochondrogenesis 2	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000807387	6	33144523 - 33144526	6	33176746 - 33176749	807387	798574		NC_000006.12:33176745:CCTTCCTTCC:CCTTCC
NM_080680.3(COL11A2):c.67dup (p.Ala23fs)	COL11A2		Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802200	6	33159950 - 33159951	6	33192173 - 33192174	802200	790615		NC_000006.12:33192173:CC:CCC
NM_080680.3(COL11A2):c.1292del (p.Pro431fs)	COL11A2	P324fs, P431fs, P345fs	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802199	6	33148102	6	33180325	802199	790614		NC_000006.12:33180324:GGGGGG:GGGGG
GRCh37/hg19 6q16.1(chr6:99330550-99393662)x1	FBXL4		not provided	Pathogenic(Last reviewed: Jun 19, 2018)	no assertion criteria provided	VCV000685291	6	99330550 - 99393662			685291	672883		
GRCh37/hg19 6q16.1(chr6:99330550-99393662)x1	FBXL4		not provided	Pathogenic(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000685024	6	99330550 - 99393662			685024	672616		
NM_080679.2(COL11A2):c.3556C>T (p.Arg1186Ter)	COL11A2	R1293*, R1207*, R1186*	not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000501115	6	33136512	6	33168735	501115	492539	rs746754428	NC_000006.12:33168734:G:A
NM_080679.2(COL11A2):c.339_340delinsG (p.Leu114fs)	COL11A2		not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000432950	6	33156858 - 33156859	6	33189081 - 33189082	432950	425694	rs1554225999	NC_000006.12:33189080:GG:C
NM_080679.2(COL11A2):c.190C>T (p.Arg64Ter)	COL11A2	R64*	not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000432697	6	33157139	6	33189362	432697	425695	rs1554226209	NC_000006.12:33189361:G:A
NM_080679.2(COL11A2):c.1760_1764delinsA (p.Gly587fs)	COL11A2		not provided	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000290911	6	33144528 - 33144532	6	33176751 - 33176755	290911	275148	rs886044584	NC_000006.12:33176750:CTTCC:T
NM_080679.2(COL11A2):c.2341C>A (p.Pro781Thr)	COL11A2	P888T, P781T, P802T	Deafness, autosomal recessive 53	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000218349	6	33141299	6	33173522	218349	215057	rs864309523	NC_000006.12:33173521:G:T
COL11A2, 9-BP DEL, NT2899	COL11A2		Fibrochondrogenesis 2	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000029651					29651	38606		
COL11A2, IVS18, 1-BP INS, +3	COL11A2		Fibrochondrogenesis 2	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000029650					29650	38605		
NM_080680.2(COL11A2):c.3962delG (p.Gly1321Valfs)	COL11A2		Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000017130	6	33135628	6	33167851	17130	32169	rs1562315748	NC_000006.12:33167850:CCC:CC
NM_080679.2(COL11A2):c.2171C>A (p.Ser724Ter)	COL11A2	S345*, S724*, S745*, S831*	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000017126	6	33141825	6	33174048	17126	32165	rs121912949	NC_000006.12:33174047:G:T
NM_080679.2(COL11A2):c.1660G>A (p.Gly554Arg)	COL11A2	G175R, G554R, G575R, G661R	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jun 13, 1997)	no assertion criteria provided	VCV000017121	6	33144993	6	33177216	17121	32160	rs121912945	NC_000006.12:33177215:C:T
NM_001278716.2(FBXL4):c.622G>T (p.Glu208Ter)	FBXL4	E208*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802253	6	99365486	6	98917610	802253	790669		NC_000006.12:98917609:C:A
NM_080680.3(COL11A2):c.4465G>A (p.Gly1489Ser)	COL11A2	G1382S, G1403S, G1489S	Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic	criteria provided, single submitter	VCV000694708	6	33133725	6	33165948	694708	682806		NC_000006.12:33165947:C:T
NM_080679.2(COL11A2):c.3670C>T (p.Arg1224Ter)	COL11A2	R845*, R1224*, R1245*, R1331*	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000017128	6	33135599	6	33167822	17128	32167	rs121912951	NC_000006.12:33167821:G:A
NM_080679.2(COL11A2):c.2102G>A (p.Gly701Glu)	COL11A2	G323E, G701E, G722E, G808E	Deafness, autosomal dominant 13	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000017125	6	33142311	6	33174534	17125	32164	rs121912948	NC_000006.12:33174533:C:T
NM_080679.2(COL11A2):c.2501_2527del (p.Glu834_Pro843delinsAla)	COL11A2		Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000017122	6	33140357 - 33140383	6	33172580 - 33172606	17122	32161	rs864309477	NC_000006.12:33172579:GCCCCGGGGGGCCTGGGTGACCTCTCT:
NM_080679.2(COL11A2):c.4071+1G>A	COL11A2		Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	VCV000017120	6	33134289	6	33166512	17120	32159	rs750995470	NC_000006.12:33166511:C:T
NM_005933.4(KMT2A):c.1868del (p.Lys623fs)	KMT2A	K623fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000208760	11	118343740	11	118473025	208760	205267	rs797044937	NC_000011.10:118473024:AAA:AA
NM_001278716.2(FBXL4):c.627_633del (p.Asn210fs)	FBXL4	N210fs	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694444	6	99365475 - 99365481	6	98917599 - 98917605	694444	682346		NC_000006.12:98917598:ACTATTTACT:ACT
NM_001278716.2(FBXL4):c.859-1G>T	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437644	6	99353547	6	98905671	437644	431229	rs368965675	NC_000006.12:98905670:C:A
NM_001278716.2(FBXL4):c.1317G>A (p.Glu439=)	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437503	6	99347144	6	98899268	437503	431140	rs1554218789	NC_000006.12:98899267:C:T
NM_001278716.2(FBXL4):c.326del (p.Ser109fs)	FBXL4	S109fs	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437496	6	99374539	6	98926663	437496	431322	rs761215749	NC_000006.12:98926662:C:
NM_001278716.2(FBXL4):c.1210C>T (p.Gln404Ter)	FBXL4	Q404*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437493	6	99347251	6	98899375	437493	431159	rs1187832552	NC_000006.12:98899374:G:A
NM_001278716.2(FBXL4):c.616C>T (p.Arg206Ter)	FBXL4	R206*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437492	6	99365492	6	98917616	437492	431273	rs964532159	NC_000006.12:98917615:G:A
NM_080679.2(COL11A2):c.109G>T (p.Ala37Ser)	COL11A2	A37S	Deafness, autosomal recessive 53|Nonsyndromic Deafness	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000160366	6	33157220	6	33189443	160366	170211	rs606231410	NC_000006.12:33189442:C:A
NM_080679.2(COL11A2):c.4001G>A (p.Gly1334Glu)	COL11A2	G955E, G1334E, G1355E, G1441E	Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Nov 2, 1998)	no assertion criteria provided	VCV000017123	6	33134513	6	33166736	17123	32162	rs121912946	NC_000006.12:33166735:C:T
USH1C, IVS5DS, G-A, +1	USH1C		Usher syndrome, type 1C	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000005145					5145	20184		
NM_022970.3(FGFR2):c.1087+1304G>C	FGFR2	C342S, C227S, C253S, C114S	Jackson-Weiss syndrome|Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374820	10	123276892	10	121517378	374820	361711	rs121918487	NC_000010.11:121517377:C:G
NM_022970.3(FGFR2):c.1087+1304G>T	FGFR2	C342F, C227F, C114F, C253F	Jackson-Weiss syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374819	10	123276892	10	121517378	374819	361710	rs121918487	NC_000010.11:121517377:C:A
NM_022970.3(FGFR2):c.833G>T (p.Cys278Phe)	FGFR2	C278F, C50F, C163F, C189F	Crouzon syndrome|Pfeiffer syndrome|FGFR2 related craniosynostosis|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265431	10	123279599	10	121520085	265431	259933	rs776587763	NC_000010.11:121520084:C:A
NM_005476.7(GNE):c.2023T>C (p.Tyr675His)	GNE	Y565H, Y601H, Y616H, Y624H, Y675H, Y706H	GNE myopathy|Sialuria	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000861130	9	36217508	9	36217511	861130	836158		NC_000009.12:36217510:A:G
NM_000466.3(PEX1):c.2368C>T (p.Arg790Ter)	PEX1	R790*, R582*, R733*	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632939	7	92131252	7	92501938	632939	621279	rs61750417	NC_000007.14:92501937:G:A
NM_000466.3(PEX1):c.358-1G>T	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1B	Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371714	7	92147570	7	92518256	371714	357622	rs1057517479	NC_000007.14:92518255:C:A
NM_005476.7(GNE):c.484C>T (p.Arg162Cys)	GNE	R193C, R162C, R103C, R157C	not provided|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000290196	9	36246160	9	36246163	290196	274433	rs769215411	NC_000009.12:36246162:G:A
NM_000466.3(PEX1):c.1714_1715CA[1] (p.His572fs)	PEX1		Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, multiple submitters, no conflicts	VCV000188984	7	92136394 - 92136395	7	92507080 - 92507081	188984	186755	rs786204606	NC_000007.14:92507079:TGTG:TG
NM_001278716.2(FBXL4):c.1288C>T (p.Arg430Ter)	FBXL4	R430*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437724	6	99347173	6	98899297	437724	431145	rs758395213	NC_000006.12:98899296:G:A
NM_001278716.2(FBXL4):c.1389+3_1389+6del	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437505	6	99328423 - 99328426	6	98880547 - 98880550	437505	431118	rs1554216735	NC_000006.12:98880546:ACTTAC:AC
NM_001278716.2(FBXL4):c.858+1G>T	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437502	6	99365249	6	98917373	437502	431232	rs1394080480	NC_000006.12:98917372:C:A
NM_001278716.2(FBXL4):c.513-1G>A	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437500	6	99365596	6	98917720	437500	431292	rs1554221258	NC_000006.12:98917719:C:T
NM_001278716.2(FBXL4):c.273_277del (p.Phe91fs)	FBXL4	F91fs	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437495	6	99374588 - 99374592	6	98926712 - 98926716	437495	431327	rs766892502	NC_000006.12:98926711:GAGTA:
NM_001278716.2(FBXL4):c.1687C>T (p.Gln563Ter)	FBXL4	Q563*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437494	6	99323306	6	98875430	437494	431071	rs1554215964	NC_000006.12:98875429:G:A
NM_001278716.2(FBXL4):c.292C>T (p.Arg98Ter)	FBXL4	R98*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437490	6	99374573	6	98926697	437490	431326	rs1554222130	NC_000006.12:98926696:G:A
NM_001278716.2(FBXL4):c.1652T>A (p.Ile551Asn)	FBXL4	I551N	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437482	6	99323341	6	98875465	437482	431078	rs1554215979	NC_000006.12:98875464:A:T
NM_000162.5(GCK):c.98T>C (p.Val33Ala)	GCK	V33A, V34A, V32A	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000585930	7	44193010	7	44153411	585930	576999	rs1554335954	NC_000007.14:44153410:A:G
NM_000162.5(GCK):c.793G>A (p.Glu265Lys)	GCK	E265K, E266K, E264K	not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000447419	7	44187319	7	44147720	447419	441101	rs104894011	NC_000007.14:44147719:C:T
NM_000162.5(GCK):c.769T>C (p.Trp257Arg)	GCK	W257R, W258R, W256R	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000447416	7	44187343	7	44147744	447416	441105	rs1554335135	NC_000007.14:44147743:A:G
NM_000162.5(GCK):c.645C>G (p.Tyr215Ter)	GCK	Y215*, Y216*, Y214*	not provided|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036238	7	44189393	7	44149794	36238	44902	rs144723656	NC_000007.14:44149793:G:C
NM_000162.5(GCK):c.629T>A (p.Met210Lys)	GCK	M210K, M211K, M209K	Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000016141	7	44189409	7	44149810	16141	31180	rs80356654	NC_000007.14:44149809:A:T
NM_002047.4(GARS1):c.1415A>G (p.His472Arg)	GARS1	H472R, H418R	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, type 2|Distal hereditary motor neuronopathy type 5|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000410314	7	30661064	7	30621448	410314	395634	rs1060502838	NC_000007.14:30621447:A:G
NM_000391.4(TPP1):c.938_939del (p.Asn313fs)	TPP1	N313fs	Neuronal ceroid lipofuscinosis|not provided|Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280248	11	6637682 - 6637683	11	6616451 - 6616452	280248	264493	rs886041487	NC_000011.10:6616450:AT:
NM_000391.4(TPP1):c.229G>C (p.Gly77Arg)	TPP1	G77R	not provided|Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207567	11	6640007	11	6618776	207567	202595	rs121908195	NC_000011.10:6618775:C:G
NM_000391.4(TPP1):c.196C>T (p.Gln66Ter)	TPP1	Q66*	Neuronal ceroid lipofuscinosis|not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207564	11	6640040	11	6618809	207564	202600	rs759080581	NC_000011.10:6618808:G:A
NM_000391.4(TPP1):c.1397T>G (p.Val466Gly)	TPP1	V466G	Neuronal ceroid lipofuscinosis|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000089086	11	6636430	11	6615199	89086	94620	rs398122959	NC_000011.10:6615198:A:C
NM_016219.5(MAN1B1):c.1833_1834del (p.Asp613fs)	MAN1B1	D613fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000521615	9	140002051 - 140002052	9	137107599 - 137107600	521615	511822	rs1382373816	NC_000009.12:137107598:AG:
NM_001278716.2(FBXL4):c.1648_1649del (p.Asp550fs)	FBXL4	D550fs	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437499	6	99323344 - 99323345	6	98875468 - 98875469	437499	431079	rs1554215986	NC_000006.12:98875467:TCT:T
NM_001278716.2(FBXL4):c.316C>T (p.Gln106Ter)	FBXL4	Q106*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437491	6	99374549	6	98926673	437491	431323	rs1554222122	NC_000006.12:98926672:G:A
NM_001278716.2(FBXL4):c.219T>A (p.Tyr73Ter)	FBXL4	Y73*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000437489	6	99374646	6	98926770	437489	431334	rs747536886	NC_000006.12:98926769:A:T
NM_001278716.2(FBXL4):c.618_621dup (p.Glu208fs)	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280414	6	99365486 - 99365487	6	98917610 - 98917611	280414	264218	rs886041625	NC_000006.12:98917610:CAGTC:CAGTCAGTC
NM_000543.5(SMPD1):c.973C>G (p.Pro325Ala)	SMPD1	P325A, H4Q, P324A	not specified|Niemann-Pick disease, type A|Niemann-Pick disease, type B	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000633427	11	6413268	11	6392038	633427	621364	rs761308217	NC_000011.10:6392037:C:G
NM_000543.5(SMPD1):c.538_539del (p.Leu180fs)	SMPD1	L179fs, L180fs	Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189096	11	6412832 - 6412833	11	6391602 - 6391603	189096	186825	rs786204694	NC_000011.10:6391601:TTT:T
NM_000543.5(SMPD1):c.1177T>G (p.Trp393Gly)	SMPD1	W391G, W393G, W86G, W392G	Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002991	11	6414531	11	6393301	2991	18030	rs120074125	NC_000011.10:6393300:T:G
NM_001360.2(DHCR7):c.1396G>A (p.Val466Met)	DHCR7	V466M	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265097	11	71146453	11	71435407	265097	260004	rs760428437	NC_000011.10:71435406:C:T
NM_006073.4(TRDN):c.568dup (p.Ile190fs)	TRDN		Catecholaminergic polymorphic ventricular tachycardia|not provided|Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225497	6	123833489 - 123833490	6	123512344 - 123512345	225497	227290	rs1085307100	NC_000006.12:123512344:TTTTTT:TTTTTTT
NM_006073.4(TRDN):c.613C>T (p.Gln205Ter)	TRDN	Q205*	Catecholaminergic polymorphic ventricular tachycardia|Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness|not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066016	6	123825044	6	123503899	66016	76926	rs397515458	NC_000006.12:123503898:G:A
NM_001134831.2(AHI1):c.2988del (p.Val997fs)	AHI1	V997fs	not provided|Retinal dystrophy|Joubert syndrome 3|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280290	6	135726089	6	135404951	280290	264200	rs755246809	NC_000006.12:135404950:TTTT:TTT
NM_001134831.2(AHI1):c.1267C>T (p.Gln423Ter)	AHI1	Q423*	not provided|Retinal dystrophy|Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217523	6	135776949	6	135455811	217523	214252	rs777668842	NC_000006.12:135455810:G:A
NM_001134831.2(AHI1):c.2174G>A (p.Trp725Ter)	AHI1	W725*	Joubert syndrome 3|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000156382	6	135754257	6	135433119	156382	166163	rs587783013	NC_000006.12:135433118:C:T
NM_006772.3(SYNGAP1):c.2454_2456delinsG (p.Ala819fs)	SYNGAP1		not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000817808	6	33410783 - 33410785	6	33443006 - 33443008	817808	805500		NC_000006.12:33443005:AGC:G
NM_006772.3(SYNGAP1):c.1296dup (p.Ala433fs)	SYNGAP1		not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000817769	6	33405977 - 33405978	6	33438200 - 33438201	817769	805499		NC_000006.12:33438200:T:TT
NM_006772.3(SYNGAP1):c.3320_3321AG[1] (p.Ser1108fs)	SYNGAP1		not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000817236	6	33411649 - 33411650	6	33443872 - 33443873	817236	805501		NC_000006.12:33443871:AGAG:AG
NM_006772.3(SYNGAP1):c.2539C>T (p.Gln847Ter)	SYNGAP1	Q847*, Q833*	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000620357	6	33410868	6	33443091	620357	611658	rs1554122200	NC_000006.12:33443090:C:T
NM_006772.3(SYNGAP1):c.2494C>T (p.Gln832Ter)	SYNGAP1	Q832*, Q818*	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000620206	6	33410823	6	33443046	620206	611657	rs1554122196	NC_000006.12:33443045:C:T
NM_006772.3(SYNGAP1):c.2104C>T (p.Gln702Ter)	SYNGAP1	Q702*	not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000620116	6	33409140	6	33441363	620116	611656	rs1554121861	NC_000006.12:33441362:C:T
NM_006772.3(SYNGAP1):c.1269T>G (p.Tyr423Ter)	SYNGAP1	Y423*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000589058	6	33405951	6	33438174	589058	579409	rs1561785045	NC_000006.12:33438173:T:G
NM_006772.3(SYNGAP1):c.355dup (p.Glu119fs)	SYNGAP1		not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000546192	6	33399995 - 33399996	6	33432218 - 33432219	546192	536716	rs1554120489	NC_000006.12:33432218:GG:GGG
NM_006772.3(SYNGAP1):c.790_798del (p.Leu264_Leu266del)	SYNGAP1		not provided	Pathogenic(Last reviewed: Oct 26, 2016)	no assertion criteria provided	VCV000545045	6	33405470 - 33405478	6	33437693 - 33437701	545045	535308	rs1554121164	NC_000006.12:33437692:TGCTAAAGCTG:TG
NM_006772.3(SYNGAP1):c.3246delinsAA (p.Pro1084fs)	SYNGAP1		not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000504103	6	33411575	6	33443798	504103	495193	rs1554122348	NC_000006.12:33443797:G:AA
NM_006772.3(SYNGAP1):c.2418del (p.Tyr807fs)	SYNGAP1	Y807fs, Y793fs	not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000504076	6	33410747	6	33442970	504076	495315	rs1554122179	NC_000006.12:33442969:C:
NM_006772.3(SYNGAP1):c.3036del (p.Ser1013fs)	SYNGAP1	S999fs, S1013fs	not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000503968	6	33411363	6	33443586	503968	495283	rs1554122289	NC_000006.12:33443585:CCC:CC
NM_006772.3(SYNGAP1):c.3415_3416del (p.Gln1139fs)	SYNGAP1	Q1125fs, Q1139fs	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000503877	6	33412227 - 33412228	6	33444450 - 33444451	503877	495196	rs1554122457	NC_000006.12:33444449:CA:
NM_006772.3(SYNGAP1):c.1345dup (p.Ser449fs)	SYNGAP1		not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000503781	6	33406026 - 33406027	6	33438249 - 33438250	503781	495192	rs1554121295	NC_000006.12:33438249:A:AA
NM_006772.3(SYNGAP1):c.2294+1G>T	SYNGAP1		not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000452569	6	33409537	6	33441760	452569	443959	rs1554121970	NC_000006.12:33441759:G:T
NM_006772.3(SYNGAP1):c.949del (p.Leu317fs)	SYNGAP1	L317fs	not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000452492	6	33405630	6	33437853	452492	443956	rs1554121211	NC_000006.12:33437852:CC:C
NM_006772.3(SYNGAP1):c.1792del (p.Leu598fs)	SYNGAP1	L598fs	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000429853	6	33408620	6	33440843	429853	421589	rs1131691635	NC_000006.12:33440842:CC:C
NM_006772.3(SYNGAP1):c.472C>T (p.Gln158Ter)	SYNGAP1	Q158*	not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000426956	6	33400546	6	33432769	426956	415048	rs1085307871	NC_000006.12:33432768:C:T
NM_006772.3(SYNGAP1):c.3471G>A (p.Trp1157Ter)	SYNGAP1	W1157*, W1143*	not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000423403	6	33412283	6	33444506	423403	406866	rs1064796403	NC_000006.12:33444505:G:A
NM_006772.3(SYNGAP1):c.3227del (p.Gln1075_Leu1076insTer)	SYNGAP1		not provided	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000422836	6	33411555	6	33443778	422836	406865	rs1064796033	NC_000006.12:33443777:TT:T
NM_006772.3(SYNGAP1):c.1716G>A (p.Trp572Ter)	SYNGAP1	W572*	not provided	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000373056	6	33408545	6	33440768	373056	359780	rs1057518178	NC_000006.12:33440767:G:A
NM_006772.3(SYNGAP1):c.3599dup (p.Glu1201fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802205	6	33414367 - 33414368	6	33446590 - 33446591	802205	790620		NC_000006.12:33446590:A:AA
NM_006772.3(SYNGAP1):c.3179del (p.Gly1060fs)	SYNGAP1	G1046fs, G1060fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802203	6	33411504	6	33443727	802203	790618		NC_000006.12:33443726:GGGGG:GGGG
NM_006772.3(SYNGAP1):c.2387del (p.Pro796fs)	SYNGAP1	P782fs, P796fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802202	6	33410712	6	33442935	802202	790617		NC_000006.12:33442934:CCCCC:CCCC
NM_006772.3(SYNGAP1):c.1618C>T (p.Gln540Ter)	SYNGAP1	Q540*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802201	6	33406638	6	33438861	802201	790616		NC_000006.12:33438860:C:T
NM_006772.3(SYNGAP1):c.509+1G>A	SYNGAP1		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000589610	6	33400584	6	33432807	589610	579305	rs1561781989	NC_000006.12:33432806:G:A
NM_006772.3(SYNGAP1):c.1685del (p.Pro562fs)	SYNGAP1	P562fs	Mental retardation, autosomal dominant 5	Pathogenic	no assertion criteria provided	VCV000375621	6	33408512	6	33440735	375621	362435	rs1057519405	NC_000006.12:33440734:CCC:CC
NM_006772.3(SYNGAP1):c.1908_1909del (p.Ser637fs)	SYNGAP1	S637fs	Mental retardation, autosomal dominant 5	Pathogenic	no assertion criteria provided	VCV000375615	6	33408735 - 33408736	6	33440958 - 33440959	375615	362429	rs1057519400	NC_000006.12:33440957:TTTT:TT
NM_006772.3(SYNGAP1):c.2576_2577GT[1] (p.Val860fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000242918	6	33410905 - 33410906	6	33443128 - 33443129	242918	244015	rs879253762	NC_000006.12:33443127:GTGT:GT
NM_006772.3(SYNGAP1):c.3788_3794del (p.Ile1263fs)	SYNGAP1	I1247fs, I1263fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000224101	6	33414557 - 33414563	6	33446780 - 33446786	224101	225831	rs869312677	NC_000006.12:33446779:TTGGCAG:
NM_014251.3(SLC25A13):c.615+5G>A	SLC25A13		not provided|Citrullinemia type II|Neonatal intrahepatic cholestasis caused by citrin deficiency|Citrin deficiency	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021517	7	95822344	7	96193032	21517	34369	rs80338717	NC_000007.14:96193031:C:T
NM_014251.3(SLC25A13):c.1177+1G>A	SLC25A13		Citrin deficiency|Citrullinemia type II|Neonatal intrahepatic cholestasis caused by citrin deficiency	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006002	7	95813588	7	96184276	6002	21041	rs80338722	NC_000007.14:96184275:C:T
NM_006772.3(SYNGAP1):c.1273_1274del (p.Thr425fs)	SYNGAP1	T425fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000841446	6	33405954 - 33405955	6	33438177 - 33438178	841446	831851		NC_000006.12:33438176:CAC:C
NM_006772.3(SYNGAP1):c.2215G>T (p.Glu739Ter)	SYNGAP1	E739*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000834121	6	33409457	6	33441680	834121	831856		NC_000006.12:33441679:G:T
NC_000006.12:g.(?_33435132)_(33438311_?)del	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000833001	6	33402909 - 33406088			833001	819686		
NM_006772.3(SYNGAP1):c.67+1G>T	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000813785	6	33388109	6	33420332	813785	802057		NC_000006.12:33420331:G:T
NM_006772.3(SYNGAP1):c.761dup (p.Asp255fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000813755	6	33403387 - 33403388	6	33435610 - 33435611	813755	801991		NC_000006.12:33435610:AA:AAA
NM_006772.3(SYNGAP1):c.3384dup (p.Leu1129fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000813751	6	33411707 - 33411708	6	33443930 - 33443931	813751	801993		NC_000006.12:33443930:GGGGGG:GGGGGGG
NM_006772.3(SYNGAP1):c.1490_1491AT[1] (p.Met498fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000813747	6	33406298 - 33406299	6	33438521 - 33438522	813747	801992		NC_000006.12:33438520:TATAT:TAT
NM_006772.3(SYNGAP1):c.3377del (p.Gly1126fs)	SYNGAP1	G1126fs, G1112fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000665761	6	33411702	6	33443925	665761	634864		NC_000006.12:33443924:GGGGG:GGGG
NM_006772.3(SYNGAP1):c.980T>C (p.Leu327Pro)	SYNGAP1	L327P	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000660421	6	33405662	6	33437885	660421	634845		NC_000006.12:33437884:T:C
NM_006772.3(SYNGAP1):c.410del (p.Leu137fs)	SYNGAP1	L137fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000659379	6	33400484	6	33432707	659379	634840		NC_000006.12:33432706:T:
NM_006772.3(SYNGAP1):c.1721del (p.Leu574fs)	SYNGAP1	L574fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000659250	6	33408550	6	33440773	659250	634849		NC_000006.12:33440772:T:
NM_006772.3(SYNGAP1):c.2755C>T (p.Gln919Ter)	SYNGAP1	Q919*, Q905*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000655800	6	33411084	6	33443307	655800	634859		NC_000006.12:33443306:C:T
NM_006772.3(SYNGAP1):c.781_784del (p.Asp261fs)	SYNGAP1	D261fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000651597	6	33405462 - 33405465	6	33437685 - 33437688	651597	634843		NC_000006.12:33437684:AGACA:A
NM_006772.3(SYNGAP1):c.937G>T (p.Glu313Ter)	SYNGAP1	E313*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000648805	6	33405619	6	33437842	648805	634844		NC_000006.12:33437841:G:T
NM_006772.3(SYNGAP1):c.3167_3188dup (p.Pro1065fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000646638	6	33411491 - 33411492	6	33443714 - 33443715	646638	634861		NC_000006.12:33443714:GGGGGCAGCGGTGGGGGTGGCGGGGG:GGGGGCAGCGGTGGGGGTGGCGGGGGGCAGCGGTGGGGGTGGCGGGGG
NM_006772.3(SYNGAP1):c.2391_2392dup (p.Pro798fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000645497	6	33410718 - 33410719	6	33442941 - 33442942	645497	634853		NC_000006.12:33442941:CAC:CACAC
NM_006772.3(SYNGAP1):c.1823_1824del (p.Phe608fs)	SYNGAP1	F608fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000643448	6	33408651 - 33408652	6	33440874 - 33440875	643448	634850		NC_000006.12:33440873:TTT:T
NM_006772.3(SYNGAP1):c.1094del (p.Val365fs)	SYNGAP1	V365fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000643101	6	33405776	6	33437999	643101	634846		NC_000006.12:33437998:T:
NM_006772.3(SYNGAP1):c.539dup (p.His181fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000620049	6	33402957 - 33402958	6	33435180 - 33435181	620049	611393	rs1561783309	NC_000006.12:33435180:C:CC
NM_006772.3(SYNGAP1):c.1736_1740del (p.Arg579fs)	SYNGAP1	R579fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	VCV000619991	6	33408563 - 33408567	6	33440786 - 33440790	619991	611395	rs1561786928	NC_000006.12:33440785:GCGAGGC:GC
NM_006772.3(SYNGAP1):c.1532-3C>G	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000619988	6	33406549	6	33438772	619988	611466	rs1561785573	NC_000006.12:33438771:C:G
NM_006772.3(SYNGAP1):c.878del (p.Arg293fs)	SYNGAP1	R293fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000582839	6	33405560	6	33437783	582839	565592	rs1561784560	NC_000006.12:33437782:G:
NM_006772.3(SYNGAP1):c.3811G>T (p.Glu1271Ter)	SYNGAP1	E1271*, E1255*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000576831	6	33415636	6	33447859	576831	565623	rs1554122888	NC_000006.12:33447858:G:T
NM_006772.3(SYNGAP1):c.2818_2852del (p.Gly940fs)	SYNGAP1	G940fs, G926fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000576152	6	33411142 - 33411176	6	33443365 - 33443399	576152	560801	rs1561789313	NC_000006.12:33443364:GGCCAGGTCCCCCAGGCGGCCATGGAGGGGGCGGTGGCCA:GGCCA
NM_006772.3(SYNGAP1):c.3124C>T (p.Gln1042Ter)	SYNGAP1	Q1042*, Q1028*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000575167	6	33411453	6	33443676	575167	563544	rs1554122305	NC_000006.12:33443675:C:T
NM_006772.3(SYNGAP1):c.2135_2142del (p.Gly712fs)	SYNGAP1	G712fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000574599	6	33409376 - 33409383	6	33441599 - 33441606	574599	565594	rs1561787690	NC_000006.12:33441598:GGTCCACTG:G
NM_006772.3(SYNGAP1):c.1001del (p.Lys334fs)	SYNGAP1	K334fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000571977	6	33405679	6	33437902	571977	560690	rs1561784687	NC_000006.12:33437901:AAAAA:AAAA
NM_006772.3(SYNGAP1):c.1235dup (p.Leu412fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000569874	6	33405915 - 33405916	6	33438138 - 33438139	569874	563522	rs1561785003	NC_000006.12:33438138:TT:TTT
NM_006772.3(SYNGAP1):c.2726del (p.Met909fs)	SYNGAP1	M895fs, M909fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000568262	6	33411055	6	33443278	568262	563535	rs1561789215	NC_000006.12:33443277:T:
NM_006772.3(SYNGAP1):c.2272dup (p.Tyr758fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000567471	6	33409513 - 33409514	6	33441736 - 33441737	567471	563527	rs1561787845	NC_000006.12:33441736:T:TT
NM_006772.3(SYNGAP1):c.3583-9G>A	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000537000	6	33414343	6	33446566	537000	521972	rs1554122689	NC_000006.12:33446565:G:A
NM_006772.3(SYNGAP1):c.199del (p.Leu67fs)	SYNGAP1	L67fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000536999	6	33393580	6	33425803	536999	521880	rs1554119814	NC_000006.12:33425802:CCCCC:CCCC
NM_006772.3(SYNGAP1):c.3233_3236del (p.Val1078fs)	SYNGAP1	V1064fs, V1078fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000536991	6	33411559 - 33411562	6	33443782 - 33443785	536991	521964	rs1554122341	NC_000006.12:33443781:CAGTCAG:CAG
NM_006772.3(SYNGAP1):c.3060del (p.Gln1021fs)	SYNGAP1	Q1021fs, Q1007fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000536990	6	33411388	6	33443611	536990	521962	rs1554122293	NC_000006.12:33443610:GG:G
NM_006772.3(SYNGAP1):c.739C>T (p.Gln247Ter)	SYNGAP1	Q247*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000496672	6	33403367	6	33435590	496672	488156	rs1554120978	NC_000006.12:33435589:C:T
NM_006772.3(SYNGAP1):c.384dup (p.Ser129fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	VCV000469158	6	33400023 - 33400024	6	33432246 - 33432247	469158	456122	rs1554120498	NC_000006.12:33432246:CCC:CCCC
NM_006772.3(SYNGAP1):c.1053del (p.Thr352fs)	SYNGAP1	T352fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000469144	6	33405734	6	33437957	469144	455538	rs1554121228	NC_000006.12:33437956:CC:C
NM_006772.3(SYNGAP1):c.896del (p.Arg299fs)	SYNGAP1	R299fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 14, 2014)	criteria provided, single submitter	VCV000217012	6	33405578	6	33437801	217012	213572	rs863224930	NC_000006.12:33437800:G:
NM_006772.3(SYNGAP1):c.762+1G>T	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000212358	6	33403391	6	33435614	212358	207403	rs797046031	NC_000006.12:33435613:G:T
NM_006772.3(SYNGAP1):c.3592del (p.Tyr1198fs)	SYNGAP1	Y1182fs, Y1198fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	VCV000212354	6	33414361	6	33446584	212354	207412	rs797046030	NC_000006.12:33446583:T:
NM_006772.3(SYNGAP1):c.2066_2071delinsC (p.Leu689fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000212349	6	33409102 - 33409107	6	33441325 - 33441330	212349	207407	rs797046029	NC_000006.12:33441324:TCTCCA:C
NM_006772.3(SYNGAP1):c.1576del (p.Glu525_Val526insTer)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000212348	6	33406595	6	33438818	212348	207406	rs797046028	NC_000006.12:33438817:GG:G
NM_006772.3(SYNGAP1):c.388-2A>G	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 9, 2014)	no assertion criteria provided	VCV000208499	6	33400460	6	33432683	208499	205012	rs797045012	NC_000006.12:33432682:A:G
NM_006772.3(SYNGAP1):c.2602del (p.Asp868fs)	SYNGAP1	D854fs, D868fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 10, 2013)	criteria provided, single submitter	VCV000130528	6	33410928	6	33443151	130528	135974	rs587780474	NC_000006.12:33443150:GGGG:GGG
NM_006772.3(SYNGAP1):c.1783del (p.Leu595fs)	SYNGAP1	L595fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	VCV000130525	6	33408611	6	33440834	130525	135971	rs587780470	NC_000006.12:33440833:CC:C
SYNGAP1, TRP267TER	SYNGAP1	W267*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060717					60717	75279		
NM_006772.3(SYNGAP1):c.2294+1G>A	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000041460	6	33409537	6	33441760	41460	49896		NC_000006.12:33441759:G:A
NM_006772.3(SYNGAP1):c.2677del (p.Gln893fs)	SYNGAP1	Q879fs, Q893fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000041459	6	33411004	6	33443227	41459	49895		NC_000006.12:33443226:CCC:CC
SYNGAP1, 501, G-A, -1	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039664					39664	48263		
NM_000466.3(PEX1):c.2032_2033CA[1] (p.His678fs)	PEX1		Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371692	7	92134082 - 92134083	7	92504768 - 92504769	371692	357601	rs61750412	NC_000007.14:92504767:TGTG:TG
NM_005476.7(GNE):c.175C>T (p.Arg59Ter)	GNE	R90*, R59*, R54*	GNE myopathy|GNE myopathy|Sialuria|not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285936	9	36246469	9	36246472	285936	270173	rs745517517	NC_000009.12:36246471:G:A
NM_006772.3(SYNGAP1):c.2209C>T (p.Gln737Ter)	SYNGAP1	Q737*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812188	6	33409451	6	33441674	812188	800668		NC_000006.12:33441673:C:T
NM_006772.3(SYNGAP1):c.2562_2578del (p.Leu855fs)	SYNGAP1	L855fs, L841fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561122	6	33410890 - 33410906	6	33443113 - 33443129	561122	552106	rs1561788984	NC_000006.12:33443112:GCCTCAACAGCAGCAGTG:G
NM_006772.3(SYNGAP1):c.3190C>T (p.Gln1064Ter)	SYNGAP1	Q1064*, Q1050*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431134	6	33411519	6	33443742	431134	424650	rs1135401805	NC_000006.12:33443741:C:T
NM_006772.3(SYNGAP1):c.509G>A (p.Arg170Gln)	SYNGAP1	R170Q	Mental retardation, autosomal dominant 5	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375528	6	33400583	6	33432806	375528	362330	rs1057519546	NC_000006.12:33432805:G:A
NM_000255.4(MMUT):c.1399C>T (p.Arg467Ter)	MMUT	R467*	Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495778	6	49416574	6	49448861	495778	487201	rs774159791	NC_000006.12:49448860:G:A
NM_000255.4(MMUT):c.982C>T (p.Leu328Phe)	MMUT	L328F	Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203844	6	49421399	6	49453686	203844	200116	rs796052002	NC_000006.12:49453685:G:A
NM_000255.4(MMUT):c.1867G>A (p.Gly623Arg)	MMUT	G623R	not provided|METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000001884	6	49408008	6	49440295	1884	16923	rs121918254	NC_000006.12:49440294:C:T
NM_001278716.2(FBXL4):c.1555C>T (p.Gln519Ter)	FBXL4	Q519*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000066090	6	99323438	6	98875562	66090	76992	rs398123059	NC_000006.12:98875561:G:A
NM_000162.5(GCK):c.127C>T (p.Arg43Cys)	GCK	R43C, R44C, R42C	not provided	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000585911	7	44192981	7	44153382	585911	576997	rs1486280029	NC_000007.14:44153381:G:A
NM_000162.5(GCK):c.295T>C (p.Trp99Arg)	GCK	W100R, W99R, W98R	not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447394	7	44191938	7	44152339	447394	441125	rs1554335751	NC_000007.14:44152338:A:G
NM_000162.5(GCK):c.1253+2T>A	GCK		Monogenic diabetes|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000393449	7	44185094	7	44145495	393449	380268	rs1057524902	NC_000007.14:44145494:A:T
NM_152419.3(HGSNAT):c.1411G>A (p.Glu471Lys)	HGSNAT	E471K, E183K, E407K	Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|not provided|Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265483	8	43048933	8	43193790	265483	259899	rs753355844	NC_000008.11:43193789:G:A
NM_006772.3(SYNGAP1):c.1453del (p.Arg485fs)	SYNGAP1	R485fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620026	6	33406261	6	33438484	620026	611394	rs1561785326	NC_000006.12:33438483:CC:C
NM_006772.3(SYNGAP1):c.3073C>T (p.Gln1025Ter)	SYNGAP1	Q1025*, Q1011*	Mental retardation, autosomal dominant 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000581705	6	33411402	6	33443625	581705	560694	rs1554122296	NC_000006.12:33443624:C:T
NM_006772.3(SYNGAP1):c.857_864dup (p.Met289fs)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000469164	6	33405537 - 33405538	6	33437760 - 33437761	469164	456125	rs1554121189	NC_000006.12:33437760:CTGGATGAC:CTGGATGACTGGATGAC
NM_006772.3(SYNGAP1):c.2899C>T (p.Arg967Ter)	SYNGAP1	R967*, R953*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000436928	6	33411228	6	33443451	436928	428626	rs749188610	NC_000006.12:33443450:C:T
NM_006772.3(SYNGAP1):c.1084T>C (p.Trp362Arg)	SYNGAP1	W362R	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000041461	6	33405766	6	33437989	41461	49897		NC_000006.12:33437988:T:C
NM_006772.3(SYNGAP1):c.1735C>T (p.Arg579Ter)	SYNGAP1	R579*	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000006393	6	33408564	6	33440787	6393	21432	rs121918316	NC_000006.12:33440786:C:T
NM_006772.3(SYNGAP1):c.412A>T (p.Lys138Ter)	SYNGAP1	K138*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000006392	6	33400486	6	33432709	6392	21431	rs121918315	NC_000006.12:33432708:A:T
NM_004562.3(PRKN):c.758G>A (p.Cys253Tyr)	PRKN	C253Y, C104Y, C225Y	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000645725	6	162206917	6	161785885	645725	634768		NC_000006.12:161785884:C:T
NM_004562.3(PRKN):c.850G>C (p.Gly284Arg)	PRKN	G284R, G135R, G256R	not provided	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000409266	6	162206825	6	161785793	409266	395419	rs751037529	NC_000006.12:161785792:C:G
NM_004562.3(PRKN):c.635G>A (p.Cys212Tyr)	PRKN	C212Y, C184Y, C63Y	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000007046	6	162394433	6	161973401	7046	22085	rs137853058	NC_000006.12:161973400:C:T
NC_000006.12:g.(?_33420245)_(33451926_?)del	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000831495	6	33388022 - 33419703			831495	819685		
NM_006772.3(SYNGAP1):c.3277C>T (p.Gln1093Ter)	SYNGAP1	Q1093*, Q1079*	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488875	6	33411606	6	33443829	488875	481762	rs1554122363	NC_000006.12:33443828:C:T
NM_006772.3(SYNGAP1):c.490C>T (p.Arg164Ter)	SYNGAP1	R164*	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373327	6	33400564	6	33432787	373327	359770	rs1057518352	NC_000006.12:33432786:C:T
NM_006772.3(SYNGAP1):c.2438del (p.Leu813fs)	SYNGAP1	L799fs, L813fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000006394	6	33410767	6	33442990	6394	21433	rs397515320	NC_000006.12:33442989:T:
NM_001167734.1(VARS2):c.1100C>T (p.Thr367Ile)	VARS2	T367I, T337I, T197I	Inborn genetic diseases|Combined oxidative phosphorylation deficiency 20	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141427	6	30886628	6	30918851	141427	151141	rs587777585	NC_000006.12:30918850:C:T
NM_003002.4(SDHD):c.13_14del (p.Trp5fs)	SDHD	W5fs	not provided|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618362	11	111957644 - 111957645	11	112086920 - 112086921	618362	609782	rs1566690018	NC_000011.10:112086919:TG:
NM_003002.4(SDHD):c.394del (p.Ser132fs)	SDHD	S132fs, S93fs, Q84fs	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Paragangliomas 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000412505	11	111965606	11	112094882	412505	398034	rs1060503773	NC_000011.10:112094881:TTT:TT
NM_003002.4(SDHD):c.155C>A (p.Ser52Ter)	SDHD	S52*	Pheochromocytoma|Paragangliomas 1|Carney-Stratakis syndrome|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000142068	11	111958683	11	112087959	142068	151782	rs587782210	NC_000011.10:112087958:C:A
NM_000391.4(TPP1):c.229G>A (p.Gly77Arg)	TPP1	G77R	Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000068744	11	6640007	11	6618776	68744	79636	rs121908195	NC_000011.10:6618775:C:T
NM_000391.4(TPP1):c.1027G>A (p.Glu343Lys)	TPP1	E343K	Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000068734	11	6637594	11	6616363	68734	79626	rs121908197	NC_000011.10:6616362:C:T
NM_000076.2(CDKN1C):c.125T>C (p.Leu42Pro)	CDKN1C	L42P, L31P	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000854857	11	2906595	11	2885365	854857	838286		NC_000011.10:2885364:A:G
NM_153676.4(USH1C):c.672C>A (p.Cys224Ter)	USH1C	C224*	Usher syndrome, type 1C|Deafness, autosomal recessive 18|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556381	11	17547896	11	17526349	556381	545971	rs1223763703	NC_000011.10:17526348:G:T
NM_153676.4(USH1C):c.496+1G>T	USH1C		Deafness, autosomal recessive 18|Usher syndrome, type 1C	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000551814	11	17548769	11	17527222	551814	546258	rs138138689	NC_000011.10:17527221:C:A
NM_153676.4(USH1C):c.497-2del	USH1C		|Usher syndrome, type 1C	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000005140	11	17548589	11	17527042	5140	20179		NC_000011.10:17527041:T:
NM_000144.5(FXN):c.389G>T (p.Gly130Val)	FXN	G130V	not provided|Friedreich's ataxia	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000003982	9	71679858	9	69064942	3982	19021	rs104894107	NC_000009.12:69064941:G:T
NM_004333.6(BRAF):c.1390G>C (p.Gly464Arg)	BRAF	G464R	not provided	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000279992	7	140481418	7	140781618	279992	264230	rs121913349	NC_000007.14:140781617:C:G
NM_004333.6(BRAF):c.1593G>T (p.Trp531Cys)	BRAF	W531C	not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000265358	7	140476813	7	140777013	265358	259851	rs606231228	NC_000007.14:140777012:C:A
NM_004333.6(BRAF):c.1722C>A (p.His574Gln)	BRAF	H574Q	not provided	Pathogenic(Last reviewed: Aug 5, 2014)	criteria provided, single submitter	VCV000180788	7	140454006	7	140754206	180788	179096	rs397507481	NC_000007.14:140754205:G:T
NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	BRAF	Q262K	not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000040352	7	140501288	7	140801488	40352	48822	rs397507470	NC_000007.14:140801487:G:T
NM_004333.6(BRAF):c.1906C>T (p.Gln636Ter)	BRAF	Q636*	Cerebral arteriovenous malformation	Pathogenic	no assertion criteria provided	VCV000690297	7	140449173	7	140749373	690297	677974		NC_000007.14:140749372:G:A
NM_004333.6(BRAF):c.1408_1410del (p.Thr470del)	BRAF	T470del	Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	VCV000223139	7	140481398 - 140481400	7	140781598 - 140781600	223139	224864	rs869025607	NC_000007.14:140781597:TGTT:T
NM_183050.4(BCKDHB):c.970C>T (p.Arg324Ter)	BCKDHB	R324*, R254*	not provided|Maple syrup urine disease type 1B|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096621	6	80982870	6	80273153	96621	102514	rs398124603	NC_000006.12:80273152:C:T
NM_001278716.2(FBXL4):c.1635_1636TG[3] (p.Cys547_Asp548delinsTer)	FBXL4		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|not provided	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265143	6	99323351 - 99323352	6	98875475 - 98875476	265143	259849	rs765882664	NC_000006.12:98875474:CACACACA:CACACA
NM_004333.6(BRAF):c.1592G>C (p.Trp531Ser)	BRAF	W531S, W571S	Noonan syndrome 7	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000666569	7	140476814	7	140777014	666569	654129		NC_000007.14:140777013:C:G
NM_004333.6(BRAF):c.1399T>G (p.Ser467Ala)	BRAF	S467A	Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000223138	7	140481409	7	140781609	223138	224865	rs869025606	NC_000007.14:140781608:A:C
NM_004333.6(BRAF):c.1574T>C (p.Leu525Pro)	BRAF	L525P	not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222077	7	140476832	7	140777032	222077	223775	rs869025340	NC_000007.14:140777031:A:G
NM_004333.6(BRAF):c.1497A>T (p.Lys499Asn)	BRAF	K499N	Cardiofaciocutaneous syndrome 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000040372	7	140477811	7	140778011	40372	48842		NC_000007.14:140778010:T:A
NM_006772.3(SYNGAP1):c.1861C>T (p.Arg621Ter)	SYNGAP1	R621*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411589	6	33408690	6	33440913	411589	395450	rs1060503386	NC_000006.12:33440912:C:T
NM_004333.6(BRAF):c.755G>C (p.Arg252Pro)	BRAF	R252P	not provided|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000451504	7	140501317	7	140801517	451504	444072	rs1325951163	NC_000007.14:140801516:C:G
NM_004333.6(BRAF):c.1720C>T (p.His574Tyr)	BRAF	H574Y, H522Y, H540Y, H486Y, H614Y, H537Y, H552Y, H577Y	Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	VCV000044810	7	140454008	7	140754208	44810	53977	rs397516894	NC_000007.14:140754207:G:A
NM_004333.6(BRAF):c.1405_1407del (p.Gly469del)	BRAF	G469del	Non-small cell lung cancer	Pathogenic(Last reviewed: Sep 21, 2009)	no assertion criteria provided	VCV000044802	7	140481401 - 140481403	7	140781601 - 140781603	44802	53969	rs397516890	NC_000007.14:140781600:TCC:
NM_005476.7(GNE):c.1844C>G (p.Ser615Ter)	GNE	S646*, S615*, S541*, S610*, S505*	GNE myopathy|not provided|GNE myopathy|Sialuria	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286439	9	36218269	9	36218272	286439	270676	rs757523840	NC_000009.12:36218271:G:C
NM_000466.3(PEX1):c.782_783del (p.Gln261fs)	PEX1	Q261fs, Q53fs	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188910	7	92147046 - 92147047	7	92517732 - 92517733	188910	186758	rs749067142	NC_000007.14:92517731:TT:
NM_000162.5(GCK):c.645C>A (p.Tyr215Ter)	GCK	Y215*, Y216*, Y214*	Maturity onset diabetes mellitus in young|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000453007	7	44189393	7	44149794	453007	444135	rs144723656	NC_000007.14:44149793:G:T
NM_000162.5(GCK):c.680-1G>A	GCK		Monogenic diabetes|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000393452	7	44187433	7	44147834	393452	380271	rs1057524905	NC_000007.14:44147833:C:T
NM_000162.5(GCK):c.616A>C (p.Thr206Pro)	GCK	T206P, T207P, T205P	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000129145	7	44189422	7	44149823	129145	134591	rs587780346	NC_000007.14:44149822:T:G
NM_000162.5(GCK):c.76C>T (p.Gln26Ter)	GCK	Q26*, Q27*, Q25*	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036256	7	44193032	7	44153433	36256	44920	rs193922329	NC_000007.14:44153432:G:A
NM_000162.5(GCK):c.449T>C (p.Phe150Ser)	GCK	F150S, F151S, F149S	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036218	7	44190589	7	44150990	36218	44882	rs193922297	NC_000007.14:44150989:A:G
NM_000162.5(GCK):c.175C>T (p.Pro59Ser)	GCK	P59S, P60S, P58S	not provided|Maturity-onset diabetes of the young, type 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036205	7	44192933	7	44153334	36205	44869	rs193922287	NC_000007.14:44153333:G:A
NM_004333.6(BRAF):c.1796C>G (p.Thr599Arg)	BRAF	T599R	not provided|Cardiofaciocutaneous syndrome 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280033	7	140453139	7	140753339	280033	264307	rs121913375	NC_000007.14:140753338:G:C
NM_004333.6(BRAF):c.1513C>T (p.Leu505Phe)	BRAF	L505F	not provided|Noonan syndrome	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000040375	7	140477795	7	140777995	40375	48845	rs397507477	NC_000007.14:140777994:G:A
NM_004333.6(BRAF):c.1502A>C (p.Glu501Ala)	BRAF	E501A	not provided|Rasopathy	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040373	7	140477806	7	140778006	40373	48843	rs180177039	NC_000007.14:140778005:T:G
NM_004333.6(BRAF):c.1497A>C (p.Lys499Asn)	BRAF	K499N	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000040371	7	140477811	7	140778011	40371	48841	rs397507476	NC_000007.14:140778010:T:G
NR_003051.3(RMRP):n.64C>T	RMRP		Metaphyseal chondrodysplasia, McKusick type|Anauxetic dysplasia 1|Metaphyseal chondrodysplasia, McKusick type|Metaphyseal dysplasia without hypotrichosis|Anauxetic dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189086	9	35657952	9	35657955	189086	187075	rs786204684	NC_000009.12:35657954:G:A
NM_004281.3(BAG3):c.262C>T (p.Gln88Ter)	BAG3	Q88*	Cardiovascular phenotype|Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000518933	10	121429444	10	119669932	518933	510148	rs1554877001	NC_000010.11:119669931:C:T
NM_006772.3(SYNGAP1):c.1167_1168del (p.Gly391fs)	SYNGAP1	G391fs	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411566	6	33405849 - 33405850	6	33438072 - 33438073	411566	395445	rs1060503378	NC_000006.12:33438071:AG:
NM_007327.4(GRIN1):c.2443G>A (p.Gly815Arg)	GRIN1	G815R, G836R	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 27, 2013)	criteria provided, single submitter	VCV000208743	9	140058120	9	137163668	208743	205260	rs797044925	NC_000009.12:137163667:G:A
NM_004333.4(BRAF):c.2128-5_2128delTGTAGA	BRAF		Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000430737	7	140434570 - 140434575	7	140734769 - 140734774	430737	424284	rs1131692058	
NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	BRAF	E501V, E467V, E479V, E449V, E464V, E541V, E413V, E504V	Cardio-facio-cutaneous syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, multiple submitters, no conflicts	VCV000040374	7	140477806	7	140778006	40374	48844	rs180177039	NC_000007.14:140778005:T:A
NM_153676.4(USH1C):c.496+1G>A	USH1C		Usher syndrome, type 1C|Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000371732	11	17548769	11	17527222	371732	357961	rs138138689	NC_000011.10:17527221:C:T
NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	HMBS	R167Q, R150Q	Acute intermittent porphyria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001446	11	118962124	11	119091414	1446	16485	rs118204095	NC_000011.10:119091413:G:A
NM_001278716.2(FBXL4):c.1703G>C (p.Gly568Ala)	FBXL4	G568A	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000066092	6	99322317	6	98874441	66092	76994	rs398123060	NC_000006.12:98874440:C:G
NM_000401.3(EXT2):c.613C>T (p.Gln205Ter)	EXT2	Q172*, Q205*	Multiple exostoses type 2|Multiple exostoses type 2|Seizures, scoliosis, and macrocephaly syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002472	11	44129776	11	44108226	2472	17511	rs121918279	NC_000011.10:44108225:C:T
NM_000322.5(PRPH2):c.647C>T (p.Pro216Leu)	PRPH2	P216L	PRPH2-Related Disorders|not provided|Retinal dystrophy|Retinitis pigmentosa 7|Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013164	6	42672284	6	42704546	13164	28203	rs61755806	NC_000006.12:42704545:G:A
NM_001127666.2(GSN):c.520G>A (p.Asp174Asn)	GSN	D187N, D174N, D214N, D180N, D171N, D163N, D199N	not provided|Meretoja syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016180	9	124073097	9	121310819	16180	31219	rs121909715	NC_000009.12:121310818:G:A
NM_006731.2(FKTN):c.139C>T (p.Arg47Ter)	FKTN	R47*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4|Walker-Warburg congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003200	9	108358912	9	105596631	3200	18239	rs119463990	NC_000009.12:105596630:C:T
NM_004333.6(BRAF):c.1779_1780delinsGA (p.Asp594Asn)	BRAF		Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375948	7	140453155 - 140453156	7	140753355 - 140753356	375948	362827	rs1057519718	NC_000007.14:140753354:CA:TC
NM_004333.6(BRAF):c.1782T>A (p.Asp594Glu)	BRAF	D594E	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375945	7	140453153	7	140753353	375945	362824	rs121913337	NC_000007.14:140753352:A:T
NM_004333.6(BRAF):c.1785T>A (p.Phe595Leu)	BRAF	F595L	Cutaneous melanoma|not provided	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	VCV000180789	7	140453150	7	140753350	180789	179094	rs121913341	NC_000007.14:140753349:A:T
NM_004333.6(BRAF):c.1722C>G (p.His574Gln)	BRAF	H574Q	Cardiofaciocutaneous syndrome 1|not provided|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040384	7	140454006	7	140754206	40384	48854	rs397507481	NC_000007.14:140754205:G:C
NM_004333.6(BRAF):c.1454T>C (p.Leu485Ser)	BRAF	L485S, L397S, L525S, L463S, L433S, L448S, L451S, L488S	Cardio-facio-cutaneous syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040370	7	140477854	7	140778054	40370	48840	rs397507475	NC_000007.14:140778053:A:G
NM_000543.5(SMPD1):c.748A>C (p.Ser250Arg)	SMPD1	S250R, S249R	not specified|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371576	11	6413043	11	6391813	371576	357987	rs750779804	NC_000011.10:6391812:A:C
NM_000466.3(PEX1):c.547C>T (p.Arg183Ter)	PEX1	R183*	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 1B	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371782	7	92147282	7	92517968	371782	357620	rs149806989	NC_000007.14:92517967:G:A
NM_005476.7(GNE):c.386G>A (p.Arg129Gln)	GNE	R160Q, R129Q, R124Q, R70Q	GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189156	9	36246258	9	36246261	189156	186790	rs748704459	NC_000009.12:36246260:C:T
NM_006269.2(RP1):c.1186C>T (p.Arg396Ter)	RP1	R396*	Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143134	8	55537628	8	54625068	143134	152852	rs201493928	NC_000008.11:54625067:C:T
NM_000048.4(ASL):c.532G>A (p.Val178Met)	ASL	V178M	Argininosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002402	7	65551738	7	66086751	2402	17441	rs28941473	NC_000007.14:66086750:G:A
NM_000162.5(GCK):c.45+1G>T	GCK		not provided|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619964	7	44228507	7	44188908	619964	611361	rs781260712	NC_000007.14:44188907:C:A
NM_018972.4(GDAP1):c.373C>T (p.Arg125Ter)	GDAP1	R125*, R16*, R57*	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, recessive intermediate A|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217229	8	75272434	8	74360199	217229	213815	rs745663149	NC_000008.11:74360198:C:T
NM_054012.4(ASS1):c.910C>T (p.Arg304Trp)	ASS1	R304W	not provided|Citrullinemia type I	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006330	9	133364791	9	130489404	6330	21369	rs121908642	NC_000009.12:130489403:C:T
NM_054012.4(ASS1):c.970G>A (p.Gly324Ser)	ASS1	G324S	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006327	9	133364851	9	130489464	6327	21366	rs121908639	NC_000009.12:130489463:G:A
NM_033360.4(KRAS):c.179G>T (p.Gly60Val)	KRAS	G60V	Cardio-facio-cutaneous syndrome|Noonan syndrome|Non-small cell lung cancer|not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000163766	12	25380279	12	25227345	163766	175855	rs727503108	NC_000012.12:25227344:C:A
NM_006772.3(SYNGAP1):c.1630C>T (p.Arg544Ter)	SYNGAP1	R544*	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522845	6	33406650	6	33438873	522845	513422	rs1554121443	NC_000006.12:33438872:C:T
NM_006772.3(SYNGAP1):c.2059C>T (p.Arg687Ter)	SYNGAP1	R687*	Mental retardation, autosomal dominant 5|not provided|High forehead|Ptosis|Infantile muscular hypotonia|Wide nasal bridge|Triangular face|Delayed speech and language development|Aggressive behavior|Downslanted palpebral fissures|Behavioral abnormality|Abnormality of the sternum|Motor delay|Bulbous tips of toes|Pointed chin	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411584	6	33409095	6	33441318	411584	395696	rs1060503383	NC_000006.12:33441317:C:T
NM_001077365.2(POMT1):c.579_580del (p.Val195fs)	POMT1	V165fs, V141fs, V195fs, V43fs, V78fs	not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000817606	9	134385169 - 134385170	9	131509782 - 131509783	817606	805606		NC_000009.12:131509781:AG:
NM_007171.3(POMT1):c.765+1G>A	POMT1		not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000593922	9	134385450	9	131510063	593922	584985	rs776061161	NC_000009.12:131510062:G:A
NM_001077365.2(POMT1):c.1921C>T (p.Leu641Phe)	POMT1	L663F, L587F, L641F, L524F, L546F, L611F, L489F, L609F	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000488581	9	134397529	9	131522142	488581	481449	rs777437871	NC_000009.12:131522141:C:T
NM_007171.3(POMT1):c.1858C>T (p.Arg620Ter)	POMT1	R620*, R446*, R544*, R503*, R566*, R568*, R598*, R481*	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000419671	9	134396826	9	131521439	419671	407566	rs761848742	NC_000009.12:131521438:C:T
NM_001077365.2(POMT1):c.2111_2112TC[3] (p.Pro706fs)	POMT1		not provided	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000280761	9	134398424 - 134398425	9	131523037 - 131523038	280761	264393	rs587777819	NC_000009.12:131523037:CTCTC:CTCTCTC
NM_007171.3(POMT1):c.1241+2dup	POMT1		not provided	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000280760	9	134388719 - 134388720	9	131513332 - 131513333	280760	264478	rs886041907	NC_000009.12:131513332:T:TT
NM_007171.3(POMT1):c.2070-1G>C	POMT1		not provided	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000195504	9	134398318	9	131522931	195504	192665	rs745738628	NC_000009.12:131522930:G:C
NM_007171.3(POMT1):c.1723del (p.Leu575fs)	POMT1	L436fs, L575fs, L499fs, L521fs, L401fs, L458fs, L523fs, L553fs	not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000194757	9	134395537	9	131520150	194757	191920	rs794727190	NC_000009.12:131520149:CCC:CC
NM_007171.3(POMT1):c.1544dup (p.Tyr515Ter)	POMT1		not provided	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000162594	9	134394335 - 134394336	9	131518948 - 131518949	162594	172241	rs727502854	NC_000009.12:131518948:A:AA
NM_007171.3(POMT1):c.1081C>T (p.Gln361Ter)	POMT1	Q361*, Q187*, Q244*, Q307*, Q339*, Q285*, Q222*, Q309*	not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000598282	9	134387456	9	131512069	598282	589343	rs756973046	NC_000009.12:131512068:C:T
NM_001077365.2(POMT1):c.443C>A (p.Thr148Asn)	POMT1	T148N, T94N, T118N, T31N	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000562183	9	134384313	9	131508926	562183	553357	rs1564341846	NC_000009.12:131508925:C:A
NM_007171.3(POMT1):c.793C>T (p.Arg265Ter)	POMT1	R265*, R148*, R211*, R213*, R91*, R126*, R189*, R243*	not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095468	9	134385674	9	131510287	95468	101367	rs398124247	NC_000009.12:131510286:C:T
NM_001077365.2(POMT1):c.1175C>T (p.Thr392Met)	POMT1	T414M, T360M, T392M, T240M, T275M, T297M, T338M, T362M	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039435	9	134388718	9	131513331	39435	48034	rs397515400	NC_000009.12:131513330:C:T
NM_001077365.2(POMT1):c.430A>G (p.Asn144Asp)	POMT1	N144D, N90D, N114D, N27D	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039434	9	134384300	9	131508913	39434	48033	rs397514501	NC_000009.12:131508912:A:G
NM_001077365.2(POMT1):c.1175+1G>A	POMT1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: May 23, 2006)	no assertion criteria provided	VCV000003251	9	134388719	9	131513332	3251	18290		NC_000009.12:131513331:G:A
POMT1, GLN590HIS	POMT1	Q590H	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: May 23, 2006)	no assertion criteria provided	VCV000003249					3249	18288		
POMT1, ARG541TER	POMT1	R541*	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: May 23, 2006)	no assertion criteria provided	VCV000003248					3248	18287		
NM_001077365.2(POMT1):c.1680G>C (p.Trp560Cys)	POMT1	W582C, W408C, W506C, W530C, W443C, W465C, W560C, W528C	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000003242	9	134395562	9	131520175	3242	18281	rs119462984	NC_000009.12:131520174:G:C
NM_001077365.2(POMT1):c.414del (p.Leu138_Leu139insTer)	POMT1		Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000864585	9	134382888	9	131507501	864585	835591		NC_000009.12:131507500:G:
NM_001077365.2(POMT1):c.1671del (p.Ile557fs)	POMT1	I405fs, I525fs, I579fs, I557fs, I503fs, I553fs, I427fs, I440fs, I462fs, I484fs, I527fs	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000848752	9	134395552	9	131520165	848752	835606		NC_000009.12:131520164:TT:T
NM_001077365.2(POMT1):c.1175+4_1175+7del	POMT1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800791	9	134388719 - 134388722	9	131513332 - 131513335	800791	789374		NC_000009.12:131513331:GTGAGTG:GTG
NM_001077365.2(POMT1):c.978C>A (p.Tyr326Ter)	POMT1	Y231*, Y209*, Y272*, Y294*, Y296*, Y348*, Y174*, Y326*	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000658622	9	134386846	9	131511459	658622	637794		NC_000009.12:131511458:C:A
NM_001077365.2(POMT1):c.606del (p.Ile203fs)	POMT1	I173fs, I51fs, I149fs, I86fs, I203fs	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000638831	9	134385290	9	131509903	638831	637793		NC_000009.12:131509902:C:
NM_001077365.2(POMT1):c.699+62del	POMT1	Q137fs, Q200fs, Q254fs	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000538723	9	134385445	9	131510058	538723	524645	rs1356791510	NC_000009.12:131510057:A:
NM_001077365.2(POMT1):c.1361T>G (p.Leu454Ter)	POMT1	L476*, L302*, L400*, L454*, L424*, L337*, L359*, L422*	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000471374	9	134393920	9	131518533	471374	458491	rs1554780670	NC_000009.12:131518532:T:G
NM_000255.4(MMUT):c.1889G>A (p.Gly630Glu)	MMUT	G630E	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426995	6	49407986	6	49440273	426995	415053	rs143023066	NC_000006.12:49440272:C:T
NM_000255.4(MMUT):c.682C>T (p.Arg228Ter)	MMUT	R228*	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203855	6	49425475	6	49457762	203855	200123	rs200596762	NC_000006.12:49457761:G:A
NM_000255.4(MMUT):c.91C>T (p.Arg31Ter)	MMUT	R31*	not provided|Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092688	6	49427089	6	49459376	92688	98595	rs398123278	NC_000006.12:49459375:G:A
NM_001077365.2(POMT1):c.280+1G>T	POMT1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic	criteria provided, single submitter	VCV000691982	9	134381841	9	131506454	691982	679729		NC_000009.12:131506453:G:T
NM_001077365.2(POMT1):c.174_176CTT[2] (p.Phe60del)	POMT1	F60del	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431953	9	134381551 - 134381553	9	131506164 - 131506166	431953	425827	rs750195040	NC_000009.12:131506163:TCTTCTTCTT:TCTTCTT
NM_001077365.2(POMT1):c.418_420del (p.Met140del)	POMT1	M140del, M86del, M110del, M23del	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003254	9	134382890 - 134382892	9	131507503 - 131507505	3254	18293	rs587777820	NC_000009.12:131507502:TGATG:TG
NM_001077365.2(POMT1):c.1704G>C (p.Gln568His)	POMT1	Q590H, Q514H, Q416H, Q538H, Q451H, Q473H, Q536H, Q568H	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided	Pathogenic(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	VCV000003246	9	134396738	9	131521351	3246	18285	rs119462986	NC_000009.12:131521350:G:C
NM_001077365.2(POMT1):c.193G>A (p.Gly65Arg)	POMT1	G65R, G11R	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003244	9	134381571	9	131506184	3244	18283	rs119462983	NC_000009.12:131506183:G:A
NM_001077365.2(POMT1):c.1194_1196del (p.Leu399del)	POMT1	L421del, L282del, L247del, L367del, L399del, L304del, L345del, L369del	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: Mar 23, 2004)	no assertion criteria provided	VCV000003241	9	134390831 - 134390833	9	131515444 - 131515446	3241	18280	rs587777818	NC_000009.12:131515443:CCT:
NM_001360.2(DHCR7):c.470T>C (p.Leu157Pro)	DHCR7	L157P	Smith-Lemli-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488492	11	71152429	11	71441383	488492	481360	rs753960624	NC_000011.10:71441382:A:G
NM_001360.2(DHCR7):c.440G>A (p.Gly147Asp)	DHCR7	G147D	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381657	11	71152459	11	71441413	381657	372666	rs777425801	NC_000011.10:71441412:C:T
NM_001077365.2(POMT1):c.2144_2147dup (p.Asp716fs)	POMT1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635337	9	134398456 - 134398457	9	131523069 - 131523070	635337	623149		NC_000009.12:131523069:GAAAGA:GAAAGAAAGA
NM_001077365.2(POMT1):c.841C>T (p.Gln281Ter)	POMT1	Q303*, Q227*, Q249*, Q186*, Q281*, Q129*, Q164*, Q251*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000003239	9	134385788	9	131510401	3239	18278	rs119462981	NC_000009.12:131510400:C:T
NM_001077365.2(POMT1):c.226G>A (p.Gly76Arg)	POMT1	G76R, G22R	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000003238	9	134381604	9	131506217	3238	18277	rs28941782	NC_000009.12:131506216:G:A
NM_000287.4(PEX6):c.1314_1321del (p.Glu439fs)	PEX6	E439fs, E351fs	Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B|Heimler syndrome 2	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224321	6	42937452 - 42937459	6	42969714 - 42969721	224321	226048	rs267608216	NC_000006.12:42969713:AGGCCTCCAGGCCT:AGGCCT
NM_153676.4(USH1C):c.1211-1175del	USH1C	G388fs, G407fs	Usher syndrome, type 1C|Deafness, autosomal recessive 18|Retinitis pigmentosa	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000555064	11	17539012	11	17517465	555064	546384	rs1207247951	NC_000011.10:17517464:CCC:CC
NM_001278716.2(FBXL4):c.1790A>C (p.Gln597Pro)	FBXL4	Q597P	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437486	6	99322230	6	98874354	437486	431036	rs201989042	NC_000006.12:98874353:T:G
NM_001077365.2(POMT1):c.990T>A (p.Tyr330Ter)	POMT1	Y352*, Y330*, Y213*, Y178*, Y276*, Y298*, Y235*, Y300*	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000502224	9	134387431	9	131512044	502224	493648	rs765230689	NC_000009.12:131512043:T:A
NM_001077365.2(POMT1):c.1892C>T (p.Pro631Leu)	POMT1	P653L, P479L, P514L, P536L, P577L, P601L, P599L, P631L	not provided|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000194962	9	134397500	9	131522113	194962	192124	rs149682171	NC_000009.12:131522112:C:T
NM_001077365.2(POMT1):c.1474C>T (p.Arg492Ter)	POMT1	R514*, R340*, R397*, R375*, R438*, R492*, R460*, R462*	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003245	9	134394332	9	131518945	3245	18284	rs119462985	NC_000009.12:131518944:C:T
NM_001077365.2(POMT1):c.598G>C (p.Ala200Pro)	POMT1	A200P, A170P, A48P, A146P, A83P	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|not provided	Pathogenic(Last reviewed: Feb 27, 2015)	criteria provided, single submitter	VCV000003243	9	134385188	9	131509801	3243	18282	rs119462982	NC_000009.12:131509800:G:C
NM_001077365.2(POMT1):c.2044dup (p.Ala682fs)	POMT1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003240	9	134398357 - 134398358	9	131522970 - 131522971	3240	18279	rs587777817	NC_000009.12:131522970:GG:GGG
NM_000448.2(RAG1):c.256_257del (p.Lys86fs)	RAG1	K86fs	RAG1-Related Disorders||Combined cellular and humoral immune defects with granulomas|not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285045	11	36595110 - 36595111	11	36573560 - 36573561	285045	269282	rs772962160	NC_000011.10:36573559:AA:
NM_022970.3(FGFR2):c.314A>G (p.Tyr105Cys)	FGFR2	Y105C	FGFR2 related craniosynostosis|Levy-Hollister syndrome|Jackson-Weiss syndrome||Crouzon syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Bent bone dysplasia syndrome|Neoplasm of stomach|Acrocephalosyndactyly type I|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449024	10	123325014	10	121565500	449024	444566	rs1434545235	NC_000010.11:121565499:T:C
NM_022970.3(FGFR2):c.1087+1305C>G	FGFR2	C342W, C253W, C114W, C227W	Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000013275	10	123276891	10	121517377	13275	28314	rs121918496	NC_000010.11:121517376:G:C
NM_004333.6(BRAF):c.741T>G (p.Phe247Leu)	BRAF	F247L	not provided|Noonan syndrome and Noonan-related syndrome|Noonan syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000055793	7	140501331	7	140801531	55793	70449	rs397509343	NC_000007.14:140801530:A:C
NM_000083.3(CLCN1):c.742A>T (p.Lys248Ter)	CLCN1	K248*	not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000620142	7	143020447	7	143323354	620142	611675	rs561470261	NC_000007.14:143323353:A:T
NM_000083.3(CLCN1):c.2401G>T (p.Glu801Ter)	CLCN1	E801*	not provided	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000429728	7	143044040	7	143346947	429728	421624	rs1131691551	NC_000007.14:143346946:G:T
NM_000083.3(CLCN1):c.2023del (p.Gln675fs)	CLCN1	Q675fs	not provided	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000280880	7	143042704	7	143345611	280880	264303	rs886042007	NC_000007.14:143345610:CCC:CC
NM_000083.3(CLCN1):c.2023C>T (p.Gln675Ter)	CLCN1	Q675*	not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000585687	7	143042706	7	143345613	585687	576953	rs1563086980	NC_000007.14:143345612:C:T
NM_000083.3(CLCN1):c.1930+1G>A	CLCN1		not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000585686	7	143039599	7	143342506	585686	576952	rs771002652	NC_000007.14:143342505:G:A
NM_000083.3(CLCN1):c.847C>T (p.Leu283Phe)	CLCN1	L283F	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021048	7	143021579	7	143324486	21048	33900	rs80356688	NC_000007.14:143324485:C:T
NM_000083.3(CLCN1):c.577G>A (p.Glu193Lys)	CLCN1	E193K	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021045	7	143018822	7	143321729	21045	33897	rs80356686	NC_000007.14:143321728:G:A
NM_000083.3(CLCN1):c.394A>T (p.Ser132Cys)	CLCN1	S132C	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021044	7	143017849	7	143320756	21044	33896	rs80356684	NC_000007.14:143320755:A:T
NM_000083.3(CLCN1):c.2512_2513insCTCA (p.His838fs)	CLCN1		Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021043	7	143047664 - 143047665	7	143350571 - 143350572	21043	33895	rs80356698	NC_000007.14:143350571::CTCA
NM_000083.3(CLCN1):c.1667T>A (p.Ile556Asn)	CLCN1	I556N	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021041	7	143039106	7	143342013	21041	33893	rs80356697	NC_000007.14:143342012:T:A
NM_000083.3(CLCN1):c.1438C>A (p.Pro480Thr)	CLCN1	P480T	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021039	7	143036382	7	143339289	21039	33891	rs80356695	NC_000007.14:143339288:C:A
NM_000083.3(CLCN1):c.1412C>T (p.Ser471Phe)	CLCN1	S471F	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021038	7	143036356	7	143339263	21038	33890	rs80356693	NC_000007.14:143339262:C:T
NM_000083.3(CLCN1):c.1478C>A (p.Ala493Glu)	CLCN1	A493E	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802379	7	143036610	7	143339517	802379	790707		NC_000007.14:143339516:C:A
NM_000083.3(CLCN1):c.949C>T (p.Arg317Ter)	CLCN1	R317*	not provided	Pathogenic(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	VCV000447077	7	143027960	7	143330867	447077	441047	rs1337473924	NC_000007.14:143330866:C:T
NM_000083.3(CLCN1):c.908G>A (p.Trp303Ter)	CLCN1	W303*	not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000447075	7	143027919	7	143330826	447075	441045	rs1229066957	NC_000007.14:143330825:G:A
NM_000083.3(CLCN1):c.1872del (p.Glu624fs)	CLCN1	E624fs	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000861405	7	143039540	7	143342447	861405	833247		NC_000007.14:143342446:G:
NM_000083.3(CLCN1):c.1299G>A (p.Trp433Ter)	CLCN1	W433*	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000857226	7	143029864	7	143332771	857226	833238		NC_000007.14:143332770:G:A
NM_000083.3(CLCN1):c.1925C>G (p.Ser642Ter)	CLCN1	S642*	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000840773	7	143039593	7	143342500	840773	833248		NC_000007.14:143342499:C:G
NC_000007.14:g.(?_143324401)_(143331662_?)del	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832454	7	143021494 - 143028755			832454	819833		
NM_000083.3(CLCN1):c.1357dup (p.Arg453fs)	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000664719	7	143029917 - 143029918	7	143332824 - 143332825	664719	635829		NC_000007.14:143332824:CCCCC:CCCCCC
NM_000083.3(CLCN1):c.751del (p.Ser251fs)	CLCN1	S251fs	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000657105	7	143020456	7	143323363	657105	635816		NC_000007.14:143323362:T:
NM_000083.3(CLCN1):c.1357del (p.Arg453fs)	CLCN1	R453fs	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000648711	7	143029918	7	143332825	648711	635828		NC_000007.14:143332824:CCCCC:CCCC
NM_000083.3(CLCN1):c.1784G>A (p.Trp595Ter)	CLCN1	W595*	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000639175	7	143039223	7	143342130	639175	635833		NC_000007.14:143342129:G:A
NM_000083.3(CLCN1):c.1278_1281TTTG[1] (p.Phe428fs)	CLCN1		Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623350	7	143029843 - 143029846	7	143332750 - 143332753	623350	612281		NC_000007.14:143332749:TTTGTTTG:TTTG
NM_000083.3(CLCN1):c.1644_1645del (p.Glu548fs)	CLCN1	E548fs	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000570543	7	143039083 - 143039084	7	143341990 - 143341991	570543	561594	rs1563084597	NC_000007.14:143341989:AT:
NM_000083.3(CLCN1):c.469del (p.Leu157fs)	CLCN1	L157fs	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	VCV000462831	7	143018492	7	143321399	462831	457465	rs1554434794	NC_000007.14:143321398:CC:C
NM_000083.3(CLCN1):c.2419C>T (p.Gln807Ter)	CLCN1	Q807*	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000462830	7	143047480	7	143350387	462830	457473	rs1554439817	NC_000007.14:143350386:C:T
NM_000083.3(CLCN1):c.220C>T (p.Gln74Ter)	CLCN1	Q74*	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000462829	7	143016887	7	143319794	462829	457447	rs1554434400	NC_000007.14:143319793:C:T
NM_000083.3(CLCN1):c.1918del (p.Val640fs)	CLCN1	V640fs	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000462826	7	143039585	7	143342492	462826	456434	rs1554438574	NC_000007.14:143342491:GG:G
NG_009815.1:g.19647-?_28496+?dup	CLCN1		Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Jun 12, 2012)	no assertion criteria provided	VCV000040242					40242	48726		
NM_000083.3(CLCN1):c.2330del (p.Gly777fs)	CLCN1	G777fs	Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000021042	7	143043715	7	143346622	21042	33894	rs80356707	NC_000007.14:143346621:GGG:GG
NM_000083.3(CLCN1):c.566C>T (p.Ser189Phe)	CLCN1	S189F	Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000017548	7	143018811	7	143321718	17548	32587	rs121912810	NC_000007.14:143321717:C:T
NM_000083.3(CLCN1):c.898_900delinsTGA (p.Arg300Ter)	CLCN1	R300*	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000017547	7	143027909 - 143027911	7	143330816 - 143330818	17547	32586		NC_000007.14:143330815:CGG:TGA
NM_000083.3(CLCN1):c.830dup (p.Cys277fs)	CLCN1		Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 12, 2000)	no assertion criteria provided	VCV000017544	7	143021561 - 143021562	7	143324468 - 143324469	17544	32583		NC_000007.14:143324468:G:GG
NM_000083.3(CLCN1):c.1495G>A (p.Gly499Arg)	CLCN1	G499R	Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Jan 28, 2000)	no assertion criteria provided	VCV000017543	7	143036627	7	143339534	17543	32582	rs121912807	NC_000007.14:143339533:G:A
NM_000083.3(CLCN1):c.979+1G>A	CLCN1		Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000017534	7	143027991	7	143330898	17534	32573	rs1563078827	NC_000007.14:143330897:G:A
NM_000083.3(CLCN1):c.1785G>A (p.Trp595Ter)	CLCN1	W595*	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000862747	7	143039224	7	143342131	862747	833246		NC_000007.14:143342130:G:A
NM_000083.3(CLCN1):c.1247G>A (p.Gly416Glu)	CLCN1	G416E	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000862321	7	143029592	7	143332499	862321	833237		NC_000007.14:143332498:G:A
NM_000083.3(CLCN1):c.789del (p.Ser264fs)	CLCN1	S264fs	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000661869	7	143021521	7	143324428	661869	635818		NC_000007.14:143324427:C:
NM_000083.3(CLCN1):c.478C>T (p.Gln160Ter)	CLCN1	Q160*	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000661766	7	143018502	7	143321409	661766	635810		NC_000007.14:143321408:C:T
NC_000007.13:g.(?_143042594)_(143047767_?)del	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	VCV000583787	7	143042594 - 143047767	7	143345501 - 143350674	583787	566054		
NM_000391.4(TPP1):c.1379G>A (p.Trp460Ter)	TPP1	W460*	Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189179	11	6636448	11	6615217	189179	186834	rs786204753	NC_000011.10:6615216:C:T
NM_001077365.2(POMT1):c.1195_1196del (p.Leu399fs)	POMT1	L282fs, L421fs, L304fs, L367fs, L369fs, L247fs, L345fs, L399fs	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000594265	9	134390832 - 134390833	9	131515445 - 131515446	594265	585328	rs1564364615	NC_000009.12:131515444:CT:
NM_000083.3(CLCN1):c.1966del (p.Glu656fs)	CLCN1	E656fs	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817974	7	143042648	7	143345555	817974	805525		NC_000007.14:143345554:GG:G
NM_000083.3(CLCN1):c.2013_2014GC[2] (p.Ala673fs)	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817723	7	143042696 - 143042697	7	143345603 - 143345604	817723	805526		NC_000007.14:143345602:GCGCGC:GCGC
NM_000083.2(CLCN1):c.50_434-202del	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000580190	7	143013355 - 143018256	7	143316262 - 143321163	580190	561583		
NM_000083.3(CLCN1):c.1179T>A (p.Tyr393Ter)	CLCN1	Y393*	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489334	7	143029524	7	143332431	489334	481778	rs1554436799	NC_000007.14:143332430:T:A
CLCN1, TRP433ARG	CLCN1	W433R	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000017549					17549	32588		
CLCN1, 14-BP DEL	CLCN1		Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000017540					17540	32579		
NM_003002.4(SDHD):c.314G>A (p.Trp105Ter)	SDHD	W105*, W66*	Pheochromocytoma|Cowden syndrome 3|Carney-Stratakis syndrome|Paragangliomas 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428939	11	111959735	11	112089011	428939	420756	rs1131691065	NC_000011.10:112089010:G:A
NM_003002.4(SDHD):c.325C>T (p.Gln109Ter)	SDHD	Q109*, Q70*	Pheochromocytoma|Paragangliomas 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000412498	11	111965539	11	112094815	412498	398068	rs1060503770	NC_000011.10:112094814:C:T
NM_003002.4(SDHD):c.416T>C (p.Leu139Pro)	SDHD	L139P, L100P	Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000006907	11	111965630	11	112094906	6907	21946	rs80338847	NC_000011.10:112094905:T:C
NM_000501.4(ELN):c.1716dup (p.Val573fs)	ELN		not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000503920	7	73474799 - 73474800	7	74060469 - 74060470	503920	495347	rs1554683650	NC_000007.14:74060469:A:AA
NM_000501.4(ELN):c.631C>T (p.Pro211Ser)	ELN	P211S, P167S, P189S, P216S, P201S, P206S	not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000419450	7	73461085	7	74046755	419450	407251	rs1064793880	NC_000007.14:74046754:C:T
NM_000501.4(ELN):c.914_930delinsGCT (p.Ala305fs)	ELN		not provided	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000284728	7	73466278 - 73466294	7	74051948 - 74051964	284728	268965	rs886044834	NC_000007.14:74051947:CAGCTGCAGCAGCAGCC:GCT
NM_000501.4(ELN):c.450C>A (p.Tyr150Ter)	ELN	Y150*, Y138*, Y145*, Y155*, Y140*	not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000265394	7	73458231	7	74043901	265394	259873	rs137854454	NC_000007.14:74043900:C:A
NM_000501.4(ELN):c.2058del (p.Gly688fs)	ELN	G664fs, G669fs, G678fs, G688fs, G750fs, G607fs, G694fs	not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000265121	7	73480299	7	74065969	265121	259874	rs886039351	NC_000007.14:74065968:A:
NM_000501.4(ELN):c.848dup (p.Gly284fs)	ELN		not provided	Pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	VCV000213197	7	73466126 - 73466127	7	74051796 - 74051797	213197	209922	rs863223528	NC_000007.14:74051796:CC:CCC
NM_000501.4(ELN):c.590del (p.Gly197fs)	ELN	G187fs, G202fs, G153fs, G192fs, G175fs, G197fs	not provided	Pathogenic(Last reviewed: Jun 11, 2011)	criteria provided, single submitter	VCV000213195	7	73461040	7	74046710	213195	209916	rs863223526	NC_000007.14:74046709:GGGGG:GGGG
NM_000501.4(ELN):c.1928_1952del (p.Gly643fs)	ELN	G562fs, G614fs, G643fs, G649fs, G629fs, G633fs, G554fs, G624fs, G595fs, G619fs, G648fs, G705fs	not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000213191	7	73477958 - 73477982	7	74063628 - 74063652	213191	209938	rs863223524	NC_000007.14:74063627:GGGAGCCGCTGGGCTCGGAGGACTCGG:GG
NM_000501.4(ELN):c.1195del (p.Val399fs)	ELN	V355fs, V363fs, V394fs, V404fs, V389fs, V385fs, V399fs	not provided	Pathogenic(Last reviewed: Dec 24, 2013)	criteria provided, single submitter	VCV000213189	7	73470642	7	74056312	213189	209927	rs863223522	NC_000007.14:74056311:GGGG:GGG
NM_000501.4(ELN):c.1161del (p.Gly388fs)	ELN	G374fs, G378fs, G383fs, G388fs, G344fs, G352fs, G393fs	not provided	Pathogenic(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	VCV000213188	7	73470609	7	74056279	213188	209926	rs863223521	NC_000007.14:74056278:CCC:CC
NM_000501.4(ELN):c.477del (p.Phe160fs)	ELN	F148fs, F160fs, F150fs, F155fs, F165fs	not provided	Pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000213186	7	73459558	7	74045228	213186	209914	rs863223519	NC_000007.14:74045227:GG:G
NM_000501.4(ELN):c.1817del (p.Leu606fs)	ELN	L582fs, L587fs, L606fs, L592fs, L611fs, L668fs, L517fs, L612fs, L525fs, L558fs, L577fs, L596fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000860361	7	73477513	7	74063183	860361	833829		NC_000007.14:74063182:T:
NM_000501.4(ELN):c.391C>T (p.Gln131Ter)	ELN	Q131*, Q136*, Q126*, Q119*, Q121*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000852728	7	73457462	7	74043132	852728	833821		NC_000007.14:74043131:C:T
NM_000501.4(ELN):c.65_69dup (p.Ser24fs)	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000852119	7	73442579 - 73442580	7	74028249 - 74028250	852119	833819		NC_000007.14:74028249:CCACCCC:CCACCCCACCCC
NM_000501.4(ELN):c.869del (p.Pro290fs)	ELN	P254fs, P280fs, P276fs, P246fs, P285fs, P290fs, P295fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000850874	7	73466148	7	74051818	850874	833823		NC_000007.14:74051817:CC:C
NM_000501.4(ELN):c.1149C>A (p.Tyr383Ter)	ELN	Y369*, Y373*, Y388*, Y339*, Y378*, Y383*, Y347*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000835472	7	73469098	7	74054768	835472	833824		NC_000007.14:74054767:C:A
NC_000007.14:g.(?_74028168)_(74028289_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000831651	7	73442498 - 73442619			831651	819913		
NM_000501.4(ELN):c.1482del (p.Val495fs)	ELN	V495fs, V500fs, V524fs, V466fs, V481fs, V485fs, V501fs, V406fs, V414fs, V462fs, V471fs, V476fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000642454	7	73474283	7	74059953	642454	636327		NC_000007.14:74059952:A:
NM_000501.4(ELN):c.690T>A (p.Tyr230Ter)	ELN	Y230*, Y225*, Y194*, Y216*, Y186*, Y220*, Y235*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000581885	7	73462476	7	74048146	581885	561743	rs1400530335	NC_000007.14:74048145:T:A
NM_000501.4(ELN):c.1227del (p.Gly410fs)	ELN	G374fs, G400fs, G396fs, G405fs, G410fs, G415fs, G366fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000580650	7	73470677	7	74056347	580650	561748	rs1563836689	NC_000007.14:74056346:C:
NM_000501.4(ELN):c.944A>G (p.Lys315Arg)	ELN	K315R, K301R, K320R, K279R, K310R, K271R, K305R	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000524218	7	73466308	7	74051978	524218	523047	rs1554676454	NC_000007.14:74051977:A:G
NM_000501.2(ELN):c.(?_-60)_(*57_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000505198	7	73442458 - 73483087			505198	496484		
NM_000501.4(ELN):c.634A>T (p.Lys212Ter)	ELN	K212*, K168*, K217*, K190*, K202*, K207*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000504955	7	73461088	7	74046758	504955	497843	rs1554672587	NC_000007.14:74046757:A:T
NM_000501.4(ELN):c.383del (p.Val128fs)	ELN	V133fs, V123fs, V116fs, V118fs, V128fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	VCV000453329	7	73457454	7	74043124	453329	456896	rs1554669800	NC_000007.14:74043123:T:
NC_000007.13:g.(?_73482987)_(73484237_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 25, 2016)	criteria provided, single submitter	VCV000417567	7	73482987 - 73484237			417567	395238		
NC_000007.13:g.(?_73442119)_(73484237_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000417566	7	73442119 - 73484237			417566	395902		
NM_000501.4(ELN):c.417del (p.Val141fs)	ELN	V129fs, V131fs, V141fs, V136fs, V146fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000238949	7	73457486	7	74043156	238949	240166	rs878854452	NC_000007.14:74043155:GGG:GG
NM_000501.4(ELN):c.1113dup (p.Ala372fs)	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000179271	7	73469060 - 73469061	7	74054730 - 74054731	179271	178268	rs730880355	NC_000007.14:74054730:AA:AAA
NM_000501.4(ELN):c.608del (p.Pro203fs)	ELN	P193fs, P208fs, P181fs, P198fs, P159fs, P203fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000178976	7	73461060	7	74046730	178976	178257	rs727504581	NC_000007.14:74046729:CCC:CC
NM_000501.4(ELN):c.890-2A>G	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 2, 2012)	criteria provided, single submitter	VCV000177997	7	73466252	7	74051922	177997	178209	rs727504434	NC_000007.14:74051921:A:G
NM_000501.4(ELN):c.1208del (p.Gly403fs)	ELN	G367fs, G359fs, G398fs, G389fs, G403fs, G393fs, G408fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 2, 2012)	criteria provided, single submitter	VCV000177996	7	73470654	7	74056324	177996	178208	rs727504433	NC_000007.14:74056323:GGGGG:GGGG
NM_000501.4(ELN):c.889+2T>C	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jun 16, 2011)	criteria provided, single submitter	VCV000177951	7	73466171	7	74051841	177951	178200	rs727504419	NC_000007.14:74051840:T:C
NM_000501.4(ELN):c.1918+1G>A	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Aug 7, 2012)	criteria provided, single submitter	VCV000163398	7	73477700	7	74063370	163398	176790	rs727503035	NC_000007.14:74063369:G:A
NM_000501.4(ELN):c.1785T>A (p.Tyr595Ter)	ELN	Y595*, Y600*, Y657*, Y514*, Y571*, Y576*, Y585*, Y601*, Y506*, Y547*, Y566*, Y581*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 30, 2012)	criteria provided, single submitter	VCV000163396	7	73475468	7	74061138	163396	176788	rs727503033	NC_000007.14:74061137:T:A
NM_000501.4(ELN):c.1097-1G>A	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Nov 29, 2013)	criteria provided, single submitter	VCV000163389	7	73469045	7	74054715	163389	176783	rs727503029	NC_000007.14:74054714:G:A
NM_000501.4(ELN):c.435del (p.Leu146fs)	ELN	L134fs, L141fs, L151fs, L136fs, L146fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000163383	7	73458213	7	74043883	163383	176777	rs727503024	NC_000007.14:74043882:GGGG:GGG
NM_000501.4(ELN):c.131del (p.Pro44fs)	ELN	P44fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 19, 2013)	criteria provided, single submitter	VCV000163382	7	73449741	7	74035411	163382	176776	rs727503023	NC_000007.14:74035410:CC:C
NM_000501.4(ELN):c.43dup (p.Leu15fs)	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 2, 2012)	criteria provided, single submitter	VCV000163381	7	73442558 - 73442559	7	74028228 - 74028229	163381	176775	rs727503022	NC_000007.14:74028228:CC:CCC
NM_000501.4(ELN):c.1858+5G>C	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000029690	7	73477559	7	74063229	29690	38645	rs1554686162	NC_000007.14:74063228:G:C
ELN, ARG610GLN AND 24-BP DUP, NT1034	ELN	R610Q	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000016733					16733	31772		
NM_000501.4(ELN):c.526A>T (p.Lys176Ter)	ELN	K176*, K166*, K181*, K164*, K171*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000016732	7	73459608	7	74045278	16732	31771	rs137854455	NC_000007.14:74045277:A:T
NM_000501.4(ELN):c.450C>G (p.Tyr150Ter)	ELN	Y150*, Y138*, Y140*, Y145*, Y155*	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000016731	7	73458231	7	74043901	16731	31770	rs137854454	NC_000007.14:74043900:C:G
ELN, 1-BP INS, FS615TER	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000016725					16725	31764		
ELN, 1-BP DEL, 1821C	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000016724					16724	31763		
ELN, IVS15AS, A-G, -2	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000016721					16721	31760		
NM_000501.4(ELN):c.1190dup (p.Tyr397Ter)	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000849178	7	73470639 - 73470640	7	74056309 - 74056310	849178	833825		NC_000007.14:74056309:A:AA
NM_000501.4(ELN):c.840_843dup (p.Val282fs)	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000840776	7	73466119 - 73466120	7	74051789 - 74051790	840776	833822		NC_000007.14:74051789:TGGT:TGGTTGGT
NC_000007.14:g.(?_74068637)_(74068720_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832918	7	73482967 - 73483050			832918	819915		
NM_000501.4(ELN):c.643+1_643+2delinsAG	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000453331	7	73461098 - 73461099	7	74046768 - 74046769	453331	457578	rs1554672602	NC_000007.14:74046767:GT:AG
NM_000501.4(ELN):c.1744del (p.Ala582fs)	ELN	A553fs, A558fs, A611fs, A563fs, A572fs, A501fs, A568fs, A582fs, A587fs, A588fs, A493fs, A534fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 28, 2011)	criteria provided, single submitter	VCV000163395	7	73474825	7	74060495	163395	176338	rs727503783	NC_000007.14:74060494:GGGG:GGG
ELN, 1621C-T	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000016737					16737	31776		
ELN, 1-BP DEL, 2159C	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000016736					16736	31775		
ELN, 25-BP DEL, NT2114	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000016735					16735	31774		
ELN, 1-BP DEL, 2039C	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000016728					16728	31767		
ELN, 1-BP DEL, 748A	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000016727					16727	31766		
ELN, 1-BP DEL, 2012G	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	VCV000016726					16726	31765		
ELN, 30-KB DEL	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000016720					16720	31759		
ELN, 100-KB DEL	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000016719					16719	31758		
NM_000501.4(ELN):c.295_296del (p.Ala99fs)	ELN	A89fs, A99fs, A87fs	not provided|Supravalvar aortic stenosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000524086	7	73457005 - 73457006	7	74042675 - 74042676	524086	514560	rs1554669297	NC_000007.14:74042674:CGC:C
NM_000501.4(ELN):c.171del (p.Pro58fs)	ELN	P58fs, P48fs	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505162	7	73452041	7	74037711	505162	497857	rs1554666513	NC_000007.14:74037710:GGGG:GGG
NM_000501.4(ELN):c.1101del (p.Val368fs)	ELN	V363fs, V373fs, V358fs, V324fs, V354fs, V332fs, V368fs	Supravalvar aortic stenosis|not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213187	7	73469049	7	74054719	213187	209925	rs863223520	NC_000007.14:74054718:TT:T
NM_000501.4(ELN):c.862dup (p.Ala288fs)	ELN		not provided|Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, multiple submitters, no conflicts	VCV000163388	7	73466138 - 73466139	7	74051808 - 74051809	163388	176782	rs727503028	NC_000007.14:74051808:GGGG:GGGGG
NM_000466.3(PEX1):c.2614C>T (p.Arg872Ter)	PEX1	R872*, R815*, R664*	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265395	7	92129122	7	92499808	265395	259881	rs61750422	NC_000007.14:92499807:G:A
NM_000083.3(CLCN1):c.2285-1G>C	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000573366	7	143043671	7	143346578	573366	561612	rs1222525763	NC_000007.14:143346577:G:C
NM_000083.3(CLCN1):c.2596-1G>A	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449534	7	143048686	7	143351593	449534	444076	rs771721648	NC_000007.14:143351592:G:A
NM_000083.2(CLCN1):c.698delG (p.Gly233Alafs)	CLCN1		not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447069	7	143020401	7	143323308	447069	441039	rs1423567292	NC_000007.14:143323307:GGG:GG
NM_000083.3(CLCN1):c.1612_1613CA[2] (p.Thr539fs)	CLCN1		not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447055	7	143039051 - 143039052	7	143341958 - 143341959	447055	441061	rs1554438432	NC_000007.14:143341957:CACACA:CACA
NM_000501.4(ELN):c.163+2T>C	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000652801	7	73450916	7	74036586	652801	651696		NC_000007.14:74036585:T:C
NM_000501.4(ELN):c.2T>C (p.Met1Thr)	ELN	M1T	Supravalvar aortic stenosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213185	7	73442519	7	74028189	213185	209907	rs863223518	NC_000007.14:74028188:T:C
ELN, EX9-33DUP	ELN		Cutis laxa, autosomal dominant 1	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000016734					16734	31773		
NM_000501.4(ELN):c.1040del (p.Pro347fs)	ELN	P337fs, P342fs, P311fs, P333fs, P347fs, P303fs, P352fs	not provided|Supravalvar aortic stenosis	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000016730	7	73467581	7	74053251	16730	31769	rs1563826213	NC_000007.14:74053250:CCC:CC
NM_000501.4(ELN):c.1621C>T (p.Arg541Ter)	ELN	R570*, R452*, R460*, R512*, R517*, R522*, R527*, R531*, R541*, R546*, R547*	not provided|Supravalvar aortic stenosis	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000016723	7	73474514	7	74060184	16723	31762	rs137854453	NC_000007.14:74060183:C:T
NM_138413.4(HOGA1):c.700+5G>T	HOGA1		not provided|Primary hyperoxaluria, type III	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204285	10	99359925	10	97600168	204285	200671	rs185803104	NC_000010.11:97600167:G:T
NM_001077365.2(POMT1):c.605+1G>C	POMT1		Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000538720	9	134385196	9	131509809	538720	524381	rs766648827	NC_000009.12:131509808:G:C
NM_001077365.2(POMT1):c.1798C>T (p.Arg600Ter)	POMT1	R622*, R483*, R568*, R600*, R448*, R570*, R505*, R546*	not provided|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194859	9	134396832	9	131521445	194859	192022	rs794727208	NC_000009.12:131521444:C:T
NC_000006.12:g.(?_162201121)_(162201262_?)del	PRKN		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000831103	6	162622153 - 162622294			831103	819677		
NM_004562.2(PRKN):c.8-?_171+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000007040	6	162864342 - 162864505	6	162443310 - 162443473	7040	22079		
NM_015570.4(AUTS2):c.856A>T (p.Lys286Ter)	AUTS2	K286*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000521942	7	70227969	7	70762983	521942	511720	rs1554480487	NC_000007.14:70762982:A:T
NM_000501.4(ELN):c.800-2A>G	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163387	7	73466078	7	74051748	163387	176781	rs727503027	NC_000007.14:74051747:A:G
GRCh37/hg19 8q11.21(chr8:48730498-48829786)x1	PRKDC		not provided	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000688051	8	48730498 - 48829786			688051	675643		
NM_006904.6(PRKDC):c.1777-723dup	PRKDC		Immunodeficiency 26 with or without neurologic abnormalities	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000154324	8	48844056 - 48844057	8	47931496 - 47931497	154324	164078	rs546905091	NC_000008.11:47931496:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_006904.6(PRKDC):c.10721C>T (p.Ala3574Val)	PRKDC	A3574V	Immunodeficiency 26 with or without neurologic abnormalities	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000154323	8	48701749	8	47789188	154323	164077	rs587777686	NC_000008.11:47789187:G:A
NM_006904.6(PRKDC):c.9185T>G (p.Leu3062Arg)	PRKDC	L3062R	Immunodeficiency 26 without neurologic abnormalities	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000154322	8	48733431	8	47820870	154322	164076	rs587777685	NC_000008.11:47820869:A:C
NM_004333.6(BRAF):c.1782T>G (p.Asp594Glu)	BRAF	D594E	Cutaneous melanoma|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375944	7	140453153	7	140753353	375944	362823	rs121913337	NC_000007.14:140753352:A:C
NM_000349.3(STAR):c.545G>A (p.Arg182His)	STAR	R182H	Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008995	8	38003586	8	38146068	8995	24034	rs104894086	NC_000008.11:38146067:C:T
VCL, 3-BP DEL, 2862GTT	VCL		Dilated cardiomyopathy 1W	Pathogenic(Last reviewed: Jan 29, 2002)	no assertion criteria provided	VCV000012196					12196	27235		
NM_178857.6(RP1L1):c.1189C>T (p.Arg397Ter)	RP1L1	R397*	Retinal dystrophy	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000865995	8	10470419	8	10612909	865995	856577		NC_000008.11:10612908:G:A
NM_178857.6:c.3955_3956insGGACTAAAGTAATAGAAGGGCTGCAAGAAGAGAGGGTGCAGTTAGAGG	RP1L1		RETINITIS PIGMENTOSA 88	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000828064					828064	816400		
NM_178857.6:c.56C>A	RP1L1	P19H	RETINITIS PIGMENTOSA 88	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000828063					828063	816399		
NM_178857.6:c.5470C>T	RP1L1	Q1824*	RETINITIS PIGMENTOSA 88	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000828062					828062	816398		
NM_178857.6(RP1L1):c.603del (p.Lys203fs)	RP1L1	K203fs	RETINITIS PIGMENTOSA 88	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000050376	8	10480109	8	10622599	50376	59496	rs387907367	NC_000008.11:10622598:CCC:CC
NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	NC_000009.12:35065350:C:T
NM_000083.3(CLCN1):c.2172+1G>A	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000836780	7	143042856	7	143345763	836780	852070		NC_000007.14:143345762:G:A
NM_000083.3(CLCN1):c.302-1G>A	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000577893	7	143017756	7	143320663	577893	566513	rs529377088	NC_000007.14:143320662:G:A
NM_000083.3(CLCN1):c.2172+1G>T	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000572040	7	143042856	7	143345763	572040	561610	rs1273524525	NC_000007.14:143345762:G:T
NM_000083.3(CLCN1):c.1261dup (p.Arg421fs)	CLCN1		not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447048	7	143029822 - 143029823	7	143332729 - 143332730	447048	441054	rs763633152	NC_000007.14:143332729:CCCC:CCCCC
NM_001278716.2(FBXL4):c.1067del (p.Gly356fs)	FBXL4	G356fs	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437498	6	99353338	6	98905462	437498	431193	rs1554219474	NC_000006.12:98905461:CC:C
NM_003977.4(AIP):c.910C>T (p.Arg304Ter)	AIP	R304*, R245*	Somatotroph adenoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000004888	11	67258381	11	67490910	4888	19927	rs104894195	NC_000011.10:67490909:C:T
NM_024649.5(BBS1):c.479G>A (p.Arg160Gln)	BBS1	R160Q	Retinal dystrophy|Bardet-Biedl syndrome 1|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370228	11	66283057	11	66515586	370228	358036	rs376894444	NC_000011.10:66515585:G:A
NM_178857.6(RP1L1):c.1972C>T (p.Arg658Ter)	RP1L1	R658*	Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000143164	8	10469636	8	10612126	143164	152882	rs527236107	NC_000008.11:10612125:G:A
NM_001077365.2(POMT1):c.1837_1852dup (p.Gly618fs)	POMT1		Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000655295	9	134397437 - 134397438	9	131522050 - 131522051	655295	637799		NC_000009.12:131522050:CTGGCTGCGCTGGGTGCTGGCTG:CTGGCTGCGCTGGGTGCTGGCTGCGCTGGGTGCTGGCTG
NM_006624.5(ZMYND11):c.1798C>T (p.Arg600Trp)	ZMYND11	R600W, R481W, R498W, R506W, R515W, R569W, R577W, R545W, R551W, R578W, R560W, R599W, R443W, R524W, R546W, R583W	not provided|Inborn genetic diseases|Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208648	10	298399	10	252459	208648	205263	rs797044854	NC_000010.11:252458:C:T
NM_016203.4(PRKAG2):c.547G>A (p.Glu183Lys)	PRKAG2	E183K, E59K, E139K	Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000430968	7	151372643	7	151675557	430968	424509	rs1131692281	NC_000007.14:151675556:C:T
NM_016203.4(PRKAG2):c.1151G>C (p.Arg384Thr)	PRKAG2	R384T, R259T, R340T, R143T, R260T	Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000183142	7	151265884	7	151568798	183142	181278	rs730882148	NC_000007.14:151568797:C:G
NM_016203.4(PRKAG2):c.1591C>G (p.Arg531Gly)	PRKAG2	R531G, R290G, R407G, R406G, R487G	Wolff-Parkinson-White syndrome, childhood-onset	Pathogenic(Last reviewed: Dec 18, 2001)	no assertion criteria provided	VCV000006851	7	151257697	7	151560611	6851	21890	rs121908990	NC_000007.14:151560610:G:C
NM_000543.5(SMPD1):c.785_807del (p.Leu262fs)	SMPD1	L262fs, L261fs	not provided|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not specified	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195086	11	6413076 - 6413098	11	6391846 - 6391868	195086	192247	rs794727252	NC_000011.10:6391845:AGCCTGTTGAGTGGGCTGGGCCCAGCC:AGCC
NM_000360.4(TH):c.672C>G (p.Tyr224Ter)	TH	Y224*, Y255*, Y251*	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000521707	11	2188688	11	2167458	521707	511908	rs1554923218	NC_000011.10:2167457:G:C
NM_020320.5(RARS2):c.1A>G (p.Met1Val)	RARS2	M1V	Pontocerebellar hypoplasia type 6|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225026	6	88299675	6	87589957	225026	226903	rs774923951	NC_000006.12:87589956:T:C
NM_004523.4(KIF11):c.2697_2700del (p.Asn899fs)	KIF11	N899fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000521913	10	94408116 - 94408119	10	92648359 - 92648362	521913	511879	rs1554863044	NC_000010.11:92648358:AATGAA:AA
NM_016203.4(PRKAG2):c.879C>A (p.Phe293Leu)	PRKAG2	F293L, F168L, F169L, F249L, F52L	Cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036698	7	151273524	7	151576438	36698	45359	rs193922697	NC_000007.14:151576437:G:T
NM_001759.4(CCND2):c.841C>G (p.Pro281Ala)	CCND2	P281A	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000520663	12	4409146	12	4299980	520663	511990	rs587777621	NC_000012.12:4299979:C:G
NM_006772.3(SYNGAP1):c.427C>T (p.Arg143Ter)	SYNGAP1	R143*	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000060716	6	33400501	6	33432724	60716	75278	rs397514741	NC_000006.12:33432723:C:T
NM_001081.3(CUBN):c.5600del (p.Phe1867fs)	CUBN	F1867fs	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Feb 21, 2018)	no assertion criteria provided	VCV000599082	10	16981095	10	16939096	599082	590293	rs747417629	NC_000010.11:16939095:AAA:AA
NM_001081.3(CUBN):c.1308_1311del (p.Glu435_Cys436insTer)	CUBN		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000593810	10	17146524 - 17146527	10	17104525 - 17104528	593810	584873	rs1564516701	NC_000010.11:17104524:CAAACA:CA
NM_001081.3(CUBN):c.1506G>A (p.Trp502Ter)	CUBN	W502*	not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000500491	10	17145148	10	17103149	500491	491915	rs145818316	NC_000010.11:17103148:C:T
NM_001081.4(CUBN):c.2496dup (p.Pro833fs)	CUBN		not specified	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000439579	10	17113560	10	17071554 - 17071555	439579	433471	rs1554816715	NC_000010.11:17071554:AAAAAAA:AAAAAAAA
NM_001081.4(CUBN):c.7330C>T (p.Arg2444Ter)	CUBN	R2444*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000838702	10	16957052	10	16915053	838702	836734		NC_000010.11:16915052:G:A
NM_001081.4(CUBN):c.10245C>A (p.Tyr3415Ter)	CUBN	Y3415*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000836099	10	16877130	10	16835131	836099	836728		NC_000010.11:16835130:G:T
NM_001081.3(CUBN):c.5530C>T (p.Gln1844Ter)	CUBN	Q1844*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000579557	10	16982049	10	16940050	579557	566213	rs1564435943	NC_000010.11:16940049:G:A
NM_001081.3(CUBN):c.7955C>A (p.Ser2652Ter)	CUBN	S2652*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522697	10	16946072	10	16904073	522697	513305	rs1554790861	NC_000010.11:16904072:G:T
NM_001081.3(CUBN):c.3329+1G>T	CUBN		Megaloblastic anemia 1, Finnish type	Pathogenic(Last reviewed: Jan 6, 2011)	no assertion criteria provided	VCV000030291	10	17089412	10	17047413	30291	39247	rs1205598688	NC_000010.11:17047412:C:A
CUBN, IVS6, C-G	CUBN		Megaloblastic anemia 1, Finnish type	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006690					6690	21729		
NM_001081.3(CUBN):c.4459C>T (p.Arg1487Ter)	CUBN	R1487*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000575738	10	17026170	10	16984171	575738	566219	rs145661597	NC_000010.11:16984170:G:A
NM_001081.3(CUBN):c.5511dup (p.Gly1838fs)	CUBN		Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000522509	10	16982067 - 16982068	10	16940068 - 16940069	522509	513084	rs1168074679	NC_000010.11:16940068:A:AA
NM_000391.4(TPP1):c.827A>T (p.Asp276Val)	TPP1	D276V	Ceroid lipofuscinosis neuronal 2|not provided|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207581	11	6637951	11	6616720	207581	202576	rs763162812	NC_000011.10:6616719:T:A
NM_000391.4(TPP1):c.380G>A (p.Arg127Gln)	TPP1	R127Q	not provided|Ceroid lipofuscinosis neuronal 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068746	11	6638857	11	6617626	68746	79638	rs121908204	NC_000011.10:6617625:C:T
NM_001081.3(CUBN):c.5428C>T (p.Arg1810Ter)	CUBN	R1810*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000581662	10	16982151	10	16940152	581662	563628	rs143944436	NC_000010.11:16940151:G:A
NM_001081.3(CUBN):c.7906C>T (p.Arg2636Ter)	CUBN	R2636*	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569408	10	16948208	10	16906209	569408	569558	rs137998687	NC_000010.11:16906208:G:A
NM_001081.3(CUBN):c.6928_6934del (p.Glu2310fs)	CUBN	E2310fs	Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189227	10	16960687 - 16960693	10	16918688 - 16918694	189227	187116	rs757649673	NC_000010.11:16918687:TAACCTCT:T
NM_000255.4(MMUT):c.2179C>T (p.Arg727Ter)	MMUT	R727*	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218998	6	49399515	6	49431802	218998	216037	rs779990936	NC_000006.12:49431801:G:A
NM_000255.4(MMUT):c.2080C>T (p.Arg694Trp)	MMUT	R694W	Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218996	6	49403213	6	49435500	218996	216039	rs777758903	NC_000006.12:49435499:G:A
NM_019098.4(CNGB3):c.339-4415_673del	CNGB3		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000521713	8	87679339 - 87687748	8	86667104 - 86675513	521713	511771		
NM_019098.4(CNGB3):c.607C>T (p.Arg203Ter)	CNGB3	R203*	Achromatopsia 3|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005223	8	87680283	8	86668055	5223	20262	rs267606739	NC_000008.11:86668054:G:A
NM_016203.4(PRKAG2):c.1588C>G (p.His530Asp)	PRKAG2	H289D, H486D, H406D, H530D, H405D	Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000855977	7	151257700	7	151560614	855977	833365		NC_000007.14:151560613:G:C
NM_006158.4(NEFL):c.64C>T (p.Pro22Ser)	NEFL	P22S	Distal lower limb muscle weakness|Peripheral neuropathy|Pes cavus|Peripheral neuropathy|Hand muscle atrophy|Decreased nerve conduction velocity|Distal muscle weakness|Peripheral demyelination|Charcot-Marie-Tooth disease type 2E|not provided|Charcot-Marie-Tooth disease, type 1C	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000014029	8	24813966	8	24956452	14029	29068	rs28928910	NC_000008.11:24956451:G:A
NM_000083.3(CLCN1):c.409T>G (p.Tyr137Asp)	CLCN1	Y137D	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000571653	7	143017864	7	143320771	571653	561385	rs748639603	NC_000007.14:143320770:T:G
NM_000083.3(CLCN1):c.1876C>T (p.Arg626Ter)	CLCN1	R626*	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447058	7	143039544	7	143342451	447058	441064	rs201894078	NC_000007.14:143342450:C:T
NM_000083.3(CLCN1):c.1129C>T (p.Arg377Ter)	CLCN1	R377*	not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447045	7	143028708	7	143331615	447045	441051	rs201714423	NC_000007.14:143331614:C:T
NM_000083.3(CLCN1):c.2831dup (p.Gly945fs)	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280103	7	143048918 - 143048919	7	143351825 - 143351826	280103	264308	rs755176513	NC_000007.14:143351825:CCCC:CCCCC
NM_000083.3(CLCN1):c.1439C>T (p.Pro480Leu)	CLCN1	P480L	Myotonia congenita|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Apr 12, 2011)	no assertion criteria provided	VCV000017537	7	143036383	7	143339290	17537	32576	rs80356694	NC_000007.14:143339289:C:T
NM_001081.3(CUBN):c.1865del (p.Thr622fs)	CUBN	T622fs	not provided|Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056323	10	17130245	10	17088246	56323	70962	rs386833771	NC_000010.11:17088245:G:
NM_001081.3(CUBN):c.3890C>T (p.Pro1297Leu)	CUBN	P1297L	Megaloblastic anemia 1, Finnish type|Megaloblastic anemia due to inborn errors of metabolism	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2000)	no assertion criteria provided	VCV000006689	10	17083159	10	17041160	6689	21728	rs121434430	NC_000010.11:17041159:G:A
NM_005476.7(GNE):c.38G>C (p.Cys13Ser)	GNE	C13S, C44S	GNE myopathy|not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000496947	9	36249315	9	36249318	496947	488371	rs1209266607	NC_000009.12:36249317:C:G
NM_001360.2(DHCR7):c.740C>T (p.Ala247Val)	DHCR7	A247V	Smith-Lemli-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280065	11	71150016	11	71438970	280065	264564	rs886041354	NC_000011.10:71438969:G:A
NM_001360.2(DHCR7):c.151C>T (p.Pro51Ser)	DHCR7	P51S	not provided|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093712	11	71155209	11	71444163	93712	99615	rs104886035	NC_000011.10:71444162:G:A
NM_001360.2(DHCR7):c.906C>G (p.Phe302Leu)	DHCR7	F302L	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021277	11	71148915	11	71437869	21277	34129	rs80338858	NC_000011.10:71437868:G:C
NM_001360.2(DHCR7):c.1055G>A (p.Arg352Gln)	DHCR7	R352Q	not provided|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006795	11	71146794	11	71435748	6795	21834	rs121909768	NC_000011.10:71435747:C:T
NM_004333.6(BRAF):c.1798G>C (p.Val600Leu)	BRAF	V600L	Cutaneous melanoma|Cardiofaciocutaneous syndrome 1	Pathogenic	criteria provided, single submitter	VCV000376289	7	140453137	7	140753337	376289	363168	rs121913378	NC_000007.14:140753336:C:G
NM_001273.5(CHD4):c.3203G>A (p.Arg1068His)	CHD4	R1068H, R1061H, R1055H	Sifrim-Hitz-Weiss syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000266124	12	6700879	12	6591713	266124	260979	rs886039915	NC_000012.12:6591712:C:T
NM_001032221.6(STXBP1):c.981_987delinsTCAGCACC (p.Ser328fs)	STXBP1		not provided	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000818067	9	130434347 - 130434353	9	127672068 - 127672074	818067	805599		NC_000009.12:127672067:GTCCCAG:TCAGCACC
NM_001032221.6(STXBP1):c.294del (p.Lys98fs)	STXBP1	K98fs, K84fs	not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000817601	9	130422354	9	127660075	817601	805598		NC_000009.12:127660074:AAA:AA
NM_001032221.6(STXBP1):c.256_257TC[2] (p.Leu87fs)	STXBP1		not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000817213	9	130422317 - 130422318	9	127660038 - 127660039	817213	805597		NC_000009.12:127660037:CTCTCTC:CTCTC
NM_001032221.6(STXBP1):c.1607_1608del (p.Arg536fs)	STXBP1	R522fs, R500fs, R533fs, R536fs	not provided	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000817209	9	130444743 - 130444744	9	127682464 - 127682465	817209	805601		NC_000009.12:127682463:CGC:C
NM_001032221.6(STXBP1):c.1383_1388delinsC (p.Lys461fs)	STXBP1		not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000817102	9	130440733 - 130440738	9	127678454 - 127678459	817102	805600		NC_000009.12:127678453:GCCGGA:C
NM_001032221.6(STXBP1):c.1662delinsAA (p.Tyr554Ter)	STXBP1		not provided	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000817014	9	130444799	9	127682520	817014	805602		NC_000009.12:127682519:C:AA
GRCh37/hg19 9q34.11(chr9:130363849-130455691)x1	STXBP1		not provided	Pathogenic(Last reviewed: Mar 29, 2019)	no assertion criteria provided	VCV000815296	9	130363849 - 130455691			815296	803505		
NC_000009.12:g.127681712_127692172del	STXBP1		Epileptic encephalopathy	Pathogenic	no assertion criteria provided	VCV000812925	9	130443991 - 130454451			812925	801110		
NM_001032221.6(STXBP1):c.1249+1G>A	STXBP1		Epileptic encephalopathy	Pathogenic	no assertion criteria provided	VCV000812769	9	130438222	9	127675943	812769	801108		NC_000009.12:127675942:G:A
NM_003165.4(STXBP1):c.1427C>G (p.Ser476Ter)	STXBP1	S476*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000620472	9	130440777	9	127678498	620472	611714	rs1564355614	NC_000009.12:127678497:C:G
NM_003165.4(STXBP1):c.586A>T (p.Lys196Ter)	STXBP1	K196*	not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000620297	9	130427533	9	127665254	620297	611713	rs1564351084	NC_000009.12:127665253:A:T
NM_003165.4(STXBP1):c.685C>T (p.Gln229Ter)	STXBP1	Q229*	not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000546026	9	130428466	9	127666187	546026	536347	rs1554777470	NC_000009.12:127666186:C:T
NM_003165.4(STXBP1):c.1569_1570del (p.His523fs)	STXBP1	H523fs	not provided	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000503942	9	130444705 - 130444706	9	127682426 - 127682427	503942	495398	rs1554778928	NC_000009.12:127682425:ATA:A
NM_003165.4(STXBP1):c.794+1G>A	STXBP1		not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000497406	9	130428576	9	127666297	497406	488830	rs1554777496	NC_000009.12:127666296:G:A
NM_003165.4(STXBP1):c.88-2A>G	STXBP1		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000489132	9	130415992	9	127653713	489132	481836	rs796053351	NC_000009.12:127653712:A:G
NM_003165.4(STXBP1):c.1075C>T (p.Gln359Ter)	STXBP1	Q359*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000488989	9	130435505	9	127673226	488989	481838	rs1554778215	NC_000009.12:127673225:C:T
NM_003165.4(STXBP1):c.1597del (p.Ser533fs)	STXBP1	S533fs	not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000450231	9	130444734	9	127682455	450231	444353	rs1554778930	NC_000009.12:127682454:A:
NM_003165.4(STXBP1):c.107T>G (p.Leu36Ter)	STXBP1	L36*	not provided	Pathogenic(Last reviewed: Sep 5, 2015)	criteria provided, single submitter	VCV000427016	9	130416013	9	127653734	427016	415154	rs1085307900	NC_000009.12:127653733:T:G
NM_003165.4(STXBP1):c.963+1G>T	STXBP1		not provided	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000426136	9	130432238	9	127669959	426136	415157	rs1085307465	NC_000009.12:127669958:G:T
NM_003165.4(STXBP1):c.420T>A (p.Tyr140Ter)	STXBP1	Y140*	not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000424476	9	130423475	9	127661196	424476	407534	rs1064796989	NC_000009.12:127661195:T:A
NM_003165.4(STXBP1):c.748C>T (p.Gln250Ter)	STXBP1	Q250*	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000423968	9	130428529	9	127666250	423968	407536	rs1064796720	NC_000009.12:127666249:C:T
NM_003165.4(STXBP1):c.709_715del (p.Phe237fs)	STXBP1	F237fs	not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000422789	9	130428489 - 130428495	9	127666210 - 127666216	422789	407535	rs1064795999	NC_000009.12:127666209:CTTTGACC:C
NM_003165.4(STXBP1):c.889G>A (p.Ala297Thr)	STXBP1	A297T	not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000420158	9	130430453	9	127668174	420158	407537	rs1064794322	NC_000009.12:127668173:G:A
NM_003165.4(STXBP1):c.84G>A (p.Trp28Ter)	STXBP1	W28*	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000419604	9	130413928	9	127651649	419604	407531	rs1064793984	NC_000009.12:127651648:G:A
NM_003165.4(STXBP1):c.1217G>T (p.Arg406Leu)	STXBP1	R406L	not provided	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000419223	9	130438189	9	127675910	419223	407541	rs886041246	NC_000009.12:127675909:G:T
NM_003165.4(STXBP1):c.1204del (p.Tyr402fs)	STXBP1	Y402fs	not provided	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000418760	9	130438175	9	127675896	418760	407540	rs1064793414	NC_000009.12:127675895:TT:T
NM_003165.4(STXBP1):c.579-2A>G	STXBP1		not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000379855	9	130427524	9	127665245	379855	369745	rs112111568	NC_000009.12:127665244:A:G
NM_003165.4(STXBP1):c.794+5G>A	STXBP1		not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000379533	9	130428580	9	127666301	379533	369748	rs1057520631	NC_000009.12:127666300:G:A
NM_003165.4(STXBP1):c.1689G>A (p.Trp563Ter)	STXBP1	W563*	not provided	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000379255	9	130444826	9	127682547	379255	370537	rs1057520544	NC_000009.12:127682546:G:A
NM_003165.3(STXBP1):c.37_37+1delAG	STXBP1		not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000373290	9	130374714 - 130374715	9	127612435 - 127612436	373290	359763	rs1057518331	NC_000009.12:127612434:GAGAGAG:GAGAG
NM_003165.4(STXBP1):c.1652G>T (p.Arg551Leu)	STXBP1	R551L	not provided	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000373210	9	130444789	9	127682510	373210	359888	rs796053374	NC_000009.12:127682509:G:T
NM_003165.4(STXBP1):c.148dup (p.Ile50fs)	STXBP1		not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000373045	9	130416053 - 130416054	9	127653774 - 127653775	373045	359721	rs1057518167	NC_000009.12:127653774:A:AA
NM_003165.4(STXBP1):c.1093_1094CT[1] (p.Cys366fs)	STXBP1		not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000373029	9	130435523 - 130435524	9	127673244 - 127673245	373029	359907	rs1057518154	NC_000009.12:127673243:CTCT:CT
NM_003165.4(STXBP1):c.1012C>T (p.Gln338Ter)	STXBP1	Q338*	not provided	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000372559	9	130434378	9	127672099	372559	359727	rs1057517856	NC_000009.12:127672098:C:T
NM_003165.4(STXBP1):c.400_401del (p.Asn134fs)	STXBP1	N134fs	not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000289276	9	130423455 - 130423456	9	127661176 - 127661177	289276	273513	rs886044141	NC_000009.12:127661175:AA:
NM_003165.4(STXBP1):c.634delinsCAACAATGATG (p.Tyr212delinsGlnGlnTer)	STXBP1		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000280913	9	130427581	9	127665302	280913	264304	rs886042031	NC_000009.12:127665301:T:CAACAATGATG
NM_003165.4(STXBP1):c.902+1G>C	STXBP1		not provided	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000280844	9	130430467	9	127668188	280844	264460	rs886041978	NC_000009.12:127668187:G:C
NM_003165.4(STXBP1):c.662dup (p.Asp224fs)	STXBP1		not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000280771	9	130427608 - 130427609	9	127665329 - 127665330	280771	264458	rs886041917	NC_000009.12:127665329:A:AA
NM_003165.4(STXBP1):c.1060T>C (p.Cys354Arg)	STXBP1	C354R	not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000280041	9	130435490	9	127673211	280041	264378	rs886041337	NC_000009.12:127673210:T:C
GRCh37/hg19 9q34.11(chr9:130430429-130430704)x1	STXBP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253494	9	130430429 - 130430704			253494	247942		
GRCh37/hg19 9q34.11(chr9:130420443-130420935)x1	STXBP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253486	9	130420443 - 130420935			253486	247934		
GRCh37/hg19 9q34.11(chr9:130415943-130420935)x1	STXBP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253463	9	130415943 - 130420935			253463	247911		
GRCh37/hg19 9q34.11(chr9:130373225-130453427)x1	STXBP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253429	9	130373225 - 130453427			253429	247877		
NM_003165.4(STXBP1):c.*40del	STXBP1	Q576fs	not provided	Pathogenic(Last reviewed: Mar 14, 2013)	criteria provided, single submitter	VCV000207462	9	130453077	9	127690798	207462	202333	rs796053393	NC_000009.12:127690797:C:
NM_003165.4(STXBP1):c.1510del (p.Thr504fs)	STXBP1	T504fs	not provided	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000207461	9	130442484	9	127680205	207461	202322	rs796053392	NC_000009.12:127680204:A:
NM_003165.4(STXBP1):c.1470del (p.Ile490fs)	STXBP1	I490fs	not provided	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000207460	9	130442443	9	127680164	207460	202321	rs796053391	NC_000009.12:127680163:TT:T
NM_003165.4(STXBP1):c.386_387CT[1] (p.Leu130fs)	STXBP1		not provided	Pathogenic(Last reviewed: Jan 31, 2012)	criteria provided, single submitter	VCV000207458	9	130423441 - 130423442	9	127661162 - 127661163	207458	202286	rs796053390	NC_000009.12:127661161:CTCT:CT
NM_003165.4(STXBP1):c.1611_1613CAT[1] (p.Ile539del)	STXBP1	I539del	not provided	Pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000207453	9	130444747 - 130444749	9	127682468 - 127682470	207453	202326	rs796053386	NC_000009.12:127682467:TCATCAT:TCAT
NM_003165.4(STXBP1):c.1296dup (p.Pro433fs)	STXBP1		not provided	Pathogenic(Last reviewed: May 7, 2012)	criteria provided, single submitter	VCV000207452	9	130438968 - 130438969	9	127676689 - 127676690	207452	202315	rs796053385	NC_000009.12:127676689:A:AA
NM_003165.4(STXBP1):c.1169_1175dup (p.Ile393fs)	STXBP1		not provided	Pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	VCV000207451	9	130438140 - 130438141	9	127675861 - 127675862	207451	202309	rs796053384	NC_000009.12:127675861:TCGTCCC:TCGTCCCTCGTCCC
NM_003165.4(STXBP1):c.895_896GT[1] (p.Ser300fs)	STXBP1		not provided	Pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	VCV000207450	9	130430459 - 130430460	9	127668180 - 127668181	207450	202302	rs796053383	NC_000009.12:127668179:GTGT:GT
NM_003165.4(STXBP1):c.578+1dup	STXBP1		not provided	Pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	VCV000207449	9	130425628 - 130425629	9	127663349 - 127663350	207449	202293	rs796053382	NC_000009.12:127663349:GGGGG:GGGGGG
NM_003165.4(STXBP1):c.124del (p.Ser42fs)	STXBP1	S42fs	not provided	Pathogenic(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	VCV000207447	9	130416030	9	127653751	207447	202278	rs796053380	NC_000009.12:127653750:T:
NM_003165.4(STXBP1):c.1672C>T (p.Gln558Ter)	STXBP1	Q558*	not provided	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	VCV000207443	9	130444809	9	127682530	207443	202331	rs796053376	NC_000009.12:127682529:C:T
NM_003165.4(STXBP1):c.1652G>C (p.Arg551Pro)	STXBP1	R551P	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000207441	9	130444789	9	127682510	207441	202329	rs796053374	NC_000009.12:127682509:G:C
NM_003165.4(STXBP1):c.1359+1G>A	STXBP1		not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000207435	9	130439033	9	127676754	207435	202316	rs796053370	NC_000009.12:127676753:G:A
NM_003165.4(STXBP1):c.1061G>A (p.Cys354Tyr)	STXBP1	C354Y	not provided	Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000207428	9	130435491	9	127673212	207428	202306	rs796053365	NC_000009.12:127673211:G:A
NM_003165.4(STXBP1):c.1030-1G>T	STXBP1		not provided	Pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	VCV000207427	9	130435459	9	127673180	207427	202305	rs796053364	NC_000009.12:127673179:G:T
NM_003165.4(STXBP1):c.904G>T (p.Glu302Ter)	STXBP1	E302*	not provided	Pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	VCV000207425	9	130432178	9	127669899	207425	202303	rs796053362	NC_000009.12:127669898:G:T
NM_003165.4(STXBP1):c.578+1G>T	STXBP1		not provided	Pathogenic(Last reviewed: Apr 24, 2013)	criteria provided, single submitter	VCV000207419	9	130425633	9	127663354	207419	202292	rs796053357	NC_000009.12:127663353:G:T
NM_003165.4(STXBP1):c.430-1G>T	STXBP1		not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000207416	9	130425483	9	127663204	207416	202289	rs796053354	NC_000009.12:127663203:G:T
NM_003165.4(STXBP1):c.88-2A>C	STXBP1		not provided	Pathogenic(Last reviewed: May 2, 2014)	criteria provided, single submitter	VCV000207413	9	130415992	9	127653713	207413	202277	rs796053351	NC_000009.12:127653712:A:C
NM_003165.4(STXBP1):c.1029+1G>T	STXBP1		not provided	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	VCV000167725	9	130434396	9	127672117	167725	178093	rs727504173	NC_000009.12:127672116:G:T
NM_001032221.6(STXBP1):c.1258G>T (p.Glu420Ter)	STXBP1	E384*, E406*, E417*, E420*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000848882	9	130438931	9	127676652	848882	835465		NC_000009.12:127676651:G:T
NC_000009.12:g.(?_127653695)_(127676773_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000831403	9	130415974 - 130439052			831403	820054		
NM_001032221.6(STXBP1):c.1427C>A (p.Ser476Ter)	STXBP1	S440*, S462*, S473*, S476*	Early infantile epileptic encephalopathy 4	Pathogenic	no assertion criteria provided	VCV000812664	9	130440777	9	127678498	812664	800915		NC_000009.12:127678497:C:A
NM_001032221.6(STXBP1):c.1261G>T (p.Glu421Ter)	STXBP1	E418*, E407*, E421*, E385*	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000807506	9	130438934	9	127676655	807506	798612		NC_000009.12:127676654:G:T
NM_001032221.6(STXBP1):c.1236del (p.Phe413_Leu414insTer)	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802514	9	130438208	9	127675929	802514	790841		NC_000009.12:127675928:C:
NM_001032221.6(STXBP1):c.579-1G>A	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802512	9	130427525	9	127665246	802512	790839		NC_000009.12:127665245:G:A
NM_001032221.6(STXBP1):c.430-1G>A	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802511	9	130425483	9	127663204	802511	790838		NC_000009.12:127663203:G:A
NM_001032221.6(STXBP1):c.241G>T (p.Glu81Ter)	STXBP1	E67*, E81*	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802508	9	130420725	9	127658446	802508	790835		NC_000009.12:127658445:G:T
NM_003165.4(STXBP1):c.578G>T (p.Gly193Val)	STXBP1	G193V	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000649479	9	130425632	9	127663353	649479	637673		NC_000009.12:127663352:G:T
NM_001032221.6(STXBP1):c.116_118dup (p.Arg39dup)	STXBP1		Spasticity|Intellectual disability	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000633836	9	130416019 - 130416020	9	127653740 - 127653741	633836	622268		NC_000009.12:127653740:GAGGA:GAGGAGGA
NM_003165.4(STXBP1):c.1557T>A (p.Tyr519Ter)	STXBP1	Y519*	Early infantile epileptic encephalopathy 4	Pathogenic	no assertion criteria provided	VCV000590289	9	130444694	9	127682415	590289	581230	rs1564357089	NC_000009.12:127682414:T:A
NC_000009.11:g.(?_130432157)_(130432257_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000583850	9	130432157 - 130432257	9	127669878 - 127669978	583850	562576		
NM_003165.4(STXBP1):c.345del (p.Phe115fs)	STXBP1	F115fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000579748	9	130423398	9	127661119	579748	563406	rs1564349850	NC_000009.12:127661118:TTT:TT
NM_003165.4(STXBP1):c.817G>T (p.Glu273Ter)	STXBP1	E273*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000573250	9	130430381	9	127668102	573250	562726	rs1564352002	NC_000009.12:127668101:G:T
NM_003165.4(STXBP1):c.22_32dup (p.Glu12fs)	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000572405	9	130374703 - 130374704	9	127612424 - 127612425	572405	568478	rs1564333757	NC_000009.12:127612424:GCTGTTGTCGG:GCTGTTGTCGGGCTGTTGTCGG
NM_003165.4(STXBP1):c.733C>G (p.His245Asp)	STXBP1	H245D	Microcephaly|Severe global developmental delay	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523457	9	130428514	9	127666235	523457	513984	rs1554777480	NC_000009.12:127666234:C:G
NM_003165.4(STXBP1):c.265del (p.Ser89fs)	STXBP1	S89fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 16, 2016)	criteria provided, single submitter	VCV000407778	9	130422327	9	127660048	407778	397036	rs1060501723	NC_000009.12:127660047:A:
NM_003165.4(STXBP1):c.1434G>A (p.Trp478Ter)	STXBP1	W478*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000407777	9	130440784	9	127678505	407777	396826	rs1060501722	NC_000009.12:127678504:G:A
NM_003165.4(STXBP1):c.1408G>T (p.Glu470Ter)	STXBP1	E470*	Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375521	9	130440758	9	127678479	375521	362334	rs1057519539	NC_000009.12:127678478:G:T
NM_003165.4(STXBP1):c.57_59del (p.Ile19_Lys20delinsMet)	STXBP1		Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375520	9	130413901 - 130413903	9	127651622 - 127651624	375520	362332	rs1057519538	NC_000009.12:127651621:AAA:
NM_003165.4(STXBP1):c.1565G>A (p.Trp522Ter)	STXBP1	W522*	Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375519	9	130444702	9	127682423	375519	362335	rs1057519537	NC_000009.12:127682422:G:A
NM_003165.4(STXBP1):c.1006C>T (p.Gln336Ter)	STXBP1	Q336*	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000375464	9	130434372	9	127672093	375464	362229	rs1057519501	NC_000009.12:127672092:C:T
NM_003165.4(STXBP1):c.798T>G (p.Tyr266Ter)	STXBP1	Y266*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000239512	9	130430362	9	127668083	239512	240447	rs751170778	NC_000009.12:127668082:T:G
NM_003165.4(STXBP1):c.87+1G>A	STXBP1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207412	9	130413932	9	127651653	207412	202276	rs796053350	NC_000009.12:127651652:G:A
NM_001032221.6(STXBP1):c.157G>T (p.Glu53Ter)	STXBP1	E39*, E53*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000836802	9	130416063	9	127653784	836802	835460		NC_000009.12:127653783:G:T
NC_000009.12:g.(?_127612384)_(127612460_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000832915	9	130374663 - 130374739			832915	820050		
NC_000009.12:g.(?_127651583)_(127690877_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000832745	9	130413862 - 130453156			832745	820053		
NC_000009.12:g.(?_127651583)_(127653816_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000830415	9	130413862 - 130416095			830415	820052		
NM_001032221.6(STXBP1):c.246+2_325+14del	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000827636	9	130420732 - 130422401	9	127658453 - 127660122	827636	815840		
NM_001032221.6(STXBP1):c.1359+1G>T	STXBP1		Global developmental delay|Autistic disorder of childhood onset	Pathogenic	no assertion criteria provided	VCV000812770	9	130439033	9	127676754	812770	801109		NC_000009.12:127676753:G:T
NM_001032221.6(STXBP1):c.1492dup (p.His498fs)	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000620007	9	130442465 - 130442466	9	127680186 - 127680187	620007	611399	rs1564356269	NC_000009.12:127680186:C:CC
NM_003165.4(STXBP1):c.607C>T (p.Gln203Ter)	STXBP1	Q203*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000567493	9	130427554	9	127665275	567493	563421	rs1564351103	NC_000009.12:127665274:C:T
NM_003165.4(STXBP1):c.360del (p.Lys120fs)	STXBP1	K120fs	Macrocephalus|Hand tremor|Behavioral abnormality|Global developmental delay|Seizures	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523458	9	130423412	9	127661133	523458	513983	rs1554776954	NC_000009.12:127661132:AAAA:AAA
NM_001032221.4(STXBP1):c.87+2T>C	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000436894	9	130413933	9	127651654	436894	428915	rs1554775960	NC_000009.12:127651653:T:C
NM_003165.4(STXBP1):c.1029+1G>C	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 13, 2014)	criteria provided, single submitter	VCV000212326	9	130434396	9	127672117	212326	207613	rs727504173	NC_000009.12:127672116:G:C
NM_001032221.4(STXBP1):c.754_755del (p.Met252fs)	STXBP1	M252fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	VCV000160071	9	130428534 - 130428535	9	127666255 - 127666256	160071	168754	rs587784454	NC_000009.12:127666254:TAT:T
NM_003165.4(STXBP1):c.169+1G>A	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000006731	9	130416076	9	127653797	6731	21770	rs587776641	NC_000009.12:127653796:G:A
NM_003165.4(STXBP1):c.251T>A (p.Val84Asp)	STXBP1	V84D	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006729	9	130422313	9	127660034	6729	21768	rs121918320	NC_000009.12:127660033:T:A
NM_003165.4(STXBP1):c.1328T>G (p.Met443Arg)	STXBP1	M443R	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006728	9	130439001	9	127676722	6728	21767	rs121918319	NC_000009.12:127676721:T:G
NM_003165.4(STXBP1):c.1631G>A (p.Gly544Asp)	STXBP1	G544D	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006726	9	130444768	9	127682489	6726	21765	rs121918317	NC_000009.12:127682488:G:A
NC_000007.14:g.(?_74028178)_(74068710_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000832968	7	73442508 - 73483040			832968	819914		
NC_000007.13:g.(?_73442498)_(73483050_?)del	ELN		Supravalvar aortic stenosis	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000524226	7	73442498 - 73483050			524226	522277		
NM_001032221.6(STXBP1):c.1030del (p.Tyr344fs)	STXBP1	Y330fs, Y344fs, Y308fs, Y341fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812177	9	130435460	9	127673181	812177	800669		NC_000009.12:127673180:T:
NM_003165.4(STXBP1):c.664-1G>C	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000660788	9	130428444	9	127666165	660788	651899		NC_000009.12:127666164:G:C
NM_003165.4(STXBP1):c.79G>T (p.Glu27Ter)	STXBP1	E27*	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561120	9	130413923	9	127651644	561120	552129	rs1564346538	NC_000009.12:127651643:G:T
NM_003165.4(STXBP1):c.578+1G>A	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561119	9	130425633	9	127663354	561119	552131	rs796053357	NC_000009.12:127663353:G:A
NM_003165.4(STXBP1):c.692dup (p.Ile232fs)	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000560298	9	130428472 - 130428473	9	127666193 - 127666194	560298	551300	rs1564351388	NC_000009.12:127666193:T:TT
NC_000009.11:g.(?_130420634)_(130420750_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000461208			9	127658355 - 127658471	461208	458126		
NM_003165.4(STXBP1):c.902+1G>A	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 9, 2016)	no assertion criteria provided	VCV000375214	9	130430467	9	127668188	375214	361912	rs886041978	NC_000009.12:127668187:G:A
NM_001077365.2(POMT1):c.2111_2112TC[1] (p.Ser705fs)	POMT1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003252	9	134398425 - 134398426	9	131523038 - 131523039	3252	18291	rs587777819	NC_000009.12:131523037:CTCTC:CTC
NM_000322.5(PRPH2):c.629C>G (p.Pro210Arg)	PRPH2	P210R	Macular dystrophy, vitelliform, adult-onset|PRPH2-Related Disorders|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013173	6	42672302	6	42704564	13173	28212	rs61755798	NC_000006.12:42704563:G:C
NM_003165.4(STXBP1):c.1381_1390del (p.Lys461fs)	STXBP1	K461fs	Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449337	9	130440723 - 130440732	9	127678444 - 127678453	449337	444351	rs1554778657	NC_000009.12:127678443:GCCGGAGCAAGCCGGAGC:GCCGGAGC
NM_003165.4(STXBP1):c.256_257TC[4] (p.Ile88fs)	STXBP1		not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419724	9	130422316 - 130422317	9	127660037 - 127660038	419724	407533	rs1554776831	NC_000009.12:127660037:CTCTCTC:CTCTCTCTC
NM_003165.4(STXBP1):c.1651C>A (p.Arg551Ser)	STXBP1	R551S	not provided|Early infantile epileptic encephalopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207439	9	130444788	9	127682509	207439	202327	rs796053373	NC_000009.12:127682508:C:A
NM_018972.4(GDAP1):c.368A>G (p.His123Arg)	GDAP1	H123R, H55R, H14R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease type 2K	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000050558	8	75272429	8	74360194	50558	59596	rs397515442	NC_000008.11:74360193:A:G
NM_054012.4(ASS1):c.835C>T (p.Arg279Ter)	ASS1	R279*	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006333	9	133355833	9	130480446	6333	21372	rs121908645	NC_000009.12:130480445:C:T
NM_054012.4(ASS1):c.539G>A (p.Ser180Asn)	ASS1	S180N	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006326	9	133346264	9	130470877	6326	21365	rs121908638	NC_000009.12:130470876:G:A
NM_018972.4(GDAP1):c.692C>T (p.Pro231Leu)	GDAP1	P231L, P122L, P173L, P163L	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004202	8	75275286	8	74363051	4202	19241	rs121908114	NC_000008.11:74363050:C:T
NM_005157.6(ABL1):c.757T>C (p.Tyr253His)	ABL1	Y253H, Y272H	Leukemia, Philadelphia chromosome-positive, resistant to imatinib|Lymphoblastic leukemia, acute, with lymphomatous features|Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000012627	9	133738357	9	130862970	12627	27666	rs121913461	NC_000009.12:130862969:T:C
NM_002047.4(GARS1):c.1000A>T (p.Ile334Phe)	GARS1	I334F, I280F	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476747	7	30651830	7	30612214	476747	457158	rs1554338260	NC_000007.14:30612213:A:T
NM_001374828.1(ARID1B):c.6144_6148del (p.Ser2048fs)	ARID1B	S1995fs, S2008fs, S1215fs, S2048fs	not provided	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000818083	6	157528047 - 157528051	6	157206913 - 157206917	818083	805486		NC_000006.12:157206912:GAGCCGAG:GAG
NM_001374828.1(ARID1B):c.4069_4072del (p.Ile1357fs)	ARID1B	I1304fs, I1357fs, I524fs, I1317fs	not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000818020	6	157511180 - 157511183	6	157190046 - 157190049	818020	805483		NC_000006.12:157190045:CAATCA:CA
NM_001374828.1(ARID1B):c.3979_3980delinsA (p.Ala1327fs)	ARID1B		not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000818000	6	157510835 - 157510836	6	157189701 - 157189702	818000	805481		NC_000006.12:157189700:GC:A
NM_001374828.1(ARID1B):c.1578del (p.Ser527fs)	ARID1B	S527fs	not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000817920	6	157100389	6	156779255	817920	805477		NC_000006.12:156779254:CCCC:CCC
NM_001374828.1(ARID1B):c.6309del (p.Leu2104fs)	ARID1B	L1271fs, L2064fs, L2104fs, L2051fs	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000817862	6	157528214	6	157207080	817862	805487		NC_000006.12:157207079:TT:T
NM_001374828.1(ARID1B):c.2323del (p.Ser775fs)	ARID1B	S775fs, S788fs	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000817445	6	157405871	6	157084737	817445	805478		NC_000006.12:157084736:T:
NM_001374828.1(ARID1B):c.4028dup (p.His1343fs)	ARID1B		not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000817319	6	157510883 - 157510884	6	157189749 - 157189750	817319	805482		NC_000006.12:157189749:A:AA
NM_001374828.1(ARID1B):c.5750del (p.Lys1917fs)	ARID1B	K1084fs, K1864fs, K1877fs, K1917fs	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000817292	6	157527652	6	157206518	817292	805485		NC_000006.12:157206517:AAAAA:AAAA
NM_001374828.1(ARID1B):c.1563del (p.Glu522fs)	ARID1B	E522fs	not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000817193	6	157100374	6	156779240	817193	805476		NC_000006.12:156779239:CCCC:CCC
NM_001374828.1(ARID1B):c.3720_3723del (p.Asn1240fs)	ARID1B	N1200fs, N1240fs, N407fs, N1187fs	not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000817175	6	157505368 - 157505371	6	157184234 - 157184237	817175	805480		NC_000006.12:157184233:AATAAA:AA
NM_001374828.1(ARID1B):c.3709del (p.Ala1237fs)	ARID1B	A1237fs, A1197fs, A404fs, A1184fs	not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000817117	6	157502306	6	157181172	817117	805479		NC_000006.12:157181171:GG:G
NM_001374828.1(ARID1B):c.4517del (p.Pro1506fs)	ARID1B	P1466fs, P1453fs, P1506fs, P673fs	not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000817087	6	157521872	6	157200738	817087	805484		NC_000006.12:157200737:CCCCC:CCCC
NM_001374828.1(ARID1B):c.1492del (p.Ala498fs)	ARID1B	A498fs	not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000817086	6	157100302	6	156779168	817086	805475		NC_000006.12:156779167:GGGGG:GGGG
NM_001374828.1(ARID1B):c.1293_1311del (p.Gly434fs)	ARID1B	G434fs	not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000817019	6	157100098 - 157100116	6	156778964 - 156778982	817019	805474		NC_000006.12:156778963:GGCGGCGGCAGCAGCAGGAGGCGGCGGC:GGCGGCGGC
GRCh37/hg19 6q25.3(chr6:157068951-157162523)x1	ARID1B		not provided	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000687134	6	157068951 - 157162523			687134	674726		
NM_020732.3(ARID1B):c.760C>T (p.Gln254Ter)	ARID1B	Q254*	not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000620534	6	157099823	6	156778689	620534	611650	rs1554247662	NC_000006.12:156778688:C:T
NM_020732.3(ARID1B):c.4105C>T (p.Gln1369Ter)	ARID1B	Q1369*, Q1409*, Q1356*, Q659*	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000620327	6	157520036	6	157198902	620327	611653	rs1554235028	NC_000006.12:157198901:C:T
NM_020732.3(ARID1B):c.3365G>A (p.Trp1122Ter)	ARID1B	W1122*, W1162*, W1109*, W412*	not provided	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000620220	6	157505384	6	157184250	620220	611651	rs1554231803	NC_000006.12:157184249:G:A
NM_020732.3(ARID1B):c.3535C>T (p.Gln1179Ter)	ARID1B	Q1179*, Q1219*, Q1166*, Q469*	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000620170	6	157505554	6	157184420	620170	611652	rs1554231904	NC_000006.12:157184419:C:T
NM_017519.2(ARID1B):c.4386C>G (p.Tyr1462Ter)	ARID1B	Y1475*, Y1515*, Y1462*, Y765*	not provided	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000598563	6	157522153	6	157201019	598563	589624	rs1562345819	NC_000006.12:157201018:C:G
NM_017519.2(ARID1B):c.3173_3177delinsCAGA (p.Leu1058fs)	ARID1B		History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000589768	6	157502179 - 157502183	6	157181045 - 157181049	589768	579202	rs1562328476	NC_000006.12:157181044:TCTGG:CAGA
NM_017519.2(ARID1B):c.5547dup (p.Gly1850fs)	ARID1B		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000589566	6	157527858 - 157527859	6	157206724 - 157206725	589566	579364	rs1562352435	NC_000006.12:157206724:AAA:AAAA
NM_017519.2(ARID1B):c.4326del (p.Ser1443fs)	ARID1B	S1443fs, S746fs, S1496fs, S1456fs	not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000545949	6	157522092	6	157200958	545949	536314	rs1554235699	NC_000006.12:157200957:CC:C
NM_001346813.1(ARID1B):c.1875C>A (p.Tyr625Ter)	ARID1B	Y625*, Y638*	not provided	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000545066	6	157222647	6	156901513	545066	535304	rs751192841	NC_000006.12:156901512:C:A
NM_017519.2(ARID1B):c.4839_4851del (p.Thr1614fs)	ARID1B	T917fs, T1614fs, T1627fs, T1667fs	not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000524143	6	157522600 - 157522612	6	157201466 - 157201478	524143	514530	rs1554236045	NC_000006.12:157201465:AAAGATTACCTCCAAAGAT:AAAGAT
NM_017519.2(ARID1B):c.5926_5927del (p.Lys1976fs)	ARID1B	K1976fs, K2029fs, K1279fs, K1989fs	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000524095	6	157528239 - 157528240	6	157207105 - 157207106	524095	514531	rs1554237785	NC_000006.12:157207104:AAA:A
NM_017519.2(ARID1B):c.1202del (p.Gly401fs)	ARID1B	G401fs	not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000524062	6	157100260	6	156779126	524062	514528	rs1554248082	NC_000006.12:156779125:GGGGGG:GGGGG
NM_017519.2(ARID1B):c.1301_1341del (p.Gly434fs)	ARID1B	G434fs	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000523968	6	157100362 - 157100402	6	156779228 - 156779268	523968	514529	rs1554248137	NC_000006.12:156779227:CGGCGGCAGCTACCCCGAGTACAGCAGCCCCAGCGCGCCGCCG:CG
NM_017519.2(ARID1B):c.2907del (p.Pro969_Met970insTer)	ARID1B		not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000504006	6	157488238	6	157167104	504006	495516	rs1554228806	NC_000006.12:157167103:CCC:CC
NM_017519.2(ARID1B):c.4661_4662delinsAGT (p.Met1554fs)	ARID1B		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000503938	6	157522428 - 157522429	6	157201294 - 157201295	503938	495526	rs1554235934	NC_000006.12:157201293:TG:AGT
NM_020732.3(ARID1B):c.3051_3052insGA (p.Ser1018fs)	ARID1B		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000503823	6	157495167 - 157495168	6	157174033 - 157174034	503823	495266	rs1554229912	NC_000006.12:157174033::GA
NM_017519.2(ARID1B):c.3739_3741delinsAG (p.Tyr1247fs)	ARID1B		not provided	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000498830	6	157511260 - 157511262	6	157190126 - 157190128	498830	490254	rs1554233122	NC_000006.12:157190125:TAC:AG
NM_020732.3(ARID1B):c.4324G>T (p.Gly1442Ter)	ARID1B	G1442*, G1482*, G1429*, G732*	not provided	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000489010	6	157522052	6	157200918	489010	481754	rs779375711	NC_000006.12:157200917:G:T
NM_020732.3(ARID1B):c.2773C>T (p.Gln925Ter)	ARID1B	Q912*, Q925*, Q162*	not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000488923	6	157469979	6	157148845	488923	481753	rs1554226097	NC_000006.12:157148844:C:T
NM_017519.2(ARID1B):c.1392_1402dup (p.Gln468fs)	ARID1B		not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000452956	6	157100452 - 157100453	6	156779318 - 156779319	452956	443921	rs1131691706	NC_000006.12:156779318:GCGGGCGGCCAGC:GCGGGCGGCCAGCGGGCGGCCAGC
NM_020732.3(ARID1B):c.4110+1G>C	ARID1B		not provided	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000452881	6	157520042	6	157198908	452881	443925	rs1554235041	NC_000006.12:157198907:G:C
NM_020732.3(ARID1B):c.5722C>T (p.Gln1908Ter)	ARID1B	Q1908*, Q1948*, Q1198*, Q1895*	not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452143	6	157527997	6	157206863	452143	443927	rs1554237606	NC_000006.12:157206862:C:T
NM_020732.3(ARID1B):c.3862+1G>A	ARID1B		not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000452035	6	157511345	6	157190211	452035	443924	rs1554233187	NC_000006.12:157190210:G:A
NM_017519.2(ARID1B):c.1044_1071del (p.Ala349fs)	ARID1B	A349fs	not provided	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000451585	6	157100093 - 157100120	6	156778959 - 156778986	451585	443920	rs1554247989	NC_000006.12:156778958:GCGGCGGCGGCGGCAGCAGCAGGAGGCGGCGGCGGCGGCGGC:GCGGCGGCGGCGGC
NM_017519.2(ARID1B):c.3389del (p.Lys1130fs)	ARID1B	K1130fs, K1183fs, K1143fs, K433fs	not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000451580	6	157505443	6	157184309	451580	443923	rs1554231830	NC_000006.12:157184308:AAAAA:AAAA
NM_020732.3(ARID1B):c.2362C>T (p.Gln788Ter)	ARID1B	Q775*, Q788*, Q25*	not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000450773	6	157431686	6	157110552	450773	443922	rs1554298232	NC_000006.12:157110551:C:T
NM_020732.3(ARID1B):c.4741C>T (p.Gln1581Ter)	ARID1B	Q1581*, Q1621*, Q871*, Q1568*	not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000450039	6	157522469	6	157201335	450039	443926	rs1554235950	NC_000006.12:157201334:C:T
NM_017519.2(ARID1B):c.4864del (p.Glu1622fs)	ARID1B	E1622fs, E1635fs, E1675fs, E925fs	not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000432571	6	157525008	6	157203874	432571	425680	rs1554236600	NC_000006.12:157203873:G:
NM_017519.2(ARID1B):c.3268_3269CT[1] (p.Tyr1091fs)	ARID1B		not provided	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000432252	6	157502274 - 157502275	6	157181140 - 157181141	432252	425679	rs1554231260	NC_000006.12:157181139:CTCT:CT
NM_017519.2(ARID1B):c.1469_1488dup (p.Ser497fs)	ARID1B		not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000430106	6	157100531 - 157100532	6	156779397 - 156779398	430106	421580	rs1554248228	NC_000006.12:156779397:GGGCGGCCGCGCAACAAAGG:GGGCGGCCGCGCAACAAAGGGGGCGGCCGCGCAACAAAGG
NM_017519.2(ARID1B):c.1389_1398dup (p.Gln467fs)	ARID1B		not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000429355	6	157100444 - 157100445	6	156779310 - 156779311	429355	421578	rs1131691339	NC_000006.12:156779310:GGGCGGCGGCGGGCGGC:GGGCGGCGGCGGGCGGCGGCGGGCGGC
NM_017519.2(ARID1B):c.1400_1410del (p.Gln467fs)	ARID1B	Q467fs	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000426825	6	157100456 - 157100466	6	156779322 - 156779332	426825	415032	rs1085307818	NC_000006.12:156779321:GGCGGCCAGCAGGCGGCC:GGCGGCC
NM_017519.2(ARID1B):c.2354_2357del (p.Arg785fs)	ARID1B	R35fs, R785fs, R798fs	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000426580	6	157454180 - 157454183	6	157133046 - 157133049	426580	415033	rs1085307695	NC_000006.12:157133045:AAAGAAA:AAA
NM_017519.2(ARID1B):c.3557_3558del (p.Gly1186fs)	ARID1B	G1186fs, G1239fs, G489fs, G1199fs	not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000426239	6	157510821 - 157510822	6	157189687 - 157189688	426239	415034	rs1085307518	NC_000006.12:157189686:GC:
NM_017519.2(ARID1B):c.3804dup (p.Phe1269fs)	ARID1B		not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000423421	6	157511321 - 157511322	6	157190187 - 157190188	423421	406840	rs1554233166	NC_000006.12:157190187:CCCC:CCCCC
NM_001363725.2(ARID1B):c.-114_-113dup	ARID1B		not provided	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000419514	6	157405931 - 157405932	6	157084797 - 157084798	419514	406838	rs1554294665	NC_000006.12:157084797:CCCC:CCCCCC
NM_001363725.2(ARID1B):c.-89dup	ARID1B		not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000419490	6	157405953 - 157405954	6	157084819 - 157084820	419490	406839	rs1554294674	NC_000006.12:157084819:GGGGGG:GGGGGGG
NM_017519.2(ARID1B):c.6459_6469del (p.Val2154fs)	ARID1B	V1457fs, V2167fs, V2154fs, V2207fs	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419478	6	157528768 - 157528778	6	157207634 - 157207644	419478	406844	rs1064793899	NC_000006.12:157207633:GATGGGGTCACGATGG:GATGG
NM_017519.2(ARID1B):c.1524_1525dup (p.Thr509fs)	ARID1B		not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000418956	6	157100586 - 157100587	6	156779452 - 156779453	418956	406837	rs1554248273	NC_000006.12:156779452:GA:GAGA
NM_017519.2(ARID1B):c.1079dup (p.Ser361fs)	ARID1B		not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000418947	6	157100137 - 157100138	6	156779003 - 156779004	418947	406836	rs1289468231	NC_000006.12:156779003:GGGGG:GGGGGG
NM_020732.3(ARID1B):c.4456C>T (p.Gln1486Ter)	ARID1B	Q1486*, Q1526*, Q1473*, Q776*	not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000418864	6	157522184	6	157201050	418864	406842	rs1064793482	NC_000006.12:157201049:C:T
NM_017519.2(ARID1B):c.2977_2981dup (p.Ala996fs)	ARID1B		not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000373383	6	157488308 - 157488309	6	157167174 - 157167175	373383	359736	rs1057518387	NC_000006.12:157167174:CAGCTC:CAGCTCAGCTC
NM_020732.3(ARID1B):c.769G>T (p.Gly257Ter)	ARID1B	G257*	not provided	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000373155	6	157099832	6	156778698	373155	359612	rs1057518256	NC_000006.12:156778697:G:T
NM_020732.3(ARID1B):c.1360C>T (p.Gln454Ter)	ARID1B	Q454*	not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000373098	6	157100423	6	156779289	373098	359594	rs1057518213	NC_000006.12:156779288:C:T
NM_020732.3(ARID1B):c.2776C>T (p.Gln926Ter)	ARID1B	Q913*, Q926*, Q163*	not provided	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000372302	6	157469982	6	157148848	372302	359767	rs1057517704	NC_000006.12:157148847:C:T
NM_017519.2(ARID1B):c.3975-1G>A	ARID1B		not provided	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000291011	6	157519944	6	157198810	291011	275248	rs886044620	NC_000006.12:157198809:G:A
NM_020732.3(ARID1B):c.5811G>A (p.Trp1937Ter)	ARID1B	W1937*, W1977*, W1227*, W1924*	not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000280651	6	157528086	6	157206952	280651	264288	rs886041819	NC_000006.12:157206951:G:A
NM_017519.2(ARID1B):c.6590_6612del (p.Glu2197fs)	ARID1B	E2197fs, E1500fs, E2250fs, E2210fs	not provided	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000280636	6	157528903 - 157528925	6	157207769 - 157207791	280636	264210	rs886041804	NC_000006.12:157207768:GAAAACCGCTCGGAATTCCTTTTG:G
NM_017519.2(ARID1B):c.5508dup (p.Ser1838fs)	ARID1B		not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000280569	6	157527816 - 157527817	6	157206682 - 157206683	280569	264206	rs35441529	NC_000006.12:157206682:CCCCCC:CCCCCCC
NM_017519.2(ARID1B):c.1245del (p.Thr416fs)	ARID1B	T416fs	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000280516	6	157100307	6	156779173	280516	264282	rs886041707	NC_000006.12:156779172:CC:C
NM_017519.2(ARID1B):c.6081_6091delinsGACTTG (p.Tyr2027_Ile2031delinsTer)	ARID1B		not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280464	6	157528395 - 157528405	6	157207261 - 157207271	280464	264291	rs886041665	NC_000006.12:157207260:CACGGAAAGCA:GACTTG
NM_017519.2(ARID1B):c.4113del (p.Lys1372fs)	ARID1B	K1425fs, K675fs, K1372fs, K1385fs	not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000280421	6	157521879	6	157200745	280421	264287	rs886041632	NC_000006.12:157200744:CC:C
NM_020732.3(ARID1B):c.3361A>T (p.Lys1121Ter)	ARID1B	K1121*, K1161*, K1108*, K411*	not provided	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000280411	6	157505380	6	157184246	280411	264203	rs886041623	NC_000006.12:157184245:A:T
NM_017519.2(ARID1B):c.3481_3482del (p.Lys1161fs)	ARID1B	K1174fs, K464fs, K1161fs, K1214fs	not provided	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000280257	6	157505536 - 157505537	6	157184402 - 157184403	280257	264252	rs886041493	NC_000006.12:157184401:AAAAA:AAA
NM_001363725.2(ARID1B):c.-90_-89delinsT	ARID1B		not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000280225	6	157405958 - 157405959	6	157084824 - 157084825	280225	264284	rs886041470	NC_000006.12:157084823:GG:T
NM_017519.2(ARID1B):c.4283dup (p.His1428fs)	ARID1B		not provided	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000280216	6	157522049 - 157522050	6	157200915 - 157200916	280216	264278	rs886041463	NC_000006.12:157200915:A:AA
NM_020732.3(ARID1B):c.3550+1G>A	ARID1B		not provided	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000265651	6	157505570	6	157184436	265651	259839	rs886039699	NC_000006.12:157184435:G:A
NM_020732.3(ARID1B):c.3025+1G>A	ARID1B		not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000265627	6	157488320	6	157167186	265627	259837	rs886039679	NC_000006.12:157167185:G:A
NM_020732.3(ARID1B):c.3263C>G (p.Ser1088Ter)	ARID1B	S1088*, S1128*, S378*, S1075*	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000265624	6	157502230	6	157181096	265624	259838	rs886039676	NC_000006.12:157181095:C:G
NM_001374828.1(ARID1B):c.1963G>T (p.Gly655Ter)	ARID1B	G655*	not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000848230	6	157150532	6	156829398	848230	831725		NC_000006.12:156829397:G:T
NM_001374828.1(ARID1B):c.3946C>T (p.Gln1316Ter)	ARID1B	Q1276*, Q1263*, Q1316*, Q483*	not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000845891	6	157510802	6	157189668	845891	831726		NC_000006.12:157189667:C:T
t(1;6)(p31;q25)dn	ARID1B		not provided	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000524176	1	73895566 - 73895579			524176	514824		
NM_020732.3(ARID1B):c.5338C>T (p.Gln1780Ter)	ARID1B	Q1780*, Q1820*, Q1767*, Q1070*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280708	6	157527613	6	157206479	280708	264204	rs750447037	NC_000006.12:157206478:C:T
NM_017519.2(ARID1B):c.2267_2269delinsTCCGCAGCCACTCC (p.Pro756fs)	ARID1B		Intellectual disability, moderate|Blepharophimosis|Long eyelashes|Absent speech|Thin upper lip vermilion|Thick lower lip vermilion	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000242865	6	157431630 - 157431632	6	157110496 - 157110498	242865	243967	rs879253856	NC_000006.12:157110495:CCG:TCCGCAGCCACTCC
NM_017519.2(ARID1B):c.3169_3170del (p.Lys1057fs)	ARID1B	K1070fs, K1110fs, K1057fs, K360fs	Intellectual disability, moderate|Blepharophimosis|Long eyelashes|Absent speech|Thin upper lip vermilion|Thick lower lip vermilion	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000242864	6	157502174 - 157502175	6	157181040 - 157181041	242864	243968	rs879253745	NC_000006.12:157181039:AAA:A
NM_020732.3(ARID1B):c.2692C>T (p.Arg898Ter)	ARID1B	R898*, R885*, R135*	not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199160	6	157469898	6	157148764	199160	196319	rs794727977	NC_000006.12:157148763:C:T
GRCh38/hg38 6q25.3(chr6:156965417-157093452)x1	ARID1B		See cases	Pathogenic(Last reviewed: Jun 11, 2012)	no assertion criteria provided	VCV000149690	6	157286551 - 157414586	6	156965417 - 157093452	149690	159441		
NM_020732.3(ARID1B):c.4377del (p.Pro1460fs)	ARID1B	P1500fs, P1447fs, P1460fs, P750fs	Coffin Siris/Intellectual Disability	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	VCV000126332	6	157522102	6	157200968	126332	131864	rs587779746	NC_000006.12:157200967:GGGG:GGG
NM_020732.3(ARID1B):c.4102C>T (p.Gln1368Ter)	ARID1B	Q1368*, Q1408*, Q1355*, Q658*	Coffin Siris/Intellectual Disability	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	VCV000126331	6	157520033	6	157198899	126331	131863	rs587779745	NC_000006.12:157198898:C:T
NM_000195.5(HPS1):c.972dup (p.Met325fs)	HPS1		not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005278	10	100186986 - 100186987	10	98427229 - 98427230	5278	20317	rs281865082	NC_000010.11:98427229:GGGGGGGG:GGGGGGGGG
NM_001374828.1(ARID1B):c.2107C>T (p.Gln703Ter)	ARID1B	Q716*, Q703*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828172	6	157222630	6	156901496	828172	816458		NC_000006.12:156901495:C:T
NM_001374828.1(ARID1B):c.1870C>T (p.Gln624Ter)	ARID1B	Q624*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000807540	6	157150439	6	156829305	807540	798571		NC_000006.12:156829304:C:T
NM_001374820.1(ARID1B):c.6776del (p.Gln2259fs)	ARID1B	Q2246fs, Q2259fs, Q1466fs, Q2299fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802287	6	157528802	6	157207668	802287	790605		NC_000006.12:157207667:A:
NM_001374820.1(ARID1B):c.4179C>A (p.Tyr1393Ter)	ARID1B	Y1433*, Y1380*, Y1393*, Y600*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802286	6	157517366	6	157196232	802286	790604		NC_000006.12:157196231:C:A
NM_001374820.1(ARID1B):c.4143del (p.Gly1382fs)	ARID1B	G589fs, G1382fs, G1369fs, G1422fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802285	6	157517329	6	157196195	802285	790603		NC_000006.12:157196194:AA:A
NM_001374820.1(ARID1B):c.1451dup (p.Phe485fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802284	6	157100259 - 157100260	6	156779125 - 156779126	802284	790602		NC_000006.12:156779125:GGGGGG:GGGGGGG
NM_020732.3(ARID1B):c.850C>T (p.Gln284Ter)	ARID1B	Q284*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000635838	6	157099913	6	156778779	635838	623652		NC_000006.12:156778778:C:T
NM_017519.2(ARID1B):c.3593dup (p.Pro1199fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic	no assertion criteria provided	VCV000524204	6	157510855 - 157510856	6	157189721 - 157189722	524204	514851	rs1554232959	NC_000006.12:157189721:AA:AAA
NM_017519.2(ARID1B):c.6215_6242dup (p.Asn2082_Val2083insProLeuTer)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000488470	6	157528527 - 157528528	6	157207393 - 157207394	488470	481338	rs1554237992	NC_000006.12:157207393:ACCCTCTGTAAACTCAGTATCCAGGACAA:ACCCTCTGTAAACTCAGTATCCAGGACAACCCTCTGTAAACTCAGTATCCAGGACAA
NM_017519.2(ARID1B):c.1735C>T (p.Gln579Ter)	ARID1B	Q579*	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000397537	6	157150553	6	156829419	397537	384434	rs1060499668	NC_000006.12:156829418:C:T
NM_017519.2(ARID1B):c.3650+1G>C	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Feb 13, 2015)	no assertion criteria provided	VCV000374317	6	157510915	6	157189781	374317	361264	rs1057518691	NC_000006.12:157189780:G:C
NM_020732.3(ARID1B):c.1612C>T (p.Gln538Ter)	ARID1B	Q538*	Global developmental delay||Hypertrichosis|Neonatal hypotonia|Nail dysplasia	Pathogenic(Last reviewed: Jan 25, 2014)	criteria provided, single submitter	VCV000374179	6	157150430	6	156829296	374179	360874	rs1057518951	NC_000006.12:156829295:C:T
NM_017519.2(ARID1B):c.5664dup (p.Lys1889Ter)	ARID1B		not provided	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280727	6	157527977 - 157527978	6	157206843 - 157206844	280727	264208	rs886041878	NC_000006.12:157206843:T:TT
NM_017519.2(ARID1B):c.6216_6217del (p.Leu2073_Cys2074insTer)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Oct 7, 2016)	no assertion criteria provided	VCV000267263	6	157528529 - 157528530	6	157207395 - 157207396	267263	262265	rs886040958	NC_000006.12:157207394:CCC:C
NM_001363725.2(ARID1B):c.-48C>T	ARID1B	Q748*, Q735*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224158	6	157406000	6	157084866	224158	225886	rs869312712	NC_000006.12:157084865:C:T
NM_017519.2(ARID1B):c.6061C>T (p.Gln2021Ter)	ARID1B	Q2034*, Q2021*, Q2074*, Q1324*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000224135	6	157528375	6	157207241	224135	225865	rs869312697	NC_000006.12:157207240:C:T
NM_016203.4(PRKAG2):c.1050_1051insTTA (p.Glu351_Leu352insLeu)	PRKAG2		Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	VCV000006848	7	151269750 - 151269751	7	151572664 - 151572665	6848	21887	rs587776643	NC_000007.14:151572664::TAA
NM_001032221.6(STXBP1):c.247-1G>A	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000846660	9	130422308	9	127660029	846660	852160		NC_000009.12:127660028:G:A
NM_003165.4(STXBP1):c.1652G>A (p.Arg551His)	STXBP1	R551H	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000566474	9	130444789	9	127682510	566474	562736	rs796053374	NC_000009.12:127682509:G:A
NM_003165.4(STXBP1):c.170-2A>G	STXBP1		Early infantile epileptic encephalopathy 4|not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488800	9	130420652	9	127658373	488800	481837	rs1554776674	NC_000009.12:127658372:A:G
NM_003165.4(STXBP1):c.326-1G>T	STXBP1		Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461293	9	130423380	9	127661101	461293	458771	rs1554776948	NC_000009.12:127661100:G:T
NM_175863.2:c.4699dup	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Aug 21, 2019)	no assertion criteria provided	VCV000827811					827811	816018		
NM_020732.3(ARID1B):c.5737C>T (p.His1913Tyr)	ARID1B	H1203Y, H1900Y, H1913Y, H1953Y, H1996Y	Coffin-Siris syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694713	6	157528012	6	157206878	694713	682805		NC_000006.12:157206877:C:T
NM_020732.3(ARID1B):c.3586dup (p.Gln1196fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694703	6	157510805 - 157510806	6	157189671 - 157189672	694703	682804		NC_000006.12:157189671:CCCCCC:CCCCCCC
NM_020732.3(ARID1B):c.3135G>A (p.Lys1045=)	ARID1B		Coffin-Siris syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694701	6	157495251	6	157174117	694701	682803		NC_000006.12:157174116:G:A
NM_020732.3(ARID1B):c.2190del (p.Ser730fs)	ARID1B	S717fs, S730fs, S813fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000691270	6	157405948	6	157084814	691270	678939		NC_000006.12:157084813:C:
NM_017519.2(ARID1B):c.2981_2986+7del	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689742	6	157488312 - 157488324	6	157167178 - 157167190	689742	677422		NC_000006.12:157167177:CTCGGCAGGTAACCT:CT
NM_017519.2(ARID1B):c.3529C>T (p.Gln1177Ter)	ARID1B	Q1190*, Q1230*, Q1177*, Q1273*, Q480*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689741	6	157510793	6	157189659	689741	677423		NC_000006.12:157189658:C:T
NM_001374828.1(ARID1B):c.2677dup (p.Gln893fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000666554	6	157454255 - 157454256	6	157133121 - 157133122	666554	654127		NC_000006.12:157133121:CC:CCC
NM_001374820.1(ARID1B):c.1508del (p.Asn503fs)	ARID1B	N420fs, N503fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000635839	6	157100321	6	156779187	635839	623653		NC_000006.12:156779186:AA:A
GRCh37/hg19 6q25.3(chr6:157133792-157495187)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625786	6	157133792 - 157495187			625786	614090		
NM_020732.3(ARID1B):c.2077G>T (p.Glu693Ter)	ARID1B	E680*, E693*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000620011	6	157405835	6	157084701	620011	611392	rs1554294593	NC_000006.12:157084700:G:T
NM_020732.3(ARID1B):c.4140C>G (p.Tyr1380Ter)	ARID1B	Y1380*, Y1420*, Y1367*, Y670*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000585304	6	157521868	6	157200734	585304	576349	rs377021700	NC_000006.12:157200733:C:G
NM_020732.3(ARID1B):c.3345+2T>G	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 28, 2017)	no assertion criteria provided	VCV000438281	6	157502314	6	157181180	438281	431912	rs1404726383	NC_000006.12:157181179:T:G
NM_017519.2(ARID1B):c.1802dup (p.Tyr601Ter)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000438280	6	157222573 - 157222574	6	156901439 - 156901440	438280	431909	rs1554265275	NC_000006.12:156901439:A:AA
NM_001363725.2(ARID1B):c.-32dup	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 22, 2016)	no assertion criteria provided	VCV000438279	6	157406013 - 157406014	6	157084879 - 157084880	438279	431911	rs1554294698	NC_000006.12:157084879:CCC:CCCC
NM_020732.3(ARID1B):c.3898C>T (p.Gln1300Ter)	ARID1B	Q1300*, Q1340*, Q1287*, Q590*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000434386	6	157517334	6	157196200	434386	428571	rs1554234341	NC_000006.12:157196199:C:T
NM_020732.3(ARID1B):c.3450del (p.Phe1150fs)	ARID1B	F1137fs, F440fs, F1150fs, F1190fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000434385	6	157505467	6	157184333	434385	428570	rs1554231845	NC_000006.12:157184332:TTT:TT
NM_020732.3(ARID1B):c.3430C>T (p.Gln1144Ter)	ARID1B	Q1144*, Q1184*, Q1131*, Q434*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000434384	6	157505449	6	157184315	434384	428569	rs1554231836	NC_000006.12:157184314:C:T
NM_020732.3(ARID1B):c.2465dup (p.Gln823fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	VCV000434380	6	157454250 - 157454251	6	157133116 - 157133117	434380	428563	rs1554301230	NC_000006.12:157133116:GGGGG:GGGGGG
NM_020732.3(ARID1B):c.1899dup (p.Ser634fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000434379	6	157222631 - 157222632	6	156901497 - 156901498	434379	428560	rs1554265319	NC_000006.12:156901497:G:GG
NM_020732.3(ARID1B):c.1483C>T (p.Gln495Ter)	ARID1B	Q495*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000434378	6	157100546	6	156779412	434378	428558	rs1554248236	NC_000006.12:156779411:C:T
NM_017519.2(ARID1B):c.2902C>T (p.Gln968Ter)	ARID1B	Q981*, Q968*, Q218*	Intellectual disability, moderate|Absent speech|Thick lower lip vermilion|Blepharophimosis|Long eyelashes|Thin upper lip vermilion	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000242867	6	157488235	6	157167101	242867	243971	rs879253747	NC_000006.12:157167100:C:T
NM_017519.2(ARID1B):c.4234dup (p.Tyr1412fs)	ARID1B		not provided|Intellectual disability, moderate|Blepharophimosis|Long eyelashes|Absent speech|Thin upper lip vermilion|Thick lower lip vermilion	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000242866	6	157522000 - 157522001	6	157200866 - 157200867	242866	243969	rs879253746	NC_000006.12:157200866:T:TT
NM_020732.3(ARID1B):c.5153del (p.Lys1718fs)	ARID1B	K1718fs, K1008fs, K1705fs, K1758fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 11, 2014)	criteria provided, single submitter	VCV000210300	6	157527427	6	157206293	210300	207382	rs797045281	NC_000006.12:157206292:AA:A
NM_020732.3(ARID1B):c.5151del (p.Lys1718fs)	ARID1B	K1718fs, K1008fs, K1705fs, K1758fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 11, 2014)	criteria provided, single submitter	VCV000210299	6	157527425	6	157206291	210299	207381	rs797045280	NC_000006.12:157206290:GG:G
NM_020732.3(ARID1B):c.5056dup (p.Tyr1686fs)	ARID1B		Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 19, 2014)	criteria provided, single submitter	VCV000210298	6	157527330 - 157527331	6	157206196 - 157206197	210298	207380	rs797045279	NC_000006.12:157206196:T:TT
NM_017519.2(ARID1B):c.4583_4592del (p.Gln1528fs)	ARID1B	Q1541fs, Q1581fs, Q831fs, Q1528fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000031217	6	157522347 - 157522356	6	157201213 - 157201222	31217	40174	rs876657382	NC_000006.12:157201212:ACCAGACGCCACC:ACC
NM_017519.2(ARID1B):c.5290A>T (p.Lys1764Ter)	ARID1B	K1777*, K1817*, K1764*, K1067*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000031215	6	157527604	6	157206470	31215	40172	rs387907143	NC_000006.12:157206469:A:T
NM_017519.2(ARID1B):c.5593del (p.Asp1865fs)	ARID1B	D1168fs, D1918fs, D1865fs, D1878fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000031214	6	157527907	6	157206773	31214	40171	rs876657381	NC_000006.12:157206772:G:
NM_017519.2(ARID1B):c.1864C>T (p.Gln622Ter)	ARID1B	Q635*, Q622*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000031213	6	157222636	6	156901502	31213	40170	rs387907142	NC_000006.12:156901501:C:T
NM_017519.2(ARID1B):c.3999T>A (p.Tyr1333Ter)	ARID1B	Y1346*, Y1386*, Y636*, Y1333*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031212	6	157519969	6	157198835	31212	40169	rs748363079	NC_000006.12:157198834:T:A
NM_017519.2(ARID1B):c.6424_6434del (p.Ser2142fs)	ARID1B	S2142fs, S1445fs, S2155fs, S2195fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031209	6	157528737 - 157528747	6	157207603 - 157207613	31209	40166	rs876657379	NC_000006.12:157207602:AAGCATTGGAAA:A
NM_017519.2(ARID1B):c.3880C>T (p.Gln1294Ter)	ARID1B	Q1307*, Q1347*, Q1294*, Q597*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031208	6	157517355	6	157196221	31208	40165	rs387907140	NC_000006.12:157196220:C:T
NM_017519.2(ARID1B):c.6661del (p.Leu2221fs)	ARID1B	L2221fs, L1524fs, L2274fs, L2234fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560954	6	157528975	6	157207841	560954	552103	rs1562355401	NC_000006.12:157207840:C:
NM_017519.2(ARID1B):c.4850del (p.Asp1617fs)	ARID1B	D1617fs, D1630fs, D1670fs, D920fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560953	6	157522617	6	157201483	560953	552102	rs1562347066	NC_000006.12:157201482:A:
NM_020732.3(ARID1B):c.4536G>A (p.Trp1512Ter)	ARID1B	W1512*, W1552*, W1499*, W802*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560952	6	157522264	6	157201130	560952	552101	rs1554235834	NC_000006.12:157201129:G:A
NM_020732.3(ARID1B):c.3737C>A (p.Ser1246Ter)	ARID1B	S1246*, S1286*, S536*, S1233*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560951	6	157511219	6	157190085	560951	552100	rs772973856	NC_000006.12:157190084:C:A
NM_017519.2(ARID1B):c.3509del (p.Pro1170fs)	ARID1B	P1183fs, P473fs, P1170fs, P1223fs	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560950	6	157505566	6	157184432	560950	552099	rs1562331655	NC_000006.12:157184431:CC:C
NM_020732.3(ARID1B):c.3228C>G (p.Tyr1076Ter)	ARID1B	Y1076*, Y1116*, Y366*, Y1063*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560949	6	157502195	6	157181061	560949	552098	rs1562328526	NC_000006.12:157181060:C:G
NM_020732.3(ARID1B):c.1828C>T (p.Gln610Ter)	ARID1B	Q597*, Q610*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560948	6	157222561	6	156901427	560948	552097	rs1554265271	NC_000006.12:156901426:C:T
NM_020732.3(ARID1B):c.5830C>T (p.Arg1944Ter)	ARID1B	R1944*, R1984*, R1931*, R1234*	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431136	6	157528105	6	157206971	431136	424649	rs1028186690	NC_000006.12:157206970:C:T
NM_000083.3(CLCN1):c.898_899delinsTA (p.Arg300Ter)	CLCN1		not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447074	7	143027909 - 143027910	7	143330816 - 143330817	447074	441044	rs1554436419	NC_000007.14:143330815:CG:TA
NM_000083.3(CLCN1):c.2635C>T (p.Gln879Ter)	CLCN1	Q879*	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Myotonia	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374131	7	143048726	7	143351633	374131	360888	rs1057518917	NC_000007.14:143351632:C:T
NM_000083.3(CLCN1):c.929C>T (p.Thr310Met)	CLCN1	T310M	not provided|Myotonia congenita	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000021051	7	143027940	7	143330847	21051	33903	rs80356691	NC_000007.14:143330846:C:T
NM_000083.3(CLCN1):c.871G>A (p.Glu291Lys)	CLCN1	E291K	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000017541	7	143027882	7	143330789	17541	32580	rs121912805	NC_000007.14:143330788:G:A
NM_020732.3(ARID1B):c.2248C>T (p.Arg750Ter)	ARID1B	R750*, R737*	not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210277	6	157406006	6	157084872	210277	207365	rs797045272	NC_000006.12:157084871:C:T
NM_020732.3(ARID1B):c.2149C>T (p.Gln717Ter)	ARID1B	Q717*, Q704*	not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210275	6	157405907	6	157084773	210275	207363	rs753933273	NC_000006.12:157084772:C:T
NM_017519.2(ARID1B):c.3284_3285del (p.Lys1095fs)	ARID1B	K398fs, K1108fs, K1095fs, K1148fs	Coffin-Siris syndrome 1	Pathogenic	criteria provided, single submitter	VCV000031211	6	157502289 - 157502290	6	157181155 - 157181156	31211	40168	rs876657380	NC_000006.12:157181154:AAA:A
NC_000009.12:g.(?_127612384)_(127690877_?)del	STXBP1		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831100	9	130374663 - 130453156			831100	820051		
NM_000048.4(ASL):c.1153C>T (p.Arg385Cys)	ASL	R385C, R359C, R365C	Argininosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002401	7	65557553	7	66092566	2401	17440	rs28940286	NC_000007.14:66092565:C:T
NM_017519.2(ARID1B):c.5351_5354TGTT[1] (p.Phe1785fs)	ARID1B		not provided|Coffin-Siris syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434390	6	157527665 - 157527668	6	157206531 - 157206534	434390	428577	rs1554237269	NC_000006.12:157206530:TGTTTGTT:TGTT
NC_000011.9:g.(?_111959581)_(111965704_?)del	SDHD		Paragangliomas 1|Pheochromocytoma|Cowden syndrome 3|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000583435	11	111959581 - 111965704	11	112088857 - 112094980	583435	566722		
NM_003002.4(SDHD):c.314+1G>T	SDHD		Hereditary cancer-predisposing syndrome|Pheochromocytoma|Paragangliomas 1|Carney-Stratakis syndrome|Cowden syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480808	11	111959736	11	112089012	480808	476431	rs1555187083	NC_000011.10:112089011:G:T
NM_003002.4(SDHD):c.147dup (p.His50fs)	SDHD		Pheochromocytoma|Paragangliomas 1|Carney-Stratakis syndrome|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231390	11	111958674 - 111958675	11	112087950 - 112087951	231390	234436	rs876659130	NC_000011.10:112087950:A:AA
NM_003002.4(SDHD):c.106C>T (p.Gln36Ter)	SDHD	Q36*	Paragangliomas 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000006892	11	111958634	11	112087910	6892	21931	rs104894303	NC_000011.10:112087909:C:T
NM_000441.2(SLC26A4):c.301C>T (p.Gln101Ter)	SLC26A4	Q101*	not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000620294	7	107303877	7	107663432	620294	611670	rs1562818685	NC_000007.14:107663431:C:T
NM_000441.2(SLC26A4):c.317C>T (p.Ala106Val)	SLC26A4	A106V	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560910	7	107312595	7	107672150	560910	552005	rs1562822565	NC_000007.14:107672149:C:T
NM_000441.2(SLC26A4):c.1264-3C>G	SLC26A4		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560908	7	107334845	7	107694400	560908	552006	rs1562835391	NC_000007.14:107694399:C:G
NM_000441.2(SLC26A4):c.2206C>T (p.Gln736Ter)	SLC26A4	Q736*	not provided	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000391651	7	107350615	7	107710170	391651	369126	rs1057524176	NC_000007.14:107710169:C:T
NM_000441.2(SLC26A4):c.382_384delinsAA (p.Phe128fs)	SLC26A4		not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000291238	7	107312660 - 107312662	7	107672215 - 107672217	291238	275475	rs886044696	NC_000007.14:107672214:TTT:AA
NM_000441.2(SLC26A4):c.1222del (p.Ser408fs)	SLC26A4	S408fs	not provided	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000285262	7	107330639	7	107690194	285262	269499	rs886043058	NC_000007.14:107690193:TTT:TT
NM_000441.2(SLC26A4):c.1164dup (p.Gly389fs)	SLC26A4		Autosomal recessive non-syndromic sensorineural deafness type DFNB	Pathogenic(Last reviewed: Oct 18, 2016)	no assertion criteria provided	VCV000267322	7	107330580 - 107330581	7	107690135 - 107690136	267322	262397	rs1554358720	NC_000007.14:107690135:TTT:TTTT
NM_000441.2(SLC26A4):c.1711G>T (p.Gly571Ter)	SLC26A4	G571*	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000838987	7	107341549	7	107701104	838987	832779		NC_000007.14:107701103:G:T
NC_000007.14:g.(?_107694391)_(107696049_?)del	SLC26A4		not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000831999	7	107334836 - 107336494			831999	819778		
NC_000007.14:g.(?_107660756)_(107661815_?)del	SLC26A4		not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000830830	7	107301201 - 107302260			830830	819775		
NC_000007.13:g.(?_107344766)_(107344840_?)del	SLC26A4		not provided	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000644815	7	107344766 - 107344840	7	107704321 - 107704395	644815	651555		
NM_000441.2(SLC26A4):c.1692del (p.Lys564fs)	SLC26A4	K564fs	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000642031	7	107340600	7	107700155	642031	635446		NC_000007.14:107700154:AAAAAA:AAAAA
NM_000441.2(SLC26A4):c.2188C>T (p.Gln730Ter)	SLC26A4	Q730*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 6, 2010)	criteria provided, single submitter	VCV000043542	7	107350597	7	107710152	43542	52711	rs397516428	NC_000007.14:107710151:C:T
NM_000441.2(SLC26A4):c.1149+3A>G	SLC26A4		Rare genetic deafness	Pathogenic(Last reviewed: Nov 11, 2008)	no assertion criteria provided	VCV000043493	7	107329648	7	107689203	43493	52663	rs111033314	NC_000007.14:107689202:A:G
NM_000441.2(SLC26A4):c.1318A>T (p.Lys440Ter)	SLC26A4	K440*	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627478	7	107334902	7	107694457	627478	615798	rs1562835480	NC_000007.14:107694456:A:T
NM_000441.2(SLC26A4):c.589G>T (p.Gly197Ter)	SLC26A4	G197*	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627477	7	107314782	7	107674337	627477	615797	rs111033380	NC_000007.14:107674336:G:T
NM_000441.2(SLC26A4):c.1340del (p.Lys447fs)	SLC26A4	K447fs	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627473	7	107334923	7	107694478	627473	615800	rs1562835515	NC_000007.14:107694477:AA:A
NM_000441.2(SLC26A4):c.1339A>T (p.Lys447Ter)	SLC26A4	K447*	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627472	7	107334923	7	107694478	627472	615799	rs1284633493	NC_000007.14:107694477:A:T
NM_000441.2(SLC26A4):c.1149+1del	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402275	7	107329645	7	107689200	402275	389226	rs1060499807	NC_000007.14:107689199:GG:G
NM_000441.2(SLC26A4):c.1614+1G>C	SLC26A4		Rare genetic deafness	Pathogenic(Last reviewed: Sep 9, 2013)	criteria provided, single submitter	VCV000179170	7	107338557	7	107698112	179170	174164	rs111033312	NC_000007.14:107698111:G:C
NM_000441.2(SLC26A4):c.1554G>A (p.Trp518Ter)	SLC26A4	W518*	Rare genetic deafness	Pathogenic(Last reviewed: Sep 9, 2013)	criteria provided, single submitter	VCV000165257	7	107338496	7	107698051	165257	174163	rs727503428	NC_000007.14:107698050:G:A
NM_000441.2(SLC26A4):c.997dup (p.Arg333fs)	SLC26A4		Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic	no assertion criteria provided	VCV000097015	7	107323976 - 107323977	7	107683531 - 107683532	97015	102920	rs431905486	NC_000007.14:107683531:AA:AAA
NM_000441.1(SLC26A4):c.1342-2_1343dup	SLC26A4		Rare genetic deafness	Pathogenic(Last reviewed: Apr 27, 2012)	criteria provided, single submitter	VCV000043506	7	107335064 - 107335067	7	107694617 - 107694618	43506	52676	rs111033407	NC_000007.14:107694617:CAGTC:CAGTCAGTC
NM_005609.4(PYGM):c.808C>T (p.Arg270Ter)	PYGM	R270*, R182*	Glycogen storage disease, type V|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188824	11	64522792	11	64755320	188824	186830	rs767739769	NC_000011.10:64755319:G:A
NM_000501.4(ELN):c.1324C>T (p.Gln442Ter)	ELN	Q442*, Q372*, Q380*, Q437*, Q447*, Q432*, Q428*	not provided|Supravalvar aortic stenosis	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016722	7	73471010	7	74056680	16722	31761	rs137854452	NC_000007.14:74056679:C:T
NM_000441.2(SLC26A4):c.2108T>C (p.Leu703Pro)	SLC26A4	L703P	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000691518	7	107350517	7	107710072	691518	679204		NC_000007.14:107710071:T:C
NM_000441.2(SLC26A4):c.641A>G (p.Tyr214Cys)	SLC26A4	Y214C	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000691509	7	107315430	7	107674985	691509	679195		NC_000007.14:107674984:A:G
NM_000441.2(SLC26A4):c.2044G>T (p.Glu682Ter)	SLC26A4	E682*	Pendred syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000558657	7	107344785	7	107704340	558657	544080	rs1554361584	NC_000007.14:107704339:G:T
NM_000441.2(SLC26A4):c.2106_2110dup (p.Glu704fs)	SLC26A4		Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446458	7	107350514 - 107350515	7	107710069 - 107710070	446458	439910	rs1554362735	NC_000007.14:107710069:GCTGG:GCTGGGCTGG
NM_000441.2(SLC26A4):c.765+2T>C	SLC26A4		Rare genetic deafness|not specified	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000043567	7	107315556	7	107675111	43567	52736	rs397516432	NC_000007.14:107675110:T:C
SLC26A4, IVS8, C-G, 1002-4	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000004833					4833	19872		
NM_000441.2(SLC26A4):c.2182_2183insG (p.Tyr728Ter)	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000004832	7	107350591 - 107350592	7	107710146 - 107710147	4832	19871		NC_000007.14:107710146::G
SLC26A4, 1-BP DEL, 1197T	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000004831					4831	19870		
NM_000441.2(SLC26A4):c.415+7A>G	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000004828	7	107312700	7	107672255	4828	19867		NC_000007.14:107672254:A:G
SLC26A4, 5-BP INS, NT2111	SLC26A4		Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000004824					4824	19863		
NM_000441.2(SLC26A4):c.917del (p.Val306fs)	SLC26A4	V306fs	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000004815	7	107323798	7	107683353	4815	19854		NC_000007.14:107683352:T:
SLC26A4, 1-BP DEL, 1421T	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000004814					4814	19853		
SLC26A4, 1-BP DEL, 1565G	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000004813					4813	19852		
NM_000441.2(SLC26A4):c.2000T>G (p.Phe667Cys)	SLC26A4	F667C	Pendred syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000004812	7	107342468	7	107702023	4812	19851	rs121908360	NC_000007.14:107702022:T:G
NM_001005463.3(EBF3):c.626G>A (p.Arg209Gln)	EBF3	R209Q	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430930	10	131676042	10	129877778	430930	424470	rs1131692261	NC_000010.11:129877777:C:T
NM_016203.4(PRKAG2):c.1463A>T (p.Asn488Ile)	PRKAG2	N488I, N247I, N363I, N364I, N444I	Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006850	7	151261285	7	151564199	6850	21889	rs121908989	NC_000007.14:151564198:T:A
NM_000441.2(SLC26A4):c.1692dup (p.Cys565fs)	SLC26A4		Enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV000627475	7	107340599 - 107340600	7	107700154 - 107700155	627475	615802	rs746427774	NC_000007.14:107700154:AAAAAA:AAAAAAA
NM_000441.2(SLC26A4):c.1147del (p.Gln383fs)	SLC26A4	Q383fs	Pendred syndrome	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000553520	7	107329642	7	107689197	553520	544034	rs1374999656	NC_000007.14:107689196:CC:C
NM_000441.2(SLC26A4):c.2074T>C (p.Phe692Leu)	SLC26A4	F692L	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446462	7	107344815	7	107704370	446462	439909	rs1399914687	NC_000007.14:107704369:T:C
NM_000441.2(SLC26A4):c.2319+1G>A	SLC26A4		Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371164	7	107353068	7	107712623	371164	357554	rs542079779	NC_000007.14:107712622:G:A
NM_000441.2(SLC26A4):c.2224del (p.Ile742fs)	SLC26A4	I742fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228397	7	107350633	7	107710188	228397	229546	rs876657723	NC_000007.14:107710187:A:
NM_000441.2(SLC26A4):c.1540C>A (p.Gln514Lys)	SLC26A4	Q514K	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: May 29, 2014)	no assertion criteria provided	VCV000004841	7	107336480	7	107696035	4841	19880	rs121908366	NC_000007.14:107696034:C:A
NM_003165.4(STXBP1):c.1702+1G>A	STXBP1		Early infantile epileptic encephalopathy|not provided|STXBP1-associated neurodevelopmental disorder	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207444	9	130444840	9	127682561	207444	202332	rs796053377	NC_000009.12:127682560:G:A
NM_003165.4(STXBP1):c.847G>A (p.Glu283Lys)	STXBP1	E283K	Early infantile epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000127076	9	130430411	9	127668132	127076	132587	rs587777310	NC_000009.12:127668131:G:A
NM_018368.4(LMBRD1):c.1056del (p.Asn353fs)	LMBRD1	N280fs, N353fs	Inborn genetic diseases|not provided|	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225048	6	70411362	6	69701470	225048	226902	rs749272546	NC_000006.12:69701469:C:
NM_000441.2(SLC26A4):c.2174_2177dup (p.Leu727fs)	SLC26A4		not provided	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000851431	7	107350582 - 107350583	7	107710137 - 107710138	851431	832780		NC_000007.14:107710137:CTAT:CTATCTAT
NM_000441.2(SLC26A4):c.1746del (p.Ala584fs)	SLC26A4	A584fs	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic	criteria provided, single submitter	VCV000627476	7	107341584	7	107701139	627476	615803	rs1241745103	NC_000007.14:107701138:G:
NM_000441.2(SLC26A4):c.1415G>A (p.Trp472Ter)	SLC26A4	W472*	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553228	7	107335139	7	107694694	553228	544045	rs1554359693	NC_000007.14:107694693:G:A
NM_000441.2(SLC26A4):c.349del (p.Leu117fs)	SLC26A4	L117fs	Pendred syndrome	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000551863	7	107312627	7	107672182	551863	544366	rs1275009555	NC_000007.14:107672181:C:
NM_000441.2(SLC26A4):c.946G>T (p.Gly316Ter)	SLC26A4	G316*	not provided	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503714	7	107323927	7	107683482	503714	495544	rs1554357231	NC_000007.14:107683481:G:T
NM_000441.2(SLC26A4):c.2007C>A (p.Asp669Glu)	SLC26A4	D669E	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446461	7	107342475	7	107702030	446461	439908	rs749013429	NC_000007.14:107702029:C:A
NM_000441.2(SLC26A4):c.296C>G (p.Thr99Arg)	SLC26A4	T99R	Enlarged vestibular aqueduct	Pathogenic, Affects(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000417623	7	107303872	7	107663427	417623	404601	rs141142414	NC_000007.14:107663426:C:G
NM_000441.2(SLC26A4):c.281C>T (p.Thr94Ile)	SLC26A4	T94I	Pendred syndrome|Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000371034	7	107303857	7	107663412	371034	357529	rs1057516953	NC_000007.14:107663411:C:T
NM_000441.2(SLC26A4):c.600+2T>A	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000370937	7	107314795	7	107674350	370937	357531	rs1057516881	NC_000007.14:107674349:T:A
NM_000441.2(SLC26A4):c.1544+1G>A	SLC26A4		Rare genetic deafness|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228395	7	107336485	7	107696040	228395	229537	rs876657722	NC_000007.14:107696039:G:A
NM_000441.2(SLC26A4):c.294_298del (p.Thr99fs)	SLC26A4	T99fs	Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Nov 8, 2015)	criteria provided, single submitter	VCV000043551	7	107303868 - 107303872	7	107663423 - 107663427	43551	52720	rs111033241	NC_000007.14:107663422:GCCACGC:GC
NM_000391.4(TPP1):c.1015C>T (p.Arg339Trp)	TPP1	R339W	not provided|Neuronal ceroid lipofuscinosis|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207586	11	6637606	11	6616375	207586	202570	rs750428882	NC_000011.10:6616374:G:A
NM_000391.4(TPP1):c.509-1G>A	TPP1		Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2|not provided	Pathogenic(Last reviewed: Sep 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207574	11	6638385	11	6617154	207574	202586	rs56144125	NC_000011.10:6617153:C:T
NM_000391.4(TPP1):c.1424C>T (p.Ser475Leu)	TPP1	S475L	Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068741	11	6636403	11	6615172	68741	79633	rs121908202	NC_000011.10:6615171:G:A
NM_000391.4(TPP1):c.1340G>A (p.Arg447His)	TPP1	R447H	Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002645	11	6636487	11	6615256	2645	17684	rs119455956	NC_000011.10:6615255:C:T
NM_020732.3(ARID1B):c.6382C>T (p.Arg2128Ter)	ARID1B	R2128*, R2168*, R2115*, R1418*	History of neurodevelopmental disorder|not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448984	6	157528657	6	157207523	448984	443928	rs1554238072	NC_000006.12:157207522:C:T
NM_004333.6(BRAF):c.739T>C (p.Phe247Leu)	BRAF	F247L	Noonan syndrome|Noonan syndrome and Noonan-related syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000180784	7	140501333	7	140801533	180784	179102	rs397516903	NC_000007.14:140801532:A:G
NM_004333.6(BRAF):c.730A>C (p.Thr244Pro)	BRAF	T244P, T156P, T192P, T210P, T247P	Cardio-facio-cutaneous syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040346	7	140501342	7	140801542	40346	48816	rs397507465	NC_000007.14:140801541:T:G
NM_004333.6(BRAF):c.1593G>C (p.Trp531Cys)	BRAF	W531C	Noonan syndrome 7|Noonan syndrome 1|Rasopathy	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000029808	7	140476813	7	140777013	29808	38763	rs606231228	NC_000007.14:140777012:C:G
NM_000441.2(SLC26A4):c.1171A>C (p.Ser391Arg)	SLC26A4	S391R	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000862716	7	107330590	7	107690145	862716	832778		NC_000007.14:107690144:A:C
NM_000441.2(SLC26A4):c.1458dup (p.Ile487fs)	SLC26A4		Pendred syndrome|Enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV000813397	7	107336397 - 107336398	7	107695952 - 107695953	813397	801644		NC_000007.14:107695952:T:TT
NM_000441.2(SLC26A4):c.737del (p.Asn246fs)	SLC26A4	N246fs	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558078	7	107315522	7	107675077	558078	544006	rs918684449	NC_000007.14:107675076:AAAAA:AAAA
NM_000441.2(SLC26A4):c.226C>T (p.Pro76Ser)	SLC26A4	P76S	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446451	7	107303802	7	107663357	446451	439900	rs1554352676	NC_000007.14:107663356:C:T
NM_000441.2(SLC26A4):c.2048T>C (p.Phe683Ser)	SLC26A4	F683S	Pendred syndrome|Enlarged vestibular aqueduct	Pathogenic, Affects(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000402277	7	107344789	7	107704344	402277	389229	rs1060499808	NC_000007.14:107704343:T:C
NM_000441.2(SLC26A4):c.1001+1G>T	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370123	7	107323983	7	107683538	370123	357536	rs80338849	NC_000007.14:107683537:G:T
NR_003051.3(RMRP):n.5C>T	RMRP		Anauxetic dysplasia|Metaphyseal chondrodysplasia, McKusick type	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552477	9	35658011	9	35658014	552477	544785	rs772443941	NC_000009.12:35658013:G:A
NR_003051.3(RMRP):n.243A>G	RMRP		Metaphyseal chondrodysplasia, McKusick type|Anauxetic dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487451	9	35657773	9	35657776	487451	480497	rs551450545	NC_000009.12:35657775:T:C
NM_000543.5(SMPD1):c.1092-1G>C	SMPD1		not provided|not specified|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093312	11	6414445	11	6393215	93312	99219	rs398123474	NC_000011.10:6393214:G:C
NM_000466.3(PEX1):c.2383C>T (p.Arg795Ter)	PEX1	R795*, R738*, R587*	Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188873	7	92131237	7	92501923	188873	186754	rs61750418	NC_000007.14:92501922:G:A
NM_000083.3(CLCN1):c.1488G>T (p.Arg496Ser)	CLCN1	R496S	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000017535	7	143036620	7	143339527	17535	32574	rs121912801	NC_000007.14:143339526:G:T
NM_000162.5(GCK):c.130G>A (p.Gly44Ser)	GCK	G44S, G43S, G45S	not provided	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000076898	7	44192978	7	44153379	76898	87789	rs267601516	NC_000007.14:44153378:C:T
NM_000162.5(GCK):c.661G>A (p.Glu221Lys)	GCK	E221K, E222K, E220K	not provided|Maturity-onset diabetes of the young, type 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036241	7	44189377	7	44149778	36241	44905	rs193922317	NC_000007.14:44149777:C:T
NM_000155.4(GALT):c.562C>T (p.Gln188Ter)	GALT	Q188*, Q79*	not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000594854	9	34648166	9	34648169	594854	585916	rs398123182	NC_000009.12:34648168:C:T
NM_000155.4(GALT):c.899G>A (p.Trp300Ter)	GALT	W300*, W191*	not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000420114	9	34649073	9	34649076	420114	407690	rs1064794295	NC_000009.12:34649075:G:A
NM_000155.4(GALT):c.513del (p.Phe171fs)	GALT	F62fs, F171fs	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000290279	9	34648115	9	34648118	290279	274516	rs886044409	NC_000009.12:34648117:TTT:TT
NM_000155.4(GALT):c.71_72insA (p.Phe24fs)	GALT		not provided	Pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000280965	9	34646772 - 34646773	9	34646775 - 34646776	280965	265202	rs886042061	NC_000009.12:34646775::A
NM_000155.4(GALT):c.118G>A (p.Glu40Lys)	GALT	E40K	not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000280964	9	34647121	9	34647124	280964	265201	rs886042060	NC_000009.12:34647123:G:A
NM_000155.4(GALT):c.905-1G>A	GALT		not provided	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000193560	9	34649406	9	34649409	193560	190723	rs794726971	NC_000009.12:34649408:G:A
NM_000155.4(GALT):c.82+2del	GALT		not provided	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000193055	9	34646785	9	34646788	193055	190220	rs794726876	NC_000009.12:34646787:T:
NM_000155.4(GALT):c.445dup (p.Ala149fs)	GALT		not provided	Pathogenic(Last reviewed: Feb 13, 2014)	criteria provided, single submitter	VCV000167128	9	34647893 - 34647894	9	34647896 - 34647897	167128	177740	rs786200978	NC_000009.12:34647896:GGG:GGGG
NM_000155.4(GALT):c.905-2A>G	GALT		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092524	9	34649405	9	34649408	92524	98433	rs398123187	NC_000009.12:34649407:A:G
NM_000155.3(GALT):c.565_578delGTATGGGCCAGCAG (p.Val189Phefs)	GALT		not provided	Pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	VCV000092519	9	34648328 - 34648341	9	34648331 - 34648344	92519	98428	rs398123183	NC_000009.12:34648330:CAGGTATGGGCCAGCAG:CAG
NM_152419.3(HGSNAT):c.234+1G>A	HGSNAT		Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030832	8	43002207	8	43147064	30832	39789	rs483352908	NC_000008.11:43147063:G:A
NM_003165.4(STXBP1):c.539G>A (p.Cys180Tyr)	STXBP1	C180Y	Early infantile epileptic encephalopathy 4|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000006727	9	130425593	9	127663314	6727	21766	rs121918318	NC_000009.12:127663313:G:A
NM_000155.4(GALT):c.134C>A (p.Ser45Ter)	GALT	S45*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802480	9	34647137	9	34647140	802480	790905		NC_000009.12:34647139:C:A
NM_000155.4(GALT):c.398_399dup (p.Trp134fs)	GALT	W134PfsX5	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038547	9	34647846 - 34647847	9	34647849 - 34647850	38547	47145	rs367543269	NC_000009.12:34647849:CCCC:CCCCCC
NM_000155.4(GALT):c.218_219CT[1] (p.Leu74fs)	GALT	L74fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038545	9	34647221 - 34647222	9	34647224 - 34647225	38545	47143	rs111033662	NC_000009.12:34647223:CTCT:CT
NM_000155.4(GALT):c.680T>C (p.Leu227Pro)	GALT	L227P, L118P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000037360	9	34648446	9	34648449	37360	45911	rs111033846	NC_000009.12:34648448:T:C
NM_000155.4(GALT):c.777G>A (p.Arg259=)	GALT	R259Q, G259D	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000037350	9	34648848	9	34648851	37350	45901	rs111033761	NC_000009.12:34648850:G:A
NM_000155.4(GALT):c.1108C>T (p.Gln370Ter)	GALT	Q370*, Q261*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025333	9	34650414	9	34650417	25333	36667	rs111033823	NC_000009.12:34650416:C:T
NM_000155.3(GALT):c.1078_1083delGCACTTins20 (p.?)	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025331	9	34650384 - 34650389	9	34650387 - 34650392	25331	36665		
NM_000155.4(GALT):c.1047del (p.Thr350fs)	GALT	L349fs, T241fs, T350fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025322	9	34649549	9	34649552	25322	36656	rs111033816	NC_000009.12:34649551:C:
NM_000155.4(GALT):c.1034C>A (p.Ala345Asp)	GALT	A345D, A236D	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025321	9	34649536	9	34649539	25321	36655	rs111033815	NC_000009.12:34649538:C:A
NM_000155.4(GALT):c.1018G>A (p.Glu340Lys)	GALT	E340K, E231K	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025317	9	34649520	9	34649523	25317	36651	rs111033806	NC_000009.12:34649522:G:A
NM_000155.4(GALT):c.998G>T (p.Arg333Leu)	GALT	R333L, R224L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025313	9	34649500	9	34649503	25313	36647	rs111033808	NC_000009.12:34649502:G:T
NM_000155.4(GALT):c.980T>C (p.Leu327Pro)	GALT	L327P, L218P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025308	9	34649482	9	34649485	25308	36642	rs111033832	NC_000009.12:34649484:T:C
NM_000155.4(GALT):c.976del (p.Leu326fs)	GALT	L326fs, L217fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025306	9	34649478	9	34649481	25306	36640	rs111033799	NC_000009.12:34649480:C:
NM_000155.4(GALT):c.968A>G (p.Tyr323Cys)	GALT	Y323C, Y214C	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025302	9	34649470	9	34649473	25302	36636	rs367543267	NC_000009.12:34649472:A:G
NM_000155.4(GALT):c.904+5G>A	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025287	9	34649083	9	34649086	25287	36621	rs367543264	NC_000009.12:34649085:G:A
NM_000155.4(GALT):c.872A>T (p.Glu291Val)	GALT	E291V, E182V	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025281	9	34649046	9	34649049	25281	36615	rs111033841	NC_000009.12:34649048:A:T
NM_000155.4(GALT):c.854A>G (p.Lys285Arg)	GALT	K285R, K176R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025277	9	34649028	9	34649031	25277	36611	rs367543263	NC_000009.12:34649030:A:G
NM_000155.4(GALT):c.836T>G (p.Met279Arg)	GALT	M279R, M170R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025275	9	34649010	9	34649013	25275	36609	rs111033779	NC_000009.12:34649012:T:G
L255AfsX12	GALT	L255AfsX12	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025258					25258	36592		
NM_000155.4(GALT):c.756G>T (p.Gln252His)	GALT	Q252H, Q143H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025256	9	34648827	9	34648830	25256	36590	rs111033769	NC_000009.12:34648829:G:T
NM_000155.4(GALT):c.719_728del (p.Leu240fs)	GALT	L240SfsX25, L131fs, L240fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025250	9	34648784 - 34648793	9	34648787 - 34648796	25250	36584	rs111033838	NC_000009.12:34648786:ACTGGTTAGTACTGGT:ACTGGT
NM_000155.4(GALT):c.635A>C (p.Gln212Pro)	GALT	Q212P, Q103P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025235	9	34648401	9	34648404	25235	36569	rs111033833	NC_000009.12:34648403:A:C
NM_000155.4(GALT):c.550C>G (p.His184Asp)	GALT	H184D, H75D	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025209	9	34648154	9	34648157	25209	36543	rs111033716	NC_000009.12:34648156:C:G
NM_000155.4(GALT):c.542C>T (p.Ser181Phe)	GALT	S181F, S72F	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025208	9	34648146	9	34648149	25208	36542	rs367543259	NC_000009.12:34648148:C:T
NM_000155.4(GALT):c.509T>C (p.Ile170Thr)	GALT	I170T, I61T	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025199	9	34648113	9	34648116	25199	36533	rs111033839	NC_000009.12:34648115:T:C
NM_000155.4(GALT):c.505C>A (p.Gln169Lys)	GALT	Q169K, Q60K	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025190	9	34647956	9	34647959	25190	36524	rs111033709	NC_000009.12:34647958:C:A
NM_000155.4(GALT):c.490C>T (p.Gln164Ter)	GALT	Q164*, Q55*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025185	9	34647941	9	34647944	25185	36519	rs111033705	NC_000009.12:34647943:C:T
NM_000155.4(GALT):c.482T>C (p.Leu161Pro)	GALT	L161P, L52P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025184	9	34647933	9	34647936	25184	36518	rs111033700	NC_000009.12:34647935:T:C
NM_000155.4(GALT):c.462G>A (p.Trp154Ter)	GALT	W154*, W45*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025183	9	34647913	9	34647916	25183	36517	rs111033704	NC_000009.12:34647915:G:A
NM_000155.4(GALT):c.460T>C (p.Trp154Arg)	GALT	W154R, W45R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025182	9	34647911	9	34647914	25182	36516	rs111033702	NC_000009.12:34647913:T:C
NM_000155.4(GALT):c.392T>G (p.Phe131Cys)	GALT	F131C, F22C	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025169	9	34647843	9	34647846	25169	36503	rs111033684	NC_000009.12:34647845:T:G
NM_000155.4(GALT):c.308A>G (p.Gln103Arg)	GALT	Q103R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025152	9	34647544	9	34647547	25152	36486	rs367543252	NC_000009.12:34647546:A:G
NM_000155.4(GALT):c.285T>G (p.Phe95Leu)	GALT	F95L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025145	9	34647521	9	34647524	25145	36479	rs111033668	NC_000009.12:34647523:T:G
NM_000155.4(GALT):c.265T>C (p.Tyr89His)	GALT	Y89H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025144	9	34647501	9	34647504	25144	36478	rs111033666	NC_000009.12:34647503:T:C
NM_000155.4(GALT):c.207_214del (p.Asp69fs)	GALT	p.D69_72Pdel, T2fs, D69fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025138	9	34647209 - 34647216	9	34647212 - 34647219	25138	36472	rs111033655	NC_000009.12:34647211:ACCCTCTCA:A
NM_000155.4(GALT):c.160C>T (p.Gln54Ter)	GALT	Q54*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025134	9	34647163	9	34647166	25134	36468	rs111033649	NC_000009.12:34647165:C:T
NM_000155.4(GALT):c.90G>C (p.Gln30His)	GALT	Q30H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025121	9	34647093	9	34647096	25121	36455	rs111033834	NC_000009.12:34647095:G:C
NM_000155.4(GALT):c.1A>G (p.Met1Val)	GALT	M1V	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025112	9	34646702	9	34646705	25112	36446	rs111033639	NC_000009.12:34646704:A:G
NM_000155.4(GALT):c.359del (p.Lys120fs)	GALT	K120fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000851656	9	34647682	9	34647685	851656	836077		NC_000009.12:34647684:AAA:AA
NC_000009.12:g.(?_34645559)_(34648914_?)del	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000833446	9	34645556 - 34648911			833446	820135		
NM_000155.4(GALT):c.252+1G>A	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic	criteria provided, single submitter	VCV000813466	9	34647256	9	34647259	813466	801676		NC_000009.12:34647258:G:A
NM_000155.4(GALT):c.2T>G (p.Met1Arg)	GALT	M1R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic	criteria provided, single submitter	VCV000813464	9	34646703	9	34646706	813464	801674		NC_000009.12:34646705:T:G
NM_000155.4(GALT):c.900G>A (p.Trp300Ter)	GALT	W191*, W300*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic	criteria provided, single submitter	VCV000813412	9	34649074	9	34649077	813412	801678		NC_000009.12:34649076:G:A
NM_000155.4(GALT):c.377+2dup	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic	criteria provided, single submitter	VCV000813411	9	34647703 - 34647704	9	34647706 - 34647707	813411	801677		NC_000009.12:34647706:T:TT
NM_000155.4(GALT):c.616C>T (p.Gln206Ter)	GALT	Q206*, Q97*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000557190	9	34648382	9	34648385	557190	545307	rs1554709366	NC_000009.12:34648384:C:T
M60091.1:c.772C>T	GALT	R258C	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038282					38282	46837		
NM_000155.4(GALT):c.950A>G (p.Gln317Arg)	GALT	Q317R, Q208R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000037353	9	34649452	9	34649455	37353	45904	rs111033786	NC_000009.12:34649454:A:G
NM_000155.4(GALT):c.416T>C (p.Leu139Pro)	GALT	L139P, L30P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000037352	9	34647867	9	34647870	37352	45903	rs111033687	NC_000009.12:34647869:T:C
NM_000155.4(GALT):c.1138T>C (p.Ter380Arg)	GALT	X380RextX50, *380R, *271R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025335	9	34650444	9	34650447	25335	36669	rs111033824	NC_000009.12:34650446:T:C
NM_000155.4(GALT):c.1098C>A (p.Tyr366Ter)	GALT	Y366*, Y257*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025332	9	34650404	9	34650407	25332	36666	rs111033822	NC_000009.12:34650406:C:A
NM_000155.4(GALT):c.1072del (p.Arg357_Leu358insTer)	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025330	9	34650378	9	34650381	25330	36664	rs397515629	NC_000009.12:34650380:C:
NM_000155.4(GALT):c.1059+56C>T	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025328	9	34649617	9	34649620	25328	36662	rs111033821	NC_000009.12:34649619:C:T
NM_000155.4(GALT):c.1048A>G (p.Thr350Ala)	GALT	T350A, T241A	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025323	9	34649550	9	34649553	25323	36657	rs111033817	NC_000009.12:34649552:A:G
NM_000155.4(GALT):c.1001A>G (p.Lys334Arg)	GALT	K334R, K225R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025314	9	34649503	9	34649506	25314	36648	rs111033809	NC_000009.12:34649505:A:G
NM_000155.4(GALT):c.989C>T (p.Ala330Val)	GALT	A330V, A221V	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025311	9	34649491	9	34649494	25311	36645	rs111033804	NC_000009.12:34649493:C:T
NM_000155.4(GALT):c.986C>T (p.Ser329Phe)	GALT	S329F, S220F	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025310	9	34649488	9	34649491	25310	36644	rs111033803	NC_000009.12:34649490:C:T
NM_000155.4(GALT):c.979del (p.Leu327fs)	GALT	L327fs, L218fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025307	9	34649480	9	34649483	25307	36641	rs111033801	NC_000009.12:34649482:CC:C
NM_000155.4(GALT):c.967T>C (p.Tyr323His)	GALT	Y323H, Y214H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025301	9	34649469	9	34649472	25301	36635	rs111033796	NC_000009.12:34649471:T:C
NM_000155.4(GALT):c.967T>G (p.Tyr323Asp)	GALT	Y323D, Y214D	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025300	9	34649469	9	34649472	25300	36634	rs111033796	NC_000009.12:34649471:T:G
NM_000155.4(GALT):c.952del (p.Leu318fs)	GALT	L318fs, L209fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025295	9	34649454	9	34649457	25295	36629	rs111033788	NC_000009.12:34649456:C:
NM_000155.4(GALT):c.951G>T (p.Gln317His)	GALT	Q317H, Q208H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025294	9	34649453	9	34649456	25294	36628	rs111033787	NC_000009.12:34649455:G:T
NM_000155.4(GALT):c.949del (p.Gln317fs)	GALT	Q317fs, Q208fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025293	9	34649451	9	34649454	25293	36627	rs111033785	NC_000009.12:34649453:C:
NM_000155.4(GALT):c.922G>A (p.Glu308Lys)	GALT	E308K, E199K	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025289	9	34649424	9	34649427	25289	36623	rs111033784	NC_000009.12:34649426:G:A
NM_000155.4(GALT):c.920C>A (p.Ser307Ter)	GALT	S307*, S198*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025288	9	34649422	9	34649425	25288	36622	rs367543265	NC_000009.12:34649424:C:A
NM_000155.4(GALT):c.882del (p.Tyr296fs)	GALT	F294fs, Y187fs, Y296fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025284	9	34649054	9	34649057	25284	36618	rs111033782	NC_000009.12:34649056:TTT:TT
NM_000155.4(GALT):c.881T>A (p.Phe294Tyr)	GALT	F294Y, F185Y	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025283	9	34649055	9	34649058	25283	36617	rs111033781	NC_000009.12:34649057:T:A
NM_000155.4(GALT):c.871G>A (p.Glu291Lys)	GALT	E291K, E182K	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025280	9	34649045	9	34649048	25280	36614	rs111033780	NC_000009.12:34649047:G:A
NM_000155.4(GALT):c.866T>G (p.Leu289Arg)	GALT	L289R, L180R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025279	9	34649040	9	34649043	25279	36613	rs111033775	NC_000009.12:34649042:T:G
NM_000155.4(GALT):c.865C>T (p.Leu289Phe)	GALT	L289F, L180F	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025278	9	34649039	9	34649042	25278	36612	rs111033774	NC_000009.12:34649041:C:T
NM_000155.4(GALT):c.833T>A (p.Ile278Asn)	GALT	I278N, I169N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025274	9	34649007	9	34649010	25274	36608	rs111033778	NC_000009.12:34649009:T:A
NM_000155.4(GALT):c.824del (p.Leu275fs)	GALT	L275fs, L166fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025273	9	34648998	9	34649001	25273	36607	rs111033777	NC_000009.12:34649000:T:
NM_000155.4(GALT):c.821-2A>G	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025272	9	34648993	9	34648996	25272	36606	rs111033767	NC_000009.12:34648995:A:G
NM_000155.4(GALT):c.814C>G (p.Arg272Gly)	GALT	R272G, R163G	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025268	9	34648885	9	34648888	25268	36602	rs111033766	NC_000009.12:34648887:C:G
NM_000155.4(GALT):c.785G>C (p.Arg262Pro)	GALT	R262P, R153P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025263	9	34648856	9	34648859	25263	36597	rs111033763	NC_000009.12:34648858:G:C
M60091.1:c.775C>T?	GALT	R259W?	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025261					25261	36595		
NM_000155.4(GALT):c.770C>T (p.Pro257Leu)	GALT	P257L, P148L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025260	9	34648841	9	34648844	25260	36594	rs111033845	NC_000009.12:34648843:C:T
NM_000155.4(GALT):c.768_770del (p.Pro257del)	GALT	p.P257del, P257del, P148del	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025259	9	34648839 - 34648841	9	34648842 - 34648844	25259	36593	rs111033770	NC_000009.12:34648841:GCC:
NM_000155.4(GALT):c.745T>C (p.Trp249Arg)	GALT	W249R, W140R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025251	9	34648816	9	34648819	25251	36585	rs111033757	NC_000009.12:34648818:T:C
NM_000155.4(GALT):c.697G>C (p.Val233Leu)	GALT	V233L, V124L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025248	9	34648768	9	34648771	25248	36582	rs111033843	NC_000009.12:34648770:G:C
NM_000155.4(GALT):c.687+2T>C	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025245	9	34648455	9	34648458	25245	36579	rs111033748	NC_000009.12:34648457:T:C
NM_000155.4(GALT):c.687G>T (p.Lys229Asn)	GALT	K229N, K120N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025244	9	34648453	9	34648456	25244	36578	rs111033753	NC_000009.12:34648455:G:T
NM_000155.4(GALT):c.677T>C (p.Leu226Pro)	GALT	L226P, L117P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025243	9	34648443	9	34648446	25243	36577	rs111033752	NC_000009.12:34648445:T:C
NM_000155.4(GALT):c.667C>A (p.Arg223Ser)	GALT	R223S, R114S	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025242	9	34648433	9	34648436	25242	36576	rs111033750	NC_000009.12:34648435:C:A
NM_000155.4(GALT):c.658dup (p.Glu220fs)	GALT	E220fsX17	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025241	9	34648422 - 34648423	9	34648425 - 34648426	25241	36575	rs111033825	NC_000009.12:34648425:GG:GGG
NM_000155.4(GALT):c.658G>A (p.Glu220Lys)	GALT	E220K, E111K	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025240	9	34648424	9	34648427	25240	36574	rs111033747	NC_000009.12:34648426:G:A
NM_000155.4(GALT):c.626A>C (p.Tyr209Ser)	GALT	Y209S, Y100S	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025232	9	34648392	9	34648395	25232	36566	rs111033744	NC_000009.12:34648394:A:C
NM_000155.4(GALT):c.611G>C (p.Arg204Pro)	GALT	R204P, R95P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025229	9	34648377	9	34648380	25229	36563	rs111033740	NC_000009.12:34648379:G:C
NM_000155.4(GALT):c.595G>A (p.Ala199Thr)	GALT	A199T, A90T	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025224	9	34648361	9	34648364	25224	36558	rs111033730	NC_000009.12:34648363:G:A
NM_000155.4(GALT):c.594T>G (p.Ile198Met)	GALT	I198M, I89M	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025223	9	34648360	9	34648363	25223	36557	rs111033729	NC_000009.12:34648362:T:G
NM_000155.4(GALT):c.575G>A (p.Ser192Asn)	GALT	S192N, S83N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025220	9	34648341	9	34648344	25220	36554	rs111033734	NC_000009.12:34648343:G:A
NM_000155.4(GALT):c.574A>G (p.Ser192Gly)	GALT	S192G, S83G	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025219	9	34648340	9	34648343	25219	36553	rs111033830	NC_000009.12:34648342:A:G
NM_000155.4(GALT):c.554C>A (p.Pro185His)	GALT	P185H, P76H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025212	9	34648158	9	34648161	25212	36546	rs111033722	NC_000009.12:34648160:C:A
NM_000155.4(GALT):c.553C>T (p.Pro185Ser)	GALT	P185S, P76S	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025211	9	34648157	9	34648160	25211	36545	rs111033826	NC_000009.12:34648159:C:T
NM_000155.4(GALT):c.541T>G (p.Ser181Ala)	GALT	S181A, S72A	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025207	9	34648145	9	34648148	25207	36541	rs111033828	NC_000009.12:34648147:T:G
NM_000155.4(GALT):c.539G>T (p.Cys180Phe)	GALT	C180F, C71F	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025206	9	34648143	9	34648146	25206	36540	rs111033844	NC_000009.12:34648145:G:T
NM_000155.4(GALT):c.536G>A (p.Gly179Asp)	GALT	G179D, G70D	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025205	9	34648140	9	34648143	25205	36539	rs111033720	NC_000009.12:34648142:G:A
NM_000155.4(GALT):c.528_529insG (p.Met177fs)	GALT	M177fsX5	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025204	9	34648132 - 34648133	9	34648135 - 34648136	25204	36538	rs111033719	NC_000009.12:34648135::G
NM_000155.4(GALT):c.509T>A (p.Ile170Asn)	GALT	I170N, I61N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025200	9	34648113	9	34648116	25200	36534	rs111033839	NC_000009.12:34648115:T:A
NM_000155.4(GALT):c.508-5G>C	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025198	9	34648107	9	34648110	25198	36532	rs111033714	NC_000009.12:34648109:G:C
NM_000155.4(GALT):c.507+2T>C	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025191	9	34647960	9	34647963	25191	36525	rs111033710	NC_000009.12:34647962:T:C
NM_000155.4(GALT):c.499T>C (p.Trp167Arg)	GALT	W167R, W58R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025188	9	34647950	9	34647953	25188	36522	rs111033708	NC_000009.12:34647952:T:C
NM_000155.4(GALT):c.460T>G (p.Trp154Gly)	GALT	W154G, W45G	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025181	9	34647911	9	34647914	25181	36515	rs111033702	NC_000009.12:34647913:T:G
NM_000155.4(GALT):c.448G>C (p.Val150Leu)	GALT	V150L, V41L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025179	9	34647899	9	34647902	25179	36513	rs111033699	NC_000009.12:34647901:G:C
NM_000155.4(GALT):c.442C>G (p.Arg148Gly)	GALT	R148G, R39G	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025177	9	34647893	9	34647896	25177	36511	rs111033693	NC_000009.12:34647895:C:G
NM_000155.4(GALT):c.425T>C (p.Met142Thr)	GALT	M142T, M33T	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025176	9	34647876	9	34647879	25176	36510	rs111033695	NC_000009.12:34647878:T:C
NM_000155.4(GALT):c.424A>G (p.Met142Val)	GALT	M142V, M33V	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025175	9	34647875	9	34647878	25175	36509	rs111033692	NC_000009.12:34647877:A:G
NM_000155.4(GALT):c.410dup (p.Thr138fs)	GALT	T138NfsX8	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025173	9	34647860 - 34647861	9	34647863 - 34647864	25173	36507	rs397515628	NC_000009.12:34647863:T:TT
NM_000155.4(GALT):c.377+1G>T	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025164	9	34647703	9	34647706	25164	36498	rs111033681	NC_000009.12:34647705:G:T
NM_000155.4(GALT):c.374T>C (p.Val125Ala)	GALT	V125A	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025163	9	34647699	9	34647702	25163	36497	rs111033680	NC_000009.12:34647701:T:C
NM_000155.4(GALT):c.368G>A (p.Arg123Gln)	GALT	R123Q	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025162	9	34647693	9	34647696	25162	36496	rs111033675	NC_000009.12:34647695:G:A
NM_000155.4(GALT):c.354A>C (p.Gln118His)	GALT	Q118H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025161	9	34647679	9	34647682	25161	36495	rs111033673	NC_000009.12:34647681:A:C
NM_000155.4(GALT):c.350T>C (p.Phe117Ser)	GALT	F117S	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025160	9	34647675	9	34647678	25160	36494	rs111033679	NC_000009.12:34647677:T:C
NM_000155.4(GALT):c.341A>T (p.His114Leu)	GALT	H114L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025159	9	34647666	9	34647669	25159	36493	rs111033678	NC_000009.12:34647668:A:T
NM_000155.4(GALT):c.337G>A (p.Asp113Asn)	GALT	D113N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025158	9	34647662	9	34647665	25158	36492	rs111033677	NC_000009.12:34647664:G:A
NM_000155.4(GALT):c.336T>C (p.Ser112=)	GALT	S112R	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025157	9	34647661	9	34647664	25157	36491	rs367543254	NC_000009.12:34647663:T:C
NM_000155.4(GALT):c.334dup (p.Ser112fs)	GALT	S112fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025156	9	34647658 - 34647659	9	34647661 - 34647662	25156	36490	rs111033676	NC_000009.12:34647661:A:AA
NM_000155.4(GALT):c.328+2T>C	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025150	9	34647566	9	34647569	25150	36484	rs111033849	NC_000009.12:34647568:T:C
NM_000155.4(GALT):c.220_221insG (p.Leu74fs)	GALT	L74fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025139	9	34647223 - 34647224	9	34647226 - 34647227	25139	36473	rs111033659	NC_000009.12:34647226::G
NM_000155.4(GALT):c.152G>T (p.Arg51Leu)	GALT	R51L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025133	9	34647155	9	34647158	25133	36467	rs111033648	NC_000009.12:34647157:G:T
NM_000155.4(GALT):c.136_140del (p.Ala46fs)	GALT	A46fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025131	9	34647136 - 34647140	9	34647139 - 34647143	25131	36465	rs111033651	NC_000009.12:34647138:TCAGCTCA:TCA
NM_000155.4(GALT):c.130G>T (p.Val44Leu)	GALT	V44L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025129	9	34647133	9	34647136	25129	36463	rs111033647	NC_000009.12:34647135:G:T
NM_000155.4(GALT):c.113A>C (p.Gln38Pro)	GALT	Q38P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025127	9	34647116	9	34647119	25127	36461	rs111033646	NC_000009.12:34647118:A:C
NM_000155.4(GALT):c.95T>A (p.Ile32Asn)	GALT	I32N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025123	9	34647098	9	34647101	25123	36457	rs111033644	NC_000009.12:34647100:T:A
NM_000155.4(GALT):c.82G>C (p.Asp28His)	GALT	D28H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025120	9	34646783	9	34646786	25120	36454	rs111033636	NC_000009.12:34646785:G:C
NM_000155.4(GALT):c.82G>T (p.Asp28Tyr)	GALT	D28Y	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025119	9	34646783	9	34646786	25119	36453	rs111033636	NC_000009.12:34646785:G:T
NM_000155.4(GALT):c.67A>G (p.Thr23Ala)	GALT	T23A	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025118	9	34646768	9	34646771	25118	36452	rs111033635	NC_000009.12:34646770:A:G
NG_009029.1:g.[4026_7188del; 7307insGAATAGACCCCA; g.7308_9602del]	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025110					25110	36444		
NG_009029.1:g.(?_4752)_(?_9014)	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025109					25109	36443		
NM_000255.4(MMUT):c.1207C>T (p.Arg403Ter)	MMUT	R403*	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167310	6	49419304	6	49451591	167310	177367	rs727504020	NC_000006.12:49451590:G:A
NM_000255.4(MMUT):c.278G>A (p.Arg93His)	MMUT	R93H	not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001880	6	49426902	6	49459189	1880	16919	rs121918251	NC_000006.12:49459188:C:T
NM_000441.2(SLC26A4):c.1105A>T (p.Lys369Ter)	SLC26A4	K369*	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553253	7	107329601	7	107689156	553253	544379	rs121908361	NC_000007.14:107689155:A:T
NM_000441.2(SLC26A4):c.1651dup (p.Ser551fs)	SLC26A4		Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446455	7	107340560 - 107340561	7	107700115 - 107700116	446455	439904	rs1554360678	NC_000007.14:107700115:TTTT:TTTTT
NM_000441.2(SLC26A4):c.601-1G>A	SLC26A4		Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446452	7	107315389	7	107674944	446452	439901	rs1554355011	NC_000007.14:107674943:G:A
NM_000441.2(SLC26A4):c.2228T>A (p.Leu743Ter)	SLC26A4	L743*	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371476	7	107350637	7	107710192	371476	357553	rs1057517303	NC_000007.14:107710191:T:A
NM_000441.2(SLC26A4):c.1920G>A (p.Trp640Ter)	SLC26A4	W640*	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189017	7	107342388	7	107701943	189017	186739	rs368119540	NC_000007.14:107701942:G:A
NM_000441.2(SLC26A4):c.1336C>T (p.Gln446Ter)	SLC26A4	Q446*	Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, multiple submitters, no conflicts	VCV000043504	7	107334920	7	107694475	43504	52674	rs397516416	NC_000007.14:107694474:C:T
NM_020732.3(ARID1B):c.3304C>T (p.Arg1102Ter)	ARID1B	R1102*, R1142*, R1089*, R392*	not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000031210	6	157502271	6	157181137	31210	40167	rs387907141	NC_000006.12:157181136:C:T
NM_000155.4(GALT):c.1030C>T (p.Gln344Ter)	GALT	Q235*, Q344*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000834891	9	34649532	9	34649535	834891	836082		NC_000009.12:34649534:C:T
NC_000009.12:g.(?_34645559)_(34649574_?)del	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000833436	9	34645556 - 34649571			833436	820136		
NM_000155.4(GALT):c.598C>T (p.Gln200Ter)	GALT	Q200*, Q91*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633236	9	34648364	9	34648367	633236	621302	rs1564101619	NC_000009.12:34648366:C:T
NM_000155.4(GALT):c.307C>T (p.Gln103Ter)	GALT	Q103*	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000498560	9	34647543	9	34647546	498560	489984	rs1225091358	NC_000009.12:34647545:C:T
NM_000155.2(GALT):c.[-1039_753del;820+50_*789delinsGAATAGACCCCA]	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000242644	9	34645661 - 34648822	9	34645664 - 34648825	242644	131978		
NM_000155.4(GALT):c.688-2A>C	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092521	9	34648757	9	34648760	92521	98430	rs398123185	NC_000009.12:34648759:A:C
NM_000155.4(GALT):c.904+1G>T	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000038554	9	34649079	9	34649082	38554	47152	rs367543271	NC_000009.12:34649081:G:T
NM_000155.4(GALT):c.748C>A (p.Pro250Thr)	GALT	P250T, P141T	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000037354	9	34648819	9	34648822	37354	45905	rs111033759	NC_000009.12:34648821:C:A
NM_000155.4(GALT):c.650T>C (p.Leu217Pro)	GALT	L217P, L108P	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000025236	9	34648416	9	34648419	25236	36570	rs111033741	NC_000009.12:34648418:T:C
NM_000155.4(GALT):c.377+53_1059+87del	GALT	C126WfsX6	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000025165	9	34647752 - 34649645	9	34647755 - 34649648	25165	36499		
NM_000155.4(GALT):c.130G>A (p.Val44Met)	GALT	V44M	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000003611	9	34647133	9	34647136	3611	18650	rs111033647	NC_000009.12:34647135:G:A
NM_023110.2(FGFR1):c.1966A>G (p.Lys656Glu)	FGFR1	K656E, K652E, K687E, K646E, K563E, K565E, K567E, K654E	Transitional cell carcinoma of the bladder|Medulloblastoma|Lymphoblastic leukemia, acute, with lymphomatous features|Encephalocraniocutaneous lipomatosis|Hepatocellular carcinoma|Astrocytoma|Glioblastoma	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000224897	8	38272308	8	38414790	224897	226760	rs869320694	NC_000008.11:38414789:T:C
NM_001002295.2(GATA3):c.587del (p.Leu196fs)	GATA3	L196fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000521009	10	8100613	10	8058650	521009	511876	rs1554794844	NC_000010.11:8058649:T:
NM_001278716.2(FBXL4):c.64C>T (p.Arg22Ter)	FBXL4	R22*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000209153	6	99374801	6	98926925	209153	205749	rs200440128	NC_000006.12:98926924:G:A
NM_183050.4(BCKDHB):c.593_594AG[1] (p.Ser199_Pro200insTer)	BCKDHB		Maple syrup urine disease|not provided|Maple syrup urine disease type 1B	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096599	6	80878707 - 80878708	6	80168990 - 80168991	96599	102492	rs398124587	NC_000006.12:80168989:AGAG:AG
NM_000360.4(TH):c.614T>C (p.Leu205Pro)	TH	L236P, L205P, L232P	Segawa syndrome, autosomal recessive|Dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012325	11	2189126	11	2167896	12325	27364	rs121917763	NC_000011.10:2167895:A:G
NM_001277269.1(OTOG):c.2500C>T (p.Gln834Ter)	OTOG	Q834*, Q822*	Rare genetic deafness|Deafness, autosomal recessive 18b|not provided|Seizures|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000417941	11	17596437	11	17574890	417941	404799	rs554847663	NC_000011.10:17574889:C:T
NM_000155.4(GALT):c.938G>A (p.Trp313Ter)	GALT	W313*, W204*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551291	9	34649440	9	34649443	551291	545155	rs1410159094	NC_000009.12:34649442:G:A
NM_000155.4(GALT):c.508-1G>C	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092517	9	34648111	9	34648114	92517	98426	rs398123181	NC_000009.12:34648113:G:C
NM_000155.4(GALT):c.163G>T (p.Gly55Cys)	GALT	G55C	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038285	9	34647166	9	34647169	38285	46840	rs111033654	NC_000009.12:34647168:G:T
NM_000155.4(GALT):c.1060-1G>A	GALT		not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	VCV000025329	9	34650365	9	34650368	25329	36663	rs367543268	NC_000009.12:34650367:G:A
NM_000155.4(GALT):c.1018G>T (p.Glu340Ter)	GALT	E340*, E231*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000025318	9	34649520	9	34649523	25318	36652	rs111033806	NC_000009.12:34649522:G:T
NM_000155.4(GALT):c.948G>A (p.Trp316Ter)	GALT	W316*, W207*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000025292	9	34649450	9	34649453	25292	36626	rs111033791	NC_000009.12:34649452:G:A
NM_000155.4(GALT):c.265T>G (p.Tyr89Asp)	GALT	Y89D	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025143	9	34647501	9	34647504	25143	36477	rs111033666	NC_000009.12:34647503:T:G
NM_000155.4(GALT):c.197C>A (p.Pro66His)	GALT	P66H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000025135	9	34647200	9	34647203	25135	36469	rs111033656	NC_000009.12:34647202:C:A
NM_000155.4(GALT):c.41delinsTT (p.Ala14fs)	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000025117	9	34646742	9	34646745	25117	36451	rs111033634	NC_000009.12:34646744:C:TT
NM_000155.4(GALT):c.580T>C (p.Phe194Leu)	GALT	F194L, F85L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000003624	9	34648346	9	34648349	3624	18663	rs111033726	NC_000009.12:34648348:T:C
NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)	PRKN	R33Q	Parkinson disease 2	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000578186	6	162864415	6	162443383	578186	560658	rs147757966	NC_000006.12:162443382:C:T
NM_007078.3(LDB3):c.869C>T (p.Pro290Leu)	LDB3	P243L, P290L, P358L	Myofibrillar myopathy	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000253222	10	88452301	10	86692544	253222	247640	rs775180716	NC_000010.11:86692543:C:T
NM_007078.3(LDB3):c.617C>T (p.Thr206Ile)	LDB3	T213I, T206I	Dilated cardiomyopathy 1C	Pathogenic(Last reviewed: Dec 3, 2003)	no assertion criteria provided	VCV000004732	10	88441488	10	86681731	4732	19771	rs121908337	NC_000010.11:86681730:C:T
NM_007078.3(LDB3):c.1035C>G (p.Ile345Met)	LDB3	I352M, I345M, I298M	Dilated cardiomyopathy 1C	Pathogenic(Last reviewed: Dec 3, 2003)	no assertion criteria provided	VCV000004730	10	88466426	10	86706669	4730	19769	rs121908336	NC_000010.11:86706668:C:G
NM_015046.7(SETX):c.243del (p.Ile81fs)	SETX	I81fs	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000452281	9	135221793	9	132346406	452281	444385	rs1455336434	NC_000009.12:132346405:AA:A
NM_015046.7(SETX):c.23C>T (p.Thr8Met)	SETX	T8M	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000378574	9	135224793	9	132349406	378574	369959	rs1057520367	NC_000009.12:132349405:G:A
NM_015046.7(SETX):c.4936C>T (p.Gln1646Ter)	SETX	Q1646*	not provided	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000280291	9	135202049	9	132326662	280291	264396	rs886041522	NC_000009.12:132326661:G:A
NM_015046.7(SETX):c.4816C>T (p.Arg1606Ter)	SETX	R1606*	not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000280027	9	135202169	9	132326782	280027	264398	rs759213174	NC_000009.12:132326781:G:A
NM_015046.7(SETX):c.6996_7002del (p.Asp2332fs)	SETX	D2332fs	Amyotrophic lateral sclerosis type 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802521	9	135150741 - 135150747	9	132275354 - 132275360	802521	790848		NC_000009.12:132275353:TCTTTTGTCTTT:TCTTT
NM_015046.7(SETX):c.5591_5592del (p.Gln1864fs)	SETX	Q1864fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448337	9	135173656 - 135173657	9	132298269 - 132298270	448337	441279	rs776470487	NC_000009.12:132298268:TT:
NM_015046.7(SETX):c.5547_5548+2del	SETX		not provided	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000448336	9	135176015 - 135176018	9	132300628 - 132300631	448336	441280	rs1554813128	NC_000009.12:132300627:ACTGACTGAC:ACTGAC
NM_001360.2(DHCR7):c.964-1G>T	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000305956	11	71146886	11	71435840	305956	315075	rs138659167	NC_000011.10:71435839:C:A
NM_001360.2(DHCR7):c.1139G>A (p.Cys380Tyr)	DHCR7	C380Y	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189069	11	71146710	11	71435664	189069	186841	rs779709646	NC_000011.10:71435663:C:T
NM_001360.2(DHCR7):c.461C>T (p.Thr154Met)	DHCR7	T154M	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188923	11	71152438	11	71441392	188923	186842	rs143312232	NC_000011.10:71441391:G:A
NM_001360.2(DHCR7):c.832-1G>C	DHCR7		Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000006776	11	71148990	11	71437944	6776	21815	rs80338863	NC_000011.10:71437943:C:G
NM_015046.7(SETX):c.5825T>C (p.Ile1942Thr)	SETX	I1942T	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000807687	9	135172398	9	132297011	807687	798616		NC_000009.12:132297010:A:G
NM_015046.7(SETX):c.6464T>G (p.Leu2155Trp)	SETX	L2155W	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000807686	9	135158733	9	132283346	807686	798615		NC_000009.12:132283345:A:C
NM_015046.7(SETX):c.6620A>T (p.Asp2207Val)	SETX	D2207V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000807685	9	135156888	9	132281501	807685	798614		NC_000009.12:132281500:T:A
NM_015046.7(SETX):c.6292C>T (p.Arg2098Ter)	SETX	R2098*	not provided	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000586555	9	135163655	9	132288268	586555	577098	rs770684782	NC_000009.12:132288267:G:A
NM_015046.7(SETX):c.719G>A (p.Gly240Asp)	SETX	G240D	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000812548	9	135210114	9	132334727	812548	800789		NC_000009.12:132334726:C:T
NM_015046.7(SETX):c.5222dup (p.Asp1742fs)	SETX		not provided|Dysdiadochokinesis|Slightly reduced reflexes|Cerebellar atrophy|Slurred speech|Cerebellar ataxia|Dysmetria|Nystagmus	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000183294	9	135201762 - 135201763	9	132326375 - 132326376	183294	181428	rs730882209	NC_000009.12:132326375:CC:CCC
NM_015046.7(SETX):c.1027G>T (p.Glu343Ter)	SETX	E343*	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000002296	9	135206510	9	132331123	2296	17335	rs121434381	NC_000009.12:132331122:C:A
NM_015046.7(SETX):c.5929C>T (p.Leu1977Phe)	SETX	L1977F	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Dec 12, 2006)	no assertion criteria provided	VCV000002295	9	135172294	9	132296907	2295	17334	rs121434380	NC_000009.12:132296906:G:A
NM_015046.7(SETX):c.2967_2971del (p.Arg989fs)	SETX	R989fs	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000002287	9	135204014 - 135204018	9	132328627 - 132328631	2287	17326	rs587776536	NC_000009.12:132328626:CTTTCCTTT:CTTT
NM_015046.7(SETX):c.6638C>T (p.Pro2213Leu)	SETX	P2213L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000002286	9	135156870	9	132281483	2286	17325	rs28940290	NC_000009.12:132281482:G:A
NM_015046.7(SETX):c.2602C>T (p.Gln868Ter)	SETX	Q868*	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000002285	9	135204383	9	132328996	2285	17324	rs121434377	NC_000009.12:132328995:G:A
NM_000441.2(SLC26A4):c.2118C>A (p.Cys706Ter)	SLC26A4	C706*	Pendred syndrome|not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551315	7	107350527	7	107710082	551315	544449	rs142656144	NC_000007.14:107710081:C:A
NM_000441.2(SLC26A4):c.416-1G>A	SLC26A4		Pendred syndrome|not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000371079	7	107314608	7	107674163	371079	357530	rs1057516988	NC_000007.14:107674162:G:A
NM_000441.2(SLC26A4):c.918+2T>C	SLC26A4		Pendred syndrome|Enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000370108	7	107323801	7	107683356	370108	357535	rs912147281	NC_000007.14:107683355:T:C
NM_000441.2(SLC26A4):c.2215C>T (p.Gln739Ter)	SLC26A4	Q739*	not provided|Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000165265	7	107350624	7	107710179	165265	174033	rs727503431	NC_000007.14:107710178:C:T
NM_000441.2(SLC26A4):c.1105A>G (p.Lys369Glu)	SLC26A4	K369E	Enlarged vestibular aqueduct	Pathogenic, Affects(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000004822	7	107329601	7	107689156	4822	19861	rs121908361	NC_000007.14:107689155:A:G
NM_003165.4(STXBP1):c.1439C>T (p.Pro480Leu)	STXBP1	P480L	Early infantile epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207432	9	130440789	9	127678510	207432	202320	rs796053368	NC_000009.12:127678509:C:T
NM_024426.6(WT1):c.1388G>A (p.Arg463Gln)	WT1	R246Q, R463Q, R458Q, R67Q, R446Q, R229Q	Diffuse mesangial sclerosis	Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000599100	11	32413577	11	32392031	599100	590302	rs1037084691	NC_000011.10:32392030:C:T
NM_024426.6(WT1):c.1400G>A (p.Arg467Gln)	WT1	R250Q, R462Q, R467Q, R450Q, R71Q, R233Q	not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000419332	11	32413565	11	32392019	419332	408336	rs121907903	NC_000011.10:32392018:C:T
NM_024426.6(WT1):c.1315C>T (p.Arg439Cys)	WT1	R366C, R434C, R222C, R417C, R422C, R205C, R439C, R43C	Meacham syndrome	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000003505	11	32414251	11	32392705	3505	18544	rs121907910	NC_000011.10:32392704:G:A
NM_024426.6(WT1):c.1393T>C (p.Phe465Leu)	WT1	F460L, F248L, F443L, F231L, F448L, F465L, F69L	Frasier syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000003504	11	32413572	11	32392026	3504	18543	rs28941779	NC_000011.10:32392025:A:G
NM_024426.6(WT1):c.1366T>C (p.Phe456Leu)	WT1	F451L, F239L, F434L, F439L, F456L, F222L, F60L	Diffuse mesangial sclerosis	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000003502	11	32413599	11	32392053	3502	18541	rs28941777	NC_000011.10:32392052:A:G
NM_024426.6(WT1):c.1338C>G (p.His446Gln)	WT1	H441Q, H229Q, H424Q, H429Q, H212Q, H446Q, H50Q	Drash syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	no assertion criteria provided	VCV000003498	11	32414228	11	32392682	3498	18537	rs121907907	NC_000011.10:32392681:G:C
NM_024426.6(WT1):c.1297T>G (p.Cys433Gly)	WT1	C428G, C216G, C411G, C199G, C37G, C433G, C416G	Drash syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	no assertion criteria provided	VCV000003496	11	32414269	11	32392723	3496	18535	rs121907905	NC_000011.10:32392722:A:C
NM_024426.6(WT1):c.1208G>A (p.Cys403Tyr)	WT1	C330Y, C398Y, C186Y, C381Y, C169Y, C386Y, C403Y, C7Y	Drash syndrome	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000003492	11	32417859	11	32396313	3492	18531	rs121907904	NC_000011.10:32396312:C:T
NM_024426.6(WT1):c.1400G>C (p.Arg467Pro)	WT1	R394P, R462P, R250P, R445P, R450P, R467P, R71P, R233P	Drash syndrome	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000003491	11	32413565	11	32392019	3491	18530	rs121907903	NC_000011.10:32392018:C:G
NM_024426.6(WT1):c.1406A>G (p.Asp469Gly)	WT1	D464G, D252G, D447G, D452G, D469G, D73G, D235G	Drash syndrome	Pathogenic(Last reviewed: Oct 18, 1991)	no assertion criteria provided	VCV000003489	11	32413559	11	32392013	3489	18528	rs121907902	NC_000011.10:32392012:T:C
NM_024426.6(WT1):c.1447+6T>A	WT1		Frasier syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000003486	11	32413512	11	32391966	3486	18525	rs587776575	NC_000011.10:32391965:A:T
NM_024426.6(WT1):c.1036A>G (p.Ser346Gly)	WT1	S341G, S129G, S324G, S329G, S112G, S346G	Mesothelioma	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000003499	11	32421571	11	32400025	3499	18538	rs121907908	NC_000011.10:32400024:T:C
NM_001077365.2(POMT1):c.1087C>T (p.Gln363Ter)	POMT1	Q385*, Q211*, Q246*, Q309*, Q331*, Q333*, Q363*, Q268*	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095452	9	134388630	9	131513243	95452	101351	rs200056620	NC_000009.12:131513242:C:T
NC_000009.11:g.(?_34646606)_(34650456_?)del	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000642055	9	34646606 - 34650456	9	34646609 - 34650459	642055	651855		
NC_000009.11:g.(?_34646583)_(34651235_?)del	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000529227	9	34646583 - 34651235	9	34646586 - 34651238	529227	524448		
NC_000009.11:g.(?_34645556)_(34651235_?)del	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000459626	9	34645556 - 34651235	9	34645559 - 34651238	459626	459173		
NM_000155.4(GALT):c.386T>C (p.Met129Thr)	GALT	M129T, M20T	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	VCV000037356	9	34647837	9	34647840	37356	45907	rs111033683	NC_000009.12:34647839:T:C
NM_000155.4(GALT):c.1057C>T (p.Gln353Ter)	GALT	Q353*, Q244*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000025325	9	34649559	9	34649562	25325	36659	rs111033818	NC_000009.12:34649561:C:T
NM_000155.4(GALT):c.904+1G>A	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000025286	9	34649079	9	34649082	25286	36620	rs367543271	NC_000009.12:34649081:G:A
NM_000155.4(GALT):c.747G>A (p.Trp249Ter)	GALT	W249*, W140*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025252	9	34648818	9	34648821	25252	36586	rs111033758	NC_000009.12:34648820:G:A
NM_015046.7(SETX):c.6213_6214AG[1] (p.Glu2072fs)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561105	9	135163731 - 135163732	9	132288344 - 132288345	561105	552135	rs1564492117	NC_000009.12:132288343:CTCT:CT
NM_015046.7(SETX):c.5927T>G (p.Leu1976Arg)	SETX	L1976R	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Dec 12, 2006)	no assertion criteria provided	VCV000002292	9	135172296	9	132296909	2292	17331	rs121434379	NC_000009.12:132296908:A:C
NM_024426.6(WT1):c.1348C>T (p.His450Tyr)	WT1	H377Y, H445Y, H233Y, H428Y, H216Y, H450Y, H433Y, H54Y	Diffuse mesangial sclerosis|Drash syndrome	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000003495	11	32414218	11	32392672	3495	18534	rs28942089	NC_000011.10:32392671:G:A
NM_020732.3(ARID1B):c.4870C>T (p.Arg1624Ter)	ARID1B	R1624*, R1664*, R914*, R1611*	Coffin-Siris syndrome 1|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503753	6	157522598	6	157201464	503753	495270	rs1554236040	NC_000006.12:157201463:C:T
NM_017519.2(ARID1B):c.5527_5530AAGA[1] (p.Lys1844fs)	ARID1B		Coffin-Siris syndrome 1|not provided	Pathogenic(Last reviewed: Jan 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280515	6	157527838 - 157527841	6	157206704 - 157206707	280515	264289	rs886041706	
NM_020732.3(ARID1B):c.5968C>T (p.Arg1990Ter)	ARID1B	R1990*, R2030*, R1280*, R1977*	not provided|Coffin-Siris syndrome 1|Capillary hemangiomas|Torticollis|Global developmental delay|Congenital talipes calcaneovalgus|Relative macrocephaly|Joint hypermobility|Generalized hypotonia|Premature birth|Dysphagia|Short stature	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210306	6	157528243	6	157207109	210306	207388	rs797045283	NC_000006.12:157207108:C:T
NM_020320.5(RARS2):c.419T>G (p.Phe140Cys)	RARS2	F140C	Pontocerebellar hypoplasia type 6|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215055	6	88258341	6	87548623	215055	211289	rs772887102	NC_000006.12:87548622:A:C
NM_003640.5(ELP1):c.2824C>T (p.Arg942Ter)	ELP1	R593*, R942*, R828*	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000848810	9	111656259	9	108893979	848810	835328		NC_000009.12:108893978:G:A
NM_003640.5(ELP1):c.2268T>A (p.Tyr756Ter)	ELP1	Y407*, Y642*, Y756*	not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000839152	9	111660966	9	108898686	839152	835330		NC_000009.12:108898685:A:T
NC_000009.12:g.(?_108930987)_(108931156_?)del	ELP1		not provided	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000831934	9	111693267 - 111693436			831934	820039		
NC_000009.11:g.(?_111640265)_(111693436_?)del	ELP1		not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000660683	9	111640265 - 111693436	9	108877985 - 108931156	660683	651934		
NM_003640.5(ELP1):c.348_351dup (p.Ser118fs)	ELP1		not provided	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000651002	9	111689685 - 111689686	9	108927405 - 108927406	651002	637598		NC_000009.12:108927405:CCAAC:CCAACCAAC
NM_003640.5(ELP1):c.2035del (p.Ser679fs)	ELP1	S330fs, S565fs, S679fs	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000640658	9	111662635	9	108900355	640658	637583		NC_000009.12:108900354:T:
NM_003640.5(ELP1):c.674_678del (p.Asn225fs)	ELP1	N225fs, N111fs	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000640148	9	111681153 - 111681157	9	108918873 - 108918877	640148	637594		NC_000009.12:108918872:TCGGTTC:TC
NM_003640.5(ELP1):c.1486C>T (p.Gln496Ter)	ELP1	Q382*, Q147*, Q496*	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000638948	9	111668740	9	108906460	638948	637587		NC_000009.12:108906459:G:A
NM_016203.4(PRKAG2):c.1592G>A (p.Arg531Gln)	PRKAG2	R531Q, R487Q, R406Q, R290Q, R407Q	not provided|Hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006852	7	151257696	7	151560610	6852	21891	rs121908991	NC_000007.14:151560609:C:T
NM_001287174.2(ABCC8):c.1732_1746dup (p.Ala578_Leu582dup)	ABCC8		not provided	Pathogenic(Last reviewed: Oct 7, 2015)	no assertion criteria provided	VCV000217848	11	17452431 - 17452432	11	17430884 - 17430885	217848	214503	rs757650373	NC_000011.10:17430884:GAGGGAGAGGGAGGC:GAGGGAGAGGGAGGCGAGGGAGAGGGAGGC
NM_001287174.2(ABCC8):c.72C>A (p.Asn24Lys)	ABCC8	N24K	not provided	Pathogenic(Last reviewed: Oct 27, 2015)	no assertion criteria provided	VCV000217847	11	17498252	11	17476705	217847	214505	rs771075821	NC_000011.10:17476704:G:T
NM_001287174.2(ABCC8):c.4457_4458AG[1] (p.Arg1487fs)	ABCC8		not provided	Pathogenic(Last reviewed: Oct 7, 2015)	no assertion criteria provided	VCV000217845	11	17415901 - 17415902	11	17394354 - 17394355	217845	214501	rs863225279	NC_000011.10:17394353:CTCT:CT
NM_001287174.2(ABCC8):c.2698-2A>T	ABCC8		not provided	Pathogenic(Last reviewed: Oct 27, 2015)	no assertion criteria provided	VCV000217844	11	17430066	11	17408519	217844	214502	rs863225278	NC_000011.10:17408518:T:A
NM_000352.6(ABCC8):c.2236G>T (p.Glu746Ter)	ABCC8	E768*, E746*, E747*, E745*	not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000848198	11	17438496	11	17416949	848198	838136		NC_000011.10:17416948:C:A
NM_000352.6(ABCC8):c.2273_2276CGAC[1] (p.Asp760fs)	ABCC8		not provided	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000836622	11	17436862 - 17436865	11	17415315 - 17415318	836622	838135		NC_000011.10:17415314:GTCGGTCG:GTCG
NC_000011.10:g.(?_17416920)_(17432254_?)del	ABCC8		not provided	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000833318	11	17438467 - 17453801			833318	820343		
NM_000352.6(ABCC8):c.598del (p.Thr200fs)	ABCC8	T200fs	Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802661	11	17483354	11	17461807	802661	791121		NC_000011.10:17461806:T:
NM_001287174.2(ABCC8):c.152G>A (p.Trp51Ter)	ABCC8	W51*	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000657643	11	17496571	11	17475024	657643	639831		NC_000011.10:17475023:C:T
NM_001287174.2(ABCC8):c.3547C>T (p.Arg1183Trp)	ABCC8	R1182W, R1183W, R1204W, R1181W	Transient neonatal diabetes mellitus 2	Pathogenic(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	VCV000210076	11	17426072	11	17404525	210076	207846	rs797045209	NC_000011.10:17404524:G:A
NM_001287174.2(ABCC8):c.4177T>G (p.Phe1393Val)	ABCC8	F1392V, F1393V, F1391V, F1414V	not provided	Pathogenic(Last reviewed: Jul 23, 2013)	criteria provided, single submitter	VCV000157701	11	17417423	11	17395876	157701	167549	rs587783171	NC_000011.10:17395875:A:C
NM_001287174.2(ABCC8):c.4058G>A (p.Arg1353His)	ABCC8	R1353H, R1352H, R1374H, R1351H	Leucine-induced hypoglycemia	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000009098	11	17418527	11	17396980	9098	24137	rs28936370	NC_000011.10:17396979:C:T
NM_015046.7(SETX):c.6322C>T (p.Gln2108Ter)	SETX	Q2108*	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243082	9	135163625	9	132288238	243082	244159	rs879253866	NC_000009.12:132288237:G:A
NM_015046.7(SETX):c.994C>T (p.Arg332Trp)	SETX	R332W	not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000002288	9	135206680	9	132331293	2288	17327	rs29001665	NC_000009.12:132331292:G:A
NM_001287174.2(ABCC8):c.496C>T (p.Gln166Ter)	ABCC8	Q166*	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000652127	11	17485068	11	17463521	652127	639830		NC_000011.10:17463520:G:A
NM_001287174.2(ABCC8):c.3110G>A (p.Trp1037Ter)	ABCC8	W1036*, W1037*, W1035*, W1058*	not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000585343	11	17428490	11	17406943	585343	577181	rs755259997	NC_000011.10:17406942:C:T
NM_001287174.2(ABCC8):c.3871-1G>A	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000552652	11	17418861	11	17397314	552652	546211	rs766431403	NC_000011.10:17397313:C:T
NM_001287174.2(ABCC8):c.4154_4155del (p.Lys1385fs)	ABCC8	K1383fs, K1384fs, K1406fs, K1385fs	not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000446773	11	17417445 - 17417446	11	17395898 - 17395899	446773	441407	rs1554905145	NC_000011.10:17395897:CT:
NM_001287174.2(ABCC8):c.1752del (p.His584fs)	ABCC8	H584fs, H583fs	Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000434060	11	17452426	11	17430879	434060	429211	rs1554926539	NC_000011.10:17430878:A:
NM_001287174.2(ABCC8):c.1792C>T (p.Arg598Ter)	ABCC8	R598*, R597*	Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000434056	11	17452386	11	17430839	434056	429210	rs139328569	NC_000011.10:17430838:G:A
NM_001287174.2(ABCC8):c.1254_1284dup (p.Met429Ter)	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000434055	11	17470110 - 17470111	11	17448563 - 17448564	434055	429214	rs768951263	NC_000011.10:17448563:GAGCTGATTGGTGTCGATGGCAACCAGATTA:GAGCTGATTGGTGTCGATGGCAACCAGATTAGAGCTGATTGGTGTCGATGGCAACCAGATTA
NM_001287174.2(ABCC8):c.3596C>T (p.Pro1199Leu)	ABCC8	P1198L, P1199L, P1197L, P1220L	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000434047	11	17424265	11	17402718	434047	429203	rs1554909277	NC_000011.10:17402717:G:A
NM_001287174.2(ABCC8):c.4453G>A (p.Gly1485Arg)	ABCC8	G1484R, G1485R, G1483R, G1506R	Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000434044	11	17415908	11	17394361	434044	429198	rs1554904102	NC_000011.10:17394360:C:T
NM_001287174.2(ABCC8):c.584dup (p.Tyr195Ter)	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000371346	11	17483367 - 17483368	11	17461820 - 17461821	371346	357957	rs1057517199	NC_000011.10:17461820:T:TT
NM_001287174.2(ABCC8):c.2117-1G>A	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000210072	11	17448702	11	17427155	210072	207848	rs797045207	NC_000011.10:17427154:C:T
NM_000352.6(ABCC8):c.1333-1013A>G	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039472	11	17465872	11	17444325	39472	48071		NC_000011.10:17444324:T:C
NM_001287174.2(ABCC8):c.674T>C (p.Leu225Pro)	ABCC8	L225P	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021170	11	17483278	11	17461731	21170	34022	rs1048095	NC_000011.10:17461730:A:G
NM_001287174.2(ABCC8):c.631C>A (p.Gln211Lys)	ABCC8	Q211K	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021169	11	17483321	11	17461774	21169	34021	rs193929366	NC_000011.10:17461773:G:T
NM_001287174.2(ABCC8):c.404T>C (p.Leu135Pro)	ABCC8	L135P	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021167	11	17491656	11	17470109	21167	34019	rs193929364	NC_000011.10:17470108:A:G
NM_001287174.2(ABCC8):c.257T>C (p.Val86Ala)	ABCC8	V86A	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021165	11	17496466	11	17474919	21165	34017	rs193929360	NC_000011.10:17474918:A:G
NM_001287174.2(ABCC8):c.134C>T (p.Pro45Leu)	ABCC8	P45L	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000009110	11	17498190	11	17476643	9110	24149	rs267606623	NC_000011.10:17476642:G:A
NM_000352.4(ABCC8):c.-190C>G	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000009101	11	17498513	11	17476966	9101	24140	rs1395224084	NC_000011.10:17476965:G:C
NM_001287174.2(ABCC8):c.4058G>C (p.Arg1353Pro)	ABCC8	R1353P, R1352P, R1374P, R1351P	Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000009094	11	17418527	11	17396980	9094	24133	rs28936370	NC_000011.10:17396979:C:G
NM_000083.3(CLCN1):c.1401+1G>T	CLCN1		not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447050	7	143029967	7	143332874	447050	441056	rs769861892	NC_000007.14:143332873:G:T
NM_000083.3(CLCN1):c.1012C>T (p.Arg338Ter)	CLCN1	R338*	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000425428	7	143028357	7	143331264	425428	413762	rs759761559	NC_000007.14:143331263:C:T
NM_000352.6(ABCC8):c.3082del (p.Ala1028fs)	ABCC8	A1027fs, A1028fs, A1029fs, A1050fs	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000845991	11	17428515	11	17406968	845991	838134		NC_000011.10:17406967:CC:C
NM_001287174.2(ABCC8):c.512dup (p.Thr172fs)	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039471	11	17485051 - 17485052	11	17463504 - 17463505	39471	48070	rs1564980510	NC_000011.10:17463504:A:AA
NM_000352.4:c.(?_1818)_(1923_?)del	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039470					39470	48069		
NM_001287174.2(ABCC8):c.627C>A (p.Asp209Glu)	ABCC8	D209E	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021168	11	17483325	11	17461778	21168	34020	rs80356640	NC_000011.10:17461777:G:T
NM_001287174.2(ABCC8):c.257T>G (p.Val86Gly)	ABCC8	V86G	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009111	11	17496466	11	17474919	9111	24150	rs193929360	NC_000011.10:17474918:A:C
NM_001287174.2(ABCC8):c.3557C>A (p.Ser1186Tyr)	ABCC8	A1185E, S1185Y, S1186Y, S1184Y, S1207Y	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009109	11	17426062	11	17404515	9109	24148	rs193929369	NC_000011.10:17404514:G:T
NM_001287174.2(ABCC8):c.1144G>A (p.Glu382Lys)	ABCC8	E382K, E381K	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009108	11	17474698	11	17453151	9108	24147	rs80356651	NC_000011.10:17453150:C:T
NM_001287174.2(ABCC8):c.215A>G (p.Asn72Ser)	ABCC8	N72S	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009107	11	17496508	11	17474961	9107	24146	rs80356634	NC_000011.10:17474960:T:C
NM_001287174.2(ABCC8):c.4273A>G (p.Ile1425Val)	ABCC8	I1424V, I1425V, I1446V, I1423V	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009104	11	17417194	11	17395647	9104	24143	rs80356653	NC_000011.10:17395646:T:C
NM_001287174.2(ABCC8):c.638T>G (p.Leu213Arg)	ABCC8	L213R	Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009103	11	17483314	11	17461767	9103	24142	rs80356642	NC_000011.10:17461766:A:C
NM_004333.6(BRAF):c.785A>C (p.Gln262Pro)	BRAF	Q262P, Q228P, Q265P, Q210P, Q174P	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044831	7	140501287	7	140801487	44831	53998	rs397516904	NC_000007.14:140801486:T:G
NM_004333.6(BRAF):c.1801A>C (p.Lys601Gln)	BRAF	K601Q, K564Q, K641Q, K549Q, K567Q, K579Q, K604Q, K513Q	Noonan syndrome|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041446	7	140453134	7	140753334	41446	49884	rs121913364	NC_000007.14:140753333:T:G
NM_152743.4(BRAT1):c.294dup (p.Leu99fs)	BRAT1		not provided|NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES|Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279703	7	2584678 - 2584679	7	2545044 - 2545045	279703	264325	rs776913277	NC_000007.14:2545044:T:TT
NM_003640.5(ELP1):c.2006C>A (p.Ser669Ter)	ELP1	S555*, S320*, S669*	Familial dysautonomia	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000664647	9	111663713	9	108901433	664647	637584		NC_000009.12:108901432:G:T
NM_003640.5(ELP1):c.349del (p.Trp117fs)	ELP1	W117fs, W3fs	Familial dysautonomia	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000648167	9	111689688	9	108927408	648167	637599		NC_000009.12:108927407:AA:A
NM_001287174.2(ABCC8):c.2698-1G>C	ABCC8		Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000371626	11	17430065	11	17408518	371626	357944	rs1057517420	NC_000011.10:17408517:C:G
NM_001287174.2(ABCC8):c.4311-2A>G	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000280114	11	17416824	11	17395277	280114	264506	rs886041391	NC_000011.10:17395276:T:C
NM_001287174.2(ABCC8):c.4122+1G>A	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000210078	11	17418462	11	17396915	210078	207844	rs797045211	NC_000011.10:17396914:C:T
NM_001287174.2(ABCC8):c.394T>G (p.Phe132Val)	ABCC8	F132V	Permanent neonatal diabetes mellitus|Neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021166	11	17491666	11	17470119	21166	34018	rs80356637	NC_000011.10:17470118:A:C
NM_001287174.2(ABCC8):c.2147G>T (p.Gly716Val)	ABCC8	G716V, G715V, G738V	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000018449	11	17448671	11	17427124	18449	33488	rs72559723	NC_000011.10:17427123:C:A
NM_001287174.2(ABCC8):c.394T>C (p.Phe132Leu)	ABCC8	F132L	Diabetes mellitus, permanent neonatal, with neurologic features|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000009102	11	17491666	11	17470119	9102	24141	rs80356637	NC_000011.10:17470118:A:G
NM_024426.6(WT1):c.1405G>A (p.Asp469Asn)	WT1	D396N, D464N, D252N, D447N, D452N, D469N, D235N, D73N	Drash syndrome|Diffuse mesangial sclerosis	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000003490	11	32413560	11	32392014	3490	18529	rs28941778	NC_000011.10:32392013:C:T
NM_024426.6(WT1):c.1316G>A (p.Arg439His)	WT1	R366H, R434H, R222H, R417H, R422H, R439H, R205H, R43H	Drash syndrome|not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000003488	11	32414250	11	32392704	3488	18527	rs121907901	NC_000011.10:32392703:C:T
NM_000391.4(TPP1):c.379C>T (p.Arg127Ter)	TPP1	R127*	Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia|Ceroid lipofuscinosis neuronal 2|not provided	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207569	11	6638858	11	6617627	207569	202591	rs756564767	NC_000011.10:6617626:G:A
NM_018972.4(GDAP1):c.581C>G (p.Ser194Ter)	GDAP1	S194*, S126*, S136*, S85*	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, type 4A|not provided	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004191	8	75275175	8	74362940	4191	19230	rs104894075	NC_000008.11:74362939:C:G
NM_006731.2(FKTN):c.1106del (p.Phe369fs)	FKTN	F237fs, F369fs, F346fs	Walker-Warburg congenital muscular dystrophy|Fukuyama congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371091	9	108382270	9	105619989	371091	357769	rs750176716	NC_000009.12:105619988:TTTTTTT:TTTTTT
NM_006731.2(FKTN):c.411C>A (p.Cys137Ter)	FKTN	C137*, C5*, C114*	not provided|Fukuyama congenital muscular dystrophy|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167069	9	108366537	9	105604256	167069	177258	rs537001725	NC_000009.12:105604255:C:A
NM_006731.2(FKTN):c.642dup (p.Asp215Ter)	FKTN		not provided|Walker-Warburg congenital muscular dystrophy|Fukuyama congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093523	9	108366764 - 108366765	9	105604483 - 105604484	93523	99428	rs398123557	NC_000009.12:105604483:TTTT:TTTTT
NM_003640.5(ELP1):c.2505C>A (p.Tyr835Ter)	ELP1	Y835*, Y486*, Y721*	Familial dysautonomia	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000568263	9	111659315	9	108897035	568263	562653	rs1564084140	NC_000009.12:108897034:G:T
NM_000352.6(ABCC8):c.1421A>G (p.Gln474Arg)	ABCC8	Q473R, Q474R	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000804489	11	17464771	11	17443224	804489	793385		NC_000011.10:17443223:T:C
NM_001287174.2(ABCC8):c.695G>A (p.Trp232Ter)	ABCC8	W232*	Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633027	11	17483257	11	17461710	633027	621349	rs1564977373	NC_000011.10:17461709:C:T
NM_001287174.2(ABCC8):c.4616G>A (p.Arg1539Gln)	ABCC8	R1538Q, R1539Q, R1560Q, R1537Q	not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000585348	11	17414671	11	17393124	585348	577176	rs1564869850	NC_000011.10:17393123:C:T
NM_001287174.2(ABCC8):c.1744C>G (p.Leu582Val)	ABCC8	L582V, L581V	Transient neonatal diabetes mellitus 2|Diabetes mellitus type 2	Pathogenic(Last reviewed: Aug 3, 2006)	no assertion criteria provided	VCV000009106	11	17452434	11	17430887	9106	24145	rs137852674	NC_000011.10:17430886:G:C
NM_001287174.2(ABCC8):c.560T>A (p.Val187Asp)	ABCC8	V187D	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000009099	11	17485004	11	17463457	9099	24138	rs137852672	NC_000011.10:17463456:A:T
NM_000155.4(GALT):c.821-7A>G	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000649344	9	34648988	9	34648991	649344	652017		NC_000009.12:34648990:A:G
NM_000155.4(GALT):c.367C>T (p.Arg123Ter)	GALT	R123*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203734	9	34647692	9	34647695	203734	200182	rs111033674	NC_000009.12:34647694:C:T
NM_000155.4(GALT):c.598del (p.Gln200fs)	GALT	Q200fs, Q91fs	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025225	9	34648362	9	34648365	25225	36559	rs111033738	NC_000009.12:34648364:CCC:CC
NM_004820.5(CYP7B1):c.334C>T (p.Arg112Ter)	CYP7B1	R112*	not provided|Inborn genetic diseases|Spastic paraplegia	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219912	8	65528764	8	64616207	219912	221765	rs200737038	NC_000008.11:64616206:G:A
NM_004820.5(CYP7B1):c.825T>A (p.Tyr275Ter)	CYP7B1	Y275*	Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided|Hereditary spastic paraplegia	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006105	8	65528273	8	64615716	6105	21144	rs121908613	NC_000008.11:64615715:A:T
NM_000322.5(PRPH2):c.422A>G (p.Tyr141Cys)	PRPH2	Y141C	not provided|Patterned dystrophy of retinal pigment epithelium|Retinal dystrophy|Macular dystrophy, vitelliform, adult-onset|PRPH2-Related Disorders	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098666	6	42689651	6	42721913	98666	104556	rs61755781	NC_000006.12:42721912:T:C
NM_000322.5(PRPH2):c.515G>A (p.Arg172Gln)	PRPH2	R172Q	PRPH2-Related Disorders|Macular dystrophy|not provided|Retinal dystrophy|Choroidal dystrophy, central areolar 2|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013167	6	42689558	6	42721820	13167	28206	rs61755793	NC_000006.12:42721819:C:T
NM_001164277.1(SLC37A4):c.818del (p.Gly273fs)	SLC37A4	G200fs, G273fs	not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801369	11	118897365	11	119026655	801369	789750		NC_000011.10:119026654:CCCCC:CCCC
NM_001164277.1(SLC37A4):c.110C>A (p.Ser37Ter)	SLC37A4	S37*	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000488601	11	118899970	11	119029260	488601	481469	rs1444468055	NC_000011.10:119029259:G:T
SLC37A4, IVS8, 4-BP DEL	SLC37A4		Phosphate transport defect	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000006927					6927	21966		
NM_000441.2(SLC26A4):c.365dup (p.Ile124fs)	SLC26A4		not provided|Pendred syndrome	Pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	VCV000189148	7	107312637 - 107312638	7	107672192 - 107672193	189148	186730	rs786204730	NC_000007.14:107672192:TTTTTT:TTTTTTT
NM_000441.2(SLC26A4):c.164+2T>C	SLC26A4		Pendred syndrome|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000043518	7	107302252	7	107661807	43518	52687	rs397516420	NC_000007.14:107661806:T:C
NM_000441.2(SLC26A4):c.1264-1G>C	SLC26A4		Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, multiple submitters, no conflicts	VCV000043500	7	107334847	7	107694402	43500	52670	rs111033311	NC_000007.14:107694401:G:C
NM_001164277.1(SLC37A4):c.495G>A (p.Trp165Ter)	SLC37A4	W92*, W165*	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000861962	11	118898469	11	119027759	861962	838048		NC_000011.10:119027758:C:T
NM_001164277.1(SLC37A4):c.927del (p.Gly310fs)	SLC37A4	G237fs, G310fs	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000846755	11	118896734	11	119026024	846755	838045		NC_000011.10:119026023:A:
NM_001164277.1(SLC37A4):c.59dup (p.Tyr21fs)	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000835295	11	118900020 - 118900021	11	119029310 - 119029311	835295	838053		NC_000011.10:119029310:CCCCC:CCCCCC
NC_000011.10:g.(?_119024900)_(119029379_?)del	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000832011	11	118895610 - 118900089			832011	820339		
NC_000011.9:g.(?_118898884)_(118900099_?)del	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000666221	11	118898884 - 118900099	11	119028174 - 119029389	666221	652375		
NM_001164277.1(SLC37A4):c.460del (p.Ile154fs)	SLC37A4	I81fs, I154fs	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000662747	11	118898504	11	119027794	662747	639767		NC_000011.10:119027793:T:
NM_001164277.1(SLC37A4):c.170C>A (p.Ser57Ter)	SLC37A4	S57*	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000654273	11	118899115	11	119028405	654273	639771		NC_000011.10:119028404:G:T
NM_001164277.1(SLC37A4):c.936dup (p.Val313fs)	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000651791	11	118896724 - 118896725	11	119026014 - 119026015	651791	639761		NC_000011.10:119026014:T:TT
NM_001164277.1(SLC37A4):c.169_175del (p.Ser57fs)	SLC37A4	S57fs	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000651195	11	118899110 - 118899116	11	119028400 - 119028406	651195	639770		NC_000011.10:119028399:CTGCCGACTG:CTG
NM_001164277.1(SLC37A4):c.796_797del (p.Met266fs)	SLC37A4	M266fs, M193fs	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000648054	11	118897386 - 118897387	11	119026676 - 119026677	648054	639763		NC_000011.10:119026675:AT:
NM_001164277.1(SLC37A4):c.345dup (p.Leu116fs)	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000529223	11	118898939 - 118898940	11	119028229 - 119028230	529223	526098	rs782604758	NC_000011.10:119028229:CCCC:CCCCC
SLC37A4, 794G-A	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000006936					6936	21975		
NM_001164277.1(SLC37A4):c.1243C>T (p.Arg415Ter)	SLC37A4	R415*, R342*, R437*	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006934	11	118895667	11	119024957	6934	21973	rs121908979	NC_000011.10:119024956:G:A
SLC37A4, IVS1, G-A, +1	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Sep 17, 1999)	no assertion criteria provided	VCV000006932					6932	21971		
SLC37A4, IVS7, G-T, +1	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Sep 17, 1999)	no assertion criteria provided	VCV000006931					6931	21970		
NM_001164277.1(SLC37A4):c.703_705GTG[1] (p.Val236del)	SLC37A4	V235del, V236del	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Sep 17, 1999)	no assertion criteria provided	VCV000006930	11	118897723 - 118897725	11	119027013 - 119027015	6930	21969	rs121908977	NC_000011.10:119027012:CACCAC:CAC
SLC37A4, 4-BP DEL, 2-BP INS, NT1094	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jul 20, 1998)	no assertion criteria provided	VCV000006924					6924	21963		
NM_015046.7(SETX):c.5821_5830del (p.Ala1941fs)	SETX	A1941fs	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, multiple submitters, no conflicts	VCV000209188	9	135172393 - 135172402	9	132297006 - 132297015	209188	205758	rs797045067	NC_000009.12:132297005:TTTCTATTGCTTTCT:TTTCT
NM_000118.3(ENG):c.726C>A (p.Cys242Ter)	ENG	C242*, C60*	not provided	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000620110	9	130587600	9	127825321	620110	611715	rs545465750	NC_000009.12:127825320:G:T
NM_000118.3(ENG):c.574_580del (p.Arg192fs)	ENG	R10fs, R192fs	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000618624	9	130588083 - 130588089	9	127825804 - 127825810	618624	609713	rs1564456347	NC_000009.12:127825803:GCGTGCGGC:GC
NM_000118.3(ENG):c.899T>C (p.Leu300Pro)	ENG	L300P, L118P	not provided	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000618623	9	130587171	9	127824892	618623	609710	rs1335718486	NC_000009.12:127824891:A:G
NM_000118.3(ENG):c.41_51del (p.Leu14fs)	ENG	L14fs	not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000618622	9	130616584 - 130616594	9	127854305 - 127854315	618622	609716	rs1564466393	NC_000009.12:127854304:GCAGCTGGCCAGCAGC:GCAGC
NM_000118.3(ENG):c.97C>T (p.Gln33Ter)	ENG	Q33*	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000618086	9	130605495	9	127843216	618086	609715	rs1564462827	NC_000009.12:127843215:G:A
NM_000118.3(ENG):c.155G>A (p.Gly52Asp)	ENG	G52D	not provided	Pathogenic(Last reviewed: Jul 9, 2017)	criteria provided, single submitter	VCV000618085	9	130605437	9	127843158	618085	609714	rs1564462765	NC_000009.12:127843157:C:T
NM_000118.3(ENG):c.690-2A>T	ENG		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000593503	9	130587638	9	127825359	593503	584567	rs1564455970	NC_000009.12:127825358:T:A
NM_000118.3(ENG):c.469del (p.Thr157fs)	ENG	T157fs	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000503866	9	130588843	9	127826564	503866	495393	rs1554810494	NC_000009.12:127826563:T:
NM_000118.3(ENG):c.98_101del (p.Gln33fs)	ENG	Q33fs	not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000453169	9	130605491 - 130605494	9	127843212 - 127843215	453169	444362	rs1554812283	NC_000009.12:127843211:GGCTG:G
NM_000118.3(ENG):c.732dup (p.Gly245fs)	ENG		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000450481	9	130587593 - 130587594	9	127825314 - 127825315	450481	444358	rs1554810254	NC_000009.12:127825314:GGG:GGGG
NM_000118.3(ENG):c.219+5G>C	ENG		not provided	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000449320	9	130605368	9	127843089	449320	444360	rs1554812252	NC_000009.12:127843088:C:G
NM_000118.3(ENG):c.736del (p.Asp246fs)	ENG	D246fs, D64fs	not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000449319	9	130587590	9	127825311	449319	444357	rs1554810249	NC_000009.12:127825310:CCCC:CCC
NM_000118.3(ENG):c.760C>T (p.Gln254Ter)	ENG	Q254*, Q72*	not specified	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000439652	9	130587566	9	127825287	439652	433060	rs1554810234	NC_000009.12:127825286:G:A
NM_000118.3(ENG):c.220-1G>A	ENG		not specified	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000439650	9	130592107	9	127829828	439650	433529	rs1554810936	NC_000009.12:127829827:C:T
NM_000118.3(ENG):c.41T>C (p.Leu14Pro)	ENG	L14P	not specified	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000439647	9	130616594	9	127854315	439647	433528	rs1554813788	NC_000009.12:127854314:A:G
NM_000118.3(ENG):c.1084_1085del (p.Lys362fs)	ENG	K362fs, K180fs	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000432681	9	130586632 - 130586633	9	127824353 - 127824354	432681	425820	rs1554810051	NC_000009.12:127824352:TTT:T
NM_000118.3(ENG):c.526C>T (p.Gln176Ter)	ENG	Q176*	not provided	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000429922	9	130588137	9	127825858	429922	421703	rs1131691674	NC_000009.12:127825857:G:A
NM_000118.3(ENG):c.712del (p.Val238fs)	ENG	V56fs, V238fs	not provided	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000280319	9	130587614	9	127825335	280319	264470	rs886041548	NC_000009.12:127825334:CC:C
NM_000118.3(ENG):c.816G>A (p.Trp272Ter)	ENG	W272*, W90*	not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000280021	9	130587510	9	127825231	280021	264386	rs886041326	NC_000009.12:127825230:C:T
NM_000118.3(ENG):c.689+2T>C	ENG		not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000213208	9	130587972	9	127825693	213208	209954	rs863223535	NC_000009.12:127825692:A:G
NM_000118.3(ENG):c.446G>A (p.Trp149Ter)	ENG	W149*	not provided	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000213207	9	130588866	9	127826587	213207	209957	rs863223534	NC_000009.12:127826586:C:T
NM_000118.3(ENG):c.600_603dup (p.Ala202fs)	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000838206	9	130588059 - 130588060	9	127825780 - 127825781	838206	835486		NC_000009.12:127825780:TGGA:TGGATGGA
NM_000118.3(ENG):c.983_984delinsAG (p.Ser328Ter)	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000665098	9	130587086 - 130587087	9	127824807 - 127824808	665098	637688		NC_000009.12:127824806:GG:CT
NM_000118.3(ENG):c.280G>T (p.Glu94Ter)	ENG	E94*	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000664833	9	130592046	9	127829767	664833	637711		NC_000009.12:127829766:C:A
NM_000118.3(ENG):c.397del (p.Val133fs)	ENG	V133fs	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000663715	9	130588915	9	127826636	663715	637708		NC_000009.12:127826635:CCCCC:CCCC
NM_001114753.2(ENG):c.562dup (p.Gln188fs)	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000663306	9	130588100 - 130588101	9	127825821 - 127825822	663306	637703		NC_000009.12:127825821:GG:GGG
NM_000118.3(ENG):c.587G>A (p.Trp196Ter)	ENG	W196*, W14*	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000654257	9	130588076	9	127825797	654257	637701		NC_000009.12:127825796:C:T
NM_000118.3(ENG):c.753_781del (p.Ile252fs)	ENG	I252fs, I70fs	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000650203	9	130587545 - 130587573	9	127825266 - 127825294	650203	637692		NC_000009.12:127825265:AGGACACGTAGGGGGGACCCTGCAGGATGAGGAC:AGGAC
NM_000118.3(ENG):c.815G>A (p.Trp272Ter)	ENG	W272*, W90*	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000648888	9	130587511	9	127825232	648888	637689		NC_000009.12:127825231:C:T
NM_000118.3(ENG):c.776del (p.Val259fs)	ENG	V259fs, V77fs	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000646817	9	130587550	9	127825271	646817	637693		NC_000009.12:127825270:A:
NM_000118.3(ENG):c.488_491del (p.Asn163fs)	ENG	N163fs	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000645811	9	130588821 - 130588824	9	127826542 - 127826545	645811	637707		NC_000009.12:127826541:TCATTCA:TCA
NM_000118.3(ENG):c.920dup (p.Asn307fs)	ENG		Cerebral arteriovenous malformation	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000545104	9	130587149 - 130587150	9	127824870 - 127824871	545104	535371	rs1554810174	NC_000009.12:127824870:TT:TTT
NM_000118.3(ENG):c.626T>A (p.Leu209Ter)	ENG	L209*, L27*	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852561	9	130588037	9	127825758	852561	835485		NC_000009.12:127825757:A:T
NM_000118.3(ENG):c.461dup (p.Ile156fs)	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000843258	9	130588850 - 130588851	9	127826571 - 127826572	843258	835491		NC_000009.12:127826571:CCCC:CCCCC
NC_000009.12:g.(?_127854279)_(127854365_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000833480	9	130616558 - 130616644			833480	820068		
NC_000009.12:g.(?_127819612)_(127829837_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000833148	9	130581891 - 130592116			833148	820062		
NC_000009.12:g.(?_127843084)_(127843255_?)dup	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000832916	9	130605363 - 130605534			832916	820067		
NM_000118.3(ENG):c.229C>T (p.Gln77Ter)	ENG	Q77*	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000651893	9	130592097	9	127829818	651893	637712		NC_000009.12:127829817:G:A
NC_000009.11:g.(?_130616558)_(130616761_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000650717	9	130616558 - 130616761	9	127854279 - 127854482	650717	651829		
NM_000118.3(ENG):c.743del (p.Asp248fs)	ENG	D66fs, D248fs	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000640315	9	130587583	9	127825304	640315	637695		NC_000009.12:127825303:T:
NM_000118.3(ENG):c.*111G>T	ENG	R618L, R436L	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426047	9	130578085	9	127815806	426047	414374	rs1085307436	NC_000009.12:127815805:C:A
NM_000118.3(ENG):c.1804del (p.Ile602fs)	ENG	I602fs, I420fs	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426046	9	130578270	9	127815991	426046	414375	rs1085307435	NC_000009.12:127815990:T:
NM_000118.3(ENG):c.682_686del (p.Ser228fs)	ENG	S228fs, S46fs	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426041	9	130587977 - 130587981	9	127825698 - 127825702	426041	414380	rs1085307430	NC_000009.12:127825697:GCCGAG:G
NM_000118.3(ENG):c.494C>T (p.Pro165Leu)	ENG	P165L	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000854634	9	130588818	9	127826539	854634	835489		NC_000009.12:127826538:G:A
NM_000118.3:c.1689_1699del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000839929					839929	852481		
NC_000009.12:g.(?_127824294)_(127824456_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000831280	9	130586573 - 130586735			831280	820063		
NM_000118.3(ENG):c.771dup (p.Tyr258fs)	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000811750	9	130587554 - 130587555	9	127825275 - 127825276	811750	799569		NC_000009.12:127825275:GGGGGG:GGGGGGG
NM_000118.3(ENG):c.838A>T (p.Lys280Ter)	ENG	K280*, K98*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000811329	9	130587232	9	127824953	811329	799568		NC_000009.12:127824952:T:A
NM_000118.3(ENG):c.667del (p.Val223fs)	ENG	V223fs, V41fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000811215	9	130587996	9	127825717	811215	799572		NC_000009.12:127825716:CCC:CC
NM_000118.3(ENG):c.588G>A (p.Trp196Ter)	ENG	W14*, W196*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000810946	9	130588075	9	127825796	810946	799573		NC_000009.12:127825795:C:T
NM_000118.3(ENG):c.314T>A (p.Val105Asp)	ENG	V105D	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000665710	9	130592012	9	127829733	665710	637710		NC_000009.12:127829732:A:T
NM_000118.3(ENG):c.166C>T (p.Gln56Ter)	ENG	Q56*	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000660455	9	130605426	9	127843147	660455	637713		NC_000009.12:127843146:G:A
NM_000118.3(ENG):c.771del (p.Tyr258fs)	ENG	Y76fs, Y258fs	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000656930	9	130587555	9	127825276	656930	637694		NC_000009.12:127825275:GGGGGG:GGGGG
NM_000118.3(ENG):c.1015_1024del (p.Ala339fs)	ENG	A157fs, A339fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Dec 20, 2017)	no assertion criteria provided	VCV000478821	9	130586693 - 130586702	9	127824414 - 127824423	478821	472247	rs1554810066	NC_000009.12:127824413:GGATCGGTGCGG:GG
NM_000118.3(ENG):c.816+6T>C	ENG		Hereditary hemorrhagic telangiectasia type 1|Systemic lupus erythematosus	Pathogenic(Last reviewed: Mar 20, 2017)	no assertion criteria provided	VCV000453308	9	130587504	9	127825225	453308	446888	rs759191907	NC_000009.12:127825224:A:G
NM_000118.3(ENG):c.880_881del (p.Asp294fs)	ENG	D112fs, D294fs	Hereditary hemorrhagic telangiectasia|not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284669	9	130587189 - 130587190	9	127824910 - 127824911	284669	268906	rs886042916	NC_000009.12:127824909:TCT:T
NM_000118.3(ENG):c.562C>T (p.Gln188Ter)	ENG	Q188*, Q6*	not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213211	9	130588101	9	127825822	213211	209956	rs863223537	NC_000009.12:127825821:G:A
ENG, 2-BP DEL, NT1153	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000016670					16670	31709		
ENG, 39-BP DEL, NT882	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000016669					16669	31708		
NM_000118.3(ENG):c.831C>G (p.Tyr277Ter)	ENG	Y277*, Y95*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000016668	9	130587239	9	127824960	16668	31707	rs121918400	NC_000009.12:127824959:G:C
NM_003640.5(ELP1):c.3592C>T (p.Arg1198Ter)	ELP1	R1198*, R1084*, R849*	not provided|Familial dysautonomia	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553107	9	111641011	9	108878731	553107	544962	rs376078668	NC_000009.12:108878730:G:A
NM_001164277.1(SLC37A4):c.74_77del (p.Tyr25fs)	SLC37A4	Y25fs	Glucose-6-phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557015	11	118900003 - 118900006	11	119029293 - 119029296	557015	546397	rs1447366650	NC_000011.10:119029292:AAGTAA:AA
NM_000466.3(PEX1):c.1952_1960dup (p.Met654_Gln655insThrValTrp)	PEX1		Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)|not provided|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093102	7	92134156 - 92134157	7	92504842 - 92504843	93102	99009	rs398123408	NC_000007.14:92504842:TCCACACTG:TCCACACTGTCCACACTG
NM_001287174.2(ABCC8):c.742C>T (p.Arg248Ter)	ABCC8	R248*	not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000585351	11	17483210	11	17461663	585351	577184	rs72559730	NC_000011.10:17461662:G:A
NM_001287174.2(ABCC8):c.1634del (p.Phe545fs)	ABCC8	F544fs, F545fs	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446765	11	17453788	11	17432241	446765	441414	rs1260178539	NC_000011.10:17432240:AAAA:AAA
NM_001287174.2(ABCC8):c.4157_4159CCT[1] (p.Ser1387del)	ABCC8	S1386del, S1387del	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000009100	11	17417438 - 17417440	11	17395891 - 17395893	9100	24139	rs387906408	NC_000011.10:17395890:AGGAGGA:AGGA
NM_000118.3(ENG):c.992-2A>G	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000663310	9	130586727	9	127824448	663310	651901		NC_000009.12:127824447:T:C
NM_000118.3(ENG):c.689+1G>A	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000661834	9	130587973	9	127825694	661834	651977		NC_000009.12:127825693:C:T
NM_000118.3(ENG):c.659T>C (p.Ile220Thr)	ENG	I220T, I38T	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000651770	9	130588004	9	127825725	651770	637698		NC_000009.12:127825724:A:G
NC_000009.11:g.(?_130586563)_(130616761_?)del	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000583412	9	130586563 - 130616761	9	127824284 - 127854482	583412	565329		
NM_000118.3(ENG):c.572del (p.Gly191fs)	ENG	G9fs, G191fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000583087	9	130588091	9	127825812	583087	563469	rs1564456374	NC_000009.12:127825811:CCC:CC
NM_000118.3(ENG):c.911_918del (p.Arg304fs)	ENG	R304fs, R122fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000579815	9	130587152 - 130587159	9	127824873 - 127824880	579815	562762	rs1564455604	NC_000009.12:127824872:GAGCATCCG:G
NM_000118.3(ENG):c.831C>A (p.Tyr277Ter)	ENG	Y277*, Y95*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000579302	9	130587239	9	127824960	579302	563447	rs121918400	NC_000009.12:127824959:G:T
NM_000118.3(ENG):c.1A>C (p.Met1Leu)	ENG	M1L	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000578951	9	130616634	9	127854355	578951	563476	rs1060501418	NC_000009.12:127854354:T:G
NM_000118.3(ENG):c.119del (p.Gly40fs)	ENG	G40fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000578632	9	130605473	9	127843194	578632	562769	rs369596004	NC_000009.12:127843193:CCCC:CCC
NM_000118.3(ENG):c.621C>A (p.Cys207Ter)	ENG	C207*, C25*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000570772	9	130588042	9	127825763	570772	565517	rs1440769928	NC_000009.12:127825762:G:T
NM_000118.3(ENG):c.683C>A (p.Ser228Ter)	ENG	S228*, S46*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000528071	9	130587980	9	127825701	528071	523975	rs1452543778	NC_000009.12:127825700:G:T
NM_000118.3(ENG):c.1024C>T (p.Gln342Ter)	ENG	Q342*, Q160*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000528057	9	130586693	9	127824414	528057	524585	rs774429348	NC_000009.12:127824413:G:A
NM_000118.3(ENG):c.904dup (p.Glu302fs)	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: May 27, 2017)	criteria provided, single submitter	VCV000458356	9	130587165 - 130587166	9	127824886 - 127824887	458356	458789	rs1554810177	NC_000009.12:127824886:CCCCC:CCCCCC
NM_000118.3(ENG):c.244del (p.Leu82fs)	ENG	L82fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000458345	9	130592082	9	127829803	458345	458798	rs1554810921	NC_000009.12:127829802:G:
NM_000118.3(ENG):c.229del (p.Gln77fs)	ENG	Q77fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000458344	9	130592097	9	127829818	458344	458284	rs1554810928	NC_000009.12:127829817:G:
NM_000118.3(ENG):c.219+1G>A	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000458343	9	130605372	9	127843093	458343	458808	rs1554812253	NC_000009.12:127843092:C:T
NM_001114753.2(ENG):c.1122_1123AG[1] (p.Glu375fs)	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Apr 8, 2017)	criteria provided, single submitter	VCV000458326	9	130586592 - 130586593	9	127824313 - 127824314	458326	459297	rs1554810037	NC_000009.12:127824312:CTCT:CT
NM_000118.3(ENG):c.1111dup (p.Val371fs)	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000458325	9	130586605 - 130586606	9	127824326 - 127824327	458325	458860	rs1554810041	NC_000009.12:127824326:CC:CCC
NC_000009.11:g.(?_130605367)_(130605530_?)del	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000458322	9	130605367 - 130605530	9	127843088 - 127843251	458322	459158		
NC_000009.11:g.(?_130591960)_(130592112_?)del	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000458321	9	130591960 - 130592112	9	127829681 - 127829833	458321	458720		
NM_000118.3(ENG):c.715G>T (p.Glu239Ter)	ENG	E239*, E57*	not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419982	9	130587611	9	127825332	419982	407548	rs1064794220	NC_000009.12:127825331:C:A
NC_000009.11:g.(?_130605373)_(130605524_?)del	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000417396	9	130605373 - 130605524	9	127843094 - 127843245	417396	396773		
NM_000118.3(ENG):c.715dup (p.Glu239fs)	ENG		not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407137	9	130587610 - 130587611	9	127825331 - 127825332	407137	396830	rs1554810257	NC_000009.12:127825331:CC:CCC
NM_000118.3(ENG):c.67del (p.Ser23fs)	ENG	S23fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000237029	9	130616568	9	127854289	237029	240464	rs878853658	NC_000009.12:127854288:TT:T
NM_000118.3(ENG):c.247C>T (p.Gln83Ter)	ENG	Q83*	not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213205	9	130592079	9	127829800	213205	209960	rs863223532	NC_000009.12:127829799:G:A
NM_000118.3(ENG):c.360+4A>G	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000016671	9	130591962	9	127829683	16671	31710	rs1564457752	NC_000009.12:127829682:T:C
NC_000011.10:g.(?_32434690)_(32435345_?)del	WT1		Wilms tumor 1|Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000833107	11	32456236 - 32456891			833107	820361		
NM_024426.6(WT1):c.882C>A (p.Tyr294Ter)	WT1	Y294*, Y77*	Wilms tumor 1|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645008	11	32449507	11	32427961	645008	639969		NC_000011.10:32427960:G:T
NM_024426.6(WT1):c.682dup (p.Asp228fs)	WT1		Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Frasier syndrome	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000476713	11	32450144 - 32450145	11	32428598 - 32428599	476713	461269	rs1554945232	NC_000011.10:32428598:C:CC
NC_000011.9:g.(?_32417797)_(32439206_?)del	WT1		Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Frasier syndrome	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000476672	11	32417797 - 32439206	11	32396251 - 32417660	476672	460431		
NM_024426.6(WT1):c.880_882del (p.Tyr294del)	WT1	Y289del, Y77del, Y294del	Wilms tumor 1	Pathogenic(Last reviewed: Mar 23, 2013)	no assertion criteria provided	VCV000438757	11	32449507 - 32449509	11	32427961 - 32427963	438757	432382	rs1554945033	NC_000011.10:32427960:GTAG:G
NM_024426.6(WT1):c.812del (p.Pro271fs)	WT1	P271fs, P54fs	Wilms tumor 1|Frasier syndrome|Drash syndrome	Pathogenic(Last reviewed: Jun 12, 2016)	criteria provided, single submitter	VCV000406680	11	32449577	11	32428031	406680	398591	rs1060501253	NC_000011.10:32428030:GGGGG:GGGG
NM_024426.6(WT1):c.1094del (p.Gly365fs)	WT1	G131fs, G148fs, G348fs, G365fs	Wilms tumor 1	Pathogenic(Last reviewed: Oct 3, 1991)	no assertion criteria provided	VCV000003485	11	32421513	11	32399967	3485	18524	rs587776574	NC_000011.10:32399966:CC:C
NM_024426.6(WT1):c.893_909del (p.Asn298fs)	WT1	N81fs, N298fs	Wilms tumor 1	Pathogenic(Last reviewed: Oct 3, 1991)	no assertion criteria provided	VCV000003484	11	32439179 - 32439195	11	32417633 - 32417649	3484	18523	rs587776573	NC_000011.10:32417632:TGTCATTTGGTATAAATTGTCA:TGTCA
NM_000162.5(GCK):c.626C>T (p.Thr209Met)	GCK	T208M, T210M, T209M	not provided	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000804851	7	44189412	7	44149813	804851	793235		NC_000007.14:44149812:G:A
NM_000162.5(GCK):c.562G>A (p.Ala188Thr)	GCK	A187T, A188T, A189T	not provided	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000804849	7	44189585	7	44149986	804849	793237		NC_000007.14:44149985:C:T
NM_000162.5(GCK):c.556C>T (p.Arg186Ter)	GCK	R186*, R187*, R185*	Diabetes mellitus, noninsulin-dependent, late-onset|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016133	7	44189591	7	44149992	16133	31172	rs104894006	NC_000007.14:44149991:G:A
NM_003002.4(SDHD):c.314+1G>A	SDHD		Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma|Cowden syndrome 3|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000438436	11	111959736	11	112089012	438436	432047	rs1555187083	NC_000011.10:112089011:G:A
NM_003002.4(SDHD):c.1A>G (p.Met1Val)	SDHD	M1V	Carotid body paraganglioma|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000006911	11	111957632	11	112086908	6911	21950	rs104894307	NC_000011.10:112086907:A:G
NM_033360.4(KRAS):c.38G>C (p.Gly13Ala)	KRAS	G13A	Non-small cell lung cancer|Neoplasm of the large intestine	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375967	12	25398281	12	25245347	375967	362846	rs112445441	NC_000012.12:25245346:C:G
NM_001164277.1(SLC37A4):c.675C>A (p.Tyr225Ter)	SLC37A4	Y152*, Y225*	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000841551	11	118897756	11	119027046	841551	838046		NC_000011.10:119027045:G:T
NM_001164277.1(SLC37A4):c.381+1G>T	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000656028	11	118898903	11	119028193	656028	652496		NC_000011.10:119028192:C:A
NM_001164277.1(SLC37A4):c.1124+1G>C	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000583102	11	118895900	11	119025190	583102	564453	rs782630676	NC_000011.10:119025189:C:G
NM_001164277.1(SLC37A4):c.1016G>A (p.Gly339Asp)	SLC37A4	G339D, G266D, G361D	not provided|Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000006935	11	118896008	11	119025298	6935	21974	rs121908980	NC_000011.10:119025297:C:T
SLC37A4, 12-BP INS, NT1103	SLC37A4		Glucose-6-phosphate transport defect|Phosphate transport defect	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000006929					6929	21968		
NM_001164277.1(SLC37A4):c.1063G>T (p.Glu355Ter)	SLC37A4	E355*, E377*, E282*	Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000006922	11	118895961	11	119025251	6922	21961	rs121908975	NC_000011.10:119025250:C:A
NM_003165.4(STXBP1):c.1631G>T (p.Gly544Val)	STXBP1	G544V	not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429757	9	130444768	9	127682489	429757	421698	rs121918317	NC_000009.12:127682488:G:T
NM_001032221.6(STXBP1):c.1099C>T (p.Arg367Ter)	STXBP1	R367*, R331*, R353*, R364*	not provided|Early infantile epileptic encephalopathy|Epileptic encephalopathy	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207429	9	130435529	9	127673250	207429	202308	rs796053366	NC_000009.12:127673249:C:T
NM_003165.4(STXBP1):c.704G>A (p.Arg235Gln)	STXBP1	R235Q	Early infantile epileptic encephalopathy|Cerebellar vermis hypoplasia|Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy 4|not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199083	9	130428485	9	127666206	199083	196242	rs794727970	NC_000009.12:127666205:G:A
NM_003165.4(STXBP1):c.1162C>T (p.Arg388Ter)	STXBP1	R388*	Early infantile epileptic encephalopathy 4|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006730	9	130438134	9	127675855	6730	21769	rs121918321	NC_000009.12:127675854:C:T
NM_000118.3(ENG):c.787_789del (p.Ile263del)	ENG	I263del, I81del	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000862246	9	130587537 - 130587539	9	127825258 - 127825260	862246	835479		NC_000009.12:127825257:GATGA:GA
NC_000009.12:g.(?_127815917)_(127854482_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000833137	9	130578196 - 130616761			833137	820060		
NC_000009.12:g.(?_127815672)_(127854482_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV000831730	9	130577951 - 130616761			831730	820057		
NC_000009.12:g.(?_127815907)_(127854365_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000830930	9	130578186 - 130616644			830930	820059		
NM_000118.3(ENG):c.991+2T>G	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000662789	9	130587077	9	127824798	662789	652099		NC_000009.12:127824797:A:C
NC_000009.11:g.(?_130616548)_(130616761_?)del	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000583891	9	130616548 - 130616761	9	127854269 - 127854482	583891	563226		
NM_000118.3(ENG):c.224del (p.Pro75fs)	ENG	P75fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000528051	9	130592102	9	127829823	528051	524525	rs1554810932	NC_000009.12:127829822:GGG:GG
NM_000118.3(ENG):c.782G>A (p.Trp261Ter)	ENG	W261*, W79*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000458353	9	130587544	9	127825265	458353	459304	rs1060501420	NC_000009.12:127825264:C:T
NM_000118.3(ENG):c.392del (p.Pro131fs)	ENG	P131fs	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	VCV000458347	9	130588920	9	127826641	458347	458792	rs1554810510	NC_000009.12:127826640:GGGGG:GGGG
NM_000118.3(ENG):c.721_725del (p.Ser241fs)	ENG	S59fs, S241fs	not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419981	9	130587601 - 130587605	9	127825322 - 127825326	419981	407547	rs1064794219	NC_000009.12:127825321:CAGCTCAG:CAG
NM_001114753.2(ENG):c.1117_1120AAGA[1] (p.Lys374fs)	ENG		not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419225	9	130586593 - 130586596	9	127824314 - 127824317	419225	407545	rs1064793734	NC_000009.12:127824313:TCTTTCTTT:TCTTT
NM_000118.3(ENG):c.219G>A (p.Thr73=)	ENG		Hereditary hemorrhagic telangiectasia|not specified	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407128	9	130605373	9	127843094	407128	397086	rs755348996	NC_000009.12:127843093:C:T
NM_000118.3(ENG):c.-127C>T	ENG		not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407113	9	130616761	9	127854482	407113	396851	rs1060501408	NC_000009.12:127854481:G:A
NM_000118.3(ENG):c.360C>A (p.Tyr120Ter)	ENG	Y120*	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000016676	9	130591966	9	127829687	16676	31715	rs121918402	NC_000009.12:127829686:G:T
NM_000118.3(ENG):c.2T>C (p.Met1Thr)	ENG	M1T	Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000016673	9	130616633	9	127854354	16673	31712	rs267606783	NC_000009.12:127854353:A:G
NM_213599.3(ANO5):c.1013+1G>A	ANO5		Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802663	11	22271918	11	22250372	802663	791125		NC_000011.10:22250371:G:A
NM_213599.2(ANO5):c.1516del (p.Ser506fs)	ANO5	S505fs, S506fs	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000596847	11	22281170	11	22259624	596847	587908	rs1302414683	NC_000011.10:22259623:AAAA:AAA
NM_213599.2(ANO5):c.1960C>T (p.Arg654Ter)	ANO5	R654*, R653*	not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000596648	11	22291919	11	22270373	596648	587709	rs1488095558	NC_000011.10:22270372:C:T
NM_213599.2(ANO5):c.835C>T (p.Arg279Ter)	ANO5	R279*, R278*	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000596409	11	22261187	11	22239641	596409	587470	rs1564930625	NC_000011.10:22239640:C:T
NM_213599.2(ANO5):c.306del (p.Glu103fs)	ANO5	E102fs, E103fs	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000593921	11	22247538	11	22225992	593921	584984	rs1564922516	NC_000011.10:22225991:AAAA:AAA
NM_213599.2(ANO5):c.2345C>G (p.Ser782Ter)	ANO5	S782*, S781*	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000502370	11	22296224	11	22274678	502370	493794	rs753138577	NC_000011.10:22274677:C:G
NM_213599.2(ANO5):c.2470del (p.Gln824fs)	ANO5	Q824fs, Q823fs	not provided	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000497102	11	22297695	11	22276149	497102	273400	rs770694933	NC_000011.10:22276148:C:
NM_213599.2(ANO5):c.1406G>A (p.Trp469Ter)	ANO5	W469*, W468*	not provided	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000290010	11	22279299	11	22257753	290010	274247	rs765427574	NC_000011.10:22257752:G:A
NM_213599.2(ANO5):c.104_105GA[2] (p.Glu36fs)	ANO5		not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000288833	11	22232825 - 22232826	11	22211279 - 22211280	288833	273070	rs886044020	NC_000011.10:22211278:AGAGAGA:AGAGA
NM_213599.2(ANO5):c.1992dup (p.Gly665fs)	ANO5		not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000286917	11	22291947 - 22291948	11	22270401 - 22270402	286917	271154	rs1554933716	NC_000011.10:22270401:TTTT:TTTTT
NM_213599.2(ANO5):c.889G>T (p.Gly297Ter)	ANO5	G297*, G296*	not provided	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000285319	11	22271793	11	22250247	285319	269556	rs886043074	NC_000011.10:22250246:G:T
NM_213599.2(ANO5):c.2446G>T (p.Glu816Ter)	ANO5	E816*, E815*	not provided	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000284139	11	22297671	11	22276125	284139	268376	rs145127621	NC_000011.10:22276124:G:T
NM_213599.2(ANO5):c.2235+1G>A	ANO5		not provided	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000282635	11	22294536	11	22272990	282635	266872	rs886042442	NC_000011.10:22272989:G:A
NM_213599.2(ANO5):c.196_200CAAAG[1] (p.Ser67fs)	ANO5		not provided	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000197908	11	22242656 - 22242660	11	22221110 - 22221114	197908	195069	rs794727745	NC_000011.10:22221109:AGCAAAGCAAAG:AGCAAAG
NM_213599.2(ANO5):c.2172_2178del (p.Ala724_His725insTer)	ANO5		not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000195002	11	22294469 - 22294475	11	22272923 - 22272929	195002	192164	rs794727231	NC_000011.10:22272922:AGCTCATAGC:AGC
NM_213599.2(ANO5):c.1709C>G (p.Ser570Ter)	ANO5	S570*, S569*	not provided	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000194688	11	22283753	11	22262207	194688	191851	rs765262083	NC_000011.10:22262206:C:G
NM_213599.2(ANO5):c.69C>A (p.Tyr23Ter)	ANO5	Y23*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000598197	11	22225378	11	22203832	598197	589258	rs762035813	NC_000011.10:22203831:C:A
NM_213599.2(ANO5):c.1207C>T (p.Gln403Ter)	ANO5	Q403*, Q402*	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000500532	11	22276943	11	22255397	500532	491956	rs1554930267	NC_000011.10:22255396:C:T
NM_213599.2(ANO5):c.1078T>C (p.Cys360Arg)	ANO5	C360R, C359R	Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437436	11	22272351	11	22250805	437436	430997	rs1554929292	NC_000011.10:22250804:T:C
NM_213599.2(ANO5):c.1541C>T (p.Thr514Ile)	ANO5	T513I, T514I	Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000060689	11	22281198	11	22259652	60689	75263	rs397514736	NC_000011.10:22259651:C:T
NM_213599.2(ANO5):c.1407+5G>A	ANO5		Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Nov 29, 2012)	no assertion criteria provided	VCV000039276	11	22279305	11	22257759	39276	47882	rs281865464	NC_000011.10:22257758:G:A
NM_003640.5(ELP1):c.2499dup (p.Lys834Ter)	ELP1		not provided|Familial dysautonomia	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423215	9	111659429 - 111659430	9	108897149 - 108897150	423215	407512	rs767527819	NC_000009.12:108897149:A:AA
NC_000011.10:g.(?_22193483)_(22226062_?)del	ANO5		Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000830674	11	22215029 - 22247608			830674	820348		
NM_213599.2(ANO5):c.1359C>G (p.Tyr453Ter)	ANO5	Y452*, Y453*	Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000694040	11	22279252	11	22257706	694040	681859		NC_000011.10:22257705:C:G
NM_213599.2(ANO5):c.1755T>A (p.Tyr585Ter)	ANO5	Y585*, Y584*	Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000694036	11	22283799	11	22262253	694036	681855		NC_000011.10:22262252:T:A
NM_213599.2(ANO5):c.775A>T (p.Lys259Ter)	ANO5	K258*, K259*	Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000650336	11	22261127	11	22239581	650336	639882		NC_000011.10:22239580:A:T
NM_213599.2(ANO5):c.873_876del (p.Ile292fs)	ANO5	I291fs, I292fs	Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000644214	11	22261223 - 22261226	11	22239677 - 22239680	644214	639885		NC_000011.10:22239676:TTGATT:TT
NM_213599.2(ANO5):c.1158del (p.Phe386fs)	ANO5	F385fs, F386fs	Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000619026	11	22272533	11	22250987	619026	610424	rs1564936489	NC_000011.10:22250986:TTT:TT
NM_213599.2(ANO5):c.1737dup (p.Gly580fs)	ANO5		Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000578516	11	22283778 - 22283779	11	22262232 - 22262233	578516	565610	rs759064817	NC_000011.10:22262232:AAA:AAAA
NM_213599.2(ANO5):c.412G>T (p.Glu138Ter)	ANO5	E138*, E137*	Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000468828	11	22248896	11	22227350	468828	461771	rs1554924356	NC_000011.10:22227349:G:T
NM_213599.2(ANO5):c.813C>G (p.Tyr271Ter)	ANO5	Y271*, Y270*	Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000468826	11	22261165	11	22239619	468826	461062	rs1380525804	NC_000011.10:22239618:C:G
NM_213599.2(ANO5):c.1409T>G (p.Met470Arg)	ANO5	M470R, M469R	Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000446703	11	22281066	11	22259520	446703	440222	rs1403946332	NC_000011.10:22259519:T:G
NM_213599.2(ANO5):c.1631-12_1631-2del	ANO5		not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000286167	11	22283663 - 22283673	11	22262117 - 22262127	286167	270404	rs886043327	NC_000011.10:22262116:TTAACTTAACA:
SLC37A4, 170-BP DEL, NT148	SLC37A4		Phosphate transport defect|Glucose-6-phosphate transport defect	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006925					6925	21964		
NM_000118.3(ENG):c.187G>T (p.Glu63Ter)	ENG	E63*	Hereditary hemorrhagic telangiectasia type 1|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811250	9	130605405	9	127843126	811250	799576		NC_000009.12:127843125:C:A
NM_000118.3(ENG):c.145G>T (p.Val49Phe)	ENG	V49F	Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000572196	9	130605447	9	127843168	572196	565523	rs1252348200	NC_000009.12:127843167:C:A
NM_000118.3(ENG):c.2T>G (p.Met1Arg)	ENG	M1R	not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000458346	9	130616633	9	127854354	458346	458812	rs267606783	NC_000009.12:127854353:A:C
NM_000118.3(ENG):c.67+1G>A	ENG		not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000449321	9	130616567	9	127854288	449321	444363	rs1554813783	NC_000009.12:127854287:C:T
NM_000118.3(ENG):c.765del (p.Tyr258fs)	ENG	Y258fs, Y76fs	not specified|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439654	9	130587561	9	127825282	439654	433059	rs1554810232	NC_000009.12:127825281:A:
NM_000118.3(ENG):c.904G>T (p.Glu302Ter)	ENG	E302*, E120*	not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000407132	9	130587166	9	127824887	407132	396409	rs1060501419	NC_000009.12:127824886:C:A
NM_000118.3(ENG):c.1A>G (p.Met1Val)	ENG	M1V	not specified|Hereditary hemorrhagic telangiectasia type 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000407131	9	130616634	9	127854355	407131	397093	rs1060501418	NC_000009.12:127854354:T:C
NM_001114753.2(ENG):c.1029_1060delinsATGGTGG (p.Thr344fs)	ENG		not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000407120	9	130586657 - 130586688	9	127824378 - 127824409	407120	397059	rs1064792934	NC_000009.12:127824377:GCTCCGGGCTACAAGTGTCCTTGGGAGGAGTG:CCACCAT
NM_000118.3(ENG):c.1080_1083del (p.Thr361fs)	ENG	T361fs, T179fs	not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213214	9	130586634 - 130586637	9	127824355 - 127824358	213214	209952	rs863223540	NC_000009.12:127824354:TGTCTG:TG
NM_004281.3(BAG3):c.1267_1276del (p.Leu423fs)	BAG3	L423fs	not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000201686	10	121436332 - 121436341	10	119676820 - 119676829	201686	198239	rs794728981	NC_000010.11:119676819:GCTGAAAGTGG:G
NM_213599.2(ANO5):c.220C>T (p.Arg74Ter)	ANO5	R74*, R73*	Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000536729	11	22242682	11	22221136	536729	526537	rs749645231	NC_000011.10:22221135:C:T
NM_213599.2(ANO5):c.1088G>A (p.Trp363Ter)	ANO5	W363*, W362*	not provided|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504242	11	22272361	11	22250815	504242	495273	rs1554929301	NC_000011.10:22250814:G:A
NM_213599.2(ANO5):c.1767C>A (p.Tyr589Ter)	ANO5	Y589*, Y588*	not provided|Limb-girdle muscular dystrophy, type 2L	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000502588	11	22283811	11	22262265	502588	494011	rs188150039	NC_000011.10:22262264:C:A
NM_213599.2(ANO5):c.299del (p.Arg100fs)	ANO5	R99fs, R100fs	not provided|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418672	11	22247534	11	22225988	418672	408319	rs1064793358	NC_000011.10:22225987:G:
NM_015046.7(SETX):c.5267T>C (p.Phe1756Ser)	SETX	F1756S	not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000586549	9	135201718	9	132326331	586549	577103	rs762175796	NC_000009.12:132326330:A:G
NM_015046.7(SETX):c.5264del (p.Thr1755fs)	SETX	T1755fs	Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000572675	9	135201721	9	132326334	572675	568595	rs776632212	NC_000009.12:132326333:G:
NM_000543.5(SMPD1):c.475T>C (p.Cys159Arg)	SMPD1	C159R, C158R	not specified|Niemann-Pick disease, type A|not provided|Niemann-Pick disease, type A|Niemann-Pick disease, type B	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167709	11	6412770	11	6391540	167709	177267	rs727504166	NC_000011.10:6391539:T:C
NM_000543.5(SMPD1):c.1624C>T (p.Arg542Ter)	SMPD1	R542*, R235*, R498*, R541*	Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093318	11	6415565	11	6394335	93318	99225	rs398123478	NC_000011.10:6394334:C:T
NM_000155.4(GALT):c.1052del (p.Pro351fs)	GALT	P351fs, P242fs	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000193559	9	34649551	9	34649554	193559	190722	rs111033813	NC_000009.12:34649553:CCCC:CCC
NM_000155.4(GALT):c.634C>T (p.Gln212Ter)	GALT	Q212*, Q103*	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, multiple submitters, no conflicts	VCV000025234	9	34648400	9	34648403	25234	36568	rs111033746	NC_000009.12:34648402:C:T
NM_000155.4(GALT):c.564+1G>A	GALT		not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025215	9	34648169	9	34648172	25215	36549	rs111033723	NC_000009.12:34648171:G:A
NM_000155.4(GALT):c.400del (p.Trp134fs)	GALT	W134fs, W25fs	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025171	9	34647851	9	34647854	25171	36505	rs111033689	NC_000009.12:34647853:T:
NM_000155.4(GALT):c.221T>C (p.Leu74Pro)	GALT	L74P, C7R	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000003615	9	34647224	9	34647227	3615	18654	rs111033663	NC_000009.12:34647226:T:C
NM_213599.2(ANO5):c.1955A>G (p.Tyr652Cys)	ANO5	Y652C, Y651C	not provided|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432005	11	22291914	11	22270368	432005	425919	rs563666662	NC_000011.10:22270367:A:G
ANO5, IVS14DS, G-A, +5	ANO5		Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3	Pathogenic(Last reviewed: Mar 20, 2012)	no assertion criteria provided	VCV000039750					39750	48349		
NM_001142649.2(ANO5):c.2304_2305CA[2] (p.Gln770fs)	ANO5		not provided|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Nov 29, 2012)	no assertion criteria provided	VCV000039277	11	22296186 - 22296187	11	22274640 - 22274641	39277	47883	rs137854528	NC_000011.10:22274639:CACACA:CACA
NM_213599.2(ANO5):c.1066T>G (p.Cys356Gly)	ANO5	C356G, C355G	not provided|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Nov 29, 2012)	no assertion criteria provided	VCV000002162	11	22272339	11	22250793	2162	17201	rs119103234	NC_000011.10:22250792:T:G
NC_000011.10:g.(?_32396247)_(32400054_?)del	WT1		Wilms tumor 1|Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000833202	11	32417793 - 32421600			833202	820359		
NM_024426.6(WT1):c.1149del (p.Val384fs)	WT1	V384fs, V150fs, V167fs, V367fs	Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome|Drash syndrome	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000543120	11	32417918	11	32396372	543120	526148	rs1554939839	NC_000011.10:32396371:AA:A
NM_078480.3(PUF60):c.496del (p.Thr166fs)	PUF60	T123fs, T165fs, T106fs, T148fs, T203fs, T137fs, T149fs, T120fs, T166fs, T186fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000521037	8	144900557	8	143818387	521037	511742	rs1554643463	NC_000008.11:143818386:T:
NM_078480.3(PUF60):c.376del (p.Ala126fs)	PUF60	A108fs, A126fs, A146fs, A83fs, A125fs, A163fs, A109fs, A80fs, A66fs, A97fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000520739	8	144900677	8	143818507	520739	511744	rs1554643598	NC_000008.11:143818506:CC:C
NM_004519.4(KCNQ3):c.679C>T (p.Arg227Ter)	KCNQ3	R227*, R107*	not provided	Pathogenic(Last reviewed: Mar 3, 2014)	criteria provided, single submitter	VCV000205961	8	133192502	8	132180255	205961	202182	rs796052675	NC_000008.11:132180254:G:A
NM_004519.4(KCNQ3):c.61_77del (p.Gly20_Gly21insTer)	KCNQ3		Benign familial neonatal seizures	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000842150	8	133492703 - 133492719	8	132480456 - 132480472	842150	834139		NC_000008.11:132480455:GCCGCCCCGCCGCCTCCGCCGCCCC:GCCGCCCC
NM_004519.4(KCNQ3):c.1722del (p.Gly575fs)	KCNQ3	G575fs, G455fs	Benign familial neonatal seizures	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000841488	8	133146614	8	132134367	841488	834123		NC_000008.11:132134366:A:
NM_004519.4(KCNQ3):c.1142C>T (p.Ala381Val)	KCNQ3	A381V, A261V	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433110	8	133182674	8	132170427	433110	426671	rs1554626549	NC_000008.11:132170426:G:A
NM_014112.5(TRPS1):c.1088T>G (p.Leu363Ter)	TRPS1	L363*, L354*, L350*, L356*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000521528	8	116617108	8	115604881	521528	511736	rs1554596397	NC_000008.11:115604880:A:C
NM_014112.5(TRPS1):c.1630C>T (p.Arg544Ter)	TRPS1	R544*, R535*, R531*, R537*	Langer-Giedion syndrome|Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I|	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000267746	8	116616566	8	115604339	267746	263045	rs886040971	NC_000008.11:115604338:G:A
NM_004519.4(KCNQ3):c.1218_1219CT[1] (p.Ser407fs)	KCNQ3		Benign familial neonatal seizures	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000839826	8	133182595 - 133182596	8	132170348 - 132170349	839826	834130		NC_000008.11:132170347:AGAGA:AGA
NM_004519.4(KCNQ3):c.914A>G (p.Asp305Gly)	KCNQ3	D305G, D185G	Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000021414	8	133187719	8	132175472	21414	34266	rs118192248	NC_000008.11:132175471:T:C
NM_004519.4(KCNQ3):c.895G>A (p.Glu299Lys)	KCNQ3	E299K, E179K	Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000021413	8	133187738	8	132175491	21413	34265	rs118192247	NC_000008.11:132175490:C:T
NM_000834.5(GRIN2B):c.3952del (p.Ala1318fs)	GRIN2B	A1318fs	not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000817872	12	13716220	12	13563286	817872	805731		NC_000012.12:13563285:CC:C
NM_000834.4(GRIN2B):c.2458G>C (p.Gly820Arg)	GRIN2B	G820R	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000546296	12	13720099	12	13567165	546296	536832	rs1555103150	NC_000012.12:13567164:C:G
NM_000834.4(GRIN2B):c.706G>T (p.Glu236Ter)	GRIN2B	E236*	not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000523893	12	13906555	12	13753621	523893	514637	rs1555133077	NC_000012.12:13753620:C:A
NM_000834.4(GRIN2B):c.4168_4169del (p.Thr1390fs)	GRIN2B	T1390fs	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000453166	12	13716003 - 13716004	12	13563069 - 13563070	453166	444948	rs1555101670	NC_000012.12:13563068:GTG:G
NM_000834.4(GRIN2B):c.2039del (p.Pro680fs)	GRIN2B	P680fs	not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000452935	12	13724870	12	13571936	452935	444951	rs1555103995	NC_000012.12:13571935:GGGGG:GGGG
NM_000834.4(GRIN2B):c.1954G>C (p.Ala652Pro)	GRIN2B	A652P	not provided	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000452873	12	13761593	12	13608659	452873	444952	rs1555110812	NC_000012.12:13608658:C:G
NM_000834.4(GRIN2B):c.838_839del (p.Val280fs)	GRIN2B	V280fs	not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000450181	12	13906422 - 13906423	12	13753488 - 13753489	450181	444955	rs1555133006	NC_000012.12:13753487:ACA:A
NM_000834.4(GRIN2B):c.1328+1G>A	GRIN2B		not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000449793	12	13769388	12	13616454	449793	444953	rs1555112323	NC_000012.12:13616453:C:T
NM_000834.4(GRIN2B):c.1576T>C (p.Ser526Pro)	GRIN2B	S526P	not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000429969	12	13768126	12	13615192	429969	421910	rs1131691702	NC_000012.12:13615191:A:G
NM_000834.4(GRIN2B):c.1440_1443dup (p.Thr482fs)	GRIN2B		not provided	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000429224	12	13768483 - 13768484	12	13615549 - 13615550	429224	421911	rs1131691268	NC_000012.12:13615549:AACCA:AACCAACCA
NM_000834.4(GRIN2B):c.2477G>A (p.Gly826Glu)	GRIN2B	G826E	not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000421209	12	13720080	12	13567146	421209	408604	rs1064794979	NC_000012.12:13567145:C:T
NM_000834.4(GRIN2B):c.1372A>T (p.Lys458Ter)	GRIN2B	K458*	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000392200	12	13768555	12	13615621	392200	374871	rs1057524392	NC_000012.12:13615620:T:A
NM_000834.4(GRIN2B):c.1555C>T (p.Arg519Ter)	GRIN2B	R519*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000391757	12	13768147	12	13615213	391757	372867	rs774592932	NC_000012.12:13615212:G:A
NM_000834.4(GRIN2B):c.1780+2_1780+3delinsGT	GRIN2B		not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000373732	12	13764656 - 13764657	12	13611722 - 13611723	373732	359943	rs1057518577	NC_000012.12:13611721:TA:AC
NM_000834.4(GRIN2B):c.1823T>A (p.Leu608Ter)	GRIN2B	L608*	not provided	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000285854	12	13761724	12	13608790	285854	270091	rs886043237	NC_000012.12:13608789:A:T
NM_000834.4(GRIN2B):c.3012C>G (p.Tyr1004Ter)	GRIN2B	Y1004*	not provided	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000280553	12	13717160	12	13564226	280553	264518	rs201439880	NC_000012.12:13564225:G:C
NM_000834.4(GRIN2B):c.2459G>T (p.Gly820Val)	GRIN2B	G820V	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000234635	12	13720098	12	13567164	234635	231836	rs797044849	NC_000012.12:13567163:C:A
NM_000834.4(GRIN2B):c.2430C>A (p.Ser810Arg)	GRIN2B	S810R	not provided	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	VCV000218471	12	13720127	12	13567193	218471	215446	rs864309560	NC_000012.12:13567192:G:T
NM_000834.4(GRIN2B):c.3210T>A (p.Tyr1070Ter)	GRIN2B	Y1070*	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802821	12	13716962	12	13564028	802821	791215		NC_000012.12:13564027:A:T
NM_000834.4(GRIN2B):c.1238A>G (p.Glu413Gly)	GRIN2B	E413G	Mental retardation, autosomal dominant 6	Pathogenic	no assertion criteria provided	VCV000143189	12	13769479	12	13616545	143189	152907	rs527236034	NC_000012.12:13616544:T:C
NM_000255.4(MMUT):c.1280G>A (p.Gly427Asp)	MMUT	G427D	not provided|Methylmalonic acidemia|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218990	6	49419231	6	49451518	218990	216044	rs753288303	NC_000006.12:49451517:C:T
NM_000255.4(MMUT):c.655A>T (p.Asn219Tyr)	MMUT	N219Y	not provided|Methylmalonic acidemia|METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001886	6	49425502	6	49457789	1886	16925	rs121918256	NC_000006.12:49457788:T:A
NM_000834.4(GRIN2B):c.2171+3A>G	GRIN2B		Intellectual disability	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000691253	12	13724735	12	13571801	691253	678961		NC_000012.12:13571800:T:C
NM_000834.4(GRIN2B):c.2560del (p.Cys854fs)	GRIN2B	C854fs	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000619997	12	13719997	12	13567063	619997	611410	rs1565455778	NC_000012.12:13567062:A:
NM_000834.4(GRIN2B):c.1821G>A (p.Trp607Ter)	GRIN2B	W607*	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000574682	12	13761726	12	13608792	574682	571720	rs1057518700	NC_000012.12:13608791:C:T
NM_000834.4(GRIN2B):c.1345G>T (p.Glu449Ter)	GRIN2B	E449*	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000544230	12	13768582	12	13615648	544230	527240	rs1555112186	NC_000012.12:13615647:C:A
NM_000834.4(GRIN2B):c.1619G>A (p.Arg540His)	GRIN2B	R540H	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000162087	12	13768083	12	13615149	162087	171803	rs672601378	NC_000012.12:13615148:C:T
NM_000834.4(GRIN2B):c.1844A>T (p.Asn615Ile)	GRIN2B	N615I	Epileptic encephalopathy, early infantile, 27	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000162086	12	13761703	12	13608769	162086	171802	rs672601377	NC_000012.12:13608768:T:A
NM_000834.4(GRIN2B):c.1853T>G (p.Val618Gly)	GRIN2B	V618G	Epileptic encephalopathy, early infantile, 27	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000162085	12	13761694	12	13608760	162085	171801	rs672601376	NC_000012.12:13608759:A:C
NM_000834.4(GRIN2B):c.1658C>T (p.Pro553Leu)	GRIN2B	P553L	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Aug 11, 2017)	no assertion criteria provided	VCV000039661	12	13764781	12	13611847	39661	48260	rs397514556	NC_000012.12:13611846:G:A
NM_000834.4(GRIN2B):c.2172-2A>G	GRIN2B		Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039659	12	13722953	12	13570019	39659	48258	rs398122824	NC_000012.12:13570018:T:C
NM_000834.4(GRIN2B):c.1367G>A (p.Cys456Tyr)	GRIN2B	C456Y	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039658	12	13768560	12	13615626	39658	48257	rs397514555	NC_000012.12:13615625:C:T
NM_000834.4(GRIN2B):c.2360-2A>G	GRIN2B		Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000029731	12	13720199	12	13567265	29731	38686	rs1057519612	NC_000012.12:13567264:T:C
NM_000834.4(GRIN2B):c.801_802CA[1] (p.Thr268fs)	GRIN2B		Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000029729	12	13906457 - 13906458	12	13753523 - 13753524	29729	38684	rs1060499526	NC_000012.12:13753522:TGTGT:TGT
NM_000834.4(GRIN2B):c.411+1G>A	GRIN2B		Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000029728	12	14018731	12	13865797	29728	38683	rs1057519611	NC_000012.12:13865796:C:T
NM_016203.4(PRKAG2):c.1592G>T (p.Arg531Leu)	PRKAG2	R531L, R290L, R406L, R407L, R487L	Hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045701	7	151257696	7	151560610	45701	54866	rs121908991	NC_000007.14:151560609:C:A
NM_000834.4(GRIN2B):c.1966C>T (p.Gln656Ter)	GRIN2B	Q656*	Epileptic encephalopathy, early infantile, 27	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431127	12	13761581	12	13608647	431127	424660	rs1135401799	NC_000012.12:13608646:G:A
NM_000834.4(GRIN2B):c.2084T>C (p.Ile695Thr)	GRIN2B	I695T	Ataxia|intellectual deficiency|not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000234790	12	13724825	12	13571891	234790	231839	rs876661219	NC_000012.12:13571890:A:G
NM_001164277.1(SLC37A4):c.359dup (p.Cys121fs)	SLC37A4		Glucose-6-phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633417	11	118898925 - 118898926	11	119028215 - 119028216	633417	621345	rs1182102272	NC_000011.10:119028215:GGGGG:GGGGGG
NM_000834.4(GRIN2B):c.2252T>C (p.Ile751Thr)	GRIN2B	I751T	not provided|Mental retardation, autosomal dominant 6	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234500	12	13722871	12	13569937	234500	231838	rs876661055	NC_000012.12:13569936:A:G
NM_000834.4(GRIN2B):c.1677G>A (p.Trp559Ter)	GRIN2B	W559*	not provided|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000039660	12	13764762	12	13611828	39660	48259	rs398122825	NC_000012.12:13611827:C:T
NM_000834.4(GRIN2B):c.2044C>T (p.Arg682Cys)	GRIN2B	R682C	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	VCV000029730	12	13724865	12	13571931	29730	38685	rs387906636	NC_000012.12:13571930:G:A
NM_000118.3(ENG):c.523G>T (p.Ala175Ser)	ENG	A175S	Hereditary hemorrhagic telangiectasia type 1|Hereditary hemorrhagic telangiectasia	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000641795	9	130588789	9	127826510	641795	637705		NC_000009.12:127826509:C:A
NM_000118.3(ENG):c.991+2T>C	ENG		Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000575140	9	130587077	9	127824798	575140	562756	rs1564455554	NC_000009.12:127824797:A:G
NM_000118.3(ENG):c.817-1G>C	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000573259	9	130587254	9	127824975	573259	563451	rs1564455715	NC_000009.12:127824974:C:G
NM_000118.3(ENG):c.593_594CG[3] (p.Thr200fs)	ENG		not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503943	9	130588066 - 130588067	9	127825787 - 127825788	503943	495390	rs1554810405	NC_000009.12:127825787:CGCG:CGCGCG
NM_000118.3(ENG):c.808C>T (p.Gln270Ter)	ENG	Q270*, Q88*	not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000458355	9	130587518	9	127825239	458355	458260	rs1554810215	NC_000009.12:127825238:G:A
NM_000118.3(ENG):c.524-2A>G	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000407119	9	130588141	9	127825862	407119	396844	rs1060501414	NC_000009.12:127825861:T:C
NM_000399.5(EGR2):c.1075C>T (p.Arg359Trp)	EGR2	R359W, R309W	Charcot-Marie-Tooth disease, demyelinating, type 1d|Dejerine-sottas neuropathy, autosomal dominant|Dejerine-Sottas disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016752	10	64573323	10	62813563	16752	31791	rs104894161	NC_000010.11:62813562:G:A
NM_213599.2(ANO5):c.148C>T (p.Arg50Ter)	ANO5	R50*, R49*	Limb-girdle muscular dystrophy, type 2L|Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468825	11	22239801	11	22218255	468825	461388	rs1168346560	NC_000011.10:22218254:C:T
NM_213599.2(ANO5):c.1639C>T (p.Arg547Ter)	ANO5	R547*, R546*	not provided|Limb-girdle muscular dystrophy, type 2L	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000288832	11	22283683	11	22262137	288832	273069	rs747719953	NC_000011.10:22262136:C:T
NM_213599.2(ANO5):c.2004del (p.Leu669fs)	ANO5	L668fs, L669fs	not provided|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000285669	11	22291961	11	22270415	285669	269906	rs886043172	NC_000011.10:22270414:GGG:GG
NM_213599.2(ANO5):c.1066T>C (p.Cys356Arg)	ANO5	C356R, C355R	not provided|Gnathodiaphyseal dysplasia	Pathogenic(Last reviewed: Nov 29, 2012)	no assertion criteria provided	VCV000002161	11	22272339	11	22250793	2161	17200	rs119103234	NC_000011.10:22250792:T:C
NM_000441.2(SLC26A4):c.249G>A (p.Trp83Ter)	SLC26A4	W83*	not provided|Pendred syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370650	7	107303825	7	107663380	370650	357528	rs1057516658	NC_000007.14:107663379:G:A
NM_000441.2(SLC26A4):c.916dup (p.Val306fs)	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370192	7	107323796 - 107323797	7	107683351 - 107683352	370192	357534	rs768245266	NC_000007.14:107683351:G:GG
NM_000441.2(SLC26A4):c.1341+1del	SLC26A4		Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	VCV000043505	7	107334925	7	107694480	43505	52675	rs397516417	NC_000007.14:107694479:GG:G
NM_000441.2(SLC26A4):c.1115C>T (p.Ala372Val)	SLC26A4	A372V	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000004823	7	107329611	7	107689166	4823	19862	rs121908364	NC_000007.14:107689165:C:T
NM_004519.4(KCNQ3):c.925T>C (p.Trp309Arg)	KCNQ3	W309R, W189R	Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000021415	8	133187708	8	132175461	21415	34267	rs118192249	NC_000008.11:132175460:A:G
NM_003640.5(ELP1):c.641del (p.Pro214fs)	ELP1	P100fs, P214fs	Familial dysautonomia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553108	9	111681541	9	108919261	553108	545098	rs759412460	NC_000009.12:108919260:GGG:GG
NM_000834.4(GRIN2B):c.3332G>A (p.Arg1111His)	GRIN2B	R1111H	not provided|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234696	12	13716840	12	13563906	234696	231831	rs876661167	NC_000012.12:13563905:C:T
NM_001287174.2(ABCC8):c.2222+1G>T	ABCC8		not provided|Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552779	11	17448595	11	17427048	552779	546191	rs1554923999	NC_000011.10:17427047:C:A
NM_001287174.2(ABCC8):c.3133_3152del (p.Thr1045fs)	ABCC8	T1045fs, T1066fs, T1043fs, T1044fs	Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280115	11	17428448 - 17428467	11	17406901 - 17406920	280115	264418	rs886041392	NC_000011.10:17406900:CAGTTCCTGGCTGCAGGGGTCAG:CAG
NM_030962.3(SBF2):c.548T>A (p.Leu183Ter)	SBF2	L183*	not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000448244	11	10050070	11	10028523	448244	441390	rs1554990103	NC_000011.10:10028522:A:T
NM_030962.3(SBF2):c.1053+2T>C	SBF2		not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000448232	11	10015466	11	9993919	448232	441498	rs1554977189	NC_000011.10:9993918:A:G
SBF2, EX11-12DEL	SBF2		Charcot-Marie-Tooth disease, type 4B2	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000002909					2909	17948		
NM_004722.4(AP4M1):c.727G>A (p.Gly243Ser)	AP4M1	G243S, G250S	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000520808	7	99702721	7	100105098	520808	511692	rs1554380093	NC_000007.14:100105097:G:A
NM_030962.3(SBF2):c.754_823del (p.Tyr252fs)	SBF2	Y252fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000582946	11	10022499 - 10022568	11	10000952 - 10001021	582946	565043	rs1565115957	
NM_030962.3(SBF2):c.3526C>T (p.Arg1176Ter)	SBF2	R1176*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000581182	11	9853897	11	9832350	581182	571096	rs774667470	NC_000011.10:9832349:G:A
NM_030962.3(SBF2):c.20_21del (p.Tyr7fs)	SBF2	Y7fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000574817	11	10315596 - 10315597	11	10294049 - 10294050	574817	564099	rs1270869520	NC_000011.10:10294048:GT:
NC_000011.9:g.(?_10215449)_(10215534_?)del	SBF2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jul 10, 2016)	criteria provided, single submitter	VCV000417314	11	10215449 - 10215534	11	10193902 - 10193987	417314	397989		
NM_000083.3(CLCN1):c.979G>A (p.Val327Ile)	CLCN1	V327I	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447078	7	143027990	7	143330897	447078	441048	rs774396430	NC_000007.14:143330896:G:A
NM_000083.3(CLCN1):c.1649C>T (p.Thr550Met)	CLCN1	T550M	Myotonia congenita|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000208084	7	143039088	7	143341995	208084	204363	rs762754992	NC_000007.14:143341994:C:T
NM_001613.4(ACTA2):c.353G>A (p.Arg118Gln)	ACTA2	R118Q	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 6|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000199670	10	90703570	10	88943813	199670	197398	rs112602953	NC_000010.11:88943812:C:T
NM_004519.4(KCNQ3):c.929G>T (p.Gly310Val)	KCNQ3	G263V, G310V, G190V	Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000007392	8	133187704	8	132175457	7392	22431	rs118192250	NC_000008.11:132175456:C:A
NM_002180.2(IGHMBP2):c.242del (p.Asn81fs)	IGHMBP2	N81fs	not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000593474	11	68673691	11	68906223	593474	584538	rs1249076926	NC_000011.10:68906222:AA:A
NM_002180.2(IGHMBP2):c.292_303delinsATGCT (p.Gly98fs)	IGHMBP2		not provided	Pathogenic(Last reviewed: Aug 29, 2015)	criteria provided, single submitter	VCV000429896	11	68675648 - 68675659	11	68908180 - 68908191	429896	421883	rs1131691657	NC_000011.10:68908179:GGCAGTCAGCTG:ATGCT
NM_002180.2(IGHMBP2):c.2598_2599del (p.Lys868fs)	IGHMBP2	K868fs	not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000287978	11	68704545 - 68704546	11	68937077 - 68937078	287978	272215	rs886043774	NC_000011.10:68937076:AGA:A
NM_002180.2(IGHMBP2):c.2560C>T (p.Gln854Ter)	IGHMBP2	Q854*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000282335	11	68704508	11	68937040	282335	266572	rs750024353	NC_000011.10:68937039:C:T
NM_002180.2(IGHMBP2):c.2197_2203delinsCA (p.Ile733fs)	IGHMBP2		not provided	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000282112	11	68704145 - 68704151	11	68936677 - 68936683	282112	266349	rs886042313	NC_000011.10:68936676:ATAGTGG:CA
NM_002180.2(IGHMBP2):c.1060+2T>C	IGHMBP2		not provided	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000245626	11	68685353	11	68917885	245626	244677	rs879253886	NC_000011.10:68917884:T:C
NM_002180.2(IGHMBP2):c.92G>A	IGHMBP2	W31*	Respiratory distress|Severe muscular hypotonia|Tachypnea|Hyperreflexia|Clonus|Failure to thrive|Ptosis	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000242499	11	68673542	11	68906074	242499	213614	rs863224880	NC_000011.10:68906073:G:A
NM_019098.4(CNGB3):c.991-3T>G	CNGB3		not provided|Leber congenital amaurosis|Retinal dystrophy|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188827	8	87656917	8	86644689	188827	186767	rs773372519	NC_000008.11:86644688:A:C
NM_002180.2(IGHMBP2):c.1202A>G (p.His401Arg)	IGHMBP2	H401R	Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic	no assertion criteria provided	VCV000626270	11	68696792	11	68929324	626270	614605	rs1566439723	NC_000011.10:68929323:A:G
NM_002180.2(IGHMBP2):c.1235+894C>A	IGHMBP2		Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000522869	11	68697719	11	68930251	522869	513440	rs1202430946	NC_000011.10:68930250:C:A
NM_002180.2(IGHMBP2):c.1118T>G (p.Val373Gly)	IGHMBP2	V373G	Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162197	11	68696708	11	68929240	162197	171905	rs724159959	NC_000011.10:68929239:T:G
NM_002180.3(IGHMBP2):c.1702del (p.Gln568fs)	IGHMBP2	Q568fs	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000860866	11	68702835	11	68935367	860866	838957		NC_000011.10:68935366:CC:C
NM_002180.3(IGHMBP2):c.216C>G (p.Tyr72Ter)	IGHMBP2	Y72*	Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000837509	11	68673666	11	68906198	837509	838934		NC_000011.10:68906197:C:G
NM_002180.3(IGHMBP2):c.2429del (p.Pro810fs)	IGHMBP2	P810fs	Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835758	11	68704373	11	68936905	835758	838967		NC_000011.10:68936904:CCCCC:CCCC
NM_002180.3(IGHMBP2):c.133del (p.Val45fs)	IGHMBP2	V45fs	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000640505	11	68673583	11	68906115	640505	640397		NC_000011.10:68906114:G:
NM_002180.2(IGHMBP2):c.1516G>T (p.Glu506Ter)	IGHMBP2	E506*	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000574350	11	68701360	11	68933892	574350	570947	rs556292818	NC_000011.10:68933891:G:T
NM_002180.2(IGHMBP2):c.2575C>T (p.Gln859Ter)	IGHMBP2	Q859*	Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000566209	11	68704523	11	68937055	566209	570976	rs1373247548	NC_000011.10:68937054:C:T
NM_002180.2(IGHMBP2):c.1681dup (p.Ile561fs)	IGHMBP2		Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000466583	11	68702812 - 68702813	11	68935344 - 68935345	466583	461950	rs1555247732	NC_000011.10:68935344:AAA:AAAA
NM_213599.2(ANO5):c.1120-1G>A	ANO5		Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000536726	11	22272496	11	22250950	536726	526031	rs561719071	NC_000011.10:22250949:G:A
NM_213599.2(ANO5):c.1210C>T (p.Arg404Ter)	ANO5	R404*, R403*	not provided|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217143	11	22276946	11	22255400	217143	213818	rs566415362	NC_000011.10:22255399:C:T
NM_002180.2(IGHMBP2):c.826C>T (p.Gln276Ter)	IGHMBP2	Q276*	Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000571351	11	68682405	11	68914937	571351	567508	rs1566430156	NC_000011.10:68914936:C:T
NM_002180.2(IGHMBP2):c.1346del (p.Met449fs)	IGHMBP2	M449fs	Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243079	11	68700877	11	68933409	243079	244163	rs879253865	NC_000011.10:68933408:T:
NM_004333.6(BRAF):c.1415A>G (p.Tyr472Cys)	BRAF	Y472C	Lung cancer	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375949	7	140481393	7	140781593	375949	362828	rs1057519719	NC_000007.14:140781592:T:C
NM_004333.6(BRAF):c.1495A>G (p.Lys499Glu)	BRAF	K499E	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013976	7	140477813	7	140778013	13976	29015	rs180177037	NC_000007.14:140778012:T:C
NM_004333.6(BRAF):c.1388T>G (p.Ile463Ser)	BRAF	I463S	Carcinoma of colon	Pathogenic(Last reviewed: Aug 15, 2003)	no assertion criteria provided	VCV000013963	7	140481420	7	140781620	13963	29002	rs180177033	NC_000007.14:140781619:A:C
NM_004333.6(BRAF):c.1385G>T (p.Arg462Ile)	BRAF	R462I	Carcinoma of colon	Pathogenic(Last reviewed: Aug 15, 2003)	no assertion criteria provided	VCV000013962	7	140481423	7	140781623	13962	29001	rs180177032	NC_000007.14:140781622:C:A
NM_023110.2(FGFR1):c.755C>G (p.Pro252Arg)	FGFR1	P252R, P244R, P250R, P283R, P161R, P163R	Pfeiffer syndrome||Jackson-Weiss syndrome|Pfeiffer syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000016279	8	38282208	8	38424690	16279	31318	rs121909627	NC_000008.11:38424689:G:C
NM_001164277.1(SLC37A4):c.1A>G (p.Met1Val)	SLC37A4	M1V	Glucose-6-phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189162	11	118900079	11	119029369	189162	186810	rs786204740	NC_000011.10:119029368:T:C
NM_000118.3(ENG):c.68-1G>A	ENG		not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237030	9	130605525	9	127843246	237030	240463	rs878853659	NC_000009.12:127843245:C:T
NM_000118.3(ENG):c.640_643del	ENG		Hereditary hemorrhagic telangiectasia type 1|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000220826	9	130588020 - 130588023	9	127825741 - 127825744	220826	221804	rs864622666	NC_000009.12:127825740:GGCCGGCC:GGCC
NM_003165.4(STXBP1):c.703C>T (p.Arg235Ter)	STXBP1	R235*	not provided|Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207422	9	130428484	9	127666205	207422	202297	rs796053359	NC_000009.12:127666204:C:T
NM_003165.4(STXBP1):c.569G>A (p.Arg190Gln)	STXBP1	R190Q	Early infantile epileptic encephalopathy|Autistic disorder of childhood onset|Photosensitive tonic-clonic seizures|Neurodegeneration|Intellectual disability, severe|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207418	9	130425623	9	127663344	207418	202291	rs796053356	NC_000009.12:127663343:G:A
NM_002180.2(IGHMBP2):c.1313dup (p.Thr439fs)	IGHMBP2		Spinal muscular atrophy, distal, autosomal recessive, 1|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582766	11	68700843 - 68700844	11	68933375 - 68933376	582766	567511	rs1566443170	NC_000011.10:68933375:T:TT
NM_002180.2(IGHMBP2):c.2368C>T (p.Arg790Ter)	IGHMBP2	R790*	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488695	11	68704316	11	68936848	488695	482002	rs773242930	NC_000011.10:68936847:C:T
NC_000011.10:g.(68906754_68906786)_(68925257_68925289)del	IGHMBP2		Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000009120	11	68674222 - 68692757	11	68906754 - 68925289	9120	24159		
NM_002180.2(IGHMBP2):c.1107C>G (p.Phe369Leu)	IGHMBP2	F369L	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000009119	11	68696697	11	68929229	9119	24158	rs137852670	NC_000011.10:68929228:C:G
NM_002180.2(IGHMBP2):c.707T>G (p.Leu236Ter)	IGHMBP2	L236*	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000009117	11	68679067	11	68911599	9117	24156	rs137852669	NC_000011.10:68911598:T:G
NM_002180.2(IGHMBP2):c.675del (p.Glu226fs)	IGHMBP2	E226fs	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000009116	11	68679034	11	68911566	9116	24155	rs786205089	NC_000011.10:68911565:TT:T
NM_002180.2(IGHMBP2):c.121C>T (p.Gln41Ter)	IGHMBP2	Q41*	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000009115	11	68673571	11	68906103	9115	24154	rs137852668	NC_000011.10:68906102:C:T
NM_030962.3(SBF2):c.3586C>T (p.Arg1196Ter)	SBF2	R1196*	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000002911	11	9853837	11	9832290	2911	17950	rs120074138	NC_000011.10:9832289:G:A
NM_004519.4(KCNQ3):c.950T>C (p.Ile317Thr)	KCNQ3	I317T, I197T	Benign familial neonatal seizures|Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000661030	8	133186580	8	132174333	661030	636596		NC_000008.11:132174332:A:G
NM_183050.4(BCKDHB):c.832G>A (p.Gly278Ser)	BCKDHB	G278S, G208S	Maple syrup urine disease|not provided|Maple syrup urine disease type 1B	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065771	6	80910740	6	80201023	65771	76679	rs386834233	NC_000006.12:80201022:G:A
NM_000155.4(GALT):c.983G>A (p.Arg328His)	GALT	R328H, R219H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025309	9	34649485	9	34649488	25309	36643	rs111033802	NC_000009.12:34649487:G:A
NM_000155.4(GALT):c.692G>A (p.Arg231His)	GALT	R231H, R122H	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000025247	9	34648763	9	34648766	25247	36581	rs111033754	NC_000009.12:34648765:G:A
NM_000155.4(GALT):c.396C>A (p.His132Gln)	GALT	H132Q, H23Q	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025170	9	34647847	9	34647850	25170	36504	rs367543256	NC_000009.12:34647849:C:A
NM_000155.4(GALT):c.290A>G (p.Asn97Ser)	GALT	N97S	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025146	9	34647526	9	34647529	25146	36480	rs111033669	NC_000009.12:34647528:A:G
NM_000834.4(GRIN2B):c.2539C>T (p.Arg847Ter)	GRIN2B	R847*	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27|not provided	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245756	12	13720018	12	13567084	245756	244793	rs879253931	NC_000012.12:13567083:G:A
NM_001287174.2(ABCC8):c.3644G>A (p.Arg1215Gln)	ABCC8	R1214Q, R1215Q, R1213Q, R1236Q	Familial hyperinsulinism	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000632619	11	17424217	11	17402670	632619	621346	rs367850779	NC_000011.10:17402669:C:T
NM_001287174.2(ABCC8):c.4160C>T (p.Ser1387Phe)	ABCC8	S1386F, S1387F, S1385F, S1408F	not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000446775	11	17417440	11	17395893	446775	441406	rs72559718	NC_000011.10:17395892:G:A
NM_001287174.2(ABCC8):c.3751C>T (p.Arg1251Ter)	ABCC8	R1250*, R1251*, R1272*, R1249*	Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370163	11	17419891	11	17398344	370163	357938	rs1057516281	NC_000011.10:17398343:G:A
NM_001287174.2(ABCC8):c.3512del (p.Leu1171fs)	ABCC8	L1170fs, L1192fs, L1169fs, L1171fs	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000157696	11	17426107	11	17404560	157696	167544	rs587783169	NC_000011.10:17404559:A:
NM_001287174.2(ABCC8):c.3548G>A (p.Arg1183Gln)	ABCC8	R1182Q, R1183Q, R1181Q, R1204Q	Neonatal diabetes mellitus|Transient neonatal diabetes mellitus 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, multiple submitters, no conflicts	VCV000035611	11	17426071	11	17404524	35611	44276	rs193922400	NC_000011.10:17404523:C:T
NM_001287174.2(ABCC8):c.4310G>A (p.Arg1437Gln)	ABCC8	R1436Q, R1437Q, R1435Q, R1458Q	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000009086	11	17417157	11	17395610	9086	24125	rs387906407	NC_000011.10:17395609:C:T
NM_213599.2(ANO5):c.139-1del	ANO5		not provided|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286467	11	22239791	11	22218245	286467	270704	rs868484837	NC_000011.10:22218244:G:
NM_213599.2(ANO5):c.1213C>T (p.Gln405Ter)	ANO5	Q405*, Q404*	Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|Muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000285742	11	22276949	11	22255403	285742	269979	rs368970223	NC_000011.10:22255402:C:T
NM_006731.2(FKTN):c.919C>T (p.Arg307Ter)	FKTN	R307*, R284*, R175*	Walker-Warburg congenital muscular dystrophy|Fukuyama congenital muscular dystrophy|not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003216	9	108380248	9	105617967	3216	18255	rs267606814	NC_000009.12:105617966:C:T
NM_006731.2(FKTN):c.920G>A (p.Arg307Gln)	FKTN	R307Q, R284Q, R175Q	Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4|not provided|Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003208	9	108380249	9	105617968	3208	18247	rs119463992	NC_000009.12:105617967:G:A
NM_000466.3(PEX1):c.1239+1G>T	PEX1		Deafness enamel hypoplasia nail defects|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217430	7	92146589	7	92517275	217430	214069	rs756876301	NC_000007.14:92517274:C:A
NM_005476.7(GNE):c.829C>T (p.Arg277Cys)	GNE	R277C, R308C, R272C, R167C	Sialuria|GNE myopathy|GNE myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188847	9	36234070	9	36234073	188847	186788	rs762106720	NC_000009.12:36234072:G:A
NM_000162.5(GCK):c.952G>A (p.Gly318Arg)	GCK	G318R, G319R, G317R	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000585929	7	44186129	7	44146530	585929	576983	rs193922340	NC_000007.14:44146529:C:T
NM_002180.2(IGHMBP2):c.449+1G>A	IGHMBP2		Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000534927	11	68675806	11	68908338	534927	527007	rs797044802	NC_000011.10:68908337:G:A
NM_000441.2(SLC26A4):c.165-1G>A	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000828068	7	107303740	7	107663295	828068	816404		NC_000007.14:107663294:G:A
NM_000441.2(SLC26A4):c.1579A>C (p.Thr527Pro)	SLC26A4	T527P	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000446454	7	107338521	7	107698076	446454	439903	rs1554360358	NC_000007.14:107698075:A:C
NM_000441.2(SLC26A4):c.304+2T>C	SLC26A4		Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189167	7	107303882	7	107663437	189167	186729	rs746238617	NC_000007.14:107663436:T:C
NM_000441.2(SLC26A4):c.2086C>T (p.Gln696Ter)	SLC26A4	Q696*	not provided|Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189164	7	107344827	7	107704382	189164	186741	rs752807925	NC_000007.14:107704381:C:T
NM_000441.2(SLC26A4):c.589G>A (p.Gly197Arg)	SLC26A4	G197R	Enlarged vestibular aqueduct|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000043562	7	107314782	7	107674337	43562	52731	rs111033380	NC_000007.14:107674336:G:A
NC_000009.12:g.(?_127825214)_(127826683_?)del	ENG		Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000833416	9	130587493 - 130588962			833416	820066		
NM_000118.3(ENG):c.511C>T (p.Arg171Ter)	ENG	R171*	not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439644	9	130588801	9	127826522	439644	433063	rs1554810490	NC_000009.12:127826521:G:A
NM_000834.4(GRIN2B):c.2065G>A (p.Gly689Ser)	GRIN2B	G689S	Epileptic encephalopathy, early infantile, 27|not provided|Mental retardation, autosomal dominant 6	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224818	12	13724844	12	13571910	224818	226651	rs869312868	NC_000012.12:13571909:C:T
NM_020376.4(PNPLA2):c.613dup (p.Leu205fs)	PNPLA2		Neutral lipid storage myopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000065419	11	822522 - 822523	11	822522 - 822523	65419	76349	rs796065308	NC_000011.10:822522:C:CC
NM_153676.4(USH1C):c.91C>T (p.Arg31Ter)	USH1C	R31*	Deafness, autosomal recessive 18|Usher syndrome, type 1C||not provided|Deafness, autosomal recessive 18|Usher syndrome, type 1C	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005146	11	17554815	11	17533268	5146	20185	rs121908370	NC_000011.10:17533267:G:A
NM_001278716.2(FBXL4):c.1444C>T (p.Arg482Trp)	FBXL4	R482W	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|not provided|Global developmental delay|Mitochondrial encephalomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000066093	6	99323549	6	98875673	66093	76995	rs398123061	NC_000006.12:98875672:G:A
NM_213599.2(ANO5):c.2018A>G (p.Tyr673Cys)	ANO5	Y673C, Y672C	Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000140555	11	22291977	11	22270431	140555	150233	rs137854527	NC_000011.10:22270430:A:G
NM_002180.2(IGHMBP2):c.638A>G (p.His213Arg)	IGHMBP2	H213R	Werdnig-Hoffmann disease|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000009113	11	68678998	11	68911530	9113	24152	rs137852666	NC_000011.10:68911529:A:G
NM_000108.5(DLD):c.1123G>A (p.Glu375Lys)	DLD	E375K, E352K, E276K, E327K	DLD-Related Disorders|Maple syrup urine disease, type 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011971	7	107557794	7	107917349	11971	27010	rs121964992	NC_000007.14:107917348:G:A
NM_004281.4(BAG3):c.1363G>A (p.Glu455Lys)	BAG3	E455K	Primary dilated cardiomyopathy|not provided|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044778	10	121436429	10	119676917	44778	53945	rs397516881	NC_000010.11:119676916:G:A
NM_032578.4(MYPN):c.295C>T (p.Arg99Ter)	MYPN	R99*	Dilated cardiomyopathy 1KK	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000851819	10	69881490	10	68121733	851819	837102		NC_000010.11:68121732:C:T
NM_032578.3(MYPN):c.3127del (p.Ser1043fs)	MYPN	S749fs, S1043fs	Dilated cardiomyopathy 1KK	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000661274	10	69955258	10	68195501	661274	639090		NC_000010.11:68195500:A:
NM_032578.3(MYPN):c.3214C>T (p.Arg1072Ter)	MYPN	R1072*, R778*	Nemaline myopathy 11, autosomal recessive	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000375568	10	69957164	10	68197407	375568	362378	rs1057519573	NC_000010.11:68197406:C:T
NM_032578.3(MYPN):c.1129C>T (p.Arg377Ter)	MYPN	R377*, R83*	Nemaline myopathy 11, autosomal recessive	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000375566	10	69905282	10	68145525	375566	362376	rs781261060	NC_000010.11:68145524:C:T
NM_032578.3(MYPN):c.3076-2A>C	MYPN		Nemaline myopathy 11, autosomal recessive	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000375565	10	69955205	10	68195448	375565	362375	rs1057519571	NC_000010.11:68195447:A:C
NM_032578.3(MYPN):c.2003del (p.Asn668fs)	MYPN	N374fs, N668fs	Nemaline myopathy 11, autosomal recessive	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000375564	10	69933851	10	68174094	375564	362374	rs1057519570	NC_000010.11:68174093:AA:A
NM_032578.3(MYPN):c.1585C>T (p.Gln529Ter)	MYPN	Q529*, Q235*	Cardiomyopathy, familial restrictive, 4|not provided	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031816	10	69925560	10	68165803	31816	40476	rs199476408	NC_000010.11:68165802:C:T
NM_000352.6(ABCC8):c.382G>A (p.Glu128Lys)	ABCC8	E128K	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000853822	11	17491678	11	17470131	853822	838137		NC_000011.10:17470130:C:T
NM_001287174.2(ABCC8):c.1176+2T>C	ABCC8		not provided|Familial hyperinsulinism	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633026	11	17474664	11	17453117	633026	621807	rs750586210	NC_000011.10:17453116:A:G
NM_001287174.2(ABCC8):c.62T>A (p.Val21Asp)	ABCC8	V21D	Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000495835	11	17498262	11	17476715	495835	487472	rs200670692	NC_000011.10:17476714:A:T
NM_001287174.2(ABCC8):c.1630+1G>T	ABCC8		not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370604	11	17464266	11	17442719	370604	357951	rs773306994	NC_000011.10:17442718:C:A
NM_001287174.2(ABCC8):c.2800C>T (p.Arg934Ter)	ABCC8	R933*, R934*, R932*, R955*	Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188864	11	17429962	11	17408415	188864	186815	rs570388861	NC_000011.10:17408414:G:A
NM_001287174.2(ABCC8):c.4138C>T (p.Arg1380Cys)	ABCC8	R1379C, R1380C, R1378C, R1401C	Diabetes mellitus type 2|Transient neonatal diabetes mellitus 2|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000009105	11	17417462	11	17395915	9105	24144	rs137852673	NC_000011.10:17395914:G:A
NM_017909.4(RMND1):c.1349G>C (p.Ter450Ser)	RMND1	*450S, *280S	Inborn genetic diseases|Combined oxidative phosphorylation deficiency 11|Mitochondrial diseases	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000143051	6	151726371	6	151405236	143051	152761	rs115079861	NC_000006.12:151405235:C:G
NM_003002.4(SDHD):c.95C>A (p.Ser32Ter)	SDHD	S32*	Paragangliomas 1|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000006901	11	111958623	11	112087899	6901	21940	rs104894305	NC_000011.10:112087898:C:A
NM_000083.3(CLCN1):c.2518_2519del (p.Leu840fs)	CLCN1	L840fs	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000567845	7	143047670 - 143047671	7	143350577 - 143350578	567845	561613	rs780534566	NC_000007.14:143350576:CT:
NM_000083.3(CLCN1):c.1444G>A (p.Gly482Arg)	CLCN1	G482R	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000546108	7	143036388	7	143339295	546108	536725	rs746125212	NC_000007.14:143339294:G:A
NM_000083.3(CLCN1):c.892G>A (p.Ala298Thr)	CLCN1	A298T	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000531747	7	143027903	7	143330810	531747	523094	rs764100025	NC_000007.14:143330809:G:A
NM_000083.3(CLCN1):c.1471+1G>A	CLCN1		not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Feb 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447052	7	143036416	7	143339323	447052	441058	rs375596425	NC_000007.14:143339322:G:A
NM_000083.3(CLCN1):c.1063G>A (p.Gly355Arg)	CLCN1	G355R	not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447043	7	143028408	7	143331315	447043	441049	rs767000881	NC_000007.14:143331314:G:A
NM_000083.3(CLCN1):c.774+1G>A	CLCN1		Myotonia congenita|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265646	7	143020480	7	143323387	265646	259852	rs776073429	NC_000007.14:143323386:G:A
NM_000155.3(GALT):c.790_792invCTA (p.Leu264Ter)	GALT	L264*	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000459627	9	34648861 - 34648863	9	34648864 - 34648866	459627	459536		NC_000009.12:34648863:CTA:TAG
NM_003165.4(STXBP1):c.875G>T (p.Arg292Leu)	STXBP1	R292L	Inborn genetic diseases	Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	VCV000208686	9	130430439	9	127668160	208686	205259	rs796053361	NC_000009.12:127668159:G:T
NM_003165.4(STXBP1):c.568C>T (p.Arg190Trp)	STXBP1	R190W	Early infantile epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207417	9	130425622	9	127663343	207417	202290	rs796053355	NC_000009.12:127663342:C:T
NM_003165.4(STXBP1):c.364C>T (p.Arg122Ter)	STXBP1	R122*	Early infantile epileptic encephalopathy 4|Global developmental delay|Strabismus|Generalized hypotonia|Muscular hypotonia of the trunk|Delayed speech and language development|Infantile spasms|Horizontal nystagmus|not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000198157	9	130423419	9	127661140	198157	195318	rs794727792	NC_000009.12:127661139:C:T
NM_001003800.2(BICD2):c.320C>T (p.Ser107Leu)	BICD2	S107L	Spinal muscular atrophy|Autosomal dominant distal hereditary motor neuropathy|Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000055857	9	95491439	9	92729157	55857	70511	rs398123028	NC_000009.12:92729156:G:A
NM_000543.5(SMPD1):c.557C>T (p.Pro186Leu)	SMPD1	P186L, P185L	Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371341	11	6412852	11	6391622	371341	357983	rs1057517195	NC_000011.10:6391621:C:T
NM_022970.3(FGFR2):c.1144T>G (p.Tyr382Asp)	FGFR2	Y381D, Y382D, Y292D, Y266D, Y153D, Y293D, Y269D	Bent bone dysplasia syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000029856	10	123274777	10	121515263	29856	38811	rs387906678	NC_000010.11:121515262:A:C
NM_000118.3(ENG):c.1134G>A (p.Ala378=)	ENG		Hereditary hemorrhagic telangiectasia type 1|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000458328	9	130586583	9	127824304	458328	459290	rs1329127701	NC_000009.12:127824303:C:T
NM_000501.4(ELN):c.1150+1G>A	ELN		Cutis laxa, autosomal dominant 1|Supravalvar aortic stenosis|Venous malformation|Abnormality of digit|Dural ectasia|Hypertelorism|not provided|Supravalvar aortic stenosis	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163391	7	73469100	7	74054770	163391	176785	rs727503030	NC_000007.14:74054769:G:A
NM_030962.3(SBF2):c.1459C>T (p.Arg487Ter)	SBF2	R487*	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000002912	11	9990029	11	9968482	2912	17951	rs120074139	NC_000011.10:9968481:G:A
NM_004333.6(BRAF):c.1405_1406delinsTT (p.Gly469Leu)	BRAF		Lung cancer	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375950	7	140481402 - 140481403	7	140781602 - 140781603	375950	362829	rs1057519720	NC_000007.14:140781601:CC:AA
NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	BRAF	F468S, F508S, F416S, F471S, F380S, F431S, F434S, F446S	Rasopathy|not provided|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040366	7	140481405	7	140781605	40366	48836	rs397507473	NC_000007.14:140781604:A:G
NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	BRAF	L485F, L451F, L433F, L448F, L488F, L397F, L463F, L525F	Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000013975	7	140477853	7	140778053	13975	29014	rs180177036	NC_000007.14:140778052:C:G
NM_002180.2(IGHMBP2):c.1708C>T (p.Arg570Ter)	IGHMBP2	R570*	Distal spinal muscular atrophy|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561032	11	68702842	11	68935374	561032	552154	rs1000091588	NC_000011.10:68935373:C:T
NM_015046.7(SETX):c.5306_5307GA[1] (p.Glu1770fs)	SETX		not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Cerebellar ataxia	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448333	9	135187207 - 135187210	9	132311820 - 132311823	448333	441283	rs750959420	NC_000009.12:132311819:TCTCTCT:TCT
NM_015046.5(SETX):c.6848_6851delCAGA (p.Thr2283Lysfs)	SETX		not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|Amyotrophic lateral sclerosis type 4	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095668	9	135152531 - 135152534	9	132277144 - 132277147	95668	101565	rs398124286	
NM_213599.2(ANO5):c.304_308del (p.Lys102fs)	ANO5	K102fs, K101fs	Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3|not provided|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280322	11	22247535 - 22247539	11	22225989 - 22225993	280322	264605	rs776859202	NC_000011.10:22225988:AAGAAAAGA:AAGA
NM_213599.2(ANO5):c.762+1G>A	ANO5		not provided|Limb-girdle muscular dystrophy, type 2L|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217144	11	22257823	11	22236277	217144	213817	rs372221490	NC_000011.10:22236276:G:A
NM_213599.2(ANO5):c.1520del (p.Phe507fs)	ANO5	F506fs, F507fs	Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|Limb-girdle muscular dystrophy, type 2L|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194577	11	22281176	11	22259630	194577	191740	rs794727158	NC_000011.10:22259629:TT:T
NM_001105206.3(LAMA4):c.2849C>T (p.Pro950Leu)	LAMA4	P943L, P950L	Dilated cardiomyopathy 1JJ	Pathogenic(Last reviewed: Jul 31, 2007)	no assertion criteria provided	VCV000050370	6	112462089	6	112140887	50370	59493	rs387907365	NC_000006.12:112140886:G:A
NM_000441.2(SLC26A4):c.1667A>G (p.Tyr556Cys)	SLC26A4	Y556C	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000446456	7	107340580	7	107700135	446456	439905	rs763006761	NC_000007.14:107700134:A:G
NM_000441.2(SLC26A4):c.235C>T (p.Arg79Ter)	SLC26A4	R79*	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188950	7	107303811	7	107663366	188950	186726	rs786204581	NC_000007.14:107663365:C:T
NM_000441.2(SLC26A4):c.2015G>A (p.Gly672Glu)	SLC26A4	G672E	not provided|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043532	7	107342483	7	107702038	43532	52701	rs111033309	NC_000007.14:107702037:G:A
NM_000441.2(SLC26A4):c.1437+2T>G	SLC26A4		Pendred syndrome|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043508	7	107335163	7	107694718	43508	52678	rs397516418	NC_000007.14:107694717:T:G
NM_152743.4(BRAT1):c.803+1G>C	BRAT1		NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000225028	7	2583223	7	2543589	225028	226904	rs869312931	NC_000007.14:2543588:C:G
NM_019098.4(CNGB3):c.1006G>T (p.Glu336Ter)	CNGB3	E336*	Achromatopsia|Retinal dystrophy|not provided|Achromatopsia 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188968	8	87656899	8	86644671	188968	186766	rs373862340	NC_000008.11:86644670:C:A
NM_001287174.2(ABCC8):c.2041-21G>A	ABCC8		Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553929	11	17449510	11	17427963	553929	546279	rs746714109	NC_000011.10:17427962:C:T
NM_001287174.2(ABCC8):c.1879del (p.His627fs)	ABCC8	H627fs, H626fs	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370909	11	17450156	11	17428609	370909	357949	rs764613146	NC_000011.10:17428608:GGGGGG:GGGGG
NM_001360.2(DHCR7):c.292C>T (p.Gln98Ter)	DHCR7	Q98*	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188723	11	71155068	11	71444022	188723	186843	rs104886039	NC_000011.10:71444021:G:A
NM_005476.7(GNE):c.1571C>T (p.Ala524Val)	GNE	A524V, A555V, A414V, A519V	GNE myopathy|Sialuria|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000424619	9	36222836	9	36222839	424619	411514	rs764698870	NC_000009.12:36222838:G:A
NM_005476.7(GNE):c.1714G>C (p.Val572Leu)	GNE	V572L, V603L, V567L, V498L, V462L	GNE myopathy|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006033	9	36219937	9	36219940	6033	21072	rs121908632	NC_000009.12:36219939:C:G
NM_000162.5(GCK):c.608T>C (p.Val203Ala)	GCK	V203A, V204A, V202A	not provided	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000585923	7	44189430	7	44149831	585923	576989	rs1562717053	NC_000007.14:44149830:A:G
NM_000155.4(GALT):c.974C>T (p.Pro325Leu)	GALT	P325L?, P325L, P216L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025305	9	34649476	9	34649479	25305	36639	rs111033794	NC_000009.12:34649478:C:T
NM_000155.4(GALT):c.820+13A>G	GALT		not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025269	9	34648904	9	34648907	25269	36603	rs111033768	NC_000009.12:34648906:A:G
NM_000155.4(GALT):c.619C>T (p.Gln207Ter)	GALT	Q207*, Q98*	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025230	9	34648385	9	34648388	25230	36564	rs111033743	NC_000009.12:34648387:C:T
NM_000155.4(GALT):c.524G>A (p.Gly175Asp)	GALT	G175D, G66D	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025203	9	34648128	9	34648131	25203	36537	rs111033718	NC_000009.12:34648130:G:A
NM_001613.4(ACTA2):c.115C>T (p.Arg39Cys)	ACTA2	R39C	Thoracic aortic aneurysm and aortic dissection|not provided|Aortic aneurysm, familial thoracic 6	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065449	10	90708573	10	88948816	65449	76366	rs112901682	NC_000010.11:88948815:G:A
NM_006731.2(FKTN):c.607C>T (p.Arg203Ter)	FKTN	R203*, R180*, R71*	Walker-Warburg congenital muscular dystrophy|not provided|Fukuyama congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4|Fukuyama congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225359	9	108366733	9	105604452	225359	227329	rs746763506	NC_000009.12:105604451:C:T
NM_002180.3(IGHMBP2):c.2356del (p.Ala786fs)	IGHMBP2	A786fs	Distal spinal muscular atrophy|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000637908	11	68704302	11	68936834	637908	625254		NC_000011.10:68936833:GGG:GG
NM_002180.2(IGHMBP2):c.1156T>C (p.Trp386Arg)	IGHMBP2	W386R	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000573815	11	68696746	11	68929278	573815	570939	rs759641927	NC_000011.10:68929277:T:C
NM_002180.3(IGHMBP2):c.127C>T (p.Arg43Ter)	IGHMBP2	R43*	Distal spinal muscular atrophy|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228355	11	68673577	11	68906109	228355	230227	rs200089714	NC_000011.10:68906108:C:T
NM_006158.4(NEFL):c.1186G>A (p.Glu396Lys)	NEFL	E396K	Charcot-Marie-Tooth disease type 2E|CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G|not provided	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066671	8	24811293	8	24953779	66671	77568	rs62636503	NC_000008.11:24953778:C:T
NM_003165.4(STXBP1):c.1651C>T (p.Arg551Cys)	STXBP1	R551C	Early infantile epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207440	9	130444788	9	127682509	207440	202328	rs796053373	NC_000009.12:127682508:C:T
NM_003165.4(STXBP1):c.1216C>T (p.Arg406Cys)	STXBP1	R406C	Early infantile epileptic encephalopathy|not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207431	9	130438188	9	127675909	207431	202311	rs796053367	NC_000009.12:127675908:C:T
NM_006269.2(RP1):c.2029C>T (p.Arg677Ter)	RP1	R677*	Retinitis pigmentosa 1|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005965	8	55538471	8	54625911	5965	21004	rs104894082	NC_000008.11:54625910:C:T
NM_000083.3(CLCN1):c.1167-10T>C	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000462828	7	143029502	7	143332409	462828	456431	rs543120965	NC_000007.14:143332408:T:C
NM_000083.3(CLCN1):c.2364+2T>A	CLCN1		Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280102	7	143043753	7	143346660	280102	264346	rs886041384	NC_000007.14:143346659:T:A
NM_213599.2(ANO5):c.1295C>G (p.Ala432Gly)	ANO5	A432G, A431G	Miyoshi muscular dystrophy 3|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|not provided|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002163	11	22277031	11	22255485	2163	17202	rs137854524	NC_000011.10:22255484:C:G
NM_020732.3(ARID1B):c.4171_4172del (p.Met1391fs)	ARID1B	M1378fs, M681fs, M1391fs, M1431fs	Inborn genetic diseases	Pathogenic	criteria provided, single submitter	VCV000208654	6	157521899 - 157521900	6	157200765 - 157200766	208654	205250	rs797044859	NC_000006.12:157200764:AT:
NM_014491.4(FOXP2):c.197T>G (p.Leu66Ter)	FOXP2	L66*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000521520	7	114174700	7	114534645	521520	511698	rs1554412300	NC_000007.14:114534644:T:G
NM_016277.5(RAB23):c.434T>A (p.Leu145Ter)	RAB23	L145*	Carpenter syndrome|Inborn genetic diseases|not provided|Carpenter syndrome 1	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004591	6	57059615	6	57194817	4591	19630	rs121908171	NC_000006.12:57194816:A:T
NM_004519.4(KCNQ3):c.988C>T (p.Arg330Cys)	KCNQ3	R330C, R210C	Benign familial neonatal seizures|Benign familial neonatal seizures 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000021417	8	133186542	8	132174295	21417	34269	rs118192251	NC_000008.11:132174294:G:A
NM_018941.3(CLN8):c.610C>T (p.Arg204Cys)	CLN8	R204C	|Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant||Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002804	8	1728482	8	1780316	2804	17843	rs104894060	NC_000008.11:1780315:C:T
NM_000441.2(SLC26A4):c.1341+1G>C	SLC26A4		not provided|Pendred syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370343	7	107334926	7	107694481	370343	357545	rs376653349	NC_000007.14:107694480:G:C
NM_000441.2(SLC26A4):c.164+1del	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188838	7	107302250	7	107661805	188838	186724	rs786204504	NC_000007.14:107661804:GG:G
NM_000441.2(SLC26A4):c.279del (p.Ser93fs)	SLC26A4	S93fs	Pendred syndrome|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188715	7	107303855	7	107663410	188715	186728	rs786204421	NC_000007.14:107663409:T:
NM_001287174.2(ABCC8):c.4631T>C (p.Leu1544Pro)	ABCC8	L1543P, L1544P, L1565P, L1542P	Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188836	11	17414656	11	17393109	188836	186811	rs72559713	NC_000011.10:17393108:A:G
NM_004333.6(BRAF):c.1783T>C (p.Phe595Leu)	BRAF	F595L, F573L, F598L, F543L, F561L, F635L, F507L, F558L	not provided|Cardiofaciocutaneous syndrome 1|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000202193	7	140453152	7	140753352	202193	198628	rs794729219	NC_000007.14:140753351:A:G
NM_004333.6(BRAF):c.1455G>T (p.Leu485Phe)	BRAF	L485F, L451F, L488F, L525F, L448F, L397F, L433F, L463F	Rasopathy|Noonan syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177844	7	140477853	7	140778053	177844	174043	rs180177036	NC_000007.14:140778052:C:A
NM_004333.6(BRAF):c.1794_1796dup (p.Thr599dup)	BRAF		Neoplasm of the large intestine|Non-small cell lung cancer|Childhood ganglioglioma	Pathogenic(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	VCV000162793	7	140453138 - 140453139	7	140753338 - 140753339	162793	176758	rs727502902	NC_000007.14:140753338:GTAG:GTAGTAG
NM_004562.3(PRKN):c.155del (p.Asn52fs)	PRKN	N52fs	not provided|Parkinson disease 2	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000536457	6	162864358	6	162443326	536457	521494	rs754809877	NC_000006.12:162443325:TT:T
NM_054012.4(ASS1):c.535T>C (p.Trp179Arg)	ASS1	W179R	not provided|Citrullinemia, mild|Citrullinemia type I	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006335	9	133346260	9	130470873	6335	21374	rs121908646	NC_000009.12:130470872:T:C
NM_003172.4(SURF1):c.312_321delinsAT (p.Pro104_Leu105insTer)	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency|Charcot-Marie-Tooth disease, type 4k|Leigh syndrome|not provided|Leigh syndrome	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215237	9	136221516 - 136221525	9	133354661 - 133354670	215237	211368	rs863224228	NC_000009.12:133354660:GGCTGGCAGA:AT
NM_000543.5(SMPD1):c.1430C>T (p.Pro477Leu)	SMPD1	P477L, P433L, P170L, P476L	Niemann-Pick disease, type A|Niemann-Pick disease, type B|not provided|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189075	11	6415215	11	6393985	189075	186827	rs753508874	NC_000011.10:6393984:C:T
NC_000011.10:g.(?_112094795)_(112094970_?)del	SDHD		Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 1|Cowden syndrome 3	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832816	11	111965519 - 111965694			832816	820335		
NC_000011.9:g.(?_111965519)_(111965704_?)del	SDHD		Paragangliomas 1|Pheochromocytoma|Cowden syndrome 3|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000584289	11	111965519 - 111965704	11	112094795 - 112094980	584289	565003		
NC_000011.9:g.(?_111965523)_(111965700_?)del	SDHD		Pheochromocytoma|Carney-Stratakis syndrome|Cowden syndrome 3|Paragangliomas 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000533799	11	111965523 - 111965700	11	112094799 - 112094976	533799	525849		
NM_003002.4(SDHD):c.342T>A (p.Tyr114Ter)	SDHD	M66K, Y114*, Y75*	Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma|Cowden syndrome 3|not specified	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000438437	11	111965556	11	112094832	438437	432050	rs1050032491	NC_000011.10:112094831:T:A
NM_002180.2(IGHMBP2):c.1336C>T (p.Gln446Ter)	IGHMBP2	Q446*	Autosomal dominant distal hereditary motor neuropathy|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620136	11	68700867	11	68933399	620136	611754	rs372181708	NC_000011.10:68933398:C:T
NM_018979.4(WNK1):c.2140-2842del	WNK1	E899fs, E984fs	Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Nov 23, 2010)	no assertion criteria provided	VCV000021269	12	977588	12	868422	21269	34121	rs137852734	NC_000012.12:868421:AA:A
NM_018979.4(WNK1):c.2140-2874C>T	WNK1	Q974*, Q889*	Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000617550	12	977557	12	868391	617550	608919		NC_000012.12:868390:C:T
NM_018979.4(WNK1):c.1585_1586GA[3] (p.Asp531fs)	WNK1		Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000005171	12	968594 - 968595	12	859428 - 859429	5171	20210	rs387906332	NC_000012.12:859427:AGAGAGAGA:AGAGAGA
NM_018979.4(WNK1):c.2140-2795del	WNK1	R1000fs, R915fs	Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000005170	12	977636	12	868470	5170	20209	rs387906331	NC_000012.12:868469:G:
WNK1, 1-BP DEL, 947C	WNK1		Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000005167					5167	20206		
NM_018979.4(WNK1):c.2140-3219C>T	WNK1	Q73*, Q859*, Q774*	Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000005164	12	977212	12	868046	5164	20203	rs111033592	NC_000012.12:868045:C:T
WNK1, 1-BP DEL, 594A	WNK1		Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000005163					5163	20202		
NM_018979.4(WNK1):c.2140-3158G>A	WNK1	W879*, W794*	Hereditary sensory and autonomic neuropathy type IIA|Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000659035	12	977273	12	868107	659035	641408		NC_000012.12:868106:G:A
NM_018979.4(WNK1):c.2275_2282dup (p.Gln761fs)	WNK1		Hereditary sensory and autonomic neuropathy type IIA|Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000658949	12	987426 - 987427	12	878260 - 878261	658949	641412		NC_000012.12:878260:CACTTTCACA:CACTTTCACACTTTCACA
NM_018979.4(WNK1):c.3331C>T (p.Arg1111Ter)	WNK1	R1111*, R1371*, R864*, R1363*	Hereditary sensory and autonomic neuropathy type IIA|Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000643570	12	991198	12	882032	643570	641438		NC_000012.12:882031:C:T
NM_018979.4(WNK1):c.2139+2872dup	WNK1		Hereditary sensory and autonomic neuropathy type IIA|Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000641047	12	974306 - 974307	12	865140 - 865141	641047	641405		NC_000012.12:865140:TT:TTT
WNK1, 1-BP INS, 1134T	WNK1		Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Apr 25, 2006)	no assertion criteria provided	VCV000005169					5169	20208		
WNK1, 1-BP INS, 918A	WNK1		Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: May 24, 2005)	no assertion criteria provided	VCV000005165					5165	20204		
NM_213655.4(WNK1):c.759+12272_760-5774del	WNK1		Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000005161	12	875762 - 917034	12	766596 - 807868	5161	20200		
NM_018979.4(WNK1):c.2140-2493C>T	WNK1	Q315*, Q1101*, Q1016*	Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Nov 23, 2010)	no assertion criteria provided	VCV000005166	12	977938	12	868772	5166	20205	rs111033590	NC_000012.12:868771:C:T
nsv513769	WNK1		Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000005162	12	885724 - 907501	12	776558 - 798335	5162	20201		
NM_000255.4(MMUT):c.1105C>T (p.Arg369Cys)	MMUT	R369C	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218989	6	49419406	6	49451693	218989	216045	rs772552898	NC_000006.12:49451692:G:A
NM_000255.4(MMUT):c.572C>A (p.Ala191Glu)	MMUT	A191E	Methylmalonic acidemia|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203854	6	49425585	6	49457872	203854	200124	rs760782399	NC_000006.12:49457871:G:T
NM_001164277.1(SLC37A4):c.82C>T (p.Arg28Cys)	SLC37A4	R28C	Glucose-6-phosphate transport defect|not provided	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000068291	11	118899998	11	119029288	68291	79182	rs193302882	NC_000011.10:119029287:G:A
NM_001164277.1(SLC37A4):c.59G>A (p.Gly20Asp)	SLC37A4	G20D	not provided|Glucose-6-phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068286	11	118900021	11	119029311	68286	79177	rs193302881	NC_000011.10:119029310:C:T
NM_000118.3(ENG):c.447G>C (p.Trp149Cys)	ENG	W149C	not provided|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237027	9	130588865	9	127826586	237027	240458	rs878853657	NC_000009.12:127826585:C:G
NM_024757.5(EHMT1):c.1292del (p.Gly431fs)	EHMT1	G431fs, G400fs, G424fs	not provided	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000817822	9	140648665	9	137754213	817822	805619		NC_000009.12:137754212:GG:G
NM_024757.5(EHMT1):c.1685_1709dup (p.Leu571fs)	EHMT1		not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000817325	9	140669596 - 140669597	9	137775144 - 137775145	817325	805620		NC_000009.12:137775144:CTGATGCGCCCCTCCAACAAGGCCCC:CTGATGCGCCCCTCCAACAAGGCCCCTGATGCGCCCCTCCAACAAGGCCCC
NM_024757.5(EHMT1):c.1262del (p.Ser421fs)	EHMT1	S421fs, S390fs, S414fs	not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000817099	9	140648636	9	137754184	817099	805618		NC_000009.12:137754183:G:
NM_024757.5(EHMT1):c.1420G>T (p.Gly474Ter)	EHMT1	G474*, G443*, G467*	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000620482	9	140652382	9	137757930	620482	611718	rs1564704133	NC_000009.12:137757929:G:T
NM_024757.5(EHMT1):c.2713-1G>A	EHMT1		not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000546455	9	140705912	9	137811460	546455	536770	rs1554895172	NC_000009.12:137811459:G:A
NM_024757.5(EHMT1):c.756del (p.Phe253fs)	EHMT1	F222fs, F253fs	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000524134	9	140622909	9	137728457	524134	514590	rs1554852664	NC_000009.12:137728456:CCCCCC:CCCCC
NM_024757.5(EHMT1):c.2958G>A (p.Trp986Ter)	EHMT1	W986*, W979*	not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000523840	9	140707548	9	137813096	523840	514592	rs1554896104	NC_000009.12:137813095:G:A
NM_024757.5(EHMT1):c.1588C>T (p.Arg530Ter)	EHMT1	R530*, R523*, R499*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000523809	9	140657213	9	137762761	523809	514591	rs1554871138	NC_000009.12:137762760:C:T
NM_024757.5(EHMT1):c.181_190delinsCCATT (p.Ser61fs)	EHMT1		not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000504382	9	140611173 - 140611182	9	137716721 - 137716730	504382	495409	rs1554846052	NC_000009.12:137716720:AGCGATGCCA:CCATT
NM_024757.5(EHMT1):c.2506-2A>G	EHMT1		not provided	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000504286	9	140693263	9	137798811	504286	495412	rs1554888910	NC_000009.12:137798810:A:G
NM_024757.5(EHMT1):c.756dup (p.Phe253fs)	EHMT1		not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000504217	9	140622908 - 140622909	9	137728456 - 137728457	504217	495647	rs1554852664	NC_000009.12:137728456:CCCCCC:CCCCCCC
NM_024757.5(EHMT1):c.1602dup (p.Leu535fs)	EHMT1		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000503816	9	140657226 - 140657227	9	137762774 - 137762775	503816	495247	rs1554871182	NC_000009.12:137762774:A:AA
NM_024757.5(EHMT1):c.3259-1G>A	EHMT1		not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000489352	9	140710398	9	137815946	489352	481853	rs1554897763	NC_000009.12:137815945:G:A
NM_024757.5(EHMT1):c.3649C>T (p.Gln1217Ter)	EHMT1	Q1217*, Q1210*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000489228	9	140728909	9	137834457	489228	481854	rs1554908411	NC_000009.12:137834456:C:T
NM_024757.5(EHMT1):c.733G>T (p.Gly245Ter)	EHMT1	G245*, G214*	not provided	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000489126	9	140622891	9	137728439	489126	481852	rs1554852648	NC_000009.12:137728438:G:T
NM_024757.5(EHMT1):c.508C>T (p.Gln170Ter)	EHMT1	Q170*, Q139*	not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000489033	9	140611500	9	137717048	489033	481851	rs1554846766	NC_000009.12:137717047:C:T
NM_024757.5(EHMT1):c.1122dup (p.Ser375fs)	EHMT1		not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000451455	9	140638493 - 140638494	9	137744041 - 137744042	451455	444456	rs1554859292	NC_000009.12:137744041:C:CC
NM_024757.5(EHMT1):c.682del (p.Arg228fs)	EHMT1	R197fs, R228fs	not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000451399	9	140622840	9	137728388	451399	444455	rs1554852597	NC_000009.12:137728387:A:
NM_024757.5(EHMT1):c.3258+1del	EHMT1		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000450076	9	140708960	9	137814508	450076	444458	rs1554897110	NC_000009.12:137814507:GG:G
NM_024757.5(EHMT1):c.3122_3123TC[2] (p.Gln1043fs)	EHMT1		not provided	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000449372	9	140707924 - 140707925	9	137813472 - 137813473	449372	444457	rs1554896575	NC_000009.12:137813471:TCTCTC:TCTC
NM_024757.5(EHMT1):c.417dup (p.Thr140fs)	EHMT1		not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000429991	9	140611408 - 140611409	9	137716956 - 137716957	429991	421742	rs1131691715	NC_000009.12:137716956:T:TT
NM_024757.5(EHMT1):c.2950C>T (p.Gln984Ter)	EHMT1	Q984*, Q977*	not provided	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000426890	9	140707540	9	137813088	426890	415186	rs1085307843	NC_000009.12:137813087:C:T
NM_024757.5(EHMT1):c.302C>G (p.Ser101Ter)	EHMT1	S101*, S70*	not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426692	9	140611294	9	137716842	426692	415185	rs1085307748	NC_000009.12:137716841:C:G
NM_024757.5(EHMT1):c.3072_3073del (p.Val1026fs)	EHMT1	V1019fs, V1026fs	not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426664	9	140707874 - 140707875	9	137813422 - 137813423	426664	415187	rs1085307734	NC_000009.12:137813421:CT:
NM_024757.5(EHMT1):c.3127C>T (p.Gln1043Ter)	EHMT1	Q1043*, Q1036*	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000424487	9	140707929	9	137813477	424487	407645	rs1064796996	NC_000009.12:137813476:C:T
NM_024757.5(EHMT1):c.1059_1060AG[1] (p.Glu354fs)	EHMT1		not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000422908	9	140638431 - 140638432	9	137743979 - 137743980	422908	407639	rs1064796085	NC_000009.12:137743978:AGAG:AG
NM_024757.5(EHMT1):c.355del (p.Val119fs)	EHMT1	V88fs, V119fs	not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000419249	9	140611347	9	137716895	419249	407638	rs1064793748	NC_000009.12:137716894:G:
NM_024757.5(EHMT1):c.2622G>A (p.Trp874Ter)	EHMT1	W874*, W867*	not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000391571	9	140695346	9	137800894	391571	371167	rs1057524142	NC_000009.12:137800893:G:A
NM_024757.5(EHMT1):c.1345_1348AGAA[1] (p.Lys450fs)	EHMT1		not provided	Pathogenic(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	VCV000281526	9	140648719 - 140648722	9	137754267 - 137754270	281526	265763	rs886042181	NC_000009.12:137754266:AGAAAGAA:AGAA
NM_024757.5(EHMT1):c.2431_2435delinsTGGG (p.Met811fs)	EHMT1		not provided	Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000280934	9	140685348 - 140685352	9	137790896 - 137790900	280934	264517	rs886042048	NC_000009.12:137790895:ATGGA:TGGG
NM_024757.5(EHMT1):c.2408C>G (p.Ser803Ter)	EHMT1	S803*, S772*, S796*	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000280895	9	140685325	9	137790873	280895	264442	rs886042018	NC_000009.12:137790872:C:G
NM_024757.5(EHMT1):c.2704C>T (p.Arg902Ter)	EHMT1	R902*, R895*	not provided	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000280682	9	140695428	9	137800976	280682	264324	rs886041844	NC_000009.12:137800975:C:T
NM_024757.5(EHMT1):c.2222del (p.Gln741fs)	EHMT1	Q734fs, Q741fs, Q710fs	not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000280627	9	140674116	9	137779664	280627	264515	rs886041797	NC_000009.12:137779663:A:
NM_024757.5(EHMT1):c.3342delinsAAG (p.Asn1114fs)	EHMT1		not provided	Pathogenic(Last reviewed: Dec 27, 2015)	criteria provided, single submitter	VCV000280200	9	140710482	9	137816030	280200	264519	rs886041450	NC_000009.12:137816029:C:AAG
NM_024757.5(EHMT1):c.2867+5G>A	EHMT1		not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000265655	9	140706072	9	137811620	265655	259922	rs886039703	NC_000009.12:137811619:G:A
NM_001134363.3(RBM20):c.1913C>G (p.Pro638Arg)	RBM20	P638R	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000202063	10	112572068	10	110812310	202063	198208	rs267607003	NC_000010.11:110812309:C:G
NM_001134363.3(RBM20):c.1910G>A (p.Ser637Asn)	RBM20	S637N	not provided	Pathogenic(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	VCV000202062	10	112572065	10	110812307	202062	198207	rs794729149	NC_000010.11:110812306:G:A
NM_001134363.3(RBM20):c.1183C>T (p.Gln395Ter)	RBM20	Q395*	not provided	Pathogenic(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	VCV000202056	10	112541550	10	110781792	202056	198196	rs794729144	NC_000010.11:110781791:C:T
NM_024757.5(EHMT1):c.3709C>T (p.Gln1237Ter)	EHMT1	Q1230*, Q1237*	Kleefstra syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802554	9	140728969	9	137834517	802554	790881		NC_000009.12:137834516:C:T
NM_024757.5(EHMT1):c.2976del (p.Ser992fs)	EHMT1	S992fs, S985fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802552	9	140707566	9	137813114	802552	790879		NC_000009.12:137813113:C:
GRCh37/hg19 9q34.3(chr9:140667620-140677737)x1	EHMT1		See cases	Pathogenic(Last reviewed: Nov 3, 2014)	no assertion criteria provided	VCV000441869	9	140667620 - 140677737			441869	435531		
GRCh37/hg19 9q34.3(chr9:140705084-140711209)x1	EHMT1		See cases	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000441543	9	140705084 - 140711209			441543	435205		
GRCh37/hg19 9q34.3(chr9:140637559-140638660)x1	EHMT1		See cases	Pathogenic	no assertion criteria provided	VCV000395381	9	140637559 - 140638660			395381	382274		
GRCh37/hg19 9q34.3(chr9:140652116-140669912)x1	EHMT1		See cases	Pathogenic	no assertion criteria provided	VCV000393901	9	140652116 - 140669912			393901	380794		
NM_024757.5(EHMT1):c.3229C>T (p.Gln1077Ter)	EHMT1	Q1077*, Q1070*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 5, 2010)	no assertion criteria provided	VCV000065736	9	140708931	9	137814479	65736	76644	rs137852725	NC_000009.12:137814478:C:T
NM_024757.5(EHMT1):c.3180+1G>T	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000065735	9	140707983	9	137813531	65735	76643	rs137852724	NC_000009.12:137813530:G:T
NM_024757.5(EHMT1):c.2868-1G>A	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000065733	9	140707457	9	137813005	65733	76641	rs137852722	NC_000009.12:137813004:G:A
NM_024757.5(EHMT1):c.2861_2862GT[1] (p.Val955fs)	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 5, 2010)	no assertion criteria provided	VCV000065732	9	140706060 - 140706061	9	137811608 - 137811609	65732	76640	rs137852721	NC_000009.12:137811607:TGTGT:TGT
NM_024757.5(EHMT1):c.2028dup (p.Pro677fs)	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000065730	9	140672340 - 140672341	9	137777888 - 137777889	65730	76638	rs1554879411	NC_000009.12:137777888:GGG:GGGG
NM_024757.5(EHMT1):c.1858C>T (p.Arg620Ter)	EHMT1	R620*, R589*, R613*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 5, 2010)	no assertion criteria provided	VCV000065729	9	140671136	9	137776684	65729	76637	rs137852718	NC_000009.12:137776683:C:T
NM_024757.5(EHMT1):c.3181-80_3233del	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000041267	9	140708803 - 140708935	9	137814351 - 137814483	41267	49691	rs1554896943	
NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp)	PRPH2	R142W	Cone/cone-rod dystrophy|Progressive cone dystrophy (without rod involvement)|PRPH2-Related Disorders|not provided|Retinal dystrophy|Choroidal dystrophy, central areolar 2|maculopathy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013183	6	42689649	6	42721911	13183	28222	rs61755783	NC_000006.12:42721910:G:A
NM_024757.5(EHMT1):c.40dup (p.Glu14fs)	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000852882	9	140605431 - 140605432	9	137710979 - 137710980	852882	835952		NC_000009.12:137710979:GGGGGG:GGGGGGG
NM_024757.5(EHMT1):c.3443del (p.Pro1148fs)	EHMT1	P1141fs, P1148fs	Kleefstra syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694702	9	140711958	9	137817506	694702	682812		NC_000009.12:137817505:CC:C
NM_024757.5(EHMT1):c.2566C>T (p.Gln856Ter)	EHMT1	Q849*, Q856*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000666593	9	140693325	9	137798873	666593	654133		NC_000009.12:137798872:C:T
NM_024757.5(EHMT1):c.1495del (p.Ala499fs)	EHMT1	A492fs, A499fs, A468fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000620057	9	140652457	9	137758005	620057	611400	rs1564704457	NC_000009.12:137758004:G:
NM_024757.5(EHMT1):c.3046C>T (p.Arg1016Ter)	EHMT1	R1016*, R1009*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000566937	9	140707848	9	137813396	566937	568908	rs1429360126	NC_000009.12:137813395:C:T
NM_001134363.3(RBM20):c.2714T>A (p.Met905Lys)	RBM20	M905K	Dilated cardiomyopathy 1DD	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000560165	10	112581091	10	110821333	560165	550881	rs1564664312	NC_000010.11:110821332:T:A
NM_024757.5(EHMT1):c.2214_2230dup (p.Phe744fs)	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000438289	9	140674107 - 140674108	9	137779655 - 137779656	438289	431918	rs1554880275	NC_000009.12:137779655:CCCAAAGCAGCTGTACT:CCCAAAGCAGCTGTACTCCCAAAGCAGCTGTACT
NM_024757.5(EHMT1):c.1434_1435del (p.Tyr479fs)	EHMT1	Y479fs, Y448fs, Y472fs	Kleefstra syndrome 1	Pathogenic	criteria provided, single submitter	VCV000431703	9	140652396 - 140652397	9	137757944 - 137757945	431703	425215	rs1554867189	NC_000009.12:137757943:GT:
NM_024757.5(EHMT1):c.1810C>T (p.Gln604Ter)	EHMT1	Q604*, Q573*, Q597*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 5, 2010)	no assertion criteria provided	VCV000065728	9	140671088	9	137776636	65728	76636	rs137852717	NC_000009.12:137776635:C:T
NM_024757.5(EHMT1):c.1529_1532AGAC[1] (p.Asp512fs)	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000065726	9	140657154 - 140657157	9	137762702 - 137762705	65726	76634	rs137852716	NC_000009.12:137762701:AGACAGAC:AGAC
NM_001134363.3(RBM20):c.1909A>G (p.Ser637Gly)	RBM20	S637G	Dilated cardiomyopathy 1DD	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000272	10	112572064	10	110812306	272	15311	rs267607005	NC_000010.11:110812305:A:G
NM_022970.3(FGFR2):c.1087+1319C>G	FGFR2	S347C, S258C, S232C, S119C	Hypertelorism|Abnormality of the posterior cranial fossa|Low-set ears|High palate|Hydrocephalus|Dilation of lateral ventricles|Narrow forehead|Choanal stenosis|Cranial asymmetry|Hypointensity of cerebral white matter on MRI|Short neck|Facial asymmetry|Wide anterior fontanel|High forehead|Mild fetal ventriculomegaly|Downslanted palpebral fissures|Abnormality of the pinna|Brachyturricephaly|Shallow orbits|Flat occiput|Abnormality of the zygomatic bone|Deviated nasal septum|Crouzon syndrome|not provided|FGFR2 related craniosynostosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013271	10	123276877	10	121517363	13271	28310	rs121918494	NC_000010.11:121517362:G:C
NM_001134363.3(RBM20):c.1901G>T (p.Arg634Leu)	RBM20	R634L	Primary dilated cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000689585	10	112572056	10	110812298	689585	677231		NC_000010.11:110812297:G:T
NM_024757.5(EHMT1):c.2224del (p.Leu742fs)	EHMT1	L711fs, L735fs, L742fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560999	9	140674118	9	137779666	560999	552139	rs1564744631	NC_000009.12:137779665:C:
NM_024757.5(EHMT1):c.391del (p.Ala131fs)	EHMT1	A100fs, A131fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	VCV000209152	9	140611382	9	137716930	209152	205761	rs797045043	NC_000009.12:137716929:GG:G
NM_024757.5(EHMT1):c.3218G>A (p.Cys1073Tyr)	EHMT1	C1042Y, C1073Y, C1066Y	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 5, 2010)	no assertion criteria provided	VCV000003607	9	140708920	9	137814468	3607	18646	rs137852726	NC_000009.12:137814467:G:A
NM_024757.5(EHMT1):c.1413_1425del (p.Pro473fs)	EHMT1	P442fs, P473fs, P466fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000003606	9	140652371 - 140652383	9	137757919 - 137757931	3606	18645	rs137852715	NC_000009.12:137757918:AGACGGCACCAGGAGAC:AGAC
NM_024757.5(EHMT1):c.3502C>T (p.Arg1168Ter)	EHMT1	R1137*, R1168*, R1161*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 5, 2010)	no assertion criteria provided	VCV000003605	9	140712552	9	137818100	3605	18644	rs121918301	NC_000009.12:137818099:C:T
NM_000155.4(GALT):c.775C>T (p.Arg259Trp)	GALT	R259W, R150W	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, multiple submitters, no conflicts	VCV000189191	9	34648846	9	34648849	189191	186785	rs786204763	NC_000009.12:34648848:C:T
NM_000155.4(GALT):c.442C>T (p.Arg148Trp)	GALT	R148W, R39W	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000037359	9	34647893	9	34647896	37359	45910	rs111033693	NC_000009.12:34647895:C:T
NM_018979.4(WNK1):c.2140-2518dup	WNK1		Hereditary sensory and autonomic neuropathy type IIA|Hereditary sensory and autonomic neuropathy type IIA|Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	VCV000021270	12	977911 - 977912	12	868745 - 868746	21270	34122	rs137852735	NC_000012.12:868745:AA:AAA
NM_024757.5(EHMT1):c.673C>T (p.Arg225Ter)	EHMT1	R225*, R194*	not provided|Kleefstra syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252987	9	140622831	9	137728379	252987	247390	rs879255531	NC_000009.12:137728378:C:T
NM_024757.5(EHMT1):c.3413G>A (p.Trp1138Ter)	EHMT1	W1138*, W1131*	Kleefstra syndrome 1|Autism spectrum disorder	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000221980	9	140711929	9	137817477	221980	223668	rs886037776	NC_000009.12:137817476:G:A
NM_033360.4(KRAS):c.108A>G (p.Ile36Met)	KRAS	I36M	Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163768	12	25398211	12	25245277	163768	175716	rs727503109	NC_000012.12:25245276:T:C
NM_033360.4(KRAS):c.173C>T (p.Thr58Ile)	KRAS	T58I	Noonan syndrome 3|Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012588	12	25380285	12	25227351	12588	27627	rs104894364	NC_000012.12:25227350:G:A
NM_033360.4(KRAS):c.178G>C (p.Gly60Arg)	KRAS	G60R	Rasopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 2|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012586	12	25380280	12	25227346	12586	27625	rs104894359	NC_000012.12:25227345:C:G
NM_001122769.3(LCA5):c.838C>T (p.Arg280Ter)	LCA5	R280*	Retinal dystrophy|Inborn genetic diseases|Leber congenital amaurosis	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000438153	6	80203350	6	79493633	438153	431718	rs866395428	NC_000006.12:79493632:G:A
NM_213599.2(ANO5):c.41-1G>A	ANO5		Limb-girdle muscular dystrophy, type 2L|not provided|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096685	11	22225349	11	22203803	96685	102578	rs398124625	NC_000011.10:22203802:G:A
GRCh37/hg19 9p24.1(chr9:6542329-6611763)x1	GLDC		not provided	Pathogenic(Last reviewed: May 23, 2018)	no assertion criteria provided	VCV000689258	9	6542329 - 6611763			689258	676850		
GRCh37/hg19 9p24.1(chr9:6548392-6620059)x1	GLDC		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	no assertion criteria provided	VCV000689250	9	6548392 - 6620059			689250	676842		
GRCh37/hg19 9p24.1(chr9:6556947-6679992)x1	GLDC		not provided	Pathogenic(Last reviewed: Jul 25, 2017)	no assertion criteria provided	VCV000688415	9	6556947 - 6679992			688415	676007		
GRCh37/hg19 9p24.1(chr9:6611112-6677371)x1	GLDC		not provided	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000687752	9	6611112 - 6677371			687752	675344		
GRCh37/hg19 9p24.1(chr9:6631701-6679992)x1	GLDC		not provided	Pathogenic(Last reviewed: Jul 31, 2017)	no assertion criteria provided	VCV000687107	9	6631701 - 6679992			687107	674699		
GRCh37/hg19 9p24.1(chr9:6523010-6708344)x1	GLDC		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	no assertion criteria provided	VCV000685972	9	6523010 - 6708344			685972	673564		
NM_000170.3(GLDC):c.2838+1G>A	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802457	9	6536063	9	6536063	802457	790915		NC_000009.12:6536062:C:T
NM_000170.2(GLDC):c.2177T>A (p.Leu726Gln)	GLDC	L726Q	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000254210	9	6556178	9	6556178	254210	248725	rs1114167353	NC_000009.12:6556177:A:T
NM_000170.3(GLDC):c.89G>A (p.Trp30Ter)	GLDC	W30*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000857611	9	6645411	9	6645411	857611	836233		NC_000009.12:6645410:C:T
NM_000170.3(GLDC):c.2531T>G (p.Leu844Ter)	GLDC	L844*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000849779	9	6550841	9	6550841	849779	836221		NC_000009.12:6550840:A:C
NM_000170.3(GLDC):c.1828C>T (p.Gln610Ter)	GLDC	Q610*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000840877	9	6587163	9	6587163	840877	836223		NC_000009.12:6587162:G:A
NC_000009.12:g.(?_6592841)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832448	9	6592841 - 6620329			832448	820156		
NC_000009.12:g.(?_6604568)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000830920	9	6604568 - 6645519			830920	820158		
NM_000170.3(GLDC):c.1059-1G>T	GLDC		Non-ketotic hyperglycinemia	Pathogenic	criteria provided, single submitter	VCV000813468	9	6602206	9	6602206	813468	801680		NC_000009.12:6602205:C:A
NM_000170.3(GLDC):c.2052+1G>A	GLDC		Non-ketotic hyperglycinemia	Pathogenic	criteria provided, single submitter	VCV000813467	9	6558558	9	6558558	813467	801679		NC_000009.12:6558557:C:T
NC_000009.11:g.(?_6610172)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000662293	9	6610172 - 6645519	9	6610172 - 6645519	662293	651867		
NM_000170.3(GLDC):c.1629del (p.Asn543fs)	GLDC	N543fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000657819	9	6588654	9	6588654	657819	638378		NC_000009.12:6588653:A:
NM_000170.2(GLDC):c.538C>T (p.Gln180Ter)	GLDC	Q180*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000650449	9	6610289	9	6610289	650449	638382		NC_000009.12:6610288:G:A
NM_000170.2(GLDC):c.2919+1G>C	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000641943	9	6534707	9	6534707	641943	652219		NC_000009.12:6534706:C:G
NM_000170.2(GLDC):c.411_412insAATA (p.Tyr138fs)	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000583199	9	6620242 - 6620243	9	6620242 - 6620243	583199	565963	rs1563864784	NC_000009.12:6620242::TATT
NM_000170.2(GLDC):c.2278dup (p.His760fs)	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000565866	9	6554705 - 6554706	9	6554705 - 6554706	565866	564104	rs1563834980	NC_000009.12:6554705:GGGG:GGGGG
NM_000170.2(GLDC):c.334+1G>T	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000557987	9	6644613	9	6644613	557987	545251	rs978795483	NC_000009.12:6644612:C:A
NM_000170.2(GLDC):c.1888C>T (p.Arg630Ter)	GLDC	R630*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000554522	9	6565392	9	6565392	554522	545232	rs751025203	NC_000009.12:6565391:G:A
NM_000170.2(GLDC):c.24G>A (p.Trp8Ter)	GLDC	W8*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000553731	9	6645476	9	6645476	553731	545624	rs1163356968	NC_000009.12:6645475:C:T
NC_000009.11:g.(?_6558539)_(6565449_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000531791	9	6558539 - 6565449	9	6558539 - 6565449	531791	523837		
NC_000009.11:g.(?_6565334)_(6565449_?)dup	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000462849	9	6565334 - 6565449	9	6565334 - 6565449	462849	458739		
NM_000170.2(GLDC):c.2544C>G (p.Tyr848Ter)	GLDC	Y848*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 18, 2017)	criteria provided, single submitter	VCV000437461	9	6550828	9	6550828	437461	431014	rs1554643354	NC_000009.12:6550827:G:C
GLDC, 2607C-A	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 26, 2005)	no assertion criteria provided	VCV000011991					11991	27030		
NM_000170.2(GLDC):c.2T>C (p.Met1Thr)	GLDC	M1T	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000011988	9	6645498	9	6645498	11988	27027	rs121964978	NC_000009.12:6645497:A:G
GLDC, 30-KB DEL	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000011984					11984	27023		
NM_024757.5(EHMT1):c.1647+2T>C	EHMT1	V519A, V550A	Kleefstra syndrome 1|Schizophrenia|Global developmental delay|Coarse facial features|Synophrys|Intellectual disability|Anteverted nares	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000374120	9	140657274	9	137762822	374120	360911	rs1057518913	NC_000009.12:137762821:T:C
NM_024757.5(EHMT1):c.2873_2876TTCT[1] (p.Ser960fs)	EHMT1		Kleefstra syndrome 1|not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065734	9	140707460 - 140707463	9	137813008 - 137813011	65734	76642	rs786205129	NC_000009.12:137813007:TCTTTCTTTCT:TCTTTCT
NM_024757.5(EHMT1):c.871C>T (p.Arg291Ter)	EHMT1	R260*, R291*, R284*	Kleefstra syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000003608	9	140637870	9	137743418	3608	18647	rs137852714	NC_000009.12:137743417:C:T
NM_000170.3(GLDC):c.492C>G (p.Tyr164Ter)	GLDC	Y164*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000840135	9	6610335	9	6610335	840135	836229		NC_000009.12:6610334:G:C
NC_000009.12:g.(?_6620174)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000832605	9	6620174 - 6620329			832605	820162		
NC_000009.12:g.(?_6606582)_(6606679_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000832249	9	6606582 - 6606679			832249	820160		
NC_000009.12:g.(?_6606572)_(6606689_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000831868	9	6606572 - 6606689			831868	820159		
NC_000009.12:g.(?_6620174)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000831793	9	6620174 - 6645509			831793	820163		
NC_000009.12:g.(?_6587121)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831447	9	6587121 - 6645519			831447	820154		
NC_000009.12:g.(?_6620164)_(6620339_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000830523	9	6620164 - 6620339			830523	820161		
NC_000009.11:g.(?_6644604)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000659612	9	6644604 - 6645509	9	6644604 - 6645509	659612	651850		
NC_000009.11:g.(?_6644594)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000643709	9	6644594 - 6645519	9	6644594 - 6645519	643709	651957		
NM_000170.2(GLDC):c.1337del (p.Val446fs)	GLDC	V446fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635297	9	6592915	9	6592915	635297	623150		NC_000009.12:6592914:A:
NM_000170.2(GLDC):c.1145G>A (p.Cys382Tyr)	GLDC	C382Y	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000531778	9	6602119	9	6602119	531778	524905	rs759133707	NC_000009.12:6602118:C:T
NM_000170.2(GLDC):c.2423_2426dup (p.Ile810fs)	GLDC		not provided|Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000495699	9	6553398 - 6553399	9	6553398 - 6553399	495699	487389	rs755313904	NC_000009.12:6553398:GAAC:GAACGAAC
NM_000170.2(GLDC):c.2919+1G>A	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000056093	9	6534707	9	6534707	56093	70732	rs386833575	NC_000009.12:6534706:C:T
NM_000170.2(GLDC):c.2284G>A (p.Gly762Arg)	GLDC	G762R	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000056069	9	6554700	9	6554700	56069	70708	rs386833550	NC_000009.12:6554699:C:T
NM_000170.2(GLDC):c.1654A>G (p.Met552Val)	GLDC	M552V	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000056048	9	6588629	9	6588629	56048	70687	rs386833529	NC_000009.12:6588628:T:C
NM_000170.2(GLDC):c.2281G>C (p.Gly761Arg)	GLDC	G761R	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000011986	9	6554703	9	6554703	11986	27025	rs386833549	NC_000009.12:6554702:C:G
NM_000170.3(GLDC):c.2755T>A (p.Phe919Ile)	GLDC	F919I	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000861636	9	6536147	9	6536147	861636	836218		NC_000009.12:6536146:A:T
NM_000170.3(GLDC):c.2315+1G>T	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000839736	9	6554668	9	6554668	839736	852191		NC_000009.12:6554667:C:A
NC_000009.12:g.(?_6558539)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832957	9	6558539 - 6645519			832957	820151		
NC_000009.12:g.(?_6558549)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000832697	9	6558549 - 6645509			832697	820152		
NC_000009.12:g.(?_6533007)_(6610366_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000832281	9	6533007 - 6610366			832281	820149		
NM_000170.2(GLDC):c.1058+2T>A	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000643420	9	6604586	9	6604586	643420	652224		NC_000009.12:6604585:A:T
NM_000170.2(GLDC):c.2838+2T>C	GLDC		Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558570	9	6536062	9	6536062	558570	544930	rs1554641887	NC_000009.12:6536061:A:G
NM_000170.2(GLDC):c.1866_1867AT[3] (p.Ala624fs)	GLDC		Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558067	9	6565410 - 6565411	9	6565410 - 6565411	558067	545332	rs772068893	NC_000009.12:6565410:ATAT:ATATAT
NM_000170.2(GLDC):c.1652G>T (p.Ser551Ile)	GLDC	S551I	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554912	9	6588631	9	6588631	554912	545338	rs751822565	NC_000009.12:6588630:C:A
NM_000170.2(GLDC):c.1723G>T (p.Glu575Ter)	GLDC	E575*	not provided|Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553781	9	6587268	9	6587268	553781	545584	rs1554646529	NC_000009.12:6587267:C:A
NM_000170.2(GLDC):c.128del (p.Asp43fs)	GLDC	D43fs	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552137	9	6645372	9	6645372	552137	545621	rs1251443902	NC_000009.12:6645371:T:
NM_000170.2(GLDC):c.2527C>T (p.Arg843Ter)	GLDC	R843*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000462875	9	6550845	9	6550845	462875	459569	rs1554643360	NC_000009.12:6550844:G:A
NM_000170.2(GLDC):c.2607C>A (p.Pro869=)	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000056084	9	6540109	9	6540109	56084	70723	rs386833565	NC_000009.12:6540108:G:T
NM_000170.2(GLDC):c.2267_2269del (p.Phe756del)	GLDC	F756del	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000056067	9	6554715 - 6554717	9	6554715 - 6554717	56067	70706	rs121964975	NC_000009.12:6554714:AGAAG:AG
NM_000170.2(GLDC):c.2186del (p.Ala729fs)	GLDC	A729fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000056062	9	6556169	9	6556169	56062	70701	rs386833543	NC_000009.12:6556168:G:
NM_000170.2(GLDC):c.2405C>T (p.Ala802Val)	GLDC	A802V	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 18, 2017)	criteria provided, single submitter	VCV000011987	9	6553420	9	6553420	11987	27026	rs121964977	NC_000009.12:6553419:G:A
NM_000170.2(GLDC):c.1691G>T (p.Ser564Ile)	GLDC	S564I	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000011982	9	6588417	9	6588417	11982	27021	rs121964974	NC_000009.12:6588416:C:A
NM_000035.4(ALDOB):c.356_359CAAA[1] (p.Asn120fs)	ALDOB		Hereditary fructosuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188861	9	104190767 - 104190770	9	101428485 - 101428488	188861	186778	rs387906225	NC_000009.12:101428484:TTTGTTTGTT:TTTGTT
NM_000035.4(ALDOB):c.1005C>G (p.Asn335Lys)	ALDOB	N335K	Hereditary fructosuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000469	9	104184181	9	101421899	469	15508	rs78340951	NC_000009.12:101421898:G:C
NM_000170.2(GLDC):c.2714T>G (p.Val905Gly)	GLDC	V905G	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000639955	9	6536188	9	6536188	639955	638363		NC_000009.12:6536187:A:C
NM_000170.2(GLDC):c.2584G>A (p.Glu862Lys)	GLDC	E862K	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555999	9	6540132	9	6540132	555999	545309	rs925908885	NC_000009.12:6540131:C:T
NM_000170.2(GLDC):c.2281G>A (p.Gly761Arg)	GLDC	G761R	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555815	9	6554703	9	6554703	555815	545205	rs386833549	NC_000009.12:6554702:C:T
NM_000170.2(GLDC):c.2980G>A (p.Gly994Arg)	GLDC	G994R	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550058	9	6533100	9	6533100	550058	545551	rs1406713104	NC_000009.12:6533099:C:T
NM_000170.2(GLDC):c.2614A>T (p.Lys872Ter)	GLDC	K872*	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462877	9	6540102	9	6540102	462877	460104	rs1430968530	NC_000009.12:6540101:T:A
NM_000170.2(GLDC):c.793del (p.Gln265fs)	GLDC	Q265fs	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056103	9	6605199	9	6605199	56103	70742	rs386833586	NC_000009.12:6605198:GG:G
NM_000048.4(ASL):c.35G>A (p.Arg12Gln)	ASL	R12Q	Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092360	7	65546812	7	66081825	92360	98271	rs145138923	NC_000007.14:66081824:G:A
NM_000170.2(GLDC):c.2203-2A>G	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000056064	9	6554783	9	6554783	56064	70703	rs386833545	NC_000009.12:6554782:T:C
NM_000170.2(GLDC):c.1270C>T (p.Arg424Ter)	GLDC	R424*	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056040	9	6592982	9	6592982	56040	70679	rs386833521	NC_000009.12:6592981:G:A
NM_001163817.2(DHCR7):c.725G>A (p.Arg242His)	DHCR7	R242H	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021276	11	71150031	11	71438985	21276	34128	rs80338857	NC_000011.10:71438984:C:T
NM_000083.3(CLCN1):c.803C>T (p.Thr268Met)	CLCN1	T268M	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided|Myotonia congenita	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021047	7	143021535	7	143324442	21047	33899	rs80356687	NC_000007.14:143324441:C:T
NM_004183.4(BEST1):c.728C>T (p.Ala243Val)	BEST1	A243V, A183V, A137V	Vitelliform macular dystrophy type 2|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002737	11	61725631	11	61958159	2737	17776	rs28940570	NC_000011.10:61958158:C:T
NM_002180.2(IGHMBP2):c.449+1G>T	IGHMBP2		Autosomal dominant distal hereditary motor neuropathy|Charcot-Marie-Tooth disease, axonal, type 2S|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	VCV000204303	11	68675806	11	68908338	204303	200698	rs797044802	NC_000011.10:68908337:G:T
NM_018979.4(WNK1):c.2140-2568C>T	WNK1	R290*, R1076*, R991*	Hereditary sensory and autonomic neuropathy type IIA|not provided|Hereditary sensory and autonomic neuropathy type IIA|Pseudohypoaldosteronism type 2C	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005168	12	977863	12	868697	5168	20207	rs111033591	NC_000012.12:868696:C:T
NM_001287174.2(ABCC8):c.683G>A (p.Gly228Asp)	ABCC8	G228D	not provided|Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217846	11	17483269	11	17461722	217846	214504	rs863225280	NC_000011.10:17461721:C:T
NM_001287174.2(ABCC8):c.4309C>T (p.Arg1437Ter)	ABCC8	R1436*, R1437*, R1458*, R1435*	Familial hyperinsulinism|Leucine-induced hypoglycemia|Transient neonatal diabetes mellitus 2|Hyperinsulinemic hypoglycemia, familial, 1|Permanent neonatal diabetes mellitus|Diabetes mellitus type 2|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035617	11	17417158	11	17395611	35617	44282	rs193922402	NC_000011.10:17395610:G:A
NM_000170.2(GLDC):c.1580+2T>G	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462856	9	6589193	9	6589193	462856	459265	rs1554646710	NC_000009.12:6589192:A:C
NM_000170.2(GLDC):c.2665+1G>C	GLDC		not provided|Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280015	9	6540050	9	6540050	280015	264336	rs149070244	NC_000009.12:6540049:C:G
NM_000170.2(GLDC):c.2489C>T (p.Thr830Met)	GLDC	T830M	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056079	9	6550883	9	6550883	56079	70718	rs386833560	NC_000009.12:6550882:G:A
NM_000170.2(GLDC):c.1786C>T (p.Arg596Ter)	GLDC	R596*	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056050	9	6587205	9	6587205	56050	70689	rs386833531	NC_000009.12:6587204:G:A
NM_000441.2(SLC26A4):c.1586T>G (p.Ile529Ser)	SLC26A4	I529S	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189160	7	107338528	7	107698083	189160	186737	rs786204739	NC_000007.14:107698082:T:G
NM_000441.2(SLC26A4):c.1522A>G (p.Thr508Ala)	SLC26A4	T508A	Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000179732	7	107336462	7	107696017	179732	174027	rs727505088	NC_000007.14:107696016:A:G
NM_000441.2(SLC26A4):c.1281_1283TGC[1] (p.Ala429del)	SLC26A4	A429del	Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043501	7	107334864 - 107334866	7	107694419 - 107694421	43501	52671	rs111033306	NC_000007.14:107694418:CTGCTGC:CTGC
NM_024757.5(EHMT1):c.2712+1G>A	EHMT1		Kleefstra syndrome 1|Global developmental delay|Polymicrogyria|Abnormal facial shape|Difficulty walking|not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374034	9	140695437	9	137800985	374034	360912	rs1057518849	NC_000009.12:137800984:G:A
NM_001164277.1(SLC37A4):c.742C>T (p.Gln248Ter)	SLC37A4	Q248*, Q175*	not provided|Glucose-6-phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188762	11	118897689	11	119026979	188762	186807	rs781784543	NC_000011.10:119026978:G:A
NM_004281.4(BAG3):c.925C>T (p.Arg309Ter)	BAG3	R309*	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided|Familial dilated cardiomyopathy|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228322	10	121435991	10	119676479	228322	229744	rs869248137	NC_000010.11:119676478:C:T
NM_078480.3(PUF60):c.449_457del (p.Ala150_Phe152del)	PUF60		Inborn genetic diseases|Verheij syndrome	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430808	8	144900596 - 144900604	8	143818426 - 143818434	430808	424347	rs1131692232	NC_000008.11:143818425:CAAAGGGGGCAAAGG:CAAAGG
NM_005609.4(PYGM):c.2392T>C (p.Trp798Arg)	PYGM	W797R, W798R, W710R	Glycogen storage disease, type V|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002312	11	64514268	11	64746796	2312	17351	rs119103258	NC_000011.10:64746795:A:G
NC_000009.12:g.(?_6595004)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000833466	9	6595004 - 6620329			833466	820157		
NC_000009.11:g.(?_6594994)_(6620339_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000531793	9	6594994 - 6620339	9	6594994 - 6620339	531793	524412		
NM_000170.2(GLDC):c.1054del (p.Thr352fs)	GLDC	T352fs	Non-ketotic hyperglycinemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056037	9	6604592	9	6604592	56037	70676	rs386833518	NC_000009.12:6604591:TT:T
NM_004333.6(BRAF):c.1789_1790delinsTC (p.Leu597Ser)	BRAF		Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375942	7	140453145 - 140453146	7	140753345 - 140753346	375942	362821	rs121913368	NC_000007.14:140753344:AG:GA
NM_000155.4(GALT):c.601C>T (p.Arg201Cys)	GALT	R201C, R92C	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025226	9	34648367	9	34648370	25226	36560	rs111033739	NC_000009.12:34648369:C:T
NM_002047.4(GARS1):c.880G>C (p.Gly294Arg)	GARS1	G240R, G294R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease type 2D	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009204	7	30649345	7	30609729	9204	24243	rs137852643	NC_000007.14:30609728:G:C
NM_213599.2(ANO5):c.1627dup (p.Met543fs)	ANO5		Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000285942	11	22281279 - 22281280	11	22259733 - 22259734	285942	270179	rs281865480	NC_000011.10:22259733:AAAAA:AAAAAA
NM_000543.5(SMPD1):c.573del (p.Ser192fs)	SMPD1	S191fs, S192fs	Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type B|not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167710	11	6412868	11	6391638	167710	178086	rs727504167	NC_000011.10:6391637:T:
NM_000318.3(PEX2):c.355C>T (p.Arg119Ter)	PEX2	R118*, R119*	Peroxisome biogenesis disorder 5a (zellweger)|Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013704	8	77896060	8	76983824	13704	28743	rs61752123	NC_000008.11:76983823:G:A
NM_003002.4(SDHD):c.170-1G>T	SDHD		Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma|Cowden syndrome 3	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000438434	11	111959590	11	112088866	438434	432045	rs1306475361	NC_000011.10:112088865:G:T
NM_003002.4(SDHD):c.304C>A (p.His102Asn)	SDHD	H102N, H63N	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 1|Cowden syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185719	11	111959725	11	112089001	185719	183479	rs786202403	NC_000011.10:112089000:C:A
NM_003002.4(SDHD):c.305A>T (p.His102Leu)	SDHD	H102L, H63L	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006898	11	111959726	11	112089002	6898	21937	rs104894302	NC_000011.10:112089001:A:T
NM_000255.4(MMUT):c.1106G>A (p.Arg369His)	MMUT	R369H	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203846	6	49419405	6	49451692	203846	200114	rs564069299	NC_000006.12:49451691:C:T
NM_000255.3(MMUT):c.322C>T	MMUT	R108C	METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001887	6	49426858	6	49459145	1887	16926	rs121918257	NC_000006.12:49459144:G:A
NC_000009.12:g.(?_6587131)_(6606679_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000833360	9	6587131 - 6606679			833360	820155		
NC_000009.12:g.(?_6587121)_(6606689_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000830434	9	6587121 - 6606689			830434	820153		
NM_000170.2(GLDC):c.806C>T (p.Thr269Met)	GLDC	T269M	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056104	9	6605186	9	6605186	56104	70743	rs386833587	NC_000009.12:6605185:G:A
NM_007126.5(VCP):c.463C>T (p.Arg155Cys)	VCP	R155C, R110C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008469	9	35065361	9	35065364	8469	23508	rs121909330	NC_000009.12:35065363:G:A
NM_003165.4(STXBP1):c.416C>T (p.Pro139Leu)	STXBP1	P139L	Early infantile epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 4|Intellectual disability|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207415	9	130423471	9	127661192	207415	202287	rs796053353	NC_000009.12:127661191:C:T
NM_024426.6(WT1):c.1120C>T (p.Arg374Ter)	WT1	R157*, R369*, R374*, R357*, R140*	Drash syndrome|not provided|Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Wilms tumor 1|Frasier syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449416	11	32417947	11	32396401	449416	444795	rs1423753702	NC_000011.10:32396400:G:A
NM_002180.2(IGHMBP2):c.2611+1G>T	IGHMBP2		Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|not provided|Autosomal dominant distal hereditary motor neuropathy|Werdnig-Hoffmann disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009118	11	68704560	11	68937092	9118	24157	rs786205090	NC_000011.10:68937091:G:T
NM_003070.5(SMARCA2):c.3593T>G (p.Val1198Gly)	SMARCA2	V1198G, V1140G	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000521357	9	2115958	9	2115958	521357	511835	rs1554629007	NC_000009.12:2115957:T:G
NM_000391.4(TPP1):c.851G>T (p.Gly284Val)	TPP1	G284V	Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002647	11	6637927	11	6616696	2647	17686	rs119455957	NC_000011.10:6616695:C:A
NM_001077365.2(POMT1):c.1939G>A (p.Ala647Thr)	POMT1	A669T, A552T, A593T, A617T, A647T, A495T, A615T, A530T	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003250	9	134397547	9	131522160	3250	18289	rs119462987	NC_000009.12:131522159:G:A
NM_022970.3(FGFR2):c.870G>T (p.Trp290Cys)	FGFR2	W290C, W175C, W62C, W201C	Pfeiffer syndrome|FGFR2 related craniosynostosis|Craniofacial-skeletal-dermatologic dysplasia	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013293	10	123279562	10	121520048	13293	28332	rs121918499	NC_000010.11:121520047:C:A
NM_003640.5(ELP1):c.2087G>C (p.Arg696Pro)	ELP1	R696P, R347P, R582P	Charcot-Marie-Tooth disease|Familial dysautonomia	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006086	9	111662583	9	108900303	6086	21125	rs137853022	NC_000009.12:108900302:C:G
NM_005476.7(GNE):c.736C>T (p.Arg246Trp)	GNE	R277W, R246W, R241W	GNE myopathy|Sialuria|not provided|GNE myopathy	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197184	9	36236862	9	36236865	197184	194345	rs773729410	NC_000009.12:36236864:G:A
NM_000083.3(CLCN1):c.1655A>G (p.Gln552Arg)	CLCN1	Q552R	Myotonia congenita|not provided|Myotonia levior|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017538	7	143039094	7	143342001	17538	32577	rs80356696	NC_000007.14:143342000:A:G
NM_000288.4(PEX7):c.903+1G>C	PEX7		Rhizomelic chondrodysplasia punctata|PEX7-Related Disorders|Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007785	6	137219380	6	136898242	7785	22824	rs148591292	NC_000006.12:136898241:G:C
NM_033360.4(KRAS):c.351A>C (p.Lys117Asn)	KRAS	K117N	Multiple myeloma|Malignant melanoma of skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Neoplasm of the large intestine|Hepatocellular carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375965	12	25378647	12	25225713	375965	362844	rs770248150	NC_000012.12:25225712:T:G
NM_000170.2(GLDC):c.2316-1G>A	GLDC		Non-ketotic hyperglycinemia|not provided	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056073	9	6553510	9	6553510	56073	70712	rs386833554	NC_000009.12:6553509:C:T
NM_001377.3(DYNC2H1):c.7442G>A (p.Arg2481Gln)	DYNC2H1	R2481Q	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802716	11	103062250	11	103191521	802716	791024		NC_000011.10:103191520:G:A
GRCh37/hg19 11q22.3(chr11:103128365-103282924)x1	DYNC2H1		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	no assertion criteria provided	VCV000688642	11	103128365 - 103282924			688642	676234		
GRCh37/hg19 11q22.3(chr11:103128365-103282924)x1	DYNC2H1		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	no assertion criteria provided	VCV000688641	11	103128365 - 103282924			688641	676233		
GRCh37/hg19 11q22.3(chr11:103297733-103368100)x1	DYNC2H1		not provided	Pathogenic(Last reviewed: Sep 11, 2017)	no assertion criteria provided	VCV000688536	11	103297733 - 103368100			688536	676128		
GRCh37/hg19 11q22.3(chr11:103128365-103282941)x1	DYNC2H1		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000688524	11	103128365 - 103282941			688524	676116		
GRCh37/hg19 11q22.3(chr11:103200944-103454659)x1	DYNC2H1		not provided	Pathogenic(Last reviewed: Aug 14, 2018)	no assertion criteria provided	VCV000685622	11	103200944 - 103454659			685622	673214		
NM_001377.3(DYNC2H1):c.2386del (p.Arg796fs)	DYNC2H1	R796fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 19, 2018)	no assertion criteria provided	VCV000638016	11	103006488	11	103135759	638016	625837		NC_000011.10:103135758:CC:C
NM_001377.3(DYNC2H1):c.8145_8146delinsAT (p.Tyr2715_Gln2716delinsTer)	DYNC2H1		not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000598476	11	103070831 - 103070832	11	103200102 - 103200103	598476	589537	rs1565390180	NC_000011.10:103200101:CC:AT
NM_001377.3(DYNC2H1):c.10024C>T (p.Arg3342Ter)	DYNC2H1	R3349*, R3342*	not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000595515	11	103116085	11	103245356	595515	586577	rs751891969	NC_000011.10:103245355:C:T
NM_001377.3(DYNC2H1):c.12156+1G>A	DYNC2H1		not provided	Pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	VCV000198957	11	103229088	11	103358360	198957	196117	rs794727944	NC_000011.10:103358359:G:A
NM_001377.3(DYNC2H1):c.11681C>G (p.Ser3894Ter)	DYNC2H1	S3901*, S3894*	not provided	Pathogenic(Last reviewed: May 21, 2014)	criteria provided, single submitter	VCV000198946	11	103187305	11	103316576	198946	196106	rs776315442	NC_000011.10:103316575:C:G
NM_001377.3(DYNC2H1):c.5846del (p.Glu1949fs)	DYNC2H1	E1949fs	not provided	Pathogenic(Last reviewed: Feb 14, 2015)	criteria provided, single submitter	VCV000196997	11	103047135	11	103176406	196997	194158	rs794727595	NC_000011.10:103176405:A:
NM_001377.3(DYNC2H1):c.8947-1G>T	DYNC2H1		not provided	Pathogenic(Last reviewed: Apr 27, 2014)	criteria provided, single submitter	VCV000167015	11	103091351	11	103220622	167015	177682	rs727503908	NC_000011.10:103220621:G:T
NM_000136.3(FANCC):c.12_14delinsAAGATCAA (p.Asp4fs)	FANCC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000818570	9	98011560 - 98011562	9	95249278 - 95249280	818570	809509		NC_000009.12:95249277:GAA:TTGATCTT
NM_001080463.1(DYNC2H1):c.7141delG (p.Val2381Tyrfs)	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000663458	11	103059225	11	103188496	663458	652215		NC_000011.10:103188495:GG:G
NM_001377.3(DYNC2H1):c.2235G>A (p.Trp745Ter)	DYNC2H1	W745*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000574328	11	103006253	11	103135524	574328	564103	rs1309577378	NC_000011.10:103135523:G:A
NM_001377.3(DYNC2H1):c.9820-2147G>A	DYNC2H1	W3280*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000567216	11	103112275	11	103241546	567216	564108	rs1565423740	NC_000011.10:103241545:G:A
NM_001377.3(DYNC2H1):c.2574+1G>A	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000558750	11	103006678	11	103135949	558750	549479	rs1565329461	NC_000011.10:103135948:G:A
Single allele	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000558749	11	103016481 - 103177263	11	103145752 - 103306534	558749	549493		
NM_001377.3(DYNC2H1):c.1855C>T (p.Gln619Ter)	DYNC2H1	Q619*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000558745	11	102996022	11	103125293	558745	549478	rs1260978141	NC_000011.10:103125292:C:T
NM_001377.3(DYNC2H1):c.729T>A (p.Tyr243Ter)	DYNC2H1	Y243*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000558744	11	102987406	11	103116677	558744	549476	rs1565311145	NC_000011.10:103116676:T:A
NM_001377.3(DYNC2H1):c.5682_5683del (p.His1896fs)	DYNC2H1	H1896fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000558742	11	103046970 - 103046971	11	103176241 - 103176242	558742	549480	rs767846762	NC_000011.10:103176240:AAA:A
NM_001377.3(DYNC2H1):c.1141_1150del (p.Trp381fs)	DYNC2H1	W381fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000528900	11	102991422 - 102991431	11	103120693 - 103120702	528900	525694	rs1555038664	NC_000011.10:103120692:TGTGGAAAGCTG:TG
NM_001377.3(DYNC2H1):c.1355_1358del (p.Ile452fs)	DYNC2H1	I452fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000459277	11	102991758 - 102991761	11	103121029 - 103121032	459277	461220	rs1223907858	NC_000011.10:103121028:AATTAA:AA
NM_001377.3(DYNC2H1):c.6161G>C (p.Cys2054Ser)	DYNC2H1	C2054S	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446688	11	103049776	11	103179047	446688	440154	rs1555057838	NC_000011.10:103179046:G:C
NM_001377.3(DYNC2H1):c.5984C>T (p.Ala1995Val)	DYNC2H1	A1995V	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446619	11	103048394	11	103177665	446619	440152	rs963717773	NC_000011.10:103177664:C:T
NM_001377.3(DYNC2H1):c.6562T>C (p.Phe2188Leu)	DYNC2H1	F2188L	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446618	11	103055709	11	103184980	446618	440159	rs1555060411	NC_000011.10:103184979:T:C
NM_001377.3(DYNC2H1):c.7945G>T (p.Gly2649Cys)	DYNC2H1	G2649C	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446617	11	103070062	11	103199333	446617	440177	rs758155107	NC_000011.10:103199332:G:T
NM_001377.3(DYNC2H1):c.5087C>T (p.Thr1696Met)	DYNC2H1	T1696M	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446616	11	103040955	11	103170226	446616	440146	rs751030969	NC_000011.10:103170225:C:T
NM_001377.3(DYNC2H1):c.11829C>G (p.Tyr3943Ter)	DYNC2H1	Y3950*, Y3943*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446615	11	103191861	11	103321132	446615	440207	rs369658526	NC_000011.10:103321131:C:G
NM_001377.3(DYNC2H1):c.4418T>C (p.Ile1473Thr)	DYNC2H1	I1473T	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446614	11	103031700	11	103160971	446614	440140	rs1555052511	NC_000011.10:103160970:T:C
NM_001377.3(DYNC2H1):c.7594C>T (p.Arg2532Trp)	DYNC2H1	R2532W	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446613	11	103062879	11	103192150	446613	440173	rs1350329646	NC_000011.10:103192149:C:T
NM_001377.3(DYNC2H1):c.11597del (p.Ser3866fs)	DYNC2H1	S3866fs, S3873fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446612	11	103182710	11	103311981	446612	440205	rs1555098222	NC_000011.10:103311980:G:
NM_001377.3(DYNC2H1):c.327C>G (p.Tyr109Ter)	DYNC2H1	Y109*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446610	11	102984397	11	103113668	446610	440120	rs755305630	NC_000011.10:103113667:C:G
NM_001377.3(DYNC2H1):c.4820T>A (p.Ile1607Asn)	DYNC2H1	I1607N	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446609	11	103039541	11	103168812	446609	440144	rs1555054771	NC_000011.10:103168811:T:A
NM_001377.3(DYNC2H1):c.12642_12643insT (p.Ile4215fs)	DYNC2H1		Short-rib polydactyly syndrome type I	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446608	11	103327078 - 103327079	11	103456350 - 103456351	446608	440209	rs756811136	NC_000011.10:103456350::T
NM_001377.3(DYNC2H1):c.8050G>T (p.Gly2684Ter)	DYNC2H1	G2684*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446607	11	103070167	11	103199438	446607	440183	rs747857715	NC_000011.10:103199437:G:T
NM_001377.3(DYNC2H1):c.7112C>T (p.Thr2371Ile)	DYNC2H1	T2371I	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446606	11	103058287	11	103187558	446606	440165	rs1322884865	NC_000011.10:103187557:C:T
NM_001377.3(DYNC2H1):c.8197G>T (p.Gly2733Cys)	DYNC2H1	G2733C	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446604	11	103070883	11	103200154	446604	440186	rs969015057	NC_000011.10:103200153:G:T
NM_001377.3(DYNC2H1):c.8070C>G (p.Phe2690Leu)	DYNC2H1	F2690L	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446603	11	103070187	11	103199458	446603	440184	rs1214801816	NC_000011.10:103199457:C:G
NM_001377.3(DYNC2H1):c.6545G>A (p.Cys2182Tyr)	DYNC2H1	C2182Y	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446602	11	103055692	11	103184963	446602	440158	rs780855765	NC_000011.10:103184962:G:A
NM_001377.3(DYNC2H1):c.7525T>C (p.Tyr2509His)	DYNC2H1	Y2509H	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446599	11	103062333	11	103191604	446599	440171	rs1386343205	NC_000011.10:103191603:T:C
NM_001377.3(DYNC2H1):c.193A>C (p.Thr65Pro)	DYNC2H1	T65P	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446598	11	102980496	11	103109767	446598	440118	rs555339053	NC_000011.10:103109766:A:C
NM_001377.3(DYNC2H1):c.12466_12469del (p.Asp4156fs)	DYNC2H1	D4163fs, D4156fs	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446597	11	103325921 - 103325924	11	103455193 - 103455196	446597	440208	rs766816050	NC_000011.10:103455192:TAGATA:TA
NM_001377.3(DYNC2H1):c.4553G>A (p.Cys1518Tyr)	DYNC2H1	C1518Y	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446596	11	103033818	11	103163089	446596	440142	rs1555053115	NC_000011.10:103163088:G:A
NM_001377.3(DYNC2H1):c.10918del (p.Leu3640fs)	DYNC2H1	L3640fs, L3647fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446595	11	103157009	11	103286280	446595	440203	rs759649136	NC_000011.10:103286279:CCC:CC
NM_001377.3(DYNC2H1):c.6866T>C (p.Leu2289Pro)	DYNC2H1	L2289P	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446594	11	103057203	11	103186474	446594	440162	rs1555061205	NC_000011.10:103186473:T:C
NM_001377.3(DYNC2H1):c.1847_1852del (p.Ile616_Leu617del)	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446593	11	102996011 - 102996016	11	103125282 - 103125287	446593	440129	rs773897318	NC_000011.10:103125281:TTATTCTTA:TTA
NM_001377.3(DYNC2H1):c.8311+1G>A	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446592	11	103074506	11	103203777	446592	440187	rs1555068270	NC_000011.10:103203776:G:A
NM_001377.3(DYNC2H1):c.1289G>A (p.Arg430His)	DYNC2H1	R430H	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446591	11	102991694	11	103120965	446591	440126	rs770380730	NC_000011.10:103120964:G:A
NM_001377.3(DYNC2H1):c.8145C>A (p.Tyr2715Ter)	DYNC2H1	Y2715*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446590	11	103070831	11	103200102	446590	440185	rs371940321	NC_000011.10:103200101:C:A
NM_001377.3(DYNC2H1):c.7663G>A (p.Val2555Met)	DYNC2H1	V2555M	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446589	11	103062948	11	103192219	446589	440175	rs746195428	NC_000011.10:103192218:G:A
NM_001377.3(DYNC2H1):c.5925del (p.Val1976fs)	DYNC2H1	V1976fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446588	11	103048334	11	103177605	446588	440151	rs1380132788	NC_000011.10:103177604:TT:T
NM_001377.3(DYNC2H1):c.8729T>C (p.Leu2910Pro)	DYNC2H1	L2910P	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446587	11	103086484	11	103215755	446587	440190	rs1555071484	NC_000011.10:103215754:T:C
NM_001377.3(DYNC2H1):c.6574C>T (p.Leu2192Phe)	DYNC2H1	L2192F	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446584	11	103055721	11	103184992	446584	440160	rs1243999036	NC_000011.10:103184991:C:T
NM_001377.3(DYNC2H1):c.11713_11716del (p.Arg3905fs)	DYNC2H1	R3905fs, R3912fs	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446583	11	103187334 - 103187337	11	103316605 - 103316608	446583	440206	rs1453448143	NC_000011.10:103316604:GACAGAC:GAC
NM_001377.3(DYNC2H1):c.5876T>A (p.Ile1959Asn)	DYNC2H1	I1959N	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446582	11	103048286	11	103177557	446582	440150	rs756556129	NC_000011.10:103177556:T:A
NM_001377.3(DYNC2H1):c.10603C>T (p.Gln3535Ter)	DYNC2H1	Q3542*, Q3535*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446581	11	103128478	11	103257749	446581	440201	rs1555082470	NC_000011.10:103257748:C:T
NM_001377.3(DYNC2H1):c.11270A>G (p.Gln3757Arg)	DYNC2H1	Q3764R, Q3757R	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446580	11	103175337	11	103304608	446580	440204	rs758727391	NC_000011.10:103304607:A:G
NM_001377.3(DYNC2H1):c.10105T>C (p.Phe3369Leu)	DYNC2H1	F3376L, F3369L	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446579	11	103124076	11	103253347	446579	440199	rs1555081345	NC_000011.10:103253346:T:C
NM_001377.3(DYNC2H1):c.5558+2T>C	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446578	11	103044036	11	103173307	446578	440148	rs762666243	NC_000011.10:103173306:T:C
NM_001377.3(DYNC2H1):c.7967G>T (p.Arg2656Leu)	DYNC2H1	R2656L	Short-rib polydactyly syndrome type I	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446577	11	103070084	11	103199355	446577	440180	rs200614421	NC_000011.10:103199354:G:T
NM_001377.3(DYNC2H1):c.7268C>A (p.Ser2423Tyr)	DYNC2H1	S2423Y	Short-rib polydactyly syndrome type I	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446576	11	103059353	11	103188624	446576	440166	rs1555062340	NC_000011.10:103188623:C:A
NM_001377.3(DYNC2H1):c.767-2A>G	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446575	11	102988358	11	103117629	446575	440123	rs762873763	NC_000011.10:103117628:A:G
NM_001377.3(DYNC2H1):c.6271A>G (p.Asn2091Asp)	DYNC2H1	N2091D	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446574	11	103049886	11	103179157	446574	440156	rs1555057881	NC_000011.10:103179156:A:G
NM_001377.3(DYNC2H1):c.8765_8766GT[2] (p.Leu2924fs)	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446573	11	103086520 - 103086521	11	103215791 - 103215792	446573	440191	rs1555071503	NC_000011.10:103215790:GTGTGT:GTGT
NM_001377.3(DYNC2H1):c.6480T>A (p.Asn2160Lys)	DYNC2H1	N2160K	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446572	11	103055627	11	103184898	446572	440157	rs775426647	NC_000011.10:103184897:T:A
NM_001377.3(DYNC2H1):c.7577T>G (p.Ile2526Ser)	DYNC2H1	I2526S	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446571	11	103062862	11	103192133	446571	440172	rs762588952	NC_000011.10:103192132:T:G
NM_001377.3(DYNC2H1):c.1657_1660del (p.Leu553fs)	DYNC2H1	L553fs	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446569	11	102993723 - 102993726	11	103122994 - 103122997	446569	440128	rs748906528	NC_000011.10:103122993:GTTTGT:GT
NM_001377.3(DYNC2H1):c.6116G>A (p.Arg2039His)	DYNC2H1	R2039H	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446568	11	103048526	11	103177797	446568	440153	rs1555057503	NC_000011.10:103177796:G:A
NM_001377.3(DYNC2H1):c.5129T>A (p.Val1710Asp)	DYNC2H1	V1710D	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446567	11	103040997	11	103170268	446567	440147	rs777396565	NC_000011.10:103170267:T:A
NM_001377.3(DYNC2H1):c.8590del (p.Ala2864fs)	DYNC2H1	A2864fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446565	11	103082568	11	103211839	446565	440189	rs1555070451	NC_000011.10:103211838:G:
NM_001377.3(DYNC2H1):c.12806T>C (p.Leu4269Ser)	DYNC2H1	L4276S, L4269S	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446564	11	103349863	11	103479135	446564	440210	rs1555143920	NC_000011.10:103479134:T:C
NM_001377.3(DYNC2H1):c.5612del (p.Thr1871fs)	DYNC2H1	T1871fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446563	11	103044837	11	103174108	446563	440149	rs1555056464	NC_000011.10:103174107:C:
NM_001377.3(DYNC2H1):c.195G>T (p.Thr65=)	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446561	11	102980498	11	103109769	446561	440119	rs896105030	NC_000011.10:103109768:G:T
NM_001377.3(DYNC2H1):c.1078C>T (p.Arg360Ter)	DYNC2H1	R360*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446560	11	102991254	11	103120525	446560	440124	rs764769351	NC_000011.10:103120524:C:T
NM_001377.3(DYNC2H1):c.8434del (p.Ser2812fs)	DYNC2H1	S2812fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446559	11	103075673	11	103204944	446559	440188	rs1555068636	NC_000011.10:103204943:T:
NM_001377.3(DYNC2H1):c.8012T>C (p.Met2671Thr)	DYNC2H1	M2671T	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446558	11	103070129	11	103199400	446558	440182	rs1196317554	NC_000011.10:103199399:T:C
NM_001377.3(DYNC2H1):c.2225T>G (p.Met742Arg)	DYNC2H1	M742R	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446557	11	103006243	11	103135514	446557	440132	rs774610143	NC_000011.10:103135513:T:G
NM_001377.3(DYNC2H1):c.10900C>T (p.Pro3634Ser)	DYNC2H1	P3641S, P3634S	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446555	11	103156993	11	103286264	446555	440202	rs769053227	NC_000011.10:103286263:C:T
NM_001377.3(DYNC2H1):c.6265A>G (p.Asn2089Asp)	DYNC2H1	N2089D	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446554	11	103049880	11	103179151	446554	440155	rs753662982	NC_000011.10:103179150:A:G
NM_001377.3(DYNC2H1):c.3095del (p.Gln1032fs)	DYNC2H1	Q1032fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446553	11	103023013	11	103152284	446553	440135	rs1555049536	NC_000011.10:103152283:A:
NM_001377.3(DYNC2H1):c.6883T>C (p.Cys2295Arg)	DYNC2H1	C2295R	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446552	11	103057220	11	103186491	446552	440163	rs1555061228	NC_000011.10:103186490:T:C
NM_001377.3(DYNC2H1):c.4699C>G (p.Leu1567Val)	DYNC2H1	L1567V	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446551	11	103036714	11	103165985	446551	440143	rs901629870	NC_000011.10:103165984:C:G
NM_001377.3(DYNC2H1):c.4964A>G (p.Tyr1655Cys)	DYNC2H1	Y1655C	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446550	11	103039685	11	103168956	446550	440145	rs1461272672	NC_000011.10:103168955:A:G
NM_001377.3(DYNC2H1):c.6634-2A>G	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446549	11	103056969	11	103186240	446549	440161	rs1555060940	NC_000011.10:103186239:A:G
NM_001377.3(DYNC2H1):c.7643T>C (p.Phe2548Ser)	DYNC2H1	F2548S	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446548	11	103062928	11	103192199	446548	440174	rs1555064376	NC_000011.10:103192198:T:C
NM_001377.3(DYNC2H1):c.9760_9764del (p.Trp3253_Lys3254insTer)	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446546	11	103107208 - 103107212	11	103236479 - 103236483	446546	440195	rs1218198013	NC_000011.10:103236478:GAAAAG:G
NM_001377.3(DYNC2H1):c.10099C>T (p.Arg3367Cys)	DYNC2H1	R3374C, R3367C	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446545	11	103124070	11	103253341	446545	440198	rs200710887	NC_000011.10:103253340:C:T
NM_001377.3(DYNC2H1):c.7277G>T (p.Arg2426Leu)	DYNC2H1	R2426L	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446544	11	103059362	11	103188633	446544	440167	rs373521030	NC_000011.10:103188632:G:T
NM_001377.3(DYNC2H1):c.9565C>T (p.Gln3189Ter)	DYNC2H1	Q3189*	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446542	11	103104887	11	103234158	446542	440193	rs373924400	NC_000011.10:103234157:C:T
NM_001377.3(DYNC2H1):c.1949T>A (p.Ile650Asn)	DYNC2H1	I650N	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446541	11	102999730	11	103129001	446541	440130	rs1555041449	NC_000011.10:103129000:T:A
NM_001377.3(DYNC2H1):c.9710-2A>G	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446540	11	103107157	11	103236428	446540	440194	rs1555077194	NC_000011.10:103236427:A:G
NM_001377.3(DYNC2H1):c.7774_7782del (p.Leu2592_Pro2594del)	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446538	11	103068724 - 103068732	11	103197995 - 103198003	446538	440176	rs1555066796	NC_000011.10:103197994:CCATTACCTCCA:CCA
NM_001377.3(DYNC2H1):c.7438-2A>G	DYNC2H1		Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446535	11	103062244	11	103191515	446535	440169	rs1555063811	NC_000011.10:103191514:A:G
NM_001377.3(DYNC2H1):c.9844G>A (p.Asp3282Asn)	DYNC2H1	D3289N, D3282N	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446534	11	103114446	11	103243717	446534	440196	rs780600124	NC_000011.10:103243716:G:A
NM_001377.3(DYNC2H1):c.7966C>T (p.Arg2656Cys)	DYNC2H1	R2656C	Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446533	11	103070083	11	103199354	446533	440178	rs371214841	NC_000011.10:103199353:C:T
NM_001377.3(DYNC2H1):c.5547del (p.Phe1849fs)	DYNC2H1	F1849fs	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000407162	11	103044023	11	103173294	407162	398130	rs771003300	NC_000011.10:103173293:C:
NM_001377.3(DYNC2H1):c.10461+1G>A	DYNC2H1		Narrow chest|Bowing of the long bones|Intrauterine growth retardation	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000374100	11	103126970	11	103256241	374100	360924	rs1057518898	NC_000011.10:103256240:G:A
NM_001377.3(DYNC2H1):c.5495C>A (p.Ser1832Ter)	DYNC2H1	S1832*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000238272	11	103043971	11	103173242	238272	240902	rs754919042	NC_000011.10:103173241:C:A
NM_001377.3(DYNC2H1):c.11650-1G>A	DYNC2H1		not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000235270	11	103187273	11	103316544	235270	236957	rs878852996	NC_000011.10:103316543:G:A
NM_001377.3(DYNC2H1):c.2702+1G>A	DYNC2H1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000220043	11	103014125	11	103143396	220043	222013	rs864622358	NC_000011.10:103143395:G:A
GRCh38/hg38 11q22.3(chr11:103328808-103570897)x1	DYNC2H1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058920	11	103199536 - 103441625	11	103328808 - 103570897	58920	73515		
NM_001377.3(DYNC2H1):c.8534del (p.Asn2845fs)	DYNC2H1	N2845fs	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000040071	11	103080677	11	103209948	40071	48582	rs431905507	NC_000011.10:103209947:AAAAAAAA:AAAAAAA
NM_001377.3(DYNC2H1):c.7486C>T (p.Pro2496Ser)	DYNC2H1	P2496S	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000040069	11	103062294	11	103191565	40069	48580	rs397514636	NC_000011.10:103191564:C:T
NM_001377.3(DYNC2H1):c.10109del (p.Leu3370fs)	DYNC2H1	L3377fs, L3370fs	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006514	11	103124076	11	103253347	6514	21553	rs431905500	NC_000011.10:103253346:TTTTT:TTTT
NM_001377.3(DYNC2H1):c.7382G>T (p.Gly2461Val)	DYNC2H1	G2461V	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006512	11	103060490	11	103189761	6512	21551	rs137853034	NC_000011.10:103189760:G:T
NM_001377.3(DYNC2H1):c.4610A>G (p.Gln1537Arg)	DYNC2H1	Q1537R	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006511	11	103033875	11	103163146	6511	21550	rs137853033	NC_000011.10:103163145:A:G
NM_001377.3(DYNC2H1):c.5151+1G>T	DYNC2H1		Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000006510	11	103041020	11	103170291	6510	21549	rs431905499	NC_000011.10:103170290:G:T
NM_001377.3(DYNC2H1):c.10042G>T (p.Gly3348Ter)	DYNC2H1	G3355*, G3348*	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006505	11	103116103	11	103245374	6505	21544	rs137853029	NC_000011.10:103245373:G:T
NM_001080463.1(DYNC2H1):c.626_654dup (p.Glu219Phefs)	DYNC2H1		Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006502	11	102987302 - 102987303	11	103116573 - 103116574	6502	21541	rs1565310938	NC_000011.10:103116573:TTTATAACTTGGACAGTCTATCCTTACTA:TTTATAACTTGGACAGTCTATCCTTACTATTTATAACTTGGACAGTCTATCCTTACTA
NM_001377.3(DYNC2H1):c.5971A>T (p.Met1991Leu)	DYNC2H1	M1991L	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006500	11	103048381	11	103177652	6500	21539	rs137853025	NC_000011.10:103177651:A:T
NM_000136.3(FANCC):c.338G>A (p.Trp113Ter)	FANCC	W113*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000823708	9	98002938	9	95240656	823708	809494		NC_000009.12:95240655:C:T
NM_001377.3(DYNC2H1):c.3719T>C (p.Ile1240Thr)	DYNC2H1	I1240T	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006504	11	103026205	11	103155476	6504	21543	rs137853028	NC_000011.10:103155475:T:C
NM_001377.3(DYNC2H1):c.2040dup (p.Ala681fs)	DYNC2H1		not provided|Jeune thoracic dystrophy	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000446679	11	103004369 - 103004370	11	103133640 - 103133641	446679	440131	rs1555042801	NC_000011.10:103133640:T:TT
NM_001377.3(DYNC2H1):c.7441C>T (p.Arg2481Ter)	DYNC2H1	R2481*	Jeune thoracic dystrophy|not specified	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000446605	11	103062249	11	103191520	446605	440170	rs537704873	NC_000011.10:103191519:C:T
NM_001377.3(DYNC2H1):c.7984C>T (p.Arg2662Trp)	DYNC2H1	R2662W	Short-rib polydactyly syndrome type I|Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446601	11	103070101	11	103199372	446601	440181	rs964711006	NC_000011.10:103199371:C:T
NM_001377.3(DYNC2H1):c.625T>A (p.Phe209Ile)	DYNC2H1	F209I	Jeune thoracic dystrophy|Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446586	11	102987302	11	103116573	446586	440121	rs771511132	NC_000011.10:103116572:T:A
NM_001377.3(DYNC2H1):c.4162_4170dup (p.Val1388_Thr1390dup)	DYNC2H1		Jeune thoracic dystrophy|Short-rib polydactyly syndrome type III	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446585	11	103029438 - 103029439	11	103158709 - 103158710	446585	440138	rs1555051720	NC_000011.10:103158709:AGTCACAACA:AGTCACAACAGTCACAACA
NM_001377.3(DYNC2H1):c.2341T>G (p.Tyr781Asp)	DYNC2H1	Y781D	Jeune thoracic dystrophy|Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446566	11	103006359	11	103135630	446566	440133	rs1555043520	NC_000011.10:103135629:T:G
NM_001377.3(DYNC2H1):c.1306G>T (p.Glu436Ter)	DYNC2H1	E436*	Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000446556	11	102991711	11	103120982	446556	440127	rs371011047	NC_000011.10:103120981:G:T
NM_001377.3(DYNC2H1):c.12829A>G (p.Arg4277Gly)	DYNC2H1	R4284G, R4277G	Short-rib polydactyly syndrome type III|Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446547	11	103349886	11	103479158	446547	440211	rs368654019	NC_000011.10:103479157:A:G
NM_001377.3(DYNC2H1):c.9353+1G>A	DYNC2H1		Jeune thoracic dystrophy|Short-rib polydactyly syndrome type III	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446543	11	103093816	11	103223087	446543	440192	rs776407305	NC_000011.10:103223086:G:A
NM_001377.3(DYNC2H1):c.3059T>G (p.Leu1020Ter)	DYNC2H1	L1020*	Short-rib polydactyly syndrome type III|not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000446537	11	103022977	11	103152248	446537	440134	rs373335226	NC_000011.10:103152247:T:G
NM_001377.3(DYNC2H1):c.10042+2T>G	DYNC2H1		Short-rib polydactyly syndrome type III|Short rib-polydactyly syndrome, Majewski type	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446536	11	103116105	11	103245376	446536	440197	rs1261505725	NC_000011.10:103245375:T:G
NM_001377.3(DYNC2H1):c.10198C>T (p.Arg3400Ter)	DYNC2H1	R3407*, R3400*	Short-rib polydactyly syndrome type III|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000423715	11	103124169	11	103253440	423715	408035	rs943680446	NC_000011.10:103253439:C:T
NM_001377.3(DYNC2H1):c.1360+2del	DYNC2H1		Short-rib polydactyly syndrome type III|not provided	Pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	VCV000199053	11	102991767	11	103121038	199053	196212	rs780539887	NC_000011.10:103121037:T:
NM_001377.3(DYNC2H1):c.3353del (p.Ser1118fs)	DYNC2H1	S1118fs	not provided|Jeune thoracic dystrophy	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000195733	11	103025230	11	103154501	195733	192894	rs755338872	NC_000011.10:103154500:G:
NM_000136.3(FANCC):c.139A>T (p.Lys47Ter)	FANCC	K47*	Fanconi anemia	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000857816	9	98011435	9	95249153	857816	836344		NC_000009.12:95249152:T:A
NM_000136.3(FANCC):c.140_143dup (p.Met48fs)	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000850204	9	98011430 - 98011431	9	95249148 - 95249149	850204	836343		NC_000009.12:95249148:ATCT:ATCTATCT
NM_000136.3(FANCC):c.353T>G (p.Leu118Ter)	FANCC	L118*	Fanconi anemia	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000850029	9	97934422	9	95172140	850029	836340		NC_000009.12:95172139:A:C
NM_000136.3(FANCC):c.451A>T (p.Lys151Ter)	FANCC	K151*	Fanconi anemia	Pathogenic(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000835085	9	97934324	9	95172042	835085	836338		NC_000009.12:95172041:T:A
NC_000009.12:g.(?_95101707)_(95317709_?)del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, single submitter	VCV000833169	9	97863989 - 98079991			833169	820171		
NC_000009.12:g.(?_95135336)_(95249379_?)del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000831704	9	97897618 - 98011661			831704	820174		
NC_000009.12:g.(?_95149913)_(95172157_?)del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000831098	9	97912195 - 97934439			831098	820175		
NC_000009.12:g.(?_95114619)_(95114720_?)del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000830972	9	97876901 - 97877002			830972	820172		
NC_000009.12:g.(?_95240639)_(95240753_?)del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000830403	9	98002921 - 98003035			830403	820177		
NM_000136.3(FANCC):c.507del (p.Phe169fs)	FANCC	F169fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000649429	9	97933375	9	95171093	649429	638445		NC_000009.12:95171092:AAA:AA
NM_000136.3(FANCC):c.389_390del (p.Glu130fs)	FANCC	E130fs	Fanconi anemia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000576659	9	97934385 - 97934386	9	95172103 - 95172104	576659	569204	rs1564720605	NC_000009.12:95172102:TT:
NM_001377.3(DYNC2H1):c.4267C>T (p.Arg1423Cys)	DYNC2H1	R1423C	Short-rib polydactyly syndrome type III|Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446611	11	103029645	11	103158916	446611	440139	rs745870321	NC_000011.10:103158915:C:T
NM_001377.3(DYNC2H1):c.1953G>A (p.Lys651=)	DYNC2H1		Jeune thoracic dystrophy|Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Feb 24, 2015)	criteria provided, single submitter	VCV000437419	11	102999734	11	103129005	437419	430981	rs1178331074	NC_000011.10:103129004:G:A
NM_000136.3(FANCC):c.485dup (p.Glu163fs)	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000409663	9	97933396 - 97933397	9	95171114 - 95171115	409663	397485	rs1554842611	NC_000009.12:95171114:C:CC
NM_001377.3(DYNC2H1):c.10585C>T (p.Arg3529Ter)	DYNC2H1	R3536*, R3529*	Short-rib polydactyly syndrome type III|Jeune thoracic dystrophy	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000407155	11	103128460	11	103257731	407155	397593	rs562139820	NC_000011.10:103257730:C:T
NM_000136.2(FANCC):c.-78-?_250+?del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000237062	9	98009714 - 98011651	9	95247432 - 95249369	237062	240435		
NM_000136.2(FANCC):c.997-?_1154+?del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000219667					219667	221802		
NM_001377.3(DYNC2H1):c.7985G>A (p.Arg2662Gln)	DYNC2H1	R2662Q	Short-rib polydactyly syndrome type III|Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000040068	11	103070102	11	103199373	40068	48579	rs397514635	NC_000011.10:103199372:G:A
NM_001377.3(DYNC2H1):c.8512C>T (p.Arg2838Ter)	DYNC2H1	R2838*	Short-rib polydactyly syndrome type III|Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000006508	11	103080662	11	103209933	6508	21547	rs137853032	NC_000011.10:103209932:C:T
NM_001377.3(DYNC2H1):c.1759C>T (p.Arg587Cys)	DYNC2H1	R587C	Short-rib polydactyly syndrome type III|Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000006506	11	102995926	11	103125197	6506	21545	rs137853030	NC_000011.10:103125196:C:T
NM_001360.2(DHCR7):c.976G>T (p.Val326Leu)	DHCR7	V326L	Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006785	11	71146873	11	71435827	6785	21824	rs80338859	NC_000011.10:71435826:C:A
NC_000009.12:g.(?_95135336)_(95135512_?)del	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000832560	9	97897618 - 97897794			832560	820173		
NM_000136.3(FANCC):c.673G>T (p.Glu225Ter)	FANCC	E225*	Fanconi anemia, complementation group C	Pathogenic	criteria provided, single submitter	VCV000813470	9	97912218	9	95149936	813470	801682		NC_000009.12:95149935:C:A
NM_000136.3(FANCC):c.355_356TC[1] (p.His120fs)	FANCC		Fanconi anemia, complementation group C	Pathogenic	criteria provided, single submitter	VCV000813413	9	97934417 - 97934418	9	95172135 - 95172136	813413	801684		NC_000009.12:95172134:GAGA:GA
NM_000136.3(FANCC):c.251-2A>G	FANCC		Fanconi anemia	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000456159	9	98003027	9	95240745	456159	459732	rs1057517219	NC_000009.12:95240744:T:C
FANCC, 250-BP DEL	FANCC		Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000012052					12052	27091		
NM_001142649.2(ANO5):c.986dup (p.Leu329fs)	ANO5		Gnathodiaphyseal dysplasia|Miyoshi muscular dystrophy 3|Limb-girdle muscular dystrophy, type 2L|Limb-girdle muscular dystrophy, type 2L|not provided|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096688	11	22271891 - 22271892	11	22250345 - 22250346	96688	102581	rs398124626	NC_000011.10:22250345:TT:TTT
NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp)	ALDOB	A175D	Hereditary fructosuria|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000465	9	104189780	9	101427498	465	15504	rs76917243	NC_000009.12:101427497:G:T
NM_000155.4(GALT):c.199C>T (p.Arg67Cys)	GALT	R67C	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025137	9	34647202	9	34647205	25137	36471	rs111033658	NC_000009.12:34647204:C:T
NM_000136.3(FANCC):c.519del (p.Arg173fs)	FANCC	R173fs	Fanconi anemia, complementation group A|Fanconi anemia, complementation group C	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000584740	9	97933363	9	95171081	584740	575796	rs1564719070	NC_000009.12:95171080:CC:C
NM_000136.3(FANCC):c.29dup (p.Cys10fs)	FANCC		not provided|Fanconi anemia	Pathogenic(Last reviewed: Nov 28, 2015)	criteria provided, multiple submitters, no conflicts	VCV000237069	9	98011544 - 98011545	9	95249262 - 95249263	237069	240643	rs878853671	NC_000009.12:95249262:C:CC
NM_000136.3(FANCC):c.165+1G>T	FANCC		Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000012051	9	98011408	9	95249126	12051	27090	rs794726668	NC_000009.12:95249125:C:A
NM_023110.2(FGFR1):c.1638C>A (p.Asn546Lys)	FGFR1	N546K, N536K, N542K, N544K, N453K, N457K, N577K, N455K	Brainstem glioma|Neuroblastoma|Medulloblastoma|Rosette-forming glioneuronal tumor|Adenocarcinoma of stomach|Encephalocraniocutaneous lipomatosis|Astrocytoma	Pathogenic	criteria provided, single submitter	VCV000224896	8	38274849	8	38417331	224896	226759	rs779707422	NC_000008.11:38417330:G:T
NM_001134363.3(RBM20):c.1901G>A (p.Arg634Gln)	RBM20	R634Q	not provided|Dilated cardiomyopathy 1DD	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000269	10	112572056	10	110812298	269	15308	rs267607001	NC_000010.11:110812297:G:A
NM_004333.6(BRAF):c.1743T>A (p.Asn581Lys)	BRAF	N581K, N529K, N547K, N559K, N493K, N544K, N584K, N621K	not provided|Cardiofaciocutaneous syndrome 1|Lung cancer|LEOPARD syndrome 3|Noonan syndrome 7|Noonan syndrome 1|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044811	7	140453192	7	140753392	44811	53978	rs397516895	NC_000007.14:140753391:A:T
NM_004333.6(BRAF):c.1796C>T (p.Thr599Ile)	BRAF	T599I	Cutaneous melanoma|Noonan syndrome|Neoplasm|not provided	Pathogenic(Last reviewed: Feb 1, 2014)	criteria provided, single submitter	VCV000040388	7	140453139	7	140753339	40388	48858	rs121913375	NC_000007.14:140753338:G:A
NM_000552.4(VWF):c.4496T>A (p.Val1499Glu)	VWF	V1499E	not specified	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000440408	12	6128088	12	6018922	440408	433118	rs1555194979	NC_000012.12:6018921:A:T
GRCh37/hg19 12p13.31(chr12:6108512-6252553)x1	VWF		See cases	Pathogenic	no assertion criteria provided	VCV000396509	12	6108512 - 6252553			396509	383402		
NM_000552.4(VWF):c.1548T>A (p.Tyr516Ter)	VWF	Y516*	not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000619930	12	6167196	12	6058030	619930	611150	rs1800379	NC_000012.12:6058029:A:T
NM_000552.4(VWF):c.4006C>T (p.Arg1336Ter)	VWF	R1336*	not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000619748	12	6128578	12	6019412	619748	611136	rs1565832211	NC_000012.12:6019411:G:A
NM_000552.4(VWF):c.2435dup (p.Met814fs)	VWF		not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000619743	12	6153463 - 6153464	12	6044297 - 6044298	619743	611143	rs62643632	NC_000012.12:6044297:GGGGGG:GGGGGGG
NM_000552.4(VWF):c.7080C>A (p.Cys2360Ter)	VWF	C2360*	Abnormality of coagulation	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627363	12	6092317	12	5983151	627363	615474		NC_000012.12:5983150:G:T
NM_000552.4(VWF):c.4382C>T (p.Ala1461Val)	VWF	A1461V	not specified|not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000100354	12	6128202	12	6019036	100354	106231	rs61750089	NC_000012.12:6019035:G:A
NM_000552.4(VWF):c.3430T>G (p.Trp1144Gly)	VWF	W1144G	not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000100262	12	6132014	12	6022848	100262	106139	rs267607325	NC_000012.12:6022847:A:C
VWF, TRP1745CYS	VWF	W1745C	von Willebrand disease type 2	Pathogenic(Last reviewed: Oct 15, 2009)	no assertion criteria provided	VCV000031010					31010	39967		
NM_000552.4(VWF):c.221-10_532+52del	VWF		von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627516	12	6219488 - 6220144	12	6110322 - 6110978	627516	615871		
NM_000552.4(VWF):c.5621-47_5842+51del	VWF		von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627514	12	6120732 - 6121343	12	6011566 - 6012177	627514	615869		
NM_000552.4(VWF):c.7252_7253TG[1] (p.Cys2418fs)	VWF		Von Willebrand disease, recessive form	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627367	12	6090984 - 6090985	12	5981818 - 5981819	627367	615473		NC_000012.12:5981817:CACA:CA
NM_000552.4(VWF):c.50dup (p.Leu17fs)	VWF		von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627085	12	6232312 - 6232313	12	6123146 - 6123147	627085	615519		NC_000012.12:6123146:AAAA:AAAAA
NM_000552.4(VWF):c.2921G>A (p.Trp974Ter)	VWF	W974*	von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627054	12	6138554	12	6029388	627054	615503		NC_000012.12:6029387:C:T
NM_000552.4(VWF):c.7360_7376del (p.Thr2454fs)	VWF	T2454fs	von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626938	12	6085338 - 6085354	12	5976172 - 5976188	626938	615471		NC_000012.12:5976171:GCATCCTCCATGTCGGTGCA:GCA
NM_000552.4(VWF):c.3925A>G (p.Ile1309Val)	VWF	I1309V	not provided|von Willebrand disorder	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000100305	12	6128659	12	6019493	100305	106182	rs61749389	NC_000012.12:6019492:T:C
NM_000552.4(VWF):c.1583A>G (p.Asn528Ser)	VWF	N528S	not provided|von Willebrand disease, type 2a	Pathogenic(Last reviewed: Jun 3, 2010)	no assertion criteria provided	VCV000000318	12	6167161	12	6057995	318	15357	rs61754010	NC_000012.12:6057994:T:C
NM_000552.4(VWF):c.3178T>C (p.Cys1060Arg)	VWF	C1060R	von Willebrand disease type 2N|not provided	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000000317	12	6134790	12	6025624	317	15356	rs61748497	NC_000012.12:6025623:A:G
NM_000552.4(VWF):c.1071C>A (p.Tyr357Ter)	VWF	Y357*	not provided|von Willebrand disease type 2N	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000000316	12	6181535	12	6072369	316	15355	rs61754002	NC_000012.12:6072368:G:T
NM_000552.4(VWF):c.2411G>T (p.Cys804Phe)	VWF	C804F	not provided|von Willebrand disease type 2N	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000000313	12	6153488	12	6044322	313	15352	rs62643630	NC_000012.12:6044321:C:A
NM_000552.4(VWF):c.2384A>G (p.Tyr795Cys)	VWF	Y795C	not provided|von Willebrand disease type 2N	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000000312	12	6153515	12	6044349	312	15351	rs61748478	NC_000012.12:6044348:T:C
NM_000552.4(VWF):c.3854C>T (p.Ser1285Phe)	VWF	S1285F	not provided|von Willebrand disease type 2M	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000311	12	6128730	12	6019564	311	15350	rs61749380	NC_000012.12:6019563:G:A
VWF, 6-BP INS, NT1212	VWF		von Willebrand disease, type 2a	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000000307					307	15346		
NM_000552.4(VWF):c.4453del (p.Val1485fs)	VWF	V1485fs	not provided|Abnormality of coagulation	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000100360	12	6128131	12	6018965	100360	106237	rs61750095	NC_000012.12:6018964:CCCCC:CCCC
NM_000552.4(VWF):c.5347T>G (p.Ser1783Ala)	VWF	S1783A	von Willebrand disease type 2|not provided	Pathogenic(Last reviewed: Oct 15, 2009)	no assertion criteria provided	VCV000031012	12	6125363	12	6016197	31012	39969	rs267607353	NC_000012.12:6016196:A:C
NM_000552.4(VWF):c.2279G>A (p.Arg760His)	VWF	R760H	von Willebrand disease type 1|not provided	Pathogenic(Last reviewed: Oct 15, 2009)	no assertion criteria provided	VCV000031011	12	6155891	12	6046725	31011	39968	rs61748467	NC_000012.12:6046724:C:T
VWF, 8.6-KB DEL, EX4-5	VWF		von Willebrand disease type 1|von Willebrand disease type 3	Pathogenic(Last reviewed: Jul 30, 2009)	no assertion criteria provided	VCV000031008					31008	39965		
NM_000552.4(VWF):c.7085G>T (p.Cys2362Phe)	VWF	C2362F	not provided|von Willebrand disease type 3	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000000315	12	6091154	12	5981988	315	15354	rs61750630	NC_000012.12:5981987:C:A
NM_000552.4(VWF):c.1648G>A (p.Gly550Arg)	VWF	G550R	not provided|von Willebrand disease, type 2a	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000000305	12	6167096	12	6057930	305	15344	rs61754011	NC_000012.12:6057929:C:T
NM_000552.4(VWF):c.4541T>G (p.Phe1514Cys)	VWF	F1514C	von Willebrand disease, type 2a|not provided	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000304	12	6128043	12	6018877	304	15343	rs61750101	NC_000012.12:6018876:A:C
NM_000552.4(VWF):c.3940G>C (p.Val1314Leu)	VWF	V1314L	von Willebrand disease, type 2b|not provided	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000302	12	6128644	12	6019478	302	15341	rs61749393	NC_000012.12:6019477:C:G
NM_000552.4(VWF):c.3814T>C (p.Cys1272Arg)	VWF	C1272R	von Willebrand disease, type 2a|not provided	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000301	12	6128770	12	6019604	301	15340	rs61749372	NC_000012.12:6019603:A:G
NM_000552.4(VWF):c.2446C>T (p.Arg816Trp)	VWF	R816W	not provided|von Willebrand disease type 2N	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000295	12	6145654	12	6036488	295	15334	rs121964894	NC_000012.12:6036487:G:A
NM_000552.4(VWF):c.4837T>C (p.Ser1613Pro)	VWF	S1613P	not provided|von Willebrand disease, type 2a	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000292	12	6127747	12	6018581	292	15331	rs61750581	NC_000012.12:6018580:A:G
NM_000552.4(VWF):c.4022G>A (p.Arg1341Gln)	VWF	R1341Q	not provided|von Willebrand disease, type 2b	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000291	12	6128562	12	6019396	291	15330	rs61749403	NC_000012.12:6019395:C:T
NM_000552.4(VWF):c.4820T>A (p.Val1607Asp)	VWF	V1607D	not provided|von Willebrand disease, type 2a	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000286	12	6127764	12	6018598	286	15325	rs61750579	NC_000012.12:6018597:A:T
NM_005609.4(PYGM):c.613G>A (p.Gly205Ser)	PYGM	G205S, G117S	not provided|Glycogen storage disease, type V	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002299	11	64525298	11	64757826	2299	17338	rs119103251	NC_000011.10:64757825:C:T
NM_002180.2(IGHMBP2):c.1813C>T (p.Arg605Ter)	IGHMBP2	R605*	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488694	11	68703761	11	68936293	488694	482001	rs991227431	NC_000011.10:68936292:C:T
NM_006269.2(RP1):c.2749C>T (p.Gln917Ter)	RP1	Q917*	Retinal dystrophy|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000236414	8	55539191	8	54626631	236414	238040	rs878853326	NC_000008.11:54626630:C:T
NM_000170.2(GLDC):c.2311G>A (p.Gly771Arg)	GLDC	G771R	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056072	9	6554673	9	6554673	56072	70711	rs386833553	NC_000009.12:6554672:C:T
NM_000170.2(GLDC):c.1009C>T (p.Arg337Ter)	GLDC	R337*	not provided|Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056036	9	6604637	9	6604637	56036	70675	rs386833517	NC_000009.12:6604636:G:A
NM_000552.4(VWF):c.4790G>A (p.Arg1597Gln)	VWF	R1597Q	von Willebrand disorder|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000100391	12	6127794	12	6018628	100391	106268	rs61750577	NC_000012.12:6018627:C:T
NM_000552.4(VWF):c.3379+1G>A	VWF		von Willebrand disorder|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000100257	12	6132796	12	6023630	100257	106134	rs2363337	NC_000012.12:6023629:C:T
NM_000552.4(VWF):c.3445T>C (p.Cys1149Arg)	VWF	C1149R	von Willebrand disease type 1|not provided	Pathogenic(Last reviewed: Nov 15, 2001)	no assertion criteria provided	VCV000000309	12	6131999	12	6022833	309	15348	rs61748511	NC_000012.12:6022832:A:G
NM_000552.4(VWF):c.8317T>C (p.Cys2773Arg)	VWF	C2773R	von Willebrand disease, type 2a|not provided	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000306	12	6058306	12	5949140	306	15345	rs61751310	NC_000012.12:5949139:A:G
NM_000552.4(VWF):c.3939G>C (p.Trp1313Cys)	VWF	W1313C	not provided|von Willebrand disease, type 2b	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000287	12	6128645	12	6019479	287	15326	rs61749392	NC_000012.12:6019478:C:G
NM_000287.4(PEX6):c.2663G>T (p.Arg888Leu)	PEX6	R888L, R800L	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000520796	6	42932816	6	42965078	520796	511679	rs267608247	NC_000006.12:42965077:C:A
NM_000136.3(FANCC):c.520C>T (p.Arg174Ter)	FANCC	R174*	Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189022	9	97933362	9	95171080	189022	186793	rs781542763	NC_000009.12:95171079:G:A
NM_000197.2(HSD17B3):c.608C>T (p.Ala203Val)	HSD17B3	A203V	Testosterone 17-beta-dehydrogenase deficiency|Pseudohermaphroditism|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000004875	9	99006675	9	96244393	4875	19914	rs119481076	NC_000009.12:96244392:G:A
NM_000552.4(VWF):c.3970G>A (p.Gly1324Ser)	VWF	G1324S	von Willebrand disease type 2M|not provided	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000300	12	6128614	12	6019448	300	15339	rs61749398	NC_000012.12:6019447:C:T
NM_000552.4(VWF):c.7603C>T (p.Arg2535Ter)	VWF	R2635*, R2535*	not provided|von Willebrand disease type 3	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000299	12	6078503	12	5969337	299	15338	rs61751296	NC_000012.12:5969336:G:A
NM_001142800.2(EYS):c.32dup (p.Met12fs)	EYS		Retinal dystrophy	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000866202	6	66205271 - 66205272	6	65495378 - 65495379	866202	856517		NC_000006.12:65495378:A:AA
NM_001142800.2(EYS):c.4361_4362delinsAG (p.Ser1454Ter)	EYS		Retinitis punctata albescens	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812316	6	65301398 - 65301399	6	64591505 - 64591506	812316	800526		NC_000006.12:64591504:GG:CT
GRCh37/hg19 6q12(chr6:65603577-65657511)x1	EYS		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000689064	6	65603577 - 65657511			689064	676656		
GRCh37/hg19 6q12(chr6:65648091-65663089)x1	EYS		not provided	Pathogenic(Last reviewed: May 18, 2017)	no assertion criteria provided	VCV000688912	6	65648091 - 65663089			688912	676504		
GRCh37/hg19 6q12(chr6:65600602-65657511)x1	EYS		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000688662	6	65600602 - 65657511			688662	676254		
GRCh37/hg19 6q12(chr6:65558549-65955260)x1	EYS		not provided	Pathogenic(Last reviewed: Jun 29, 2017)	no assertion criteria provided	VCV000687180	6	65558549 - 65955260			687180	674772		
GRCh37/hg19 6q12(chr6:65614168-65949448)x1	EYS		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000686649	6	65614168 - 65949448			686649	674241		
GRCh37/hg19 6q12(chr6:65611750-65764521)x1	EYS		not provided	Pathogenic(Last reviewed: Jun 20, 2018)	no assertion criteria provided	VCV000686239	6	65611750 - 65764521			686239	673831		
GRCh37/hg19 6q12(chr6:65690292-65840802)x1	EYS		not provided	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000684904	6	65690292 - 65840802			684904	672496		
NM_001142800.2(EYS):c.7422_7423del (p.Gly2474_Asp2475insTer)	EYS		not provided	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000498165	6	64499106 - 64499107	6	63789213 - 63789214	498165	489589	rs1554169630	NC_000006.12:63789212:CGC:C
NM_001142800.2(EYS):c.7654del (p.Tyr2551_Val2552insTer)	EYS		not provided	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000422819	6	64498067	6	63788174	422819	406886	rs1064796020	NC_000006.12:63788173:C:
NM_001142800.2(EYS):c.4608_4609GA[1] (p.Arg1537fs)	EYS		not provided	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000283384	6	65301149 - 65301150	6	64591256 - 64591257	283384	267621	rs886042613	NC_000006.12:64591255:TCTCT:TCT
NM_001142800.2(EYS):c.2055T>A (p.Cys685Ter)	EYS	C685*	not provided	Pathogenic(Last reviewed: May 8, 2015)	criteria provided, single submitter	VCV000194194	6	65767589	6	65057696	194194	191357	rs372354156	NC_000006.12:65057695:A:T
NM_001142800.2(EYS):c.5748del (p.Tyr1917fs)	EYS	Y1917fs	not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000862857	6	65149142	6	64439249	862857	832213		NC_000006.12:64439248:GG:G
NM_001142800.2(EYS):c.7943del (p.Thr2648fs)	EYS	T2648fs	not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000862313	6	64472482	6	63762589	862313	832186		NC_000006.12:63762588:G:
NM_001142800.2(EYS):c.2109C>G (p.Tyr703Ter)	EYS	Y703*	not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000861939	6	65767535	6	65057642	861939	832262		NC_000006.12:65057641:G:C
NM_001142800.2(EYS):c.96G>A (p.Trp32Ter)	EYS	W32*	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000860620	6	66205208	6	65495315	860620	832282		NC_000006.12:65495314:C:T
NM_001142800.2(EYS):c.5149del (p.Val1716_Leu1717insTer)	EYS		not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000854153	6	65300611	6	64590718	854153	832225		NC_000006.12:64590717:G:
NM_001142800.2(EYS):c.5290dup (p.Ile1764fs)	EYS		not provided	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000853125	6	65300469 - 65300470	6	64590576 - 64590577	853125	832223		NC_000006.12:64590576:TTT:TTTT
NM_001142800.2(EYS):c.1234del (p.Cys412fs)	EYS	C412fs	not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000850336	6	66094344	6	65384451	850336	832274		NC_000006.12:65384450:A:
NM_001142800.2(EYS):c.3970del (p.Leu1324fs)	EYS	L1324fs	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000846934	6	65301790	6	64591897	846934	832234		NC_000006.12:64591896:G:
NM_001142800.2(EYS):c.6490del (p.Val2164fs)	EYS	V2164fs	not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000842411	6	64791830	6	64081937	842411	832203		NC_000006.12:64081936:C:
NM_001142800.2(EYS):c.4606C>T (p.Gln1536Ter)	EYS	Q1536*	not provided	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000842140	6	65301154	6	64591261	842140	832226		NC_000006.12:64591260:G:A
NM_001142800.2(EYS):c.6102dup (p.Thr2035fs)	EYS		not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000841140	6	65016951 - 65016952	6	64307058 - 64307059	841140	832207		NC_000006.12:64307058:AAAA:AAAAA
NM_001142800.2(EYS):c.5958_5961del (p.Thr1987fs)	EYS	T1987fs	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000837224	6	65098700 - 65098703	6	64388807 - 64388810	837224	832209		NC_000006.12:64388806:AGTCAG:AG
NM_001142800.2(EYS):c.3561C>A (p.Cys1187Ter)	EYS	C1187*	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000837223	6	65336021	6	64626128	837223	832239		NC_000006.12:64626127:G:T
NM_001142800.2(EYS):c.1650T>G (p.Tyr550Ter)	EYS	Y550*	not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000836856	6	66044989	6	65335096	836856	832268		NC_000006.12:65335095:A:C
NM_001142800.2(EYS):c.8143C>T (p.Arg2715Ter)	EYS	R2736*, R2715*	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000836619	6	64436502	6	63726609	836619	832182		NC_000006.12:63726608:G:A
NC_000006.12:g.(?_65402468)_(65495865_?)del	EYS		not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000833464	6	66112361 - 66205758			833464	819742		
NC_000006.12:g.(?_64590213)_(64626255_?)del	EYS		not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000833171	6	65300106 - 65336148			833171	819711		
NC_000006.12:g.(?_65295853)_(65384510_?)del	EYS		not provided	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000833149	6	66005746 - 66094403			833149	819735		
NC_000006.12:g.(?_65384386)_(65495410_?)del	EYS		not provided	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000833083	6	66094279 - 66205303			833083	819740		
NC_000006.12:g.(?_64912474)_(64912753_?)del	EYS		not provided	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000832930	6	65622367 - 65622646			832930	819724		
NC_000006.12:g.(?_65490584)_(65495865_?)del	EYS		not provided	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832613	6	66200477 - 66205758			832613	819743		
NC_000006.12:g.(?_64902103)_(64902510_?)del	EYS		not provided	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000832225	6	65611996 - 65612403			832225	819721		
NC_000006.12:g.(?_64902113)_(65495410_?)del	EYS		not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000832175	6	65612006 - 66205303			832175	819723		
NC_000006.12:g.(?_65295853)_(65335156_?)del	EYS		not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000832140	6	66005746 - 66045049			832140	819734		
NC_000006.12:g.(?_64945783)_(64945924_?)del	EYS		not provided	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000831763	6	65655676 - 65655817			831763	819725		
NC_000006.12:g.(?_64997572)_(65495865_?)del	EYS		not provided	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000831737	6	65707465 - 66205758			831737	819730		
NC_000006.12:g.(?_63864176)_(63999193_?)del	EYS		not provided	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000831550	6	64574069 - 64709086			831550	819704		
NC_000006.12:g.(?_64230592)_(64230824_?)del	EYS		not provided	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000831504	6	64940485 - 64940717			831504	819709		
NC_000006.12:g.(?_64945783)_(65057737_?)del	EYS		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831425	6	65655676 - 65767630			831425	819726		
NC_000006.12:g.(?_64590213)_(65495865_?)del	EYS		not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000831343	6	65300106 - 66205758			831343	819712		
NC_000006.12:g.(?_65332314)_(65335156_?)del	EYS		not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000830939	6	66042207 - 66045049			830939	819737		
NC_000006.12:g.(?_64945793)_(64997703_?)del	EYS		not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000830706	6	65655686 - 65707596			830706	819727		
NM_001142800.2(EYS):c.875_890delinsTTTCT (p.Glu292fs)	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 3, 2019)	no assertion criteria provided	VCV000829892	6	66115233 - 66115248	6	65405340 - 65405355	829892	818252		NC_000006.12:65405339:GGTTTTGCTGACACCT:AGAAA
NM_001142800.2(EYS):c.4613_4616del (p.Leu1538fs)	EYS	L1538fs	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000811908	6	65301144 - 65301147	6	64591251 - 64591254	811908	799449		NC_000006.12:64591250:GTGAGT:GT
NM_001142800.2(EYS):c.1328dup (p.Asn443fs)	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802241	6	66063481 - 66063482	6	65353588 - 65353589	802241	790656		NC_000006.12:65353588:TTTTTT:TTTTTTT
NM_001142800.2(EYS):c.2053_2054TG[1] (p.Ala686fs)	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802240	6	65767588 - 65767589	6	65057695 - 65057696	802240	790655		NC_000006.12:65057694:CACAC:CAC
NM_001142800.2(EYS):c.2748C>A (p.Cys916Ter)	EYS	C916*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802239	6	65612104	6	64902211	802239	790654		NC_000006.12:64902210:G:T
NM_001142800.2(EYS):c.2820_2824del (p.Gly941fs)	EYS	G941fs	Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802238	6	65612028 - 65612032	6	64902135 - 64902139	802238	790653		NC_000006.12:64902134:TTCCATT:TT
NM_001142800.2(EYS):c.4651G>T (p.Glu1551Ter)	EYS	E1551*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802235	6	65301109	6	64591216	802235	790650		NC_000006.12:64591215:C:A
NM_001142800.2(EYS):c.5182del (p.Ser1728fs)	EYS	S1728fs	Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802234	6	65300578	6	64590685	802234	790649		NC_000006.12:64590684:TTTTTT:TTTTT
NM_001142800.2(EYS):c.7572G>A (p.Trp2524Ter)	EYS	W2524*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802232	6	64498957	6	63789064	802232	790647		NC_000006.12:63789063:C:T
NM_001142800.2(EYS):c.361del (p.Glu121fs)	EYS	E121fs	not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000659823	6	66204943	6	65495050	659823	635125		NC_000006.12:65495049:CC:C
NM_001142800.2(EYS):c.6791dup (p.Pro2265fs)	EYS		not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000659734	6	64709010 - 64709011	6	63999117 - 63999118	659734	635120		NC_000006.12:63999117:GG:GGG
NM_001142800.2(EYS):c.1426C>T (p.Gln476Ter)	EYS	Q476*	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000656918	6	66063384	6	65353491	656918	635124		NC_000006.12:65353490:G:A
NM_001142800.2(EYS):c.6102del (p.Phe2034fs)	EYS	F2034fs	not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000649430	6	65016952	6	64307059	649430	635121		NC_000006.12:64307058:AAAA:AAA
NC_000006.11:g.(?_66094269)_(66094403_?)del	EYS		not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000645880	6	66094269 - 66094403	6	65384376 - 65384510	645880	651501		
NC_000006.11:g.(?_65327301)_(65327436_?)del	EYS		not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000644814	6	65327301 - 65327436	6	64617408 - 64617543	644814	651487		
NM_001142800.2(EYS):c.4116_4117insGC (p.Ile1373fs)	EYS		not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000639098	6	65301643 - 65301644	6	64591750 - 64591751	639098	635122		NC_000006.12:64591750::GC
NM_001142800.1:c.(2023+1_2024-1)_(3443+1_3444-1)del	EYS		Retinal dystrophy	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636132					636132	624017		
NM_001142800.2(EYS):c.5243T>A (p.Leu1748Ter)	EYS	L1748*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000635417	6	65300517	6	64590624	635417	623295		NC_000006.12:64590623:A:T
NM_001142800.1(EYS):c.(6424+1_6425-1)_(6571+1_6572-1)del	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000565297			6	64066492 - 64230591	565297	551621		
NM_001142800.1(EYS):c.(3243+1_3244-1)_(3443+1_3444-1)dup	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000565296	6	65336139 - 65531537	6	64626246 - 64821644	565296	551622		
NM_001142800.1(EYS):c.(2137+1_2138-1)_(2259+1_2260-1)dup	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000565295	6	65655808 - 65767506	6	64945915 - 65057613	565295	551624		
NM_001142800.1(EYS):c.(2023+1_2024-1)_(3443+1_3444-1)del	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000565294			6	64626246 - 65295862	565294	551623		
NM_001142800.2(EYS):c.5167_5168del (p.Leu1723fs)	EYS	L1723fs	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560458	6	65300592 - 65300593	6	64590699 - 64590700	560458	551546	rs1562079314	NC_000006.12:64590698:AA:
NM_001142800.2(EYS):c.1499dup (p.Tyr500Ter)	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560457	6	66054030 - 66054031	6	65344137 - 65344138	560457	551548	rs1562109990	NC_000006.12:65344137:T:TT
NM_001142800.2(EYS):c.1161del (p.Lys387fs)	EYS	K387fs	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560454	6	66112394	6	65402501	560454	551551	rs1562154478	NC_000006.12:65402500:TTT:TT
NM_001142800.2(EYS):c.103C>T (p.Gln35Ter)	EYS	Q35*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560453	6	66205201	6	65495308	560453	551552	rs749410700	NC_000006.12:65495307:G:A
NM_001142800.1(EYS):c.(748+1_749-1)_(1299+1_1300-1)del	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560451			6	65353618 - 65494662	560451	551608		
NM_001142800.2(EYS):c.3001_3002TG[1] (p.Cys1001_Glu1002delinsTer)	EYS		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000849100	6	65532704 - 65532705	6	64822811 - 64822812	849100	832246		NC_000006.12:64822810:CACA:CA
NM_001142800.2(EYS):c.2889T>A (p.Cys963Ter)	EYS	C963*	not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000842696	6	65596693	6	64886800	842696	832251		NC_000006.12:64886799:A:T
NC_000006.12:g.(?_65295863)_(65304939_?)del	EYS		not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000833061	6	66005756 - 66014832			833061	819736		
NC_000006.12:g.(?_64066338)_(64082002_?)del	EYS		not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000833030	6	64776231 - 64791895			833030	819706		
NC_000006.12:g.(?_64813368)_(65057737_?)del	EYS		not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000832931	6	65523261 - 65767630			832931	819714		
NC_000006.12:g.(?_64813378)_(65057727_?)del	EYS		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832460	6	65523271 - 65767620			832460	819717		
NC_000006.12:g.(?_64066328)_(64082012_?)del	EYS		not provided	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000831989	6	64776221 - 64791905			831989	819705		
NC_000006.12:g.(?_64436164)_(65495865_?)del	EYS		not provided	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000831967	6	65146057 - 66205758			831967	819710		
NC_000006.12:g.(?_64997582)_(64997703_?)del	EYS		not provided	Pathogenic(Last reviewed: Aug 10, 2019)	criteria provided, single submitter	VCV000831786	6	65707475 - 65707596			831786	819731		
NC_000006.12:g.(?_64813378)_(64945914_?)del	EYS		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831708	6	65523271 - 65655807			831708	819716		
NM_001142800.2(EYS):c.6269G>A (p.Trp2090Ter)	EYS	W2090*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000619959	6	64940640	6	64230747	619959	611354	rs1562263385	NC_000006.12:64230746:C:T
EYS, 1-BP DEL, 6714T	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000539					539	15578		
NM_001142800.2(EYS):c.5857G>T (p.Glu1953Ter)	EYS	E1953*	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000537	6	65146137	6	64436244	537	15576	rs137853189	NC_000006.12:64436243:C:A
NM_001142800.1(EYS):c.2260-51191_2992+45990del	EYS		Retinitis pigmentosa 25	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000535	6	65550600 - 65706998	6	64840707 - 64997105	535	15574		
NM_001142800.2(EYS):c.2710_2726del (p.Asp904fs)	EYS	D904fs	Retinitis pigmentosa 25	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000534	6	65612309 - 65612325	6	64902416 - 64902432	534	15573	rs878853253	NC_000006.12:64902415:ACCATATCTTCACAGTCACCATA:ACCATA
NM_001142800.2(EYS):c.4199C>A (p.Ser1400Ter)	EYS	S1400*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000853292	6	65301561	6	64591668	853292	832230		NC_000006.12:64591667:G:T
NC_000006.12:g.(?_64886697)_(64945914_?)del	EYS		not provided	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000833021	6	65596590 - 65655807			833021	819719		
NC_000006.12:g.(?_64997572)_(65057737_?)del	EYS		not provided	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000831214	6	65707465 - 65767630			831214	819729		
NC_000006.12:g.(?_64902113)_(64945914_?)del	EYS		not provided	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000831046	6	65612006 - 65655807			831046	819722		
NC_000006.12:g.(?_64997582)_(65057727_?)del	EYS		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830607	6	65707475 - 65767620			830607	819732		
NC_000006.11:g.65376653_65743428del	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812468	6	65376653 - 65743428			812468	800711		
NC_000006.11:g.64666416_66194230del	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812467	6	64666416 - 66194230			812467	800710		
NM_001142800.2(EYS):c.403_423delinsCTTTT (p.Thr135fs)	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812320	6	66204881 - 66204901	6	65494988 - 65495008	812320	800530		NC_000006.12:65494987:CAGCCACTTAGAATTAACAGT:AAAAG
NM_001142800.2(EYS):c.1558_1560AAT[1] (p.Asn521del)	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812319	6	66053967 - 66053969	6	65344074 - 65344076	812319	800529		NC_000006.12:65344073:ATTATTAT:ATTAT
NM_001142800.2(EYS):c.1961dup (p.Asn654fs)	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812318	6	66005817 - 66005818	6	65295924 - 65295925	812318	800528		NC_000006.12:65295924:TTTTT:TTTTTT
NM_001142800.2(EYS):c.3715G>T (p.Glu1239Ter)	EYS	E1239*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812317	6	65303172	6	64593279	812317	800527		NC_000006.12:64593278:C:A
NC_000006.12:g.64349976_64426764del	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812315	6	65059867 - 65136655			812315	800525		
NM_001142800.2(EYS):c.8105del (p.Asn2702fs)	EYS	N2702fs, N2723fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812314	6	64436540	6	63726647	812314	800524		NC_000006.12:63726646:TT:T
NM_001142800.2(EYS):c.8167C>T (p.Gln2723Ter)	EYS	Q2723*, Q2744*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812313	6	64436478	6	63726585	812313	800523		NC_000006.12:63726584:G:A
NC_000006.11:g.(?_65611996)_(65655817_?)del	EYS		not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000640456	6	65611996 - 65655817	6	64902103 - 64945924	640456	651496		
NM_001142800.2(EYS):c.2811C>A (p.Cys937Ter)	EYS	C937*	not provided	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620108	6	65612041	6	64902148	620108	611659	rs1466666397	NC_000006.12:64902147:G:T
NM_001142800.2(EYS):c.2194C>T (p.Gln732Ter)	EYS	Q732*	not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000194358	6	65707540	6	64997647	194358	191521	rs794727120	NC_000006.12:64997646:G:A
NM_001142800.2(EYS):c.7793G>A (p.Gly2598Asp)	EYS	G2598D	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143111	6	64488004	6	63778111	143111	152829	rs527236064	NC_000006.12:63778110:C:T
NM_001142800.2(EYS):c.2981del (p.Pro994fs)	EYS	P994fs	not provided|Retinitis pigmentosa 25	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000802237	6	65596601	6	64886708	802237	790652		NC_000006.12:64886707:GGGG:GGG
NM_001142800.2(EYS):c.7228+1G>A	EYS		not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000658881	6	64574078	6	63864185	658881	651630		NC_000006.12:63864184:C:T
NM_001142800.2(EYS):c.6079_6191del (p.Met2027Ilefs)	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636168	6	65016863 - 65016975	6	64306970 - 64307082	636168	624038		
NM_001142800.1(EYS):c.(6078+1_6079-1)_(6191+1_6192-1)dup	EYS		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636135					636135	624020		
NM_001142800.2(EYS):c.6591_6594del (p.Lys2198fs)	EYS	K2198fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636028	6	64776362 - 64776365	6	64066469 - 64066472	636028	623855		NC_000006.12:64066468:CTTTC:C
NM_001142800.2(EYS):c.232del (p.Cys78fs)	EYS	C78fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636025	6	66205072	6	65495179	636025	623860		NC_000006.12:65495178:AAA:AA
NM_001142800.2(EYS):c.3699del (p.Leu1234fs)	EYS	L1234fs	Retinitis pigmentosa 25|not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000619216	6	65303188	6	64593295	619216	610616	rs1318739667	NC_000006.12:64593294:CCC:CC
NM_001142800.2(EYS):c.6229_6238del (p.Val2077fs)	EYS	V2077fs	Retinitis pigmentosa 25|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553961	6	64940671 - 64940680	6	64230778 - 64230787	553961	544203	rs1554220416	NC_000006.12:64230777:AAGCATCAACAA:AA
NM_000543.5(SMPD1):c.739G>A (p.Gly247Ser)	SMPD1	G247S, G246S	Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided|Niemann-Pick disease, type A|	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000100731	11	6413034	11	6391804	100731	106596	rs587779408	NC_000011.10:6391803:G:A
NM_001287174.2(ABCC8):c.3577del (p.Asp1193fs)	ABCC8	D1192fs, D1214fs, D1191fs, D1193fs	not provided|Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370210	11	17424284	11	17402737	370210	357940	rs1057516317	NC_000011.10:17402736:CC:C
NM_001287174.2(ABCC8):c.331G>A (p.Gly111Arg)	ABCC8	G111R	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210074	11	17491729	11	17470182	210074	207858	rs761749884	NC_000011.10:17470181:C:T
NM_001287174.2(ABCC8):c.4261C>T (p.Arg1421Cys)	ABCC8	R1421C, R1420C, R1419C, R1442C	Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009095	11	17417206	11	17395659	9095	24134	rs28938469	NC_000011.10:17395658:G:A
NM_001142800.2(EYS):c.8107G>T (p.Glu2703Ter)	EYS	E2703*, E2724*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000853127	6	64436538	6	63726645	853127	832184		NC_000006.12:63726644:C:A
NM_001142800.2(EYS):c.3003T>A (p.Cys1001Ter)	EYS	C1001*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000844797	6	65532705	6	64822812	844797	832247		NC_000006.12:64822811:A:T
NM_001142800.2(EYS):c.2380C>T (p.Arg794Ter)	EYS	R794*	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000650440	6	65655687	6	64945794	650440	635123		NC_000006.12:64945793:G:A
NM_003002.4(SDHD):c.3G>A (p.Met1Ile)	SDHD	M1I	Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000579968	11	111957634	11	112086910	579968	564393	rs80338842	NC_000011.10:112086909:G:A
NM_003002.4(SDHD):c.33C>A (p.Cys11Ter)	SDHD	C11*	Pheochromocytoma|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006915	11	111957664	11	112086940	6915	21954	rs104894309	NC_000011.10:112086939:C:A
NM_003002.4(SDHD):c.337_340del (p.Asp113fs)	SDHD	D113fs, D74fs, T65fs	not provided|Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006912	11	111965548 - 111965551	11	112094824 - 112094827	6912	21951	rs587776648	NC_000011.10:112094823:ACTGACT:ACT
NM_001142800.2(EYS):c.6137G>A (p.Trp2046Ter)	EYS	W2046*	Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000236448	6	65016917	6	64307024	236448	238030	rs878853350	NC_000006.12:64307023:C:T
NM_001142800.2(EYS):c.2826_2827del (p.Val944fs)	EYS	V944fs	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236446	6	65612025 - 65612026	6	64902132 - 64902133	236446	238031	rs878853349	NC_000006.12:64902131:AT:
NM_001142800.2(EYS):c.6528C>A (p.Tyr2176Ter)	EYS	Y2176*	not provided|Retinal dystrophy|Retinitis pigmentosa 25	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208578	6	64791792	6	64081899	208578	205152	rs797045089	NC_000006.12:64081898:G:T
NM_001164277.1(SLC37A4):c.352T>C (p.Trp118Arg)	SLC37A4	W118R, W45R	Glucose-6-phosphate transport defect|not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000006923	11	118898933	11	119028223	6923	21962	rs80356489	NC_000011.10:119028222:A:G
NM_000118.3(ENG):c.662T>C (p.Leu221Pro)	ENG	L221P, L39P	Hereditary hemorrhagic telangiectasia|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000435060	9	130588001	9	127825722	435060	428921	rs1554810378	NC_000009.12:127825721:A:G
NM_000118.3(ENG):c.991G>A (p.Gly331Ser)	ENG	G331S, G149S	Hereditary hemorrhagic telangiectasia type 1|Hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000407115	9	130587079	9	127824800	407115	396689	rs1060501410	NC_000009.12:127824799:C:T
NM_000391.4(TPP1):c.1497del (p.Gly501fs)	TPP1	G501fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000522104	11	6636151	11	6614920	522104	511921	rs1554901523	NC_000011.10:6614919:A:
NM_000370.3(TTPA):c.513_514insTT (p.Thr172fs)	TTPA		Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009139	8	63978501 - 63978502	8	63065942 - 63065943	9139	24178	rs397515379	NC_000008.11:63065942::AA
NM_054012.4(ASS1):c.787G>A (p.Val263Met)	ASS1	V263M	not provided|Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092372	9	133355785	9	130480398	92372	98283	rs192838388	NC_000009.12:130480397:G:A
NM_018972.4(GDAP1):c.487C>T (p.Gln163Ter)	GDAP1	Q163*, Q105*, Q54*, Q95*	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Neuropathy, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004193	8	75274121	8	74361886	4193	19232	rs104894077	NC_000008.11:74361885:C:T
NM_001377.3(DYNC2H1):c.10573C>T (p.Arg3525Ter)	DYNC2H1	R3532*, R3525*	not provided|Short-rib thoracic dysplasia 3 with or without polydactyly|Short-rib polydactyly syndrome type III|Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446570	11	103128448	11	103257719	446570	440200	rs181011657	NC_000011.10:103257718:C:T
NM_000136.3(FANCC):c.485_486GA[2] (p.Asn164fs)	FANCC		Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216037	9	97933392 - 97933393	9	95171110 - 95171111	216037	212687	rs730881708	NC_000009.12:95171109:TCTCTCT:TCTCT
NM_001377.3(DYNC2H1):c.988C>T (p.Arg330Cys)	DYNC2H1	R330C	Jeune thoracic dystrophy|Short-rib polydactyly syndrome type III|Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000040070	11	102988581	11	103117852	40070	48581	rs397514637	NC_000011.10:103117851:C:T
NM_000441.2(SLC26A4):c.1225C>T (p.Arg409Cys)	SLC26A4	R409C	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371421	7	107330644	7	107690199	371421	357540	rs147952620	NC_000007.14:107690198:C:T
NM_000083.3(CLCN1):c.1013G>A (p.Arg338Gln)	CLCN1	R338Q	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided|Myotonia congenita	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021037	7	143028358	7	143331265	21037	33889	rs80356703	NC_000007.14:143331264:G:A
NM_001142800.2(EYS):c.4120C>T (p.Arg1374Ter)	EYS	R1374*	Retinitis pigmentosa 25|not provided	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802236	6	65301640	6	64591747	802236	790651		NC_000006.12:64591746:G:A
NM_001142800.2(EYS):c.3775C>T (p.Gln1259Ter)	EYS	Q1259*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000438196	6	65303112	6	64593219	438196	431709	rs1291867456	NC_000006.12:64593218:G:A
NM_001142800.2(EYS):c.1155T>A (p.Cys385Ter)	EYS	C385*	Retinitis pigmentosa 25|Retinal dystrophy	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000236447	6	66112400	6	65402507	236447	238032	rs143994166	NC_000006.12:65402506:A:T
NM_001142800.2(EYS):c.881C>G (p.Ser294Ter)	EYS	S294*	not provided|Retinal dystrophy|Retinitis pigmentosa 25	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208579	6	66115242	6	65405349	208579	205153	rs752683070	NC_000006.12:65405348:G:C
NM_005476.7(GNE):c.1132G>T (p.Asp378Tyr)	GNE	D378Y, D409Y, D268Y, D373Y, D319Y, D327Y	GNE myopathy|not provided|GNE myopathy|Sialuria	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283278	9	36227394	9	36227397	283278	267515	rs199877522	NC_000009.12:36227396:C:A
NM_005476.7(GNE):c.1760T>C (p.Ile587Thr)	GNE	I587T, I618T, I477T, I582T, I513T	GNE myopathy|not provided|Sialuria|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188882	9	36219891	9	36219894	188882	186786	rs748949603	NC_000009.12:36219893:A:G
NM_000552.4(VWF):c.3437A>G (p.Tyr1146Cys)	VWF	Y1146C	von Willebrand disorder|von Willebrand disease type 2|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000031009	12	6132007	12	6022841	31009	39966	rs267607326	NC_000012.12:6022840:T:C
NM_000552.4(VWF):c.4975C>T (p.Arg1659Ter)	VWF	R1659*	von Willebrand disease type 3|von Willebrand disease type 1|not provided	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000297	12	6127609	12	6018443	297	15336	rs61750595	NC_000012.12:6018442:G:A
NM_022970.3(FGFR2):c.1087+1303T>C	FGFR2	C342R, C114R, C253R, C227R	Jackson-Weiss syndrome|Pfeiffer syndrome|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013266	10	123276893	10	121517379	13266	28305	rs121918488	NC_000010.11:121517378:A:G
NM_000170.2(GLDC):c.1166C>T (p.Ala389Val)	GLDC	A389V	Non-ketotic hyperglycinemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011989	9	6595109	9	6595109	11989	27028	rs121964979	NC_000009.12:6595108:G:A
NM_001278716.2(FBXL4):c.827del (p.Asn276fs)	FBXL4	N276fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000520628	6	99365281	6	98917405	520628	511691	rs1240941970	NC_000006.12:98917404:TTT:TT
NM_000155.4(GALT):c.947G>A (p.Trp316Ter)	GALT	W316X?, W316*, W207*	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000025291	9	34649449	9	34649452	25291	36625	rs111033790	NC_000009.12:34649451:G:A
NM_000155.4(GALT):c.329-2A>C	GALT		not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025154	9	34647652	9	34647655	25154	36488	rs111033667	NC_000009.12:34647654:A:C
NM_001142800.2(EYS):c.1673G>A (p.Trp558Ter)	EYS	W558*	Retinal dystrophy|Retinitis pigmentosa 25|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000522342	6	66044966	6	65335073	522342	512912	rs201823777	NC_000006.12:65335072:C:T
NM_001142800.2(EYS):c.4045C>T (p.Arg1349Ter)	EYS	R1349*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000438197	6	65301715	6	64591822	438197	431708	rs930421180	NC_000006.12:64591821:G:A
NM_002778.4(PSAP):c.650C>T (p.Thr217Ile)	PSAP	T217I	Inborn genetic diseases|Sphingolipid activator protein 1 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013361	10	73587841	10	71828084	13361	28400	rs121918103	NC_000010.11:71828083:G:A
NM_033360.4(KRAS):c.65A>G (p.Gln22Arg)	KRAS	Q22R	Cardiofaciocutaneous syndrome 2|Noonan syndrome 3|not provided|Rasopathy|not specified|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040452	12	25398254	12	25245320	40452	48922	rs727503110	NC_000012.12:25245319:T:C
NM_033360.4(KRAS):c.101C>G (p.Pro34Arg)	KRAS	P34R	RAS-associated autoimmune leukoproliferative disorder|Cardiofaciocutaneous syndrome 2|Noonan syndrome 3|Acute myeloid leukemia|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012590	12	25398218	12	25245284	12590	27629	rs104894366	NC_000012.12:25245283:G:C
NM_000552.4(VWF):c.4135C>T (p.Arg1379Cys)	VWF	R1379C	not provided|von Willebrand disorder	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000100333	12	6128449	12	6019283	100333	106210	rs61750074	NC_000012.12:6019282:G:A
NM_000552.4(VWF):c.3917G>A (p.Arg1306Gln)	VWF	R1306Q	not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000100300	12	6128667	12	6019501	100300	106177	rs61749385	NC_000012.12:6019500:C:T
NM_000136.3(FANCC):c.65G>A (p.Trp22Ter)	FANCC	W22*	Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188926	9	98011509	9	95249227	188926	186794	rs377294947	NC_000009.12:95249226:C:T
NM_000136.3(FANCC):c.319C>T (p.Gln107Ter)	FANCC	Q107*	not provided|Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000182497	9	98002957	9	95240675	182497	180359	rs730881731	NC_000009.12:95240674:G:A
NM_002180.2(IGHMBP2):c.978_982AAGAA[1] (p.Lys328fs)	IGHMBP2		Charcot-Marie-Tooth disease, axonal, type 2S|Charcot-Marie-Tooth disease|Autosomal dominant distal hereditary motor neuropathy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217449	11	68685269 - 68685273	11	68917801 - 68917805	217449	214089	rs746581714	NC_000011.10:68917800:AAGAAAAGAA:AAGAA
NM_001360.2(DHCR7):c.1210C>T (p.Arg404Cys)	DHCR7	R404C	not provided|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006788	11	71146639	11	71435593	6788	21827	rs61757582	NC_000011.10:71435592:G:A
NM_012472.6(LRRC6):c.630del (p.Trp210fs)	LRRC6	W128fs, W210fs, W90fs	Inborn genetic diseases|Ciliary dyskinesia, primary, 19|Kartagener syndrome	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208996	8	133645009	8	132632763	208996	205560	rs760123202	NC_000008.11:132632762:CC:C
NM_001130438.3(SPTAN1):c.4813C>T (p.His1605Tyr)	SPTAN1	H1605Y, H1600Y, H1580Y, H1585Y	Early infantile epileptic encephalopathy 5	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632592	9	131374032	9	128611753	632592	621028	rs1564286708	NC_000009.12:128611752:C:T
NM_001130438.3(SPTAN1):c.6854A>G (p.Asn2285Ser)	SPTAN1	N2285S, N2306S, N2265S, N2260S, N2280S	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433115	9	131394497	9	128632218	433115	426678	rs1441152520	NC_000009.12:128632217:A:G
NM_001130438.3(SPTAN1):c.4852G>A (p.Gly1618Ser)	SPTAN1	G1618S, G1593S, G1598S, G1613S	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433114	9	131374071	9	128611792	433114	426677	rs1554759745	NC_000009.12:128611791:G:A
NM_001130438.3(SPTAN1):c.2224C>T (p.Arg742Cys)	SPTAN1	R742C	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433112	9	131346591	9	128584312	433112	426675	rs780658554	NC_000009.12:128584311:C:T
SPTAN1, 6-BP DUP, NT6923	SPTAN1		Early infantile epileptic encephalopathy 5	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000012867					12867	27906		
NM_015046.7(SETX):c.3399dup (p.Gly1134fs)	SETX		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000521631	9	135203585 - 135203586	9	132328198 - 132328199	521631	511808	rs1554820931	NC_000009.12:132328198:TTTTTT:TTTTTTT
NM_015046.7(SETX):c.900del (p.Gly301fs)	SETX	G301fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000521469	9	135206774	9	132331387	521469	511810	rs1554822175	NC_000009.12:132331386:AA:A
NM_001130438.3(SPTAN1):c.6899_6907ACCAGCTGG[1] (p.2300_2302DQL[1])	SPTAN1		Focal epilepsy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207380	9	131394540 - 131394548	9	128632261 - 128632269	207380	202439	rs587784440	NC_000009.12:128632260:GGACCAGCTGGACCAGCTGG:GGACCAGCTGG
NM_001130438.3(SPTAN1):c.6917_6922GCATGC[3] (p.Arg2308_Met2309dup)	SPTAN1		not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000207370	9	131394559 - 131394560	9	128632280 - 128632281	207370	202442	rs796053335	NC_000009.12:128632280:GCATGCGCATGC:GCATGCGCATGCGCATGC
NM_004183.4(BEST1):c.652C>T (p.Arg218Cys)	BEST1	R218C, R158C, R112C	Vitelliform macular dystrophy type 2|Retinitis pigmentosa 50|Vitelliform macular dystrophy type 2|Bestrophinopathy, autosomal recessive|Vitreoretinochoroidopathy|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099735	11	61724874	11	61957402	99735	105624	rs281865238	NC_000011.10:61957401:C:T
NM_001130438.3(SPTAN1):c.6605_6607del (p.Gln2202del)	SPTAN1	Q2202del, Q2182del, Q2197del, Q2177del	not provided|Early infantile epileptic encephalopathy 5	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000035483	9	131389692 - 131389694	9	128627413 - 128627415	35483	44156	rs398122865	NC_000009.12:128627412:CAGC:C
NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	BRAF	L245F, L211F, L157F, L248F, L193F	Noonan syndrome with multiple lentigines|Noonan syndrome and Noonan-related syndrome|not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040348	7	140501337	7	140801537	40348	48818	rs397507466	NC_000007.14:140801536:T:A
NM_001142800.2(EYS):c.5450G>A (p.Trp1817Ter)	EYS	W1817*	not provided|Retinitis pigmentosa 25|Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000802233	6	65300310	6	64590417	802233	790648		NC_000006.12:64590416:C:T
NM_001142800.2(EYS):c.1211dup (p.Asn404fs)	EYS		Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000636023	6	66094366 - 66094367	6	65384473 - 65384474	636023	623857		NC_000006.12:65384473:TTTTTTT:TTTTTTTT
NM_001142800.2(EYS):c.8111T>G (p.Leu2704Ter)	EYS	L2704*, L2725*	not provided|Retinitis pigmentosa|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632492	6	64436534	6	63726641	632492	620238	rs779983752	NC_000006.12:63726640:A:C
NM_024426.6(WT1):c.1303C>T (p.Arg435Ter)	WT1	R362*, R430*, R218*, R413*, R201*, R39*, R418*, R435*	Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome|Wilms tumor 1|Drash syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome|Wilms tumor 1|Meacham syndrome|Aniridia 1|Drash syndrome|Mesothelioma, malignant|Diffuse mesangial sclerosis|Drash syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003497	11	32414263	11	32392717	3497	18536	rs121907906	NC_000011.10:32392716:G:A
NM_001134363.3(RBM20):c.1900C>T (p.Arg634Trp)	RBM20	R634W	not provided|Dilated cardiomyopathy 1DD	Pathogenic/Likely pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411653	10	112572055	10	110812297	411653	397694	rs796734066	NC_000010.11:110812296:C:T
NM_001287174.2(ABCC8):c.4414G>A (p.Asp1472Asn)	ABCC8	D1471N, D1472N, D1493N, D1470N	Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188931	11	17416719	11	17395172	188931	186812	rs72559716	NC_000011.10:17395171:C:T
NM_000552.4(VWF):c.5557C>T (p.Arg1853Ter)	VWF	R1852*, R1853*	von Willebrand disease type 3|von Willebrand disease type 1|not provided|von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000000298	12	6122710	12	6013544	298	15337	rs61750612	NC_000012.12:6013543:G:A
NM_020822.3(KCNT1):c.2688G>C (p.Met896Ile)	KCNT1	M896I, M851I	not provided	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000379933	9	138670627	9	135778781	379933	370161	rs797044544	NC_000009.12:135778780:G:C
NM_020822.3(KCNT1):c.1420C>A (p.Arg474Ser)	KCNT1	R474S, R429S	not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000280254	9	138660693	9	135768847	280254	264492	rs866242631	NC_000009.12:135768846:C:A
NM_020822.3(KCNT1):c.1426T>C (p.Trp476Arg)	KCNT1	W476R, W431R	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000265211	9	138660699	9	135768853	265211	259919	rs886039397	NC_000009.12:135768852:T:C
NM_020822.3(KCNT1):c.808C>G (p.Gln270Glu)	KCNT1	Q270E, Q222E	not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000445339	9	138650308	9	135758462	445339	438611	rs1554771476	NC_000009.12:135758461:C:G
NM_020822.3(KCNT1):c.2943+1G>C	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000853172	9	138675972	9	135784126	853172	851256		NC_000009.12:135784125:G:C
NM_020822.3(KCNT1):c.2687T>G (p.Met896Arg)	KCNT1	M896R, M851R	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000412308	9	138670626	9	135778780	412308	396724	rs1060503696	NC_000009.12:135778779:T:G
NM_020822.3(KCNT1):c.1546A>G (p.Met516Val)	KCNT1	M516V, M471V	Malignant migrating partial seizures of infancy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280499	9	138661828	9	135769982	280499	264434	rs886041691	NC_000009.12:135769981:A:G
NM_020822.3(KCNT1):c.2688G>A (p.Met896Ile)	KCNT1	M896I, M851I	Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Feb 19, 2015)	no assertion criteria provided	VCV000183028	9	138670627	9	135778781	183028	181176	rs797044544	NC_000009.12:135778780:G:A
NM_020822.3(KCNT1):c.2849G>T (p.Arg950Leu)	KCNT1	R950L, R905L	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000473378	9	138675877	9	135784031	473378	458896	rs886043455	NC_000009.12:135784030:G:T
NM_000118.3(ENG):c.360+1G>A	ENG		Hereditary hemorrhagic telangiectasia|not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265370	9	130591965	9	127829686	265370	259913	rs886039505	NC_000009.12:127829685:C:T
NM_001142800.2(EYS):c.2620C>T (p.Gln874Ter)	EYS	Q874*	Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438194	6	65622398	6	64912505	438194	431711	rs760798455	NC_000006.12:64912504:G:A
NM_001142800.2(EYS):c.4825_4828CATT[1] (p.Ser1610fs)	EYS		not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289905	6	65300928 - 65300931	6	64591035 - 64591038	289905	274142	rs886044304	NC_000006.12:64591034:AATGAATG:AATG
NM_001142800.2(EYS):c.4957dup (p.Ser1653fs)	EYS		Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000143105	6	65300802 - 65300803	6	64590909 - 64590910	143105	152823	rs527236065	NC_000006.12:64590909:TT:TTT
NM_020822.3(KCNT1):c.1038C>G (p.Phe346Leu)	KCNT1	F346L, F301L	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000853550	9	138656879	9	135765033	853550	835804		NC_000009.12:135765032:C:G
NM_020822.3(KCNT1):c.785G>A (p.Arg262Gln)	KCNT1	R262Q, R214Q	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432096	9	138650285	9	135758439	432096	425833	rs1554771469	NC_000009.12:135758438:G:A
NM_000543.5(SMPD1):c.880C>A (p.Gln294Lys)	SMPD1	Q292K, Q294K, Q293K	Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|Niemann-Pick disease, type B|not specified|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002994	11	6413175	11	6391945	2994	18033	rs120074128	NC_000011.10:6391944:C:A
NM_000543.5(SMPD1):c.911T>C (p.Leu304Pro)	SMPD1	L302P, L304P, L303P	not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002989	11	6413206	11	6391976	2989	18028	rs120074124	NC_000011.10:6391975:T:C
NM_033056.4(PCDH15):c.1736dup (p.Tyr579Ter)	PCDH15		not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000817007	10	55912907 - 55912908	10	54153147 - 54153148	817007	805643		NC_000010.11:54153147:T:TT
GRCh37/hg19 10q21.1(chr10:55942657-56054330)x1	PCDH15		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000689162	10	55942657 - 56054330			689162	676754		
GRCh37/hg19 10q21.1(chr10:55938132-56040206)x1	PCDH15		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	no assertion criteria provided	VCV000688604	10	55938132 - 56040206			688604	676196		
GRCh37/hg19 10q21.1(chr10:54976143-55915352)x1	PCDH15		not provided	Pathogenic(Last reviewed: Dec 21, 2017)	no assertion criteria provided	VCV000688218	10	54976143 - 55915352			688218	675810		
GRCh37/hg19 10q21.1(chr10:55468897-55645953)x1	PCDH15		not provided	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000687837	10	55468897 - 55645953			687837	675429		
NM_033056.4(PCDH15):c.4035T>A (p.Tyr1345Ter)	PCDH15	Y1345*, Y1274*, Y1357*, Y1308*, Y1323*, Y1350*, Y1352*	not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379654	10	55591242	10	53831482	379654	371305	rs1057520678	NC_000010.11:53831481:A:T
NM_033056.4(PCDH15):c.3963_3964insA (p.Asp1322fs)	PCDH15		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000842613	10	55600099 - 55600100	10	53840339 - 53840340	842613	836962		NC_000010.11:53840339::T
NM_033056.4(PCDH15):c.1343_1350del (p.Tyr448fs)	PCDH15	Y426fs, Y448fs, Y455fs, Y411fs, Y453fs, Y460fs	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000842584	10	55944984 - 55944991	10	54185224 - 54185231	842584	836978		NC_000010.11:54185223:TGAGGTGT:
NC_000010.11:g.(?_53806579)_(54664262_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000833392	10	55566339 - 56424022			833392	820211		
NC_000010.11:g.(?_54369120)_(54378942_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000832955	10	56128880 - 56138702			832955	820220		
NC_000010.11:g.(?_54378772)_(54378952_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000832555	10	56138532 - 56138712			832555	820221		
NC_000010.11:g.(?_53938805)_(54664272_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000832083	10	55698565 - 56424032			832083	820215		
NC_000010.11:g.(?_53903233)_(54664272_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000831546	10	55662993 - 56424032			831546	820214		
NC_000010.11:g.(?_54527802)_(54664272_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000831509	10	56287562 - 56424032			831509	820222		
NC_000010.11:g.(?_53806569)_(54664272_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000831462	10	55566329 - 56424032			831462	820210		
NM_033056.4(PCDH15):c.366del (p.Asn122fs)	PCDH15	N100fs, N122fs, N127fs	not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000664974	10	56128988	10	54369228	664974	638976		NC_000010.11:54369227:G:
NM_033056.4(PCDH15):c.3661C>T (p.Gln1221Ter)	PCDH15	Q1228*, Q1199*, Q1233*, Q1150*, Q1184*, Q1221*, Q1226*	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000650919	10	55626458	10	53866698	650919	638973		NC_000010.11:53866697:G:A
NM_033056.4(PCDH15):c.1475dup (p.Val493fs)	PCDH15		not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000650649	10	55943318 - 55943319	10	54183558 - 54183559	650649	638974		NC_000010.11:54183558:GG:GGG
NM_033056.4(PCDH15):c.1209T>G (p.Tyr403Ter)	PCDH15	Y381*, Y403*, Y366*, Y408*	not provided	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000641711	10	55955539	10	54195779	641711	638975		NC_000010.11:54195778:A:C
NM_033056.4(PCDH15):c.3946del (p.Gln1316fs)	PCDH15	Q1294fs, Q1328fs, Q1316fs, Q1323fs, Q1245fs, Q1279fs, Q1321fs	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000641407	10	55600117	10	53840357	641407	638972		NC_000010.11:53840356:GGGGG:GGGG
NC_000010.10:g.(55839185_55849743)_(55892768_55912859)del	PCDH15		Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619174	10	55839185 - 55912859	10	54079425 - 54153099	619174	610569		
NM_033056.4(PCDH15):c.788C>A (p.Pro263Gln)	PCDH15	P263Q, P226Q, P241Q, P268Q	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562080	10	56077119	10	54317359	562080	553261	rs1564949059	NC_000010.11:54317358:G:T
NM_001142769.3(PCDH15):c.4726C>T (p.Gln1576Ter)	PCDH15	Q1576*, Q1569*	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402273	10	55569099	10	53809339	402273	389231	rs1056396947	NC_000010.11:53809338:G:A
GRCh38/hg38 10q21.1(chr10:53954459-54098171)x0	PCDH15		See cases	Pathogenic(Last reviewed: Jan 16, 2012)	no assertion criteria provided	VCV000149046	10	55714219 - 55857931	10	53954459 - 54098171	149046	158797		
NM_033056.4(PCDH15):c.4644_4689dup (p.Arg1564delinsCysArgProIlePheThrGlnAsnThrSerGlnGluTer)	PCDH15		not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000847264	10	55582796 - 55582797	10	53823036 - 53823037	847264	836955		NC_000010.11:53823036:CAGAGACTTACTCTTGGCTTGTATTTTGGGTGAAAATGGGTCTACA:CAGAGACTTACTCTTGGCTTGTATTTTGGGTGAAAATGGGTCTACACAGAGACTTACTCTTGGCTTGTATTTTGGGTGAAAATGGGTCTACA
NM_033056.4(PCDH15):c.4548_4551dup (p.Asp1518delinsIleTer)	PCDH15		not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000847128	10	55582934 - 55582935	10	53823174 - 53823175	847128	836958		NC_000010.11:53823174:AGATAGA:AGATAGATAGA
NC_000010.11:g.(?_54346355)_(54378952_?)dup	PCDH15		not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000833343	10	56106115 - 56138712			833343	820218		
NC_000010.11:g.(?_53821848)_(53831543_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000833118	10	55581608 - 55591303			833118	820212		
NC_000010.11:g.(?_53903233)_(53903380_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000832984	10	55662993 - 55663140			832984	820213		
NC_000010.11:g.(?_53806569)_(54528412_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000832155	10	55566329 - 56288172			832155	820209		
NC_000010.11:g.(?_54664162)_(54664272_?)del	PCDH15		not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000830696	10	56423922 - 56424032			830696	820223		
NM_033056.4(PCDH15):c.1863T>G (p.Tyr621Ter)	PCDH15	Y626*, Y628*, Y599*, Y621*, Y584*, Y633*		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802574	10	55892689	10	54132929	802574	790965		NC_000010.11:54132928:A:C
NM_033056.4(PCDH15):c.2645_2646del (p.Asp881_Tyr882insTer)	PCDH15			Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802573	10	55780057 - 55780058	10	54020297 - 54020298	802573	790964		NC_000010.11:54020296:ATA:A
NM_033056.4(PCDH15):c.706-3_717del	PCDH15		not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501870	10	56077190 - 56077204	10	54317430 - 54317444	501870	493294	rs769348776	NC_000010.11:54317429:TTGGGCACGGTCCTGTT:TT
NM_033056.4(PCDH15):c.3040_3047dup (p.Met1016delinsIleLeuTer)	PCDH15		not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501868	10	55719566 - 55719567	10	53959806 - 53959807	501868	493292	rs1554882652	NC_000010.11:53959806:ATCACAGG:ATCACAGGATCACAGG
NM_033056.4(PCDH15):c.1583T>A (p.Val528Asp)	PCDH15	V528D, V491D, V535D, V506D, V533D, V540D	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000018429	10	55943211	10	54183451	18429	33468	rs267606932	NC_000010.11:54183450:A:T
NM_033056.4(PCDH15):c.785G>A (p.Gly262Asp)	PCDH15	G262D, G240D, G267D, G225D	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Dec 15, 2003)	no assertion criteria provided	VCV000004935	10	56077122	10	54317362	4935	19974	rs137853002	NC_000010.11:54317361:C:T
NM_033056.4(PCDH15):c.394dup (p.Glu132fs)	PCDH15		Usher syndrome, type 1G	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000065739	10	56128959 - 56128960	10	54369199 - 54369200	65739	76647	rs397515566	NC_000010.11:54369199:C:CC
NM_033056.4(PCDH15):c.1940C>G (p.Ser647Ter)	PCDH15	S647*, S625*, S654*, S652*, S659*, S610*		Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004938	10	55849801	10	54090041	4938	19977	rs137853004	NC_000010.11:54090040:G:C
PCDH15, IVS27, A-G, -2	PCDH15			Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000004930					4930	19969		
NM_033056.4(PCDH15):c.3984-1G>C	PCDH15		not provided|	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000379716	10	55591294	10	53831534	379716	373399	rs1057520709	NC_000010.11:53831533:C:G
NM_033056.4(PCDH15):c.3358C>T (p.Arg1120Ter)	PCDH15	R1120*, R1083*, R1125*, R1127*, R1049*, R1132*, R1098*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228389	10	55698590	10	53938830	228389	229815	rs773404494	NC_000010.11:53938829:G:A
NM_033056.3(PCDH15):c.(?_3374)_(3501_?)del (p.(?))	PCDH15		Rare genetic deafness	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000228388	10	55663003 - 55663130	10	53903243 - 53903370	228388	229712		
NM_033056.4(PCDH15):c.158-1G>A	PCDH15			Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226439	10	56138703	10	54378943	226439	228230	rs876657418	NC_000010.11:54378942:C:T
NM_033056.4(PCDH15):c.1088del (p.Leu363fs)	PCDH15	L368fs, L341fs, L363fs, L326fs		Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000004932	10	55973706	10	54213946	4932	19971	rs199469706	NC_000010.11:54213945:AAA:AA
NM_018941.3(CLN8):c.703del (p.Val236fs)	CLN8	V236fs	Inborn genetic diseases|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457979	8	1728574	8	1780408	457979	458651	rs761621368	NC_000008.11:1780407:CC:C
NM_020822.3(KCNT1):c.1420C>T (p.Arg474Cys)	KCNT1	R474C, R429C	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265210	9	138660693	9	135768847	265210	259918	rs866242631	NC_000009.12:135768846:C:T
NM_033056.4(PCDH15):c.274C>T (p.Gln92Ter)	PCDH15	Q92*, Q97*, Q70*	|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555038	10	56138586	10	54378826	555038	545915	rs143842048	NC_000010.11:54378825:G:A
NM_033056.4(PCDH15):c.1997+1G>A	PCDH15		not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379720	10	55849743	10	54089983	379720	371313	rs763797356	NC_000010.11:54089982:C:T
NM_033056.4(PCDH15):c.2419dup (p.Ile807fs)	PCDH15		Rare genetic deafness|	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371039	10	55782758 - 55782759	10	54022998 - 54022999	371039	357859	rs781148814	NC_000010.11:54022998:T:TT
NM_033056.4(PCDH15):c.1627del (p.Glu543fs)	PCDH15	E555fs, E543fs, E548fs, E550fs, E506fs, E521fs	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370952	10	55913017	10	54153257	370952	357866	rs1057516892	NC_000010.11:54153256:CCCC:CCC
NM_033056.4(PCDH15):c.1998-2A>G	PCDH15		|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000046449	10	55839186	10	54079426	46449	55614	rs397517452	NC_000010.11:54079425:T:C
NM_000083.3(CLCN1):c.937G>A (p.Ala313Thr)	CLCN1	A313T	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided|Myotonia congenita	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021052	7	143027948	7	143330855	21052	33904	rs80356692	NC_000007.14:143330854:G:A
NM_000083.3(CLCN1):c.920T>C (p.Phe307Ser)	CLCN1	F307S	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided|Myotonia congenita	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021050	7	143027931	7	143330838	21050	33902	rs80356701	NC_000007.14:143330837:T:C
NM_003002.4(SDHD):c.92_93TC[1] (p.Ala33fs)	SDHD		Paragangliomas 1|not provided|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006908	11	111958620 - 111958621	11	112087896 - 112087897	6908	21947	rs397514034	NC_000011.10:112087895:TCTC:TC
PCDH15, 3-BP DEL, 5601AAC	PCDH15		USHER SYNDROME, TYPE ID/F, DIGENIC|	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000004934					4934	19973		
NM_000162.5(GCK):c.667G>A (p.Gly223Ser)	GCK	G223S, G224S, G222S	Maturity-onset diabetes of the young, type 2|Diabetes mellitus type 2|Maturity-onset diabetes of the young, type 2|Permanent neonatal diabetes mellitus|Hyperinsulinism due to glucokinase deficiency|not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000435306	7	44189371	7	44149772	435306	428730	rs1360415315	NC_000007.14:44149771:C:T
NM_000155.4(GALT):c.691C>T (p.Arg231Cys)	GALT	R231C, R122C	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025246	9	34648762	9	34648765	25246	36580	rs111033749	NC_000009.12:34648764:C:T
NM_000155.4(GALT):c.292G>A (p.Asp98Asn)	GALT	D98N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025148	9	34647528	9	34647531	25148	36482	rs111033670	NC_000009.12:34647530:G:A
NM_000155.4(GALT):c.957C>A (p.His319Gln)	GALT	H319Q, H210Q	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003617	9	34649459	9	34649462	3617	18656	rs111033792	NC_000009.12:34649461:C:A
NM_054012.4(ASS1):c.1087C>T (p.Arg363Trp)	ASS1	R363W	not provided|Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006328	9	133370370	9	130494983	6328	21367	rs121908640	NC_000009.12:130494982:C:T
NM_018972.4(GDAP1):c.358C>T (p.Arg120Trp)	GDAP1	R120W, R11W, R52W	Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004198	8	75272419	8	74360184	4198	19237	rs104894078	NC_000008.11:74360183:C:T
NM_000136.3(FANCC):c.339G>A (p.Trp113Ter)	FANCC	W113*	Fanconi anemia|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370175	9	98002937	9	95240655	370175	357835	rs1057516291	NC_000009.12:95240654:C:T
NM_001142800.2(EYS):c.1308C>A (p.Cys436Ter)	EYS	C436*	Retinitis pigmentosa 25|not provided|Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619215	6	66063502	6	65353609	619215	610617	rs1471994744	NC_000006.12:65353608:G:T
NM_001142800.2(EYS):c.8133_8137del (p.Phe2712fs)	EYS	F2712fs, F2733fs	Retinitis pigmentosa 25|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558163	6	64436508 - 64436512	6	63726615 - 63726619	558163	544272	rs751629543	NC_000006.12:63726614:GAAAGGAA:GAA
NM_001142800.2(EYS):c.6794del (p.Pro2265fs)	EYS	P2265fs	Retinitis pigmentosa 25|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281325	6	64709008	6	63999115	281325	265562	rs758109813	NC_000006.12:63999114:GG:G
NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	NC_000009.12:35065254:C:T
NM_012434.5(SLC17A5):c.115C>T (p.Arg39Cys)	SLC17A5	R39C	Salla disease|Salla disease|Sialic acid storage disease, severe infantile type|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005615	6	74354306	6	73644583	5615	20654	rs80338794	NC_000006.12:73644582:G:A
NM_022970.3(FGFR2):c.799T>C (p.Ser267Pro)	FGFR2	S267P, S152P, S178P, S39P	Pfeiffer syndrome|Crouzon syndrome|Neoplasm of stomach|not provided|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013290	10	123279633	10	121520119	13290	28329	rs121918505	NC_000010.11:121520118:A:G
NM_016203.4(PRKAG2):c.1589A>G (p.His530Arg)	PRKAG2	H530R, H406R, H289R, H486R, H405R	not provided|Hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006854	7	151257699	7	151560613	6854	21893	rs267606977	NC_000007.14:151560612:T:C
NM_012203.2(GRHPR):c.103del (p.Asp35fs)	GRHPR	D35fs	Nephrolithiasis|Nephrocalcinosis|not provided|Primary hyperoxaluria, type II	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005636	9	37424859	9	37424862	5636	20675	rs80356708	NC_000009.12:37424861:GGG:GG
NM_001360.2(DHCR7):c.1A>G (p.Met1Val)	DHCR7	M1V	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006794	11	71155998	11	71444952	6794	21833	rs104886033	NC_000011.10:71444951:T:C
NM_001360.2(DHCR7):c.1342G>A (p.Glu448Lys)	DHCR7	E448K	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006792	11	71146507	11	71435461	6792	21831	rs80338864	NC_000011.10:71435460:C:T
NM_004333.6(BRAF):c.1390G>A (p.Gly464Arg)	BRAF	G464R	Rasopathy|not provided|Cardio-facio-cutaneous syndrome|Cutaneous melanoma	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372572	7	140481418	7	140781618	372572	359643	rs121913349	NC_000007.14:140781617:C:T
NM_004333.6(BRAF):c.1501G>A (p.Glu501Lys)	BRAF	E501K, E504K, E541K, E467K, E413K, E449K, E464K, E479K	Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013977	7	140477807	7	140778007	13977	29016	rs180177038	NC_000007.14:140778006:C:T
NM_000552.4(VWF):c.7390C>T (p.Arg2464Cys)	VWF	R2464C	not provided|von Willebrand disorder	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100467	12	6085324	12	5976158	100467	106344	rs61751286	NC_000012.12:5976157:G:A
NM_033056.4(PCDH15):c.3441dup (p.Phe1148fs)	PCDH15		Rare genetic deafness|	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370113	10	55663062 - 55663063	10	53903302 - 53903303	370113	357850	rs770832663	NC_000010.11:53903302:TTTTTT:TTTTTTT
NM_001164277.1(SLC37A4):c.83G>A (p.Arg28His)	SLC37A4	R28H	not provided|Glucose-6-phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006933	11	118899997	11	119029287	6933	21972	rs121908978	NC_000011.10:119029286:C:T
NM_001142800.2(EYS):c.3443+1G>T	EYS		not provided|Retinal dystrophy|Retinitis pigmentosa 25	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195665	6	65523270	6	64813377	195665	192826	rs373441420	NC_000006.12:64813376:C:A
NM_203447.4(DOCK8):c.850_851del (p.Leu284fs)	DOCK8	L216fs, L284fs	not provided	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000817037	9	325693 - 325694	9	325693 - 325694	817037	805622		NC_000009.12:325692:CT:
GRCh37/hg19 9p24.3(chr9:260680-436983)x1	DOCK8		not provided	Pathogenic(Last reviewed: Mar 6, 2019)	no assertion criteria provided	VCV000815191	9	260680 - 436983			815191	803400		
NM_203447.3(DOCK8):c.5132C>A (p.Ser1711Ter)	DOCK8	S1711*, S1611*, S1643*	not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000523787	9	439297	9	439297	523787	514596	rs1554707993	NC_000009.12:439296:C:A
NM_203447.3(DOCK8):c.4162C>T (p.Arg1388Ter)	DOCK8	R1388*, R1288*, R1320*	not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000523786	9	422056	9	422056	523786	514595	rs1476130680	NC_000009.12:422055:C:T
NM_001190458.2(DOCK8):c.2574+3672_2574+3678del	DOCK8	M867fs, M935fs	not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000452218	9	386357 - 386363	9	386357 - 386363	452218	444501	rs1554687151	NC_000009.12:386356:GTCTTAC:
NM_203447.3(DOCK8):c.2971-1G>A	DOCK8		not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000379134	9	396784	9	396784	379134	371307	rs777066716	NC_000009.12:396783:G:A
NM_203447.3(DOCK8):c.5261del (p.Leu1754fs)	DOCK8	L1754fs, L1654fs, L1686fs	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000280647	9	441323	9	441323	280647	264547	rs886041815	NC_000009.12:441322:T:
NM_203447.3(DOCK8):c.2606-1G>A	DOCK8		not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000280306	9	382512	9	382512	280306	264414	rs886041535	NC_000009.12:382511:G:A
NM_203447.3(DOCK8):c.949C>T (p.Arg317Ter)	DOCK8	R249*, R317*	not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000279929	9	328076	9	328076	279929	264327	rs113432057	NC_000009.12:328075:C:T
NM_203447.4(DOCK8):c.3500_3507dup (p.Ala1170fs)	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000860084	9	407038 - 407039	9	407038 - 407039	860084	836182		NC_000009.12:407038:TGGCTGCT:TGGCTGCTTGGCTGCT
NM_203447.4(DOCK8):c.3803del (p.Phe1268fs)	DOCK8	F1200fs, F1168fs, F1268fs	Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000839960	9	418168	9	418168	839960	836186		NC_000009.12:418167:TTT:TT
NC_000009.12:g.(?_336562)_(386446_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 19, 2019)	criteria provided, single submitter	VCV000831769	9	336562 - 386446			831769	820133		
NC_000009.12:g.(?_370210)_(452137_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000831756	9	370210 - 452137			831756	820143		
NC_000009.12:g.(?_304561)_(399279_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000831454	9	304561 - 399279			831454	820128		
NC_000009.12:g.(?_271607)_(340341_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000831380	9	271607 - 340341			831380	820125		
NC_000009.12:g.(?_332378)_(334404_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000831070	9	332378 - 334404			831070	820131		
NM_203447.4(DOCK8):c.3438_3439del (p.Met1146fs)	DOCK8	M1146fs, M1046fs, M1078fs	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827704	9	406976 - 406977	9	406976 - 406977	827704	815922		NC_000009.12:406975:TGT:T
NC_000009.11:g.(?_334205)_(340341_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000647937	9	334205 - 340341	9	334205 - 340341	647937	651854		
NC_000009.11:g.(?_286441)_(464239_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000536619	9	286441 - 464239	9	286441 - 464239	536619	524408		
NC_000009.11:g.(?_304561)_(464239_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000468735	9	304561 - 464239	9	304561 - 464239	468735	459170		
NM_203447.3(DOCK8):c.6019dup (p.Tyr2007fs)	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	VCV000224488	9	452067 - 452068	9	452067 - 452068	224488	226224	rs869312169	NC_000009.12:452067:T:TT
NM_203447.3(DOCK8):c.3504_3505insTGGCTGCT (p.Ala1169fs)	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000060563	9	407040 - 407041	9	407040 - 407041	60563	75139	rs886037645	NC_000009.12:407040:GCT:GCTTGGCTGCT
NM_203447.3(DOCK8):c.3494del (p.Thr1165fs)	DOCK8	T1065fs, T1097fs, T1165fs	Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000060562	9	407033	9	407033	60562	75138	rs113944762	NC_000009.12:407032:C:
nsv469505	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000000951	9	311734 - 398139	9	311734 - 398139	951	15990		
NM_203447.3(DOCK8):c.1126-395_2971-2751del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000000950	9	333830 - 394034	9	333830 - 394034	950	15989		
NM_203447.3(DOCK8):c.1418A>G (p.Lys473Arg)	DOCK8	K405R, K473R	Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 19, 2009)	no assertion criteria provided	VCV000000949	9	336714	9	336714	949	15988	rs112321280	NC_000009.12:336713:A:G
NC_000009.12:g.(?_271607)_(452137_?)del	DOCK8		Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000831986	9	271607 - 452137			831986	820126		
NM_000441.2(SLC26A4):c.1174A>T (p.Asn392Tyr)	SLC26A4	N392Y	Enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446453	7	107330593	7	107690148	446453	439902	rs201562855	NC_000007.14:107690147:A:T
NM_000441.2(SLC26A4):c.1079C>T (p.Ala360Val)	SLC26A4	A360V	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188793	7	107329575	7	107689130	188793	186734	rs786204474	NC_000007.14:107689129:C:T
NM_000441.2(SLC26A4):c.1541A>G (p.Gln514Arg)	SLC26A4	Q514R	not specified|not provided|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043511	7	107336481	7	107696036	43511	52680	rs111033316	NC_000007.14:107696035:A:G
NM_000441.2(SLC26A4):c.1588T>C (p.Tyr530His)	SLC26A4	Y530H	Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004836	7	107338530	7	107698085	4836	19875	rs111033254	NC_000007.14:107698084:T:C
NM_001370259.2(MEN1):c.219_220del (p.Gly74fs)	MEN1	G74fs	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000817595	11	64577362 - 64577363	11	64809890 - 64809891	817595	805705		NC_000011.10:64809889:CGC:C
NM_000244.3(MEN1):c.938C>A (p.Ser313Ter)	MEN1	S308*, S313*, S273*	not provided	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000618712	11	64573830	11	64806358	618712	609801	rs1565644366	NC_000011.10:64806357:G:T
NM_000244.3(MEN1):c.1502del (p.Lys501fs)	MEN1	K461fs, K496fs, K501fs, K538fs	not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000618209	11	64572152	11	64804680	618209	609800	rs1565637724	NC_000011.10:64804679:TT:T
NM_000244.3(MEN1):c.511C>T (p.Gln171Ter)	MEN1	Q166*, Q171*	not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000618208	11	64575521	11	64808049	618208	609802	rs1565648511	NC_000011.10:64808048:G:A
NM_000244.3(MEN1):c.332dup (p.Val112fs)	MEN1		not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000545863	11	64577249 - 64577250	11	64809777 - 64809778	545863	536401	rs1555166435	NC_000011.10:64809777:CCCCC:CCCCCC
NM_000244.3(MEN1):c.1262dup (p.Tyr422fs)	MEN1		not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000545861	11	64572608 - 64572609	11	64805136 - 64805137	545861	536400	rs1555164305	NC_000011.10:64805136:AA:AAA
NM_000244.3(MEN1):c.954T>G (p.Tyr318Ter)	MEN1	Y313*, Y318*, Y278*	not specified	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000439894	11	64573814	11	64806342	439894	433091	rs1555165128	NC_000011.10:64806341:A:C
NM_000244.3(MEN1):c.350del (p.Leu117fs)	MEN1	L117fs	not specified	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000439892	11	64577232	11	64809760	439892	433094	rs1555166387	NC_000011.10:64809759:A:
NM_000244.3(MEN1):c.927+2T>C	MEN1		not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000431826	11	64574481	11	64807009	431826	425938	rs1555165256	NC_000011.10:64807008:A:G
NM_000244.3(MEN1):c.958G>T (p.Asp320Tyr)	MEN1	D315Y, D320Y, D280Y	not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000429809	11	64573810	11	64806338	429809	421872	rs747851909	NC_000011.10:64806337:C:A
NM_000244.3(MEN1):c.1393delinsACATAGT (p.Arg465delinsThrTer)	MEN1		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000424268	11	64572261	11	64804789	424268	408404	rs1064796889	NC_000011.10:64804788:G:ACTATGT
NM_000244.3(MEN1):c.105dup (p.Leu36fs)	MEN1		not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000423376	11	64577476 - 64577477	11	64810004 - 64810005	423376	408414	rs1555166711	NC_000011.10:64810004:C:CC
NM_000244.3(MEN1):c.432del (p.Phe144fs)	MEN1	F144fs	not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000419057	11	64577150	11	64809678	419057	408413	rs1064793613	NC_000011.10:64809677:G:
NM_000244.3(MEN1):c.1520dup (p.Leu509fs)	MEN1		not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000418694	11	64572133 - 64572134	11	64804661 - 64804662	418694	408403	rs1555163591	NC_000011.10:64804661:TT:TTT
NM_000244.3(MEN1):c.207del (p.Asp70fs)	MEN1	D70fs	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000372643	11	64577375	11	64809903	372643	359899	rs1057517902	NC_000011.10:64809902:GGGGG:GGGG
NM_000244.3(MEN1):c.461-2A>C	MEN1		not provided	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000280917	11	64575573	11	64808101	280917	264562	rs886042035	NC_000011.10:64808100:T:G
NM_000244.3(MEN1):c.1351del (p.Arg451fs)	MEN1	R446fs, R488fs, R411fs, R451fs	not provided	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000280564	11	64572520	11	64805048	280564	264438	rs886041746	NC_000011.10:64805047:GG:G
NM_000244.3(MEN1):c.505_506delinsT (p.Ala169fs)	MEN1		not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000280424	11	64575526 - 64575527	11	64808054 - 64808055	280424	264491	rs886041634	NC_000011.10:64808053:GC:A
NM_000244.3(MEN1):c.1444dup (p.Glu482fs)	MEN1		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000279851	11	64572209 - 64572210	11	64804737 - 64804738	279851	264489	rs886041214	NC_000011.10:64804737:CCC:CCCC
NM_000244.3(MEN1):c.1605del (p.Gly536fs)	MEN1	G496fs, G536fs, G531fs, G573fs	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000265242	11	64572049	11	64804577	265242	259992	rs886039421	NC_000011.10:64804576:TT:T
NM_000244.3(MEN1):c.1213C>T (p.Gln405Ter)	MEN1	Q400*, Q405*, Q442*, Q365*	not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000265240	11	64572658	11	64805186	265240	259994	rs886039419	NC_000011.10:64805185:G:A
NM_000244.3(MEN1):c.1207C>T (p.Gln403Ter)	MEN1	Q398*, Q403*, Q363*, Q440*	not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000265239	11	64572664	11	64805192	265239	259995	rs886039418	NC_000011.10:64805191:G:A
NM_000244.3(MEN1):c.292C>T (p.Arg98Ter)	MEN1	R98*	not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000265234	11	64577290	11	64809818	265234	260001	rs886039413	NC_000011.10:64809817:G:A
NM_000244.3(MEN1):c.1617_1633dup (p.Pro545fs)	MEN1		not provided	Pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	VCV000201022	11	64572020 - 64572021	11	64804548 - 64804549	201022	197522	rs794728660	NC_000011.10:64804548:GTGCTGGCACCTGAGCCGTGCTG:GTGCTGGCACCTGAGCCGTGCTGGCACCTGAGCCGTGCTG
NM_000244.3(MEN1):c.164dup (p.Thr56fs)	MEN1		not provided	Pathogenic(Last reviewed: Jan 10, 2014)	criteria provided, single submitter	VCV000201018	11	64577417 - 64577418	11	64809945 - 64809946	201018	197560	rs794728656	NC_000011.10:64809945:GGG:GGGG
NM_000244.3(MEN1):c.55del (p.Val19fs)	MEN1	V19fs	not provided	Pathogenic(Last reviewed: May 11, 2010)	criteria provided, single submitter	VCV000201017	11	64577527	11	64810055	201017	197567	rs794728655	NC_000011.10:64810054:C:
NM_000244.3(MEN1):c.1666del (p.Leu556fs)	MEN1	L593fs, L516fs, L551fs, L556fs	not provided	Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	VCV000201003	11	64571988	11	64804516	201003	197520	rs794728645	NC_000011.10:64804515:G:
NM_000244.3(MEN1):c.1563dup (p.Lys522fs)	MEN1		not provided	Pathogenic(Last reviewed: Feb 24, 2014)	criteria provided, single submitter	VCV000201002	11	64572090 - 64572091	11	64804618 - 64804619	201002	197524	rs761695866	NC_000011.10:64804618:CC:CCC
NM_000244.3(MEN1):c.1356del (p.Phe452fs)	MEN1	F447fs, F452fs, F412fs, F489fs	not provided	Pathogenic(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	VCV000201000	11	64572515	11	64805043	201000	197529	rs794728643	NC_000011.10:64805042:AAAA:AAA
NM_000244.3(MEN1):c.965_972del (p.His322fs)	MEN1	H317fs, H322fs, H282fs	not provided	Pathogenic(Last reviewed: Dec 18, 2013)	criteria provided, single submitter	VCV000200998	11	64573796 - 64573803	11	64806324 - 64806331	200998	197536	rs794728641	NC_000011.10:64806323:GTAGATGTGT:GT
NM_000244.3(MEN1):c.147dup (p.Val50fs)	MEN1		not provided	Pathogenic(Last reviewed: Jul 25, 2013)	criteria provided, single submitter	VCV000200995	11	64577434 - 64577435	11	64809962 - 64809963	200995	197561	rs794728638	NC_000011.10:64809962:A:AA
NM_000244.3(MEN1):c.79_88del (p.Leu27fs)	MEN1	L27fs	not provided	Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	VCV000200994	11	64577494 - 64577503	11	64810022 - 64810031	200994	197563	rs794728637	NC_000011.10:64810021:CTCGGCCCAGCTCGGC:CTCGGC
NM_000244.3(MEN1):c.57_58insT (p.Val20fs)	MEN1		not provided	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000200993	11	64577524 - 64577525	11	64810052 - 64810053	200993	197566	rs794728636	NC_000011.10:64810052::A
NM_000244.3(MEN1):c.1702G>T (p.Glu568Ter)	MEN1	E563*, E568*, E528*, E605*	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000200989	11	64571952	11	64804480	200989	197517	rs794728632	NC_000011.10:64804479:C:A
NM_001370259.2(MEN1):c.825-1_828delinsTACCTAGAGGTT	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000827534	11	64574567 - 64574571	11	64807095 - 64807099	827534	815504		NC_000011.10:64807094:GTACC:AACCTCTAGGTA
NM_001370259.2(MEN1):c.666C>A (p.Tyr222Ter)	MEN1	Y227*, Y222*, Y187*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000826542	11	64575141	11	64807669	826542	810827		NC_000011.10:64807668:G:T
NM_001370259.2(MEN1):c.577del (p.Thr193fs)	MEN1	T193fs, T198fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000825965	11	64575440	11	64807968	825965	810829		NC_000011.10:64807967:T:
NM_001370259.2(MEN1):c.39_40GC[3] (p.Ser15fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000824594	11	64577539 - 64577540	11	64810067 - 64810068	824594	810847		NC_000011.10:64810067:GCGC:GCGCGC
NM_001370259.2(MEN1):c.32del (p.Phe11fs)	MEN1	F11fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000823494	11	64577550	11	64810078	823494	810848		NC_000011.10:64810077:AA:A
NM_001370259.2(MEN1):c.1100_1131del (p.Val367fs)	MEN1	V372fs, V332fs, V367fs, V409fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000822170	11	64573161 - 64573192	11	64805689 - 64805720	822170	810812		NC_000011.10:64805688:CTTCAGCAGGTTGGGGATGACATCATTGGCTACTTCA:CTTCA
NM_001370259.2(MEN1):c.1154_1155dup (p.Gly386fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000818434	11	64573136 - 64573137	11	64805664 - 64805665	818434	810810		NC_000011.10:64805664:CGC:CGCGC
NM_001370259.2(MEN1):c.696dup (p.Lys233fs)	MEN1		Ependymoma	Pathogenic(Last reviewed: Dec 29, 2017)	no assertion criteria provided	VCV000487778	11	64575111	11	64807638 - 64807639	487778	480785	rs1555165565	NC_000011.10:64807638:G:GG
NM_000244.3(MEN1):c.1262_1269del (p.Phe421fs)	MEN1	F381fs, F421fs, F458fs, F416fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000428090	11	64572602 - 64572609	11	64805130 - 64805137	428090	419800	rs1114167542	NC_000011.10:64805129:GTCGTAGA:
NM_000244.3(MEN1):c.982del (p.Tyr328fs)	MEN1	Y323fs, Y328fs, Y288fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	VCV000428088	11	64573786	11	64806314	428088	419819	rs1114167541	NC_000011.10:64806313:A:
NM_000244.3(MEN1):c.417del (p.His139fs)	MEN1	H139fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	VCV000428087	11	64577165	11	64809693	428087	419849	rs1114167540	NC_000011.10:64809692:G:
NM_000244.3(MEN1):c.1285G>T (p.Glu429Ter)	MEN1	E424*, E429*, E466*, E389*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000428086	11	64572586	11	64805114	428086	419795	rs1114167477	NC_000011.10:64805113:C:A
NM_000244.3(MEN1):c.640del (p.Gln214fs)	MEN1	Q209fs, Q214fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 22, 2013)	criteria provided, single submitter	VCV000428084	11	64575392	11	64807920	428084	419837	rs1114167538	NC_000011.10:64807919:GG:G
NM_000244.3(MEN1):c.1267G>T (p.Asp423Tyr)	MEN1	D418Y, D423Y, D383Y, D460Y	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 7, 2013)	criteria provided, single submitter	VCV000428083	11	64572604	11	64805132	428083	419801	rs104894264	NC_000011.10:64805131:C:A
NM_000244.3(MEN1):c.721_724dup (p.Ala242fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000428078	11	64575097 - 64575098	11	64807625 - 64807626	428078	419832	rs1114167534	NC_000011.10:64807625:CCACC:CCACCCACC
NM_000244.3(MEN1):c.742_749del (p.Ile248fs)	MEN1	I243fs, I248fs, I208fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000428076	11	64575073 - 64575080	11	64807601 - 64807608	428076	419831	rs1114167532	NC_000011.10:64807600:GGGTTGATGG:GG
NM_000244.3(MEN1):c.1658_1736delinsTG (p.Gly553fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000428067	11	64571918 - 64571996	11	64804446 - 64804524	428067	419777	rs1555163136	
NM_000244.3(MEN1):c.16_17del (p.Ala6fs)	MEN1	A6fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000428065	11	64577565 - 64577566	11	64810093 - 64810094	428065	419864	rs1114167523	NC_000011.10:64810092:GCG:G
NM_130799.2(MEN1):c.1391_1392ins13 (p.?)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2015)	criteria provided, single submitter	VCV000428063	11	64572247 - 64572248	11	64804775 - 64804776	428063	419788		
NM_000244.3(MEN1):c.1345del (p.Ser448_Leu449insTer)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	VCV000428062	11	64572526	11	64805054	428062	419792	rs1114167520	NC_000011.10:64805053:GGG:GG
NM_000244.3(MEN1):c.697_700dup (p.Arg234fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000428061	11	64575121 - 64575122	11	64807649 - 64807650	428061	419835	rs1114167519	NC_000011.10:64807649:GCATG:GCATGCATG
NM_000244.3(MEN1):c.273_276del (p.Arg92fs)	MEN1	R92fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000428058	11	64577306 - 64577309	11	64809834 - 64809837	428058	419855	rs1114167516	NC_000011.10:64809833:GCGGGC:GC
NM_000244.3(MEN1):c.416A>G (p.His139Arg)	MEN1	H139R	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000428056	11	64577166	11	64809694	428056	419850	rs1114167515	NC_000011.10:64809693:T:C
NM_000244.3(MEN1):c.1589del (p.Thr530fs)	MEN1	T567fs, T525fs, T490fs, T530fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000428055	11	64572065	11	64804593	428055	419783	rs1114167514	NC_000011.10:64804592:G:
NM_000244.3(MEN1):c.1229dup (p.Asp411fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 19, 2015)	criteria provided, single submitter	VCV000428054	11	64572641 - 64572642	11	64805169 - 64805170	428054	419803	rs1114167513	NC_000011.10:64805169:T:TT
NM_000244.3(MEN1):c.1680_1683del (p.Ser560fs)	MEN1	S555fs, S520fs, S560fs, S597fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000428051	11	64571971 - 64571974	11	64804499 - 64804502	428051	419780	rs1114167510	NC_000011.10:64804498:CTCACTC:CTC
NM_000244.3(MEN1):c.1363C>T (p.Gln455Ter)	MEN1	Q450*, Q455*, Q415*, Q492*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	VCV000428050	11	64572508	11	64805036	428050	419791	rs1114167509	NC_000011.10:64805035:G:A
NM_000244.3(MEN1):c.985del (p.Leu329fs)	MEN1	L329fs, L289fs, L324fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	VCV000428049	11	64573783	11	64806311	428049	419818	rs1114167508	NC_000011.10:64806310:GG:G
NM_000244.3(MEN1):c.1019delinsTT (p.Arg340fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	VCV000428046	11	64573749	11	64806277	428046	419817	rs1114167506	NC_000011.10:64806276:C:AA
NM_000244.3(MEN1):c.545del (p.Leu182fs)	MEN1	L182fs, L177fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000428043	11	64575487	11	64808015	428043	419840	rs1114167503	NC_000011.10:64808014:A:
NM_000244.3(MEN1):c.1405delinsCCT (p.Ala469fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	VCV000428040	11	64572249	11	64804777	428040	419789	rs1114167500	NC_000011.10:64804776:C:AGG
NM_000244.3(MEN1):c.712A>T (p.Lys238Ter)	MEN1	K233*, K238*, K198*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000428039	11	64575110	11	64807638	428039	419834	rs1114167499	NC_000011.10:64807637:T:A
NM_000244.3(MEN1):c.1653_1654dup (p.Glu552fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 28, 2014)	criteria provided, single submitter	VCV000428035	11	64571999 - 64572000	11	64804527 - 64804528	428035	419782	rs1114167496	NC_000011.10:64804527:CC:CCCC
NM_000244.3(MEN1):c.378del (p.Ile125_Trp126insTer)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	VCV000428030	11	64577204	11	64809732	428030	419851	rs1114167492	NC_000011.10:64809731:CC:C
NM_000244.3(MEN1):c.1192C>T (p.Gln398Ter)	MEN1	Q393*, Q398*, Q435*, Q358*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	VCV000428027	11	64573115	11	64805643	428027	419804	rs1060499984	NC_000011.10:64805642:G:A
NM_000244.3(MEN1):c.265del (p.Leu89fs)	MEN1	L89fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	VCV000428026	11	64577317	11	64809845	428026	419857	rs1114167490	NC_000011.10:64809844:GGG:GG
NM_000244.3(MEN1):c.223del (p.Leu75fs)	MEN1	L75fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	VCV000428021	11	64577359	11	64809887	428021	419859	rs1114167485	NC_000011.10:64809886:GG:G
NM_000244.3(MEN1):c.1016_1020dup (p.Glu341fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	VCV000428019	11	64573747 - 64573748	11	64806275 - 64806276	428019	419816	rs1114167483	NC_000011.10:64806275:CCGCAC:CCGCACCGCAC
NM_000244.3(MEN1):c.429_432delinsATT (p.Phe144fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	VCV000428017	11	64577150 - 64577153	11	64809678 - 64809681	428017	419847	rs1114167481	NC_000011.10:64809677:GAAG:AAT
NM_000244.3(MEN1):c.336del (p.Ser113fs)	MEN1	S113fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2013)	criteria provided, single submitter	VCV000428013	11	64577246	11	64809774	428013	419853	rs1114167478	NC_000011.10:64809773:G:
NM_000244.3(MEN1):c.1519_1522dup (p.Gly508fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	VCV000428010	11	64572131 - 64572132	11	64804659 - 64804660	428010	419785	rs1114167476	NC_000011.10:64804659:CCTT:CCTTCCTT
NM_000244.3(MEN1):c.799-2A>G	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000428006	11	64574693	11	64807221	428006	419829	rs1114167472	NC_000011.10:64807220:T:C
NM_000244.3(MEN1):c.544_545del (p.Leu182fs)	MEN1	L182fs, L177fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2012)	criteria provided, single submitter	VCV000428004	11	64575487 - 64575488	11	64808015 - 64808016	428004	419839	rs1114167470	NC_000011.10:64808014:AG:
NM_000244.3(MEN1):c.1321T>C (p.Trp441Arg)	MEN1	W436R, W441R, W401R, W478R	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	VCV000428003	11	64572550	11	64805078	428003	419793	rs104894259	NC_000011.10:64805077:A:G
NM_000244.3(MEN1):c.152del (p.Asn51fs)	MEN1	N51fs	Primary hyperparathyroidism	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000217128	11	64577430	11	64809958	217128	213769	rs869312167	NC_000011.10:64809957:TT:T
NM_000244.3(MEN1):c.1700dup (p.Glu568fs)	MEN1		not provided	Pathogenic(Last reviewed: Jan 21, 2013)	no assertion criteria provided	VCV000096251	11	64571953 - 64571954	11	64804481 - 64804482	96251	102145	rs398124436	NC_000011.10:64804481:TT:TTT
NM_000244.3(MEN1):c.1669A>T (p.Thr557Ser)	MEN1	T552S, T557S, T517S, T594S	Adenoma of the adrenal gland	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000016698	11	64571985	11	64804513	16698	31737	rs121913035	NC_000011.10:64804512:T:A
NM_000244.3(MEN1):c.1089_1090delinsAA (p.Glu364Lys)	MEN1	E359K, E364K	Angiofibroma, somatic	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000016695	11	64573217 - 64573218	11	64805745 - 64805746	16695	31734	rs267607234	NC_000011.10:64805744:CC:TT
MEN1, 1-BP INS, 1650C	MEN1		Lung carcinoid tumor	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000016691					16691	31730		
NM_001370259.2(MEN1):c.719_720TG[2] (p.Ala242fs)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000826922	11	64575083 - 64575084	11	64807611 - 64807612	826922	810825		NC_000011.10:64807610:CACACAC:CACAC
NM_001370259.2(MEN1):c.655-1G>C	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000826480	11	64575153	11	64807681	826480	815506		NC_000011.10:64807680:C:G
NM_001370259.2(MEN1):c.911del (p.Lys304fs)	MEN1	K304fs, K309fs, K269fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000823028	11	64574484	11	64807012	823028	810816		NC_000011.10:64807011:TT:T
NM_001370259.2(MEN1):c.1015C>T (p.Gln339Ter)	MEN1	Q344*, Q304*, Q339*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000822013	11	64573738	11	64806266	822013	810813		NC_000011.10:64806265:G:A
NM_000244.3(MEN1):c.1846T>A (p.Ter616Arg)	MEN1	*616R, *611R, *576R, *653R	Somatotroph adenoma	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000446502	11	64571808	11	64804336	446502	440018	rs1565635212	NC_000011.10:64804335:A:T
NM_000244.3(MEN1):c.1068C>G (p.Tyr356Ter)	MEN1	Y351*, Y356*, Y316*, Y393*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000428089	11	64573239	11	64805767	428089	419811	rs767078097	NC_000011.10:64805766:G:C
NM_000244.3(MEN1):c.270T>A (p.Tyr90Ter)	MEN1	Y90*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000428070	11	64577312	11	64809840	428070	419856	rs1114167527	NC_000011.10:64809839:A:T
NM_000244.3(MEN1):c.1544_1545del (p.Ala515fs)	MEN1	A552fs, A510fs, A475fs, A515fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000428064	11	64572109 - 64572110	11	64804637 - 64804638	428064	419784	rs1114167522	NC_000011.10:64804636:TG:
NM_000244.3(MEN1):c.431_432delinsAA (p.Phe144Ter)	MEN1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000428052	11	64577150 - 64577151	11	64809678 - 64809679	428052	419846	rs1114167511	NC_000011.10:64809677:GA:TT
NM_000244.3(MEN1):c.1681G>T (p.Glu561Ter)	MEN1	E556*, E561*, E598*, E521*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 22, 2015)	criteria provided, single submitter	VCV000428041	11	64571973	11	64804501	428041	419781	rs1114167501	NC_000011.10:64804500:C:A
NM_000244.3(MEN1):c.1564A>T (p.Lys522Ter)	MEN1	K517*, K522*, K482*, K559*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000200986	11	64572090	11	64804618	200986	197523	rs794728630	NC_000011.10:64804617:T:A
NM_000244.3(MEN1):c.1365+1G>A	MEN1		Hyperparathyroidism 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000016707	11	64572505	11	64805033	16707	31746	rs863223311	NC_000011.10:64805032:C:T
NM_000244.3(MEN1):c.403A>T (p.Lys135Ter)	MEN1	K135I, K135*	Angiofibroma, somatic	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000016694	11	64577179	11	64809707	16694	31733	rs121913034	NC_000011.10:64809706:T:A
NM_000244.3(MEN1):c.371_372del (p.Val124fs)	MEN1	V124fs	Pancreatic insulin-producing neuroendocrine tumor|Calcium nephrolithiasis|Primary hyperparathyroidism|Medullary thyroid carcinoma|Abnormality of calcium homeostasis|Parathyroid adenoma	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523339	11	64577210 - 64577211	11	64809738 - 64809739	523339	514012	rs1555166368	NC_000011.10:64809737:GA:
NM_000244.3(MEN1):c.529G>T (p.Asp177Tyr)	MEN1	D172Y, D177Y	Hereditary cancer-predisposing syndrome|not specified	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428032	11	64575503	11	64808031	428032	419841	rs1114167494	NC_000011.10:64808030:C:A
NM_000244.3(MEN1):c.1064+1G>C	MEN1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2015)	criteria provided, multiple submitters, no conflicts	VCV000428025	11	64573703	11	64806231	428025	419812	rs1114167489	NC_000011.10:64806230:C:G
NM_000244.3(MEN1):c.461-1G>A	MEN1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419140	11	64575572	11	64808100	419140	408412	rs1064793672	NC_000011.10:64808099:C:T
NM_000244.3(MEN1):c.1479del (p.Lys493fs)	MEN1	K453fs, K488fs, K530fs, K493fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, multiple submitters, no conflicts	VCV000265241	11	64572175	11	64804703	265241	259993	rs886039420	NC_000011.10:64804702:C:
NM_000244.3(MEN1):c.1546_1547GT[3] (p.Ser517fs)	MEN1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, multiple submitters, no conflicts	VCV000201021	11	64572104 - 64572105	11	64804632 - 64804633	201021	197526	rs794728659	NC_000011.10:64804632:ACAC:ACACAC
NM_001130438.3(SPTAN1):c.6616_6618GAG[1] (p.Glu2207del)	SPTAN1	E2207del	not provided|Early infantile epileptic encephalopathy 5	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160024	9	131389702 - 131389704	9	128627423 - 128627425	160024	168788	rs587784438	NC_000009.12:128627422:AGGAGGAG:AGGAG
NM_000543.5(SMPD1):c.757G>C (p.Asp253His)	SMPD1	D253H, D252H	Niemann-Pick disease, type B|Niemann-Pick disease, type A|not specified|not provided|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093320	11	6413052	11	6391822	93320	99227	rs398123479	NC_000011.10:6391821:G:C
NM_000543.4(SMPD1):c.1426C>T	SMPD1	R476W, R169W, R475W, R432W	Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not specified|not provided|Sphingomyelin/cholesterol lipidosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093315	11	6415211	11	6393981	93315	99222	rs182812968	NC_000011.10:6393980:C:T
NM_000543.5(SMPD1):c.1327C>T (p.Arg443Ter)	SMPD1	R441*, R443*, R442*, R136*, R399*	not provided|Niemann-Pick disease, type A|Niemann-Pick disease, type B|not specified|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002993	11	6414910	11	6393680	2993	18032	rs120074127	NC_000011.10:6393679:C:T
NM_033056.4(PCDH15):c.2971C>T (p.Arg991Ter)	PCDH15	R991*, R996*, R1003*, R920*, R969*, R998*, R954*	|	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000224747	10	55721550	10	53961790	224747	226531	rs754391973	NC_000010.11:53961789:G:A
NM_033056.4(PCDH15):c.1927C>T (p.Arg643Ter)	PCDH15	R643*, R621*, R650*, R655*, R606*, R648*	||Rare genetic deafness	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177724	10	55849814	10	54090054	177724	175133	rs727504301	NC_000010.11:54090053:G:A
NM_000244.3(MEN1):c.1284G>A (p.Trp428Ter)	MEN1	W423*, W428*, W388*, W465*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428077	11	64572587	11	64805115	428077	419797	rs1114167533	NC_000011.10:64805114:C:T
NM_000244.3(MEN1):c.669+1del	MEN1		Gastrointestinal stromal tumor|Chronic diarrhea|Thyroid adenoma (disease)|Parathyroid adenoma|Diabetes mellitus|Hypertensive disorder	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000374107	11	64575362	11	64807890	374107	360931	rs1057518903	NC_000011.10:64807889:CCC:CC
NM_000244.3(MEN1):c.928-1G>A	MEN1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373724	11	64573841	11	64806369	373724	360059	rs1057518572	NC_000011.10:64806368:C:T
NM_000244.3(MEN1):c.1125del (p.Asp375fs)	MEN1	D375fs, D335fs, D370fs, D412fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201020	11	64573182	11	64805710	201020	197535	rs794728658	NC_000011.10:64805709:A:
NM_001134363.3(RBM20):c.2737G>A (p.Glu913Lys)	RBM20	E913K	Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|Cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043998	10	112581114	10	110821356	43998	53166	rs397516607	NC_000010.11:110821355:G:A
NM_000244.3(MEN1):c.675G>A (p.Trp225Ter)	MEN1	W220*, W225*, W185*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265235	11	64575147	11	64807675	265235	259999	rs886039414	NC_000011.10:64807674:C:T
NC_000011.10:g.(?_94470461)_(94492811_?)del	MRE11		Ataxia-telangiectasia-like disorder	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000833144	11	94203627 - 94225977			833144	820424		
NM_005591.4(MRE11):c.775C>T (p.Gln259Ter)	MRE11	Q259*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000827245	11	94204810	11	94471644	827245	811054		NC_000011.10:94471643:G:A
NM_005591.4(MRE11):c.652C>T (p.Gln218Ter)	MRE11	Q218*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000826464	11	94209462	11	94476296	826464	811067		NC_000011.10:94476295:G:A
NM_005591.4(MRE11):c.895del (p.Ile299fs)	MRE11	I299fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000822843	11	94203759	11	94470593	822843	811041		NC_000011.10:94470592:TTTT:TTT
NM_005591.4(MRE11):c.1112_1127del (p.Gly371fs)	MRE11	G371fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000822199	11	94197377 - 94197392	11	94464211 - 94464226	822199	811018		NC_000011.10:94464210:AAAGGTTCAAAACCTC:
NM_005591.4(MRE11):c.215_219dup (p.Thr74fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000820802	11	94219184 - 94219185	11	94486018 - 94486019	820802	811100		NC_000011.10:94486018:ATGTAATGT:ATGTAATGTAATGT
NM_005591.4(MRE11):c.1885C>T (p.Gln629Ter)	MRE11	Q601*, Q628*, Q629*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000820257	11	94170384	11	94437218	820257	810965		NC_000011.10:94437217:G:A
NM_005591.4(MRE11):c.1882A>T (p.Arg628Ter)	MRE11	R600*, R627*, R628*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000820248	11	94170387	11	94437221	820248	810966		NC_000011.10:94437220:T:A
NM_005591.4(MRE11):c.1806_1809del (p.Thr603fs)	MRE11	T602fs, T603fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000820111	11	94179034 - 94179037	11	94445868 - 94445871	820111	810974		NC_000011.10:94445867:GGTAG:G
NM_005591.4(MRE11):c.1531_1532del (p.Asn511fs)	MRE11	N511fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000819468	11	94189473 - 94189474	11	94456307 - 94456308	819468	810992		NC_000011.10:94456306:TTTTTTT:TTTTT
NM_005591.4(MRE11):c.1485del (p.Asp495fs)	MRE11	D495fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000819342	11	94192589	11	94459423	819342	810995		NC_000011.10:94459422:G:
NM_005591.4(MRE11):c.1442_1443CA[1] (p.Gln482fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000819233	11	94192629 - 94192630	11	94459463 - 94459464	819233	810999		NC_000011.10:94459462:TGTGT:TGT
NM_005591.4(MRE11):c.1210C>T (p.Gln404Ter)	MRE11	Q404*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000818597	11	94197294	11	94464128	818597	811014		NC_000011.10:94464127:G:A
NM_005590.4(MRE11):c.1047_1048del (p.Glu350fs)	MRE11	E350fs	Ataxia-telangiectasia-like disorder	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000660377	11	94201029 - 94201030	11	94467863 - 94467864	660377	640516		NC_000011.10:94467862:CCC:C
NM_005591.3(MRE11):c.664A>T (p.Lys222Ter)	MRE11	K222*	Ataxia-telangiectasia-like disorder	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000659921	11	94204921	11	94471755	659921	640521		NC_000011.10:94471754:T:A
NM_005590.4(MRE11):c.1252dup (p.Ile418fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000485812	11	94194175 - 94194176	11	94461009 - 94461010	485812	476143	rs1555009931	NC_000011.10:94461009:T:TT
NM_005590.4(MRE11):c.1773_1774del (p.Gly593fs)	MRE11	G593fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000483659	11	94180394 - 94180395	11	94447228 - 94447229	483659	476055	rs1555005270	NC_000011.10:94447227:TTT:T
NM_005590.4(MRE11):c.1720del (p.Arg574fs)	MRE11	R574fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000483632	11	94180448	11	94447282	483632	476071	rs767787348	NC_000011.10:94447281:TT:T
NM_005590.4(MRE11):c.291_294GTCA[1] (p.Val99fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000481758	11	94219106 - 94219109	11	94485940 - 94485943	481758	476241	rs1555017184	NC_000011.10:94485939:TGACTGACTGA:TGACTGA
NM_005590.4(MRE11):c.211del (p.Thr71fs)	MRE11	T71fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000479745	11	94219193	11	94486027	479745	476244	rs1555017238	NC_000011.10:94486026:TTTT:TTT
NM_005590.4(MRE11):c.1813del (p.Arg605fs)	MRE11	R605fs, R632fs, R633fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000479740	11	94170372	11	94437206	479740	476378	rs1555002419	NC_000011.10:94437205:GGG:GG
NM_005591.3(MRE11):c.170T>G (p.Leu57Ter)	MRE11	L57*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000479719	11	94219234	11	94486068	479719	476727	rs951805101	NC_000011.10:94486067:A:C
NM_005590.4(MRE11):c.1785del (p.Phe596fs)	MRE11	F624fs, F596fs, F623fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000479714	11	94170400	11	94437234	479714	476042	rs1264516058	NC_000011.10:94437233:GG:G
NM_005591.3(MRE11):c.806C>G (p.Ser269Ter)	MRE11	S269*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000233262	11	94204779	11	94471613	233262	234522	rs776912688	NC_000011.10:94471612:G:C
NM_005590.4(MRE11):c.1783+1366dup	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000233221	11	94179016 - 94179017	11	94445850 - 94445851	233221	234467	rs876660269	NC_000011.10:94445850:TTT:TTTT
NM_005590.4(MRE11):c.1633_1640del (p.Leu545fs)	MRE11	L545fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000233090	11	94180528 - 94180535	11	94447362 - 94447369	233090	234474	rs876660186	NC_000011.10:94447361:CTCATAAG:
NM_005590.4(MRE11):c.1336del (p.Leu446fs)	MRE11	L446fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	criteria provided, single submitter	VCV000187370	11	94192738	11	94459572	187370	183527	rs786203682	NC_000011.10:94459571:G:
NM_005590.4(MRE11):c.1445_1446delinsTTAA (p.Gln482fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 22, 2014)	criteria provided, single submitter	VCV000186907	11	94192628 - 94192629	11	94459462 - 94459463	186907	183524	rs786203314	NC_000011.10:94459461:CT:TTAA
NM_005590.4(MRE11):c.1135dup (p.Leu379fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000186193	11	94197368 - 94197369	11	94464202 - 94464203	186193	183538	rs786202764	NC_000011.10:94464202:G:GG
NM_005590.4(MRE11):c.821_823delinsA (p.Leu274fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000185250	11	94204762 - 94204764	11	94471596 - 94471598	185250	183555	rs786202032	NC_000011.10:94471595:AAA:T
NM_005590.4(MRE11):c.627_628del (p.Trp210fs)	MRE11	W210fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000182554	11	94209486 - 94209487	11	94476320 - 94476321	182554	180543	rs730881752	NC_000011.10:94476319:AA:
NM_005591.3(MRE11):c.508C>T (p.Gln170Ter)	MRE11	Q170*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000141813	11	94211937	11	94478771	141813	151527	rs587782030	NC_000011.10:94478770:G:A
NM_005590.4(MRE11):c.923dup (p.Met309fs)	MRE11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000141542	11	94203730 - 94203731	11	94470564 - 94470565	141542	151256	rs587781828	NC_000011.10:94470564:AAAAA:AAAAAA
NM_005591.3(MRE11):c.1771C>T (p.Gln591Ter)	MRE11	Q591*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000479737	11	94180397	11	94447231	479737	476064	rs1215450873	NC_000011.10:94447230:G:A
NM_005590.4(MRE11):c.1441del (p.Thr481fs)	MRE11	T481fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2015)	criteria provided, single submitter	VCV000216095	11	94192633	11	94459467	216095	212957	rs747832587	NC_000011.10:94459466:TTTTTT:TTTTT
NM_005591.4(MRE11):c.1442C>A (p.Thr481Lys)	MRE11	T481K	Ataxia-telangiectasia-like disorder 1	Pathogenic(Last reviewed: Sep 15, 2004)	no assertion criteria provided	VCV000008785	11	94192632	11	94459466	8785	23824	rs137852762	NC_000011.10:94459465:G:T
NM_016035.5(COQ4):c.469C>A (p.Gln157Lys)	COQ4	Q157K	Inborn genetic diseases|Coenzyme Q10 deficiency, primary, 7	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488488	9	131094498	9	128332219	488488	481356	rs1045118320	NC_000009.12:128332218:C:A
NM_005591.3(MRE11):c.845+2T>A	MRE11		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000140936	11	94204738	11	94471572	140936	150650	rs587781381	NC_000011.10:94471571:A:T
NM_005591.4(MRE11):c.571C>T (p.Arg191Ter)	MRE11	R191*	Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825924	11	94209543	11	94476377	825924	811078		NC_000011.10:94476376:G:A
NM_005591.3(MRE11):c.1414G>T (p.Glu472Ter)	MRE11	E472*	Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481748	11	94192660	11	94459494	481748	476109	rs1376550081	NC_000011.10:94459493:C:A
NM_005591.3(MRE11):c.1015A>T (p.Lys339Ter)	MRE11	K339*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447736	11	94203639	11	94470473	447736	441487	rs984874083	NC_000011.10:94470472:T:A
NM_005591.3(MRE11):c.1447C>T (p.Arg483Ter)	MRE11	R483*	Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231449	11	94192627	11	94459461	231449	234486	rs780001540	NC_000011.10:94459460:G:A
NM_002180.2(IGHMBP2):c.138T>A (p.Cys46Ter)	IGHMBP2	C46*	Spinal muscular atrophy, distal, autosomal recessive, 1|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162194	11	68673588	11	68906120	162194	171902	rs372000714	NC_000011.10:68906119:T:A
NM_000155.4(GALT):c.998G>A (p.Arg333Gln)	GALT	R333Q, R224Q	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038288	9	34649500	9	34649503	38288	46843	rs111033808	NC_000009.12:34649502:G:A
NM_018238.4(AGK):c.424-3C>G	AGK		Autosomal recessive AGK-related phenotype|Cataract, autosomal recessive congenital 5|Inborn genetic diseases|Sengers syndrome	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000209129	7	141315268	7	141615468	209129	205751	rs766413410	NC_000007.14:141615467:C:G
NM_000244.3(MEN1):c.974C>T (p.Pro325Leu)	MEN1	P320L, P325L, P285L	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000428002	11	64573794	11	64806322	428002	419820	rs1114167469	NC_000011.10:64806321:G:A
NM_005591.3(MRE11):c.1143del (p.Phe381fs)	MRE11	F381fs	Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216094	11	94197361	11	94464195	216094	212962	rs863224508	NC_000011.10:94464194:AAA:AA
NM_005590.4(MRE11):c.739dup (p.His247fs)	MRE11		Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000187699	11	94204845 - 94204846	11	94471679 - 94471680	187699	183559	rs786203931	NC_000011.10:94471679:G:GG
NM_005591.3(MRE11):c.504_511del (p.Leu169fs)	MRE11	L169fs	Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185530	11	94211934 - 94211941	11	94478768 - 94478775	185530	183571	rs786202253	NC_000011.10:94478767:TTTGAAGC:
NM_001613.4(ACTA2):c.445C>T (p.Arg149Cys)	ACTA2	R149C	Cardiovascular phenotype|not provided|Aortic aneurysm, familial thoracic 2|Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018276	10	90701551	10	88941794	18276	33315	rs121434526	NC_000010.11:88941793:G:A
NM_004329.2(BMPR1A):c.64C>T (p.Gln22Ter)	BMPR1A	Q22*	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000452092	10	88635839	10	86876082	452092	444665	rs1554886821	NC_000010.11:86876081:C:T
NM_004329.2(BMPR1A):c.369del (p.Glu123fs)	BMPR1A	E123fs	not provided	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000127901	10	88659585	10	86899828	127901	133358	rs587780109	NC_000010.11:86899827:AA:A
NM_004329.3(BMPR1A):c.824_825del (p.Thr275fs)	BMPR1A	T275fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000827529	10	88677038 - 88677039	10	86917281 - 86917282	827529	810021		NC_000010.11:86917280:ACA:A
NM_004329.3(BMPR1A):c.905G>A (p.Trp302Ter)	BMPR1A	W302*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000822968	10	88678965	10	86919208	822968	810026		NC_000010.11:86919207:G:A
NM_004329.3(BMPR1A):c.1095del (p.Ser365fs)	BMPR1A	S365fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000822155	10	88679155	10	86919398	822155	810038		NC_000010.11:86919397:C:
NM_004329.3(BMPR1A):c.373del (p.Cys125fs)	BMPR1A	C125fs	not provided	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000801059	10	88659589	10	86899832	801059	789490		NC_000010.11:86899831:TT:T
NM_004329.2(BMPR1A):c.1245_1246dup (p.Ser416fs)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000486821	10	88681353 - 88681354	10	86921596 - 86921597	486821	475144	rs1554891331	NC_000010.11:86921596:AAA:AAAAA
NM_004329.2(BMPR1A):c.271C>T (p.Gln91Ter)	BMPR1A	Q91*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000486808	10	88651924	10	86892167	486808	475360	rs878854667	NC_000010.11:86892166:C:T
NM_004329.2(BMPR1A):c.15C>A (p.Tyr5Ter)	BMPR1A	Y5*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000486804	10	88635790	10	86876033	486804	475083	rs1392086533	NC_000010.11:86876032:C:A
NM_004329.2(BMPR1A):c.1401C>A (p.Tyr467Ter)	BMPR1A	Y467*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000486797	10	88683191	10	86923434	486797	475223	rs149787558	NC_000010.11:86923433:C:A
NM_004329.2(BMPR1A):c.1101del (p.Asn367fs)	BMPR1A	N367fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000486796	10	88679161	10	86919404	486796	475333	rs1554891102	NC_000010.11:86919403:C:
NM_004329.2(BMPR1A):c.874dup (p.Ile292fs)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000482884	10	88678933 - 88678934	10	86919176 - 86919177	482884	475391	rs1554891016	NC_000010.11:86919176:A:AA
NM_004329.2(BMPR1A):c.325del (p.Gln109fs)	BMPR1A	Q109fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000482882	10	88651978	10	86892221	482882	475099	rs1554888329	NC_000010.11:86892220:C:
NM_004329.2(BMPR1A):c.199_203dup (p.Asp69fs)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000482872	10	88649948 - 88649949	10	86890191 - 86890192	482872	475304	rs1554888134	NC_000010.11:86890191:CTGTCC:CTGTCCTGTCC
NM_004329.2(BMPR1A):c.1061del (p.Gly354fs)	BMPR1A	G354fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000482862	10	88679120	10	86919363	482862	475412	rs1554891089	NC_000010.11:86919362:GG:G
NM_004329.2(BMPR1A):c.551C>G (p.Ser184Ter)	BMPR1A	S184*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000429107	10	88672017	10	86912260	429107	421054	rs1131691185	NC_000010.11:86912259:C:G
NM_004329.2(BMPR1A):c.1058_1059dup (p.Gly354fs)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000429106	10	88679117 - 88679118	10	86919360 - 86919361	429106	421058	rs1131691184	NC_000010.11:86919360:AA:AAAA
NM_004329.2(BMPR1A):c.160del (p.Asp54fs)	BMPR1A	D54fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000429105	10	88649910	10	86890153	429105	421046	rs1131691183	NC_000010.11:86890152:GG:G
NM_004329.2(BMPR1A):c.735T>G (p.Tyr245Ter)	BMPR1A	Y245*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000429104	10	88676950	10	86917193	429104	421055	rs1131691182	NC_000010.11:86917192:T:G
NM_004329.2(BMPR1A):c.373T>G (p.Cys125Gly)	BMPR1A	C125G	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 10, 2013)	criteria provided, single submitter	VCV000429101	10	88659590	10	86899833	429101	421048	rs1131691180	NC_000010.11:86899832:T:G
NM_004329.2(BMPR1A):c.454C>T (p.Arg152Ter)	BMPR1A	R152*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	VCV000429099	10	88659807	10	86900050	429099	421051	rs1131691178	NC_000010.11:86900049:C:T
NM_004329.2(BMPR1A):c.458G>A (p.Trp153Ter)	BMPR1A	W153*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000429097	10	88659811	10	86900054	429097	421052	rs1131691176	NC_000010.11:86900053:G:A
NM_004329.2(BMPR1A):c.1460G>A (p.Trp487Ter)	BMPR1A	W487*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000429096	10	88683250	10	86923493	429096	421062	rs1131691175	NC_000010.11:86923492:G:A
NM_004329.2(BMPR1A):c.367del (p.Glu123fs)	BMPR1A	E123fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	VCV000429093	10	88659584	10	86899827	429093	421047	rs1131691173	NC_000010.11:86899826:G:
NM_004329.2(BMPR1A):c.481del (p.Ala161fs)	BMPR1A	A161fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	VCV000429092	10	88659833	10	86900076	429092	421053	rs1131691172	NC_000010.11:86900075:GG:G
NM_004329.2:c.1373_1385delins5	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	VCV000429090	10	88683163 - 88683175	10	86923406 - 86923418	429090	421061		
NM_004329.2(BMPR1A):c.388T>C (p.Cys130Arg)	BMPR1A	C130R	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 19, 2012)	criteria provided, single submitter	VCV000429088	10	88659605	10	86899848	429088	421049	rs1131691168	NC_000010.11:86899847:T:C
NM_004329.2(BMPR1A):c.964A>T (p.Lys322Ter)	BMPR1A	K322*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 18, 2012)	criteria provided, single submitter	VCV000429087	10	88679024	10	86919267	429087	421057	rs1131691167	NC_000010.11:86919266:A:T
NM_004329.2(BMPR1A):c.884delinsGTTCATAGCGG (p.Asp295delinsGlySerTer)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000232787	10	88678944	10	86919187	232787	233820	rs876659988	NC_000010.11:86919186:A:GTTCATAGCGG
NM_004329.2(BMPR1A):c.246C>A (p.Cys82Ter)	BMPR1A	C82*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000231283	10	88651899	10	86892142	231283	233800	rs759647230	NC_000010.11:86892141:C:A
NM_004329.2(BMPR1A):c.309T>G (p.Tyr103Ter)	BMPR1A	Y103*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000230999	10	88651962	10	86892205	230999	233803	rs876658891	NC_000010.11:86892204:T:G
NM_004329.2(BMPR1A):c.420del (p.Val141fs)	BMPR1A	V141fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000184822	10	88659637	10	86899880	184822	182968	rs786201715	NC_000010.11:86899879:T:
NM_004329.2(BMPR1A):c.216dup (p.Asn73Ter)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000184498	10	88649965 - 88649966	10	86890208 - 86890209	184498	182964	rs786201501	NC_000010.11:86890208:TT:TTT
GRCh38/hg38 10q23.2(chr10:86787518-86892381)x1	BMPR1A		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058774	10	88547275 - 88652138	10	86787518 - 86892381	58774	73369		
BMPR1A, DEL	BMPR1A		Juvenile polyposis of infancy	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000008238					8238	23277		
NM_004329.2(BMPR1A):c.189C>A (p.Cys63Ter)	BMPR1A	C63*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000631320	10	88649940	10	86890183	631320	617554	rs1413243663	NC_000010.11:86890182:C:A
NM_004329.3(BMPR1A):c.1065del (p.Lys355fs)	BMPR1A	K355fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000630668	10	88679125	10	86919368	630668	617571	rs1564724278	NC_000010.11:86919367:G:
NM_004329.2(BMPR1A):c.275del (p.Gly92fs)	BMPR1A	G92fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 16, 2016)	criteria provided, single submitter	VCV000490989	10	88651926	10	86892169	490989	484168	rs1554888317	NC_000010.11:86892168:GGG:GG
NM_004329.2(BMPR1A):c.1010C>A (p.Ser337Ter)	BMPR1A	S337*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000486799	10	88679070	10	86919313	486799	475396	rs1554891075	NC_000010.11:86919312:C:A
NM_004329.2(BMPR1A):c.286_289dup (p.Ala97fs)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224552	10	88651938 - 88651939	10	86892181 - 86892182	224552	226334	rs869312783	NC_000010.11:86892181:TTAG:TTAGTTAG
NM_004329.2(BMPR1A):c.-152-?_1473+?del	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224522					224522	226332		
NM_004329.2(BMPR1A):c.3G>C (p.Met1Ile)	BMPR1A	M1I	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224521	10	88635778	10	86876021	224521	226333	rs869312758	NC_000010.11:86876020:G:C
BMPR1A, 11-BP DEL, CODON 42	BMPR1A		Hereditary mixed polyposis syndrome 2	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000008237					8237	23276		
NM_000162.5(GCK):c.184G>A (p.Val62Met)	GCK	V62M, V63M, V61M	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419624	7	44192924	7	44153325	419624	407147	rs1064793998	NC_000007.14:44153324:C:T
NM_004329.3(BMPR1A):c.3G>A (p.Met1Ile)	BMPR1A	M1I	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000824482	10	88635778	10	86876021	824482	809978		NC_000010.11:86876020:G:A
NM_004329.2(BMPR1A):c.987_992delinsTGTA (p.Arg329fs)	BMPR1A		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545847	10	88679047 - 88679052	10	86919290 - 86919295	545847	536366	rs1554891056	NC_000010.11:86919289:AGCCCT:TGTA
NM_004329.2(BMPR1A):c.961del (p.Phe320_Leu321insTer)	BMPR1A		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000486814	10	88679020	10	86919263	486814	475331	rs1554891044	NC_000010.11:86919262:CC:C
NM_004329.2(BMPR1A):c.1A>C (p.Met1Leu)	BMPR1A	M1L	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000429102	10	88635776	10	86876019	429102	421043	rs786203157	NC_000010.11:86876018:A:C
NM_004329.2(BMPR1A):c.360del (p.Thr121fs)	BMPR1A	T121fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419669	10	88659576	10	86899819	419669	407934	rs1064794031	NC_000010.11:86899818:GG:G
NM_003002.4(SDHD):c.1A>T (p.Met1Leu)	SDHD	M1L	Carney-Stratakis syndrome|Cowden syndrome 3|Pheochromocytoma|Paragangliomas 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422629	11	111957632	11	112086908	422629	408270	rs104894307	NC_000011.10:112086907:A:T
NM_020822.3(KCNT1):c.2782C>T (p.Arg928Cys)	KCNT1	R928C, R883C	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000039597	9	138671257	9	135779411	39597	48196	rs397515405	NC_000009.12:135779410:C:T
NM_004329.2(BMPR1A):c.697C>T (p.Gln233Ter)	BMPR1A	Q233*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449463	10	88676912	10	86917155	449463	444666	rs1554890743	NC_000010.11:86917154:C:T
NM_004329.2(BMPR1A):c.262G>T (p.Glu88Ter)	BMPR1A	E88*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182065	10	88651915	10	86892158	182065	180369	rs730881431	NC_000010.11:86892157:G:T
NM_004329.3(BMPR1A):c.583C>T (p.Gln195Ter)	BMPR1A	Q195*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802600	10	88672049	10	86912292	802600	790994		NC_000010.11:86912291:C:T
NM_000244.3(MEN1):c.683T>C (p.Leu228Pro)	MEN1	L223P, L228P, L188P	not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265236	11	64575139	11	64807667	265236	259998	rs886039415	NC_000011.10:64807666:A:G
NM_000244.3(MEN1):c.927+1G>A	MEN1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096254	11	64574482	11	64807010	96254	102148	rs398124437	NC_000011.10:64807009:C:T
NM_015046.7(SETX):c.1166T>C (p.Leu389Ser)	SETX	L389S	Distal spinal muscular atrophy|not provided|Amyotrophic lateral sclerosis type 4|Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002289	9	135205819	9	132330432	2289	17328	rs29001584	NC_000009.12:132330431:A:G
NM_004329.3(BMPR1A):c.1100del (p.Asn367fs)	BMPR1A	N367fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000859429	10	88679156	10	86919399	859429	837396		NC_000010.11:86919398:AAAAA:AAAA
NM_004329.3(BMPR1A):c.1152del (p.Val385fs)	BMPR1A	V385fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000854188	10	88679212	10	86919455	854188	837399		NC_000010.11:86919454:T:
NM_004329.3(BMPR1A):c.184_187dup (p.Cys63fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 3, 2019)	criteria provided, single submitter	VCV000852393	10	88649934 - 88649935	10	86890177 - 86890178	852393	837377		NC_000010.11:86890177:TATT:TATTTATT
NM_004329.3(BMPR1A):c.1131_1153dup (p.Val385fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000840888	10	88679184 - 88679185	10	86919427 - 86919428	840888	837397		NC_000010.11:86919427:TTGCTGCATTGCTGACCTGGGCCTTGCTG:TTGCTGCATTGCTGACCTGGGCCTTGCTGCATTGCTGACCTGGGCCTTGCTG
NM_004329.3(BMPR1A):c.834C>G (p.Tyr278Ter)	BMPR1A	Y278*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000839418	10	88677049	10	86917292	839418	837392		NC_000010.11:86917291:C:G
NM_004329.3(BMPR1A):c.244del (p.Cys82fs)	BMPR1A	C82fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000661530	10	88651896	10	86892139	661530	639220		NC_000010.11:86892138:TT:T
NC_000010.10:g.(?_88635766)_(88635852_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000660680	10	88635766 - 88635852	10	86876009 - 86876095	660680	651982		
NM_004329.3(BMPR1A):c.1267del (p.Gln423fs)	BMPR1A	Q423fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000646709	10	88681376	10	86921619	646709	639247		NC_000010.11:86921618:CC:C
NM_004329.2(BMPR1A):c.110_111insCCATGGCACTGGGAT (p.Asp38_Ser39insHisGlyThrGlyIle)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000644978	10	88649861 - 88649862	10	86890104 - 86890105	644978	639214		NC_000010.11:86890104::CCATGGCACTGGGAT
NM_004329.3(BMPR1A):c.150del (p.Ala51fs)	BMPR1A	A51fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000644109	10	88649901	10	86890144	644109	639215		NC_000010.11:86890143:A:
NM_004329.2(BMPR1A):c.813G>A (p.Trp271Ter)	BMPR1A	W271*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000642114	10	88677028	10	86917271	642114	639234		NC_000010.11:86917270:G:A
NC_000010.10:g.(?_88671987)_(88677093_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000584294	10	88671987 - 88677093	10	86912230 - 86917336	584294	566112		
NM_004329.2(BMPR1A):c.133_134del (p.Glu45fs)	BMPR1A	E45fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000581321	10	88649883 - 88649884	10	86890126 - 86890127	581321	563983	rs1564714804	NC_000010.11:86890125:AGA:A
NM_004329.2(BMPR1A):c.1374C>A (p.Tyr458Ter)	BMPR1A	Y458*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Apr 8, 2018)	criteria provided, single submitter	VCV000578684	10	88683164	10	86923407	578684	564827	rs1564725603	NC_000010.11:86923406:C:A
NM_004329.2(BMPR1A):c.566dup (p.Tyr189Ter)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000571137	10	88672031 - 88672032	10	86912274 - 86912275	571137	566538	rs1564721929	NC_000010.11:86912274:A:AA
NM_004329.2(BMPR1A):c.1314G>A (p.Trp438Ter)	BMPR1A	W438*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000569831	10	88681424	10	86921667	569831	563994	rs1564725052	NC_000010.11:86921666:G:A
NM_004329.2(BMPR1A):c.139G>T (p.Gly47Ter)	BMPR1A	G47*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000567654	10	88649890	10	86890133	567654	564787	rs1564714809	NC_000010.11:86890132:G:T
NM_004329.2(BMPR1A):c.847dup (p.Met283fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000566699	10	88677060 - 88677061	10	86917303 - 86917304	566699	564821	rs1564723486	NC_000010.11:86917303:AA:AAA
NM_004329.2(BMPR1A):c.366_384del (p.Glu123fs)	BMPR1A	E123fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000529927	10	88659579 - 88659597	10	86899822 - 86899840	529927	525701	rs1554888970	NC_000010.11:86899821:CAATAGAATGTTGTCGGACCAAT:CAAT
NM_004329.2(BMPR1A):c.731dup (p.Tyr245fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000529921	10	88676945 - 88676946	10	86917188 - 86917189	529921	525544	rs1554890759	NC_000010.11:86917188:G:GG
NM_004329.2(BMPR1A):c.864dup (p.Leu289fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000529920	10	88677078 - 88677079	10	86917321 - 86917322	529920	525716	rs1554890815	NC_000010.11:86917321:A:AA
NM_004329.2(BMPR1A):c.419del (p.Pro140fs)	BMPR1A	P140fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000529904	10	88659632	10	86899875	529904	525706	rs1554888986	NC_000010.11:86899874:CCCCC:CCCC
NM_004329.2(BMPR1A):c.910C>T (p.Gln304Ter)	BMPR1A	Q304*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000529903	10	88678970	10	86919213	529903	525547	rs1404557708	NC_000010.11:86919212:C:T
NM_004329.2(BMPR1A):c.957dup (p.Phe320fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000460517	10	88679016 - 88679017	10	86919259 - 86919260	460517	461040	rs1554891043	NC_000010.11:86919259:C:CC
NM_004329.2(BMPR1A):c.834C>A (p.Tyr278Ter)	BMPR1A	Y278*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000460512	10	88677049	10	86917292	460512	460332	rs1230919713	NC_000010.11:86917291:C:A
NM_004329.2(BMPR1A):c.578dup (p.Leu193fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000460506	10	88672041 - 88672042	10	86912284 - 86912285	460506	460329	rs1554890219	NC_000010.11:86912284:TTT:TTTT
NM_004329.2(BMPR1A):c.567C>A (p.Tyr189Ter)	BMPR1A	Y189*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000460505	10	88672033	10	86912276	460505	461026	rs1554890213	NC_000010.11:86912275:C:A
NC_000010.10:g.(?_88598622)_(88659883_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000417562	10	88598622 - 88659883	10	86838865 - 86900126	417562	397328		
NM_004329.2(BMPR1A):c.917_920dup (p.Ile308fs)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Sep 25, 2016)	criteria provided, single submitter	VCV000411629	10	88678975 - 88678976	10	86919218 - 86919219	411629	397998	rs1554891032	NC_000010.11:86919218:TATTT:TATTTATTT
NM_004329.2(BMPR1A):c.213_228del (p.Ala71_Ile72insTer)	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000411600	10	88649960 - 88649975	10	86890203 - 86890218	411600	397986	rs1064792985	NC_000010.11:86890202:ATGCTATTAATAACACATGC:ATGC
NM_004329.2(BMPR1A):c.771del (p.Val258fs)	BMPR1A	V258fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000239867	10	88676982	10	86917225	239867	240862	rs878854673	NC_000010.11:86917224:AAAAA:AAAA
NM_004329.2(BMPR1A):c.-152-?_*1469del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000239852	10	88635624 - 88684945	10	86875867 - 86925188	239852	240720		
NM_004329.2(BMPR1A):c.247_251del (p.Phe83fs)	BMPR1A	F83fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000188270	10	88651896 - 88651900	10	86892139 - 86892143	188270	186121	rs786204187	NC_000010.11:86892138:TTGCTTTGC:TTGC
NM_004329.2(BMPR1A):c.1127G>A (p.Cys376Tyr)	BMPR1A	C376Y	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000008235	10	88679187	10	86919430	8235	23274	rs199476088	NC_000010.11:86919429:G:A
BMPR1A, 1-BP DEL, 961C	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000008232					8232	23271		
NM_004329.2(BMPR1A):c.812G>A (p.Trp271Ter)	BMPR1A	W271*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000008231	10	88677027	10	86917270	8231	23270	rs199476085	NC_000010.11:86917269:G:A
NM_004329.2(BMPR1A):c.715C>T (p.Gln239Ter)	BMPR1A	Q239*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000008230	10	88676930	10	86917173	8230	23269	rs199476084	NC_000010.11:86917172:C:T
BMPR1A, 4-BP DEL, 44TGTT	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000008229					8229	23268		
NM_001142800.2(EYS):c.490C>T (p.Arg164Ter)	EYS	R164*	not provided|Retinitis pigmentosa|Retinitis pigmentosa 25	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197186	6	66204814	6	65494921	197186	194347	rs794727631	NC_000006.12:65494920:G:A
NM_001142800.2(EYS):c.7919G>A (p.Trp2640Ter)	EYS	W2640*	Retinitis pigmentosa 25|Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143112	6	64472506	6	63762613	143112	152830	rs527236066	NC_000006.12:63762612:C:T
NM_001142800.2(EYS):c.7095T>G (p.Tyr2365Ter)	EYS	Y2365*	Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093621	6	64574212	6	63864319	93621	99525	rs398123575	NC_000006.12:63864318:A:C
NM_024426.6(WT1):c.1447+4C>T	WT1		Diffuse mesangial sclerosis|Frasier syndrome|not provided|Nephrotic range proteinuria|Hereditary nephrotic syndrome	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000003500	11	32413514	11	32391968	3500	18539	rs587776577	NC_000011.10:32391967:G:A
NM_033056.4(PCDH15):c.3316C>T (p.Arg1106Ter)	PCDH15	R1106*, R1084*, R1118*, R1069*, R1035*, R1111*, R1113*	|Deafness, autosomal recessive 23|||Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000046464	10	55698632	10	53938872	46464	55629	rs202033121	NC_000010.11:53938871:G:A
NM_000260.4(MYO7A):c.5749G>T (p.Glu1917Ter)	MYO7A	E1868*, E1917*, E1879*	Retinal dystrophy	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000866518	11	76918340	11	77207295	866518	856747		NC_000011.10:77207294:G:T
NM_000260.4(MYO7A):c.5420_5421dup (p.Pro1808fs)	MYO7A		not provided	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000817194	11	76915212 - 76915213	11	77204167 - 77204168	817194	805711		NC_000011.10:77204167:GAG:GAGAG
NM_000260.4(MYO7A):c.321_322insA (p.Tyr108fs)	MYO7A		not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000817097	11	76866988 - 76866989	11	77155942 - 77155943	817097	805710		NC_000011.10:77155942::A
NM_000260.4(MYO7A):c.6439-1G>A	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802710	11	76924904	11	77213859	802710	791181		NC_000011.10:77213858:G:A
NM_000260.4(MYO7A):c.4489G>C (p.Gly1497Arg)	MYO7A	G1497R, G1486R	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802708	11	76909587	11	77198542	802708	791179		NC_000011.10:77198541:G:C
NM_000260.4(MYO7A):c.2750del (p.Glu917fs)	MYO7A	E906fs, E917fs	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802707	11	76892481	11	77181435	802707	791178		NC_000011.10:77181434:A:
NM_000260.4(MYO7A):c.1708C>T (p.Arg570Ter)	MYO7A	R559*, R570*	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802705	11	76877119	11	77166073	802705	791176		NC_000011.10:77166072:C:T
NM_000260.4(MYO7A):c.1198_1199dup (p.Gly401fs)	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802704	11	76871324 - 76871325	11	77160278 - 77160279	802704	791175		NC_000011.10:77160278:AAA:AAAAA
NM_000260.4(MYO7A):c.183del (p.Thr62fs)	MYO7A	T62fs, T51fs	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802701	11	76858891	11	77147845	802701	791172		NC_000011.10:77147844:CCCC:CCC
NM_000260.4(MYO7A):c.4439C>A (p.Ser1480Ter)	MYO7A	S1480*, S1469*	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627465	11	76908641	11	77197596	627465	615816	rs1565455391	NC_000011.10:77197595:C:A
NM_000260.4(MYO7A):c.6230G>A (p.Trp2077Ter)	MYO7A	W2077*, W2028*, W2039*	not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000620345	11	76922375	11	77211330	620345	611757	rs776930594	NC_000011.10:77211329:G:A
NM_000260.4(MYO7A):c.5856+5G>C	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562097	11	76918452	11	77207407	562097	553268	rs1386887007	NC_000011.10:77207406:G:C
NM_000260.4(MYO7A):c.2339del (p.Gly780fs)	MYO7A	G769fs, G780fs	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562093	11	76890144	11	77179098	562093	553266	rs1565402473	NC_000011.10:77179097:GGGG:GGG
NM_000260.4(MYO7A):c.3728C>G (p.Pro1243Arg)	MYO7A	P1243R, P1232R	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562092	11	76901162	11	77190117	562092	553267	rs750358148	NC_000011.10:77190116:C:G
NM_000260.4(MYO7A):c.20G>T (p.Gly7Val)	MYO7A	G7V	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562084	11	76853756	11	77142710	562084	553265	rs781989117	NC_000011.10:77142709:G:T
NM_000260.4(MYO7A):c.3590T>C (p.Leu1197Pro)	MYO7A	L1197P, L1186P	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560899	11	76900475	11	77189430	560899	552018	rs1565430886	NC_000011.10:77189429:T:C
NM_000260.4(MYO7A):c.5345G>C (p.Gly1782Ala)	MYO7A	G1782A, G1744A, G1733A	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560898	11	76915139	11	77204094	560898	552020	rs751242455	NC_000011.10:77204093:G:C
NM_000260.4(MYO7A):c.3364C>A (p.Leu1122Ile)	MYO7A	L1122I, L1111I	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560897	11	76894191	11	77183146	560897	552017	rs192378817	NC_000011.10:77183145:C:A
NM_000260.4(MYO7A):c.5326+3A>G	MYO7A		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560895	11	76914265	11	77203220	560895	552019	rs1565469959	NC_000011.10:77203219:A:G
NM_000260.4(MYO7A):c.5522C>G (p.Thr1841Arg)	MYO7A	T1841R, T1803R, T1792R	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560894	11	76916548	11	77205503	560894	552021	rs746667217	NC_000011.10:77205502:C:G
NM_000260.4(MYO7A):c.1353_1360del (p.Gln451fs)	MYO7A	Q440fs, Q451fs	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000504020	11	76873172 - 76873179	11	77162126 - 77162133	504020	495282	rs1555069242	NC_000011.10:77162125:GCAGCTCTGCA:GCA
NM_000260.4(MYO7A):c.133G>T (p.Glu45Ter)	MYO7A	E45*, E34*	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000498920	11	76858844	11	77147798	498920	490344	rs368877140	NC_000011.10:77147797:G:T
NM_000260.4(MYO7A):c.4225del (p.Leu1409fs)	MYO7A	L1409fs, L1398fs	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000498918	11	76905470	11	77194425	498918	490342	rs1398609491	NC_000011.10:77194424:CC:C
NM_000260.4(MYO7A):c.338_348dup (p.Glu117fs)	MYO7A		not provided	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000418366	11	76867001 - 76867002	11	77155955 - 77155956	418366	408477	rs1064793208	NC_000011.10:77155955:CCATCTACTCGCCA:CCATCTACTCGCCATCTACTCGCCA
NM_000260.4(MYO7A):c.4153-2A>G	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402268	11	76905397	11	77194352	402268	389241	rs1060499803	NC_000011.10:77194351:A:G
NM_000260.4(MYO7A):c.6211C>T (p.Gln2071Ter)	MYO7A	Q2071*, Q2022*, Q2033*	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402266	11	76922356	11	77211311	402266	389243	rs1060499802	NC_000011.10:77211310:C:T
NM_000260.4(MYO7A):c.620A>G (p.Asn207Ser)	MYO7A	N207S, N196S	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236051	11	76867935	11	77156889	236051	237613	rs878853235	NC_000011.10:77156888:A:G
NM_000260.4(MYO7A):c.6029A>G (p.Asp2010Gly)	MYO7A	D2010G, D1972G, D1961G	Rare genetic deafness	Pathogenic(Last reviewed: Oct 28, 2006)	no assertion criteria provided	VCV000043314	11	76919826	11	77208781	43314	52484	rs111033175	NC_000011.10:77208780:A:G
NM_000260.4(MYO7A):c.2838del (p.Met946fs)	MYO7A	M935fs, M946fs	not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000862312	11	76892569	11	77181523	862312	839056		NC_000011.10:77181522:G:
NM_000260.4(MYO7A):c.2707C>T (p.Gln903Ter)	MYO7A	Q892*, Q903*	not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000856159	11	76892438	11	77181392	856159	839052		NC_000011.10:77181391:C:T
NM_000260.4(MYO7A):c.5820_5821AG[1] (p.Glu1941fs)	MYO7A		not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000854618	11	76918411 - 76918412	11	77207366 - 77207367	854618	839082		NC_000011.10:77207365:AGAG:AG
NM_000260.4(MYO7A):c.1074del (p.Glu360fs)	MYO7A	E349fs, E360fs	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000853315	11	76870563	11	77159517	853315	839035		NC_000011.10:77159516:G:
NM_000260.4(MYO7A):c.5458C>T (p.Gln1820Ter)	MYO7A	Q1771*, Q1782*, Q1820*	not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000849694	11	76915252	11	77204207	849694	839080		NC_000011.10:77204206:C:T
NM_000260.4(MYO7A):c.4613del (p.Cys1538fs)	MYO7A	C1538fs	not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000846729	11	76910624	11	77199579	846729	839068		NC_000011.10:77199578:G:
NM_000260.4(MYO7A):c.3143del (p.Phe1048fs)	MYO7A	F1048fs, F1037fs	not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000845753	11	76893502	11	77182457	845753	839059		NC_000011.10:77182456:TT:T
NM_000260.4(MYO7A):c.3957dup (p.Met1320fs)	MYO7A		not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000844516	11	76903127 - 76903128	11	77192082 - 77192083	844516	839064		NC_000011.10:77192082:C:CC
NM_000260.4(MYO7A):c.2019del (p.Ile674fs)	MYO7A	I674fs, I663fs	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000839872	11	76885882	11	77174836	839872	839043		NC_000011.10:77174835:CCCC:CCC
NM_000260.4(MYO7A):c.397del (p.His133fs)	MYO7A	H133fs, H122fs	not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000835296	11	76867058	11	77156012	835296	839029		NC_000011.10:77156011:CCCCCCC:CCCCCC
NM_000260.4(MYO7A):c.385G>T (p.Glu129Ter)	MYO7A	E118*, E129*	not provided	Pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000834391	11	76867052	11	77156006	834391	839028		NC_000011.10:77156005:G:T
NC_000011.9:g.(?_76877092)_(76888699_?)del	MYO7A		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000653517	11	76877092 - 76888699	11	77166046 - 77177653	653517	652062		
NM_000260.4(MYO7A):c.6196del (p.Gln2066fs)	MYO7A	Q2017fs, Q2028fs, Q2066fs	not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000649487	11	76922338	11	77211293	649487	640468		NC_000011.10:77211292:CCCC:CCC
NM_000260.4(MYO7A):c.4248C>A (p.Tyr1416Ter)	MYO7A	Y1416*, Y1405*	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000643819	11	76905494	11	77194449	643819	640465		NC_000011.10:77194448:C:A
NM_000260.4(MYO7A):c.6044_6047dup (p.Tyr2016Ter)	MYO7A		not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000639321	11	76919840 - 76919841	11	77208795 - 77208796	639321	640467		NC_000011.10:77208795:ATTA:ATTAATTA
NM_000260.4(MYO7A):c.565_566del (p.Val189fs)	MYO7A	V178fs, V189fs	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000397509	11	76867800 - 76867801	11	77156754 - 77156755	397509	384410	rs1060499651	NC_000011.10:77156753:GT:
NM_000260.4(MYO7A):c.5845_5855del (p.Ile1949fs)	MYO7A	I1911fs, I1949fs, I1900fs	Rare genetic deafness	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000228380	11	76918436 - 76918446	11	77207389 - 77207399	228380	230248	rs876657713	NC_000011.10:77207388:AAATTGCAGACAA:AA
NM_000260.4(MYO7A):c.4555del (p.Val1519fs)	MYO7A	V1508fs, V1519fs	Rare genetic deafness	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000228379	11	76909653	11	77198608	228379	230242	rs876657712	NC_000011.10:77198607:G:
NM_000260.4(MYO7A):c.6231dup (p.Lys2078fs)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	VCV000179745	11	76922374 - 76922375	11	77211329 - 77211330	179745	175237	rs730880367	NC_000011.10:77211329:GG:GGG
NM_000260.4(MYO7A):c.3564_3571delinsA (p.Tyr1188_Gly1191delinsTer)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: May 13, 2013)	criteria provided, single submitter	VCV000179061	11	76900449 - 76900456	11	77189404 - 77189411	179061	178260	rs797044513	NC_000011.10:77189403:TGCCCGGG:A
NM_000260.4(MYO7A):c.973_976del (p.Ile325fs)	MYO7A	I314fs, I325fs	Rare genetic deafness	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000164663	11	76869444 - 76869447	11	77158398 - 77158401	164663	176879	rs797044490	NC_000011.10:77158397:CCATCC:CC
NM_000260.4(MYO7A):c.6498C>A (p.Tyr2166Ter)	MYO7A	Y2166*, Y2126*, Y2117*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 21, 2011)	criteria provided, single submitter	VCV000043330	11	76924964	11	77213919	43330	52500	rs397516331	NC_000011.10:77213918:C:A
NM_000260.4(MYO7A):c.582del (p.Ile195fs)	MYO7A	I184fs, I195fs	Rare genetic deafness	Pathogenic(Last reviewed: Jan 16, 2012)	criteria provided, single submitter	VCV000043301	11	76867813	11	77156767	43301	52471	rs111033238	NC_000011.10:77156766:CCCCC:CCCC
NM_000260.4(MYO7A):c.5581dup (p.Arg1861fs)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Mar 11, 2010)	criteria provided, single submitter	VCV000043289	11	76916604 - 76916605	11	77205559 - 77205560	43289	52459	rs397516320	NC_000011.10:77205559:CCC:CCCC
NM_000260.4(MYO7A):c.3728dup (p.Pro1244fs)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Aug 13, 2010)	criteria provided, single submitter	VCV000043219	11	76901160 - 76901161	11	77190115 - 77190116	43219	52389	rs397516304	NC_000011.10:77190115:CC:CCC
NM_000260.4(MYO7A):c.3696_3706del (p.Arg1232fs)	MYO7A	R1221fs, R1232fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 23, 2010)	criteria provided, single submitter	VCV000043217	11	76901130 - 76901140	11	77190084 - 77190094	43217	52387	rs397516303	NC_000011.10:77190083:GAAGGACCTTTG:G
NM_000260.4(MYO7A):c.3327del (p.His1109fs)	MYO7A	H1098fs, H1109fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 7, 2010)	criteria provided, single submitter	VCV000043202	11	76894154	11	77183109	43202	52372	rs111033433	NC_000011.10:77183108:C:
NM_000260.4(MYO7A):c.2094+1G>A	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Dec 23, 2010)	criteria provided, single submitter	VCV000043171	11	76885961	11	77174915	43171	52341	rs111033404	NC_000011.10:77174914:G:A
NM_000260.3(MYO7A):c.1556delG (p.Gly519Alafs)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Apr 8, 2010)	criteria provided, single submitter	VCV000043152	11	76873898	11	77162852	43152	52322	rs606231379	NC_000011.10:77162851:GGG:GG
NM_000260.4(MYO7A):c.141G>A (p.Trp47Ter)	MYO7A	W47*, W36*	Rare genetic deafness	Pathogenic(Last reviewed: May 14, 2012)	criteria provided, single submitter	VCV000043146	11	76858852	11	77147806	43146	52316	rs397516285	NC_000011.10:77147805:G:A
NM_000260.4(MYO7A):c.1184G>A (p.Arg395His)	MYO7A	R395H, R384H	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000029926	11	76871312	11	77160266	29926	38881	rs387906700	NC_000011.10:77160265:G:A
NM_000260.4(MYO7A):c.5143_5145GAG[1] (p.Glu1716del)	MYO7A	E1716del	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011864	11	76913443 - 76913445	11	77202398 - 77202400	11864	26903	rs1555102843	NC_000011.10:77202397:GGAGGAG:GGAG
MYO7A, IVS27AS, G-C, -1	MYO7A		Usher syndrome, type 1B	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000011861					11861	26900		
NM_000260.4(MYO7A):c.1884C>A (p.Cys628Ter)	MYO7A	C628*, C617*	Usher syndrome, type 1B	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000011858	11	76883880	11	77172834	11858	26897	rs121965083	NC_000011.10:77172833:C:A
MYO7A, 1-BP INS, EX28	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000011855					11855	26894		
NM_000260.4(MYO7A):c.652_657del (p.Asp218_Ile219del)	MYO7A		Usher syndrome, type 1B	Pathogenic(Last reviewed: Oct 10, 1995)	no assertion criteria provided	VCV000011849	11	76867962 - 76867967	11	77156916 - 77156921	11849	26888	rs1555062984	NC_000011.10:77156915:ACATCGACATC:ACATC
NM_000260.4(MYO7A):c.5785C>T (p.Gln1929Ter)	MYO7A	Q1880*, Q1891*, Q1929*	not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000864590	11	76918376	11	77207331	864590	839081		NC_000011.10:77207330:C:T
NM_000260.4(MYO7A):c.2914C>T (p.Arg972Ter)	MYO7A	R972*, R961*	not provided	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000855092	11	76893006	11	77181960	855092	839057		NC_000011.10:77181959:C:T
NM_000260.4(MYO7A):c.2116C>T (p.Gln706Ter)	MYO7A	Q695*, Q706*	not provided	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000834808	11	76886439	11	77175393	834808	839044		NC_000011.10:77175392:C:T
NC_000011.10:g.(?_77208430)_(77211937_?)del	MYO7A		not provided	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000831981	11	76919475 - 76922982			831981	820417		
NM_000260.4(MYO7A):c.5944G>A (p.Gly1982Arg)	MYO7A	G1982R, G1933R, G1944R	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Nov 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000500416	11	76919562	11	77208517	500416	491840	rs761469964	NC_000011.10:77208516:G:A
NM_000260.4(MYO7A):c.1563del (p.Asp521fs)	MYO7A	D521fs, D510fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419644	11	76873907	11	77162861	419644	408478	rs1064794012	NC_000011.10:77162860:C:
NC_000011.9:g.(?_76923997)_(76925741_?)del	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Sep 22, 2013)	criteria provided, single submitter	VCV000179327	11	76923997 - 76925741	11	77212952 - 77214696	179327	174722		
NM_000260.4(MYO7A):c.496del (p.Glu166fs)	MYO7A	E166fs, E155fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 7, 2010)	criteria provided, single submitter	VCV000043266	11	76867730	11	77156684	43266	52436	rs111033448	NC_000011.10:77156683:GG:G
NM_000260.4(MYO7A):c.2172del (p.Lys725fs)	MYO7A	K714fs, K725fs	Rare genetic deafness	Pathogenic(Last reviewed: May 19, 2010)	criteria provided, single submitter	VCV000043174	11	76886494	11	77175448	43174	52344	rs397516294	NC_000011.10:77175447:CC:C
NM_000260.4(MYO7A):c.1373A>T (p.Asn458Ile)	MYO7A	N458I, N447I	Deafness, autosomal dominant 11	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011863	11	76873195	11	77162149	11863	26902	rs121965084	NC_000011.10:77162148:A:T
MYO7A, 9-BP DEL, EX22	MYO7A		Deafness, autosomal dominant 11	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011857					11857	26896		
NM_000260.4(MYO7A):c.731G>C (p.Arg244Pro)	MYO7A	R244P, R233P	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011853	11	76868046	11	77157000	11853	26892	rs121965081	NC_000011.10:77156999:G:C
NM_000260.4(MYO7A):c.5069_5070insC (p.Gln1690fs)	MYO7A			Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812351	11	76913370 - 76913371	11	77202325 - 77202326	812351	800573		NC_000011.10:77202325::C
NM_000260.4(MYO7A):c.2187+1G>T	MYO7A			Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812350	11	76886511	11	77175465	812350	800695		NC_000011.10:77175464:G:T
NM_000260.4(MYO7A):c.1134_1146dup (p.Ser383fs)	MYO7A			Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812349	11	76871260 - 76871261	11	77160214 - 77160215	812349	800572		NC_000011.10:77160214:GCGGGGAGACGGTG:GCGGGGAGACGGTGCGGGGAGACGGTG
NM_000260.4(MYO7A):c.5215C>T (p.Arg1739Ter)	MYO7A	R1690*, R1739*, R1701*	not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000658273	11	76914151	11	77203106	658273	640466		NC_000011.10:77203105:C:T
NM_000260.4(MYO7A):c.1952T>C (p.Leu651Pro)	MYO7A	L651P, L640P		Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226432	11	76885818	11	77174772	226432	228234	rs876657416	NC_000011.10:77174771:T:C
NM_000260.4(MYO7A):c.999T>A (p.Tyr333Ter)	MYO7A	Y322*, Y333*	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000864525	11	76869472	11	77158426	864525	839033		NC_000011.10:77158425:T:A
NM_000260.4(MYO7A):c.4354C>T (p.Gln1452Ter)	MYO7A	Q1452*, Q1441*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000852300	11	76908556	11	77197511	852300	839066		NC_000011.10:77197510:C:T
NM_000260.4(MYO7A):c.3872_3873TC[3] (p.Leu1293fs)	MYO7A			Pathogenic	criteria provided, single submitter	VCV000813431	11	76901863 - 76901864	11	77190818 - 77190819	813431	801715		NC_000011.10:77190817:TCTCTCTC:TCTCTC
NM_000260.4(MYO7A):c.4996_4997del (p.Ser1666fs)	MYO7A	S1617fs, S1628fs, S1666fs		Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812101	11	76912636 - 76912637	11	77201591 - 77201592	812101	800360		NC_000011.10:77201590:AG:
NM_000260.4(MYO7A):c.5886_5889del (p.Phe1962fs)	MYO7A	F1913fs, F1924fs, F1962fs	|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000553558	11	76919502 - 76919505	11	77208457 - 77208460	553558	546856	rs1397834886	NC_000011.10:77208456:TTCTTT:TT
NM_000260.4(MYO7A):c.3587_3588CT[2] (p.Cys1198fs)	MYO7A		Rare genetic deafness|not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000228378	11	76900471 - 76900472	11	77189426 - 77189427	228378	231388	rs1555090368	NC_000011.10:77189425:TCTCTCT:TCTCT
NM_000260.4(MYO7A):c.2115C>A (p.Cys705Ter)	MYO7A	C705*, C694*	Deafness, autosomal recessive 2|Rare genetic deafness	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000228377	11	76886438	11	77175392	228377	231387	rs782255281	NC_000011.10:77175391:C:A
NP_000251.3(MYO7A):p.Tyr1302fsTer97	MYO7A			Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226435					226435	228238		
NM_000260.4(MYO7A):c.2311G>T (p.Ala771Ser)	MYO7A	A771S, A760S		Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226433	11	76890119	11	77179073	226433	228235	rs782384464	NC_000011.10:77179072:G:T
NM_000260.4(MYO7A):c.223del (p.Asp75fs)	MYO7A	D64fs, D75fs		Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226431	11	76858930	11	77147884	226431	228233	rs876657415	NC_000011.10:77147883:GGGGG:GGGG
NM_000260.4(MYO7A):c.1845del (p.Lys615fs)	MYO7A	K615fs, K604fs		Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000218192	11	76883841	11	77172795	218192	214846	rs886037762	NC_000011.10:77172794:G:
NM_000260.4(MYO7A):c.4544_4551delinsCA (p.Glu1515_Met1517delinsAla)	MYO7A		Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000043245	11	76909642 - 76909649	11	77198597 - 77198604	43245	52415	rs111033259	NC_000011.10:77198596:AGATCATG:CA
NM_000260.4(MYO7A):c.4293G>A (p.Trp1431Ter)	MYO7A	W1431*, W1420*	Retinal dystrophy|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043236	11	76905539	11	77194494	43236	52406	rs397516308	NC_000011.10:77194493:G:A
NM_000260.4(MYO7A):c.1963C>T (p.Gln655Ter)	MYO7A	Q655*, Q644*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043167	11	76885829	11	77174783	43167	52337	rs397516291	NC_000011.10:77174782:C:T
NC_000010.11:g.(?_86875868)_(86876095_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000832863	10	88635625 - 88635852			832863	820256		
NC_000010.10:g.(?_88635766)_(88683486_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000649055	10	88635766 - 88683486	10	86876009 - 86923729	649055	652285		
NM_004329.2(BMPR1A):c.674del (p.Leu225fs)	BMPR1A	L225fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000572096	10	88672139	10	86912382	572096	569798	rs1564722014	NC_000010.11:86912381:TT:T
NM_004329.2(BMPR1A):c.1221C>G (p.Tyr407Ter)	BMPR1A	Y407*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429103	10	88681331	10	86921574	429103	421060	rs1131691181	NC_000010.11:86921573:C:G
NM_017780.4(CHD7):c.2389dup (p.Ala797fs)	CHD7		not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000818066	8	61714098 - 61714099	8	60801539 - 60801540	818066	805582		NC_000008.11:60801539:G:GG
NM_017780.4(CHD7):c.3357_3360del (p.Glu1119fs)	CHD7	E1119fs	not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000818003	8	61736551 - 61736554	8	60823992 - 60823995	818003	805584		NC_000008.11:60823991:GGAGGGA:GGA
NM_017780.4(CHD7):c.2349del (p.Ser784fs)	CHD7	S784fs	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000817911	8	61713053	8	60800494	817911	805581		NC_000008.11:60800493:CCCCC:CCCC
NM_017780.4(CHD7):c.2846del (p.Pro949fs)	CHD7	P949fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000817735	8	61734592	8	60822033	817735	805583		NC_000008.11:60822032:CC:C
NM_017780.4(CHD7):c.6018dup (p.Ser2007fs)	CHD7		not provided	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000817591	8	61765174 - 61765175	8	60852615 - 60852616	817591	805585		NC_000008.11:60852615:AAAAAA:AAAAAAA
NM_017780.4(CHD7):c.2171del (p.Asn724fs)	CHD7	N724fs	not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000817400	8	61707616	8	60795057	817400	805580		NC_000008.11:60795056:AAAA:AAA
NM_017780.4(CHD7):c.559C>T (p.Gln187Ter)	CHD7	Q187*	not specified	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000811739	8	61654550	8	60741991	811739	799556		NC_000008.11:60741990:C:T
NM_017780.4(CHD7):c.7803C>A (p.Tyr2601Ter)	CHD7	Y2601*	not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000620425	8	61773657	8	60861098	620425	611705	rs1563669432	NC_000008.11:60861097:C:A
NM_017780.4(CHD7):c.6454C>T (p.Gln2152Ter)	CHD7	Q2152*	not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000620332	8	61765738	8	60853179	620332	611704	rs373241264	NC_000008.11:60853178:C:T
NM_017780.4(CHD7):c.511C>T (p.Gln171Ter)	CHD7	Q171*	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000620120	8	61654502	8	60741943	620120	611702	rs1563560018	NC_000008.11:60741942:C:T
NM_017780.4(CHD7):c.538C>T (p.Gln180Ter)	CHD7	Q180*	not provided	Pathogenic(Last reviewed: Apr 22, 2018)	criteria provided, single submitter	VCV000618017	8	61654529	8	60741970	618017	609700	rs1563560149	NC_000008.11:60741969:C:T
NM_017780.4(CHD7):c.6989del (p.Gly2330fs)	CHD7	G2330fs	not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000618016	8	61768585	8	60856026	618016	609701	rs1563664199	NC_000008.11:60856025:GG:G
NM_017780.4(CHD7):c.5971C>T (p.Gln1991Ter)	CHD7	Q1991*	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000593811	8	61765133	8	60852574	593811	584874	rs1563659730	NC_000008.11:60852573:C:T
NM_017780.4(CHD7):c.4793C>G (p.Ser1598Ter)	CHD7	S1598*	not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000593209	8	61754554	8	60841995	593209	584273	rs1563649180	NC_000008.11:60841994:C:G
NM_017780.4(CHD7):c.917_921del (p.Asn306fs)	CHD7	N306fs	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000589448	8	61654906 - 61654910	8	60742347 - 60742351	589448	579618	rs1563560966	NC_000008.11:60742346:CAACTCA:CA
NM_017780.4(CHD7):c.364C>T (p.Gln122Ter)	CHD7	Q122*	not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000504189	8	61654355	8	60741796	504189	495611	rs1554581127	NC_000008.11:60741795:C:T
NM_017780.4(CHD7):c.2413dup (p.Ile805fs)	CHD7		not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000504140	8	61714117 - 61714118	8	60801558 - 60801559	504140	495233	rs1554593023	NC_000008.11:60801558:AAAAAA:AAAAAAA
NM_017780.4(CHD7):c.2178_2179insCTAA (p.Asp728fs)	CHD7		not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000503878	8	61707626 - 61707627	8	60795067 - 60795068	503878	495370	rs1554591634	NC_000008.11:60795067::CTAA
NM_017780.4(CHD7):c.5044del (p.His1682fs)	CHD7	H1682fs	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000503855	8	61757615	8	60845056	503855	495389	rs1554602459	NC_000008.11:60845055:CC:C
NM_017780.4(CHD7):c.7524del (p.Pro2508_Met2509insTer)	CHD7		not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000503745	8	61769361	8	60856802	503745	495392	rs1554605128	NC_000008.11:60856801:CCC:CC
NM_017780.4(CHD7):c.5050+1G>A	CHD7		not provided	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000503614	8	61757623	8	60845064	503614	495377	rs1554602466	NC_000008.11:60845063:G:A
NM_017780.4(CHD7):c.3859C>T (p.Gln1287Ter)	CHD7	Q1287*	not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000489257	8	61748712	8	60836153	489257	481821	rs1554600522	NC_000008.11:60836152:C:T
NM_017780.4(CHD7):c.2114C>G (p.Ser705Ter)	CHD7	S705*	not provided	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000489047	8	61707562	8	60795003	489047	481820	rs1554591598	NC_000008.11:60795002:C:G
NM_017780.4(CHD7):c.5968C>T (p.Gln1990Ter)	CHD7	Q1990*	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000488680	8	61765130	8	60852571	488680	481822	rs1554603970	NC_000008.11:60852570:C:T
NM_017780.4(CHD7):c.2086A>T (p.Lys696Ter)	CHD7	K696*	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000451591	8	61693979	8	60781420	451591	444292	rs1554588769	NC_000008.11:60781419:A:T
NM_017780.4(CHD7):c.760C>T (p.Gln254Ter)	CHD7	Q254*	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000450263	8	61654751	8	60742192	450263	444291	rs1554581354	NC_000008.11:60742191:C:T
NM_017780.4(CHD7):c.3302G>A (p.Cys1101Tyr)	CHD7	C1101Y	not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000449371	8	61736499	8	60823940	449371	444293	rs1554598013	NC_000008.11:60823939:G:A
NM_017780.4(CHD7):c.4112T>G (p.Leu1371Ter)	CHD7	L1371*	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000432973	8	61749498	8	60836939	432973	425800	rs1554600633	NC_000008.11:60836938:T:G
NM_017780.4(CHD7):c.5960del (p.Pro1987fs)	CHD7	P1987fs	not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000432380	8	61765120	8	60852561	432380	425801	rs1554603963	NC_000008.11:60852560:CCC:CC
NM_017780.4(CHD7):c.3130del (p.Val1044fs)	CHD7	V1044fs	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000430304	8	61735233	8	60822674	430304	421683	rs1131691892	NC_000008.11:60822673:GG:G
NM_017780.4(CHD7):c.310C>T (p.Gln104Ter)	CHD7	Q104*	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000430014	8	61654301	8	60741742	430014	421682	rs1131691733	NC_000008.11:60741741:C:T
NM_017780.4(CHD7):c.1797del (p.Lys601fs)	CHD7	K601fs	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000426844	8	61693690	8	60781131	426844	415140	rs1085307830	NC_000008.11:60781130:G:
NM_017780.4(CHD7):c.2442+1G>T	CHD7		not provided	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000426350	8	61714153	8	60801594	426350	415141	rs1085307582	NC_000008.11:60801593:G:T
NM_017780.4(CHD7):c.6994dup (p.Trp2332fs)	CHD7		not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000423496	8	61768590 - 61768591	8	60856031 - 60856032	423496	407431	rs1554604772	NC_000008.11:60856031:T:TT
NM_017780.4(CHD7):c.4507G>T (p.Glu1503Ter)	CHD7	E1503*	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000420034	8	61750788	8	60838229	420034	407421	rs1064794248	NC_000008.11:60838228:G:T
NM_017780.4(CHD7):c.3905_3906dup (p.Lys1303Ter)	CHD7		not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000419812	8	61748757 - 61748758	8	60836198 - 60836199	419812	407418	rs1554600530	NC_000008.11:60836198:TG:TGTG
NM_017780.4(CHD7):c.2052del (p.Ala685fs)	CHD7	A685fs	not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000419683	8	61693943	8	60781384	419683	407406	rs1064794040	NC_000008.11:60781383:AAA:AA
NM_017780.4(CHD7):c.961_962delinsTA (p.Gly321Ter)	CHD7		not provided	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000419621	8	61654952 - 61654953	8	60742393 - 60742394	419621	407402	rs1064793996	NC_000008.11:60742392:GG:TA
NM_017780.4(CHD7):c.961G>T (p.Gly321Ter)	CHD7	G321*	not provided	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000419619	8	61654952	8	60742393	419619	407401	rs1064793994	NC_000008.11:60742392:G:T
NM_017780.4(CHD7):c.7297del (p.Val2433fs)	CHD7	V2433fs	not provided	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000419586	8	61769135	8	60856576	419586	407433	rs1064793972	NC_000008.11:60856575:GG:G
NM_017780.4(CHD7):c.4407T>G (p.Tyr1469Ter)	CHD7	Y1469*	not provided	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000419570	8	61750688	8	60838129	419570	407420	rs1064793962	NC_000008.11:60838128:T:G
NM_017780.4(CHD7):c.207del (p.Phe69fs)	CHD7	F69fs	not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	VCV000419492	8	61654195	8	60741636	419492	407398	rs1064793909	NC_000008.11:60741635:TTTT:TTT
NM_017780.4(CHD7):c.7647dup (p.Glu2550fs)	CHD7		not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419372	8	61773500 - 61773501	8	60860941 - 60860942	419372	407436	rs1554605972	NC_000008.11:60860941:A:AA
NM_017780.4(CHD7):c.7629del (p.Ala2544fs)	CHD7	A2544fs	not provided	Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	VCV000419284	8	61773481	8	60860922	419284	407435	rs1064793769	NC_000008.11:60860921:AAA:AA
NM_017780.4(CHD7):c.8518del (p.Thr2840fs)	CHD7	T2840fs, T791fs	not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000419129	8	61778016	8	60865457	419129	407438	rs1064793664	NC_000008.11:60865456:A:
NM_017780.4(CHD7):c.3807del (p.Phe1269fs)	CHD7	F1269fs	not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000418832	8	61748658	8	60836099	418832	407417	rs1064793463	NC_000008.11:60836098:TTT:TT
NM_017780.4(CHD7):c.2383_2384del (p.Ser794_Val795insTer)	CHD7		not provided	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000418785	8	61714092 - 61714093	8	60801533 - 60801534	418785	407409	rs1064793432	NC_000008.11:60801532:TGT:T
NM_017780.4(CHD7):c.4609A>T (p.Lys1537Ter)	CHD7	K1537*	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000392465	8	61754278	8	60841719	392465	369989	rs1057524501	NC_000008.11:60841718:A:T
NM_017780.4(CHD7):c.1170T>G (p.Tyr390Ter)	CHD7	Y390*	not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000379836	8	61655161	8	60742602	379836	371928	rs554737227	NC_000008.11:60742601:T:G
NM_017780.4(CHD7):c.1123C>T (p.Gln375Ter)	CHD7	Q375*	not provided	Pathogenic(Last reviewed: May 12, 2015)	criteria provided, single submitter	VCV000379790	8	61655114	8	60742555	379790	369983	rs1057520734	NC_000008.11:60742554:C:T
NM_017780.4(CHD7):c.6175G>T (p.Glu2059Ter)	CHD7	E2059*	not provided	Pathogenic(Last reviewed: May 13, 2015)	criteria provided, single submitter	VCV000379722	8	61765459	8	60852900	379722	369542	rs1057520712	NC_000008.11:60852899:G:T
NM_017780.4(CHD7):c.1281T>A (p.Tyr427Ter)	CHD7	Y427*	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000379337	8	61655272	8	60742713	379337	370292	rs373942842	NC_000008.11:60742712:T:A
NM_017780.4(CHD7):c.5177_5190delinsT (p.Ser1726fs)	CHD7		not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000373731	8	61757935 - 61757948	8	60845376 - 60845389	373731	359895	rs1057518576	NC_000008.11:60845375:GCTACAAGAAACAC:T
NM_017780.4(CHD7):c.7655dup (p.Pro2553fs)	CHD7		not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000372739	8	61773505 - 61773506	8	60860946 - 60860947	372739	359876	rs1057517957	NC_000008.11:60860946:CCCC:CCCCC
NM_017780.4(CHD7):c.6757G>T (p.Glu2253Ter)	CHD7	E2253*	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000372738	8	61766041	8	60853482	372738	359865	rs1057517956	NC_000008.11:60853481:G:T
NM_017780.4(CHD7):c.5315G>A (p.Trp1772Ter)	CHD7	W1772*	not provided	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000372320	8	61761624	8	60849065	372320	359741	rs1057517713	NC_000008.11:60849064:G:A
NM_017780.4(CHD7):c.380del (p.Pro127fs)	CHD7	P127fs	not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000288585	8	61654369	8	60741810	288585	272822	rs886043945	NC_000008.11:60741809:CCC:CC
NM_017780.4(CHD7):c.2848del (p.Ala950fs)	CHD7	A950fs	not provided	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000287868	8	61734595	8	60822036	287868	272105	rs886043750	NC_000008.11:60822035:G:
NM_017780.4(CHD7):c.7641_7651del (p.Glu2547fs)	CHD7	E2547fs	not provided	Pathogenic(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	VCV000282110	8	61773492 - 61773502	8	60860933 - 60860943	282110	266347	rs886042312	NC_000008.11:60860932:AGAAGATATAGAGA:AGA
NM_017780.4(CHD7):c.6781del (p.Ala2261fs)	CHD7	A2261fs	not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280921	8	61766927	8	60854368	280921	264400	rs886042039	NC_000008.11:60854367:G:
NM_017780.4(CHD7):c.6105del (p.Glu2035fs)	CHD7	E2035fs	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000280905	8	61765388	8	60852829	280905	264371	rs886042024	NC_000008.11:60852828:AA:A
NM_017780.4(CHD7):c.8062dup (p.Ile2688fs)	CHD7		not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000280789	8	61775196 - 61775197	8	60862637 - 60862638	280789	264433	rs886041933	NC_000008.11:60862637:A:AA
NM_017780.4(CHD7):c.7820del (p.Ser2607fs)	CHD7	S2607fs	not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000280640	8	61773674	8	60861115	280640	264431	rs886041808	NC_000008.11:60861114:G:
NM_017780.4(CHD7):c.4961del (p.Tyr1654fs)	CHD7	Y1654fs	not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000280542	8	61757533	8	60844974	280542	264366	rs886041729	NC_000008.11:60844973:A:
NM_017780.4(CHD7):c.6243C>A (p.Cys2081Ter)	CHD7	C2081*	not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000280354	8	61765527	8	60852968	280354	264427	rs886041575	NC_000008.11:60852967:C:A
NM_017780.4(CHD7):c.6754del (p.Glu2252fs)	CHD7	E2252fs	not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000279763	8	61766037	8	60853478	279763	264429	rs886041170	NC_000008.11:60853477:GG:G
NM_017780.4(CHD7):c.5029C>T (p.Arg1677Ter)	CHD7	R1677*	not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000279762	8	61757601	8	60845042	279762	264397	rs777652245	NC_000008.11:60845041:C:T
NM_017780.4(CHD7):c.4189C>T (p.Gln1397Ter)	CHD7	Q1397*	not provided	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000279761	8	61750230	8	60837671	279761	264283	rs886041169	NC_000008.11:60837670:C:T
NM_017780.4(CHD7):c.3089A>G (p.Asn1030Ser)	CHD7	N1030S	not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000279758	8	61735193	8	60822634	279758	264281	rs886041167	NC_000008.11:60822633:A:G
NM_017780.4(CHD7):c.434G>A (p.Trp145Ter)	CHD7	W145*	not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000279753	8	61654425	8	60741866	279753	264364	rs886041163	NC_000008.11:60741865:G:A
NM_017780.4(CHD7):c.6613C>T (p.Gln2205Ter)	CHD7	Q2205*	not provided	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000265638	8	61765897	8	60853338	265638	259904	rs886039688	NC_000008.11:60853337:C:T
NM_017780.4(CHD7):c.7840del (p.Asp2614fs)	CHD7	D2614fs	not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000265574	8	61774764	8	60862205	265574	259905	rs886039636	NC_000008.11:60862204:G:
NM_017780.4(CHD7):c.6165_6166del (p.Tyr2056fs)	CHD7	Y2056fs	not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000265405	8	61765448 - 61765449	8	60852889 - 60852890	265405	259903	rs886039528	NC_000008.11:60852888:TGT:T
NM_017780.4(CHD7):c.1714C>T (p.Gln572Ter)	CHD7	Q572*	not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000265404	8	61693607	8	60781048	265404	259902	rs886039527	NC_000008.11:60781047:C:T
NM_017780.4(CHD7):c.550C>T (p.Gln184Ter)	CHD7	Q184*	not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000265403	8	61654541	8	60741982	265403	259901	rs886039526	NC_000008.11:60741981:C:T
NM_017780.4(CHD7):c.151C>T (p.Gln51Ter)	CHD7	Q51*	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000265398	8	61654142	8	60741583	265398	259900	rs886039523	NC_000008.11:60741582:C:T
NM_017780.4(CHD7):c.8453_8463dup (p.Ala2822fs)	CHD7		not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000197040	8	61777949 - 61777950	8	60865390 - 60865391	197040	194201	rs797044725	NC_000008.11:60865390:AACCCTCTGTCA:AACCCTCTGTCAACCCTCTGTCA
NM_017780.4(CHD7):c.6529G>T (p.Glu2177Ter)	CHD7	E2177*	not provided	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000196707	8	61765813	8	60853254	196707	193868	rs750047137	NC_000008.11:60853253:G:T
NM_017780.4(CHD7):c.1224_1234del (p.Pro409fs)	CHD7	P409fs	not provided	Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	VCV000195329	8	61655212 - 61655222	8	60742653 - 60742663	195329	192490	rs794727295	NC_000008.11:60742652:CACTCCTCCTCCAC:CAC
NM_017780.4(CHD7):c.7145dup (p.Ser2383fs)	CHD7		not provided	Pathogenic(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	VCV000166873	8	61768741 - 61768742	8	60856182 - 60856183	166873	177598	rs786200969	NC_000008.11:60856182:C:CC
NM_017780.4(CHD7):c.2933G>A (p.Trp978Ter)	CHD7	W978*	not provided	Pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	VCV000166862	8	61734680	8	60822121	166862	177590	rs727503863	NC_000008.11:60822120:G:A
NM_017780.4(CHD7):c.1369C>T (p.Gln457Ter)	CHD7	Q457*	not provided	Pathogenic(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	VCV000166858	8	61655360	8	60742801	166858	177254	rs727503861	NC_000008.11:60742800:C:T
NM_017780.4(CHD7):c.1090C>T (p.Gln364Ter)	CHD7	Q364*	not provided	Pathogenic(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	VCV000166857	8	61655081	8	60742522	166857	176991	rs727503860	NC_000008.11:60742521:C:T
NM_017780.4(CHD7):c.5895-1G>C	CHD7		not provided	Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	VCV000095797	8	61765056	8	60852497	95797	101694	rs398124322	NC_000008.11:60852496:G:C
NM_017780.4(CHD7):c.5181C>G (p.Tyr1727Ter)	CHD7	Y1727*	not provided	Pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	VCV000095793	8	61757939	8	60845380	95793	101690	rs398124320	NC_000008.11:60845379:C:G
NM_017780.4(CHD7):c.2740G>T (p.Glu914Ter)	CHD7	E914*	not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000804691	8	61734391	8	60821832	804691	793283		NC_000008.11:60821831:G:T
NM_017780.4(CHD7):c.4015C>T (p.Arg1339Ter)	CHD7	R1339*	not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000592245	8	61749401	8	60836842	592245	583283	rs1563644066	NC_000008.11:60836841:C:T
NM_017780.4(CHD7):c.6892C>T (p.Gln2298Ter)	CHD7	Q2298*	Progressive hearing impairment|Myopia (disease)|Hypothyroidism|Dolichocephaly|Poor coordination|Scoliosis	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000374090	8	61767038	8	60854479	374090	360900	rs1057518891	NC_000008.11:60854478:C:T
NM_017780.4(CHD7):c.8006dup (p.Pro2670fs)	CHD7			Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV000818212	8	61775140 - 61775141	8	60862581 - 60862582	818212	806423		NC_000008.11:60862581:T:TT
NM_017780.4(CHD7):c.1513C>T (p.Gln505Ter)	CHD7	Q505*	Hearing impairment|Chorioretinal coloboma|Pulmonary artery atresia|Retinal coloboma	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523521	8	61655504	8	60742945	523521	513977	rs1554581757	NC_000008.11:60742944:C:T
NM_017780.4(CHD7):c.8456_8457CT[1] (p.Leu2820fs)	CHD7			Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000267364	8	61777954 - 61777955	8	60865395 - 60865396	267364	262560	rs886040962	NC_000008.11:60865394:CTCT:CT
NM_017780.4(CHD7):c.1465C>T (p.Gln489Ter)	CHD7	Q489*	not provided	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000195334	8	61655456	8	60742897	195334	192495	rs794727298	NC_000008.11:60742896:C:T
NM_017780.4(CHD7):c.164A>G (p.His55Arg)	CHD7	H55R		Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002036	8	61654155	8	60741596	2036	17075	rs121434345	NC_000008.11:60741595:A:G
NM_017780.4(CHD7):c.2613+5G>A	CHD7			Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002035	8	61729065	8	60816506	2035	17074	rs202143667	NC_000008.11:60816505:G:A
NM_001287174.2(ABCC8):c.221G>A (p.Arg74Gln)	ABCC8	R74Q	not provided|Leucine-induced hypoglycemia|Permanent neonatal diabetes mellitus|Transient neonatal diabetes mellitus 2|Diabetes mellitus type 2|Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495834	11	17496502	11	17474955	495834	487507	rs72559734	NC_000011.10:17474954:C:T
NM_001287174.2(ABCC8):c.4163_4165del (p.Phe1388del)	ABCC8	F1388del, F1387del, F1409del, F1386del	Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196880	11	17417435 - 17417437	11	17395888 - 17395890	196880	194041	rs151344624	NC_000011.10:17395887:AGAAG:AG
NM_001287174.2(ABCC8):c.4480C>T (p.Arg1494Trp)	ABCC8	R1494W, R1493W, R1515W, R1492W	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009096	11	17415881	11	17394334	9096	24135	rs28936371	NC_000011.10:17394333:G:A
NM_000260.4(MYO7A):c.19-2A>G	MYO7A		|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000558668	11	76853753	11	77142707	558668	546382	rs1555051384	NC_000011.10:77142706:A:G
NM_000260.4(MYO7A):c.5632del (p.Ala1877_Leu1878insTer)	MYO7A		|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000556569	11	76916656	11	77205611	556569	546838	rs1299898646	NC_000011.10:77205610:CCC:CC
NM_000260.4(MYO7A):c.3594C>A (p.Cys1198Ter)	MYO7A	C1198*, C1187*	|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000555608	11	76900479	11	77189434	555608	546761	rs782694195	NC_000011.10:77189433:C:A
NM_000260.4(MYO7A):c.6321G>A (p.Trp2107Ter)	MYO7A	W2107*, W2069*, W2058*	|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000551885	11	76922949	11	77211904	551885	546870	rs773945008	NC_000011.10:77211903:G:A
NM_000260.4(MYO7A):c.2461C>T (p.Gln821Ter)	MYO7A	Q821*, Q810*	|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000550026	11	76890874	11	77179828	550026	546756	rs1279918132	NC_000011.10:77179827:C:T
NM_000260.4(MYO7A):c.285+2T>C	MYO7A		Rare genetic deafness|not provided|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489095	11	76858998	11	77147952	489095	482004	rs782292032	NC_000011.10:77147951:T:C
NM_000260.4(MYO7A):c.285+1G>C	MYO7A		Deafness, autosomal recessive 2||not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419493	11	76858997	11	77147951	419493	408476	rs782661097	NC_000011.10:77147950:G:C
NM_000260.4(MYO7A):c.1797G>A (p.Met599Ile)	MYO7A	M599I, M588I	Deafness, autosomal recessive 2|Usher syndrome, type 1B	Pathogenic(Last reviewed: Jun 15, 2001)	no assertion criteria provided	VCV000011856	11	76877208	11	77166162	11856	26895	rs121965082	NC_000011.10:77166161:G:A
NM_001277115.2(DNAH11):c.1648del (p.Arg550fs)	DNAH11	R550fs	not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000524059	7	21621576	7	21581958	524059	514556	rs1554314722	NC_000007.14:21581957:AA:A
NM_001277115.2(DNAH11):c.1426-2A>G	DNAH11		not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000419646	7	21611422	7	21571804	419646	407117	rs1064794014	NC_000007.14:21571803:A:G
NM_001277115.2(DNAH11):c.4818-2A>G	DNAH11		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000289323	7	21678555	7	21638937	289323	273560	rs886044152	NC_000007.14:21638936:A:G
NM_001277115.2(DNAH11):c.10219_10220CT[1] (p.Cys3408fs)	DNAH11		not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000283902	7	21847554 - 21847555	7	21807936 - 21807937	283902	268139	rs886042735	NC_000007.14:21807935:CTCT:CT
NM_001277115.2(DNAH11):c.9706C>T (p.Arg3236Ter)	DNAH11	R3236*	not provided	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000283798	7	21826350	7	21786732	283798	268035	rs753101269	NC_000007.14:21786731:C:T
NM_001277115.2(DNAH11):c.2974del (p.Thr992fs)	DNAH11	T992fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000847513	7	21639710	7	21600092	847513	833435		NC_000007.14:21600091:AA:A
NM_001277115.2(DNAH11):c.2569C>T (p.Arg857Ter)	DNAH11	R857*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000845439	7	21631097	7	21591479	845439	833431		NC_000007.14:21591478:C:T
NM_001277115.2(DNAH11):c.13008G>A (p.Trp4336Ter)	DNAH11	W4336*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000842993	7	21934576	7	21894958	842993	833490		NC_000007.14:21894957:G:A
NM_001277115.2(DNAH11):c.1358G>A (p.Trp453Ter)	DNAH11	W453*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000838553	7	21609850	7	21570232	838553	833426		NC_000007.14:21570231:G:A
NM_001277115.2(DNAH11):c.3595del (p.Leu1199fs)	DNAH11	L1199fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000837909	7	21641181	7	21601563	837909	833441		NC_000007.14:21601562:CCC:CC
NM_001277115.2(DNAH11):c.3220G>T (p.Glu1074Ter)	DNAH11	E1074*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000837408	7	21640513	7	21600895	837408	833439		NC_000007.14:21600894:G:T
NC_000007.14:g.(?_21681526)_(21745083_?)dup	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000831933	7	21721144 - 21784701			831933	819861		
NC_000007.14:g.(?_21655812)_(21656001_?)del	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000830896	7	21695430 - 21695619			830896	819860		
NM_001277115.2(DNAH11):c.1311T>A (p.Tyr437Ter)	DNAH11	Y437*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000663179	7	21609803	7	21570185	663179	635985		NC_000007.14:21570184:T:A
NM_001277115.2(DNAH11):c.3208G>T (p.Glu1070Ter)	DNAH11	E1070*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000654459	7	21640501	7	21600883	654459	635997		NC_000007.14:21600882:G:T
NM_001277115.2(DNAH11):c.8141C>G (p.Ser2714Ter)	DNAH11	S2714*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000653305	7	21781771	7	21742153	653305	636023		NC_000007.14:21742152:C:G
NM_001277115.2(DNAH11):c.13171C>T (p.Gln4391Ter)	DNAH11	Q4391*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000652933	7	21939606	7	21899988	652933	636047		NC_000007.14:21899987:C:T
NM_001277115.2(DNAH11):c.4950_4951del (p.Cys1651fs)	DNAH11	C1651fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000652424	7	21695455 - 21695456	7	21655837 - 21655838	652424	636007		NC_000007.14:21655836:AT:
NM_001277115.2(DNAH11):c.13240dup (p.Thr4414fs)	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000651667	7	21939668 - 21939669	7	21900050 - 21900051	651667	636048		NC_000007.14:21900050:AAAAAAA:AAAAAAAA
NM_001277115.2(DNAH11):c.12232A>T (p.Lys4078Ter)	DNAH11	K4078*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000642923	7	21920356	7	21880738	642923	636041		NC_000007.14:21880737:A:T
NM_001277115.2(DNAH11):c.2200_2240dup (p.Leu747delinsPhePheTer)	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000642434	7	21630564 - 21630565	7	21590946 - 21590947	642434	635989		NC_000007.14:21590946:TCTTTTGATGTTGAAGAAACAAGACATACCAGATTCAGCTTT:TCTTTTGATGTTGAAGAAACAAGACATACCAGATTCAGCTTTCTTTTGATGTTGAAGAAACAAGACATACCAGATTCAGCTTT
NC_000007.13:g.(?_21775238)_(21790002_?)del	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 11, 2018)	criteria provided, single submitter	VCV000584258	7	21775238 - 21790002	7	21735620 - 21750384	584258	563854		
NM_001277115.2(DNAH11):c.11288_11289dup (p.Ile3764fs)	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000582081	7	21901555 - 21901556	7	21861937 - 21861938	582081	561482	rs1562590250	NC_000007.14:21861937:GC:GCGC
NM_001277115.2(DNAH11):c.2559del (p.Glu854fs)	DNAH11	E854fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000577884	7	21631087	7	21591469	577884	561780	rs1562684798	NC_000007.14:21591468:A:
NM_001277115.2(DNAH11):c.3544C>T (p.Arg1182Ter)	DNAH11	R1182*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000577162	7	21641132	7	21601514	577162	561796	rs374107286	NC_000007.14:21601513:C:T
NM_001277115.2(DNAH11):c.8130_8131GA[1] (p.Arg2711fs)	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000576254	7	21781760 - 21781763	7	21742142 - 21742145	576254	561828	rs1562521048	NC_000007.14:21742141:GAGAGA:GA
NC_000007.13:g.(?_21932023)_(21934637_?)del	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000525586	7	21932023 - 21934637	7	21892405 - 21895019	525586	522634		
NC_000007.13:g.(?_21723382)_(21723582_?)del	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000525582	7	21723382 - 21723582	7	21683764 - 21683964	525582	522291		
NM_001277115.2(DNAH11):c.10048A>T (p.Arg3350Ter)	DNAH11	R3350*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000525307	7	21840776	7	21801158	525307	523212	rs1554282583	NC_000007.14:21801157:A:T
NM_001277115.2(DNAH11):c.12466del (p.Leu4156fs)	DNAH11	L4156fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000517449	7	21923987	7	21884369	517449	496925	rs1554292398	NC_000007.14:21884368:C:
NM_001277115.2(DNAH11):c.9288dup (p.Glu3097fs)	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000454719	7	21813563 - 21813564	7	21773945 - 21773946	454719	456577	rs771781357	NC_000007.14:21773945:AAAAAA:AAAAAAA
NM_001277115.2(DNAH11):c.7279C>T (p.Gln2427Ter)	DNAH11	Q2427*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000454703	7	21765441	7	21725823	454703	457208	rs202236144	NC_000007.14:21725822:C:T
NM_001277115.2(DNAH11):c.6265G>T (p.Glu2089Ter)	DNAH11	E2089*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000454695	7	21742412	7	21702794	454695	457206	rs1275718084	NC_000007.14:21702793:G:T
NM_001277115.2(DNAH11):c.6130C>T (p.Arg2044Ter)	DNAH11	R2044*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000454692	7	21737781	7	21698163	454692	456982	rs767595964	NC_000007.14:21698162:C:T
NM_001277115.2(DNAH11):c.5885_5922del (p.Val1962fs)	DNAH11	V1962fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000454689	7	21727103 - 21727140	7	21687485 - 21687522	454689	456975	rs1554269295	NC_000007.14:21687484:AAGTGAAAATGATTCATGATGCCATCAGAAACAGGAAGAAG:AAG
NM_001277115.2(DNAH11):c.5778+1G>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000454688	7	21726874	7	21687256	454688	456971	rs72657333	NC_000007.14:21687255:G:A
NM_001277115.2(DNAH11):c.546T>A (p.Cys182Ter)	DNAH11	C182*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000454685	7	21598470	7	21558852	454685	456944	rs1554309352	NC_000007.14:21558851:T:A
NM_001277115.2(DNAH11):c.5368G>T (p.Glu1790Ter)	DNAH11	E1790*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000454684	7	21721203	7	21681585	454684	457200	rs1164659091	NC_000007.14:21681584:G:T
NM_001277115.2(DNAH11):c.4567C>T (p.Gln1523Ter)	DNAH11	Q1523*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000454676	7	21675555	7	21635937	454676	456963	rs1286036654	NC_000007.14:21635936:C:T
NM_001277115.2(DNAH11):c.1593+1G>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000454663	7	21611592	7	21571974	454663	457178	rs1554312483	NC_000007.14:21571973:G:A
NM_001277115.2(DNAH11):c.1486A>T (p.Lys496Ter)	DNAH11	K496*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000454662	7	21611484	7	21571866	454662	457176	rs769637393	NC_000007.14:21571865:A:T
NM_001277115.2(DNAH11):c.12196-2A>G	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000454648	7	21920318	7	21880700	454648	457650	rs1554291973	NC_000007.14:21880699:A:G
NC_000007.13:g.(?_21737673)_(21805227_?)del	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000454503	7	21737673 - 21805227	7	21698055 - 21765609	454503	455866		
NM_001277115.2(DNAH11):c.6527C>T (p.Ala2176Val)	DNAH11	A2176V	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000410873	7	21745136	7	21705518	410873	395945	rs770279400	NC_000007.14:21705517:C:T
NM_001277115.2(DNAH11):c.10789C>T (p.Gln3597Ter)	DNAH11	Q3597*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000410859	7	21882259	7	21842641	410859	395605	rs1060503063	NC_000007.14:21842640:C:T
NM_001277115.2(DNAH11):c.13075C>T (p.Arg4359Ter)	DNAH11	R4359*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000410858	7	21938979	7	21899361	410858	396285	rs774903187	NC_000007.14:21899360:C:T
NM_001277115.2(DNAH11):c.8610C>G (p.Tyr2870Ter)	DNAH11	Y2870*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, single submitter	VCV000238935	7	21788297	7	21748679	238935	240056	rs878854446	NC_000007.14:21748678:C:G
NM_001277115.2(DNAH11):c.7140_7141del (p.Val2382fs)	DNAH11	V2382fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000238930	7	21760347 - 21760348	7	21720729 - 21720730	238930	240051	rs878854445	NC_000007.14:21720728:TAT:T
NM_001277115.2(DNAH11):c.4621C>T (p.Arg1541Ter)	DNAH11	R1541*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000238921	7	21675609	7	21635991	238921	240043	rs757013900	NC_000007.14:21635990:C:T
NM_001277115.2(DNAH11):c.3122G>A (p.Trp1041Ter)	DNAH11	W1041*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000238906	7	21640415	7	21600797	238906	240029	rs878854441	NC_000007.14:21600796:G:A
NM_001277115.2(DNAH11):c.11381T>A (p.Leu3794Ter)	DNAH11	L3794*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 30, 2016)	criteria provided, single submitter	VCV000238890	7	21904160	7	21864542	238890	240071	rs878854435	NC_000007.14:21864541:T:A
NM_001277115.2(DNAH11):c.7508_7509insTTG (p.Lys2504_Pro2505insTer)	DNAH11		Ciliary dyskinesia, primary, 7	Pathogenic(Last reviewed: Jan 21, 2015)	criteria provided, single submitter	VCV000208573	7	21775324 - 21775325	7	21735706 - 21735707	208573	205155	rs797045086	NC_000007.14:21735706:G:GTTG
NM_001277115.2(DNAH11):c.6506C>A (p.Ser2169Ter)	DNAH11	S2176*, S2169*	Ciliary dyskinesia, primary, 7	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000036983	7	21745115	7	21705497	36983	45641	rs373946181	NC_000007.14:21705496:C:A
NM_001277115.2(DNAH11):c.12697C>T (p.Gln4233Ter)	DNAH11	Q4233*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000837205	7	21932232	7	21892614	837205	833488		NC_000007.14:21892613:C:T
NM_001277115.2(DNAH11):c.4095+2C>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000580732	7	21655912	7	21616294	580732	561797	rs532007878	NC_000007.14:21616293:C:A
NM_001277115.2(DNAH11):c.13183C>T (p.Arg4395Ter)	DNAH11	R4395*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000525271	7	21939618	7	21900000	525271	522831	rs757784023	NC_000007.14:21899999:C:T
NM_001277115.2(DNAH11):c.4438C>T (p.Arg1480Ter)	DNAH11	R1480*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000238918	7	21659634	7	21620016	238918	240040	rs72657321	NC_000007.14:21620015:C:T
NM_001277115.2(DNAH11):c.10324C>T (p.Gln3442Ter)	DNAH11	Q3442*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000238887	7	21847659	7	21808041	238887	240068	rs72657393	NC_000007.14:21808040:C:T
NM_001277115.2(DNAH11):c.4333C>T (p.Arg1445Ter)	DNAH11	R1445*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000228332	7	21658796	7	21619178	228332	229575	rs72657316	NC_000007.14:21619177:C:T
NM_001277115.2(DNAH11):c.12363C>G (p.Tyr4121Ter)	DNAH11	Y4128*, Y4121*	Ciliary dyskinesia, primary, 7	Pathogenic(Last reviewed: Sep 15, 2011)	no assertion criteria provided	VCV000006475	7	21920487	7	21880869	6475	21514	rs121908855	NC_000007.14:21880868:C:G
NM_017780.4(CHD7):c.7246A>T (p.Lys2416Ter)	CHD7	K2416*	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802412	8	61769085	8	60856526	802412	790812		NC_000008.11:60856525:A:T
NM_017780.4(CHD7):c.5914dup (p.Ala1972fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802411	8	61765074 - 61765075	8	60852515 - 60852516	802411	790811		NC_000008.11:60852515:GG:GGG
NM_017780.4(CHD7):c.5051-1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802410	8	61757808	8	60845249	802410	790810		NC_000008.11:60845248:G:A
NM_017780.4(CHD7):c.2957+5G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802408	8	61734709	8	60822150	802408	790808		NC_000008.11:60822149:G:A
NM_017780.4(CHD7):c.8015G>A (p.Trp2672Ter)	CHD7	W2672*, W623*	CHARGE association	Pathogenic	no assertion criteria provided	VCV000625860	8	61775150	8	60862591	625860	614164	rs1563670964	NC_000008.11:60862590:G:A
NM_017780.4(CHD7):c.5678_5679AG[3] (p.Ser1894fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488480	8	61764588 - 61764589	8	60852029 - 60852030	488480	481348	rs1554603818	NC_000008.11:60852029:GAGAG:GAGAGAG
NM_017780.4(CHD7):c.2858G>A (p.Trp953Ter)	CHD7	W953*	CHARGE association	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488479	8	61734605	8	60822046	488479	481347	rs1554597465	NC_000008.11:60822045:G:A
NM_017780.4(CHD7):c.2990del (p.Leu997fs)	CHD7	L997fs	CHARGE association	Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000441170	8	61735092	8	60822533	441170	434798	rs1554597677	NC_000008.11:60822532:TTT:TT
NM_017780.4(CHD7):c.6292del (p.Arg2098fs)	CHD7	R2098fs	CHARGE association	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000403716	8	61765575	8	60853016	403716	390691	rs1060499560	NC_000008.11:60853015:CC:C
NM_017780.4(CHD7):c.1552C>T (p.Gln518Ter)	CHD7	Q518*	CHARGE association	Pathogenic	no assertion criteria provided	VCV000375575	8	61655543	8	60742984	375575	362385	rs1057519423	NC_000008.11:60742983:C:T
NM_017780.4(CHD7):c.8730_8731del (p.Pro2911fs)	CHD7	P2911fs, P862fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267441	8	61778227 - 61778228	8	60865668 - 60865669	267441	262665	rs886041000	NC_000008.11:60865667:CTC:C
NM_017780.4(CHD7):c.7282dup (p.Arg2428fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267437	8	61769120 - 61769121	8	60856561 - 60856562	267437	262662	rs886040997	NC_000008.11:60856561:C:CC
NM_017780.4(CHD7):c.5235_5236dup (p.Tyr1746fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267433	8	61761096 - 61761097	8	60848537 - 60848538	267433	262658	rs886040994	NC_000008.11:60848537:TGT:TGTGT
NM_017780.4(CHD7):c.4837_4838del (p.Leu1613fs)	CHD7	L1613fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267431	8	61754597 - 61754598	8	60842038 - 60842039	267431	262656	rs886040992	NC_000008.11:60842037:TCT:T
NM_017780.4(CHD7):c.3811_3814del (p.Glu1271fs)	CHD7	E1271fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267429	8	61748661 - 61748664	8	60836102 - 60836105	267429	262654	rs886040990	NC_000008.11:60836101:AAAGAAA:AAA
NM_017780.4(CHD7):c.3674dup (p.Asn1225fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267428	8	61743030 - 61743031	8	60830471 - 60830472	267428	262653	rs886040989	NC_000008.11:60830471:AA:AAA
NM_017780.4(CHD7):c.3572_3573del (p.Lys1191fs)	CHD7	K1191fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267426	8	61742929 - 61742930	8	60830370 - 60830371	267426	262651	rs886040987	NC_000008.11:60830369:AAA:A
NM_017780.4(CHD7):c.3526C>T (p.Gln1176Ter)	CHD7	Q1176*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267425	8	61742884	8	60830325	267425	262650	rs886040986	NC_000008.11:60830324:C:T
NM_017780.4(CHD7):c.3071dup (p.Leu1025fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267422	8	61735171 - 61735172	8	60822612 - 60822613	267422	262647	rs886040984	NC_000008.11:60822612:CCCC:CCCCC
NM_017780.4(CHD7):c.1073del (p.Gly358fs)	CHD7	G358fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267417	8	61655063	8	60742504	267417	262642	rs886040980	NC_000008.11:60742503:GG:G
NM_001277115.2(DNAH11):c.3133C>T (p.Arg1045Ter)	DNAH11	R1045*	Primary ciliary dyskinesia|not provided	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620379	7	21640426	7	21600808	620379	611679	rs377691013	NC_000007.14:21600807:C:T
NM_001277115.2(DNAH11):c.11533C>T (p.Arg3845Ter)	DNAH11	R3845*	Primary ciliary dyskinesia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620303	7	21906124	7	21866506	620303	611680	rs1309805676	NC_000007.14:21866505:C:T
NM_001277115.2(DNAH11):c.13069C>T (p.Arg4357Ter)	DNAH11	R4357*	Ciliary dyskinesia, primary, 7|Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000454655	7	21938973	7	21899355	454655	457024	rs775720394	NC_000007.14:21899354:C:T
NM_004333.6(BRAF):c.1574T>A (p.Leu525Gln)	BRAF	L525Q	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000520890	7	140476832	7	140777032	520890	511701	rs869025340	NC_000007.14:140777031:A:T
NM_004333.6(BRAF):c.1799_1800delinsAT (p.Val600Asp)	BRAF		Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375939	7	140453135 - 140453136	7	140753335 - 140753336	375939	362818	rs121913377	NC_000007.14:140753334:CA:AT
NM_000260.4(MYO7A):c.4108_4111del (p.Gln1370fs)	MYO7A	Q1359fs, Q1370fs	|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557834	11	76903278 - 76903281	11	77192233 - 77192236	557834	546793	rs1480697910	NC_000011.10:77192232:GCAGG:G
NM_000260.4(MYO7A):c.5581C>T (p.Arg1861Ter)	MYO7A	R1861*, R1812*, R1823*	|Deafness, autosomal recessive 2|	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000557045	11	76916607	11	77205562	557045	546716	rs878864531	NC_000011.10:77205561:C:T
NM_000260.4(MYO7A):c.4297del (p.Gln1433fs)	MYO7A	Q1433fs, Q1422fs	|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000556038	11	76905541	11	77194496	556038	546803	rs1555096223	NC_000011.10:77194495:CCC:CC
NM_000260.4(MYO7A):c.3504-1G>C	MYO7A		|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000554480	11	76900388	11	77189343	554480	546687	rs1555090171	NC_000011.10:77189342:G:C
NM_000260.4(MYO7A):c.1976C>A (p.Ser659Ter)	MYO7A	S659*, S648*	Retinal dystrophy|	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000236487	11	76885842	11	77174796	236487	238053	rs878853378	NC_000011.10:77174795:C:A
NM_000260.4(MYO7A):c.5968C>T (p.Gln1990Ter)	MYO7A	Q1990*, Q1952*, Q1941*	not provided|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197497	11	76919765	11	77208720	197497	194658	rs773844428	NC_000011.10:77208719:C:T
NM_000260.4(MYO7A):c.77C>A (p.Ala26Glu)	MYO7A	A26E, A15E	Rare genetic deafness	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000177731	11	76853813	11	77142767	177731	178186	rs369125667	NC_000011.10:77142766:C:A
NM_000260.4(MYO7A):c.4821T>A (p.Tyr1607Ter)	MYO7A	Y1607*, Y1558*, Y1569*	Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043261	11	76910832	11	77199787	43261	52431	rs397516315	NC_000011.10:77199786:T:A
NM_000260.4(MYO7A):c.1200+1G>A	MYO7A		Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043138	11	76871329	11	77160283	43138	52308	rs397516283	NC_000011.10:77160282:G:A
NM_001277115.2(DNAH11):c.3765+1G>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000854164	7	21646161	7	21606543	854164	852352		NC_000007.14:21606542:G:A
NM_001277115.2(DNAH11):c.7266+1G>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000644117	7	21760475	7	21720857	644117	651793		NC_000007.14:21720856:G:A
NM_001277115.2(DNAH11):c.11373+1G>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000568379	7	21901642	7	21862024	568379	561850	rs1175443221	NC_000007.14:21862023:G:A
NM_001277115.2(DNAH11):c.6004C>T (p.Arg2002Ter)	DNAH11	R2002*	Ciliary dyskinesia, primary, 7|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000454691	7	21730462	7	21690844	454691	456980	rs373844629	NC_000007.14:21690843:C:T
NM_001277115.2(DNAH11):c.8746C>T (p.Gln2916Ter)	DNAH11	Q2916*	Ciliary dyskinesia, primary, 7|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208572	7	21789368	7	21749750	208572	205156	rs797045085	NC_000007.14:21749749:C:T
NM_001277115.2(DNAH11):c.8533C>T (p.Arg2845Ter)	DNAH11	R2852*, R2845*	Ciliary dyskinesia, primary, 7|CILIARY DYSKINESIA, PRIMARY, 7, WITH SITUS INVERSUS	Pathogenic(Last reviewed: Sep 15, 2011)	no assertion criteria provided	VCV000006474	7	21788220	7	21748602	6474	21513	rs121908854	NC_000007.14:21748601:C:T
NM_017780.4(CHD7):c.5330del (p.Phe1777fs)	CHD7	F1777fs	CHARGE association	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000853417	8	61761637	8	60849078	853417	834958		NC_000008.11:60849077:TTT:TT
NM_017780.4(CHD7):c.4942_4943GT[1] (p.Tyr1649fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000852941	8	61757514 - 61757515	8	60844955 - 60844956	852941	834954		NC_000008.11:60844954:GTGT:GT
NM_017780.4(CHD7):c.1267del (p.Glu423fs)	CHD7	E423fs	CHARGE association	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000841990	8	61655257	8	60742698	841990	834934		NC_000008.11:60742697:GG:G
NM_017780.4(CHD7):c.281del (p.Pro94fs)	CHD7	P94fs	CHARGE association	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000841463	8	61654269	8	60741710	841463	834925		NC_000008.11:60741709:CCCC:CCC
NM_017780.4(CHD7):c.4738G>T (p.Glu1580Ter)	CHD7	E1580*	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000839015	8	61754499	8	60841940	839015	834952		NC_000008.11:60841939:G:T
NM_017780.4(CHD7):c.5110C>T (p.Gln1704Ter)	CHD7	Q1704*	CHARGE association	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000838744	8	61757868	8	60845309	838744	834956		NC_000008.11:60845308:C:T
NM_017780.4(CHD7):c.2729C>G (p.Ser910Ter)	CHD7	S910*	CHARGE association	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000836642	8	61734380	8	60821821	836642	834939		NC_000008.11:60821820:C:G
NC_000008.11:g.(?_60741413)_(60856908_?)dup	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000832837	8	61653972 - 61769467			832837	819971		
NC_000008.11:g.60838256G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000816902					816902	805138		
NM_017780.4(CHD7):c.635del (p.Gln212fs)	CHD7	Q212fs	CHARGE association	Pathogenic	criteria provided, single submitter	VCV000694716	8	61654626	8	60742067	694716	682810		NC_000008.11:60742066:A:
NM_017780.4(CHD7):c.2520G>A (p.Trp840Ter)	CHD7	W840*	CHARGE association	Pathogenic	criteria provided, single submitter	VCV000694697	8	61728967	8	60816408	694697	682811		NC_000008.11:60816407:G:A
NM_017780.4(CHD7):c.807del (p.Ala270fs)	CHD7	A270fs	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000692075	8	61654797	8	60742238	692075	679761		NC_000008.11:60742237:TT:T
NM_017780.4(CHD7):c.7540_7541dup (p.Arg2515fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000692003	8	61769376 - 61769377	8	60856817 - 60856818	692003	679763		NC_000008.11:60856817:GGGG:GGGGGG
NM_017780.4(CHD7):c.2919_2922GGAG[1] (p.Glu974_Gly975insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000689644	8	61734666 - 61734669	8	60822107 - 60822110	689644	677315		NC_000008.11:60822106:GGAGGGAG:GGAG
NM_017780.4(CHD7):c.4185+1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000689639	8	61749572	8	60837013	689639	677321		NC_000008.11:60837012:G:A
NM_017780.4(CHD7):c.7344_7345del (p.Glu2450fs)	CHD7	E2450fs	CHARGE association	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000689617	8	61769183 - 61769184	8	60856624 - 60856625	689617	677293		NC_000008.11:60856623:AA:
NM_017780.4(CHD7):c.8049del (p.Asp2684fs)	CHD7	D2684fs, D635fs	CHARGE association	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000689612	8	61775184	8	60862625	689612	677294		NC_000008.11:60862624:A:
NM_017780.4(CHD7):c.889C>T (p.Gln297Ter)	CHD7	Q297*	CHARGE association	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000661514	8	61654880	8	60742321	661514	637309		NC_000008.11:60742320:C:T
NM_017780.4(CHD7):c.6401del (p.Asn2134fs)	CHD7	N2134fs	CHARGE association	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000659630	8	61765682	8	60853123	659630	637335		NC_000008.11:60853122:AAAA:AAA
NM_017780.4(CHD7):c.4652del (p.Leu1551fs)	CHD7	L1551fs	CHARGE association	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000658937	8	61754413	8	60841854	658937	637330		NC_000008.11:60841853:T:
NM_017780.4(CHD7):c.2195dup (p.Pro733fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000657791	8	61707638 - 61707639	8	60795079 - 60795080	657791	637318		NC_000008.11:60795079:CCCCC:CCCCCC
NM_017780.4(CHD7):c.2710dup (p.Tyr904fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000655446	8	61734360 - 61734361	8	60821801 - 60821802	655446	637323		NC_000008.11:60821801:T:TT
NM_017780.4(CHD7):c.7824T>G (p.Tyr2608Ter)	CHD7	Y2608*	CHARGE association	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000655421	8	61773678	8	60861119	655421	637349		NC_000008.11:60861118:T:G
NM_017780.4(CHD7):c.2295del (p.Phe765fs)	CHD7	F765fs	CHARGE association	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000654941	8	61713003	8	60800444	654941	637320		NC_000008.11:60800443:C:
NM_017780.4(CHD7):c.3999del (p.Pro1332_Tyr1333insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000654472	8	61749385	8	60836826	654472	637327		NC_000008.11:60836825:T:
NM_017780.4(CHD7):c.1300C>T (p.Gln434Ter)	CHD7	Q434*	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000653661	8	61655291	8	60742732	653661	637313		NC_000008.11:60742731:C:T
NM_017780.4(CHD7):c.7781G>A (p.Trp2594Ter)	CHD7	W2594*	CHARGE association	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000651792	8	61773635	8	60861076	651792	637348		NC_000008.11:60861075:G:A
NM_017780.4(CHD7):c.2700del (p.Pro900_Val901insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000651761	8	61734351	8	60821792	651761	637322		NC_000008.11:60821791:T:
NM_017780.4(CHD7):c.3577_3583del (p.Asp1193fs)	CHD7	D1193fs	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000648507	8	61742933 - 61742939	8	60830374 - 60830380	648507	637325		NC_000008.11:60830373:AGGATGTAG:AG
NM_017780.4(CHD7):c.4295_4296del (p.Leu1432fs)	CHD7	L1432fs	CHARGE association	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000645093	8	61750336 - 61750337	8	60837777 - 60837778	645093	637329		NC_000008.11:60837776:TG:
NM_017780.4(CHD7):c.29_30del (p.Phe10fs)	CHD7	F10fs	CHARGE association	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000644954	8	61654017 - 61654018	8	60741458 - 60741459	644954	637303		NC_000008.11:60741457:TTTTT:TTT
NM_017780.4(CHD7):c.7356_7357dup (p.Ser2453fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000642853	8	61769194 - 61769195	8	60856635 - 60856636	642853	637345		NC_000008.11:60856635:AA:AAAA
NM_017780.4(CHD7):c.7222G>T (p.Glu2408Ter)	CHD7	E2408*	CHARGE association	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000619296	8	61769061	8	60856502	619296	610694		NC_000008.11:60856501:G:T
NM_001316690.1(CHD7):c.1716+235_1716+236delinsT	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000619295	8	61693844 - 61693845	8	60781285 - 60781286	619295	610693	rs1563595095	NC_000008.11:60781284:AA:T
NM_017780.4(CHD7):c.8076+1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000598779	8	61775212	8	60862653	598779	589840	rs1563671108	NC_000008.11:60862652:G:C
NM_017780.4(CHD7):c.4662del (p.Asp1554fs)	CHD7	D1554fs	CHARGE association	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000581472	8	61754423	8	60841864	581472	568037	rs1563648905	NC_000008.11:60841863:T:
NM_017780.4(CHD7):c.6473del (p.Ser2158fs)	CHD7	S2158fs	CHARGE association	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000581030	8	61765757	8	60853198	581030	562481	rs1563660938	NC_000008.11:60853197:C:
NM_017780.4(CHD7):c.2229_2230insCC (p.Gly744fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000579768	8	61707677 - 61707678	8	60795118 - 60795119	579768	568022	rs1563607193	NC_000008.11:60795118::CC
NM_017780.4(CHD7):c.2090del (p.Lys697fs)	CHD7	K697fs	CHARGE association	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000576625	8	61693979	8	60781420	576625	568015	rs1563595385	NC_000008.11:60781419:AAAAA:AAAA
NM_017780.4(CHD7):c.2452_2462del (p.Gly818fs)	CHD7	G818fs	CHARGE association	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000575329	8	61720784 - 61720794	8	60808225 - 60808235	575329	568032	rs1563618176	NC_000008.11:60808224:TGGAGAGGAGGT:T
NM_017780.4(CHD7):c.1952_1955del (p.Lys651fs)	CHD7	K651fs	CHARGE association	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000574634	8	61693844 - 61693847	8	60781285 - 60781288	574634	565191	rs1563595101	NC_000008.11:60781284:AAAGA:A
NM_017780.4(CHD7):c.3379G>T (p.Glu1127Ter)	CHD7	E1127*	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000573842	8	61741222	8	60828663	573842	565194	rs1563636399	NC_000008.11:60828662:G:T
NM_017780.4(CHD7):c.4494dup (p.Thr1499fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000572561	8	61750773 - 61750774	8	60838214 - 60838215	572561	562994	rs1563645417	NC_000008.11:60838214:TT:TTT
NM_017780.4(CHD7):c.6888_6889del (p.Ala2297fs)	CHD7	A2297fs	CHARGE association	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000567248	8	61767034 - 61767035	8	60854475 - 60854476	567248	568045	rs1563662791	NC_000008.11:60854474:AG:
NM_017780.4(CHD7):c.3412C>T (p.Gln1138Ter)	CHD7	Q1138*	CHARGE association	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000548946	8	61741255	8	60828696	548946	539430	rs1554599035	NC_000008.11:60828695:C:T
NM_017780.4(CHD7):c.8744dup (p.Leu2916fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547198	8	61778236 - 61778237	8	60865677 - 60865678	547198	537838	rs1554607313	NC_000008.11:60865677:GGGGGG:GGGGGGG
NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter)	CHD7	R2024*	CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547195	8	61765232	8	60852673	547195	537835	rs1360515765	NC_000008.11:60852672:C:T
NM_017780.4(CHD7):c.5210+3A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547193	8	61757971	8	60845412	547193	537833	rs1554602588	NC_000008.11:60845411:A:G
NM_017780.4(CHD7):c.1294del (p.His432fs)	CHD7	H432fs	CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547190	8	61655282	8	60742723	547190	537830	rs1554581646	NC_000008.11:60742722:CCCC:CCC
NM_017780.4(CHD7):c.7132G>T (p.Glu2378Ter)	CHD7	E2378*	CHARGE association	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000529132	8	61768729	8	60856170	529132	524267	rs878975068	NC_000008.11:60856169:G:T
NM_017780.4(CHD7):c.478del (p.Tyr160fs)	CHD7	Y160fs	CHARGE association	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000529127	8	61654469	8	60741910	529127	523645	rs1554581198	NC_000008.11:60741909:T:
NM_017780.4(CHD7):c.8067del (p.Lys2690fs)	CHD7	K641fs, K2690fs	CHARGE association	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000459565	8	61775201	8	60862642	459565	458581	rs1554606375	NC_000008.11:60862641:TT:T
NM_017780.4(CHD7):c.6841_6842insTA (p.Asp2281fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000459561	8	61766987 - 61766988	8	60854428 - 60854429	459561	458572	rs1554604441	NC_000008.11:60854428::TA
NM_017780.4(CHD7):c.6473C>A (p.Ser2158Ter)	CHD7	S2158*	CHARGE association	Pathogenic(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	VCV000459559	8	61765757	8	60853198	459559	458569	rs376056567	NC_000008.11:60853197:C:A
NM_017780.4(CHD7):c.604C>T (p.Gln202Ter)	CHD7	Q202*	CHARGE association	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000459557	8	61654595	8	60742036	459557	458971	rs1554581277	NC_000008.11:60742035:C:T
NM_017780.4(CHD7):c.5238C>G (p.Tyr1746Ter)	CHD7	Y1746*	CHARGE association	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000459551	8	61761101	8	60848542	459551	458496	rs1554603151	NC_000008.11:60848541:C:G
NM_017780.4(CHD7):c.5101del (p.Gln1701fs)	CHD7	Q1701fs	CHARGE association	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000459549	8	61757857	8	60845298	459549	458490	rs1554602557	NC_000008.11:60845297:CCC:CC
NM_017780.4(CHD7):c.3937del (p.Ser1313fs)	CHD7	S1313fs	CHARGE association	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000459547	8	61748787	8	60836228	459547	457929	rs1554600538	NC_000008.11:60836227:TTTT:TTT
NM_017780.4(CHD7):c.3490C>T (p.Gln1164Ter)	CHD7	Q1164*	CHARGE association	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000459546	8	61741333	8	60828774	459546	458489	rs1554599065	NC_000008.11:60828773:C:T
NM_017780.4(CHD7):c.1735C>T (p.Gln579Ter)	CHD7	Q579*	CHARGE association	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000459542	8	61693628	8	60781069	459542	458486	rs780953224	NC_000008.11:60781068:C:T
NM_017780.4(CHD7):c.7165-4A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000444870	8	61769000	8	60856441	444870	438510	rs1554604915	NC_000008.11:60856440:A:G
NM_017780.4(CHD7):c.5706C>G (p.Tyr1902Ter)	CHD7	Y1902*	CHARGE association	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000431034	8	61764618	8	60852059	431034	424563	rs1131692325	NC_000008.11:60852058:C:G
NM_017780.4(CHD7):c.7312C>T (p.Gln2438Ter)	CHD7	Q2438*	CHARGE association	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000411190	8	61769151	8	60856592	411190	396674	rs1060503188	NC_000008.11:60856591:C:T
NM_017780.4(CHD7):c.3093G>C (p.Trp1031Cys)	CHD7	W1031C	CHARGE association	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000411188	8	61735197	8	60822638	411188	396259	rs1060503187	NC_000008.11:60822637:G:C
NM_017780.4(CHD7):c.6161_6162CT[1] (p.Leu2055fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000411186	8	61765445 - 61765446	8	60852886 - 60852887	411186	396671	rs1060503185	NC_000008.11:60852885:CTCT:CT
NM_017780.4(CHD7):c.1058del (p.Phe353fs)	CHD7	F353fs	CHARGE association	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000411185	8	61655048	8	60742489	411185	396250	rs1060503184	NC_000008.11:60742488:TT:T
NM_017780.4(CHD7):c.3202-3T>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000411184	8	61736396	8	60823837	411184	396262	rs1060503183	NC_000008.11:60823836:T:G
NM_017780.4(CHD7):c.2097-1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000411182	8	61707544	8	60794985	411182	396666	rs1060503182	NC_000008.11:60794984:G:C
NM_017780.4(CHD7):c.2568del (p.Lys857fs)	CHD7	K857fs	CHARGE association	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000411180	8	61729014	8	60816455	411180	396912	rs1060503181	NC_000008.11:60816454:TT:T
NM_017780.4(CHD7):c.5211-1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: May 22, 2016)	criteria provided, single submitter	VCV000411179	8	61761073	8	60848514	411179	396667	rs1060503180	NC_000008.11:60848513:G:C
NM_017780.4(CHD7):c.2215G>T (p.Glu739Ter)	CHD7	E739*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267419	8	61707663	8	60795104	267419	262644	rs886040981	NC_000008.11:60795103:G:T
NM_017780.4(CHD7):c.3768C>G (p.Tyr1256Ter)	CHD7	Y1256*	CHARGE association	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000241192	8	61743126	8	60830567	241192	240395	rs878855032	NC_000008.11:60830566:C:G
NM_017780.4(CHD7):c.4915del (p.Asp1638_Val1639insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 19, 2015)	criteria provided, single submitter	VCV000220281	8	61757487	8	60844928	220281	221763	rs864622455	NC_000008.11:60844927:G:
NM_017780.4(CHD7):c.5199dup (p.His1734fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000216901	8	61757956 - 61757957	8	60845397 - 60845398	216901	213580	rs863224856	NC_000008.11:60845397:T:TT
NM_017780.4(CHD7):c.7663del (p.Arg2555fs)	CHD7	R2555fs	CHARGE association	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000216875	8	61773516	8	60860957	216875	212636	rs863224843	NC_000008.11:60860956:AA:A
NM_017780.4(CHD7):c.3678del (p.Phe1226fs)	CHD7	F1226fs	CHARGE association	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000216116	8	61743036	8	60830477	216116	212635	rs863224518	NC_000008.11:60830476:C:
NM_017780.4(CHD7):c.1505del (p.Pro502fs)	CHD7	P502fs	CHARGE association	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000216115	8	61655495	8	60742936	216115	212634	rs863224517	NC_000008.11:60742935:CC:C
NM_017780.4(CHD7):c.7940_7941dup (p.Pro2648fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210726	8	61774862 - 61774863	8	60862303 - 60862304	210726	207563	rs797045473	NC_000008.11:60862303:GTG:GTGTG
NM_017780.4(CHD7):c.6825dup (p.Met2276fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210724	8	61766969 - 61766970	8	60854410 - 60854411	210724	207562	rs797045472	NC_000008.11:60854410:CC:CCC
NM_017780.4(CHD7):c.6526del (p.Glu2176fs)	CHD7	E2176fs	CHARGE association	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000210723	8	61765809	8	60853250	210723	207561	rs797045471	NC_000008.11:60853249:GG:G
NM_017780.4(CHD7):c.6446del (p.Gly2149fs)	CHD7	G2149fs	CHARGE association	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000210722	8	61765729	8	60853170	210722	207560	rs797045470	NC_000008.11:60853169:GG:G
NM_017780.4(CHD7):c.5638dup (p.Glu1880fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210721	8	61763849 - 61763850	8	60851290 - 60851291	210721	207559	rs797045469	NC_000008.11:60851290:GG:GGG
NM_017780.4(CHD7):c.528dup (p.Pro177fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210720	8	61654515 - 61654516	8	60741956 - 60741957	210720	207549	rs797045468	NC_000008.11:60741956:GGGG:GGGGG
NM_017780.4(CHD7):c.5023C>T (p.Gln1675Ter)	CHD7	Q1675*	CHARGE association	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000210719	8	61757595	8	60845036	210719	207558	rs797045467	NC_000008.11:60845035:C:T
NM_017780.4(CHD7):c.2642dup (p.Tyr881Ter)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210716	8	61732593 - 61732594	8	60820034 - 60820035	210716	207555	rs797045465	NC_000008.11:60820034:A:AA
NM_017780.4(CHD7):c.2502_2509dup (p.His837fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210714	8	61728946 - 61728947	8	60816387 - 60816388	210714	207553	rs797045463	NC_000008.11:60816387:TCTTATCTTC:TCTTATCTTCTTATCTTC
NM_017780.4(CHD7):c.1678dup (p.Glu560fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000210712	8	61693569 - 61693570	8	60781010 - 60781011	210712	207551	rs797045461	NC_000008.11:60781010:GG:GGG
NM_017780.4(CHD7):c.1488dup (p.Pro497fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000188297	8	61655478 - 61655479	8	60742919 - 60742920	188297	186090	rs786204200	NC_000008.11:60742919:A:AA
NM_017780.4(CHD7):c.8055G>A (p.Trp2685Ter)	CHD7	W2685*, W636*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158322	8	61775190	8	60862631	158322	168638	rs587783459	NC_000008.11:60862630:G:A
NM_017780.4(CHD7):c.7380_7383TCTT[1] (p.Ser2462fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158316	8	61769219 - 61769222	8	60856660 - 60856663	158316	168632	rs587783456	NC_000008.11:60856659:TCTTTCTT:TCTT
NM_017780.4(CHD7):c.5666-2A>C	CHD7		CHARGE association	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	VCV000158304	8	61764576	8	60852017	158304	168620	rs587783448	NC_000008.11:60852016:A:C
NM_017780.4(CHD7):c.5551G>T (p.Glu1851Ter)	CHD7	E1851*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158303	8	61763607	8	60851048	158303	168619	rs587783447	NC_000008.11:60851047:G:T
NM_017780.4(CHD7):c.4634del (p.Ala1544_Leu1545insTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158298	8	61754302	8	60841743	158298	168614	rs587783443	NC_000008.11:60841742:TT:T
NM_017780.4(CHD7):c.4318C>T (p.Gln1440Ter)	CHD7	Q1440*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158294	8	61750359	8	60837800	158294	168609	rs587783440	NC_000008.11:60837799:C:T
NM_017780.4(CHD7):c.2815G>T (p.Glu939Ter)	CHD7	E939*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158285	8	61734466	8	60821907	158285	168602	rs587783434	NC_000008.11:60821906:G:T
NM_017780.4(CHD7):c.2643T>G (p.Tyr881Ter)	CHD7	Y881*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158284	8	61732595	8	60820036	158284	168601	rs587783433	NC_000008.11:60820035:T:G
NM_017780.4(CHD7):c.2613+1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158283	8	61729061	8	60816502	158283	168599	rs587783432	NC_000008.11:60816501:G:A
NM_017780.4(CHD7):c.187_190CAAA[1] (p.Thr64fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158281	8	61654178 - 61654181	8	60741619 - 60741622	158281	168589	rs587783431	NC_000008.11:60741618:CAAACAAA:CAAA
NM_017780.4(CHD7):c.1246G>T (p.Gly416Ter)	CHD7	G416*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158278	8	61655237	8	60742678	158278	168593	rs587783428	NC_000008.11:60742677:G:T
NM_017780.4(CHD7):c.8682_8683insT (p.Leu2895fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 15, 2007)	no assertion criteria provided	VCV000002037	8	61778180 - 61778181	8	60865621 - 60865622	2037	17076	rs1563674576	NC_000008.11:60865621::T
NM_017780.4(CHD7):c.6322G>A (p.Gly2108Arg)	CHD7	G2108R	CHARGE association	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002032	8	61765606	8	60853047	2032	17071	rs121434343	NC_000008.11:60853046:G:A
CHD7, DEL EXONS 8-12	CHD7		CHARGE association	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002031					2031	17070		
NM_017780.4(CHD7):c.5752dup (p.Thr1918fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000002029	8	61764663 - 61764664	8	60852104 - 60852105	2029	17068	rs786200873	NC_000008.11:60852104:A:AA
NM_017780.4(CHD7):c.3811G>T (p.Glu1271Ter)	CHD7	E1271*	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002028	8	61748664	8	60836105	2028	17067	rs121434342	NC_000008.11:60836104:G:T
NM_017780.4(CHD7):c.6955C>A (p.Arg2319Ser)	CHD7	R2319S	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002027	8	61768552	8	60855993	2027	17066	rs121434341	NC_000008.11:60855992:C:A
NM_017780.4(CHD7):c.5418C>G (p.Tyr1806Ter)	CHD7	Y1806*	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002024	8	61763065	8	60850506	2024	17063	rs121434340	NC_000008.11:60850505:C:G
NM_017780.4(CHD7):c.3770T>G (p.Leu1257Arg)	CHD7	L1257R	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002023	8	61743128	8	60830569	2023	17062	rs121434339	NC_000008.11:60830568:T:G
NM_001360.2(DHCR7):c.866C>T (p.Thr289Ile)	DHCR7	T289I	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006789	11	71148955	11	71437909	6789	21828	rs121909765	NC_000011.10:71437908:G:A
NM_004329.3(BMPR1A):c.430+1G>A	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000835681	10	88659648	10	86899891	835681	851790		NC_000010.11:86899890:G:A
NM_004329.2(BMPR1A):c.44_47del (p.Leu15fs)	BMPR1A	L15fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000529908	10	88635817 - 88635820	10	86876060 - 86876063	529908	525532	rs1554886816	NC_000010.11:86876059:TTTGTT:TT
NM_004329.2(BMPR1A):c.1360C>T (p.Gln454Ter)	BMPR1A	Q454*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486794	10	88683150	10	86923393	486794	475422	rs1554891570	NC_000010.11:86923392:C:T
NM_004329.2(BMPR1A):c.441_458delinsGA (p.Phe147fs)	BMPR1A		Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429100	10	88659794 - 88659811	10	86900037 - 86900054	429100	421050	rs1131691179	NC_000010.11:86900036:TGATGGCAGCATTCGATG:GA
NM_004329.2(BMPR1A):c.947_948CT[1] (p.Leu317fs)	BMPR1A		Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411642	10	88679006 - 88679009	10	86919249 - 86919252	411642	397653	rs1060503409	NC_000010.11:86919248:TCTCTCT:TCT
NM_033360.4(KRAS):c.37G>A (p.Gly13Ser)	KRAS	G13S	Neoplasm of the large intestine|Non-small cell lung cancer|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375968	12	25398282	12	25245348	375968	362847	rs121913535	NC_000012.12:25245347:C:T
NM_020822.3(KCNT1):c.2386T>C (p.Tyr796His)	KCNT1	Y796H, Y751H	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000039598	9	138669220	9	135777374	39598	48197	rs397515406	NC_000009.12:135777373:T:C
NM_001277115.2(DNAH11):c.3426-1G>A	DNAH11		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000853420	7	21641013	7	21601395	853420	852074		NC_000007.14:21601394:G:A
NM_001277115.2(DNAH11):c.6244C>T (p.Arg2082Ter)	DNAH11	R2082*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228333	7	21742391	7	21702773	228333	229579	rs200693106	NC_000007.14:21702772:C:T
NM_001370259.2(MEN1):c.312_315dup (p.Tyr106fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802683	11	64577266 - 64577267	11	64809794 - 64809795	802683	791150		NC_000011.10:64809794:GAGGGA:GAGGGAGGGA
NM_000260.4(MYO7A):c.4006C>T (p.Gln1336Ter)	MYO7A	Q1336*, Q1325*	Usher syndrome, type 1B||Deafness, autosomal dominant 11|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561263	11	76903177	11	77192132	561263	552405	rs750647872	NC_000011.10:77192131:C:T
NM_000260.4(MYO7A):c.47T>A (p.Leu16Ter)	MYO7A	L16*, L5*	|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549974	11	76853783	11	77142737	549974	546385	rs1052030	NC_000011.10:77142736:T:A
NM_000260.4(MYO7A):c.689C>T (p.Ala230Val)	MYO7A	A230V, A219V	Deafness, autosomal dominant 11|Rare genetic deafness|not specified	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000178993	11	76868004	11	77156958	178993	178258	rs797044512	NC_000011.10:77156957:C:T
NM_000260.4(MYO7A):c.448C>T (p.Arg150Ter)	MYO7A	R150*, R139*	Rare genetic deafness|Usher syndrome, type 1B	Pathogenic(Last reviewed: Jun 8, 2012)	criteria provided, single submitter	VCV000011847	11	76867115	11	77156069	11847	26886	rs121965079	NC_000011.10:77156068:C:T
NM_017780.4(CHD7):c.8077-2A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000862228	8	61777573	8	60865014	862228	851698		NC_000008.11:60865013:A:G
NM_017780.4(CHD7):c.3514_3515del (p.Glu1172fs)	CHD7	E1172fs	CHARGE association	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000854705	8	61741356 - 61741357	8	60828797 - 60828798	854705	834947		NC_000008.11:60828796:AGA:A
NM_017780.4(CHD7):c.7180_7181CT[2] (p.Ser2395fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000804335	8	61769019 - 61769020	8	60856460 - 60856461	804335	792672		NC_000008.11:60856459:CTCTCT:CTCT
NM_017780.4(CHD7):c.8077-1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000656743	8	61777574	8	60865015	656743	651995		NC_000008.11:60865014:G:C
NM_017780.4(CHD7):c.8618_8634del (p.Ser2873fs)	CHD7	S824fs, S2873fs	CHARGE association	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000640219	8	61778115 - 61778131	8	60865556 - 60865572	640219	637357		NC_000008.11:60865555:TCTGTTGGTGCTGCTACT:T
NM_017780.4(CHD7):c.7123del (p.Ser2375fs)	CHD7	S2375fs	CHARGE association|	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000620060	8	61768720	8	60856161	620060	611398	rs1563664506	NC_000008.11:60856160:A:
NM_017780.4(CHD7):c.8549_8555del (p.Asn2850fs)	CHD7	N2850fs, N801fs	CHARGE association	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000578478	8	61778044 - 61778050	8	60865485 - 60865491	578478	563037	rs1563674316	NC_000008.11:60865484:AGAATGAAGA:AGA
NM_017780.4(CHD7):c.718del (p.Gln240fs)	CHD7	Q240fs	CHARGE association	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000574274	8	61654706	8	60742147	574274	565185	rs1563560493	NC_000008.11:60742146:CCCC:CCC
NC_000008.10:g.(?_61653972)_(61778512_?)del	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000529154	8	61653972 - 61778512	8	60741413 - 60865953	529154	523175		
NM_017780.4(CHD7):c.1925del (p.Lys642fs)	CHD7	K642fs	CHARGE association	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000529122	8	61693812	8	60781253	529122	524239	rs1554588712	NC_000008.11:60781252:AAAAAAA:AAAAAA
NM_017780.4(CHD7):c.1312C>T (p.Gln438Ter)	CHD7	Q438*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000529121	8	61655303	8	60742744	529121	524254	rs1554581657	NC_000008.11:60742743:C:T
NM_017780.4(CHD7):c.2915A>G (p.Gln972Arg)	CHD7	Q972R	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488372	8	61734662	8	60822103	488372	481215	rs1554597512	NC_000008.11:60822102:A:G
NM_017780.4(CHD7):c.925C>T (p.Gln309Ter)	CHD7	Q309*	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488371	8	61654916	8	60742357	488371	481212	rs1436515577	NC_000008.11:60742356:C:T
NM_017780.4(CHD7):c.5409T>G (p.Tyr1803Ter)	CHD7	Y1803*	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488370	8	61763056	8	60850497	488370	481222	rs1021645395	NC_000008.11:60850496:T:G
NM_017780.4(CHD7):c.5210+2T>C	CHD7		CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488368	8	61757970	8	60845411	488368	481220	rs1554602587	NC_000008.11:60845410:T:C
NM_017780.4(CHD7):c.3606_3616dup (p.Ile1206fs)	CHD7		CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488367	8	61742962 - 61742963	8	60830403 - 60830404	488367	481218	rs1554599462	NC_000008.11:60830403:AAGAAACTATTA:AAGAAACTATTAAGAAACTATTA
NM_017780.4(CHD7):c.3209del (p.Val1070fs)	CHD7	V1070fs	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488366	8	61736406	8	60823847	488366	481217	rs1554597952	NC_000008.11:60823846:T:
NM_017780.4(CHD7):c.4835del (p.Asn1612fs)	CHD7	N1612fs	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488365	8	61754595	8	60842036	488365	481219	rs1554601654	NC_000008.11:60842035:AA:A
NM_017780.4(CHD7):c.1340_1341AG[1] (p.Arg448fs)	CHD7		CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488364	8	61655331 - 61655332	8	60742772 - 60742773	488364	481213	rs1554581674	NC_000008.11:60742771:AGAG:AG
NM_017780.4(CHD7):c.5355G>A (p.Trp1785Ter)	CHD7	W1785*	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488363	8	61761664	8	60849105	488363	481221	rs1554603276	NC_000008.11:60849104:G:A
NM_017780.4(CHD7):c.5405-2A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000430832	8	61763050	8	60850491	430832	424375	rs1131692153	NC_000008.11:60850490:A:G
NM_017780.4(CHD7):c.5405-13G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000428610	8	61763039	8	60850480	428610	420429	rs1131690787	NC_000008.11:60850479:G:A
NM_017780.4(CHD7):c.5405-18C>A	CHD7		CHARGE association	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000428609	8	61763034	8	60850475	428609	420428	rs199981784	NC_000008.11:60850474:C:A
NM_017780.4(CHD7):c.7285G>T (p.Glu2429Ter)	CHD7	E2429*	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411189	8	61769124	8	60856565	411189	396545	rs773047607	NC_000008.11:60856564:G:T
NM_017780.4(CHD7):c.8962dup (p.Asp2988fs)	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267440	8	61778453 - 61778454	8	60865894 - 60865895	267440	262666	rs771806027	NC_000008.11:60865894:GGGGGGG:GGGGGGGG
NM_017780.4(CHD7):c.2504_2508del (p.Tyr835fs)	CHD7	Y835fs	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000267420	8	61728947 - 61728951	8	60816388 - 60816392	267420	262645	rs886040982	NC_000008.11:60816387:TCTTATCTT:TCTT
NM_017780.4(CHD7):c.496C>T (p.Gln166Ter)	CHD7	Q166*	CHARGE association	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267414	8	61654487	8	60741928	267414	262639	rs886040978	NC_000008.11:60741927:C:T
NM_017780.4(CHD7):c.3964del (p.Leu1322fs)	CHD7	L1322fs	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000252713	8	61748817	8	60836258	252713	247033	rs879255410	NC_000008.11:60836257:C:
NM_017780.4(CHD7):c.3881T>C (p.Leu1294Pro)	CHD7	L1294P	not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000218745	8	61748734	8	60836175	218745	215385	rs864309609	NC_000008.11:60836174:T:C
NM_213599.2(ANO5):c.1733T>C (p.Phe578Ser)	ANO5	F578S, F577S	Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140553	11	22283777	11	22262231	140553	150231	rs137854526	NC_000011.10:22262230:T:C
NM_005590.4(MRE11):c.1222dup (p.Thr408fs)	MRE11		Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder|Ovarian Neoplasms|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184556	11	94197281 - 94197282	11	94464115 - 94464116	184556	183531	rs774440500	NC_000011.10:94464115:TTTTTT:TTTTTTT
NM_001277115.2(DNAH11):c.5924+1G>C	DNAH11		not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265099	7	21727146	7	21687528	265099	259856	rs886039340	NC_000007.14:21687527:G:C
NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys)	VWF	R1308C	not provided|von Willebrand disease, type 2b|von Willebrand disorder	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000289	12	6128662	12	6019496	289	15328	rs61749387	NC_000012.12:6019495:G:A
NM_000441.2(SLC26A4):c.1707+5G>A	SLC26A4		not provided|Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446457	7	107340625	7	107700180	446457	439906	rs192366176	NC_000007.14:107700179:G:A
NM_000260.4(MYO7A):c.133-2A>G	MYO7A		|Deafness, autosomal recessive 2|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000555778	11	76858842	11	77147796	555778	546607	rs782064437	NC_000011.10:77147795:A:G
NM_000260.4(MYO7A):c.4838del (p.Asp1613fs)	MYO7A	D1575fs, D1613fs, D1564fs	Deafness, autosomal recessive 2||Usher syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000438178	11	76910849	11	77199804	438178	431767	rs1199012623	NC_000011.10:77199803:A:
NM_033056.4(PCDH15):c.1737C>G (p.Tyr579Ter)	PCDH15	Y579*, Y542*, Y557*, Y584*, Y586*, Y591*	|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371411	10	55912907	10	54153147	371411	357865	rs1057517251	NC_000010.11:54153146:G:C
NM_033056.4(PCDH15):c.2785C>T (p.Arg929Ter)	PCDH15	R929*, R934*, R858*, R941*, R892*, R907*, R936*	not provided|Deafness, autosomal recessive 23|	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370242	10	55755492	10	53995732	370242	357856	rs1057516342	NC_000010.11:53995731:G:A
NC_000010.10:g.(?_88514773)_(88683486_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 11, 2018)	criteria provided, single submitter	VCV000639386	10	88514773 - 88683486	10	86755016 - 86923729	639386	652261		
NM_004329.2(BMPR1A):c.176T>A (p.Leu59Ter)	BMPR1A	L59*	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617784	10	88649927	10	86890170	617784	609169	rs1564714834	NC_000010.11:86890169:T:A
NM_004329.2(BMPR1A):c.-547_-268+1del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 25, 2018)	criteria provided, single submitter	VCV000571700	10	88516395 - 88516675	10	86756638 - 86756918	571700	563978	rs1564673999	
NM_004329.2(BMPR1A):c.1511G>A (p.Trp504Ter)	BMPR1A	W504*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000239856	10	88683388	10	86923631	239856	240866	rs878854664	NC_000010.11:86923630:G:A
NM_004329.2(BMPR1A):c.405dup (p.Pro136fs)	BMPR1A		Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233491	10	88659620 - 88659621	10	86899863 - 86899864	233491	233806	rs876660442	NC_000010.11:86899863:AA:AAA
NM_004329.2(BMPR1A):c.826_827del (p.Glu276fs)	BMPR1A	E276fs	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141674	10	88677040 - 88677041	10	86917283 - 86917284	141674	151388	rs587781928	NC_000010.11:86917282:AGA:A
NM_001363118.2(SLC52A2):c.935T>C (p.Leu312Pro)	SLC52A2	L312P, L148P	Inborn genetic diseases|Brown-Vialetto-Van Laere syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210041	8	145584087	8	144360427	210041	206607	rs754320812	NC_000008.11:144360426:T:C
NM_000127.2(EXT1):c.1018C>T (p.Arg340Cys)	EXT1	R340C	not provided|Multiple congenital exostosis|Multiple exostoses type 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002500	8	118849385	8	117837146	2500	17539	rs119103290	NC_000008.11:117837145:G:A
NM_017780.4(CHD7):c.2836-1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000665863	8	61734582	8	60822023	665863	651906		NC_000008.11:60822022:G:A
NM_017780.4(CHD7):c.2257C>T (p.Gln753Ter)	CHD7	Q753*	not specified|CHARGE association	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660551	8	61712965	8	60800406	660551	637319		NC_000008.11:60800405:C:T
NM_017780.4(CHD7):c.3905T>C (p.Leu1302Pro)	CHD7	L1302P	CHARGE association	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000626915	8	61748758	8	60836199	626915	615268	rs1563643394	NC_000008.11:60836198:T:C
NM_017780.4(CHD7):c.2572C>T (p.Arg858Ter)	CHD7	R858*	CHARGE association|not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620086	8	61729019	8	60816460	620086	611703	rs1563625351	NC_000008.11:60816459:C:T
NM_017780.4(CHD7):c.282del (p.Asn96fs)	CHD7	N96fs	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560976	8	61654273	8	60741714	560976	552125	rs1563559321	NC_000008.11:60741713:T:
NM_017780.4(CHD7):c.1803_1806del (p.Lys602fs)	CHD7	K602fs	not provided|CHARGE association	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000524142	8	61693693 - 61693696	8	60781134 - 60781137	524142	514575	rs1554588671	NC_000008.11:60781133:AAAGAAA:AAA
NM_017780.4(CHD7):c.6114_6120del (p.Leu2039fs)	CHD7	L2039fs	CHARGE association|not provided	Pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429504	8	61765398 - 61765404	8	60852839 - 60852845	429504	421685	rs1131691420	NC_000008.11:60852838:CCTCTCC:
NM_017780.4(CHD7):c.7879C>T (p.Arg2627Ter)	CHD7	R2627*, R578*	not provided|CHARGE association	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418655	8	61774803	8	60862244	418655	407437	rs1064793346	NC_000008.11:60862243:C:T
NM_017780.4(CHD7):c.7802dup (p.Tyr2601Ter)	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267438	8	61773655 - 61773656	8	60861096 - 60861097	267438	262663	rs886040998	NC_000008.11:60861096:A:AA
NM_017780.4(CHD7):c.6148C>T (p.Arg2050Ter)	CHD7	R2050*	not provided|CHARGE association	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267436	8	61765432	8	60852873	267436	262661	rs886040996	NC_000008.11:60852872:C:T
NM_017780.4(CHD7):c.2836-2A>T	CHD7		not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000241191	8	61734581	8	60822022	241191	240394	rs878855031	NC_000008.11:60822021:A:T
Single allele	CHD7		CHARGE association	Pathogenic(Last reviewed: Dec 1, 2013)	criteria provided, single submitter	VCV000218417	8	61716600 - 61721089	8	60804042 - 60808531	218417	215174		
NM_017780.4(CHD7):c.6995G>A (p.Trp2332Ter)	CHD7	W2332*	CHARGE association|not provided	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000196870	8	61768592	8	60856033	196870	194031	rs794727569	NC_000008.11:60856032:G:A
NM_017780.4(CHD7):c.4379_4380del (p.Ile1460fs)	CHD7	I1460fs	CHARGE association|not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095789	8	61750659 - 61750660	8	60838100 - 60838101	95789	101686	rs398124319	NC_000008.11:60838099:ATA:A
NM_000048.4(ASL):c.857A>G (p.Gln286Arg)	ASL	Q286R, Q260R	Argininosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002399	7	65554101	7	66089114	2399	17438	rs28941472	NC_000007.14:66089113:A:G
NM_001277115.2(DNAH11):c.8698C>T (p.Arg2900Ter)	DNAH11	R2907*, R2900*	Ciliary dyskinesia, primary, 7|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036981	7	21789320	7	21749702	36981	45639	rs368260932	NC_000007.14:21749701:C:T
NM_001142800.2(EYS):c.2259+1G>A	EYS		Retinitis pigmentosa 25|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558511	6	65707474	6	64997581	558511	543937	rs752736741	NC_000006.12:64997580:C:T
NM_001142800.2(EYS):c.6557G>A (p.Gly2186Glu)	EYS	G2186E	Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143108	6	64791763	6	64081870	143108	152826	rs527236068	NC_000006.12:64081869:C:T
NM_001370259.2(MEN1):c.639del (p.Gly214fs)	MEN1	G214fs, G219fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000852102	11	64575378	11	64807906	852102	838737		NC_000011.10:64807905:GG:G
NM_130799.2:c.914del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000844517					844517	851445		
NM_001370259.2(MEN1):c.269_270dup (p.Ala91fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000841275	11	64577311 - 64577312	11	64809839 - 64809840	841275	838743		NC_000011.10:64809839:ATA:ATATA
NM_000244.3(MEN1):c.406_415delinsTCCCT (p.Asp136fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000664398	11	64577167 - 64577176	11	64809695 - 64809704	664398	640304		NC_000011.10:64809694:GGGCCCGATC:AGGGA
NM_001370259.2(MEN1):c.1420del (p.Glu474fs)	MEN1	E439fs, E474fs, E479fs, E516fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000663804	11	64572219	11	64804747	663804	640265		NC_000011.10:64804746:CC:C
NM_000244.3(MEN1):c.810G>A (p.Trp270Ter)	MEN1	W230*, W265*, W270*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000653034	11	64574680	11	64807208	653034	640291		NC_000011.10:64807207:C:T
NM_001370259.2(MEN1):c.1311del (p.Thr438fs)	MEN1	T403fs, T480fs, T438fs, T443fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000650907	11	64572545	11	64805073	650907	640270		NC_000011.10:64805072:GG:G
NM_000244.3(MEN1):c.1234_1235del (p.Asp411_Pro412insTer)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000649025	11	64572636 - 64572637	11	64805164 - 64805165	649025	640274		NC_000011.10:64805163:GGG:G
NM_001370259.2(MEN1):c.758del (p.Ser253fs)	MEN1	S218fs, S253fs, S258fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000646514	11	64575049	11	64807577	646514	640292		NC_000011.10:64807576:G:
NM_000244.3(MEN1):c.761_764dup (p.Thr256fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000642851	11	64575057 - 64575058	11	64807585 - 64807586	642851	640293		NC_000011.10:64807585:TGCA:TGCATGCA
NM_000244.3(MEN1):c.510C>A (p.Cys170Ter)	MEN1	C170*, C165*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000640227	11	64575522	11	64808050	640227	640302		NC_000011.10:64808049:G:T
NM_000244.3(MEN1):c.386del (p.Leu129fs)	MEN1	L129fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000583070	11	64577196	11	64809724	583070	567442	rs1565651223	NC_000011.10:64809723:A:
NM_000244.3(MEN1):c.1349del (p.Gly450fs)	MEN1	G450fs, G487fs, G410fs, G445fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000581965	11	64572522	11	64805050	581965	564826	rs1565640081	NC_000011.10:64805049:CC:C
NM_000244.3(MEN1):c.322_323insT (p.Arg108fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000567215	11	64577259 - 64577260	11	64809787 - 64809788	567215	567445	rs1565651568	NC_000011.10:64809787::A
NM_000244.3(MEN1):c.1118C>A (p.Ala373Asp)	MEN1	A368D, A373D, A333D, A410D	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547518	11	64573189	11	64805717	547518	537877	rs1555164707	NC_000011.10:64805716:G:T
NC_000011.9:g.(?_64577131)_(64577587_?)del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000527321	11	64577131 - 64577587	11	64809659 - 64810115	527321	525678		
NM_000244.3(MEN1):c.142del (p.Leu48fs)	MEN1	L48fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000527271	11	64577440	11	64809968	527271	526681	rs1555166681	NC_000011.10:64809967:G:
NM_000244.3(MEN1):c.1208dup (p.Ser404fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527241	11	64572662 - 64572663	11	64805190 - 64805191	527241	526358	rs1555164430	NC_000011.10:64805190:T:TT
NM_000244.3(MEN1):c.955_1065-227del	MEN1	R314fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000457345	11	64573469 - 64573813	11	64805997 - 64806341	457345	461284	rs1555164870	
NM_000244.3(MEN1):c.754_760del (p.Ile252fs)	MEN1	I212fs, I247fs, I252fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000457337	11	64575062 - 64575068	11	64807590 - 64807596	457337	461830	rs1555165503	NC_000011.10:64807589:GGTCAATGG:GG
NM_000244.3(MEN1):c.578_579del (p.Pro193fs)	MEN1	P188fs, P193fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000457327	11	64575453 - 64575454	11	64807981 - 64807982	457327	461847	rs1555165756	NC_000011.10:64807980:GGG:G
NM_000244.3(MEN1):c.317_318del (p.Tyr106fs)	MEN1	Y106fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000457321	11	64577264 - 64577265	11	64809792 - 64809793	457321	462189	rs1555166466	NC_000011.10:64809791:ATA:A
NM_000244.3(MEN1):c.1550C>G (p.Ser517Ter)	MEN1	S512*, S517*, S477*, S554*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000457305	11	64572104	11	64804632	457305	462115	rs141679530	NC_000011.10:64804631:G:C
NM_000244.3(MEN1):c.1390_1397del (p.Ser464fs)	MEN1	S464fs, S424fs, S501fs, S459fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000457290	11	64572257 - 64572264	11	64804785 - 64804792	457290	462128	rs1555163883	NC_000011.10:64804784:TCTCGGCT:
NC_000011.9:g.(?_64570986)_(64572288_?)del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV000417317	11	64570986 - 64572288	11	64803514 - 64804816	417317	398007		
NC_000011.9:g.(?_64570986)_(64577604_?)del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000417316	11	64570986 - 64577604	11	64803514 - 64810132	417316	397583		
NM_000244.3(MEN1):c.1397_1419dup (p.Glu474fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 11, 2016)	criteria provided, single submitter	VCV000403843	11	64572234 - 64572235	11	64804762 - 64804763	403843	398707	rs1555163780	NC_000011.10:64804762:CTCGGCCTCGGCCGCCTCGGCCTCTCGGC:CTCGGCCTCGGCCGCCTCGGCCTCTCGGCCTCGGCCGCCTCGGCCTCTCGGC
NM_000244.3(MEN1):c.346G>T (p.Glu116Ter)	MEN1	E116*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000403842	11	64577236	11	64809764	403842	398411	rs1060499992	NC_000011.10:64809763:C:A
NM_000244.3(MEN1):c.318T>A (p.Tyr106Ter)	MEN1	Y106*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000403833	11	64577264	11	64809792	403833	398878	rs1060499987	NC_000011.10:64809791:A:T
NM_000244.3(MEN1):c.252_253insTT (p.Ile85fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000403822	11	64577329 - 64577330	11	64809857 - 64809858	403822	398425	rs386134253	NC_000011.10:64809857:A:AAA
NM_000244.3(MEN1):c.280_284dup (p.Gln96fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000403815	11	64577297 - 64577298	11	64809825 - 64809826	403815	398421	rs1555166494	NC_000011.10:64809825:GCGGTG:GCGGTGCGGTG
NM_000244.3(MEN1):c.839+1G>T	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000403810	11	64574650	11	64807178	403810	398303	rs1060499976	NC_000011.10:64807177:C:A
NM_000244.3(MEN1):c.648del (p.Asn217fs)	MEN1	N217fs, N212fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	VCV000241818	11	64575384	11	64807912	241818	241195	rs878855196	NC_000011.10:64807911:G:
NM_000244.3(MEN1):c.358A>T (p.Lys120Ter)	MEN1	K120*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000241812	11	64577224	11	64809752	241812	241201	rs878855192	NC_000011.10:64809751:T:A
NM_000244.3(MEN1):c.323del (p.Arg108fs)	MEN1	R108fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000241811	11	64577259	11	64809787	241811	241202	rs878855191	NC_000011.10:64809786:C:
NM_000244.3(MEN1):c.839+1G>A	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000016710	11	64574650	11	64807178	16710	31749	rs1060499976	NC_000011.10:64807177:C:T
MEN1, 6-BP INS, NT879	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000016706					16706	31745		
NM_000244.3(MEN1):c.1077C>A (p.Cys359Ter)	MEN1	C354*, C359*, C319*, C396*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000016705	11	64573230	11	64805758	16705	31744	rs104894265	NC_000011.10:64805757:G:T
MEN1, 1-BP DEL, 7773C	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016704					16704	31743		
MEN1, 4-BP DEL, 4480CAGT	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016702					16702	31741		
NM_000244.3(MEN1):c.566T>A (p.Val189Glu)	MEN1	V184E, V189E	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 16, 1998)	no assertion criteria provided	VCV000016697	11	64575466	11	64807994	16697	31736	rs104894262	NC_000011.10:64807993:A:T
NM_000244.3(MEN1):c.778G>A (p.Glu260Lys)	MEN1	E255K, E260K, E220K	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000016696	11	64575044	11	64807572	16696	31735	rs104894268	NC_000011.10:64807571:C:T
NM_130799.2(MEN1):c.1024delG (p.Ala342Argfs)	MEN1	A342fs, A307fs, A347fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Apr 18, 1997)	no assertion criteria provided	VCV000016684	11	64573729	11	64806257	16684	31723	rs1555164986	NC_000011.10:64806256:CCC:CC
NM_000244.3(MEN1):c.608G>A (p.Trp203Ter)	MEN1	W198*, W203*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Apr 18, 1997)	no assertion criteria provided	VCV000016682	11	64575424	11	64807952	16682	31721	rs104894258	NC_000011.10:64807951:C:T
NM_002180.2(IGHMBP2):c.1540G>A (p.Glu514Lys)	IGHMBP2	E514K	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1|Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009112	11	68701934	11	68934466	9112	24151	rs137852665	NC_000011.10:68934465:G:A
NM_000083.3(CLCN1):c.180+3A>T	CLCN1		Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000289967	7	143013488	7	143316395	289967	274204	rs202217420	NC_000007.14:143316394:A:T
NM_000083.3(CLCN1):c.1453A>G (p.Met485Val)	CLCN1	M485V	Myotonia congenita|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280101	7	143036397	7	143339304	280101	264231	rs146457619	NC_000007.14:143339303:A:G
NM_000083.3(CLCN1):c.854G>A (p.Gly285Glu)	CLCN1	G285E	Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280100	7	143027865	7	143330772	280100	264312	rs150885084	NC_000007.14:143330771:G:A
NM_000083.3(CLCN1):c.1592C>T (p.Ala531Val)	CLCN1	A531V	not provided|Myotonia congenita|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021040	7	143039031	7	143341938	21040	33892	rs80356704	NC_000007.14:143341937:C:T
NM_000083.3(CLCN1):c.689G>A (p.Gly230Glu)	CLCN1	G230E	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Myotonia congenita|not provided|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017532	7	143018934	7	143321841	17532	32571	rs80356700	NC_000007.14:143321840:G:A
NM_000155.4(GALT):c.602G>A (p.Arg201His)	GALT	R201H, R92H	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025227	9	34648368	9	34648371	25227	36561	rs111033735	NC_000009.12:34648370:G:A
NM_000155.2(GALT):c.-119_-116delGTCA	GALT		Classical galactosemia, homozygous Duarte-type|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic, other(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000025111	9	34646583 - 34646586	9	34646576 - 34646579	25111	36445	rs111033640	
NM_000543.5(SMPD1):c.1267C>T (p.His423Tyr)	SMPD1	H421Y, H423Y, H116Y, H422Y, H379Y	Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002992	11	6414850	11	6393620	2992	18031	rs120074126	NC_000011.10:6393619:C:T
NM_000543.5(SMPD1):c.996del (p.Phe333fs)	SMPD1	F332fs, F333fs, P12fs	Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002990	11	6413286	11	6392056	2990	18029	rs387906289	NC_000011.10:6392055:CCCCCC:CCCCC
NM_000391.4(TPP1):c.1094G>A (p.Cys365Tyr)	TPP1	C365Y	Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002642	11	6637287	11	6616056	2642	17681	rs119455954	NC_000011.10:6616055:C:T
NM_000553.5(WRN):c.2900dup (p.Leu967Phefs)	WRN		not provided	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000499439	8	30989951 - 30989952	8	31132435 - 31132436	499439	490863	rs1554530901	NC_000008.11:31132435:TTTT:TTTTT
NM_000553.5(WRN):c.561A>G (p.Lys187=)	WRN		not provided	Pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	VCV000198099	8	30924605	8	31067089	198099	195260	rs775802030	NC_000008.11:31067088:A:G
NM_000260.4(MYO7A):c.5880_5882CTT[2] (p.Phe1963del)	MYO7A	F1963del	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043308	11	76919498 - 76919500	11	77208453 - 77208455	43308	52478	rs111033232	NC_000011.10:77208452:CTTCTTCTT:CTTCTT
NM_000260.4(MYO7A):c.5660C>T (p.Pro1887Leu)	MYO7A	P1887L, P1849L, P1838L	Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043295	11	76917165	11	77206120	43295	52465	rs199606180	NC_000011.10:77206119:C:T
NM_000260.4(MYO7A):c.1344-2A>G	MYO7A		Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043143	11	76873164	11	77162118	43143	52313	rs111033415	NC_000011.10:77162117:A:G
NM_000260.4(MYO7A):c.634C>T (p.Arg212Cys)	MYO7A	R212C, R201C	Usher syndrome, type 1B|not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000011851	11	76867949	11	77156903	11851	26890	rs121965080	NC_000011.10:77156902:C:T
NM_000553.6(WRN):c.2359dup (p.Leu787fs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000864323	8	30973954 - 30973955	8	31116438 - 31116439	864323	834666		NC_000008.11:31116438:C:CC
NM_000553.6(WRN):c.3308del (p.Lys1103fs)	WRN	K1103fs	Werner syndrome	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000863728	8	31000215	8	31142699	863728	834694		NC_000008.11:31142698:AA:A
NM_000553.6(WRN):c.272del (p.Arg91fs)	WRN	R91fs	Werner syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000862827	8	30921867	8	31064351	862827	834605		NC_000008.11:31064350:G:
NM_000553.6(WRN):c.1828A>T (p.Lys610Ter)	WRN	K610*	Werner syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000860775	8	30948457	8	31090941	860775	834648		NC_000008.11:31090940:A:T
NM_000553.6(WRN):c.2584del (p.Ser862fs)	WRN	S862fs	Werner syndrome	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, single submitter	VCV000857079	8	30977892	8	31120376	857079	834675		NC_000008.11:31120375:AAA:AA
NM_000553.6(WRN):c.2974C>T (p.Gln992Ter)	WRN	Q992*	Werner syndrome	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000853066	8	30998952	8	31141436	853066	834682		NC_000008.11:31141435:C:T
NM_000553.6(WRN):c.3724C>T (p.Gln1242Ter)	WRN	Q1242*	Werner syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000852798	8	31012176	8	31154660	852798	834712		NC_000008.11:31154659:C:T
NM_000553.6(WRN):c.1993dup (p.Ile665fs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000852678	8	30958375 - 30958376	8	31100859 - 31100860	852678	834652		NC_000008.11:31100859:A:AA
NM_000553.6(WRN):c.3676_3679del (p.Asn1226fs)	WRN	N1226fs	Werner syndrome	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000851232	8	31007959 - 31007962	8	31150443 - 31150446	851232	834709		NC_000008.11:31150442:AAATA:A
NM_000553.6(WRN):c.921_922del (p.Glu308fs)	WRN	E308fs	Werner syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000849560	8	30938464 - 30938465	8	31080948 - 31080949	849560	834622		NC_000008.11:31080947:TG:
NM_000553.6(WRN):c.3238A>T (p.Lys1080Ter)	WRN	K1080*	Werner syndrome	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000846517	8	31000146	8	31142630	846517	834691		NC_000008.11:31142629:A:T
NC_000008.11:g.(?_31076163)_(31076297_?)del	WRN		Werner syndrome	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000833336	8	30933679 - 30933813			833336	819958		
NC_000008.11:g.(?_31058448)_(31111809_?)del	WRN		Werner syndrome	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000832139	8	30915964 - 30969325			832139	819956		
NC_000008.11:g.(?_31058438)_(31059275_?)del	WRN		Werner syndrome	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000830432	8	30915954 - 30916791			830432	819955		
NM_000553.6(WRN):c.2345del (p.Gly782fs)	WRN	G782fs	Werner syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000665278	8	30973940	8	31116424	665278	637125		NC_000008.11:31116423:GG:G
NM_000553.4:c.3042G>A	WRN	W1014*	Werner syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000664656	8	30999020	8	31141504	664656	637154		NC_000008.11:31141503:G:A
NM_000553.4:c.1290_1293del	WRN	N430fs	Werner syndrome	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000664338	8	30941233 - 30941236	8	31083717 - 31083720	664338	637093		NC_000008.11:31083716:AATGAA:AA
NM_000553.4:c.3394C>T	WRN	Q1132*	Werner syndrome	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000663649	8	31004579	8	31147063	663649	637169		NC_000008.11:31147062:C:T
NM_000553.4:c.2028G>A	WRN	W676*	Werner syndrome	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000657431	8	30958411	8	31100895	657431	637118		NC_000008.11:31100894:G:A
NM_000553.4:c.1908C>A	WRN	Y636*	Werner syndrome	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000656412	8	30954293	8	31096777	656412	637111		NC_000008.11:31096776:C:A
NM_000553.4:c.3937C>T	WRN	Q1313*	Werner syndrome	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000655857	8	31015001	8	31157485	655857	637187		NC_000008.11:31157484:C:T
NM_000553.4:c.2544T>A	WRN	Y848*	Werner syndrome	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000653972	8	30977854	8	31120338	653972	637141		NC_000008.11:31120337:T:A
NM_000553.4:c.171C>G	WRN	Y57*	Werner syndrome	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000653140	8	30916743	8	31059227	653140	637063		NC_000008.11:31059226:C:G
NM_000553.6(WRN):c.2503del (p.Gln835fs)	WRN	Q835fs	Werner syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000651657	8	30977812	8	31120296	651657	637140		NC_000008.11:31120295:CC:C
NM_000553.4:c.2359_2361delCTGinsTT	WRN		Werner syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000647126	8	30973955 - 30973957	8	31116439 - 31116441	647126	637127		NC_000008.11:31116438:CTG:TT
NM_000553.4:c.515_516delCA	WRN		Werner syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000644752	8	30924557 - 30924558	8	31067041 - 31067042	644752	637072		NC_000008.11:31067040:CACA:CA
NM_000553.4:c.980_983dupGAGT	WRN		Werner syndrome	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000642354	8	30938522 - 30938523	8	31081006 - 31081007	642354	637085		NC_000008.11:31081006:GAGT:GAGTGAGT
NM_000553.6(WRN):c.859del (p.Asp287fs)	WRN	D287fs	Werner syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000641348	8	30938401	8	31080885	641348	637081		NC_000008.11:31080884:GG:G
NM_000553.4:c.961G>T	WRN	E321*	Werner syndrome	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000641343	8	30938504	8	31080988	641343	637084		NC_000008.11:31080987:G:T
NM_000553.6(WRN):c.1665del (p.Lys555_Val556insTer)	WRN		Werner syndrome	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000640381	8	30947991	8	31090475	640381	637105		NC_000008.11:31090474:AAA:AA
NM_000553.4(WRN):c.2994T>A (p.Tyr998Ter)	WRN	Y998*	Werner syndrome	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000582165	8	30998972	8	31141456	582165	562366	rs1563376347	NC_000008.11:31141455:T:A
NM_000553.5(WRN):c.3382dup (p.Ser1128Lysfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000581978	8	31001131 - 31001132	8	31143615 - 31143616	581978	562383	rs778872619	NC_000008.11:31143615:AAAAAAA:AAAAAAAA
NM_000553.5(WRN):c.3682del (p.Val1228Phefs)	WRN	V1228fs	Werner syndrome	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000581085	8	31007966	8	31150450	581085	562390	rs1563382597	NC_000008.11:31150449:G:
NM_000553.5(WRN):c.1111G>T (p.Glu371Ter)	WRN	E371*	Werner syndrome	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000580245	8	30938654	8	31081138	580245	567815	rs1563338837	NC_000008.11:31081137:G:T
NM_000553.4(WRN):c.3961C>T (p.Arg1321Ter)	WRN	R1321*	Werner syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000578242	8	31015025	8	31157509	578242	565073	rs1303126572	NC_000008.11:31157508:C:T
NM_000553.4(WRN):c.3711delA (p.Lys1237Asnfs)	WRN	K1237fs	Werner syndrome	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000577673	8	31012160	8	31154644	577673	567905	rs1563385391	NC_000008.11:31154643:AAAA:AAA
NM_000553.5(WRN):c.554T>G (p.Leu185Ter)	WRN	L185*	Werner syndrome	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000577438	8	30924598	8	31067082	577438	565006	rs1563331288	NC_000008.11:31067081:T:G
NM_000553.5(WRN):c.755_758del (p.Lys252Serfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000573403	8	30933715 - 30933718	8	31076199 - 31076202	573403	562299	rs1244318419	NC_000008.11:31076198:AACAAACA:AACA
NM_000553.5(WRN):c.3382del (p.Ser1128Valfs)	WRN	S1128fs	Werner syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000571933	8	31001132	8	31143616	571933	565066	rs778872619	NC_000008.11:31143615:AAAAAAA:AAAAAA
NM_000553.5(WRN):c.2170C>T (p.Gln724Ter)	WRN	Q724*	Werner syndrome	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000570679	8	30969212	8	31111696	570679	565051	rs1563357741	NC_000008.11:31111695:C:T
NM_000553.5(WRN):c.88G>T (p.Glu30Ter)	WRN	E30*	Werner syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000569323	8	30916051	8	31058535	569323	562285	rs1198210848	NC_000008.11:31058534:G:T
NM_000553.5(WRN):c.1744C>T (p.Gln582Ter)	WRN	Q582*	Werner syndrome	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000568746	8	30948373	8	31090857	568746	565039	rs757808169	NC_000008.11:31090856:C:T
NM_000553.5(WRN):c.3102T>G (p.Tyr1034Ter)	WRN	Y1034*	Werner syndrome	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000567775	8	30999080	8	31141564	567775	562370	rs1563376526	NC_000008.11:31141563:T:G
NM_000553.5(WRN):c.1114_1115delGAinsC (p.Asp372Leufs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000566883	8	30938657 - 30938658	8	31081141 - 31081142	566883	567818	rs1563338855	NC_000008.11:31081140:GA:C
NM_000553.5(WRN):c.509_510dup (p.Cys171Asnfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000528158	8	30924551 - 30924552	8	31067035 - 31067036	528158	524041	rs1554519254	NC_000008.11:31067035:AAA:AAAAA
NM_000553.5(WRN):c.2332C>T (p.Gln778Ter)	WRN	Q778*	Werner syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000528157	8	30973928	8	31116412	528157	524082	rs1554527775	NC_000008.11:31116411:C:T
NM_000553.5(WRN):c.2604G>A (p.Trp868Ter)	WRN	W868*	Werner syndrome	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000528134	8	30977914	8	31120398	528134	524116	rs1554528411	NC_000008.11:31120397:G:A
NM_000553.5(WRN):c.522_523dup (p.Trp175Serfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000528095	8	30924565 - 30924566	8	31067049 - 31067050	528095	524043	rs1361270203	NC_000008.11:31067049:CT:CTCT
NM_000553.5(WRN):c.3408dup (p.Ala1137Serfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000458452	8	31004588 - 31004589	8	31147072 - 31147073	458452	458438	rs1284409960	NC_000008.11:31147072:AAAAA:AAAAAA
NM_000553.5(WRN):c.327T>A (p.Cys109Ter)	WRN	C109*	Werner syndrome	Pathogenic(Last reviewed: Jul 16, 2017)	criteria provided, single submitter	VCV000458445	8	30921922	8	31064406	458445	457738	rs371538747	NC_000008.11:31064405:T:A
NM_000553.5(WRN):c.3037_3038delAG (p.Ser1013Leufs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000458440	8	30999011 - 30999012	8	31141495 - 31141496	458440	457800	rs759972548	NC_000008.11:31141494:AGAGAG:AGAG
NM_000553.6(WRN):c.229dup (p.Asp77Glyfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000458413	8	30921820 - 30921821	8	31064304 - 31064305	458413	458696	rs747587698	NC_000008.11:31064304:GGGG:GGGGG
NM_000553.5(WRN):c.2107dup (p.Thr703Asnfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000458405	8	30969148 - 30969149	8	31111632 - 31111633	458405	458786	rs1554526707	NC_000008.11:31111632:A:AA
NC_000008.10:g.(?_30916663)_(30916787_?)del	WRN		Werner syndrome	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000458372	8	30916663 - 30916787	8	31059147 - 31059271	458372	457695		
NC_000008.10:g.(?_31007857)_(31015046_?)del	WRN		Werner syndrome	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000417322	8	31007857 - 31015046	8	31150341 - 31157530	417322	396110		
NM_000553.4(WRN):c.2665C>T (p.Arg889Ter)	WRN	R889*	Werner syndrome	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000404045	8	30982072	8	31124556	404045	396209	rs774765029	NC_000008.11:31124555:C:T
NM_000553.4(WRN):c.673C>T (p.Arg225Ter)	WRN	R225*	Werner syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000404010	8	30925792	8	31068276	404010	396812	rs370324188	NC_000008.11:31068275:C:T
NM_000553.4(WRN):c.2546_2547dupAT (p.Gln850Ilefs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000238140	8	30977854 - 30977855	8	31120338 - 31120339	238140	240368	rs878854136	NC_000008.11:31120338:TAT:TATAT
NM_000553.4(WRN):c.15delA (p.Lys5Asnfs)	WRN	K5fs	Werner syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000238124	8	30915971	8	31058455	238124	240338	rs878854133	NC_000008.11:31058454:AAAAAAAA:AAAAAAA
NM_000553.4(WRN):c.3460-2A>C	WRN		Werner syndrome	Pathogenic(Last reviewed: Nov 17, 2011)	no assertion criteria provided	VCV000038889	8	31004878	8	31147362	38889	47492	rs281865159	NC_000008.11:31147361:A:C
RECQL2, 1-BP DEL, NT1396	WRN		Werner syndrome	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000005451					5451	20490		
NM_000553.4(WRN):c.3686A>T (p.Gln1229Leu)	WRN	Q1229L	Werner syndrome	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000005450	8	31007970	8	31150454	5450	20489	rs369158322	NC_000008.11:31150453:A:T
NM_000553.5(WRN):c.3915dup (p.Ala1306Serfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000005448	8	31014978 - 31014979	8	31157462 - 31157463	5448	20487	rs587776621	NC_000008.11:31157462:A:AA
NM_183050.4(BCKDHB):c.548G>C (p.Arg183Pro)	BCKDHB	R183P, R113P	Maple syrup urine disease type 1B|Maple syrup urine disease|MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011937	6	80878662	6	80168945	11937	26976	rs79761867	NC_000006.12:80168944:G:C
NM_000553.6(WRN):c.171C>A (p.Tyr57Ter)	WRN	Y57*	Werner syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000862046	8	30916743	8	31059227	862046	834597		NC_000008.11:31059226:C:A
NM_000553.6(WRN):c.1486A>T (p.Lys496Ter)	WRN	K496*	Werner syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000835120	8	30945346	8	31087830	835120	834638		NC_000008.11:31087829:A:T
NC_000008.11:g.(?_31108591)_(31125010_?)del	WRN		Werner syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832593	8	30966107 - 30982526			832593	819959		
NM_000553.4(WRN):c.525delG (p.Trp175Terfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000579824	8	30924568	8	31067052	579824	562819	rs752830087	NC_000008.11:31067051:GG:G
NM_000553.4(WRN):c.3030_3033delAACA (p.Thr1011Argfs)	WRN	T1011fs	Werner syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000575023	8	30999006 - 30999009	8	31141490 - 31141493	575023	562892	rs748860208	NC_000008.11:31141489:CAAACA:CA
NM_000553.5(WRN):c.2194C>T (p.Arg732Ter)	WRN	R732*	Werner syndrome	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000528133	8	30969236	8	31111720	528133	524100	rs143916053	NC_000008.11:31111719:C:T
NM_000553.5(WRN):c.2221C>T (p.Arg741Ter)	WRN	R741*	Werner syndrome	Pathogenic(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	VCV000528094	8	30969263	8	31111747	528094	524101	rs763089663	NC_000008.11:31111746:C:T
NM_000553.4(WRN):c.2103_2104delAC (p.Leu702Tyrfs)	WRN	L702fs	Werner syndrome	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000458404	8	30969144 - 30969145	8	31111628 - 31111629	458404	457771	rs1383589957	NC_000008.11:31111627:CAC:C
NM_000553.5(WRN):c.2179dup (p.Cys727Leufs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Nov 17, 2011)	no assertion criteria provided	VCV000038887	8	30969220 - 30969221	8	31111704 - 31111705	38887	47490	rs281865158	NC_000008.11:31111704:T:TT
NM_000553.4(WRN):c.1730A>T (p.Lys577Met)	WRN	K577M	Werner syndrome	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005452	8	30948359	8	31090843	5452	20491	rs121908448	NC_000008.11:31090842:A:T
NM_000255.4(MMUT):c.2150G>T (p.Gly717Val)	MMUT	G717V	not provided|Methylmalonic acidemia|METHYLMALONIC ACIDURIA, mut(-) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001881	6	49399544	6	49431831	1881	16920	rs121918252	NC_000006.12:49431830:C:A
NM_017780.4(CHD7):c.3301T>C (p.Cys1101Arg)	CHD7	C1101R	CHARGE association	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000690306	8	61736498	8	60823939	690306	677982		NC_000008.11:60823938:T:C
NM_017780.4(CHD7):c.6937-2A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000651945	8	61768532	8	60855973	651945	651795		NC_000008.11:60855972:A:G
NM_017780.4(CHD7):c.8023G>T (p.Glu2675Ter)	CHD7	E2675*, E626*	CHARGE association|not provided	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504190	8	61775158	8	60862599	504190	495395	rs748504264	NC_000008.11:60862598:G:T
NM_017780.4(CHD7):c.6199C>T (p.Gln2067Ter)	CHD7	Q2067*	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488803	8	61765483	8	60852924	488803	481823	rs766862122	NC_000008.11:60852923:C:T
NM_017780.4(CHD7):c.2440C>T (p.Gln814Ter)	CHD7	Q814*	CHARGE association	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000488369	8	61714150	8	60801591	488369	481214	rs1554593049	NC_000008.11:60801590:C:T
NM_017780.4(CHD7):c.3655C>T (p.Arg1219Ter)	CHD7	R1219*	CHARGE association|not provided	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279759	8	61743013	8	60830454	279759	264411	rs372174845	NC_000008.11:60830453:C:T
NM_017780.4(CHD7):c.2905_2906del (p.Arg969fs)	CHD7	R969fs	CHARGE association|not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158287	8	61734652 - 61734653	8	60822093 - 60822094	158287	168604	rs587783436	NC_000008.11:60822092:AG:
NM_017780.4(CHD7):c.2839C>T (p.Arg947Ter)	CHD7	R947*	not provided|CHARGE association|	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095781	8	61734586	8	60822027	95781	101678	rs200220845	NC_000008.11:60822026:C:T
NM_017780.4(CHD7):c.4795C>T (p.Gln1599Ter)	CHD7	Q1599*	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	VCV000002038	8	61754556	8	60841997	2038	17077	rs267606724	NC_000008.11:60841996:C:T
NM_017780.4(CHD7):c.2501C>T (p.Ser834Phe)	CHD7	S834F	CHARGE association|Hypogonadotropic hypogonadism 5 without anosmia	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002033	8	61728948	8	60816389	2033	17072	rs121434344	NC_000008.11:60816388:C:T
NM_032888.4(COL27A1):c.371del (p.Leu124fs)	COL27A1	L124fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000520547	9	116930206	9	114167926	520547	511778	rs1554787366	NC_000009.12:114167925:T:
NM_000553.6(WRN):c.2242C>T (p.Gln748Ter)	WRN	Q748*	Werner syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000835212	8	30969284	8	31111768	835212	834660		NC_000008.11:31111767:C:T
NM_000553.6(WRN):c.3383+1G>T	WRN		Werner syndrome	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000644283	8	31001140	8	31143624	644283	651955		NC_000008.11:31143623:G:T
NM_000553.4(WRN):c.502_503delAA (p.Lys168Alafs)	WRN	K168fs	Werner syndrome	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000403979	8	30922574 - 30922575	8	31065058 - 31065059	403979	396161	rs776785728	NC_000008.11:31065057:AAAAA:AAA
NM_000553.4(WRN):c.3590delA (p.Asn1197Thrfs)	WRN	N1197fs	Werner syndrome	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000038890	8	31007871	8	31150355	38890	47493	rs281865160	NC_000008.11:31150354:AAAA:AAA
NM_000553.4(WRN):c.2089-3024A>G	WRN		Werner syndrome	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000038886	8	30966107	8	31108591	38886	47489	rs281865157	NC_000008.11:31108590:A:G
NM_000553.4(WRN):c.3493C>T (p.Gln1165Ter)	WRN	Q1165*	Werner syndrome	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000005445	8	31004913	8	31147397	5445	20484	rs121908447	NC_000008.11:31147396:C:T
NM_004329.2(BMPR1A):c.934del (p.His312fs)	BMPR1A	H312fs	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411641	10	88678993	10	86919236	411641	397650	rs1060503408	NC_000010.11:86919235:CC:C
NM_004329.2(BMPR1A):c.176del (p.Phe58_Leu59insTer)	BMPR1A		Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183711	10	88649922	10	86890165	183711	182963	rs786201038	NC_000010.11:86890164:TTTTTT:TTTTT
NM_005476.7(GNE):c.647T>C (p.Val216Ala)	GNE	V216A, V247A, V211A	not provided|GNE myopathy|Sialuria|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218297	9	36236951	9	36236954	218297	214934	rs779694939	NC_000009.12:36236953:A:G
NM_000162.5(GCK):c.766G>A (p.Glu256Lys)	GCK	E256K, E257K, E255K	Maturity-onset diabetes of the young, type 2|Permanent neonatal diabetes mellitus|Diabetes mellitus type 2|Hyperinsulinism due to glucokinase deficiency|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265175	7	44187346	7	44147747	265175	259865	rs769268803	NC_000007.14:44147746:C:T
NM_000162.5(GCK):c.781G>A (p.Gly261Arg)	GCK	G261R, G262R, G260R	not provided|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016135	7	44187331	7	44147732	16135	31174	rs104894008	NC_000007.14:44147731:C:T
NM_000136.3(FANCC):c.521+1G>A	FANCC		Fanconi anemia|Fanconi anemia, complementation group C|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237074	9	97933360	9	95171078	237074	240638	rs145394391	NC_000009.12:95171077:C:T
NM_001277115.2(DNAH11):c.6727C>T (p.Arg2243Ter)	DNAH11	R2243*	Primary ciliary dyskinesia|not provided|Ciliary dyskinesia, primary, 7	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289324	7	21750214	7	21710596	289324	273561	rs201943194	NC_000007.14:21710595:C:T
NM_000553.4:c.1578delC	WRN	L528fs	not provided|Werner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000624320	8	30946407	8	31088891	624320	612815	rs780555196	NC_000008.11:31088890:C:
NM_000553.4(WRN):c.2959C>T (p.Arg987Ter)	WRN	R987*	Werner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000362809	8	30990014	8	31132498	362809	314093	rs747319628	NC_000008.11:31132497:C:T
NM_000553.5(WRN):c.487_488del (p.Asp163Cysfs)	WRN	D163fs	Werner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208642	8	30922561 - 30922562	8	31065045 - 31065046	208642	205206	rs797045118	NC_000008.11:31065044:AGA:A
NM_000553.4(WRN):c.3690_3693delAGAC (p.Asp1231Serfs)	WRN		Werner syndrome	Pathogenic(Last reviewed: Nov 3, 2018)	criteria provided, single submitter	VCV000005446	8	31012142 - 31012145	8	31154622 - 31154625	5446	20485	rs606231162	
NM_003002.4(SDHD):c.57del (p.Leu20fs)	SDHD	L20fs	not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006917	11	111958585	11	112087861	6917	21956	rs587776649	NC_000011.10:112087860:G:
NM_001370259.2(MEN1):c.1672_1679del (p.Met558fs)	MEN1	M563fs, M523fs, M558fs, M600fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000859580	11	64571960 - 64571967	11	64804488 - 64804495	859580	838707		NC_000011.10:64804487:CCCTTCATC:C
NM_001370259.2(MEN1):c.1136dup (p.Ala380fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811888	11	64573155 - 64573156	11	64805683 - 64805684	811888	799656		NC_000011.10:64805683:G:GG
NM_000244.3(MEN1):c.1268_1271del (p.Asp423fs)	MEN1	D383fs, D460fs, D418fs, D423fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000663669	11	64572600 - 64572603	11	64805128 - 64805131	663669	640271		NC_000011.10:64805127:CCGTC:C
NM_001370259.2(MEN1):c.734del (p.Pro245fs)	MEN1	P245fs, P210fs, P250fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000623186	11	64575073	11	64807601	623186	612191	rs1565646772	NC_000011.10:64807600:GGG:GG
NM_000244.3(MEN1):c.674G>A (p.Trp225Ter)	MEN1	W225*, W220*, W185*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000574621	11	64575148	11	64807676	574621	570799	rs1565647197	NC_000011.10:64807675:C:T
NM_000244.3(MEN1):c.640C>T (p.Gln214Ter)	MEN1	Q214*, Q209*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000571001	11	64575392	11	64807920	571001	566009	rs1565647767	NC_000011.10:64807919:G:A
NM_000244.3(MEN1):c.838del (p.Arg280fs)	MEN1	R240fs, R275fs, R280fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000527280	11	64574652	11	64807180	527280	526883	rs1555165360	NC_000011.10:64807179:TTT:TT
NM_000244.3(MEN1):c.231C>G (p.Tyr77Ter)	MEN1	Y77*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000527270	11	64577351	11	64809879	527270	526405	rs1555166567	NC_000011.10:64809878:G:C
NM_000244.3(MEN1):c.696C>A (p.Tyr232Ter)	MEN1	Y227*, Y232*, Y192*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 3, 2018)	criteria provided, single submitter	VCV000457331	11	64575126	11	64807654	457331	461846	rs778921501	NC_000011.10:64807653:G:T
MEN1, 1-BP INS, 1657C	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000016709					16709	31748		
MEN1, 12-BP DEL, NT1466	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000016708					16708	31747		
MEN1, 3-BP DEL, 2641GAA	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016701					16701	31740		
NM_000260.4(MYO7A):c.2307del (p.Asn769fs)	MYO7A	N758fs, N769fs	|Deafness, autosomal recessive 2|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000402264	11	76890115	11	77179069	402264	389240	rs1060499800	NC_000011.10:77179068:C:
NM_000260.4(MYO7A):c.3724C>T (p.Gln1242Ter)	MYO7A	Q1242*, Q1231*	not provided|Deafness, autosomal recessive 2||Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372560	11	76901158	11	77190113	372560	360049	rs1057517857	NC_000011.10:77190112:C:T
NM_000260.4(MYO7A):c.470+1G>A	MYO7A		|Deafness, autosomal recessive 2||Rare genetic deafness	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000177712	11	76867138	11	77156092	177712	178183	rs797044510	NC_000011.10:77156091:G:A
NM_000260.4(MYO7A):c.5101C>T (p.Arg1701Ter)	MYO7A	R1701*, R1663*, R1652*	Rare genetic deafness|Retinal dystrophy|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043270	11	76913402	11	77202357	43270	52440	rs111033182	NC_000011.10:77202356:C:T
NM_017780.4(CHD7):c.4353+1G>T	CHD7		CHARGE association	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000854953	8	61750395	8	60837836	854953	852142		NC_000008.11:60837835:G:T
NM_017780.4(CHD7):c.2959C>T (p.Arg987Ter)	CHD7	R987*	CHARGE association|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267421	8	61735063	8	60822504	267421	262646	rs886040983	NC_000008.11:60822503:C:T
NM_017780.4(CHD7):c.3379-2A>C	CHD7		CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220434	8	61741220	8	60828661	220434	221761	rs864622523	NC_000008.11:60828660:A:C
NM_017780.4(CHD7):c.7891C>T (p.Arg2631Ter)	CHD7	R2631*, R582*	CHARGE association|not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158320	8	61774815	8	60862256	158320	168636	rs587783457	NC_000008.11:60862255:C:T
NM_017780.4(CHD7):c.5458C>T (p.Arg1820Ter)	CHD7	R1820*	CHARGE association|not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158302	8	61763105	8	60850546	158302	168618	rs587783446	NC_000008.11:60850545:C:T
NM_005591.3(MRE11):c.659+1G>A	MRE11		Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder 1|Ataxia-telangiectasia-like disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230014	11	94209454	11	94476288	230014	234531	rs759130031	NC_000011.10:94476287:C:T
NM_005591.3(MRE11):c.1090C>T (p.Arg364Ter)	MRE11	R364*	Ataxia-telangiectasia-like disorder 1|Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000140953	11	94200987	11	94467821	140953	150667	rs371077728	NC_000011.10:94467820:G:A
NM_017841.2(SDHAF2):c.232G>A (p.Gly78Arg)	SDHAF2	G78R	Hereditary cancer-predisposing syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 2	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000401	11	61205292	11	61437820	401	15440	rs113560320	NC_000011.10:61437819:G:A
NM_000552.4(VWF):c.4120C>T (p.Arg1374Cys)	VWF	R1374C	von Willebrand disorder|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100329	12	6128464	12	6019298	100329	106206	rs61750071	NC_000012.12:6019297:G:A
NM_001164277.1(SLC37A4):c.1015G>T (p.Gly339Cys)	SLC37A4	G339C, G266C, G361C	Glucose-6-phosphate transport defect|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006921	11	118896009	11	119025299	6921	21960	rs80356490	NC_000011.10:119025298:C:A
NM_022970.3(FGFR2):c.1087+1303T>A	FGFR2	C342S, C227S, C253S, C114S	Jackson-Weiss syndrome|Pfeiffer syndrome|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013267	10	123276893	10	121517379	13267	28306	rs121918488	NC_000010.11:121517378:A:T
NC_000010.11:g.(?_86755016)_(86923719_?)del	BMPR1A		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000832499	10	88514773 - 88683476			832499	820249		
NM_004329.2(BMPR1A):c.1081C>T (p.Arg361Ter)	BMPR1A	R361*	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183728	10	88679141	10	86919384	183728	182979	rs764466442	NC_000010.11:86919383:C:T
NM_004329.2(BMPR1A):c.1480C>T (p.Arg494Ter)	BMPR1A	R494*	Juvenile polyposis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183720	10	88683357	10	86923600	183720	182987	rs786201040	NC_000010.11:86923599:C:T
NM_004333.6(BRAF):c.1798_1799delinsAG (p.Val600Arg)	BRAF		Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375940	7	140453136 - 140453137	7	140753336 - 140753337	375940	362819	rs121913227	NC_000007.14:140753335:AC:CT
NM_001130438.3(SPTAN1):c.6899_6907ACCAGCTGG[3] (p.2300_2302DQL[3])	SPTAN1		not provided|Seizures|Early infantile epileptic encephalopathy 5|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160028	9	131394539 - 131394540	9	128632260 - 128632261	160028	168792	rs587784440	NC_000009.12:128632260:GGACCAGCTGGACCAGCTGG:GGACCAGCTGGACCAGCTGGACCAGCTGG
NM_001382.4(DPAGT1):c.380_395dup (p.Ser133fs)	DPAGT1		Inborn genetic diseases|DPAGT1-CDG|Congenital myasthenic syndrome 13	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521720	11	118971440 - 118971441	11	119100730 - 119100731	521720	511902	rs1185483085	NC_000011.10:119100730:GCAGCTGTAGGTAGCAGCAGCT:GCAGCTGTAGGTAGCAGCAGCTGTAGGTAGCAGCAGCT
NM_001142800.2(EYS):c.5928-2A>G	EYS		Retinitis pigmentosa 25|Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438200	6	65098735	6	64388842	438200	431705	rs181169439	NC_000006.12:64388841:T:C
NM_213599.2(ANO5):c.1898+1G>A	ANO5		not provided|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194805	11	22284590	11	22263044	194805	191968	rs142027093	NC_000011.10:22263043:G:A
NM_033360.4(KRAS):c.437C>T (p.Ala146Val)	KRAS	A146V	Neoplasm of the large intestine|Non-small cell lung cancer|OCULOECTODERMAL SYNDROME, SOMATIC|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000375962	12	25378561	12	25225627	375962	362841	rs1057519725	NC_000012.12:25225626:G:A
NM_000553.6(WRN):c.3913C>T (p.Arg1305Ter)	WRN	R1305*	Werner syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005444	8	31014977	8	31157461	5444	20483	rs121908446	NC_000008.11:31157460:C:T
NM_000260.4(MYO7A):c.52C>T (p.Gln18Ter)	MYO7A	Q18*, Q7*	Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000504505	11	76853788	11	77142742	504505	497811	rs1555051455	NC_000011.10:77142741:C:T
NM_000260.4(MYO7A):c.1555-8C>G	MYO7A		not provided|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372430	11	76873891	11	77162845	372430	359920	rs1057517774	NC_000011.10:77162844:C:G
NM_000260.4(MYO7A):c.2323C>T (p.Gln775Ter)	MYO7A	Q775*, Q764*	|Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371700	11	76890131	11	77179085	371700	358080	rs201892914	NC_000011.10:77179084:C:T
NM_000260.4(MYO7A):c.6070C>T (p.Arg2024Ter)	MYO7A	R2024*, R1975*, R1986*	|Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043318	11	76922215	11	77211170	43318	52488	rs111033198	NC_000011.10:77211169:C:T
NM_000260.4(MYO7A):c.401T>A (p.Ile134Asn)	MYO7A	I134N, I123N	Retinal dystrophy|Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043230	11	76867068	11	77156022	43230	52400	rs111033181	NC_000011.10:77156021:T:A
NM_000441.2(SLC26A4):c.2089+1G>A	SLC26A4		Pendred syndrome|not provided|Enlarged vestibular aqueduct|Rare genetic deafness	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000165263	7	107344831	7	107704386	165263	174032	rs727503430	NC_000007.14:107704385:G:A
NM_020822.3(KCNT1):c.862G>A (p.Gly288Ser)	KCNT1	G288S, G243S	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|Early infantile epileptic encephalopathy 14|not provided	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126421	9	138651532	9	135759686	126421	131953	rs587777264	NC_000009.12:135759685:G:A
NM_001370259.2(MEN1):c.1A>C (p.Met1Leu)	MEN1	M1L	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000850884	11	64577581	11	64810109	850884	838754		NC_000011.10:64810108:T:G
NC_000011.10:g.(?_64804334)_(64810716_?)del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000832847	11	64571806 - 64578188			832847	820400		
NM_001370259.2(MEN1):c.1670del (p.Lys557fs)	MEN1	K557fs, K522fs, K562fs, K599fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000666173	11	64571969	11	64804497	666173	640255		NC_000011.10:64804496:TT:T
NM_000244.3(MEN1):c.839G>A (p.Arg280Lys)	MEN1	R240K, R280K, R275K	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000662978	11	64574651	11	64807179	662978	640288		NC_000011.10:64807178:C:T
NM_000244.3(MEN1):c.461-1G>C	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000662500	11	64575572	11	64808100	662500	652225		NC_000011.10:64808099:C:G
NC_000011.9:g.(?_64571796)_(64578188_?)del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000655218	11	64571796 - 64578188	11	64804324 - 64810716	655218	652380		
NM_000244.3(MEN1):c.1065-2A>G	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000646754	11	64573244	11	64805772	646754	652582		NC_000011.10:64805771:T:C
NM_000244.3(MEN1):c.1065-2A>T	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000576171	11	64573244	11	64805772	576171	565979	rs1565642765	NC_000011.10:64805771:T:A
NM_000244.3(MEN1):c.1488del (p.Glu496fs)	MEN1	E491fs, E533fs, E456fs, E496fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527285	11	64572166	11	64804694	527285	526591	rs1555163646	NC_000011.10:64804693:C:
NM_000244.3(MEN1):c.927+1G>C	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428012	11	64574482	11	64807010	428012	419824	rs398124437	NC_000011.10:64807009:C:G
NM_000244.3(MEN1):c.168del (p.Asn57fs)	MEN1	N57fs	not provided|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000403837	11	64577414	11	64809942	403837	398892	rs1060499990	NC_000011.10:64809941:GG:G
NM_000244.3(MEN1):c.1189G>T (p.Glu397Ter)	MEN1	E397*, E392*, E434*, E357*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000403811	11	64573118	11	64805646	403811	398854	rs772588551	NC_000011.10:64805645:C:A
NM_000244.3(MEN1):c.609G>A (p.Trp203Ter)	MEN1	W198*, W203*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000201010	11	64575423	11	64807951	201010	197549	rs104894257	NC_000011.10:64807950:C:T
NM_000244.3(MEN1):c.563G>A (p.Trp188Ter)	MEN1	W183*, W188*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201009	11	64575469	11	64807997	201009	197550	rs794728650	NC_000011.10:64807996:C:T
NM_000244.3(MEN1):c.252dup (p.Ile85fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036528	11	64577329 - 64577330	11	64809857 - 64809858	36528	45190	rs386134253	NC_000011.10:64809857:A:AA
NM_000244.3(MEN1):c.793C>T (p.Gln265Ter)	MEN1	Q260*, Q265*, Q225*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000016690	11	64575029	11	64807557	16690	31729	rs104894266	NC_000011.10:64807556:G:A
NM_017780.4(CHD7):c.7282C>T (p.Arg2428Ter)	CHD7	R2428*	CHARGE association	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523619	8	61769121	8	60856562	523619	514270	rs1320897198	NC_000008.11:60856561:C:T
NM_017780.4(CHD7):c.3106C>T (p.Arg1036Ter)	CHD7	R1036*	not provided|CHARGE association	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488373	8	61735210	8	60822651	488373	481216	rs1554597716	NC_000008.11:60822650:C:T
NM_017780.4(CHD7):c.5428C>T (p.Arg1810Ter)	CHD7	R1810*	CHARGE association|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459555	8	61763075	8	60850516	459555	458975	rs1554603552	NC_000008.11:60850515:C:T
NM_005590.4(MRE11):c.1726C>T (p.Arg576Ter)	MRE11	R576*	Ataxia-telangiectasia-like disorder 1|Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184445	11	94180442	11	94447276	184445	183503	rs774277300	NC_000011.10:94447275:G:A
NM_005591.4(MRE11):c.630G>C (p.Trp210Cys)	MRE11	W210C	Ataxia-telangiectasia-like disorder 1|not provided	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000008786	11	94209484	11	94476318	8786	23825	rs137852763	NC_000011.10:94476317:C:G
NM_000136.3(FANCC):c.485_486GA[1] (p.Glu163fs)	FANCC		not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182465	9	97933392 - 97933395	9	95171110 - 95171113	182465	180355	rs730881708	NC_000009.12:95171109:TCTCTCT:TCT
NM_033056.4(PCDH15):c.16del (p.Tyr6fs)	PCDH15	Y6fs	not provided|||USHER SYNDROME, TYPE ID/F, DIGENIC|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000046446	10	56424007	10	54664247	46446	55611	rs397517451	NC_000010.11:54664246:AAAA:AAA
NM_004329.2(BMPR1A):c.1A>G (p.Met1Val)	BMPR1A	M1V	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186704	10	88635776	10	86876019	186704	182959	rs786203157	NC_000010.11:86876018:A:G
NM_004329.2(BMPR1A):c.682C>T (p.Arg228Ter)	BMPR1A	R228*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000142735	10	88676897	10	86917140	142735	152449	rs587782682	NC_000010.11:86917139:C:T
NM_000155.4(GALT):c.610C>T (p.Arg204Ter)	GALT	R204*, R95*	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025228	9	34648376	9	34648379	25228	36562	rs111033737	NC_000009.12:34648378:C:T
NM_000155.4(GALT):c.997C>G (p.Arg333Gly)	GALT	R333G, R224G	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003623	9	34649499	9	34649502	3623	18662	rs111033800	NC_000009.12:34649501:C:G
NM_000719.7(CACNA1C):c.2578C>G (p.Arg860Gly)	CACNA1C	R860G, R857G	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000190702	12	2702426	12	2593260	190702	188573	rs758786846	NC_000012.12:2593259:C:G
NM_000719.7(CACNA1C):c.4425C>G (p.Ile1475Met)	CACNA1C	I1475M, I1523M, I1462M, I1495M, I1492M, I1464M, I1497M, I1472M, I1503M	Long QT syndrome 8	Pathogenic(Last reviewed: Jun 5, 2019)	no assertion criteria provided	VCV000633648	12	2774773	12	2665607	633648	622080	rs1569139160	NC_000012.12:2665606:C:G
NM_000719.7(CACNA1C):c.1745C>A (p.Ala582Asp)	CACNA1C	A582D, A579D	Long QT syndrome 8	Pathogenic(Last reviewed: Jun 5, 2019)	no assertion criteria provided	VCV000633647	12	2676810	12	2567644	633647	622079	rs1568469857	NC_000012.12:2567643:C:A
NM_000719.7(CACNA1C):c.2500A>G (p.Lys834Glu)	CACNA1C	K834E, K831E	Long QT syndrome 8	Pathogenic(Last reviewed: Jun 5, 2019)	no assertion criteria provided	VCV000633645	12	2695040	12	2585874	633645	622077	rs1555836187	NC_000012.12:2585873:A:G
NM_000719.7(CACNA1C):c.2570C>G (p.Pro857Arg)	CACNA1C	P857R, P854R	Long QT syndrome 8	Pathogenic(Last reviewed: Jun 5, 2019)	no assertion criteria provided	VCV000633643	12	2702418	12	2593252	633643	622075	rs750835733	NC_000012.12:2593251:C:G
NM_000719.7(CACNA1C):c.1114-304G>A	CACNA1C	G406R	not provided|Timothy syndrome	Pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	VCV000190633	12	2613704	12	2504538	190633	188541	rs786205745	NC_000012.12:2504537:G:A
NM_000719.7(CACNA1C):c.1114-304G>C	CACNA1C	G406R	Timothy syndrome|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190634	12	2613704	12	2504538	190634	188542	rs786205745	NC_000012.12:2504537:G:C
NM_000719.7(CACNA1C):c.1552C>T (p.Arg518Cys)	CACNA1C	R518C, R515C	not provided|Long QT syndrome	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190642	12	2675631	12	2566465	190642	188554	rs786205748	NC_000012.12:2566464:C:T
NM_000255.4(MMUT):c.323G>A (p.Arg108His)	MMUT	R108H	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic acidemia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100707	6	49426857	6	49459144	100707	106572	rs483352778	NC_000006.12:49459143:C:T
NM_017890.4(VPS13B):c.6879del (p.Phe2293fs)	VPS13B	F2293fs, F2268fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000817631	8	100732717	8	99720489	817631	805591		NC_000008.11:99720488:TTT:TT
GRCh37/hg19 8q22.2(chr8:100120427-100423020)x1	VPS13B		not provided	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000689112	8	100120427 - 100423020			689112	676704		
GRCh37/hg19 8q22.2(chr8:99991771-100220890)x1	VPS13B		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000688896	8	99991771 - 100220890			688896	676488		
GRCh37/hg19 8q22.2(chr8:100091912-100198780)x1	VPS13B		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	no assertion criteria provided	VCV000687432	8	100091912 - 100198780			687432	675024		
NM_017890.4(VPS13B):c.7522C>T (p.Gln2508Ter)	VPS13B	Q2483*, Q2508*	not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000620417	8	100790927	8	99778699	620417	611707	rs980463746	NC_000008.11:99778698:C:T
NM_017890.4(VPS13B):c.8014C>T (p.Gln2672Ter)	VPS13B	Q2647*, Q2672*	not provided	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000620341	8	100796702	8	99784474	620341	611708	rs753282248	NC_000008.11:99784473:C:T
NM_017890.4(VPS13B):c.9709C>T (p.Gln3237Ter)	VPS13B	Q3212*, Q3237*	not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000620087	8	100847444	8	99835216	620087	611709	rs1563499381	NC_000008.11:99835215:C:T
NM_017890.4(VPS13B):c.6823C>T (p.Gln2275Ter)	VPS13B	Q2250*, Q2275*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000588148	8	100732663	8	99720435	588148	579490	rs1014496937	NC_000008.11:99720434:C:T
NM_015243.2(VPS13B):c.1336C>T (p.Gln446Ter)	VPS13B	Q446*	not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000504075	8	100147276	8	99135048	504075	495241	rs1554634138	NC_000008.11:99135047:C:T
NM_017890.4(VPS13B):c.6030G>A (p.Trp2010Ter)	VPS13B	W1985*, W2010*	not provided	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000451620	8	100673628	8	99661400	451620	444317	rs1554892040	NC_000008.11:99661399:G:A
NM_017890.4(VPS13B):c.8362del (p.Ala2788fs)	VPS13B	A2788fs, A2763fs	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000451400	8	100829956	8	99817728	451400	444318	rs1554565645	NC_000008.11:99817727:GG:G
NM_015243.2(VPS13B):c.816dup (p.Met273fs)	VPS13B		not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000450634	8	100127980 - 100127981	8	99115752 - 99115753	450634	444313	rs1554622647	NC_000008.11:99115752:T:TT
NM_015243.2(VPS13B):c.2018C>G (p.Ser673Ter)	VPS13B	S673*	not provided	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000450566	8	100168781	8	99156553	450566	444314	rs1554645551	NC_000008.11:99156552:C:G
NM_017890.4(VPS13B):c.11468-2A>C	VPS13B		not provided	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000449623	8	100883011	8	99870783	449623	444320	rs1554588038	NC_000008.11:99870782:A:C
NM_017890.4(VPS13B):c.5984-2A>T	VPS13B		not provided	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000449599	8	100673580	8	99661352	449599	444316	rs1554892004	NC_000008.11:99661351:A:T
NM_017890.4(VPS13B):c.6384_6385del (p.Ser2129fs)	VPS13B	S2104fs, S2129fs	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000424350	8	100712014 - 100712015	8	99699786 - 99699787	424350	407506	rs1064796925	NC_000008.11:99699785:TTT:T
NM_017890.4(VPS13B):c.11199_11200delinsT (p.Asn3734fs)	VPS13B		not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000419248	8	100874083 - 100874084	8	99861855 - 99861856	419248	407508	rs1064793747	NC_000008.11:99861854:CA:T
NM_017890.4(VPS13B):c.2788C>T (p.Gln930Ter)	VPS13B	Q930*	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000392412	8	100287446	8	99275218	392412	370420	rs372949456	NC_000008.11:99275217:C:T
NM_015243.2(VPS13B):c.292-1G>A	VPS13B		not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000379880	8	100108539	8	99096311	379880	372039	rs1057520768	NC_000008.11:99096310:G:A
NM_017890.4(VPS13B):c.11246_11249dup (p.Leu3751fs)	VPS13B		not provided	Pathogenic(Last reviewed: Nov 20, 2016)	criteria provided, single submitter	VCV000373116	8	100874128 - 100874129	8	99861900 - 99861901	373116	359718	rs1057518228	NC_000008.11:99861900:GAGGG:GAGGGAGGG
NM_017890.4(VPS13B):c.5080dup (p.Ser1694fs)	VPS13B		not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000284716	8	100587936 - 100587937	8	99575708 - 99575709	284716	268953	rs886042930	NC_000008.11:99575708:TTTTT:TTTTTT
NM_017890.4(VPS13B):c.6200T>A (p.Leu2067Ter)	VPS13B	L2042*, L2067*	not provided	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000280580	8	100711831	8	99699603	280580	264295	rs371364257	NC_000008.11:99699602:T:A
NM_017890.4(VPS13B):c.8254C>T (p.Gln2752Ter)	VPS13B	Q2727*, Q2752*	not provided	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000280484	8	100829849	8	99817621	280484	264300	rs886041678	NC_000008.11:99817620:C:T
NM_017890.4(VPS13B):c.7623_7626TGTC[1] (p.Cys2543fs)	VPS13B		not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000280369	8	100791026 - 100791029	8	99778798 - 99778801	280369	264406	rs886041587	NC_000008.11:99778797:TCTGTCTGTC:TCTGTC
NM_017890.4(VPS13B):c.11453C>G (p.Ser3818Ter)	VPS13B	S3793*, S3818*	not provided	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000198021	8	100880679	8	99868451	198021	195182	rs794727771	NC_000008.11:99868450:C:G
GRCh37/hg19 8q22.2(chr8:100123326-100182391)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000813330	8	100123326 - 100182391			813330	801577		
NM_017890.4(VPS13B):c.5417dup (p.Gln1807fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812464	8	100654159 - 100654160	8	99641931 - 99641932	812464	800543		NC_000008.11:99641931:T:TT
NM_017890.4(VPS13B):c.11504_11507dup (p.Arg3837fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802431	8	100883046 - 100883047	8	99870818 - 99870819	802431	790831		NC_000008.11:99870818:CAAACA:CAAACAAACA
NM_017890.4(VPS13B):c.5295G>T (p.Glu1765Asp)	VPS13B	E1740D, E1765D	Cohen syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802428	8	100589861	8	99577633	802428	790828		NC_000008.11:99577632:G:T
NM_015243.2(VPS13B):c.1079del (p.Asp360fs)	VPS13B	D360fs	Cohen syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802427	8	100133546	8	99121318	802427	790827		NC_000008.11:99121317:A:
NM_017890.4(VPS13B):c.8318C>T (p.Ser2773Leu)	VPS13B	S2748L, S2773L	not provided	Pathogenic	no assertion criteria provided	VCV000068093	8	100829913	8	99817685	68093	78984	rs180177370	NC_000008.11:99817684:C:T
NM_017890.4(VPS13B):c.8292C>A (p.Cys2764Ter)	VPS13B	C2739*, C2764*	not provided	Pathogenic	no assertion criteria provided	VCV000068092	8	100829887	8	99817659	68092	78983	rs180177369	NC_000008.11:99817658:C:A
NM_017890.4(VPS13B):c.7322_7322+1delinsATGGAGC	VPS13B		not provided	Pathogenic	no assertion criteria provided	VCV000068091	8	100779198 - 100779199	8	99766970 - 99766971	68091	78982	rs180177367	NC_000008.11:99766969:GG:ATGGAGC
NM_017890.4(VPS13B):c.7153G>T (p.Glu2385Ter)	VPS13B	E2360*, E2385*	not provided	Pathogenic	no assertion criteria provided	VCV000068090	8	100779029	8	99766801	68090	78981	rs180177368	NC_000008.11:99766800:G:T
NM_017890.4(VPS13B):c.4955C>G (p.Ser1652Ter)	VPS13B	S1627*, S1652*	not provided	Pathogenic	no assertion criteria provided	VCV000068087	8	100568812	8	99556584	68087	78978	rs180177361	NC_000008.11:99556583:C:G
NM_015243.2(VPS13B):c.1563G>A (p.Lys521=)	VPS13B		not provided	Pathogenic	no assertion criteria provided	VCV000068084	8	100147961	8	99135733	68084	78975	rs180177355	NC_000008.11:99135732:G:A
NM_017890.4(VPS13B):c.11562_11563AT[1] (p.Tyr3855fs)	VPS13B		not provided	Pathogenic	no assertion criteria provided	VCV000068082	8	100883107 - 100883108	8	99870879 - 99870880	68082	78973	rs180177373	NC_000008.11:99870878:ATAT:AT
NM_017890.4(VPS13B):c.11245G>T (p.Glu3749Ter)	VPS13B	E3724*, E3749*	not provided	Pathogenic	no assertion criteria provided	VCV000068081	8	100874129	8	99861901	68081	78972	rs180177372	NC_000008.11:99861900:G:T
NM_017890.4(VPS13B):c.11439del (p.Ala3814fs)	VPS13B	A3814fs, A3789fs	Cohen syndrome	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000864213	8	100880665	8	99868437	864213	835273		NC_000008.11:99868436:T:
NM_015243.2(VPS13B):c.2347_2348del (p.Gln783fs)	VPS13B	Q783fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000862275	8	100205117 - 100205118	8	99192889 - 99192890	862275	835193		NC_000008.11:99192888:CA:
NM_017890.4(VPS13B):c.5429_5450del (p.Gln1810fs)	VPS13B	Q1810fs, Q1785fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000858359	8	100654172 - 100654193	8	99641944 - 99641965	858359	835222		NC_000008.11:99641943:AGCACAGTGGTGCCAGTCAGCA:
NM_017890.4(VPS13B):c.7903del (p.Cys2635fs)	VPS13B	C2635fs, C2610fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000854662	8	100796591	8	99784363	854662	835247		NC_000008.11:99784362:T:
NM_017890.4(VPS13B):c.6806del (p.Glu2269fs)	VPS13B	E2244fs, E2269fs	Cohen syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000846904	8	100732646	8	99720418	846904	835231		NC_000008.11:99720417:A:
NM_017890.4(VPS13B):c.11206C>T (p.Gln3736Ter)	VPS13B	Q3711*, Q3736*	Cohen syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000844524	8	100874090	8	99861862	844524	835270		NC_000008.11:99861861:C:T
NC_000008.11:g.(?_99661344)_(99784486_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000833514	8	100673572 - 100796714			833514	820027		
NC_000008.11:g.(?_99135015)_(99143165_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000832881	8	100147243 - 100155393			832881	820014		
NC_000008.11:g.(?_99096302)_(99136762_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000832379	8	100108530 - 100148990			832379	820005		
NC_000008.11:g.(?_99481579)_(99721067_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000832137	8	100493807 - 100733295			832137	820022		
NC_000008.11:g.(?_99501677)_(99502960_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000832133	8	100513905 - 100515188			832133	820023		
NC_000008.11:g.(?_99013769)_(99209688_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000832081	8	100025997 - 100221916			832081	820003		
NC_000008.11:g.(?_99467404)_(99467644_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000832002	8	100479632 - 100479872			832002	820020		
NC_000008.11:g.(?_99135005)_(99143175_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000831519	8	100147233 - 100155403			831519	820013		
NC_000008.11:g.(?_99391557)_(99556653_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000831437	8	100403785 - 100568881			831437	820019		
NC_000008.11:g.(?_99170039)_(99170163_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000831433	8	100182267 - 100182391			831433	820016		
NC_000008.11:g.(?_99102953)_(99170163_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000831045	8	100115181 - 100182391			831045	820009		
NC_000008.11:g.(?_99520899)_(99584089_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000830905	8	100533127 - 100596317			830905	820025		
NC_000008.11:g.(?_99699505)_(99721067_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000830743	8	100711733 - 100733295			830743	820028		
NC_000008.11:g.(?_99096302)_(99556663_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000830631	8	100108530 - 100568891			830631	820006		
NM_015243.2(VPS13B):c.468_471del (p.Asn157fs)	VPS13B	N157fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812108	8	100115236 - 100115239	8	99103008 - 99103011	812108	800357		NC_000008.11:99103007:TAAT:
NM_017890.4(VPS13B):c.6121+1G>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812107	8	100673720	8	99661492	812107	800371		NC_000008.11:99661491:G:C
NM_017890.4(VPS13B):c.7758del (p.Lys2586fs)	VPS13B	K2561fs, K2586fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812106	8	100791163	8	99778935	812106	800358		NC_000008.11:99778934:G:
NM_015243.2(VPS13B):c.2014-2A>G	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800514	8	100168775	8	99156547	800514	789124		NC_000008.11:99156546:A:G
NM_017890.4(VPS13B):c.8902C>T (p.Arg2968Ter)	VPS13B	R2943*, R2968*	Cohen syndrome	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000663053	8	100832183	8	99819955	663053	637540		NC_000008.11:99819954:C:T
NM_152564.4(VPS13B):c.4874_4875GT[1] (p.Val1626fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000660338	8	100568806 - 100568807	8	99556578 - 99556579	660338	637517		NC_000008.11:99556577:GTGT:GT
NM_152564.4(VPS13B):c.6143_6144CA[2] (p.His2049fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000659660	8	100711849 - 100711850	8	99699621 - 99699622	659660	637528		NC_000008.11:99699620:CACACA:CACA
NM_017890.4(VPS13B):c.8496del (p.Asn2833fs)	VPS13B	N2833fs, N2808fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000658663	8	100830736	8	99818508	658663	637535		NC_000008.11:99818507:CCC:CC
NM_017890.4(VPS13B):c.5246del (p.Gln1748_Leu1749insTer)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000653338	8	100589811	8	99577583	653338	637521		NC_000008.11:99577582:TT:T
NC_000008.10:g.(?_100673562)_(100673739_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000651830	8	100673562 - 100673739	8	99661334 - 99661511	651830	651833		
NC_000008.10:g.(?_100403765)_(100533258_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000650184	8	100403765 - 100533258	8	99391537 - 99521030	650184	651730		
NM_017890.4(VPS13B):c.5608dup (p.Thr1870fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000645667	8	100654345 - 100654346	8	99642117 - 99642118	645667	637523		NC_000008.11:99642117:AAAAAA:AAAAAAA
NM_015243.2(VPS13B):c.572del (p.Asp191fs)	VPS13B	D191fs	Cohen syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000642885	8	100115340	8	99103112	642885	637497		NC_000008.11:99103111:A:
NC_000008.10:g.(?_100568658)_(100589881_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000640450	8	100568658 - 100589881	8	99556430 - 99577653	640450	651831		
NM_017890.4(VPS13B):c.11486dup (p.Leu3830fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638298	8	100883029 - 100883030	8	99870801 - 99870802	638298	626182		NC_000008.11:99870801:GG:GGG
NC_000008.10:g.(?_100568658)_(100654746_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000584011	8	100568658 - 100654746	8	99556430 - 99642518	584011	567309		
NC_000008.10:g.(?_100146840)_(100149000_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000583567	8	100146840 - 100149000	8	99134612 - 99136772	583567	562333		
NC_000008.10:g.(?_100127908)_(100205305_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000583454	8	100127908 - 100205305	8	99115680 - 99193077	583454	564566		
NM_017890.4(VPS13B):c.9491G>A (p.Trp3164Ter)	VPS13B	W3139*, W3164*	Cohen syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000568179	8	100844682	8	99832454	568179	565309	rs1563497844	NC_000008.11:99832453:G:A
NM_015243.2(VPS13B):c.1418del (p.Ser473fs)	VPS13B	S473fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000562046	8	100147358	8	99135130	562046	553172	rs1563560592	NC_000008.11:99135129:G:
NM_017890.4(VPS13B):c.6653_6654insTA (p.Trp2218fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548537	8	100729522 - 100729523	8	99717294 - 99717295	548537	539016	rs1554922054	NC_000008.11:99717294::TA
NM_017890.4(VPS13B):c.4684_4685del (p.Glu1562fs)	VPS13B	E1562fs, E1537fs	Cohen syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548466	8	100523715 - 100523716	8	99511487 - 99511488	548466	539015	rs1554826615	NC_000008.11:99511486:AGA:A
NM_017890.4(VPS13B):c.6374_6383del (p.Trp2125fs)	VPS13B	W2125fs, W2100fs	Cohen syndrome	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000459247	8	100712002 - 100712011	8	99699774 - 99699783	459247	458643	rs1554911731	NC_000008.11:99699773:TGTGGAGAGCTGT:TGT
Single allele	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000459244			8	99121157 - 99193077	459244	457745		
NM_017890.4(VPS13B):c.7174del (p.Ala2392fs)	VPS13B	A2367fs, A2392fs	Cohen syndrome	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000437259	8	100779050	8	99766822	437259	428876	rs1554948192	NC_000008.11:99766821:G:
NM_017890.4(VPS13B):c.4620del (p.Ser1541fs)	VPS13B	S1516fs, S1541fs	Retinal dystrophy|Short foot|Intellectual disability|Neutropenia|Microcephaly|Short stature|Small hand|Progressive visual loss|Recurrent aphthous stomatitis	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000374163	8	100523652	8	99511424	374163	360902	rs1057518939	NC_000008.11:99511423:A:
NM_017890.4(VPS13B):c.10240_10282del (p.Leu3414fs)	VPS13B	L3389fs, L3414fs	Cohen syndrome	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000226118	8	100865782 - 100865824	8	99853554 - 99853596	226118	227918	rs875989882	NC_000008.11:99853553:CTCACACTGGACAACATTTTTCTCTGTGTGGCCCCGGGAGCTG:
NM_017890.4(VPS13B):c.8990G>A (p.Trp2997Ter)	VPS13B	W2972*, W2997*	Cohen syndrome	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000212584	8	100832271	8	99820043	212584	207590	rs797046098	NC_000008.11:99820042:G:A
NM_017890.4(VPS13B):c.11119+2T>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000132795	8	100871710	8	99859482	132795	136544	rs587777382	NC_000008.11:99859481:T:C
NM_017890.4(VPS13B):c.6578T>G (p.Leu2193Arg)	VPS13B	L2193R, L2168R	Cohen syndrome	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002819	8	100729447	8	99717219	2819	17858	rs120074149	NC_000008.11:99717218:T:G
NM_017890.4(VPS13B):c.5615dup (p.Ser1873fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000848471	8	100654356 - 100654357	8	99642128 - 99642129	848471	835223		NC_000008.11:99642128:AA:AAA
NM_017890.4(VPS13B):c.5319dup (p.Val1774fs)	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000845268	8	100654056 - 100654057	8	99641828 - 99641829	845268	835219		NC_000008.11:99641828:AAAAAA:AAAAAAA
NC_000008.11:g.(?_99121167)_(99721057_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000833226	8	100133395 - 100733285			833226	820011		
NC_000008.11:g.(?_99467404)_(99521020_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000832188	8	100479632 - 100533248			832188	820021		
NC_000008.11:g.(?_99111088)_(99170173_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000831638	8	100123316 - 100182401			831638	820010		
NC_000008.11:g.(?_99520889)_(99521020_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000831307	8	100533117 - 100533248			831307	820024		
NC_000008.11:g.(?_99575648)_(99577643_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000831249	8	100587876 - 100589871			831249	820026		
NM_017890.4(VPS13B):c.9070-2A>G	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000554219	8	100833520	8	99821292	554219	545032	rs1554569259	NC_000008.11:99821291:A:G
NM_017890.4(VPS13B):c.5229delinsCC (p.Gln1744fs)	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550106	8	100589795	8	99577567	550106	545013	rs1554853667	NC_000008.11:99577566:T:CC
NC_000008.10:g.(?_100221800)_(100403952_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000528872	8	100221800 - 100403952	8	99209572 - 99391724	528872	523181		
NM_017890.4(VPS13B):c.9850dup (p.Ile3284Asnfs)	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000498787	8	100847792 - 100847793	8	99835564 - 99835565	498787	490211	rs774357106	NC_000008.11:99835564:AAAAAAA:AAAAAAAA
NM_017890.4(VPS13B):c.8117_8118del (p.Gly2706fs)	VPS13B	G2681fs, G2706fs	Cohen syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000459250	8	100821703 - 100821704	8	99809475 - 99809476	459250	458110	rs1554560735	NC_000008.11:99809474:GT:
NM_017890.4(VPS13B):c.9405+1G>C	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449600	8	100836207	8	99823979	449600	444319	rs756013171	NC_000008.11:99823978:G:C
NM_152564.4(VPS13B):c.6009del (p.Phe2003fs)	VPS13B	F2028fs, F2003fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000437257	8	100673680	8	99661452	437257	428874	rs1357171752	NC_000008.11:99661451:TTT:TT
NM_152564.4(VPS13B):c.11520del (p.Arg3840fs)	VPS13B	R3840fs, R3865fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000371090	8	100883700	8	99871472	371090	357751	rs747217399	NC_000008.11:99871471:A:
NM_152564.4(VPS13B):c.3027_3045dup (p.Tyr1016delinsIleIleSerGlyLeuTer)	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370665	8	100403875 - 100403876	8	99391647 - 99391648	370665	357694	rs1057516670	NC_000008.11:99391647:AATCATATCAGGCCTCTGAA:AATCATATCAGGCCTCTGAAATCATATCAGGCCTCTGAA
NM_017890.4(VPS13B):c.9760C>T (p.Arg3254Ter)	VPS13B	R3229*, R3254*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370254	8	100847495	8	99835267	370254	357735	rs941969577	NC_000008.11:99835266:C:T
NM_017890.4(VPS13B):c.5753_5754del (p.Leu1918fs)	VPS13B	L1918fs, L1893fs	not provided|Cohen syndrome	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000280368	8	100654496 - 100654497	8	99642268 - 99642269	280368	264375	rs886041586	NC_000008.11:99642267:TT:
NM_017890.4(VPS13B):c.7292del (p.Asn2431fs)	VPS13B	N2406fs, N2431fs	Cohen syndrome|not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000279781	8	100779167	8	99766939	279781	264296	rs886041184	NC_000008.11:99766938:AA:A
NM_017890.4(VPS13B):c.9406-1G>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000189197	8	100844596	8	99832368	189197	187088	rs386834119	NC_000008.11:99832367:G:C
NM_017890.4(VPS13B):c.8945T>A (p.Leu2982Ter)	VPS13B	L2957*, L2982*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, multiple submitters, no conflicts	VCV000167832	8	100832226	8	99819998	167832	177388	rs727504219	NC_000008.11:99819997:T:A
NM_017890.4(VPS13B):c.2591C>A (p.Ser864Ter)	VPS13B	S864*	not provided|Abnormality of the eye	Pathogenic(Last reviewed: Nov 14, 2012)	criteria provided, single submitter	VCV000095840	8	100286501	8	99274273	95840	101737	rs140936527	NC_000008.11:99274272:C:A
NM_017890.4(VPS13B):c.5827C>T (p.Arg1943Ter)	VPS13B	R1943*, R1918*	Cohen syndrome	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000056679	8	100654570	8	99642342	56679	71318	rs386834099	NC_000008.11:99642341:C:T
VPS13B, EX46-50DEL	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000002830					2830	17869		
VPS13B, 1-BP DEL, 11564A	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000002829					2829	17868		
NM_017890.4(VPS13B):c.8459T>C (p.Ile2820Thr)	VPS13B	I2820T, I2795T	Cohen syndrome	Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	VCV000002827	8	100830701	8	99818473	2827	17866	rs120074155	NC_000008.11:99818472:T:C
NM_000162.5(GCK):c.214G>A (p.Gly72Arg)	GCK	G72R, G73R, G71R	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036209	7	44192019	7	44152420	36209	44873	rs193922289	NC_000007.14:44152419:C:T
NM_000162.5(GCK):c.683C>T (p.Thr228Met)	GCK	T228M, T229M, T227M	not provided|Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016134	7	44187429	7	44147830	16134	31173	rs80356655	NC_000007.14:44147829:G:A
NM_000260.4(MYO7A):c.6028G>A (p.Asp2010Asn)	MYO7A	D2010N, D1961N, D1972N	|Deafness, autosomal recessive 2||Deafness, autosomal dominant 11|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551533	11	76919825	11	77208780	551533	547079	rs755934966	NC_000011.10:77208779:G:A
NM_000260.4(MYO7A):c.4117C>T (p.Arg1373Ter)	MYO7A	R1373*, R1362*	|Deafness, autosomal recessive 2|not provided||Deafness, autosomal dominant 11|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551138	11	76903288	11	77192243	551138	546696	rs766641715	NC_000011.10:77192242:C:T
NM_000260.4(MYO7A):c.1258A>T (p.Lys420Ter)	MYO7A	K420*, K409*	|Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000504508	11	76872076	11	77161030	504508	497812	rs782539587	NC_000011.10:77161029:A:T
NM_000260.4(MYO7A):c.6487G>A (p.Gly2163Ser)	MYO7A	G2163S, G2123S, G2114S	Deafness, autosomal recessive 2|not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000402267	11	76924953	11	77213908	402267	389244	rs747656448	NC_000011.10:77213907:G:A
NM_000260.4(MYO7A):c.6439-2A>G	MYO7A		Rare genetic deafness|MYO7A-Related Disorders|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043329	11	76924903	11	77213858	43329	52499	rs397516330	NC_000011.10:77213857:A:G
NM_000260.4(MYO7A):c.5824G>T (p.Gly1942Ter)	MYO7A	G1942*, G1893*, G1904*	|MYO7A-Related Disorders|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043300	11	76918415	11	77207370	43300	52470	rs111033192	NC_000011.10:77207369:G:T
NM_000260.4(MYO7A):c.2283-1G>T	MYO7A		Deafness, autosomal recessive 2||Rare genetic deafness|	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043178	11	76890090	11	77179044	43178	52348	rs397516295	NC_000011.10:77179043:G:T
NM_000260.4(MYO7A):c.1900C>T (p.Arg634Ter)	MYO7A	R634*, R623*	Rare genetic deafness||Deafness, autosomal recessive 2||Deafness, autosomal dominant 11	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043164	11	76883896	11	77172850	43164	52334	rs111033180	NC_000011.10:77172849:C:T
NM_000260.4(MYO7A):c.1996C>T (p.Arg666Ter)	MYO7A	R666*, R655*	Rare genetic deafness|Deafness, autosomal recessive 2||Usher syndrome, type 1B	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011860	11	76885862	11	77174816	11860	26899	rs121965085	NC_000011.10:77174815:C:T
NC_000008.10:g.(?_100396416)_(100523760_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000660699	8	100396416 - 100523760	8	99384188 - 99511532	660699	651830		
NC_000008.10:g.(?_100108520)_(100205305_?)del	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000583528	8	100108520 - 100205305	8	99096292 - 99193077	583528	564559		
NM_017890.4(VPS13B):c.2932C>T (p.Gln978Ter)	VPS13B	Q978*	Cohen syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566147	8	100396543	8	99384315	566147	563189	rs1563700205	NC_000008.11:99384314:C:T
NM_017890.4(VPS13B):c.5590C>T (p.Gln1864Ter)	VPS13B	Q1839*, Q1864*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370619	8	100654333	8	99642105	370619	357705	rs1057516633	NC_000008.11:99642104:C:T
NM_015243.2(VPS13B):c.2158C>T (p.Gln720Ter)	VPS13B	Q720*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000369684	8	100168921	8	99156693	369684	353898	rs777593389	NC_000008.11:99156692:C:T
NM_017890.4(VPS13B):c.8697-9A>G	VPS13B		Cohen syndrome|not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000056697	8	100831631	8	99819403	56697	71336	rs386834116	NC_000008.11:99819402:A:G
NM_017890.4(VPS13B):c.5461dup (p.Arg1821fs)	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056674	8	100654201 - 100654202	8	99641973 - 99641974	56674	71313	rs180177364	NC_000008.11:99641973:CCC:CCCC
NM_017890.4(VPS13B):c.5215_5232del (p.Ser1739_Gln1744del)	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056671	8	100589780 - 100589797	8	99577552 - 99577569	56671	71310	rs180177362	NC_000008.11:99577551:AAGTGTGGCTCAAGTTCAA:A
NM_017890.4(VPS13B):c.4878_4880dup (p.Tyr1627Ter)	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056670	8	100568733 - 100568734	8	99556505 - 99556506	56670	71309	rs180177359	NC_000008.11:99556505:AATA:AATAATA
NM_015243.2(VPS13B):c.1225G>T (p.Glu409Ter)	VPS13B	E409*	Cohen syndrome|not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000056646	8	100146878	8	99134650	56646	71285	rs386834071	NC_000008.11:99134649:G:T
NM_017890.4(VPS13B):c.11125del (p.Leu3709fs)	VPS13B	L3709fs, L3684fs	Cohen syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000056632	8	100874007	8	99861779	56632	71271	rs386834058	NC_000008.11:99861778:CCC:CC
VPS13B, EX6-16DEL	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000002828					2828	17867		
NM_000552.4(VWF):c.2435del (p.Pro812fs)	VWF	P812fs	not provided|von Willebrand disease type 3|Abnormal bleeding|von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000303	12	6153464	12	6044298	303	15342	rs62643632	NC_000012.12:6044297:GGGGGG:GGGGG
NM_003718.5(CDK13):c.2525A>G (p.Asn842Ser)	CDK13	N842S	not provided|Marfanoid habitus and intellectual disability|Inborn genetic diseases|Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235887	7	40085606	7	40046007	235887	237522	rs878853160	NC_000007.14:40046006:A:G
NM_000426.4(LAMA2):c.7024C>T (p.Gln2342Ter)	LAMA2	Q2342*	not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000817556	6	129785466	6	129464321	817556	805465		NC_000006.12:129464320:C:T
GRCh37/hg19 6q22.33(chr6:129236792-129488075)x1	LAMA2		not provided	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000685687	6	129236792 - 129488075			685687	673279		
NM_001079823.2(LAMA2):c.1277_1278GT[1] (p.Val427fs)	LAMA2		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000524014	6	129486790 - 129486791	6	129165645 - 129165646	524014	514521	rs1554230429	NC_000006.12:129165644:TGTGT:TGT
NM_000426.3(LAMA2):c.1781_1782del (p.Lys594fs)	LAMA2	K594fs	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000503907	6	129513996 - 129513997	6	129192851 - 129192852	503907	495188	rs1554238384	NC_000006.12:129192850:AAA:A
NM_000426.3(LAMA2):c.3237C>A (p.Cys1079Ter)	LAMA2	C1079*	not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000496856	6	129634068	6	129312923	496856	488280	rs1554268940	NC_000006.12:129312922:C:A
NM_000426.3(LAMA2):c.2350dup (p.Tyr784fs)	LAMA2		not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000423308	6	129591795 - 129591796	6	129270650 - 129270651	423308	406805	rs1554260284	NC_000006.12:129270650:T:TT
NM_000426.3(LAMA2):c.5605G>T (p.Glu1869Ter)	LAMA2	E1869*	not provided	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000290668	6	129723511	6	129402366	290668	274905	rs746762473	NC_000006.12:129402365:G:T
NM_000426.3(LAMA2):c.1032_1042del (p.Cys344fs)	LAMA2	C344fs	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000290093	6	129475650 - 129475660	6	129154505 - 129154515	290093	274330	rs886044344	NC_000006.12:129154504:CATGCAATTGTCATG:CATG
NM_000426.3(LAMA2):c.2352T>G (p.Tyr784Ter)	LAMA2	Y784*	not provided	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	VCV000290015	6	129591798	6	129270653	290015	274252	rs886044330	NC_000006.12:129270652:T:G
NM_000426.3(LAMA2):c.7155+1G>A	LAMA2		not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000287677	6	129785598	6	129464453	287677	271914	rs886043692	NC_000006.12:129464452:G:A
NM_000426.3(LAMA2):c.7439+1G>A	LAMA2		not provided	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000287415	6	129794498	6	129473353	287415	271652	rs886043630	NC_000006.12:129473352:G:A
NM_000426.3(LAMA2):c.1610_1611del (p.Ile537fs)	LAMA2	I537fs	not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000286388	6	129513825 - 129513826	6	129192680 - 129192681	286388	270625	rs886043374	NC_000006.12:129192679:ATA:A
NM_000426.3(LAMA2):c.3979_3985dup (p.Phe1329Ter)	LAMA2		not provided	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000284319	6	129637236 - 129637237	6	129316091 - 129316092	284319	268556	rs886042847	NC_000006.12:129316091:GAAGACT:GAAGACTGAAGACT
NM_000426.3(LAMA2):c.444dup (p.Pro149fs)	LAMA2		not provided	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000282978	6	129419363 - 129419364	6	129098218 - 129098219	282978	267215	rs759516529	NC_000006.12:129098218:GG:GGG
NM_000426.3(LAMA2):c.7810C>T (p.Arg2604Ter)	LAMA2	R2604*, R2600*	not provided	Pathogenic(Last reviewed: Aug 5, 2014)	criteria provided, single submitter	VCV000197987	6	129807679	6	129486534	197987	195148	rs766920075	NC_000006.12:129486533:C:T
NM_000426.3(LAMA2):c.524_534dup (p.Leu179delinsSerAlaTer)	LAMA2		not provided	Pathogenic(Last reviewed: Nov 23, 2014)	criteria provided, single submitter	VCV000197143	6	129419443 - 129419444	6	129098298 - 129098299	197143	194304	rs797044728	NC_000006.12:129098298:GAGTGCCTAACG:GAGTGCCTAACGAGTGCCTAACG
NM_000426.3(LAMA2):c.1855_1856insATGTTCAC (p.Arg619fs)	LAMA2		not provided	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000194172	6	129571327 - 129571328	6	129250182 - 129250183	194172	191335	rs797044643	NC_000006.12:129250182:AC:ACATGTTCAC
NM_000426.3(LAMA2):c.9212-1G>A	LAMA2		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092995	6	129837334	6	129516189	92995	98902	rs398123391	NC_000006.12:129516188:G:A
NM_000426.3(LAMA2):c.6038del (p.Leu2012_Leu2013insTer)	LAMA2		not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000092973	6	129759859	6	129438714	92973	98880	rs398123380	NC_000006.12:129438713:TT:T
NM_000426.3(LAMA2):c.6011del (p.Asn2004fs)	LAMA2	N2004fs	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000092972	6	129759830	6	129438685	92972	98879	rs398123379	NC_000006.12:129438684:AAAA:AAA
NM_000426.3(LAMA2):c.4523+1G>A	LAMA2		not provided	Pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	VCV000092961	6	129670530	6	129349385	92961	98868	rs398123375	NC_000006.12:129349384:G:A
NM_000426.3(LAMA2):c.2750-1G>C	LAMA2		not provided	Pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	VCV000092947	6	129612758	6	129291613	92947	98854	rs9492297	NC_000006.12:129291612:G:C
NM_000426.3(LAMA2):c.184G>T (p.Gly62Ter)	LAMA2	G62*	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000092942	6	129371134	6	129049989	92942	98849	rs398123368	NC_000006.12:129049988:G:T
NM_000426.3(LAMA2):c.1127del (p.Gly376fs)	LAMA2	G376fs	Congenital Muscular Dystrophy, LAMA2-related	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638501	6	129475745	6	129154600	638501	626155		NC_000006.12:129154599:GGGGG:GGGG
NM_000426.3(LAMA2):c.8669dup (p.Leu2890fs)	LAMA2		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000503808	6	129826464 - 129826465	6	129505319 - 129505320	503808	495254	rs1554316216	NC_000006.12:129505319:TT:TTT
NM_017780.4(CHD7):c.5833C>T (p.Arg1945Ter)	CHD7	R1945*	not provided|CHARGE association	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267434	8	61764745	8	60852186	267434	262659	rs757160222	NC_000008.11:60852185:C:T
NM_017780.4(CHD7):c.7252C>T (p.Arg2418Ter)	CHD7	R2418*	CHARGE association|not specified|not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158314	8	61769091	8	60856532	158314	168630	rs587783455	NC_000008.11:60856531:C:T
NM_017780.4(CHD7):c.6850C>T (p.Arg2284Ter)	CHD7	R2284*	CHARGE association	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158313	8	61766996	8	60854437	158313	168629	rs587783454	NC_000008.11:60854436:C:T
NM_017780.4(CHD7):c.2442+5G>C	CHD7		|CHARGE association	Pathogenic	criteria provided, single submitter	VCV000002034	8	61714157	8	60801598	2034	17073	rs387906271	NC_000008.11:60801597:G:C
NM_000426.4(LAMA2):c.3449_3453del (p.Pro1150fs)	LAMA2	P1150fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000864296	6	129635834 - 129635838	6	129314689 - 129314693	864296	831514		NC_000006.12:129314688:GGCCTGGC:GGC
NM_000426.4(LAMA2):c.6150_6156del (p.Asp2050fs)	LAMA2	D2050fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000863298	6	129762025 - 129762031	6	129440880 - 129440886	863298	831528		NC_000006.12:129440879:TGTACTG:
NM_000426.4(LAMA2):c.1382_1383del (p.Thr461fs)	LAMA2	T461fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000854669	6	129498926 - 129498927	6	129177781 - 129177782	854669	831498		NC_000006.12:129177780:CT:
NM_000426.4(LAMA2):c.8127del (p.Cys2710fs)	LAMA2	C2706fs, C2710fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000854117	6	129813511	6	129492366	854117	831543		NC_000006.12:129492365:C:
NM_000426.4(LAMA2):c.8020_8023dup (p.Arg2675fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000850600	6	129813164 - 129813165	6	129492019 - 129492020	850600	831541		NC_000006.12:129492019:CACTCA:CACTCACTCA
NM_000426.4(LAMA2):c.6072del (p.Ala2025fs)	LAMA2	A2025fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000847248	6	129759894	6	129438749	847248	831527		NC_000006.12:129438748:A:
NM_000426.4(LAMA2):c.8692del (p.Arg2898fs)	LAMA2	R2898fs, R2894fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000842717	6	129826488	6	129505343	842717	831548		NC_000006.12:129505342:AA:A
NM_000426.4(LAMA2):c.8678_8682ACTAC[1] (p.Thr2895fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000842378	6	129826475 - 129826479	6	129505330 - 129505334	842378	831547		NC_000006.12:129505329:ACTACACTAC:ACTAC
NM_000426.4(LAMA2):c.7044T>G (p.Tyr2348Ter)	LAMA2	Y2348*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000839949	6	129785486	6	129464341	839949	831535		NC_000006.12:129464340:T:G
NM_000426.4(LAMA2):c.7623del (p.Val2542fs)	LAMA2	V2542fs, V2538fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000835405	6	129802458	6	129481313	835405	831540		NC_000006.12:129481312:T:
NM_000426.4(LAMA2):c.1190del (p.Phe397fs)	LAMA2	F397fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000835404	6	129475811	6	129154666	835404	831496		NC_000006.12:129154665:TT:T
NC_000006.12:g.(?_129491891)_(129492493_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000832073	6	129813036 - 129813638			832073	819662		
NC_000006.12:g.(?_129049908)_(129280157_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000831906	6	129371053 - 129601302			831906	819656		
NC_000006.12:g.(?_129177696)_(129177876_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831576	6	129498841 - 129499021			831576	819658		
NM_000426.3(LAMA2):c.2560C>T (p.Gln854Ter)	LAMA2	Q854*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000661592	6	129609014	6	129287869	661592	634560		NC_000006.12:129287868:C:T
NM_000426.3(LAMA2):c.1727_1767del (p.Gln576fs)	LAMA2	Q576fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000660619	6	129513942 - 129513982	6	129192797 - 129192837	660619	634554		NC_000006.12:129192796:CAAGCCCTGCCGCACAGCTACTACTGGAGCGCGCCGGCTCCC:C
NM_000426.3(LAMA2):c.2068_2071del (p.Tyr690fs)	LAMA2	Y690fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000652901	6	129573409 - 129573412	6	129252264 - 129252267	652901	634556		NC_000006.12:129252263:ACATACA:ACA
NM_000426.3(LAMA2):c.6690C>A (p.Tyr2230Ter)	LAMA2	Y2230*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000652729	6	129775416	6	129454271	652729	634596		NC_000006.12:129454270:C:A
NC_000006.11:g.(?_129204381)_(129419570_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000652379	6	129204381 - 129419570	6	128883236 - 129098425	652379	651567		
NM_000426.3(LAMA2):c.7181del (p.Thr2394fs)	LAMA2	T2394fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000652292	6	129786315	6	129465170	652292	634603		NC_000006.12:129465169:C:
NM_000426.3(LAMA2):c.8769dup (p.Gln2924fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000651333	6	129828697 - 129828698	6	129507552 - 129507553	651333	634614		NC_000006.12:129507552:AA:AAA
NC_000006.11:g.(?_129670433)_(129725114_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000650191	6	129670433 - 129725114	6	129349288 - 129403969	650191	651573		
NM_000426.3(LAMA2):c.8581_8584dup (p.Tyr2862fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000649490	6	129826375 - 129826376	6	129505230 - 129505231	649490	634610		NC_000006.12:129505230:TTCTTT:TTCTTTCTTT
NM_000426.3(LAMA2):c.1291A>T (p.Lys431Ter)	LAMA2	K431*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000647980	6	129486805	6	129165660	647980	634549		NC_000006.12:129165659:A:T
NM_000426.3(LAMA2):c.391C>T (p.Gln131Ter)	LAMA2	Q131*	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23	Pathogenic(Last reviewed: Oct 5, 2018)	no assertion criteria provided	VCV000585013	6	129381036	6	129059891	585013	576068	rs1562200866	NC_000006.12:129059890:C:T
NM_000426.3(LAMA2):c.4860+2delinsGGCC	LAMA2		MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23	Pathogenic(Last reviewed: Oct 5, 2018)	no assertion criteria provided	VCV000585012	6	129687508	6	129366363	585012	576067	rs1562497781	NC_000006.12:129366362:T:GGCC
NM_000426.3(LAMA2):c.728T>C (p.Leu243Pro)	LAMA2	L243P	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23	Pathogenic(Last reviewed: Oct 5, 2018)	no assertion criteria provided	VCV000585011	6	129465134	6	129143989	585011	576066	rs1562273395	NC_000006.12:129143988:T:C
NM_000426.3(LAMA2):c.253dup (p.Ile85fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000567730	6	129371201 - 129371202	6	129050056 - 129050057	567730	563376	rs1248727589	NC_000006.12:129050056:AA:AAA
NC_000006.11:g.(?_129670423)_(129725124_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000543887	6	129670423 - 129725124	6	129349278 - 129403979	543887	521877		
NC_000006.11:g.(?_129204371)_(129837512_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000543886	6	129204371 - 129837512	6	128883226 - 129516367	543886	521621		
NM_000426.3(LAMA2):c.7207_7208dup (p.Asp2403fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000543839	6	129786340 - 129786341	6	129465195 - 129465196	543839	521758	rs1554301883	NC_000006.12:129465195:GA:GAGA
NM_000426.3(LAMA2):c.828C>G (p.Tyr276Ter)	LAMA2	Y276*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000477517	6	129468112	6	129146967	477517	455187	rs1028599119	NC_000006.12:129146966:C:G
NM_000426.3(LAMA2):c.7710_7711insG (p.Pro2571fs)	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000477508	6	129802545 - 129802546	6	129481400 - 129481401	477508	455934	rs1554305937	NC_000006.12:129481400::G
NM_000426.3(LAMA2):c.7156-5_7157delinsT	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jul 3, 2016)	criteria provided, single submitter	VCV000477503	6	129786285 - 129786291	6	129465140 - 129465146	477503	455924	rs1554301854	NC_000006.12:129465139:AATAGAG:T
NM_000426.3(LAMA2):c.6268+2T>C	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000477498	6	129762145	6	129441000	477498	455916	rs1554297727	NC_000006.12:129440999:T:C
NM_000426.3(LAMA2):c.5853del (p.Ala1952fs)	LAMA2	A1952fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000477494	6	129725091	6	129403946	477494	455256	rs1554290311	NC_000006.12:129403945:AA:A
NM_000426.3(LAMA2):c.5071+3104del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000477481	6	129707482	6	129386337	477481	455249	rs1554285766	NC_000006.12:129386336:C:
NM_000426.3(LAMA2):c.4876C>T (p.Gln1626Ter)	LAMA2	Q1626*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	VCV000477476	6	129691052	6	129369907	477476	455904	rs369776766	NC_000006.12:129369906:C:T
NM_000426.3(LAMA2):c.3829C>T (p.Arg1277Ter)	LAMA2	R1277*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000477464	6	129637000	6	129315855	477464	455360	rs1554269891	NC_000006.12:129315854:C:T
NM_000426.3(LAMA2):c.2836C>T (p.Gln946Ter)	LAMA2	Q946*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000477458	6	129612845	6	129291700	477458	455351	rs375638381	NC_000006.12:129291699:C:T
NM_000426.3(LAMA2):c.1301del (p.Arg434fs)	LAMA2	R434fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000477439	6	129486815	6	129165670	477439	456074	rs1554230455	NC_000006.12:129165669:G:
Single allele	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000477435			6	129486474 - 129486622	477435	455109		
Single allele	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000477433			6	129287827 - 129288078	477433	455103		
NM_000426.3(LAMA2):c.1762del (p.Ala588fs)	LAMA2	A588fs	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000191334	6	129513977	6	129192832	191334	189137	rs786205654	NC_000006.12:129192831:GG:G
NM_017890.4(VPS13B):c.10810A>T (p.Lys3604Ter)	VPS13B	K3579*, K3604*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379881	8	100866352	8	99854124	379881	369643	rs1057520769	NC_000008.11:99854123:A:T
NM_152564.4(VPS13B):c.11705_11709delinsAGAA (p.Thr3902fs)	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189182	8	100883885 - 100883889	8	99871657 - 99871661	189182	186773	rs386834067	NC_000008.11:99871656:CAGTG:AGAA
NM_017890.4(VPS13B):c.3598C>T (p.Arg1200Ter)	VPS13B	R1200*	Cohen syndrome|not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095846	8	100479794	8	99467566	95846	101743	rs140353201	NC_000008.11:99467565:C:T
NM_017890.4(VPS13B):c.6733-2A>G	VPS13B		Cohen syndrome|not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000056684	8	100732571	8	99720343	56684	71323	rs386834103	NC_000008.11:99720342:A:G
NM_017890.4(VPS13B):c.4820+2T>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000056669	8	100533240	8	99521012	56669	71308	rs386834091	NC_000008.11:99521011:T:C
NM_017890.4(VPS13B):c.2727_2730dup (p.Asn911fs)	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056654	8	100287384 - 100287385	8	99275156 - 99275157	56654	71293	rs180177357	NC_000008.11:99275156:GCTC:GCTCGCTC
NM_000426.4(LAMA2):c.4533del (p.Gly1512fs)	LAMA2	G1512fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000841906	6	129674318	6	129353173	841906	831519		NC_000006.12:129353172:T:
NC_000006.12:g.(?_129486464)_(129486632_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000831646	6	129807609 - 129807777			831646	819661		
NC_000006.12:g.(?_128883236)_(128883367_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000830836	6	129204381 - 129204512			830836	819653		
NC_000006.12:g.(?_129049908)_(129192863_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jun 23, 2019)	criteria provided, single submitter	VCV000830393	6	129371053 - 129514008			830393	819655		
NM_000426.3(LAMA2):c.6207C>A (p.Tyr2069Ter)	LAMA2	Y2069*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000662072	6	129762082	6	129440937	662072	634593		NC_000006.12:129440936:C:A
NM_000426.3(LAMA2):c.6443del (p.Val2148fs)	LAMA2	V2148fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000660013	6	129774146	6	129453001	660013	634594		NC_000006.12:129453000:T:
NM_000426.3(LAMA2):c.8180_8181del (p.Ile2727fs)	LAMA2	I2723fs, I2727fs	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000477512	6	129813563 - 129813564	6	129492418 - 129492419	477512	456124	rs1205783002	NC_000006.12:129492417:ATA:A
NM_000426.3(LAMA2):c.1467+1G>T	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000477441	6	129499012	6	129177867	477441	455197	rs1554234161	NC_000006.12:129177866:G:T
NC_000006.11:g.(?_129711182)_(129712718_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000477434	6	129711182 - 129712718	6	129390037 - 129391573	477434	455104		
NM_000426.3(LAMA2):c.523G>T	LAMA2	E175*	Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000242517	6	129419444	6	129098299	242517	213563	rs863224891	NC_000006.12:129098298:G:T
NM_000426.4(LAMA2):c.4312-1G>C	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000840856	6	129663487	6	129342342	840856	852237		NC_000006.12:129342341:G:C
NM_000426.4(LAMA2):c.4280del (p.Ser1427fs)	LAMA2	S1427fs	Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817614	6	129649526	6	129328381	817614	805464		NC_000006.12:129328380:G:
NM_001079823.2(LAMA2):c.6196A>T (p.Lys2066Ter)	LAMA2	K2066*	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802266	6	129762071	6	129440926	802266	790584		NC_000006.12:129440925:A:T
NM_001079823.2(LAMA2):c.4936G>T (p.Glu1646Ter)	LAMA2	E1646*	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802265	6	129691112	6	129369967	802265	790583		NC_000006.12:129369966:G:T
NM_001079823.2(LAMA2):c.4739dup (p.Leu1581fs)	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802264	6	129687383 - 129687384	6	129366238 - 129366239	802264	790582		NC_000006.12:129366238:GG:GGG
NM_001079823.2(LAMA2):c.3560_3561CT[1] (p.Leu1188fs)	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802263	6	129636625 - 129636626	6	129315480 - 129315481	802263	790581		NC_000006.12:129315479:CTCT:CT
NM_001079823.2(LAMA2):c.3329del (p.Leu1110fs)	LAMA2	L1110fs	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802262	6	129634160	6	129313015	802262	790580		NC_000006.12:129313014:T:
NC_000006.11:g.(?_129380919)_(129419570_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000645374	6	129380919 - 129419570	6	129059774 - 129098425	645374	651569		
NC_000006.11:g.(?_129837315)_(129837512_?)del	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000543885	6	129837315 - 129837512	6	129516170 - 129516367	543885	521623		
NM_000426.3(LAMA2):c.8245-2A>G	LAMA2		not provided|Congenital muscular dystrophy due to partial LAMA2 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372750	6	129823802	6	129502657	372750	359761	rs914395925	NC_000006.12:129502656:A:G
NM_000426.3(LAMA2):c.7536del (p.Asp2513fs)	LAMA2	D2509fs, D2513fs	Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092986	6	129799920	6	129478775	92986	98893	rs398123387	NC_000006.12:129478774:CCC:CC
NM_003002.4(SDHD):c.129G>A (p.Trp43Ter)	SDHD	W43*	Paragangliomas 1|not provided|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006913	11	111958657	11	112087933	6913	21952	rs104894308	NC_000011.10:112087932:G:A
NC_000011.10:g.(?_64809655)_(64810716_?)del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 23, 2019)	criteria provided, single submitter	VCV000833351	11	64577127 - 64578188			833351	820402		
NM_000244.3(MEN1):c.638_1065-143del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000664768	11	64573385 - 64575394	11	64805913 - 64807922	664768	652585		
NM_000244.3(MEN1):c.1235_1236del (p.Pro412fs)	MEN1	P372fs, P407fs, P412fs, P449fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000651589	11	64572635 - 64572636	11	64805163 - 64805164	651589	640273		NC_000011.10:64805162:AG:
NM_000244.3(MEN1):c.1366-2_*132del	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000580649	11	64571674 - 64572290	11	64804202 - 64804818	580649	564808	rs1565634591	
NM_000244.3(MEN1):c.1689dup (p.Lys564fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000569154	11	64571964 - 64571965	11	64804492 - 64804493	569154	565970	rs1565635941	NC_000011.10:64804492:C:CC
NM_000244.3(MEN1):c.1064+1G>A	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000527268	11	64573703	11	64806231	527268	526627	rs1114167489	NC_000011.10:64806230:C:T
NM_000244.3(MEN1):c.378G>A (p.Trp126Ter)	MEN1	W126*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000527240	11	64577204	11	64809732	527240	526904	rs1555166365	NC_000011.10:64809731:C:T
NM_000244.3(MEN1):c.237del (p.Val80fs)	MEN1	V80fs	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428022	11	64577345	11	64809873	428022	419858	rs1114167486	NC_000011.10:64809872:GGG:GG
NM_000244.3(MEN1):c.421C>T (p.Gln141Ter)	MEN1	Q141*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265450	11	64577161	11	64809689	265450	260000	rs886039553	NC_000011.10:64809688:G:A
NM_130799.2(MEN1):c.1174del (p.Glu392fs)	MEN1	E397fs, E357fs, E392fs, E434fs	Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265238	11	64573118	11	64805646	265238	259996	rs386134247	NC_000011.10:64805645:CCCCC:CCCC
NM_000244.3(MEN1):c.787C>T (p.Gln263Ter)	MEN1	Q258*, Q263*, Q223*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265237	11	64575035	11	64807563	265237	259997	rs886039416	NC_000011.10:64807562:G:A
NM_000244.3(MEN1):c.3G>A (p.Met1Ile)	MEN1	M1I	Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188376	11	64577579	11	64810107	188376	186159	rs786204242	NC_000011.10:64810106:C:T
NM_000244.3(MEN1):c.951C>G (p.Tyr317Ter)	MEN1	Y312*, Y317*, Y277*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000036537	11	64573817	11	64806345	36537	45199	rs386134260	NC_000011.10:64806344:G:C
NM_000426.3(LAMA2):c.1893_1897del (p.Asp631fs)	LAMA2	D631fs	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000800887	6	129573234 - 129573238	6	129252089 - 129252093	800887	788791		NC_000006.12:129252088:TGACTTGA:TGA
NM_001079823.2(LAMA2):c.4959+1del	LAMA2		Merosin deficient congenital muscular dystrophy|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000689487	6	129691134	6	129369989	689487	677124		NC_000006.12:129369988:GGG:GG
NM_000426.3(LAMA2):c.1122del (p.Gly376fs)	LAMA2	G376fs	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000552820	6	129475744	6	129154599	552820	543947	rs1338860420	NC_000006.12:129154598:A:
NM_000426.3(LAMA2):c.5156_5159del (p.Lys1719fs)	LAMA2	K1719fs	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000551648	6	129712717 - 129712720	6	129391572 - 129391575	551648	543535	rs1554286963	NC_000006.12:129391571:AGAAAGA:AGA
NM_000426.3(LAMA2):c.819+2T>C	LAMA2		Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000477514	6	129465227	6	129144082	477514	455339	rs1554226188	NC_000006.12:129144081:T:C
NM_000426.3(LAMA2):c.3215del (p.Cys1072fs)	LAMA2	C1072fs	Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279978	6	129634046	6	129312901	279978	264267	rs886041297	NC_000006.12:129312900:G:
NM_000426.3(LAMA2):c.8665G>A (p.Gly2889Arg)	LAMA2	G2889R, G2885R	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000266017	6	129826462	6	129505317	266017	260810	rs886039896	NC_000006.12:129505316:G:A
NM_000426.3(LAMA2):c.5374G>T (p.Glu1792Ter)	LAMA2	E1792*	Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265425	6	129714329	6	129393184	265425	259831	rs746201268	NC_000006.12:129393183:G:T
NM_000426.3(LAMA2):c.6488del (p.Lys2163fs)	LAMA2	K2163fs	Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265332	6	129774190	6	129453045	265332	259833	rs886039482	NC_000006.12:129453044:AA:A
NM_001079823.2(LAMA2):c.7277_7278CT[1] (p.Leu2427fs)	LAMA2		Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092983	6	129786411 - 129786412	6	129465266 - 129465267	92983	98890	rs398123385	NC_000006.12:129465265:CTCT:CT
NM_000426.3(LAMA2):c.825del (p.Tyr276fs)	LAMA2	Y276fs	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000014302	6	129468109	6	129146964	14302	29341	rs1562275792	NC_000006.12:129146963:C:
LAMA2, 2-BP DEL, 2098AG	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 9, 2001)	no assertion criteria provided	VCV000014295					14295	29334		
NM_000426.3(LAMA2):c.7691T>C	LAMA2	L2564P, L2560P	Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 9, 2001)	no assertion criteria provided	VCV000014294	6	129802526	6	129481381	14294	29333	rs121913570	NC_000006.12:129481380:T:C
LAMA2, 1-BP DEL, 8314A	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 9, 2001)	no assertion criteria provided	VCV000014292					14292	29331		
LAMA2, IVS30, A-T, -2	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000014289					14289	29328		
NM_017890.4(VPS13B):c.8521-1G>T	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000459251	8	100830940	8	99818712	459251	458111	rs1554566596	NC_000008.11:99818711:G:T
NM_152564.4(VPS13B):c.5921_5922CT[1] (p.Leu1975fs)	VPS13B		Cohen syndrome|not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280018	8	100673594 - 100673595	8	99661366 - 99661367	280018	264439	rs886041323	NC_000008.11:99661365:CTCT:CT
NM_015243.2(VPS13B):c.1915C>T (p.Arg639Ter)	VPS13B	R639*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265334	8	100160140	8	99147912	265334	259908	rs764776104	NC_000008.11:99147911:C:T
NM_015243.2(VPS13B):c.1504C>T (p.Arg502Ter)	VPS13B	R502*	Cohen syndrome|not provided	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000068083	8	100147902	8	99135674	68083	78974	rs180177354	NC_000008.11:99135673:C:T
NM_017890.4(VPS13B):c.5086C>T (p.Arg1696Ter)	VPS13B	R1696*, R1671*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056803	8	100587947	8	99575719	56803	71431	rs386834093	NC_000008.11:99575718:C:T
NM_017890.4(VPS13B):c.2889G>A (p.Trp963Ter)	VPS13B	W963*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056655	8	100396500	8	99384272	56655	71294	rs386834078	NC_000008.11:99384271:G:A
NM_017890.4(VPS13B):c.10946G>A (p.Trp3649Ter)	VPS13B	W3649*, W3624*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056631	8	100871535	8	99859307	56631	71270	rs386834057	NC_000008.11:99859306:G:A
NM_001287174.2(ABCC8):c.563A>G (p.Asn188Ser)	ABCC8	N188S	not provided|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210082	11	17485001	11	17463454	210082	207857	rs797045213	NC_000011.10:17463453:T:C
NM_001142800.2(EYS):c.4350_4356del (p.Ile1451fs)	EYS	I1451fs	not provided|Retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 25	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195936	6	65301404 - 65301410	6	64591511 - 64591517	195936	193097	rs761238771	NC_000006.12:64591510:AGCTATAAGC:AGC
NM_000426.3(LAMA2):c.5290dup (p.Glu1764fs)	LAMA2		Congenital muscular dystrophy due to partial LAMA2 deficiency|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000631972	6	129714239 - 129714240	6	129393094 - 129393095	631972	620211	rs1415944134	NC_000006.12:129393094:GGGGGG:GGGGGGG
NM_000426.3(LAMA2):c.7490_7493dup (p.Asp2498fs)	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000558356	6	129799874 - 129799875	6	129478729 - 129478730	558356	543891	rs1480934961	NC_000006.12:129478729:AAAGA:AAAGAAAGA
NM_000426.3(LAMA2):c.8155G>T (p.Glu2719Ter)	LAMA2	E2719*, E2715*	not provided|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000500711	6	129813539	6	129492394	500711	492135	rs1289855948	NC_000006.12:129492393:G:T
NM_000426.3(LAMA2):c.7452-1G>A	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437435	6	129799837	6	129478692	437435	430993	rs1554304931	NC_000006.12:129478691:G:A
NM_000426.3(LAMA2):c.397-4_478del	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437434	6	129419314 - 129419399	6	129098169 - 129098254	437434	430992	rs1554217494	
NM_000426.3(LAMA2):c.5866-1G>A	LAMA2		not provided|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424557	6	129748896	6	129427751	424557	406809	rs1064797040	NC_000006.12:129427750:G:A
NM_000426.3(LAMA2):c.7991del (p.Gly2664fs)	LAMA2	G2660fs, G2664fs	Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265427	6	129813134	6	129491989	265427	259834	rs886039541	NC_000006.12:129491988:GGGGG:GGGG
NM_000426.3(LAMA2):c.5706_5712del (p.Asp1902fs)	LAMA2	D1902fs	Merosin deficient congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092970	6	129723612 - 129723618	6	129402467 - 129402473	92970	98877	rs398123377	NC_000006.12:129402466:CTCATCT:
NM_000426.3(LAMA2):c.5050G>T (p.Glu1684Ter)	LAMA2	E1684*	Merosin deficient congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092964	6	129704357	6	129383212	92964	98871	rs201632009	NC_000006.12:129383211:G:T
NM_000426.3(LAMA2):c.7750-1713_7899-2153del	LAMA2		Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Jun 7, 2012)	no assertion criteria provided	VCV000014303	6	129805906 - 129810893	6	129484761 - 129489748	14303	29342		
NM_017890.4(VPS13B):c.7322+2T>C	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000583375	8	100779200	8	99766972	583375	562561	rs1563908020	NC_000008.11:99766971:T:C
NM_015243.2(VPS13B):c.901_904del (p.Thr301fs)	VPS13B	T301fs	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370733	8	100128063 - 100128066	8	99115835 - 99115838	370733	357681	rs759536357	NC_000008.11:99115834:CTTACTT:CTT
NM_017890.4(VPS13B):c.6002del (p.Pro2001fs)	VPS13B	P1976fs, P2001fs	Cohen syndrome|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279779	8	100673599	8	99661371	279779	264404	rs755125969	NC_000008.11:99661370:CC:C
NM_017890.4(VPS13B):c.6370_6371delAT	VPS13B	M2099fs, M2124fs	Cohen syndrome|not provided|Abnormality of the eye	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242548	8	100712001 - 100712002	8	99699773 - 99699774	242548	205460	rs748404277	NC_000008.11:99699772:AT:
NM_017890.4(VPS13B):c.4471G>T (p.Glu1491Ter)	VPS13B	E1491*, E1466*	Cohen syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002822	8	100523503	8	99511275	2822	17861	rs120074151	NC_000008.11:99511274:G:T
NM_017890.4(VPS13B):c.7051C>T (p.Arg2351Ter)	VPS13B	R2351*, R2326*	Cohen syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002820	8	100733201	8	99720973	2820	17859	rs120074150	NC_000008.11:99720972:C:T
NM_001876.4(CPT1A):c.1436C>T (p.Pro479Leu)	CPT1A	P479L	Carnitine palmitoyltransferase I deficiency|not provided|CPT1A ARCTIC VARIANT|CARNITINE PALMITOYLTRANSFERASE IA POLYMORPHISM|Carnitine palmitoyl transferase 1A deficiency	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000065644	11	68548130	11	68780662	65644	76552	rs80356779	NC_000011.10:68780661:G:A
NM_001079823.2(LAMA2):c.1255del (p.Ile419fs)	LAMA2	I419fs	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802260	6	129486768	6	129165623	802260	790578		NC_000006.12:129165622:AA:A
NM_000426.3(LAMA2):c.1300C>T (p.Arg434Ter)	LAMA2	R434*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000477436	6	129486814	6	129165669	477436	455881	rs1374568851	NC_000006.12:129165668:C:T
NM_000426.3(LAMA2):c.817A>T (p.Arg273Ter)	LAMA2	R273*	Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000287489	6	129465223	6	129144078	287489	271726	rs886043648	NC_000006.12:129144077:A:T
NM_001079823.2(LAMA2):c.9089_9092dup (p.His3031fs)	LAMA2		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092994	6	129835627 - 129835628	6	129514482 - 129514483	92994	98901	rs398123390	NC_000006.12:129514482:CAAACA:CAAACAAACA
NM_017890.4(VPS13B):c.11571-2A>G	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449747	8	100883674	8	99871446	449747	444321	rs1554588353	NC_000008.11:99871445:A:G
NM_017890.4(VPS13B):c.5920C>T (p.Arg1974Ter)	VPS13B	R1949*, R1974*	Cohen syndrome|not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068089	8	100654663	8	99642435	68089	78980	rs180177365	NC_000008.11:99642434:C:T
NM_017890.4(VPS13B):c.11907dup (p.Ser3970fs)	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056644	8	100887727 - 100887728	8	99875499 - 99875500	56644	71283	rs180177374	NC_000008.11:99875499:CCCCC:CCCCCC
NM_017890.4(VPS13B):c.11695_11698del (p.Ser3901fs)	VPS13B	S3901fs, S3876fs	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056640	8	100883797 - 100883800	8	99871569 - 99871572	56640	71279	rs386834066	NC_000008.11:99871568:GTGAGTG:GTG
NM_017890.4(VPS13B):c.9260dupT (p.Leu3087Phefs)	VPS13B		Cohen syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000002826	8	100836059 - 100836060	8	99823831 - 99823832	2826	17865	rs180177329	NC_000008.11:99823831:TT:TTT
NM_152564.4(VPS13B):c.3346_3347CT[1] (p.Cys1117fs)	VPS13B		Cohen syndrome|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002818	8	100454764 - 100454765	8	99442536 - 99442537	2818	17857	rs180177327	NC_000008.11:99442535:CTCT:CT
NM_001005463.3(EBF3):c.488G>A (p.Arg163Gln)	EBF3	R163Q	Hypotonia, ataxia, and delayed development syndrome|Intellectual disability|Ataxia|Expressive language delay|Global developmental delay|Muscular hypotonia|Inborn genetic diseases|Robin sequence	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000268156	10	131755588	10	129957324	268156	263783	rs1057519389	NC_000010.11:129957323:C:T
NM_000719.7(CACNA1C):c.2573G>A (p.Arg858His)	CACNA1C	R858H, R855H	Long QT syndrome 8|Long QT syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000190653	12	2702421	12	2593255	190653	188572	rs786205753	NC_000012.12:2593254:G:A
NM_000719.7(CACNA1C):c.116C>T (p.Ala39Val)	CACNA1C	A39V	Brugada syndrome 3|Brugada syndrome	Pathogenic(Last reviewed: Apr 10, 2014)	no assertion criteria provided	VCV000017635	12	2224456	12	2115290	17635	32674	rs121912776	NC_000012.12:2115289:C:T
NM_000426.3(LAMA2):c.4198C>T (p.Arg1400Ter)	LAMA2	R1400*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557566	6	129649444	6	129328299	557566	543868	rs775112258	NC_000006.12:129328298:C:T
NM_000426.3(LAMA2):c.329G>A (p.Trp110Ter)	LAMA2	W110*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557331	6	129380974	6	129059829	557331	543756	rs1441933780	NC_000006.12:129059828:G:A
NM_000426.3(LAMA2):c.5325dup (p.Leu1776fs)	LAMA2		Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551387	6	129714275 - 129714276	6	129393130 - 129393131	551387	543547	rs768458445	NC_000006.12:129393130:AAAAA:AAAAAA
NM_000426.3(LAMA2):c.498G>A (p.Trp166Ter)	LAMA2	W166*	Merosin deficient congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551094	6	129419419	6	129098274	551094	543943	rs553221833	NC_000006.12:129098273:G:A
NM_000426.3(LAMA2):c.5866-2A>G	LAMA2		Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000477495	6	129748895	6	129427750	477495	456105	rs1554295204	NC_000006.12:129427749:A:G
NM_000426.3(LAMA2):c.2962C>T (p.Gln988Ter)	LAMA2	Q988*	Merosin deficient congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092950	6	129618935	6	129297790	92950	98857	rs398123371	NC_000006.12:129297789:C:T
NM_000136.3(FANCC):c.535C>T (p.Arg179Ter)	FANCC	R179*	Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235535	9	97912356	9	95150074	235535	237216	rs769039987	NC_000009.12:95150073:G:A
NM_000136.3(FANCC):c.355_360delinsA (p.Ser119fs)	FANCC		Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000127540	9	97934415 - 97934420	9	95172133 - 95172138	127540	132997	rs587779904	NC_000009.12:95172132:ATGAGA:T
NM_000260.3(MYO7A):c.1969C>T	MYO7A	R657W, R646W	Deafness, autosomal recessive 2|Deafness, autosomal recessive 2||Deafness, autosomal recessive 2||Deafness, autosomal dominant 11	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242392	11	76885835	11	77174789	242392	237614	rs878853236	NC_000011.10:77174788:C:T
NM_000260.4(MYO7A):c.5392C>T (p.Gln1798Ter)	MYO7A	Q1798*, Q1749*, Q1760*	not provided|Rare genetic deafness|Retinal dystrophy|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: May 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043282	11	76915186	11	77204141	43282	52452	rs397516317	NC_000011.10:77204140:C:T
NM_000260.4(MYO7A):c.3476G>T (p.Gly1159Val)	MYO7A	G1159V, G1148V	Retinal dystrophy|Deafness, autosomal recessive 2|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043206	11	76895733	11	77184688	43206	52376	rs199897298	NC_000011.10:77184687:G:T
NM_017617.5(NOTCH1):c.2448dup (p.Cys817fs)	NOTCH1		not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000817997	9	139407491 - 139407492	9	136513039 - 136513040	817997	805615		NC_000009.12:136513039:G:GG
NM_017617.5(NOTCH1):c.6045del (p.Asn2016fs)	NOTCH1	N2016fs	not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000504027	9	139393601	9	136499149	504027	495644	rs1554826736	NC_000009.12:136499148:G:
NM_017617.5(NOTCH1):c.6593C>A (p.Ser2198Ter)	NOTCH1	S2198*	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000426360	9	139391598	9	136497146	426360	415178	rs761562076	NC_000009.12:136497145:G:T
NM_017617.5(NOTCH1):c.2023del (p.Cys675fs)	NOTCH1	C675fs	not provided	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000422753	9	139409146	9	136514694	422753	407625	rs1064795976	NC_000009.12:136514693:A:
NM_017617.5(NOTCH1):c.4775T>G (p.Phe1592Cys)	NOTCH1	F1592C	Early T cell progenitor acute lymphoblastic leukemia	Pathogenic	no assertion criteria provided	VCV000208337	9	139399368	9	136504916	208337	204574	rs796065341	NC_000009.12:136504915:A:C
NM_017617.5(NOTCH1):c.1015_1016TG[1] (p.Ala340fs)	NOTCH1		Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000845149	9	139413124 - 139413125	9	136518672 - 136518673	845149	835923		NC_000009.12:136518671:CACA:CA
NM_017617.5(NOTCH1):c.550C>T (p.Gln184Ter)	NOTCH1	Q184*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000645087	9	139417494	9	136523042	645087	638099		NC_000009.12:136523041:G:A
NM_017617.5(NOTCH1):c.4127del (p.Gly1376fs)	NOTCH1	G1376fs	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000642523	9	139400221	9	136505769	642523	638075		NC_000009.12:136505768:CCC:CC
NM_017617.5(NOTCH1):c.1396del (p.Thr466fs)	NOTCH1	T466fs	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000572044	9	139412249	9	136517797	572044	563849	rs1564199476	NC_000009.12:136517796:T:
NM_017617.5(NOTCH1):c.4071C>A (p.Cys1357Ter)	NOTCH1	C1357*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000566177	9	139400277	9	136505825	566177	568847	rs1564191302	NC_000009.12:136505824:G:T
NM_017617.5(NOTCH1):c.3266G>A (p.Trp1089Ter)	NOTCH1	W1089*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000544179	9	139402743	9	136508291	544179	524992	rs1554728428	NC_000009.12:136508290:C:T
NM_017617.5(NOTCH1):c.2365C>T (p.Gln789Ter)	NOTCH1	Q789*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000544178	9	139407575	9	136513123	544178	524710	rs1554729118	NC_000009.12:136513122:G:A
NM_017617.5(NOTCH1):c.4222G>T (p.Glu1408Ter)	NOTCH1	E1408*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523597	9	139400126	9	136505674	523597	514243	rs587778569	NC_000009.12:136505673:C:A
NM_017617.5(NOTCH1):c.3281G>A (p.Cys1094Tyr)	NOTCH1	C1094Y	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523596	9	139402728	9	136508276	523596	514244	rs1554728424	NC_000009.12:136508275:C:T
NM_017617.5(NOTCH1):c.2704C>T (p.Arg902Cys)	NOTCH1	R902C	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523595	9	139405141	9	136510689	523595	514245	rs1448345366	NC_000009.12:136510688:G:A
NM_017617.5(NOTCH1):c.2380G>T (p.Glu794Ter)	NOTCH1	E794*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523594	9	139407560	9	136513108	523594	514246	rs1554729113	NC_000009.12:136513107:C:A
NM_017617.5(NOTCH1):c.1933_1934TG[1] (p.Ala646fs)	NOTCH1		Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523585	9	139409820 - 139409821	9	136515368 - 136515369	523585	514247	rs1554729443	NC_000009.12:136515367:CACA:CA
NM_017617.5(NOTCH1):c.794_797delinsCC (p.Asn265fs)	NOTCH1		Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523584	9	139413963 - 139413966	9	136519511 - 136519514	523584	514249	rs1554730184	NC_000009.12:136519510:CAGT:GG
NM_017617.5(NOTCH1):c.415C>T (p.Gln139Ter)	NOTCH1	Q139*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523583	9	139417629	9	136523177	523583	514250	rs1554730670	NC_000009.12:136523176:G:A
NM_017617.5(NOTCH1):c.6348C>G (p.Tyr2116Ter)	NOTCH1	Y2116*	Aortic valve disorder	Pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	VCV000374271	9	139391843	9	136497391	374271	361195	rs1057518661	NC_000009.12:136497390:G:C
NM_017617.5(NOTCH1):c.578G>A (p.Gly193Asp)	NOTCH1	G193D	Tetralogy of Fallot	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000221999	9	139417466	9	136523014	221999	223689	rs774966208	NC_000009.12:136523013:C:T
NM_017617.5(NOTCH1):c.4739dup (p.Met1580fs)	NOTCH1		Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	VCV000219381	9	139399403 - 139399404	9	136504951 - 136504952	219381	221064	rs864622061	NC_000009.12:136504951:A:AA
NM_017617.5(NOTCH1):c.4663G>T (p.Glu1555Ter)	NOTCH1	E1555*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	VCV000219380	9	139399480	9	136505028	219380	221065	rs746342893	NC_000009.12:136505027:C:A
NM_017617.5(NOTCH1):c.1343G>A (p.Arg448Gln)	NOTCH1	R448Q	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Feb 24, 2015)	criteria provided, single submitter	VCV000219375	9	139412302	9	136517850	219375	221070	rs864622056	NC_000009.12:136517849:C:T
NOTCH1, PRO1797HIS	NOTCH1	P1797H	Aortic valve disorder	Pathogenic(Last reviewed: Jul 14, 2006)	no assertion criteria provided	VCV000635566					635566	623396		
NM_017617.5(NOTCH1):c.1649dup (p.Tyr550Ter)	NOTCH1	Y550*	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Jan 7, 2014)	criteria provided, single submitter	VCV000219378	9	139410452 - 139410453	9	136516000 - 136516001	219378	221067	rs864622059	NC_000009.12:136516000:T:TT
NM_017617.5(NOTCH1):c.743-1G>T	NOTCH1		Adams-Oliver syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156213	9	139414018	9	136519566	156213	166010	rs587777735	NC_000009.12:136519565:C:A
NM_017617.5(NOTCH1):c.4487G>A (p.Cys1496Tyr)	NOTCH1	C1496Y	Adams-Oliver syndrome 5	Pathogenic	criteria provided, single submitter	VCV000156007	9	139399861	9	136505409	156007	165811	rs587781259	NC_000009.12:136505408:C:T
NM_017617.5(NOTCH1):c.4512del (p.Cys1505fs)	NOTCH1	C1505fs	Aortic valve disorder	Pathogenic(Last reviewed: Sep 8, 2005)	no assertion criteria provided	VCV000012477	9	139399836	9	136505384	12477	27516	rs41309766	NC_000009.12:136505383:G:
NM_017617.5(NOTCH1):c.3319C>T (p.Arg1107Ter)	NOTCH1	R1108*, R1107*	Aortic valve disorder	Pathogenic(Last reviewed: Sep 8, 2005)	no assertion criteria provided	VCV000012476	9	139402690	9	136508238	12476	27515	rs41309764	NC_000009.12:136508237:G:A
NM_017780.4(CHD7):c.4393C>T (p.Arg1465Ter)	CHD7	R1465*	CHARGE association|not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267430	8	61750674	8	60838115	267430	262655	rs886040991	NC_000008.11:60838114:C:T
NM_017780.4(CHD7):c.5167dup (p.Gln1723fs)	CHD7		Inborn genetic diseases	Pathogenic	criteria provided, single submitter	VCV000208735	8	61757923 - 61757924	8	60845364 - 60845365	208735	205257	rs797044919	NC_000008.11:60845364:CC:CCC
NM_017780.4(CHD7):c.4480C>T (p.Arg1494Ter)	CHD7	R1494*	CHARGE association|not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158296	8	61750761	8	60838202	158296	168611	rs587783442	NC_000008.11:60838201:C:T
NM_017617.5(NOTCH1):c.2439C>G (p.Tyr813Ter)	NOTCH1	Y813*	Aortic valve disorder	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000221998	9	139407501	9	136513049	221998	223688	rs1057515422	NC_000009.12:136513048:G:C
NM_017617.5(NOTCH1):c.3765C>A (p.Cys1255Ter)	NOTCH1	C1255*	Aortic valve disorder	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000221997	9	139401304	9	136506852	221997	223687	rs1057515423	NC_000009.12:136506851:G:T
NM_017617.5(NOTCH1):c.6049_6050del (p.Ser2017fs)	NOTCH1	S2017fs	Adams-Oliver syndrome 5	Pathogenic(Last reviewed: Jan 7, 2014)	criteria provided, single submitter	VCV000219383	9	139393596 - 139393597	9	136499144 - 136499145	219383	221062	rs864622063	NC_000009.12:136499143:GAG:G
NM_017617.5(NOTCH1):c.1285T>C (p.Cys429Arg)	NOTCH1	C429R	Adams-Oliver syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156214	9	139412360	9	136517908	156214	166011	rs587777736	NC_000009.12:136517907:A:G
NM_017617.5(NOTCH1):c.1342C>T (p.Arg448Ter)	NOTCH1	R448*	Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000222756	9	139412303	9	136517851	222756	224370	rs869025494	NC_000009.12:136517850:G:A
NM_017890.4(VPS13B):c.6802G>T (p.Glu2268Ter)	VPS13B	E2268*, E2243*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279780	8	100732642	8	99720414	279780	264450	rs146960401	NC_000008.11:99720413:G:T
NM_004562.3(PRKN):c.1289G>A (p.Gly430Asp)	PRKN	G430D, G281D, G402D	Parkinson disease 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000356016	6	161771240	6	161350208	356016	306532	rs191486604	NC_000006.12:161350207:C:T
NM_001077365.2(POMT1):c.2101dup (p.Asp701fs)	POMT1		not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|POMT1-Related Disorders|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003255	9	134398412 - 134398413	9	131523025 - 131523026	3255	18294	rs398124245	NC_000009.12:131523025:GGGG:GGGGG
NM_000244.3(MEN1):c.670-1G>A	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000661933	11	64575153	11	64807681	661933	652591		NC_000011.10:64807680:C:T
NM_000244.3(MEN1):c.799-1G>C	MEN1		Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449445	11	64574692	11	64807220	449445	444851	rs1555165377	NC_000011.10:64807219:C:G
NM_000244.3(MEN1):c.928-2A>G	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428037	11	64573842	11	64806370	428037	419823	rs1114167498	NC_000011.10:64806369:T:C
NM_000244.3(MEN1):c.461-2A>G	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428001	11	64575573	11	64808101	428001	419842	rs886042035	NC_000011.10:64808100:T:C
NM_000244.3(MEN1):c.191_195AGCCC[3] (p.Asp70fs)	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000403814	11	64577381 - 64577382	11	64809909 - 64809910	403814	398752	rs1555166609	NC_000011.10:64809909:GGGCTGGGCTGG:GGGCTGGGCTGGGCTGG
NM_000244.3(MEN1):c.796C>T (p.Gln266Ter)	MEN1	Q261*, Q266*, Q226*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379789	11	64575026	11	64807554	379789	372280	rs1057520733	NC_000011.10:64807553:G:A
NM_000244.3(MEN1):c.415C>G (p.His139Asp)	MEN1	H139D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000016699	11	64577167	11	64809695	16699	31738	rs104894263	NC_000011.10:64809694:G:C
NM_000244.3(MEN1):c.1321T>A (p.Trp441Arg)	MEN1	W436R, W441R, W478R, W401R	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016686	11	64572550	11	64805078	16686	31725	rs104894259	NC_000011.10:64805077:A:T
NM_000426.3(LAMA2):c.3955C>T (p.Arg1319Ter)	LAMA2	R1319*	Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623353	6	129637213	6	129316068	623353	612274	rs1180309541	NC_000006.12:129316067:C:T
NM_000426.3(LAMA2):c.5259del (p.Lys1753_Val1754insTer)	LAMA2		Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551353	6	129714209	6	129393064	551353	543539	rs1211739649	NC_000006.12:129393063:AAAAAA:AAAAA
NM_000426.3(LAMA2):c.2T>C (p.Met1Thr)	LAMA2	M1T	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000477459	6	129204392	6	128883247	477459	456070	rs374403765	NC_000006.12:128883246:T:C
NM_000426.3(LAMA2):c.4048C>T (p.Arg1350Ter)	LAMA2	R1350*	Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000284984	6	129637306	6	129316161	284984	269221	rs756854513	NC_000006.12:129316160:C:T
NM_000426.3(LAMA2):c.4645C>T (p.Arg1549Ter)	LAMA2	R1549*	Congenital muscular dystrophy due to partial LAMA2 deficiency|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000014299	6	129674430	6	129353285	14299	29338	rs121913575	NC_000006.12:129353284:C:T
NM_014251.3(SLC25A13):c.852_855del (p.Met285fs)	SLC25A13	M285fs	Neonatal intrahepatic cholestasis caused by citrin deficiency|Citrullinemia type II|Citrin deficiency|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225472	7	95818684 - 95818687	7	96189372 - 96189375	225472	227314	rs80338720	NC_000007.14:96189371:CATAC:C
NM_000155.4(GALT):c.425T>A (p.Met142Lys)	GALT	M142K, M33K	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003609	9	34647876	9	34647879	3609	18648	rs111033695	NC_000009.12:34647878:T:A
NM_005609.4(PYGM):c.2262del (p.Lys754fs)	PYGM	K754fs, K666fs	not provided|Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095296	11	64514746	11	64747274	95296	101195	rs398124210	NC_000011.10:64747273:TTT:TT
NM_000083.3(CLCN1):c.870C>G (p.Ile290Met)	CLCN1	I290M	Myotonia congenita|not provided|Myotonia|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017539	7	143027881	7	143330788	17539	32578	rs80356690	NC_000007.14:143330787:C:G
NM_000552.4(VWF):c.4883T>C (p.Ile1628Thr)	VWF	I1628T	not provided|von Willebrand disorder|von Willebrand disease, type 2a	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000284	12	6127701	12	6018535	284	15323	rs61750584	NC_000012.12:6018534:A:G
NM_006158.4(NEFL):c.293A>G (p.Asn98Ser)	NEFL	N98S	Charcot-Marie-Tooth disease type 2E|CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G|Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|not provided|CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041236	8	24813737	8	24956223	41236	49660	rs58982919	NC_000008.11:24956222:T:C
NM_004329.2(BMPR1A):c.817C>T (p.Arg273Ter)	BMPR1A	R273*	Juvenile polyposis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000142351	10	88677032	10	86917275	142351	152065	rs587782400	NC_000010.11:86917274:C:T
GRCh37/hg19 6p12.3(chr6:51589088-51673301)x1	PKHD1		not provided	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000686576	6	51589088 - 51673301			686576	674168		
NM_138694.4(PKHD1):c.3958_3959del (p.Gly1320fs)	PKHD1	G1320fs	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000636609	6	51890649 - 51890650	6	52025851 - 52025852	636609	624324		NC_000006.12:52025850:CCC:C
NM_138694.4(PKHD1):c.4118dup (p.Met1373fs)	PKHD1		not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000595103	6	51890489 - 51890490	6	52025691 - 52025692	595103	586165	rs752305132	NC_000006.12:52025691:A:AA
NM_138694.4(PKHD1):c.10998del (p.Ile3666fs)	PKHD1	I3666fs	not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000504428	6	51523926	6	51659128	504428	495319	rs1554183097	NC_000006.12:51659127:AA:A
NM_138694.4(PKHD1):c.602+1G>A	PKHD1		not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000497635	6	51936912	6	52072114	497635	489059	rs1554223950	NC_000006.12:52072113:C:T
NM_138694.4(PKHD1):c.7963_7964CA[2] (p.Thr2656fs)	PKHD1		not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000287202	6	51712712 - 51712713	6	51847914 - 51847915	287202	271439	rs886043593	NC_000006.12:51847913:TGTGTG:TGTG
NM_138694.4(PKHD1):c.7719dup (p.Met2574fs)	PKHD1		not provided	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000197601	6	51732674 - 51732675	6	51867876 - 51867877	197601	194762	rs797044745	NC_000006.12:51867876:A:AA
NM_138694.4(PKHD1):c.7194G>A (p.Trp2398Ter)	PKHD1	W2398*	not provided	Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000197534	6	51750686	6	51885888	197534	194695	rs794727680	NC_000006.12:51885887:C:T
NM_138694.4(PKHD1):c.5325_5326del (p.Val1776fs)	PKHD1	V1776fs	not provided	Pathogenic(Last reviewed: May 23, 2014)	criteria provided, single submitter	VCV000196878	6	51887653 - 51887654	6	52022855 - 52022856	196878	194039	rs794727572	NC_000006.12:52022854:CTC:C
NM_138694.4(PKHD1):c.765C>G (p.Tyr255Ter)	PKHD1	Y255*	not provided	Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000193941	6	51934268	6	52069470	193941	191104	rs794727037	NC_000006.12:52069469:G:C
NM_138694.4(PKHD1):c.6499C>T (p.Gln2167Ter)	PKHD1	Q2167*	not provided	Pathogenic(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	VCV000167485	6	51774264	6	51909466	167485	177106	rs368263958	NC_000006.12:51909465:G:A
NM_138694.4(PKHD1):c.4415delinsTATTCCCC (p.Cys1472fs)	PKHD1		not provided	Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	VCV000096404	6	51890193	6	52025395	96404	102298	rs398124486	NC_000006.12:52025394:C:GGGGAATA
NM_138694.4(PKHD1):c.391-1G>C	PKHD1		not provided	Pathogenic(Last reviewed: Sep 12, 2012)	criteria provided, single submitter	VCV000096400	6	51941132	6	52076334	96400	102294	rs398124485	NC_000006.12:52076333:C:G
NM_138694.4(PKHD1):c.2827_2828del (p.Asp943fs)	PKHD1	D943fs	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000096392	6	51907926 - 51907927	6	52043128 - 52043129	96392	102286	rs398124481	NC_000006.12:52043127:TC:
NM_138694.4(PKHD1):c.2452C>T (p.Gln818Ter)	PKHD1	Q818*	not provided	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000096390	6	51910942	6	52046144	96390	102284	rs398124480	NC_000006.12:52046143:G:A
NM_138694.4(PKHD1):c.2407+1G>A	PKHD1		not provided	Pathogenic(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	VCV000096389	6	51913289	6	52048491	96389	102283	rs398124479	NC_000006.12:52048490:C:T
NM_138694.4(PKHD1):c.1694-1G>A	PKHD1		not provided	Pathogenic(Last reviewed: Mar 26, 2013)	criteria provided, single submitter	VCV000096380	6	51920528	6	52055730	96380	102274	rs398124477	NC_000006.12:52055729:C:T
NM_138694.4(PKHD1):c.1602+1G>A	PKHD1		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000096379	6	51921687	6	52056889	96379	102273	rs398124476	NC_000006.12:52056888:C:T
NM_138694.4(PKHD1):c.5081dup (p.Val1695fs)	PKHD1		Polycystic kidney dysplasia|Ventricular hypertrophy|Renal cyst	Pathogenic(Last reviewed: Aug 21, 2014)	criteria provided, single submitter	VCV000374180	6	51889526 - 51889527	6	52024728 - 52024729	374180	360880	rs1057518952	NC_000006.12:52024728:CCC:CCCC
NM_138694.4(PKHD1):c.9182_9183insATTAGTGACA (p.Asn3062fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000807462	6	51613231 - 51613232	6	51748433 - 51748434	807462	798577		NC_000006.12:51748433::TGTCACTAAT
NM_138694.4(PKHD1):c.1180G>A (p.Ala394Thr)	PKHD1	A394T	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802229	6	51924779	6	52059981	802229	790644		NC_000006.12:52059980:C:T
NM_138694.4(PKHD1):c.1693+2T>G	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802228	6	51921494	6	52056696	802228	790643		NC_000006.12:52056695:A:C
NM_138694.4(PKHD1):c.8798-2A>T	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000635497	6	51618153	6	51753355	635497	623293		NC_000006.12:51753354:T:A
NM_138694.4(PKHD1):c.7351-1G>C	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438689	6	51735438	6	51870640	438689	432297	rs1554282540	NC_000006.12:51870639:C:G
NM_138694.4(PKHD1):c.1233+99_1694-441del	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Nov 13, 2015)	no assertion criteria provided	VCV000433027	6	51920968 - 51924627	6	52056170 - 52059829	433027	426535		
NM_138694.4(PKHD1):c.6778del (p.Tyr2260fs)	PKHD1	Y2260fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000864135	6	51771043	6	51906245	864135	832014		NC_000006.12:51906244:A:
NM_138694.4(PKHD1):c.4543G>T (p.Glu1515Ter)	PKHD1	E1515*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000863665	6	51890065	6	52025267	863665	832020		NC_000006.12:52025266:C:A
NM_138694.4(PKHD1):c.4005del (p.Cys1336fs)	PKHD1	C1336fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000861244	6	51890603	6	52025805	861244	832023		NC_000006.12:52025804:G:
NM_138694.4(PKHD1):c.3473G>A (p.Trp1158Ter)	PKHD1	W1158*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000857034	6	51893041	6	52028243	857034	832025		NC_000006.12:52028242:C:T
NM_138694.4(PKHD1):c.3549del (p.His1184fs)	PKHD1	H1184fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000855953	6	51892965	6	52028167	855953	832024		NC_000006.12:52028166:AA:A
NM_138694.4(PKHD1):c.11475G>A (p.Trp3825Ter)	PKHD1	W3825*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000847108	6	51503678	6	51638880	847108	831999		NC_000006.12:51638879:C:T
NM_138694.4(PKHD1):c.954del (p.Arg319fs)	PKHD1	R319fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000846728	6	51929775	6	52064977	846728	832029		NC_000006.12:52064976:C:
NM_138694.4(PKHD1):c.10906C>T (p.Gln3636Ter)	PKHD1	Q3636*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000845029	6	51524018	6	51659220	845029	832002		NC_000006.12:51659219:G:A
NM_138694.4(PKHD1):c.9699del (p.Ser3234fs)	PKHD1	S3234fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000844553	6	51612715	6	51747917	844553	832004		NC_000006.12:51747916:GGG:GG
NM_138694.4(PKHD1):c.525del (p.Asp175fs)	PKHD1	D175fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000844269	6	51938263	6	52073465	844269	832030		NC_000006.12:52073464:A:
NM_138694.4(PKHD1):c.2563C>T (p.Gln855Ter)	PKHD1	Q855*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000842435	6	51910831	6	52046033	842435	832027		NC_000006.12:52046032:G:A
NM_138694.4(PKHD1):c.6568C>T (p.Gln2190Ter)	PKHD1	Q2190*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000836470	6	51774195	6	51909397	836470	832015		NC_000006.12:51909396:G:A
NM_138694.4(PKHD1):c.5767C>T (p.Gln1923Ter)	PKHD1	Q1923*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835281	6	51824809	6	51960011	835281	832018		NC_000006.12:51960010:G:A
NM_138694.4(PKHD1):c.4932G>A (p.Trp1644Ter)	PKHD1	W1644*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000834198	6	51889676	6	52024878	834198	832019		NC_000006.12:52024877:C:T
NC_000006.12:g.(?_52055567)_(52055749_?)del	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000830429	6	51920365 - 51920547			830429	819697		
NM_138694.4(PKHD1):c.281+1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813396	6	51947189	6	52082391	813396	801643		NC_000006.12:52082390:C:T
NM_138694.4(PKHD1):c.731G>A (p.Trp244Ter)	PKHD1	W244*	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813393	6	51934302	6	52069504	813393	801640		NC_000006.12:52069503:C:T
NM_138694.4(PKHD1):c.2140+1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813386	6	51917873	6	52053075	813386	801633		NC_000006.12:52053074:C:T
NM_138694.4(PKHD1):c.4105dup (p.Arg1369fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813385	6	51890502 - 51890503	6	52025704 - 52025705	813385	801632		NC_000006.12:52025704:G:GG
NM_138694.4(PKHD1):c.5600+1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813381	6	51882207	6	52017409	813381	801628		NC_000006.12:52017408:C:T
NM_138694.4(PKHD1):c.7062del (p.Ala2355fs)	PKHD1	A2355fs	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813378	6	51751978	6	51887180	813378	801625		NC_000006.12:51887179:TT:T
NM_138694.4(PKHD1):c.8174-2A>T	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813377	6	51695789	6	51830991	813377	801624		NC_000006.12:51830990:T:A
NM_138694.4(PKHD1):c.8629del (p.Ser2877fs)	PKHD1	S2877fs	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813375	6	51637513	6	51772715	813375	801622		NC_000006.12:51772714:A:
NM_138694.4(PKHD1):c.8935C>T (p.Arg2979Ter)	PKHD1	R2979*	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813373	6	51618014	6	51753216	813373	801620		NC_000006.12:51753215:G:A
NM_138694.4(PKHD1):c.11399-1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000813371	6	51503755	6	51638957	813371	801618		NC_000006.12:51638956:C:T
NM_138694.4(PKHD1):c.2950C>T (p.Gln984Ter)	PKHD1	Q984*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000812161	6	51907804	6	52043006	812161	800397		NC_000006.12:52043005:G:A
NM_138694.4(PKHD1):c.4492_4494delinsAG (p.Ser1498_Leu1499insTer)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000664731	6	51890114 - 51890116	6	52025316 - 52025318	664731	634968		NC_000006.12:52025315:AGA:CT
NM_138694.4(PKHD1):c.9003C>G (p.Tyr3001Ter)	PKHD1	Y3001*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000663999	6	51613411	6	51748613	663999	634957		NC_000006.12:51748612:G:C
NM_138694.4(PKHD1):c.10126del (p.Ala3376fs)	PKHD1	A3376fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000653999	6	51609213	6	51744415	653999	634953		NC_000006.12:51744414:CC:C
NC_000006.11:g.(?_51824658)_(51875267_?)del	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000653510	6	51824658 - 51875267	6	51959860 - 52010469	653510	651560		
NM_138694.4(PKHD1):c.2310dup (p.Ser771fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000649691	6	51913386 - 51913387	6	52048588 - 52048589	649691	634972		NC_000006.12:52048588:T:TT
NM_138694.4(PKHD1):c.9723dup (p.Gly3242fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000648363	6	51612690 - 51612691	6	51747892 - 51747893	648363	634955		NC_000006.12:51747892:AA:AAA
NC_000006.11:g.(?_51497343)_(51512936_?)del	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000647461	6	51497343 - 51512936	6	51632545 - 51648138	647461	651485		
NM_138694.4(PKHD1):c.6507_6511del (p.Cys2169_Tyr2171delinsTer)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000646338	6	51774252 - 51774256	6	51909454 - 51909458	646338	634964		NC_000006.12:51909453:ACAAA:
NM_138694.4(PKHD1):c.7973_7977del (p.Leu2658fs)	PKHD1	L2658fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000642865	6	51712703 - 51712707	6	51847905 - 51847909	642865	634960		NC_000006.12:51847904:CGGCA:
NM_138694.4(PKHD1):c.2176_2177delinsT (p.Gly726fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000642403	6	51915057 - 51915058	6	52050259 - 52050260	642403	634974		NC_000006.12:52050258:CC:A
NM_138694.4(PKHD1):c.7811_7827del (p.Arg2604fs)	PKHD1	R2604fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000642402	6	51720775 - 51720791	6	51855977 - 51855993	642402	634962		NC_000006.12:51855976:GTTAGACAATGTATCACGT:GT
NM_138694.4(PKHD1):c.5665del (p.Glu1889fs)	PKHD1	E1889fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000640725	6	51875193	6	52010395	640725	634966		NC_000006.12:52010394:C:
NM_138694.4(PKHD1):c.7888del (p.Leu2630fs)	PKHD1	L2630fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000639653	6	51720714	6	51855916	639653	634961		NC_000006.12:51855915:GG:G
NM_138694.4(PKHD1):c.3907del (p.Val1303fs)	PKHD1	V1303fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000637052	6	51890701	6	52025903	637052	624852		NC_000006.12:52025902:C:
NM_138694.4(PKHD1):c.4485del (p.Ser1496fs)	PKHD1	S1496fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000627590	6	51890123	6	52025325	627590	615937	rs1325403863	NC_000006.12:52025324:GG:G
NM_138694.4(PKHD1):c.5953del (p.Ala1985fs)	PKHD1	A1985fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000574622	6	51799076	6	51934278	574622	563622	rs1561921358	NC_000006.12:51934277:CCC:CC
NM_138694.4(PKHD1):c.4417C>T (p.Gln1473Ter)	PKHD1	Q1473*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000556021	6	51890191	6	52025393	556021	544221	rs1554198717	NC_000006.12:52025392:G:A
NM_138694.4(PKHD1):c.1A>G (p.Met1Val)	PKHD1	M1V	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000550469	6	51949731	6	52084933	550469	544192	rs376987651	NC_000006.12:52084932:T:C
NM_138694.4(PKHD1):c.4352_4356delinsAAGGGGTCA (p.Pro1451fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000528302	6	51890252 - 51890256	6	52025454 - 52025458	528302	521690	rs1554198780	NC_000006.12:52025453:CAAGG:TGACCCCTT
NM_138694.4(PKHD1):c.9646C>T (p.Gln3216Ter)	PKHD1	Q3216*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000528297	6	51612768	6	51747970	528297	522009	rs758732107	NC_000006.12:51747969:G:A
NM_138694.4(PKHD1):c.4295del (p.Val1432fs)	PKHD1	V1432fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000458596	6	51890313	6	52025515	458596	455834	rs1246693314	NC_000006.12:52025514:A:
NM_138694.4(PKHD1):c.10443del (p.Leu3481fs)	PKHD1	L3481fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000458584	6	51524481	6	51659683	458584	456222	rs1554183559	NC_000006.12:51659682:C:
NM_138694.4(PKHD1):c.6907A>T (p.Ile2303Phe)	PKHD1	I2303F	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000406889	6	51768484	6	51903686	406889	395415	rs751084512	NC_000006.12:51903685:T:A
NM_138694.3(PKHD1):c.8108-?_8173+?del	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000220428					220428	221620		
NM_138694.4(PKHD1):c.7560dup (p.Ala2521fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000216135	6	51732833 - 51732834	6	51868035 - 51868036	216135	212525	rs863224528	NC_000006.12:51868035:A:AA
NM_138694.4(PKHD1):c.8303-1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 27, 2015)	criteria provided, single submitter	VCV000188368	6	51656172	6	51791374	188368	186054	rs786204241	NC_000006.12:51791373:C:T
NM_138694.4(PKHD1):c.9053C>T (p.Ser3018Phe)	PKHD1	S3018F	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004110	6	51613361	6	51748563	4110	19149	rs137852945	NC_000006.12:51748562:G:A
NM_138694.4(PKHD1):c.4991C>T (p.Ser1664Phe)	PKHD1	S1664F	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004109	6	51889617	6	52024819	4109	19148	rs28937907	NC_000006.12:52024818:G:A
NM_138694.4(PKHD1):c.8122C>T (p.Gln2708Ter)	PKHD1	Q2708*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000863593	6	51701253	6	51836455	863593	832011		NC_000006.12:51836454:G:A
NM_138694.4(PKHD1):c.7177C>T (p.Gln2393Ter)	PKHD1	Q2393*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000854964	6	51750703	6	51885905	854964	832012		NC_000006.12:51885904:G:A
NC_000006.12:g.(?_52053066)_(52054175_?)del	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000831341	6	51917864 - 51918973			831341	819696		
NM_138694.4(PKHD1):c.10350C>A (p.Cys3450Ter)	PKHD1	C3450*	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633355	6	51524574	6	51659776	633355	621211	rs765652131	NC_000006.12:51659775:G:T
NM_138694.4(PKHD1):c.6029del (p.Gln2010fs)	PKHD1	Q2010fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000577036	6	51799000	6	51934202	577036	560742	rs1561920869	NC_000006.12:51934201:T:
NM_138694.4(PKHD1):c.11G>A (p.Trp4Ter)	PKHD1	W4*	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557333	6	51949721	6	52084923	557333	544185	rs1554229312	NC_000006.12:52084922:C:T
NM_138694.4(PKHD1):c.6383del (p.Ile2127_Leu2128insTer)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000557288	6	51776704	6	51911906	557288	544126	rs1405067373	NC_000006.12:51911905:AAAA:AAA
NM_138694.4(PKHD1):c.7122del (p.Phe2374fs)	PKHD1	F2374fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000556905	6	51750758	6	51885960	556905	544103	rs1554289495	NC_000006.12:51885959:AAA:AA
NM_138694.4(PKHD1):c.8555-2A>G	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553645	6	51637589	6	51772791	553645	544212	rs1020621286	NC_000006.12:51772790:T:C
NM_138694.4(PKHD1):c.10856del (p.Lys3619fs)	PKHD1	K3619fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000552098	6	51524068	6	51659270	552098	543774	rs1554183235	NC_000006.12:51659269:TTT:TT
NM_138694.4(PKHD1):c.1068dup (p.Asn357Ter)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000551993	6	51927366 - 51927367	6	52062568 - 52062569	551993	544261	rs1554219449	NC_000006.12:52062568:A:AA
NM_138694.4(PKHD1):c.10036_10045del (p.Cys3346fs)	PKHD1	C3346fs	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551074	6	51609294 - 51609303	6	51744496 - 51744505	551074	544184	rs1554216571	NC_000006.12:51744495:GACTTGCACAG:G
NM_138694.4(PKHD1):c.8677dup (p.His2893fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550537	6	51619701 - 51619702	6	51754903 - 51754904	550537	543811	rs1554221465	NC_000006.12:51754903:GGGGG:GGGGGG
NM_138694.4(PKHD1):c.3463C>T (p.Gln1155Ter)	PKHD1	Q1155*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000528301	6	51893051	6	52028253	528301	522385	rs1554200780	NC_000006.12:52028252:G:A
NM_138694.4(PKHD1):c.11776del (p.Val3926fs)	PKHD1	V3926fs	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371506	6	51491804	6	51627006	371506	357435	rs1057517324	NC_000006.12:51627005:CC:C
NM_138694.4(PKHD1):c.3313del (p.Ser1105fs)	PKHD1	S1105fs	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370990	6	51897879	6	52033081	370990	357483	rs1057516922	NC_000006.12:52033080:AA:A
NM_138694.4(PKHD1):c.3694_3725del (p.Val1232fs)	PKHD1	V1232fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000370781	6	51890883 - 51890914	6	52026085 - 52026116	370781	357481	rs1057516762	NC_000006.12:52026084:AAGTTCACAATGTCACAGGACCGATTGCCCACAAGT:AAGT
NM_138694.4(PKHD1):c.707+1G>A	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000285761	6	51935203	6	52070405	285761	269998	rs748365248	NC_000006.12:52070404:C:T
NM_138694.4(PKHD1):c.4733del (p.Tyr1578fs)	PKHD1	Y1578fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000167487	6	51889875	6	52025077	167487	177955	rs727504087	NC_000006.12:52025076:T:
NM_138694.4(PKHD1):c.5236+1G>A	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096406	6	51889371	6	52024573	96406	102300	rs398124487	NC_000006.12:52024572:C:T
NM_017890.4(VPS13B):c.3427C>T (p.Arg1143Ter)	VPS13B	R1143*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Oct 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056658	8	100454845	8	99442617	56658	71297	rs386834080	NC_000008.11:99442616:C:T
NM_015243.2(VPS13B):c.2074C>T (p.Arg692Ter)	VPS13B	R692*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056650	8	100168837	8	99156609	56650	71289	rs180177356	NC_000008.11:99156608:C:T
NM_015243.2(VPS13B):c.1219C>T (p.Gln407Ter)	VPS13B	Q407*	not provided|Cohen syndrome|Global developmental delay|Generalized joint laxity|Microcephaly|Attention deficit hyperactivity disorder|Unsteady gait|Muscular hypotonia|Intellectual disability|Carious teeth	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056645	8	100146872	8	99134644	56645	71284	rs386834070	NC_000008.11:99134643:C:T
NM_017890.4(VPS13B):c.10156dup (p.Thr3386fs)	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056629	8	100865697 - 100865698	8	99853469 - 99853470	56629	71268	rs386834055	NC_000008.11:99853469:A:AA
NM_015046.7(SETX):c.4087C>T (p.Arg1363Ter)	SETX	R1363*	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000002284	9	135202898	9	132327511	2284	17323	rs121434376	NC_000009.12:132327510:G:A
NM_138694.4(PKHD1):c.5830G>A (p.Asp1944Asn)	PKHD1	D1944N	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000862704	6	51824746	6	51959948	862704	832017		NC_000006.12:51959947:C:T
NM_138694.4(PKHD1):c.8642+1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000633352	6	51637499	6	51772701	633352	621752	rs1485161784	NC_000006.12:51772700:C:T
NM_138694.4(PKHD1):c.11747C>G (p.Ser3916Ter)	PKHD1	S3916*	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000597072	6	51491833	6	51627035	597072	588133	rs760426769	NC_000006.12:51627034:G:C
NM_138694.4(PKHD1):c.383del (p.Thr128fs)	PKHD1	T128fs	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000594678	6	51944705	6	52079907	594678	585740	rs868562051	NC_000006.12:52079906:G:
NM_138694.4(PKHD1):c.5448T>A (p.Tyr1816Ter)	PKHD1	Y1816*	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550965	6	51882360	6	52017562	550965	544210	rs1554194511	NC_000006.12:52017561:A:T
NM_138694.4(PKHD1):c.881-1G>A	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000499351	6	51929849	6	52065051	499351	490775	rs1554220431	NC_000006.12:52065050:C:T
NM_138694.4(PKHD1):c.5411del (p.Arg1804fs)	PKHD1	R1804fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000458602	6	51882397	6	52017599	458602	455634	rs1554194574	NC_000006.12:52017598:C:
NM_138694.4(PKHD1):c.4882C>G (p.Pro1628Ala)	PKHD1	P1628A	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371295	6	51889726	6	52024928	371295	357473	rs267601070	NC_000006.12:52024927:G:C
NM_138694.4(PKHD1):c.9718C>T (p.Arg3240Ter)	PKHD1	R3240*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370548	6	51612696	6	51747898	370548	357448	rs1057516577	NC_000006.12:51747897:G:A
NM_138694.4(PKHD1):c.8190del (p.Glu2731fs)	PKHD1	E2731fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000283651	6	51695771	6	51830973	283651	267888	rs886042676	NC_000006.12:51830972:A:
NM_138694.4(PKHD1):c.5877_5878CA[1] (p.Thr1960fs)	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000196990	6	51824696 - 51824697	6	51959898 - 51959899	196990	194151	rs771180444	NC_000006.12:51959897:TGTGT:TGT
NM_138694.4(PKHD1):c.3528dup (p.Ser1177fs)	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000196636	6	51892985 - 51892986	6	52028187 - 52028188	196636	193797	rs797044713	NC_000006.12:52028187:G:GG
NM_138694.4(PKHD1):c.1830T>A (p.Tyr610Ter)	PKHD1	Y610*	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, multiple submitters, no conflicts	VCV000189100	6	51920391	6	52055593	189100	186717	rs749293235	NC_000006.12:52055592:A:T
NM_138694.4(PKHD1):c.1880T>A (p.Met627Lys)	PKHD1	M627K	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, single submitter	VCV000189098	6	51918920	6	52054122	189098	186715	rs786204696	NC_000006.12:52054121:A:T
NM_138694.4(PKHD1):c.10412T>G (p.Val3471Gly)	PKHD1	V3471G	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000004115	6	51524512	6	51659714	4115	19154	rs137852950	NC_000006.12:51659713:A:C
NM_020822.3(KCNT1):c.2800G>A (p.Ala934Thr)	KCNT1	A934T, A889T	not provided|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039594	9	138671275	9	135779429	39594	48193	rs397515403	NC_000009.12:135779428:G:A
NM_000426.3(LAMA2):c.6993-2A>C	LAMA2		Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551050	6	129785433	6	129464288	551050	543992	rs200669208	NC_000006.12:129464287:A:C
NM_000426.3(LAMA2):c.7658del (p.Ser2553fs)	LAMA2	S2549fs, S2553fs	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000477507	6	129802493	6	129481348	477507	456115	rs1293303410	NC_000006.12:129481347:C:
NM_000426.3(LAMA2):c.3799_3821del (p.Phe1267fs)	LAMA2	F1267fs	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280520	6	129636968 - 129636990	6	129315823 - 129315845	280520	264273	rs750220830	NC_000006.12:129315822:GTTTCTCTACATATAATCCTCAAGT:GT
NM_000426.4(LAMA2):c.2461A>C (p.Thr821Pro)	LAMA2	T821P	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242608	6	129601216	6	129280071	242608	188050	rs186538779	NC_000006.12:129280070:A:C
NM_000426.3(LAMA2):c.4348C>T (p.Arg1450Ter)	LAMA2	R1450*	Merosin deficient congenital muscular dystrophy|not provided|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000191214	6	129663524	6	129342379	191214	189017	rs200923373	NC_000006.12:129342378:C:T
NM_000426.3(LAMA2):c.3623_3645del (p.Lys1208fs)	LAMA2	K1208fs	Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167242	6	129636685 - 129636707	6	129315540 - 129315562	167242	177811	rs727503992	NC_000006.12:129315539:CCAAGGGCATTGTTTTTCAACATCCA:CCA
NM_000426.3(LAMA2):c.5914C>T (p.Gln1972Ter)	LAMA2	Q1972*	Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092971	6	129748945	6	129427800	92971	98878	rs398123378	NC_000006.12:129427799:C:T
NM_005476.7(GNE):c.737G>A (p.Arg246Gln)	GNE	R246Q, R241Q, R277Q	not provided|Sialuria|GNE myopathy|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006030	9	36236861	9	36236864	6030	21069	rs121908629	NC_000009.12:36236863:C:T
NM_001458.4(FLNC):c.774del (p.Lys259fs)	FLNC	K259fs	Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000478133	7	128477523	7	128837469	478133	456223	rs1554397506	NC_000007.14:128837468:CCCC:CCC
NM_001458.4(FLNC):c.697C>T (p.Gln233Ter)	FLNC	Q233*	Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000478130	7	128477309	7	128837255	478130	456775	rs1554397464	NC_000007.14:128837254:C:T
NM_001458.4(FLNC):c.3039C>A (p.Cys1013Ter)	FLNC	C1013*	Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000478124	7	128484167	7	128844113	478124	456606	rs1554399014	NC_000007.14:128844112:C:A
NM_001458.4(FLNC):c.4871C>T (p.Ser1624Leu)	FLNC	S1624L	Cardiomyopathy, familial restrictive, 5	Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	VCV000253126	7	128488980	7	128848926	253126	247538	rs879255639	NC_000007.14:128848925:C:T
NM_001458.4(FLNC):c.368T>C (p.Val123Ala)	FLNC	V123A	Cardiomyopathy, familial hypertrophic, 26	Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	VCV000253125	7	128475395	7	128835341	253125	247537	rs1562991002	NC_000007.14:128835340:T:C
NM_001458.4(FLNC):c.4615G>A (p.Ala1539Thr)	FLNC	A1539T	Cardiomyopathy, familial hypertrophic, 26	Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	VCV000253123	7	128488649	7	128848595	253123	247535	rs1562999443	NC_000007.14:128848594:G:A
NM_138694.4(PKHD1):c.1836+1G>A	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813388	6	51920384	6	52055586	813388	801635		NC_000006.12:52055585:C:T
NM_138694.4(PKHD1):c.10628_10635del (p.Leu3543fs)	PKHD1	L3543fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000813372	6	51524289 - 51524296	6	51659491 - 51659498	813372	801619		NC_000006.12:51659490:AACATACAA:A
NM_138694.4(PKHD1):c.6809-2A>T	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000649517	6	51768842	6	51904044	649517	651568		NC_000006.12:51904043:T:A
NM_138694.4(PKHD1):c.10765C>T (p.Gln3589Ter)	PKHD1	Q3589*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000633362	6	51524159	6	51659361	633362	621209	rs780182068	NC_000006.12:51659360:G:A
NM_138694.4(PKHD1):c.6866-2_6866-1delinsGA	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000597249	6	51768526 - 51768527	6	51903728 - 51903729	597249	588310	rs1562581286	NC_000006.12:51903727:CT:TC
NM_138694.4(PKHD1):c.11074C>T (p.Arg3692Ter)	PKHD1	R3692*	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000593691	6	51523850	6	51659052	593691	584755	rs769559267	NC_000006.12:51659051:G:A
NM_138694.4(PKHD1):c.2811G>A (p.Trp937Ter)	PKHD1	W937*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000458592	6	51908433	6	52043635	458592	455649	rs1344820986	NC_000006.12:52043634:C:T
NM_138694.4(PKHD1):c.11612G>A (p.Trp3871Ter)	PKHD1	W3871*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000458588	6	51497416	6	51632618	458588	456216	rs1554167673	NC_000006.12:51632617:C:T
NM_138694.4(PKHD1):c.5912G>A (p.Gly1971Asp)	PKHD1	G1971D	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000377269	6	51799117	6	51934319	377269	364147	rs180675584	NC_000006.12:51934318:C:T
NM_138694.4(PKHD1):c.4141del (p.Val1381fs)	PKHD1	V1381fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371324	6	51890467	6	52025669	371324	357478	rs778537772	NC_000006.12:52025668:CC:C
NM_138694.4(PKHD1):c.1458C>A (p.Tyr486Ter)	PKHD1	Y486*	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, multiple submitters, no conflicts	VCV000189171	6	51923175	6	52058377	189171	186719	rs786204749	NC_000006.12:52058376:G:T
NM_138694.4(PKHD1):c.85G>T (p.Glu29Ter)	PKHD1	E29*	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096435	6	51948021	6	52083223	96435	102329	rs398124498	NC_000006.12:52083222:C:A
NM_001458.4(FLNC):c.1844dup (p.Ile616fs)	FLNC		Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000860643	7	128481252 - 128481253	7	128841198 - 128841199	860643	833015		NC_000007.14:128841198:AA:AAA
NM_001458.4(FLNC):c.3415del (p.His1139fs)	FLNC	H1139fs	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000859741	7	128484932	7	128844878	859741	833043		NC_000007.14:128844877:CCC:CC
NM_001458.4(FLNC):c.1027A>T (p.Lys343Ter)	FLNC	K343*	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000859534	7	128478098	7	128838044	859534	833002		NC_000007.14:128838043:A:T
NM_001458.4(FLNC):c.2507del (p.Pro836fs)	FLNC	P836fs	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000858026	7	128482964	7	128842910	858026	833025		NC_000007.14:128842909:CC:C
NM_001458.4(FLNC):c.964G>T (p.Glu322Ter)	FLNC	E322*	Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000853279	7	128477804	7	128837750	853279	833000		NC_000007.14:128837749:G:T
NM_001458.4(FLNC):c.4984C>T (p.Gln1662Ter)	FLNC	Q1662*	Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000852214	7	128489417	7	128849363	852214	833068		NC_000007.14:128849362:C:T
NM_001458.4(FLNC):c.3933_3937del (p.Tyr1312fs)	FLNC	Y1312fs	Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000849977	7	128486185 - 128486189	7	128846131 - 128846135	849977	833050		NC_000007.14:128846130:CCTACC:C
NM_001458.4(FLNC):c.3854del (p.Gly1285fs)	FLNC	G1285fs	Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000843605	7	128486106	7	128846052	843605	833049		NC_000007.14:128846051:GG:G
NM_001458.4(FLNC):c.4108C>T (p.Arg1370Ter)	FLNC	R1370*	Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000842060	7	128486498	7	128846444	842060	833055		NC_000007.14:128846443:C:T
NM_001458.4(FLNC):c.3084C>A (p.Tyr1028Ter)	FLNC	Y1028*	Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000841507	7	128484212	7	128844158	841507	833038		NC_000007.14:128844157:C:A
NM_001458.4(FLNC):c.3699del (p.Val1235fs)	FLNC	V1235fs	Cardiomyopathy, familial hypertrophic, 26|Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related|Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000834916	7	128485218	7	128845164	834916	833048		NC_000007.14:128845163:T:
NC_000007.14:g.(?_128848551)_(128848992_?)del	FLNC		Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000830847	7	128488605 - 128489046			830847	819825		
NM_001458.4(FLNC):c.1861_1885dup (p.Arg629fs)	FLNC		Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000663736	7	128481269 - 128481270	7	128841215 - 128841216	663736	635653		NC_000007.14:128841215:CAAGGGGGATGGCTCCTGCGATGTGC:CAAGGGGGATGGCTCCTGCGATGTGCAAGGGGGATGGCTCCTGCGATGTGC
NM_001458.4(FLNC):c.4729C>T (p.Gln1577Ter)	FLNC	Q1577*	Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000645256	7	128488763	7	128848709	645256	635709		NC_000007.14:128848708:C:T
NM_001458.4(FLNC):c.554G>A (p.Trp185Ter)	FLNC	W185*	Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000643595	7	128475581	7	128835527	643595	635634		NC_000007.14:128835526:G:A
NM_001458.4(FLNC):c.3937C>T (p.Arg1313Ter)	FLNC	R1313*	Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|Cardiomyopathy, familial hypertrophic, 26	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000579589	7	128486190	7	128846136	579589	566446	rs766330686	NC_000007.14:128846135:C:T
NM_001458.4(FLNC):c.4621A>T (p.Lys1541Ter)	FLNC	K1541*	Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000577928	7	128488655	7	128848601	577928	561336	rs1562999451	NC_000007.14:128848600:A:T
NM_001458.4(FLNC):c.4333_4336del (p.Gly1444_Lys1445insTer)	FLNC		Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related|Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000571885	7	128487793 - 128487796	7	128847739 - 128847742	571885	561468	rs1562998858	NC_000007.14:128847738:GGAAGG:GG
NM_001127487.2(FLNC):c.147delinsTCT (p.Lys51fs)	FLNC		Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related|Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000567163	7	128470838	7	128830784	567163	564018	rs1562988883	NC_000007.14:128830783:C:TCT
NM_001458.4(FLNC):c.444G>A (p.Trp148Ter)	FLNC	W148*	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000539439	7	128475471	7	128835417	539439	522405	rs1554397197	NC_000007.14:128835416:G:A
NM_001458.4(FLNC):c.805C>T (p.Arg269Ter)	FLNC	R269*	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000539411	7	128477557	7	128837503	539411	522409	rs755583250	NC_000007.14:128837502:C:T
NM_001458.4(FLNC):c.5165del (p.Gly1722fs)	FLNC	G1722fs	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000539390	7	128489594	7	128849540	539390	522500	rs1554400242	NC_000007.14:128849539:GGGGG:GGGG
NM_001458.4(FLNC):c.1605C>A (p.Cys535Ter)	FLNC	C535*	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, single submitter	VCV000539354	7	128480657	7	128840603	539354	522522	rs199976790	NC_000007.14:128840602:C:A
NM_001458.4(FLNC):c.4926_4927insACGTCACA (p.Val1643fs)	FLNC		Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000478128	7	128489028 - 128489029	7	128848974 - 128848975	478128	456851	rs1402879259	NC_000007.14:128848974:CGTCACA:CGTCACAACGTCACA
NM_001458.4(FLNC):c.2390-10_2406del	FLNC		Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000478125	7	128482836 - 128482862	7	128842782 - 128842808	478125	456588	rs1554398674	NC_000007.14:128842781:GCTTCTCTGCAGGCGACGTGAGCATCGGC:GC
NM_001458.4(FLNC):c.1519_1525del (p.Gly507fs)	FLNC	G507fs	Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000478121	7	128480181 - 128480187	7	128840127 - 128840133	478121	456551	rs1554398092	NC_000007.14:128840126:AGCGGGGAGC:AGC
NM_001458.4(FLNC):c.752T>C (p.Met251Thr)	FLNC	M251T	Myopathy, distal, 4	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000029591	7	128477504	7	128837450	29591	38545	rs387906586	NC_000007.14:128837449:T:C
NM_001458.4(FLNC):c.2789_2800del (p.Val930_Thr933del)	FLNC		Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000018467	7	128483608 - 128483619	7	128843554 - 128843565	18467	33506	rs1562995872	NC_000007.14:128843553:GTCAAGTACACCG:G
NM_001458.4(FLNC):c.2119C>T (p.Gln707Ter)	FLNC	Q707*	Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000849024	7	128481619	7	128841565	849024	833020		NC_000007.14:128841564:C:T
NM_001458.4(FLNC):c.4127+1G>T	FLNC		Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000643473	7	128486518	7	128846464	643473	651755		NC_000007.14:128846463:G:T
NM_001458.4(FLNC):c.2065G>T (p.Glu689Ter)	FLNC	E689*	Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000539448	7	128481565	7	128841511	539448	522897	rs1446694237	NC_000007.14:128841510:G:T
NM_001458.4(FLNC):c.4716del (p.Leu1573fs)	FLNC	L1573fs	Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000478127	7	128488747	7	128848693	478127	456290	rs1554400021	NC_000007.14:128848692:GGGG:GGG
NM_001458.4(FLNC):c.3934_3937dup (p.Arg1313fs)	FLNC		Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000478126	7	128486183 - 128486184	7	128846129 - 128846130	478126	457288	rs1554399513	NC_000007.14:128846129:ACCTACC:ACCTACCTACC
NM_001458.4(FLNC):c.4969C>T (p.Arg1657Ter)	FLNC	R1657*	Cardiomyopathy, familial hypertrophic, 26|Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620418	7	128489402	7	128849348	620418	611673	rs1563000044	NC_000007.14:128849347:C:T
NM_001458.4(FLNC):c.3180del (p.Asp1061fs)	FLNC	D1061fs	not provided|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421585	7	128484308	7	128844254	421585	406970	rs1064795229	NC_000007.14:128844253:T:
NM_001458.4(FLNC):c.1948C>T (p.Arg650Ter)	FLNC	R650*	not provided|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421215	7	128481358	7	128841304	421215	406969	rs770606675	NC_000007.14:128841303:C:T
NM_001287174.2(ABCC8):c.2860C>T (p.Gln954Ter)	ABCC8	Q953*, Q954*, Q975*, Q952*	Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188905	11	17428964	11	17407417	188905	186814	rs541269678	NC_000011.10:17407416:G:A
NM_000260.4(MYO7A):c.1190C>A (p.Ala397Asp)	MYO7A	A397D, A386D	|Deafness, autosomal recessive 2|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553245	11	76871318	11	77160272	553245	546746	rs1555067667	NC_000011.10:77160271:C:A
NM_000260.4(MYO7A):c.999T>G (p.Tyr333Ter)	MYO7A	Y333*, Y322*	not provided|Rare genetic deafness|Retinal dystrophy|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jan 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043345	11	76869472	11	77158426	43345	52515	rs111033285	NC_000011.10:77158425:T:G
NM_000260.4(MYO7A):c.494C>T (p.Thr165Met)	MYO7A	T165M, T154M	Rare genetic deafness|not provided|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043264	11	76867729	11	77156683	43264	52434	rs111033174	NC_000011.10:77156682:C:T
NM_000260.4(MYO7A):c.2904G>T (p.Glu968Asp)	MYO7A	E968D, E957D	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043196	11	76892635	11	77181589	43196	52366	rs111033233	NC_000011.10:77181588:G:T
NM_001458.4(FLNC):c.4021C>T (p.Arg1341Ter)	FLNC	R1341*	Cardiomyopathy, familial hypertrophic, 26|Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620373	7	128486411	7	128846357	620373	611672	rs1562998062	NC_000007.14:128846356:C:T
NM_000719.7(CACNA1C):c.1204G>A (p.Gly402Ser)	CACNA1C	G402S, G399S	Timothy syndrome|Congenital long QT syndrome|not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000017633	12	2614098	12	2504932	17633	32672	rs80315385	NC_000012.12:2504931:G:A
NM_001278716.2(FBXL4):c.106A>T (p.Arg36Ter)	FBXL4	R36*	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437488	6	99374759	6	98926883	437488	431351	rs1182326570	NC_000006.12:98926882:T:A
NM_138694.4(PKHD1):c.5751+3A>G	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813379	6	51875104	6	52010306	813379	801626		NC_000006.12:52010305:T:C
NM_138694.4(PKHD1):c.7916C>A (p.Ser2639Ter)	PKHD1	S2639*	Autosomal recessive polycystic kidney disease|Polycystic kidney dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2015)	criteria provided, multiple submitters, no conflicts	VCV000189143	6	51712764	6	51847966	189143	186709	rs181208607	NC_000006.12:51847965:G:T
NM_138694.4(PKHD1):c.8824C>T (p.Arg2942Ter)	PKHD1	R2942*	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096439	6	51618125	6	51753327	96439	102333	rs398124500	NC_000006.12:51753326:G:A
NM_138694.4(PKHD1):c.8011C>T (p.Arg2671Ter)	PKHD1	R2671*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004112	6	51712669	6	51847871	4112	19151	rs137852947	NC_000006.12:51847870:G:A
NM_001458.4(FLNC):c.3791-1G>C	FLNC		Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy, filamin C-related|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420146	7	128486043	7	128845989	420146	406971	rs781135153	NC_000007.14:128845988:G:C
NM_000118.3(ENG):c.277C>T (p.Arg93Ter)	ENG	R93*	Pulmonary arterial hypertension|Hereditary hemorrhagic telangiectasia|Hereditary hemorrhagic telangiectasia type 1|not provided	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265371	9	130592049	9	127829770	265371	259914	rs886039506	NC_000009.12:127829769:G:A
NM_017890.4(VPS13B):c.8515C>T (p.Arg2839Ter)	VPS13B	R2839*, R2814*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056694	8	100830757	8	99818529	56694	71333	rs386834113	NC_000008.11:99818528:C:T
NM_138694.4(PKHD1):c.474G>A (p.Trp158Ter)	PKHD1	W158*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813395	6	51938314	6	52073516	813395	801642		NC_000006.12:52073515:C:T
NM_138694.4(PKHD1):c.5323C>T (p.Arg1775Ter)	PKHD1	R1775*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550139	6	51887656	6	52022858	550139	543839	rs770522674	NC_000006.12:52022857:G:A
NM_138694.4(PKHD1):c.8555-2A>C	PKHD1		not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429814	6	51637589	6	51772791	429814	421593	rs1020621286	NC_000006.12:51772790:T:G
NM_138694.4(PKHD1):c.9559del (p.Ser3187fs)	PKHD1	S3187fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208604	6	51612855	6	51748057	208604	205151	rs797045101	NC_000006.12:51748056:AAAA:AAA
NM_138694.4(PKHD1):c.5060T>C (p.Ile1687Thr)	PKHD1	I1687T	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000196807	6	51889548	6	52024750	196807	193968	rs794727566	NC_000006.12:52024749:A:G
NM_138694.4(PKHD1):c.2810G>A (p.Trp937Ter)	PKHD1	W937*	Autosomal recessive polycystic kidney disease|Polycystic kidney dysplasia|Ventricular hypertrophy|Polycystic kidney dysplasia|Renal cyst	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189110	6	51908434	6	52043636	189110	186713	rs786204707	NC_000006.12:52043635:C:T
NM_138694.4(PKHD1):c.10452dup (p.Leu3485fs)	PKHD1		Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189084	6	51524471 - 51524472	6	51659673 - 51659674	189084	186705	rs771623148	NC_000006.12:51659673:AAAAAA:AAAAAAA
NM_138694.4(PKHD1):c.2279G>A (p.Arg760His)	PKHD1	R760H	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, multiple submitters, no conflicts	VCV000188876	6	51914955	6	52050157	188876	186714	rs745770404	NC_000006.12:52050156:C:T
NM_138694.4(PKHD1):c.2725C>T (p.Arg909Ter)	PKHD1	R909*	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167491	6	51908519	6	52043721	167491	177238	rs727504089	NC_000006.12:52043720:G:A
NM_138694.4(PKHD1):c.10031T>G (p.Leu3344Ter)	PKHD1	L3344*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096365	6	51609308	6	51744510	96365	102259	rs398124475	NC_000006.12:51744509:A:C
NM_001370259.2(MEN1):c.1202del (p.Gly401fs)	MEN1	G366fs, G443fs, G406fs, G401fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000836644	11	64572654	11	64805182	836644	838728		NC_000011.10:64805181:CC:C
NM_000244.3(MEN1):c.1415_1428del (p.Ala472fs)	MEN1	A432fs, A467fs, A472fs, A509fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000657179	11	64572226 - 64572239	11	64804754 - 64804767	657179	640266		NC_000011.10:64804753:CCACGGCTCCTCGGCC:CC
NM_000244.3(MEN1):c.1239_1240insGTCC (p.Cys414fs)	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428066	11	64572631 - 64572632	11	64805159 - 64805160	428066	419802	rs1114167524	NC_000011.10:64805159::GGAC
NM_000244.3(MEN1):c.1A>T (p.Met1Leu)	MEN1	M1L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428034	11	64577581	11	64810109	428034	419865	rs386134250	NC_000011.10:64810108:T:A
NM_000244.3(MEN1):c.1037G>A (p.Trp346Ter)	MEN1	W341*, W346*, W306*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428018	11	64573731	11	64806259	428018	419813	rs1114167482	NC_000011.10:64806258:C:T
NM_000244.3(MEN1):c.1427G>A (p.Trp476Ter)	MEN1	W471*, W476*, W436*, W513*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 2, 2017)	criteria provided, single submitter	VCV000403839	11	64572227	11	64804755	403839	398357	rs1060499991	NC_000011.10:64804754:C:T
NM_000244.3(MEN1):c.984C>A (p.Tyr328Ter)	MEN1	Y323*, Y328*, Y288*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000403838	11	64573784	11	64806312	403838	398284	rs750904332	NC_000011.10:64806311:G:T
NM_000244.3(MEN1):c.340dup (p.Ser114fs)	MEN1		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279850	11	64577241 - 64577242	11	64809769 - 64809770	279850	264443	rs886041213	NC_000011.10:64809769:T:TT
NM_000244.3(MEN1):c.1339C>T (p.Gln447Ter)	MEN1	Q442*, Q447*, Q407*, Q484*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201016	11	64572532	11	64805060	201016	197530	rs794728654	NC_000011.10:64805059:G:A
NM_000426.3(LAMA2):c.1467+2T>C	LAMA2		MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554368	6	129499013	6	129177868	554368	543769	rs1554234163	NC_000006.12:129177867:T:C
NM_000426.3(LAMA2):c.363C>A (p.Tyr121Ter)	LAMA2	Y121*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551699	6	129381008	6	129059863	551699	543492	rs535635043	NC_000006.12:129059862:C:A
NM_000426.3(LAMA2):c.3085C>T (p.Arg1029Ter)	LAMA2	R1029*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551522	6	129621928	6	129300783	551522	543865	rs145420388	NC_000006.12:129300782:C:T
NM_001079823.2(LAMA2):c.2556del (p.Phe852fs)	LAMA2	F852fs	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000477455	6	129609007	6	129287862	477455	456077	rs750731624	NC_000006.12:129287861:TTTT:TTT
NM_000426.3(LAMA2):c.4717+1G>T	LAMA2		Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429903	6	129674503	6	129353358	429903	421568	rs1131691660	NC_000006.12:129353357:G:T
NM_000426.3(LAMA2):c.396+1G>T	LAMA2		not provided|Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282977	6	129381042	6	129059897	282977	267214	rs770617208	NC_000006.12:129059896:G:T
NM_000426.3(LAMA2):c.5260del (p.Lys1753_Val1754insTer)	LAMA2		Laminin alpha 2-related dystrophy|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000196993	6	129714215	6	129393070	196993	194154	rs794727594	NC_000006.12:129393069:G:
NM_000426.3(LAMA2):c.112+1G>A	LAMA2		Laminin alpha 2-related dystrophy|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092937	6	129204503	6	128883358	92937	98844	rs398123367	NC_000006.12:128883357:G:A
NM_005157.6(ABL1):c.944C>T (p.Thr315Ile)	ABL1	T315I, T334I	Leukemia, Philadelphia chromosome-positive, resistant to imatinib|Lymphoblastic leukemia, acute, with lymphomatous features|Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000012624	9	133748283	9	130872896	12624	27663	rs121913459	NC_000009.12:130872895:C:T
NM_004333.6(BRAF):c.736G>C (p.Ala246Pro)	BRAF	A246P, A158P, A194P, A212P, A249P	Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013965	7	140501336	7	140801536	13965	29004	rs180177034	NC_000007.14:140801535:C:G
NM_022970.3(FGFR2):c.1087+1304G>A	FGFR2	C342Y, C253Y, C227Y, C114Y	Pfeiffer syndrome|Crouzon syndrome|FGFR2 related craniosynostosis||Pfeiffer syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Bent bone dysplasia syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Neoplasm of stomach	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013263	10	123276892	10	121517378	13263	28302	rs121918487	NC_000010.11:121517377:C:T
NM_000093.5(COL5A1):c.3804dup (p.Gln1269fs)	COL5A1		not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000817600	9	137704509 - 137704510	9	134812663 - 134812664	817600	805613		NC_000009.12:134812663:A:AA
NM_001278074.1(COL5A1):c.292G>T (p.Glu98Ter)	COL5A1	E98*	not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000523845	9	137591769	9	134699923	523845	514588	rs369126350	NC_000009.12:134699922:G:T
NM_001278074.1(COL5A1):c.904G>T (p.Glu302Ter)	COL5A1	E302*	not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000523829	9	137620633	9	134728787	523829	514589	rs1554787811	NC_000009.12:134728786:G:T
NM_001278074.1(COL5A1):c.730_731TG[1] (p.Cys244_Asp245delinsTer)	COL5A1		not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000504044	9	137619187 - 137619188	9	134727341 - 134727342	504044	495638	rs1554787557	NC_000009.12:134727340:TGTG:TG
NM_001278074.1(COL5A1):c.1183G>T (p.Glu395Ter)	COL5A1	E395*	not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000489371	9	137623360	9	134731514	489371	481846	rs1554788339	NC_000009.12:134731513:G:T
NM_001278074.1(COL5A1):c.1503del (p.Gly502fs)	COL5A1	G502fs	not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000452770	9	137642396	9	134750550	452770	444396	rs1554792011	NC_000009.12:134750549:T:
NM_001278074.1(COL5A1):c.3726_3732del (p.Gly1243fs)	COL5A1	G1243fs	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000450689	9	137704325 - 137704331	9	134812479 - 134812485	450689	444399	rs1554805076	NC_000009.12:134812478:GAGACAGGAGAC:GAGAC
NM_001278074.1(COL5A1):c.1502del (p.Pro501fs)	COL5A1	P501fs	not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000426926	9	137642390	9	134750544	426926	415169	rs1085307855	NC_000009.12:134750543:CCCCCC:CCCCC
NM_001278074.1(COL5A1):c.1332+1G>T	COL5A1		not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000423890	9	137623510	9	134731664	423890	407589	rs1064796684	NC_000009.12:134731663:G:T
NM_001278074.1(COL5A1):c.1207G>T (p.Glu403Ter)	COL5A1	E403*	not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000287458	9	137623384	9	134731538	287458	271695	rs886043641	NC_000009.12:134731537:G:T
NM_001278074.1(COL5A1):c.4283del (p.Gln1428fs)	COL5A1	Q1428fs	not provided	Pathogenic(Last reviewed: Jan 3, 2014)	criteria provided, single submitter	VCV000213034	9	137710554	9	134818708	213034	210098	rs863223474	NC_000009.12:134818707:A:
NM_001278074.1(COL5A1):c.2784del (p.Lys929fs)	COL5A1	K929fs	not provided	Pathogenic(Last reviewed: Feb 23, 2014)	criteria provided, single submitter	VCV000213032	9	137687144	9	134795298	213032	210056	rs863223472	NC_000009.12:134795297:GGG:GG
NM_001278074.1(COL5A1):c.2347_2348insT (p.Gln783fs)	COL5A1		not provided	Pathogenic(Last reviewed: Dec 29, 2014)	criteria provided, single submitter	VCV000213031	9	137666720 - 137666721	9	134774874 - 134774875	213031	210045	rs863223471	NC_000009.12:134774874::T
NM_001278074.1(COL5A1):c.2162dup (p.Gln722fs)	COL5A1		not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000213030	9	137658872 - 137658873	9	134767026 - 134767027	213030	210040	rs863223470	NC_000009.12:134767026:GG:GGG
NM_001278074.1(COL5A1):c.2159dup (p.Gly721fs)	COL5A1		not provided	Pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	VCV000213029	9	137658865 - 137658866	9	134767019 - 134767020	213029	210039	rs863223469	NC_000009.12:134767019:CCCCCC:CCCCCCC
NM_001278074.1(COL5A1):c.4282C>T (p.Gln1428Ter)	COL5A1	Q1428*	not provided	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000212975	9	137710553	9	134818707	212975	210097	rs863223454	NC_000009.12:134818706:C:T
NM_001278074.1(COL5A1):c.4184del (p.Pro1395fs)	COL5A1	P1395fs	not provided	Pathogenic(Last reviewed: Feb 17, 2015)	criteria provided, single submitter	VCV000197959	9	137709627	9	134817781	197959	195120	rs794727760	NC_000009.12:134817780:CCCCC:CCCC
NM_001278074.1(COL5A1):c.1663-1G>C	COL5A1		not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000194320	9	137644434	9	134752588	194320	191483	rs794727114	NC_000009.12:134752587:G:C
NM_001278074.1(COL5A1):c.3983del (p.Pro1328fs)	COL5A1	P1328fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000519638	9	137706717	9	134814871	519638	510032	rs1554805638	NC_000009.12:134814870:CCC:CC
NM_001278074.1(COL5A1):c.2203dup (p.Gln735fs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000375637	9	137659166 - 137659167	9	134767320 - 134767321	375637	362443	rs1057519596	NC_000009.12:134767320:CCCCC:CCCCCC
NM_001278074.1(COL5A1):c.3762del (p.Gly1255fs)	COL5A1	G1255fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000374262	9	137704468	9	134812622	374262	361194	rs1057518653	NC_000009.12:134812621:T:
NM_000093.5(COL5A1):c.876dup (p.Ser293fs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000859807	9	137620600 - 137620601	9	134728754 - 134728755	859807	835750		NC_000009.12:134728754:CCCCC:CCCCCC
NM_000093.5(COL5A1):c.2553del (p.Asn852fs)	COL5A1	N852fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000858095	9	137676901	9	134785055	858095	835761		NC_000009.12:134785054:CCC:CC
NM_000093.5(COL5A1):c.2159del (p.Pro720fs)	COL5A1	P720fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000856462	9	137658866	9	134767020	856462	835760		NC_000009.12:134767019:CCCCCC:CCCCC
NM_000093.5(COL5A1):c.3297del (p.Ile1101fs)	COL5A1	I1101fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000854017	9	137698071	9	134806225	854017	835769		NC_000009.12:134806224:GGG:GG
NM_000093.5(COL5A1):c.1094_1095del (p.Asp365fs)	COL5A1	D365fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000853480	9	137622251 - 137622252	9	134730405 - 134730406	853480	835753		NC_000009.12:134730404:AC:
NM_000093.5(COL5A1):c.1639C>T (p.Gln547Ter)	COL5A1	Q547*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000840700	9	137642705	9	134750859	840700	835757		NC_000009.12:134750858:C:T
NC_000009.12:g.(?_134642178)_(134701343_?)del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000830770	9	137534024 - 137593189			830770	820091		
NC_000009.11:g.(?_137582748)_(137619253_?)del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000662836	9	137582748 - 137619253	9	134690902 - 134727407	662836	652041		
NM_001278074.1(COL5A1):c.2425G>T (p.Glu809Ter)	COL5A1	E809*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000660562	9	137671987	9	134780141	660562	637968		NC_000009.12:134780140:G:T
NM_000093.5(COL5A1):c.2660del (p.Phe887fs)	COL5A1	F887fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000660180	9	137681013	9	134789167	660180	637969		NC_000009.12:134789166:TT:T
NM_001278074.1(COL5A1):c.297_304dup (p.Ile102fs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000659911	9	137591772 - 137591773	9	134699926 - 134699927	659911	637942		NC_000009.12:134699926:ACTTCTCCA:ACTTCTCCACTTCTCCA
NM_001278074.1(COL5A1):c.494G>A (p.Trp165Ter)	COL5A1	W165*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000646030	9	137593019	9	134701173	646030	637943		NC_000009.12:134701172:G:A
GRCh37/hg19 9q34.3(chr9:137496881-137648441)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625555	9	137496881 - 137648441			625555	613859		
NM_001278074.1(COL5A1):c.4338+1G>A	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000619958	9	137710610	9	134818764	619958	611363	rs1564481053	NC_000009.12:134818763:G:A
NC_000009.11:g.(?_137591735)_(137591988_?)del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000583819	9	137591735 - 137591988	9	134699889 - 134700142	583819	562596		
NM_001278074.1(COL5A1):c.1364del (p.Lys455fs)	COL5A1	K455fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000580851	9	137623945	9	134732099	580851	568756	rs1564418237	NC_000009.12:134732098:AAAA:AAA
NM_001278074.1(COL5A1):c.2164C>T (p.Gln722Ter)	COL5A1	Q722*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000580705	9	137658876	9	134767030	580705	568772	rs1564446117	NC_000009.12:134767029:C:T
NM_001278074.1(COL5A1):c.2565del (p.Gly856fs)	COL5A1	G856fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000578798	9	137676912	9	134785066	578798	565720	rs1564457102	NC_000009.12:134785065:CCCC:CCC
NM_000093.4(COL5A1):c.1720-136_1929del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000573641	9	137645560 - 137650136	9	134753714 - 134758290	573641	562961		
NM_000093.4(COL5A1):c.3746delG	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000573613	9	137704450	9	134812604	573613	563726	rs35002351	NC_000009.12:134812603:GGG:GG
NM_000093.4(COL5A1):c.2389delG	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000569177	9	137671947	9	134780101	569177	568780	rs1564453833	NC_000009.12:134780100:GGGGG:GGGG
NM_001278074.1(COL5A1):c.3309_3325dup (p.Pro1109fs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000568667	9	137698084 - 137698085	9	134806238 - 134806239	568667	562974	rs1564471440	NC_000009.12:134806238:TCCAGGGAGACCTGGGC:TCCAGGGAGACCTGGGCTCCAGGGAGACCTGGGC
NM_001278074.1(COL5A1):c.3684del (p.Leu1229fs)	COL5A1	L1229fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000568293	9	137703436	9	134811590	568293	562977	rs1564475090	NC_000009.12:134811589:GGGG:GGG
NC_000009.11:g.(?_137644415)_(137644511_?)del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000529307	9	137644415 - 137644511	9	134752569 - 134752665	529307	524435		
NM_001278074.1(COL5A1):c.2897del (p.Pro966fs)	COL5A1	P966fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000529237	9	137688741	9	134796895	529237	524560	rs1179967153	NC_000009.12:134796894:CCCCCC:CCCCC
NM_001278074.1(COL5A1):c.3805C>T (p.Gln1269Ter)	COL5A1	Q1269*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000459681	9	137704511	9	134812665	459681	459193	rs1554805142	NC_000009.12:134812664:C:T
NM_001278074.1(COL5A1):c.3206dup (p.Ala1070Serfs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000459671	9	137697005 - 137697006	9	134805159 - 134805160	459671	459223	rs1554803622	NC_000009.12:134805159:GGG:GGGG
NC_000009.11:g.(?_137582738)_(137655603_?)del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000459648	9	137582738 - 137655603	9	134690892 - 134763757	459648	458647		
NM_000093.4(COL5A1):c.4232delG	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000409114	9	137710501	9	134818655	409114	396698	rs1060502259	NC_000009.12:134818654:GGG:GG
NM_001278074.1(COL5A1):c.2143G>T (p.Gly715Ter)	COL5A1	G715*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000409113	9	137658855	9	134767009	409113	396867	rs1060502258	NC_000009.12:134767008:G:T
NM_001278074.1(COL5A1):c.2988del (p.Gly997fs)	COL5A1	G997fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000409108	9	137693829	9	134801983	409108	396891	rs764693725	NC_000009.12:134801982:CCCCCCC:CCCCCC
NM_001278074.1(COL5A1):c.4203del (p.Gly1402fs)	COL5A1	G1402fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000409107	9	137709649	9	134817803	409107	396687	rs1060502255	NC_000009.12:134817802:AA:A
NM_001278074.1(COL5A1):c.2430+1G>A	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000409094	9	137671993	9	134780147	409094	397280	rs1060502248	NC_000009.12:134780146:G:A
NM_001278074.1(COL5A1):c.226_227AG[1] (p.Arg76fs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000409087	9	137582874 - 137582875	9	134691028 - 134691029	409087	396843	rs1060502242	NC_000009.12:134691027:AGAG:AG
NM_001278074.1(COL5A1):c.1075G>T (p.Glu359Ter)	COL5A1	E359*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000409086	9	137622232	9	134730386	409086	396858	rs769752636	NC_000009.12:134730385:G:T
NM_000093.4(COL5A1):c.4339-1delG	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000017193	9	137710693	9	134818847	17193	32232	rs786205102	NC_000009.12:134818846:GGG:GG
NM_001278074.1(COL5A1):c.655-2A>G	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000017192	9	137619110	9	134727264	17192	32231	rs786205101	NC_000009.12:134727263:A:G
NM_001278074.1(COL5A1):c.2374C>T (p.Arg792Ter)	COL5A1	R792*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000017191	9	137666747	9	134774901	17191	32230	rs121912933	NC_000009.12:134774900:C:T
NM_001278074.1(COL5A1):c.3752del (p.Pro1251fs)	COL5A1	P1251fs	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000017190	9	137704453	9	134812607	17190	32229	rs786205100	NC_000009.12:134812606:CCCCCC:CCCCC
NM_000093.4(COL5A1):c.3259_3366del (p.Ser1088_Gly1123del)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000017186					17186	32225		
NM_000093.5(COL5A1):c.265C>T (p.Gln89Ter)	COL5A1	Q89*	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000849026	9	137582913	9	134691067	849026	835745		NC_000009.12:134691066:C:T
NM_001278074.1(COL5A1):c.2952+2_2952+3del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000662439	9	137690307 - 137690308	9	134798461 - 134798462	662439	651922		NC_000009.12:134798460:TGTG:TG
NM_001278074.1(COL5A1):c.2988dup (p.Gly997fs)	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000459667	9	137693828 - 137693829	9	134801982 - 134801983	459667	459215	rs764693725	NC_000009.12:134801982:CCCCCCC:CCCCCCCC
NM_001278074.1(COL5A1):c.4126dup (p.Ser1376fs)	COL5A1		Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000430182	9	137708874 - 137708875	9	134817028 - 134817029	430182	421723	rs1131691820	NC_000009.12:134817028:T:TT
NM_001278074.1(COL5A1):c.3397C>T (p.Arg1133Ter)	COL5A1	R1133*	Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280931	9	137701059	9	134809213	280931	264322	rs886042045	NC_000009.12:134809212:C:T
NM_001278074.1(COL5A1):c.2734C>T (p.Arg912Ter)	COL5A1	R912*	Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213045	9	137686961	9	134795115	213045	210054	rs863223478	NC_000009.12:134795114:C:T
NM_001278074.1(COL5A1):c.3184C>T (p.Arg1062Ter)	COL5A1	R1062*	Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000029639	9	137696890	9	134805044	29639	38593	rs387906606	NC_000009.12:134805043:C:T
NM_001278074.1(COL5A1):c.2701-25T>G	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000017188	9	137686903	9	134795057	17188	32227	rs765079080	NC_000009.12:134795056:T:G
NM_004329.2(BMPR1A):c.730C>T (p.Arg244Ter)	BMPR1A	R244*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome|not provided	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421656	10	88676945	10	86917188	421656	407938	rs759363072	NC_000010.11:86917187:C:T
NM_138694.4(PKHD1):c.9719G>A (p.Arg3240Gln)	PKHD1	R3240Q	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000572902	6	51612695	6	51747897	572902	560863	rs146649803	NC_000006.12:51747896:C:T
NM_138694.4(PKHD1):c.5825A>G (p.Asp1942Gly)	PKHD1	D1942G	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000434018	6	51824751	6	51959953	434018	427318	rs1210846081	NC_000006.12:51959952:T:C
NM_138694.4(PKHD1):c.11314C>T (p.Arg3772Ter)	PKHD1	R3772*	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370289	6	51512913	6	51648115	370289	357436	rs199839578	NC_000006.12:51648114:G:A
NM_138694.4(PKHD1):c.2854G>A (p.Gly952Arg)	PKHD1	G952R	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196052	6	51907900	6	52043102	196052	193213	rs773136605	NC_000006.12:52043101:C:T
NM_138694.4(PKHD1):c.982C>T (p.Arg328Ter)	PKHD1	R328*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000096445	6	51927453	6	52062655	96445	102339	rs398124503	NC_000006.12:52062654:G:A
NM_138694.4(PKHD1):c.930del (p.Thr311fs)	PKHD1	T311fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096442	6	51929799	6	52065001	96442	102336	rs398124501	NC_000006.12:52065000:GG:G
NM_001278074.1(COL5A1):c.1780C>T (p.Arg594Ter)	COL5A1	R594*	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519624	9	137646125	9	134754279	519624	510020	rs1554792869	NC_000009.12:134754278:C:T
NM_001278074.1(COL5A1):c.2034+1G>A	COL5A1		Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000281486	9	137655584	9	134763738	281486	265723	rs886042173	NC_000009.12:134763737:G:A
NM_001278074.1(COL5A1):c.3069dup (p.Gly1024fs)	COL5A1		not provided|Ehlers-Danlos syndrome, classic type	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213033	9	137694790 - 137694791	9	134802944 - 134802945	213033	210063	rs863223473	NC_000009.12:134802944:CCCCCC:CCCCCCC
NM_001278074.1(COL5A1):c.3906+3G>T	COL5A1		Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000017183	9	137705885	9	134814039	17183	32222	rs786200922	NC_000009.12:134814038:G:T
NM_000441.1(SLC26A4):c.578C>T	SLC26A4	T193I	Enlarged vestibular aqueduct|Pendred syndrome|Enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004830	7	107314771	7	107674326	4830	19869	rs111033348	NC_000007.14:107674325:C:T
NM_000719.7(CACNA1C):c.3497T>C (p.Ile1166Thr)	CACNA1C	I1166T, I1186T, I1163T	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	VCV000208682	12	2717817	12	2608651	208682	205275	rs797044881	NC_000012.12:2608650:T:C
NM_000719.7(CACNA1C):c.1114-316G>A	CACNA1C	G402S	Paroxysmal familial ventricular fibrillation 1|not provided|Long QT syndrome	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000155775	12	2613692	12	2504526	155775	165527	rs587782933	NC_000012.12:2504525:G:A
NM_004281.4(BAG3):c.367C>T (p.Arg123Ter)	BAG3	R123*	not provided|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|Cardiovascular phenotype|Dilated cardiomyopathy 1HH|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030397	10	121429549	10	119670037	30397	39354	rs387906875	NC_000010.11:119670036:C:T
NM_002180.2(IGHMBP2):c.1488C>A (p.Cys496Ter)	IGHMBP2	C496*	Charcot-Marie-Tooth disease, axonal, type 2S|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234316	11	68701332	11	68933864	234316	231807	rs145226920	NC_000011.10:68933863:C:A
NM_002180.2(IGHMBP2):c.1478C>T (p.Thr493Ile)	IGHMBP2	T493I	not provided|Charcot-Marie-Tooth disease, axonal, type 2S|Autosomal dominant distal hereditary motor neuropathy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217450	11	68701322	11	68933854	217450	214090	rs780594709	NC_000011.10:68933853:C:T
NM_033360.4(KRAS):c.181C>A (p.Gln61Lys)	KRAS	Q61K	Neoplasm of the large intestine|Non-small cell lung cancer|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	VCV000177777	12	25380277	12	25227343	177777	175715	rs121913238	NC_000012.12:25227342:G:T
NM_033360.4(KRAS):c.37G>T (p.Gly13Cys)	KRAS	G13C	not provided|RAS-associated autoimmune leukoproliferative disorder|Neoplasm of the large intestine|Non-small cell lung cancer	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045123	12	25398282	12	25245348	45123	54290	rs121913535	NC_000012.12:25245347:C:A
NM_015243.2(VPS13B):c.2410C>T (p.Gln804Ter)	VPS13B	Q804*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000225000	8	100205180	8	99192952	225000	226909	rs869312923	NC_000008.11:99192951:C:T
NC_000009.12:g.(?_134782657)_(134842313_?)del	COL5A1		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000831806	9	137674503 - 137734159			831806	820093		
NM_001278074.1(COL5A1):c.3752dup (p.Pro1253fs)	COL5A1		not provided|Ehlers-Danlos syndrome, classic type	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459680	9	137704452 - 137704453	9	134812606 - 134812607	459680	458796	rs786205100	NC_000009.12:134812606:CCCCCC:CCCCCCC
NM_000553.4(WRN):c.3139-1G>C	WRN		Werner syndrome|not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005447	8	30999196	8	31141680	5447	20486	rs113993961	NC_000008.11:31141679:G:C
NM_000155.4(GALT):c.1030C>A (p.Gln344Lys)	GALT	Q344K, Q235K	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025320	9	34649532	9	34649535	25320	36654	rs111033814	NC_000009.12:34649534:C:A
NM_000155.4(GALT):c.253-2A>G	GALT		Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025142	9	34647487	9	34647490	25142	36476	rs111033661	NC_000009.12:34647489:A:G
NM_004183.4(BEST1):c.584C>T (p.Ala195Val)	BEST1	A195V, A135V, A89V	Bestrophinopathy, autosomal recessive|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099725	11	61724418	11	61956946	99725	105614	rs200277476	NC_000011.10:61956945:C:T
NM_000260.4(MYO7A):c.5899C>T (p.Arg1967Ter)	MYO7A	R1967*, R1929*, R1918*	Deafness, autosomal recessive 2|Rare genetic deafness||Retinal dystrophy|MYO7A-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000178495	11	76919517	11	77208472	178495	175522	rs376764423	NC_000011.10:77208471:C:T
NM_000260.4(MYO7A):c.3764del (p.Lys1255fs)	MYO7A	K1244fs, K1255fs	Deafness, autosomal recessive 2|Usher syndrome|Rare genetic deafness|	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000043223	11	76901754	11	77190709	43223	52393	rs111033347	NC_000011.10:77190708:AA:A
NM_000426.3(LAMA2):c.2230C>T (p.Arg744Ter)	LAMA2	R744*	Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554268	6	129588272	6	129267127	554268	543503	rs775676341	NC_000006.12:129267126:C:T
NM_000426.3(LAMA2):c.5234+1G>A	LAMA2		Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447687	6	129712799	6	129391654	447687	440913	rs781376927	NC_000006.12:129391653:G:A
NM_000426.3(LAMA2):c.283+1G>A	LAMA2		Laminin alpha 2-related dystrophy|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381584	6	129371234	6	129050089	381584	370142	rs200288072	NC_000006.12:129050088:G:A
NM_000426.3(LAMA2):c.2749+1G>C	LAMA2		Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194920	6	129609204	6	129288059	194920	192082	rs759555791	NC_000006.12:129288058:G:C
NM_000426.3(LAMA2):c.6955C>T (p.Arg2319Ter)	LAMA2	R2319*	Elevated serum creatine phosphokinase|Exercise-induced myalgia|Myalgia|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092980	6	129781432	6	129460287	92980	98887	rs398123383	NC_000006.12:129460286:C:T
NM_000426.3(LAMA2):c.3630del (p.Ile1210fs)	LAMA2	I1210fs	Laminin alpha 2-related dystrophy|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092954	6	129636694	6	129315549	92954	98861	rs398123372	NC_000006.12:129315548:TT:T
NM_000426.3(LAMA2):c.2901C>A (p.Cys967Ter)	LAMA2	C967*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000014301	6	129618874	6	129297729	14301	29340	rs121913577	NC_000006.12:129297728:C:A
NM_000426.3(LAMA2):c.3718C>T (p.Gln1240Ter)	LAMA2	Q1241*, Q1240*	not provided|Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014290	6	129636783	6	129315638	14290	29329	rs121913569	NC_000006.12:129315637:C:T
NM_017780.4(CHD7):c.3205C>T (p.Arg1069Ter)	CHD7	R1069*	CHARGE association||CHARGE association|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267423	8	61736402	8	60823843	267423	262648	rs886040985	NC_000008.11:60823842:C:T
NM_000083.3(CLCN1):c.1437_1450del (p.Pro480fs)	CLCN1	P480fs	Myotonia congenita|Autosomal dominant intermediate Charcot-Marie-Tooth disease|not provided|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279778	7	143036380 - 143036393	7	143339287 - 143339300	279778	264314	rs768119034	NC_000007.14:143339286:TACCCTGCGGAGGCT:T
NM_000083.3(CLCN1):c.950G>A (p.Arg317Gln)	CLCN1	R317Q	not provided|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Memory impairment|EMG: neuropathic changes|Limb pain|Migraine|EMG: myotonic runs|Muscle cramps|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|Myotonia congenita	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017542	7	143027961	7	143330868	17542	32581	rs80356702	NC_000007.14:143330867:G:A
NM_138694.4(PKHD1):c.8518C>T (p.Arg2840Cys)	PKHD1	R2840C	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636941	6	51640642	6	51775844	636941	624316		NC_000006.12:51775843:G:A
NM_138694.4(PKHD1):c.1123C>T (p.Arg375Trp)	PKHD1	R375W	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000528296	6	51924836	6	52060038	528296	522386	rs376040501	NC_000006.12:52060037:G:A
NM_138694.4(PKHD1):c.2264C>T (p.Pro755Leu)	PKHD1	P755L	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371292	6	51914970	6	52050172	371292	357490	rs1057517158	NC_000006.12:52050171:G:A
NM_138694.4(PKHD1):c.9319C>T (p.Arg3107Ter)	PKHD1	R3107*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189090	6	51613095	6	51748297	189090	186707	rs786204688	NC_000006.12:51748296:G:A
NM_001363118.2(SLC52A2):c.1016T>C (p.Leu339Pro)	SLC52A2	L339P, L175P	Inborn genetic diseases|not provided|Brown-Vialetto-Van Laere syndrome 2	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039577	8	145584264	8	144360604	39577	48176	rs148234606	NC_000008.11:144360603:T:C
NM_001122769.3(LCA5):c.835C>T (p.Gln279Ter)	LCA5	Q279*	Retinal dystrophy|Leber congenital amaurosis|Inborn genetic diseases|not provided|Leber congenital amaurosis 5	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000968	6	80203353	6	79493636	968	16007	rs121918165	NC_000006.12:79493635:G:A
NM_024757.5(EHMT1):c.3346C>T (p.Arg1116Ter)	EHMT1	R1116*, R1109*	Inborn genetic diseases	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000521743	9	140710486	9	137816034	521743	511831	rs749848324	NC_000009.12:137816033:C:T
NM_024757.5(EHMT1):c.2188dup (p.Glu730fs)	EHMT1		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000521290	9	140672501 - 140672502	9	137778049 - 137778050	521290	511829	rs1554879633	NC_000009.12:137778049:GG:GGG
NM_024757.5(EHMT1):c.3321_3326delinsTT (p.Ala1108fs)	EHMT1		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000521188	9	140710461 - 140710466	9	137816009 - 137816014	521188	511830	rs1554897852	NC_000009.12:137816008:CGCGTG:TT
NM_001370259.2(MEN1):c.783+1G>C	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000810855	11	64575023	11	64807551	810855	799658		NC_000011.10:64807550:C:G
NM_000244.3(MEN1):c.984C>G (p.Tyr328Ter)	MEN1	Y323*, Y328*, Y288*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449058	11	64573784	11	64806312	449058	444850	rs750904332	NC_000011.10:64806311:G:C
NM_000244.3(MEN1):c.1397_1404dup (p.Ala469fs)	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428075	11	64572249 - 64572250	11	64804777 - 64804778	428075	419790	rs1114167531	NC_000011.10:64804777:CTCGGCCTCTCGGC:CTCGGCCTCTCGGCCTCTCGGC
NM_000244.3(MEN1):c.1365+1_1365+11del	MEN1		not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201001	11	64572495 - 64572505	11	64805023 - 64805033	201001	197528	rs764570645	NC_000011.10:64805022:CTGTCCCTCACCTGTCCCTCA:CTGTCCCTCA
NM_001370259.2(MEN1):c.654+1G>T	MEN1		Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200978	11	64575362	11	64807890	200978	197545	rs794728622	NC_000011.10:64807889:C:A
NM_000244.3(MEN1):c.669+1G>A	MEN1		Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000039763	11	64575362	11	64807890	39763	48362	rs794728622	NC_000011.10:64807889:C:T
NM_000244.3(MEN1):c.211_212del (p.Pro71fs)	MEN1	P71fs	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036526	11	64577370 - 64577371	11	64809898 - 64809899	36526	45188	rs386134251	NC_000011.10:64809897:GGG:G
NM_000244.3(MEN1):c.1322G>A (p.Trp441Ter)	MEN1	W436*, W441*, W478*, W401*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016687	11	64572549	11	64805077	16687	31726	rs104894260	NC_000011.10:64805076:C:T
NM_001287174.2(ABCC8):c.4435G>A (p.Gly1479Arg)	ABCC8	G1478R, G1479R, G1477R, G1500R	Hyperinsulinemic hypoglycemia, familial, 1|Leucine-induced hypoglycemia|Diabetes mellitus type 2|Hyperinsulinemic hypoglycemia, familial, 1|Permanent neonatal diabetes mellitus|Transient neonatal diabetes mellitus 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000434045	11	17415926	11	17394379	434045	429199	rs72559715	NC_000011.10:17394378:C:T
NM_003718.5(CDK13):c.2149G>A (p.Gly717Arg)	CDK13	G717R	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375737	7	40039066	7	39999467	375737	362622	rs1057519632	NC_000007.14:39999466:G:A
NM_005591.4(MRE11):c.1897C>T (p.Arg633Ter)	MRE11	R633*, R605*, R632*	Ataxia-telangiectasia-like disorder|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008782	11	94170372	11	94437206	8782	23821	rs137852759	NC_000011.10:94437205:G:A
NM_000170.2(GLDC):c.1545G>C (p.Arg515Ser)	GLDC	R515S	Non-ketotic hyperglycinemia|Obesity|Global developmental delay|Generalized epilepsy	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011985	9	6589230	9	6589230	11985	27024	rs121964976	NC_000009.12:6589229:C:G
NM_138694.4(PKHD1):c.10174C>T (p.Gln3392Ter)	PKHD1	Q3392*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488579	6	51524750	6	51659952	488579	481447	rs201082169	NC_000006.12:51659951:G:A
NM_138694.4(PKHD1):c.711_714del (p.Met238fs)	PKHD1	M238fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188960	6	51934319 - 51934322	6	52069521 - 52069524	188960	186720	rs786204588	NC_000006.12:52069520:CATT:
NM_138694.4(PKHD1):c.370C>T (p.Arg124Ter)	PKHD1	R124*	not provided|Autosomal recessive polycystic kidney disease|Abnormality of the intrahepatic bile duct	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167499	6	51944718	6	52079920	167499	177240	rs727504096	NC_000006.12:52079919:G:A
NM_006772.3(SYNGAP1):c.3718C>T (p.Arg1240Ter)	SYNGAP1	R1240*, R1224*	Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225077	6	33414487	6	33446710	225077	226901	rs869312955	NC_000006.12:33446709:C:T
NM_001458.4(FLNC):c.3557C>T (p.Ala1186Val)	FLNC	A1186V	Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related|Cardiomyopathy, familial hypertrophic, 26	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427928	7	128485076	7	128845022	427928	419002	rs1114167361	NC_000007.14:128845021:C:T
NM_001083116.3(PRF1):c.445G>A (p.Gly149Ser)	PRF1	G149S	|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520942	10	72360214	10	70600458	520942	511872	rs147462227	NC_000010.11:70600457:C:T
NM_000256.3(MYBPC3):c.3258G>A (p.Trp1086Ter)	MYBPC3	W1086*	not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000816955	11	47354817	11	47333266	816955	805695		NC_000011.10:47333265:C:T
NM_000256.3(MYBPC3):c.655-2A>C	MYBPC3		not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000636516	11	47370094	11	47348543	636516	624796		NC_000011.10:47348542:T:G
NM_000256.3(MYBPC3):c.2453G>A (p.Trp818Ter)	MYBPC3	W818*	not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000620091	11	47359091	11	47337540	620091	611747	rs1419032418	NC_000011.10:47337539:C:T
NM_000256.3(MYBPC3):c.1521del (p.Gln508fs)	MYBPC3	Q508fs	not provided	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000545946	11	47364232	11	47342681	545946	536398	rs1555122177	NC_000011.10:47342680:CCC:CC
NM_000256.3(MYBPC3):c.405dup (p.Gly136fs)	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000520386	11	47372053 - 47372054	11	47350502 - 47350503	520386	510334	rs1555123597	NC_000011.10:47350502:TTT:TTTT
NM_000256.3(MYBPC3):c.505_505+7del	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000520377	11	47371558 - 47371565	11	47350007 - 47350014	520377	510332	rs1555123473	NC_000011.10:47350006:CACTCACCCAC:CAC
NM_000256.3(MYBPC3):c.1927G>T (p.Glu643Ter)	MYBPC3	E643*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000520359	11	47362554	11	47341003	520359	510315	rs1555121871	NC_000011.10:47341002:C:A
NM_000256.3(MYBPC3):c.3228_3229insT (p.Ala1077fs)	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000520334	11	47354846 - 47354847	11	47333295 - 47333296	520334	510300	rs1555120529	NC_000011.10:47333295::A
NM_000256.3(MYBPC3):c.2310del (p.Asp770fs)	MYBPC3	D770fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000520330	11	47359344	11	47337793	520330	510311	rs1555121331	NC_000011.10:47337792:G:
NM_000256.3(MYBPC3):c.660T>G (p.Tyr220Ter)	MYBPC3	Y220*	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000520326	11	47370087	11	47348536	520326	510330	rs1555123138	NC_000011.10:47348535:A:C
NM_000256.3(MYBPC3):c.1827_1846delinsTACAGC (p.Asp610fs)	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000520312	11	47362740 - 47362759	11	47341189 - 47341208	520312	510316	rs1555121907	NC_000011.10:47341188:AGCTGTAGTCAGCCTCGTCG:GCTGTA
NM_000256.3(MYBPC3):c.1103_1107dup (p.Glu370fs)	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000520308	11	47365158 - 47365159	11	47343607 - 47343608	520308	510326	rs1555122462	NC_000011.10:47343607:CAGCT:CAGCTCAGCT
NM_000256.3(MYBPC3):c.2604_2605insA (p.Pro869fs)	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000520284	11	47357560 - 47357561	11	47336009 - 47336010	520284	510306	rs1555120956	NC_000011.10:47336009::T
NM_000256.3(MYBPC3):c.2451del (p.Trp818fs)	MYBPC3	W818fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000520271	11	47359093	11	47337542	520271	510310	rs1555121247	NC_000011.10:47337541:CC:C
NM_000256.3(MYBPC3):c.1570_1594del (p.His524fs)	MYBPC3	H524fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000520268	11	47364159 - 47364183	11	47342608 - 47342632	520268	510320	rs1555122156	NC_000011.10:47342607:CCCCGCTAGTGCACAGTGCATAGTGCCCCGC:CCCCGC
NM_000256.3(MYBPC3):c.3331-1G>C	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000519194	11	47354525	11	47332974	519194	510295	rs727504305	NC_000011.10:47332973:C:G
NM_000256.3(MYBPC3):c.1483del (p.Arg495fs)	MYBPC3	R495fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000519005	11	47364270	11	47342719	519005	510321	rs1555122196	NC_000011.10:47342718:GGG:GG
NM_000256.3(MYBPC3):c.1812_1813dup (p.Asp605fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000504090	11	47362772 - 47362773	11	47341221 - 47341222	504090	495496	rs764743402	NC_000011.10:47341221:CG:CGCG
NM_000256.3(MYBPC3):c.2391C>G (p.Tyr797Ter)	MYBPC3	Y797*	not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000489060	11	47359263	11	47337712	489060	481994	rs727504864	NC_000011.10:47337711:G:C
NM_000256.3(MYBPC3):c.1303C>T (p.Gln435Ter)	MYBPC3	Q435*	not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000488797	11	47364620	11	47343069	488797	481995	rs1432810664	NC_000011.10:47343068:G:A
NM_000256.3(MYBPC3):c.2526C>G (p.Tyr842Ter)	MYBPC3	Y842*	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000488796	11	47359018	11	47337467	488796	481993	rs373792537	NC_000011.10:47337466:G:C
NM_000256.3(MYBPC3):c.2526C>A (p.Tyr842Ter)	MYBPC3	Y842*	not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000450582	11	47359018	11	47337467	450582	444814	rs373792537	NC_000011.10:47337466:G:T
NM_000256.3(MYBPC3):c.2738-1G>A	MYBPC3		not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000449610	11	47356761	11	47335210	449610	444811	rs1555120792	NC_000011.10:47335209:C:T
NM_000256.3(MYBPC3):c.2067+1G>A	MYBPC3		not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000449066	11	47361201	11	47339650	449066	444818	rs1444727212	NC_000011.10:47339649:C:T
NM_000256.3(MYBPC3):c.1823_1830delinsA (p.Pro608fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000432903	11	47362756 - 47362763	11	47341205 - 47341212	432903	425930	rs1555121924	NC_000011.10:47341204:GTCGGCAG:T
NM_000256.3(MYBPC3):c.2719G>T (p.Glu907Ter)	MYBPC3	E907*	not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000432126	11	47357446	11	47335895	432126	425928	rs1555120920	NC_000011.10:47335894:C:A
NM_000256.3(MYBPC3):c.1624G>T (p.Glu542Ter)	MYBPC3	E542*	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000430571	11	47364129	11	47342578	430571	421856	rs121909374	NC_000011.10:47342577:C:A
NM_000256.3(MYBPC3):c.627_637del (p.His210fs)	MYBPC3	H210fs	not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000430008	11	47371342 - 47371352	11	47349791 - 47349801	430008	421859	rs1555123389	NC_000011.10:47349790:AGCTGTCGTGCAGCTG:AGCTG
NM_000256.3(MYBPC3):c.1621C>T (p.Gln541Ter)	MYBPC3	Q541*	not provided	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000419964	11	47364132	11	47342581	419964	408372	rs1064794209	NC_000011.10:47342580:G:A
NM_000256.3(MYBPC3):c.3191-3C>G	MYBPC3		not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419467	11	47354887	11	47333336	419467	408363	rs1064793891	NC_000011.10:47333335:G:C
NM_000256.3(MYBPC3):c.2058del (p.Ile687fs)	MYBPC3	I687fs	not provided	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000419099	11	47361211	11	47339660	419099	408369	rs1064793642	NC_000011.10:47339659:A:
NM_000256.3(MYBPC3):c.978del (p.Gln327fs)	MYBPC3	Q327fs	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000418933	11	47367870	11	47346319	418933	408374	rs1064793536	NC_000011.10:47346318:CC:C
NM_000256.3(MYBPC3):c.2153_2154TG[2] (p.Cys719_Glu720delinsTer)	MYBPC3		not provided	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000418781	11	47360221 - 47360222	11	47338670 - 47338671	418781	408368	rs1064793429	NC_000011.10:47338669:CACACA:CACA
NM_000256.3(MYBPC3):c.2700_2703dup (p.Asp902fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000418750	11	47357461 - 47357462	11	47335910 - 47335911	418750	408366	rs1555120927	NC_000011.10:47335910:CAGGC:CAGGCAGGC
NM_000256.3(MYBPC3):c.3514_3515TA[4] (p.Lys1173delinsIleTer)	MYBPC3		not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000418717	11	47354226 - 47354227	11	47332675 - 47332676	418717	408361	rs1555120309	NC_000011.10:47332675:TATA:TATATATA
NM_000256.3(MYBPC3):c.1351+1G>C	MYBPC3		not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379619	11	47364571	11	47343020	379619	371449	rs727503204	NC_000011.10:47343019:C:G
NM_000256.3(MYBPC3):c.236dup (p.Tyr79Ter)	MYBPC3		not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000372710	11	47372845 - 47372846	11	47351294 - 47351295	372710	359987	rs1057517939	NC_000011.10:47351294:T:TT
NM_000256.3(MYBPC3):c.1458G>A (p.Trp486Ter)	MYBPC3	W486*	not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000372678	11	47364295	11	47342744	372678	359882	rs1057517920	NC_000011.10:47342743:C:T
NM_000256.3(MYBPC3):c.3617G>A (p.Gly1206Asp)	MYBPC3	G1206D	not provided	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000372421	11	47354127	11	47332576	372421	359954	rs1057517769	NC_000011.10:47332575:C:T
NM_000256.3(MYBPC3):c.2716del (p.Val906fs)	MYBPC3	V906fs	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000280011	11	47357449	11	47335898	280011	264551	rs886041320	NC_000011.10:47335897:C:
NM_000256.3(MYBPC3):c.906-1G>A	MYBPC3		not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000279971	11	47368581	11	47347030	279971	264553	rs587776700	NC_000011.10:47347029:C:T
NM_000256.3(MYBPC3):c.2158G>T (p.Glu720Ter)	MYBPC3	E720*	Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000264065	11	47360221	11	47338670	264065	258701	rs886039028	NC_000011.10:47338669:C:A
NM_000256.3(MYBPC3):c.2727C>A (p.Cys909Ter)	MYBPC3	C909*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 15, 2013)	criteria provided, single submitter	VCV000263484	11	47357438	11	47335887	263484	258700	rs886038822	NC_000011.10:47335886:G:T
NM_000256.3(MYBPC3):c.655G>T (p.Val219Phe)	MYBPC3	V219F	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000188531	11	47370092	11	47348541	188531	186403	rs397516068	NC_000011.10:47348540:C:A
NM_000256.3(MYBPC3):c.324del (p.Ala109fs)	MYBPC3	A109fs	not provided	Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	VCV000181157	11	47372135	11	47350584	181157	179396	rs730880721	NC_000011.10:47350583:A:
NM_000256.3(MYBPC3):c.1188G>A (p.Trp396Ter)	MYBPC3	W396*	not provided	Pathogenic(Last reviewed: Aug 31, 2011)	criteria provided, single submitter	VCV000181141	11	47365078	11	47343527	181141	179334	rs397515890	NC_000011.10:47343526:C:T
NM_000256.3(MYBPC3):c.3021G>A (p.Trp1007Ter)	MYBPC3	W1007*	not provided	Pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	VCV000181135	11	47355277	11	47333726	181135	179219	rs730880701	NC_000011.10:47333725:C:T
NM_000256.3(MYBPC3):c.3553C>T (p.Gln1185Ter)	MYBPC3	Q1185*	not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000181133	11	47354191	11	47332640	181133	179188	rs730880699	NC_000011.10:47332639:G:A
NM_000256.3(MYBPC3):c.1624+5G>A	MYBPC3		not provided	Pathogenic(Last reviewed: Aug 8, 2011)	criteria provided, single submitter	VCV000181120	11	47364124	11	47342573	181120	179301	rs730880691	NC_000011.10:47342572:C:T
NM_000256.3(MYBPC3):c.1120dup (p.Gln374fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	VCV000181116	11	47365145 - 47365146	11	47343594 - 47343595	181116	179339	rs730880688	NC_000011.10:47343594:GG:GGG
NM_000256.3(MYBPC3):c.1069_1072delinsGC (p.Arg357fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000181115	11	47367776 - 47367779	11	47346225 - 47346228	181115	179346	rs730880687	NC_000011.10:47346224:CGCG:GC
NM_000256.3(MYBPC3):c.722dup (p.Ser242fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Sep 30, 2013)	criteria provided, single submitter	VCV000181111	11	47370024 - 47370025	11	47348473 - 47348474	181111	179364	rs730880683	NC_000011.10:47348473:A:AA
NM_000256.3(MYBPC3):c.586del (p.Trp196fs)	MYBPC3	W196fs	not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000181109	11	47371393	11	47349842	181109	179370	rs730880681	NC_000011.10:47349841:A:
NM_000256.3(MYBPC3):c.455_456del (p.Asp152fs)	MYBPC3	D152fs	not provided	Pathogenic(Last reviewed: Jul 24, 2013)	criteria provided, single submitter	VCV000181108	11	47371614 - 47371615	11	47350063 - 47350064	181108	179384	rs730880680	NC_000011.10:47350062:GT:
NM_000256.3(MYBPC3):c.453del (p.Asp151fs)	MYBPC3	D151EfsX8, D151fs	not provided	Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	VCV000181107	11	47371617	11	47350066	181107	179385	rs730880679	NC_000011.10:47350065:A:
NM_000256.3(MYBPC3):c.3190+3del	MYBPC3		not provided	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	VCV000181094	11	47355105	11	47333554	181094	179210	rs730880667	NC_000011.10:47333553:C:
NM_000256.3(MYBPC3):c.182del (p.Gly61fs)	MYBPC3	G61fs	not provided	Pathogenic(Last reviewed: May 14, 2013)	criteria provided, single submitter	VCV000181090	11	47372900	11	47351349	181090	179404	rs730880663	NC_000011.10:47351348:CCC:CC
NM_000256.3(MYBPC3):c.172del (p.Ala58fs)	MYBPC3	A58fs	not provided	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000181089	11	47372910	11	47351359	181089	179405	rs730880662	NC_000011.10:47351358:CC:C
NM_000256.3(MYBPC3):c.2744del (p.Glu915fs)	MYBPC3	E915fs	not provided	Pathogenic(Last reviewed: Jan 19, 2014)	criteria provided, single submitter	VCV000181088	11	47356754	11	47335203	181088	179235	rs730880661	NC_000011.10:47335202:T:
NM_000256.3(MYBPC3):c.2737del (p.Cys913fs)	MYBPC3	C913fs	not provided	Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000181085	11	47357428	11	47335877	181085	179237	rs730880658	NC_000011.10:47335876:A:
NM_000256.3(MYBPC3):c.2221del (p.Ala741fs)	MYBPC3	A741fs	not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000181077	11	47360158	11	47338607	181077	179265	rs730880650	NC_000011.10:47338606:CCCCC:CCCC
NM_000256.3(MYBPC3):c.1806del (p.Ile603fs)	MYBPC3	I603fs	not provided	Pathogenic(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	VCV000181075	11	47362780	11	47341229	181075	179284	rs730880648	NC_000011.10:47341228:GG:G
NM_000256.3(MYBPC3):c.1410_1411del (p.Val471fs)	MYBPC3	V471fs	not provided	Pathogenic(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	VCV000181069	11	47364427 - 47364428	11	47342876 - 47342877	181069	179316	rs730880642	NC_000011.10:47342875:CCC:C
NM_000256.3(MYBPC3):c.1223+2T>G	MYBPC3		not provided	Pathogenic(Last reviewed: Jan 18, 2014)	criteria provided, single submitter	VCV000181068	11	47365041	11	47343490	181068	179330	rs730880641	NC_000011.10:47343489:A:C
NM_000256.3(MYBPC3):c.1201C>T (p.Gln401Ter)	MYBPC3	Q401*	not provided	Pathogenic(Last reviewed: Feb 14, 2013)	criteria provided, single submitter	VCV000181064	11	47365065	11	47343514	181064	179333	rs730880637	NC_000011.10:47343513:G:A
NM_000256.3(MYBPC3):c.1090+2T>G	MYBPC3		not provided	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	VCV000181059	11	47367756	11	47346205	181059	179342	rs730880634	NC_000011.10:47346204:A:C
NM_000256.3(MYBPC3):c.553A>T (p.Lys185Ter)	MYBPC3	K185*	not provided	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000181044	11	47371426	11	47349875	181044	179372	rs375607980	NC_000011.10:47349874:T:A
NM_000256.3(MYBPC3):c.3775C>T (p.Gln1259Ter)	MYBPC3	Q1259*	not provided	Pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	VCV000181024	11	47353662	11	47332111	181024	179173	rs730880605	NC_000011.10:47332110:G:A
NM_000256.3(MYBPC3):c.3664G>T (p.Gly1222Ter)	MYBPC3	G1222*	not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000181016	11	47353773	11	47332222	181016	179183	rs730880598	NC_000011.10:47332221:C:A
NM_000256.3(MYBPC3):c.3034C>T (p.Gln1012Ter)	MYBPC3	Q1012*	not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000180997	11	47355264	11	47333713	180997	179217	rs730880586	NC_000011.10:47333712:G:A
NM_000256.3(MYBPC3):c.2995-1G>A	MYBPC3		not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000180995	11	47355304	11	47333753	180995	179221	rs730880584	NC_000011.10:47333752:C:T
NM_000256.3(MYBPC3):c.2992C>T (p.Gln998Ter)	MYBPC3	Q998*	not provided	Pathogenic(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	VCV000180993	11	47355475	11	47333924	180993	179222	rs11570112	NC_000011.10:47333923:G:A
NM_000256.3(MYBPC3):c.2893C>T (p.Gln965Ter)	MYBPC3	Q965*	not provided	Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	VCV000180986	11	47356605	11	47335054	180986	179227	rs730880578	NC_000011.10:47335053:G:A
NM_000256.3(MYBPC3):c.2414G>A (p.Gly805Asp)	MYBPC3	G805D	not provided	Pathogenic(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	VCV000180969	11	47359130	11	47337579	180969	179257	rs730880566	NC_000011.10:47337578:C:T
NM_000256.3(MYBPC3):c.1791-2A>C	MYBPC3		not provided	Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	VCV000180949	11	47362797	11	47341246	180949	179287	rs112179534	NC_000011.10:47341245:T:G
NM_000256.3(MYBPC3):c.1457G>A (p.Trp486Ter)	MYBPC3	W486*	not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000180937	11	47364381	11	47342830	180937	179312	rs730880542	NC_000011.10:47342829:C:T
NM_000256.3(MYBPC3):c.1405C>T (p.Gln469Ter)	MYBPC3	Q469*	not provided	Pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	VCV000180934	11	47364433	11	47342882	180934	179317	rs730880539	NC_000011.10:47342881:G:A
NM_000256.3(MYBPC3):c.1387C>T (p.Gln463Ter)	MYBPC3	Q463*	not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000180933	11	47364451	11	47342900	180933	179318	rs730880538	NC_000011.10:47342899:G:A
NM_000256.3(MYBPC3):c.1252A>T (p.Lys418Ter)	MYBPC3	K418*	not provided	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000180927	11	47364671	11	47343120	180927	179327	rs730880533	NC_000011.10:47343119:T:A
NM_000256.3(MYBPC3):c.3690_3691del (p.Phe1230fs)	MYBPC3	F1230fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000177899	11	47353746 - 47353747	11	47332195 - 47332196	177899	175141	rs727504390	NC_000011.10:47332194:TG:
NM_000256.3(MYBPC3):c.2604_2605delinsA (p.Ser871fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000177870	11	47357560 - 47357561	11	47336009 - 47336010	177870	175163	rs727504371	NC_000011.10:47336008:GA:T
NM_000256.3(MYBPC3):c.2541C>A (p.Tyr847Ter)	MYBPC3	Y847*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000177852	11	47359003	11	47337452	177852	175165	rs397515974	NC_000011.10:47337451:G:T
NM_000256.3(MYBPC3):c.3753T>G (p.Tyr1251Ter)	MYBPC3	Y1251*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000177818	11	47353684	11	47332133	177818	174728	rs397516039	NC_000011.10:47332132:A:C
NM_000256.3(MYBPC3):c.2906-2A>G	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000177811	11	47355563	11	47334012	177811	174746	rs727504333	NC_000011.10:47334011:T:C
NM_000256.3(MYBPC3):c.3476_3477del (p.Phe1159fs)	MYBPC3	F1159fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000177784	11	47354378 - 47354379	11	47332827 - 47332828	177784	174733	rs727504321	NC_000011.10:47332826:AAA:A
NM_000256.3(MYBPC3):c.333dup (p.Glu112Ter)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000177675	11	47372125 - 47372126	11	47350574 - 47350575	177675	174798	rs730880335	NC_000011.10:47350574:A:AA
NM_000256.3(MYBPC3):c.2437A>T (p.Lys813Ter)	MYBPC3	K813*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000177641	11	47359107	11	47337556	177641	174758	rs727504252	NC_000011.10:47337555:T:A
NM_000256.3(MYBPC3):c.533del (p.Val178fs)	MYBPC3	V178fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000164148	11	47371446	11	47349895	164148	175205	rs727503217	NC_000011.10:47349894:A:
NM_000256.3(MYBPC3):c.2965G>T (p.Glu989Ter)	MYBPC3	E989*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000164053	11	47355502	11	47333951	164053	174743	rs727503178	NC_000011.10:47333950:C:A
NM_000256.3(MYBPC3):c.2865del (p.Val956fs)	MYBPC3	V956fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000864120	11	47356633	11	47335082	864120	838501		NC_000011.10:47335081:A:
NM_000256.3(MYBPC3):c.2510_2513del (p.Ile837fs)	MYBPC3	I837fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000859341	11	47359031 - 47359034	11	47337480 - 47337483	859341	838504		NC_000011.10:47337479:TCGATC:TC
NM_000256.3(MYBPC3):c.568_569del (p.Lys190fs)	MYBPC3	K190fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000857087	11	47371410 - 47371411	11	47349859 - 47349860	857087	838533		NC_000011.10:47349858:TT:
NM_000256.3(MYBPC3):c.1119C>G (p.Tyr373Ter)	MYBPC3	Y373*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000856666	11	47365147	11	47343596	856666	838528		NC_000011.10:47343595:G:C
NM_000256.3(MYBPC3):c.2240_2245delinsCCTTC (p.Gly747fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000849425	11	47360134 - 47360139	11	47338583 - 47338588	849425	838513		NC_000011.10:47338582:AGACGC:GAAGG
NM_000256.3(MYBPC3):c.1569del (p.His524fs)	MYBPC3	H524fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000835859	11	47364184	11	47342633	835859	838521		NC_000011.10:47342632:CCCC:CCC
NC_000011.10:g.(?_47347416)_(47352657_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000831373	11	47368967 - 47374208			831373	820379		
NM_000256.3(MYBPC3):c.1224-80G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 17, 2019)	no assertion criteria provided	VCV000693982	11	47364893	11	47343342	693982	681801	rs1025692267	NC_000011.10:47343341:C:T
NM_000256.3(MYBPC3):c.1227-1G>C	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000692124	11	47364697	11	47343146	692124	679872		NC_000011.10:47343145:C:G
NM_000256.3(MYBPC3):c.1927+600C>T	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 17, 2019)	no assertion criteria provided	VCV000692114	11	47361954	11	47340403	692114	679857		NC_000011.10:47340402:G:A
NM_000256.3(MYBPC3):c.2905+445_2905+448del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000692113	11	47356145 - 47356148	11	47334594 - 47334597	692113	679856		NC_000011.10:47334593:TCTGTC:TC
NM_000256.3(MYBPC3):c.3570_3573del (p.Val1192fs)	MYBPC3	V1192fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000664646	11	47354171 - 47354174	11	47332620 - 47332623	664646	640094		NC_000011.10:47332619:CGAGCG:CG
NC_000011.9:g.(?_47370117)_(47373066_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000660700	11	47370117 - 47373066	11	47348566 - 47351515	660700	652196		
NM_000256.3(MYBPC3):c.1755del (p.Asp587fs)	MYBPC3	D587fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000655991	11	47363577	11	47342026	655991	640113		NC_000011.10:47342025:C:
NM_000256.3(MYBPC3):c.1319_1328del (p.Gly440fs)	MYBPC3	G440fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000654620	11	47364595 - 47364604	11	47343044 - 47343053	654620	640120		NC_000011.10:47343043:CACTTCTCGCCAC:CAC
NM_000256.3(MYBPC3):c.2572_2576dup (p.Ser861fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000654573	11	47358967 - 47358968	11	47337416 - 47337417	654573	640103		NC_000011.10:47337416:GGGCTGGGC:GGGCTGGGCTGGGC
NM_000256.3(MYBPC3):c.2438del (p.Lys813fs)	MYBPC3	K813fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000652425	11	47359106	11	47337555	652425	640105		NC_000011.10:47337554:TT:T
NM_000256.3(MYBPC3):c.3799del (p.Arg1267fs)	MYBPC3	R1267fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000651464	11	47353638	11	47332087	651464	640091		NC_000011.10:47332086:GG:G
NM_000256.3(MYBPC3):c.440del (p.Pro147fs)	MYBPC3	P147fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000650481	11	47371630	11	47350079	650481	640125		NC_000011.10:47350078:GGGG:GGG
NM_000256.3(MYBPC3):c.(2148+1_2149-1)_(2737+1_2738-1)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000619292					619292	610690		
NM_000256.3(MYBPC3):c.2737+1G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000619256	11	47357427	11	47335876	619256	610679	rs727504314	NC_000011.10:47335875:C:T
NM_000256.3(MYBPC3):c.2541_2542CG[3] (p.Val849fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000619254	11	47358999 - 47359000	11	47337448 - 47337449	619254	610661		NC_000011.10:47337448:CGCG:CGCGCG
NM_000256.3(MYBPC3):c.711C>A (p.Tyr237Ter)	MYBPC3	Y237*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000619250	11	47370036	11	47348485	619250	610666	rs774316050	NC_000011.10:47348484:G:T
NM_000256.3(MYBPC3):c.313del (p.Ala105fs)	MYBPC3	A105fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000619248	11	47372146	11	47350595	619248	610669	rs1565631424	NC_000011.10:47350594:CC:C
NM_000256.3(MYBPC3):c.2306_2309dup (p.Val771fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000581813	11	47360070 - 47360071	11	47338519 - 47338520	581813	570684	rs1565625777	NC_000011.10:47338519:CGAT:CGATCGAT
NM_000256.3(MYBPC3):c.2377dup (p.Glu793fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000580434	11	47359276 - 47359277	11	47337725 - 47337726	580434	567291	rs1565625473	NC_000011.10:47337725:CCC:CCCC
NM_000256.3(MYBPC3):c.2868dup (p.Thr957fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000576555	11	47356629 - 47356630	11	47335078 - 47335079	576555	570678	rs1565624090	NC_000011.10:47335078:AA:AAA
NM_000256.3(MYBPC3):c.2003dup (p.Leu669fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000573073	11	47361265 - 47361266	11	47339714 - 47339715	573073	567296	rs1565626409	NC_000011.10:47339714:C:CC
NM_000256.3(MYBPC3):c.1174del (p.Ala392fs)	MYBPC3	A392fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000568945	11	47365092	11	47343541	568945	567306	rs1565628486	NC_000011.10:47343540:C:
NM_000256.3(MYBPC3):c.1422del (p.Glu474fs)	MYBPC3	E474fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000567881	11	47364416	11	47342865	567881	567299	rs1565628062	NC_000011.10:47342864:C:
NM_000256.3(MYBPC3):c.310del (p.Leu104fs)	MYBPC3	L104fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000567779	11	47372149	11	47350598	567779	570699	rs1565631428	NC_000011.10:47350597:G:
NM_000256.3(MYBPC3):c.292G>T (p.Glu98Ter)	MYBPC3	E98*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000525015	11	47372790	11	47351239	525015	526275	rs868819340	NC_000011.10:47351238:C:A
NM_000256.3(MYBPC3):c.3627+2del	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000519195	11	47354115	11	47332564	519195	510289	rs1555120258	NC_000011.10:47332563:A:
NM_000256.3(MYBPC3):c.926+1G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000517283	11	47368177	11	47346626	517283	497619	rs767239679	NC_000011.10:47346625:C:T
NM_000256.3(MYBPC3):c.926+1_926+5del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000504898	11	47368173 - 47368177	11	47346622 - 47346626	504898	497618	rs1555122811	NC_000011.10:47346621:CTCACCTC:CTC
NM_000256.3(MYBPC3):c.317del (p.Pro106fs)	MYBPC3	P106fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 10, 2017)	criteria provided, single submitter	VCV000454324	11	47372142	11	47350591	454324	461163	rs1555123629	NC_000011.10:47350590:GGGG:GGG
NM_000256.3(MYBPC3):c.2568del (p.Arg856fs)	MYBPC3	R856fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000454317	11	47358976	11	47337425	454317	461984	rs1555121172	NC_000011.10:47337424:CC:C
NM_000256.3(MYBPC3):c.2512G>T (p.Glu838Ter)	MYBPC3	E838*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 16, 2017)	criteria provided, single submitter	VCV000454316	11	47359032	11	47337481	454316	461342	rs397515969	NC_000011.10:47337480:C:A
NC_000011.9:g.(?_47368957)_(47374218_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000454298	11	47368957 - 47374218	11	47347406 - 47352667	454298	460464		
NC_000011.9:g.(?_47353402)_(47374218_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000454297	11	47353402 - 47374218	11	47331851 - 47352667	454297	460462		
NC_000011.9:g.(?_47371325)_(47373056_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000417402	11	47371325 - 47373056	11	47349774 - 47351505	417402	397581		
NC_000011.9:g.(?_47353396)_(47357562_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000417401	11	47353396 - 47357562	11	47331845 - 47336011	417401	398122		
NM_000256.3(MYBPC3):c.257_259delinsGGAGG (p.Ser86fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000407332	11	47372823 - 47372825	11	47351272 - 47351274	407332	398312	rs1064792936	NC_000011.10:47351271:TGG:CCTCC
NM_000256.3(MYBPC3):c.2572_2573insAA (p.Ser858fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000407322	11	47358971 - 47358972	11	47337420 - 47337421	407322	398268	rs1060501481	NC_000011.10:47337420:T:TTT
NM_000256.3(MYBPC3):c.3665del (p.Gly1222fs)	MYBPC3	G1222fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000407321	11	47353772	11	47332221	407321	398200	rs1060501480	NC_000011.10:47332220:CCC:CC
NM_000256.3(MYBPC3):c.65_66insG (p.Ala23fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000407318	11	47373016 - 47373017	11	47351465 - 47351466	407318	398757	rs1060501479	NC_000011.10:47351465::C
NM_000256.3(MYBPC3):c.2279del (p.Asp760fs)	MYBPC3	D760fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000407313	11	47360100	11	47338549	407313	398269	rs1060501478	NC_000011.10:47338548:T:
NM_000256.3(MYBPC3):c.3100del (p.Ala1034fs)	MYBPC3	A1034fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000407309	11	47355198	11	47333647	407309	398706	rs1060501475	NC_000011.10:47333646:CCC:CC
NM_000256.3(MYBPC3):c.3257G>A (p.Trp1086Ter)	MYBPC3	W1086*	not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373084	11	47354818	11	47333267	373084	360009	rs779650200	NC_000011.10:47333266:C:T
NM_000256.3(MYBPC3):c.1236dup (p.Glu413Ter)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000237422	11	47364686 - 47364687	11	47343135 - 47343136	237422	241148	rs397515894	NC_000011.10:47343135:AAA:AAAA
NM_000256.3(MYBPC3):c.3512del (p.Asn1171fs)	MYBPC3	N1171fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000228371	11	47354232	11	47332681	228371	230202	rs876657706	NC_000011.10:47332680:TT:T
NM_000256.3(MYBPC3):c.1075G>T (p.Glu359Ter)	MYBPC3	E359*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000228367	11	47367773	11	47346222	228367	230216	rs876657702	NC_000011.10:47346221:C:A
NM_000256.3(MYBPC3):c.1091-?_2308+?del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000219725					219725	222010		
NM_000256.3(MYBPC3):c.2894_2905+4del	MYBPC3		Cardiomyopathy	Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000181153	11	47356589 - 47356604	11	47335038 - 47335053	181153	179225	rs730880717	NC_000011.10:47335037:TCACGCAGGATCTCCT:
NM_000256.3(MYBPC3):c.2792dup (p.Lys932fs)	MYBPC3		not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000181152	11	47356705 - 47356706	11	47335154 - 47335155	181152	179231	rs730880716	NC_000011.10:47335154:A:AA
NM_000256.3(MYBPC3):c.2543del (p.Ala848fs)	MYBPC3	A848fs	Cardiomyopathy	Pathogenic(Last reviewed: Dec 13, 2011)	criteria provided, single submitter	VCV000181151	11	47359001	11	47337450	181151	179246	rs730880715	NC_000011.10:47337449:G:
NM_000256.3(MYBPC3):c.410C>G (p.Ser137Ter)	MYBPC3	S137*	not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000181137	11	47371660	11	47350109	181137	179391	rs730880703	NC_000011.10:47350108:G:C
NM_000256.3(MYBPC3):c.1156_1171dup (p.Asp391delinsGlyThrGlyTer)	MYBPC3		Cardiomyopathy	Pathogenic(Last reviewed: Mar 29, 2012)	criteria provided, single submitter	VCV000181117	11	47365094 - 47365095	11	47343543 - 47343544	181117	179336	rs730880689	NC_000011.10:47343543:CATGGTCAGCCAGTTCCA:CATGGTCAGCCAGTTCCATGGTCAGCCAGTTCCA
NM_000256.3(MYBPC3):c.3472_3481del (p.Val1158fs)	MYBPC3	V1158fs	Cardiomyopathy	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	VCV000181103	11	47354374 - 47354383	11	47332823 - 47332832	181103	179193	rs730880675	NC_000011.10:47332822:GGATAAAGACGG:GG
NM_000256.3:c.3315delG	MYBPC3		Cardiomyopathy	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000181099					181099	179922	rs1565623093	
NM_000256.3(MYBPC3):c.3300_3301CA[1] (p.Thr1101fs)	MYBPC3		Cardiomyopathy	Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	VCV000181098	11	47354772 - 47354773	11	47333221 - 47333222	181098	179203	rs730880671	NC_000011.10:47333220:TGTGT:TGT
NM_000256.3(MYBPC3):c.2604del (p.Ser871fs)	MYBPC3	S871fs	Cardiomyopathy	Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	VCV000181082	11	47357561	11	47336010	181082	179241	rs730880655	NC_000011.10:47336009:A:
NM_000256.3(MYBPC3):c.1015C>T (p.Gln339Ter)	MYBPC3	Q339*	not provided	Pathogenic(Last reviewed: May 8, 2013)	criteria provided, single submitter	VCV000181056	11	47367833	11	47346282	181056	179350	rs730880631	NC_000011.10:47346281:G:A
NM_000256.3(MYBPC3):c.1227-2A>G	MYBPC3		not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000180925	11	47364698	11	47343147	180925	179329	rs730880531	NC_000011.10:47343146:T:C
NM_000256.3(MYBPC3):c.1330del (p.Ser444fs)	MYBPC3	S444fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000179821	11	47364593	11	47343042	179821	175192	rs727505152	NC_000011.10:47343041:T:
NM_000256.3(MYBPC3):c.214_215dup (p.Pro73fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	VCV000179537	11	47372866 - 47372867	11	47351315 - 47351316	179537	178284	rs730880362	NC_000011.10:47351315:CCC:CCCCC
NM_000256.3(MYBPC3):c.3644dup (p.Lys1216fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	VCV000179527	11	47353792 - 47353793	11	47332241 - 47332242	179527	175142	rs730880361	NC_000011.10:47332241:AA:AAA
NM_000256.3(MYBPC3):c.2391C>A (p.Tyr797Ter)	MYBPC3	Y797*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	VCV000179435	11	47359263	11	47337712	179435	174760	rs727504864	NC_000011.10:47337711:G:T
NM_000256.3(MYBPC3):c.1678del (p.Asp560fs)	MYBPC3	D560fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000177864	11	47363654	11	47342103	177864	174770	rs727504366	NC_000011.10:47342102:CC:C
NM_000256.3(MYBPC3):c.3331-1G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	VCV000177742	11	47354525	11	47332974	177742	174736	rs727504305	NC_000011.10:47332973:C:T
NM_000256.3(MYBPC3):c.979C>T (p.Gln327Ter)	MYBPC3	Q327*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000164135	11	47367869	11	47346318	164135	174787	rs727503210	NC_000011.10:47346317:G:A
NM_000256.3(MYBPC3):c.993dup (p.Glu332Ter)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000164134	11	47367854 - 47367855	11	47346303 - 47346304	164134	175198	rs727503209	NC_000011.10:47346303:A:AA
NM_000256.3(MYBPC3):c.2517_2538del (p.Val840fs)	MYBPC3	V840fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000164073	11	47359006 - 47359027	11	47337455 - 47337476	164073	174754	rs727503187	NC_000011.10:47337454:GACGCGCATCTCGTACACCACG:
NM_000256.3(MYBPC3):c.2737+2T>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 12, 2015)	criteria provided, single submitter	VCV000164063	11	47357426	11	47335875	164063	174749	rs727503184	NC_000011.10:47335874:A:T
NM_000256.3(MYBPC3):c.2994+2T>C	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	VCV000164051	11	47355471	11	47333920	164051	174742	rs727503176	NC_000011.10:47333919:A:G
NM_000256.3(MYBPC3):c.3089_3101del (p.Leu1030fs)	MYBPC3	L1030fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 20, 2013)	criteria provided, single submitter	VCV000164049	11	47355197 - 47355209	11	47333646 - 47333658	164049	175152	rs727503175	NC_000011.10:47333645:GCCCGGATGAACAG:G
NM_000256.3(MYBPC3):c.984_1054del (p.Pro329fs)	MYBPC3	P329fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 17, 2010)	criteria provided, single submitter	VCV000042814	11	47367794 - 47367864	11	47346243 - 47346313	42814	51984	rs1555122751	
NM_000256.3(MYBPC3):c.821+2T>C	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000042795	11	47369406	11	47347855	42795	51965	rs397516076	NC_000011.10:47347854:A:G
NM_000256.3(MYBPC3):c.541_560del (p.Ala181fs)	MYBPC3	A181fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 30, 2010)	criteria provided, single submitter	VCV000042770	11	47371420 - 47371439	11	47349868 - 47349887	42770	51940	rs397516058	NC_000011.10:47349867:GGCGGCTTCAGGAGGCTGGCG:G
NM_000256.3(MYBPC3):c.506-1G>T	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	VCV000042764	11	47371474	11	47349923	42764	51934	rs397516056	NC_000011.10:47349922:C:A
NM_000256.3(MYBPC3):c.431_432del (p.Gly144fs)	MYBPC3	G144fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 10, 2012)	criteria provided, single submitter	VCV000042749	11	47371638 - 47371639	11	47350087 - 47350088	42749	51919	rs397516047	NC_000011.10:47350086:AC:
NM_000256.3(MYBPC3):c.3040del (p.Leu1014fs)	MYBPC3	L1014fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 28, 2010)	criteria provided, single submitter	VCV000042677	11	47355258	11	47333707	42677	51847	rs397515997	NC_000011.10:47333706:GGGG:GGG
NM_000256.3(MYBPC3):c.2943_2947del (p.Gln981fs)	MYBPC3	Q981fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2012)	criteria provided, single submitter	VCV000042672	11	47355520 - 47355524	11	47333969 - 47333973	42672	51842	rs397515995	NC_000011.10:47333968:TGGTCTGG:TGG
NM_000256.3(MYBPC3):c.2163del (p.Glu722fs)	MYBPC3	E722fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 24, 2012)	criteria provided, single submitter	VCV000042602	11	47360216	11	47338665	42602	51772	rs397515952	NC_000011.10:47338664:GG:G
NM_000256.3(MYBPC3):c.1863del (p.Phe621fs)	MYBPC3	F621fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000042578	11	47362723	11	47341172	42578	51748	rs397515931	NC_000011.10:47341171:G:
NM_000256.3(MYBPC3):c.1156G>T (p.Glu386Ter)	MYBPC3	E386*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 13, 2010)	criteria provided, single submitter	VCV000042507	11	47365110	11	47343559	42507	51677	rs397515888	NC_000011.10:47343558:C:A
NM_000256.3(MYBPC3):c.2843A>C (p.Asn948Thr)	MYBPC3	N948T	Left ventricular noncompaction 10	Pathogenic(Last reviewed: Oct 18, 2002)	no assertion criteria provided	VCV000008615	11	47356655	11	47335104	8615	23654	rs121909376	NC_000011.10:47335103:T:G
NM_000256.3(MYBPC3):c.1440_1441delinsC (p.Glu480fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000662561	11	47364397 - 47364398	11	47342846 - 47342847	662561	640118		NC_000011.10:47342845:CC:G
NM_000256.3(MYBPC3):c.711C>G (p.Tyr237Ter)	MYBPC3	Y237*	Cardiomyopathy	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000626783	11	47370036	11	47348485	626783	615025	rs774316050	NC_000011.10:47348484:G:C
NM_000256.3(MYBPC3):c.1890del (p.Phe631fs)	MYBPC3	F631fs	Cardiomyopathy	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000626766	11	47362696	11	47341145	626766	615014	rs1565627110	NC_000011.10:47341144:G:
NM_000256.3(MYBPC3):c.1725_1726TG[2] (p.Trp577fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000582082	11	47363602 - 47363603	11	47342051 - 47342052	582082	567298	rs1565627536	NC_000011.10:47342050:CACACAC:CACAC
NM_000256.3(MYBPC3):c.3357C>A (p.Tyr1119Ter)	MYBPC3	Y1119*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000579276	11	47354498	11	47332947	579276	567284	rs1565622952	NC_000011.10:47332946:G:T
NM_000256.3(MYBPC3):c.821+2T>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000567968	11	47369406	11	47347855	567968	567307	rs397516076	NC_000011.10:47347854:A:T
NC_000011.9:g.(?_47357408)_(47360310_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000525134	11	47357408 - 47360310	11	47335857 - 47338759	525134	526000		
NM_000256.3(MYBPC3):c.2950C>T (p.Gln984Ter)	MYBPC3	Q984*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000525030	11	47355517	11	47333966	525030	526230	rs1555120651	NC_000011.10:47333965:G:A
NM_000256.3(MYBPC3):c.1622dup (p.Glu542fs)	MYBPC3		not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000523710	11	47364130 - 47364131	11	47342579 - 47342580	523710	514356	rs1555122143	NC_000011.10:47342579:T:TT
NM_000256.3(MYBPC3):c.480del (p.Pro161fs)	MYBPC3	P161fs	Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520371	11	47371590	11	47350039	520371	510333	rs1555123496	NC_000011.10:47350038:CC:C
NM_000256.3(MYBPC3):c.3294G>A (p.Trp1098Ter)	MYBPC3	W1098*	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000520341	11	47354781	11	47333230	520341	510298	rs767039057	NC_000011.10:47333229:C:T
NM_000256.3(MYBPC3):c.2258dup (p.Lys754fs)	MYBPC3		Cardiovascular phenotype	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000518947	11	47360120 - 47360121	11	47338569 - 47338570	518947	510313	rs774521272	NC_000011.10:47338569:A:AA
NM_000256.3(MYBPC3):c.506-3_506dup	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000454332	11	47371472 - 47371473	11	47349921 - 47349922	454332	462003	rs1555123438	NC_000011.10:47349921:CCTGC:CCTGCCTGC
NM_000256.3(MYBPC3):c.373_374del (p.Ala124_Ala125insTer)	MYBPC3		not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372418	11	47372085 - 47372086	11	47350534 - 47350535	372418	359981	rs1057517767	NC_000011.10:47350533:GCG:G
NM_000256.3(MYBPC3):c.852-1G>A	MYBPC3		Cardiomyopathy	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000181053	11	47369031	11	47347480	181053	179358	rs368121566	NC_000011.10:47347479:C:T
NM_000256.3(MYBPC3):c.3335G>A (p.Trp1112Ter)	MYBPC3	W1112*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000177680	11	47354520	11	47332969	177680	175147	rs727504276	NC_000011.10:47332968:C:T
NM_000256.3(MYBPC3):c.1628del (p.Lys543fs)	MYBPC3	K543fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000177637	11	47363704	11	47342153	177637	174772	rs727504248	NC_000011.10:47342152:TTTT:TTT
NM_000256.3(MYBPC3):c.2875_2876del (p.Thr959fs)	MYBPC3	T959fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 24, 2012)	criteria provided, single submitter	VCV000164059	11	47356622 - 47356623	11	47335071 - 47335072	164059	174747	rs727503182	NC_000011.10:47335070:GTG:G
NM_000256.3(MYBPC3):c.3068dup (p.Asn1023fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 17, 2011)	criteria provided, single submitter	VCV000042683	11	47355229 - 47355230	11	47333678 - 47333679	42683	51853	rs397516001	NC_000011.10:47333678:TT:TTT
NM_000256.3(MYBPC3):c.2905+1G>C	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	VCV000042667	11	47356592	11	47335041	42667	51837	rs397515991	NC_000011.10:47335040:C:G
NM_000256.3(MYBPC3):c.2040dup (p.Val681fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000042593	11	47361228 - 47361229	11	47339677 - 47339678	42593	51763	rs397515944	NC_000011.10:47339677:A:AA
NM_000256.3(MYBPC3):c.1693A>T (p.Lys565Ter)	MYBPC3	K565*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 21, 2012)	criteria provided, single submitter	VCV000042560	11	47363639	11	47342088	42560	51730	rs397515920	NC_000011.10:47342087:T:A
NM_000256.3(MYBPC3):c.3408C>G (p.Tyr1136Ter)	MYBPC3	Y1136*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000851340	11	47354447	11	47332896	851340	838494		NC_000011.10:47332895:G:C
NM_000256.3(MYBPC3):c.25+1G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000810740	11	47374173	11	47352622	810740	799019		NC_000011.10:47352621:C:T
NM_000256.3(MYBPC3):c.305_308dup (p.Met103fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000454323	11	47372150 - 47372151	11	47350599 - 47350600	454323	461693	rs1555123633	NC_000011.10:47350599:ATGG:ATGGATGG
NM_000256.3(MYBPC3):c.2648_2673dup (p.Pro892fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000454318	11	47357491 - 47357492	11	47335940 - 47335941	454318	461139	rs1555120937	NC_000011.10:47335940:CCGCCACTTGAGGGAGACCGTGGTGTC:CCGCCACTTGAGGGAGACCGTGGTGTCCGCCACTTGAGGGAGACCGTGGTGTC
NM_000256.3(MYBPC3):c.1633_1640del (p.Leu545fs)	MYBPC3	L545fs	Cardiovascular phenotype|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000237424	11	47363692 - 47363699	11	47342141 - 47342148	237424	241146	rs878853831	NC_000011.10:47342140:ACCTCCAG:
NM_000256.3(MYBPC3):c.1444dup (p.Ala482fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228368	11	47364393 - 47364394	11	47342842 - 47342843	228368	230214	rs876657703	NC_000011.10:47342842:CCCCC:CCCCCC
NM_000256.3(MYBPC3):c.162del (p.Lys54fs)	MYBPC3	K54fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000219730	11	47372920	11	47351369	219730	222147	rs864622224	NC_000011.10:47351368:C:
NM_000256.3(MYBPC3):c.1377del (p.Leu460fs)	MYBPC3	L460fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188548	11	47364461	11	47342910	188548	186386	rs786204339	NC_000011.10:47342909:GGGG:GGG
NM_000256.3(MYBPC3):c.3467dup (p.Pro1157fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181156	11	47354387 - 47354388	11	47332836 - 47332837	181156	179194	rs730880720	NC_000011.10:47332836:T:TT
NM_000256.3(MYBPC3):c.1577_1580dup (p.Cys528fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	VCV000181148	11	47364172 - 47364173	11	47342621 - 47342622	181148	179306	rs730880712	NC_000011.10:47342621:AGTG:AGTGAGTG
NM_000256.3(MYBPC3):c.923_924insAACT (p.Arg309fs)	MYBPC3	R309TfsX25	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181106	11	47368180 - 47368181	11	47346629 - 47346630	181106	179353	rs730880678	NC_000011.10:47346629::AGTT
NM_000256.3(MYBPC3):c.3321dup (p.Lys1108fs)	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181100	11	47354753 - 47354754	11	47333202 - 47333203	181100	179200	rs730880672	NC_000011.10:47333202:C:CC
NM_000256.3(MYBPC3):c.2709_2719del (p.Tyr904fs)	MYBPC3	Y904fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181084	11	47357446 - 47357456	11	47335895 - 47335905	181084	179238	rs730880657	NC_000011.10:47335894:CCACGCTGTAGCCA:CCA
NM_000256.3(MYBPC3):c.2610del (p.Ser871fs)	MYBPC3	S871fs	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181083	11	47357555	11	47336004	181083	179240	rs397515979	NC_000011.10:47336003:GGGGGG:GGGGG
NM_000256.3(MYBPC3):c.2532_2538del (p.Met844fs)	MYBPC3	M844fs	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181081	11	47359006 - 47359012	11	47337455 - 47337461	181081	179247	rs730880654	NC_000011.10:47337454:GACGCGC:
NM_000256.3(MYBPC3):c.2511del (p.Ile837fs)	MYBPC3	I837fs	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181080	11	47359033	11	47337482	181080	179252	rs730880653	NC_000011.10:47337481:G:
NM_000256.3(MYBPC3):c.2267del (p.Pro756fs)	MYBPC3	P756fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181078	11	47360112	11	47338561	181078	179263	rs730880651	NC_000011.10:47338560:GGG:GG
NM_000256.3(MYBPC3):c.1792delG	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181074	11	47362794	11	47341243	181074	179286	rs730880647	NC_000011.10:47341242:CCC:CC
NM_000256.3(MYBPC3):c.1734del (p.Lys579fs)	MYBPC3	K579fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181073	11	47363598	11	47342047	181073	179291	rs730880646	NC_000011.10:47342046:C:
NM_000256.3(MYBPC3):c.1595del (p.Gly532fs)	MYBPC3	G532fs	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181067	11	47364158	11	47342607	181067	179305	rs730880640	NC_000011.10:47342606:CCCCC:CCCC
NM_000256.3(MYBPC3):c.505+1G>A	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181041	11	47371564	11	47350013	181041	179377	rs730880620	NC_000011.10:47350012:C:T
NM_000256.3(MYBPC3):c.484C>T (p.Gln162Ter)	MYBPC3	Q162*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000181038	11	47371586	11	47350035	181038	179380		NC_000011.10:47350034:G:A
NM_000256.3(MYBPC3):c.3330+2T>C	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181007	11	47354743	11	47333192	181007	179198	rs387906397	NC_000011.10:47333191:A:G
NM_000256.3(MYBPC3):c.466dup (p.Leu156Profs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000179709	11	47371603 - 47371604	11	47350052 - 47350053	179709	175208	rs730880366	NC_000011.10:47350052:GG:GGG
NM_000256.3(MYBPC3):c.2953A>T (p.Lys985Ter)	MYBPC3	K985*	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177956	11	47355514	11	47333963	177956	174744	rs727504423	NC_000011.10:47333962:T:A
NM_000256.3(MYBPC3):c.2737+1G>C	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000177766	11	47357427	11	47335876	177766	175161	rs727504314	NC_000011.10:47335875:C:G
NM_000256.3(MYBPC3):c.1924C>T (p.Gln642Ter)	MYBPC3	Q642*	Cardiovascular phenotype|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000177705	11	47362557	11	47341006	177705	175177	rs727504293	NC_000011.10:47341005:G:A
NM_000256.3(MYBPC3):c.3129C>A (p.Tyr1043Ter)	MYBPC3	Y1043*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164048	11	47355169	11	47333618	164048	174740	rs573821685	NC_000011.10:47333617:G:T
NM_000256.3(MYBPC3):c.3476_3479dup (p.Pro1161fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 29, 2013)	criteria provided, multiple submitters, no conflicts	VCV000042714	11	47354375 - 47354376	11	47332824 - 47332825	42714	51884	rs397516019	NC_000011.10:47332824:ATAAA:ATAAATAAA
NM_000256.3(MYBPC3):c.2113dup (p.Thr705fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, multiple submitters, no conflicts	VCV000042597	11	47360909 - 47360910	11	47339358 - 47339359	42597	51767	rs397515948	NC_000011.10:47339358:T:TT
NM_000256.3(MYBPC3):c.1892del (p.Phe631fs)	MYBPC3	F631fs	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042580	11	47362694	11	47341143	42580	51750	rs397515933	NC_000011.10:47341142:AA:A
NM_000256.3(MYBPC3):c.1273C>T (p.Gln425Ter)	MYBPC3	Q425*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	VCV000042517	11	47364650	11	47343099	42517	51687	rs397515895	NC_000011.10:47343098:G:A
NM_054012.4(ASS1):c.1168G>A (p.Gly390Arg)	ASS1	G390R	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006329	9	133374932	9	130499545	6329	21368	rs121908641	NC_000009.12:130499544:G:A
NM_004333.6(BRAF):c.1785T>G (p.Phe595Leu)	BRAF	F595L, F573L, F598L, F543L, F635L, F507L, F558L, F561L	Rasopathy|Neoplasm|Cutaneous melanoma|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000177672	7	140453150	7	140753350	177672	174042	rs121913341	NC_000007.14:140753349:A:C
NM_004333.6(BRAF):c.1790T>A (p.Leu597Gln)	BRAF	L597Q, L509Q, L600Q, L560Q, L637Q, L563Q, L545Q, L575Q	Cutaneous melanoma|Adenocarcinoma of prostate|Multiple myeloma|Malignant melanoma of skin	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000076687	7	140453145	7	140753345	76687	87578	rs121913366	NC_000007.14:140753344:A:T
NM_004333.6(BRAF):c.1502A>G (p.Glu501Gly)	BRAF	E501G, E467G, E504G, E464G, E479G, E413G, E449G, E541G	Ventricular hypertrophy|Pulmonic stenosis (disease)|Ventricular septal defect|Low-set, posteriorly rotated ears|Wide intermamillary distance|Webbed neck|Neonatal respiratory distress|High forehead|Downslanted palpebral fissures|Premature birth|Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013978	7	140477806	7	140778006	13978	29017	rs180177039	NC_000007.14:140778005:T:C
NM_000256.3(MYBPC3):c.821+1G>T	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000850376	11	47369407	11	47347856	850376	851880		NC_000011.10:47347855:C:A
NC_000011.10:g.(?_47331843)_(47336021_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000833039	11	47353394 - 47357572			833039	820376		
NM_000256.3(MYBPC3):c.3476_3477insATTT (p.Phe1159fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000810764	11	47354378 - 47354379	11	47332827 - 47332828	810764	798998		NC_000011.10:47332827:AA:AAATAA
NM_000256.3(MYBPC3):c.3627+2T>G	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000656071	11	47354115	11	47332564	656071	652193		NC_000011.10:47332563:A:C
NM_000256.3(MYBPC3):c.852-2A>G	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572149	11	47369032	11	47347481	572149	565837	rs1565629792	NC_000011.10:47347480:T:C
NC_000011.9:g.(?_47353402)_(47370112_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	VCV000525136	11	47353402 - 47370112	11	47331851 - 47348561	525136	525602		
NM_000256.3(MYBPC3):c.506-1G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000525018	11	47371474	11	47349923	525018	526263	rs397516056	NC_000011.10:47349922:C:T
NM_000256.3(MYBPC3):c.747C>A (p.Cys249Ter)	MYBPC3	C249*	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418352	11	47370000	11	47348449	418352	408375	rs771929829	NC_000011.10:47348448:G:T
NM_000256.3(MYBPC3):c.3617del (p.Gly1206fs)	MYBPC3	G1206fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000407336	11	47354127	11	47332576	407336	398203	rs1060501484	NC_000011.10:47332575:CCCC:CCC
NM_000256.3(MYBPC3):c.2504del (p.Arg835fs)	MYBPC3	R835fs	Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000228369	11	47359040	11	47337489	228369	230208	rs876657704	NC_000011.10:47337488:C:
NM_000256.3(MYBPC3):c.1084dup (p.Ser362fs)	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000181159	11	47367763 - 47367764	11	47346212 - 47346213	181159	179344	rs730880723	NC_000011.10:47346212:T:TT
NM_000256.3(MYBPC3):c.3327del (p.Met1110fs)	MYBPC3	M1110fs	Cardiomyopathy|not provided	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000181155	11	47354748	11	47333197	181155	179199	rs730880719	NC_000011.10:47333196:GG:G
NM_000256.3(MYBPC3):c.1028del (p.Thr343fs)	MYBPC3	T343fs	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181114	11	47367820	11	47346269	181114	179348	rs730880686	NC_000011.10:47346268:G:
NM_000256.3(MYBPC3):c.3217dup (p.Arg1073fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181096	11	47354857 - 47354858	11	47333306 - 47333307	181096	179207	rs730880668	NC_000011.10:47333306:GG:GGG
NM_000256.3(MYBPC3):c.1223+1G>A	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181066	11	47365042	11	47343491	181066	179331	rs730880639	NC_000011.10:47343490:C:T
NM_000256.3(MYBPC3):c.3773T>G (p.Leu1258Ter)	MYBPC3	L1258*	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181023	11	47353664	11	47332113	181023	179174	rs730880604	NC_000011.10:47332112:A:C
NM_000256.3(MYBPC3):c.1731G>A (p.Trp577Ter)	MYBPC3	W577*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180943	11	47363601	11	47342050	180943	179292	rs730880546	NC_000011.10:47342049:C:T
NM_000256.3(MYBPC3):c.1522C>T (p.Gln508Ter)	MYBPC3	Q508*	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000180941	11	47364231	11	47342680	180941	179309	rs730880544	NC_000011.10:47342679:G:A
NM_000256.3(MYBPC3):c.2556del (p.Ile852fs)	MYBPC3	I852fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, multiple submitters, no conflicts	VCV000164071	11	47358988	11	47337437	164071	174753	rs727503186	NC_000011.10:47337436:G:
NM_000256.3(MYBPC3):c.3166dup (p.Ala1056fs)	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000164047	11	47355131 - 47355132	11	47333580 - 47333581	164047	175151	rs727503174	NC_000011.10:47333580:CC:CCC
NM_000256.3(MYBPC3):c.3233G>A (p.Trp1078Ter)	MYBPC3	W1078*	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042692	11	47354842	11	47333291	42692	51862	rs397516006	NC_000011.10:47333290:C:T
NM_000256.3(MYBPC3):c.2610dup (p.Ser871fs)	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042646	11	47357554 - 47357555	11	47336003 - 47336004	42646	51816	rs397515979	NC_000011.10:47336003:GGGGGG:GGGGGGG
NM_000256.3(MYBPC3):c.1310del (p.Val437fs)	MYBPC3	V437fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042522	11	47364613	11	47343062	42522	51692	rs397515896	NC_000011.10:47343061:A:
NM_004519.4(KCNQ3):c.688C>T (p.Arg230Cys)	KCNQ3	R230C, R110C	Benign familial neonatal seizures|Severe neurodevelopmental delay|Benign familial neonatal seizures 2|Seizures, benign familial infantile, 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205963	8	133192493	8	132180246	205963	202181	rs796052676	NC_000008.11:132180245:G:A
NM_000256.3(MYBPC3):c.2413+1G>A	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000810754	11	47359240	11	47337689	810754	799018		NC_000011.10:47337688:C:T
NM_000256.3(MYBPC3):c.299_308del (p.Ala100fs)	MYBPC3	A100fs	Cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000582266	11	47372151 - 47372160	11	47350600 - 47350609	582266	567318	rs1565631430	NC_000011.10:47350599:ATGGGCTCTG:
NM_000256.3(MYBPC3):c.2149-1G>T	MYBPC3		Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522435	11	47360231	11	47338680	522435	513091	rs727504334	NC_000011.10:47338679:C:A
NM_000256.3(MYBPC3):c.237C>A (p.Tyr79Ter)	MYBPC3	Y79*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000407333	11	47372845	11	47351294	407333	398654	rs730880698	NC_000011.10:47351293:G:T
NM_000256.3(MYBPC3):c.(?_2906)_(3627_?)del	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000228366	11	47354117 - 47355561	11	47332566 - 47334010	228366	229955		
NM_000256.3(MYBPC3):c.3182_3190+4del	MYBPC3		Hypertrophic cardiomyopathy|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181154	11	47355104 - 47355116	11	47333553 - 47333565	181154	179209	rs730880718	NC_000011.10:47333552:GCACCAACAACCTGCA:GCA
NM_000256.3(MYBPC3):c.2382del (p.Pro795fs)	MYBPC3	P795fs	Hypertrophic cardiomyopathy|Cardiomyopathy	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181150	11	47359272	11	47337721	181150	179258	rs730880714	NC_000011.10:47337720:C:
NM_000256.3(MYBPC3):c.1774_1775GT[1] (p.Ser593fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181149	11	47363555 - 47363556	11	47342004 - 47342005	181149	179289	rs730880713	NC_000011.10:47342003:ACAC:AC
NM_000256.3(MYBPC3):c.237C>G (p.Tyr79Ter)	MYBPC3	Y79*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181132	11	47372845	11	47351294	181132	179400	rs730880698	NC_000011.10:47351293:G:C
NM_000256.3(MYBPC3):c.237del (p.Ser78_Tyr79insTer)	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181091	11	47372845	11	47351294	181091	179401	rs730880664	NC_000011.10:47351293:G:
NM_000256.3(MYBPC3):c.3732C>A (p.Cys1244Ter)	MYBPC3	C1244*	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181019	11	47353705	11	47332154	181019	179179	rs730880600	NC_000011.10:47332153:G:T
NM_000256.3(MYBPC3):c.2748G>A (p.Trp916Ter)	MYBPC3	W916*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180982	11	47356750	11	47335199	180982	179234	rs730880576	NC_000011.10:47335198:C:T
NM_000256.3(MYBPC3):c.3600_3609del (p.Cys1201fs)	MYBPC3	C1201fs	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000177670	11	47354135 - 47354144	11	47332584 - 47332593	177670	174732	rs727504271	NC_000011.10:47332583:AGCACAGCAGAGCA:AGCA
NM_000256.3(MYBPC3):c.613C>T (p.Gln205Ter)	MYBPC3	Q205*	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042774	11	47371366	11	47349815	42774	51944	rs397516061	NC_000011.10:47349814:G:A
NM_000256.3(MYBPC3):c.506-2A>C	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042765	11	47371475	11	47349924	42765	51935	rs397516057	NC_000011.10:47349923:T:G
NM_000256.3(MYBPC3):c.362del (p.Pro121fs)	MYBPC3	P121fs	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042729	11	47372097	11	47350546	42729	51899	rs397516032	NC_000011.10:47350545:GGGG:GGG
NM_000256.3(MYBPC3):c.3491-2A>T	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042717	11	47354255	11	47332704	42717	51887	rs397516022	NC_000011.10:47332703:T:A
NM_000260.4(MYO7A):c.73G>A (p.Gly25Arg)	MYO7A	G25R, G14R	|Deafness, autosomal recessive 2|Retinal dystrophy|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177722	11	76853809	11	77142763	177722	178185	rs782252317	NC_000011.10:77142762:G:A
NM_000260.4(MYO7A):c.5617C>T (p.Arg1873Trp)	MYO7A	R1873W, R1824W, R1835W	not provided|Rare genetic deafness|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043291	11	76916643	11	77205598	43291	52461	rs397516321	NC_000011.10:77205597:C:T
NM_000260.4(MYO7A):c.1556G>A (p.Gly519Asp)	MYO7A	G519D, G508D	Rare genetic deafness||Deafness, autosomal recessive 2||not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043151	11	76873900	11	77162854	43151	52321	rs111033206	NC_000011.10:77162853:G:A
NM_000260.4(MYO7A):c.700C>T (p.Gln234Ter)	MYO7A	Q234*, Q223*	|Rare genetic deafness|Deafness, autosomal recessive 2||Usher syndrome, type 1B	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011848	11	76868015	11	77156969	11848	26887	rs41298133	NC_000011.10:77156968:C:T
NM_194456.1(KRIT1):c.1363C>T (p.Gln455Ter)	KRIT1	Q248*, Q407*, Q455*, Q217*	Cerebral cavernous malformation|not provided|Cerebral cavernous malformations 1|not specified	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005721	7	91852184	7	92222870	5721	20760	rs267607203	NC_000007.14:92222869:G:A
NM_000552.4(VWF):c.3946G>A (p.Val1316Met)	VWF	V1316M	not provided|von Willebrand disease type 2|von Willebrand disease, type 2b|not specified|von Willebrand disorder	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000290	12	6128638	12	6019472	290	15329	rs61749397	NC_000012.12:6019471:C:T
NM_017780.4(CHD7):c.7957C>T (p.Arg2653Ter)	CHD7	R2653*, R604*	CHARGE association|not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158321	8	61774881	8	60862322	158321	168637	rs587783458	NC_000008.11:60862321:C:T
NM_022970.3(FGFR2):c.1087+1331C>G	FGFR2	S351C, S123C, S262C, S236C	Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided|FGFR2 related craniosynostosis|Pfeiffer syndrome, type III	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013286	10	123276865	10	121517351	13286	28325	rs121918502	NC_000010.11:121517350:G:C
NM_000256.3(MYBPC3):c.1367del (p.Ile456fs)	MYBPC3	I456fs	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000637963	11	47364471	11	47342920	637963	625810		NC_000011.10:47342919:A:
NM_000256.3(MYBPC3):c.2766del (p.Gly922_Leu923insTer)	MYBPC3		Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000627591	11	47356732	11	47335181	627591	615940	rs1565624196	NC_000011.10:47335180:CCCC:CCC
NM_000256.3(MYBPC3):c.3559del (p.Leu1187fs)	MYBPC3	L1187fs	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000437416	11	47354185	11	47332634	437416	430964	rs1555120300	NC_000011.10:47332633:GGGG:GGG
NM_000256.3(MYBPC3):c.3124_3125insAA (p.Thr1042fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418356	11	47355173 - 47355174	11	47333622 - 47333623	418356	408364	rs1064793202	NC_000011.10:47333622:T:TTT
NM_000256.3(MYBPC3):c.2265C>A (p.Asn755Lys)	MYBPC3	N755K	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000407308	11	47360114	11	47338563	407308	398273	rs1060501474	NC_000011.10:47338562:G:T
NM_000256.3(MYBPC3):c.3324_3325del (p.Lys1108fs)	MYBPC3	K1108fs	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000397542	11	47354750 - 47354751	11	47333199 - 47333200	397542	384440	rs1060499673	NC_000011.10:47333198:TCT:T
NM_000256.3(MYBPC3):c.332_335dup (p.Glu112delinsAspTer)	MYBPC3		Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000254154	11	47372123 - 47372124	11	47350572 - 47350573	254154	248635	rs886037901	NC_000011.10:47350572:TCAG:TCAGTCAG
NM_000256.3(MYBPC3):c.3331-2A>C	MYBPC3		Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000222710	11	47354526	11	47332975	222710	224422	rs869025469	NC_000011.10:47332974:T:G
NM_000256.3(MYBPC3):c.3641G>A (p.Trp1214Ter)	MYBPC3	W1214*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000181015	11	47353796	11	47332245	181015	179184	rs730880597	NC_000011.10:47332244:C:T
NM_000256.3(MYBPC3):c.1210C>T (p.Gln404Ter)	MYBPC3	Q404*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177796	11	47365056	11	47343505	177796	174783	rs727504329	NC_000011.10:47343504:G:A
NM_000256.3(MYBPC3):c.1357_1358del (p.Pro453fs)	MYBPC3	P453fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164118	11	47364480 - 47364481	11	47342929 - 47342930	164118	175190	rs727503203	NC_000011.10:47342928:GGGGG:GGG
NM_000256.3(MYBPC3):c.1469G>T (p.Gly490Val)	MYBPC3	G490V	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Jun 28, 2013)	no assertion criteria provided	VCV000064617	11	47364284	11	47342733	64617	75580	rs397514752	NC_000011.10:47342732:C:A
NM_000256.3(MYBPC3):c.175A>G (p.Thr59Ala)	MYBPC3	T59A	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Jan 29, 2002)	no assertion criteria provided	VCV000008614	11	47372907	11	47351356	8614	23653	rs121909375	NC_000011.10:47351355:T:C
NM_000256.3(MYBPC3):c.3659_3662delinsTTCAAGAATGGC (p.Asp1220fs)	MYBPC3		Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000008612	11	47353775 - 47353778	11	47332224 - 47332227	8612	23651	rs886041031	NC_000011.10:47332223:AGGT:GCCATTCTTGAA
NM_000256.3(MYBPC3):c.2309-26A>G	MYBPC3		Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000008610	11	47359371	11	47337820	8610	23649	rs886041030	NC_000011.10:47337819:T:C
NM_019098.4(CNGB3):c.819_826del (p.Arg274fs)	CNGB3	R274fs	Nystagmus|Abnormal electroretinogram|Achromatopsia 3|Achromatopsia|Retinal dystrophy|not provided|Leber congenital amaurosis	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374027	8	87679179 - 87679186	8	86666951 - 86666958	374027	360901	rs775796581	NC_000008.11:86666950:GGAGTCTGGG:GG
NM_000235.4(LIPA):c.894G>A (p.Gln298=)	LIPA		not provided|LIPA-Related Disorders|Lysosomal acid lipase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000203361	10	90982268	10	89222511	203361	199794	rs116928232	NC_000010.11:89222510:C:T
NM_000441.2(SLC26A4):c.1614+1G>A	SLC26A4		Pendred syndrome|Rare genetic deafness|not provided|Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043516	7	107338557	7	107698112	43516	52685	rs111033312	NC_000007.14:107698111:G:A
NM_002180.2(IGHMBP2):c.1082T>C (p.Leu361Pro)	IGHMBP2	L361P	not provided|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245627	11	68696672	11	68929204	245627	244678	rs201060167	NC_000011.10:68929203:T:C
NM_020822.3(KCNT1):c.1193G>A (p.Arg398Gln)	KCNT1	R398Q, R353Q	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|not provided|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039599	9	138657034	9	135765188	39599	48198	rs397515407	NC_000009.12:135765187:G:A
NM_001360.2(DHCR7):c.1337G>A (p.Arg446Gln)	DHCR7	R446Q	not provided|History of neurodevelopmental disorder|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431994	11	71146512	11	71435466	431994	425943	rs751604696	NC_000011.10:71435465:C:T
NM_138694.4(PKHD1):c.10637del (p.Val3546fs)	PKHD1	V3546fs	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279874	6	51524287	6	51659489	279874	264271	rs770461067	NC_000006.12:51659488:A:
NM_138694.4(PKHD1):c.10219C>T (p.Gln3407Ter)	PKHD1	Q3407*	not provided|Autosomal recessive polycystic kidney disease|Polycystic liver disease	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198314	6	51524705	6	51659907	198314	195475	rs781368899	NC_000006.12:51659906:G:A
NM_138694.4(PKHD1):c.3367G>A (p.Gly1123Ser)	PKHD1	G1123S	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188959	6	51893147	6	52028349	188959	186712	rs142107837	NC_000006.12:52028348:C:T
NM_000256.3(MYBPC3):c.481C>T (p.Pro161Ser)	MYBPC3	P161S	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000518242	11	47371589	11	47350038	518242	508866	rs397516053	NC_000011.10:47350037:G:A
NM_000256.3(MYBPC3):c.1090G>A (p.Ala364Thr)	MYBPC3	A364T	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000454301	11	47367758	11	47346207	454301	461685	rs794727046	NC_000011.10:47346206:C:T
NM_000256.3(MYBPC3):c.357del (p.Ala120fs)	MYBPC3	A120fs	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000222704	11	47372102	11	47350551	222704	224431	rs869025463	NC_000011.10:47350550:TT:T
NM_000256.3(MYBPC3):c.3710_3711CT[1] (p.Leu1238fs)	MYBPC3		Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000217836	11	47353724 - 47353725	11	47332173 - 47332174	217836	214489	rs863225272	NC_000011.10:47332172:AGAG:AG
NM_000256.3(MYBPC3):c.1359del (p.Val454fs)	MYBPC3	V454fs	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	VCV000217835	11	47364479	11	47342928	217835	214491	rs863225271	NC_000011.10:47342927:A:
NM_000256.3(MYBPC3):c.2371C>T (p.Gln791Ter)	MYBPC3	Q791*	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217478	11	47359283	11	47337732	217478	214116	rs863225106	NC_000011.10:47337731:G:A
NM_000256.3(MYBPC3):c.416C>G (p.Ser139Ter)	MYBPC3	S139*	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, multiple submitters, no conflicts	VCV000181138	11	47371654	11	47350103	181138	179390	rs730880704	NC_000011.10:47350102:G:C
NM_000256.3(MYBPC3):c.884del (p.Phe295fs)	MYBPC3	F295fs	Familial hypertrophic cardiomyopathy 4|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000181112	11	47368998	11	47347447	181112	179357	rs730880684	NC_000011.10:47347446:AA:A
NM_000256.3(MYBPC3):c.3079G>AA	MYBPC3		Hypertrophic cardiomyopathy|not provided|Cardiomyopathy	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181093	11	47355219	11	47333668	181093	179216	rs730880666	NC_000011.10:47333667:C:TT
NM_000256.3(MYBPC3):c.2455_2459del (p.Met819fs)	MYBPC3	M819fs	Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181079	11	47359085 - 47359089	11	47337534 - 47337538	181079	179255	rs730880652	NC_000011.10:47337533:CGCATC:C
NM_000256.3(MYBPC3):c.1700_1701del (p.Glu567fs)	MYBPC3	E567fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181072	11	47363631 - 47363632	11	47342080 - 47342081	181072	179294	rs727503197	NC_000011.10:47342079:CTC:C
NM_000256.3(MYBPC3):c.1120C>T (p.Gln374Ter)	MYBPC3	Q374*	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 12, 2012)	criteria provided, multiple submitters, no conflicts	VCV000181061	11	47365146	11	47343595	181061	179340	rs730880635	NC_000011.10:47343594:G:A
NM_000256.3(MYBPC3):c.1898-1G>A	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180958	11	47362584	11	47341033	180958	179275	rs730880558	NC_000011.10:47341032:C:T
NM_000256.3(MYBPC3):c.2149-1G>A	MYBPC3		Hypertrophic cardiomyopathy|not provided|not specified	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177814	11	47360231	11	47338680	177814	174763	rs727504334	NC_000011.10:47338679:C:T
NM_000256.3(MYBPC3):c.1090+1G>A	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177668	11	47367757	11	47346206	177668	175196	rs727504269	NC_000011.10:47346205:C:T
NM_000256.3(MYBPC3):c.3293G>A (p.Trp1098Ter)	MYBPC3	W1098*	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042701	11	47354782	11	47333231	42701	51871	rs397516013	NC_000011.10:47333230:C:T
NM_000256.3(MYBPC3):c.2308+1G>T	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042611	11	47360070	11	47338519	42611	51781	rs112738974	NC_000011.10:47338518:C:A
NM_000256.3(MYBPC3):c.2182G>T (p.Glu728Ter)	MYBPC3	E728*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042605	11	47360197	11	47338646	42605	51775	rs397515954	NC_000011.10:47338645:C:A
NM_000256.3(MYBPC3):c.206G>A (p.Arg69Gln)	MYBPC3	R69Q	Primary familial hypertrophic cardiomyopathy|not specified	Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	VCV000042594	11	47372876	11	47351325	42594	51764	rs397515945	NC_000011.10:47351324:C:T
NM_000256.3(MYBPC3):c.2013_2016delinsGG (p.Pro672fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042592	11	47361253 - 47361256	11	47339702 - 47339705	42592	51762	rs397515943	NC_000011.10:47339701:AGGG:CC
NM_000155.4(GALT):c.443G>A (p.Arg148Gln)	GALT	R148Q, R39Q	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025178	9	34647894	9	34647897	25178	36512	rs111033694	NC_000009.12:34647896:G:A
NM_000256.3(MYBPC3):c.221C>TT	MYBPC3		Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523708	11	47372861	11	47351310	523708	514357	rs1555123743	NC_000011.10:47351309:G:AA
NM_000256.3(MYBPC3):c.1153_1168del (p.Val385fs)	MYBPC3	V385fs	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222706	11	47365098 - 47365113	11	47343547 - 47343562	222706	224429	rs869025465	NC_000011.10:47343546:GGTCAGCCAGTTCCACGGTCAGCC:GGTCAGCC
NM_000256.3(MYBPC3):c.1302C>A (p.Tyr434Ter)	MYBPC3	Y434*	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000217827	11	47364621	11	47343070	217827	214492	rs190228518	NC_000011.10:47343069:G:T
NM_000256.3(MYBPC3):c.2376G>A (p.Trp792Ter)	MYBPC3	W792*	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217484	11	47359278	11	47337727	217484	214115	rs863225112	NC_000011.10:47337726:C:T
NM_000256.3(MYBPC3):c.676_701dup (p.Gly235fs)	MYBPC3		Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188532	11	47370045 - 47370046	11	47348494 - 47348495	188532	186400	rs786204329	NC_000011.10:47348494:GTGAAGGCAGGCTGGGCATCGGTGATGTG:GTGAAGGCAGGCTGGGCATCGGTGATGTGAAGGCAGGCTGGGCATCGGTGATGTG
NM_000256.3(MYBPC3):c.1358dup (p.Val454fs)	MYBPC3		Cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2011)	criteria provided, multiple submitters, no conflicts	VCV000181147	11	47364479 - 47364480	11	47342928 - 47342929	181147	179321	rs727503203	NC_000011.10:47342928:GGGGG:GGGGGG
NM_000256.3(MYBPC3):c.821+1G>C	MYBPC3		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 21, 2013)	criteria provided, single submitter	VCV000178946	11	47369407	11	47347856	178946	175202	rs397516073	NC_000011.10:47347855:C:G
NM_000256.3(MYBPC3):c.2747G>A (p.Trp916Ter)	MYBPC3	W916*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177835	11	47356751	11	47335200	177835	175160	rs727504349	NC_000011.10:47335199:C:T
NM_000256.3(MYBPC3):c.1999_2000delinsG (p.Leu667fs)	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164091	11	47361269 - 47361270	11	47339718 - 47339719	164091	174764	rs727503192	NC_000011.10:47339717:AG:C
NM_000256.3(MYBPC3):c.3735del (p.Phe1246fs)	MYBPC3	F1246fs	Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042737	11	47353702	11	47332151	42737	51907	rs397516038	NC_000011.10:47332150:GGGG:GGG
NM_000256.3(MYBPC3):c.3694A>T (p.Lys1232Ter)	MYBPC3	K1232*	Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2011)	criteria provided, multiple submitters, no conflicts	VCV000042733	11	47353743	11	47332192	42733	51903	rs397516035	NC_000011.10:47332191:T:A
NM_000256.3(MYBPC3):c.350del (p.Pro117fs)	MYBPC3	P117fs	not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042718	11	47372109	11	47350558	42718	51888	rs397516023	NC_000011.10:47350557:GGGG:GGG
NM_000256.3(MYBPC3):c.2048G>A (p.Trp683Ter)	MYBPC3	W683*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042591	11	47361221	11	47339670	42591	51761	rs397515942	NC_000011.10:47339669:C:T
NM_000256.3(MYBPC3):c.1575T>G (p.Tyr525Ter)	MYBPC3	Y525*	Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	VCV000042547	11	47364178	11	47342627	42547	51717	rs397515910	NC_000011.10:47342626:A:C
NM_000256.3(MYBPC3):c.1224-2A>G	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042511	11	47364815	11	47343264	42511	51681	rs397515891	NC_000011.10:47343263:T:C
NM_017890.4(VPS13B):c.11314C>T (p.Gln3772Ter)	VPS13B	Q3772*, Q3747*	not provided|Cohen syndrome|Retinal dystrophy|Short foot|Small hand|Recurrent aphthous stomatitis|Short stature|Microcephaly|Neutropenia|Intellectual disability|Progressive visual loss	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056635	8	100880540	8	99868312	56635	71274	rs386834061	NC_000008.11:99868311:C:T
NM_000244.3(MEN1):c.1366_*820del (p.Val456fs)	MEN1	V493fs, V416fs, V456fs, V451fs	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, single submitter	VCV000572762	11	64570986 - 64572288	11	64803514 - 64804816	572762	570769		
NM_000244.3(MEN1):c.1421_1428dup (p.Gly477fs)	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428080	11	64572225 - 64572226	11	64804753 - 64804754	428080	419786	rs1114167536	NC_000011.10:64804753:CCACGGCTCC:CCACGGCTCCACGGCTCC
NM_000244.3(MEN1):c.85C>T (p.Arg29Ter)	MEN1	R29*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200970	11	64577497	11	64810025	200970	197564	rs794728615	NC_000011.10:64810024:G:A
NM_000426.3(LAMA2):c.5476C>T (p.Arg1826Ter)	LAMA2	R1826*	Merosin deficient congenital muscular dystrophy|not provided|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265426	6	129722399	6	129401254	265426	259832	rs747349942	NC_000006.12:129401253:C:T
NM_000426.3(LAMA2):c.1303C>T (p.Arg435Ter)	LAMA2	R435*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235805	6	129486817	6	129165672	235805	237464	rs773209126	NC_000006.12:129165671:C:T
NM_000360.4(TH):c.605G>A (p.Arg202His)	TH	R233H, R229H	Segawa syndrome, autosomal recessive|not provided|Dystonia	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012327	11	2189135	11	2167905	12327	27366	rs80338892	NC_000011.10:2167904:C:T
NM_004260.3(RECQL4):c.2752G>T (p.Glu918Ter)	RECQL4	E918*	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000597188	8	145738233	8	144512850	597188	588249	rs762028333	NC_000008.11:144512849:C:A
NM_004260.3(RECQL4):c.3025C>T (p.Gln1009Ter)	RECQL4	Q1009*	not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000593151	8	145737805	8	144512422	593151	584215	rs1564790457	NC_000008.11:144512421:G:A
NM_004260.3(RECQL4):c.517C>T (p.Gln173Ter)	RECQL4	Q173*	not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000450210	8	145741986	8	144516602	450210	444256	rs373180788	NC_000008.11:144516601:G:A
NM_004260.3(RECQL4):c.1568del (p.Ser523fs)	RECQL4	S523fs	not provided	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000285440	8	145740372	8	144514988	285440	269677	rs886043102	NC_000008.11:144514987:C:
NM_004260.3(RECQL4):c.1259-1G>A	RECQL4		not provided	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000284397	8	145740842	8	144515458	284397	268634	rs372380880	NC_000008.11:144515457:C:T
NM_004260.3(RECQL4):c.1102del (p.Ala368fs)	RECQL4	A368fs	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280459	8	145741401	8	144516017	280459	264351	rs886041662	NC_000008.11:144516016:CCC:CC
NM_004260.3(RECQL4):c.82C>T (p.Gln28Ter)	RECQL4	Q28*	not provided	Pathogenic(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	VCV000193272	8	145743087	8	144517703	193272	190436	rs794726912	NC_000008.11:144517702:G:A
RECQL4, GLU1091TER	RECQL4	E1091*	Rapadilino syndrome	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000006071					6071	21110		
RECQL4, IVS7, 1-BP DEL, +2	RECQL4		Rapadilino syndrome	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000006070					6070	21109		
NM_004260.4(RECQL4):c.2998del (p.Leu1000fs)	RECQL4	L1000fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000857835	8	145737832	8	144512449	857835	834351		NC_000008.11:144512448:G:
NM_004260.4(RECQL4):c.3613C>T (p.Gln1205Ter)	RECQL4	Q1205*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000857300	8	145736828	8	144511445	857300	834321		NC_000008.11:144511444:G:A
NM_004260.4(RECQL4):c.1759del (p.Ala587fs)	RECQL4	A587fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000854411	8	145739692	8	144514308	854411	834427		NC_000008.11:144514307:CCCCC:CCCC
NM_004260.4(RECQL4):c.187_196del (p.Glu63fs)	RECQL4	E63fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000847782	8	145742815 - 145742824	8	144517431 - 144517440	847782	834514		NC_000008.11:144517430:GGAGCGACTCGGAGC:GGAGC
NM_004260.4(RECQL4):c.1583del (p.Leu528fs)	RECQL4	L528fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000847133	8	145740357	8	144514973	847133	834434		NC_000008.11:144514972:AA:A
NM_004260.4(RECQL4):c.854del (p.Pro285fs)	RECQL4	P285fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000846137	8	145741649	8	144516265	846137	834478		NC_000008.11:144516264:GGGGG:GGGG
NM_004260.4(RECQL4):c.1409dup (p.Gln471fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000845205	8	145740607 - 145740608	8	144515223 - 144515224	845205	834443		NC_000008.11:144515223:AA:AAA
NM_004260.4(RECQL4):c.2539C>T (p.Gln847Ter)	RECQL4	Q847*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000843922	8	145738446	8	144513063	843922	834375		NC_000008.11:144513062:G:A
NM_004260.4(RECQL4):c.1137G>A (p.Trp379Ter)	RECQL4	W379*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000843640	8	145741269	8	144515885	843640	834455		NC_000008.11:144515884:C:T
NM_004260.4(RECQL4):c.2410_2414CGGGC[1] (p.Ala805_Gly806insTer)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000843639	8	145738645 - 145738649	8	144513262 - 144513266	843639	834383		NC_000008.11:144513261:GCCCGGCCCGGCCC:GCCCGGCCC
NM_004260.4(RECQL4):c.3433C>T (p.Gln1145Ter)	RECQL4	Q1145*	Baller-Gerold syndrome	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000837971	8	145737133	8	144511750	837971	834330		NC_000008.11:144511749:G:A
NC_000008.11:g.(?_144514926)_(144517794_?)del	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000831322	8	145740310 - 145743178			831322	819954		
NM_004260.3(RECQL4):c.690_709del (p.Gly231fs)	RECQL4	G231fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000661531	8	145741794 - 145741813	8	144516410 - 144516429	661531	636967		NC_000008.11:144516409:GGCCCTGGGAGCCAGCACCAGG:GG
NM_004260.3(RECQL4):c.1051_1052del (p.Gly351fs)	RECQL4	G351fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000658938	8	145741451 - 145741452	8	144516067 - 144516068	658938	636943		NC_000008.11:144516066:CCCC:CC
NM_004260.3(RECQL4):c.3006_3007TG[1] (p.Val1003fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000657598	8	145737821 - 145737822	8	144512438 - 144512439	657598	636840		NC_000008.11:144512437:CACA:CA
NM_004260.3(RECQL4):c.3280G>T (p.Glu1094Ter)	RECQL4	E1094*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000657236	8	145737407	8	144512024	657236	636824		NC_000008.11:144512023:C:A
NM_004260.3(RECQL4):c.642_643AG[1] (p.Glu215fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000649166	8	145741858 - 145741859	8	144516474 - 144516475	649166	636971		NC_000008.11:144516473:CTCT:CT
NM_004260.3(RECQL4):c.3139_3140GA[1] (p.Lys1048fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000649113	8	145737621 - 145737622	8	144512238 - 144512239	649113	636833		NC_000008.11:144512237:TCTC:TC
NM_004260.3(RECQL4):c.315C>G (p.Tyr105Ter)	RECQL4	Y105*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000643471	8	145742473	8	144517089	643471	636990		NC_000008.11:144517088:G:C
NM_004260.4(RECQL4):c.2889del (p.Pro965fs)	RECQL4	P965fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000642493	8	145737941	8	144512558	642493	636845		NC_000008.11:144512557:A:
NM_004260.3(RECQL4):c.910C>T (p.Gln304Ter)	RECQL4	Q304*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000641783	8	145741593	8	144516209	641783	636954		NC_000008.11:144516208:G:A
NM_004260.4(RECQL4):c.686del (p.Gly229fs)	RECQL4	G229fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000641082	8	145741817	8	144516433	641082	636968		NC_000008.11:144516432:CC:C
NM_004260.3(RECQL4):c.1223_1224insT (p.Gln408fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000640388	8	145741182 - 145741183	8	144515798 - 144515799	640388	636932		NC_000008.11:144515798::A
NM_004260.3(RECQL4):c.1171_1172delinsC (p.Gly391fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000577898	8	145741234 - 145741235	8	144515850 - 144515851	577898	562719	rs1564804342	NC_000008.11:144515849:CC:G
NM_004260.3(RECQL4):c.318del (p.Gln107fs)	RECQL4	Q107fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000576993	8	145742470	8	144517086	576993	567724	rs775439596	NC_000008.11:144517085:CCC:CC
NM_004260.3(RECQL4):c.1400del (p.Ala467fs)	RECQL4	A467fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000574681	8	145740617	8	144515233	574681	562709	rs1564802464	NC_000008.11:144515232:G:
NM_004260.3(RECQL4):c.574C>T (p.Gln192Ter)	RECQL4	Q192*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000573617	8	145741929	8	144516545	573617	562771	rs1564808132	NC_000008.11:144516544:G:A
NM_004260.3(RECQL4):c.641C>A (p.Ser214Ter)	RECQL4	S214*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000571451	8	145741862	8	144516478	571451	567697	rs1317950691	NC_000008.11:144516477:G:T
NM_004260.3(RECQL4):c.1699C>T (p.Gln567Ter)	RECQL4	Q567*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000568068	8	145739831	8	144514447	568068	562683	rs770709355	NC_000008.11:144514446:G:A
NM_004260.3(RECQL4):c.2869C>T (p.Gln957Ter)	RECQL4	Q957*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000566972	8	145738041	8	144512658	566972	562584	rs368081792	NC_000008.11:144512657:G:A
NM_004260.3(RECQL4):c.674_675insT (p.Ala226fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000566483	8	145741828 - 145741829	8	144516444 - 144516445	566483	562203	rs1564807584	NC_000008.11:144516444::A
NM_004260.3(RECQL4):c.1203del (p.Glu401fs)	RECQL4	E401fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Apr 8, 2018)	criteria provided, single submitter	VCV000565331	8	145741203	8	144515819	565331	567689	rs1220902289	NC_000008.11:144515818:C:
NM_004260.3(RECQL4):c.3148C>T (p.Gln1050Ter)	RECQL4	Q1050*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000529008	8	145737615	8	144512232	529008	523794	rs1554896691	NC_000008.11:144512231:G:A
NM_004260.3(RECQL4):c.1838G>A (p.Trp613Ter)	RECQL4	W613*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000528983	8	145739613	8	144514229	528983	523315	rs1554899720	NC_000008.11:144514228:C:T
NM_004260.3(RECQL4):c.1960C>T (p.Gln654Ter)	RECQL4	Q654*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000528982	8	145739410	8	144514026	528982	523871	rs552960344	NC_000008.11:144514025:G:A
NM_004260.3(RECQL4):c.1834C>T (p.Gln612Ter)	RECQL4	Q612*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000528933	8	145739617	8	144514233	528933	523874	rs1554899728	NC_000008.11:144514232:G:A
NM_004260.3(RECQL4):c.925C>T (p.Gln309Ter)	RECQL4	Q309*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000459529	8	145741578	8	144516194	459529	458293	rs1554902528	NC_000008.11:144516193:G:A
NM_004260.3(RECQL4):c.194_200del (p.Leu65fs)	RECQL4	L65fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000459359	8	145742811 - 145742817	8	144517427 - 144517433	459359	458332	rs1554904685	NC_000008.11:144517426:GCGGGGAGCG:GCG
NM_004260.3(RECQL4):c.143_144del (p.Leu48fs)	RECQL4	L48fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000459326	8	145742867 - 145742868	8	144517483 - 144517484	459326	457674	rs1554904773	NC_000008.11:144517482:CA:
NM_004260.3(RECQL4):c.1164_1165GT[1] (p.Cys389fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000459307	8	145741239 - 145741240	8	144515855 - 144515856	459307	458228	rs34134064	NC_000008.11:144515854:ACAC:AC
NM_004260.3(RECQL4):c.1015del (p.Leu339fs)	RECQL4	L339fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000407030	8	145741488	8	144516104	407030	396714	rs1060501384	NC_000008.11:144516103:GGGGGG:GGGGG
NM_004260.3(RECQL4):c.805del (p.Trp269fs)	RECQL4	W269fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000406956	8	145741698	8	144516314	406956	396719	rs1060501370	NC_000008.11:144516313:A:
NM_004260.3(RECQL4):c.1131_1131+3del	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000406879	8	145741369 - 145741372	8	144515985 - 144515988	406879	396063	rs1060501353	NC_000008.11:144515984:TACCT:T
NM_004260.3(RECQL4):c.2379_2380dup (p.Ser794fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000239722	8	145738683 - 145738684	8	144513300 - 144513301	239722	240280	rs878854645	NC_000008.11:144513300:TT:TTTT
NM_004260.3(RECQL4):c.1816G>T (p.Glu606Ter)	RECQL4	E606*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000239708	8	145739635	8	144514251	239708	240293	rs878854644	NC_000008.11:144514250:C:A
NM_004260.3(RECQL4):c.1919_1924del (p.Leu640_Ala642delinsPro)	RECQL4		Rothmund-Thomson syndrome type 2	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000006076	8	145739446 - 145739451	8	144514062 - 144514067	6076	21115	rs786200890	NC_000008.11:144514061:CTGTGA:
NM_004260.3(RECQL4):c.2059-1G>C	RECQL4		Rothmund-Thomson syndrome type 2	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000006069	8	145739097	8	144513713	6069	21108	rs386833849	NC_000008.11:144513712:C:G
NM_004260.3(RECQL4):c.2059-1G>T	RECQL4		Rothmund-Thomson syndrome type 2	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000006065	8	145739097	8	144513713	6065	21104	rs386833849	NC_000008.11:144513712:C:A
NM_004260.3(RECQL4):c.1650_1656del (p.Ala551fs)	RECQL4	A551fs	Rothmund-Thomson syndrome type 2	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000006062	8	145739874 - 145739880	8	144514490 - 144514496	6062	21101	rs786200887	NC_000008.11:144514489:GCAGGCCGC:GC
NM_005591.4(MRE11):c.1714C>T (p.Arg572Ter)	MRE11	R571*, R572*	Ataxia-telangiectasia-like disorder|Ovarian Neoplasms|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008784	11	94180454	11	94447288	8784	23823	rs137852761	NC_000011.10:94447287:G:A
NM_004260.4(RECQL4):c.2636del (p.Pro879fs)	RECQL4	P879fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000855952	8	145738349	8	144512966	855952	834370		NC_000008.11:144512965:GGGGGG:GGGGG
NM_004260.4(RECQL4):c.2636dup (p.Gln880fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000651496	8	145738348 - 145738349	8	144512965 - 144512966	651496	636860		NC_000008.11:144512965:GGGGGG:GGGGGGG
NM_004260.3(RECQL4):c.2410_2414CGGGC[3] (p.Arg807fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000641449	8	145738644 - 145738645	8	144513261 - 144513262	641449	636871		NC_000008.11:144513261:GCCCGGCCCGGCCC:GCCCGGCCCGGCCCGGCCC
NM_004260.3(RECQL4):c.1770_1807del (p.Pro591fs)	RECQL4	P591fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000575425	8	145739644 - 145739681	8	144514260 - 144514297	575425	562662	rs780542343	NC_000008.11:144514259:AGGCAAAAGCAACTGGAGGCAGCTGTGCGGCTGGAGGGAGGC:AGGC
NM_004260.3(RECQL4):c.2161C>T (p.Arg721Ter)	RECQL4	R721*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000572305	8	145738994	8	144513610	572305	567625	rs746691436	NC_000008.11:144513609:G:A
NM_004260.3(RECQL4):c.3277del (p.Asp1093fs)	RECQL4	D1093fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000528978	8	145737410	8	144512027	528978	523535	rs1356876749	NC_000008.11:144512026:CC:C
NM_004260.3(RECQL4):c.2085del (p.Lys695fs)	RECQL4	K695fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000528955	8	145739070	8	144513686	528955	523307	rs1457411812	NC_000008.11:144513685:TTT:TT
NM_004260.3(RECQL4):c.2590C>T (p.Gln864Ter)	RECQL4	Q864*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000528954	8	145738395	8	144513012	528954	523821	rs1054186954	NC_000008.11:144513011:G:A
NM_004260.3(RECQL4):c.1236G>A (p.Trp412Ter)	RECQL4	W412*	Baller-Gerold syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000528932	8	145741170	8	144515786	528932	523334	rs1554901674	NC_000008.11:144515785:C:T
NM_004260.3(RECQL4):c.2464-1G>A	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000577322	8	145738522	8	144513139	577322	564878	rs398124117	NC_000008.11:144513138:C:T
NM_004260.3(RECQL4):c.1149G>A (p.Trp383Ter)	RECQL4	W383*	Rothmund-Thomson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561097	8	145741257	8	144515873	561097	552121	rs1564804479	NC_000008.11:144515872:C:T
NM_004260.3(RECQL4):c.871del (p.Ala291fs)	RECQL4	A291fs	Baller-Gerold syndrome	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000459525	8	145741632	8	144516248	459525	457649	rs1389647533	NC_000008.11:144516247:CCCC:CCC
NM_004260.3(RECQL4):c.752del (p.Ser251fs)	RECQL4	S251fs	not provided|Baller-Gerold syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423196	8	145741751	8	144516367	423196	407348	rs1064796290	NC_000008.11:144516366:C:
NM_004260.3(RECQL4):c.2662C>T (p.Gln888Ter)	RECQL4	Q888*	not provided|Baller-Gerold syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666165	8	145738323	8	144512940	666165	636859		NC_000008.11:144512939:G:A
NM_004260.3(RECQL4):c.1717C>T (p.Gln573Ter)	RECQL4	Q573*	Undifferentiated Pleomorphic Sarcoma|Baller-Gerold syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000620609	8	145739734	8	144514350	620609	611998	rs1483085748	NC_000008.11:144514349:G:A
NM_004260.3(RECQL4):c.219_220AG[1] (p.Glu74fs)	RECQL4		Baller-Gerold syndrome|Rothmund-Thomson syndrome	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000459388	8	145742566 - 145742567	8	144517182 - 144517183	459388	458324	rs773325186	NC_000008.11:144517181:CTCT:CT
NM_004260.3(RECQL4):c.2545_2546GT[1] (p.Phe850fs)	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000406969	8	145738437 - 145738438	8	144513054 - 144513055	406969	396224	rs778141083	NC_000008.11:144513053:ACAC:AC
NM_004260.3(RECQL4):c.3072del (p.Val1026fs)	RECQL4	V1026fs	Rapadilino syndrome|Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000056407	8	145737691	8	144512308	56407	71046	rs386833852	NC_000008.11:144512307:T:
NM_004260.3(RECQL4):c.806G>A (p.Trp269Ter)	RECQL4	W269*	Rapadilino syndrome|Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000006072	8	145741697	8	144516313	6072	21111	rs137853231	NC_000008.11:144516312:C:T
NM_024426.6(WT1):c.1387C>T (p.Arg463Ter)	WT1	R390*, R458*, R246*, R441*, R229*, R446*, R463*, R67*	Frasier syndrome|not provided|Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome|Wilms tumor 1|Drash syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003494	11	32413578	11	32392032	3494	18533	rs121907909	NC_000011.10:32392031:G:A
NM_000256.3(MYBPC3):c.654+1G>A	MYBPC3		Familial hypertrophic cardiomyopathy 4|not provided	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000440947	11	47371324	11	47349773	440947	434640	rs730880621	NC_000011.10:47349772:C:T
NM_000256.3(MYBPC3):c.2065C>T (p.Gln689Ter)	MYBPC3	Q689*	Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216055	11	47361204	11	47339653	216055	212928	rs863224483	NC_000011.10:47339652:G:A
NM_000256.3(MYBPC3):c.2394dup (p.Gly799fs)	MYBPC3		Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2015)	criteria provided, multiple submitters, no conflicts	VCV000177862	11	47359259 - 47359260	11	47337708 - 47337709	177862	175171	rs730880341	NC_000011.10:47337708:A:AA
NM_000256.3(MYBPC3):c.966G>A (p.Trp322Ter)	MYBPC3	W322*	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164136	11	47367882	11	47346331	164136	175199	rs727503211	NC_000011.10:47346330:C:T
NM_000256.3(MYBPC3):c.459del (p.Ile154fs)	MYBPC3	I154fs	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042755	11	47371611	11	47350060	42755	51925	rs397516052	NC_000011.10:47350059:GGGG:GGG
NM_000256.3(MYBPC3):c.2454G>A (p.Trp818Ter)	MYBPC3	W818*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042622	11	47359090	11	47337539	42622	51792	rs397515965	NC_000011.10:47337538:C:T
NM_000256.3(MYBPC3):c.1458-1G>A	MYBPC3		Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042532	11	47364296	11	47342745	42532	51702	rs397515903	NC_000011.10:47342744:C:T
NM_000264.5(PTCH1):c.278dup (p.Tyr93Ter)	PTCH1		not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000816995	9	98268804 - 98268805	9	95506522 - 95506523	816995	805627		NC_000009.12:95506522:T:TT
GRCh37/hg19 9q22.32(chr9:98226015-98298532)x1	PTCH1		not provided	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000563570	9	98226015 - 98298532			563570	554754		
NM_001083602.2(PTCH1):c.463G>T (p.Glu155Ter)	PTCH1	E155*, E221*, E70*, E220*	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000545965	9	98244316	9	95482034	545965	536362	rs1554700647	NC_000009.12:95482033:C:A
NM_001083602.2(PTCH1):c.1207_1225del (p.Val403fs)	PTCH1	V468fs, V318fs, V403fs, V469fs	not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000545925	9	98239909 - 98239927	9	95477627 - 95477645	545925	536359	rs1554698587	NC_000009.12:95477626:GGACGCCAGCCAGCCCCACGG:GG
NM_001083602.2(PTCH1):c.2514dup (p.Gln839fs)	PTCH1		not provided	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000545878	9	98222056 - 98222057	9	95459774 - 95459775	545878	536356	rs143091773	NC_000009.12:95459774:TTT:TTTT
NM_001083602.2(PTCH1):c.3116dup (p.Thr1040fs)	PTCH1		not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000545867	9	98215894 - 98215895	9	95453612 - 95453613	545867	536355	rs1554690484	NC_000009.12:95453612:A:AA
NM_001083602.2(PTCH1):c.624del (p.Val209fs)	PTCH1	V124fs, V275fs, V209fs, V274fs	not provided	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000545818	9	98242795	9	95480513	545818	536360	rs1554699964	NC_000009.12:95480512:TT:T
NM_001083602.2(PTCH1):c.619_622delinsGAT (p.Tyr207fs)	PTCH1		not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000545751	9	98242797 - 98242800	9	95480515 - 95480518	545751	536361	rs1554699969	NC_000009.12:95480514:GATA:ATC
NM_001083602.2(PTCH1):c.2428G>T (p.Gly810Ter)	PTCH1	G810*, G876*, G725*, G824*, G875*	not provided	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000430055	9	98224215	9	95461933	430055	421764	rs1131691758	NC_000009.12:95461932:C:A
NM_001083602.2(PTCH1):c.870-1G>A	PTCH1		not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000426701	9	98241430	9	95479148	426701	415208	rs1085307752	NC_000009.12:95479147:C:T
NM_001083602.2(PTCH1):c.2503C>T (p.Gln835Ter)	PTCH1	Q835*, Q901*, Q849*, Q900*, Q750*	not provided	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000423765	9	98224140	9	95461858	423765	407781	rs1064796618	NC_000009.12:95461857:G:A
NM_001083602.2(PTCH1):c.291_292insTA (p.Glu98Ter)	PTCH1		not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423140	9	98248061 - 98248062	9	95485779 - 95485780	423140	407791	rs1064796259	NC_000009.12:95485779:T:TAT
NM_001083602.2(PTCH1):c.1417dup (p.Glu473fs)	PTCH1		not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000422858	9	98238428 - 98238429	9	95476146 - 95476147	422858	407784	rs878853847	NC_000009.12:95476146:CCCC:CCCCC
NM_001083602.2(PTCH1):c.408del (p.Leu136fs)	PTCH1	L136fs, L51fs, L201fs, L202fs	not provided	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000419804	9	98244464	9	95482182	419804	407789	rs1064794117	NC_000009.12:95482181:C:
NM_001083602.2(PTCH1):c.2662_2671delinsTAGT (p.Asp888_Pro891delinsTer)	PTCH1		not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000419615	9	98221900 - 98221909	9	95459618 - 95459627	419615	407779	rs1064793991	NC_000009.12:95459617:GCATGTAGTC:ACTA
NM_001083602.2(PTCH1):c.1150-2A>G	PTCH1		not provided	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000419592	9	98239986	9	95477704	419592	407786	rs1064793978	NC_000009.12:95477703:T:C
NM_001083602.2(PTCH1):c.888dup (p.Met297fs)	PTCH1		not provided	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000418849	9	98241410 - 98241411	9	95479128 - 95479129	418849	407787	rs1064793474	NC_000009.12:95479128:GG:GGG
NM_001083602.2(PTCH1):c.1387A>T (p.Lys463Ter)	PTCH1	K463*, K529*, K378*, K477*, K528*	not provided	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000379879	9	98239058	9	95476776	379879	371079	rs780434261	NC_000009.12:95476775:T:A
NM_001083602.2(PTCH1):c.2701G>T (p.Glu901Ter)	PTCH1	E901*, E967*, E966*, E816*, E915*	not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000280802	9	98220564	9	95458282	280802	264552	rs886041943	NC_000009.12:95458281:C:A
NM_001083602.2(PTCH1):c.2846_2873del (p.Phe949fs)	PTCH1	F949fs, F1015fs, F1014fs, F864fs, F963fs	not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000265626	9	98220392 - 98220419	9	95458110 - 95458137	265626	259929	rs886039678	NC_000009.12:95458109:AGGCCGATGTACTGCTCCCAGAAGAGGAAGG:AGG
NM_001083602.2(PTCH1):c.2844del (p.Phe949fs)	PTCH1	F963fs, F949fs, F1014fs, F864fs, F1015fs	not provided	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000265424	9	98220421	9	95458139	265424	259930	rs886039540	NC_000009.12:95458138:GGGG:GGG
NM_001083602.2(PTCH1):c.145G>T (p.Gly49Ter)	PTCH1	G115*, G49*, G114*	not provided	Pathogenic(Last reviewed: Dec 15, 2014)	criteria provided, single submitter	VCV000195052	9	98268740	9	95506458	195052	192214	rs794727242	NC_000009.12:95506457:C:A
NM_000264.5(PTCH1):c.3250dup (p.Val1084fs)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000823310	9	98218613 - 98218614	9	95456331 - 95456332	823310	809554		NC_000009.12:95456331:CC:CCC
NM_000264.5(PTCH1):c.1341dup (p.Leu448fs)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 21, 2018)	criteria provided, single submitter	VCV000818896	9	98240342 - 98240343	9	95478060 - 95478061	818896	809616		NC_000009.12:95478060:T:TT
NM_001083602.2(PTCH1):c.2363-1G>A	PTCH1		not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000429958	9	98224281	9	95461999	429958	421765	rs1131691700	NC_000009.12:95461998:C:T
NM_001083602.2(PTCH1):c.921del (p.Met306_Tyr307insTer)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000428857	9	98241378	9	95479096	428857	420481	rs1131691002	NC_000009.12:95479095:G:
NM_000264.4(PTCH1):c.3450del (p.Arg1150Serfs)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000428856	9	98212222	9	95449940	428856	420460	rs1131691001	
NM_001083602.2(PTCH1):c.803_812del (p.Tyr268fs)	PTCH1	Y268fs, Y334fs, Y183fs, Y333fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000428855	9	98242308 - 98242317	9	95480026 - 95480035	428855	420484	rs1554699612	NC_000009.12:95480025:CAGTGCATAT:
NM_001083602.2(PTCH1):c.2596del (p.Val866fs)	PTCH1	V781fs, V880fs, V931fs, V932fs, V866fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000428852	9	98221975	9	95459693	428852	420467	rs1131690997	NC_000009.12:95459692:C:
NM_001083602.2(PTCH1):c.548+1G>C	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000428848	9	98244230	9	95481948	428848	420489	rs1131690994	NC_000009.12:95481947:C:G
NM_001083602.2(PTCH1):c.465_466AT[1] (p.Tyr156fs)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000428847	9	98244311 - 98244312	9	95482029 - 95482030	428847	420491	rs1131690993	NC_000009.12:95482028:ATAT:AT
NM_001083602.2(PTCH1):c.4-2A>C	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000428844	9	98268883	9	95506601	428844	420499	rs878853849	NC_000009.12:95506600:T:G
NM_001083602.2(PTCH1):c.1306-2A>C	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000428837	9	98239141	9	95476859	428837	420475	rs1131690984	NC_000009.12:95476858:T:G
NM_001083602.2(PTCH1):c.284_293del (p.Thr95fs)	PTCH1	T160fs, T161fs, T95fs, T10fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2015)	criteria provided, single submitter	VCV000428833	9	98248060 - 98248069	9	95485778 - 95485787	428833	420493	rs1131690981	NC_000009.12:95485777:TCTTTAGGGGTCT:TCT
NM_001083602.2(PTCH1):c.2937_2940CTTC[1] (p.Phe980_Leu981insTer)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000428831	9	98220321 - 98220324	9	95458039 - 95458042	428831	420465	rs1131690980	NC_000009.12:95458038:GAAGGAAG:GAAG
NM_001083602.2(PTCH1):c.747+2T>C	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000428830	9	98242670	9	95480388	428830	420485	rs1131690979	NC_000009.12:95480387:A:G
NM_001083602.2(PTCH1):c.1136del (p.Gly379fs)	PTCH1	G379fs, G294fs, G444fs, G445fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2015)	criteria provided, single submitter	VCV000428828	9	98240350	9	95478068	428828	420479	rs1131690978	NC_000009.12:95478067:CC:C
NM_001083602.2(PTCH1):c.173_189del (p.Asn58fs)	PTCH1	N123fs, N124fs, N58fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000428827	9	98268696 - 98268712	9	95506414 - 95506430	428827	420496	rs1554708626	NC_000009.12:95506413:CCACAGCTCCTCCACGT:
NM_001083602.2(PTCH1):c.3261del (p.Phe1087fs)	PTCH1	F1087fs, F1101fs, F1152fs, F1153fs, F1002fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2014)	criteria provided, single submitter	VCV000428826	9	98212213	9	95449931	428826	420459	rs1131690976	NC_000009.12:95449930:AAA:AA
NM_001083602.2(PTCH1):c.2400del (p.Ile802fs)	PTCH1	I816fs, I868fs, I717fs, I802fs, I867fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	VCV000428825	9	98224243	9	95461961	428825	420469	rs1131690975	NC_000009.12:95461960:CCC:CC
NM_001083602.2(PTCH1):c.1181G>A (p.Trp394Ter)	PTCH1	W394*, W460*, W309*, W459*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	VCV000428824	9	98239953	9	95477671	428824	420477	rs1131690974	NC_000009.12:95477670:C:T
NM_001083602.2(PTCH1):c.679_689del (p.Asp227fs)	PTCH1	D142fs, D227fs, D292fs, D293fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	VCV000428823	9	98242730 - 98242740	9	95480448 - 95480458	428823	420486	rs1131690973	NC_000009.12:95480447:CAGGGGCGGTCCA:CA
NM_001083602.2(PTCH1):c.2564_2567dup (p.Thr858fs)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	VCV000428822	9	98222003 - 98222004	9	95459721 - 95459722	428822	420468	rs1131690972	NC_000009.12:95459721:TAGAT:TAGATAGAT
NM_001083602.2(PTCH1):c.2829C>A (p.Tyr943Ter)	PTCH1	Y1009*, Y943*, Y1008*, Y957*, Y858*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	VCV000428821	9	98220436	9	95458154	428821	420466	rs747234651	NC_000009.12:95458153:G:T
NM_001083602.2(PTCH1):c.517dup (p.Ala173fs)	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2013)	criteria provided, single submitter	VCV000428820	9	98244261 - 98244262	9	95481979 - 95481980	428820	420490	rs1131690971	NC_000009.12:95481979:CCCC:CCCCC
NM_001083602.2(PTCH1):c.824T>A (p.Leu275Ter)	PTCH1	L275*, L341*, L190*, L340*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000428819	9	98242296	9	95480014	428819	420483	rs1131690970	NC_000009.12:95480013:A:T
NM_001083602.2(PTCH1):c.96C>A (p.Cys32Ter)	PTCH1	C32*, C98*, C97*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	VCV000428816	9	98268789	9	95506507	428816	420498	rs1131690968	NC_000009.12:95506506:G:T
NM_001083602.2(PTCH1):c.3142A>T (p.Arg1048Trp)	PTCH1	R1048W, R1114W, R963W, R1062W, R1113W	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000008220	9	98215869	9	95453587	8220	23259	rs587776689	NC_000009.12:95453586:T:A
PTCH1, PRO-SER, 451C-T	PTCH1		Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000008219					8219	23258		
NM_000264.5(PTCH1):c.3150del (p.Trp1051fs)	PTCH1	W1050fs, W1051fs, W985fs, W900fs, W999fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000822998	9	98220313	9	95458031	822998	809556		NC_000009.12:95458030:GGGG:GGG
NM_001083602.2(PTCH1):c.1405-2A>C	PTCH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000486220	9	98238443	9	95476161	486220	474949	rs1064793921	NC_000009.12:95476160:T:G
NM_002485.4(NBN):c.1635_1636del (p.Arg546fs)	NBN	R464fs, R546fs	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000618749	8	90965681 - 90965682	8	89953453 - 89953454	618749	609703	rs1563526063	NC_000008.11:89953452:TT:
NM_002485.4(NBN):c.974del (p.Pro325fs)	NBN	P243fs, P325fs	not provided	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000545874	8	90976658	8	89964430	545874	536340	rs1554562110	NC_000008.11:89964429:GG:G
NM_002485.4(NBN):c.702+1G>T	NBN		not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000419245	8	90983400	8	89971172	419245	407477	rs1057517104	NC_000008.11:89971171:C:A
NM_002485.4(NBN):c.325G>T (p.Glu109Ter)	NBN	E109*, E27*	not provided	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000418371	8	90993117	8	89980889	418371	407488	rs587780096	NC_000008.11:89980888:C:A
NM_002485.5(NBN):c.827del (p.Thr276fs)	NBN	T194fs, T276fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000827555	8	90982661	8	89970433	827555	809265		NC_000008.11:89970432:G:
NM_002485.5(NBN):c.672del (p.Thr226fs)	NBN	T226fs, T144fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000826585	8	90983431	8	89971203	826585	809270		NC_000008.11:89971202:CCC:CC
NM_002485.5(NBN):c.589dup (p.Tyr197fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000826039	8	90983513 - 90983514	8	89971285 - 89971286	826039	809274		NC_000008.11:89971285:AAAAA:AAAAAA
NM_002485.5(NBN):c.563dup (p.Gln189fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000825865	8	90990468 - 90990469	8	89978240 - 89978241	825865	809277		NC_000008.11:89978240:TT:TTT
NM_002485.5(NBN):c.552_568dup (p.Pro190fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000825802	8	90990463 - 90990464	8	89978235 - 89978236	825802	809275		NC_000008.11:89978235:GCTGCTTCTTGGACTCA:GCTGCTTCTTGGACTCAGCTGCTTCTTGGACTCA
NM_002485.5(NBN):c.492dup (p.Leu165fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000825298	8	90990539 - 90990540	8	89978311 - 89978312	825298	809283		NC_000008.11:89978311:T:TT
NM_002485.5(NBN):c.320G>A (p.Arg107Lys)	NBN	R107K, R25K	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000823200	8	90993603	8	89981375	823200	809292		NC_000008.11:89981374:C:T
NM_002485.5(NBN):c.880_886del (p.Met294fs)	NBN	M294fs, M212fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000822753	8	90982602 - 90982608	8	89970374 - 89970380	822753	809259		NC_000008.11:89970373:TATCCATTAT:TAT
NM_002485.5(NBN):c.1146del (p.Glu383fs)	NBN	E301fs, E383fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000822251	8	90967762	8	89955534	822251	809240		NC_000008.11:89955533:TTTT:TTT
NM_002485.5(NBN):c.1048G>T (p.Glu350Ter)	NBN	E268*, E350*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000822047	8	90971029	8	89958801	822047	809245		NC_000008.11:89958800:C:A
NM_002485.5(NBN):c.1478_1479CA[1] (p.Gln494fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000819332	8	90965836 - 90965837	8	89953608 - 89953609	819332	809223		NC_000008.11:89953607:TGTGT:TGT
NM_002485.5(NBN):c.1259del (p.Thr420fs)	NBN	T420fs, T338fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000818728	8	90967649	8	89955421	818728	809234		NC_000008.11:89955420:G:
NM_002485.5(NBN):c.1089C>G (p.Tyr363Ter)	NBN	Y363*, Y281*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000818355	8	90970988	8	89958760	818355	809242		NC_000008.11:89958759:G:C
NM_002485.4(NBN):c.871C>T (p.Gln291Ter)	NBN	Q291*, Q209*	Premature ovarian insufficiency	Pathogenic(Last reviewed: Jan 15, 2017)	no assertion criteria provided	VCV000495048	8	90982617	8	89970389	495048	486603	rs1554563822	NC_000008.11:89970388:G:A
NM_002485.4(NBN):c.2041C>T (p.Gln681Ter)	NBN	Q681*, Q599*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000485928	8	90958397	8	89946169	485928	474701	rs1554556485	NC_000008.11:89946168:G:A
NM_002485.4(NBN):c.535_537delinsT (p.Glu179fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000483971	8	90990495 - 90990497	8	89978267 - 89978269	483971	474794	rs1554566678	NC_000008.11:89978266:TTC:A
NM_002485.4(NBN):c.1583del (p.Asp527_Leu528insTer)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000483964	8	90965734	8	89953506	483964	474860	rs1554558406	NC_000008.11:89953505:AAA:AA
NM_002485.4(NBN):c.1612_1696del (p.Lys538fs)	NBN	K456fs, K538fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000483958	8	90965621 - 90965705	8	89953393 - 89953477	483958	474745	rs1554558319	
NM_002485.4(NBN):c.1124G>A (p.Trp375Ter)	NBN	W375*, W293*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000483949	8	90970953	8	89958725	483949	474950	rs1394437421	NC_000008.11:89958724:C:T
NM_002485.4(NBN):c.1554dup (p.Asp519fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000483945	8	90965762 - 90965763	8	89953534 - 89953535	483945	474735	rs1554558423	NC_000008.11:89953534:T:TT
NM_002485.4(NBN):c.844dup (p.Ile282fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000481848	8	90982643 - 90982644	8	89970415 - 89970416	481848	474806	rs1554563861	NC_000008.11:89970415:TT:TTT
NM_002485.4(NBN):c.328del (p.Tyr110fs)	NBN	Y110fs, Y28fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000481844	8	90993114	8	89980886	481844	474999	rs1554568029	NC_000008.11:89980885:A:
NM_002485.4(NBN):c.1940del (p.Ser647fs)	NBN	S565fs, S647fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000480040	8	90958498	8	89946270	480040	474708	rs1554556587	NC_000008.11:89946269:C:
NM_001024688.2(NBN):c.-222dup	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	VCV000480025	8	90995045 - 90995046	8	89982817 - 89982818	480025	475016	rs1199711768	NC_000008.11:89982817:AA:AAA
NM_001024688.2(NBN):c.654_678del (p.Gly219fs)	NBN	G219fs, G301fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000375604	8	90976708 - 90976732	8	89964480 - 89964504	375604	362418	rs1057519587	NC_000008.11:89964479:TGCTTCAGGAATAGGTCTAAGACCTTGC:TGC
NM_002485.4(NBN):c.681del (p.Phe227fs)	NBN	F145fs, F227fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000375602	8	90983422	8	89971194	375602	362415	rs1057519586	NC_000008.11:89971193:AAA:AA
NM_002485.4(NBN):c.1040C>G (p.Ser347Ter)	NBN	S347*, S265*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 9, 2015)	criteria provided, single submitter	VCV000233253	8	90971037	8	89958809	233253	233671	rs876660290	NC_000008.11:89958808:G:C
NM_001024688.2(NBN):c.-242_-241del	NBN	L19fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000231696	8	90995065 - 90995066	8	89982837 - 89982838	231696	233722	rs876659305	NC_000008.11:89982836:AAAA:AA
NM_002485.4(NBN):c.2056A>T (p.Lys686Ter)	NBN	K686*, K604*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2014)	criteria provided, single submitter	VCV000187686	8	90958382	8	89946154	187686	182834	rs786203920	NC_000008.11:89946153:T:A
NM_002485.4(NBN):c.1986_1999del (p.Val663fs)	NBN	V581fs, V663fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000142701	8	90958439 - 90958452	8	89946211 - 89946224	142701	152415	rs587782653	NC_000008.11:89946210:AGTTTTTAATCACCAGT:AGT
NM_002485.4(NBN):c.1550dup (p.Asn517fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2013)	criteria provided, single submitter	VCV000142262	8	90965766 - 90965767	8	89953538 - 89953539	142262	151976	rs587782344	NC_000008.11:89953538:TTT:TTTT
NM_001024688.2(NBN):c.-64del	NBN	D61fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000141966	8	90993740	8	89981512	141966	151680	rs587782147	NC_000008.11:89981511:A:
NM_001083602.2(PTCH1):c.196+1G>A	PTCH1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428849	9	98268688	9	95506406	428849	420495	rs1131690995	NC_000009.12:95506405:C:T
NM_001083602.2(PTCH1):c.2525T>G (p.Val842Gly)	PTCH1	V908G, V842G, V856G, V907G, V757G	Holoprosencephaly 7	Pathogenic(Last reviewed: Dec 15, 2007)	no assertion criteria provided	VCV000008225	9	98222046	9	95459764	8225	23264	rs199476093	NC_000009.12:95459763:A:C
NM_002485.5(NBN):c.2173C>T (p.Gln725Ter)	NBN	Q643*, Q725*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000864166	8	90955492	8	89943264	864166	835091		NC_000008.11:89943263:G:A
NM_002485.5(NBN):c.877del (p.Ser292_Ile293insTer)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000861544	8	90982611	8	89970383	861544	835130		NC_000008.11:89970382:TT:T
NM_002485.5(NBN):c.604G>T (p.Glu202Ter)	NBN	E120*, E202*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000861347	8	90983499	8	89971271	861347	835135		NC_000008.11:89971270:C:A
NM_002485.5(NBN):c.2140_2143del (p.Lys715fs)	NBN	K633fs, K715fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000860347	8	90955522 - 90955525	8	89943294 - 89943297	860347	835093		NC_000008.11:89943293:TTCG:
NM_002485.5(NBN):c.429G>A (p.Trp143Ter)	NBN	W61*, W143*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000856035	8	90993013	8	89980785	856035	835137		NC_000008.11:89980784:C:T
NM_002485.5(NBN):c.1645A>T (p.Lys549Ter)	NBN	K549*, K467*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000855637	8	90965672	8	89953444	855637	835108		NC_000008.11:89953443:T:A
NM_002485.5(NBN):c.1496C>G (p.Ser499Ter)	NBN	S417*, S499*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000852729	8	90965821	8	89953593	852729	835113		NC_000008.11:89953592:G:C
NM_002485.5(NBN):c.1203_1206dup (p.Val403fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000851009	8	90967701 - 90967702	8	89955473 - 89955474	851009	835123		NC_000008.11:89955473:AGTG:AGTGAGTG
NM_002485.5(NBN):c.2102del (p.His701fs)	NBN	H619fs, H701fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000848085	8	90955563	8	89943335	848085	835098		NC_000008.11:89943334:T:
NM_002485.5(NBN):c.2140del (p.Arg714fs)	NBN	R714fs, R632fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000839680	8	90955525	8	89943297	839680	835094		NC_000008.11:89943296:G:
NC_000008.11:g.(?_89935582)_(89984561_?)del	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000833016	8	90947810 - 90996789			833016	819994		
NC_000008.11:g.(?_89978210)_(89984571_?)del	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000832956	8	90990438 - 90996799			832956	819999		
NC_000008.11:g.(?_89980724)_(89984571_?)del	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000832539	8	90992952 - 90996799			832539	820000		
NM_002485.4(NBN):c.1253C>A (p.Ser418Ter)	NBN	S418*, S336*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000661854	8	90967655	8	89955427	661854	637452		NC_000008.11:89955426:G:T
NM_002485.4(NBN):c.1787_1788insC (p.Ile597fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000660563	8	90965529 - 90965530	8	89953301 - 89953302	660563	637426		NC_000008.11:89953301::G
NM_002485.5(NBN):c.1332dup (p.Arg445Ter)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000660286	8	90967575 - 90967576	8	89955347 - 89955348	660286	637450		NC_000008.11:89955347:A:AA
NM_002485.5(NBN):c.1697dup (p.Leu566fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000658743	8	90965619 - 90965620	8	89953391 - 89953392	658743	637431		NC_000008.11:89953391:AA:AAA
NM_002485.5(NBN):c.1780del (p.Arg594fs)	NBN	R512fs, R594fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000656516	8	90965537	8	89953309	656516	637428		NC_000008.11:89953308:TT:T
NM_002485.4(NBN):c.250C>T (p.Gln84Ter)	NBN	Q84*, Q2*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000649395	8	90993673	8	89981445	649395	637476		NC_000008.11:89981444:G:A
NM_002485.4(NBN):c.966C>G (p.Tyr322Ter)	NBN	Y240*, Y322*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000649280	8	90976666	8	89964438	649280	637458		NC_000008.11:89964437:G:C
NM_002485.5(NBN):c.231dup (p.Val78fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000645512	8	90993691 - 90993692	8	89981463 - 89981464	645512	637478		NC_000008.11:89981463:AAA:AAAA
NM_002485.4(NBN):c.1327A>T (p.Lys443Ter)	NBN	K361*, K443*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000645490	8	90967581	8	89955353	645490	637451		NC_000008.11:89955352:T:A
NM_002485.5(NBN):c.499dup (p.Cys167fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000643026	8	90990532 - 90990533	8	89978304 - 89978305	643026	637469		NC_000008.11:89978304:AAA:AAAA
NM_002485.4(NBN):c.241G>T (p.Glu81Ter)	NBN	E81*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000641301	8	90993682	8	89981454	641301	637477		NC_000008.11:89981453:C:A
NM_002485.4(NBN):c.1693C>T (p.Gln565Ter)	NBN	Q565*, Q483*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000639322	8	90965624	8	89953396	639322	637432		NC_000008.11:89953395:G:A
NM_002485.4(NBN):c.448del (p.Val151fs)	NBN	V151fs, V69fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2018)	criteria provided, single submitter	VCV000631145	8	90992994	8	89980766	631145	617490	rs1563578727	NC_000008.11:89980765:GG:G
NM_002485.5(NBN):c.844del (p.Ile282fs)	NBN	I282fs, I200fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000630956	8	90982644	8	89970416	630956	617477	rs1554563861	NC_000008.11:89970415:TT:T
NM_002485.4(NBN):c.266_270dup (p.Leu91fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000628943	8	90993652 - 90993653	8	89981424 - 89981425	628943	617497	rs1563580865	NC_000008.11:89981424:AGTTC:AGTTCAGTTC
NM_002485.5(NBN):c.1029dup (p.Gln344fs)	NBN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000628054	8	90971047 - 90971048	8	89958819 - 89958820	628054	617471	rs1563539146	NC_000008.11:89958819:T:TT
NM_002485.4(NBN):c.1675dup (p.Glu559fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000577083	8	90965641 - 90965642	8	89953413 - 89953414	577083	565239	rs1563525678	NC_000008.11:89953413:C:CC
NM_002485.4(NBN):c.468del (p.Val157fs)	NBN	V157fs, V75fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000577077	8	90992974	8	89980746	577077	565269	rs1563578596	NC_000008.11:89980745:TTT:TT
NM_002485.4(NBN):c.872dup (p.Ser292fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000576309	8	90982615 - 90982616	8	89970387 - 89970388	576309	568168	rs1563559078	NC_000008.11:89970387:T:TT
NM_002485.4(NBN):c.1737del (p.Val580fs)	NBN	V580fs, V498fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000575328	8	90965580	8	89953352	575328	562512	rs1563525210	NC_000008.11:89953351:TTT:TT
NM_002485.4(NBN):c.222T>G (p.Tyr74Ter)	NBN	Y74*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000574500	8	90993701	8	89981473	574500	568239	rs1563581193	NC_000008.11:89981472:A:C
NM_002485.4(NBN):c.1769del (p.Arg590fs)	NBN	R508fs, R590fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000572817	8	90965548	8	89953320	572817	568128	rs1563525004	NC_000008.11:89953319:C:
NM_002485.4(NBN):c.911del (p.Pro304fs)	NBN	P304fs, P222fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000570010	8	90976721	8	89964493	570010	563132	rs1563549036	NC_000008.11:89964492:GG:G
NM_002485.4(NBN):c.474del (p.Ile159fs)	NBN	I77fs, I159fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000569322	8	90992968	8	89980740	569322	563139	rs1563578540	NC_000008.11:89980739:GG:G
NM_002485.4(NBN):c.1526dup (p.Ser509_Glu510insTer)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000566863	8	90965790 - 90965791	8	89953562 - 89953563	566863	568149	rs1563526747	NC_000008.11:89953562:G:GG
NM_002485.4(NBN):c.1654dup (p.Glu552fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000530754	8	90965662 - 90965663	8	89953434 - 89953435	530754	524351	rs760237820	NC_000008.11:89953434:CCC:CCCC
NM_002485.4(NBN):c.1154_1155del (p.Lys385fs)	NBN	K385fs, K303fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000530740	8	90967753 - 90967754	8	89955525 - 89955526	530740	524051	rs748513310	NC_000008.11:89955524:TTT:T
NM_002485.4(NBN):c.1750G>T (p.Glu584Ter)	NBN	E584*, E502*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000530738	8	90965567	8	89953339	530738	524341	rs1554558270	NC_000008.11:89953338:C:A
NM_002485.4(NBN):c.377del (p.Thr126fs)	NBN	T126fs, T44fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000530729	8	90993065	8	89980837	530729	523754	rs1554567972	NC_000008.11:89980836:G:
NM_002485.4(NBN):c.496_512del (p.Ile166fs)	NBN	I166fs, I84fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000530724	8	90990520 - 90990536	8	89978292 - 89978308	530724	524389	rs758830069	NC_000008.11:89978291:ATTGGACGTCCACAAAT:
NM_002485.4(NBN):c.2188C>T (p.Gln730Ter)	NBN	Q730*, Q648*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000530714	8	90949300	8	89937072	530714	523712	rs1554554267	NC_000008.11:89937071:G:A
NM_002485.4(NBN):c.574C>T (p.Gln192Ter)	NBN	Q192*, Q110*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2017)	criteria provided, single submitter	VCV000492123	8	90990458	8	89978230	492123	484243	rs1554566613	NC_000008.11:89978229:G:A
NM_002485.4(NBN):c.565C>T (p.Gln189Ter)	NBN	Q189*, Q107*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000492121	8	90990467	8	89978239	492121	484096	rs1198614767	NC_000008.11:89978238:G:A
NM_002485.4(NBN):c.1186del (p.Leu396fs)	NBN	L396fs, L314fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000492084	8	90967722	8	89955494	492084	484203	rs1554559314	NC_000008.11:89955493:G:
NM_002485.4(NBN):c.1150del (p.Ile384fs)	NBN	I384fs, I302fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 24, 2017)	criteria provided, single submitter	VCV000492082	8	90967758	8	89955530	492082	484208	rs1554559348	NC_000008.11:89955529:TTT:TT
NM_002485.4(NBN):c.836del (p.Gln279fs)	NBN	Q197fs, Q279fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000461583	8	90982652	8	89970424	461583	458070	rs1554563878	NC_000008.11:89970423:T:
NM_001024688.2(NBN):c.-21dup	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000461551	8	90993696 - 90993697	8	89981468 - 89981469	461551	458698	rs1554568340	NC_000008.11:89981468:T:TT
NM_002485.4(NBN):c.2083G>T (p.Gly695Ter)	NBN	G695*, G613*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000461538	8	90955582	8	89943354	461538	458011	rs1554555835	NC_000008.11:89943353:C:A
NM_002485.4(NBN):c.1377dup (p.Gln460fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000461506	8	90967530 - 90967531	8	89955302 - 89955303	461506	458599	rs1554559028	NC_000008.11:89955302:AAA:AAAA
NC_000008.10:g.(?_90992962)_(90996899_?)del	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000417563	8	90992962 - 90996899	8	89980734 - 89984671	417563	396518		
NM_001024688.2(NBN):c.-271del	NBN	G9fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000411783	8	90996764	8	89984536	411783	396352	rs1060503485	NC_000008.11:89984535:CCC:CC
NM_002485.4(NBN):c.1647_1651del (p.Lys550fs)	NBN	K550fs, K468fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000411776	8	90965666 - 90965670	8	89953438 - 89953442	411776	396956	rs766044684	NC_000008.11:89953437:TTTTTTT:TT
NM_002485.4(NBN):c.1553C>G (p.Ser518Ter)	NBN	S518*, S436*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000411775	8	90965764	8	89953536	411775	396298	rs1060503480	NC_000008.11:89953535:G:C
NM_001024688.2(NBN):c.790_791GT[3] (p.Ser265fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000411753	8	90971037 - 90971038	8	89958809 - 89958810	411753	396606	rs1554560432	NC_000008.11:89958809:ACAC:ACACAC
NM_002485.4(NBN):c.383T>G (p.Leu128Ter)	NBN	L128*, L46*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000411751	8	90993059	8	89980831	411751	396632	rs1060503463	NC_000008.11:89980830:A:C
NM_002485.4(NBN):c.1125G>A (p.Trp375Ter)	NBN	W375*, W293*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000375605	8	90967783	8	89955555	375605	362414	rs1057519588	NC_000008.11:89955554:C:T
NM_002485.4(NBN):c.330T>G (p.Tyr110Ter)	NBN	Y110*, Y28*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000375601	8	90993112	8	89980884	375601	362416	rs1057519585	NC_000008.11:89980883:A:C
NM_002485.4(NBN):c.897-?_2184+?del	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Apr 24, 2016)	criteria provided, single submitter	VCV000216087	8	90955481 - 90976735	8	89943253 - 89964507	216087	212625		
NM_002485.4(NBN):c.2165G>A (p.Trp722Ter)	NBN	W722*, W640*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000188259	8	90955500	8	89943272	188259	186092	rs786204181	NC_000008.11:89943271:C:T
NM_002485.4(NBN):c.1958dup (p.Leu654fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000461532	8	90958479 - 90958480	8	89946251 - 89946252	461532	458015	rs780235686	NC_000008.11:89946251:TTTTTT:TTTTTTT
NM_002485.4(NBN):c.2161G>T (p.Glu721Ter)	NBN	E721*, E639*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000422497	8	90955504	8	89943276	422497	407459	rs1064795816	NC_000008.11:89943275:C:A
NM_002485.4(NBN):c.265C>T (p.Arg89Ter)	NBN	R89*, R7*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370213	8	90993658	8	89981430	370213	357670	rs1057516320	NC_000008.11:89981429:G:A
NM_002485.4(NBN):c.817dup (p.Thr273fs)	NBN		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000182702	8	90982670 - 90982671	8	89970442 - 89970443	182702	180295	rs730881839	NC_000008.11:89970442:T:TT
NM_001024688.2(NBN):c.596dup (p.Leu199fs)	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000006943	8	90982645 - 90982646	8	89970417 - 89970418	6943	21982	rs864309669	NC_000008.11:89970417:AA:AAA
NM_002485.4(NBN):c.836_839del (p.Gln279fs)	NBN	Q279fs, Q197fs	Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000006942	8	90982649 - 90982652	8	89970421 - 89970424	6942	21981	rs864309668	NC_000008.11:89970420:GTCTGT:GT
NM_000264.5(PTCH1):c.1350del (p.Ala451fs)	PTCH1	A300fs, A451fs, A385fs, A450fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000818931	9	98239982	9	95477700	818931	809614		NC_000009.12:95477699:G:
NM_000264.5(PTCH1):c.808A>T (p.Lys270Ter)	PTCH1	K119*, K204*, K270*, K269*	Gorlin syndrome	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000807475	9	98242809	9	95480527	807475	798623		NC_000009.12:95480526:T:A
NM_000264.5(PTCH1):c.3281_3282dup (p.Glu1095fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802501	9	98218581 - 98218582	9	95456299 - 95456300	802501	790930		NC_000009.12:95456299:CAC:CACAC
NM_001083602.2(PTCH1):c.92del (p.Asn31fs)	PTCH1	N31fs, N96fs, N97fs	Gorlin syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488582	9	98268793	9	95506511	488582	481450	rs1554708751	NC_000009.12:95506510:TTTTTTT:TTTTTT
NM_001083602.2(PTCH1):c.2635C>T (p.Arg879Ter)	PTCH1	R879*, R945*, R794*, R944*, R893*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000420053	9	98221936	9	95459654	420053	407780	rs1064794260	NC_000009.12:95459653:G:A
NM_004260.4(RECQL4):c.1391-2A>G	RECQL4		Baller-Gerold syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000857592	8	145740628	8	144515244	857592	851187		NC_000008.11:144515243:T:C
NM_004260.4(RECQL4):c.1038_1039del (p.Arg347fs)	RECQL4	R347fs	Baller-Gerold syndrome|Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|Rapadilino syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804413	8	145741464 - 145741465	8	144516080 - 144516081	804413	792772		NC_000008.11:144516079:GGG:G
NM_004260.4(RECQL4):c.1089C>G (p.Tyr363Ter)	RECQL4	Y363*	Rothmund-Thomson syndrome|Baller-Gerold syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666982	8	145741414	8	144516030	666982	654505		NC_000008.11:144516029:G:C
NM_004260.3(RECQL4):c.2272C>T (p.Arg758Ter)	RECQL4	R758*	Baller-Gerold syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000489031	8	145738793	8	144513409	489031	481812	rs758790200	NC_000008.11:144513408:G:A
NM_004260.3(RECQL4):c.3072_3073del (p.Val1026fs)	RECQL4	V1026fs	not provided|Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000239754	8	145737690 - 145737691	8	144512307 - 144512308	239754	240251	rs771538008	NC_000008.11:144512306:CT:
NM_002485.4(NBN):c.992_994+3del	NBN		Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000581757	8	90976635 - 90976640	8	89964407 - 89964412	581757	563127	rs1563548315	NC_000008.11:89964406:TACCTGTAC:TAC
NM_002485.4(NBN):c.800dup (p.Thr268fs)	NBN		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000545860	8	90982687 - 90982688	8	89970459 - 89970460	545860	536341	rs1554563955	NC_000008.11:89970459:CCC:CCCC
NM_002485.4(NBN):c.1515del (p.Glu505fs)	NBN	E505fs, E423fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484000	8	90965802	8	89953574	484000	474744	rs759232053	NC_000008.11:89953573:C:
NM_002485.4(NBN):c.935T>A (p.Leu312Ter)	NBN	L312*, L230*	Microcephaly, normal intelligence and immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461584	8	90976697	8	89964469	461584	458617	rs371480039	NC_000008.11:89964468:A:T
NM_001024688.2(NBN):c.-35_-32del	NBN	N71fs	Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422213	8	90993708 - 90993711	8	89981480 - 89981483	422213	407493	rs1064795634	NC_000008.11:89981479:GAAT:
NM_001024688.2(NBN):c.-209_-208del	NBN	N30fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000141398	8	90995032 - 90995033	8	89982804 - 89982805	141398	151112	rs587781718	NC_000008.11:89982803:TTTTT:TTT
NM_000162.5(GCK):c.106C>T (p.Arg36Trp)	GCK	R36W, R37W, R35W	Maturity-onset diabetes of the young, type 2|Maturity onset diabetes mellitus in young|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431973	7	44193002	7	44153403	431973	425758	rs762263694	NC_000007.14:44153402:G:A
NM_001287174.2(ABCC8):c.4519G>A (p.Glu1507Lys)	ABCC8	E1506K, E1507K, E1505K, E1528K	Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009097	11	17415842	11	17394295	9097	24136	rs137852671	NC_000011.10:17394294:C:T
NM_000264.5(PTCH1):c.3850C>T (p.Gln1284Ter)	PTCH1	Q1284*, Q1232*, Q1283*, Q1218*, Q1133*	Gorlin syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000858666	9	98209688	9	95447406	858666	836361		NC_000009.12:95447405:G:A
NM_000264.5(PTCH1):c.250_251del (p.Gln84fs)	PTCH1	Q83fs, Q18fs, Q84fs	Gorlin syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000857987	9	98268832 - 98268833	9	95506550 - 95506551	857987	836442		NC_000009.12:95506549:TG:
NM_000264.5(PTCH1):c.3944_3945insT (p.Tyr1316fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000855009	9	98209593 - 98209594	9	95447311 - 95447312	855009	836358		NC_000009.12:95447311::A
NM_000264.5(PTCH1):c.3525_3529del (p.Leu1175fs)	PTCH1	L1109fs, L1123fs, L1174fs, L1024fs, L1175fs	Gorlin syndrome	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000848279	9	98212143 - 98212147	9	95449861 - 95449865	848279	836371		NC_000009.12:95449860:AAGACAA:AA
NM_000264.5(PTCH1):c.681_684del (p.Ile228fs)	PTCH1	I228fs, I77fs, I162fs, I227fs	Gorlin syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000846378	9	98244293 - 98244296	9	95482011 - 95482014	846378	836433		NC_000009.12:95482010:AATCAA:AA
NM_000264.5(PTCH1):c.2723_2724del (p.Val908fs)	PTCH1	V907fs, V908fs, V842fs, V856fs, V757fs	Gorlin syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000843674	9	98222045 - 98222046	9	95459763 - 95459764	843674	836393		NC_000009.12:95459762:CAC:C
NM_000264.5(PTCH1):c.347T>A (p.Leu116Ter)	PTCH1	L50*, L115*, L116*	Gorlin syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000841309	9	98268736	9	95506454	841309	836437		NC_000009.12:95506453:A:T
NM_000264.5(PTCH1):c.1151del (p.His384fs)	PTCH1	H233fs, H318fs, H384fs, H383fs	Gorlin syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000839078	9	98241346	9	95479064	839078	836422		NC_000009.12:95479063:T:
NM_000264.5(PTCH1):c.724C>T (p.Gln242Ter)	PTCH1	Q176*, Q241*, Q242*, Q91*	Gorlin syndrome	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000837425	9	98244253	9	95481971	837425	836431		NC_000009.12:95481970:G:A
NM_000264.5(PTCH1):c.452_464del (p.Ala151fs)	PTCH1	A85fs, A150fs, A151fs, M1fs	Gorlin syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000836837	9	98248087 - 98248099	9	95485805 - 95485817	836837	836435		NC_000009.12:95485804:GGATTAAACATAG:
NM_000264.5(PTCH1):c.289_290del (p.Asn97fs)	PTCH1	N31fs, N97fs, N96fs	Gorlin syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000835447	9	98268793 - 98268794	9	95506511 - 95506512	835447	836440		NC_000009.12:95506510:TTTTTTT:TTTTT
NM_001083602.2(PTCH1):c.3477T>A (p.Tyr1159Ter)	PTCH1	Y1225*, Y1173*, Y1074*, Y1159*, Y1224*	Gorlin syndrome	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000664486	9	98211480	9	95449198	664486	638480		NC_000009.12:95449197:A:T
NM_000264.5(PTCH1):c.1128del (p.Phe376fs)	PTCH1	F225fs, F375fs, F310fs, F376fs	Gorlin syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000658125	9	98241369	9	95479087	658125	638560		NC_000009.12:95479086:G:
NM_001083602.2(PTCH1):c.1027C>T (p.Gln343Ter)	PTCH1	Q343*, Q409*, Q258*, Q408*	Gorlin syndrome	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000656716	9	98240459	9	95478177	656716	638555		NC_000009.12:95478176:G:A
NM_001083602.2(PTCH1):c.2767G>T (p.Glu923Ter)	PTCH1	E988*, E923*, E937*, E989*, E838*	Gorlin syndrome	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000653436	9	98220498	9	95458216	653436	638503		NC_000009.12:95458215:C:A
NM_001083602.2(PTCH1):c.53_60del (p.Gln18fs)	PTCH1	Q84fs, Q18fs, Q83fs	Gorlin syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000651867	9	98268825 - 98268832	9	95506543 - 95506550	651867	638579		NC_000009.12:95506542:GAGTCTCTGA:GA
NM_001083602.2(PTCH1):c.3252-2_3285del	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000651497	9	98212189 - 98212224	9	95449907 - 95449942	651497	651975		NC_000009.12:95449906:GATGGTGAGGATCGCCAGCACAGCAAAGAAATACCTG:G
NM_000264.5(PTCH1):c.961del (p.Val322fs)	PTCH1	V256fs, V321fs, V322fs, V171fs	Gorlin syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000648714	9	98242357	9	95480075	648714	638566		NC_000009.12:95480074:GGG:GG
NM_001083602.2(PTCH1):c.804T>G (p.Tyr268Ter)	PTCH1	Y183*, Y334*, Y268*, Y333*	Gorlin syndrome	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000645694	9	98242316	9	95480034	645694	638563		NC_000009.12:95480033:A:C
NM_001083602.2(PTCH1):c.963G>A (p.Trp321Ter)	PTCH1	W321*, W386*, W236*, W387*	Gorlin syndrome	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000644903	9	98241336	9	95479054	644903	638558		NC_000009.12:95479053:C:T
NM_001083602.2(PTCH1):c.772_778del (p.Asn258fs)	PTCH1	N323fs, N324fs, N258fs, N173fs	Gorlin syndrome	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000644877	9	98242342 - 98242348	9	95480060 - 95480066	644877	638564		NC_000009.12:95480059:CACCATTCA:CA
NM_000264.5(PTCH1):c.3287dup (p.Thr1097fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000643365	9	98218576 - 98218577	9	95456294 - 95456295	643365	638493		NC_000009.12:95456294:AA:AAA
NM_000264.5(PTCH1):c.1625dup (p.Arg543fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000643017	9	98238418 - 98238419	9	95476136 - 95476137	643017	638544		NC_000009.12:95476136:TT:TTT
NM_001083602.2(PTCH1):c.2604T>G (p.Tyr868Ter)	PTCH1	Y868*, Y934*, Y882*, Y933*, Y783*	Gorlin syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000582760	9	98221967	9	95459685	582760	569264	rs1356231878	NC_000009.12:95459684:A:C
NM_001083602.2(PTCH1):c.454dup (p.Gln152fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000580728	9	98244417 - 98244418	9	95482135 - 95482136	580728	569313	rs1564058147	NC_000009.12:95482135:G:GG
NM_001083602.2(PTCH1):c.429del (p.Ile144fs)	PTCH1	I209fs, I144fs, I210fs, I59fs	Gorlin syndrome	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000580040	9	98244443	9	95482161	580040	566061	rs1564058222	NC_000009.12:95482160:AA:A
NM_001083602.2(PTCH1):c.381C>A (p.Tyr127Ter)	PTCH1	Y193*, Y127*, Y42*, Y192*	Gorlin syndrome	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000578127	9	98247972	9	95485690	578127	566062	rs1333346461	NC_000009.12:95485689:G:T
NM_001083602.2(PTCH1):c.98del (p.Gly33fs)	PTCH1	G33fs, G98fs, G99fs	Gorlin syndrome	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000577984	9	98268787	9	95506505	577984	563442	rs1564088181	NC_000009.12:95506504:CC:C
NM_001083602.2(PTCH1):c.3290del (p.Gly1097fs)	PTCH1	G1012fs, G1111fs, G1163fs, G1097fs, G1162fs	Gorlin syndrome	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000576630	9	98212184	9	95449902	576630	569250	rs1564009755	NC_000009.12:95449901:CC:C
NM_001083602.2(PTCH1):c.740C>G (p.Ser247Ter)	PTCH1	S247*, S313*, S162*, S312*	Gorlin syndrome	Pathogenic(Last reviewed: Mar 4, 2018)	criteria provided, single submitter	VCV000576491	9	98242679	9	95480397	576491	564323	rs1564055259	NC_000009.12:95480396:G:C
NM_001083602.2(PTCH1):c.1155_1158dup (p.Ala387fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000576308	9	98239975 - 98239976	9	95477693 - 95477694	576308	563413	rs1564050405	NC_000009.12:95477693:ATAG:ATAGATAG
NM_001083602.2(PTCH1):c.992_999del (p.Glu331fs)	PTCH1	E246fs, E397fs, E396fs, E331fs	Gorlin syndrome	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000575234	9	98241300 - 98241307	9	95479018 - 95479025	575234	569291	rs1564053040	NC_000009.12:95479017:CCAGGCCTCCAGG:CCAGG
NM_001083602.2(PTCH1):c.570del (p.Arg189_Trp190insTer)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000575174	9	98242849	9	95480567	575174	564327	rs1564055868	NC_000009.12:95480566:CC:C
NM_001083602.2(PTCH1):c.1011T>G (p.Tyr337Ter)	PTCH1	Y337*, Y403*, Y252*, Y402*	Gorlin syndrome	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000524572	9	98241288	9	95479006	524572	524794	rs1432645175	NC_000009.12:95479005:A:C
NM_001083602.2(PTCH1):c.250G>T (p.Glu84Ter)	PTCH1	E84*, E150*, E149*	Gorlin syndrome	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000524571	9	98248103	9	95485821	524571	525361	rs1344258746	NC_000009.12:95485820:C:A
NM_001083602.2(PTCH1):c.569G>A (p.Trp190Ter)	PTCH1	W190*, W256*, W255*, W105*	Gorlin syndrome	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000524563	9	98242850	9	95480568	524563	525042	rs1554700010	NC_000009.12:95480567:C:T
NM_001083602.2(PTCH1):c.235C>T (p.Gln79Ter)	PTCH1	Q79*, Q145*, Q144*	Gorlin syndrome	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000524548	9	98248118	9	95485836	524548	525205	rs1554702186	NC_000009.12:95485835:G:A
NM_001083602.2(PTCH1):c.417del (p.Lys139fs)	PTCH1	K139fs, K205fs, K204fs, K54fs	Gorlin syndrome	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000524543	9	98244455	9	95482173	524543	525202	rs1554700720	NC_000009.12:95482172:TTT:TT
NM_001083602.2(PTCH1):c.4-16_29del	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000524530	9	98268856 - 98268897	9	95506574 - 95506615	524530	525216	rs1554708795	NC_000009.12:95506573:GGCGCTTTCCGGCCAGTAGCCTTCCCCTGGGGACGAAGCAGA:
NM_001083602.2(PTCH1):c.937dup (p.Tyr313fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000524496	9	98241361 - 98241362	9	95479079 - 95479080	524496	525031	rs1554699216	NC_000009.12:95479079:A:AA
NM_001083602.2(PTCH1):c.723dup (p.Ala242fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000453918	9	98242695 - 98242696	9	95480413 - 95480414	453918	459467	rs1554699837	NC_000009.12:95480413:T:TT
NM_001083602.2(PTCH1):c.404del (p.His135fs)	PTCH1	H200fs, H50fs, H135fs, H201fs	Gorlin syndrome	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000453906	9	98244468	9	95482186	453906	459883	rs1554700742	NC_000009.12:95482185:T:
NM_001083602.2(PTCH1):c.3342_3345delinsTCC (p.Tyr1115fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000453855	9	98212129 - 98212132	9	95449847 - 95449850	453855	459781	rs1554689667	NC_000009.12:95449846:ATAT:GGA
NM_001083602.2(PTCH1):c.3230_3231del (p.Gly1076_Ser1077insTer)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000453851	9	98215780 - 98215781	9	95453498 - 95453499	453851	459782	rs1554690411	NC_000009.12:95453497:AGA:A
NM_001083602.2(PTCH1):c.2927dup (p.Cys977fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	VCV000453841	9	98220337 - 98220338	9	95458055 - 95458056	453841	459796	rs1554691354	NC_000009.12:95458055:A:AA
NM_001083602.2(PTCH1):c.2733_2734insGTAGA (p.Leu912fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000453836	9	98220531 - 98220532	9	95458249 - 95458250	453836	460269	rs1554691423	NC_000009.12:95458249::TCTAC
NM_001083602.2(PTCH1):c.2441del (p.Gly814fs)	PTCH1	G879fs, G880fs, G814fs, G729fs, G828fs	Gorlin syndrome	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000453826	9	98224202	9	95461920	453826	459666	rs1554692266	NC_000009.12:95461919:CC:C
NM_001083602.2(PTCH1):c.2421C>G (p.Tyr807Ter)	PTCH1	Y873*, Y807*, Y821*, Y722*, Y872*	Gorlin syndrome	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000453824	9	98224222	9	95461940	453824	459430	rs1554692291	NC_000009.12:95461939:G:C
NM_001083602.2(PTCH1):c.1511_1523del (p.Leu504fs)	PTCH1	L569fs, L419fs, L504fs, L570fs, L518fs	Gorlin syndrome	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000453796	9	98238323 - 98238335	9	95476041 - 95476053	453796	459838	rs1554697839	NC_000009.12:95476040:GAGAACGCCCGCAGAG:GAG
NM_001083602.2(PTCH1):c.1385dup (p.Asn462fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000453793	9	98239059 - 98239060	9	95476777 - 95476778	453793	459454	rs1554698258	NC_000009.12:95476777:TT:TTT
NM_001083602.2(PTCH1):c.1287del (p.Phe429fs)	PTCH1	F429fs, F495fs, F494fs, F344fs	Gorlin syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000453789	9	98239847	9	95477565	453789	459852	rs1554698531	NC_000009.12:95477564:AAA:AA
NM_001083602.2(PTCH1):c.1109dup (p.Asp370fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000453783	9	98240376 - 98240377	9	95478094 - 95478095	453783	459684	rs1554698800	NC_000009.12:95478094:T:TT
NM_001083602.2(PTCH1):c.2805T>A (p.Tyr935Ter)	PTCH1	Y1001*, Y935*, Y1000*, Y850*, Y949*	Gorlin syndrome	Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000409212	9	98220460	9	95458178	409212	397380	rs1060502298	NC_000009.12:95458177:A:T
NM_001083602.2(PTCH1):c.957del (p.Asn320fs)	PTCH1	N235fs, N385fs, N386fs, N320fs	Gorlin syndrome	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000409211	9	98241342	9	95479060	409211	397017	rs1060502297	NC_000009.12:95479059:G:
NM_001083602.2(PTCH1):c.1110del (p.Asp370fs)	PTCH1	D285fs, D435fs, D436fs, D370fs	Gorlin syndrome	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000409199	9	98240376	9	95478094	409199	397435	rs1060502295	NC_000009.12:95478093:G:
NM_001083602.2(PTCH1):c.510G>A (p.Trp170Ter)	PTCH1	W236*, W170*, W235*, W85*	Gorlin syndrome	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000409184	9	98244269	9	95481987	409184	397247	rs1060502287	NC_000009.12:95481986:C:T
NM_001083602.2(PTCH1):c.1008_1009AT[1] (p.Tyr337fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000409183	9	98241288 - 98241289	9	95479006 - 95479007	409183	397232	rs1060502286	NC_000009.12:95479005:ATAT:AT
NM_001083602.2(PTCH1):c.256_257del (p.Met86fs)	PTCH1	M151fs, M152fs, M1fs, M86fs	Gorlin syndrome	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000409169	9	98248096 - 98248097	9	95485814 - 95485815	409169	397254	rs1060502280	NC_000009.12:95485813:ATA:A
NM_001083602.2(PTCH1):c.2776G>T (p.Glu926Ter)	PTCH1	E926*, E992*, E841*, E940*, E991*	Gorlin syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000409163	9	98220489	9	95458207	409163	397527	rs1060502278	NC_000009.12:95458206:C:A
NM_001083602.2(PTCH1):c.870-2A>T	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000409147	9	98241431	9	95479149	409147	397242	rs1060502271	NC_000009.12:95479148:T:A
NM_001083602.2(PTCH1):c.3262del (p.Ala1088fs)	PTCH1	A1153fs, A1102fs, A1154fs, A1003fs, A1088fs	Gorlin syndrome	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000409127	9	98212212	9	95449930	409127	396963	rs1060502264	NC_000009.12:95449929:C:
NM_001083602.2(PTCH1):c.72_106del (p.Tyr27fs)	PTCH1	Y92fs, Y93fs, Y27fs	Gorlin syndrome	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000220567	9	98268779 - 98268813	9	95506497 - 95506531	220567	221926	rs864622583	NC_000009.12:95506496:AGAACTTGCCGCAGTTTTTTTGAATGTAACAACCCAG:AG
NM_001083602.2(PTCH1):c.1131del (p.Ser378fs)	PTCH1	S444fs, S378fs, S293fs, S443fs	Gorlin syndrome	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000220079	9	98240355	9	95478073	220079	221917	rs864622374	NC_000009.12:95478072:GG:G
GRCh37/hg19 9q22.32(chr9:98207091-98210940)x1	PTCH1		Gorlin syndrome	Pathogenic	criteria provided, single submitter	VCV000217297	9	98207091 - 98210940	9	95444809 - 95448658	217297	213948		
NM_001083602.2(PTCH1):c.1393_1403del (p.Ile465fs)	PTCH1	I380fs, I479fs, I465fs, I531fs, I530fs	Gorlin syndrome	Pathogenic	criteria provided, single submitter	VCV000217296	9	98239042 - 98239052	9	95476760 - 95476770	217296	213946	rs863225055	NC_000009.12:95476759:TCAAAAGGGATTC:TC
NM_001083602.2(PTCH1):c.1304A>G (p.Gln435Arg)	PTCH1	Q435R, Q501R, Q350R, Q500R	Gorlin syndrome	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000217294	9	98239830	9	95477548	217294	213947	rs863225054	NC_000009.12:95477547:T:C
NM_001083602.2(PTCH1):c.468T>A (p.Tyr156Ter)	PTCH1	Y156*, Y222*, Y71*, Y221*	Gorlin syndrome	Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000216059	9	98244311	9	95482029	216059	212747	rs863224487	NC_000009.12:95482028:A:T
NM_001083602.2(PTCH1):c.414C>G (p.Tyr138Ter)	PTCH1	Y138*, Y204*, Y203*, Y53*	Gorlin syndrome	Pathogenic(Last reviewed: Jun 6, 2015)	criteria provided, single submitter	VCV000216058	9	98244458	9	95482176	216058	212748	rs863224486	NC_000009.12:95482175:G:C
NM_001083602.2(PTCH1):c.2644_2651del (p.Trp882fs)	PTCH1	W947fs, W948fs, W797fs, W882fs, W896fs	Gorlin syndrome	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000216057	9	98221920 - 98221927	9	95459638 - 95459645	216057	212715	rs863224485	NC_000009.12:95459637:TGGACCCAT:T
NM_001083602.2(PTCH1):c.2601del (p.Tyr868fs)	PTCH1	Y783fs, Y868fs, Y934fs, Y882fs, Y933fs	Gorlin syndrome	Pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	VCV000216056	9	98221970	9	95459688	216056	212717	rs863224484	NC_000009.12:95459687:C:
NM_001083602.2(PTCH1):c.747+1G>A	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	VCV000215987	9	98242671	9	95480389	215987	212745	rs863224444	NC_000009.12:95480388:C:T
NM_001083602.2(PTCH1):c.2970+2T>C	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	VCV000188082	9	98220293	9	95458011	188082	186105	rs786204056	NC_000009.12:95458010:A:G
PTCH1, 1-BP DEL, 2583C	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008218					8218	23257		
PTCH1, 1-BP INS, 2000C	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008217					8217	23256		
PTCH1, 2-BP INS, 2047CT	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008216					8216	23255		
PTCH1, 1148G-A	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008215					8215	23254		
PTCH1, 37-BP DEL, NT808	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008214					8214	23253		
PTCH1, 11-BP DEL, NT2442	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008212					8212	23251		
PTCH1, 9-BP INS, CODON 815, PRO-ASN-ILE INS	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000008211					8211	23250		
NM_000553.4(WRN):c.1105C>T (p.Arg369Ter)	WRN	R368*, R369*	Medulloblastoma|Werner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005449	8	30938648	8	31081132	5449	20488	rs17847577	NC_000008.11:31081131:C:T
NM_002485.5(NBN):c.272del (p.Thr90_Leu91insTer)	NBN		Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000821723	8	90993651	8	89981423	821723	809296		NC_000008.11:89981422:AAA:AA
NM_002485.5(NBN):c.584+2T>C	NBN		Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813459	8	90990446	8	89978218	813459	801662		NC_000008.11:89978217:A:G
NM_002485.4(NBN):c.676del (p.Thr226fs)	NBN	T144fs, T226fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580755	8	90983427	8	89971199	580755	568177	rs1563561558	NC_000008.11:89971198:TTTT:TTT
NM_002485.4(NBN):c.1648_1651del (p.Lys550fs)	NBN	K468fs, K550fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000483999	8	90965666 - 90965669	8	89953438 - 89953441	483999	474856	rs766044684	NC_000008.11:89953437:TTTTTTT:TTT
NM_002485.4(NBN):c.917del (p.Pro306fs)	NBN	P306fs, P224fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000483998	8	90976715	8	89964487	483998	474938	rs1554562185	NC_000008.11:89964486:GG:G
NM_001024688.2(NBN):c.-214_-208del	NBN	R28fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000483951	8	90995032 - 90995038	8	89982804 - 89982810	483951	474861	rs1554569106	NC_000008.11:89982803:TTTTTCCTT:TT
NM_001024688.2(NBN):c.345_357delinsTTG (p.Pro116fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481871	8	90983500 - 90983512	8	89971272 - 89971284	481871	474809	rs1554564297	NC_000008.11:89971271:ATCAAGAGGTGGG:CAA
NM_002485.4(NBN):c.1336del (p.Ala446fs)	NBN	A446fs, A364fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481837	8	90967572	8	89955344	481837	474940	rs1554559083	NC_000008.11:89955343:CCC:CC
NM_002485.4(NBN):c.1399G>T (p.Glu467Ter)	NBN	E467*, E385*	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481828	8	90965918	8	89953690	481828	474756	rs1554558613	NC_000008.11:89953689:C:A
NM_002485.4(NBN):c.1171C>T (p.Gln391Ter)	NBN	Q391*, Q309*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480063	8	90967737	8	89955509	480063	474773	rs1554559323	NC_000008.11:89955508:G:A
NM_002485.4(NBN):c.1854_1857del (p.Asn618fs)	NBN	N618fs, N536fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411754	8	90960109 - 90960112	8	89947881 - 89947884	411754	396694	rs1060503466	NC_000008.11:89947880:TTCATT:TT
NM_002485.4(NBN):c.211_212insGA (p.Asn71fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216086	8	90993711 - 90993712	8	89981483 - 89981484	216086	212647	rs762664474	NC_000008.11:89981483:T:TCT
NM_002485.4(NBN):c.105_135del (p.Ile35fs)	NBN	I35fs	Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182703	8	90994986 - 90995016	8	89982758 - 89982788	182703	180306	rs730881840	NC_000008.11:89982757:ATGATTTCGGCTGATCGACTGATCATTTTCAAT:AT
NM_000136.3(FANCC):c.455dup (p.Asn152fs)	FANCC		not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000409657	9	97934319 - 97934320	9	95172037 - 95172038	409657	396906	rs774170058	NC_000009.12:95172037:TTTTT:TTTTTT
NM_138694.4(PKHD1):c.2507T>C (p.Val836Ala)	PKHD1	V836A	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632491	6	51910887	6	52046089	632491	620237	rs199568593	NC_000006.12:52046088:A:G
NM_138694.4(PKHD1):c.9689del (p.Asp3230fs)	PKHD1	D3230fs	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096444	6	51612725	6	51747927	96444	102338	rs398124502	NC_000006.12:51747926:T:
NM_000264.5(PTCH1):c.233G>A (p.Trp78Ter)	PTCH1	W12*, W77*, W78*	Gorlin syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000863310	9	98268850	9	95506568	863310	836444		NC_000009.12:95506567:C:T
NM_000264.5(PTCH1):c.1138G>T (p.Glu380Ter)	PTCH1	E379*, E380*, E314*, E229*	Gorlin syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000862484	9	98241359	9	95479077	862484	836423		NC_000009.12:95479076:C:A
NM_000264.5(PTCH1):c.3039C>A (p.Tyr1013Ter)	PTCH1	Y961*, Y1012*, Y1013*, Y862*, Y947*	Gorlin syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000860922	9	98220424	9	95458142	860922	836381		NC_000009.12:95458141:G:T
NM_000264.5(PTCH1):c.3054G>A (p.Trp1018Ter)	PTCH1	W867*, W1018*, W952*, W1017*, W966*	Gorlin syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000853524	9	98220409	9	95458127	853524	836380		NC_000009.12:95458126:C:T
NM_001083602.2(PTCH1):c.1000C>T (p.Gln334Ter)	PTCH1	Q334*, Q399*, Q249*, Q400*	Gorlin syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000654759	9	98241299	9	95479017	654759	638556		NC_000009.12:95479016:G:A
NM_001083602.2(PTCH1):c.675C>G (p.Tyr225Ter)	PTCH1	Y225*, Y291*, Y140*, Y290*	Gorlin syndrome	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000581926	9	98242744	9	95480462	581926	569312	rs1564055606	NC_000009.12:95480461:G:C
NM_001083602.2(PTCH1):c.1214_1217TGGC[1] (p.Gly407fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000580740	9	98239913 - 98239916	9	95477631 - 95477634	580740	566058	rs1564050178	NC_000009.12:95477630:GCCAGCCAGCC:GCCAGCC
NM_001083602.2(PTCH1):c.1144_1147del (p.Leu382fs)	PTCH1	L297fs, L382fs, L448fs, L447fs	Gorlin syndrome	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000577642	9	98240339 - 98240342	9	95478057 - 95478060	577642	569290	rs1564051237	NC_000009.12:95478056:TGAGT:T
NM_001083602.2(PTCH1):c.1506del (p.Ala503fs)	PTCH1	A418fs, A569fs, A503fs, A517fs, A568fs	Gorlin syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000577436	9	98238340	9	95476058	577436	564290	rs776154605	NC_000009.12:95476057:GGG:GG
NM_001083602.2(PTCH1):c.675del (p.Gly224_Tyr225insTer)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000566404	9	98242744	9	95480462	566404	563429	rs1564055612	NC_000009.12:95480461:G:
NM_001083602.2(PTCH1):c.209dup (p.Ser71fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000562011	9	98248143 - 98248144	9	95485861 - 95485862	562011	553156	rs1564063386	NC_000009.12:95485861:A:AA
NM_001083602.2(PTCH1):c.81del (p.Cys26_Tyr27insTer)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000524575	9	98268804	9	95506522	524575	525207	rs1554708753	NC_000009.12:95506521:G:
NM_001083602.2(PTCH1):c.1453dup (p.Thr485fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000524542	9	98238392 - 98238393	9	95476110 - 95476111	524542	525150	rs1554697928	NC_000009.12:95476110:T:TT
NM_001083602.2(PTCH1):c.54_55GA[1] (p.Arg19fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000524519	9	98268828 - 98268829	9	95506546 - 95506547	524519	525051	rs1554708771	NC_000009.12:95506545:TCTCT:TCT
PTCH1, 1-BP INS, 1247T	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000008226					8226	23265		
NM_001083602.2(PTCH1):c.883C>T (p.Gln295Ter)	PTCH1	Q295*, Q360*, Q361*	Gorlin syndrome	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000008213	9	98241416	9	95479134	8213	23252	rs199476090	NC_000009.12:95479133:G:A
NM_004260.3(RECQL4):c.2464-1G>C	RECQL4		not provided|Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094889	8	145738522	8	144513139	94889	100789	rs398124117	NC_000008.11:144513138:C:G
NM_002485.4(NBN):c.1155dup (p.Val386fs)	NBN		Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000630220	8	90967752 - 90967753	8	89955524 - 89955525	630220	617465	rs748513310	NC_000008.11:89955524:TTT:TTTT
NM_002485.4(NBN):c.7A>T (p.Lys3Ter)	NBN	K3*	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000492131	8	90996783	8	89984555	492131	484024	rs779098734	NC_000008.11:89984554:T:A
NM_002485.4(NBN):c.1366del (p.Arg456fs)	NBN	R456fs, R374fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492090	8	90967542	8	89955314	492090	484197	rs1554559038	NC_000008.11:89955313:T:
NM_001024688.2(NBN):c.-182del	NBN	Q39fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220399	8	90995006	8	89982778	220399	221797	rs864622511	NC_000008.11:89982777:G:
NM_001024688.2(NBN):c.1173_1185dup (p.Cys396fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000219993	8	90965885 - 90965886	8	89953657 - 89953658	219993	221778	rs864622333	NC_000008.11:89953657:TGAAGACATTTCTTGA:TGAAGACATTTCTTGAAGACATTTCTTGA
NM_001024688.2(NBN):c.-206_-205TG[1]	NBN		Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219789	8	90995027 - 90995028	8	89982799 - 89982800	219789	221798	rs864622253	NC_000008.11:89982798:CACA:CA
NM_001278716.2(FBXL4):c.1304G>A (p.Arg435Gln)	FBXL4	R435Q	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430470	6	99347157	6	98899281	430470	421607	rs754142863	NC_000006.12:98899280:C:T
NM_000260.4(MYO7A):c.93C>A (p.Cys31Ter)	MYO7A	C31*, C20*	Rare genetic deafness|Deafness, autosomal recessive 2||Retinitis pigmentosa|Usher syndrome, type 1B	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011859	11	76853829	11	77142783	11859	26898	rs35689081	NC_000011.10:77142782:C:A
NM_017780.4(CHD7):c.6079C>T (p.Arg2027Ter)	CHD7	R2027*	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267435	8	61765241	8	60852682	267435	262660	rs886040995	NC_000008.11:60852681:C:T
NC_000009.12:g.(?_95446912)_(95516818_?)del	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000830750	9	98209194 - 98279100			830750	820180		
NM_001083602.2(PTCH1):c.85C>T (p.Gln29Ter)	PTCH1	Q94*, Q29*, Q95*	Gorlin syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000663028	9	98268800	9	95506518	663028	638578		NC_000009.12:95506517:G:A
NM_001083602.2(PTCH1):c.3252-1G>A	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000661808	9	98212223	9	95449941	661808	652065		NC_000009.12:95449940:C:T
NM_000264.5(PTCH1):c.1364dup (p.Thr456fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000640853	9	98239967 - 98239968	9	95477685 - 95477686	640853	638549		NC_000009.12:95477685:A:AA
NM_001083602.2(PTCH1):c.1150-14_1172del	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000524578	9	98239962 - 98239998	9	95477680 - 95477716	524578	525339	rs1554698613	NC_000009.12:95477679:ATGGTTAGACAGGCATAGGCGAGCTGCAAGCAGAACAATGG:ATGG
NM_001083602.2(PTCH1):c.61_62del (p.Leu21fs)	PTCH1	L87fs, L86fs, L21fs	Gorlin syndrome	Pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, single submitter	VCV000524566	9	98268823 - 98268824	9	95506541 - 95506542	524566	524809	rs1554708760	NC_000009.12:95506540:AA:
NM_001083602.2(PTCH1):c.2363-2A>G	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000524511	9	98224282	9	95462000	524511	525307	rs878853852	NC_000009.12:95461999:T:C
NM_001083602.2(PTCH1):c.609_612del (p.Lys203_Lys204insTer)	PTCH1		Gorlin syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428817	9	98242807 - 98242810	9	95480525 - 95480528	428817	420488	rs1131690969	NC_000009.12:95480524:TTTCTTT:TTT
NM_001083602.2(PTCH1):c.392G>A (p.Trp131Ter)	PTCH1	W131*, W197*, W196*, W46*	Gorlin syndrome|not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419509	9	98244480	9	95482198	419509	407790	rs1064793922	NC_000009.12:95482197:C:T
NM_001083602.2(PTCH1):c.2954G>A (p.Trp985Ter)	PTCH1	W1051*, W985*, W900*, W1050*, W999*	Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000409220	9	98220311	9	95458029	409220	396973	rs1060502301	NC_000009.12:95458028:C:T
NM_001083602.2(PTCH1):c.543C>A (p.Tyr181Ter)	PTCH1	Y181*, Y247*, Y96*, Y246*	Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000409170	9	98244236	9	95481954	409170	397574	rs1060502281	NC_000009.12:95481953:G:T
NM_001083602.2(PTCH1):c.387-1G>C	PTCH1		not provided|Gorlin syndrome	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000379374	9	98244486	9	95482204	379374	371433	rs1057520590	NC_000009.12:95482203:C:G
NM_001083602.2(PTCH1):c.4-1649del	PTCH1	L39fs	Gorlin syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374274	9	98270530	9	95508248	374274	361199	rs751977093	NC_000009.12:95508247:CCCCCCC:CCCCCC
NM_001083602.2(PTCH1):c.1305+1G>C	PTCH1		Gorlin syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, multiple submitters, no conflicts	VCV000219879	9	98239828	9	95477546	219879	221915	rs864622293	NC_000009.12:95477545:C:G
NM_002485.4(NBN):c.60del (p.Gly21fs)	NBN	G21fs	Hereditary cancer-predisposing syndrome|not provided|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545793	8	90995061	8	89982833	545793	536346	rs758708229	NC_000008.11:89982832:A:
NM_002485.4(NBN):c.1255_1258del (p.Asn419fs)	NBN	N337fs, N419fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000530753	8	90967650 - 90967653	8	89955422 - 89955425	530753	524330	rs1238152597	NC_000008.11:89955421:TATTT:T
NM_002485.4(NBN):c.1882_1885del (p.Glu628fs)	NBN	E628fs, E546fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492103	8	90960081 - 90960084	8	89947853 - 89947856	492103	483990	rs1178384498	NC_000008.11:89947852:CTTCCTT:CTT
NM_002485.4(NBN):c.1396dup (p.Arg466fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000492093	8	90967511 - 90967512	8	89955283 - 89955284	492093	483981	rs1349928568	NC_000008.11:89955283:TTTTTTT:TTTTTTTT
NM_001024688.2(NBN):c.-59del	NBN	I63fs	not provided|Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000232165	8	90993735	8	89981507	232165	233710	rs876659592	NC_000008.11:89981506:A:
NM_001024688.2(NBN):c.1237_1238delinsA (p.Pro413fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186736	8	90965833 - 90965834	8	89953605 - 89953606	186736	182845	rs764884516	NC_000008.11:89953604:GG:T
NM_002485.4(NBN):c.1397+2T>A	NBN		Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000182721	8	90967509	8	89955281	182721	180289	rs730881850	NC_000008.11:89955280:A:T
NM_000256.3(MYBPC3):c.897del (p.Lys301fs)	MYBPC3	K301fs	Cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000522221	11	47368985	11	47347434	522221	512849	rs1555122928	NC_000011.10:47347433:C:
NM_000256.3(MYBPC3):c.1458-1G>C	MYBPC3		Cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522220	11	47364296	11	47342745	522220	512848	rs397515903	NC_000011.10:47342744:C:G
NM_000256.3(MYBPC3):c.1404del (p.Gln469fs)	MYBPC3	Q469fs	Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254153	11	47364434	11	47342883	254153	248633	rs886037900	NC_000011.10:47342882:CCCC:CCC
NM_000256.3(MYBPC3):c.2789del (p.Leu930fs)	MYBPC3	L930fs	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228370	11	47356709	11	47335158	228370	230207	rs876657705	NC_000011.10:47335157:A:
NM_000256.3(MYBPC3):c.906-36G>A	MYBPC3		Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219660	11	47368616	11	47347065	219660	222146	rs864622197	NC_000011.10:47347064:C:T
NM_000256.3(MYBPC3):c.1838dup (p.Asp613fs)	MYBPC3		not provided|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, multiple submitters, no conflicts	VCV000181076	11	47362747 - 47362748	11	47341196 - 47341197	181076	179278	rs730880649	NC_000011.10:47341196:T:TT
NM_000256.3(MYBPC3):c.901A>T (p.Lys301Ter)	MYBPC3	K301*	not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181054	11	47368981	11	47347430	181054	179356	rs730880629	NC_000011.10:47347429:T:A
NM_000256.3(MYBPC3):c.1090+1G>T	MYBPC3		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177686	11	47367757	11	47346206	177686	174784	rs727504269	NC_000011.10:47346205:C:A
NM_000256.3(MYBPC3):c.2776_2777CA[2] (p.Thr927fs)	MYBPC3		not provided|Cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177660	11	47356717 - 47356718	11	47335166 - 47335167	177660	174748	rs727504265	NC_000011.10:47335165:TGTGTG:TGTG
NM_000256.3(MYBPC3):c.1624+2T>C	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164107	11	47364127	11	47342576	164107	175184	rs111437311	NC_000011.10:47342575:A:G
NM_000256.3(MYBPC3):c.2920C>T (p.Gln974Ter)	MYBPC3	Q974*	Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000164055	11	47355547	11	47333996	164055	174745	rs727503180	NC_000011.10:47333995:G:A
NM_000256.3(MYBPC3):c.772+1G>A	MYBPC3		Cardiovascular phenotype|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042790	11	47369974	11	47348423	42790	51960	rs397516072	NC_000011.10:47348422:C:T
NM_000256.3(MYBPC3):c.2558del (p.Gly853fs)	MYBPC3	G853fs	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042641	11	47358986	11	47337435	42641	51811	rs397515977	NC_000011.10:47337434:CC:C
NM_000256.3(MYBPC3):c.2524dup (p.Tyr842fs)	MYBPC3		Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: May 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000042632	11	47359019 - 47359020	11	47337468 - 47337469	42632	51802	rs397515970	NC_000011.10:47337468:A:AA
NM_000256.3(MYBPC3):c.1895del (p.Met632fs)	MYBPC3	M632fs	Hypertrophic cardiomyopathy|Cardiomyopathy|not provided	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042581	11	47362691	11	47341140	42581	51751	rs397515934	NC_000011.10:47341139:A:
NM_001195248.2(APTX):c.837G>A (p.Trp279Ter)	APTX	W279*, W293*, W225*, W191*, W207*	not provided|Ataxia-oculomotor apraxia type 1	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004431	9	32974493	9	32974495	4431	19470	rs104894103	NC_000009.12:32974494:C:T
NM_004260.3(RECQL4):c.2476C>T (p.Arg826Ter)	RECQL4	R826*	not provided|Baller-Gerold syndrome|Rapadilino syndrome	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056406	8	145738509	8	144513126	56406	71045	rs386833851	NC_000008.11:144513125:G:A
NM_004260.3(RECQL4):c.3061C>T (p.Arg1021Trp)	RECQL4	R1021W	Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000006073	8	145737702	8	144512319	6073	21112	rs137853232	NC_000008.11:144512318:G:A
NM_020822.3(KCNT1):c.1283G>A (p.Arg428Gln)	KCNT1	R428Q, R383Q	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|not provided|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039593	9	138657552	9	135765706	39593	48192	rs397515402	NC_000009.12:135765705:G:A
NM_000264.5(PTCH1):c.290dup (p.Asn97fs)	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000650991	9	98268792 - 98268793	9	95506510 - 95506511	650991	638577		NC_000009.12:95506510:TTTTTTT:TTTTTTTT
NM_001083602.2(PTCH1):c.1018-1G>A	PTCH1		Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561094	9	98240469	9	95478187	561094	552143	rs1564051834	NC_000009.12:95478186:C:T
NM_001083602.2(PTCH1):c.688del (p.Cys230fs)	PTCH1	C230fs, C295fs, C145fs, C296fs	Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428840	9	98242731	9	95480449	428840	420487	rs1131690987	NC_000009.12:95480448:A:
NM_001083602.2(PTCH1):c.3166_3167del (p.Met1056fs)	PTCH1	M1056fs, M1121fs, M1070fs, M1122fs, M971fs	Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000409150	9	98215844 - 98215845	9	95453562 - 95453563	409150	397365	rs1060502273	NC_000009.12:95453561:AT:
NM_001083602.2(PTCH1):c.1417del (p.Glu473fs)	PTCH1	E388fs, E487fs, E473fs, E538fs, E539fs	Gorlin syndrome|not provided	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000237457	9	98238429	9	95476147	237457	240682	rs878853847	NC_000009.12:95476146:CCCC:CCC
NM_001083602.2(PTCH1):c.3252-2A>G	PTCH1		Gorlin syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000215986	9	98212224	9	95449942	215986	212705	rs863224443	NC_000009.12:95449941:T:C
NM_001083602.2(PTCH1):c.189G>A (p.Trp63Ter)	PTCH1	W129*, W128*, W63*	Gorlin syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000037076	9	98268696	9	95506414	37076	45752		NC_000009.12:95506413:C:T
NM_002485.4(NBN):c.445del (p.His149fs)	NBN	H67fs, H149fs	not provided|Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480026	8	90992997	8	89980769	480026	474801	rs1554567892	NC_000008.11:89980768:G:
NM_002485.4(NBN):c.1397+1del	NBN		Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411756	8	90967510	8	89955282	411756	396708	rs1060503467	NC_000008.11:89955281:CC:C
NM_002485.4(NBN):c.163_171+3del	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370793	8	90994947 - 90994958	8	89982719 - 89982730	370793	357672	rs1057516772	NC_000008.11:89982718:TACCAGGTTGGTTAC:TAC
NM_002485.4(NBN):c.1747C>T (p.Gln583Ter)	NBN	Q583*, Q501*	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219533	8	90965570	8	89953342	219533	221777	rs864622143	NC_000008.11:89953341:G:A
NM_002485.4(NBN):c.181_182del (p.Thr60_Asp61insTer)	NBN		Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186540	8	90993741 - 90993742	8	89981513 - 89981514	186540	182903	rs768378152	NC_000008.11:89981512:TCT:T
NM_001024688.2(NBN):c.-37_-36del	NBN	D70fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185838	8	90993712 - 90993713	8	89981484 - 89981485	185838	182901	rs786202494	NC_000008.11:89981483:TAT:T
NM_002485.4(NBN):c.1723G>T (p.Glu575Ter)	NBN	E575*, E493*	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184862	8	90965594	8	89953366	184862	182843	rs786201745	NC_000008.11:89953365:C:A
NM_002485.4(NBN):c.976C>T (p.Gln326Ter)	NBN	Q326*, Q244*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006945	8	90976656	8	89964428	6945	21984	rs121908973	NC_000008.11:89964427:G:A
NM_000426.3(LAMA2):c.5562+5G>C	LAMA2		Laminin alpha 2-related dystrophy|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197024	6	129722490	6	129401345	197024	194185	rs771046502	NC_000006.12:129401344:G:C
NM_000426.3(LAMA2):c.3976C>T (p.Arg1326Ter)	LAMA2	R1326*	Laminin alpha 2-related dystrophy|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Merosin deficient congenital muscular dystrophy|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092956	6	129637234	6	129316089	92956	98863	rs398123373	NC_000006.12:129316088:C:T
NM_000426.3(LAMA2):c.7147C>T (p.Arg2383Ter)	LAMA2	R2383*	not provided|Congenital muscular dystrophy due to partial LAMA2 deficiency|Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014300	6	129785589	6	129464444	14300	29339	rs121913576	NC_000006.12:129464443:C:T
NM_004260.3(RECQL4):c.1048_1049del (p.Arg350fs)	RECQL4	R350fs	not provided|Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197759	8	145741454 - 145741455	8	144516070 - 144516071	197759	194920	rs746636748	NC_000008.11:144516069:CT:
NM_004260.3(RECQL4):c.1390+2del	RECQL4		Baller-Gerold syndrome|Rapadilino syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000056398	8	145740708	8	144515324	56398	71037	rs386833843	NC_000008.11:144515323:A:
NM_004260.3(RECQL4):c.2492_2493del (p.His831fs)	RECQL4	H831fs	Baller-Gerold syndrome|Rothmund-Thomson syndrome type 2	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000006064	8	145738492 - 145738493	8	144513109 - 144513110	6064	21103	rs752729755	NC_000008.11:144513108:AT:
NM_022970.3(FGFR2):c.1087+1311G>A	FGFR2	A344A	Craniosynostosis, nonclassifiable autosomal dominant|Crouzon syndrome|Craniosynostosis|FGFR2 related craniosynostosis||Pfeiffer syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Bent bone dysplasia syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Neoplasm of stomach|Scaphocephaly and axenfeld-rieger anomaly	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013268	10	123276885	10	121517371	13268	28307	rs121918491	NC_000010.11:121517370:C:T
NM_000441.2(SLC26A4):c.716T>A (p.Val239Asp)	SLC26A4	V239D	Pendred syndrome|Rare genetic deafness|Enlarged vestibular aqueduct|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043566	7	107315505	7	107675060	43566	52735	rs111033256	NC_000007.14:107675059:T:A
NM_000244.3(MEN1):c.493G>C (p.Ala165Pro)	MEN1	A160P, A165P	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000579050	11	64575539	11	64808067	579050	570807	rs1565648656	NC_000011.10:64808066:C:G
NM_000244.3(MEN1):c.1228C>T (p.Gln410Ter)	MEN1	Q410*, Q405*, Q447*, Q370*	not specified|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220643	11	64572643	11	64805171	220643	222156	rs864622615	NC_000011.10:64805170:G:A
NM_000244.3(MEN1):c.1444G>T (p.Glu482Ter)	MEN1	E477*, E482*, E519*, E442*	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216133	11	64572210	11	64804738	216133	212934	rs863224526	NC_000011.10:64804737:C:A
NM_000244.3(MEN1):c.197_201GCCCC[3] (p.Asp70fs)	MEN1		Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000183079	11	64577375 - 64577376	11	64809903 - 64809904	183079	181217	rs730882136	NC_000011.10:64809903:GGGGCGGGGC:GGGGCGGGGCGGGGC
NM_000256.3(MYBPC3):c.1038_1042dup (p.Met348fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Left ventricular noncompaction	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000177698	11	47367806 - 47367810	11	47346254 - 47346255	177698	178182	rs730880336	NC_000011.10:47346254:TGCCG:TGCCGTGCCG
NM_000256.3(MYBPC3):c.3330+5G>T	MYBPC3		Cardiovascular phenotype|Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042707	11	47354740	11	47333189	42707	51877	rs373746463	NC_000011.10:47333188:C:A
NM_000256.3(MYBPC3):c.2833_2834del (p.Arg945fs)	MYBPC3	R945fs	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042660	11	47356664 - 47356665	11	47335113 - 47335114	42660	51830	rs397515987	NC_000011.10:47335112:CGC:C
NM_000256.3(MYBPC3):c.1897+1G>A	MYBPC3		Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042582	11	47362688	11	47341137	42582	51752	rs397515935	NC_000011.10:47341136:C:T
NM_001083602.2(PTCH1):c.58_59CT[1] (p.Leu21fs)	PTCH1		Gorlin syndrome|not provided	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219697	9	98268824 - 98268825	9	95506542 - 95506543	219697	221928	rs864622212	NC_000009.12:95506541:AGAG:AG
NM_001083602.2(PTCH1):c.895C>T (p.Gln299Ter)	PTCH1	Q299*, Q365*, Q210*, Q214*, Q364*	Gorlin syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000156352	9	98241404	9	95479122	156352	166132	rs267606984	NC_000009.12:95479121:G:A
NM_001024688.2(NBN):c.-158_-157GT[1]	NBN		Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545774	8	90994979 - 90994980	8	89982751 - 89982752	545774	536345	rs750375741	NC_000008.11:89982750:ACACA:ACA
NM_002485.4(NBN):c.1716dup (p.Glu573fs)	NBN		Hereditary cancer-predisposing syndrome|not provided|Microcephaly, normal intelligence and immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411780	8	90965600 - 90965601	8	89953372 - 89953373	411780	396697	rs1060503483	NC_000008.11:89953372:T:TT
NM_002485.4(NBN):c.842T>G	NBN	L281*, L199*	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190228	8	90982646	8	89970418	190228	188058	rs786205135	NC_000008.11:89970417:A:C
NM_002485.4(NBN):c.1474C>T (p.Gln492Ter)	NBN	Q492*, Q410*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141946	8	90965843	8	89953615	141946	151660	rs587782130	NC_000008.11:89953614:G:A
NM_002485.4(NBN):c.123del (p.Ser42fs)	NBN	S42fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141631	8	90994998	8	89982770	141631	151345	rs587781891	NC_000008.11:89982769:G:
NM_001024688.2(NBN):c.495_496dup (p.Glu166fs)	NBN		not provided|Microcephaly, normal intelligence and immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006949	8	90982745 - 90982746	8	89970517 - 89970518	6949	21988	rs864309670	NC_000008.11:89970517:CCCC:CCCCCC
NM_002485.4(NBN):c.1089C>A (p.Tyr363Ter)	NBN	Y363*, Y281*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000006947	8	90970988	8	89958760	6947	21986	rs121908974	NC_000008.11:89958759:G:T
NM_138694.4(PKHD1):c.1480C>T (p.Arg494Ter)	PKHD1	R494*	Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189026	6	51923153	6	52058355	189026	186718	rs754392766	NC_000006.12:52058354:G:A
NM_020745.4(AARS2):c.1774C>T (p.Arg592Trp)	AARS2	R592W	Inborn genetic diseases|not provided|Combined oxidative phosphorylation deficiency 8|Pulmonary hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030940	6	44272249	6	44304512	30940	39897	rs138119149	NC_000006.12:44304511:G:A
NM_004260.3(RECQL4):c.1568_1573delinsCCCCC (p.Ser523fs)	RECQL4		not provided|Baller-Gerold syndrome	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407029	8	145740367 - 145740372	8	144514983 - 144514988	407029	396696	rs1060501383	NC_000008.11:144514982:AGGGGC:GGGGG
NM_004260.3(RECQL4):c.1704+1G>A	RECQL4		Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006077	8	145739825	8	144514441	6077	21116	rs760363252	NC_000008.11:144514440:C:T
NM_001134363.3(RBM20):c.1906C>A (p.Arg636Ser)	RBM20	R636S	not provided|Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000270	10	112572061	10	110812303	270	15309	rs267607002	NC_000010.11:110812302:C:A
NM_001083602.2(PTCH1):c.1405-2A>G	PTCH1		Gorlin syndrome|not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419508	9	98238443	9	95476161	419508	407785	rs1064793921	NC_000009.12:95476160:T:C
NM_001083602.2(PTCH1):c.4-2A>G	PTCH1		Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237465	9	98268883	9	95506601	237465	240700	rs878853849	NC_000009.12:95506600:T:C
NM_002485.4(NBN):c.1651dup (p.Arg551fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234246	8	90965665 - 90965666	8	89953437 - 89953438	234246	233641	rs766044684	NC_000008.11:89953437:TTTTTTT:TTTTTTTT
NM_017780.4(CHD7):c.6955C>T (p.Arg2319Cys)	CHD7	R2319C	CHARGE association	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235889	8	61768552	8	60855993	235889	237524	rs121434341	NC_000008.11:60855992:C:T
NM_017780.4(CHD7):c.6157C>T (p.Arg2053Ter)	CHD7	R2053*	|CHARGE association|CHARGE association|not provided	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158307	8	61765441	8	60852882	158307	168623	rs587783450	NC_000008.11:60852881:C:T
NM_017780.4(CHD7):c.1480C>T (p.Arg494Ter)	CHD7	R494*	CHARGE association|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158279	8	61655471	8	60742912	158279	168594	rs587783429	NC_000008.11:60742911:C:T
NM_000256.3(MYBPC3):c.2149-2del	MYBPC3		Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000437425	11	47360232	11	47338681	437425	430982	rs1555121488	NC_000011.10:47338680:T:
NM_000256.3(MYBPC3):c.3490+1G>T	MYBPC3		not provided|Hypertrophic cardiomyopathy|MYBPC3-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181008	11	47354364	11	47332813	181008	179192	rs397516020	NC_000011.10:47332812:C:A
NM_000256.3(MYBPC3):c.3372C>A (p.Cys1124Ter)	MYBPC3	C1124*	Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177701	11	47354483	11	47332932	177701	174735	rs727504289	NC_000011.10:47332931:G:T
NM_000256.3(MYBPC3):c.655-1G>A	MYBPC3		Cardiovascular phenotype|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042783	11	47370093	11	47348542	42783	51953	rs397516067	NC_000011.10:47348541:C:T
NM_000256.3(MYBPC3):c.906-1G>C	MYBPC3		Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008619	11	47368581	11	47347030	8619	23658	rs587776700	NC_000011.10:47347029:C:G
NM_004092.4(ECHS1):c.410_411del (p.Tyr137fs)	ECHS1	Y137fs	not provided|Inborn genetic diseases|Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418830	10	135183411 - 135183412	10	133369907 - 133369908	418830	407832	rs777218310	NC_000010.11:133369906:ATA:A
NM_001287174.2(ABCC8):c.3643C>T (p.Arg1215Trp)	ABCC8	R1214W, R1215W, R1213W, R1236W	Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235633	11	17424218	11	17402671	235633	237314	rs139964066	NC_000011.10:17402670:G:A
NM_017890.4(VPS13B):c.9547C>T (p.Gln3183Ter)	VPS13B	Q3158*, Q3183*	Inborn genetic diseases|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000225027	8	100844738	8	99832510	225027	226911	rs753770252	NC_000008.11:99832509:C:T
NM_004260.3(RECQL4):c.2059-1G>A	RECQL4		Baller-Gerold syndrome|Rapadilino syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000056404	8	145739097	8	144513713	56404	71043	rs386833849	NC_000008.11:144513712:C:T
NM_000426.3(LAMA2):c.5116C>T (p.Arg1706Ter)	LAMA2	R1706*	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000287913	6	129712680	6	129391535	287913	272150	rs758775001	NC_000006.12:129391534:C:T
NM_000197.2(HSD17B3):c.277+4A>T	HSD17B3		Testosterone 17-beta-dehydrogenase deficiency|not provided|Pseudohermaphroditism|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208587	9	99017146	9	96254864	208587	205160	rs201115371	NC_000009.12:96254863:T:A
NM_001024688.2(NBN):c.-286del	NBN	L4fs	not provided|Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418370	8	90996779	8	89984551	418370	407498	rs1064793210	NC_000008.11:89984550:A:
NM_001024688.2(NBN):c.1728del (p.Glu576fs)	NBN	E576fs, E658fs	Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370663	8	90958464	8	89946236	370663	357660	rs1057516668	NC_000008.11:89946235:TT:T
NM_001024688.2(NBN):c.60del (p.Phe20fs)	NBN	F20fs, F102fs	Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140828	8	90993617	8	89981389	140828	150542	rs587781305	NC_000008.11:89981388:AAA:AA
NM_003002.4(SDHD):c.187_188TC[2] (p.Leu64fs)	SDHD		not provided|Paragangliomas 1 with sensorineural hearing loss|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006904	11	111959608 - 111959609	11	112088884 - 112088885	6904	21943	rs387906358	NC_000011.10:112088883:TCTCTC:TCTC
NM_003002.4(SDHD):c.274G>T (p.Asp92Tyr)	SDHD	D92Y, D53Y	Paragangliomas 1|Pheochromocytoma|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006897	11	111959695	11	112088971	6897	21936	rs80338845	NC_000011.10:112088970:G:T
NM_138694.4(PKHD1):c.353del (p.Ser118fs)	PKHD1	S118fs	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096397	6	51944735	6	52079937	96397	102291	rs398124483	NC_000006.12:52079936:C:
NM_004333.6(BRAF):c.1786G>C (p.Gly596Arg)	BRAF	G596R	Multiple myeloma|Glioblastoma|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375943	7	140453149	7	140753349	375943	362822	rs121913361	NC_000007.14:140753348:C:G
NM_018972.4(GDAP1):c.715C>T (p.Leu239Phe)	GDAP1	L239F, L181F, L171F, L130F	Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, type 4A|GDAP1-Related Disorders|Charcot-Marie-Tooth disease|Peripheral axonal neuropathy|Elevated alkaline phosphatase|Polyneuropathy|Elevated serum creatine phosphokinase|Sensory neuropathy|not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004200	8	75276240	8	74364005	4200	19239	rs104894080	NC_000008.11:74364004:C:T
NM_000368.5(TSC1):c.116_119dup (p.Met40fs)	TSC1		not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000817972	9	135802678 - 135802679	9	132927291 - 132927292	817972	805612		NC_000009.12:132927291:ATAG:ATAGATAG
NM_000368.5(TSC1):c.2640del (p.Met880fs)	TSC1	M759fs, M829fs, M879fs, M880fs	not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000817599	9	135772983	9	132897596	817599	805610		NC_000009.12:132897595:C:
NM_000368.5(TSC1):c.1237del (p.Gln413fs)	TSC1	Q362fs, Q292fs, Q413fs, Q412fs	not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000817113	9	135785984	9	132910597	817113	805611		NC_000009.12:132910596:GGGGG:GGGG
NM_000368.4(TSC1):c.2656A>T (p.Lys886Ter)	TSC1	K886*, K765*, K885*, K835*	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000546490	9	135772967	9	132897580	546490	536763	rs1554813568	NC_000009.12:132897579:T:A
NM_000368.4(TSC1):c.2866C>T (p.Gln956Ter)	TSC1	Q956*, Q835*, Q905*, Q955*	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000545991	9	135772680	9	132897293	545991	536348	rs1554813331	NC_000009.12:132897292:G:A
NM_000368.4(TSC1):c.1533dup (p.Leu512fs)	TSC1		not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000504410	9	135781431 - 135781432	9	132906044 - 132906045	504410	495245	rs1554816029	NC_000009.12:132906044:A:AA
NM_001162426.2(TSC1):c.1195_1196CT[1] (p.Cys400fs)	TSC1		not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000504146	9	135786020 - 135786021	9	132910633 - 132910634	504146	495396	rs1554817140	NC_000009.12:132910632:AGAG:AG
NM_000368.4(TSC1):c.2215C>T (p.Gln739Ter)	TSC1	Q739*, Q618*, Q738*, Q688*	not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000499737	9	135778168	9	132902781	499737	491161	rs1554815054	NC_000009.12:132902780:G:A
NM_000368.4(TSC1):c.2380C>T (p.Gln794Ter)	TSC1	Q794*, Q743*, Q793*, Q673*	not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000489349	9	135778003	9	132902616	489349	481844	rs781371665	NC_000009.12:132902615:G:A
NM_000368.4(TSC1):c.2001_2004del (p.Leu667fs)	TSC1	L666fs, L616fs, L667fs, L546fs	not provided	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000452172	9	135779835 - 135779838	9	132904448 - 132904451	452172	444386	rs1554815476	NC_000009.12:132904447:AGGCA:A
NM_000368.4(TSC1):c.1157del (p.Thr386fs)	TSC1	T335fs, T265fs, T385fs, T386fs	not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000451040	9	135786064	9	132910677	451040	444387	rs1554817164	NC_000009.12:132910676:G:
NM_000368.4(TSC1):c.1388del (p.Phe462_Leu463insTer)	TSC1		not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000423113	9	135782168	9	132906781	423113	407575	rs1064796237	NC_000009.12:132906780:AAAAA:AAAA
NM_000368.4(TSC1):c.590_594del (p.Cys197fs)	TSC1	C197fs, C76fs, C146fs	not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000423010	9	135797275 - 135797279	9	132921888 - 132921892	423010	407581	rs1064796162	NC_000009.12:132921887:GTTGC:
NM_000368.4(TSC1):c.1702_1703del (p.Gly568fs)	TSC1	G447fs, G567fs, G568fs, G517fs	not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000422990	9	135781262 - 135781263	9	132905875 - 132905876	422990	407571	rs397514777	NC_000009.12:132905874:CCC:C
NM_000368.4(TSC1):c.989_990insTT (p.Leu330_Ser331insTer)	TSC1		not provided	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000422626	9	135786879 - 135786880	9	132911492 - 132911493	422626	407580	rs118203478	NC_000009.12:132911492:A:AAA
NM_000368.4(TSC1):c.1696_1697insTC (p.Pro566fs)	TSC1		not provided	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000420876	9	135781268 - 135781269	9	132905881 - 132905882	420876	407572	rs1064794760	NC_000009.12:132905881:G:GAG
NM_000368.4(TSC1):c.2292_2293insT (p.Gln765fs)	TSC1		not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000420479	9	135778090 - 135778091	9	132902703 - 132902704	420479	407569	rs1064794504	NC_000009.12:132902703::A
NM_001162426.2(TSC1):c.1157_1158CT[1] (p.Leu387fs)	TSC1		not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000419396	9	135786058 - 135786059	9	132910671 - 132910672	419396	407578	rs1064793844	NC_000009.12:132910670:AGAG:AG
NM_000368.4(TSC1):c.1443_1445delinsC (p.Ile482_Ser483insTer)	TSC1		not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000419172	9	135781520 - 135781522	9	132906133 - 132906135	419172	407574	rs1064793693	NC_000009.12:132906132:ATT:G
NM_000368.4(TSC1):c.1367dup (p.Ser457fs)	TSC1		not provided	Pathogenic(Last reviewed: May 8, 2015)	criteria provided, single submitter	VCV000419004	9	135782188 - 135782189	9	132906801 - 132906802	419004	407576	rs1554816245	NC_000009.12:132906801:A:AA
NM_000368.4(TSC1):c.2641A>T (p.Lys881Ter)	TSC1	K881*, K830*, K760*, K880*	not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000378981	9	135772982	9	132897595	378981	369962	rs1057520444	NC_000009.12:132897594:T:A
NM_000368.4(TSC1):c.1998-2A>G	TSC1		not provided	Pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000373102	9	135779843	9	132904456	373102	359777	rs1057518217	NC_000009.12:132904455:T:C
NM_000368.4(TSC1):c.2106_2109delinsTTGTTTTAAGAGCGTTT (p.Leu702fs)	TSC1		not provided	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000372541	9	135779137 - 135779140	9	132903750 - 132903753	372541	359892	rs1057517842	NC_000009.12:132903749:GAGT:AAACGCTCTTAAAACAA
NM_000368.4(TSC1):c.2075_2120dup (p.Phe707delinsLeuArgProValAlaPheThrAlaGlnProValThrLeuTer)	TSC1		not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280887	9	135779125 - 135779126	9	132903738 - 132903739	280887	264318	rs886042012	NC_000009.12:132903738:AAACGCTCATAGAGTAACTGGTTGTGCAGTAAAAGCAACTGGTCTC:AAACGCTCATAGAGTAACTGGTTGTGCAGTAAAAGCAACTGGTCTCAAACGCTCATAGAGTAACTGGTTGTGCAGTAAAAGCAACTGGTCTC
NM_000368.4(TSC1):c.850_881delinsGCTTTCCTCATCGTT (p.Arg284fs)	TSC1		not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000280843	9	135787701 - 135787732	9	132912314 - 132912345	280843	264417	rs886041977	NC_000009.12:132912313:GTGGTGACATCGGCTGAACGATGAGGAAAGCG:AACGATGAGGAAAGC
NM_001362177.2(TSC1):c.-186dup	TSC1		not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000280821	9	135804185 - 135804186	9	132928798 - 132928799	280821	264421	rs886041959	NC_000009.12:132928798:A:AA
NM_000368.4(TSC1):c.1727del (p.Leu576fs)	TSC1	L576fs, L455fs, L575fs, L525fs	not provided	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000280491	9	135781238	9	132905851	280491	264320	rs886041684	NC_000009.12:132905850:AAA:AA
NM_000368.4(TSC1):c.914-2A>G	TSC1		not provided	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000280429	9	135786957	9	132911570	280429	264415	rs886041638	NC_000009.12:132911569:T:C
NM_000368.4(TSC1):c.1165G>T (p.Gly389Ter)	TSC1	G389*, G268*, G388*, G338*	not provided	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000280293	9	135786056	9	132910669	280293	264480	rs886041524	NC_000009.12:132910668:C:A
NM_000368.4(TSC1):c.2156del (p.Leu719fs)	TSC1	L598fs, L668fs, L718fs, L719fs	not provided	Pathogenic(Last reviewed: Dec 28, 2015)	criteria provided, single submitter	VCV000280208	9	135779090	9	132903703	280208	264410	rs886041456	NC_000009.12:132903702:A:
NM_001162426.2(TSC1):c.2480_2483TCAG[1] (p.Ser828fs)	TSC1		not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000265690	9	135776988 - 135776991	9	132901601 - 132901604	265690	259917	rs886039735	NC_000009.12:132901600:CTGACTGA:CTGA
NM_000368.4(TSC1):c.2593C>T (p.Gln865Ter)	TSC1	Q865*, Q814*, Q744*, Q864*	not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000265605	9	135776134	9	132900747	265605	259916	rs886039662	NC_000009.12:132900746:G:A
GRCh37/hg19 9q34.13(chr9:135771359-135821093)x1	TSC1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253482	9	135771359 - 135821093			253482	247930		
NM_000368.4(TSC1):c.1713del (p.Glu571fs)	TSC1	E450fs, E571fs, E520fs, E570fs	not provided	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000207652	9	135781252	9	132905865	207652	202483	rs796053471	NC_000009.12:132905864:TT:T
NM_000368.4(TSC1):c.1509dup (p.Asp504Ter)	TSC1		not provided	Pathogenic(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	VCV000207651	9	135781455 - 135781456	9	132906068 - 132906069	207651	202486	rs796053470	NC_000009.12:132906068:AAA:AAAA
NM_000368.4(TSC1):c.1441del (p.Ala481fs)	TSC1	A360fs, A430fs, A480fs, A481fs	not provided	Pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, single submitter	VCV000207647	9	135781524	9	132906137	207647	202487	rs796053466	NC_000009.12:132906136:C:
NM_000368.4(TSC1):c.737_737+1dup	TSC1		not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000207646	9	135796748 - 135796749	9	132921361 - 132921362	207646	202498	rs118203435	NC_000009.12:132921361:CC:CCCC
NM_000368.4(TSC1):c.587del (p.Pro196fs)	TSC1	P196fs, P145fs, P75fs	not provided	Pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	VCV000207645	9	135797282	9	132921895	207645	202499	rs796053464	NC_000009.12:132921894:GGG:GG
NM_000368.5(TSC1):c.2818C>T (p.Gln940Ter)	TSC1	Q939*, Q889*, Q940*, Q819*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000821847	9	135772728	9	132897341	821847	809320		NC_000009.12:132897340:G:A
NM_000368.5(TSC1):c.2551C>T (p.Gln851Ter)	TSC1	Q851*, Q850*, Q730*, Q800*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000821464	9	135776176	9	132900789	821464	809325		NC_000009.12:132900788:G:A
NM_000368.5(TSC1):c.2161del (p.Arg721fs)	TSC1	R670fs, R600fs, R720fs, R721fs	not provided	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000805692	9	135779085	9	132903698	805692	793334		NC_000009.12:132903697:GG:G
NM_000368.5(TSC1):c.2152_2153insAGCC (p.Arg718fs)	TSC1		not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000805691	9	135779093 - 135779094	9	132903706 - 132903707	805691	793335		NC_000009.12:132903706:G:GGCTG
NM_000368.4(TSC1):c.661A>T (p.Lys221Ter)	TSC1	K221*, K100*, K170*	not provided	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000586848	9	135797208	9	132921821	586848	577117	rs1564497826	NC_000009.12:132921820:T:A
NM_000368.4(TSC1):c.651_663dup (p.Pro222fs)	TSC1		not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000448719	9	135797205 - 135797206	9	132921818 - 132921819	448719	441318	rs1554819509	NC_000009.12:132921818:CTTGACCACTTCT:CTTGACCACTTCTCTTGACCACTTCT
NM_001162426.2(TSC1):c.451_455delinsTTTC (p.Leu151fs)	TSC1		not provided	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000448717	9	135798788 - 135798792	9	132923401 - 132923405	448717	441320	rs1554819900	NC_000009.12:132923400:AGAAG:GAAA
NM_000368.4(TSC1):c.1264-1G>A	TSC1		not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000448714	9	135782758	9	132907371	448714	441316	rs1554816432	NC_000009.12:132907370:C:T
NM_000368.4(TSC1):c.637dup (p.Leu213fs)	TSC1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000428192	9	135797231 - 135797232	9	132921844 - 132921845	428192	419687	rs1114167620	NC_000009.12:132921844:GG:GGG
NM_000368.4(TSC1):c.389_390delinsT (p.Thr130fs)	TSC1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000428190	9	135798853 - 135798854	9	132923466 - 132923467	428190	419688	rs1554819932	NC_000009.12:132923465:TG:A
NM_000368.4(TSC1):c.2530C>T (p.Gln844Ter)	TSC1	Q844*, Q793*, Q843*, Q723*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000428189	9	135776197	9	132900810	428189	419686	rs1114167619	NC_000009.12:132900809:G:A
NM_000244.3(MEN1):c.1323G>T (p.Trp441Cys)	MEN1	W436C, W441C, W401C, W478C	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096250	11	64572548	11	64805076	96250	102144	rs398124435	NC_000011.10:64805075:C:A
NM_000368.4(TSC1):c.107-1G>A	TSC1		not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418877	9	135802692	9	132927305	418877	407583	rs1064793494	NC_000009.12:132927304:C:T
NM_000368.5(TSC1):c.959_965del (p.Leu320fs)	TSC1	L269fs, L199fs, L320fs	Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000667421	9	135786904 - 135786910	9	132911517 - 132911523	667421	654533		NC_000009.12:132911516:ATATTTAA:A
NM_000368.5(TSC1):c.2446A>T (p.Lys816Ter)	TSC1	K695*, K765*, K815*, K816*	Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000667420	9	135777032	9	132901645	667420	654532		NC_000009.12:132901644:T:A
NM_000368.4(TSC1):c.495C>A (p.Cys165Ter)	TSC1	C165*, C44*, C114*	Lymphangiomyomatosis	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000005102	9	135798748	9	132923361	5102	20141	rs118203388	NC_000009.12:132923360:G:T
NM_000368.4(TSC1):c.737+1G>T	TSC1		not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000064836	9	135796749	9	132921362	64836	75765	rs118203438	NC_000009.12:132921361:C:A
NM_000368.4(TSC1):c.2806C>T (p.Gln936Ter)	TSC1	Q936*, Q885*, Q815*, Q935*	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000049002	9	135772817	9	132897430	49002	58164	rs118203735	NC_000009.12:132897429:G:A
NM_000368.4(TSC1):c.1152del (p.Gly385fs)	TSC1	G334fs, G264fs, G384fs, G385fs	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	VCV000048748	9	135786069	9	132910682	48748	57910	rs118203501	NC_000009.12:132910681:TTTT:TTT
NM_000368.4(TSC1):c.2128C>T (p.Gln710Ter)	TSC1	Q710*, Q709*, Q589*, Q659*	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000064830	9	135779118	9	132903731	64830	75759	rs397514874	NC_000009.12:132903730:G:A
NM_001162426.2(TSC1):c.2100_2103dup (p.Leu702fs)	TSC1		not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000064707	9	135779139 - 135779140	9	132903752 - 132903753	64707	75636	rs118203638	NC_000009.12:132903752:TAACT:TAACTAACT
NM_000368.4(TSC1):c.260T>G (p.Leu87Ter)	TSC1	L87*	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000064703	9	135801077	9	132925690	64703	75632	rs397514776	NC_000009.12:132925689:A:C
NM_001162426.2(TSC1):c.810_811AT[1] (p.Ser270_Tyr271insTer)	TSC1		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	VCV000049107	9	135787769 - 135787770	9	132912382 - 132912383	49107	58269	rs118203451	NC_000009.12:132912381:ATAT:AT
NM_000368.4(TSC1):c.491G>A (p.Trp164Ter)	TSC1	W164*, W113*, W43*	not provided|Lymphangiomyomatosis|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	VCV000049046	9	135798752	9	132923365	49046	58208	rs118203387	NC_000009.12:132923364:C:T
NM_000368.4(TSC1):c.2401G>T (p.Glu801Ter)	TSC1	E801*, E800*, E680*, E750*	Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000048949	9	135777077	9	132901690	48949	58111	rs118203687	NC_000009.12:132901689:C:A
NM_000368.4(TSC1):c.2293C>T (p.Gln765Ter)	TSC1	Q765*, Q644*, Q714*, Q764*	Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000048934	9	135778090	9	132902703	48934	58096	rs118203673	NC_000009.12:132902702:G:A
NM_000368.4(TSC1):c.1997+1G>A	TSC1		not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000048863	9	135780967	9	132905580	48863	58025	rs118203610	NC_000009.12:132905579:C:T
NM_000256.3(MYBPC3):c.436dup (p.Thr146fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|not specified	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042751	11	47371633 - 47371634	11	47350082 - 47350083	42751	51921	rs397516049	NC_000011.10:47350082:T:TT
NM_000256.3(MYBPC3):c.3297dup (p.Tyr1100fs)	MYBPC3		Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042702	11	47354777 - 47354778	11	47333226 - 47333227	42702	51872	rs397516014	NC_000011.10:47333226:CCCCC:CCCCCC
NM_000256.3(MYBPC3):c.3253G>T (p.Glu1085Ter)	MYBPC3	E1085*	Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042696	11	47354822	11	47333271	42696	51866	rs397516010	NC_000011.10:47333270:C:A
NM_000256.3(MYBPC3):c.2534_2538del (p.Arg845fs)	MYBPC3	R845fs	Familial hypertrophic cardiomyopathy 4|Cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 10, 2012)	criteria provided, multiple submitters, no conflicts	VCV000042635	11	47359006 - 47359010	11	47337455 - 47337459	42635	51805	rs397515973	NC_000011.10:47337454:GACGCG:G
NM_004260.3(RECQL4):c.1391-1G>A	RECQL4		Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000006067	8	145740627	8	144515243	6067	21106	rs117642173	NC_000008.11:144515242:C:T
NM_000368.5(TSC1):c.461del (p.Phe154fs)	TSC1	F154fs, F103fs, F33fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802528	9	135798782	9	132923395	802528	790855		NC_000009.12:132923394:AAA:AA
NM_000368.5(TSC1):c.998del (p.Pro333fs)	TSC1	P212fs, P282fs, P333fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802527	9	135786871	9	132911484	802527	790854		NC_000009.12:132911483:GGGG:GGG
NM_000368.5(TSC1):c.1389del (p.Gly464fs)	TSC1	G343fs, G463fs, G413fs, G464fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802526	9	135782167	9	132906780	802526	790853		NC_000009.12:132906779:T:
NM_000368.5(TSC1):c.1513_1514TC[1] (p.Pro506fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802525	9	135781449 - 135781450	9	132906062 - 132906063	802525	790852		NC_000009.12:132906061:GAGAG:GAG
NM_000368.5(TSC1):c.2440del (p.Glu813_Leu814insTer)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802524	9	135777038	9	132901651	802524	790851		NC_000009.12:132901650:G:
NM_001162426.2(TSC1):c.2566del (p.Glu856fs)	TSC1	E806fs, E857fs, E736fs, E856fs	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000048977	9	135776158	9	132900771	48977	58139	rs118203712	NC_000009.12:132900770:CCCC:CCC
NM_004281.3(BAG3):c.626C>T (p.Pro209Leu)	BAG3	P209L	Charcot-Marie-Tooth disease|Dilated cardiomyopathy 1HH|Myofibrillar myopathy, BAG3-related|Myofibrillar myopathy, BAG3-related|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005981	10	121431885	10	119672373	5981	21020	rs121918312	NC_000010.11:119672372:C:T
NM_001360.2(DHCR7):c.1054C>T (p.Arg352Trp)	DHCR7	R352W	not provided|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006787	11	71146795	11	71435749	6787	21826	rs80338860	NC_000011.10:71435748:G:A
NM_002485.4(NBN):c.1502G>A (p.Trp501Ter)	NBN	W501*, W419*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000480057	8	90965815	8	89953587	480057	474927	rs1554558472	NC_000008.11:89953586:C:T
NM_000368.5(TSC1):c.2605A>T (p.Lys869Ter)	TSC1	K748*, K868*, K818*, K869*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000859442	9	135776122	9	132900735	859442	835658		NC_000009.12:132900734:T:A
NM_000368.5(TSC1):c.507del (p.Gly170fs)	TSC1	G170fs, G49fs, G119fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000848848	9	135798736	9	132923349	848848	835717		NC_000009.12:132923348:T:
NC_000009.12:g.132904457_132904458insAAAAAGGCAACCTA	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000847472	9	135779832 - 135779833	9	132904445 - 132904446	847472	835679		NC_000009.12:132904445:AAAGGCAACCTA:AAAGGCAACCTAAAAAAGGCAACCTA
NM_000368.5(TSC1):c.1057dup (p.Cys353fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000847152	9	135786472 - 135786473	9	132911085 - 132911086	847152	835703		NC_000009.12:132911085:AAA:AAAA
NM_000368.5(TSC1):c.2590G>T (p.Glu864Ter)	TSC1	E863*, E864*, E743*, E813*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000840442	9	135776137	9	132900750	840442	835659		NC_000009.12:132900749:C:A
NM_000368.5(TSC1):c.1677C>A (p.Cys559Ter)	TSC1	C559*, C508*, C438*, C558*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000834986	9	135781288	9	132905901	834986	835688		NC_000009.12:132905900:G:T
NC_000009.12:g.(?_132921343)_(132921993_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000832801	9	135796730 - 135797380			832801	820087		
NC_000009.12:g.(?_132900348)_(132921993_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000831599	9	135775735 - 135797380			831599	820085		
NC_000009.12:g.(?_132927181)_(132927324_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830656	9	135802568 - 135802711			830656	820088		
NC_000009.12:g.(?_132910551)_(132928892_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000830564	9	135785938 - 135804279			830564	820086		
NM_000368.4(TSC1):c.2340_2343del (p.Arg780fs)	TSC1	R659fs, R729fs, R779fs, R780fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000666036	9	135778040 - 135778043	9	132902653 - 132902656	666036	637858		NC_000009.12:132902652:CTGTCTG:CTG
NM_000368.4(TSC1):c.965_978del (p.Met322fs)	TSC1	M271fs, M201fs, M322fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000661877	9	135786891 - 135786904	9	132911504 - 132911517	661877	637899		NC_000009.12:132911503:TAGCTGCCCTGGCATA:TA
NM_000368.5(TSC1):c.2360del (p.Glu787fs)	TSC1	E786fs, E787fs, E736fs, E666fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000659922	9	135778023	9	132902636	659922	637857		NC_000009.12:132902635:T:
NM_000368.4(TSC1):c.871_886dup (p.Pro296fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000656878	9	135787695 - 135787696	9	132912308 - 132912309	656878	637901		NC_000009.12:132912308:GGCTGGTGGTGACATCGGCTG:GGCTGGTGGTGACATCGGCTGGTGGTGACATCGGCTG
NM_000368.4(TSC1):c.555C>G (p.Tyr185Ter)	TSC1	Y134*, Y64*, Y185*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000653437	9	135797314	9	132921927	653437	637910		NC_000009.12:132921926:G:C
NM_000368.4(TSC1):c.10C>T (p.Gln4Ter)	TSC1	Q4*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000652151	9	135804250	9	132928863	652151	637932		NC_000009.12:132928862:G:A
NM_000368.5(TSC1):c.271del (p.Ser91fs)	TSC1	S91fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000652137	9	135801066	9	132925679	652137	637918		NC_000009.12:132925678:A:
NM_000368.4(TSC1):c.1715_1722dup (p.Ser575fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000648763	9	135781242 - 135781243	9	132905855 - 132905856	648763	637883		NC_000009.12:132905855:AGTCTGGCA:AGTCTGGCAGTCTGGCA
NM_000368.4(TSC1):c.2715_2716dup (p.Gln906fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000647260	9	135772906 - 135772907	9	132897519 - 132897520	647260	637845		NC_000009.12:132897519:GGG:GGGGG
NM_000368.5(TSC1):c.734dup (p.Arg246fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000641211	9	135796752 - 135796753	9	132921365 - 132921366	641211	637905		NC_000009.12:132921365:C:CC
NC_000009.11:g.(?_135776102)_(135787844_?)dup	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000583696	9	135776102 - 135787844	9	132900715 - 132912457	583696	563231		
NM_000368.4(TSC1):c.1896del (p.Gly633fs)	TSC1	G582fs, G632fs, G633fs, G512fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000577202	9	135781069	9	132905682	577202	568679	rs1564480935	NC_000009.12:132905681:TTTT:TTT
NM_000368.4(TSC1):c.2545_2566del (p.Asn849fs)	TSC1	N728fs, N848fs, N849fs, N798fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000572590	9	135776161 - 135776182	9	132900774 - 132900795	572590	568631	rs1564474974	NC_000009.12:132900773:CAAGAACCAACAGCTGCCTGTTCAAGAAC:CAAGAAC
NM_000368.4(TSC1):c.1453G>T (p.Glu485Ter)	TSC1	E485*, E364*, E484*, E434*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000572255	9	135781512	9	132906125	572255	568700	rs1564482622	NC_000009.12:132906124:C:A
NM_000368.4(TSC1):c.2105_2106insCT (p.Leu702fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000570719	9	135779140 - 135779141	9	132903753 - 132903754	570719	568666	rs1564478705	NC_000009.12:132903753:A:AGA
NM_000368.4(TSC1):c.2488C>T (p.Gln830Ter)	TSC1	Q830*, Q709*, Q779*, Q829*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000569006	9	135776990	9	132901603	569006	563631	rs1564475884	NC_000009.12:132901602:G:A
NM_001162426.2(TSC1):c.1538_1546delinsTG (p.Gly513fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000567435	9	135781416 - 135781424	9	132906029 - 132906037	567435	563658	rs1564482288	NC_000009.12:132906028:GCTGAGAAC:CA
NM_000368.4(TSC1):c.988_989insGA (p.Leu330fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000567168	9	135786880 - 135786881	9	132911493 - 132911494	567168	565684	rs1564488810	NC_000009.12:132911493::TC
NM_000368.4(TSC1):c.997_998del (p.Pro333fs)	TSC1	P282fs, P212fs, P333fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000565594	9	135786871 - 135786872	9	132911484 - 132911485	565594	568726	rs1564488773	NC_000009.12:132911483:GGGG:GG
NM_000368.4(TSC1):c.1208C>A (p.Ser403Ter)	TSC1	S403*, S352*, S282*, S402*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000534465	9	135786013	9	132910626	534465	524813	rs118203504	NC_000009.12:132910625:G:T
NM_000368.4(TSC1):c.1758del (p.Pro585_Cys586insTer)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000534458	9	135781207	9	132905820	534458	524779	rs1554815856	NC_000009.12:132905819:A:
NM_000368.4(TSC1):c.751G>T (p.Glu251Ter)	TSC1	E251*, E200*, E130*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000534436	9	135787831	9	132912444	534436	524486	rs1554817691	NC_000009.12:132912443:C:A
NM_000368.4(TSC1):c.1130_1131del (p.Phe377fs)	TSC1	F256fs, F326fs, F377fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000534421	9	135786399 - 135786400	9	132911012 - 132911013	534421	524814	rs1554817222	NC_000009.12:132911011:AAA:A
NM_000368.4(TSC1):c.1301dup (p.Gln435fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000534420	9	135782719 - 135782720	9	132907332 - 132907333	534420	524805	rs1554816394	NC_000009.12:132907332:C:CC
NM_001162426.2(TSC1):c.1441_1442AT[1] (p.Ile481_Ser482insTer)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000534409	9	135781518 - 135781519	9	132906131 - 132906132	534409	524792	rs1554816076	NC_000009.12:132906130:ATAT:AT
NM_000368.4(TSC1):c.1073del (p.Pro358fs)	TSC1	P307fs, P358fs, P237fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000534408	9	135786457	9	132911070	534408	524216	rs1554817259	NC_000009.12:132911069:GG:G
NM_000368.4(TSC1):c.850dup (p.Arg284fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000466159	9	135787731 - 135787732	9	132912344 - 132912345	466159	459591	rs1554817612	NC_000009.12:132912344:GGG:GGGG
NM_001362177.2(TSC1):c.-236_-218delinsCAA	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000466078	9	135804218 - 135804236	9	132928831 - 132928849	466078	458764	rs1554821022	NC_000009.12:132928830:CAGCATGGCAAGAAGCTCC:TTG
NM_000368.4(TSC1):c.2231_2235del (p.Glu744fs)	TSC1	E744fs, E693fs, E743fs, E623fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000466069	9	135778148 - 135778152	9	132902761 - 132902765	466069	459063	rs1554815049	NC_000009.12:132902760:CTTCTCTT:CTT
NM_000368.4(TSC1):c.2177_2180dup (p.Ala728fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000466063	9	135779065 - 135779066	9	132903678 - 132903679	466063	459513	rs1554815246	NC_000009.12:132903678:GCTG:GCTGGCTG
NM_000368.4(TSC1):c.1781del (p.Val594fs)	TSC1	V473fs, V543fs, V593fs, V594fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000466042	9	135781184	9	132905797	466042	459096	rs1554815829	NC_000009.12:132905796:A:
NM_000368.4(TSC1):c.1388dup (p.Leu463fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000466027	9	135782167 - 135782168	9	132906780 - 132906781	466027	459107	rs1064796237	NC_000009.12:132906780:AAAAA:AAAAAA
NC_000009.11:g.(?_135785938)_(135787864_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000466000	9	135785938 - 135787864	9	132910551 - 132912477	466000	458727		
NM_000368.4(TSC1):c.2208+2T>A	TSC1		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419826	9	135779036	9	132903649	419826	407570	rs1064794132	NC_000009.12:132903648:A:T
NM_000368.4(TSC1):c.2165del (p.Lys722fs)	TSC1	K721fs, K671fs, K601fs, K722fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000411255	9	135779081	9	132903694	411255	396779	rs1060503213	NC_000009.12:132903693:TT:T
NM_000368.4(TSC1):c.1518del (p.Tyr508fs)	TSC1	Y387fs, Y457fs, Y507fs, Y508fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Aug 14, 2016)	criteria provided, single submitter	VCV000411251	9	135781447	9	132906060	411251	396547	rs1060503210	NC_000009.12:132906059:GGG:GG
NM_000368.4(TSC1):c.2341_2360dup (p.Glu787fs)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jul 31, 2016)	criteria provided, single submitter	VCV000411223	9	135778022 - 135778023	9	132902635 - 132902636	411223	397173	rs1554814935	NC_000009.12:132902635:TCTCGGTCATGCTGCAGCTGTCT:TCTCGGTCATGCTGCAGCTGTCTCGGTCATGCTGCAGCTGTCT
NM_000368.4(TSC1):c.1998-1G>T	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000237706	9	135779842	9	132904455	237706	240484	rs118203614	NC_000009.12:132904454:C:A
NM_000368.4(TSC1):c.772G>T (p.Glu258Ter)	TSC1	E258*, E137*, E207*	Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000049106	9	135787810	9	132912423	49106	58268	rs118203450	NC_000009.12:132912422:C:A
NM_000368.4(TSC1):c.2283C>A (p.Tyr761Ter)	TSC1	Y761*, Y640*, Y710*, Y760*	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000048929	9	135778100	9	132902713	48929	58091	rs118203668	NC_000009.12:132902712:G:T
NM_001162426.2(TSC1):c.2142del (p.Asn715fs)	TSC1	N595fs, N715fs, N665fs, N716fs	Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000048910	9	135779101	9	132903714	48910	58072	rs118203650	NC_000009.12:132903713:CC:C
NM_001162426.2(TSC1):c.2020del (p.Asp674fs)	TSC1	D554fs, D675fs, D624fs, D674fs	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000048873	9	135779816	9	132904429	48873	58035	rs118203620	NC_000009.12:132904428:C:
NM_000368.4(TSC1):c.1963C>T (p.Gln655Ter)	TSC1	Q655*, Q534*, Q604*, Q654*	Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000048859	9	135781002	9	132905615	48859	58021	rs118203606	NC_000009.12:132905614:G:A
NM_033360.4(KRAS):c.37G>C (p.Gly13Arg)	KRAS	G13R	Pilocytic astrocytoma|Neoplasm of the large intestine|Non-small cell lung cancer|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Apr 15, 2011)	criteria provided, single submitter	VCV000012593	12	25398282	12	25245348	12593	27632	rs121913535	NC_000012.12:25245347:C:G
NM_000083.3(CLCN1):c.1238T>G (p.Phe413Cys)	CLCN1	F413C	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|not provided|Congenital myotonia, autosomal dominant form	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017531	7	143029583	7	143332490	17531	32570	rs121912799	NC_000007.14:143332489:T:G
NM_000260.4(MYO7A):c.635G>A (p.Arg212His)	MYO7A	R212H, R201H	Rare genetic deafness|Deafness, autosomal recessive 2||Retinal dystrophy|Usher syndrome, type 1B	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011850	11	76867950	11	77156904	11850	26889	rs28934610	NC_000011.10:77156903:G:A
NM_000368.5(TSC1):c.740G>A (p.Trp247Ter)	TSC1	W126*, W196*, W247*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000848476	9	135787842	9	132912455	848476	835713		NC_000009.12:132912454:C:T
NM_000368.5(TSC1):c.813T>G (p.Tyr271Ter)	TSC1	Y150*, Y271*, Y220*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000840265	9	135787769	9	132912382	840265	835710		NC_000009.12:132912381:A:C
NM_000368.5(TSC1):c.298C>T (p.Gln100Ter)	TSC1	Q100*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000836879	9	135801039	9	132925652	836879	835726		NC_000009.12:132925651:G:A
NM_000368.4(TSC1):c.1119_1123del (p.Tyr373_Lys375delinsTer)	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000666182	9	135786407 - 135786411	9	132911020 - 132911024	666182	637895		NC_000009.12:132911019:TACTGTA:TA
NM_000368.4(TSC1):c.2242C>T (p.Gln748Ter)	TSC1	Q748*, Q697*, Q627*, Q747*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000662905	9	135778141	9	132902754	662905	637862		NC_000009.12:132902753:G:A
NM_000368.5(TSC1):c.2721del (p.Lys907fs)	TSC1	K786fs, K907fs, K856fs, K906fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000658887	9	135772902	9	132897515	658887	637844		NC_000009.12:132897514:TTTTT:TTTT
NM_000368.4(TSC1):c.1546C>T (p.Gln516Ter)	TSC1	Q465*, Q395*, Q515*, Q516*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000649818	9	135781419	9	132906032	649818	637888		NC_000009.12:132906031:G:A
NM_001162427.2(TSC1):c.2473G>T (p.Glu825Ter)	TSC1	E876*, E825*, E875*, E755*	Tuberous sclerosis 1|not provided	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000620094	9	135772997	9	132897610	620094	611967	rs747602915	NC_000009.12:132897609:C:A
NM_001362177.2(TSC1):c.-174_-170dup	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000569229	9	135804169 - 135804170	9	132928782 - 132928783	569229	565705	rs1564504869	NC_000009.12:132928782:TTTAA:TTTAATTTAA
NM_000368.4(TSC1):c.1849del (p.His617fs)	TSC1	H496fs, H566fs, H617fs, H616fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000566148	9	135781116	9	132905729	566148	562922	rs1564481122	NC_000009.12:132905728:GGG:GG
NM_000368.4(TSC1):c.492G>A (p.Trp164Ter)	TSC1	W164*, W113*, W43*	Tuberous sclerosis 1|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000452870	9	135798751	9	132923364	452870	444389	rs1554819870	NC_000009.12:132923363:C:T
NM_024757.5(EHMT1):c.2193-1G>C	EHMT1		Inborn genetic diseases|Kleefstra syndrome 1	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000065731	9	140674086	9	137779634	65731	76639	rs137852720	NC_000009.12:137779633:G:C
NM_001134363.3(RBM20):c.1913C>T (p.Pro638Leu)	RBM20	P638L	not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1S|Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000268	10	112572068	10	110812310	268	15307	rs267607003	NC_000010.11:110812309:C:T
NM_017780.4(CHD7):c.3082A>G (p.Ile1028Val)	CHD7	I1028V	not provided||CHARGE association|CHARGE association	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002022	8	61735186	8	60822627	2022	17061	rs121434338	NC_000008.11:60822626:A:G
NM_000426.3(LAMA2):c.8244+1G>A	LAMA2		MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550992	6	129813629	6	129492484	550992	543600	rs749522728	NC_000006.12:129492483:G:A
NM_000426.3(LAMA2):c.3924+2T>C	LAMA2		Merosin deficient congenital muscular dystrophy|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Congenital muscular dystrophy due to partial LAMA2 deficiency|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447685	6	129637097	6	129315952	447685	440912	rs1554269966	NC_000006.12:129315951:T:C
NM_000426.3(LAMA2):c.7074C>A (p.Tyr2358Ter)	LAMA2	Y2358*	Laminin alpha 2-related dystrophy|Merosin deficient congenital muscular dystrophy|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Merosin deficient congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431964	6	129785516	6	129464371	431964	425666	rs762806915	NC_000006.12:129464370:C:A
NM_000426.3(LAMA2):c.7732C>T (p.Arg2578Ter)	LAMA2	R2578*, R2574*	not provided|Merosin deficient congenital muscular dystrophy|Merosin deficient congenital muscular dystrophy|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014296	6	129802567	6	129481422	14296	29335	rs121913572	NC_000006.12:129481421:C:T
NM_000368.5(TSC1):c.261dup (p.Ser88fs)	TSC1		not provided|Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000662173	9	135801075 - 135801076	9	132925688 - 132925689	662173	637920		NC_000009.12:132925688:T:TT
NC_000009.11:g.(?_135771602)_(135804279_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000652970	9	135771602 - 135804279	9	132896215 - 132928892	652970	652027		
NC_000009.11:g.(?_135771616)_(135804265_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000534520	9	135771616 - 135804265	9	132896229 - 132928878	534520	524105		
NM_000368.4(TSC1):c.2027G>A (p.Trp676Ter)	TSC1	W676*, W555*, W625*, W675*	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466057	9	135779812	9	132904425	466057	459066	rs1554815454	NC_000009.12:132904424:C:T
NM_000368.4(TSC1):c.1987G>T (p.Glu663Ter)	TSC1	E663*, E612*, E662*, E542*	not provided|Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280309	9	135780978	9	132905591	280309	264413	rs886041538	NC_000009.12:132905590:C:A
NM_000368.4(TSC1):c.825T>G (p.Tyr275Ter)	TSC1	Y275*, Y224*, Y154*	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000049110	9	135787757	9	132912370	49110	58272	rs118203454	NC_000009.12:132912369:A:C
NM_000368.4(TSC1):c.2689C>T (p.Gln897Ter)	TSC1	Q897*, Q776*, Q846*, Q896*	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, multiple submitters, no conflicts	VCV000048991	9	135772934	9	132897547	48991	58153	rs118203727	NC_000009.12:132897546:G:A
NM_000368.4(TSC1):c.2503-2A>G	TSC1		Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000048967	9	135776226	9	132900839	48967	58129	rs118203704	NC_000009.12:132900838:T:C
NM_000256.3(MYBPC3):c.1000G>T (p.Glu334Ter)	MYBPC3	E334*	Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000177850	11	47367848	11	47346297	177850	174785	rs573916965	NC_000011.10:47346296:C:A
NM_000256.3(MYBPC3):c.999C>G (p.Tyr333Ter)	MYBPC3	Y333*	Hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177706	11	47367849	11	47346298	177706	174786	rs367947846	NC_000011.10:47346297:G:C
NM_000256.3(MYBPC3):c.3642G>A (p.Trp1214Ter)	MYBPC3	W1214*	Familial hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162506	11	47353795	11	47332244	162506	172177	rs368765949	NC_000011.10:47332243:C:T
NM_000256.3(MYBPC3):c.3624dup (p.Lys1209fs)	MYBPC3		Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042726	11	47354119 - 47354120	11	47332568 - 47332569	42726	51896	rs397516029	NC_000011.10:47332568:GGGG:GGGGG
NM_000256.3(MYBPC3):c.2670G>A (p.Trp890Ter)	MYBPC3	W890*	Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042650	11	47357495	11	47335944	42650	51820	rs397515982	NC_000011.10:47335943:C:T
NM_000256.3(MYBPC3):c.2311dup (p.Val771fs)	MYBPC3		Hypertrophic cardiomyopathy|Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042615	11	47359342 - 47359343	11	47337791 - 47337792	42615	51785	rs397515960	NC_000011.10:47337791:C:CC
NM_001083602.2(PTCH1):c.205C>T (p.Arg69Ter)	PTCH1	R135*, R69*, R134*	Hereditary cancer-predisposing syndrome|Gorlin syndrome|not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428839	9	98248148	9	95485866	428839	420494	rs1131690986	NC_000009.12:95485865:G:A
NM_203447.3(DOCK8):c.918_919insTTGAACT (p.Asp310fs)	DOCK8		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000418635	9	328045 - 328046	9	328045 - 328046	418635	407685	rs1064793335	NC_000009.12:328045::TTGAACT
NM_213599.3(ANO5):c.2272C>T (p.Arg758Cys)	ANO5	R758C, R757C	not provided|Miyoshi muscular dystrophy 3|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002166	11	22296151	11	22274605	2166	17205	rs137854529	NC_000011.10:22274604:C:T
NM_000244.3(MEN1):c.322C>T (p.Arg108Ter)	MEN1	R108*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000201006	11	64577260	11	64809788	201006	197558	rs794728647	NC_000011.10:64809787:G:A
NM_000244.3(MEN1):c.1675C>T (p.Gln559Ter)	MEN1	Q554*, Q559*, Q519*, Q596*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200988	11	64571979	11	64804507	200988	197519	rs794728631	NC_000011.10:64804506:G:A
NC_000009.12:g.(?_132896215)_(132900857_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000830757	9	135771602 - 135776244			830757	820082		
NC_000009.11:g.(?_135771602)_(135779861_?)del	TSC1		Tuberous sclerosis 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000583495	9	135771602 - 135779861	9	132896215 - 132904474	583495	562588		
NM_000368.4(TSC1):c.982C>T (p.Gln328Ter)	TSC1	Q328*, Q207*, Q277*	Tuberous sclerosis 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547821	9	135786887	9	132911500	547821	537842	rs1554817388	NC_000009.12:132911499:G:A
NM_000368.4(TSC1):c.2515_2518del (p.Glu839fs)	TSC1	E788fs, E839fs, E838fs, E718fs	Tuberous sclerosis 1|not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000195458	9	135776209 - 135776212	9	132900822 - 132900825	195458	192619	rs794727320	NC_000009.12:132900821:ACTCACT:ACT
NM_000368.5(TSC1):c.2672del (p.Asn891fs)	TSC1	N890fs, N770fs, N840fs, N891fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000064834	9	135772951	9	132897564	64834	75763	rs118203724	NC_000009.12:132897563:TTTTTTT:TTTTTT
NM_000368.4(TSC1):c.2041+1G>A	TSC1		Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000064792	9	135779797	9	132904410	64792	75721	rs397514842	NC_000009.12:132904409:C:T
NM_000368.5(TSC1):c.989_990del (p.Leu330fs)	TSC1	L330fs, L209fs, L279fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	VCV000049134	9	135786879 - 135786880	9	132911492 - 132911493	49134	58296	rs118203479	NC_000009.12:132911491:CA:
NM_001162426.2(TSC1):c.986_987CT[1] (p.Leu330fs)	TSC1		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000049132	9	135786880 - 135786881	9	132911493 - 132911494	49132	58294	rs118203477	NC_000009.12:132911492:AGAG:AG
NM_000368.4(TSC1):c.664-1G>C	TSC1		Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 27, 2012)	criteria provided, single submitter	VCV000049081	9	135796824	9	132921437	49081	58243	rs118203423	NC_000009.12:132921436:C:G
NM_000368.4(TSC1):c.647_648del (p.Thr215_Phe216insTer)	TSC1		not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000049074	9	135797221 - 135797222	9	132921834 - 132921835	49074	58236	rs118203417	NC_000009.12:132921833:AAAA:AA
NM_001162427.2(TSC1):c.210+1527dup	TSC1		Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000048998	9	135801060 - 135801061	9	132925673 - 132925674	48998	58160	rs118203362	NC_000009.12:132925673:T:TT
NM_000368.5(TSC1):c.269_270TC[1] (p.Ser91fs)	TSC1		Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 9, 2013)	criteria provided, single submitter	VCV000048996	9	135801065 - 135801066	9	132925678 - 132925679	48996	58158	rs118203360	NC_000009.12:132925677:GAGAG:GAG
NM_000368.4(TSC1):c.2341C>T (p.Gln781Ter)	TSC1	Q781*, Q660*, Q730*, Q780*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 19, 2016)	criteria provided, single submitter	VCV000048941	9	135778042	9	132902655	48941	58103	rs118203680	NC_000009.12:132902654:G:A
NM_000368.4(TSC1):c.2249G>A (p.Trp750Ter)	TSC1	W750*, W699*, W629*, W749*	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000048922	9	135778134	9	132902747	48922	58084	rs118203662	NC_000009.12:132902746:C:T
NM_000368.4(TSC1):c.2227C>T (p.Gln743Ter)	TSC1	Q743*, Q622*, Q692*, Q742*	not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000048921	9	135778156	9	132902769	48921	58083	rs118203661	NC_000009.12:132902768:G:A
NM_000368.4(TSC1):c.2131C>T (p.Gln711Ter)	TSC1	Q711*, Q710*, Q590*, Q660*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000048907	9	135779115	9	132903728	48907	58069	rs118203647	NC_000009.12:132903727:G:A
NM_000368.4(TSC1):c.211-2A>C	TSC1		Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000048903	9	135801128	9	132925741	48903	58065	rs118203352	NC_000009.12:132925740:T:G
NM_000368.5(TSC1):c.1431_1434del (p.Glu478fs)	TSC1	E357fs, E427fs, E478fs, E477fs	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	VCV000048779	9	135782122 - 135782125	9	132906735 - 132906738	48779	57941	rs118203527	NC_000009.12:132906734:TTCTTT:TT
NM_000368.4(TSC1):c.1271_1272delGA (p.Arg424Asnfs)	TSC1		Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000048756	9	135782749 - 135782750	9	132907362 - 132907363	48756	57918	rs118203509	NC_000009.12:132907361:TCTCTCT:TCTCT
NM_000368.4(TSC1):c.539T>C (p.Leu180Pro)	TSC1	L180P, L129P, L59P	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000005105	9	135797330	9	132921943	5105	20144	rs118203396	NC_000009.12:132921942:A:G
NM_001142800.2(EYS):c.6714del (p.Ile2239fs)	EYS	I2239fs	Retinitis pigmentosa|Retinal dystrophy|not provided|Retinitis pigmentosa 25	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000357699	6	64776242	6	64066349	357699	303823	rs752953889	NC_000006.12:64066348:A:
NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	BRAF	V487G, V527G, V399G, V465G, V435G, V450G, V453G, V490G	Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044806	7	140477848	7	140778048	44806	53973	rs397516893	NC_000007.14:140778047:A:C
NM_004333.6(BRAF):c.735A>C (p.Leu245Phe)	BRAF	L245F, L211F, L157F, L248F, L193F	Noonan syndrome and Noonan-related syndrome|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3|Cardiofaciocutaneous syndrome 1|Noonan syndrome 1|Lung cancer|Noonan syndrome 7|not provided|LEOPARD syndrome 3	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040347	7	140501337	7	140801537	40347	48817	rs397507466	NC_000007.14:140801536:T:G
NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	BRAF	T241R	Noonan syndrome 7|Noonan syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000029806	7	140501350	7	140801550	29806	38761	rs387906660	NC_000007.14:140801549:G:C
NM_006731.2(FKTN):c.1167dup (p.Phe390fs)	FKTN		Walker-Warburg congenital muscular dystrophy|Fukuyama congenital muscular dystrophy|not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4|FKTN-Related Disorders	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003203	9	108382330 - 108382331	9	105620049 - 105620050	3203	18242	rs398123555	NC_000009.12:105620049:AAAAAAA:AAAAAAAA
NM_000441.2(SLC26A4):c.1198del (p.Cys400fs)	SLC26A4	C400fs	Pendred syndrome|not provided|Enlarged vestibular aqueduct|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043494	7	107330616	7	107690171	43494	52664	rs397516413	NC_000007.14:107690170:TT:T
NM_001163817.2(DHCR7):c.278C>T (p.Thr93Met)	DHCR7	T93M	not provided|Abnormality of brain morphology|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006783	11	71155082	11	71444036	6783	21822	rs80338853	NC_000011.10:71444035:G:A
NM_000426.3(LAMA2):c.3752dup (p.Lys1252fs)	LAMA2		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000522087	6	129636918 - 129636919	6	129315773 - 129315774	522087	511626	rs1554269855	NC_000006.12:129315773:GGGGG:GGGGGG
NM_000368.4(TSC1):c.738-2A>T	TSC1		not provided|Tuberous sclerosis 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280757	9	135787846	9	132912459	280757	264419	rs118203440	NC_000009.12:132912458:T:A
NM_000368.4(TSC1):c.1530_1531del (p.Asp510fs)	TSC1	D459fs, D509fs, D510fs, D389fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 25, 2015)	criteria provided, single submitter	VCV000237701	9	135781434 - 135781435	9	132906047 - 132906048	237701	240489	rs118203544	NC_000009.12:132906046:TGT:T
NM_000368.5(TSC1):c.2675_2676del (p.Arg892fs)	TSC1	R841fs, R891fs, R892fs, R771fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000217251	9	135772947 - 135772948	9	132897560 - 132897561	217251	213816	rs118203726	NC_000009.12:132897559:TCT:T
NM_000368.5(TSC1):c.2698C>T (p.Gln900Ter)	TSC1	Q900*, Q779*, Q899*, Q849*	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	VCV000064826	9	135772925	9	132897538	64826	75755	rs397514871	NC_000009.12:132897537:G:A
NM_000368.5(TSC1):c.866C>G (p.Ser289Ter)	TSC1	S289*, S168*, S238*	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000064822	9	135787716	9	132912329	64822	75751	rs397514867	NC_000009.12:132912328:G:C
NM_001362177.2(TSC1):c.-154+1502del	TSC1	Y49fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Aug 26, 2017)	criteria provided, single submitter	VCV000064812	9	135802652	9	132927265	64812	75741	rs397514861	NC_000009.12:132927264:T:
NM_000368.4(TSC1):c.325C>T (p.Gln109Ter)	TSC1	Q109*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000064701	9	135801012	9	132925625	64701	75630	rs397514774	NC_000009.12:132925624:G:A
NM_000368.4(TSC1):c.901C>T (p.Gln301Ter)	TSC1	Q301*, Q180*, Q250*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000049119	9	135787681	9	132912294	49119	58281	rs118203463	NC_000009.12:132912293:G:A
NM_000368.4(TSC1):c.445C>T (p.Gln149Ter)	TSC1	Q149*, Q28*, Q98*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000049043	9	135798798	9	132923411	49043	58205	rs118203384	NC_000009.12:132923410:G:A
NM_001162426.2(TSC1):c.395_406delinsCA (p.Gly132fs)	TSC1		Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000049039	9	135798837 - 135798848	9	132923450 - 132923461	49039	58201	rs118203380	NC_000009.12:132923449:ACACCAAGACGC:TG
NM_000368.4(TSC1):c.2716C>T (p.Gln906Ter)	TSC1	Q906*, Q785*, Q855*, Q905*	Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048995	9	135772907	9	132897520	48995	58157	rs118203732	NC_000009.12:132897519:G:A
NM_001162426.2(TSC1):c.2556_2559del (p.Leu852fs)	TSC1	L732fs, L853fs, L802fs, L852fs	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000048976	9	135776165 - 135776168	9	132900778 - 132900781	48976	58138	rs118203711	NC_000009.12:132900777:AACCAAC:AAC
NM_000368.4(TSC1):c.2510dup (p.Asn837fs)	TSC1		Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000048973	9	135776216 - 135776217	9	132900829 - 132900830	48973	58135	rs118203709	NC_000009.12:132900829:TTT:TTTT
NM_000256.3(MYBPC3):c.2449C>T (p.Arg817Trp)	MYBPC3	R817W	not specified|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164078	11	47359095	11	47337544	164078	175168	rs727503188	NC_000011.10:47337543:G:A
NM_000256.3(MYBPC3):c.1639_1640GT[1] (p.Tyr548fs)	MYBPC3		Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092689	11	47363690 - 47363691	11	47342139 - 47342140	92689	98596	rs398123279	NC_000011.10:47342138:ACAC:AC
NM_000256.3(MYBPC3):c.3624del (p.Lys1209fs)	MYBPC3	K1209fs	Cardiomyopathy|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042727	11	47354120	11	47332569	42727	51897	rs397516029	NC_000011.10:47332568:GGGG:GGG
NM_000256.3(MYBPC3):c.3226_3227insT (p.Asp1076fs)	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042694	11	47354848 - 47354849	11	47333297 - 47333298	42694	51864	rs397516008	NC_000011.10:47333297::A
NM_000256.3(MYBPC3):c.1235_1236del (p.Ile411_Phe412insTer)	MYBPC3		Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042514	11	47364687 - 47364688	11	47343136 - 47343137	42514	51684	rs397515894	NC_000011.10:47343135:AAA:A
NM_000256.3(MYBPC3):c.1168del (p.His390fs)	MYBPC3	H390fs	Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042508	11	47365098	11	47343547	42508	51678	rs397515889	NC_000011.10:47343546:GG:G
NM_138694.4(PKHD1):c.10444C>T (p.Arg3482Cys)	PKHD1	R3482C	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188896	6	51524480	6	51659682	188896	186706	rs148617572	NC_000006.12:51659681:G:A
NM_002485.4(NBN):c.1030C>T	NBN	Q344*, Q262*	Microcephaly, normal intelligence and immunodeficiency|Microcephaly, normal intelligence and immunodeficiency|Acute lymphoid leukemia|Aplastic anemia|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190229	8	90971047	8	89958819	190229	188057	rs767215758	NC_000008.11:89958818:G:A
NM_001024688.2(NBN):c.558_559GT[2] (p.Val188fs)	NBN		Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185833	8	90982679 - 90982680	8	89970451 - 89970452	185833	182868	rs786202490	NC_000008.11:89970450:ACACAC:ACAC
NM_002485.4(NBN):c.2117C>G (p.Ser706Ter)	NBN	S706*, S624*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182728	8	90955548	8	89943320	182728	180280	rs730881857	NC_000008.11:89943319:G:C
NM_000260.4(MYO7A):c.5648G>A (p.Arg1883Gln)	MYO7A	R1883Q, R1845Q, R1834Q	|not provided|Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043294	11	76917153	11	77206108	43294	52464	rs111033215	NC_000011.10:77206107:G:A
NM_017780.4(CHD7):c.469C>T (p.Arg157Ter)	CHD7	R157*	CHARGE association|not specified|not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195321	8	61654460	8	60741901	195321	192482	rs794727293	NC_000008.11:60741900:C:T
NM_033360.4(KRAS):c.182A>G (p.Gln61Arg)	KRAS	Q61R	Noonan syndrome|Neoplasm of the thyroid gland|Non-small cell lung cancer|Neoplasm of the large intestine	Pathogenic(Last reviewed: Nov 4, 2009)	criteria provided, single submitter	VCV000045115	12	25380276	12	25227342	45115	54282	rs121913240	NC_000012.12:25227341:T:C
NM_000170.2(GLDC):c.499G>T (p.Glu167Ter)	GLDC	E167*	Inborn genetic diseases|Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370365	9	6610328	9	6610328	370365	357818	rs191905539	NC_000009.12:6610327:C:A
NM_000391.4(TPP1):c.311T>A (p.Leu104Ter)	TPP1	L104*	Ceroid lipofuscinosis neuronal 2|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207561	11	6638926	11	6617695	207561	202593	rs202189057	NC_000011.10:6617694:A:T
NM_000535.7(PMS2):c.830del (p.Thr277fs)	PMS2	T142fs, T174fs, T277fs, T171fs, T86fs	Ovarian Neoplasms	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000634791	7	6035238	7	5995607	634791	622535	rs1562664549	NC_000007.14:5995606:G:
NM_000535.7(PMS2):c.2319dup (p.Lys774Ter)	PMS2		not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000546057	7	6017344 - 6017345	7	5977713 - 5977714	546057	536326	rs1554293975	NC_000007.14:5977713:A:AA
NM_000535.7(PMS2):c.1874_1877delinsAGG (p.Leu625_Ala626delinsTer)	PMS2		not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000546052	7	6026519 - 6026522	7	5986888 - 5986891	546052	536327	rs1554297153	NC_000007.14:5986887:GCTA:CCT
NM_000535.7(PMS2):c.1863del (p.Ser621_Met622insTer)	PMS2		not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000546051	7	6026533	7	5986902	546051	536328	rs1554297164	NC_000007.14:5986901:A:
NM_000535.7(PMS2):c.1699C>T (p.Gln567Ter)	PMS2	Q567*, Q432*, Q464*, Q256*, Q515*, Q380*, Q461*, Q376*	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000545989	7	6026697	7	5987066	545989	536330	rs1554297342	NC_000007.14:5987065:G:A
NM_000535.7(PMS2):c.986C>G (p.Ser329Ter)	PMS2	S329*, S138*, S18*, S223*, S226*, S194*	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000545975	7	6031606	7	5991975	545975	536332	rs1461669945	NC_000007.14:5991974:G:C
NM_000535.6(PMS2):c.1688_1732del45ins46 (p.?)	PMS2		not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000545866	7	6026664 - 6026708	7	5987033 - 5987077	545866	536329		
NM_000535.7(PMS2):c.2005del (p.Ser669fs)	PMS2	S478fs, S534fs, S358fs, S563fs, S669fs, S482fs, S566fs, S617fs	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000503869	7	6026391	7	5986760	503869	495334	rs773174603	NC_000007.14:5986759:TT:T
NM_000535.7(PMS2):c.1687_1693del (p.Arg563fs)	PMS2	R372fs, R457fs, R460fs, R252fs, R376fs, R511fs, R428fs, R563fs	not provided	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000421758	7	6026703 - 6026709	7	5987072 - 5987078	421758	407183	rs1064795345	NC_000007.14:5987071:AAACTCGAAA:AAA
NM_000535.7(PMS2):c.247_250dup (p.Thr84fs)	PMS2		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000420580	7	6043602 - 6043603	7	6003971 - 6003972	420580	407228	rs1554304940	NC_000007.14:6003971:TTAA:TTAATTAA
NM_000535.7(PMS2):c.116del (p.Val39fs)	PMS2	V39fs	not provided	Pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000419857	7	6045570	7	6005939	419857	407235	rs1064794152	NC_000007.14:6005938:A:
NM_000535.7(PMS2):c.510del (p.His170fs)	PMS2	H64fs, H67fs, H170fs, H35fs	not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000418685	7	6042111	7	6002480	418685	407219	rs1064793365	NC_000007.14:6002479:A:
NM_000535.7(PMS2):c.641_644dup (p.Cys216fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000863052	7	6038799 - 6038800	7	5999168 - 5999169	863052	833776		NC_000007.14:5999168:ACCA:ACCAACCA
NM_000535.7(PMS2):c.1810C>T (p.Gln604Ter)	PMS2	Q293*, Q413*, Q417*, Q501*, Q552*, Q604*, Q498*, Q469*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000858883	7	6026586	7	5986955	858883	833750		NC_000007.14:5986954:G:A
NM_000535.7(PMS2):c.878dup (p.Asn293fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000858553	7	6035189 - 6035190	7	5995558 - 5995559	858553	833768		NC_000007.14:5995558:TT:TTT
NM_000535.7(PMS2):c.630del (p.Lys210fs)	PMS2	K107fs, K210fs, K75fs, K104fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000856141	7	6038814	7	5999183	856141	833777		NC_000007.14:5999182:TTTT:TTT
NM_000535.7(PMS2):c.1802C>G (p.Ser601Ter)	PMS2	S410*, S466*, S549*, S601*, S290*, S414*, S495*, S498*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000855903	7	6026594	7	5986963	855903	833751		NC_000007.14:5986962:G:C
NM_000535.7(PMS2):c.520C>T (p.Gln174Ter)	PMS2	Q68*, Q71*, Q174*, Q39*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000853252	7	6042101	7	6002470	853252	833783		NC_000007.14:6002469:G:A
NM_000535.7(PMS2):c.1897del (p.His633fs)	PMS2	H322fs, H527fs, H530fs, H581fs, H633fs, H442fs, H446fs, H498fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000853214	7	6026499	7	5986868	853214	833745		NC_000007.14:5986867:G:
NM_000535.7(PMS2):c.1855del (p.Asp619fs)	PMS2	D428fs, D516fs, D619fs, D432fs, D484fs, D567fs, D308fs, D513fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000849299	7	6026541	7	5986910	849299	833746		NC_000007.14:5986909:CC:C
NM_000535.7(PMS2):c.1709dup (p.Asn570fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000844871	7	6026686 - 6026687	7	5987055 - 5987056	844871	833754		NC_000007.14:5987055:TT:TTT
NM_000535.7(PMS2):c.1936del (p.Arg646fs)	PMS2	R455fs, R335fs, R511fs, R540fs, R459fs, R543fs, R594fs, R646fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000843334	7	6026460	7	5986829	843334	833742		NC_000007.14:5986828:T:
NM_000535.7(PMS2):c.1842dup (p.Val615fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000837672	7	6026553 - 6026554	7	5986922 - 5986923	837672	833748		NC_000007.14:5986922:TTT:TTTT
NM_000535.7(PMS2):c.870del (p.Phe291fs)	PMS2	F100fs, F156fs, F185fs, F291fs, F188fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000836940	7	6035198	7	5995567	836940	833769		NC_000007.14:5995566:G:
NM_000535.7(PMS2):c.1117dup (p.Ser373fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000836354	7	6029457 - 6029458	7	5989826 - 5989827	836354	833767		NC_000007.14:5989826:T:TT
NM_000535.7(PMS2):c.742dup (p.Ser248fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000835406	7	6037017 - 6037018	7	5997386 - 5997387	835406	833772		NC_000007.14:5997386:T:TT
NC_000007.14:g.(?_6003680)_(6004068_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000832078	7	6043311 - 6043699			832078	819901		
NM_000535.7(PMS2):c.758_759del (p.Glu253fs)	PMS2	E118fs, E150fs, E253fs, E62fs, E147fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000827134	7	6037001 - 6037002	7	5997370 - 5997371	827134	809137		NC_000007.14:5997369:TT:
NM_000535.7(PMS2):c.752_757delinsCGTGTGTT (p.Val251fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000827099	7	6037003 - 6037008	7	5997372 - 5997377	827099	809138		NC_000007.14:5997371:CACACA:AACACACG
NM_000535.7(PMS2):c.730del (p.Gln244fs)	PMS2	Q53fs, Q138fs, Q244fs, Q109fs, Q141fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000826956	7	6037030	7	5997399	826956	809139		NC_000007.14:5997398:G:
NM_000535.7(PMS2):c.452_457delinsCCCCG (p.Arg151fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000824968	7	6042164 - 6042169	7	6002533 - 6002538	824968	809156		NC_000007.14:6002532:TGGGGC:CGGGG
NM_000535.7(PMS2):c.447C>A (p.Tyr149Ter)	PMS2	Y149*, Y14*, Y46*, Y43*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000824921	7	6042174	7	6002543	824921	809158		NC_000007.14:6002542:G:T
NM_000535.7(PMS2):c.939T>G (p.Tyr313Ter)	PMS2	Y122*, Y2*, Y210*, Y313*, Y178*, Y207*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000823215	7	6031653	7	5992022	823215	809122		NC_000007.14:5992021:A:C
NM_000535.7(PMS2):c.1111_1112del (p.Asn371fs)	PMS2	N268fs, N180fs, N265fs, N60fs, N236fs, N371fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000822197	7	6029463 - 6029464	7	5989832 - 5989833	822197	809114		NC_000007.14:5989831:TTT:T
NM_000535.7(PMS2):c.2536G>T (p.Gly846Ter)	PMS2	G655*, G711*, G722*, G740*, G743*, G535*, G659*, G794*, G846*, G857*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000821412	7	6013083	7	5973452	821412	809032		NC_000007.14:5973451:C:A
NM_000535.7(PMS2):c.2471del (p.Thr824fs)	PMS2	T689fs, T721fs, T772fs, T633fs, T637fs, T700fs, T835fs, T513fs, T718fs, T824fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000821342	7	6013148	7	5973517	821342	809039		NC_000007.14:5973516:G:
NM_000535.7(PMS2):c.232_235del (p.Glu78fs)	PMS2	E78fs, R6fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000821094	7	6043618 - 6043621	7	6003987 - 6003990	821094	809174		NC_000007.14:6003986:TTTCTT:TT
NM_000535.7(PMS2):c.2269G>T (p.Glu757Ter)	PMS2	E622*, E654*, E705*, E651*, E570*, E757*, E446*, E566*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000820987	7	6018233	7	5978602	820987	809057		NC_000007.14:5978601:C:A
NM_000535.7(PMS2):c.2180dup (p.Thr728fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000820854	7	6018321 - 6018322	7	5978690 - 5978691	820854	809061		NC_000007.14:5978690:T:TT
NM_000535.7(PMS2):c.2113G>T (p.Glu705Ter)	PMS2	E514*, E570*, E518*, E394*, E599*, E602*, E705*, E653*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000820749	7	6022516	7	5982885	820749	809065		NC_000007.14:5982884:C:A
NM_000535.7(PMS2):c.1356dup (p.Met453fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000818995	7	6027039 - 6027040	7	5987408 - 5987409	818995	809099		NC_000007.14:5987408:A:AA
NM_000535.7(PMS2):c.135_136del (p.Asn45fs)	PMS2	N45fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000818928	7	6045550 - 6045551	7	6005919 - 6005920	818928	809182		NC_000007.14:6005918:TGT:T
NC_000007.13:g.(?_6026380)_(6029596_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000665635	7	6026380 - 6029596	7	5986749 - 5989965	665635	651615		
NM_000535.7(PMS2):c.1366del (p.Ser456fs)	PMS2	S269fs, S321fs, S350fs, S404fs, S145fs, S265fs, S353fs, S456fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000662931	7	6027030	7	5987399	662931	636249		NC_000007.14:5987398:AA:A
NM_000535.7(PMS2):c.1553del (p.Glu518fs)	PMS2	E207fs, E466fs, E327fs, E331fs, E412fs, E415fs, E518fs, E383fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000660996	7	6026843	7	5987212	660996	636238		NC_000007.14:5987211:T:
NM_000535.7(PMS2):c.648C>A (p.Cys216Ter)	PMS2	C110*, C113*, C216*, C81*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000658711	7	6038796	7	5999165	658711	636288		NC_000007.14:5999164:G:T
NM_000535.7(PMS2):c.478C>T (p.Gln160Ter)	PMS2	Q25*, Q160*, Q54*, Q57*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000657559	7	6042143	7	6002512	657559	636295		NC_000007.14:6002511:G:A
NM_000535.7(PMS2):c.717_723dup (p.Phe242fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000656308	7	6037036 - 6037037	7	5997405 - 5997406	656308	636284		NC_000007.14:5997405:AGGAATGAGG:AGGAATGAGGAATGAGG
NM_000535.7(PMS2):c.2249del (p.Gly750fs)	PMS2	G615fs, G559fs, G644fs, G698fs, G563fs, G647fs, G439fs, G750fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000652767	7	6018253	7	5978622	652767	636215		NC_000007.14:5978621:CC:C
NC_000007.13:g.(?_6038729)_(6045672_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000649622	7	6038729 - 6045672	7	5999098 - 6006041	649622	651621		
NM_000535.7(PMS2):c.1177G>T (p.Glu393Ter)	PMS2	E258*, E287*, E393*, E82*, E341*, E202*, E206*, E290*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000646128	7	6027219	7	5987588	646128	636259		NC_000007.14:5987587:C:A
NM_000535.7(PMS2):c.2023G>T (p.Glu675Ter)	PMS2	E484*, E488*, E540*, E364*, E623*, E569*, E572*, E675*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000643328	7	6022606	7	5982975	643328	636223		NC_000007.14:5982974:C:A
NM_000535.7(PMS2):c.1115_1118TCAG[1] (p.Gln374fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000642485	7	6029453 - 6029456	7	5989822 - 5989825	642485	636266		NC_000007.14:5989821:CTGACTGAC:CTGAC
NC_000007.13:g.(?_6042074)_(6043699_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000583709	7	6042074 - 6043699	7	6002443 - 6004068	583709	566118		
NC_000007.13:g.(?_6031594)_(6048660_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000583640	7	6031594 - 6048660	7	5991963 - 6009029	583640	561082		
NM_000535.7(PMS2):c.2128_2142delinsTCGTATA (p.Glu710fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000582564	7	6022487 - 6022501	7	5982856 - 5982870	582564	561657	rs1562614946	NC_000007.14:5982855:CTGCTGCAGCATCTC:TATACGA
NM_000535.7(PMS2):c.1892_1902delinsTAAA (p.Gln631fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000579805	7	6026494 - 6026504	7	5986863 - 5986873	579805	562037	rs1562626204	NC_000007.14:5986862:ATGATGTAACT:TTTA
NM_000535.7(PMS2):c.2357_2445+510del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000579556	7	6016709 - 6017307	7	5977078 - 5977676	579556	566916	rs1562598658	
NM_000535.7(PMS2):c.1481C>A (p.Ser494Ter)	PMS2	S494*, S359*, S388*, S391*, S183*, S307*, S303*, S442*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000579525	7	6026915	7	5987284	579525	562052	rs587782602	NC_000007.14:5987283:G:T
NM_000535.7(PMS2):c.1027del (p.Ile343fs)	PMS2	I152fs, I343fs, I208fs, I32fs, I237fs, I240fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000574143	7	6029548	7	5989917	574143	564367	rs1562644987	NC_000007.14:5989916:TTT:TT
NM_000535.7(PMS2):c.1472_1485del (p.Glu491fs)	PMS2	E300fs, E180fs, E304fs, E356fs, E385fs, E439fs, E388fs, E491fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000572207	7	6026911 - 6026924	7	5987280 - 5987293	572207	562051	rs1562632035	NC_000007.14:5987279:CCCCGAGTCCTTCTCC:CC
NM_000535.7(PMS2):c.1239_1240insT (p.Asp414Ter)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000570785	7	6027156 - 6027157	7	5987525 - 5987526	570785	562061	rs1562635799	NC_000007.14:5987525::A
NM_000535.7(PMS2):c.2123del (p.Asn708fs)	PMS2	N521fs, N708fs, N605fs, N656fs, N397fs, N517fs, N573fs, N602fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000569051	7	6022506	7	5982875	569051	561660	rs781078805	NC_000007.14:5982874:TT:T
NM_000535.7(PMS2):c.1313dup (p.Thr439fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000568315	7	6027082 - 6027083	7	5987451 - 5987452	568315	562053	rs1562634737	NC_000007.14:5987451:TTT:TTTT
NM_000535.7(PMS2):c.1672del (p.Thr558fs)	PMS2	T455fs, T423fs, T452fs, T506fs, T247fs, T367fs, T371fs, T558fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000567801	7	6026724	7	5987093	567801	562045	rs1562629003	NC_000007.14:5987092:T:
NM_000535.7(PMS2):c.1053del (p.Leu351fs)	PMS2	L216fs, L245fs, L351fs, L248fs, L40fs, L160fs	Colon cancer	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000560019	7	6029522	7	5989891	560019	550738	rs1554298756	NC_000007.14:5989890:C:
NM_000535.7(PMS2):c.1264G>T (p.Glu422Ter)	PMS2	E422*, E231*, E316*, E370*, E111*, E235*, E319*, E287*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000525843	7	6027132	7	5987501	525843	523135	rs587782175	NC_000007.14:5987500:C:A
NM_000535.7(PMS2):c.1746del (p.Glu583fs)	PMS2	E272fs, E477fs, E480fs, E396fs, E583fs, E392fs, E448fs, E531fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000525822	7	6026650	7	5987019	525822	523330	rs1554297285	NC_000007.14:5987018:TT:T
NM_000535.7(PMS2):c.2324_2328delinsGCTGA (p.Asn775_Trp776delinsSerTer)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000525809	7	6017336 - 6017340	7	5977705 - 5977709	525809	523123	rs1554293959	NC_000007.14:5977704:CCAGT:TCAGC
NM_000535.7(PMS2):c.1036C>T (p.Gln346Ter)	PMS2	Q346*, Q155*, Q240*, Q211*, Q243*, Q35*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000525740	7	6029539	7	5989908	525740	523344	rs1554298786	NC_000007.14:5989907:G:A
NM_000535.7(PMS2):c.1959T>A (p.Cys653Ter)	PMS2	C653*, C466*, C518*, C342*, C462*, C547*, C550*, C601*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000525739	7	6026437	7	5986806	525739	522968	rs1554297082	NC_000007.14:5986805:A:T
NM_000535.7(PMS2):c.1559del (p.Ala520fs)	PMS2	A209fs, A414fs, A417fs, A468fs, A385fs, A333fs, A520fs, A329fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000525692	7	6026837	7	5987206	525692	522980	rs1554297564	NC_000007.14:5987205:G:
NM_000535.7(PMS2):c.1606C>T (p.Gln536Ter)	PMS2	Q536*, Q345*, Q401*, Q433*, Q225*, Q484*, Q349*, Q430*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000486937	7	6026790	7	5987159	486937	474571	rs1554297488	NC_000007.14:5987158:G:A
NM_000535.7(PMS2):c.119_122dup (p.Leu42fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000486929	7	6045563 - 6045564	7	6005932 - 6005933	486929	474671	rs1554306391	NC_000007.14:6005932:TCCTT:TCCTTCCTT
NM_000535.7(PMS2):c.1999_2000GA[1] (p.Glu667fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000486927	7	6026394 - 6026395	7	5986763 - 5986764	486927	474690	rs1554297058	NC_000007.14:5986762:TCTCT:TCT
NM_000535.7(PMS2):c.240del (p.Phe80fs)	PMS2	R9fs, F80fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000484324	7	6043613	7	6003982	484324	474754	rs1554304957	NC_000007.14:6003981:G:
NM_000535.7(PMS2):c.1345C>T (p.Gln449Ter)	PMS2	Q449*, Q258*, Q346*, Q343*, Q138*, Q262*, Q314*, Q397*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000484309	7	6027051	7	5987420	484309	474637	rs876661256	NC_000007.14:5987419:G:A
NM_000535.7(PMS2):c.1408delinsGTCTTCTAGCACTTCAGGTGCCATCTCTGACAAAGGCGTCCTGAGAT (p.Pro470delinsValPheTer)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000484306	7	6026988	7	5987357	484306	474738	rs1554297781	NC_000007.14:5987356:G:ATCTCAGGACGCCTTTGTCAGAGATGGCACCTGAAGTGCTAGAAGAC
NM_000535.7(PMS2):c.2296A>T (p.Lys766Ter)	PMS2	K766*, K660*, K714*, K663*, K455*, K579*, K575*, K631*, K642*, K777*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000484265	7	6017368	7	5977737	484265	474552	rs1554293991	NC_000007.14:5977736:T:A
NM_000535.7(PMS2):c.1196dup (p.Gln400fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000484257	7	6027199 - 6027200	7	5987568 - 5987569	484257	474640	rs1554298056	NC_000007.14:5987568:TTTT:TTTTT
NM_000535.7(PMS2):c.383C>A (p.Ser128Ter)	PMS2	S128*, S22*, S25*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000480941	7	6042238	7	6002607	480941	474840	rs116373169	NC_000007.14:6002606:G:T
NM_000535.7(PMS2):c.535A>T (p.Lys179Ter)	PMS2	K179*, K44*, K76*, K73*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000480938	7	6042086	7	6002455	480938	474824	rs1554303861	NC_000007.14:6002454:T:A
NM_000535.7(PMS2):c.922_933delinsA (p.Glu308fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000480364	7	6031659 - 6031670	7	5992028 - 5992039	480364	474781	rs1554299430	NC_000007.14:5992027:GTGGTAGACCTC:T
NM_000535.7(PMS2):c.1571dup (p.Gly525fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000480313	7	6026824 - 6026825	7	5987193 - 5987194	480313	474597	rs1554297534	NC_000007.14:5987193:GGGG:GGGGG
NM_000535.7(PMS2):c.748_749del (p.Ser250fs)	PMS2	S147fs, S59fs, S144fs, S250fs, S115fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000455740	7	6037011 - 6037012	7	5997380 - 5997381	455740	457861	rs1554301486	NC_000007.14:5997379:GAG:G
NM_000535.7(PMS2):c.2353G>T (p.Glu785Ter)	PMS2	E785*, E594*, E796*, E474*, E598*, E661*, E682*, E733*, E650*, E679*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000455699	7	6017311	7	5977680	455699	457824	rs1554293920	NC_000007.14:5977679:C:A
NM_000535.7(PMS2):c.1579del (p.Arg527fs)	PMS2	R336fs, R340fs, R421fs, R527fs, R216fs, R424fs, R392fs, R475fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000455662	7	6026817	7	5987186	455662	457434	rs1554297523	NC_000007.14:5987185:T:
NM_000535.7(PMS2):c.1151T>G (p.Leu384Ter)	PMS2	L384*, L249*, L278*, L332*, L281*, L73*, L193*, L197*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000455641	7	6027245	7	5987614	455641	456804	rs1554298087	NC_000007.14:5987613:A:C
NM_000535.7(PMS2):c.1068del (p.Thr357fs)	PMS2	T222fs, T46fs, T166fs, T251fs, T254fs, T357fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000455637	7	6029507	7	5989876	455637	457270	rs1554298741	NC_000007.14:5989875:C:
NC_000007.13:g.(?_6042078)_(6043695_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000455104	7	6042078 - 6043695	7	6002447 - 6004064	455104	455879		
NC_000007.13:g.(?_6013024)_(6013179_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000455085	7	6013024 - 6013179	7	5973393 - 5973548	455085	456470		
NC_000007.13:g.(?_6026384)_(6027257_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000455074	7	6026384 - 6027257			455074	455868		
NM_000535.7(PMS2):c.1348A>T (p.Lys450Ter)	PMS2	K450*, K398*, K259*, K347*, K344*, K139*, K263*, K315*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000411069	7	6027048	7	5987417	411069	395718	rs1060503142	NC_000007.14:5987416:T:A
NM_000535.7(PMS2):c.684_685CT[1] (p.Ser229fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000411063	7	6038757 - 6038758	7	5999126 - 5999127	411063	395972	rs746766787	NC_000007.14:5999125:AGAG:AG
NM_000535.7(PMS2):c.1198C>T (p.Gln400Ter)	PMS2	Q400*, Q294*, Q89*, Q297*, Q209*, Q265*, Q213*, Q348*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000230950	7	6027198	7	5987567	230950	233534	rs876658862	NC_000007.14:5987566:G:A
NM_000535.7(PMS2):c.1411C>T (p.Gln471Ter)	PMS2	Q471*, Q419*, Q284*, Q336*, Q365*, Q368*, Q160*, Q280*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 26, 2014)	criteria provided, single submitter	VCV000187043	7	6026985	7	5987354	187043	182750	rs63751228	NC_000007.14:5987353:G:A
NM_000535.7(PMS2):c.1281del (p.His428fs)	PMS2	H237fs, H322fs, H117fs, H325fs, H241fs, H428fs, H293fs, H376fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000847304	7	6027115	7	5987484	847304	833763		NC_000007.14:5987483:A:
NC_000007.14:g.(?_5991963)_(6006041_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV000833043	7	6031594 - 6045672			833043	819897		
NC_000007.14:g.(?_5991963)_(5999285_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000832147	7	6031594 - 6038916			832147	819896		
NC_000007.14:g.(?_5989790)_(5995643_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000831484	7	6029421 - 6035274			831484	819894		
NC_000007.14:g.(?_5997316)_(6006041_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000831346	7	6036947 - 6045672			831346	819899		
NC_000007.14:g.(?_5989790)_(6009029_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000831114	7	6029421 - 6048660			831114	819895		
NM_000535.7(PMS2):c.65C>A (p.Ser22Ter)	PMS2	S22*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000826502	7	6045621	7	6005990	826502	809185		NC_000007.14:6005989:G:T
NM_000535.7(PMS2):c.2446-1G>A	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000821292	7	6013174	7	5973543	821292	815383		NC_000007.14:5973542:C:T
NM_000535.7(PMS2):c.1515del (p.Phe506fs)	PMS2	F195fs, F506fs, F403fs, F371fs, F400fs, F454fs, F315fs, F319fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000819374	7	6026881	7	5987250	819374	809090		NC_000007.14:5987249:CCCC:CCC
NM_000535.7(PMS2):c.451del (p.Arg151fs)	PMS2	R48fs, R16fs, R45fs, R151fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000630800	7	6042170	7	6002539	630800	617416	rs1562689635	NC_000007.14:6002538:GGGGG:GGGG
NM_000535.7(PMS2):c.939T>A (p.Tyr313Ter)	PMS2	Y313*, Y178*, Y207*, Y210*, Y122*, Y2*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000630753	7	6031653	7	5992022	630753	617399	rs1562651617	NC_000007.14:5992021:A:T
NM_000535.7(PMS2):c.1909_1913del (p.Gln637fs)	PMS2	Q585fs, Q326fs, Q446fs, Q531fs, Q534fs, Q450fs, Q502fs, Q637fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000629050	7	6026483 - 6026487	7	5986852 - 5986856	629050	617371	rs1562626011	NC_000007.14:5986851:TGCTGTGCT:TGCT
NM_000535.7(PMS2):c.1639dup (p.Ser547fs)	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000628449	7	6026756 - 6026757	7	5987125 - 5987126	628449	617379	rs863224498	NC_000007.14:5987125:AAAAA:AAAAAA
NM_000535.7(PMS2):c.1908del (p.Gln637fs)	PMS2	Q446fs, Q531fs, Q534fs, Q326fs, Q585fs, Q637fs, Q450fs, Q502fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000628434	7	6026488	7	5986857	628434	617372	rs1562626121	NC_000007.14:5986856:T:
NM_000535.6(PMS2):c.(?-1)_(*1_?)del	PMS2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000584580					584580	575637		
NC_000007.13:g.(?_6017209)_(6022632_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000584341	7	6017209 - 6022632	7	5977578 - 5983001	584341	563859		
NC_000007.13:g.(?_6029421)_(6031698_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000584261	7	6029421 - 6031698	7	5989790 - 5992067	584261	561076		
NC_000007.13:g.(?_6045513)_(6045672_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000583871	7	6045513 - 6045672	7	6005882 - 6006041	583871	561156		
NC_000007.13:g.(?_6031594)_(6042277_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000583745	7	6031594 - 6042277	7	5991963 - 6002646	583745	563867		
NC_000007.13:g.(?_6036947)_(6037064_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000583683	7	6036947 - 6037064	7	5997316 - 5997433	583683	563880		
NC_000007.13:g.(?_6045517)_(6045668_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 10, 2018)	criteria provided, single submitter	VCV000526005	7	6045517 - 6045668	7	6005886 - 6006037	526005	522261		
NC_000007.13:g.(?_6038733)_(6048656_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000525972	7	6038733 - 6048656	7	5999102 - 6009025	525972	522304		
NM_000535.7(PMS2):c.73C>T (p.Gln25Ter)	PMS2	Q25*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000492293	7	6045613	7	6005982	492293	484017	rs1554306528	NC_000007.14:6005981:G:A
NM_000535.7(PMS2):c.712del (p.Ser238fs)	PMS2	S103fs, S135fs, S238fs, S132fs, S47fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000492292	7	6037048	7	5997417	492292	484130	rs1554301561	NC_000007.14:5997416:TTT:TT
NM_000535.7(PMS2):c.1120C>T (p.Gln374Ter)	PMS2	Q374*, Q239*, Q268*, Q183*, Q271*, Q63*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000492246	7	6029455	7	5989824	492246	484101	rs1437858319	NC_000007.14:5989823:G:A
NM_000535.7(PMS2):c.2192T>A (p.Leu731Ter)	PMS2	L731*, L540*, L596*, L679*, L625*, L628*, L420*, L544*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000480369	7	6018310	7	5978679	480369	474545	rs1060503110	NC_000007.14:5978678:A:T
NM_000535.7(PMS2):c.2016del (p.Met672fs)	PMS2	M361fs, M481fs, M485fs, M569fs, M537fs, M566fs, M620fs, M672fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000455681	7	6022613	7	5982982	455681	457197	rs1554295967	NC_000007.14:5982981:C:
NC_000007.13:g.(?_6026384)_(6037060_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000455095	7	6026384 - 6037060	7	5986753 - 5997429	455095	456139		
Single allele	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000455089			7	5977582 - 5978702	455089	456473		
NM_000535.7(PMS2):c.1981G>T (p.Glu661Ter)	PMS2	E661*, E350*, E474*, E609*, E470*, E526*, E558*, E555*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000185743	7	6026415	7	5986784	185743	182709	rs778531080	NC_000007.14:5986783:C:A
NC_000007.14:g.(?_5973399)_(5973552_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000832771	7	6013030 - 6013183			832771	819885		
NC_000007.14:g.(?_5978586)_(5978706_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000832711	7	6018217 - 6018337			832711	819890		
NC_000007.14:g.(?_5995524)_(5997433_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000831329	7	6035155 - 6037064			831329	819898		
NM_000535.7(PMS2):c.1A>C (p.Met1Leu)	PMS2	M1L	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000820477	7	6048650	7	6009019	820477	809188		NC_000007.14:6009018:T:G
NM_000535.7(PMS2):c.862C>T (p.Gln288Ter)	PMS2	Q288*, Q153*, Q182*, Q97*, Q185*	Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802297	7	6035206	7	5995575	802297	790746		NC_000007.14:5995574:G:A
NC_000007.13:g.(?_6013020)_(6013183_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000654112	7	6013020 - 6013183	7	5973389 - 5973552	654112	651676		
NC_000007.13:g.(?_6031594)_(6031698_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000639387	7	6031594 - 6031698	7	5991963 - 5992067	639387	651640		
NC_000007.13:g.(?_6035155)_(6035274_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000583983	7	6035155 - 6035274	7	5995524 - 5995643	583983	566109		
NC_000007.13:g.(?_6036947)_(6038916_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000583771	7	6036947 - 6038916	7	5997316 - 5999285	583771	566114		
NM_000535.7(PMS2):c.1532del (p.Thr511fs)	PMS2	T200fs, T376fs, T324fs, T405fs, T459fs, T408fs, T511fs, T320fs	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545777	7	6026864	7	5987233	545777	536331	rs1554297636	NC_000007.14:5987232:G:
NC_000007.13:g.(?_6035159)_(6035270_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000455102	7	6035159 - 6035270	7	5995528 - 5995639	455102	456841		
NC_000007.13:g.(?_6031598)_(6037060_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000455100	7	6031598 - 6037060	7	5991967 - 5997429	455100	456479		
NM_000535.7(PMS2):c.1987G>T (p.Glu663Ter)	PMS2	E663*, E352*, E472*, E560*, E611*, E476*, E528*, E557*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449941	7	6026409	7	5986778	449941	444147	rs1554297061	NC_000007.14:5986777:C:A
NM_000535.7(PMS2):c.655G>T (p.Gly219Ter)	PMS2	G219*, G113*, G84*, G116*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423043	7	6038789	7	5999158	423043	407213	rs1064796190	NC_000007.14:5999157:C:A
NM_000535.7(PMS2):c.688_689GT[1] (p.Phe231fs)	PMS2		not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000421919	7	6038753 - 6038754	7	5999122 - 5999123	421919	407212	rs1064795447	NC_000007.14:5999121:ACACA:ACA
NM_000535.7(PMS2):c.828C>A (p.Cys276Ter)	PMS2	C276*, C141*, C173*, C85*, C170*	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421403	7	6035240	7	5995609	421403	407208	rs757324104	NC_000007.14:5995608:G:T
NM_000535.7(PMS2):c.142del (p.Asp48fs)	PMS2	D48fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419888	7	6045544	7	6005913	419888	407233	rs1064794173	NC_000007.14:6005912:CC:C
NM_000535.7(PMS2):c.248T>G (p.Leu83Ter)	PMS2	L83*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: May 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419752	7	6043605	7	6003974	419752	407229	rs1064794083	NC_000007.14:6003973:A:C
NM_000535.7(PMS2):c.537+1del	PMS2		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000419435	7	6042083	7	6002452	419435	407218	rs1064793868	NC_000007.14:6002451:CC:C
NM_000535.7(PMS2):c.2140C>T (p.Gln714Ter)	PMS2	Q714*, Q403*, Q523*, Q579*, Q608*, Q611*, Q662*, Q527*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000392296	7	6022489	7	5982858	392296	369177	rs1057524433	NC_000007.14:5982857:G:A
NM_000535.7(PMS2):c.139_146del (p.Leu47fs)	PMS2	L47fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265547	7	6045540 - 6045547	7	6005909 - 6005916	265547	259871	rs886039615	NC_000007.14:6005908:GCATCCAG:
NM_000535.7(PMS2):c.945_946AC[1] (p.His316fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000237934	7	6031644 - 6031645	7	5992013 - 5992014	237934	240129	rs878854060	NC_000007.14:5992012:GTGT:GT
NM_000535.7(PMS2):c.1500dup (p.Val501fs)	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000237887	7	6026895 - 6026896	7	5987264 - 5987265	237887	240118	rs759151952	NC_000007.14:5987264:GG:GGG
NM_000535.7(PMS2):c.7C>T (p.Arg3Ter)	PMS2	R3*	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234658	7	6048644	7	6009013	234658	231695	rs763939668	NC_000007.14:6009012:G:A
NM_000535.7(PMS2):c.1638_1639del (p.Ser547fs)	PMS2	S356fs, S360fs, S441fs, S236fs, S412fs, S444fs, S495fs, S547fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216075	7	6026757 - 6026758	7	5987126 - 5987127	216075	212594	rs863224498	NC_000007.14:5987125:AAAAA:AAA
NM_000535.7(PMS2):c.354-1G>A	PMS2	S15N	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 11, 2018)	criteria provided, single submitter	VCV000187726	7	6042268	7	6002637	187726	182800	rs786203954	NC_000007.14:6002636:C:T
NM_000535.7(PMS2):c.1067del (p.Lys356fs)	PMS2	K250fs, K45fs, K165fs, K221fs, K253fs, K356fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000140957	7	6029508	7	5989877	140957	150671	rs587781395	NC_000007.14:5989876:TTT:TT
NM_000535.7(PMS2):c.804-2A>G	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000850689	7	6035266	7	5995635	850689	852372		NC_000007.14:5995634:T:C
NC_000007.14:g.(?_5986749)_(6009116_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832347	7	6026380 - 6048747			832347	819891		
NC_000007.14:g.(?_5973399)_(5983001_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831236	7	6013030 - 6022632			831236	819887		
NC_000007.13:g.(?_6036947)_(6043699_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000665029	7	6036947 - 6043699	7	5997316 - 6004068	665029	651618		
NC_000007.13:g.(?_6026380)_(6031698_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000656811	7	6026380 - 6031698	7	5986749 - 5992067	656811	651619		
NM_000535.7(PMS2):c.1912del (p.Gln638fs)	PMS2	Q451fs, Q327fs, Q447fs, Q503fs, Q532fs, Q535fs, Q586fs, Q638fs	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619889	7	6026484	7	5986853	619889	611076	rs1562626070	NC_000007.14:5986852:G:
NC_000007.13:g.(?_6048618)_(6048660_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000584392	7	6048618 - 6048660	7	6008987 - 6009029	584392	561158		
NC_000007.13:g.(?_6026380)_(6048660_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000583645	7	6026380 - 6048660	7	5986749 - 6009029	583645	566083		
NM_000535.7(PMS2):c.33del (p.Ala12fs)	PMS2	A12fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545869	7	6045653	7	6006022	545869	536333	rs1554306605	NC_000007.14:6006021:A:
NM_000535.7(PMS2):c.206C>A (p.Ser69Ter)	PMS2	S69*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000492272	7	6043647	7	6004016	492272	484146	rs730881914	NC_000007.14:6004015:G:T
NM_000535.7(PMS2):c.1425_1428del (p.Ser476fs)	PMS2	S289fs, S476fs, S165fs, S370fs, S373fs, S285fs, S341fs, S424fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484330	7	6026968 - 6026971	7	5987337 - 5987340	484330	474616	rs1554297764	NC_000007.14:5987336:ACTCACT:ACT
NM_000535.7(PMS2):c.162_163insAATT (p.Asp55delinsAsnTer)	PMS2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484246	7	6045523 - 6045524	7	6005892 - 6005893	484246	474772	rs1554306288	NC_000007.14:6005892:AAT:AATTAAT
NM_000535.7(PMS2):c.1181del (p.Lys394fs)	PMS2	K259fs, K288fs, K342fs, K394fs, K207fs, K291fs, K83fs, K203fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480320	7	6027215	7	5987584	480320	474766	rs1554298067	NC_000007.14:5987583:TTTT:TTT
NC_000007.13:g.(?_6026384)_(6031694_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000455093	7	6026384 - 6031694	7	5986753 - 5992063	455093	456833		
NM_000535.7(PMS2):c.2275+1G>A	PMS2		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449208	7	6018226	7	5978595	449208	444146	rs1554294393	NC_000007.14:5978594:C:T
NM_000535.7(PMS2):c.1653C>A (p.Cys551Ter)	PMS2	C551*, C240*, C416*, C448*, C499*, C360*, C364*, C445*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411087	7	6026743	7	5987112	411087	396031	rs876659162	NC_000007.14:5987111:G:T
NM_000535.7(PMS2):c.2192T>G (p.Leu731Ter)	PMS2	L731*, L625*, L628*, L679*, L420*, L540*, L544*, L596*	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411015	7	6018310	7	5978679	411015	396341	rs1060503110	NC_000007.14:5978678:A:C
NC_000007.13:g.(?_6026384)_(6048656_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000267334	7	6026384 - 6048656	7	5986753 - 6009025	267334	262407		
NM_000535.7(PMS2):c.1237_1239del (p.Lys413del)	PMS2	K413del, K412del, K307del, K102del, K222del, K226del, K310del, K278del, K361del	Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000091298	7	6027157 - 6027159	7	5987526 - 5987528	91298	96773	rs267608159	NC_000007.14:5987525:TTTTTTTT:TTTTT
NM_000535.7(PMS2):c.846del (p.Ser283fs)	PMS2	S148fs, S177fs, S283fs, S92fs, S180fs	Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000009243	7	6035222	7	5995591	9243	24282	rs1057515571	NC_000007.14:5995590:CC:C
NM_000368.4(TSC1):c.2524C>T (p.Gln842Ter)	TSC1	Q842*, Q791*, Q721*, Q841*	Tuberous sclerosis 1|not provided	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000466085	9	135776203	9	132900816	466085	459509	rs1447417010	NC_000009.12:132900815:G:A
NM_000368.5(TSC1):c.897_898CA[2] (p.Gln301fs)	TSC1		Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, multiple submitters, no conflicts	VCV000049120	9	135787680 - 135787681	9	132912293 - 132912294	49120	58282	rs118203464	NC_000009.12:132912292:TGTGTGT:TGTGT
NM_000368.4(TSC1):c.2362G>T (p.Glu788Ter)	TSC1	E788*, E667*, E737*, E787*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000048946	9	135778021	9	132902634	48946	58108	rs118203685	NC_000009.12:132902633:C:A
NM_000368.4(TSC1):c.211-1G>A	TSC1		Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000048902	9	135801127	9	132925740	48902	58064	rs118203353	NC_000009.12:132925739:C:T
NM_001162426.2(TSC1):c.1705_1706del (p.Arg569fs)	TSC1	R519fs, R449fs, R570fs, R569fs	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000048818	9	135781256 - 135781257	9	132905869 - 132905870	48818	57980	rs118203564	NC_000009.12:132905868:CT:
NM_000368.5(TSC1):c.1580_1581del (p.Gln527fs)	TSC1	Q406fs, Q526fs, Q476fs, Q527fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000048805	9	135781384 - 135781385	9	132905997 - 132905998	48805	57967	rs118203550	NC_000009.12:132905996:CT:
NM_000368.4(TSC1):c.671T>G (p.Met224Arg)	TSC1	M224R, M103R, M173R	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000005104	9	135796816	9	132921429	5104	20143	rs118203426	NC_000009.12:132921428:A:C
NM_000368.4(TSC1):c.749T>A (p.Leu250Ter)	TSC1	L250*, L199*, L129*	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000005098	9	135787833	9	132912446	5098	20137	rs118203447	NC_000009.12:132912445:A:T
NM_000535.7(PMS2):c.634C>T (p.Gln212Ter)	PMS2	Q212*, Q106*, Q109*, Q77*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000574729	7	6038810	7	5999179	574729	567051	rs1562678257	NC_000007.14:5999178:G:A
NM_000535.7(PMS2):c.1332del (p.Ser445fs)	PMS2	S134fs, S258fs, S310fs, S339fs, S445fs, S254fs, S342fs, S393fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000492250	7	6027064	7	5987433	492250	483996	rs1554297877	NC_000007.14:5987432:CC:C
NM_000535.7(PMS2):c.223del (p.Gly74_Val75insTer)	PMS2	G3fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000455694	7	6043630	7	6003999	455694	457905	rs1554304974	NC_000007.14:6003998:CCCC:CCC
NM_000535.7(PMS2):c.752_753TG[2] (p.Cys252_Glu253delinsTer)	PMS2		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421093	7	6037003 - 6037004	7	5997372 - 5997373	421093	407210	rs1064794905	NC_000007.14:5997371:CACACAC:CACAC
NM_000535.6(PMS2):c.2182_2184delinsG (p.Thr728Alafs)	PMS2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231999	7	6018318 - 6018320	7	5978687 - 5978689	231999	233484	rs1554294508	NC_000007.14:5978686:AGT:C
NM_000535.7(PMS2):c.2155C>T (p.Gln719Ter)	PMS2	Q719*, Q408*, Q613*, Q528*, Q584*, Q667*, Q532*, Q616*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231993	7	6022474	7	5982843	231993	233486	rs876659480	NC_000007.14:5982842:G:A
NM_000535.7(PMS2):c.853_856ACAG[1] (p.Asp286fs)	PMS2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183860	7	6035204 - 6035211	7	5995573 - 5995580	183860	182780	rs267608154	NC_000007.14:5995572:CTGTCTGTCTGT:CTGT
NM_000287.4(PEX6):c.821C>T (p.Pro274Leu)	PEX6	P274L	Heimler syndrome 2|Inborn genetic diseases|Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B|Peroxisome biogenesis disorder 4B	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217424	6	42946068	6	42978330	217424	214063	rs61753219	NC_000006.12:42978329:G:A
NC_000007.14:g.(?_5977578)_(5978706_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000831096	7	6017209 - 6018337			831096	819888		
NM_000535.7(PMS2):c.1206del (p.Gln402fs)	PMS2	Q211fs, Q299fs, Q267fs, Q296fs, Q350fs, Q402fs, Q215fs, Q91fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000628359	7	6027190	7	5987559	628359	617393	rs1562636427	NC_000007.14:5987558:TT:T
NC_000007.13:g.(?_6035155)_(6038916_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000583779	7	6035155 - 6038916	7	5995524 - 5999285	583779	566113		
NC_000007.13:g.(?_6029421)_(6029596_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000583476	7	6029421 - 6029596	7	5989790 - 5989965	583476	566108		
NM_000535.7(PMS2):c.1743del (p.Glu582fs)	PMS2	E271fs, E395fs, E447fs, E479fs, E391fs, E530fs, E582fs, E476fs	Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372470	7	6026653	7	5987022	372470	359650	rs1057517801	NC_000007.14:5987021:TTTTTT:TTTTT
NM_000535.7(PMS2):c.445del (p.Tyr149fs)	PMS2	Y149fs, Y43fs, Y46fs, Y14fs	Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372468	7	6042176	7	6002545	372468	359807	rs769742496	NC_000007.14:6002544:A:
NM_000535.7(PMS2):c.851C>G (p.Ser284Ter)	PMS2	S284*, S149*, S181*, S93*, S178*	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233656	7	6035217	7	5995586	233656	233552	rs587782898	NC_000007.14:5995585:G:C
NM_000535.7(PMS2):c.1492_1502del (p.Ser498fs)	PMS2	S307fs, S392fs, S395fs, S363fs, S187fs, S446fs, S311fs, S498fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233521	7	6026894 - 6026904	7	5987263 - 5987273	233521	233518	rs876660459	NC_000007.14:5987262:ACGGAAGTGCT:
NM_000535.7(PMS2):c.2137C>T (p.Gln713Ter)	PMS2	Q713*, Q402*, Q526*, Q607*, Q610*, Q522*, Q578*, Q661*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232650	7	6022492	7	5982861	232650	233487	rs876659900	NC_000007.14:5982860:G:A
NM_000535.7(PMS2):c.23+1G>T	PMS2		not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141871	7	6048627	7	6008996	141871	151585	rs587782074	NC_000007.14:6008995:C:A
NM_000535.7(PMS2):c.219T>A (p.Cys73Ter)	PMS2	C73*, W2R	Turcot syndrome	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000009249	7	6043634	7	6004003	9249	24288	rs121434630	NC_000007.14:6004002:A:T
NM_000244.3(MEN1):c.134A>G (p.Glu45Gly)	MEN1	E45G	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000643100	11	64577448	11	64809976	643100	640314		NC_000011.10:64809975:T:C
NM_000244.3(MEN1):c.1267G>C (p.Asp423His)	MEN1	D418H, D423H, D460H, D383H	Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201015	11	64572604	11	64805132	201015	197531	rs104894264	NC_000011.10:64805131:C:G
NM_000244.3(MEN1):c.518T>C (p.Leu173Pro)	MEN1	L168P, L173P	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036532	11	64575514	11	64808042	36532	45194	rs386134256	NC_000011.10:64808041:A:G
NM_000244.3(MEN1):c.1A>G (p.Met1Val)	MEN1	M1V	Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036525	11	64577581	11	64810109	36525	45187	rs386134250	NC_000011.10:64810108:T:C
NM_000535.7(PMS2):c.730C>T (p.Gln244Ter)	PMS2	Q244*, Q141*, Q53*, Q109*, Q138*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620098	7	6037030	7	5997399	620098	611683	rs1562671039	NC_000007.14:5997398:G:A
NC_000007.13:g.(?_6017209)_(6017398_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000584041	7	6017209 - 6017398	7	5977578 - 5977767	584041	566078		
NM_000535.7(PMS2):c.2413C>T (p.Gln805Ter)	PMS2	Q805*, Q614*, Q699*, Q816*, Q618*, Q681*, Q702*, Q494*, Q670*, Q753*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486924	7	6017251	7	5977620	486924	474645	rs1554293810	NC_000007.14:5977619:G:A
NC_000007.13:g.(?_6017213)_(6017394_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000455088	7	6017213 - 6017394	7	5977582 - 5977763	455088	456126		
NM_003002.4(SDHD):c.64C>T (p.Arg22Ter)	SDHD	R22*	not provided|Pheochromocytoma|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome|Paragangliomas 1	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006903	11	111958592	11	112087868	6903	21942	rs104894306	NC_000011.10:112087867:C:T
NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	SDHD	Y114C, M66V, Y75C	Paragangliomas 1|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006900	11	111965555	11	112094831	6900	21939	rs104894304	NC_000011.10:112094830:A:G
NM_002485.4(NBN):c.1903A>T (p.Lys635Ter)	NBN	K635*, K553*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided|Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia|Acute lymphoid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142559	8	90960063	8	89947835	142559	152273	rs587782545	NC_000008.11:89947834:T:A
NM_000256.3(MYBPC3):c.1790G>A (p.Arg597Gln)	MYBPC3	R597Q	Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164098	11	47363542	11	47341991	164098	175179	rs727503195	NC_000011.10:47341990:C:T
NM_000256.3(MYBPC3):c.3490+1G>A	MYBPC3		Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042715	11	47354364	11	47332813	42715	51885	rs397516020	NC_000011.10:47332812:C:T
NM_000256.3(MYBPC3):c.1351+2T>C	MYBPC3		not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042525	11	47364570	11	47343019	42525	51695	rs397515897	NC_000011.10:47343018:A:G
NM_000256.3(MYBPC3):c.3330+5G>A	MYBPC3		Familial hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008602	11	47354740	11	47333189	8602	23641	rs373746463	NC_000011.10:47333188:C:T
NM_182961.4(SYNE1):c.18715C>T (p.Gln6239Ter)	SYNE1	Q6168*, Q6239*	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000620275	6	152589291	6	152268156	620275	611648	rs1562643321	NC_000006.12:152268155:G:A
NM_182961.4(SYNE1):c.10145+1G>A	SYNE1		not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000597825	6	152685981	6	152364846	597825	588886	rs1563391747	NC_000006.12:152364845:C:T
NM_182961.4(SYNE1):c.253C>T (p.Arg85Ter)	SYNE1	R85*	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000593026	6	152841650	6	152520515	593026	584090	rs768958602	NC_000006.12:152520514:G:A
NM_182961.4(SYNE1):c.17229T>G (p.Tyr5743Ter)	SYNE1	Y5672*, Y5743*	not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000523789	6	152629741	6	152308606	523789	514527	rs377344899	NC_000006.12:152308605:A:C
NM_182961.4(SYNE1):c.23979-2A>G	SYNE1		not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000502723	6	152476179	6	152155044	502723	494146	rs1362058277	NC_000006.12:152155043:T:C
NM_182961.4(SYNE1):c.21052G>T (p.Glu7018Ter)	SYNE1	E6947*, E7018*	not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000502082	6	152551825	6	152230690	502082	493506	rs1554246434	NC_000006.12:152230689:C:A
NM_182961.4(SYNE1):c.639del (p.His214fs)	SYNE1	H221fs, H214fs	not provided	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000502007	6	152826475	6	152505340	502007	493431	rs1412791793	NC_000006.12:152505339:AAA:AA
NM_182961.4(SYNE1):c.1912C>T (p.Gln638Ter)	SYNE1	Q638*, Q645*	not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000500903	6	152786413	6	152465278	500903	492327	rs1554756035	NC_000006.12:152465277:G:A
NM_182961.4(SYNE1):c.14644C>T (p.Arg4882Ter)	SYNE1	R4811*, R4882*	not provided	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000498361	6	152651176	6	152330041	498361	489785	rs375077588	NC_000006.12:152330040:G:A
NM_182961.3(SYNE1):c.9973delG (p.Ala3325Leufs)	SYNE1		not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000497675	6	152686154	6	152365019	497675	489099	rs1554550339	
NM_182961.4(SYNE1):c.23020-1G>A	SYNE1		not provided	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000497560	6	152523085	6	152201950	497560	488984	rs1554544827	NC_000006.12:152201949:C:T
NM_182961.4(SYNE1):c.19223T>A (p.Leu6408Ter)	SYNE1	L6337*, L6408*	not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000452536	6	152576763	6	152255628	452536	443905	rs758337239	NC_000006.12:152255627:A:T
NM_182961.4(SYNE1):c.24127G>T (p.Glu8043Ter)	SYNE1	E7972*, E8043*, E245*, E198*	not provided	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000379276	6	152476029	6	152154894	379276	368408	rs1057520552	NC_000006.12:152154893:C:A
NM_182961.4(SYNE1):c.12121C>T (p.Arg4041Ter)	SYNE1	R4041*, R3970*	not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000288640	6	152665320	6	152344185	288640	272877	rs886043963	NC_000006.12:152344184:G:A
NM_182961.4(SYNE1):c.23071_23099del (p.Thr7691fs)	SYNE1	T7620fs, T7691fs	not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000287467	6	152523005 - 152523033	6	152201870 - 152201898	287467	271704	rs886043645	NC_000006.12:152201869:AGAGACTGCGAAAGCTTCTTTTTGAAAGT:
NM_182961.4(SYNE1):c.19514dup (p.Tyr6505Ter)	SYNE1		not provided	Pathogenic(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	VCV000285068	6	152570353 - 152570354	6	152249218 - 152249219	285068	269305	rs886043012	NC_000006.12:152249218:T:TT
NM_182961.4(SYNE1):c.10443+1G>T	SYNE1		not provided	Pathogenic(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	VCV000284128	6	152680449	6	152359314	284128	268365	rs886042799	NC_000006.12:152359313:C:A
NM_182961.4(SYNE1):c.18738_18739TC[1] (p.Leu6247fs)	SYNE1		not provided	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000283562	6	152589265 - 152589266	6	152268130 - 152268131	283562	267799	rs886042657	NC_000006.12:152268129:GAGA:GA
NM_182961.4(SYNE1):c.21934C>T (p.Gln7312Ter)	SYNE1	Q7312*, Q7241*	not provided	Pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	VCV000282553	6	152540248	6	152219113	282553	266790	rs886042421	NC_000006.12:152219112:G:A
NM_182961.4(SYNE1):c.17816_17820del (p.Asp5939fs)	SYNE1	D5939fs, D5868fs	not provided	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000199228	6	152615125 - 152615129	6	152293990 - 152293994	199228	196387	rs794727986	NC_000006.12:152293989:CAAATCA:CA
NM_182961.4(SYNE1):c.4370_4371CT[1] (p.Leu1458fs)	SYNE1		not provided	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000196929	6	152755018 - 152755019	6	152433883 - 152433884	196929	194090	rs794727577	NC_000006.12:152433882:AGAG:AG
NM_182961.4(SYNE1):c.4908C>A (p.Tyr1636Ter)	SYNE1	Y1636*, Y1643*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000807697	6	152749408	6	152428273	807697	798570		NC_000006.12:152428272:G:T
NM_182961.4(SYNE1):c.12247C>T (p.Gln4083Ter)	SYNE1	Q4083*, Q4012*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000807507	6	152660480	6	152339345	807507	798569		NC_000006.12:152339344:G:A
NM_182961.4(SYNE1):c.1562C>G (p.Ser521Ter)	SYNE1	S521*, S528*	not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000805557	6	152792802	6	152471667	805557	793176		NC_000006.12:152471666:G:C
NM_182961.4(SYNE1):c.23461-1G>A	SYNE1		Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638338	6	152497696	6	152176561	638338	626309		NC_000006.12:152176560:C:T
NM_182961.3(SYNE1):c.24979del (p.Asp8327Thrfs)	SYNE1		not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000586728	6	152464898	6	152143763	586728	576861	rs1562984446	
NM_182961.4(SYNE1):c.14212G>T (p.Glu4738Ter)	SYNE1	E4667*, E4738*	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000586711	6	152651608	6	152330473	586711	576874	rs1563118316	NC_000006.12:152330472:C:A
NM_182961.4(SYNE1):c.13861dup (p.Thr4621fs)	SYNE1		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000586710	6	152651958 - 152651959	6	152330823 - 152330824	586710	576875	rs1563123183	NC_000006.12:152330823:T:TT
NM_182961.4(SYNE1):c.20970del (p.Asp6991fs)	SYNE1	D6920fs, D6991fs	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549688	6	152552595	6	152231460	549688	540447	rs1554247806	NC_000006.12:152231459:A:
NM_182961.4(SYNE1):c.4939C>T (p.Gln1647Ter)	SYNE1	Q1647*, Q1654*	not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000448603	6	152749377	6	152428242	448603	441006	rs1554681651	NC_000006.12:152428241:G:A
NM_182961.4(SYNE1):c.3842del (p.Lys1281fs)	SYNE1	K1281fs, K1288fs	not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000448599	6	152763376	6	152442241	448599	441010	rs1554709875	NC_000006.12:152442240:TTTT:TTT
NM_182961.4(SYNE1):c.23492del (p.Glu7831fs)	SYNE1	E7760fs, E7831fs, E33fs	not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000448586	6	152497664	6	152176529	448586	440945	rs1554491478	NC_000006.12:152176528:T:
NM_182961.4(SYNE1):c.16085_16092del (p.Ile5362fs)	SYNE1	I5291fs, I5362fs	not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000448559	6	152642517 - 152642524	6	152321382 - 152321389	448559	440970	rs1554440887	NC_000006.12:152321381:TAGGAGAAT:T
NM_182961.4(SYNE1):c.24284G>A (p.Arg8095His)	SYNE1	R257H, R8024H, R8095H, R297H, R250H	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000002332	6	152473122	6	152151987	2332	17371	rs119103246	NC_000006.12:152151986:C:T
NM_182961.4(SYNE1):c.2536C>T (p.Gln846Ter)	SYNE1	Q853*, Q846*	Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000863071	6	152779924	6	152458789	863071	831714		NC_000006.12:152458788:G:A
NM_182961.4(SYNE1):c.17648C>A (p.Ser5883Ter)	SYNE1	S5812*, S5883*	Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000843446	6	152621810	6	152300675	843446	831672		NC_000006.12:152300674:G:T
NM_182961.4(SYNE1):c.4513G>T (p.Glu1505Ter)	SYNE1	E1505*, E1512*	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000662396	6	152751793	6	152430658	662396	634734		NC_000006.12:152430657:C:A
NM_182961.4(SYNE1):c.24221C>G (p.Ser8074Ter)	SYNE1	S229*, S8074*, S8003*, S276*	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000650439	6	152473185	6	152152050	650439	634679		NC_000006.12:152152049:G:C
NM_182961.4(SYNE1):c.551T>A (p.Leu184Ter)	SYNE1	L184*, L191*	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000650230	6	152831358	6	152510223	650230	634745		NC_000006.12:152510222:A:T
NM_182961.4(SYNE1):c.21741C>A (p.Tyr7247Ter)	SYNE1	Y7176*, Y7247*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jul 11, 2019)	no assertion criteria provided	VCV000635784	6	152542097	6	152220962	635784	623615		NC_000006.12:152220961:G:T
NM_182961.4(SYNE1):c.5098C>T (p.Gln1700Ter)	SYNE1	Q1700*, Q1707*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634538	6	152748830	6	152427695	634538	622358	rs1563941569	NC_000006.12:152427694:G:A
NM_182961.4(SYNE1):c.3023G>A (p.Trp1008Ter)	SYNE1	W1008*, W1015*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634536	6	152774725	6	152453590	634536	622360	rs1564136499	NC_000006.12:152453589:C:T
NM_182961.4(SYNE1):c.18012+1G>T	SYNE1		Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634534	6	152614722	6	152293587	634534	622505	rs1562842409	NC_000006.12:152293586:C:A
NM_182961.4(SYNE1):c.17215C>T (p.Gln5739Ter)	SYNE1	Q5668*, Q5739*	Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000571581	6	152629755	6	152308620	571581	565468	rs746328978	NC_000006.12:152308619:G:A
NM_182961.4(SYNE1):c.1369del (p.Asp457fs)	SYNE1	D464fs, D457fs	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000522811	6	152793530	6	152472395	522811	513419	rs1554768245	NC_000006.12:152472394:CC:C
NM_182961.4(SYNE1):c.21732C>A (p.Tyr7244Ter)	SYNE1	Y7173*, Y7244*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000520413	6	152542106	6	152220971	520413	511008	rs1554226673	NC_000006.12:152220970:G:T
NM_182961.4(SYNE1):c.3499_3500del (p.Ala1166_Val1167insTer)	SYNE1		Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000465780	6	152770672 - 152770673	6	152449537 - 152449538	465780	455481	rs1554721227	NC_000006.12:152449536:AC:
NM_182961.4(SYNE1):c.1021G>T (p.Glu341Ter)	SYNE1	E341*, E348*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	VCV000436909	6	152809557	6	152488422	436909	428533	rs1203553546	NC_000006.12:152488421:C:A
NM_182961.4(SYNE1):c.5161G>T (p.Glu1721Ter)	SYNE1	E1721*, E1728*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000436907	6	152746622	6	152425487	436907	428531	rs1554676394	NC_000006.12:152425486:C:A
NM_182961.4(SYNE1):c.22408G>T (p.Glu7470Ter)	SYNE1	E7399*, E7470*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000436906	6	152534833	6	152213698	436906	428530	rs1554573328	NC_000006.12:152213697:C:A
NM_182961.4(SYNE1):c.23001dup (p.Leu7668fs)	SYNE1		Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000436905	6	152527320 - 152527321	6	152206185 - 152206186	436905	428529	rs1554553667	NC_000006.12:152206185:TTTTTT:TTTTTTT
NM_182961.4(SYNE1):c.6877del (p.Glu2293fs)	SYNE1	E2293fs, E2300fs	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000212344	6	152722425	6	152401290	212344	207335	rs797046026	NC_000006.12:152401289:C:
NM_182961.4(SYNE1):c.25009C>T (p.Gln8337Ter)	SYNE1	Q8289*, Q8337*, Q515*, Q539*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Feb 13, 2015)	criteria provided, single submitter	VCV000212342	6	152464868	6	152143733	212342	207327	rs797046025	NC_000006.12:152143732:G:A
NM_182961.4(SYNE1):c.16421C>A (p.Ser5474Ter)	SYNE1	S5403*, S5474*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Feb 13, 2015)	criteria provided, single submitter	VCV000212339	6	152639367	6	152318232	212339	207330	rs797046024	NC_000006.12:152318231:G:T
NM_182961.4(SYNE1):c.13299del (p.His4433fs)	SYNE1	H4433fs, H4362fs	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000204299	6	152652521	6	152331386	204299	200696	rs1563130387	NC_000006.12:152331385:G:
NM_182961.4(SYNE1):c.10768C>T (p.Arg3590Ter)	SYNE1	R3597*, R3590*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000157658	6	152675952	6	152354817	157658	167504	rs606231292	NC_000006.12:152354816:G:A
NM_182961.4(SYNE1):c.24313-2A>G	SYNE1		ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE	Pathogenic(Last reviewed: Sep 15, 2009)	no assertion criteria provided	VCV000002335	6	152472827	6	152151692	2335	17374		NC_000006.12:152151691:T:C
NM_182961.4(SYNE1):c.11909_11910del (p.Met3970fs)	SYNE1	M3899fs, M3970fs	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000002331	6	152668362 - 152668363	6	152347227 - 152347228	2331	17370	rs606231135	NC_000006.12:152347226:CA:
NM_182961.4(SYNE1):c.22369C>T (p.Gln7457Ter)	SYNE1	Q7386*, Q7457*	Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000002330	6	152534872	6	152213737	2330	17369	rs119103245	NC_000006.12:152213736:G:A
SYNE1, 5-BP DEL, NT334338	SYNE1		Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000002328					2328	17367		
NM_182961.4(SYNE1):c.1217_1218CT[1] (p.Leu407fs)	SYNE1		Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000568019	6	152804350 - 152804351	6	152483215 - 152483216	568019	565498	rs1564367104	NC_000006.12:152483214:AGAGA:AGA
NM_182961.4(SYNE1):c.22709_22763del (p.Glu7570fs)	SYNE1	E7499fs, E7570fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448583	6	152529168 - 152529222	6	152208033 - 152208087	448583	440948	rs1554558620	
NM_004333.6(BRAF):c.1802A>C (p.Lys601Thr)	BRAF	K601T, K564T, K567T, K579T, K604T, K641T, K513T, K549T	Cardiofaciocutaneous syndrome 1|Neoplasm of the thyroid gland|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Malignant melanoma of skin|Lung adenocarcinoma|Chronic lymphocytic leukemia|Adenocarcinoma of prostate|Cardio-facio-cutaneous syndrome|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000044818	7	140453133	7	140753333	44818	53985	rs397507484	NC_000007.14:140753332:T:G
NM_000535.7(PMS2):c.1970dup (p.Asn657fs)	PMS2		Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420579	7	6026425 - 6026426	7	5986794 - 5986795	420579	407176	rs1064794566	NC_000007.14:5986794:TTTT:TTTTT
NM_000535.7(PMS2):c.251-2A>C	PMS2		Hereditary cancer-predisposing syndrome|Colon polyps	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233781	7	6043425	7	6003794	233781	233596	rs587779340	NC_000007.14:6003793:T:G
NM_000535.7(PMS2):c.2T>G (p.Met1Arg)	PMS2	M1R	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231873	7	6048649	7	6009018	231873	233615	rs587780059	NC_000007.14:6009017:A:C
NM_000535.7(PMS2):c.2007-2A>C	PMS2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142251	7	6022624	7	5982993	142251	151965	rs587782336	NC_000007.14:5982992:T:G
NM_000535.7(PMS2):c.325del (p.Glu109fs)	PMS2	E109fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141395	7	6043349	7	6003718	141395	151109	rs587781716	NC_000007.14:6003717:CCCCCC:CCCCC
NM_182961.4(SYNE1):c.16390-2A>C	SYNE1		Spinocerebellar ataxia, autosomal recessive 8|not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000465779	6	152639400	6	152318265	465779	455466	rs759460806	NC_000006.12:152318264:T:G
NM_182961.4(SYNE1):c.18682C>T (p.Gln6228Ter)	SYNE1	Q6157*, Q6228*	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379571	6	152590313	6	152269178	379571	368927	rs910956017	NC_000006.12:152269177:G:A
NM_182961.4(SYNE1):c.23131C>T (p.Gln7711Ter)	SYNE1	Q7640*, Q7711*	not provided|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000002329	6	152522973	6	152201838	2329	17368	rs119103244	NC_000006.12:152201837:G:A
NM_138694.4(PKHD1):c.1486C>T (p.Arg496Ter)	PKHD1	R496*	Autosomal recessive polycystic kidney disease|Polycystic liver disease|not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004114	6	51923147	6	52058349	4114	19153	rs137852949	NC_000006.12:52058348:G:A
NM_182961.4(SYNE1):c.480_481CT[1] (p.Ser160_Ser161insTer)	SYNE1		not provided|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000436910	6	152831426 - 152831427	6	152510291 - 152510292	436910	428534	rs1554829141	NC_000006.12:152510290:AGAG:AG
NM_182961.4(SYNE1):c.24577C>T (p.Arg8193Ter)	SYNE1	R8122*, R8193*, R348*, R395*	ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE|not provided	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000284512	6	152470677	6	152149542	284512	268749	rs760715690	NC_000006.12:152149541:G:A
NM_033071.3(SYNE1):c.20050C>T	SYNE1	R6684*, R6755*	not provided|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242515	6	152557375	6	152236240	242515	213565	rs780451185	NC_000006.12:152236239:G:A
NM_000368.4(TSC1):c.2389C>T (p.Gln797Ter)	TSC1	Q797*, Q676*, Q746*, Q796*	Tuberous sclerosis syndrome|Tuberous sclerosis 1|not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000064813	9	135777994	9	132902607	64813	75742	rs397514862	NC_000009.12:132902606:G:A
NM_000368.4(TSC1):c.2272C>T (p.Gln758Ter)	TSC1	Q758*, Q757*, Q707*, Q637*	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000064712	9	135778111	9	132902724	64712	75641	rs397514783	NC_000009.12:132902723:G:A
NM_000368.5(TSC1):c.973C>T (p.Gln325Ter)	TSC1	Q325*, Q204*, Q274*	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000049130	9	135786896	9	132911509	49130	58292	rs118203474	NC_000009.12:132911508:G:A
NM_000368.4(TSC1):c.1697del (p.Pro566fs)	TSC1	P515fs, P445fs, P565fs, P566fs	Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048817	9	135781268	9	132905881	48817	57979	rs118203563	NC_000009.12:132905880:GGG:GG
NM_000368.5(TSC1):c.1257del (p.Arg420fs)	TSC1	R369fs, R420fs, R299fs, R419fs	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	VCV000048753	9	135785964	9	132910577	48753	57915	rs118203506	NC_000009.12:132910576:GGGGGG:GGGGG
NC_000007.13:g.(?_6026380)_(6027261_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000662870	7	6026380 - 6027261	7	5986749 - 5987630	662870	651607		
NM_000535.5(PMS2):c.904-10_*10del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000648932			7	5973389 - 5992067	648932	651718		
NC_000007.13:g.(?_6013020)_(6022632_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000583516	7	6013020 - 6022632	7	5973389 - 5983001	583516	561151		
NM_000535.7(PMS2):c.269_270dup (p.Lys91fs)	PMS2		Hereditary nonpolyposis colorectal cancer type 4|not provided|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548899	7	6043403 - 6043404	7	6003772 - 6003773	548899	539271	rs1554304745	NC_000007.14:6003772:AGA:AGAGA
NC_000007.13:g.(?_6013024)_(6022628_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000455086			7	5973393 - 5982997	455086	456123		
NM_000535.7(PMS2):c.1579_1580del (p.Arg527fs)	PMS2	R424fs, R527fs, R336fs, R392fs, R475fs, R216fs, R421fs, R340fs	not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418417	7	6026816 - 6026817	7	5987185 - 5987186	418417	407186	rs1064793234	NC_000007.14:5987184:CT:
NM_000535.7(PMS2):c.631C>T (p.Arg211Ter)	PMS2	R211*, R76*, R105*, R108*	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234508	7	6038813	7	5999182	234508	231681	rs760228510	NC_000007.14:5999181:G:A
NM_000535.7(PMS2):c.2156del (p.Gln719fs)	PMS2	Q584fs, Q528fs, Q532fs, Q719fs, Q408fs, Q613fs, Q616fs, Q667fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000183755	7	6022473	7	5982842	183755	182699	rs786201062	NC_000007.14:5982841:T:
NM_001134363.3(RBM20):c.1907G>A (p.Arg636His)	RBM20	R636H	not provided|Cardiomyopathy|Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|Familial dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000271	10	112572062	10	110812304	271	15310	rs267607004	NC_000010.11:110812303:G:A
NM_005609.4(PYGM):c.1768+1G>A	PYGM		Inborn genetic diseases|Glycogen storage disease, type V|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194389	11	64519395	11	64751923	194389	191552	rs771427957	NC_000011.10:64751922:C:T
NC_000007.13:g.(?_6026380)_(6035274_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000661735	7	6026380 - 6035274	7	5986749 - 5995643	661735	651625		
NM_000535.7(PMS2):c.1471G>T (p.Glu491Ter)	PMS2	E491*, E356*, E439*, E180*, E388*, E300*, E304*, E385*	Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486935	7	6026925	7	5987294	486935	474600	rs1064794577	NC_000007.14:5987293:C:A
NM_000535.7(PMS2):c.1164del (p.His388fs)	PMS2	H201fs, H282fs, H285fs, H336fs, H388fs, H197fs, H77fs, H253fs	Turcot syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480324	7	6027232	7	5987601	480324	474621	rs1554298082	NC_000007.14:5987600:A:
NM_000535.7(PMS2):c.241G>T (p.Glu81Ter)	PMS2	E81*, R9L	not provided|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439243	7	6043612	7	6003981	439243	432650	rs730881919	NC_000007.14:6003980:C:A
NM_000535.7(PMS2):c.1778del (p.Lys593fs)	PMS2	K402fs, K458fs, K487fs, K541fs, K593fs, K282fs, K406fs, K490fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234673	7	6026618	7	5986987	234673	231662	rs766389591	NC_000007.14:5986986:TTTT:TTT
NM_000535.7(PMS2):c.354-2A>G	PMS2	S15G	not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185340	7	6042269	7	6002638	185340	182801	rs786202098	NC_000007.14:6002637:T:C
NM_002485.4(NBN):c.127C>T (p.Arg43Ter)	NBN	R43*	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142203	8	90994994	8	89982766	142203	151917	rs200287925	NC_000008.11:89982765:G:A
NM_000391.4(TPP1):c.1266G>C (p.Gln422His)	TPP1	Q422H	not provided|Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068738	11	6636673	11	6615442	68738	79630	rs121908200	NC_000011.10:6615441:C:G
NM_182961.4(SYNE1):c.15918-12A>G	SYNE1		Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|Spinocerebellar ataxia, autosomal recessive 8	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002326	6	152643033	6	152321898	2326	17365	rs606231134	NC_000006.12:152321897:T:C
NM_005476.7(GNE):c.2135T>C (p.Met712Thr)	GNE	M712T, M743T, M707T, M602T, M638T	not provided|Sialuria|GNE myopathy|GNE myopathy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006025	9	36217396	9	36217399	6025	21064	rs28937594	NC_000009.12:36217398:A:G
NM_000256.3(MYBPC3):c.2556_2557delinsTCT (p.Gly853fs)	MYBPC3		Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042639	11	47358987 - 47358988	11	47337436 - 47337437	42639	51809	rs397515975	NC_000011.10:47337435:CG:AGA
NM_000162.5(GCK):c.571C>T (p.Arg191Trp)	GCK	R191W, R192W, R190W	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426122	7	44189576	7	44149977	426122	415104	rs1085307455	NC_000007.14:44149976:G:A
NM_000368.4(TSC1):c.2692C>T (p.Gln898Ter)	TSC1	Q898*, Q847*, Q897*, Q777*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048992	9	135772931	9	132897544	48992	58154	rs118203728	NC_000009.12:132897543:G:A
NM_000368.4(TSC1):c.2507C>G (p.Ser836Ter)	TSC1	S836*, S715*, S785*, S835*	Tuberous sclerosis 1|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048969	9	135776220	9	132900833	48969	58131	rs118203706	NC_000009.12:132900832:G:C
NM_000368.5(TSC1):c.1959dup (p.Gln654fs)	TSC1		Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048857	9	135781005 - 135781006	9	132905618 - 132905619	48857	58019	rs118203603	NC_000009.12:132905618:T:TT
NM_000368.4(TSC1):c.1579C>T (p.Gln527Ter)	TSC1	Q527*, Q406*, Q476*, Q526*	Tuberous sclerosis syndrome|Bladder cancer, somatic|Tuberous sclerosis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048804	9	135781386	9	132905999	48804	57966	rs118203549	NC_000009.12:132905998:G:A
NM_001370259.2(MEN1):c.1664G>A (p.Ser555Asn)	MEN1	S555N, S560N, S597N, S520N	not specified|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216134	11	64571975	11	64804503	216134	212931	rs863224527	NC_000011.10:64804502:C:T
NM_000244.3(MEN1):c.402del (p.Phe134fs)	MEN1	F134fs	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016681	11	64577180	11	64809708	16681	31720	rs397515385	NC_000011.10:64809707:G:
NM_001278716.2(FBXL4):c.1303C>T (p.Arg435Ter)	FBXL4	R435*	Inborn genetic diseases|Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|Mitochondrial DNA depletion syndrome	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000066091	6	99347158	6	98899282	66091	76993	rs201889294	NC_000006.12:98899281:G:A
NM_033056.4(PCDH15):c.7C>T (p.Arg3Ter)	PCDH15	R3*	Rare genetic deafness|not provided||Deafness, autosomal recessive 23	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004931	10	56424016	10	54664256	4931	19970	rs137853001	NC_000010.11:54664255:G:A
NC_000007.13:g.(?_6026380)_(6037064_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000584094	7	6026380 - 6037064	7	5986749 - 5997433	584094	561154		
NM_000535.7(PMS2):c.2382dup (p.Gly795fs)	PMS2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480351	7	6017281 - 6017282	7	5977650 - 5977651	480351	474518	rs1231406078	NC_000007.14:5977650:A:AA
Single allele	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000455090			7	5977582 - 5982997	455090	456133		
NM_000535.7(PMS2):c.3G>A (p.Met1Ile)	PMS2	M1I	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000450786	7	6048648	7	6009017	450786	444148	rs1554309086	NC_000007.14:6009016:C:T
NM_000535.7(PMS2):c.1864_1865del (p.Met622fs)	PMS2	M431fs, M487fs, M519fs, M435fs, M570fs, M311fs, M516fs, M622fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411059	7	6026531 - 6026532	7	5986900 - 5986901	411059	395940	rs1060503137	NC_000007.14:5986899:ATA:A
NM_182961.4(SYNE1):c.16390-2A>G	SYNE1		not provided|Spinocerebellar ataxia, autosomal recessive 8|Autosomal recessive cerebellar ataxia	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000667389	6	152639400	6	152318265	667389	654425		NC_000006.12:152318264:T:C
NM_004333.6(BRAF):c.1780G>C (p.Asp594His)	BRAF	D594H	Malignant melanoma of skin|Neoplasm of brain|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Lung adenocarcinoma|Chronic lymphocytic leukemia|Multiple myeloma|Adrenocortical carcinoma|Cutaneous melanoma|Transitional cell carcinoma of the bladder	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375947	7	140453155	7	140753355	375947	362826	rs397516896	NC_000007.14:140753354:C:G
NM_001173990.3(TMEM216):c.218G>T (p.Arg73Leu)	TMEM216	R73L, R12L	Joubert syndrome 2||Joubert syndrome 2|TMEM216-Related Disorders||not provided|Joubert syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000197	11	61161437	11	61393965	197	15236	rs201108965	NC_000011.10:61393964:G:T
NM_000260.4(MYO7A):c.5573T>C (p.Leu1858Pro)	MYO7A	L1858P, L1809P, L1820P	Deafness, autosomal dominant 11|Deafness, autosomal recessive 2||MYO7A-Related Disorders|Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043288	11	76916599	11	77205554	43288	52458	rs368657015	NC_000011.10:77205553:T:C
NM_022970.3(FGFR2):c.758C>G (p.Pro253Arg)	FGFR2	P253R, C937G, P138R, P164R, P25R	Head and Neck Neoplasms|not provided|FGFR2 related craniosynostosis||Pfeiffer syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Bent bone dysplasia syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Neoplasm of stomach|Acrocephalosyndactyly type I	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013273	10	123279674	10	121520160	13273	28312	rs77543610	NC_000010.11:121520159:G:C
NM_004260.3(RECQL4):c.792G>A (p.Trp264Ter)	RECQL4	W264*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000521456	8	145741711	8	144516327	521456	511750	rs1554902811	NC_000008.11:144516326:C:T
NM_000535.7(PMS2):c.709C>T (p.Gln237Ter)	PMS2	Q237*, Q134*, Q102*, Q46*, Q131*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439245	7	6037051	7	5997420	439245	432648	rs1458321358	NC_000007.14:5997419:G:A
NM_000535.7(PMS2):c.809C>G (p.Ser270Ter)	PMS2	S270*, S79*, S135*, S164*, S167*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183732	7	6035259	7	5995628	183732	182782	rs786201047	NC_000007.14:5995627:G:C
NM_001083602.2(PTCH1):c.1328G>A (p.Gly443Asp)	PTCH1	G509D, G443D, G457D, G358D, G508D	Hereditary cancer-predisposing syndrome|Gorlin syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000409140	9	98239117	9	95476835	409140	397429	rs1060502268	NC_000009.12:95476834:C:T
NM_002485.4(NBN):c.2140C>T (p.Arg714Ter)	NBN	R714*, R632*	Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome|Aplastic anemia|Microcephaly, normal intelligence and immunodeficiency|Acute lymphoid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182737	8	90955525	8	89943297	182737	180279	rs730881864	NC_000008.11:89943296:G:A
NM_000368.4(TSC1):c.663+1G>A	TSC1		Tuberous sclerosis 1|Bladder cancer, somatic|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000049076	9	135797205	9	132921818	49076	58238	rs118203419	NC_000009.12:132921817:C:T
NM_033360.4(KRAS):c.40G>A (p.Val14Ile)	KRAS	V14I	Noonan syndrome 3|Cardio-facio-cutaneous syndrome|Noonan syndrome|Rasopathy|Noonan syndrome|Endometrial carcinoma|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012589	12	25398279	12	25245345	12589	27628	rs104894365	NC_000012.12:25245344:C:T
NM_006766.5(KAT6A):c.3385C>T (p.Arg1129Ter)	KAT6A	R1129*	Mental retardation, autosomal dominant 32|Inborn genetic diseases|KAT6A syndrome	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000180229	8	41792353	8	41934835	180229	178417	rs786200960	NC_000008.11:41934834:G:A
NM_000136.3(FANCC):c.37C>T (p.Gln13Ter)	FANCC	Q13*	Hereditary cancer-predisposing syndrome|Fanconi anemia|not provided|Fanconi anemia, complementation group C	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012046	9	98011537	9	95249255	12046	27085	rs121917784	NC_000009.12:95249254:G:A
NM_000256.3(MYBPC3):c.3190+2T>G	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042691	11	47355106	11	47333555	42691	51861	rs113358486	NC_000011.10:47333554:A:C
NM_000256.3(MYBPC3):c.2541C>G (p.Tyr847Ter)	MYBPC3	Y847*	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042636	11	47359003	11	47337452	42636	51806	rs397515974	NC_000011.10:47337451:G:C
NM_000256.3(MYBPC3):c.2309-2A>G	MYBPC3		not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042613	11	47359347	11	47337796	42613	51783	rs111729952	NC_000011.10:47337795:T:C
NM_000256.3(MYBPC3):c.932C>A (p.Ser311Ter)	MYBPC3	S311*	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036615	11	47367916	11	47346365	36615	45277	rs193922386	NC_000011.10:47346364:G:T
NM_000256.3(MYBPC3):c.3408C>A (p.Tyr1136Ter)	MYBPC3	Y1136*	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036611	11	47354447	11	47332896	36611	45273	rs193922383	NC_000011.10:47332895:G:T
NM_001287174.2(ABCC8):c.2509C>T (p.Arg837Ter)	ABCC8	R836*, R837*, R835*, R858*	Transient neonatal diabetes mellitus 2|Permanent neonatal diabetes mellitus|Leucine-induced hypoglycemia|Diabetes mellitus type 2|Hyperinsulinemic hypoglycemia, familial, 1|Hyperinsulinemic hypoglycemia, familial, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188915	11	17434263	11	17412716	188915	186816	rs72559722	NC_000011.10:17412715:G:A
NM_005476.7(GNE):c.527A>T (p.Asp176Val)	GNE	D207V, D176V, D117V, D171V	not provided|GNE myopathy|Sialuria|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041233	9	36246117	9	36246120	41233	49657	rs139425890	NC_000009.12:36246119:T:A
NM_000162.5(GCK):c.544G>A (p.Val182Met)	GCK	V182M, V183M, V181M	Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young, type 2|Hyperinsulinism due to glucokinase deficiency|Diabetes mellitus type 2|not provided|	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000129144	7	44189603	7	44150004	129144	134590	rs587780345	NC_000007.14:44150003:C:T
NM_000244.3(MEN1):c.307del (p.Leu103fs)	MEN1	L103fs	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200996	11	64577275	11	64809803	200996	197559	rs794728639	NC_000011.10:64809802:GG:G
NM_000552.4(VWF):c.1533+1G>T	VWF		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000521600	12	6172119	12	6062953	521600	512032	rs1555198839	NC_000012.12:6062952:C:A
NC_000007.13:g.(?_6026384)_(6042273_?)del	PMS2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000525985	7	6026384 - 6042273	7	5986753 - 6002642	525985	521889		
NM_000535.7(PMS2):c.746_753del (p.Asp249fs)	PMS2	D143fs, D58fs, D146fs, D114fs, D249fs	Hereditary cancer-predisposing syndrome|Tumor susceptibility linked to germline BAP1 mutations|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142778	7	6037007 - 6037014	7	5997376 - 5997383	142778	152492	rs587782710	NC_000007.14:5997375:CACGGAGTCAC:CAC
NM_000535.7(PMS2):c.989-1G>T	PMS2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127802	7	6029587	7	5989956	127802	133259	rs587780064	NC_000007.14:5989955:C:A
NM_138694.4(PKHD1):c.8870T>C (p.Ile2957Thr)	PKHD1	I2957T	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000357423	6	51618079	6	51753281	357423	303588	rs760222236	NC_000006.12:51753280:A:G
NM_138694.4(PKHD1):c.5895dup (p.Leu1966fs)	PKHD1		Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167486	6	51824680 - 51824681	6	51959882 - 51959883	167486	177954	rs746838237	NC_000006.12:51959882:T:TT
NM_138694.4(PKHD1):c.2341C>T (p.Arg781Ter)	PKHD1	R781*	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096387	6	51913356	6	52048558	96387	102281	rs398124478	NC_000006.12:52048557:G:A
NM_152564.4(VPS13B):c.6657+1G>A	VPS13B		not provided|Cohen syndrome	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056683	8	100729602	8	99717374	56683	71322	rs180177366	NC_000008.11:99717373:G:A
NM_003002.4(SDHD):c.3G>C (p.Met1Ile)	SDHD	M1I	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006906	11	111957634	11	112086910	6906	21945	rs80338842	NC_000011.10:112086909:G:C
NM_006772.3(SYNGAP1):c.510-2A>G	SYNGAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000522081	6	33402927	6	33435150	522081	511663	rs1554120894	NC_000006.12:33435149:A:G
NM_006772.3(SYNGAP1):c.3416dup (p.Thr1140fs)	SYNGAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000522008	6	33412227 - 33412228	6	33444450 - 33444451	522008	511673	rs1554122458	NC_000006.12:33444450:A:AA
NM_006772.3(SYNGAP1):c.628_629CA[4] (p.Ser211fs)	SYNGAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000522003	6	33403046 - 33403047	6	33435269 - 33435270	522003	511664	rs1554120939	NC_000006.12:33435269:CACA:CACACACA
NM_006772.3(SYNGAP1):c.1495del (p.Arg499fs)	SYNGAP1	R499fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000521508	6	33406304	6	33438527	521508	511667	rs1554121353	NC_000006.12:33438526:A:
NM_006772.3(SYNGAP1):c.698_699dup (p.Arg234fs)	SYNGAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000521281	6	33403324 - 33403325	6	33435547 - 33435548	521281	511665	rs1554120966	NC_000006.12:33435547:TGT:TGTGT
NM_006772.3(SYNGAP1):c.3642del (p.Lys1215fs)	SYNGAP1	K1199fs, K1215fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000521197	6	33414410	6	33446633	521197	511675	rs1554122710	NC_000006.12:33446632:GG:G
NM_006772.3(SYNGAP1):c.2789_2790CT[2] (p.Phe932fs)	SYNGAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000520888	6	33411118 - 33411119	6	33443341 - 33443342	520888	511671	rs1554122252	NC_000006.12:33443340:CTCTCT:CTCT
NM_006772.3(SYNGAP1):c.1891C>T (p.Gln631Ter)	SYNGAP1	Q631*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000520809	6	33408720	6	33440943	520809	511669	rs1554121729	NC_000006.12:33440942:C:T
NM_006772.3(SYNGAP1):c.3408+1G>A	SYNGAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000520755	6	33411738	6	33443961	520755	511672	rs1554122402	NC_000006.12:33443960:G:A
NM_004260.3(RECQL4):c.1573del (p.Cys525fs)	RECQL4	C525fs	Baller-Gerold syndrome|Rothmund-Thomson syndrome type 2|High Grade Surface Osteosarcoma|B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)|Rothmund-Thomson syndrome|Rapadilino syndrome	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006066	8	145740367	8	144514983	6066	21105	rs386833845	NC_000008.11:144514982:A:
NM_000368.4(TSC1):c.1680_1702del (p.Ser561fs)	TSC1	S561fs, S440fs, S510fs, S560fs	Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000064763	9	135781263 - 135781285	9	132905876 - 132905898	64763	75692	rs118203557	NC_000009.12:132905875:CCGCAGGGCTTTCATCAGCACTGCCGCAGGGC:CCGCAGGGC
NM_000368.4(TSC1):c.664-1G>A	TSC1		not provided|Bladder cancer, somatic|Tuberous sclerosis 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000049080	9	135796824	9	132921437	49080	58242	rs118203423	NC_000009.12:132921436:C:T
NM_001162426.2(TSC1):c.2108_2109del (p.Leu702_Tyr703insTer)	TSC1		Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048905	9	135779134 - 135779135	9	132903747 - 132903748	48905	58067	rs118203645	NC_000009.12:132903746:ATA:A
NM_001162426.2(TSC1):c.1902_1903AG[1] (p.Glu635fs)	TSC1		Bladder cancer, somatic|Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000048852	9	135781057 - 135781058	9	132905670 - 132905671	48852	58014	rs118203599	NC_000009.12:132905669:CTCT:CT
NM_004333.6(BRAF):c.769C>A (p.Gln257Lys)	BRAF	Q257K, Q223K, Q260K, Q205K, Q169K	Inborn genetic diseases|not provided|Noonan syndrome|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040351	7	140501303	7	140801503	40351	48821	rs397507469	NC_000007.14:140801502:G:T
NM_004333.6(BRAF):c.721A>C (p.Thr241Pro)	BRAF	T241P, T189P, T244P, T207P, T153P	Noonan syndrome with multiple lentigines|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|Lung cancer|LEOPARD syndrome 3|Noonan syndrome 1|LEOPARD syndrome 3|Cardiofaciocutaneous syndrome 1|Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029807	7	140501351	7	140801551	29807	38762	rs387906661	NC_000007.14:140801550:T:G
NM_004333.6(BRAF):c.722C>T (p.Thr241Met)	BRAF	T241M, T189M, T207M, T244M, T153M	Noonan syndrome 1|Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|Lung cancer|LEOPARD syndrome 3|Noonan syndrome 1|Noonan syndrome 7|Noonan syndrome|Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029805	7	140501350	7	140801550	29805	38760	rs387906660	NC_000007.14:140801549:G:A
NM_002180.2(IGHMBP2):c.2T>C (p.Met1Thr)	IGHMBP2	M1T	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Inborn genetic diseases|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217448	11	68671422	11	68903954	217448	214088	rs886037759	NC_000011.10:68903953:T:C
NM_000441.2(SLC26A4):c.2162C>T (p.Thr721Met)	SLC26A4	T721M	Rare genetic deafness|not provided|Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004826	7	107350571	7	107710126	4826	19865	rs121908363	NC_000007.14:107710125:C:T
NM_001360.2(DHCR7):c.1228G>A (p.Gly410Ser)	DHCR7	G410S	not provided|History of neurodevelopmental disorder|Smith-Lemli-Opitz syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021272	11	71146621	11	71435575	21272	34124	rs80338862	NC_000011.10:71435574:C:T
NM_000256.3(MYBPC3):c.3627+1G>A	MYBPC3		not provided|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042728	11	47354116	11	47332565	42728	51898	rs397516031	NC_000011.10:47332564:C:T
NM_000256.3(MYBPC3):c.3192dup (p.Lys1065fs)	MYBPC3		Cardiovascular phenotype|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042693	11	47354883	11	47333331 - 47333332	42693	51863	rs397516007	NC_000011.10:47333331:G:GG
NM_000256.3(MYBPC3):c.177_187del (p.Glu60fs)	MYBPC3	E60fs	Hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042565	11	47372895 - 47372905	11	47351344 - 47351354	42565	51735	rs397515925	NC_000011.10:47351343:GTGTGCCCTCTGTG:GTG
NM_000535.7(PMS2):c.1376C>G (p.Ser459Ter)	PMS2	S459*, S148*, S272*, S356*, S268*, S353*, S407*, S324*	Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393103	7	6027020	7	5987389	393103	369830	rs587780724	NC_000007.14:5987388:G:C
NM_000535.7(PMS2):c.2506G>T (p.Glu836Ter)	PMS2	E836*, E525*, E712*, E649*, E730*, E701*, E733*, E784*, E847*, E645*	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183718	7	6013113	7	5973482	183718	182684	rs786201039	NC_000007.14:5973481:C:A
NM_000155.4(GALT):c.626A>G (p.Tyr209Cys)	GALT	Y209C, Y100C	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025231	9	34648392	9	34648395	25231	36565	rs111033744	NC_000009.12:34648394:A:G
NM_000155.4(GALT):c.512T>C (p.Phe171Ser)	GALT	F171S, F62S	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003616	9	34648116	9	34648119	3616	18655	rs111033715	NC_000009.12:34648118:T:C
NM_000501.4(ELN):c.800-3C>G	ELN		Supravalvar aortic stenosis|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043586	7	73466077	7	74051747	43586	52755	rs397516433	NC_000007.14:74051746:C:G
NM_000244.3(MEN1):c.798+1G>A	MEN1		Metastatic pancreatic neuroendocrine tumours|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428081	11	64575023	11	64807551	428081	419830	rs794728652	NC_000011.10:64807550:C:T
NM_000244.3(MEN1):c.355_357AAG[1] (p.Lys120del)	MEN1	K120del, K119del	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201019	11	64577222 - 64577224	11	64809750 - 64809752	201019	197557	rs794728657	NC_000011.10:64809749:CTTCTTC:CTTC
NM_001370259.2(MEN1):c.784-9G>A	MEN1		not specified|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200981	11	64574700	11	64807228	200981	197538	rs794728625	NC_000011.10:64807227:C:T
NM_000244.3(MEN1):c.1102_1104del (p.Glu368del)	MEN1	E363del, E368del, E405del, E328del	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016685	11	64573203 - 64573205	11	64805731 - 64805733	16685	31724	rs869025185	NC_000011.10:64805730:CTCCT:CT
NM_000552.4(VWF):c.3614G>A (p.Arg1205His)	VWF	R1205H	von Willebrand factor Vicenza|von Willebrand disease type 1|Reduced quantity of Von Willebrand factor|Reduced von Willebrand factor activity|not provided|von Willebrand disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000308	12	6131126	12	6021960	308	15347	rs121964895	NC_000012.12:6021959:C:T
NM_000552.4(VWF):c.3916C>T (p.Arg1306Trp)	VWF	R1306W	not provided|von Willebrand disease, type 2b|Abnormality of coagulation|von Willebrand disorder|von Willebrand disease type 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000288	12	6128668	12	6019502	288	15327	rs61749384	NC_000012.12:6019501:G:A
NM_001162426.2(TSC1):c.2669dup (p.Asn890fs)	TSC1		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048989	9	135772950 - 135772951	9	132897563 - 132897564	48989	58151	rs118203724	NC_000009.12:132897563:TTTTTTT:TTTTTTTT
NM_000535.6(PMS2):c.989-?_*(160_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091387	7	6012870 - 6029586	7	5973239 - 5989955	91387	96862		
NM_000535.7(PMS2):c.989-296_1144+706del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091385	7	6028725 - 6029882	7	5989094 - 5990251	91385	96860		
NM_000535.6(PMS2):c.904-?_988+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091380					91380	96855		
NM_000535.6(PMS2):c.904-?_*(160_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091378	7	6012870 - 6031688	7	5973239 - 5992057	91378	96853		
NM_000535.6(PMS2):c.804-?_903+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091374					91374	96849		
NM_000535.5(PMS2):c.804-60_804-59insJN866832.1	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091372					91372	96847		
NM_000535.6(PMS2):c.706-?_803+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091365					91365	96840		
NM_000535.7(PMS2):c.593dup (p.Arg199fs)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091360	7	6038850 - 6038851	7	5999219 - 5999220	91360	96835	rs267608148	NC_000007.14:5999219:A:AA
NM_000535.7(PMS2):c.543del (p.Glu180_Tyr181insTer)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091358	7	6038901	7	5999270	91358	96833	rs63751029	NC_000007.14:5999269:A:
NM_000535.7(PMS2):c.538-478_705+456del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091357	7	6038283 - 6039384	7	5998652 - 5999753	91357	96832		
NM_000535.6(PMS2):c.354-?_803+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091354					91354	96829		
NM_000535.6(PMS2):c.354-?_*(160_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091353	7	6012870 - 6042267	7	5973239 - 6002636	91353	96828		
NM_000535.6(PMS2):c.24-?_163+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091342					91342	96817		
NM_000535.7(PMS2):c.2276-91_2445+790del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091336	7	6016429 - 6017479	7	5976798 - 5977848	91336	96811		
NM_000535.7(PMS2):c.2276-113_2445+1596del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091335	7	6015623 - 6017501	7	5975992 - 5977870	91335	96810		
NM_000535.7(PMS2):c.217_218TG[3] (p.Gly74fs)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091332	7	6043632 - 6043633	7	6004001 - 6004002	91332	96807	rs587779336	NC_000007.14:6004001:CACA:CACACA
NM_000535.7(PMS2):c.1768del (p.Ile590fs)	PMS2	I403fs, I487fs, I279fs, I484fs, I399fs, I538fs, I455fs, I590fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091314	7	6026628	7	5986997	91314	96789	rs63750477	NC_000007.14:5986996:T:
NM_000535.5(PMS2):c.164-518_803+252delinsCG	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091309	7	6036705 - 6044207	7	5997074 - 6004576	91309	96784		
NM_000535.6(PMS2):c.1145-?_2174+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091294					91294	96769		
NM_000535.5(PMS2):c.1145-1350_*20545del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091292					91292	96767		
NM_000535.6(PMS2):c.(?_-87)_1144+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091275	7	6029431 - 6048737	7	5989800 - 6009106	91275	96750		
NM_000535.5(PMS2):c.(?_-87)_(*160_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091274					91274	96749		
NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14 without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	NC_000009.12:35065362:C:T
NM_022970.3(FGFR2):c.1127A>G (p.Tyr376Cys)	FGFR2	Y375C, Y376C, Y263C, Y147C, Y286C, Y287C, Y260C	Endometrial carcinoma|Endometrial neoplasm||Pfeiffer syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Bent bone dysplasia syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Neoplasm of stomach|not provided|FGFR2 related craniosynostosis|	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013277	10	123274794	10	121515280	13277	28316	rs121913478	NC_000010.11:121515279:T:C
NM_000441.2(SLC26A4):c.1975G>C (p.Val659Leu)	SLC26A4	V659L	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188889	7	107342443	7	107701998	188889	186740	rs200455203	NC_000007.14:107701997:G:C
NM_000256.3(MYBPC3):c.551dup (p.Lys185fs)	MYBPC3		Familial hypertrophic cardiomyopathy 4|Familial dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042771	11	47371427 - 47371428	11	47349876 - 47349877	42771	51941	rs397516059	NC_000011.10:47349876:A:AA
NM_000256.3(MYBPC3):c.1800del (p.Lys600fs)	MYBPC3	K600fs	Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042568	11	47362786	11	47341235	42568	51738	rs397515926	NC_000011.10:47341234:TTT:TT
NM_001360.2(DHCR7):c.1409T>A (p.Leu470Gln)	DHCR7	L470Q	Inborn genetic diseases|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520690	11	71146440	11	71435394	520690	511941	rs1331331095	NC_000011.10:71435393:A:T
NM_001360.3(DHCR7):c.724C>T (p.Arg242Cys)	DHCR7	R242C	not provided|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021275	11	71150032	11	71438986	21275	34127	rs80338856	NC_000011.10:71438985:G:A
NM_033360.4(KRAS):c.183A>C (p.Gln61His)	KRAS	Q61H	Acute myeloid leukemia|Neoplasm of the large intestine|Non-small cell lung cancer|Juvenile myelomonocytic leukemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000177881	12	25380275	12	25227341	177881	175854	rs17851045	NC_000012.12:25227340:T:G
NM_033360.4(KRAS):c.182A>T (p.Gln61Leu)	KRAS	Q61L	Non-small cell lung cancer|Neoplasm of the thyroid gland|Multiple myeloma|Medullary thyroid carcinoma|Neoplasm of the large intestine	Pathogenic(Last reviewed: Nov 2, 2011)	criteria provided, single submitter	VCV000045116	12	25380276	12	25227342	45116	54283	rs121913240	NC_000012.12:25227341:T:A
NM_000368.4(TSC1):c.737+1G>A	TSC1		not provided|Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000049092	9	135796749	9	132921362	49092	58254	rs118203438	NC_000009.12:132921361:C:T
NM_000368.4(TSC1):c.1960C>T (p.Gln654Ter)	TSC1	Q654*, Q533*, Q603*, Q653*	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048858	9	135781005	9	132905618	48858	58020	rs75820036	NC_000009.12:132905617:G:A
NM_000368.4(TSC1):c.1498C>T (p.Arg500Ter)	TSC1	R500*, R379*, R499*, R449*	Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048791	9	135781467	9	132906080	48791	57953	rs118203537	NC_000009.12:132906079:G:A
NM_000535.7(PMS2):c.2239A>T (p.Arg747Ter)	PMS2	R747*, R641*, R556*, R695*, R436*, R560*, R612*, R644*	Lynch syndrome	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000504753	7	6018263	7	5978632	504753	497094	rs1554294448	NC_000007.14:5978631:T:A
NM_000535.7(PMS2):c.2458dup (p.Thr820fs)	PMS2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000434032	7	6013160 - 6013161	7	5973529 - 5973530	434032	427323	rs1554292880	NC_000007.14:5973529:T:TT
NM_000535.7(PMS2):c.2446_2589del (p.Val816_Ter863del)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Dec 11, 2014)	criteria provided, single submitter	VCV000434031	7	6013030 - 6013173	7	5973399 - 5973542	434031	427322	rs1554292684	
NM_000535.7(PMS2):c.2184del (p.Leu729fs)	PMS2	L538fs, L594fs, L677fs, L729fs, L542fs, L418fs, L623fs, L626fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000434030	7	6018318	7	5978687	434030	427324	rs1554294505	NC_000007.14:5978686:A:
NC_000007.13:g.(?_6031604)_(6038906_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Jul 30, 2016)	criteria provided, single submitter	VCV000417549	7	6031604 - 6038906	7	5991973 - 5999275	417549	395621		
NC_000007.13:g.(?_6031604)_(6048737_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000417548	7	6031604 - 6048737	7	5991973 - 6009106	417548	395249		
NC_000007.13:g.(?_6036957)_(6043689_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000417547	7	6036957 - 6043689	7	5997326 - 6004058	417547	395501		
NC_000007.13:g.(?_6031604)_(6045662_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000417546	7	6031604 - 6045662	7	5991973 - 6006031	417546	395248		
NC_000007.13:g.(?_6031604)_(6042267_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Jun 5, 2016)	criteria provided, single submitter	VCV000417545	7	6031604 - 6042267	7	5991973 - 6002636	417545	395911		
NC_000007.13:g.(?_6043321)_(6043689_?)del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Dec 26, 2016)	criteria provided, single submitter	VCV000417544	7	6043321 - 6043689	7	6003690 - 6004058	417544	395914		
NM_000535.7(PMS2):c.129del (p.Glu44fs)	PMS2	E44fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000411082	7	6045557	7	6005926	411082	396114	rs1060503148	NC_000007.14:6005925:T:
NM_000535.7(PMS2):c.859dup (p.Arg287fs)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000411027	7	6035208 - 6035209	7	5995577 - 5995578	411027	396069	rs1554300763	NC_000007.14:5995577:T:TT
NM_000535.7(PMS2):c.779_780delinsAG (p.Ser260Ter)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000411019	7	6036980 - 6036981	7	5997349 - 5997350	411019	396073	rs730881920	NC_000007.14:5997348:GG:CT
NM_000535.6(PMS2):c.2276-?_2445+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000267344	7	6017219 - 6017388	7	5977588 - 5977757	267344	262406		
NM_000535.6(PMS2):c.164-?_2006+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000254091					254091	248498		
NM_000535.6(PMS2):c.-87_537+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000254086					254086	248495		
NM_000535.6(PMS2):c.2276-?_*160+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000237904					237904	239954		
NM_000535.7(PMS2):c.1591G>T (p.Glu531Ter)	PMS2	E531*, E220*, E428*, E340*, E396*, E425*, E479*, E344*	Lynch syndrome	Pathogenic(Last reviewed: Feb 13, 2016)	criteria provided, single submitter	VCV000237890	7	6026805	7	5987174	237890	240115	rs878854037	NC_000007.14:5987173:C:A
NM_000535.7(PMS2):c.1750dup (p.Ile584fs)	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	VCV000220605	7	6026645 - 6026646	7	5987014 - 5987015	220605	221712	rs864622600	NC_000007.14:5987014:TTT:TTTT
NM_000535.6(PMS2):c.538-?_903+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000219811	7	6035165 - 6038906	7	5995534 - 5999275	219811	221641		
NM_000535.7(PMS2):c.121G>T (p.Glu41Ter)	PMS2	E41*	Lynch syndrome	Pathogenic(Last reviewed: Jan 31, 2016)	criteria provided, single submitter	VCV000219674	7	6045565	7	6005934	219674	221737	rs3209663	NC_000007.14:6005933:C:A
NM_000535.6(PMS2):c.989-?_1144+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000216076	7	6029431 - 6029586	7	5989800 - 5989955	216076	212529		
NM_000535.7(PMS2):c.1239dup (p.Asp414fs)	PMS2		not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216072	7	6027156 - 6027157	7	5987525 - 5987526	216072	212601	rs267608159	NC_000007.14:5987525:TTTTTTTT:TTTTTTTTT
NM_000535.7(PMS2):c.1185del (p.Met396fs)	PMS2	M205fs, M293fs, M261fs, M290fs, M209fs, M344fs, M396fs, M85fs	Lynch syndrome	Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000188149	7	6027211	7	5987580	188149	186084	rs786204104	NC_000007.14:5987579:GGG:GG
NM_000535.7(PMS2):c.904-2A>G	PMS2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000140880	7	6031690	7	5992059	140880	150594	rs587781339	NC_000007.14:5992058:T:C
NM_000535.7(PMS2):c.1687C>T (p.Arg563Ter)	PMS2	R563*, R428*, R457*, R460*, R511*, R252*, R372*, R376*	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000135067	7	6026709	7	5987078	135067	138806	rs587778618	NC_000007.14:5987077:G:A
NM_000535.7(PMS2):c.1731_1732delinsAGT (p.Arg578fs)	PMS2		Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4|Turcot syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009244	7	6026664 - 6026665	7	5987033 - 5987034	9244	24283	rs1057515572	NC_000007.14:5987032:GC:ACT
NM_000244.3(MEN1):c.843C>A (p.Tyr281Ter)	MEN1	Y276*, Y281*, Y241*	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418292	11	64574567	11	64807095	418292	408406	rs1060503789	NC_000011.10:64807094:G:T
NM_003002.4(SDHD):c.112C>T (p.Arg38Ter)	SDHD	R38*	not provided|Paragangliomas 1|Pheochromocytoma|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006893	11	111958640	11	112087916	6893	21932	rs80338843	NC_000011.10:112087915:C:T
NM_213599.2(ANO5):c.692G>T (p.Gly231Val)	ANO5	G231V, G230V	not provided|Hereditary fructosuria|ANO5-Related Disorders|Miyoshi muscular dystrophy 3|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002165	11	22257752	11	22236206	2165	17204	rs137854523	NC_000011.10:22236205:G:T
NM_006772.3(SYNGAP1):c.43del (p.Ala15fs)	SYNGAP1	A15fs	Inborn genetic diseases|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000521836	6	33388084	6	33420307	521836	511661	rs1554304258	NC_000006.12:33420306:G:
NM_006772.3(SYNGAP1):c.403C>T (p.Arg135Ter)	SYNGAP1	R135*	Mental retardation, autosomal recessive 5|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000430834	6	33400477	6	33432700	430834	424377	rs1131692154	NC_000006.12:33432699:C:T
NM_006772.3(SYNGAP1):c.2916del (p.Asp974fs)	SYNGAP1	D960fs, D974fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000423642	6	33411245	6	33443468	423642	406864	rs1064796547	NC_000006.12:33443467:T:
NM_018026.4(PACS1):c.607C>T (p.Arg203Trp)	PACS1	R203W	Inborn genetic diseases|Multiple congenital anomalies|not provided|Mitral valve prolapse|Aortic root dilatation|Optic disc pallor|Horseshoe kidney|Hypotelorism|Schuurs-hoeijmakers syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039581	11	65978677	11	66211206	39581	48180	rs398123009	NC_000011.10:66211205:C:T
NM_000834.4(GRIN2B):c.2458G>A (p.Gly820Arg)	GRIN2B	G820R	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000521172	12	13720099	12	13567165	521172	511981	rs1555103150	NC_000012.12:13567164:C:T
NM_000834.4(GRIN2B):c.1916C>T (p.Ala639Val)	GRIN2B	A639V	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000208749	12	13761631	12	13608697	208749	205274	rs797044930	NC_000012.12:13608696:G:A
NM_004333.6(BRAF):c.1405G>C (p.Gly469Arg)	BRAF	G469R	Cutaneous melanoma|Squamous cell lung carcinoma|Non-Hodgkin lymphoma|Multiple myeloma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Malignant melanoma of skin|Adenocarcinoma of prostate|Neoplasm of the large intestine|not provided|Squamous cell carcinoma of the skin	Pathogenic(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	VCV000013970	7	140481403	7	140781603	13970	29009	rs121913357	NC_000007.14:140781602:C:G
NM_000260.4(MYO7A):c.6025del (p.Ala2009fs)	MYO7A	A1971fs, A1960fs, A2009fs	|Rare genetic deafness|Retinal dystrophy|Deafness, autosomal recessive 2|not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043313	11	76919821	11	77208776	43313	52483	rs397516326	NC_000011.10:77208775:GG:G
NM_000260.4(MYO7A):c.3508G>A (p.Glu1170Lys)	MYO7A	E1170K, E1159K	Retinal dystrophy|Deafness, autosomal recessive 2|Rare genetic deafness|Deafness, autosomal recessive 2||Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043208	11	76900393	11	77189348	43208	52378	rs111033214	NC_000011.10:77189347:G:A
NM_000256.3(MYBPC3):c.2603-1G>C	MYBPC3		Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000419380	11	47357563	11	47336012	419380	408367	rs977277400	NC_000011.10:47336011:C:G
NM_000256.3(MYBPC3):c.3190+1G>A	MYBPC3		not provided|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177837	11	47355107	11	47333556	177837	175150	rs111683277	NC_000011.10:47333555:C:T
NM_000256.3(MYBPC3):c.2490dup (p.His831fs)	MYBPC3		Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042625	11	47359053 - 47359054	11	47337502 - 47337503	42625	51795	rs397515966	NC_000011.10:47337502:A:AA
NM_000256.3(MYBPC3):c.2096del (p.Pro699fs)	MYBPC3	P699fs	Hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042596	11	47360927	11	47339376	42596	51766	rs397515947	NC_000011.10:47339375:GGGG:GGG
NM_005933.4(KMT2A):c.2318del (p.Pro773fs)	KMT2A	P773fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000522154	11	118344186	11	118473471	522154	511887	rs782297546	NC_000011.10:118473470:CCCCCCC:CCCCCC
NM_001197104.1(KMT2A):c.1522G>T (p.Glu508Ter)	KMT2A	E508*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000522151	11	118343396	11	118472681	522151	511884	rs781978013	NC_000011.10:118472680:G:T
NM_005933.4(KMT2A):c.134del (p.Pro45fs)	KMT2A	P45fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000521924	11	118307357	11	118436642	521924	511883	rs1555138529	NC_000011.10:118436641:CCCCC:CCCC
NM_005933.4(KMT2A):c.7488del (p.Val2497fs)	KMT2A	V2497fs, V2500fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000521923	11	118374104	11	118503389	521923	511897	rs1555046615	NC_000011.10:118503388:A:
NM_005933.4(KMT2A):c.4029del (p.Lys1343fs)	KMT2A	K1343fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000521886	11	118353151	11	118482436	521886	511892	rs1555039606	NC_000011.10:118482435:AAA:AA
NM_001197104.1(KMT2A):c.7150C>T (p.Gln2384Ter)	KMT2A	Q2384*, Q2381*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000521866	11	118373757	11	118503042	521866	511895	rs1555046404	NC_000011.10:118503041:C:T
NM_005933.4(KMT2A):c.3649_3650GA[1] (p.Lys1219fs)	KMT2A		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000521750	11	118352443 - 118352444	11	118481728 - 118481729	521750	511890	rs1555039242	NC_000011.10:118481727:AGAGA:AGA
NM_001197104.1(KMT2A):c.3451C>T (p.Arg1151Ter)	KMT2A	R1151*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000521403	11	118348798	11	118478083	521403	511888	rs868985556	NC_000011.10:118478082:C:T
NM_005933.4(KMT2A):c.9103_9106del (p.Val3035fs)	KMT2A	V3038fs, V3035fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000521101	11	118375718 - 118375721	11	118505003 - 118505006	521101	511898	rs1555047506	NC_000011.10:118505002:TGTTT:T
NM_005933.4(KMT2A):c.7178_7182dup (p.Glu2395fs)	KMT2A		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000520882	11	118373793 - 118373794	11	118503078 - 118503079	520882	511896	rs1555046428	NC_000011.10:118503078:CAGAT:CAGATCAGAT
NM_005933.4(KMT2A):c.2193del (p.Ser732fs)	KMT2A	S732fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000520673	11	118344067	11	118473352	520673	511885	rs1555036394	NC_000011.10:118473351:A:
NM_005933.4(KMT2A):c.2262del (p.Ser754_Met755insTer)	KMT2A		Inborn genetic diseases	Pathogenic(Last reviewed: May 12, 2015)	criteria provided, single submitter	VCV000520666	11	118344135	11	118473420	520666	511886	rs1555036436	NC_000011.10:118473419:CC:C
NM_005933.4(KMT2A):c.4329_4330AG[3] (p.Phe1445fs)	KMT2A		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000520644	11	118355686 - 118355687	11	118484971 - 118484972	520644	511893	rs1555040480	NC_000011.10:118484971:AGAG:AGAGAG
NM_000288.4(PEX7):c.875T>A (p.Leu292Ter)	PEX7	L292*	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Phytanic acid storage disease|PEX7-Related Disorders|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007780	6	137219351	6	136898213	7780	22819	rs1805137	NC_000006.12:136898212:T:A
NM_000441.2(SLC26A4):c.1489G>A (p.Gly497Ser)	SLC26A4	G497S	not provided|Enlarged vestibular aqueduct|Rare genetic deafness|Pendred syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043510	7	107336429	7	107695984	43510	19855	rs111033308	NC_000007.14:107695983:G:A
NM_000441.2(SLC26A4):c.1151A>G (p.Glu384Gly)	SLC26A4	E384G	not provided|SLC26A4-Related Disorders|Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004820	7	107330570	7	107690125	4820	19859	rs111033244	NC_000007.14:107690124:A:G
NM_000535.7(PMS2):c.2445+1G>T	PMS2		not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234604	7	6017218	7	5977587	234604	231656	rs876661113	NC_000007.14:5977586:C:A
NM_000535.5:c.(1144+1_1145-1)_(2174+1_2715-1)dup	PMS2		Lynch syndrome I	Pathogenic(Last reviewed: Nov 24, 2015)	reviewed by expert panel	VCV000219293					219293	220984		
NM_000535.6(PMS2):c.804-?_2006+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091373	7	6026390 - 6035264	7	5986759 - 5995633	91373	96848		
NM_000535.6(PMS2):c.(?_-87)_23+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091276	7	6048628 - 6048737	7	6008997 - 6009106	91276	96751		
NM_000368.4(TSC1):c.1724del (p.Ser575fs)	TSC1	S454fs, S524fs, S575fs, S574fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000521557	9	135781241	9	132905854	521557	511811	rs1554815889	NC_000009.12:132905853:G:
NM_031263.4(HNRNPK):c.859C>T (p.Arg287Ter)	HNRNPK	R287*, R263*	Inborn genetic diseases|AU-KLINE SYNDROME	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503603	9	86586891	9	83971976	503603	495044	rs1554698878	NC_000009.12:83971975:G:A
NM_016042.4(EXOSC3):c.395A>C (p.Asp132Ala)	EXOSC3	D132A	Inborn genetic diseases|not provided|Pontocerebellar hypoplasia, type 1b|Muscular hypotonia|Neurodevelopmental delay	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031688	9	37783990	9	37783993	31688	40348	rs141138948	NC_000009.12:37783992:T:G
NM_138694.4(PKHD1):c.3761_3762delinsG (p.Ala1254fs)	PKHD1		Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096398	6	51890846 - 51890847	6	52026048 - 52026049	96398	102292	rs398124484	NC_000006.12:52026047:GG:C
NM_001540.5(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	R136L	Charcot-Marie-Tooth disease|Inborn genetic diseases|not provided|	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217230	7	75933161	7	76303844	217230	213813	rs863225022	NC_000007.14:76303843:G:T
NM_017890.4(VPS13B):c.5462_5465dup (p.Arg1824fs)	VPS13B		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000521711	8	100654202 - 100654203	8	99641974 - 99641975	521711	511776	rs1554884733	NC_000008.11:99641974:CCGTCC:CCGTCCGTCC
NM_000256.3(MYBPC3):c.710A>C (p.Tyr237Ser)	MYBPC3	Y237S	not specified|not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042787	11	47370037	11	47348486	42787	51957	rs397516070	NC_000011.10:47348485:T:G
NM_017519.2(ARID1B):c.2789dup (p.Glu931fs)	ARID1B		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000521995	6	157470033 - 157470034	6	157148899 - 157148900	521995	511637	rs1554226131	NC_000006.12:157148899:A:AA
NM_017519.2(ARID1B):c.5061del (p.Glu1687fs)	ARID1B	E1700fs, E1740fs, E1687fs, E990fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000521927	6	157527374	6	157206240	521927	511644	rs1554237050	NC_000006.12:157206239:AA:A
NM_020732.3(ARID1B):c.3183C>G (p.Tyr1061Ter)	ARID1B	Y1061*, Y1101*, Y351*, Y1048*	Inborn genetic diseases	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000521793	6	157502150	6	157181016	521793	511638	rs758570139	NC_000006.12:157181015:C:G
NM_017519.2(ARID1B):c.717_730delinsG (p.Ala240fs)	ARID1B		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000521684	6	157099780 - 157099793	6	156778646 - 156778659	521684	511634	rs1554247637	NC_000006.12:156778645:TGCGAGCGGCGGCC:G
NM_020732.3(ARID1B):c.4470C>G (p.Tyr1490Ter)	ARID1B	Y1490*, Y1530*, Y1477*, Y780*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000521539	6	157522198	6	157201064	521539	511641	rs1554235792	NC_000006.12:157201063:C:G
NM_020732.3(ARID1B):c.6039G>A (p.Trp2013Ter)	ARID1B	W2013*, W2053*, W1303*, W2000*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000521515	6	157528314	6	157207180	521515	511645	rs1554237848	NC_000006.12:157207179:G:A
NM_017519.2(ARID1B):c.3338del (p.Ala1113fs)	ARID1B	A1126fs, A416fs, A1166fs, A1113fs	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000520937	6	157505396	6	157184262	520937	511639	rs1554231814	NC_000006.12:157184261:C:
NM_020732.3(ARID1B):c.3993T>A (p.Tyr1331Ter)	ARID1B	Y1331*, Y1371*, Y621*, Y1318*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	VCV000520835	6	157517429	6	157196295	520835	511640	rs1554234424	NC_000006.12:157196294:T:A
NM_017519.2(ARID1B):c.4849dup (p.Asp1617fs)	ARID1B		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 1, 2015)	criteria provided, single submitter	VCV000520741	6	157522615 - 157522616	6	157201481 - 157201482	520741	511643	rs1554236054	NC_000006.12:157201481:G:GG
NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	BRAF	G464V, G427V, G376V, G442V, G412V, G430V, G467V, G504V	Rasopathy|Neoplasm of the breast|Non-small cell lung cancer|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000040364	7	140481417	7	140781617	40364	48834	rs121913348	NC_000007.14:140781616:C:A
NM_004333.6(BRAF):c.1790T>G (p.Leu597Arg)	BRAF	L597R	Multiple myeloma|Malignant melanoma of skin|Lung adenocarcinoma|Ovarian Neoplasms|Adenocarcinoma of prostate|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000013968	7	140453145	7	140753345	13968	29007	rs121913366	NC_000007.14:140753344:A:C
NM_000260.4(MYO7A):c.2005C>T (p.Arg669Ter)	MYO7A	R669*, R658*	Usher syndrome|Deafness, autosomal recessive 2|Rare genetic deafness|not provided||Deafness, autosomal recessive 2||Deafness, autosomal dominant 11	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043169	11	76885871	11	77174825	43169	52339	rs111033201	NC_000011.10:77174824:C:T
NM_000535.7(PMS2):c.1970del (p.Asn657fs)	PMS2	N470fs, N466fs, N522fs, N605fs, N554fs, N657fs, N346fs, N551fs	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000496034	7	6026426	7	5986795	496034	487220	rs1064794566	NC_000007.14:5986794:TTTT:TTT
NM_000535.7(PMS2):c.325dup (p.Glu109fs)	PMS2		not provided|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233300	7	6043348 - 6043349	7	6003717 - 6003718	233300	233589	rs587781716	NC_000007.14:6003717:CCCCCC:CCCCCCC
NM_000535.7(PMS2):c.1576del (p.Asp526fs)	PMS2	D335fs, D339fs, D420fs, D474fs, D526fs, D423fs, D215fs, D391fs	Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000216074	7	6026820	7	5987189	216074	212597	rs863224497	NC_000007.14:5987188:CCCC:CCC
NM_000535.7(PMS2):c.1376C>A (p.Ser459Ter)	PMS2	S459*, S148*, S272*, S356*, S407*, S268*, S324*, S353*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000135936	7	6027020	7	5987389	135936	139648	rs587780724	NC_000007.14:5987388:G:T
NM_000535.7(PMS2):c.2T>C (p.Met1Thr)	PMS2	M1T	Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127788	7	6048649	7	6009018	127788	133245	rs587780059	NC_000007.14:6009017:A:G
NM_000535.7(PMS2):c.780del (p.Asp261fs)	PMS2	D155fs, D70fs, D126fs, D158fs, D261fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091367	7	6036980	7	5997349	91367	96842	rs587779344	NC_000007.14:5997348:GG:G
NM_002180.2(IGHMBP2):c.439C>T (p.Arg147Ter)	IGHMBP2	R147*	Inborn genetic diseases|Autosomal dominant distal hereditary motor neuropathy|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521206	11	68675795	11	68908327	521206	511936	rs1324667543	NC_000011.10:68908326:C:T
NM_000136.3(FANCC):c.553C>T (p.Arg185Ter)	FANCC	R185*	Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012044	9	97912338	9	95150056	12044	27083	rs121917783	NC_000009.12:95150055:G:A
NM_152743.4(BRAT1):c.638dup (p.Val214fs)	BRAT1		Inborn genetic diseases|Rigidity and multifocal seizure syndrome, lethal neonatal|NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES|not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031199	7	2583388 - 2583389	7	2543754 - 2543755	31199	40156	rs730880324	NC_000007.14:2543754:TT:TTT
NM_138694.4(PKHD1):c.6992T>A (p.Ile2331Lys)	PKHD1	I2331K	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188813	6	51768399	6	51903601	188813	186710	rs200179145	NC_000006.12:51903600:A:T
NM_024426.6(WT1):c.1447+5G>A	WT1		Diffuse mesangial sclerosis|Frasier syndrome|Drash syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome|Wilms tumor 1|Drash syndrome|Hereditary nephrotic syndrome	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003493	11	32413513	11	32391967	3493	18532	rs587776576	NC_000011.10:32391966:C:T
NM_001024688.2(NBN):c.452_455del (p.Lys151fs)	NBN	K233fs, K151fs	not provided|Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127878	8	90983402 - 90983405	8	89971174 - 89971177	127878	133335	rs587780100	NC_000008.11:89971173:TGTTTG:TG
NM_003640.5(ELP1):c.2204+6T>C	ELP1		Charcot-Marie-Tooth disease|Familial dysautonomia|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006085	9	111662096	9	108899816	6085	21124	rs111033171	NC_000009.12:108899815:A:G
NM_000162.5(GCK):c.676G>A (p.Val226Met)	GCK	V226M, V227M, V225M	Maturity onset diabetes mellitus in young|Maturity-onset diabetes of the young, type 2|Maturity-onset diabetes of the young, type 2|Permanent neonatal diabetes mellitus|Diabetes mellitus type 2|Hyperinsulinism due to glucokinase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036243	7	44189362	7	44149763	36243	44907	rs148311934	NC_000007.14:44149762:C:T
NM_000244.3(MEN1):c.1258C>T (p.Arg420Ter)	MEN1	R415*, R420*, R457*, R380*	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000403802	11	64572613	11	64805141	403802	398266	rs1060499974	NC_000011.10:64805140:G:A
NM_003172.4(SURF1):c.841_842CT[2] (p.Ser282fs)	SURF1		Leigh syndrome due to mitochondrial complex IV deficiency|Leigh syndrome|Muscle weakness|Abnormal pyramidal signs|Cerebellar ataxia|Dysarthria|not provided|Leigh syndrome due to COX IV deficiency|Charcot-Marie-Tooth disease, type 4k|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012770	9	136218825 - 136218826	9	133351970 - 133351971	12770	27809	rs782316919	NC_000009.12:133351969:AGAGAG:AGAG
NM_006772.3(SYNGAP1):c.3706C>T (p.Gln1236Ter)	SYNGAP1	Q1236*, Q1220*	Mental retardation, autosomal dominant 5|Inborn genetic diseases	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521432	6	33414475	6	33446698	521432	511676	rs1554122729	NC_000006.12:33446697:C:T
NM_000535.7(PMS2):c.741del (p.Ser248fs)	PMS2	S57fs, S142fs, S248fs, S113fs, S145fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000667013	7	6037019	7	5997388	667013	654494		NC_000007.14:5997387:A:
NM_000535.7(PMS2):c.1275_1279del (p.Leu426fs)	PMS2	L323fs, L426fs, L291fs, L320fs, L115fs, L374fs, L235fs, L239fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000505722	7	6027117 - 6027121	7	5987486 - 5987490	505722	496497	rs1554297962	NC_000007.14:5987485:GAAGAGAA:GAA
NM_000535.7(PMS2):c.1912C>T (p.Gln638Ter)	PMS2	Q638*, Q503*, Q586*, Q447*, Q535*, Q327*, Q451*, Q532*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411084	7	6026484	7	5986853	411084	396025	rs764342199	NC_000007.14:5986852:G:A
NM_000535.7(PMS2):c.1891C>T (p.Gln631Ter)	PMS2	Q631*, Q444*, Q528*, Q440*, Q496*, Q525*, Q320*, Q579*	Lynch syndrome|not provided	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000411061	7	6026505	7	5986874	411061	396356	rs1060503138	NC_000007.14:5986873:G:A
NM_000535.6(PMS2):c.904-?_1144+?del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091379	7	6029431 - 6031688	7	5989800 - 5992057	91379	96854		
NM_000535.7(PMS2):c.703C>T (p.Gln235Ter)	PMS2	Q235*, Q100*, Q129*, Q132*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091363	7	6038741	7	5999110	91363	96838	rs63750261	NC_000007.14:5999109:G:A
NM_000256.3(MYBPC3):c.3181C>T (p.Gln1061Ter)	MYBPC3	Q1061*	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042690	11	47355117	11	47333566	42690	51860	rs397516005	NC_000011.10:47333565:G:A
NM_004333.6(BRAF):c.1600G>C (p.Gly534Arg)	BRAF	G534R, G446R, G500R, G512R, G537R, G574R, G482R, G497R	Inborn genetic diseases|Cardiofaciocutaneous syndrome 1|Genetic syndrome with a Dandy-Walker malformation as major feature|PHACE syndrome|Tethered cord|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013980	7	140476806	7	140777006	13980	29019	rs180177041	NC_000007.14:140777005:C:G
NM_001197104.1(KMT2A):c.3790C>T (p.Arg1264Ter)	KMT2A	R1264*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522088	11	118352585	11	118481870	522088	511891	rs1555039343	NC_000011.10:118481869:C:T
NM_001197104.1(KMT2A):c.4504C>T (p.Arg1502Ter)	KMT2A	R1502*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000392919	11	118360531	11	118489816	392919	372204	rs150800017	NC_000011.10:118489815:C:T
NM_001197104.1(KMT2A):c.5251A>T (p.Lys1751Ter)	KMT2A	K1751*, K1748*	not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280748	11	118365075	11	118494360	280748	264455	rs886041896	NC_000011.10:118494359:A:T
NM_000260.4(MYO7A):c.640G>A (p.Gly214Arg)	MYO7A	G214R, G203R	|not provided|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2||Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043327	11	76867955	11	77156909	43327	52497	rs111033283	NC_000011.10:77156908:G:A
NM_017780.4(CHD7):c.5405-7G>A	CHD7		not provided||CHARGE association	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095795	8	61763045	8	60850486	95795	101692	rs398124321	NC_000008.11:60850485:G:A
NM_033360.4(KRAS):c.35G>C (p.Gly12Ala)	KRAS	G12A	Gastrointestinal stromal tumor|Ovarian Neoplasms|Multiple myeloma|Non-small cell lung cancer|Lung adenocarcinoma|Neoplasm of the large intestine	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2019)	no assertion criteria provided	VCV000045122	12	25398284	12	25245350	45122	54289	rs121913529	NC_000012.12:25245349:C:G
NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	KRAS	K5N	Inborn genetic diseases|Noonan syndrome|Cardiofaciocutaneous syndrome 2|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012594	12	25398304	12	25245370	12594	27633	rs104894361	NC_000012.12:25245369:T:A
NM_153676.4(USH1C):c.216G>A (p.Val72=)	USH1C		Deafness, autosomal recessive 18|Usher syndrome, type 1C|||not provided|Rare genetic deafness|Usher syndrome|Deafness, autosomal recessive 18|Usher syndrome, type 1C	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005143	11	17552978	11	17531431	5143	20182	rs151045328	NC_000011.10:17531430:C:T
NM_000552.4(VWF):c.4121G>A (p.Arg1374His)	VWF	R1374H	Abnormal bleeding|Prolonged bleeding time|not provided|von Willebrand disorder|von Willebrand disease type 2	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100330	12	6128463	12	6019297	100330	106207	rs61750072	NC_000012.12:6019296:C:T
NM_000535.7(PMS2):c.1297A>T (p.Lys433Ter)	PMS2	K433*, K242*, K122*, K298*, K381*, K246*, K327*, K330*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216073	7	6027099	7	5987468	216073	212600	rs863224496	NC_000007.14:5987467:T:A
NM_000535.6(PMS2):c.736_741delCCCCCTins11 (p.?)	PMS2		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000141845	7	6037019 - 6037024	7	5997388 - 5997393	141845	151559		
NM_000535.7(PMS2):c.182del (p.Tyr61fs)	PMS2	Y61fs	Lynch syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091316	7	6043671	7	6004040	91316	96791	rs63750793	NC_000007.14:6004039:T:
NM_000535.7(PMS2):c.1730dup (p.Arg578fs)	PMS2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091310	7	6026665 - 6026666	7	5987034 - 5987035	91310	96785	rs587779330	NC_000007.14:5987034:TTT:TTTT
NM_000535.7(PMS2):c.1306dup (p.Ser436fs)	PMS2		Lynch syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091300	7	6027089 - 6027090	7	5987458 - 5987459	91300	96775	rs63750106	NC_000007.14:5987458:T:TT
NM_000535.6(PMS2):c.1169_1170ins20 (p.?)	PMS2		Lynch syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091296	7	6027226 - 6027227	7	5987595 - 5987596	91296	96771		
NM_000535.6(PMS2):c.1145-?_2445+?del	PMS2		Lynch syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091295					91295	96770		
NM_000256.3(MYBPC3):c.1483C>T (p.Arg495Trp)	MYBPC3	R495W	Hypertrophic cardiomyopathy|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164114	11	47364270	11	47342719	164114	175188	rs397515905	NC_000011.10:47342718:G:A
NM_000256.3(MYBPC3):c.2905C>T (p.Gln969Ter)	MYBPC3	Q969*	not provided|Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042669	11	47356593	11	47335042	42669	51839	rs397515992	NC_000011.10:47335041:G:A
NM_017519.2(ARID1B):c.1392_1402del (p.Gln467fs)	ARID1B	Q467fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429976	6	157100453 - 157100463	6	156779319 - 156779329	429976	421579	rs1131691706	NC_000006.12:156779318:GCGGGCGGCCAGC:GC
NM_000441.2(SLC26A4):c.707T>C (p.Leu236Pro)	SLC26A4	L236P	Pendred syndrome|Rare genetic deafness|not provided|SLC26A4-Related Disorders|Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004817	7	107315496	7	107675051	4817	19856	rs80338848	NC_000007.14:107675050:T:C
NM_007327.4(GRIN1):c.1643G>A (p.Arg548Gln)	GRIN1	R548Q, R569Q	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000521298	9	140056634	9	137162182	521298	511824	rs1554770044	NC_000009.12:137162181:G:A
NM_007327.4(GRIN1):c.1958C>G (p.Ala653Gly)	GRIN1	A653G, A674G	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000521282	9	140057136	9	137162684	521282	511826	rs1554770258	NC_000009.12:137162683:C:G
NM_007327.4(GRIN1):c.1645A>C (p.Ser549Arg)	GRIN1	S549R, S570R	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000520575	9	140056636	9	137162184	520575	511825	rs1554770046	NC_000009.12:137162183:A:C
NM_002485.4(NBN):c.175C>T (p.Gln59Ter)	NBN	Q59*	Hereditary breast and ovarian cancer syndrome|Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496163	8	90993748	8	89981520	496163	487345	rs1554568427	NC_000008.11:89981519:G:A
NM_001024688.2(NBN):c.896del (p.Pro299fs)	NBN	P299fs, P381fs	Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141731	8	90967766	8	89955538	141731	151445	rs587781969	NC_000008.11:89955537:GG:G
NM_000244.3(MEN1):c.1594C>T (p.Arg532Ter)	MEN1	R527*, R532*, R569*, R492*	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|Metastatic pancreatic neuroendocrine tumours	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016688	11	64572060	11	64804588	16688	31727	rs104894261	NC_000011.10:64804587:G:A
NM_000535.7(PMS2):c.851del (p.Ser283_Ser284insTer)	PMS2		Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000231108	7	6035217	7	5995586	231108	233553	rs876658964	NC_000007.14:5995585:G:
NM_000035.4(ALDOB):c.448G>C (p.Ala150Pro)	ALDOB	A150P	Hereditary fructosuria|not provided	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000464	9	104189856	9	101427574	464	15503	rs1800546	NC_000009.12:101427573:C:G
NM_033360.4(KRAS):c.34G>C (p.Gly12Arg)	KRAS	G12R	Squamous cell lung carcinoma|Neoplasm of the large intestine|Non-small cell lung cancer|Bladder cancer, somatic|Ovarian Neoplasms|Adenoid cystic carcinoma|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000012579	12	25398285	12	25245351	12579	27618	rs121913530	NC_000012.12:25245350:C:G
NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	BRAF	G596V, G508V, G599V, G544V, G559V, G574V, G562V, G636V	Rasopathy|Noonan syndrome|Cardio-facio-cutaneous syndrome|not provided|Lung adenocarcinoma|Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome|Glioblastoma|Transitional cell carcinoma of the bladder|Multiple myeloma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040387	7	140453148	7	140753348	40387	48857	rs397507483	NC_000007.14:140753347:C:A
NM_000256.3(MYBPC3):c.833del (p.Gly278fs)	MYBPC3	G278fs	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164140	11	47369220	11	47347669	164140	175201	rs727503212	NC_000011.10:47347668:CC:C
NM_000256.3(MYBPC3):c.1624+4A>T	MYBPC3		Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042556	11	47364125	11	47342574	42556	51726	rs397515916	NC_000011.10:47342573:T:A
NM_000256.3(MYBPC3):c.3286G>T (p.Glu1096Ter)	MYBPC3	E1096*	Hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008616	11	47354789	11	47333238	8616	23655	rs121909377	NC_000011.10:47333237:C:A
NM_000441.2(SLC26A4):c.626G>T (p.Gly209Val)	SLC26A4	G209V	not provided|SLC26A4-Related Disorders|Enlarged vestibular aqueduct|Enlarged vestibular aqueduct|Pendred syndrome|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004821	7	107315415	7	107674970	4821	19860	rs111033303	NC_000007.14:107674969:G:T
NM_000155.4(GALT):c.855G>T (p.Lys285Asn)	GALT	K285N, K176N	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003621	9	34649029	9	34649032	3621	18660	rs111033773	NC_000009.12:34649031:G:T
NM_001083602.2(PTCH1):c.36G>A (p.Trp12Ter)	PTCH1	W12*, W78*, W77*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000521551	9	98268849	9	95506567	521551	511848	rs1554708787	NC_000009.12:95506566:C:T
NM_001083602.2(PTCH1):c.2909T>A (p.Leu970Ter)	PTCH1	L1036*, L970*, L885*, L984*, L1035*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000521307	9	98220356	9	95458074	521307	511846	rs1554691359	NC_000009.12:95458073:A:T
NM_000535.7(PMS2):c.802dup (p.Tyr268fs)	PMS2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091369	7	6036957 - 6036958	7	5997326 - 5997327	91369	96844	rs267608149	NC_000007.14:5997326:AAAAAA:AAAAAAA
NM_000535.7(PMS2):c.24-12_107delinsAAAT	PMS2		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091341	7	6045579 - 6045674	7	6005948 - 6006043	91341	96816	rs1554306445	
NM_000535.7(PMS2):c.2239_2242AGAA[1] (p.Lys748fs)	PMS2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091333	7	6018256 - 6018259	7	5978625 - 5978628	91333	96808	rs267608173	NC_000007.14:5978624:TTCTTTCT:TTCT
NM_000535.7(PMS2):c.1221del (p.Thr408fs)	PMS2	T273fs, T217fs, T305fs, T97fs, T221fs, T302fs, T408fs, T356fs	Lynch syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000009235	7	6027175	7	5987544	9235	24274	rs587776715	NC_000007.14:5987543:CC:C
NM_000244.3(MEN1):c.1393C>T (p.Arg465Ter)	MEN1	R460*, R465*, R502*, R425*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016692	11	64572261	11	64804789	16692	31731	rs104894267	NC_000011.10:64804788:G:A
NM_006772.3(SYNGAP1):c.333del (p.Lys114fs)	SYNGAP1	K114fs	Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430456	6	33399975	6	33432198	430456	421588	rs1131691979	NC_000006.12:33432197:A:
NM_000426.3(LAMA2):c.939_940del (p.Cys314fs)	LAMA2	C314fs	Merosin deficient congenital muscular dystrophy|Inborn genetic diseases|Laminin alpha 2-related dystrophy	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000477529	6	129470153 - 129470154	6	129149008 - 129149009	477529	455873	rs1209130981	NC_000006.12:129149007:AT:
NM_004333.6(BRAF):c.1406G>T (p.Gly469Val)	BRAF	G469V, G381V, G435V, G447V, G417V, G432V, G472V, G509V	Non-small cell lung cancer|Multiple myeloma|Squamous cell lung carcinoma|Malignant melanoma of skin|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Adenocarcinoma of prostate|Neoplasm	Pathogenic(Last reviewed: Dec 30, 2011)	criteria provided, single submitter	VCV000044803	7	140481402	7	140781602	44803	53970	rs121913355	NC_000007.14:140781601:C:A
NM_000256.3(MYBPC3):c.1351+1G>A	MYBPC3		Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164119	11	47364571	11	47343020	164119	174779	rs727503204	NC_000011.10:47343019:C:T
NM_000368.5(TSC1):c.989dup (p.Ser331fs)	TSC1		Renal insufficiency|Cortical dysplasia|Renal cortical cysts|Tuberous sclerosis 1|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000049135	9	135786879 - 135786880	9	132911492 - 132911493	49135	58297	rs118203478	NC_000009.12:132911492:A:AA
NM_000368.5(TSC1):c.2509_2512del (p.Asn837fs)	TSC1	N716fs, N837fs, N786fs, N836fs	Tuberous sclerosis 1|Cortical tubers|Seizures|Multiple renal cysts|not provided|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048971	9	135776215 - 135776218	9	132900828 - 132900831	48971	58133	rs118203707	NC_000009.12:132900827:TGTTTG:TG
NM_000441.2(SLC26A4):c.1334T>G (p.Leu445Trp)	SLC26A4	L445W	not provided|Enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004829	7	107334918	7	107694473	4829	19868	rs111033307	NC_000007.14:107694472:T:G
NM_138694.4(PKHD1):c.664A>G (p.Ile222Val)	PKHD1	I222V	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406891	6	51935807	6	52071009	406891	395418	rs369925690	NC_000006.12:52071008:T:C
NM_000535.7(PMS2):c.2533del (p.His845fs)	PMS2	H658fs, H856fs, H721fs, H739fs, H845fs, H742fs, H793fs, H534fs, H654fs, H710fs	not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423571	7	6013086	7	5973455	423571	407165	rs1064796500	NC_000007.14:5973454:GGGG:GGG
NM_000535.7(PMS2):c.1500del (p.Val501fs)	PMS2	V314fs, V190fs, V310fs, V366fs, V395fs, V398fs, V449fs, V501fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224541	7	6026896	7	5987265	224541	226328	rs759151952	NC_000007.14:5987264:GG:G
NM_017890.4(VPS13B):c.9793dup (p.Met3265fs)	VPS13B		not provided|Cohen syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279782	8	100847523 - 100847524	8	99835295 - 99835296	279782	264452	rs886041185	NC_000008.11:99835295:AAAAA:AAAAAA
NM_000244.3(MEN1):c.1561dup (p.Arg521fs)	MEN1		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279852	11	64572092 - 64572093	11	64804620 - 64804621	279852	264436	rs767319284	NC_000011.10:64804620:GGGGGGG:GGGGGGGG
NM_000244.3(MEN1):c.249_252del (p.Ile85fs)	MEN1	I85fs	not provided|Hereditary cancer-predisposing syndrome|Lipoma, somatic|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016693	11	64577330 - 64577333	11	64809858 - 64809861	16693	31732	rs587776841	NC_000011.10:64809857:AGACAG:AG
NM_020732.3(ARID1B):c.1762G>T (p.Glu588Ter)	ARID1B	E588*	Inborn genetic diseases|Coffin-Siris syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520728	6	157192772	6	156871638	520728	511636	rs201653711	NC_000006.12:156871637:G:T
NM_020732.3(ARID1B):c.5404C>T (p.Arg1802Ter)	ARID1B	R1802*, R1842*, R1092*, R1789*	Inborn genetic diseases|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000210302	6	157527679	6	157206545	210302	207384	rs797045282	NC_000006.12:157206544:C:T
NM_000256.3(MYBPC3):c.821+1G>A	MYBPC3		Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042791	11	47369407	11	47347856	42791	51961	rs397516073	NC_000011.10:47347855:C:T
NM_000256.3(MYBPC3):c.2308+1G>A	MYBPC3		Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not provided|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042610	11	47360070	11	47338519	42610	51780	rs112738974	NC_000011.10:47338518:C:T
NM_000256.3(MYBPC3):c.2374T>C (p.Trp792Arg)	MYBPC3	W792R	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036605	11	47359280	11	47337729	36605	45267	rs187830361	NC_000011.10:47337728:A:G
NM_000368.5(TSC1):c.682C>T (p.Arg228Ter)	TSC1	R228*, R177*, R107*	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 1|Focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000049083	9	135796805	9	132921418	49083	58245	rs118203427	NC_000009.12:132921417:G:A
NM_001162426.2(TSC1):c.1899_1900CA[1] (p.Thr634fs)	TSC1		Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005100	9	135781060 - 135781061	9	132905673 - 132905674	5100	20139	rs118203597	NC_000009.12:132905672:TGTGT:TGT
NM_000466.3(PEX1):c.2097dup (p.Ile700fs)	PEX1		Peroxisome biogenesis disorder 1B|not provided|Retinal dystrophy|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)|Deafness enamel hypoplasia nail defects|Deafness enamel hypoplasia nail defects|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007519	7	92132483 - 92132484	7	92503169 - 92503170	7519	22558	rs61750415	NC_000007.14:92503169:AAA:AAAA
NM_001083602.2(PTCH1):c.4-1576G>T	PTCH1	E63*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429530	9	98270457	9	95508175	429530	421767	rs781768965	NC_000009.12:95508174:C:A
NM_000535.7(PMS2):c.1144+1G>A	PMS2		not provided|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162508	7	6029430	7	5989799	162508	172174	rs373885654	NC_000007.14:5989798:C:T
NM_000535.7(PMS2):c.1738A>T (p.Lys580Ter)	PMS2	K580*, K477*, K269*, K389*, K445*, K393*, K474*, K528*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091312	7	6026658	7	5987027	91312	96787	rs267608169	NC_000007.14:5987026:T:A
NM_017890.4(VPS13B):c.2911C>T (p.Arg971Ter)	VPS13B	R971*	Cohen syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002823	8	100396522	8	99384294	2823	17862	rs120074152	NC_000008.11:99384293:C:T
NM_000244.3(MEN1):c.1561del (p.Arg521fs)	MEN1	R516fs, R481fs, R521fs, R558fs	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200999	11	64572093	11	64804621	200999	197525	rs767319284	NC_000011.10:64804620:GGGGGGG:GGGGGG
NM_000244.3(MEN1):c.643_646del (p.Thr215fs)	MEN1	T210fs, T215fs	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200997	11	64575386 - 64575389	11	64807914 - 64807917	200997	197548	rs794728640	NC_000011.10:64807913:CTGTCTG:CTG
NM_020732.3(ARID1B):c.1618C>T (p.Gln540Ter)	ARID1B	Q540*	Coffin-Siris syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000520639	6	157150436	6	156829302	520639	511635	rs1554256703	NC_000006.12:156829301:C:T
NM_020732.3(ARID1B):c.4009C>T (p.Arg1337Ter)	ARID1B	R1337*, R1377*, R1324*, R627*	Inborn genetic diseases|not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488469	6	157517445	6	157196311	488469	481337	rs773740590	NC_000006.12:157196310:C:T
NM_004519.4(KCNQ3):c.689G>A (p.Arg230His)	KCNQ3	R230H, R110H	Benign familial neonatal seizures 2|Inborn genetic diseases|Benign familial neonatal seizures|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000424397	8	133192492	8	132180245	424397	407314	rs749205120	NC_000008.11:132180244:C:T
NM_000108.5(DLD):c.685G>T (p.Gly229Cys)	DLD	G229C, G181C, G130C, G206C	DLD-Related Disorders|Maple syrup urine disease, type 3|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011966	7	107555951	7	107915506	11966	27005	rs121964990	NC_000007.14:107915505:G:T
NM_000441.2(SLC26A4):c.1246A>C (p.Thr416Pro)	SLC26A4	T416P	Pendred syndrome|not provided|SLC26A4-Related Disorders|Enlarged vestibular aqueduct|Pendred syndrome|Enlarged vestibular aqueduct|Rare genetic deafness	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004818	7	107330665	7	107690220	4818	19857	rs28939086	NC_000007.14:107690219:A:C
NM_000256.3(MYBPC3):c.3288del (p.Glu1096fs)	MYBPC3	E1096fs	Familial hypertrophic cardiomyopathy 4|Cardiomyopathy|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164042	11	47354787	11	47333236	164042	174737	rs727503172	NC_000011.10:47333235:C:
NM_000256.3(MYBPC3):c.913_914del (p.Phe305fs)	MYBPC3	F305fs	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042801	11	47368190 - 47368191	11	47346639 - 47346640	42801	51971	rs397516080	NC_000011.10:47346638:AAA:A
NM_000256.3(MYBPC3):c.3811C>T (p.Arg1271Ter)	MYBPC3	R1271*	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|Long QT syndrome|Hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042744	11	47353626	11	47332075	42744	51914	rs397516042	NC_000011.10:47332074:G:A
NM_000256.3(MYBPC3):c.3330+5G>C	MYBPC3		Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|not provided|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042706	11	47354740	11	47333189	42706	51876	rs373746463	NC_000011.10:47333188:C:G
NM_000256.3(MYBPC3):c.2459G>A (p.Arg820Gln)	MYBPC3	R820Q	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008617	11	47359085	11	47337534	8617	23656	rs2856655	NC_000011.10:47337533:C:T
NM_002180.2(IGHMBP2):c.2909_2910AG[1] (p.Arg971fs)	IGHMBP2		Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162195	11	68707126 - 68707127	11	68939658 - 68939659	162195	171903	rs724159994	NC_000011.10:68939657:AGAG:AG
NM_000155.4(GALT):c.584T>C (p.Leu195Pro)	GALT	L195P, L86P	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025222	9	34648350	9	34648353	25222	36556	rs111033728	NC_000009.12:34648352:T:C
NM_017780.4(CHD7):c.1808dup (p.Asn603fs)	CHD7		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000521935	8	61693696 - 61693697	8	60781137 - 60781138	521935	511758	rs1554588675	NC_000008.11:60781137:AAAAA:AAAAAA
NM_017780.4(CHD7):c.3414_3430del (p.Gln1138fs)	CHD7	Q1138fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000521885	8	61741257 - 61741273	8	60828698 - 60828714	521885	511760	rs1554599036	NC_000008.11:60828697:GAACACTGTGGAAGAAC:
NM_017780.4(CHD7):c.5534+1G>A	CHD7		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000521544	8	61763182	8	60850623	521544	511767	rs1554603589	NC_000008.11:60850622:G:A
NM_017780.4(CHD7):c.5114dup (p.Val1706fs)	CHD7		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000521250	8	61757870 - 61757871	8	60845311 - 60845312	521250	511762	rs1554602564	NC_000008.11:60845311:CC:CCC
NM_017780.4(CHD7):c.7281dup (p.Arg2428fs)	CHD7		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000521189	8	61769118 - 61769119	8	60856559 - 60856560	521189	511769	rs1554605030	NC_000008.11:60856559:TT:TTT
NM_017780.4(CHD7):c.6141_6142AG[1] (p.Glu2048fs)	CHD7		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000521152	8	61765425 - 61765426	8	60852866 - 60852867	521152	511768	rs1554604059	NC_000008.11:60852865:AGAG:AG
NM_017780.4(CHD7):c.5426T>G (p.Met1809Arg)	CHD7	M1809R	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000521017	8	61763073	8	60850514	521017	511766	rs1554603550	NC_000008.11:60850513:T:G
NM_000719.7(CACNA1C):c.1216G>A (p.Gly406Arg)	CACNA1C	G406R, G403R	Long QT syndrome|CACNA1C-Related Disorders|Timothy syndrome|Congenital long QT syndrome|not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017632	12	2614110	12	2504944	17632	32671	rs79891110	NC_000012.12:2504943:G:A
NM_000535.7(PMS2):c.538-1G>C	PMS2		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000434027	7	6038907	7	5999276	434027	427327	rs988423880	NC_000007.14:5999275:C:G
NM_000535.7(PMS2):c.949C>T (p.Gln317Ter)	PMS2	Q317*, Q182*, Q211*, Q214*, Q126*, Q6*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091383	7	6031643	7	5992012	91383	96858	rs143277125	NC_000007.14:5992011:G:A
NM_004333.6(BRAF):c.1914T>G (p.Asp638Glu)	BRAF	D638E, D601E, D604E, D641E, D586E, D616E, D678E, D550E	Noonan syndrome 1|Cardio-facio-cutaneous syndrome|Rasopathy|Inborn genetic diseases|Cardiofaciocutaneous syndrome 1|not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162797	7	140449165	7	140749365	162797	174176	rs180177042	NC_000007.14:140749364:A:C
NM_003165.4(STXBP1):c.956del (p.Gly319fs)	STXBP1	G319fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000522094	9	130432229	9	127669950	522094	511785	rs1554777919	NC_000009.12:127669949:GG:G
NM_003165.4(STXBP1):c.1593C>A (p.Tyr531Ter)	STXBP1	Y531*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000521069	9	130444730	9	127682451	521069	511790	rs767199598	NC_000009.12:127682450:C:A
NM_003165.4(STXBP1):c.1110G>A (p.Gln370=)	STXBP1		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000520996	9	130435540	9	127673261	520996	511787	rs1554778227	NC_000009.12:127673260:G:A
NM_003165.4(STXBP1):c.1359+2T>C	STXBP1		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000520961	9	130439034	9	127676755	520961	511788	rs1554778509	NC_000009.12:127676754:T:C
NM_003165.4(STXBP1):c.298del (p.Arg100fs)	STXBP1	R100fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	VCV000520745	9	130422359	9	127660080	520745	511783	rs1554776842	NC_000009.12:127660079:CC:C
NM_003165.4(STXBP1):c.1631del (p.Gly544fs)	STXBP1	G544fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000520694	9	130444764	9	127682485	520694	511791	rs1554778941	NC_000009.12:127682484:GGGGG:GGGG
NM_003165.4(STXBP1):c.639dup (p.Ala214fs)	STXBP1		Inborn genetic diseases	Pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	VCV000520654	9	130427583 - 130427584	9	127665304 - 127665305	520654	511784	rs1554777375	NC_000009.12:127665304:AAA:AAAA
NM_001079823.2(LAMA2):c.1854_1861dup (p.Leu621fs)	LAMA2		Inborn genetic diseases|Laminin alpha 2-related dystrophy|not provided|Merosin deficient congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038339	6	129571327 - 129571328	6	129250182 - 129250183	38339	46903	rs202247791	NC_000006.12:129250182:ACGTGTTC:ACGTGTTCACGTGTTC
NM_000441.2(SLC26A4):c.1001+1G>A	SLC26A4		Pendred syndrome|not provided|SLC26A4-Related Disorders|Enlarged vestibular aqueduct|Enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004819	7	107323983	7	107683538	4819	19858	rs80338849	NC_000007.14:107683537:G:A
NM_000368.5(TSC1):c.733C>T (p.Arg245Ter)	TSC1	R245*, R194*, R124*	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000049091	9	135796754	9	132921367	49091	58253	rs118203434	NC_000009.12:132921366:G:A
NM_000260.4(MYO7A):c.1623dup (p.Lys542fs)	MYO7A		Inborn genetic diseases|Retinal dystrophy|	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521129	11	76873960 - 76873961	11	77162914 - 77162915	521129	511946	rs782077721	NC_000011.10:77162914:CCCCCCC:CCCCCCCC
NM_005476.7(GNE):c.1892C>T (p.Ala631Val)	GNE	A631V, A662V, A521V, A626V, A557V	Sialuria|GNE myopathy|GNE myopathy|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006035	9	36218221	9	36218224	6035	21074	rs62541771	NC_000009.12:36218223:G:A
NM_017617.5(NOTCH1):c.166C>T (p.Arg56Ter)	NOTCH1	R56*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000521568	9	139418406	9	136523954	521568	511821	rs1348892740	NC_000009.12:136523953:G:A
NM_017617.5(NOTCH1):c.5950C>T (p.Arg1984Ter)	NOTCH1	R1984*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000520784	9	139393696	9	136499244	520784	511818	rs1554826746	NC_000009.12:136499243:G:A
NM_017617.5(NOTCH1):c.3052del (p.Cys1018fs)	NOTCH1	C1018fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	VCV000520577	9	139403441	9	136508989	520577	511819	rs1554728529	NC_000009.12:136508988:A:
NM_004333.6(BRAF):c.1397G>T (p.Gly466Val)	BRAF	G466V, G429V, G378V, G414V, G469V, G506V, G432V, G444V	Squamous cell lung carcinoma|Multiple myeloma|Malignant melanoma of skin|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell carcinoma of the head and neck|Lung cancer|Neoplasm of the large intestine	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000013967	7	140481411	7	140781611	13967	29006	rs121913351	NC_000007.14:140781610:C:A
NM_000535.7(PMS2):c.823C>T (p.Gln275Ter)	PMS2	Q275*, Q84*, Q169*, Q172*, Q140*	Hereditary nonpolyposis colorectal cancer type 4|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127796	7	6035245	7	5995614	127796	133253	rs587780062	NC_000007.14:5995613:G:A
NM_033360.4(KRAS):c.34G>A (p.Gly12Ser)	KRAS	G12S	Neoplasm of the large intestine|Neoplasm of stomach|Non-small cell lung cancer|Juvenile myelomonocytic leukemia|Neoplasm of ovary|Neoplasm of the thyroid gland|not provided	Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	VCV000012584	12	25398285	12	25245351	12584	27623	rs121913530	NC_000012.12:25245350:C:T
NM_000256.3(MYBPC3):c.3776del (p.Gln1259fs)	MYBPC3	Q1259fs	Cardiomyopathy|Left ventricular noncompaction|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164021	11	47353661	11	47332110	164021	175138	rs727503166	NC_000011.10:47332109:T:
NM_017780.4(CHD7):c.934C>T (p.Arg312Ter)	CHD7	R312*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	VCV000279757	8	61654925	8	60742366	279757	264409	rs886041166	NC_000008.11:60742365:C:T
NM_004333.6(BRAF):c.1914T>A (p.Asp638Glu)	BRAF	D638E	Inborn genetic diseases|Cardiofaciocutaneous syndrome 1|not provided|Cardiofaciocutaneous syndrome 1|Lung cancer|LEOPARD syndrome 3|Noonan syndrome 7|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013981	7	140449165	7	140749365	13981	29020	rs180177042	NC_000007.14:140749364:A:T
NM_000834.4(GRIN2B):c.2459G>C (p.Gly820Ala)	GRIN2B	G820A	Mental retardation, autosomal dominant 6|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208643	12	13720098	12	13567164	208643	205273	rs797044849	NC_000012.12:13567163:C:G
NM_000535.7(PMS2):c.88C>T (p.Gln30Ter)	PMS2	Q30*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142650	7	6045598	7	6005967	142650	152364	rs141577476	NC_000007.14:6005966:G:A
NM_000535.7(PMS2):c.1112_1113delinsTTTA (p.Asn371fs)	PMS2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091290	7	6029462 - 6029463	7	5989831 - 5989832	91290	96765	rs587779326	NC_000007.14:5989830:AT:TAAA
NM_000441.2(SLC26A4):c.412G>T (p.Val138Phe)	SLC26A4	V138F	not provided|SLC26A4-Related Disorders|Enlarged vestibular aqueduct|Pendred syndrome|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	VCV000004835	7	107312690	7	107672245	4835	19874	rs111033199	NC_000007.14:107672244:G:T
NM_033056.4(PCDH15):c.733C>T (p.Arg245Ter)	PCDH15	R245*, R208*, R223*, R250*	Rare genetic deafness|not provided|Deafness, autosomal recessive 23||||Deafness, autosomal recessive 23|Usher syndrome, type 1G||	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004933	10	56077174	10	54317414	4933	19972	rs111033260	NC_000010.11:54317413:G:A
NM_005709.3(USH1C):c.238dupC (p.Arg80Profs)	USH1C		Retinal dystrophy|not provided||Retinitis pigmentosa|Rare genetic deafness|Usher syndrome|Deafness, autosomal recessive 18|Usher syndrome, type 1C	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005141	11	17552955 - 17552956	11	17531408 - 17531409	5141	20180	rs397515359	NC_000011.10:17531408:GGGGGG:GGGGGGG
NM_000136.3(FANCC):c.67del (p.Asp23fs)	FANCC	D23fs	Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia|Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012049	9	98011507	9	95249225	12049	27088	rs104886459	NC_000009.12:95249224:CCC:CC
NM_020732.3(ARID1B):c.5776C>T (p.Arg1926Ter)	ARID1B	R1926*, R1966*, R1913*, R1216*	Inborn genetic diseases|not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488678	6	157528051	6	157206917	488678	481755	rs1554237658	NC_000006.12:157206916:C:T
NM_033360.4(KRAS):c.34G>T (p.Gly12Cys)	KRAS	G12C	Neoplasm of the large intestine|Non-small cell lung cancer|Lung adenocarcinoma|Endometrial carcinoma|Lung cancer|Ovarian Neoplasms|Neoplasm of the thyroid gland	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000012578	12	25398285	12	25245351	12578	27617	rs121913530	NC_000012.12:25245350:C:A
NM_000552.4(VWF):c.4789C>T (p.Arg1597Trp)	VWF	R1597W	not provided|von Willebrand disorder|von Willebrand disease, type 2a|Inborn genetic diseases|not specified	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000285	12	6127795	12	6018629	285	15324	rs61750117	NC_000012.12:6018628:G:A
NM_000535.7(PMS2):c.2361_2364del (p.Phe788fs)	PMS2	F601fs, F653fs, F682fs, F685fs, F597fs, F788fs, F477fs, F664fs, F736fs, F799fs	Lynch syndrome|Turcot syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091338	7	6017300 - 6017303	7	5977669 - 5977672	91338	96813	rs267608160	NC_000007.14:5977668:GAAG:
NM_001083602.2(PTCH1):c.1381C>T (p.Gln461Ter)	PTCH1	Q461*, Q527*, Q526*, Q376*, Q475*	Gorlin syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520981	9	98239064	9	95476782	520981	511847	rs1554698260	NC_000009.12:95476781:G:A
NM_000155.4(GALT):c.997C>T (p.Arg333Trp)	GALT	R333W, R224W	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003610	9	34649499	9	34649502	3610	18649	rs111033800	NC_000009.12:34649501:C:T
NM_000256.3(MYBPC3):c.3190+5G>A	MYBPC3		Cardiovascular phenotype|Left ventricular noncompaction 10|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Heart block|Hypertrophic cardiomyopathy|Asymmetric septal hypertrophy|Ventricular extrasystoles|Dyspnea|Tachycardia|Noncompaction cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000155808	11	47355103	11	47333552	155808	165560	rs587782958	NC_000011.10:47333551:C:T
NM_000368.5(TSC1):c.1884_1887AAAG[1] (p.Lys630fs)	TSC1		not provided|Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005097	9	135781074 - 135781077	9	132905687 - 132905690	5097	20136		NC_000009.12:132905686:CTTTCTTT:CTTT
NM_007327.4(GRIN1):c.1858G>C (p.Gly620Arg)	GRIN1	G620R, G641R	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209159	9	140056962	9	137162510	209159	205760	rs797045047	NC_000009.12:137162509:G:C
NM_001370259.2(MEN1):c.1252G>A (p.Asp418Asn)	MEN1	D418N, D423N, D383N, D460N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016703	11	64572604	11	64805132	16703	31742	rs104894264	NC_000011.10:64805131:C:T
NM_000535.7(PMS2):c.1076dup (p.Leu359fs)	PMS2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091289	7	6029498 - 6029499	7	5989867 - 5989868	91289	96764	rs267608156	NC_000007.14:5989867:AAA:AAAA
NM_000256.3(MYBPC3):c.927-9G>A	MYBPC3		Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042807	11	47367930	11	47346379	42807	51977	rs397516083	NC_000011.10:47346378:C:T
NM_000256.3(MYBPC3):c.655G>C (p.Val219Leu)	MYBPC3	V219L	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042784	11	47370092	11	47348541	42784	51954	rs397516068	NC_000011.10:47348540:C:G
NM_000256.3(MYBPC3):c.3742_3759dup (p.Gly1248_Cys1253dup)	MYBPC3		Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008603	11	47353677 - 47353678	11	47332126 - 47332127	8603	23642	rs193922384	NC_000011.10:47332126:GCAGACATAGATGCCCCCG:GCAGACATAGATGCCCCCGCAGACATAGATGCCCCCG
NM_213599.2(ANO5):c.191dupA	ANO5		ANO5-Related Disorders|not provided|Muscular Diseases|Achilles tendon contracture|Lower limb muscle weakness|Elevated serum creatine phosphokinase|Lower limb amyotrophy|Polycystic kidney dysplasia|Miyoshi muscular dystrophy 3|Limb-girdle muscular dystrophy, type 2L|Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002164	11	22242646 - 22242647	11	22221100 - 22221101	2164	17203	rs137854521	NC_000011.10:22221100:AAAAAAA:AAAAAAAA
NM_000155.4(GALT):c.404C>T (p.Ser135Leu)	GALT	S135L, S26L	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003618	9	34647855	9	34647858	3618	18657	rs111033690	NC_000009.12:34647857:C:T
NM_000155.4(GALT):c.563A>G (p.Gln188Arg)	GALT	Q188R, Q79R	Galactosemia|not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003614	9	34648167	9	34648170	3614	18653	rs75391579	NC_000009.12:34648169:A:G
NM_001024688.2(NBN):c.-141_-140del	NBN	S53fs	Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary breast and ovarian cancer syndrome|Acute lymphoid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371121	8	90994964 - 90994965	8	89982736 - 89982737	371121	357674	rs767454740	NC_000008.11:89982735:AAAA:AA
NM_000535.7(PMS2):c.2500_2501delinsG (p.Met834fs)	PMS2		Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141280	7	6013118 - 6013119	7	5973487 - 5973488	141280	150994	rs587781626	NC_000007.14:5973486:AT:C
NM_000535.7(PMS2):c.862_863del (p.Gln288fs)	PMS2	Q288fs, Q182fs, Q153fs, Q185fs, Q97fs	Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091376	7	6035205 - 6035206	7	5995574 - 5995575	91376	96851	rs63750246	NC_000007.14:5995573:TGT:T
NM_004333.6(BRAF):c.1741A>G (p.Asn581Asp)	BRAF	N581D, N547D, N529D, N559D, N584D, N621D, N493D, N544D	Inborn genetic diseases|Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013979	7	140453987	7	140754187	13979	29018	rs180177040	NC_000007.14:140754186:T:C
NM_004333.6(BRAF):c.1781A>G (p.Asp594Gly)	BRAF	D594G, D560G, D506G, D542G, D557G, D572G, D597G, D634G	Non-Hodgkin lymphoma|Multiple myeloma|Lung adenocarcinoma|Malignant melanoma of skin|Non-small cell lung cancer|Squamous cell carcinoma of the head and neck|Adrenocortical carcinoma|Neoplasm of the large intestine|Neoplasm of brain|Chronic lymphocytic leukemia|Cutaneous melanoma|Transitional cell carcinoma of the bladder	Pathogenic(Last reviewed: Jun 11, 2012)	criteria provided, single submitter	VCV000013972	7	140453154	7	140753354	13972	29011	rs121913338	NC_000007.14:140753353:T:C
NM_007327.4(GRIN1):c.2530C>T (p.Arg844Cys)	GRIN1	R844C, R865C	Inborn genetic diseases|NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|not provided|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521354	9	140058297	9	137163845	521354	511828	rs1554770667	NC_000009.12:137163844:C:T
NM_001613.4(ACTA2):c.536G>A (p.Arg179His)	ACTA2	R179H	Aortic aneurysm, familial thoracic 6|Multisystemic smooth muscle dysfunction syndrome|Moyamoya disease 5|not provided|Connective tissue disease|alterations of great arteries and veins|Cardiovascular phenotype|Moyamoya disease 5|Thoracic aortic aneurysm and aortic dissection|Multisystemic smooth muscle dysfunction syndrome|Aortic aneurysm, familial thoracic 6	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029598	10	90701066	10	88941309	29598	38552	rs387906592	NC_000010.11:88941308:C:T
NM_020732.3(ARID1B):c.3223C>T (p.Arg1075Ter)	ARID1B	R1075*, R1115*, R365*, R1062*	not provided|Coffin-Siris syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031216	6	157502190	6	157181056	31216	40173	rs387907144	NC_000006.12:157181055:C:T
NM_000256.3(MYBPC3):c.26-2A>G	MYBPC3		Familial hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042644	11	47373058	11	47351507	42644	51814	rs376395543	NC_000011.10:47351506:T:C
NM_000256.3(MYBPC3):c.1505G>A (p.Arg502Gln)	MYBPC3	R502Q	Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042541	11	47364248	11	47342697	42541	51711	rs397515907	NC_000011.10:47342696:C:T
NM_000136.3(FANCC):c.456+4A>T	FANCC		Hereditary cancer-predisposing syndrome|Fanconi anemia|not provided|Fanconi anemia, complementation group C	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012045	9	97934315	9	95172033	12045	27084	rs104886456	NC_000009.12:95172032:T:A
NM_004408.4(DNM1):c.713G>T (p.Ser238Ile)	DNM1	S238I	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000520714	9	130982484	9	128220205	520714	511795	rs1554773487	NC_000009.12:128220204:G:T
NM_005476.7(GNE):c.2086G>A (p.Val696Met)	GNE	V696M, V586M, V622M, V691M, V727M	GNE myopathy|not provided|Sialuria|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006028	9	36217445	9	36217448	6028	21067	rs121908627	NC_000009.12:36217447:C:T
NM_000552.4(VWF):c.2561G>A (p.Arg854Gln)	VWF	R854Q	von Willebrand disease type 2|von Willebrand disease type 1|von Willebrand disease type 2N|Abnormality of coagulation|von Willebrand disease type 2|Von Willebrand disease, recessive form|von Willebrand disease type 1|not provided|von Willebrand disorder	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000296	12	6143978	12	6034812	296	15335	rs41276738	NC_000012.12:6034811:C:T
NM_001164277.1(SLC37A4):c.1042_1043del (p.Leu348fs)	SLC37A4	L275fs, L348fs, L370fs	Glycogen storage disease|not provided|Inborn genetic diseases|Glucose-6-phosphate transport defect|Phosphate transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006926	11	118895981 - 118895982	11	119025271 - 119025272	6926	21965	rs80356491	NC_000011.10:119025270:AG:
NM_000368.5(TSC1):c.2356C>T (p.Arg786Ter)	TSC1	R786*, R735*, R785*, R665*	Tuberous sclerosis 1|Seizures|Hamartoma|Cardiac rhabdomyoma|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048943	9	135778027	9	132902640	48943	58105	rs118203682	NC_000009.12:132902639:G:A
NM_004260.3(RECQL4):c.2269C>T (p.Gln757Ter)	RECQL4	Q757*	Baller-Gerold syndrome|Rothmund-Thomson syndrome type 2|Rapadilino syndrome|Rothmund-Thomson syndrome|Baller-Gerold syndrome|Rothmund-Thomson syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006063	8	145738796	8	144513412	6063	21102	rs137853229	NC_000008.11:144513411:G:A
NM_000535.7(PMS2):c.538-2A>G	PMS2		Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411028	7	6038908	7	5999277	411028	395978	rs758304323	NC_000007.14:5999276:T:C
NM_000535.7(PMS2):c.697C>T (p.Gln233Ter)	PMS2	Q233*, Q127*, Q98*, Q130*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091362	7	6038747	7	5999116	91362	96837	rs587779343	NC_000007.14:5999115:G:A
NM_017780.4(CHD7):c.6292C>T (p.Arg2098Ter)	CHD7	R2098*	Inborn genetic diseases|CHARGE association	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226115	8	61765576	8	60853017	226115	227917	rs875989879	NC_000008.11:60853016:C:T
NM_020822.3(KCNT1):c.1421G>A (p.Arg474His)	KCNT1	R474H, R429H	Inborn genetic diseases|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|not provided|Early infantile epileptic encephalopathy 14	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039595	9	138660694	9	135768848	39595	48194	rs397515404	NC_000009.12:135768847:G:A
NM_001287174.2(ABCC8):c.3992-9G>A	ABCC8		not provided|Familial hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009088	11	17418602	11	17397055	9088	24127	rs151344623	NC_000011.10:17397054:C:T
NM_004408.4(DNM1):c.1075G>A (p.Gly359Arg)	DNM1	G359R	Epileptic encephalopathy, early infantile, 31|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520737	9	130984822	9	128222543	520737	511796	rs1554774587	NC_000009.12:128222542:G:A
NM_000441.2(SLC26A4):c.1226G>A (p.Arg409His)	SLC26A4	R409H	Pendred syndrome|not provided|Enlarged vestibular aqueduct|Rare genetic deafness|not specified	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043496	7	107330645	7	107690200	43496	52666	rs111033305	NC_000007.14:107690199:G:A
NM_000441.2(SLC26A4):c.919-2A>G	SLC26A4		not provided|Enlarged vestibular aqueduct|Pendred syndrome|Pendred syndrome|Enlarged vestibular aqueduct|Rare genetic deafness	Pathogenic(Last reviewed: Sep 20, 2018)	reviewed by expert panel	VCV000004840	7	107323898	7	107683453	4840	19879	rs111033313	NC_000007.14:107683452:A:G
NM_000083.3(CLCN1):c.2680C>T (p.Arg894Ter)	CLCN1	R894*	not provided|Muscular Diseases|EMG: myopathic abnormalities|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Myotonia congenita	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017545	7	143048771	7	143351678	17545	32584	rs55960271	NC_000007.14:143351677:C:T
NM_000260.4(MYO7A):c.3503G>A (p.Arg1168Gln)	MYO7A	R1168Q, R1157Q	Inborn genetic diseases|not specified||Deafness, autosomal recessive 2|Usher syndrome	Pathogenic(Last reviewed: Sep 16, 2019)	reviewed by expert panel	VCV000179479	11	76895760	11	77184715	179479	178280	rs797044516	NC_000011.10:77184714:G:A
NM_017780.4(CHD7):c.3623T>A (p.Val1208Asp)	CHD7	V1208D	not provided|CHARGE association|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267427	8	61742981	8	60830422	267427	262652	rs886040988	NC_000008.11:60830421:T:A
NM_000535.7(PMS2):c.1874del (p.Ser624_Leu625insTer)	PMS2		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186596	7	6026522	7	5986891	186596	182719	rs786203073	NC_000007.14:5986890:AAA:AA
NM_000535.7(PMS2):c.1A>T (p.Met1Leu)	PMS2	M1L	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142777	7	6048650	7	6009019	142777	152491	rs587779333	NC_000007.14:6009018:T:A
NM_004333.6(BRAF):c.1789C>G (p.Leu597Val)	BRAF	L597V, L509V, L545V, L563V, L600V, L637V, L560V, L575V	Noonan syndrome 1|Non-small cell lung cancer|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cutaneous melanoma|Lung cancer|not provided|Neoplasm|Noonan syndrome 7	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013969	7	140453146	7	140753346	13969	29008	rs121913369	NC_000007.14:140753345:G:C
NM_024426.6(WT1):c.1399C>T (p.Arg467Trp)	WT1	R394W, R462W, R250W, R445W, R467W, R233W, R450W, R71W	Diffuse mesangial sclerosis|Meacham syndrome|Drash syndrome|not provided|Steroid-resistant nephrotic syndrome|Nephrotic range proteinuria|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome|Wilms tumor 1|Drash syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003487	11	32413566	11	32392020	3487	18526	rs121907900	NC_000011.10:32392019:G:A
NM_000256.3(MYBPC3):c.927-2A>G	MYBPC3		Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042806	11	47367923	11	47346372	42806	51976	rs397516082	NC_000011.10:47346371:T:C
NM_022970.3(FGFR2):c.1087+1340C>G	FGFR2	S354C, S126C, S239C, S265C	Crouzon syndrome|Inborn genetic diseases|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013265	10	123276856	10	121517342	13265	28304	rs121918490	NC_000010.11:121517341:G:C
NM_000535.7(PMS2):c.1021del (p.Arg341fs)	PMS2	R206fs, R341fs, R150fs, R235fs, R238fs, R30fs	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000009240	7	6029554	7	5989923	9240	24279	rs63750049	NC_000007.14:5989922:TTTT:TTT
NM_000256.3(MYBPC3):c.3697C>T (p.Gln1233Ter)	MYBPC3	Q1233*	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Left ventricular hypertrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042735	11	47353740	11	47332189	42735	51905	rs397516037	NC_000011.10:47332188:G:A
NM_000441.2(SLC26A4):c.2168A>G (p.His723Arg)	SLC26A4	H723R	not provided|SLC26A4-Related Disorders|Enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004825	7	107350577	7	107710132	4825	19864	rs121908362	NC_000007.14:107710131:A:G
NM_004333.6(BRAF):c.1406G>C (p.Gly469Ala)	BRAF	G469A, G447A, G435A, G472A, G381A, G417A, G432A, G509A	Squamous cell lung carcinoma|Non-Hodgkin lymphoma|Multiple myeloma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Malignant melanoma of skin|Non-small cell lung cancer|Adenocarcinoma of prostate|Lung cancer|Neoplasm of the large intestine|Neoplasm|Squamous cell carcinoma of the skin	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000013971	7	140481402	7	140781602	13971	29010	rs121913355	NC_000007.14:140781601:C:G
NM_017780.4(CHD7):c.3398C>T (p.Thr1133Met)	CHD7	T1133M	CHARGE association||not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418124	8	61741241	8	60828682	418124	407414	rs1064793083	NC_000008.11:60828681:C:T
NM_033360.4(KRAS):c.183A>T (p.Gln61His)	KRAS	Q61H	Non-small cell lung cancer|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm of the thyroid gland|Multiple myeloma|Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Hepatocellular carcinoma|Malignant melanoma of skin|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Chronic lymphocytic leukemia|Acute myeloid leukemia	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000045117	12	25380275	12	25227341	45117	54284	rs17851045	NC_000012.12:25227340:T:A
NM_000535.7(PMS2):c.1840A>T (p.Lys614Ter)	PMS2	K614*, K427*, K479*, K508*, K562*, K303*, K423*, K511*	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091318	7	6026556	7	5986925	91318	96793	rs63750490	NC_000007.14:5986924:T:A
NM_000535.7(PMS2):c.1261C>T (p.Arg421Ter)	PMS2	R421*, R230*, R234*, R315*, R110*, R286*, R318*, R369*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091299	7	6027135	7	5987504	91299	96774	rs587778617	NC_000007.14:5987503:G:A
NM_000256.3(MYBPC3):c.1483C>G (p.Arg495Gly)	MYBPC3	R495G	not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042537	11	47364270	11	47342719	42537	51707	rs397515905	NC_000011.10:47342718:G:C
NM_033360.4(KRAS):c.*12A>T	KRAS	D153V	Noonan syndrome 3|Rasopathy|Carcinoma of pancreas|Hereditary diffuse gastric cancer|RAS-associated autoimmune leukoproliferative disorder|Lung cancer|Cardiofaciocutaneous syndrome 2|Bladder cancer, somatic|Noonan syndrome 3|Familial cancer of breast|Cerebral arteriovenous malformation|Epidermal nevus syndrome|Acute myeloid leukemia|not specified|Noonan syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 2|not provided	Pathogenic(Last reviewed: Nov 15, 2018)	reviewed by expert panel	VCV000012587	12	25362838	12	25209904	12587	27626	rs104894360	NC_000012.12:25209903:T:A
NM_003165.4(STXBP1):c.875G>A (p.Arg292His)	STXBP1	R292H	Early infantile epileptic encephalopathy|not provided|Inborn genetic diseases|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207424	9	130430439	9	127668160	207424	202301	rs796053361	NC_000009.12:127668159:G:A
NM_022970.3(FGFR2):c.755C>G (p.Ser252Trp)	FGFR2	S252W, C934G, S137W, S163W, S24W	Endometrial carcinoma|Acrocephalosyndactyly|Endometrial neoplasm|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach||Pfeiffer syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Bent bone dysplasia syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Neoplasm of stomach|not provided|FGFR2 related craniosynostosis|Acrocephalosyndactyly type I	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013272	10	123279677	10	121520163	13272	28311	rs79184941	NC_000010.11:121520162:G:C
NM_000535.7(PMS2):c.765C>A (p.Tyr255Ter)	PMS2	Y255*, Y152*, Y64*, Y120*, Y149*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183716	7	6036995	7	5997364	183716	182785	rs573125799	NC_000007.14:5997363:G:T
NM_016203.4(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	R302Q, R61Q, R178Q, R177Q, R258Q	Cardiovascular phenotype|not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006846	7	151273498	7	151576412	6846	21885	rs121908987	NC_000007.14:151576411:C:T
NM_003165.6(STXBP1):c.1217G>A	STXBP1	R406H	Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 4|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279904	9	130438189	9	127675910	279904	264306	rs886041246	NC_000009.12:127675909:G:A
NM_003002.4(SDHD):c.242C>T (p.Pro81Leu)	SDHD	P81L, P42L	not provided|Paragangliomas 1 with sensorineural hearing loss|Paragangliomas 1|Mitochondrial complex II deficiency|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Pheochromocytoma|Carney-Stratakis syndrome|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome|not specified|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006896	11	111959663	11	112088939	6896	21935	rs80338844	NC_000011.10:112088938:C:T
NM_004562.3(PRKN):c.823C>T (p.Arg275Trp)	PRKN	R275W, R126W, R247W	not provided|Parkinson disease 2|Young-onset Parkinson disease|Leprosy 2|Parkinson disease 2|Neoplasm of ovary|Lung cancer	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007050	6	162206852	6	161785820	7050	22089	rs34424986	NC_000006.12:161785819:G:A
NM_033360.4(KRAS):c.38G>A (p.Gly13Asp)	KRAS	G13D	Neoplasm of the large intestine|Acute myeloid leukemia|Juvenile myelomonocytic leukemia|OCULOECTODERMAL SYNDROME, SOMATIC|Non-small cell lung cancer|RAS-associated autoimmune leukoproliferative disorder|Breast adenocarcinoma|Ovarian Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Nov 2, 2011)	criteria provided, single submitter	VCV000012580	12	25398281	12	25245347	12580	27619	rs112445441	NC_000012.12:25245346:C:T
NM_000391.4(TPP1):c.509-1G>C	TPP1		Ceroid lipofuscinosis neuronal 2|Inborn genetic diseases|Ceroid lipofuscinosis neuronal 2|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia|not provided|Neuronal ceroid lipofuscinosis|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002644	11	6638385	11	6617154	2644	17683	rs56144125	NC_000011.10:6617153:C:G
NM_000256.3(MYBPC3):c.2864_2865del (p.Pro955fs)	MYBPC3	P955fs	not provided|Left ventricular noncompaction 10|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042663	11	47356633 - 47356634	11	47335082 - 47335083	42663	51833	rs397515990	NC_000011.10:47335081:AG:
NM_000256.3(MYBPC3):c.3330+2T>G	MYBPC3		Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 4|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008621	11	47354743	11	47333192	8621	23660	rs387906397	NC_000011.10:47333191:A:C
NM_000535.7(PMS2):c.1939A>T (p.Lys647Ter)	PMS2	K647*, K456*, K544*, K336*, K512*, K595*, K460*, K541*	not specified|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091321	7	6026457	7	5986826	91321	96796	rs201451115	NC_000007.14:5986825:T:A
NM_000535.7(PMS2):c.1882C>T (p.Arg628Ter)	PMS2	R628*, R317*, R493*, R522*, R576*, R437*, R441*, R525*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000009242	7	6026514	7	5986883	9242	24281	rs63750451	NC_000007.14:5986882:G:A
NM_138694.4(PKHD1):c.107C>T (p.Thr36Met)	PKHD1	T36M	Autosomal recessive polycystic kidney disease|Colorectal cancer, protection against|Polycystic kidney dysplasia|Periportal fibrosis|Polycystic kidney dysplasia|Oligohydramnios|Polycystic liver disease|not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004108	6	51947999	6	52083201	4108	19147	rs137852944	NC_000006.12:52083200:G:A
NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	SHOC2	S2G	not provided|Noonan syndrome 3|Rasopathy|Noonan syndrome-like disorder with loose anagen hair 1|Inborn genetic diseases|Noonan syndrome|Noonan syndrome-like disorder with loose anagen hair|not specified	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000006821	10	112724120	10	110964362	6821	21860	rs267607048	NC_000010.11:110964361:A:G
NM_000466.3(PEX1):c.2528G>A (p.Gly843Asp)	PEX1	G843D, G635D, G786D	Peroxisome biogenesis disorder 1B|not provided|Retinal dystrophy|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Leber congenital amaurosis|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)|Deafness enamel hypoplasia nail defects|Deafness enamel hypoplasia nail defects|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisomal disorder	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007516	7	92130876	7	92501562	7516	22555	rs61750420	NC_000007.14:92501561:C:T
NM_000256.3(MYBPC3):c.2827C>T (p.Arg943Ter)	MYBPC3	R943*	Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037039	11	47356671	11	47335120	37039	45725	rs387907267	NC_000011.10:47335119:G:A
NM_000256.3(MYBPC3):c.2308G>A (p.Asp770Asn)	MYBPC3	D770N	Conduction disorder of the heart|Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036604	11	47360071	11	47338520	36604	45266	rs36211723	NC_000011.10:47338519:C:T
NM_004333.6(BRAF):c.1801A>G (p.Lys601Glu)	BRAF	K601E, K567E, K579E, K513E, K604E, K641E, K549E, K564E	Malignant melanoma of skin|Non-small cell lung cancer|Lung adenocarcinoma|Adenocarcinoma of prostate|Neoplasm of the thyroid gland|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm|Cutaneous melanoma|Chronic lymphocytic leukemia|Carcinoma of colon|Follicular thyroid carcinoma	Pathogenic(Last reviewed: Aug 23, 2011)	criteria provided, single submitter	VCV000013966	7	140453134	7	140753334	13966	29005	rs121913364	NC_000007.14:140753333:T:C
NM_000535.7(PMS2):c.251-2A>T	PMS2		Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183893	7	6043425	7	6003794	183893	182807	rs587779340	NC_000007.14:6003793:T:A
NM_005609.4(PYGM):c.148C>T (p.Arg50Ter)	PYGM	R50*	not provided|Glycogen storage disease, type V|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002298	11	64527223	11	64759751	2298	17337	rs116987552	NC_000011.10:64759750:G:A
NM_000368.5(TSC1):c.1525C>T (p.Arg509Ter)	TSC1	R509*, R458*, R388*, R508*	not provided|Bladder cancer, somatic|Focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 1|Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048796	9	135781440	9	132906053	48796	57958	rs118203542	NC_000009.12:132906052:G:A
NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)	BRAF	G469E, G381E, G447E, G417E, G432E, G472E, G435E, G509E	Cutaneous melanoma|Squamous cell lung carcinoma|Multiple myeloma|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Cardiofaciocutaneous syndrome 1|Adenocarcinoma of prostate|Cardio-facio-cutaneous syndrome|Neoplasm of the large intestine|not provided|Rasopathy|not specified|Squamous cell carcinoma of the skin	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013974	7	140481402	7	140781602	13974	29013	rs121913355	NC_000007.14:140781601:C:T
NM_000256.3(MYBPC3):c.1928-2A>G	MYBPC3		Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|not provided|MYBPC3-Related Disorders|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042585	11	47361343	11	47339792	42585	51755	rs397515937	NC_000011.10:47339791:T:C
NM_000535.6(PMS2):c.(?_989)-5_(2445_?)+5del	PMS2		Lynch syndrome	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000517372	7	6017214 - 6029591	7	5977583 - 5989960	517372	496586		
NM_000535.7(PMS2):c.2192_2196del (p.Leu731fs)	PMS2	L420fs, L625fs, L628fs, L679fs, L540fs, L544fs, L596fs, L731fs	Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000091331	7	6018306 - 6018310	7	5978675 - 5978679	91331	96806	rs63750695	NC_000007.14:5978674:AGTTAAGTT:AGTT
NM_000535.7(PMS2):c.2T>A (p.Met1Lys)	PMS2	M1K	Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182809	7	6048649	7	6009018	182809	180273	rs587780059	NC_000007.14:6009017:A:T
NM_000535.7(PMS2):c.2174+1G>A	PMS2		Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 14, 2014)	reviewed by expert panel	VCV000091329	7	6022454	7	5982823	91329	96804	rs267608172	NC_000007.14:5982822:C:T
NM_000535.7(PMS2):c.2117del (p.Lys706fs)	PMS2	K519fs, K603fs, K515fs, K571fs, K600fs, K654fs, K706fs, K395fs	Hereditary cancer|Hereditary cancer-predisposing syndrome|not specified|Lynch syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142765	7	6022512	7	5982881	142765	152479	rs587782704	NC_000007.14:5982880:TT:T
NM_000535.7(PMS2):c.853_856ACAG[2] (p.Arg287fs)	PMS2		Hereditary nonpolyposis colon cancer|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091375	7	6035204 - 6035207	7	5995573 - 5995576	91375	96850	rs267608154	NC_000007.14:5995572:CTGTCTGTCTGT:CTGTCTGT
NM_033360.4(KRAS):c.35G>T (p.Gly12Val)	KRAS	G12V	Neoplasm of the large intestine|Acute myeloid leukemia|Non-small cell lung cancer|Juvenile myelomonocytic leukemia|Nevus sebaceous|Carcinoma of pancreas|Cerebral arteriovenous malformation|Ovarian Neoplasms|Neoplasm of the thyroid gland|not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012583	12	25398284	12	25245350	12583	27622	rs121913529	NC_000012.12:25245349:C:A
NM_000368.5(TSC1):c.2074C>T (p.Arg692Ter)	TSC1	R692*, R571*, R641*, R691*	not provided|Bladder cancer, somatic|Tuberous sclerosis 1|Focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048885	9	135779172	9	132903785	48885	58047	rs118203631	NC_000009.12:132903784:G:A
NM_000441.2(SLC26A4):c.1229C>T (p.Thr410Met)	SLC26A4	T410M	Pendred syndrome|not provided|Enlarged vestibular aqueduct|Rare genetic deafness|Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	VCV000043498	7	107330648	7	107690203	43498	52668	rs111033220	NC_000007.14:107690202:C:T
NM_000535.7(PMS2):c.2404C>T (p.Arg802Ter)	PMS2	R802*, R491*, R696*, R699*, R611*, R750*, R615*, R667*, R678*, R813*	Hereditary nonpolyposis colon cancer|Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome|not provided|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000009237	7	6017260	7	5977629	9237	24276	rs63751466	NC_000007.14:5977628:G:A
NM_000391.4(TPP1):c.622C>T (p.Arg208Ter)	TPP1	R208*	Ceroid lipofuscinosis neuronal 2|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002643	11	6638271	11	6617040	2643	17682	rs119455955	NC_000011.10:6617039:G:A
NM_000256.3(MYBPC3):c.2373dup (p.Trp792fs)	MYBPC3		Cardiovascular phenotype|Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042619	11	47359281	11	47337729 - 47337730	42619	51789	rs397515963	NC_000011.10:47337729:C:CC
NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	BRAF	Q257R, Q205R, Q223R, Q260R, Q169R	Inborn genetic diseases|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|not provided|Rasopathy|Cardiofaciocutaneous syndrome 1|LEOPARD syndrome 3|Noonan syndrome 7|not specified	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013973	7	140501302	7	140801502	13973	29012	rs180177035	NC_000007.14:140801501:T:C
NM_000535.7(PMS2):c.943C>T (p.Arg315Ter)	PMS2	R315*, R209*, R180*, R212*, R124*, R4*	Hereditary nonpolyposis colon cancer|Colorectal cancer, non-polyposis|not provided|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091382	7	6031649	7	5992018	91382	96857	rs200640585	NC_000007.14:5992017:G:A
NM_000535.7(PMS2):c.1927C>T (p.Gln643Ter)	PMS2	Q643*, Q332*, Q508*, Q452*, Q537*, Q591*, Q456*, Q540*	Pulmonary arterial hypertension|Respiratory insufficiency|Pulmonary insufficiency|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer|Turcot syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091320	7	6026469	7	5986838	91320	96795	rs63751422	NC_000007.14:5986837:G:A
NM_000535.7(PMS2):c.2113G>A (p.Glu705Lys)	PMS2	E705K, E570K, E599K, E602K, E653K, E518K, E394K, E514K	not provided|Lynch syndrome I|Hereditary nonpolyposis colon cancer|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000091328	7	6022516	7	5982885	91328	96803	rs267608161	NC_000007.14:5982884:C:T
NM_001360.2(DHCR7):c.964-1G>C	DHCR7		not provided|History of neurodevelopmental disorder|Inborn genetic diseases|Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093725	11	71146886	11	71435840	93725	99628	rs138659167	NC_000011.10:71435839:C:G
NM_000535.7(PMS2):c.736_741delinsTGTGTGTGAAG (p.Pro246_Pro247delinsCysValTer)	PMS2		Burkitt lymphoma|Lymphoma|not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colorectal cancer type 4|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091366	7	6037019 - 6037024	7	5997388 - 5997393	91366	96841	rs267608150	NC_000007.14:5997387:AGGGGG:CTTCACACACA
NM_000260.4(MYO7A):c.3719G>A (p.Arg1240Gln)	MYO7A	R1240Q, R1229Q	Retinal dystrophy|not provided|Usher syndrome|MYO7A-Related Disorders|Inborn genetic diseases|Deafness, autosomal recessive 2|Rare genetic deafness||Deafness, autosomal recessive 2||Deafness, autosomal dominant 11	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043218	11	76901153	11	77190108	43218	52388	rs111033178	NC_000011.10:77190107:G:A
NM_000535.7(PMS2):c.400C>T (p.Arg134Ter)	PMS2	R134*, R31*, R28*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000009234	7	6042221	7	6002590	9234	24273	rs63750871	NC_000007.14:6002589:G:A
NM_000256.3(MYBPC3):c.1484G>A (p.Arg495Gln)	MYBPC3	R495Q	not provided|Familial hypertrophic cardiomyopathy 4|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|MYBPC3-Related Disorders|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164113	11	47364269	11	47342718	164113	174776	rs200411226	NC_000011.10:47342717:C:T
NM_033360.4(KRAS):c.35G>A (p.Gly12Asp)	KRAS	G12D	Neoplasm of the large intestine|Rasopathy|Neoplasm of ovary|Acute myeloid leukemia|Epidermal nevus|Non-small cell lung cancer|Juvenile myelomonocytic leukemia|Primary low grade serous adenocarcinoma of ovary|Vascular Tumors Including Pyogenic Granuloma|Epidermal nevus syndrome|RAS-associated autoimmune leukoproliferative disorder|Nevus sebaceous|Neoplasm of stomach|Carcinoma of pancreas|Cerebral arteriovenous malformation|Lung cancer|Ovarian Neoplasms|Neoplasm of the thyroid gland|not provided	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012582	12	25398284	12	25245350	12582	27621	rs121913529	NC_000012.12:25245349:C:T
NM_000535.7(PMS2):c.1831dup (p.Ile611fs)	PMS2		Hereditary nonpolyposis colorectal cancer type 4|not specified|Burkitt lymphoma|Lymphoma|Acute lymphoid leukemia|Glioblastoma|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091317	7	6026564 - 6026565	7	5986933 - 5986934	91317	96792	rs63750250	NC_000007.14:5986933:TTTT:TTTTT
NM_000256.3(MYBPC3):c.772G>A (p.Glu258Lys)	MYBPC3	E258K	Familial hypertrophic cardiomyopathy 4|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042792	11	47369975	11	47348424	42792	51962	rs397516074	NC_000011.10:47348423:C:T
NM_000256.3(MYBPC3):c.1624G>C (p.Glu542Gln)	MYBPC3	E542Q	Hypertrophic cardiomyopathy|Familial dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008608	11	47364129	11	47342578	8608	23647	rs121909374	NC_000011.10:47342577:C:G
NM_001024688.2(NBN):c.411_415del (p.Lys137fs)	NBN	K137fs, K219fs	Ovarian Neoplasms|not provided|Lissencephaly|Microcephaly|Breast-ovarian cancer, familial 1|Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome|not specified	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006940	8	90983442 - 90983446	8	89971214 - 89971218	6940	21979	rs587776650	NC_000008.11:89971213:TTTGTTTT:TTT
NM_004333.6(BRAF):c.1799T>A (p.Val600Glu)	BRAF	V600E, V512E, V578E, V603E, V548E, V566E, V563E, V640E	Colorectal cancer|Cutaneous melanoma|Multiple myeloma|Malignant melanoma of skin|Carcinoma of colon|Lung adenocarcinoma|Non-small cell lung cancer|Colonic neoplasm|Ovarian Neoplasms|Papillary renal cell carcinoma, sporadic|Cardio-facio-cutaneous syndrome|Germ cell tumor, nonseminomatous|Gastrointestinal stromal tumor|Papillary thyroid carcinoma|Cerebral arteriovenous malformation|Squamous cell carcinoma of the head and neck|Lung cancer|Astrocytoma, low-grade, somatic|Cystic epithelial invagination containing papillae lined by columnar epithelium|Neoplasm of the large intestine|Glioblastoma|Neoplasm of brain|not provided|Neoplasm|Trametinib-Dabrafenib Response|Vemurafenib-Cobimetinib Response|Brainstem glioma	Pathogenic, drug response, other(Last reviewed: Oct 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000013961	7	140453136	7	140753336	13961	29000	rs113488022	NC_000007.14:140753335:A:T
